>XP_042375690.1 disease resistance protein RPM1-like isoform X1 [Zingiber officinale]
MAETIAPIVQLVASTIAGPIANEGQILLTVEEKVGWLHRELRRMHSFLAD
AERSATDDPQSSRWISEIRDLVYDSEDIIDAFDAIGTYPVACFFCHLRSR
HQIGSRILELKSRLDEFFRSKSDYGIPTDGGPNSDDRWIHGLLASSPLIH
QGDFVGFESHFNEVIDWAMSDRQELSVLSLVAMGGSGKTTLVKRVFNHNV
VKRRFDRLAWIYVSKSFRMRNLFKEVAKGLMTMPSEEVNALNEKQLQELL
LETLKEKRFLLVLDDVWDASVWEAIRLVLPRNENGSRVIITTRNSAVASS
ITEVKSCCHELQPLSFEQSWELFCRKVFPESEPCPDELKEDAEGIVKNCH
GLPLAIVTIGGMMSRKGRSQLEWNNVLAKMYSNLIGNEVEVQGPLFLSYK
HLPYPLKSCFLLFSIFPHDSNIRSKKLIRLLMAEGLVKEGEGEGERMEDV
AEKYLMELINRSMIQISILGSTGRVKTFRIHHLIHQLSISIAKMQSFSIV
HEDRRAKHPNNAYRISLQKSSYDALNNTGEKKLRSLFVFGIDEPLRINHR
IVDKLRFLRVLDLEDVCLFKLPNEVGNLIHLRYLSLKGTRLKMLPLSLNN
LLNLQTLDIRRTRLRKLLFEINNLKNLRNLEMKQGEKSIIIPSQFSQLEN
LQVITGVQADQAVVRGVGKLTHLRKLAIEDIQIENVSELCSSINNLPGLL
SLSMYSIDVSTTLELEKLNPLSLQKLHIAGRLERLPSWFSGIRNLTKLRL
GLTNLSADPFEALQQLPNLVFLQLYQAYQGKVMRCSHHGFRKLKILILTD
LEKLEEWKVEDGTLQCIQEIWIMSCLELRSVPPGLKYLVTLLQLRLVSMP
QNFISRLNPLGGADFPAIKHIPSIQVT
>XP_042375699.1 putative disease resistance RPP13-like protein 3 isoform X2 [Zingiber officinale]
MAETIAPIVQLVASTIAGPIANEGQILLTVEEKVGWLHRELRRMHSFLAD
AERSATDDPQSSRWISEIRDLVYDSEDIIDAFDAIGTYPVACFFCHLRSR
HQIGSRILELKSRLDEFFRSKSDYGIPTDGGPNSDDRWIHGLLASSPLIH
QGDFVGFESHFNEVIDWAMSDRQELSVLSLVAMGGSGKTTLVKRVFNHNV
VKRRFDRLAWIYVSKSFRMRNLFKEVAKGLMTMPSEEVNALNEKQLQELL
LETLKEKRFLLVLDDVWDASVWEAIRLVLPRNENGSRVIITTRNSAVASS
ITEVKSCCHELQPLSFEQSWELFCRKVFPESEPCPDELKEDAEGIVKNCH
GLPLAIVTIGGMMSRKGRSQLEWNNVLAKMYSNLIGNEVEVQGPLFLSYK
HLPYPLKSCFLLFSIFPHDSNIRSKKLIRLLMAEGLVKEGEGEGERMEDV
AEKYLMELINRSMIQISILGSTGRVKTFRIHHLIHQLSISIAKMQSFSIV
HEDRRAKHPNNAYRISLQKSSYDALNNTGTNI
>XP_042375707.1 putative disease resistance RPP13-like protein 3 isoform X3 [Zingiber officinale]
MAETIAPIVQLVASTIAGPIANEGQILLTVEEKVGWLHRELRRMHSFLAD
AERSATDDPQSSRWISEIRDLVYDSEDIIDAFDAIGTYPVACFFCHLRSR
HQIGSRILELKSRLDEFFRSKSDYGIPTDGGPNSDDRWIHGLLASSPLIH
QGDFVGFESHFNEVIDWAMSDRQELSVLSLVAMGGSGKTTLVKRVFNHNV
VKRRFDRLAWIYVSKSFRMRNLFKEVAKGLMTMPSEEVNALNEKQLQELL
LETLKEKRFLLVLDDVWDASVWEAIRLVLPRNENGSRVIITTRNSAVASS
ITEVKSCCHELQPLSFEQSWELFCRKVFPESEPCPDELKEDAEGIVKNCH
GLPLAIVTIGGMMSRKGRSQLEWNNVLAKMYSNLIGNEVEVQGPLFLSYK
HLPYPLKSCFLLFSIFPHDSNIRSKKLIRLLMAEGLVKEGEGEGERMEDV
AEKYLMELINRSMIQISILGSTGRVKTFRIHHLIHQLSISIAKMQSFSIV
HEDRRAKHPNNAYRISLQKSSYDALNNTDT
>XP_042375889.1 disease resistance protein RGA2-like [Zingiber officinale]
MSTALAIGGWFAQGFIQTLLDKASDSAVQRLAGLRGLDGDLRRLRASLFK
IHALLDMAERRRCNSSNLVELMKQLKDASFDAENLLDEFEYQNLKHKIEG
QASDFFTLAFNAAKNFFSADGDGFGSRLRAIQEKLCEIAADMIDIMQLLS
MDDAGRQSTGKLVRRETSSFLTEEIVFGRDNEREKVIALLLGSAEGSESS
NHVFSVLPLVGIGGVGKTTLAQLVYNDDRVGNYFQLKIWICVSDDFDVKR
LTKELIESTTKEEQSGLTNLDTLQSRLKEKIELKRFLLVLDDVWSENKDE
WDKLCAPLSFGAHGSKIIVTTRHTKVASIVGTVSTIFLHGLEDDALWELF
KKHAFASQIVVEEHPELVIIGREIASKLKGSPLAAKTLGSLLRSDLNEQH
WRTIMESEVWQLPQQENEILPVLQLSYHYLSGHLKQCFAFCSVFRKDYIF
CEHTLVSIWMAEGFIAPQENMRMEDVGSSCFHELVSRSFFQETQRRGRFV
MHDLIHDLAQFVSVGECHRVDGDKFEEIPKTICHLSATLTAQRKLMEFSG
YHKLRTLMINYQNNQNQFVLRIETPLVPDDLFRRLKDIRVLSLPKCGMKE
LTETIGEIIHLRYLDISYNSGIVKLPESLCVLYNLQVLRLCGCQLQGFPQ
GMSNLINLRQLHAADEIISKVKEVGKLISLQELPIFKVLKYDDGHKLAQL
CDLKQLHGELTISNLENVNSEEEASLAKLKNKKYLDALKLEWKAGQESNL
EKEHVSEEVLEGLQPHHSLRSLTIRRYNGGVLPSWLQASPVLKLETLKLE
SCKRCRDLSCTGELPLLKVLHIKGMPQVKQISPSLCCHTKSKFFQQLHEL
VLEDMLALEELPDLGQLPYLKSIQMKGMNALRCIGNGFHGANGSNWFPRL
EKLRLQNMQAMEELPFLGHLPCLKVIDIRQMPALKHIYHAHYDSIERNWF
STLEVMVLENMLSLEELPCLGQLPCVKYLRLDIKKIAHGFFRVPSENNWL
PKLEKLELKGIPGYEELPSLEQLPHLTVLHLDGMTSVKAIRQGCTFTAEQ
IKCFSRLEELVFRDMPTWEEWSWAEGGEHFACLCRLKIAQCPKLKQLPPL
PACLLELELIHVGLTELPGLWKGTNGNSRSKISSLTRLHISECPSLRNLE
EGLLSNHLPHINSILILDCVELMFLPVKKFSELTSLEMFSVRHCPKLMMT
QSQDIDVQLPTSIKILGLCNCASFGKSLPGCLYSLSLLTRLSISNCPHME
TLPGEAMLHLKQLWDVSIKSCDELRSIGGITFLSTLTRLELADCPKLLLN
GMVEEGKCLSLLELRVDNTALLKVSPILNSLPSIHFLYIFSSYQAVMFDG
EDQGLLQSLTAIKCLEFGFCKNLKSLPTELHSLPSLKSLALFECPEIQSL
PEKGLPPFLTDLRFQGCHSLLTKKLEEHLQEIKNSGRFDSVFA
>XP_042377360.1 disease resistance protein RGA2-like [Zingiber officinale]
MKDDYEYRLIYLKSLAIAAAMDIVSPILEISGVNHVINKLVDKTTNYLQD
QCYWETYLQEELKSLQDLLPQIEAVVSFAEHRLTSYESSDRALIKWLWKF
RDVIDEAEDVLDELEYFELKKKANSDKNRLSRRVDASVKAAKRLLKFDDV
LARLRTCVKNLNTSASDVGKFLALVAPTGGADIGQTQQGILPLSQQSRIT
SSLPVLSFKGREKEKQIIIQFLLGEEAEIQISENVHCLPLVGMGGMGKTS
LAQQVFDHFKTVKKEHFDIKIWVCDSLPDLNASNLIKKILEYLTGGSESG
PLELIPEKLKEKLHSKRFLLILDDVWDDKNQREWEKLCAPLLYGQKGSWV
LLTTRSKSVANMVAREIRGTMMPMMLQGLSEDECRSLLYEYAFAGQDPNG
FPLLKEIGTEILKKLKGVPLLAKSIGGALNSKLEVDHWTSILRSELWKRP
QDSTYNFIPALTLSYVMHPPRLKRCFAYCSIFPQDYKFNKQKLVCMWVAA
GLIYSDGLEEGSNEEDIANCCFDMLCNKSFFDVHHFYQSPFFYNKVPYAL
EEDYYTMHDMLNCLACHISQYECCRIVDGTTPSLILDNNTIRHIYITCSN
AQLHDLANIVSKLKHLRTLWIEYDGDRQQFEDFIRDACKSPRRIRVLIMD
SNLSDRCLKSISNFVKIRFLQIQNKFLPSISMRKFYFLQVLMGEVNILAK
DVKDVKDANKLTNLRHLYKVHEDALLSVAKVGKLTSLLELCFTVGTKPRY
RIDELMNMDNLRQLKIKQLSNVRSLEEANMVNLVKKRYLIRLELDWNDAS
NPVDDASNPELDQPVLAALQPYSTIRELTIRGYKGGRAAPWMDTPSLSLL
ENLQLNDCTSLEELPSLWKLPCLKFLELNKMNAIRSLGCHFFGQIDIQFP
VLEEL
>XP_042377374.1 disease resistance protein RGA2-like [Zingiber officinale]
MDVVSPILQVSGASHVVNKLVDKATTYVRDQYYWKTDLQEELQNLRRLLP
QIQVIVGFAEDRLTSYGSSNRALMEWLGQFRDGIDEAEEVLDELEYLELE
KKANSDKNRLSKTVDGSVKAAKRFLKFDDLLIERLRACVKNLNASASNAH
NFLAILGHTGGIGTGQMQQEFLPLTDQSRITSSLPEVLFKGREEQKQEII
RYLSGESVEESEIQMSENVHCLPLVAMGGMGKTTLAQQVFDHFENMKKEH
FGIRIWVCDSLPDLDATSILKKILDSTRQSDDSSTNLDASSLMKKMLDLT
HQSESSELLPVKLKEKLSSKKFLLVLDDAWDDKNQTAWKRLCDPLLHGQK
GSWILLTTRMESVAKMVSKVIKGTMKSMKLQGLSKDECRSLLYEHAFAGQ
DPDKFPQLKEIGEEILEKLKGVPLLAKSIGGALNSKLTEDHWTSISRSEL
WKTPLESKYEFRPVLILSYLMLPPRLKRCFSYCGIFPQDYEFNKQKLMYM
WVAAGLIYSEESEEGSDEDIANSCFDTLCNKSFFDNRSMPRMKKIFFYDT
TEEIYTMHDMLNSLACHVSRYECCRIVHGTPSRILDSNVIRHISITYSTD
AQLLDLAKMVCKLKHLQTLWIQYNGDPKKLDDFIRDACKSPRRIRVLIVQ
SNDFKISNQCLKSIRDFVKIRFLEIQTIPPSLSMRKFYFLQYLIGDRYHS
HLGCLAKDSNKLTNLRHLYQVAEDALLSVAEVGKLTSLQELCFTVGTKPR
YRIDELMYMNNLRQLKIKQLSNVQSLEEANMVNLVEKRHLTSLELDWFGK
RDASNPDLDQQEVLAALQPSTTIKELMIRWNKGGRPVPWMDTPSLSRLEH
LQLEFCTSWEELPPLWKLPHLKFLRLVYMKAIRSLGCPLSDRMDIQFPVL
EELEFHDLPLLEEWNGADDYVWFPLLKSVQIEKCPRLKKIPDLPLSIENL
RFKDLGLEDLPRFYKCSNGSRTFGGFQQLMFLKSLEIYKCPGIAQIGAIG
EEDDHLLPSSLETLELENIEEHKDLANYLRSLTLLTKFHLHCSPGLESFP
LASELEHLTVLQDLCISDGESLTSLGDLYILKSLKSLEIFDCPKFLVAEV
ESEKFLKDTTRKHAVSSSSIFDQSAGNKAARILPSSLESLKFKNSDISQE
RLGRCLQDLTSLRRLEVSNCQHLMSLPNIEYLHNLTALRALDISDCKELC
ELESLTTIASLIYLDIKCCPKLLATTFATLQNPATATEQSATKKKKGTLP
FLERIDIDDIFYLPMLPISEKLKRLYIESSDKEFTCFPSEIEESLLQYRK
SLEYLGLDRIPHLQSLPAILESFSSLKDLCIYSAPALKSLPRMPVSLERL
RIFGCSAKLKKRCQENIGRDWPNIKHIPYIDIRAGKENKAEAQVNCNCVS
SRLWSSK
>XP_042377441.1 disease resistance protein RPM1-like [Zingiber officinale]
MAASGALQFALQKLDSILVQEQQLLRGFNTRIKDIRDELESLKIFLRGAD
AGDDKDDIKAWMRQLRDIAYDMEDLLEEYTFHFGQPHRHRLLGFLTTSIQ
SLRHLFTRRKMSIAIQDIKTQLRNISERRSTYKFNSSFNATKKRVHDRHL
AALFMEEAELVGIRKPKEEIVGRLVKGGGSSSLTVVSVVGMGGLGKTTLV
RKVYDDEQVKGWFNSHAWITVTPSFTVEELLKSIIIQFYEERHEKLPARI
QTMECIQLIDTLRQFLQDKRYIAVLDDLWHITPWECLKYALPNSDCGSRI
VVTTRNKDIGLSCIESCGSLYELQPLPQPEAWFLFCKKAFRSVSAGVCPS
ELQDVAEDIVKVCGGLPLAIVTIAGLLSKKAHVLEWRKLRDNLHAELANN
PKLEIIKQILLLSYNDLPHFLKSCILYFSIFPKEHAVTRITLIRLWIAEG
FIESERGETMERIAGDYLNDLIDRSMVQVAERYDYGRVRSCRVHDLIHEV
IVLKSEEENFSTLMITRDTKRHGKIRRSSTHAAGEHLLQSDLSHLRALFM
FRENVLPIPSVVNLLSRLRLLRILDLTGAPIESFPLEFGKLPHLRYLSFR
NTKISKLSKSLGQLKNLETLDLKETYVTELPKTILNLQNLRHLLAYHYYT
SHRPPYYLADGVKLPHGIGKFRELQKLTYLEINQDSRIVRELGNLTQLKR
LGLVKLRRVDGASLCKSIEKMEKLLSLSVTSVGMDEYLNLRSLTSPPPLL
QRLYLRGPLQALPNWISSLKHLVRMRLRWSRLKEDSFGVLEELPSLVELT
LIHAYDGANLRCQKGGFQKLKILDLERLNNLNHVVVDGSMPNLQKMYIRS
CVQLQEVPQGIQQLVLLKEIHLFDMPEEFVQRLEGEDYAQVSHVPIRRSY
DSEKGVYKEL
>XP_042377448.1 disease resistance protein RGA2-like isoform X2 [Zingiber officinale]
MDIVSPILEKAGASYVINKLIDAATGYVQDQYYWKTDLQGELQKLGRLLP
QIQAVVDFAEPRLTMYESSNPALIKWLWQFRNGIDEAEDVLDDLEYIELE
KKANSDKSRLSRRVDTSVKAAKRLLKFDDVLGRLRACVKNLNTFASDVQN
FLALVTQTAGIGTGQMQYYHSSRITNPLPVLSFKGREDEKGKIIQYLLGE
SVEKSEIWINESVHCLPLVAIGGMGKTVLAKQVFHHFENVKKKHFDIKIW
VCDSLPDLNASSLIKKILEYQTGGSESGPLERLPVKLQKILHSKRFLLVL
DDVWDDNNQTEWEKLCAPLVYSQKGSWIILTTRLRSVAKMISKVIRSTME
PMILRGLSNDECRSLLYEHAFYGEDPNKFPLLKEIGEEIVEKLKGVPLLA
KSIGGALNSKLEADHWTSISRSELWKMSIDSKYEFNPVLRLSYVMLPPRL
KRCFSYCSIFPQDYQFKKQKLVCMWVAAGLIYKDELEDGLDEEDIANRCF
DILCNKSFFDVHTYSRSLSHSQMLFCQRYSLYDFKEDFYTMHDMLNGLAC
HVSRYECCRIVHGTPSHILDNNAIRHIYVTSSHAQLHDLAKIVSKLKHLR
TLWINYHGDPQKLDDCIRYACKSSRRIRVLIMESNYSRSSYQCLKSINDF
LKL
>XP_042377449.1 disease resistance protein RGA2-like isoform X2 [Zingiber officinale]
MDIVSPILEKAGASYVINKLIDAATGYVQDQYYWKTDLQGELQKLGRLLP
QIQAVVDFAEPRLTMYESSNPALIKWLWQFRNGIDEAEDVLDDLEYIELE
KKANSDKSRLSRRVDTSVKAAKRLLKFDDVLGRLRACVKNLNTFASDVQN
FLALVTQTAGIGTGQMQYYHSSRITNPLPVLSFKGREDEKGKIIQYLLGE
SVEKSEIWINESVHCLPLVAIGGMGKTVLAKQVFHHFENVKKKHFDIKIW
VCDSLPDLNASSLIKKILEYQTGGSESGPLERLPVKLQKILHSKRFLLVL
DDVWDDNNQTEWEKLCAPLVYSQKGSWIILTTRLRSVAKMISKVIRSTME
PMILRGLSNDECRSLLYEHAFYGEDPNKFPLLKEIGEEIVEKLKGVPLLA
KSIGGALNSKLEADHWTSISRSELWKMSIDSKYEFNPVLRLSYVMLPPRL
KRCFSYCSIFPQDYQFKKQKLVCMWVAAGLIYKDELEDGLDEEDIANRCF
DILCNKSFFDVHTYSRSLSHSQMLFCQRYSLYDFKEDFYTMHDMLNGLAC
HVSRYECCRIVHGTPSHILDNNAIRHIYVTSSHAQLHDLAKIVSKLKHLR
TLWINYHGDPQKLDDCIRYACKSSRRIRVLIMESNYSRSSYQCLKSINDF
LKL
>XP_042377450.1 putative disease resistance protein RGA3 isoform X3 [Zingiber officinale]
MDIVSPILEKAGASYVINKLIDAATGYVQDQYYWKTDLQGELQKLGRLLP
QIQAVVDFAEPRLTMYESSNPALIKWLWQFRNGIDEAEDVLDDLEYIELE
KKANSDKSRLSRRVDTSVKAAKRLLKFDDVLGRLRACVKNLNTFASDVQN
FLALVTQTAGIGTGQMQYYHSSRITNPLPVLSFKGREDEKGKIIQYLLGE
SVEKSEIWINESVHCLPLVAIGGMGKTVLAKQVFHHFENVKKKHFDIKIW
VCDSLPDLNASSLIKKILEYQTGGSESGPLERLPVKLQKILHSKRFLLVL
DDVWDDNNQTEWEKLCAPLVYSQKGSWIILTTRLRSVAKMISKVIRSTME
PMILRGLSNDECRSLLYEHAFYGEDPNKFPLLKEIGEEIVEKLKGVPLLA
KSIGGALNSKLEADHWTSISRSELWKMSIDSKYEFNPVLRLSYVMLPPRL
KRCFSYCSIFPQDYQFKKQKLVCMWVAAGLIYKDELEDGLDEEDIANRCF
DILCNKSFFDVHTYSRSLSHSQMLFCQRLKSIATVSAADFGVPHDHI
>XP_042377451.1 putative disease resistance protein RGA3 isoform X3 [Zingiber officinale]
MDIVSPILEKAGASYVINKLIDAATGYVQDQYYWKTDLQGELQKLGRLLP
QIQAVVDFAEPRLTMYESSNPALIKWLWQFRNGIDEAEDVLDDLEYIELE
KKANSDKSRLSRRVDTSVKAAKRLLKFDDVLGRLRACVKNLNTFASDVQN
FLALVTQTAGIGTGQMQYYHSSRITNPLPVLSFKGREDEKGKIIQYLLGE
SVEKSEIWINESVHCLPLVAIGGMGKTVLAKQVFHHFENVKKKHFDIKIW
VCDSLPDLNASSLIKKILEYQTGGSESGPLERLPVKLQKILHSKRFLLVL
DDVWDDNNQTEWEKLCAPLVYSQKGSWIILTTRLRSVAKMISKVIRSTME
PMILRGLSNDECRSLLYEHAFYGEDPNKFPLLKEIGEEIVEKLKGVPLLA
KSIGGALNSKLEADHWTSISRSELWKMSIDSKYEFNPVLRLSYVMLPPRL
KRCFSYCSIFPQDYQFKKQKLVCMWVAAGLIYKDELEDGLDEEDIANRCF
DILCNKSFFDVHTYSRSLSHSQMLFCQRLKSIATVSAADFGVPHDHI
>XP_042377487.1 putative disease resistance protein RGA3 [Zingiber officinale]
MDVVSPIMEKAGARCVINKLIDAATTYVRDQYYWKTDLKEELQSLRRLLP
QIEAVVDFAEHRLTMYESSNRALMEWLWQFRNGIEEAEEVLDELEYLELK
KKVNRDKNRLSLTVDASVKTAKRLLKFDDVLERLRTCVKNLNTSASDVQN
FLTLVTQKDGNSNGQMQCYLSSRITNPLPVLSFKGREEEKGKIIRYLLGE
SVEESKIQMSENVHCLPLVAMGGMGKTALAKQVFDHFENVKKEHFDIKIW
ICDSLPNLDASSLMKKILKYLTCQSESDPLELVAVKLKEKLHSKRFLLVL
DDAWDDKNQTEWDKLCDPLLYGQKGSWILLTTRLRSVAKIVSKVIKRGTM
EPMILQGLSNDACRSLLYEHAFVGRDPNGFPLLREIGEEIIEKLKGVPLL
VKSIGGALNSKLEADHWTSISRSELWKMPQDSKYEFSPVLTLSYVMLPPR
LKRCFSYCGIFPQDYRFNKQKLVCMWVAAGLIYSEESEAGSDEDIANCCF
DMLCNKSFFDVHIYGQIWSSFWERNSLYDLEEDYYTMHDMLSCLACHVSR
YECCKIVHDAPSCILDYNAVRHLSITSNLVQLHDLAKMVCKFQHLRTLWI
EDDGNHQQFHEVILDACKSPRRIRVLIMESNYSRISYPCLERISDFVKLR
FLEMSRFSGPPSLSKCKFYFLQVLIGYNVIPTKDANKLTNLRHLYRVHHD
ALFSVAKVGKLTSLQELCFTVGTKPEYRIDELMNMDNLHQLTIQQLSNVR
SHKEASMVNLVKKRHLTRLALNYWFGVSNPDGVSNSDIDHQEILAALQPP
PTIRELIITGYKGGRPAPWMDTSSLSRLEYLQLHTCTSLEELPPLWKLPC
LKFLKLHDMKAIRSLGCHFSNQMDIQFPVLENLIFYALPLWEEWNGVDSH
IWFPHLKRFEIYHCPKLKKIPDLPLSIENLKMEYLGLEALPHSYKCSNGT
RTFGGFQQLMSLESLHIYQCPGIVQIGTIGEEDDNLLPSSLKQLGLGGIF
VEHKYLASYLRGLTSLTHLSLSCSRGMTSLPLANELEHLTTLQHLRIWGG
EAFISPGGLYIIKSLKSLEISNCPKFLSAEAESREFLKDKPTKHAVSSSL
VFDHSASNKATSILPSSLVSLKLENSDILQESLGRCLQGLTSLKELQVSY
CHHLVSFPNIEYLHNLAAFETLDISNCKELCELESLTTLASLRELYIERC
PKLLTTTFSTLQNPAATTEQSATKKKKGTLPSLEHIYMDEIFYLPILPIP
ERLNSLSIDNIFMGNSQVFPCFPSEIEEWLLQCRESLEVLELGQMPHLQS
LPASLESFSSLRSLRIDFSPELKSLSRMPTSLKILKIYGCSAKLKKRCQE
NIGPDWPNISHIPDIHIIVGKDDKDEAQVNCNCVSSRLWSSR
>XP_042378549.1 probable disease resistance protein RF45 [Zingiber officinale]
MYDADDIIDICMIKGGKLLKARALSGDEDEISSFEEIGIKLVNKCDGLPL
AIKAIAGVLYHQNKAKWEEVLESDAWNMDQIEEELRPLYLSYEDLPSRFK
QCFLYCSLYPQKDMFSMEIVQFWAAEGLIMSEEDNWRRDLPTQNQRTLED
LGEEIYRELLGRNLLEAKKDELSKSFFSMHDHFRSLCANLMREEGILYRH
GREFKADDNVKVRRLSISCMGPMLVLPAQILRQACLRTLILTDSPQTKTI
EDSVVRALLCLRVLDLSETSIEKIPDCIGELLHLRYLDLDGTNIREIPTT
IGNLVNLQSLNIIRCKFLERLPVSITKLHNLRWLNMIGCPLLTYVPKGIG
KLENIYSLYGFMIGQNDSTSEEGCDLEELKNLSKLRVLIILRLERAEKGA
SALANKPFLKDLTLSWMRPDEEEDDNGGGHDAQANEEEDGDGKDDGSGQR
TETKEEEEDENEEVEDEGEEEEDENEEVDGEEEEKGWNEEQISKAERICN
EMSQPSSTLVHLHFYDYPGRQFPSWMTSSSLAESFPNLTYLMLLGLPCCV
ELLPLGTLPQLKYLRIESANAITTIGSQFLGSRSSAFPKLEALRFEDMPR
WEEWTFNGAPLSVKLFPSLMECAIIDCPMLRALPDGLHRATNLNQLGLLR
TYELGEINNITLAYRLEVAKCRGLKKISNISSLRSLVVIECGNLECVENL
DKLQHLVLICSEEMEQLPQWFMDLIEQHNNMASSHRSLKKFEMACNLQLL
MSCLEGNENWDILKHIPVVEIQTYSSKEYIRYTKDPYNYDTNIPSN
>XP_042378553.1 putative disease resistance protein RGA3 isoform X1 [Zingiber officinale]
MAMILDFFVSKFMTITANMVEVEIFKVLGVDKEIKALQERLGTINGYLHE
AKEKRHENDEIDLWVRKLKDVMYDADDVIDLCMIEGGKLLKARALSGSTT
INIPFNYLFSCFQCLKYRHDIANQIIALNNRLEDLKKDIVIRSNLDRTTK
ESIEYVNRLVTHETSHLQVEGDIIGTQIKNATEVLVNLILENNPKKYRVL
GVVGTGGIGKSTLASKIFEDERIKDNFSNRIWLYVSKNYTESDLLKNLIR
SAEGSETKGENLEGKSKVELENKLVSILTQNTFIVLDDVWNSSVWVDFLR
KPIMKSATSCTVLVTSRIEKIVMLMKPRYIHPVEKMDEESGWTLLKHLVF
DVEGDEDEISSFEEIGIKLVNKCDGLPLAIKAIAGVLYQQNKAKWEDVLE
SDAWNMDQIEEELRPLYLSYEDLPSRFKQCFLYCSLYPQKDMYSKEIVQF
WVAEGLIMDEQDELRRDIPNKKQRTMEDLGEEIYRELLGRNLLEAKKNDL
SKSFFSMHDHFRSLCANLLREEGVLYRHGREFKVDDNVKIRRLSISCMGP
MLVLPAQILRQACLRTLILTDSPQTKTIEDSVLQALLCLRVLDLTKTSIE
KIPDCIGDLLHLRYLDLDETNIREIPTTIGNLVNLQSLNILRCKFLERLP
VSITKLHNLRWLNMIGCPLLTYVPKGIGKLENIYSLYGFMIGQNDSTEEG
CDLEELKNLSKLRVLIILRLERAEKGASALANKPFLKDLTLSWMRPNEEE
DDNGGGHDAQANEEEDGDGKDDGSGQRTETKEEEEDENEEVEDEGEEEED
ENEEVDGEEEEKGWNEVQISKAERICNEMSQPSSTLIHLHFYEYCGRQFP
SWMASSSLAESFPNLTYLKLVGLPCCTELPPLGTLPQLKFLSIVSANAIT
AIGSQFLGSRSSAFPKLEVLRFEDMPKWEEWTFKGTPLAVKLFPSLRSCA
IINFPKLRALPDDLHRAANLNELYLFQTYELREINNLPLAYKLKVANGRG
LKKISNIPSLRYLEVDDCPNLECVENLDKLQHLVLICSEEMEQLPQWFQD
LIEQHNNMASTHRSLKKFEMHCNLQLLMSCLEGNENWDILKHIPVVKIQT
YSSKEYIRYTKDPYNYDANIPSN
>XP_042378554.1 putative disease resistance protein RGA3 isoform X1 [Zingiber officinale]
MAMILDFFVSKFMTITANMVEVEIFKVLGVDKEIKALQERLGTINGYLHE
AKEKRHENDEIDLWVRKLKDVMYDADDVIDLCMIEGGKLLKARALSGSTT
INIPFNYLFSCFQCLKYRHDIANQIIALNNRLEDLKKDIVIRSNLDRTTK
ESIEYVNRLVTHETSHLQVEGDIIGTQIKNATEVLVNLILENNPKKYRVL
GVVGTGGIGKSTLASKIFEDERIKDNFSNRIWLYVSKNYTESDLLKNLIR
SAEGSETKGENLEGKSKVELENKLVSILTQNTFIVLDDVWNSSVWVDFLR
KPIMKSATSCTVLVTSRIEKIVMLMKPRYIHPVEKMDEESGWTLLKHLVF
DVEGDEDEISSFEEIGIKLVNKCDGLPLAIKAIAGVLYQQNKAKWEDVLE
SDAWNMDQIEEELRPLYLSYEDLPSRFKQCFLYCSLYPQKDMYSKEIVQF
WVAEGLIMDEQDELRRDIPNKKQRTMEDLGEEIYRELLGRNLLEAKKNDL
SKSFFSMHDHFRSLCANLLREEGVLYRHGREFKVDDNVKIRRLSISCMGP
MLVLPAQILRQACLRTLILTDSPQTKTIEDSVLQALLCLRVLDLTKTSIE
KIPDCIGDLLHLRYLDLDETNIREIPTTIGNLVNLQSLNILRCKFLERLP
VSITKLHNLRWLNMIGCPLLTYVPKGIGKLENIYSLYGFMIGQNDSTEEG
CDLEELKNLSKLRVLIILRLERAEKGASALANKPFLKDLTLSWMRPNEEE
DDNGGGHDAQANEEEDGDGKDDGSGQRTETKEEEEDENEEVEDEGEEEED
ENEEVDGEEEEKGWNEVQISKAERICNEMSQPSSTLIHLHFYEYCGRQFP
SWMASSSLAESFPNLTYLKLVGLPCCTELPPLGTLPQLKFLSIVSANAIT
AIGSQFLGSRSSAFPKLEVLRFEDMPKWEEWTFKGTPLAVKLFPSLRSCA
IINFPKLRALPDDLHRAANLNELYLFQTYELREINNLPLAYKLKVANGRG
LKKISNIPSLRYLEVDDCPNLECVENLDKLQHLVLICSEEMEQLPQWFQD
LIEQHNNMASTHRSLKKFEMHCNLQLLMSCLEGNENWDILKHIPVVKIQT
YSSKEYIRYTKDPYNYDANIPSN
>XP_042378555.1 putative disease resistance protein RGA3 isoform X1 [Zingiber officinale]
MAMILDFFVSKFMTITANMVEVEIFKVLGVDKEIKALQERLGTINGYLHE
AKEKRHENDEIDLWVRKLKDVMYDADDVIDLCMIEGGKLLKARALSGSTT
INIPFNYLFSCFQCLKYRHDIANQIIALNNRLEDLKKDIVIRSNLDRTTK
ESIEYVNRLVTHETSHLQVEGDIIGTQIKNATEVLVNLILENNPKKYRVL
GVVGTGGIGKSTLASKIFEDERIKDNFSNRIWLYVSKNYTESDLLKNLIR
SAEGSETKGENLEGKSKVELENKLVSILTQNTFIVLDDVWNSSVWVDFLR
KPIMKSATSCTVLVTSRIEKIVMLMKPRYIHPVEKMDEESGWTLLKHLVF
DVEGDEDEISSFEEIGIKLVNKCDGLPLAIKAIAGVLYQQNKAKWEDVLE
SDAWNMDQIEEELRPLYLSYEDLPSRFKQCFLYCSLYPQKDMYSKEIVQF
WVAEGLIMDEQDELRRDIPNKKQRTMEDLGEEIYRELLGRNLLEAKKNDL
SKSFFSMHDHFRSLCANLLREEGVLYRHGREFKVDDNVKIRRLSISCMGP
MLVLPAQILRQACLRTLILTDSPQTKTIEDSVLQALLCLRVLDLTKTSIE
KIPDCIGDLLHLRYLDLDETNIREIPTTIGNLVNLQSLNILRCKFLERLP
VSITKLHNLRWLNMIGCPLLTYVPKGIGKLENIYSLYGFMIGQNDSTEEG
CDLEELKNLSKLRVLIILRLERAEKGASALANKPFLKDLTLSWMRPNEEE
DDNGGGHDAQANEEEDGDGKDDGSGQRTETKEEEEDENEEVEDEGEEEED
ENEEVDGEEEEKGWNEVQISKAERICNEMSQPSSTLIHLHFYEYCGRQFP
SWMASSSLAESFPNLTYLKLVGLPCCTELPPLGTLPQLKFLSIVSANAIT
AIGSQFLGSRSSAFPKLEVLRFEDMPKWEEWTFKGTPLAVKLFPSLRSCA
IINFPKLRALPDDLHRAANLNELYLFQTYELREINNLPLAYKLKVANGRG
LKKISNIPSLRYLEVDDCPNLECVENLDKLQHLVLICSEEMEQLPQWFQD
LIEQHNNMASTHRSLKKFEMHCNLQLLMSCLEGNENWDILKHIPVVKIQT
YSSKEYIRYTKDPYNYDANIPSN
>XP_042378556.1 putative disease resistance RPP13-like protein 1 isoform X2 [Zingiber officinale]
MAMILDFFVSKFMTITANMVEVEIFKVLGVDKEIKALQERLGTINGYLHE
AKEKRHENDEIDLWVRKLKDVMYDADDVIDLCMIEGGKLLKARALSGDED
EISSFEEIGIKLVNKCDGLPLAIKAIAGVLYQQNKAKWEDVLESDAWNMD
QIEEELRPLYLSYEDLPSRFKQCFLYCSLYPQKDMYSKEIVQFWVAEGLI
MDEQDELRRDIPNKKQRTMEDLGEEIYRELLGRNLLEAKKNDLSKSFFSM
HDHFRSLCANLLREEGVLYRHGREFKVDDNVKIRRLSISCMGPMLVLPAQ
ILRQACLRTLILTDSPQTKTIEDSVLQALLCLRVLDLTKTSIEKIPDCIG
DLLHLRYLDLDETNIREIPTTIGNLVNLQSLNILRCKFLERLPVSITKLH
NLRWLNMIGCPLLTYVPKGIGKLENIYSLYGFMIGQNDSTEEGCDLEELK
NLSKLRVLIILRLERAEKGASALANKPFLKDLTLSWMRPNEEEDDNGGGH
DAQANEEEDGDGKDDGSGQRTETKEEEEDENEEVEDEGEEEEDENEEVDG
EEEEKGWNEVQISKAERICNEMSQPSSTLIHLHFYEYCGRQFPSWMASSS
LAESFPNLTYLKLVGLPCCTELPPLGTLPQLKFLSIVSANAITAIGSQFL
GSRSSAFPKLEVLRFEDMPKWEEWTFKGTPLAVKLFPSLRSCAIINFPKL
RALPDDLHRAANLNELYLFQTYELREINNLPLAYKLKVANGRGLKKISNI
PSLRYLEVDDCPNLECVENLDKLQHLVLICSEEMEQLPQWFQDLIEQHNN
MASTHRSLKKFEMHCNLQLLMSCLEGNENWDILKHIPVVKIQTYSSKEYI
RYTKDPYNYDANIPSN
>XP_042378558.1 putative disease resistance RPP13-like protein 1 isoform X1 [Zingiber officinale]
MQNKYHTPKFVSPFLFHIPIMAMVLDFFISKFITATTNMMETEIFKVLGV
DKEIKALQERLGTINGYLRQAEQKRHGNDEIDIWMQKLKDLMYDADDIID
LCIIEGGMLLKARALSGSSTVSIPFSYLFSCFQCLKYRHDIANQIIALNS
KIEDLKKDTVIKNNLDWATKVPVEYVNRVITHETSHLQVEGDIVGTQIET
ATETLINWIVKKNPKCRVFGVVGTGGIGKSTLARKIFEDERIKDYFPNRK
WLYVSKNYIEIDLLKKLIRFDEGSETNGEILEGKSKAELENKLVSILTRN
TFIVLDDVWNSSVWADCLRIPIMKGAASCTVLVTSRKEQVVTLMKATYIY
PVEKMNDESGWNLLKHLAFEGEGDEDQISSFEEIGIKLVNKCDGLPLAIK
AIAGVLYQQNKAKWEEVLQSDAWNMDQIKEELRPLYLSYEDLPSSLKQCF
LYCSLYPQKDMYSKEIVQFWVTEGLIMDEQDKLRRDLPTEKQRTKEDIGE
EIYRELLCRNLLEVDVDLDMSKSFFSMHDHFRSLGAHLMREEGILYRHGR
EFKVDDNIKIRRLSISCMGPKLVLPAQVLRQGCLRTLILTDSPKTKTIED
SVLRALPCLRVLDLTKTSIEKIPDCIGDLLHLRYLDLDGTNISEIPTSIG
NLVNLQSLNISECEFLERLPVSITKLHNLRWLDMRDSPMLTHVPKGIGKL
ENFYNLEGFMVGQNGSASEEGCDLEELKNLSELRVLSIYRLERAEGGASA
LANMPFLMELVLGWKRPDEEEDAKADEEVEGDGKDDGDADKDMGDGDDDG
SGAEDENEETEKEDENEEDSEEEDKGWSEEQISKAERICNEMTQPSSTIF
DLLFSQYPGRQFPIWMQSSSLAESFPNLTYLKLIRLPCCTKLPPLGTLPQ
LKYLRIESATAITTIGSQFLGSRSSAFPKLEMLQFQDMPSWEEWTFNGTP
LAVKLFPILRTCNIIDCPNLRALPEGLCRATNFNQLCLHETYELGEIDNL
ALAYRLEVTNGIELKKISNIPSLRYLAVDGCPSLECVENLGKLQHLALIC
SEETEQLPQWLLGLIEQHNNTASTQRSLRKFEMQCNLQLLKSCLEGNENW
DIIKQIPNVKIQTYSSQEYMFYTKDPYNYDAKIPSN
>XP_042378560.1 putative disease resistance RPP13-like protein 1 isoform X2 [Zingiber officinale]
MKGAASCTVLVTSRKEQVVTLMKATYIYPVEKMNDESGWNLLKHLAFEGE
GDEDQISSFEEIGIKLVNKCDGLPLAIKAIAGVLYQQNKAKWEEVLQSDA
WNMDQIKEELRPLYLSYEDLPSSLKQCFLYCSLYPQKDMYSKEIVQFWVT
EGLIMDEQDKLRRDLPTEKQRTKEDIGEEIYRELLCRNLLEVDVDLDMSK
SFFSMHDHFRSLGAHLMREEGILYRHGREFKVDDNIKIRRLSISCMGPKL
VLPAQVLRQGCLRTLILTDSPKTKTIEDSVLRALPCLRVLDLTKTSIEKI
PDCIGDLLHLRYLDLDGTNISEIPTSIGNLVNLQSLNISECEFLERLPVS
ITKLHNLRWLDMRDSPMLTHVPKGIGKLENFYNLEGFMVGQNGSASEEGC
DLEELKNLSELRVLSIYRLERAEGGASALANMPFLMELVLGWKRPDEEED
AKADEEVEGDGKDDGDADKDMGDGDDDGSGAEDENEETEKEDENEEDSEE
EDKGWSEEQISKAERICNEMTQPSSTIFDLLFSQYPGRQFPIWMQSSSLA
ESFPNLTYLKLIRLPCCTKLPPLGTLPQLKYLRIESATAITTIGSQFLGS
RSSAFPKLEMLQFQDMPSWEEWTFNGTPLAVKLFPILRTCNIIDCPNLRA
LPEGLCRATNFNQLCLHETYELGEIDNLALAYRLEVTNGIELKKISNIPS
LRYLAVDGCPSLECVENLGKLQHLALICSEETEQLPQWLLGLIEQHNNTA
STQRSLRKFEMQCNLQLLKSCLEGNENWDIIKQIPNVKIQTYSSQEYMFY
TKDPYNYDAKIPSN
>XP_042378561.1 disease resistance protein RGA2-like isoform X1 [Zingiber officinale]
MTMVLDFFVSKFIAATTNMMETEIFKVLGVNKEIKTLQERLGAINGYLRQ
AERKRHGNDEIDLWVRKLKDIMYDIDDVIDLCMIEGGKLLKSQALSSSTT
VSIPFNYLFSCFQCLKYRHDIANQIIALNSKLEDLKNDTFIKNNLDWVTK
EQVEYVNRVITYETSHLQIEGDVIGTQIEIAIETLIDWILKNNPNKCRVF
GVVGTGGIGKSTLAGKIFEDERIKDYFPNRKWLYVSKNYMESDLLKKLIK
FGEGSETKGEYLEGKSKAELENILVSVLTQNTFIVLDDVWNSSVWVDFLR
KPIMKSASSCTVLVTTRKENIVKLMKPTYIHLVEKMDEESGWNLLKHLVF
EGEGDEDEISSFEEIGIKLVNKCDGLPLAIKAIAGVLYQQNKARWVEVLQ
SDAWNMNQIEEELRPLYLSYEDLPSSLRQCFLYCSLYPQKYMFSKEVIQF
WIAEGLIMDEQDKLRMDLPTEKLRTMEDIGDEIYRELLGRNLLEANEYEE
SKNFFSMHDHFRSLCANLMREEGILYRHGREFKAGDIVKIRRLSVSYMGP
NLVLPDQIIRQACLRTLILTDSPKTKTIEDRVLQALPCLRVLDLTKTSIE
KIPDCIGDLLHLRYLDLDGTNIREIPTTIGNLVNLQSLNISDCEFLERLP
VSITKLHNLRSLNMNDCPLLTYVPKGIGKLENFYSLDGFIVGQNDSASEE
GCDLEELKNLSELRILSIYRLDRAAGGASALANKPFLKVLMLSWMQPDEE
EEEEDGRWVEVKANEEADGDGKDDGSGQGTEIKEEEEDVNEEVEREEEEK
GWSEEQISKAERICNEMAQPSSTLFQLHLGEYPGRQFPSWMASSSLAESF
PNLAYLNLFGLPCCAELLPLGTLPQLKYLRIKSASAITTIGSQFLGSRSS
AFPKLQVLIFNDMPAWEEWTFNGTPLAVKLFPSLRECVIIDCPELRALPE
GLHRATNLYRVCLRQTYELGEIENLTLAYRLEVTNGIGLKKISNIPSLRY
LRVGNCPNLECVENLGKLQHLVVIYSVETEQLPQWLRGLIEQHNNTASTH
RSFRKFEMHCNLSLLKSCLEGNENWDIVKQIPNVKVQTYSGQEYMRYTKD
PYNYDANIPSN
>XP_042378586.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAMVLDFFVSKFITATTNMMETEIFKVLGVNKEIKTLQERLGAINGYLHQ
VERKRHGNDEIDLWVRKLKDIMYDADDVIDLCMIEGGKLLKSQALSSSST
VSIPFNYLFSCFQCLKYRHDIANQIIALNSKLEDLKNDTFIKNNLDWVTK
EPVEYVNRVITYETSHLQIEGDVIGTQIETAIETLIDWILKNNPNKCHVF
GVVGTGGIGKSTLASKIFEDERIKDYFPNRKWLYISKNYMESDLLKKLIK
FGEGSETKGENLEGKSKAELENILVSVLTQNTFIVLDDVWNSSVWVDFLR
KPIMKCASSCTVLVTTRKENIVKLMKPTYIHPVEKMDEESGWNLLKHLVF
ESEGDEDEISSFEEIGIKLVNKCDGLPLAIKAIAGVLYQQNKAKWVEILQ
SDAWNMNQIKEELRPLYLSYEDLPSSLKQCFLYCSLYPQKDMYSKEIVQS
WVAEGLIMDEQDQLRRDLPIENQRTMEEIGEEMYRELICRNLLEADASFD
LSKSFFSMHDHFRSLSANLMREEGILYRHGREFKVDDTIKIRRLSISCMG
PKLVLPAEILRQACLRTLILIDSPKTKTIEDSVLQALPCLRVLDLTKTSI
EKIPDCIGDLLHLRYLDLDGTNICEIPTSIGNLVNLQSLDISVCMYLERL
PESIAKLHNLRRLDISCCPLLTYVPKGIGILEILYSLHGFMVGQNNSTSE
KGCDLEELKNLSKLRSITIDRLERAEGGASALANKPFLKQLSLSWMQPDE
EEEVDNGRGDDAKANEEADGDGTYDEDGNNDMGDGKDDGYGQGNESEEAG
DTSTGSEVENEETENEEKVWSEEQISKAERICNEMTQPSSTIFNILFRQY
PGRQFPSWMTSSSLAESFPNLTYLKLLGLPCCTELPPFGTLPQLKYLNIE
RASSITAIGSQFLGSRSSAFPKLEVLQFEDMPGWEEWTFNGAPLAVKLFP
SLRACAIINCPKLRALPDGLHRATNLNELGLLQTYELGEINNITLAYRLE
VTNGIGLKKISNIPSLRYLEVNDCPNLECVENLGKLQHLDLVCSEEMEQL
PLWLRGLIEQHNNTASTHRSLKKFEMRCNRQLLKSCLEGNENWDIIEQIP
NVKVQTYSGQEYLFYTKDPYNYDAKIDSTPTMATLRQKINALRQLQLSQI
QA
>XP_042378607.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEAALVGAASRFMVDKVAVLLKLDEKLKTITGTKRKMEKLKELAPIIDTV
IQHIESRPLMEDAVKELLKKLKYLAYDLEDVVDYYDTKVFQKKQRSKSLL
RPVSVFFSADNQVAFKSRVGGMIKAITDSLDSILLQNSILSNLLQEQGSI
PMSEPSLNNRETHSRNSFVVIGREPEKNKIVDMLTKDDDDDDDDESHHGT
VKVIAIVGMGGLGKTTLAQHVYNDARVQDHFASPTMWKVVGAEFNPTKIM
KSLLELATGGSSVNSFEIDLVKRKLEEELSGKRFLLVLDDVWNDNELQWG
VLKAALTCGARGSKILVTTRSKWVSSIMSSSDTTHQLQQLSGDDCLSLFQ
RFAFGDQAVDQNLMAIGAKVVEKCGGVPLAAISLGSMLRSTREENYWSSV
LNSEIWKLGNQEDKVLAVLKLSYDALPLRSKRCFAFASLFSKDVTMKKDE
LIKLWIANGFVRSEGNFDAETVGKHVFDDLVLRSFFLLVPSKYVTECTMH
DLMYDLARSVSADAYWNSYQDSVENFGNRTYHLQIDRRKFPNMTQDLGKK
PLYLRTFMHIYTFSHLSINLLELFSELKPLHLRALDLTHGGIREVPTSIG
ILIHLRYLNLSWNDIEVLPDSITLLPNLQYFNLSFNHKLRELPKELGNIQ
NLRDLDLQTYSRFITHMPCGLSRLTNLRSLPLFIAGDKTGACSIIELENL
KLHGKMVIQFSEDFKNYSCDGRKILKNIDLNELCIEFNERYDKDMFVDLC
PNTSLKKLDICRYRSPQFPAWLMESQLPNLVEVSLGNCRGCELIPPFGNL
QFLKKLDLDYMDGITHLGAEFHGYRGFPSLRELSLVRMFNLEEWSESHVV
DQLFPLLRKLLISWCPKLKSTPRLPRIQELKISYSESILSCIGRFTSLSL
LQLTGMPDIASLPSGSIRNLTSLTKFQIRNCRQLQSLPVDEMQFLEMLRS
LTIEECDNLVFFPSEVGSLSFLCFRWNGVIPQPKELVQILNLVDEFQIEI
CDNKVDLRGQLQYLTHAQKIMSIWFTS
>XP_042378608.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEAALVGAASRFMVDKVAVLLKLDEKLKTITGTKRKMEKLKELAPIIDTV
IQHIESRPLMEDAVKELLKKLKYLAYDLEDVVDYYDTKVFQKKQRSKSLL
RPVSVFFSADNQVAFKSRVGGMIKAITDSLDSILLQNSILSNLLQEQGSI
PMSEPSLNNRETHSRNSFVVIGREPEKNKIVDMLTKDDDDDDDDESHHGT
VKVIAIVGMGGLGKTTLAQHVYNDARVQDHFASPTMWKVVGAEFNPTKIM
KSLLELATGGSSVNSFEIDLVKRKLEEELSGKRFLLVLDDVWNDNELQWG
VLKAALTCGARGSKILVTTRSKWVSSIMSSSDTTHQLQQLSGDDCLSLFQ
RFAFGDQAVDQNLMAIGAKVVEKCGGVPLAAISLGSMLRSTREENYWSSV
LNSEIWKLGNQEDKVLAVLKLSYDALPLRSKRCFAFASLFSKDVTMKKDE
LIKLWIANGFVRSEGNFDAETVGKHVFDDLVLRSFFLLVPSKYVTECTMH
DLMYDLARSVSADAYWNSYQDSVENFGNRTYHLQIDRRKFPNMTQDLGKK
PLYLRTFMHIYTFSHLSINLLELFSELKPLHLRALDLTHGGIREVPTSIG
ILIHLRYLNLSWNDIEVLPDSITLLPNLQYFNLSFNHKLRELPKELGNIQ
NLRDLDLQTYSRFITHMPCGLSRLTNLRSLPLFIAGDKTGACSIIELENL
KLHGKMVIQFSEDFKNYSCDGRKILKNIDLNELCIEFNERYDKDMFVDLC
PNTSLKKLDICRYRSPQFPAWLMESQLPNLVEVSLGNCRGCELIPPFGNL
QFLKKLDLDYMDGITHLGAEFHGYRGFPSLRELSLVRMFNLEEWSESHVV
DQLFPLLRKLLISWCPKLKSTPRLPRIQELKISYSESILSCIGRFTSLSL
LQLTGMPDIASLPSGSIRNLTSLTKFQIRNCRQLQSLPVDEMQFLEMLRS
LTIEECDNLVFFPSEVGSLSFLCFRWNGVIPQPKELVQILNLVDEFQIEI
CDNKVDLRGQLQYLTHAQKIMSIWFTS
>XP_042378664.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEGALVAAAARLMFDKVTALLQVDEKLKTITGTKRKMEKLKELSTIIDMV
IRDIEYRPFIDDAVKDLLKKLKYLAYDLEDVVDYYDTKVLQKKQRSKTSL
GSVRDFFSADNQVVFKSRVGGMIKAITESLDSILLQKSILLNLPQSSIRM
PEPSLCRETHSCNSFVVIGREPEKNKIVDMLTKDDDDESNHGTVKVIAIV
GMGGLGKTSLAQLVYNDARVQDHFASLTMWKVVGAEFNPTKIMKSILELA
TGASVNISEIDLVKQNLEKELSGRRFMLVLDDVWNEDELQWGVLKAALTC
GARGSKILVTTRSQQVSSIMGSSNSTHQIHQLSRGDCLSLFQQFAFGDQA
VDQNLMKIGEKIVEKCGGVPLAAISLGSMLRSTREENYWSSVLNSEIWKL
RNEEEKVLAVLKLSYDSLPPRSKKCFAFASLFPKNYWLAKDELIKLWIAN
GFVCSEGNFDAETNGNHVFNDLQMGSFFLLAPSRDYEYVSHVTKCTMHDL
MHDLARSVFADVYWNFKQDLLKDIGKRTYHLQIYLREKSSMTHVLGKKPL
YLRTFMPQVTFSRVSINLLEVFPKLKYLRALDLTDGEIREVPTSIGNLIH
LRYLNLSKNKIKVLPDSITLLPNLQYLNLSFNNRLRELPKELGKMQNLRD
LNFSKSDFRLTYIPCGISRLTNLRSLPLFIASDKTDTCSIIELEDLKLHG
KMEIKFSKDFKNYSCGGRKILKNKDLTELWLEFNNSERCDKDMLDDLCPN
TSLKKLTIWDYTSPQFPTWLIELQVPNLVEVNLSNCFDCEYIPPLGNLQF
LKKLELCLMNGITQMGAKFHGYRGFPSLQELILNRMYNLEEWSESNVVDQ
LFPLLQKLWISNCPELKCMPRLPRIQELEILYCSKSILSCIRRLASLSVL
RVKNMIDMTSLPSDCIRTLTSLTELQITECRELQSLPGDEMQCLKMLRSL
TIERCDNLASFPSEVGRLSSLCFLRLSQCPSITLQPEELVQILNSVHDFQ
IQICDNKVNLRGQLQYLPILKKLSLFGSHVTNNYMIGLGLSTLSICCCHE
LESLMTAEPTSSIVLKQLYINGISYLTTLPDWLQHLKSLRFLLIEDCPQL
ERVPRGLKNLHMLEKLWIVRCPQLKSRCERETGEDWPVISHVRHVDIS
>XP_042378692.1 putative disease resistance protein RGA4 [Zingiber officinale]
MIQVVTNSLDSILLQKSILLNLPQSNSHMSLNSYRETHSCNSFVVIGREL
EKNKIVNMLTKDDNESSHGTLKVITIVGMGGLGKTTLAQLAFNDEGVKAH
FESSRMWTVVGAEFNPVKIMKSVLELATDAPVKISQIDSVRKNLEKTLSG
KKFLLVLDDVWNKDPLKWGVLKAALTCGARGSKILVTTRSQQVSSIMGSS
NTTHQLQQLSGYDCLSLFKQFAFGDEVADRTLMEIGRKIVEKCGGVPLAA
ISLGSMLRSSREETYWSSVLKSEIWQLGNEEDKVLAVLKLSYDTLPPRSK
KCFAFASLFPKNTRIAKDELIRLWIANGFIRSEGNFDAETNGKHVFNDLV
MGLFFLFEDKCTMHDLMRDLARSVSANIYWNSKEDLVKHSGNRTYHLHLE
SSDISKITQALGKKSLYLRTLILIHCYLYVNLPAIVFSELKFLRVLDLSY
NGIREVPTSIENLIHLRYLNLSRNHIEVLPDSVTLLPNLQYLNLSFNHGL
RQLPKELGNMQNLWDFNLSGNNIQVLPDSITLLSNLRYLNLSFNVELREL
PKELGNMQNLRDLDLQRDFRLTHMPCGLSQLTNLRSLPLFIAGDKTSACS
IIELEDLKLHGKMEIKFSNDYKNYSCGGRKILKNKDLNELCLEFNGSERY
DNDMLDDLCPNTSLKKLSIWDYMSPQFPTWLIELQLPKLVEVSLVNCRGC
EPIPPFGNLQFLKKLCLRSMADFTQMGAEFYGYRGFPSLQELFLYEMNNL
EEWSESHGVVELFPKLQSLKILGCRKLKSMPRLPRIQHLDISCCSGSILS
CIGGLTSLSVLQVEKMNDMTSLPSGWIRNLTSLTELQIKGCRQLQSLPGD
EMQYLEMLRSLTIEQCYNLASFPSKVGRLSSLCFLRLRGCPSIILQPEEL
VEILNSVHEFKIHICGNKVNLSGQLQYLHKLKKLSLCGAHDESFTYNYKI
GNEIQKLTICCCDELESLMTTEPTSSALQKLKINDISNLTTLPEWLQHLK
SLHFLSIQDCPRLERVPRGLKNLYMLKRLWIVGCPQLKSRCQRETGEDWP
IISYVPYVHIP
>XP_042378693.1 putative disease resistance protein RGA4 [Zingiber officinale]
MIQVVTNSLDSILLQKSILLNLPQSNSHMSLNSYRETHSCNSFVVIGREL
EKNKIVNMLTKDDNESSHGTLKVITIVGMGGLGKTTLAQLAFNDEGVKAH
FESSRMWTVVGAEFNPVKIMKSVLELATDAPVKISQIDSVRKNLEKTLSG
KKFLLVLDDVWNKDPLKWGVLKAALTCGARGSKILVTTRSQQVSSIMGSS
NTTHQLQQLSGYDCLSLFKQFAFGDEVADRTLMEIGRKIVEKCGGVPLAA
ISLGSMLRSSREETYWSSVLKSEIWQLGNEEDKVLAVLKLSYDTLPPRSK
KCFAFASLFPKNTRIAKDELIRLWIANGFIRSEGNFDAETNGKHVFNDLV
MGLFFLFEDKCTMHDLMRDLARSVSANIYWNSKEDLVKHSGNRTYHLHLE
SSDISKITQALGKKSLYLRTLILIHCYLYVNLPAIVFSELKFLRVLDLSY
NGIREVPTSIENLIHLRYLNLSRNHIEVLPDSVTLLPNLQYLNLSFNHGL
RQLPKELGNMQNLWDFNLSGNNIQVLPDSITLLSNLRYLNLSFNVELREL
PKELGNMQNLRDLDLQRDFRLTHMPCGLSQLTNLRSLPLFIAGDKTSACS
IIELEDLKLHGKMEIKFSNDYKNYSCGGRKILKNKDLNELCLEFNGSERY
DNDMLDDLCPNTSLKKLSIWDYMSPQFPTWLIELQLPKLVEVSLVNCRGC
EPIPPFGNLQFLKKLCLRSMADFTQMGAEFYGYRGFPSLQELFLYEMNNL
EEWSESHGVVELFPKLQSLKILGCRKLKSMPRLPRIQHLDISCCSGSILS
CIGGLTSLSVLQVEKMNDMTSLPSGWIRNLTSLTELQIKGCRQLQSLPGD
EMQYLEMLRSLTIEQCYNLASFPSKVGRLSSLCFLRLRGCPSIILQPEEL
VEILNSVHEFKIHICGNKVNLSGQLQYLHKLKKLSLCGAHDESFTYNYKI
GNEIQKLTICCCDELESLMTTEPTSSALQKLKINDISNLTTLPEWLQHLK
SLHFLSIQDCPRLERVPRGLKNLYMLKRLWIVGCPQLKSRCQRETGEDWP
IISYVPYVHIP
>XP_042378695.1 putative disease resistance protein RGA4 [Zingiber officinale]
MIQVVTNSLDSILLQKSILLNLPQSNSHMSLNSYRETHSCNSFVVIGREL
EKNKIVNMLTKDDNESSHGTLKVITIVGMGGLGKTTLAQLAFNDEGVKAH
FESSRMWTVVGAEFNPVKIMKSVLELATDAPVKISQIDSVRKNLEKTLSG
KKFLLVLDDVWNKDPLKWGVLKAALTCGARGSKILVTTRSQQVSSIMGSS
NTTHQLQQLSGYDCLSLFKQFAFGDEVADRTLMEIGRKIVEKCGGVPLAA
ISLGSMLRSSREETYWSSVLKSEIWQLGNEEDKVLAVLKLSYDTLPPRSK
KCFAFASLFPKNTRIAKDELIRLWIANGFIRSEGNFDAETNGKHVFNDLV
MGLFFLFEDKCTMHDLMRDLARSVSANIYWNSKEDLVKHSGNRTYHLHLE
SSDISKITQALGKKSLYLRTLILIHCYLYVNLPAIVFSELKFLRVLDLSY
NGIREVPTSIENLIHLRYLNLSRNHIEVLPDSVTLLPNLQYLNLSFNHGL
RQLPKELGNMQNLWDFNLSGNNIQVLPDSITLLSNLRYLNLSFNVELREL
PKELGNMQNLRDLDLQRDFRLTHMPCGLSQLTNLRSLPLFIAGDKTSACS
IIELEDLKLHGKMEIKFSNDYKNYSCGGRKILKNKDLNELCLEFNGSERY
DNDMLDDLCPNTSLKKLSIWDYMSPQFPTWLIELQLPKLVEVSLVNCRGC
EPIPPFGNLQFLKKLCLRSMADFTQMGAEFYGYRGFPSLQELFLYEMNNL
EEWSESHGVVELFPKLQSLKILGCRKLKSMPRLPRIQHLDISCCSGSILS
CIGGLTSLSVLQVEKMNDMTSLPSGWIRNLTSLTELQIKGCRQLQSLPGD
EMQYLEMLRSLTIEQCYNLASFPSKVGRLSSLCFLRLRGCPSIILQPEEL
VEILNSVHEFKIHICGNKVNLSGQLQYLHKLKKLSLCGAHDESFTYNYKI
GNEIQKLTICCCDELESLMTTEPTSSALQKLKINDISNLTTLPEWLQHLK
SLHFLSIQDCPRLERVPRGLKNLYMLKRLWIVGCPQLKSRCQRETGEDWP
IISYVPYVHIP
>XP_042379848.1 putative disease resistance protein RGA3 [Zingiber officinale]
MSHPTGVIPIRGRTAEEETMLQALLETTTAHGESFLNCSKFSVLSIVGPG
GIGKTVLAQLAFHNKVVKRHFDIMAWVCVSTQFDLKKLTIKIIESASMKR
PSDLREIISLGELRKILTAGMQGKRFLIVLDDVWEESTTAWRYLLTPLNC
GKEGSKVVVTTRLEEIARMLETKVMIKLDGLEEEEYLELLKDSAFGVERT
FLQPDMEQMCCDIARQLGGLPLAAVRIRDFLKDRFGRGNWPPAETSLVAR
DGDLMSVLGQSYQQLPEHLKQCYVSCALFPKNYCFDKNQLLRFWMALGLT
PRNGSSSSYNLVDDLSSRSFFVDAWRKKNKFVIHAMMHELADHICDGEFF
RLEEDADEEIEIPTKAHHVYVTADNFVRFSKVLRKRKILRSLVVDGRLSS
HISNSEFMDSLREVLKDSSRLRLLMLSELPGNLPDAIVHLRHLRYLEFPD
TGVNKLPKSFCRLYHRWRLNLKAGSKHLLLRNNMDQVIKLCALDPNLEDV
YIPAPCPN
>XP_042380219.1 putative disease resistance protein RGA3 [Zingiber officinale]
MDIVSPILEISGVNHVINKLVDKTTNYLQDQCYWETYLQEELKSLQDLLP
QIEAVVYFAEHRLTSYESSDRALIKWLWKFRDVIDEAEDVLDELEYLELE
RKANSDKSWLSRRVDASVNAAKRLLKFDDVLGRLRTCVKNLNTSASDVEK
FLALVTPTGGVGTGQMQQGILPLSHQSRITFSLPVSSFKGRVEEKEKIIK
YLLGEESEIQISENVHCLPLVALGGMGKTALAQEVFDHFKNVKKEHFDIK
IWVCDSLPDLNSSNLTKKILEYSTGRSESGPLELIPEKLKEKLHSKRFLL
VLDDAWDDKNQREWEKLCAPLLYGQKGSWVLLTTRSKSVANMVAREIKGT
MMPMMLQGLSEDECLSLLYEHAFAGQDPNGFPLLKEIGREIVKKLKGVPL
LAKSIGGALNSKLEADHWTSILRSELWKRSQDSTYNFIPVLTLSYVMLPP
RLKRCFAYCSMNSRLQI
>XP_042380220.1 putative disease resistance protein RGA3 [Zingiber officinale]
MGKTALAQEVFDHFKNVKKEHFDIKIWVCDSLPDLNSSNLTKKILEYSTG
RSESGPLELIPEKLKEKLHSKRFLLVLDDAWDDKNQREWEKLCAPLLYGQ
KGSWVLLTTRSKSVANMVAREIKGTMMPMMLQGLSEDECLSLLYQHAFAG
QDPNGFPLLKEIGREIVKKLKGVPLLAKSIGGALNSKLEADHWTNILRSE
LWKRSQDSTYNFIPVLTLSYVMLPPRLKRCFAYCSIFPQDYKFNK
>XP_042380240.1 disease resistance protein RPM1-like [Zingiber officinale]
MAETALQFVLQKLNYWIVQEQQLLGGLRPAIKDIRDELECIAEFIREADA
GEDKDGAKAFMRQLREIAYDIEDHLEDYTLHFGQPQEDRCFGMLRRSLHD
LKHWRSWHRMATEIREIKSRVRSISDRRKMYKFRTTNSTASRNILHDRHV
AALFMDEAELVGISEPREQIIRWLVEGKSNLQAISVVGMGGLGKTTLVRK
VYDDERVKAFFTSHAWISVTQSYTEEVLLRSIISQLYEEIHETLPARIET
MGIIQLIPTLRHFLEHKRYIIVFDDIWHIHAWNCFKLALPDDHCGSRVLV
TTRIGDVGLHCLEACGHVYQLEPLLPAVAWSLFCKKAFRSLPGAACPPEL
HVISQEIVRVCEGLPLAIVTLAGLLSKKNSLLEWTTLHDNLHAELANNPK
LETIMRILQLSYNDLPHHLKPCFLYFSIFPKERSVSRITLIRLWMAEGFI
ETDESESMERVASEYLDDLIDRNMVEVTEHYDYGRVKNCRVHDLFHELIV
FKSKEENFSTSFIRQGSQIQEKIRRLSTHNISEPLLQGTDLSHLRAIFVF
GQNASAISSQANLFSRLKLLKILDLSGAPIESCSFEFGNLPHLRYLSFRY
TRIKKLSKSLGKLKNLETLDLKGTYVTELPKTILNLQRLRHLLAYRYYTD
DEPPLYHVVGMKLPKGIGAFRELQKLAYLEMNQDGIIKELGSLTQLKRLA
IVKLRREDGANVCSSLEKMKQLKSFSASSSHMGEFLHLEALKSPPPFLER
LYFRGPLRSLPSWISSLNSLISLRLRWSRLPENSLGILEALPNLLELVLV
HAYVGGRLFFHKGGFQRLKVLDLEQLDSLNYVILDGAMPNLQIMYIRSCA
QLEMVPQGIEELIHLKELHLFDMPEVFLQRLWRLKGIDHPKVNHIPIVRS
YDDQNRVYEI
>XP_042380247.1 putative disease resistance protein RGA4 [Zingiber officinale]
MEQLPVKLKEKLHSKRFLLVLDDAWDDNNQIEWEKLCAPLLYGQKGSWII
LTTRLISVAKMVSKVMRGVTMEPMMLQGLSNDECRSLLYEHAFVGQDPNR
FPLLKEIGEEIVEKLKGVPLLAKSIGGVLNSRLEVDHWTSISRSELWKMP
QDSKYDFIPSLTLSYMMLPPRLKRCFSYCGIFPQDYKFNKQKLVCMWVAA
GLIYSDGLEEGSDEDIANCCFDMLCNKSFFDIHTYIWRSI
>XP_042380382.1 putative disease resistance protein RGA1 [Zingiber officinale]
MASHQEDEHEKSLFEMSIESIDEGGVSTKENSSSREATDNEIDKDQSFRL
RSKPIAYFNMQQDVVSEGRRKVIESSSLISTVSIPWSYLFSCFRCLKYRH
NIANQIIALNSKLEDLKKDIVITNYLDRAIKEVVENVDIVIAHETSHLQV
EGDIVGAQIENAIEALVNLILENNPKKCRVFGVVGTGGIGKSTLASKIFE
DERIKDNFPKRIWLYVSKIYTESDLLKKLIRSYEGSETKGENFEGKSKAE
LENTLVSILTRNTFIVLDDVWNSSVWTDFLRKPIMKSAINCTVLVTTRKE
KVVMLMKPRYIHPVEKMDEESGWTLLKHLVFDVEGDEDEISSFEEIGIKL
VNKCDGLPLAIKAIAGVLYQQNKAKWEEVLESDAWNMDQIEEELRPLYLS
YKDLPSRFKQCFLYCSLYPQKDMFSKEIVQFWAAEGLIMSEEDNWRRDLP
TQNQRTMEDLGEEIYRELLGRNLLEAKKNELSKSFFSMHDHFRSLCANLM
REEGILYRHGREFKADDNVKIRRLSISCMGPMLVLPAQILRQACLRTLIL
TDSPQTKTIEDSVVQALLCLRVLDLSETSIEKIPDCIGELLHLRYLDLDG
TNIREIPTTIGNLVNLQSLNIIRCKFLERLPVSITKLHNLRWLNMIGCPL
LIYVPKGIGKLENIYSLYGFMIGQNDSTSEEGCDLEELKNLSKLRVLIIL
RLERAEKGASALANKPFLKELTLSWMRPNAEEDDNGGGHDAQANEEEDSD
GKDDGSGQRTETIEEEEDENEEVESEGEEEEDENEEVDGEEEEKGWNEEQ
ISKAERICNEMSQPSSTLVHLHFYVYPGRQFPSWMTSSSLAESFPNLAYL
DLFGLPCCVELLPLGTLPQLKFLCIESANAITAIGSQFLGSRSSAFPKLE
VLRFVDMPKWEEWTFNGAPLAVKLFPSLKECAIIDCPMLRALPDGLHRAT
NLNQLGLLRTYELGEINNITLAYRLEVAKCRGLKKISNISSLRSLVVIEC
GDLECVENLDKLQHLIVECYETEQLPQWLPGLIERHNNTASTHRSLKKFE
MACNLQLLMSCLEGNENWDILKHIPVVEIQTYSSKEYIRYTKDPYNYDTN
IPSN
>XP_042380387.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAMVLDFFISKFMTVTANMVEAEIFKVLGVDKEIKALQERLGIINGYLHQ
AERNRHGNNEIDIWVRKLKDVMYDADDVIDLCMIEGGKLLKAQVLSGSST
VSIPFNYLFSCFQCLKYRHDIANQIIALNSKLEDLKKDVVIKNNLDWATK
EPDEYVNRATAHETSHLQVEGDIIGTQIETAIETLVSLILENNPKKCRVF
GVVGTGGIGKSTLASKIFEDERIKDYFPNRKWLYVSKNYTESDLLKKLIK
FEEGSETKGKNLEGNSRAELENRFVSVLTRNTLIVLDDVWDSSVWIDFLR
KPIMNSTISCTVLVTSRKEKVIIPMKPRYIHPVEKMDEGSGWNLLKHLAF
EAEGDEDEISSFEEIGIKLVNKCDGLPLAIKAIGGVLYQQNKAKWEEVLE
SDAWHMDLIEEELRPLYLSYEDLPSSLRQCFLYCSLYPQKDMYSKKVIQF
WVAEGLIMDEQDKLRRDLPSQKQRTMEDLGEQIYRELICRNLLEADALLD
VSKSFFSMHDHFRSLSANLMREEGILYRHGRELQVDDNIKIRRLSISCME
LNLVLPTQIIRQGCLRTLILMDSPETKMIEDSVLQALPCLRVLDLTATSI
EKIPDCIGDLLHLRYLDLAGTDIREIPTTIGNLINLQTLNVYGCQYLERL
PASITKLHNLRWLNMIDCLLLTYVPRGIGKLENFYCLEGFMVGQNDSAYE
EGCDLEELKNLSELRFLSIFRLERAGGGASALANKPFLKHLALSYSKGQM
QITSWFAMLHGAASLGHTASAQVPPY
>XP_042380389.1 putative disease resistance protein RGA4, partial [Zingiber officinale]
MEAALVGAASRFMVDKVAVLLKLDEKLKTITGTKRKMEKLKELAPMIDTV
IQHIESRPLMEDTVKELLKKLKYLAYDLEDVVDYYDTKVFQKKQRSKAFL
RPVSDFFSADNQVAFKSRVGGMIKAITESLDSILLQKSILSNLLQGSSPM
SEPSLNNRETHSRNSFVVIGREPEKNKIVDMLTNDDDDDESHHGTVKVIA
IVGMGGLGKTTLAQHVYNDARVQDHFASPTMWKVVGAEFDPTEIMKAVLQ
LATGGSSVNISEIDLVKRKLEEELSGKRFLLVLDDVWNEDALKWGVLKAA
LTCGARGSKILVTTRSQRVSSLMSSSKTTHQLQQLSRDDCLSLFQRFAFG
DQAVDQNLMAIGAKVVEKCGGVPLAAISLGSMLRSTREENYWSSVLNSEI
WKLGNQEDKVLAVLKLSYDALPLRSKKCFAFASLFSKDVKMKKNELIKLW
IANGFVRSEGNFDAETVGEHVFDDLVLRSFFLLVPSQYVTECTMHDLMHD
LARSVSADVYWNSYQDSVENFGNRTYHLQIDRRKFPNMTQDLGKKPLYLR
TFMHIYTFSHLSINLLELFSELKPLHLRALDLTHGGIREVPTSIGILIHL
RYLNLSWNDIEVLPDSITLCKKKN
>XP_042380391.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEAALVGAASRFMVDKVADLLQLDEKLKTITGTKRKMEKLKELPPIIDMV
IQHIESRPLMEDAVKELLKKLKYLAYDLEDVVDYYDTKVFQKKQRSKSFL
RPVSDFFSADNQVAFKSRVGGMIKAITDSLDSILLQKSILSNLLQEQGSI
SMSEPSLNNRETHSRNSFVVIGREPEKNKIVDMLTKDDDDDESHHGTVKV
IAIVGMGGLGKTTLAQHVYNDARVQDHFASLTMWKVVGAEFNPTKIMKSL
LELTTGGSSVNIFEIDLLNRKLEEELSGKRFLLVLDDVWNENELQWDILK
AALTCGARGSKILVTTRSKRVSSIMSSSNTTHQLQQLSRDDCLSLFQRFA
FGDQAVDQNLMAIGAKVVEKCGGVPLAAISLGSMLRSTREENYWSSVLNS
EIWQLGNEEDKVLAVLKLSYDALPLRSKKCFAFASLFSKDVPMEKDELIK
LWIANGFIRSEGNFDAETVGEHVFDDLVLRSLFVTSQYVTECTMHDLMYD
LARSVSADVYWNSYQDSVENFGNRTYHLQIDPRKFPNITQDLGKKPLYLR
TFMHIDTFSHLSINLLELLSELKPLYLRALDLSNAGIREVPTSIGILIHL
RYLNLSWNHIEVLPDSITLLPNLQYFNLSFNHELRELPKELGNMQNLRDL
DLQTYSRFITHMPCGLSRLTNLRSLPLFIAGDKTGACSIIELENLKLHGK
MVIQFSEDFKNYSCDGRKILKNIDLNELCIEFNERYDKDMFVDLCPNTSL
KKLDICRYRSPQFPAWLMESQLPNLVEVRLRDCSGCEHIPPFGNLQFLKR
LDLDYMNGITHLGAEFHGYRGFPSLRELSLNWISNLEEWSECHVVDQLFP
LLQKLLICWCPKLKSTPRFPRIQELQISCGNGSILSCIGRFTSLSVLQLT
AMPDIASLPSGCIRNLTSLTKLQITNCRQLQSLPGDEMQFLEMLRSLIIE
RCDNLVFFPSEVGSLSSLCFRRNGTISQPKELVQILNSVDEFHIEICDNK
VDLRGQLQYLHTLKILSLFGSHAANQLTIQNGIRKLSICCCDELESLMAA
EEVSNTVLEQLYINRFSNLTTLPDWLQHLKSLRILSIRNCPRLERVPRDL
KNLHMLKTLNIVGCPQLKSRCARETGEDWPIISNIPNVDIE
>XP_042380401.1 putative disease resistance protein RGA3 [Zingiber officinale]
MEGALVAAAARLMFDKVTALLQVDEKLKTITGTKRKMEKLKELSTIIDMV
IQDIEYRPFIHDAVKDLLKKLKYLAYDLEDVVDYYDTKVLQKKQRSKTSL
RPVRDFFSFDNQVVFKSRVGGMIKAITESLDSILLQKSILLNLPQSSIRM
SEPSLCRETHSCNSFVVIGREPEKNKIVDMLTKDDDDESNHGIVKVIAIV
GMGGLGKTTLAQLVYNDARVQDHFSSLTMWKVVGAEFNPTKIMKSVLELA
TGASVNISEIDLVKQKLEKALSRKKFLLVLDDVWNEDELQWGVLKAALTC
GARGSKILVTTRSQQVSLIMGSSNTTHPIQQLSRDDCLSLFQQFAFGDQA
VDQNLMKIGAKIVEKCGGVPLAAISLGSMLRSTREETYWSSVLNSEIWRL
GNQEDKVLAVLKLSYDTLHPWSKKCFSFASLIPKNYRMAKDLLIKLWIAN
GFVRSEGNFDAETNGNHVFNDLVMRSFLILFTPYYDYYSDSHVTECTMHD
LMHDLARSVSADVYWNSDEDSVEDIGKRIYHLQIYERKFPNMTRVVLDKK
PLHLRTFMYFTPPPIYITFEKDQSA
>XP_042381036.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEAALVATTARFVADKVTILVQLDEKLKTITGTKRKMEKLKELSTIIDMV
IRDIECRPFIDDAVKDMLKKLKYLAYDLEDVVDYYDTKVLQKKQRSKTSL
RPVRDFFSFDNQVVFKSRVGGMIKAITESLDSILLQKSILLNLPQSSIRM
SEPISLYRETHSCNSFVVIGRGPEKNKIVNMLTKDDDDDDDDDDAESNHG
TVKVFAIVGMGGIGKTTLAQLVFNDEKVKAHFASLKMWTVVGAEFDPKRI
MKSVLELATDAEVNISQIELVRQNLEKALSGKKFLLVLDDVWNEDELQWG
VLKAALTCGARGSKILVTTRSQQVSLIMGSSNTTHQIQQLSVDDCLSLFK
QFAFGDQAADRTLMKIGGKIVEKCGGVPLAAISLGSMLRSTREETYWSSV
LNSEIWQLRNEEDKVLSVLKLSYDTLPPRSKKCFAFASLFPKKYRMAKDE
LIKLWIANGFIHSEGNFDAETNGNHVFNDLVMGSFFLLAPSRDYEYDSHV
TKCTMHDLMHDLARSVSVDVYWNSIQDSVEDIGKRTYHLQISKGDLLDMT
QVLGKKPLYLRTFMHLYTLSRSISCLSINLFEIVFSELKFLRVVDLSYNA
IREVPTSIGNLKHLKYLNLSKNNIEVLPDSITLLPNLQYFNLSFNYELKE
LPKELGNIQNLRDLDLQYDLTLTHMPCGLSRLTNLRSLPLFIADDKTSTC
SIIELEDLKLHGGMKIKFSKEFKNYSCDGRKILKNKDLNELCIEFNGSKI
YDKYMLDDLCPNTSLKKLDIWYYRSPQFPTWLIELQLPNLVEVSLQNCRD
CEHIPPFGNLQFLKKLYLQSMTDVTQMGDEFHGYGGFPSLQELFLHGMDN
LEEWSESHGVDELFPKLQSLNIFNCPKLKSMPRLPRIQHLKISYCSGSIL
SCIRGLTSLSVLKVEEMNDMTSLPSGCIRNLTSLTELQITECRQLQSLRG
DEMQYLEMLRSFTIESCDNLTSFPSEVEHLSSLCCLRLSDCPSIILKPEE
LVQILNSVDKYGIRKLSICYCDELQSLMTTEAASSTVLEELYIDGISNLT
TLPDWLQHLNSFRLLSIENCPQLERVPRCLKNGRLSVAHN
>XP_042383417.1 putative disease resistance protein RGA3 [Zingiber officinale]
MDIVSPILEISGVNHVINKLVDKTTNYLQDQCCWETYLQEELKSLQDLLP
QIEAVVSFAEHRLTSYESSDRALIKWLWKFRDVIDEAEDVLDELEYLELE
RKANSDKSWLSRRVDASVNAAKRLLKFDDVLGRLRTCVKNLNTSASDVEK
FLALVTPTGGVGTGQMQQGILPLSHQSRITTSLPVSSFKGRVEEKEKIIK
YLLGEESEIQISENVHCLPLVALGGMGKTALAQQVFDYFKNVKKEHFDIK
IWVCDSLPDLNASNLMKKILEYSTGGSESGPLELIPEKLKEKLHSKRFLL
VLDDAWDDKNQREWEKLCAPLLYGQKGSWILLTTRSKSVANMVSKEIRGT
MVPMMLQGLSEDECRSLLYERAFAGQDPNGFPLLKDIGGEIVKKLNGVPL
LAKSIGGALNSKLEANHWMSISRSELWEMPQDLTYNFIPALTLSYVMLPS
CLKRCFSYCSIFPQDYEFNKQKLVCMWVAAGLIYSDGLEEGSDEDIANCC
FDMLYNKSFFDAHHDNWSPFFYDKTLYVLEEDYYTMHDMLNSLACHVSHY
ECCRIVDGTTPSLILDNNTIRHISITCSHAQLHDLANIVSKLKHLRTLWI
EYDGDRQQFEDFIRDACKSPRRIRVLIMASNLSDRCLKSISNFVKIRFLQ
IPNHFLPSLSMRKFYFLQVLMGEDSILAKDANKLTNLRHLYEVHEDALLS
VAKVGKLTSLQELCFTVGTKPRYRIDELMNMNNLHKLSIKQLSNVRSLEE
ANMVNLVKKRYLIRLELDWNDVSNPDDYASNPDLDQPVLAALQPYPTIRE
LTIRGYKGGRLAPWMDTSLSLLQNLQLNACTSLEELPSLWKLPCLKFLKL
KEMNAIRSLGCHFSGQIDIQFPVLEKLGFYDLPLWEEWNGADDYIWFPHL
KNFQILDCPKIKKIPELPLSIENLTMKNLGLEALPRSYNYKCSNGSRTFG
GFQRLMFLETLQIYECAKIVQIGSIGEEDDHLLPSSLKELTLSILFKDDD
LASYLQGLTSLTDLSLYFSPDVESLPSANELEHLTTLQTLYIRGGETLTS
PGGLYIIKSLKFLKISHCPKFLSAAAEVESEEFLKDKTRKHAVSSSSGFD
HSTSDKVTSILPSSLEYLIFTDSGISQESLGRCLQGLSSLKGLEVSGCHR
LVSLPNIEYLHNLTALEELGIFYCKELCELESLTALASLRKLDIKRCPKL
ATTTEQSATKIKKGTLPSLENIDIDDIFYLPILPISEKLKTLFIKSNDKE
FTCFPSEIEESLLQYRKSLENLYLYWMSHLESLPGILESFSSLKKLIIHS
APALKSLPRMPASLEELRISGCSAKLKKRYQKNIRRDLPNIKYIEITADK
EDKAEAQVNCNWVSSRLWCST
>XP_042383418.1 putative disease resistance protein RGA3 [Zingiber officinale]
MDIVSPILEISGVNHVINKLVDKTTNYLQDQCCWETYLQEELKSLQDLLP
QIEAVVSFAEHRLTSYESSDRALIKWLWKFRDVIDEAEDVLDELEYLELE
RKANSDKSWLSRRVDASVNAAKRLLKFDDVLGRLRTCVKNLNTSASDVEK
FLALVTPTGGVGTGQMQQGILPLSHQSRITTSLPVSSFKGRVEEKEKIIK
YLLGEESEIQISENVHCLPLVALGGMGKTALAQQVFDYFKNVKKEHFDIK
IWVCDSLPDLNASNLMKKILEYSTGGSESGPLELIPEKLKEKLHSKRFLL
VLDDAWDDKNQREWEKLCAPLLYGQKGSWILLTTRSKSVANMVSKEIRGT
MVPMMLQGLSEDECRSLLYERAFAGQDPNGFPLLKDIGGEIVKKLNGVPL
LAKSIGGALNSKLEANHWMSISRSELWEMPQDLTYNFIPALTLSYVMLPS
CLKRCFSYCSIFPQDYEFNKQKLVCMWVAAGLIYSDGLEEGSDEDIANCC
FDMLYNKSFFDAHHDNWSPFFYDKTLYVLEEDYYTMHDMLNSLACHVSHY
ECCRIVDGTTPSLILDNNTIRHISITCSHAQLHDLANIVSKLKHLRTLWI
EYDGDRQQFEDFIRDACKSPRRIRVLIMASNLSDRCLKSISNFVKIRFLQ
IPNHFLPSLSMRKFYFLQVLMGEDSILAKDANKLTNLRHLYEVHEDALLS
VAKVGKLTSLQELCFTVGTKPRYRIDELMNMNNLHKLSIKQLSNVRSLEE
ANMVNLVKKRYLIRLELDWNDVSNPDDYASNPDLDQPVLAALQPYPTIRE
LTIRGYKGGRLAPWMDTSLSLLQNLQLNACTSLEELPSLWKLPCLKFLKL
KEMNAIRSLGCHFSGQIDIQFPVLEKLGFYDLPLWEEWNGADDYIWFPHL
KNFQILDCPKIKKIPELPLSIENLTMKNLGLEALPRSYNYKCSNGSRTFG
GFQRLMFLETLQIYECAKIVQIGSIGEEDDHLLPSSLKELTLSILFKDDD
LASYLQGLTSLTDLSLYFSPDVESLPSANELEHLTTLQTLYIRGGETLTS
PGGLYIIKSLKFLKISHCPKFLSAAAEVESEEFLKDKTRKHAVSSSSGFD
HSTSDKVTSILPSSLEYLIFTDSGISQESLGRCLQGLSSLKGLEVSGCHR
LVSLPNIEYLHNLTALEELGIFYCKELCELESLTALASLRKLDIKRCPKL
ATTTEQSATKIKKGTLPSLENIDIDDIFYLPILPISEKLKTLFIKSNDKE
FTCFPSEIEESLLQYRKSLENLYLYWMSHLESLPGILESFSSLKKLIIHS
APALKSLPRMPASLEELRISGCSAKLKKRYQKNIRRDLPNIKYIEITADK
EDKAEAQVNCNWVSSRLWCST
>XP_042383440.1 disease resistance protein RGA2-like [Zingiber officinale]
MDVVSPILQVSGASHVVNKLVDKATTYVRDQYYWKTDLQEELQNLRRLLP
QIQVIVGFAEDRLTSYGSSNRALMEWLGQFRDGIDEAEEVLDELEYLELE
KKANSDKNRLSKTVDGSVKAAKRFLKFDDLLIERLRACVKNLNASASNAH
NFLAILGQTGGIGTGQMQQEFLPLTDQSRITSSLPEVSFKGREEQKQEII
RYLSGESVEESEIQISENVHCLPLVAMGGMGKTTLAQQVCDHFENMKKEH
FDIRIWVCDSLPDLDATSILKKILDSTRQSDDSSTNLDASNLMKKMLDLT
HQSEPSELIPVKLKEKLSSKKFLLVLDDAWDDKNQTAWKRLCDPLLHGQK
GSWILLTTRMESVAKMISKVIKGTMKSMMLQGLSKDECRPLLYEHAFDGQ
DPNKFPRLKEIGEEILEKLKGVPLLAKSIGGALNSKLTEDHWTNISRSEL
WKTPLESKYEFRPILVLSYLMLPPRLKRCFSYCGIFPQDYRFKKQQLVCM
WVAAGLIYSEGSEEGSDEDIANRCFDTLCNKSFFDNRSMLWMKKILFYDT
TEEIYTMHDMLNSLACHVSRYECCRIVHGTPSRILDSNAIRHISITCSID
AQLLDLAKMVCKLKHLRTLWIQYNGDPQKLDDFIRDACKSPRRIRVLIVR
SNDFKVSNQCLKSISDFVKIRFLEIQTILPSLSMRKFYFLQYLIGDQYGS
HLGRLAKDANKLTNLRHLYQVTEDALLSVAEVGKLTSLQELCFTVGTKPR
YRIDELMNMDNLRQLKIKKLSNVRSLEEANMANLVKKYHLTGLDLHWIGA
SNPDLDEQEVLAALQPSTTIKELMIRWYKGGRPAPWMDTPSLSRLEHLQL
EFCTSLEELPPLWKLPCLKFLKLKYMEAIRSLGGHFSDWMGIQFPVLEEL
EFCDLPLLEEWNGADDYVWFPLLKSFQIEKCPRLKNIPDLPLSIENLRFK
DLGLEVLPRFYKCSNGSRTFGGFQQLMFLKSLEIYKCPGIVQIGSIGEED
DHLLPLSLETLELENIEEHKDLANYLRGLTLLTKFHLHCSPGLESFPLAS
ELEHLTVLQDLGISDGESLTSLGDLYILKSLKSLEIFDCPKFLVAEVESE
EFLKDTTRKHAVSSSSIFDQSASNKAARILPSSLESLEFKNSGISQEPLG
RCLQGLTSLERLIVSGCHHLVSLPNIEYLHNLTALQTLNISDCKELCELE
SLTAIASLRHLCINCCPKLLATTFSALQNPATATEHSATKKKKGTLPSLE
NIYIDDIFYLPSLPISEKLKTLSIQSSDKEFTCFPSEIEESLLQYRKSLE
YLSLGGMHHLQYLPASLESFSSLKNLGIYSAPALKSLPRMPVSLVRLRIF
GCSAKLKKRCQENIGRDWPNIKHIPYIDITAGNEDEAEAQVNCNWLSSRL
WSSK
>XP_042383441.1 disease resistance protein RGA2-like [Zingiber officinale]
MDVVSPILQVSGASHVVNKLVDKATTYVRDQYYWKTDLQEELQNLRRLLP
QIQVIVGFAEDRLTSYGSSNRALMEWLGQFRDGIDEAEEVLDELEYLELE
KKANSDKNRLSKTVDGSVKAAKRFLKFDDLLIERLRACVKNLNASASNAH
NFLAILGQTGGIGTGQMQQEFLPLTDQSRITSSLPEVSFKGREEQKQEII
RYLSGESVEESEIQISENVHCLPLVAMGGMGKTTLAQQVCDHFENMKKEH
FDIRIWVCDSLPDLDATSILKKILDSTRQSDDSSTNLDASNLMKKMLDLT
HQSEPSELIPVKLKEKLSSKKFLLVLDDAWDDKNQTAWKRLCDPLLHGQK
GSWILLTTRMESVAKMISKVIKGTMKSMMLQGLSKDECRPLLYEHAFDGQ
DPNKFPRLKEIGEEILEKLKGVPLLAKSIGGALNSKLTEDHWTNISRSEL
WKTPLESKYEFRPILVLSYLMLPPRLKRCFSYCGIFPQDYRFKKQQLVCM
WVAAGLIYSEGSEEGSDEDIANRCFDTLCNKSFFDNRSMLWMKKILFYDT
TEEIYTMHDMLNSLACHVSRYECCRIVHGTPSRILDSNAIRHISITCSID
AQLLDLAKMVCKLKHLRTLWIQYNGDPQKLDDFIRDACKSPRRIRVLIVR
SNDFKVSNQCLKSISDFVKIRFLEIQTILPSLSMRKFYFLQYLIGDQYGS
HLGRLAKDANKLTNLRHLYQVTEDALLSVAEVGKLTSLQELCFTVGTKPR
YRIDELMNMDNLRQLKIKKLSNVRSLEEANMANLVKKYHLTGLDLHWIGA
SNPDLDEQEVLAALQPSTTIKELMIRWYKGGRPAPWMDTPSLSRLEHLQL
EFCTSLEELPPLWKLPCLKFLKLKYMEAIRSLGGHFSDWMGIQFPVLEEL
EFCDLPLLEEWNGADDYVWFPLLKSFQIEKCPRLKNIPDLPLSIENLRFK
DLGLEVLPRFYKCSNGSRTFGGFQQLMFLKSLEIYKCPGIVQIGSIGEED
DHLLPLSLETLELENIEEHKDLANYLRGLTLLTKFHLHCSPGLESFPLAS
ELEHLTVLQDLGISDGESLTSLGDLYILKSLKSLEIFDCPKFLVAEVESE
EFLKDTTRKHAVSSSSIFDQSASNKAARILPSSLESLEFKNSGISQEPLG
RCLQGLTSLERLIVSGCHHLVSLPNIEYLHNLTALQTLNISDCKELCELE
SLTAIASLRHLCINCCPKLLATTFSALQNPATATEHSATKKKKGTLPSLE
NIYIDDIFYLPSLPISEKLKTLSIQSSDKEFTCFPSEIEESLLQYRKSLE
YLSLGGMHHLQYLPASLESFSSLKNLGIYSAPALKSLPRMPVSLVRLRIF
GCSAKLKKRCQENIGRDWPNIKHIPYIDITAGNEDEAEAQVNCNWLSSRL
WSSK
>XP_042383442.1 disease resistance protein RGA2-like [Zingiber officinale]
MDVVSPILQVSGASHVVNKLVDKATTYVRDQYYWKTDLQEELQNLRRLLP
QIQVIVGFAEDRLTSYGSSNRALMEWLGQFRDGIDEAEEVLDELEYLELE
KKANSDKNRLSKTVDGSVKAAKRFLKFDDLLIERLRACVKNLNASASNAH
NFLAILGQTGGIGTGQMQQEFLPLTDQSRITSSLPEVSFKGREEQKQEII
RYLSGESVEESEIQISENVHCLPLVAMGGMGKTTLAQQVCDHFENMKKEH
FDIRIWVCDSLPDLDATSILKKILDSTRQSDDSSTNLDASNLMKKMLDLT
HQSEPSELIPVKLKEKLSSKKFLLVLDDAWDDKNQTAWKRLCDPLLHGQK
GSWILLTTRMESVAKMISKVIKGTMKSMMLQGLSKDECRPLLYEHAFDGQ
DPNKFPRLKEIGEEILEKLKGVPLLAKSIGGALNSKLTEDHWTNISRSEL
WKTPLESKYEFRPILVLSYLMLPPRLKRCFSYCGIFPQDYRFKKQQLVCM
WVAAGLIYSEGSEEGSDEDIANRCFDTLCNKSFFDNRSMLWMKKILFYDT
TEEIYTMHDMLNSLACHVSRYECCRIVHGTPSRILDSNAIRHISITCSID
AQLLDLAKMVCKLKHLRTLWIQYNGDPQKLDDFIRDACKSPRRIRVLIVR
SNDFKVSNQCLKSISDFVKIRFLEIQTILPSLSMRKFYFLQYLIGDQYGS
HLGRLAKDANKLTNLRHLYQVTEDALLSVAEVGKLTSLQELCFTVGTKPR
YRIDELMNMDNLRQLKIKKLSNVRSLEEANMANLVKKYHLTGLDLHWIGA
SNPDLDEQEVLAALQPSTTIKELMIRWYKGGRPAPWMDTPSLSRLEHLQL
EFCTSLEELPPLWKLPCLKFLKLKYMEAIRSLGGHFSDWMGIQFPVLEEL
EFCDLPLLEEWNGADDYVWFPLLKSFQIEKCPRLKNIPDLPLSIENLRFK
DLGLEVLPRFYKCSNGSRTFGGFQQLMFLKSLEIYKCPGIVQIGSIGEED
DHLLPLSLETLELENIEEHKDLANYLRGLTLLTKFHLHCSPGLESFPLAS
ELEHLTVLQDLGISDGESLTSLGDLYILKSLKSLEIFDCPKFLVAEVESE
EFLKDTTRKHAVSSSSIFDQSASNKAARILPSSLESLEFKNSGISQEPLG
RCLQGLTSLERLIVSGCHHLVSLPNIEYLHNLTALQTLNISDCKELCELE
SLTAIASLRHLCINCCPKLLATTFSALQNPATATEHSATKKKKGTLPSLE
NIYIDDIFYLPSLPISEKLKTLSIQSSDKEFTCFPSEIEESLLQYRKSLE
YLSLGGMHHLQYLPASLESFSSLKNLGIYSAPALKSLPRMPVSLVRLRIF
GCSAKLKKRCQENIGRDWPNIKHIPYIDITAGNEDEAEAQVNCNWLSSRL
WSSK
>XP_042383503.1 disease resistance protein RPM1-like [Zingiber officinale]
MAETALQFVLQKLNYWIVQEQQLLGGLRPAIKDIRDELECIAEFIREADA
GEDKDGAKAFMRQLREIAYDIEDHLEDYTLHFGQPQEDRCFGMLRRSLHD
LKHWRSWHRMATEIREIKSRVRSISDRRKMYKFRTTNSTASRNILHDRHV
AALFMDEAELVGISEPREQIIRWLVEGKSNLQAISVVGMGGLGKTTLVRK
VYDDERVKAFFTSHAWISVTQSYTEEVLLRSIISQLYEEIHETLPARIET
MGIIQLIPTLRHFLEHKRYIIVFDDIWHIHAWNCFKLALPDDHCGSRVLV
TTRIGDVGLHCLEACGHVYQLEPLPPAVAWSLFCKKAFRSLPGAACPPEL
HVISQEIVRVCEGLPLAIVTLAGLLSKKNSVLEWTTMRDNLHAELANNPK
LETIMRILQLSYNDLPHHLKPCFLYFSIFPKERSVELPVSRITLIRLWIA
EGFIETDESESMERVATEYLNDLIDRNMVEVAVHYDYGRVKSCRVHDLFH
ELIVFKSKEENFSTSLIRKGSQIQEKIRRLSTHNISEPLLQGTDLSHLRA
IFVFGQNASVISSQANLFSRLKLLKILDLSEAPIESCPFEFGNLPHLRYL
SFRNTRIKKLSKSLGKLKNLETLDLKGTYVTELPKTILNLQRLRHLLAYR
YYTDDEPPLYHVVGMKLPKGIGAFRELQKLAYLEMDQDGGIIKELGSLTQ
LKRLAIVKLRREDGANVCSSLEKMKQLKSFSASSSHMGEFLHLEALKSPP
PFLERLYFRGPLRSLPSWISSLNSLISLRLRWSRLPENSLGILEALPNLL
ELVLVHAYVGARLFFHKGGFQRLKVLDLEQLDSLNYVILDGAMPNLQIMY
IRSCAQLEMVPQGIEELIHLKELHLFDMPEVFLQRLWRLKGIDHPKVNHI
PIVRSYDDQNRVYEI
>XP_042383505.1 disease resistance protein RPM1-like [Zingiber officinale]
MAETALQFVLQKLNYWIVQEQQLLGGLRPAIKDIRDELECIAEFIREADA
GEDKDGAKAFMRQLREIAYDIEDHLEDYTLHFGQPQEDRCFGMLRRSLHD
LKHWRSWHRMATEIREIKSRVRSISDRRKMYKFRTTNSTASRNILHDRHV
AALFMDEAELVGISEPREQIIRWLVEGKSNLQAISVVGMGGLGKTTLVRK
VYDDERVKAFFTSHAWISVTQSYTEEVLLRSIISQLYEEIHETLPARIET
MGIIQLIPTLRHFLEHKRYIIVFDDIWHIHAWNCFKLALPDDHCGSRVLV
TTRIGDVGLHCLEACGHVYQLEPLPPAVAWSLFCKKAFRSLPGAACPPEL
HVISQEIVRVCEGLPLAIVTLAGLLSKKNSVLEWTTMRDNLHAELANNPK
LETIMRILQLSYNDLPHHLKPCFLYFSIFPKERSVELPVSRITLIRLWIA
EGFIETDESESMERVATEYLNDLIDRNMVEVAVHYDYGRVKSCRVHDLFH
ELIVFKSKEENFSTSLIRKGSQIQEKIRRLSTHNISEPLLQGTDLSHLRA
IFVFGQNASVISSQANLFSRLKLLKILDLSEAPIESCPFEFGNLPHLRYL
SFRNTRIKKLSKSLGKLKNLETLDLKGTYVTELPKTILNLQRLRHLLAYR
YYTDDEPPLYHVVGMKLPKGIGAFRELQKLAYLEMDQDGGIIKELGSLTQ
LKRLAIVKLRREDGANVCSSLEKMKQLKSFSASSSHMGEFLHLEALKSPP
PFLERLYFRGPLRSLPSWISSLNSLISLRLRWSRLPENSLGILEALPNLL
ELVLVHAYVGARLFFHKGGFQRLKVLDLEQLDSLNYVILDGAMPNLQIMY
IRSCAQLEMVPQGIEELIHLKELHLFDMPEVFLQRLWRLKGIDHPKVNHI
PIVRSYDDQNRVYEI
>XP_042383507.1 disease resistance protein RPM1-like [Zingiber officinale]
MAASGALQFALQKLDSILVQEQQLLRGFNTRIKDIRDELESLKIFLRGAD
AGDDKDDIKAWMRQLRDIAYDMEDLLEEYTFHFGQPHRHRLLGFLTTSIQ
SLRHLFTRRKMSIAIQDIKTQLRNISERRSTYKFNSSFNATKKRVHDRHL
AALFMEEAELVGIRKPKEEIVGRLVKGGGSSSLTVVSVVGMGGLGKTTLV
RKVYDDEQVKGWFNSHAWITVTPSFTVEELLKSIIIQFYEERHEKLPARI
QTMECIQLIDTLRQFLQDKRYIAVLDDLWHITPWECLKYALPNSECGSRI
VVTTRNKDIGLSCIESCGSLYELQPLPQPEAWFLFCKKAFRSVSAGVCPS
ELQDVAEDIVKVCGGLPLAIVTIAGLLSKKAHVLEWRKLRDNLHAELANN
PKLEIIKQILLLSYNDLPHFLKSCILYFSIFPKEHAVTRITLIRLWIAEG
FIESERGETMERIAGDYLNDLIDRSMVQVAERYDYGRVRSCRVHDLIHEV
IVLKSEEENFSTLMITRDTKRHGKIRRSSTHAAGEHLLQSDLSHLRALFM
FRENVLPIPSVVNLLSRLRLLRILDLTGAPIESFPLEFGKLPHLRYLSFR
NTRISKLPKSLGQLKNLETLDLKETYVTELPKTILNLQNLRHLLAYHYYT
SHRPPYYLADGVKLPHGIGKFRELQKLTYLEINQDSRIVRELGNLTQLKR
LGLVKLRRVDGASLCKSIEKMEKLLSLSVTSVGMDEYLNLRSLTSPPPLL
QRLYLRGPLQALPNWISSLKHLVRMRLRWSRLKEDSFGVLEELPSLVELT
LIHAYDGANLRCQKGGFQKLKILDLERLNNLNHVVVDGSMPNLQKMYIRS
CVQLQEVPQGIQQLVLLKEIHLFDMPEEFVQRLEGEDYALVSHVPIRRSY
DSEKGVYKEL
>XP_042383508.1 disease resistance protein RPM1-like [Zingiber officinale]
MAASGALQFALQKLDSILVQEQQLLRGFNTRIKDIRDELESLKIFLRGAD
AGDDKDDIKAWMRQLRDIAYDMEDLLEEYTFHFGQPHRHRLLGFLTTSIQ
SLRHLFTRRKMSIAIQDIKTQLRNISERRSTYKFNSSFNATKKRVHDRHL
AALFMEEAELVGIRKPKEEIVGRLVKGGGSSSLTVVSVVGMGGLGKTTLV
RKVYDDEQVKGWFNSHAWITVTPSFTVEELLKSIIIQFYEERHEKLPARI
QTMECIQLIDTLRQFLQDKRYIAVLDDLWHITPWECLKYALPNSECGSRI
VVTTRNKDIGLSCIESCGSLYELQPLPQPEAWFLFCKKAFRSVSAGVCPS
ELQDVAEDIVKVCGGLPLAIVTIAGLLSKKAHVLEWRKLRDNLHAELANN
PKLEIIKQILLLSYNDLPHFLKSCILYFSIFPKEHAVTRITLIRLWIAEG
FIESERGETMERIAGDYLNDLIDRSMVQVAERYDYGRVRSCRVHDLIHEV
IVLKSEEENFSTLMITRDTKRHGKIRRSSTHAAGEHLLQSDLSHLRALFM
FRENVLPIPSVVNLLSRLRLLRILDLTGAPIESFPLEFGKLPHLRYLSFR
NTRISKLPKSLGQLKNLETLDLKETYVTELPKTILNLQNLRHLLAYHYYT
SHRPPYYLADGVKLPHGIGKFRELQKLTYLEINQDSRIVRELGNLTQLKR
LGLVKLRRVDGASLCKSIEKMEKLLSLSVTSVGMDEYLNLRSLTSPPPLL
QRLYLRGPLQALPNWISSLKHLVRMRLRWSRLKEDSFGVLEELPSLVELT
LIHAYDGANLRCQKGGFQKLKILDLERLNNLNHVVVDGSMPNLQKMYIRS
CVQLQEVPQGIQQLVLLKEIHLFDMPEEFVQRLEGEDYALVSHVPIRRSY
DSEKGVYKEL
>XP_042383519.1 disease resistance protein RGA2-like [Zingiber officinale]
MDIVSPILEKAGASYVINKLIDAATGYVQDQYYWKTDLQGELQNLGRLLP
QIQAVVDFAEPRLTMYESSNPALIKWLWQFRNGIDEAEDVLDDLEYIELE
KKANSDKSRLSRRVDASVKAAKRLLKFDDVLGRLRACVKNLNTFASDVQN
FLALVTQTVGIGTGQMRYYHSSRITNPLPVLSFKGREDEKGKIIQYLLGE
SVEKSEMWINESVHCLPLVAIGGMGKTVLAKQVFHHFENVKKKHFDIKIW
VCDSLPDLNASSLIKKILEYQTGGSESGPLERLPVKLQKILHSKRFLLVL
DDVWDDNNQTEWEKLCAPLVYSQKGSWIILTTRLRSVAKMISKVIRSTME
PMILRGLSNDECRSLLYEHAFSGEDPNKFPLLKEIGEEIVEKLKGVPLLA
KSIGGALNSKLEADHWTSISRSELWQMPIDSKYEFNPVLTLSYVMLPPRL
KRCFSYCSIFPQDYQFKKQKLVCMWVAADLIYKDELEDGLDEEDIANRCF
DILCNKSFFDVHTYSRSLSRSQMLFCQRYSLYDFKEDFYTMHDMLNGLAC
HVSRYECCRIVHDTPSHILDNNVIRHIYVTGSHAQLHDLAKIVSKLKHLR
TLWINYHGDPQKLDDCIRYACKSSRRIRVLIMESNYSRSSYQCLKSINDF
LKLRFLEMTGLLLPP
>XP_042383549.1 putative disease resistance protein RGA3 [Zingiber officinale]
MDVVSPIMEKAGARCVINKLIDAATTYVRDQYYWKTDLKEELQSLRRLLP
QIEAVVGFAEHRLTMYESSNRALMEWLWQFRNGIEEAEEVLDELEYLELK
KKVNRDKNRLSLTVDASVKTAKRLLKFDDVLERLRTCVKNLNTSASDVQN
FLTLVTQKDGNSNGQMQCYLSSRITNPLPVLSFKGREEEKGKIIRYLLGE
SVEESKIQMNENVHCLPLVAMGGMGKTALAKQVFDHFENVKKEHFDIKIW
ICDSLPNLDASSLMKKILKYLACQSESDPLELTPVKLKEKLHSKRFLLVL
DDAWDDKNQTEWDKLCDPLLYGQKGSWILLTTRLRSVAKIVSKVIKRGTM
EPMILQGLSNDECRSLLYEHAFAGQDPNGFPLLKEIGEEIVEKLKGVPLL
AKSIGGALNSKLEANHWTSISRSELWKMPQDSKYEFSPVLTLSYVMLPPR
LKRCFSYCGIFPQDYRFNKQKLVCMWVAAGLIYSEESEEGSNEDIANCCF
DMLCNKSFFDVHIYGQIWSSFWERNSLYDLEEDYYTMHDMLNCLACHVSR
YECCKIVHDAPSCILDYNAIRHLSITNNLVQLHDLSKMVCKFQHLRTLWI
EDDGNHQQFHEVILDACKSPRRIRVLIMKSNYSRISYQCLERISDFVKLR
FLEMSRFSGPPSLSKCKFYFLQVLIGYNVIPAKDANKLANLRHLYRVHDD
ALFSVAKVGKLTSLQELCFTVGTKPEYRIDELMNMDNLHQLTIQQLSNVQ
SHKEANMANLVKKRHLTRLALNYWFGVSNPDGVSNPDIDHQEILAALQPP
PTIRELIITGYKGGRPAPWMDTPSISRLEYLQLHTCTSLEELPPLWKLPC
LKFLKLHDMKTIRSLGCHFSNQMDIQFPVLENLIFYALPLWEEWNGVDSH
IWFPHLKRFEIYHCPKLKKIPDLPLSIENLKMEYLGLEALPHSYKCSNGS
RTFGGFQQLMSLESLHIYQCPGIVQIGTIGEEDDNLLPSSLKQLGLGGIF
VEHKYLASYLRGLTSLTHLSLSCSRGMTSLPLANELEHLTTLQHLRIWGG
EAFISPRGLYIIKSLKSLEISNCPKFLSAEVESQEFLKDKPTKHAVSSSL
VFDHSASNKATSILPSSLVSLKLENSDILQESLGRCLQGLTSLKELQVSY
CHHLVSFPNIEYLHNLAAFETLDISNCKELCELESLTTLASLRELYIERC
PKLLTTTFSTLQNPAATTEQSATKKKKGTLPSLEHIYMDEIFYLPSLPIP
ERLNSLSIDNIFMGSSQVFHCFPSEIEDWLLQCRESLEVLELGQMPHLQS
LPASLESFSSLRSLRIDFSPELKSLSKMPTSLKILKLYGCSAKLKKRCQE
NIGPDWPNISHMPDIHIIVGKDDKDEVQINCNCVSSRLWSSR
>XP_042383550.1 putative disease resistance protein RGA3 [Zingiber officinale]
MDVVSPIMEKAGARCVINKLIDAATTYVRDQYYWKTDLKEELQSLRRLLP
QIEAVVGFAEHRLTMYESSNRALMEWLWQFRNGIEEAEEVLDELEYLELK
KKVNRDKNRLSLTVDASVKTAKRLLKFDDVLERLRTCVKNLNTSASDVQN
FLTLVTQKDGNSNGQMQCYLSSRITNPLPVLSFKGREEEKGKIIRYLLGE
SVEESKIQMNENVHCLPLVAMGGMGKTALAKQVFDHFENVKKEHFDIKIW
ICDSLPNLDASSLMKKILKYLACQSESDPLELTPVKLKEKLHSKRFLLVL
DDAWDDKNQTEWDKLCDPLLYGQKGSWILLTTRLRSVAKIVSKVIKRGTM
EPMILQGLSNDECRSLLYEHAFAGQDPNGFPLLKEIGEEIVEKLKGVPLL
AKSIGGALNSKLEANHWTSISRSELWKMPQDSKYEFSPVLTLSYVMLPPR
LKRCFSYCGIFPQDYRFNKQKLVCMWVAAGLIYSEESEEGSNEDIANCCF
DMLCNKSFFDVHIYGQIWSSFWERNSLYDLEEDYYTMHDMLNCLACHVSR
YECCKIVHDAPSCILDYNAIRHLSITNNLVQLHDLSKMVCKFQHLRTLWI
EDDGNHQQFHEVILDACKSPRRIRVLIMKSNYSRISYQCLERISDFVKLR
FLEMSRFSGPPSLSKCKFYFLQVLIGYNVIPAKDANKLANLRHLYRVHDD
ALFSVAKVGKLTSLQELCFTVGTKPEYRIDELMNMDNLHQLTIQQLSNVQ
SHKEANMANLVKKRHLTRLALNYWFGVSNPDGVSNPDIDHQEILAALQPP
PTIRELIITGYKGGRPAPWMDTPSISRLEYLQLHTCTSLEELPPLWKLPC
LKFLKLHDMKTIRSLGCHFSNQMDIQFPVLENLIFYALPLWEEWNGVDSH
IWFPHLKRFEIYHCPKLKKIPDLPLSIENLKMEYLGLEALPHSYKCSNGS
RTFGGFQQLMSLESLHIYQCPGIVQIGTIGEEDDNLLPSSLKQLGLGGIF
VEHKYLASYLRGLTSLTHLSLSCSRGMTSLPLANELEHLTTLQHLRIWGG
EAFISPRGLYIIKSLKSLEISNCPKFLSAEVESQEFLKDKPTKHAVSSSL
VFDHSASNKATSILPSSLVSLKLENSDILQESLGRCLQGLTSLKELQVSY
CHHLVSFPNIEYLHNLAAFETLDISNCKELCELESLTTLASLRELYIERC
PKLLTTTFSTLQNPAATTEQSATKKKKGTLPSLEHIYMDEIFYLPSLPIP
ERLNSLSIDNIFMGSSQVFHCFPSEIEDWLLQCRESLEVLELGQMPHLQS
LPASLESFSSLRSLRIDFSPELKSLSKMPTSLKILKLYGCSAKLKKRCQE
NIGPDWPNISHMPDIHIIVGKDDKDEVQINCNCVSSRLWSSR
>XP_042383553.1 disease resistance protein RGA2-like [Zingiber officinale]
MEWLWQFRDGIDEAEEVLDELEYLERKKKANSDKNRLSRMVDATVKAAKR
LLKFDDVLGRLRTCVKNLNTSASDVQNFLTLVMQKDGNSTGQMQQEILPL
SSIQSRITSSLPVLSFKGREEEKGTIIQYLLGESVEESEIQISENVHFLP
LVAMGGMGKTALAQQVFDHFENVKKEHFDIKIWVCISTDFDASSLMKKIL
EYSTSRSEFGPMEQLPVKLKEKLHSKRFLLVLDDAWDDNNQIEWEKLCAP
LLYGQKGSWIILTTRLTSVAKMVSKVMRGVTMEPMMLQGLSNDECRSLLY
EHAFVGQDPNRFPLLKEIGEEIVEKLKGVPLLAKSIGGALNSRLEVDHWT
SISRSELWKMPQDSKYDFIPSLTLSYMMLPPRLKRCFSYCGIFPQDYKFN
KQKLVCMWVAAGLIYLDGLEEGSDEDIANCCFDMLCNKSFFDIHTYIWRS
IWIGQTCNAPYGLGQDYYTMHDMLNGLACYVSRYECCRIIHGAPTCILDY
NAICHISFTSNHPAQLHELGKMLCKFQHLRTLWIEYDGDHQQFDNFIRDA
CKSSRRI
>XP_042383554.1 disease resistance protein RGA2-like [Zingiber officinale]
MEWLWQFRDGIDEAEEVLDELEYLERKKKANSDKNRLSRMVDATVKAAKR
LLKFDDVLGRLRTCVKNLNTSASDVQNFLTLVMQKDGNSTGQMQQEILPL
SSIQSRITSSLPVLSFKGREEEKGTIIQYLLGESVEESEIQISENVHFLP
LVAMGGMGKTALAQQVFDHFENVKKEHFDIKIWVCISTDFDASSLMKKIL
EYSTSRSEFGPMEQLPVKLKEKLHSKRFLLVLDDAWDDNNQIEWEKLCAP
LLYGQKGSWIILTTRLTSVAKMVSKVMRGVTMEPMMLQGLSNDECRSLLY
EHAFVGQDPNRFPLLKEIGEEIVEKLKGVPLLAKSIGGALNSRLEVDHWT
SISRSELWKMPQDSKYDFIPSLTLSYMMLPPRLKRCFSYCGIFPQDYKFN
KQKLVCMWVAAGLIYLDGLEEGSDEDIANCCFDMLCNKSFFDIHTYIWRS
IWIGQTCNAPYGLGQDYYTMHDMLNGLACYVSRYECCRIIHGAPTCILDY
NAICHISFTSNHPAQLHELGKMLCKFQHLRTLWIEYDGDHQQFDNFIRDA
CKSSRRI
>XP_042383555.1 disease resistance protein RGA2-like [Zingiber officinale]
MEWLWQFRDGIDEAEEVLDELEYLERKKKANSDKNRLSRMVDATVKAAKR
LLKFDDVLGRLRTCVKNLNTSASDVQNFLTLVMQKDGNSTGQMQQEILPL
SSIQSRITSSLPVLSFKGREEEKGTIIQYLLGESVEESEIQISENVHFLP
LVAMGGMGKTALAQQVFDHFENVKKEHFDIKIWVCISTDFDASSLMKKIL
EYSTSRSEFGPMEQLPVKLKEKLHSKRFLLVLDDAWDDNNQIEWEKLCAP
LLYGQKGSWIILTTRLTSVAKMVSKVMRGVTMEPMMLQGLSNDECRSLLY
EHAFVGQDPNRFPLLKEIGEEIVEKLKGVPLLAKSIGGALNSRLEVDHWT
SISRSELWKMPQDSKYDFIPSLTLSYMMLPPRLKRCFSYCGIFPQDYKFN
KQKLVCMWVAAGLIYLDGLEEGSDEDIANCCFDMLCNKSFFDIHTYIWRS
IWIGQTCNAPYGLGQDYYTMHDMLNGLACYVSRYECCRIIHGAPTCILDY
NAICHISFTSNHPAQLHELGKMLCKFQHLRTLWIEYDGDHQQFDNFIRDA
CKSSRRI
>XP_042383556.1 disease resistance protein RGA2-like [Zingiber officinale]
MEWLWQFRDGIDEAEEVLDELEYLERKKKANSDKNRLSRMVDATVKAAKR
LLKFDDVLGRLRTCVKNLNTSASDVQNFLTLVMQKDGNSTGQMQQEILPL
SSIQSRITSSLPVLSFKGREEEKGTIIQYLLGESVEESEIQISENVHFLP
LVAMGGMGKTALAQQVFDHFENVKKEHFDIKIWVCISTDFDASSLMKKIL
EYSTSRSEFGPMEQLPVKLKEKLHSKRFLLVLDDAWDDNNQIEWEKLCAP
LLYGQKGSWIILTTRLTSVAKMVSKVMRGVTMEPMMLQGLSNDECRSLLY
EHAFVGQDPNRFPLLKEIGEEIVEKLKGVPLLAKSIGGALNSRLEVDHWT
SISRSELWKMPQDSKYDFIPSLTLSYMMLPPRLKRCFSYCGIFPQDYKFN
KQKLVCMWVAAGLIYLDGLEEGSDEDIANCCFDMLCNKSFFDIHTYIWRS
IWIGQTCNAPYGLGQDYYTMHDMLNGLACYVSRYECCRIIHGAPTCILDY
NAICHISFTSNHPAQLHELGKMLCKFQHLRTLWIEYDGDHQQFDNFIRDA
CKSSRRI
>XP_042383557.1 disease resistance protein RGA2-like [Zingiber officinale]
MEWLWQFRDGIDEAEEVLDELEYLERKKKANSDKNRLSRMVDATVKAAKR
LLKFDDVLGRLRTCVKNLNTSASDVQNFLTLVMQKDGNSTGQMQQEILPL
SSIQSRITSSLPVLSFKGREEEKGTIIQYLLGESVEESEIQISENVHFLP
LVAMGGMGKTALAQQVFDHFENVKKEHFDIKIWVCISTDFDASSLMKKIL
EYSTSRSEFGPMEQLPVKLKEKLHSKRFLLVLDDAWDDNNQIEWEKLCAP
LLYGQKGSWIILTTRLTSVAKMVSKVMRGVTMEPMMLQGLSNDECRSLLY
EHAFVGQDPNRFPLLKEIGEEIVEKLKGVPLLAKSIGGALNSRLEVDHWT
SISRSELWKMPQDSKYDFIPSLTLSYMMLPPRLKRCFSYCGIFPQDYKFN
KQKLVCMWVAAGLIYLDGLEEGSDEDIANCCFDMLCNKSFFDIHTYIWRS
IWIGQTCNAPYGLGQDYYTMHDMLNGLACYVSRYECCRIIHGAPTCILDY
NAICHISFTSNHPAQLHELGKMLCKFQHLRTLWIEYDGDHQQFDNFIRDA
CKSSRRI
>XP_042383558.1 disease resistance protein RGA2-like [Zingiber officinale]
MEWLWQFRDGIDEAEEVLDELEYLERKKKANSDKNRLSRMVDATVKAAKR
LLKFDDVLGRLRTCVKNLNTSASDVQNFLTLVMQKDGNSTGQMQQEILPL
SSIQSRITSSLPVLSFKGREEEKGTIIQYLLGESVEESEIQISENVHFLP
LVAMGGMGKTALAQQVFDHFENVKKEHFDIKIWVCISTDFDASSLMKKIL
EYSTSRSEFGPMEQLPVKLKEKLHSKRFLLVLDDAWDDNNQIEWEKLCAP
LLYGQKGSWIILTTRLTSVAKMVSKVMRGVTMEPMMLQGLSNDECRSLLY
EHAFVGQDPNRFPLLKEIGEEIVEKLKGVPLLAKSIGGALNSRLEVDHWT
SISRSELWKMPQDSKYDFIPSLTLSYMMLPPRLKRCFSYCGIFPQDYKFN
KQKLVCMWVAAGLIYLDGLEEGSDEDIANCCFDMLCNKSFFDIHTYIWRS
IWIGQTCNAPYGLGQDYYTMHDMLNGLACYVSRYECCRIIHGAPTCILDY
NAICHISFTSNHPAQLHELGKMLCKFQHLRTLWIEYDGDHQQFDNFIRDA
CKSSRRI
>XP_042384165.1 disease resistance protein RGA2-like isoform X1 [Zingiber officinale]
MEGALVAAAARLMFDKVTALLQVDEKLKTITGTKRKMEKLKELSTIIDMV
IRDIECRPFIDDAVKDMLKKLKYLAYDLEDVVDYYDTKVLQKKQRSKTSL
RPVRDFFSFDNQVVFKSRVGGMIKAITESLDSILLQKSILLNLPQSSIRM
SEPSLCRETHSCNSFVVIGREPEKNKIVDMLTKDDDDESNHGTVKVIAIV
GMGGLGKTSLAQLVYNDARVQNHFASLTMWKVVGAEFNPTKIMKSVLELA
TGASVNISEIDLVKQKLEKALSRKKFLLVLDDVWNEDELQWGVLKAALTC
GARGSKILVTTRSQQVSLIMGSSNTTHQIQQLSRDDCLSLFQQFAFGDQA
VDQNLMKIGAKIVEKCGGVPLAAISLGSMLRSTRDETYWSSVLNSEIWRL
GNQEDKVLAVLKLSYDTLHPWSKKCFSFASLIPKNYRMAKDLLIKLWIAN
GFVRSEGNFDAETNGNHVFNDLVMRSFLILFTPYYDYYSDSHVTECTMHD
LMHDLARSVSADVYWNSDEDSVEDIGKRIYHLQIYERKFPNMTRVVLDKK
PLHLRTFMSFTPPLYILRSRRINQLEVISELKFLRALDLNNGGIKEVPTS
IGNLIHLRYLNLSRNYIEVLPDSITLLPNLQYLNLSFNYTLRELPKELGN
IQNLRDLSILESDSELTHMPCGLSRLTNLGSLPLFIAGDKIGACSIIELV
DLKLYGKMKIEFSKNFKNYSCGGRKILKNKVLNELCLEFNGSEIYDKDML
DDLCPNTSLKKLSIFNYRSPQFPTWLIELQLPNLVEVRLENCRDCEHIPP
LGNLQKLQMYNCLELKCMPRLPRIQELSISYCSGSLLSCVERLTSLSVLK
VDGFNGMTSLPSGCIRNLTSLTELQISNCGQLQSLPGDEMQYLKMLRSLT
IQMCDNLTSFPSEVGRLSSLCFLRISECTNIILQPEELAQILNPVHEFDI
EICGNKVNLRGQLQYLHTLQNLSLHGSHVTNNYTFGCEIRKLSICCCDEL
ESLMTVEPASSTVLEQLYIDGISNLMALPDWLQHLNSLRFLLIEDCPRLE
RVPRGLKNLHMLEYLRIVGCPQLESRCERETGEDWPIISHVPHTCLYLID
ISDSGYGWKDQCVREV
>XP_042384166.1 disease resistance protein RGA2-like isoform X1 [Zingiber officinale]
MEGALVAAAARLMFDKVTALLQVDEKLKTITGTKRKMEKLKELSTIIDMV
IRDIECRPFIDDAVKDMLKKLKYLAYDLEDVVDYYDTKVLQKKQRSKTSL
RPVRDFFSFDNQVVFKSRVGGMIKAITESLDSILLQKSILLNLPQSSIRM
SEPSLCRETHSCNSFVVIGREPEKNKIVDMLTKDDDDESNHGTVKVIAIV
GMGGLGKTSLAQLVYNDARVQNHFASLTMWKVVGAEFNPTKIMKSVLELA
TGASVNISEIDLVKQKLEKALSRKKFLLVLDDVWNEDELQWGVLKAALTC
GARGSKILVTTRSQQVSLIMGSSNTTHQIQQLSRDDCLSLFQQFAFGDQA
VDQNLMKIGAKIVEKCGGVPLAAISLGSMLRSTRDETYWSSVLNSEIWRL
GNQEDKVLAVLKLSYDTLHPWSKKCFSFASLIPKNYRMAKDLLIKLWIAN
GFVRSEGNFDAETNGNHVFNDLVMRSFLILFTPYYDYYSDSHVTECTMHD
LMHDLARSVSADVYWNSDEDSVEDIGKRIYHLQIYERKFPNMTRVVLDKK
PLHLRTFMSFTPPLYILRSRRINQLEVISELKFLRALDLNNGGIKEVPTS
IGNLIHLRYLNLSRNYIEVLPDSITLLPNLQYLNLSFNYTLRELPKELGN
IQNLRDLSILESDSELTHMPCGLSRLTNLGSLPLFIAGDKIGACSIIELV
DLKLYGKMKIEFSKNFKNYSCGGRKILKNKVLNELCLEFNGSEIYDKDML
DDLCPNTSLKKLSIFNYRSPQFPTWLIELQLPNLVEVRLENCRDCEHIPP
LGNLQKLQMYNCLELKCMPRLPRIQELSISYCSGSLLSCVERLTSLSVLK
VDGFNGMTSLPSGCIRNLTSLTELQISNCGQLQSLPGDEMQYLKMLRSLT
IQMCDNLTSFPSEVGRLSSLCFLRISECTNIILQPEELAQILNPVHEFDI
EICGNKVNLRGQLQYLHTLQNLSLHGSHVTNNYTFGCEIRKLSICCCDEL
ESLMTVEPASSTVLEQLYIDGISNLMALPDWLQHLNSLRFLLIEDCPRLE
RVPRGLKNLHMLEYLRIVGCPQLESRCERETGEDWPIISHVPHTCLYLID
ISDSGYGWKDQCVREV
>XP_042384167.1 disease resistance protein RGA2-like isoform X2 [Zingiber officinale]
MEGALVAAAARLMFDKVTALLQVDEKLKTITGTKRKMEKLKELSTIIDMV
IRDIECRPFIDDAVKDMLKKLKYLAYDLEDVVDYYDTKVLQKKQRSKTSL
RPVRDFFSFDNQVVFKSRVGGMIKAITESLDSILLQKSILLNLPQSSIRM
SEPSLCRETHSCNSFVVIGREPEKNKIVDMLTKDDDDESNHGTVKVIAIV
GMGGLGKTSLAQLVYNDARVQNHFASLTMWKVVGAEFNPTKIMKSVLELA
TGASVNISEIDLVKQKLEKALSRKKFLLVLDDVWNEDELQWGVLKAALTC
GARGSKILVTTRSQQVSLIMGSSNTTHQIQQLSRDDCLSLFQQFAFGDQA
VDQNLMKIGAKIVEKCGGVPLAAISLGSMLRSTRDETYWSSVLNSEIWRL
GNQEDKVLAVLKLSYDTLHPWSKKCFSFASLIPKNYRMAKDLLIKLWIAN
GFVRSEGNFDAETNGNHVFNDLVMRSFLILFTPYYDYYSDSHVTECTMHD
LMHDLARSVSADVYWNSDEDSVEDIGKRIYHLQIYERKFPNMTRVVLDKK
PLHLRTFMSFTPPLYILRSRRINQLEVISELKFLRALDLNNGGIKEVPTS
IGNLIHLRYLNLSRNYIEVLPDSITLLPNLQYLNLSFNYTLRELPKELGN
IQNLRDLSILESDSELTHMPCGLSRLTNLGSLPLFIAGDKIGACSIIELV
DLKLYGKMKIEFSKNFKNYSCGGRKILKNKVLNELCLEFNGSEIYDKDML
DDLCPNTSLKKLSIFNYRSPQFPTWLIELQLPNLVEVRLENCRDCEHIPP
LGNLQKLQMYNCLELKCMPRLPRIQELSISYCSGSLLSCVERLTSLSVLK
VDGFNGMTSLPSGCIRNLTSLTELQISNCGQLQSLPGDEMQYLKMLRSLT
IQMCDNLTSFPSEVGRLSSLCFLRISECTNIILQPEELAQILNPVHEFDI
EICGNKVNLRGQLQYLHTLQNLSLHGSHVTNNYTFGCEIRKLSICCCDEL
ESLMTVEPASSTVLEQLYIDGISNLMALPDWLQHLNSLRFLLIEDCPRLE
RVPRGLKNLHMLEYLRIVGCPQLESRCERETGEDWPIISHVPHTCLYLID
ISDSGYGWKDNKR
>XP_042384168.1 disease resistance protein RGA2-like isoform X3 [Zingiber officinale]
MEGALVAAAARLMFDKVTALLQVDEKLKTITGTKRKMEKLKELSTIIDMV
IRDIECRPFIDDAVKDMLKKLKYLAYDLEDVVDYYDTKVLQKKQRSKTSL
RPVRDFFSFDNQVVFKSRVGGMIKAITESLDSILLQKSILLNLPQSSIRM
SEPSLCRETHSCNSFVVIGREPEKNKIVDMLTKDDDDESNHGTVKVIAIV
GMGGLGKTSLAQLVYNDARVQNHFASLTMWKVVGAEFNPTKIMKSVLELA
TGASVNISEIDLVKQKLEKALSRKKFLLVLDDVWNEDELQWGVLKAALTC
GARGSKILVTTRSQQVSLIMGSSNTTHQIQQLSRDDCLSLFQQFAFGDQA
VDQNLMKIGAKIVEKCGGVPLAAISLGSMLRSTRDETYWSSVLNSEIWRL
GNQEDKVLAVLKLSYDTLHPWSKKCFSFASLIPKNYRMAKDLLIKLWIAN
GFVRSEGNFDAETNGNHVFNDLVMRSFLILFTPYYDYYSDSHVTECTMHD
LMHDLARSVSADVYWNSDEDSVEDIGKRIYHLQIYERKFPNMTRVVLDKK
PLHLRTFMSFTPPLYILRSRRINQLEVISELKFLRALDLNNGGIKEVPTS
IGNLIHLRYLNLSRNYIEVLPDSITLLPNLQYLNLSFNYTLRELPKELGN
IQNLRDLSILESDSELTHMPCGLSRLTNLGSLPLFIAGDKIGACSIIELV
DLKLYGKMKIEFSKNFKNYSCGGRKILKNKVLNELCLEFNGSEIYDKDML
DDLCPNTSLKKLSIFNYRSPQFPTWLIELQLPNLVEVRLENCRDCEHIPP
LGNLQKLQMYNCLELKCMPRLPRIQELSISYCSGSLLSCVERLTSLSVLK
VDGFNGMTSLPSGCIRNLTSLTELQISNCGQLQSLPGDEMQYLKMLRSLT
IQMCDNLTSFPSEVGRLSSLCFLRISECTNIILQPEELAQILNPVHEFDI
EICGNKVNLRGQLQYLHTLQNLSLHGSHVTNNYTFGCEIRKLSICCCDEL
ESLMTVEPASSTVLEQLYIDGISNLMALPDWLQHLNSLRFLLIEDCPRLE
RVPRGLKNLHMLEYLRIVGCPQLESRCERETGEDWPIISHVPHTCLYLID
ISDSGYGWKG
>XP_042384169.1 putative disease resistance protein RGA4 isoform X4 [Zingiber officinale]
MVGKVGAASRFMVDKVADLLQVDEKLKTITGTKRKMEKLKELSTIIDMVI
QDIESRPFIHDAVKDLLKKLKYLAYDLEDVVDYYDTKVFQKKQRSKAFLR
PVSDFFSADNQVAFKSRVGGMIKAITESLDSILLQKSILSNLLQGTIPAS
EPSPYRDTFSSNSLVVIGRESEKNEIVDMLTKDDDDDDESNHGTVKVIAI
VGMGGMGKTALAQLVYNDARVQDHFARSKMYWKVVGTEFDPAKIMKSVLE
LATGASDNISEIELVKQKLKKELSGKRFLLVLDDVWNDNQSKWNVLKAAL
TCGARGSKILVTTRSQQVSSIMGSSNTTHQIQQLSRDDCLSLFQQFAFGD
QVVDQNLMEIGGKIVEKCGGVPLAAISLGSMLRSTREETYWSSVLNSEIW
KLRNEEDKVLAVLKLSYDTLHPWSKKCFAFTSLFPKNERMAKDELIKLWI
ANGFVRSQGNFDAETNGNYVFDDLVMGSFLILLAPYNDYHSDSHVTECTM
HDLMHDLARSVSADVYWNSDEDSVEDIGKRTYHLQIYEGKLPNMTRVVLD
KKPLYLRTFMPLYVFSSWRRINLFEVFSELKFLRALDLTGGGISEVPTAI
GNLIHLRYLNLSKNNIEILPESITLLSNLQYLNLSFNSRLRELPKELGNM
QNLRDLDILPKYSILTHMPCGSSRLTNLLSLPLFIASDKASTCSITELEN
LKLRGKMIIRFSEDFKKYSCGGRKILKNKNLTELGLMFNG
>XP_042384170.1 putative disease resistance protein RGA4 isoform X5 [Zingiber officinale]
MVDKVADLLQVDEKLKTITGTKRKMEKLKELSTIIDMVIQDIESRPFIHD
AVKDLLKKLKYLAYDLEDVVDYYDTKVFQKKQRSKAFLRPVSDFFSADNQ
VAFKSRVGGMIKAITESLDSILLQKSILSNLLQGTIPASEPSPYRDTFSS
NSLVVIGRESEKNEIVDMLTKDDDDDDESNHGTVKVIAIVGMGGMGKTAL
AQLVYNDARVQDHFARSKMYWKVVGTEFDPAKIMKSVLELATGASDNISE
IELVKQKLKKELSGKRFLLVLDDVWNDNQSKWNVLKAALTCGARGSKILV
TTRSQQVSSIMGSSNTTHQIQQLSRDDCLSLFQQFAFGDQVVDQNLMEIG
GKIVEKCGGVPLAAISLGSMLRSTREETYWSSVLNSEIWKLRNEEDKVLA
VLKLSYDTLHPWSKKCFAFTSLFPKNERMAKDELIKLWIANGFVRSQGNF
DAETNGNYVFDDLVMGSFLILLAPYNDYHSDSHVTECTMHDLMHDLARSV
SADVYWNSDEDSVEDIGKRTYHLQIYEGKLPNMTRVVLDKKPLYLRTFMP
LYVFSSWRRINLFEVFSELKFLRALDLTGGGISEVPTAIGNLIHLRYLNL
SKNNIEILPESITLLSNLQYLNLSFNSRLRELPKELGNMQNLRDLDILPK
YSILTHMPCGSSRLTNLLSLPLFIASDKASTCSITELENLKLRGKMIIRF
SEDFKKYSCGGRKILKNKNLTELGLMFNG
>XP_042384171.1 putative disease resistance protein RGA4 isoform X6 [Zingiber officinale]
MVGKVGAASRFMVDKVADLLQVDEKLKTITGTKRKMEKLKELSTIIDMVI
QDIESRPFIHDAVKDLLKKLKYLAYDLEDVVDYYDTKVFQKKQRSKAFLR
PVSDFFSADNQVAFKSRVGGMIKAITESLDSILLQKSILSNLLQGTIPAS
EPSPYRDTFSSNSLVVIGRESEKNEIVDMLTKDDDDDDESNHGTVKVIAI
VGMGGMGKTALAQLVYNDARVQDHFARSKMYWKVVGTEFDPAKIMKSVLE
LATGASDNISEIELVKQKLKKELSGKRFLLVLDDVWNDNQSKWNVLKAAL
TCGARGSKILVTTRSQQVSSIMGSSNTTHQIQQLSRDDCLSLFQQFAFGD
QVVDQNLMEIGGKIVEKCGGVPLAAISLGSMLRSTREETYWSSVLNSEIW
KLRNEEDKVLAVLKLSYDTLHPWSKKCFAFTSLFPKNERMAKDELIKLWI
ANGFVRSQGNFDAETNGNYVFDDLVMGSFLILLAPYNDYHSDSHVTECTM
HDLMHDLARSVSADVYWNSDEDSVEDIGKRTYHLQIYEGKLPNMTRVVLD
KKPLYLRTFMPLYVFSSWRRINLFEVFSELKFLRALDLTGGGISEVPTAI
GNLIHLRMKVEGGG
>XP_042384173.1 putative disease resistance protein RGA4 isoform X7 [Zingiber officinale]
MLTKDDDDDDESNHGTVKVIAIVGMGGMGKTALAQLVYNDARVQDHFARS
KMYWKVVGTEFDPAKIMKSVLELATGASDNISEIELVKQKLKKELSGKRF
LLVLDDVWNDNQSKWNVLKAALTCGARGSKILVTTRSQQVSSIMGSSNTT
HQIQQLSRDDCLSLFQQFAFGDQVVDQNLMEIGGKIVEKCGGVPLAAISL
GSMLRSTREETYWSSVLNSEIWKLRNEEDKVLAVLKLSYDTLHPWSKKCF
AFTSLFPKNERMAKDELIKLWIANGFVRSQGNFDAETNGNYVFDDLVMGS
FLILLAPYNDYHSDSHVTECTMHDLMHDLARSVSADVYWNSDEDSVEDIG
KRTYHLQIYEGKLPNMTRVVLDKKPLYLRTFMPLYVFSSWRRINLFEVFS
ELKFLRALDLTGGGISEVPTAIGNLIHLRYLNLSKNNIEILPESITLLSN
LQYLNLSFNSRLRELPKELGNMQNLRDLDILPKYSILTHMPCGSSRLTNL
LSLPLFIASDKASTCSITELENLKLRGKMIIRFSEDFKKYSCGGRKILKN
KNLTELGLMFNG
>XP_042384266.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEAALVGAASRFMVDKVADLLQLDEKFKTITGTKRKMEKLKELSPIIDMV
IQHIESRPLMEDAAKELLKKLKYLAYDIEDVVDYYDTKVFQKKQRSKNFL
RPVRDFISSENQVMFKSRIGGMIKAITESLDSILLQKSILSNLIQEQGSI
PASEPSLYNRVAHSRNSFVVIGRETEKQMIVNMLIKDDDDDESSHGTLKI
ISIVGMGGLGKTTLAQHVFNDEKVKEHFASLKLWTVIGAEFDPVEIMKSV
LQLATLKPVNISEIDLVMQELETALSGKRFLLVLDDVWNEYESKWNVLKA
ALTCGARGSKILVTTRSQRVSSIMSSSNTTHQIQQLSGDDCLSLFQQSAF
GHQAADQNLMEIGEKIVEKCGGVPLAAISLGSMLRSNREENYWSSVLNSE
IWQLRNEEQKVLAVLKLSYVTLPLRSKKCFVFASLFPKNYRMAKDELIKL
WIANGFVRSEGNFDAETNGNRVFNDLVMGSFFLLAPSRDFEYDSHVTKCM
MHDLMHDLARSTSADVYWNSDQESVEDIGNRIYHLQIDQRMFQNMTQVIS
GKKPLYLRTFMLLHSFSAFTRLSINLLEVFSELKFLRALDLTYGGIWEVP
TSIGNLIHLRYLNLSNNNIGVLPDSVTLLPNLQYLNLSFNRELRELPKEL
GNMQNLRDLNLQKDFRLTHMPCGLSRLTNLRSLPLFIASEKTGTCSILEL
EDLKLHGEMKIKFSKDFKNYSCGGRKILKNKDLNELWLEFNGLERYDKDI
LDDLYPNTSLKKFNIFNYRSPQFPAWLMELQLPNLVEVRLENCSGCEHIP
PFGNLQFLKKLRLRSIADITHIGAEFHGYGGFPSLQELFLHEMDNLEEWS
SESHVVDQLFPVLQKLWISKCPKLESMPRLPRVQELTISYFSGSLLSCLR
RLTSLHVLKVNNKDDMTSLPSGCIRSLTSLRELEIIECRELQSLPGDEIL
YLEMLRSLTIERCNNLASFLSEVGRRLSSLRFLRLSQCPSIISQPEELVQ
ILNSVDRLQIQICGMKVNLRGQLQHLHTLKELSLCDSHVTSNYKIVNGIR
KLSICCCHKLELLMTAEPTRSTALEQLYIEGFSYLTMLPKWLQHLKYLRF
LSIRNCPELIWLPRDLENLHMLETLKIVGCPELKSGYEWLNISHIPRVDI
S
>XP_042384267.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEAALVGAASRFMVDKVAVLLKLDEKLKTITGTKRKMEKLKELAPIIDTV
IQHIESRPLMEDAVKELLKKLKYLAYDLEDVVDYYDTKVFQKKQRSKSLL
RPVSDFFSADNQVAFKSRVGGMIKAITDSLDSILLQNSILSNLLQEQGSI
PMSEPSLNNRETHSRNGFVVIGREPEKNKIVNMLTKDDDDDDESNHGIVK
VIAIVGTGGLGKTTLAQHVYNDARVQDHFASPTMWKVVGAEFNPTKIMKS
LLELATGGSSVNISEIDLVKRKLEEALSGKRFLLVLDDVWNEDELQWGVL
KAALTCGARGSKILVTTRSKRVSSIMSSSNTTHQIQQLSRGDCLFLFQQF
AFGDQTVDQNLMAIGAKIVEKCGGVPLAAISLGSMLRSTREENYWSSVLN
SEIWKLGNQEDKVLAVLKLSYDALPLRSKKCFAFASLFSKDVTMKKYELI
KLWIANGFVRSEGNFDAETVGEHVFDDLVLRSFFLLVPSRYVTECTMHDL
MRDLARSVSADVYWNSYQDSVENFGNRTYHLQIDGRKFPNMTQDLGKKPL
YLRTFMQIYTFSHLSINLLELFSELKPLYLRALDLTNGGIREVPTSIGIL
IHLRYLNLSQNHIEVLPDSITLLPNLQYLNLRCNYELRELPKELGEMKNL
RDLDLLSNSRLTHMPCGLSRLTNLRSLPLFIAGGKTGACSIIELENLKLH
GKMRIEFLKDFKNYSCGGRKILKNKNLNELCIVFNESYDKDMFVDLCPNT
SLKRLELWGYSSPQFPVWLMESQLPNLVEVSLRNCRDCELIPPFGNLQFL
KKLNLYSMNGITHLGDEFHGYRGFPSLRELSLNWMSNLEEWSESHVVDQL
FPLLQKLLIFWCPKLKSTPRLPRIRRLEISSSESILSCIGRFTSLSLLQL
TGMPDIASLPSGCIRNLTSLTNLQIISCRRLQSLPRDEMQYLEMLRSLTI
DECDNLVFFPSEVGSLSSLCFRQNGVISQPKELVQILNSVDEFRIEICGN
KVDLRGQLQYLHTLKILSLFGSHLNNQLMFKYEIRALSICCCDELESFMA
AEATNSTKLEQLYINGFSNLTTMPDWLQHLKSLRRLSIRNCPRLERVPRD
LKNLHMLKTLKIVGCPRLKSRCARETGEDWPIISNVPNVDIE
>XP_042384268.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEAALVGAASRFMVDKVAVLLKLDEKLKTITGTKRKMEKLKELAPIIDTV
IQHIESRPLMEDAVKELLKKLKYLAYDLEDVVDYYDTKVFQKKQRSKSLL
RPVSDFFSADNQVAFKSRVGGMIKAITDSLDSILLQNSILSNLLQEQGSI
PMSEPSLNNRETHSRNGFVVIGREPEKNKIVNMLTKDDDDDDESNHGIVK
VIAIVGTGGLGKTTLAQHVYNDARVQDHFASPTMWKVVGAEFNPTKIMKS
LLELATGGSSVNISEIDLVKRKLEEALSGKRFLLVLDDVWNEDELQWGVL
KAALTCGARGSKILVTTRSKRVSSIMSSSNTTHQIQQLSRGDCLFLFQQF
AFGDQTVDQNLMAIGAKIVEKCGGVPLAAISLGSMLRSTREENYWSSVLN
SEIWKLGNQEDKVLAVLKLSYDALPLRSKKCFAFASLFSKDVTMKKYELI
KLWIANGFVRSEGNFDAETVGEHVFDDLVLRSFFLLVPSRYVTECTMHDL
MRDLARSVSADVYWNSYQDSVENFGNRTYHLQIDGRKFPNMTQDLGKKPL
YLRTFMQIYTFSHLSINLLELFSELKPLYLRALDLTNGGIREVPTSIGIL
IHLRYLNLSQNHIEVLPDSITLLPNLQYLNLRCNYELRELPKELGEMKNL
RDLDLLSNSRLTHMPCGLSRLTNLRSLPLFIAGGKTGACSIIELENLKLH
GKMRIEFLKDFKNYSCGGRKILKNKNLNELCIVFNESYDKDMFVDLCPNT
SLKRLELWGYSSPQFPVWLMESQLPNLVEVSLRNCRDCELIPPFGNLQFL
KKLNLYSMNGITHLGDEFHGYRGFPSLRELSLNWMSNLEEWSESHVVDQL
FPLLQKLLIFWCPKLKSTPRLPRIRRLEISSSESILSCIGRFTSLSLLQL
TGMPDIASLPSGCIRNLTSLTNLQIISCRRLQSLPRDEMQYLEMLRSLTI
DECDNLVFFPSEVGSLSSLCFRQNGVISQPKELVQILNSVDEFRIEICGN
KVDLRGQLQYLHTLKILSLFGSHLNNQLMFKYEIRALSICCCDELESFMA
AEATNSTKLEQLYINGFSNLTTMPDWLQHLKSLRRLSIRNCPRLERVPRD
LKNLHMLKTLKIVGCPRLKSRCARETGEDWPIISNVPNVDIE
>XP_042384269.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEAALVGAASRFMVDKVAVLLKLDEKLKTITGTKRKMEKLKELAPIIDTV
IQHIESRPLMEDAVKELLKKLKYLAYDLEDVVDYYDTKVFQKKQRSKSLL
RPVSDFFSADNQVAFKSRVGGMIKAITDSLDSILLQNSILSNLLQEQGSI
PMSEPSLNNRETHSRNGFVVIGREPEKNKIVNMLTKDDDDDDESNHGIVK
VIAIVGTGGLGKTTLAQHVYNDARVQDHFASPTMWKVVGAEFNPTKIMKS
LLELATGGSSVNISEIDLVKRKLEEALSGKRFLLVLDDVWNEDELQWGVL
KAALTCGARGSKILVTTRSKRVSSIMSSSNTTHQIQQLSRGDCLFLFQQF
AFGDQTVDQNLMAIGAKIVEKCGGVPLAAISLGSMLRSTREENYWSSVLN
SEIWKLGNQEDKVLAVLKLSYDALPLRSKKCFAFASLFSKDVTMKKYELI
KLWIANGFVRSEGNFDAETVGEHVFDDLVLRSFFLLVPSRYVTECTMHDL
MRDLARSVSADVYWNSYQDSVENFGNRTYHLQIDGRKFPNMTQDLGKKPL
YLRTFMQIYTFSHLSINLLELFSELKPLYLRALDLTNGGIREVPTSIGIL
IHLRYLNLSQNHIEVLPDSITLLPNLQYLNLRCNYELRELPKELGEMKNL
RDLDLLSNSRLTHMPCGLSRLTNLRSLPLFIAGGKTGACSIIELENLKLH
GKMRIEFLKDFKNYSCGGRKILKNKNLNELCIVFNESYDKDMFVDLCPNT
SLKRLELWGYSSPQFPVWLMESQLPNLVEVSLRNCRDCELIPPFGNLQFL
KKLNLYSMNGITHLGDEFHGYRGFPSLRELSLNWMSNLEEWSESHVVDQL
FPLLQKLLIFWCPKLKSTPRLPRIRRLEISSSESILSCIGRFTSLSLLQL
TGMPDIASLPSGCIRNLTSLTNLQIISCRRLQSLPRDEMQYLEMLRSLTI
DECDNLVFFPSEVGSLSSLCFRQNGVISQPKELVQILNSVDEFRIEICGN
KVDLRGQLQYLHTLKILSLFGSHLNNQLMFKYEIRALSICCCDELESFMA
AEATNSTKLEQLYINGFSNLTTMPDWLQHLKSLRRLSIRNCPRLERVPRD
LKNLHMLKTLKIVGCPRLKSRCARETGEDWPIISNVPNVDIE
>XP_042384270.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEAALVATTARFMVDKVVDLLQLDEKLKTITGIKRKMEKLKELSPIIDTV
IQHIESRPLMEDTVKELLKKLKYLAYDLEDVVDYYDTKVFQKKQRSKAFL
RPVSDFFSVDNQVAFKSRVGGMIKAITDSLDSILLQKSILSNLLQEQGSI
PMSEPSLNNRETHSHNSFVVVGREPEKNKIVDMLTKDDDDDDDDDESHHG
TVKVIAIVGMGGLGKTTLAQHVYNDARVQDHFASPTMWKVVGAEFNPAEI
MKAVLQLATGGSSVNISEIDLVKRKLEEELSGKRFLLVLDDVWNEDALKW
GVLKAALTCGARGSKILVTTRSKRVSSIMSSSDTTHQLQQLSRDDCLSLF
QRFAFRDQAVDQNLMAIGAKVVEKCGGVPLAAISLGSMLRSTRDENYWSS
VLNSEIWKLGNQEDKVLAVLKLSYDALPLRSKKCFAFASLFSKDVKMKKD
ELIKLWIANGFVRSEGNFDAETVGEHVFDDLVLRSFFLLVPSQYVTECTM
HDLMHDLARSVSADVYWNSYQDSVENFGNRTYHLQIDPRKFPNMTQDLSK
KPLYLRTFMHIYTFSHLSINLLELFSELKPLYLRALDLTRGRIREVPTSI
GILIHLRYLNLSWNHIEVLLDSITLLPNLQYFNLSFNQKLRELPKKLGNM
QNLRDLDLLSNYRLTHMPCGLSRLTNLRSLPLFIASGKPGACSIIELENL
KLHGKMTIKFLKDFKNYSCGGRKILNNKNLNELCIVSNERYDKGMFVDLC
PNTSLKRLEICGYSSPQFPVWLMESQLPNLVEVSLGNCRGCELIPPFGNL
QFLKKLDLDYMDGITHLGAEFHGYRGFPSLRELSLVRMFNLEEWSESHVV
DQLFPLLRKLLISWCPKLKSTPRLPRIQELKISYSESILSCIGRFTSLSL
LQLTGMPDIASLPSGSIRNLTSLTKFQIRNCRQLQSLPVDEMQFLEMLRS
LTIEECDNLVFFPSEVGSLSFLCFRWNGVIPQPKELVQILNLVDEFQIEI
CDNKFDLRGQLQYLTHAQKIMSIWFTS
>XP_042384310.1 putative disease resistance RPP13-like protein 1 isoform X1 [Zingiber officinale]
MKCAASCTVLVTSRKEQVVTLMKATYIYPVEKMNDESGWNLLKHLAFEGE
GDEDQISSFEEIGIKLVYKCDGLPLAIKAIAGVLYQQNKAKWEEVLQSDA
WNMDQIKEELRPLYLSYEDLPSSLKQCFLYCSLYPQKDMYSKEIVQFWVA
EGLIMDEQDKLRRDLPTEKQRTKEDIGEEIYRELLCRNLLEVDVDLDMSK
SFFSMHDHFRSLGAHLMREEGILYRHGREFKGDDNIKIRRLSISCMGPKL
VLPAQILRQACLRTLILTDSPKTKTIEDSVLQALPCLRVLDLTKTSIEKI
PDCIGDLLHLRYLDLDGTNIREIPTTIGNLVNLLSLNISECEFLERLPVS
ITKLHNLRWLDMRDSPMLTHVPKGIGKLENFYNLEGFMVGQNGSASEEGC
DLEELKNLSELRVLSIYRLERAEGGASALANMPFLMELVLGWKRPDEEEV
DAKADEEVEGDGKDDGDADKDMGDGDYDGSGAEDENEETEKEDENEEEDS
EEEDKGWSEEQISKAERICNEMTQPSSTIFDLLFSQYPGRQFPIWMQSSS
LAESFPNLTYLKLIRLPCCTKLPPLGTLPQLKYLRIESATAITTIGSQFL
GSRSSAFPKLEMLQFQDMPSWEEWTFNGTPLAVKLFPILRTCNIIDCPNL
RALPEGLCRATNFNQLCLHETYELGEIDNLALAYRLEVTNGIELKKISNI
PSLRYLAVNGCPSLECVENLGKLQHLALICSEETEQLPQWLLGLIEQHNN
TASTQRSLRKFEMQCNLQLLKSCLEGNENWDIIKQIPNVKIQTFSSQEFM
FYTKDPYNYDAKIPSN
>XP_042384311.1 putative disease resistance RPP13-like protein 1 isoform X2 [Zingiber officinale]
MKATYIYPVEKMNDESGWNLLKHLAFEGEGDEDQISSFEEIGIKLVYKCD
GLPLAIKAIAGVLYQQNKAKWEEVLQSDAWNMDQIKEELRPLYLSYEDLP
SSLKQCFLYCSLYPQKDMYSKEIVQFWVAEGLIMDEQDKLRRDLPTEKQR
TKEDIGEEIYRELLCRNLLEVDVDLDMSKSFFSMHDHFRSLGAHLMREEG
ILYRHGREFKGDDNIKIRRLSISCMGPKLVLPAQILRQACLRTLILTDSP
KTKTIEDSVLQALPCLRVLDLTKTSIEKIPDCIGDLLHLRYLDLDGTNIR
EIPTTIGNLVNLLSLNISECEFLERLPVSITKLHNLRWLDMRDSPMLTHV
PKGIGKLENFYNLEGFMVGQNGSASEEGCDLEELKNLSELRVLSIYRLER
AEGGASALANMPFLMELVLGWKRPDEEEVDAKADEEVEGDGKDDGDADKD
MGDGDYDGSGAEDENEETEKEDENEEEDSEEEDKGWSEEQISKAERICNE
MTQPSSTIFDLLFSQYPGRQFPIWMQSSSLAESFPNLTYLKLIRLPCCTK
LPPLGTLPQLKYLRIESATAITTIGSQFLGSRSSAFPKLEMLQFQDMPSW
EEWTFNGTPLAVKLFPILRTCNIIDCPNLRALPEGLCRATNFNQLCLHET
YELGEIDNLALAYRLEVTNGIELKKISNIPSLRYLAVNGCPSLECVENLG
KLQHLALICSEETEQLPQWLLGLIEQHNNTASTQRSLRKFEMQCNLQLLK
SCLEGNENWDIIKQIPNVKIQTFSSQEFMFYTKDPYNYDAKIPSN
>XP_042384317.1 putative disease resistance protein RGA3 isoform X1 [Zingiber officinale]
MAMILDFFVSKFMTITANMVEVEIFKVLGVDKEIKALQERLGTINGYLHR
AEEKKHENDEIDLWVRKLKDVMYDADDVIDLCMIEGGKLLKAQALSGSTT
INIPFSYLFSCFQCLKYRHDIANQIIALNNRLEDLKKDIVIRSNLDRTAK
ESIEYVNRLVTHETSHLQVEGDIIGTQIKNATEVLVNLILENNPKKYRVL
GVVGTGGIGKSTLASKIFEDEKIKDNFSNRIWLYVSKNYTESDLLKKLIR
SVEGNETKGENLEGKSKVELENKLVSILTQNTFIVLDDVWKSSVWVDFLR
KPIMKSATSCTVLVTSRIEKIVMLMKPRYIHPVEKMDEESGWTLLKHLVF
DVEGDEDEISSFEEIGIKLVNKCDGLPLAIKAIAGVLYQQNKAKWEDVLE
SDAWNMDQIEEELRPLYLSYEDLPSRLKQCFLYCSLYPQKDMYSKEIVQF
WIAEGLIMDEQDELRRDIPNKKQRTMEDLGEEIYRELLGRNLLEAIRNDL
SKSFFSMHDHFRSLCANLLREEGVLYRHGREFKVDDNVKIRRLSISCMGP
MLVLPAQILRQACLRTLILTDSPQTKTIEDSVLQALLCLRVLDLTKTSIE
KIPDCIGDLLHLRYLDLDETNIREIPTTIGNLVNLQSLNILRCKFLERLP
VSITKLHNLRWLNMIGCPLLTYVPKGIGKLENIYSLYGFMIGQNDSTSEE
GCDLEELKNLSKLRVLIILRLERAEKGASALANKPFLKELTLSWMRPNEE
EDDNGGGHDAQANEEEDGDGKDDGSGQRTETKEEEEDENEEVEDEGEEEE
DENEEVDGEEEEKGWNEEQISKAERICNEMSQPSSTLVHLHFYEYCGRQF
PSWMASSSLAESFPNLTYLKLVGLPCCTELPPLGTLPQLKFLSIVSANAI
TAIGSQFLGSRSSAFPKLEVLRFEDMPKWEEWAFKGTPLAVKLFPSLRSC
AIINCPKLRALPDGLHRAANLNELYLFQTYELREINNLPLAYKLKVSNGR
WLKKISNIPLLRYLEVGNCPNLECVENLDKLQHLVLICSEEMEQLPQWFQ
DLIEQHNNMASSHRSLKKFEMHCNLQLLMSCLEGNENWDIIKHIPVVKIQ
TYSSKEYIRYTKDPYNYDANIPSN
>XP_042384318.1 putative disease resistance protein RGA3 isoform X1 [Zingiber officinale]
MAMILDFFVSKFMTITANMVEVEIFKVLGVDKEIKALQERLGTINGYLHR
AEEKKHENDEIDLWVRKLKDVMYDADDVIDLCMIEGGKLLKAQALSGSTT
INIPFSYLFSCFQCLKYRHDIANQIIALNNRLEDLKKDIVIRSNLDRTAK
ESIEYVNRLVTHETSHLQVEGDIIGTQIKNATEVLVNLILENNPKKYRVL
GVVGTGGIGKSTLASKIFEDEKIKDNFSNRIWLYVSKNYTESDLLKKLIR
SVEGNETKGENLEGKSKVELENKLVSILTQNTFIVLDDVWKSSVWVDFLR
KPIMKSATSCTVLVTSRIEKIVMLMKPRYIHPVEKMDEESGWTLLKHLVF
DVEGDEDEISSFEEIGIKLVNKCDGLPLAIKAIAGVLYQQNKAKWEDVLE
SDAWNMDQIEEELRPLYLSYEDLPSRLKQCFLYCSLYPQKDMYSKEIVQF
WIAEGLIMDEQDELRRDIPNKKQRTMEDLGEEIYRELLGRNLLEAIRNDL
SKSFFSMHDHFRSLCANLLREEGVLYRHGREFKVDDNVKIRRLSISCMGP
MLVLPAQILRQACLRTLILTDSPQTKTIEDSVLQALLCLRVLDLTKTSIE
KIPDCIGDLLHLRYLDLDETNIREIPTTIGNLVNLQSLNILRCKFLERLP
VSITKLHNLRWLNMIGCPLLTYVPKGIGKLENIYSLYGFMIGQNDSTSEE
GCDLEELKNLSKLRVLIILRLERAEKGASALANKPFLKELTLSWMRPNEE
EDDNGGGHDAQANEEEDGDGKDDGSGQRTETKEEEEDENEEVEDEGEEEE
DENEEVDGEEEEKGWNEEQISKAERICNEMSQPSSTLVHLHFYEYCGRQF
PSWMASSSLAESFPNLTYLKLVGLPCCTELPPLGTLPQLKFLSIVSANAI
TAIGSQFLGSRSSAFPKLEVLRFEDMPKWEEWAFKGTPLAVKLFPSLRSC
AIINCPKLRALPDGLHRAANLNELYLFQTYELREINNLPLAYKLKVSNGR
WLKKISNIPLLRYLEVGNCPNLECVENLDKLQHLVLICSEEMEQLPQWFQ
DLIEQHNNMASSHRSLKKFEMHCNLQLLMSCLEGNENWDIIKHIPVVKIQ
TYSSKEYIRYTKDPYNYDANIPSN
>XP_042384319.1 putative disease resistance RPP13-like protein 1 isoform X2 [Zingiber officinale]
MAMILDFFVSKFMTITANMVEVEIFKVLGVDKEIKALQERLGTINGYLHR
AEEKKHENDEIDLWVRKLKDVMYDADDVIDLCMIEGGKLLKAQALSGDED
EISSFEEIGIKLVNKCDGLPLAIKAIAGVLYQQNKAKWEDVLESDAWNMD
QIEEELRPLYLSYEDLPSRLKQCFLYCSLYPQKDMYSKEIVQFWIAEGLI
MDEQDELRRDIPNKKQRTMEDLGEEIYRELLGRNLLEAIRNDLSKSFFSM
HDHFRSLCANLLREEGVLYRHGREFKVDDNVKIRRLSISCMGPMLVLPAQ
ILRQACLRTLILTDSPQTKTIEDSVLQALLCLRVLDLTKTSIEKIPDCIG
DLLHLRYLDLDETNIREIPTTIGNLVNLQSLNILRCKFLERLPVSITKLH
NLRWLNMIGCPLLTYVPKGIGKLENIYSLYGFMIGQNDSTSEEGCDLEEL
KNLSKLRVLIILRLERAEKGASALANKPFLKELTLSWMRPNEEEDDNGGG
HDAQANEEEDGDGKDDGSGQRTETKEEEEDENEEVEDEGEEEEDENEEVD
GEEEEKGWNEEQISKAERICNEMSQPSSTLVHLHFYEYCGRQFPSWMASS
SLAESFPNLTYLKLVGLPCCTELPPLGTLPQLKFLSIVSANAITAIGSQF
LGSRSSAFPKLEVLRFEDMPKWEEWAFKGTPLAVKLFPSLRSCAIINCPK
LRALPDGLHRAANLNELYLFQTYELREINNLPLAYKLKVSNGRWLKKISN
IPLLRYLEVGNCPNLECVENLDKLQHLVLICSEEMEQLPQWFQDLIEQHN
NMASSHRSLKKFEMHCNLQLLMSCLEGNENWDIIKHIPVVKIQTYSSKEY
IRYTKDPYNYDANIPSN
>XP_042384321.1 probable disease resistance protein RF45 [Zingiber officinale]
MYDADDIIDICMIEGGKLLKARALSGDEDEISSFEEIGIKLVNKCDGLPL
AIKAIAGVLYHQNKAKWEEVLESDAWNMDQIEEELRPLYLSYEDLPSRFK
QCFLYCSLYPQKDMFSMEIVQFWAAEGLIMSEEDNWRRDLPTQNQRTLED
LGEEIYRELLGRNLLEAKKDELSKSFFSMHDHFRSLCANLMREEGILYRH
GREFKADDNVKVRRLSISCMGPMLVLPAQILRQACLRTLILTDSPQTKTI
EDSVVQALLCLRVLDLSETSIEKIPDCIGELLHLRYLDLDGTNIREIPTT
IGNLVNLQSLNIIRCKFLERLPVSITKLHNLRWLNMIGCPLLTYVPKGIG
KLENIYSLYGFMIGQNDSTSEEGCDLEELKNLSKLRVLIILRLERAEKGA
SALANKPFLKDLTLSWMRPDEEEDDNGGGHDAQANEEEDGDGKDDGSGQR
TETKEEEEDENEEVEDEGEEEEDENEEVDGEEEEKGWNEEQISKAERICN
EMSQPSSTLVHLHFYDYPGRQFPSWMTSSSLAESFPNLTYLMLLGLPCCV
ELLPLGTLPQLKYLRIESANAITTIGSQFLGSRSSAFPKLEALRFEDMPR
WEEWTFNGAPLSVKLFPSLMECAIIDCPMLRALPDGLHRATNLNQLGLLR
TYELGEINNITLAYRLEVAKCRGLKKISNISSLRSLVVIECGDLECVENL
NKLQHLIVECFETEQLPQWLPGLIERHNNTASTHRSLKKFEMACNLQLLM
SCLEGNENWDILKHIPVVEIHTYSSKEYIRYTKDPYNYDTNIPSN
>XP_042384322.1 probable disease resistance protein RF45 isoform X1 [Zingiber officinale]
MALVLDFFVSKFLTATANMVETEIFKVLGINKEIKSLQKRLGTINDNLQQ
VEQKRRINHEIDIWARKLKDIMYDADDIIDICMIEGGKLLKARALSGDED
EISSFEEIGIKLVNKCDGLPLAIKAIAGVLYHQNKAKWEEVLESDAWNMD
QIEEELRPLYLSYEDLPSRFKQCFLYCSLYPQKDMFSMEIVQFWAAEGLI
MSEEDNWRRDLPTQNQRTLEDLGEEIYRELLGRNLLEAKKDELSKSFFSM
HDHFRSLCANLMREEGILYRHGREFKADDNVKVRRLSISCMGPMLVLPAQ
ILRQACLRTLILTDSPQTKTIEDSVVQALLCLRVLDLSETSIEKIPDCIG
ELLHLRYLDLDGTNIREIPTTIGNLVNLQSLNIIRCKFLERLPVSITKLH
NLRWLNMIGCPLLTYVPKGIGKLENIYSLYGFMIGQNDSTSEEGCDLEEL
KNLSKLRVLIILRLERAEKGASALANKPFLKDLTLSWMRPDEEEDDNGGG
HDAQANEEEDGDGKDDGSGQRTETKEEEEDENEEVEDEGEEEEDENEEVD
GEEEEKGWNEEQISKAERICNEMSQPSSTLVHLHFYDYPGRQFPSWMTSS
SLAESFPNLTYLMLLGLPCCVELLPLGTLPQLKYLRIESANAITTIGSQF
LGSRSSAFPKLEALRFEDMPRWEEWTFNGAPLSVKLFPSLMECAIIDCPM
LRALPDGLHRATNLNQLGLLRTYELGEINNITLAYRLEVAKCRGLKKISN
ISSLRSLVVIECGNLECVENLDKLQHLVLICSEEMEQLPQWFMDLIEQHN
NMASSHRSLKKFEMACNLQLLMSCLEGNENWDILKHIPVVEIQTYSSKEY
IRYTKDPYNYDTNIPSN
>XP_042384324.1 putative disease resistance protein RGA3 [Zingiber officinale]
MALVLDFFVSKFLTATANMVEAEISKVLGINKEIKSLQKRLGTINGYLQQ
VEQKRRINHEIDIWARKLKDIMYDADDIIDICMIEGGKLLKARALSSSST
VSIPWSYLFSCFRCLKYRHNIANQIIALNSKLEDLKKDIVITNYLDRAIK
EVVENVDIVIAHETSHLQVEGDIVGAQIENAIEALVNLILENNPKKCRVF
GVVGTGGIGKSTLASKIFEDERIKDNFPKRIWLYVSKIYTESDLLKKLIR
SYEGSETKGENFEGKSKAELENTLVSILTRNTFIVLDDVWNSSVWTDFLR
KPIMKSAISCTVLVTTRKEKVVMLMKPRYIHPVEKMDEESGWTLLKHLVF
DVEGDEDEISSFEEIGIKLVNKCDGLPLAIKAIAGVLYHQNKAKWEEVLE
SDAWNMDQIEEELRPLYLSYEDLPSRFKQCFLYCSLYPQKDMFSMEIVQF
WAAEGLIMSEEDNWRRDLPTQNQRTLEDLGEEIYRELLGRNLLEAKKDEL
SKSFFSMHDHFRSLCANLMREEGILYRHGREFKADDNVKVRRLSISCMGP
MLVLPAQILRQACLRTLILTDSPQTKTIEDSVVRALLCLRVLDLSETSIE
KIPDCIGELLHLRYLDLDGTNIREIPTTIGNLVNLQSLNILGCKFLERLP
VSITKLHNLRWLNMIGCPLLTYVPKGIGKLENIYSLYGFMIGQNDSTSEE
GCDLEELKNLSKLRVLIILRLERAEKGASALANKPFLKDLTLSWMRPDEE
EDDNGGGHDAQANEEEDGDGKDDGSGQRTETKEEEEDENEEVEDEGEEEE
DENEEVDGEEEEKGWNEEQISKAERICNEMSQPSSTLVHLHFYDYPGRQF
PSWMTSSSLAESFPNLTYLMLLGLPCCVELLPLGTLPQLKYLRIESANAI
TTIGSQFLGSRSSAFPKLEALRFEDMPRWEEWTFNGAPLSVKLFPSLMEC
AIIDCPMLRALPDGLHRATNLNQLGLLRTYELGEINNITLAYRLEVAKCR
GLKKISNISSLRSLVVIECGNLECVENLDKLQHLVLICSEEMEQLPQWFM
DLIEQHNNMASSHRSLKKFEMACNLQLLMSCLEGNENWDILKHIPVVEIQ
TYSSKEYIRYTKDPYNYDTNIPSN
>XP_042386861.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MDEESGWNLLKHLVFESEGDEDEISSFEEIGIKLVNKCDGLPLAIKAIAG
VLYQQDKAKWVEILQNMYSKEIVQSWVAEGLIMDEQDQLRRDLPIENQRT
MEEIGEEMYRELICRNLLEADASFDLSKSFFSMHDHFRSLSANLMREEGI
LYRHAEILRQACLRTLILIDSPKTKTIEDSVLQALPCLRVLDLTKTSIEK
IPDCIGDLLHLRYLDLDGTNICEIPTSIGNLVNLQSLDISVCMYLERLPE
SIAKLHNLRRLDISCCPLLTYVPKGIGKLENLYSLHGFMVGQNNSTSEKG
CDLEELKNLSKLRSITIDRLERAEGGASALANKPFLKQLSLSWMQPDEEE
EVDNGRGDDAKANEEADGDGTYDEDANNDMGDGKDDGYGQGNESEEAGDT
STGSEVENEETENEEKVWSEEQISKAERICNEMTQPSSTIFNILFRQYPG
RQFPSWMTSSSLAESFPNLTYLKLLGLPCCTELPPFGTLPQLKYLNIERA
SSITAIGSQFLGSRSSAFPKLEVLQFEDMPRWEEWTFNGAPLAVKLFPSL
RACAIIDCPKLRALPDGLHRATNLNQLGLLQTYELGEINNITLAYRLEVT
NGIGLKKISNIPSLRYLEVNDCPNLECVENLGKLQHLDLVCSEEMEQLPL
WLRGLIEQHNNTASTHRSLKKFEMRCNRQLLKSCLEGNENWDIIEQIPNV
KVQTYSGQEYLFYTKDPYNYDAKIDSTPTMATLRQKINALRQLQLSQIQA
>XP_042387485.1 disease resistance protein RPP8-like isoform X1 [Zingiber officinale]
MKEAEMAYTAVNLVVGKLGELASSEVVGLLNVDGEVKSLTETLALIQSFL
RDADQKPRYEQSHSLQEWMRQIRNLAFEMEDLVDEYATRLGRASADGGRK
SRLRRIAAFPSRIRTRHRLASRLQDIHARFQDVCKQASQLGVQLGSSSSS
SSSSSAANATLARRFELEEDIVGFDEDMKDIKRQLFDVSSTSRVVLSVVG
PGGLGKTTLANKIFRSTDVKNYFQRKAWVFVSQKYEVKELLRSIVKQVFD
FKDGEEKGMEELEMKEKLWEHLSDGRRYLVVMDDIWEVAAWNAIKAAFPK
ESTGSRVLLTTRKMNVANVADVPPHKLKVWNAEESWNLFCRKAFRTACCP
PELEQFKVDIFKKTKGLPLAIVVLGGILRGTNQASEWRKKLEYISYEFRE
GEDQILRILALSYHDLPHHLKPCFLYFAAFPEDYSISAERIRLLWIAEGF
IQTKDKVDQTMEDLAEAYLKDLIDRSMLQMERVDHLYARDVRIHDLLLDL
ARHEARELHFFGSIDDIGEDDPRALRRLSVTENANDHISLNCSTTKLRSL
VVCLNEGFQRPLAAAIAGAKFLRVLDIQKLPIEHIPKEIGDLILLRYLNL
SQSKLEELPSSIGNLIHLQTFDIRMTKIQHLPDAFWKIRTLRHVFLNNEN
TSMPKATYCPEDIQTLVNISSGPWICDGGVLEKLRNLRRLHLKNMSSSDG
DALANAIQNLSRLEMLTLFGESLPVSVLLTSSCCRHLQILYLRGPWARPA
RIHIDAENSSIFSNLIYLAIWQTRLEKDKDIAMLASLANLQTLQLRIDAF
VGRVLVFPKRGFPRLQEILLYRLSAMEQWEVGEGAMPLLRDLRLWDCKNM
RMLPEGLVRLTELKQIEISGMEMIERRVDKHTGEDYHKIKHVPCIEVN
>XP_042387486.1 disease resistance protein RPP8-like isoform X2 [Zingiber officinale]
MAYTAVNLVVGKLGELASSEVVGLLNVDGEVKSLTETLALIQSFLRDADQ
KPRYEQSHSLQEWMRQIRNLAFEMEDLVDEYATRLGRASADGGRKSRLRR
IAAFPSRIRTRHRLASRLQDIHARFQDVCKQASQLGVQLGSSSSSSSSSS
AANATLARRFELEEDIVGFDEDMKDIKRQLFDVSSTSRVVLSVVGPGGLG
KTTLANKIFRSTDVKNYFQRKAWVFVSQKYEVKELLRSIVKQVFDFKDGE
EKGMEELEMKEKLWEHLSDGRRYLVVMDDIWEVAAWNAIKAAFPKESTGS
RVLLTTRKMNVANVADVPPHKLKVWNAEESWNLFCRKAFRTACCPPELEQ
FKVDIFKKTKGLPLAIVVLGGILRGTNQASEWRKKLEYISYEFREGEDQI
LRILALSYHDLPHHLKPCFLYFAAFPEDYSISAERIRLLWIAEGFIQTKD
KVDQTMEDLAEAYLKDLIDRSMLQMERVDHLYARDVRIHDLLLDLARHEA
RELHFFGSIDDIGEDDPRALRRLSVTENANDHISLNCSTTKLRSLVVCLN
EGFQRPLAAAIAGAKFLRVLDIQKLPIEHIPKEIGDLILLRYLNLSQSKL
EELPSSIGNLIHLQTFDIRMTKIQHLPDAFWKIRTLRHVFLNNENTSMPK
ATYCPEDIQTLVNISSGPWICDGGVLEKLRNLRRLHLKNMSSSDGDALAN
AIQNLSRLEMLTLFGESLPVSVLLTSSCCRHLQILYLRGPWARPARIHID
AENSSIFSNLIYLAIWQTRLEKDKDIAMLASLANLQTLQLRIDAFVGRVL
VFPKRGFPRLQEILLYRLSAMEQWEVGEGAMPLLRDLRLWDCKNMRMLPE
GLVRLTELKQIEISGMEMIERRVDKHTGEDYHKIKHVPCIEVN
>XP_042387685.1 disease resistance protein RPM1-like [Zingiber officinale]
MPFADVASRMRRISSEFEHIHTFLSNIDVQKHNTVMESWLRLAREIENNL
EDVIDEFLYLTAEKQSQILNRSEVFTYHVGGHTRKTKILQRISSNLEEIE
GDLLHLDAMKERYDIKKFLSEDGGCSPRLNTRRLRIDPSDLLENFKDDKT
IHRQKKEILRGWLVDGESNCYLITVLGRGGVGKTTMVDDIYRSKEIASRF
DCKIWITLSKSCGMKELLTRILKELSAKEEENYDVLDLINLLYKVNNLLQ
ETTYLLILDDVLNLQLILDVQRLLIDNTRGSRIVITTCLLEVEVAAQVND
VMPIKLDELNMDESFELFKRQADIHDLAASENLREILDYCQGLPLAIVAV
ARLWILTNKETEELERIHCKLKQQPKSSNADDVNQVLSLCYEYLPTNLKN
CFLYCSMFQLDAGIKRKKLIRLWVAENFVQDEDKQTKEEVAENILNELIY
RSLLRVVEKNNDGSVRRCGMSNLFRKISLSAARKEKFSMVWNESEAPKLR
DEARRLSVHDFTKNSVLFKMDFSRTRSLLIYKHNFSACYYLLHTISTKAK
YMRVIDLENANIDRVPDGLTELFNLHYLGLRGTRVTELPETIRKLQNLQT
IDARYTRIVKLPKGITLLKNLLHLFASGLEDPSRREFHSIRHVKVPKGLQ
NLTRLQQFDLEADDESVRQLQNLTNIRVLIISKVRSVHCSQLRFSISQMP
FLYKLSIAACDENEELNLKEFGLFMKNVRVFYLQGKLVELELIDAPQSLL
KDNYVQLSQTFISLSDNLRVLRLSWSRLQRDPLPALYQLQNLTVLYLQKA
YDGVTLIFRNTWFPNLKELHLLHLPNLGKITIYQGSLRNLQFLIMEGLLQ
LTTIPTGIEFLKSLQKLHFSECNPSFLNAINRDQRSKVEHIPDICYDDGI
HGSRTLDIFPRTSGVIPDQQNLTKVGAEVSLKSVNDADKIVGAGVVQTLD
SNARVGGYEIGPNWAGIRLGTPMDNAEHLIRPYGGLKTIGHAKGSLIAWP
CSLLSIRQKL
>XP_042387789.1 putative disease resistance protein RGA3 [Zingiber officinale]
MSSRQTCLTRGLSNLHDEAVKRSRCNLVASRGHSDLAEALRPTKSLQEVL
PSPAMMAQGRLLCIQNHLAMVCDSLWAINSMMIIPKMRVLYNMYLQSKKL
DGVLDVPIEFADWETDVAASVTDAGELLGRILDWEASLHRYIVGNPQQVH
FRHVILVELKEMLCCLNSLVLRGSAMGLRRDPMSSMNPLREDYSIVLNNE
VVGRQEDIEKLIVIFQQYQPVPSNNNGNDSDPFVIVIVGKEGVGKATLAR
MIYHHTWVCKQFHHRIWVDVPRLSPFKIVNIIRKEFARSINNEEYCDLHR
ELPLHAFWEYINEQLDGRRYLLVLHFEYLASLTQQEWNELKNILLPVGGP
GSGVLIINRSSTQSVSDMGFLHTVKNIRTYCLNPLSEDAWLELFKRHAAT
TIPSKQDKSEIDELIPFTKQHFQNLIHQPLLAKIVGWLNHDVQTTFPSPL
PAALEEFYMLRNLQLVNIRVLQYRILLSGIQNEYNAILRVLTTEYLIPTE
MAGLGWIESHYTTQEVLEFMIPRMVYYLRTKVPKDSTTIPRCCRYLRLEI
NPRATLFRLPIVPIEVSRKLISLILQEDETATQEYDEEEITLQAYKKRRM
KAATAILKFLNNMLVRLVHLRILIVETSIIQTLPNEVSMLVNLRYLHLSK
LKMELLPKSLFDLHNLRVLSLICCKKLQKIPERIYKLEKLEVLSLAYCTK
LQQLPKSITRLQNLLQLDMEGCCWLRKLPEDLFRFKSLRVLHVTGCASLS
QIPLGIEQLFGLRSLVVILAGVDGCFGLAELQALTNLQQLTLQNLERVKE
TQTEMLMGQQRLRILSLRWGGEEANDSSESATPLQLRSDSSISGGVLHYH
HLVNFPVS
>XP_042387842.1 probable disease resistance protein At1g52660 [Zingiber officinale]
MACINLNLDINVNHCLSGLWTSLRQGRPKSGIENLKKEMQNLSDKRDDMK
SSIDQAELEGRIPTKQVNQWLLDMETLEGQVADIEKDFQSMSCFSFHCFN
QTRTGGMSQAQQAGDQVPIREPSNYYSIIRRVSKMLGEANKLMDRAKGLD
PIAKVQPQEPIVMLPISDQPPIGIESYVKDISSCINGGEGNVIGIYGMGG
VGKTTLLNSIQQHYYRNQSIFDCFIWVVASKDCKLKKLQMDIAKSQGLKT
LEESDEEQTCGNKLFIYLKKRNCLLFLDDIWEHLDLRLLGMAHSASRQGQ
QRKVVVFTTRSETVCTQMKAQKKIKVRCLDPNQAWQLFLGNSDVDILRSD
KEINSYAKQLAKECAGLPRALITVAQAMLGNKPLVVWKDALQQITNNHEW
TTNGHSEDSLIMHKARKLSCYILENDFMMMQETLGNFAIYIRIILIFCIL
GF
>XP_042389068.1 disease resistance protein RPM1-like [Zingiber officinale]
MDPSFLIGRAILALAGEAITVIRTLLEDGQLMPFGDIASRMRRIISEFQH
IHTFLSNVDVQKHNTVMEPWLQRAREIANNLEDAIDEFLYLTAVPKRSQI
SDLLAYRRVWGFHNRKTMILQRISSNLEQIEGDLAHLDAMKERYDIKNFL
SKNGGCSDEPNTGRVRIDPSDLLEHSEDDKTIHRKEREILRGWLADGEPK
RSLITVVGKRGVGKTTMVGEVYRSKALASRFDCKIWITLSKSCEMEELLT
RILKELSAKEEEIYNASDLINLPYKVNNLLQETRYLLILDDVLNLQLISD
VQRLLIDNKQGSRIVITTCLVDVDKKVNDLKPMKLNKLNDQESFELFKRQ
ADIHDLVASENLWEILKYCQGLPVAIVAVARLWMLTNKETAELERIHCKL
KQQPKSSNADDVNQVLSLCYEYLPGNVKNCFLYCSMFQLDNYIKGKKMIR
LWVAENFVQDEDKQTKEEVAEEIFNELIYRSLLRVVEKNNDGSVRRCEMS
NLFLKITLSAARKEQFSMVWNESEAPKLRDEARRLSVHDFTKNSVLFKMD
FSRTRSLLIYKHNSSAFDELMRTISKEAKFMRVIDLENANIDRVPDGLTE
LYNLHYLGLRRTRVTQLPETIKKLQNLQTIDARYTRIVKLPKAITLLKNL
LHLLASRLDDPSRREFHSIRHVKVPKGLQNLTRLQHLDLEADDESVWQLQ
NLTNIRVLIISKVRSVHCSQLRYSISQMPFLYKLSIAAYDENEVLNLREF
GLFMKNLRVLYLQGKLVELELIDAPQSLLKDNYVQLSQTFISLSDNLRVL
RLSWSRLQRDPLPALYQLQNLTVLYLQKAYDGVTLTFRNTWFPNLKELHL
LHLPNLGKITIYQGSLRNLQLLIMEGLLQLMTIPIGIEFLASLQKLHFSE
CNPFFLNAITEQRSKVEHIPDICYDDGIHGSRTLDIFPRTGGVIPDQQNL
TKEEERSGLLHDQIEDEKSSLKVGAEVSLKSLNDADKIVGIGVVQTLDSN
ARVGGYEIGPNWAGIHLGTPMDNTEHLIRPYGSVKILGDAKGSLIAWPCC
LLSIHQNLRDEDSR
>XP_042389958.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MAFATINLNLDVNSCLNGLWASLRLGRPKSGIQKLEKEMARLRSKRGDIK
NKIGEAEREGKIPTDEVSQWLREVEELEGQVADINQDFQSMSCFSYNCFY
QTGGSSSQTQQARDQVPIRESSNYCSISRRMVKLLCEANELMSRAGALDP
IATVGPPEPAVMLPISHRLPVGIESYVENIVGYIDGGEGNIIGIYGMGGV
GKTTMLKSIQRHYYNHRIFDHVIWVVASKEYQLKMLQMDIAKSLELKTLQ
ETDDERTCGDKLFSYLKNRNCLLLLDDIWEHLDLQLLGMAHSATERGQQQ
QQLPRKVVVFTTRSETVCARMIAEKKIKVKCLDPNQAWQLFKENSDDDVL
SSDKRISSCAQDLAKECAGLPLALVTVARAMSGKKSWELWNDALHQIRDK
HEWTTMDLLEEDSVMYKAFKLSYDSLENDSIRECLLCCALWPEDYDIHKF
EELIPCWIGCGIIREFNVINEAFTKGCSHLEALMAASLLEHSSRRWDYYE
ARHVKMHDVIRDMALLMVPRLKGNGRKWIVKAGIGLHNLPRQEEWQEAEQ
ASFMQNRILSLPEYEASTFSKLSKLFLLLNDNPLNIPPSLFASMPRLTYL
DLSKCDIKELPMEICNLTELQYLNLSYTFIRSLPLEFGCLCKLEYLLLRY
TKLETIPNGAISNLSMLKWLDIRGYFPVFDLLNELKCFKGCHQLSVGITI
NPADLERLGMVPNVSVWNLTVRGWQSSEFLKYDLDSISDNLERLTISDVP
GDKLTMNAGVTCESSSRYFKTLYFESLRQLETICLNGAGFNNLCDLYIYG
CDKLKDVSWILQLPSLNLLDMKYCEEIEELISNVGNYNSSFGIKMLNLAF
MKNLHHIACQPCHFPYLEYVRVYDCPRLKKLPFGVEILKSRLKEIIGDQT
WWDNLDWDDENNKNSFTFYFRDRFH
>XP_042389988.1 disease resistance protein UNI-like isoform X1 [Zingiber officinale]
MAFIKLNLNVDANSCLSGLWASLQLGRPKSGIKKLEKEMARLKGKRDDIK
NQIGEAEREGKISTNEVDQWLREVEELEGQVADINQDFQSMSCFNCNCFN
QTGSTSSQTQLAGDQILIRESSNCCSIIRKVAKKLGEANELMSRAGALDP
IATVALPEPTVMLSMSHRPPVGIESYVKETVGYIDGGKDIIGIYGMGGVG
KTTMLKSIQRYYSNHRLFDLVIWVVASKDCQLKKLQMDIAKSLELNTLQK
SDDEPTCGDKLFKYLKNRNCLLLLDDIWEHLDLQLLGMAHSATKQGQQQQ
QQGQQQQQPRKAVVFTTRSETLCGRMKAEKKIKVKCLDPNQAWQLFKENS
DEDVLSSDRGINSCAQDLAKECAGLPLALITVARAMSGKKSWEVWKEALH
QIRDEHEWTTVCLPEDSIVMYKAFKLSYDSLENDSIKECLLCCALWPEDY
EIHKFKELIPCWIGCGIICEFNVINEAFAKGCSYLETLMAASLLERSSRP
HNYYEADHVKMHDIIRDMALLMVSELKGNERKWIVKAGIGLHNLPRQEEW
QEAERASFMKNRILSLPEYKASTFSELSILILQYNHLTTIPPSLSASMPH
LTYLDLSNCDIKELPTEIGSLTELQYLNLSYTDIRSLPLEFGCLGKLKYL
LLRDTYFKTVPNGVISNLPMLKWLDITQQFPVCEQWWDELVRFKGRHQLS
LGIAIYAANLESLNVLPNVSVWNLTMSGLSSEFQMLQWSHRLSDNLECLT
IANVRGDKLMMNASVDCESSFRCLKTLIFDRIEELEKSWLNGIGFDNLRD
LYINCCYKLKNVSWVLQLPCLNLLDISDCWEMEELISNIENSNSNFGIKM
LTLCHMKKLHRIAHQPLCFSYLEYMRVHDCPRLQKLPFGVEILKSRLKEI
EGDRTWWDNLDWDDESTKDSLTPYFRD
>XP_042389989.1 probable disease resistance protein At1g61190 isoform X2 [Zingiber officinale]
MSRAGALDPIATVALPEPTVMLSMSHRPPVGIESYVKETVGYIDGGKDII
GIYGMGGVGKTTMLKSIQRYYSNHRLFDLVIWVVASKDCQLKKLQMDIAK
SLELNTLQKSDDEPTCGDKLFKYLKNRNCLLLLDDIWEHLDLQLLGMAHS
ATKQGQQQQQQGQQQQQPRKAVVFTTRSETLCGRMKAEKKIKVKCLDPNQ
AWQLFKENSDEDVLSSDRGINSCAQDLAKECAGLPLALITVARAMSGKKS
WEVWKEALHQIRDEHEWTTVCLPEDSIVMYKAFKLSYDSLENDSIKECLL
CCALWPEDYEIHKFKELIPCWIGCGIICEFNVINEAFAKGCSYLETLMAA
SLLERSSRPHNYYEADHVKMHDIIRDMALLMVSELKGNERKWIVKAGIGL
HNLPRQEEWQEAERASFMKNRILSLPEYKASTFSELSILILQYNHLTTIP
PSLSASMPHLTYLDLSNCDIKELPTEIGSLTELQYLNLSYTDIRSLPLEF
GCLGKLKYLLLRDTYFKTVPNGVISNLPMLKWLDITQQFPVCEQWWDELV
RFKGRHQLSLGIAIYAANLESLNVLPNVSVWNLTMSGLSSEFQMLQWSHR
LSDNLECLTIANVRGDKLMMNASVDCESSFRCLKTLIFDRIEELEKSWLN
GIGFDNLRDLYINCCYKLKNVSWVLQLPCLNLLDISDCWEMEELISNIEN
SNSNFGIKMLTLCHMKKLHRIAHQPLCFSYLEYMRVHDCPRLQKLPFGVE
ILKSRLKEIEGDRTWWDNLDWDDESTKDSLTPYFRD
>XP_042390024.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MAFAIINLNVDVDSCLSGLWASLGLGRPKSGIKKLEKEMARLRGKRDDIK
NQIDEAEREGRIPTNEVSQWLLEVETLEGKVAAIKQDFQSIGCFSCHCFN
QTGGMLSQAQQAREQVSIRESLNCCSMNRRVAKKLGEANELMSRADALDP
IATVGPPEPTVILPISHRPPVGIESYVKDIVGYIDGGDDSVIAIYGMGGV
GKTTMLKSIHQHYLLKHSIFDRVIWLVASKDCQFKRLQMDISKSLGLKTM
QENDDERTCGDKLFSYLKNKKCLLLLDDIWEHVNLQLLGMAHSATERRQQ
QQPRKVVVFTTRSETICAQMKAGKKIKVKCLDTNQAWQLFEENSYGDVLC
SDGGINFIARELAKECAGLPLALITVAQAMSGKRSWEAWNDALHQIRDKH
EWTTIGLPEDSVVMYKAFKLSYDSLENDSIRECLLCCALWPEDYGIHKYY
ELIPCWIGCGIIREFNVINEAFAKGRSHLEALMAASLLERSSEIGNFYSR
HCVTMHDVIRDMALLMVSGLDLEGIKRKWIVKAGIGLSHLLRQEEWQEAE
RASFMSNQITSLQEYGASTFSKLSMLFLHANCGLTIPPAFFASMPHLEYL
DLSNCRITQLPEDIDSLTELQYLNLSYNPIIRLPTKFGCLGKLEYLRLRK
TKIETMLNGTISNLSMLKWLDIREIHPTPEWWWDELKCFKGHPQLSVAID
IDATTANIERLNILPNVSIWNLTIYGKDASSKLPSLDLSTLLWSYNVSDN
LESLTIINVAVDKLMLTVDMGHESSFGCLKILYLFDLQLLEKISLNGVVL
RELYIFGCPMLKDVSWVLQLSCLNHLEINNCPKMKELISQVGNSDSNSIC
SSSIQRLALNDMPNLNCIADQPLLFPYLEYISVLDCPKLKKLPFGVEILK
NRLKRIDGEDNWWNNLDWDDQIIKNSLTPYFRFR
>XP_042390027.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MACIKLNLNVDVNSCLKGLQATLRLRRPKSEIKRLEKEMARLRGKRDDIK
NQIDEAERKGKILTNEVSQWLREVEILEGQATDIKQDFQSMSCLSCNCFN
RTGDTSRNRTEAFAVNLEDEENSTTGQTQQPEDHVSMRESSNCCSIIQRA
AKKLSEANELMSRAGALVQIATVQPPEPVVMLPISHRLPVGIESYVKAIV
GYIDGGKENIIGIYGMGGVGKTTVLKSIQQYYLNQSKFDHVIWVVASKDC
QLKRLQEEIATRLGLMTLQENDDEKACGDKLFIYLKNKKCLLFLDDIWEQ
LDLQLLGMAHSATERGQQQPRKVVVFTTRSETVCGQMTTTTKFKVKCLDP
DKAWQLFEQNIDGDILKSDGGIKFVAQELAKECAGLPLALITVARAMLGK
RSWEVWNDALHQIRDKHEWSTIGLSKDSVVMYKAFKLSYDSLENDSIREC
LLCCSLWPEDYEIDKFEELIPCWIGCGIINEFNVINEAFTKGCSHLEALM
AASLLEHSSEEYYTEKYVKMHDVIRDMALLMVSELKRSKRKWIVKAGTGL
SHLPRQEEWQEAERASFMRNKITSLQEYGASTFPKLSMLILRVNDCLTIP
RSLFASMPRLTYLDLSKCRISELPMEIGTLTDLRYLNLSDNLIRTLPVEF
GCLSKLEYLLLRDTKLKIVPNGTISNLSMLKWLDIRGVFTIRDWWLNELD
IRGMHPMFEWWWDELKCLKGHHQLSVGIDINATTANIERLNMLSNVSIWD
LTMDGENISELPNLDLGTPQWCYNISDNLESLTILNVAVDKLMLTARCLK
TLHFSELKLLEKVSLNGVGVYNLRALYIYGCWMLKDVSWVLQLPHLNLLV
ISECPGMKNLISNFGNSNSSSNIRRLSLFFMLNLNCITDQPLHFPYLEYM
QVRACPRFKKLPFGAEILKSRLREIHGDQIWWNNLEWDEENNKNSLTPYF
IPDSRRRLWRQSGGEGGGGGNGDCHGDDNSLENSEGS
>XP_042390936.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MKDTESDYMISLNTPERKYVPEAKHWQSVASFTMGDAVLSPFVSYVVNKA
LIEAEQELKLIAGVNKELSKFSQTYETIRAVLEDAEEKQVKNPTVRDWLR
NLKDVFYEADDFLDEFAFQALRRKMEGGEQTSQVCGVLSCFGLSHLSFST
KAAHKIKDIRERLDGIAKERETLRLRELTDTGRFEILRRPPTSSLVDEST
VFGREKDKENVIKLLLSEDNNNNTTSTLSVLPILGLGGLGKSTLAQIIYN
DTRVTEHFDLRMWVFVSQNFNNIKLTNAMVEAATKSKFDLTNLNMLQETL
AEKLKGKKFFLVLDDVWNENRVVWEQACLPLKTGRSGSKVVVTTRNQRVA
EIMGTQPAYPLKRLSEDDCWTLFCRAAFAEDEFADNEKLKAIGKEIVSKL
DGVPLAAKTVGSMLFAKYNEDDWQKVLNSEFWELPVNENDIMPPLKLSYQ
TLPSHLKQCFSYCSIFQKGYAFDKEKLIKIWMAQGFLQQQGEKQMEDVGS
ENFDDLLGRSFFHKVKGSYNMHDMMHALAQYVSIDECFIAQDGRLQGIPN
KVRHLSLTSETLQPISLEALFGFSNLRTLIVLYGFNSNPVQVPTDLFIKL
KCLRVLDFSNTFLEELPESISNLLHLRYLDLSATAIAKLPDSICRLWNLQ
TLRLRDCFSLKGLPNGITSLINLRYLEEDSRLISNVVGIGNLTSLRELPL
FKVQKEIGHKITELKDMTELRGRLCILNLENVADAYEAKEAKLSSKRHIQ
ALQLEWTDYGVPDWTDENVLECLQPHDNLKELYIEGYNGTRFPSWIGDPI
FTCLTQVRLDYCKCINLPPLGQLQFLSHLQVQGLDEIKRVGNEFYGHGSN
AGFPSLKALHFEEMQQWSEWSEVKKSHFPCIRELSIVRCPKLKGLPTLSS
LSSMNISSCSSLRQLPVNMTRLERLAIQHCENIVVQPESYGLQSLLSLEQ
LDIENCPNFMSLAKLDEVHLPTSIRKLRISSCIGPENMIFKEIKSLTSLQ
SLEISDCRNLTSLPEGLHGLPSLESFYVIRCAMVEDFPEESLPKTLQYLS
IEGCPTLSECCRKEIALDKHITDHVPNIIIDGQRVTRRKSSVPDQTIE
>XP_042390937.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MKDTESDYMISLNTPERKYVPEAKHWQSVASFTMGDAVLSPFVSYVVNKA
LIEAEQELKLIAGVNKELSKFSQTYETIRAVLEDAEEKQVKNPTVRDWLR
NLKDVFYEADDFLDEFAFQALRRKMEGGEQTSQVCGVLSCFGLSHLSFST
KAAHKIKDIRERLDGIAKERETLRLRELTDTGRFEILRRPPTSSLVDEST
VFGREKDKENVIKLLLSEDNNNNTTSTLSVLPILGLGGLGKSTLAQIIYN
DTRVTEHFDLRMWVFVSQNFNNIKLTNAMVEAATKSKFDLTNLNMLQETL
AEKLKGKKFFLVLDDVWNENRVVWEQACLPLKTGRSGSKVVVTTRNQRVA
EIMGTQPAYPLKRLSEDDCWTLFCRAAFAEDEFADNEKLKAIGKEIVSKL
DGVPLAAKTVGSMLFAKYNEDDWQKVLNSEFWELPVNENDIMPPLKLSYQ
TLPSHLKQCFSYCSIFQKGYAFDKEKLIKIWMAQGFLQQQGEKQMEDVGS
ENFDDLLGRSFFHKVKGSYNMHDMMHALAQYVSIDECFIAQDGRLQGIPN
KVRHLSLTSETLQPISLEALFGFSNLRTLIVLYGFNSNPVQVPTDLFIKL
KCLRVLDFSNTFLEELPESISNLLHLRYLDLSATAIAKLPDSICRLWNLQ
TLRLRDCFSLKGLPNGITSLINLRYLEEDSRLISNVVGIGNLTSLRELPL
FKVQKEIGHKITELKDMTELRGRLCILNLENVADAYEAKEAKLSSKRHIQ
ALQLEWTDYGVPDWTDENVLECLQPHDNLKELYIEGYNGTRFPSWIGDPI
FTCLTQVRLDYCKCINLPPLGQLQFLSHLQVQGLDEIKRVGNEFYGHGSN
AGFPSLKALHFEEMQQWSEWSEVKKSHFPCIRELSIVRCPKLKGLPTLSS
LSSMNISSCSSLRQLPVNMTRLERLAIQHCENIVVQPESYGLQSLLSLEQ
LDIENCPNFMSLAKLDEVHLPTSIRKLRISSCIGPENMIFKEIKSLTSLQ
SLEISDCRNLTSLPEGLHGLPSLESFYVIRCAMVEDFPEESLPKTLQYLS
IEGCPTLSECCRKEIALDKHITDHVPNIIIDGQRVTRRKSSVPDQTIE
>XP_042390938.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MKDTESDYMISLNTPERKYVPEAKHWQSVASFTMGDAVLSPFVSYVVNKA
LIEAEQELKLIAGVNKELSKFSQTYETIRAVLEDAEEKQVKNPTVRDWLR
NLKDVFYEADDFLDEFAFQALRRKMEGGEQTSQVCGVLSCFGLSHLSFST
KAAHKIKDIRERLDGIAKERETLRLRELTDTGRFEILRRPPTSSLVDEST
VFGREKDKENVIKLLLSEDNNNNTTSTLSVLPILGLGGLGKSTLAQIIYN
DTRVTEHFDLRMWVFVSQNFNNIKLTNAMVEAATKSKFDLTNLNMLQETL
AEKLKGKKFFLVLDDVWNENRVVWEQACLPLKTGRSGSKVVVTTRNQRVA
EIMGTQPAYPLKRLSEDDCWTLFCRAAFAEDEFADNEKLKAIGKEIVSKL
DGVPLAAKTVGSMLFAKYNEDDWQKVLNSEFWELPVNENDIMPPLKLSYQ
TLPSHLKQCFSYCSIFQKGYAFDKEKLIKIWMAQGFLQQQGEKQMEDVGS
ENFDDLLGRSFFHKVKGSYNMHDMMHALAQYVSIDECFIAQDGRLQGIPN
KVRHLSLTSETLQPISLEALFGFSNLRTLIVLYGFNSNPVQVPTDLFIKL
KCLRVLDFSNTFLEELPESISNLLHLRYLDLSATAIAKLPDSICRLWNLQ
TLRLRDCFSLKGLPNGITSLINLRYLEEDSRLISNVVGIGNLTSLRELPL
FKVQKEIGHKITELKDMTELRGRLCILNLENVADAYEAKEAKLSSKRHIQ
ALQLEWTDYGVPDWTDENVLECLQPHDNLKELYIEGYNGTRFPSWIGDPI
FTCLTQVRLDYCKCINLPPLGQLQFLSHLQVQGLDEIKRVGNEFYGHGSN
AGFPSLKALHFEEMQQWSEWSEVKKSHFPCIRELSIVRCPKLKGLPTLSS
LSSMNISSCSSLRQLPVNMTRLERLAIQHCENIVVQPESYGLQSLLSLEQ
LDIENCPNFMSLAKLDEVHLPTSIRKLRISSCIGPENMIFKEIKSLTSLQ
SLEISDCRNLTSLPEGLHGLPSLESFYVIRCAMVEDFPEESLPKTLQYLS
IEGCPTLSECCRKEIALDKHITDHVPNIIIDGQRVTRRKSSVPDQTIE
>XP_042392065.1 putative disease resistance protein At5g05400 isoform X1 [Zingiber officinale]
MAFIKLNLNVDVNSCLNGLWASLRLGRPKSGIKKLEKEMARLKGKRDGIK
NQIGEAEREGKVSTNEVNQWLREVEELEGQVADINQDFQSMSCFSCNCFN
QNGGTLSQTQQAGDHVPIRESSSNCCSINRRVVKKLSEANELMSRTGALD
PIVTVGPPEPVVMFPISHRPPIGMDSYVQDIVGYIDGGEGNIIGIYGMGG
VGKTTILKSIQRHYC
>XP_042392679.1 disease resistance protein RPP8-like [Zingiber officinale]
MAYTAVNLVLGKLGELASSEVVGLLNVDGEVKSLTETLALIQSFLRDADQ
KPRHEQSHSLQEWMRQIRNLAFEMEDLVDEYATRLGRASANGSRKSRLRC
IAAFPSRIRTRHRLASRLQDIHARFQDVCKQASQLGIQLGSSSSSSSSSA
ASATLARRFELEEDIVGFDEDMKDIKRQLFDVSSTSRVVLSVVGPGGLGK
TTLANKIYRSTDVKNYFQRKAWVFVSQKYEVQELLRSIVKQVFDFKDGEE
KGMEELEMKEKLWEHLSDGRRYLVVMDDIWEVAAWNAIKAAFPKESTGSR
VLLTTRKMNVANVADVPPHKLKVWNAEESWNLFCRKAFRTACCPPELEQF
KVDIFKKTKGLPLAIVVLGGILRGTNQASEWRKKLEYISYEFREGEDQIL
RILALSYHDLPHHLKPCFLYFAAFPEDYSISAERIILLWIAEGFIQTKDK
VDQTMEDLAEAYLMDLIDRSMLQMERVSQLYAQEVRIHDLLLDLARHEAR
ELHFFRSIDDIGEDDPRALRRLSVTENVNDHISSNCSTTKLRSLVVCLNE
GFQRPLAAAIAGAKFLRILDIQKLPIEHIPKEIGDLILLRYLNLSQSKLE
ELPSSIGNLIHLQTFDIRVTKIQHLPDAFWKIRTLRHVFLNNENTSMPKA
TYCPEDIQTLVNISSGPWICDGGVLEKLRNLRRLHLKNMSSSDGDALANA
IQNLSRLEMLTLFGESLPVSVLLTASCCRHLQILYLRGPWVRPARIHIDA
ENSSIFSNLICLAIWQTRLEKDEDIAMLASLANLQTLELRIDAFVGRVLV
FPKGGFPRLQEIVLYRLSTMEQWEVGEGAMPLLRDLRLWDCKNMRMLPEG
LVRLTELKQIEISGMEIIERRVDKHTGEDYHKIKHVPCIEVN
>XP_042393807.1 disease resistance protein RPM1-like [Zingiber officinale]
MDPSFLIGRAILALAGEAITVIRTLLKDGQLMPFGDIASRMRRISSEFQH
IQTFLSNVDVQKHNTVMEPWLQRAREIANNLEDAIDEFLYLTAVPKRSQI
SDLLAYRRVWGFHNRKTMILQRISSNLEQIEGDLAHLDAMKERYDIKNFL
SKNGGCSDEPNTGRVRIDPSDLLEHSEDDKTIHRKEREILRGWLADGEPK
RSLITVLGKRGVGKTTMVGEVYRSKALASRFDCKIWITLSKSCEMEELLT
RILKKLSAKEEEIYNAFDLINLPYKVNNLLQETRYLLIIDDVLNLQLISD
VQRLLIDNKQGSRIVITTCLVDVDKKVNDVKPMKLNKLNDQESFELFKRQ
TGLADELDFDASENLREILNYCQGLPVAIVAVARLWILTNKETAELKRIH
CRLKQKPKSSNADDVNQVLSLCYEYLPGNLKNCFLYCSMFQLDNYIKGKK
MIRLWVAENFVQDEDKQTKEEVAEEIFNELIYRSLLRVVEKNNDGSVRRC
EMSNLFLKISLSAARKEQFSMVWNESEAPKLRDEARRLSVHDFTKNSVLF
KMDFSRTRSLLIYKHNSSAFDELMRTISKEAKFMRVIDLENANIDRVPDG
LTELYNLHYLGLRRTRVTQLPETIKKLQNLQTIDARYTRIVKLPKEITLL
KNLLHLLASRLDDRSRREFHSIRHVKVPKGLQNLTRLQHLDLEADDESVW
QLQNLTNIRVLIISKVRSVHCSQLRNSISQMPFLYKLSIAAYDENEVLNL
REFGLFMKNLRVLYLQGKLVELELIDAPQTLLKDNYVQLSQTFISLGDNL
RVLRLSWSRLQRDPLPALYQLQNLTVLYLQKAYDGVTLTFRNTWFPNLKE
LHLLHLPNLGKITIYQGSLSNLQLLFMEGLLQLMTIPIGIEFLESLQKLH
FSECSPFFLNAITEQRSKVEHISDICYDDGIHGSRTLDIFPRTGGVIPDQ
QNLTKEEERSGLLHDQIEDEKSSLKVGAEVSLKSLNDADKIVGIGVVQTL
DSNARVGGYEIGPNWAGIHLGTPMDNTEHLIRPYGSVKTLGDAKGSLIAW
PCCLLSIHRNLREEDSP
>XP_042394702.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MAFATINLNLDVNSCLNGLWASLRLGRPKSGIQKLEKEMARLRSKRGDIK
NKIGEAEREGKIPTDEVSQWLREVEELEGQVADINQDFQSMSCFSCNCFY
QTGGTSNQTPQAGDQVPIRESSNYCSISRRMVKLLCEANELMSRAGALDP
IATVGPPEPAVMLPISHRLPVGIESYVENIVGYIDGGEGNIIGIYGMGGV
GKTTMLKSIQRHYYNHRIFDHVIWVVASKEYQLKMLQMDIAKSLELKTLQ
ETDDERTCGDKLFSYLKNRNCLLLLDDIWEHLDLQLLGMAHSATERGQQQ
QQLPRKVVVFTTRSETVCARMIAEKKIKVKCLDPNQAWQLFKDNSDEDVL
SSDKRINSCAQDLAKECAGLPLALVTVARAMSGKKSWELWNDALHQIRDK
HEWTTMDLLEEDSVMYKAFKLSYDSLENDSIRECLLCCALWPEDYDIHKF
EELIPCWIGCGIIREFNVINEAFTKGCSHLEALMAASLLEHSSRRWDYYE
AQHVKMHDVIRDMALLMVPRLKGNGRKWIVKAGIGLHNLPRQEEWQEAER
ASFMQNRILSLPEYEASTFSKLSKLFLLLNDNPLNIPPSLFASMPRLTYL
DLSKCDIKELPMEICNLTELQYLNLSYTFIGSLPLKFGCLCKLEYLLLRY
TKLETIPNGAISNLSMLKWLDIRGYFPVFDLLNELKCFKGCHQLSLGITI
NPADLERLGMVPNVSVWNLTVRGWQSSEFLKYDLDSVSDNLERLTISDVP
GDKLTMNAGVNCESSSRYFKTLYFESLRQLETICLNGVGFNNLCDLYIYG
CDKLKDVSWVLQLPSLNLLDMKYCEEIEELISNVGNYNSSFGIKMLNLAF
MKNLHHIACQPCHFPYLEYIRVYDCPSLKKLPFGVEILKSRLKEIIGDQT
WWDNLDWDDENNKNSFTFYFRDRFH
>XP_042394727.1 putative disease resistance protein At5g05400 [Zingiber officinale]
MAFATINLNVDVNSCLSGLWASLRLGRPKSGIQKLEKEMARLRSKRGDIK
NKIGEAEREGKIPTDEVNQWLREVEELEGQVADINQDFQSMSCFSCNCFN
QTGCTSSQTQLAGDQIPIRESSNCCSIIRKVAKKLGEANELMSRAGALDP
IATVALPEPTVMLSMSHRPPVGIESYVKETVGYIDGGKDIIGIYGMGGVG
KTTKSIQRYYSNHRLFDLVIWVVASKDCQLKKLQMDIAKSLELNTLQKSD
DEPTCGDKLFKYLKNRNCLLLLDDIWEHLDLQLLGMAHSATKQGQQQQQQ
QQPRKAVVFTRDIVWANESRKEDQSQMPGSKSSMATL
>XP_042394772.1 probable disease resistance protein At1g61300 isoform X1 [Zingiber officinale]
MRESSNCCSIIQRVAKKLSEANELMSRAGALVQIATVQPPEPVVMLPISH
RLPVGIESYVKAIVGYIDVGKENIIGIYGMGGVGKTTILKSIQQYYLNQS
KFDHVIWVVASKDCQLKRLQEEIATRLGLMTLQENDDEKACGDKLFIYLK
NKKCLLFLDDIWEQLDLQLLGMAHSATERDQQQPRKVVVFTTRSETVCGQ
MTTTTKFKVKCLDPDKAWQLFEQNIDGDILKSDGGIKFVAQELAKECAGL
PLALITVARAMLGKRSWEVWNDALHQIRDKHEWSTIGLSKDSVVMYKAFK
LSYDSLENDSIRECLLCCSLWPEDYEIDKFEELIPCWIGCGIISEFNVIN
EAFTKGCSHLEALMAASLLEHSSEEYYTEKYVKMHDVIRDMALLMVSELK
RSKRKWIVKAGTGMSHLPRQEEWQEAERASFMRNKITSLQEYGASTFPKL
SMLILRVNNCLTIPPSLFASMPRLTYLDISKCRISELPMEIGSLTELRYL
NLSGNLVRTLPVEFGCLSKLEYLLLRDTKLKIVPNGTISNLSMLKWLDIR
GVFTIRDWWLNELDIRGMHPMSEWWWDELKCFKGCHQLSVGINIDATTAN
IERLNMLSNVSIWDLIMDGENISELPNLDLGTPQWCYNISDNLESLTILN
VAVDKLMLTARCLKTLHFSELKLLEKVSLNGVGVYNLRALYIYGCWMLKD
VSWVLQLPHLNLLVISECPGMKNLISNFGNSNSSSNIRRLSLFFMLNLNC
ITEQPLHFPYLEYMQVRACPRFKKLPFGAEILKNRLREIHGDQIWWNNLE
WDEENNKNSLTPYFIPDFRRRLWRQSRGGEGGSGSNGDCDGDDNSLENSE
GS
>XP_042394773.1 probable disease resistance protein At1g61300 isoform X2 [Zingiber officinale]
MRESSNCCSIIQRVAKKLSEANELMSRAGALVQIATVQPPEPVVMLPISH
RLPVGIESYVKAIVGYIDVGKENIIGIYGMGGVGKTTILKSIQQYYLNQS
KFDHVIWVVASKDCQLKRLQEEIATRLGLMTLQENDDEKACGDKLFIYLK
NKKCLLFLDDIWEQLDLQLLGMAHSATERDQQQPRKVVVFTTRSETVCGQ
MTTTTKFKVKCLDPDKAWQLFEQNIDGDILKSDGGIKFVAQELAKECAGL
PLALITVARAMLGKRSWEVWNDALHQIRDKHEWSTIGLSKDSVVMYKAFK
LSYDSLENDSIRECLLCCSLWPEDYEIDKFEELIPCWIGCGIISEFNVIN
EAFTKGCSHLEALMAASLLEHSSEEYYTEKYVKMHDVIRDMALLMVSELK
RSKRKWIVKAGTGMSHLPRQEEWQEAERASFMRNKITSLQEYGASTFPKL
SMLILRVNNCLTIPPSLFASMPRLTYLDISKCRISELPMEIGSLTELRYL
NLSGNLVRTLPVEFGCLSKLEYLLLRDTKLKIVPNGTISNLSMLKWLDIR
GVFTIRDWWLNELDIRGMHPMSEWWWDELKCFKGCHQLSVGINIDATTAN
IERLNMLSNVSIWDLIMDGENISELPNLDLGTPQWCYNISDNLESLTILN
VAVDKLMLTARCLKTLHFSELKLLEKVSLNGVGVYNLRALYIYGCWMLKD
VSWVLQLPHLNLLVISECPGMKNLISNFGNSNSSSNIRRLSLFFMLNLNC
ITEQPLHFPYLEYMQVRACPRFKKLPFGAEILKNRLREIHGDQIWWNNLE
WDEENNKNSLTPYFIPDFRRLAAAKAAAAAMATATVMTTVLRTRKVPKI
>XP_042395656.1 putative disease resistance protein RGA3 [Zingiber officinale]
MGDAVLSAFVTYVVNKALIEAEEELKLIAGVNKELSKFSQTYETIRAVLE
DAEEKQVKNPTVRDWLRNLKDVFYEADDFLDEFAFQALRRKMEGGEQTSQ
VCGVLSCFGLSHLSFSTKAAHKIKDIRERLDGIAKERETLRLRELTDTGR
FEILRRPPTSSLVDESTVFGREKDKENIIKLLLSEDNNNNTTITLSVLPI
LGLGGLGKSTLAQIIYNDTRVTEHFDLRMWVFVSQNFNNIKLTNAMVEAA
TKSKFDLTNLNMLQETLAEKLKGKKFFLVLDDVWNENRVVWEQACLPLKT
GRSGSKVVVTTRNQRVAEIMGTQPAYPLKRLSEDDCWTLFCRAAFAEDEF
ADNEKLKAIGKEIVSKLDGVPLAAKTVGSMLFAKYNEDDWQKVLNSEFWE
LPVNENDIMPPLKLSYQTLPSHLKQCFSYCSIFQKGYAFDKEKLIKIWMA
QGFLQQQGEKQMEDVGSENFDDLLGRSFFHKVKGSYNMHDMMHALAQYVS
IDECFIAQDGRLQGIPNKVRHLSLTSETLQPISLEALFGFSNLRTLIVLN
GFNSNPVQVPTDLFIKLKCLRVLDFSNTFLEELPESISNLLHLRYLDLSA
TAIAKLPDSICRLWNLQTLRLRDCFSLKGLPNGITSLINLRYLEEDSRLI
SNVVGIGNLTSLRELPLFKVQKEIGHRITELKDMTELRGRLCILNLENVA
DAYEAKEAKLSSKRHIQALQLEWTDYGVPDWTDENVLECLQPHDNLKELY
IEGYNGARFPSWIGDPIFTCLTQVRLDYCKCINLPPLGQLQFLSHLQVQG
LDEIKRVGNEFYGHGSNAGFPSLKALHFEEMQQWSEWSEVKKSHFPCIRE
LSIIRCPKLKGLPTLSSLSSMNISSCSSLRHLPVNMTRLERLAIQHCENI
VVRPESYGLQSLLSLEQLDIENCPNFMSLAKLDEVHLPTSIRKLRISSCI
GPENMIFKEIKSLTSLQSLEISDCRNLTSLPEGLHGLPSLENFYVIRCAM
VEDFPEESLPKTLQYLSIEGCPTLSECCRKEIALDKHITDHVPNIIIDGQ
RVTRRKSSVPDQTIE
>XP_042395657.1 putative disease resistance protein RGA3 [Zingiber officinale]
MGDAVLSAFVTYVVNKALIEAEEELKLIAGVNKELSKFSQTYETIRAVLE
DAEEKQVKNPTVRDWLRNLKDVFYEADDFLDEFAFQALRRKMEGGEQTSQ
VCGVLSCFGLSHLSFSTKAAHKIKDIRERLDGIAKERETLRLRELTDTGR
FEILRRPPTSSLVDESTVFGREKDKENIIKLLLSEDNNNNTTITLSVLPI
LGLGGLGKSTLAQIIYNDTRVTEHFDLRMWVFVSQNFNNIKLTNAMVEAA
TKSKFDLTNLNMLQETLAEKLKGKKFFLVLDDVWNENRVVWEQACLPLKT
GRSGSKVVVTTRNQRVAEIMGTQPAYPLKRLSEDDCWTLFCRAAFAEDEF
ADNEKLKAIGKEIVSKLDGVPLAAKTVGSMLFAKYNEDDWQKVLNSEFWE
LPVNENDIMPPLKLSYQTLPSHLKQCFSYCSIFQKGYAFDKEKLIKIWMA
QGFLQQQGEKQMEDVGSENFDDLLGRSFFHKVKGSYNMHDMMHALAQYVS
IDECFIAQDGRLQGIPNKVRHLSLTSETLQPISLEALFGFSNLRTLIVLN
GFNSNPVQVPTDLFIKLKCLRVLDFSNTFLEELPESISNLLHLRYLDLSA
TAIAKLPDSICRLWNLQTLRLRDCFSLKGLPNGITSLINLRYLEEDSRLI
SNVVGIGNLTSLRELPLFKVQKEIGHRITELKDMTELRGRLCILNLENVA
DAYEAKEAKLSSKRHIQALQLEWTDYGVPDWTDENVLECLQPHDNLKELY
IEGYNGARFPSWIGDPIFTCLTQVRLDYCKCINLPPLGQLQFLSHLQVQG
LDEIKRVGNEFYGHGSNAGFPSLKALHFEEMQQWSEWSEVKKSHFPCIRE
LSIIRCPKLKGLPTLSSLSSMNISSCSSLRHLPVNMTRLERLAIQHCENI
VVRPESYGLQSLLSLEQLDIENCPNFMSLAKLDEVHLPTSIRKLRISSCI
GPENMIFKEIKSLTSLQSLEISDCRNLTSLPEGLHGLPSLENFYVIRCAM
VEDFPEESLPKTLQYLSIEGCPTLSECCRKEIALDKHITDHVPNIIIDGQ
RVTRRKSSVPDQTIE
>XP_042395658.1 putative disease resistance protein RGA3 [Zingiber officinale]
MGDAVLSAFVTYVVNKALIEAEEELKLIAGVNKELSKFSQTYETIRAVLE
DAEEKQVKNPTVRDWLRNLKDVFYEADDFLDEFAFQALRRKMEGGEQTSQ
VCGVLSCFGLSHLSFSTKAAHKIKDIRERLDGIAKERETLRLRELTDTGR
FEILRRPPTSSLVDESTVFGREKDKENIIKLLLSEDNNNNTTITLSVLPI
LGLGGLGKSTLAQIIYNDTRVTEHFDLRMWVFVSQNFNNIKLTNAMVEAA
TKSKFDLTNLNMLQETLAEKLKGKKFFLVLDDVWNENRVVWEQACLPLKT
GRSGSKVVVTTRNQRVAEIMGTQPAYPLKRLSEDDCWTLFCRAAFAEDEF
ADNEKLKAIGKEIVSKLDGVPLAAKTVGSMLFAKYNEDDWQKVLNSEFWE
LPVNENDIMPPLKLSYQTLPSHLKQCFSYCSIFQKGYAFDKEKLIKIWMA
QGFLQQQGEKQMEDVGSENFDDLLGRSFFHKVKGSYNMHDMMHALAQYVS
IDECFIAQDGRLQGIPNKVRHLSLTSETLQPISLEALFGFSNLRTLIVLN
GFNSNPVQVPTDLFIKLKCLRVLDFSNTFLEELPESISNLLHLRYLDLSA
TAIAKLPDSICRLWNLQTLRLRDCFSLKGLPNGITSLINLRYLEEDSRLI
SNVVGIGNLTSLRELPLFKVQKEIGHRITELKDMTELRGRLCILNLENVA
DAYEAKEAKLSSKRHIQALQLEWTDYGVPDWTDENVLECLQPHDNLKELY
IEGYNGARFPSWIGDPIFTCLTQVRLDYCKCINLPPLGQLQFLSHLQVQG
LDEIKRVGNEFYGHGSNAGFPSLKALHFEEMQQWSEWSEVKKSHFPCIRE
LSIIRCPKLKGLPTLSSLSSMNISSCSSLRHLPVNMTRLERLAIQHCENI
VVRPESYGLQSLLSLEQLDIENCPNFMSLAKLDEVHLPTSIRKLRISSCI
GPENMIFKEIKSLTSLQSLEISDCRNLTSLPEGLHGLPSLENFYVIRCAM
VEDFPEESLPKTLQYLSIEGCPTLSECCRKEIALDKHITDHVPNIIIDGQ
RVTRRKSSVPDQTIE
>XP_042396672.1 disease resistance protein RPM1-like [Zingiber officinale]
MPFADVASRMRRISSEFEHIHTFLSNIDVQKHNTVMESWLRRAREIENNL
EDVIDEFLYLTAEKQSQILNRSEVFTYYVGGIHTRKTKILQRISSNLEEI
EGDLLHLDAMKERYDIKKFLSEDGGCSPRLNTRRLRIDPSDLLENFKDDK
TIHRQKKEILRGWLVDGESNCYLITVLGRGGVGKTTMVDDIYRSKEIASR
FDCKIWITLSKSCGMKELLTRILKELSAKEEENYDVLDLINLLYKVNNLL
QETTYLLILDDVLNLQLIWDVQRLLIDNTRGSRIVITTCLLEVEVAAQVN
DVMPIKLDELNMDESFELFKREADMHDLAASENLREILDYCQGLPLAIVA
VARLWILTNKETEELERIHCKLKQQPKSSNADDVNQVLSLCYEYLPTNLK
NCFLYCSMFQLDAGIKRKKLIRLWVAENFVQDEDKQTKEEVAENILNELI
YRSLLRVVEKNNDGSVRRCGMSNLFRKLSLSAARKEKFSMVWNESEALKL
RDEARRLSVHDFTKNSVLFKMDFSRTRSLLIYKHNFSACYYLLHTISTKA
KYMRVIDLENANIDRVPDGLTELFNLHYLGLRGTRVTELPETIRKLQNLQ
TIDARYTRIVKLPKGITLLKNLLHLFASGLEDPSRREFHSIRHVKVPKGL
QNLTRLQQFDLEADDESVRQLQNLTNIRVLIISKVRSVHCSELRFSISQM
PFLYKLSIAACDENEELNLKEFGLFMKNVRVFYLQGKLVELELIDAPQSL
LKDNYVQLSQTFISLSDNLRVLRLSWSRLQRDPLPALYQLQNLTVLYLQK
AYDAVTLIFRNTWFPNLKELHLLHLPNLRKITIYQGSLRNLQLLIMEGLL
QLTTIPTGIEFLKSLQKLHFSECNPSFLNAINRDQRSKVEHIPDICYDDG
IHGSRTLDIFPRTSGVIPDQQNLTKVGAEVSLKSVNDADKIVGAGVVQTL
DSNARVGGYEIGPNWAGIRLGTPMDNAEHLIRPYGGLKTIGHAKGSLIAW
PCSLLSIRQKL
>XP_042396735.1 disease resistance protein RGA2-like [Zingiber officinale]
MVCDSLWAINSMIIIPKMGVLYNMHLQFKKLDRLLDVPVEFADWEIDVAA
TLTDVGELLGRILDWEASLHFRHVILVELKEMLCCLNSLVLRGSAMGLRR
DPMSSMNPLREDYSIVLKDEVVGREEDLEKLIEIFQQHQPVPSNNNDNDN
NPFVIVIVGKEGVGKATLARMIYHHTWVCQQFHHRIWVDVPRLSPFKIVN
IIRKEFARSINNEEYCDLHRELPLQALWESINEQFDGRRYLLVLHFEYLA
SLTQQEWNELKNILLCVGGPGSGVLIINRSSTQSISDMGFLHTVKNIRTY
CLNPLSEDAWLDLFKRHAATTIPSKQDKSEIDELIPFAKQHFQNLIHQPL
LAKIVGWLNHDVQTTFPSPLPAAPEDFYMFSNVRLVNIRVLQYRALLSNI
QNKYNVILNVLTTEYLMPAEMAELGWIERHRTTQELLEFMIPRMVSYLCM
KVPKDSTTIPRCCRYLRLEINPRATLFRLPIVPIEVSRKLISLILQEDET
ATQEDEEEITVQVYKKRRMKSATAILKFLNNMLVRLVHLRMLIVETSIIQ
SLPNEVSMLVNLRYLHLSKLKMELLPKSLFDLQNLRVLSLICCKKLQKIP
ERIYKLEKLEVLSLAYCTKLQQLPKSITRLQNLLQLDMEGCCWLKKLPED
LFRFKSLRILHVTGCASLSQIPLGIEQLFGLISLVVILAGDDGGFGLAQL
QALTNLQRLILQNLERVEETQTEMLMGQQRLRNLSLHWGGEEANDSSE
>XP_042396791.1 putative disease resistance protein RGA4 [Zingiber officinale]
MAVELAIDASLLMGEIVVDFISEKVVDLLQLNFKVKAITDIEGKMDKLKD
LSTIIDKVIQDLDSRPFIDDAVKDLLKKLKYLARDLEDVVDYYDTKVFQK
QQRSNTSFGMVRDFFSSNNQLLFKSRVGVMIKAITKSLDYILLQKSFLHN
LPQGSIRMSEPSLYDSLVTGRETERQMIVNMLTKDDDYDSNNVTLKVISI
VGMGGLGKTTLAQFVYNDERVQDYFASLTMWKVVGAEFNPTKIIKSILEL
ATGASVDISEIYLVKQKLKNELSGKRFLLVLDDVWNENESKWIALKTALT
CGLRGSKILVTTRSQQVSKIMGSSNTTHQIQQLSRDDCLSLFYQFAFGDE
VADQNLMNIGAKIVEKCGGVPLAAISLGSMLRGTREEAYWSSVLKSEISQ
LGNEEDKVLDVLKFSYDTLPVRSKKCFAFASLFPKNYWMTKDELIKLWIA
NGFVCSEGNFDAETNGNHVFNDLVMGSFFILAPSRDFEDDSYVTKCKMHD
LMYDLARSVSANIYWNSKQDSVKDIGKRTYHLQLFPGELPNDIFSQLLNK
KPLYLRTFISPRTFSCLSINLLEVFSELKFLRVLDLSYNGIKEVPTSIGN
LIHLSISISVSIKNFKSYQNN
>XP_042397235.1 disease resistance protein RPS2-like [Zingiber officinale]
MESVSTSSVMDILNLLKACCSQSCNYIMTYGGTFSSLASEVGQLKDKSSD
VKRDVEAATRDGQTPRSEVLGWLSSVQDMEGEAESIERKYNQKIKCLCSF
PLNVCSAYRLRNRAEAALATIRELKQSAEFTKLADNLNLTRSIKMPTTKT
IGMDKVFEELQRHAKDDSLSVIGIHGMGGVGKTALLRRFNNDFPSETEAD
VVIFLELSIDYKLEEVQKSLFDRLSLTWQDEVTHRDRATKLFRVLSTLKF
ILLLDNLWEPLNYQVVGIPLPAPPSKCKIIFTTRTEDTCSHMGTEKMIKM
ECLEEEAAWNLFRNSARMDVIDADKNVRIEARDLVKECGGLPAALIVLAQ
AMAPKKTWEEWMHALTIMKDTPHQLPGMTNNVFSILKLSYDRLSSDNMRV
CASYGALFIKGSWIGKFNIRNSWIGEGIIDNVQNVMDADHKTQFLLGILH
AASLTVRVHDDYFTMHPMTRAMILWVQRECGKKENKWLVWDRERVEEAPA
AEKWRDAERIALVWNQISDLPEAPQCPNLIFLDLQVNKFLRKIPNGFFLH
MPLLRILELQETSIEELPWLIMMDSYSGWKEGQSCEGGVSFEELESLKRL
KVIGMTVSTLAALQNLCDSPRLAPLTH
>XP_042397241.1 disease resistance protein RPS2-like [Zingiber officinale]
MGYVSPSSLMDIFNLLKACCSPSCNYIMTYDGTFSSLASEVGQLKDKSSD
VKRDVEAATRDGMTPRSEVLGWLSSVQDMEGEAESIERKYNQKIKCLCSF
PLNVCSAYRLRNRAEVALATIRELKRSAEFTKLADNLNLTRSIKMPTTKT
IGMEKVFEELQRHAKDDSLSVIGIHGMGGVGKTALLRRFNNDFPSEIEVD
VIIFLELSIDYKLEEVQKSLFDRLSLTWQDEVTQRDRATKLFRVLSKLKF
ILLLDNLWEPLNYQVVGIPLPAPPSKCKIIFTTRTEDICSHMGTEKMIKM
ECLEEEAAWNLFRNSARMDVIDTDENILIEARDLVKECGGLPAALIVLAQ
AMAPKKTWEEWIHALSIMKDTPHQLPGMTNNVLSILKLSYDRLSSDNLRV
CASYGALFEKGSWIYKYNIRHYWIGEGIIDNADTILDATRKTQFLLGILH
AASLTVRVDDVYFTMHPMTRAMILWVQRECGKKENKWLVLNREQVKEENW
RDAERISLGVNQIRELPETPQCPDLIFLNLEFNELLSKIPNGFFLHMPHL
KILNLRNTSIQELPASIGNLVQLHYLDLSRTRITSLPKEMAALVNLKLLS
LAFMTSLRIIPDQLFSSLRELQWLDMCDSYTGWREGQIWEGGVSFEELES
LKRLRVIGITVSTLAALQNLCISPRLAAFTCWLYIEGCRDLTLFDIPSKD
FHLENMLEVFCIRLHAMCELEEVVIGNLKPILQSLQQLRLSSLPKAKLVW
RATFPSTLFKLEIDGCGAIDRLIKLEGEANGSGETVITIFPDLHTMVLRR
LPELKSLSDGERILNFPSLKTIKVEDCPKLTKLTLVADGLKEIKCERSWW
EQLNWGDERTKSFEHLYNPMNID
>XP_042397250.1 disease resistance protein RPS2-like [Zingiber officinale]
MGYVSPSSLMDIFNLLKACCSPSCNYIMTYDGTFSSLASEVGQLKDKSSD
VKRDVEAATRDGMTPRSEVLGWLSSVQDMEGEAESIERKYNQKIKCLCSF
PLNVCSAYRLRNRAEVALATIRELKRSAEFTKLADNLNLTRSIKMPTTKT
IGMEKVFEELQRHAKDDSLSVIGIHGMGGVGKTALLRRFNNDFPSEIEVD
VIIFLELSIDYKLEEVQKSLFDRLSLTWQDEVTQRDRATKLFRVLSKLKF
ILLLDNLWEPLNYQVVGIPLPAPPSKCKIIFTTRTEDICSHMGTEKMIKM
ECLEEEAAWNLFRNSARMDVIDTDENILIEARDLVKECGGLPAALIVLAQ
AMAPKKTWEEWIHALSIMKDTPHQLPGMTNNVLSILKLSYDRLSSDNLRV
CASYGALFEKGSWIYKYNIRDYWIGEGIIDNADTILDATRKTQFLLGILH
AASLTVRVDDVYFTMHPMTRAMILWVQRECGKKENKWLVLNREQVKEENW
RDAERISLGVNQIRELPEAPQCPDLIFLNLEFNELLSKIPNGFFLHMPHL
KILNLGNTSIQELPASIGNLVQLHYLDLSMTRITSLPKEMAALVNLKLLS
LAFTTSLRIIPDQLFSSLRELQWLDMCDSYTGWREGQIWEGGVSFEELES
LKRLRVIGITVSTLAALQNLCISPRLAAFTYWLYIEGCRGLTLFDIPSKD
FHVENMLKVFCIRLHAMCELEEVVIGNLKPILQSLQQLRLSSLPKAKLVW
RATFPSTLFKLEIDGCGAIDRLIKLEGEANGSGETVITIFPDLHTMVLRR
LPELKSLSDGERILNFPSLRTIKVEDCPKLTKLMLVADGLKEIECERSWW
EQLNWGDERTNSFQHLYKPMYID
>XP_042397259.1 disease resistance protein RPS2-like isoform X1 [Zingiber officinale]
MEGQATAGRRILLQDRISNASLGHTARLLLFVTSRSSSTMGSVSTSSVMD
IFNLLKACCSQSCNYIMTYGGTFSSLASEVGQLKDKSSDVKRGVEAATRD
GMTPRSEVLGWLSSVQDMEGEAESIERKYNQKIKCLCSFPLNVCSAYRLR
NRAEAALATIRELKQSVEFTKLADNLNLIRSIKMPTNKTIGMDKVFEELL
RHAKDDSLSVIGIHGMGGVGKTALLRRFNNDFPSETEADVVIFLELSIDY
KLEEVQKSLFDRLSLTWKDEVTHRDRATKLFRVLSTLKFILLLDNLWEPL
NYQVVGIPLPAPPSKCKIIFTSRTEDTCSHMGTEKMIKMECLEQEAAWNL
FRNSARMDVIDADKNIRIKARDLHKECGGLPAALIVLAQAMAPKKTWEEW
IHALTIMKDTPHQLPGMTKTVFSILKLSYDRLSSDNLRVCASYGALFKKG
SWIDKFDIRDLWIGEGIFDNADNICDSTQQTQFLLGILHAASLTVRVHDD
YFTMHPMTRAMILWVQRECGKKENKWLVRDRERVEEAPAAEKWRDAERIA
LVWNQIRDLPEAPECPNLIFLNLHVNKFLRKIPNGFFLHMPHLKILDLRD
TSIRELPVSIGNLVQLHYLSLCETRITSLPKEMAALVNLKYLSLESMKYL
RNIPDRLISGLRELQWLDMGDSYSGWREGQTWEGGVSFEEMESLKRLKFI
GITVSTFAALQNLCDSPRLAAFTHWLHIKGCPDLTTFNLPSMNFHAETMP
RVIHIELHAMSELEEVVIGNRKHILPSLQELRLSSLPKAKLVWRARFPNA
LCELEIEDCRALDRLIKLEEEANGSGERVITIFPHLHTMVLRRLPELKSL
SDGE
>XP_042397267.1 disease resistance protein RPS2-like isoform X2 [Zingiber officinale]
MEGQATAGRRILLQDRISNASLGHTARLLLFVTSRSSTMGSVSTSSVMDI
FNLLKACCSQSCNYIMTYGGTFSSLASEVGQLKDKSSDVKRGVEAATRDG
MTPRSEVLGWLSSVQDMEGEAESIERKYNQKIKCLCSFPLNVCSAYRLRN
RAEAALATIRELKQSVEFTKLADNLNLIRSIKMPTNKTIGMDKVFEELLR
HAKDDSLSVIGIHGMGGVGKTALLRRFNNDFPSETEADVVIFLELSIDYK
LEEVQKSLFDRLSLTWKDEVTHRDRATKLFRVLSTLKFILLLDNLWEPLN
YQVVGIPLPAPPSKCKIIFTSRTEDTCSHMGTEKMIKMECLEQEAAWNLF
RNSARMDVIDADKNIRIKARDLHKECGGLPAALIVLAQAMAPKKTWEEWI
HALTIMKDTPHQLPGMTKTVFSILKLSYDRLSSDNLRVCASYGALFKKGS
WIDKFDIRDLWIGEGIFDNADNICDSTQQTQFLLGILHAASLTVRVHDDY
FTMHPMTRAMILWVQRECGKKENKWLVRDRERVEEAPAAEKWRDAERIAL
VWNQIRDLPEAPECPNLIFLNLHVNKFLRKIPNGFFLHMPHLKILDLRDT
SIRELPVSIGNLVQLHYLSLCETRITSLPKEMAALVNLKYLSLESMKYLR
NIPDRLISGLRELQWLDMGDSYSGWREGQTWEGGVSFEEMESLKRLKFIG
ITVSTFAALQNLCDSPRLAAFTHWLHIKGCPDLTTFNLPSMNFHAETMPR
VIHIELHAMSELEEVVIGNRKHILPSLQELRLSSLPKAKLVWRARFPNAL
CELEIEDCRALDRLIKLEEEANGSGERVITIFPHLHTMVLRRLPELKSLS
DGE
>XP_042398134.1 probable disease resistance protein At4g33300 [Zingiber officinale]
MDSSFAGEVATELIKELMKVIRGTYLCRPAAEQLKRSVDSLLPIVQEIRH
SGVELPQHRQSQLSELADRLRFALDLARKAAASPRWNVYRSVQLARKMEG
IESWISRWIERHMPVHVLADVHHIRVDCAARLDRIERALDMAASSPVAAT
ASKVPVAFGSAPFSGFPMSDMMDPMAPVKTPFAMGNTLSSGFPMMEGFFP
SPAPTKVPVAMGKPPSSGYPVANIMDGLMMAGEGVKPVGVGIRIGKEKVK
EMLMEGSDRSPVVGIFGIGGSGKTTLAREICKDPEIRSYFKDRIYFTTLS
QSPNLESLKLKLWEQISGNMVLGAYNQIPKWQMELGQIEKGFSLIVLDDV
WSLSELEELIFSLRGCKILVVSRFNFPSIVKNTYEIELLGEEDALSLFCH
AAFEQKSVPFSVDKKLVKQVVDKCKGLPLALKVIGASLRDQPPKFWLRAK
NKLTRGEAICESHENKLIERMASSIEFLSAKVRECFLDLGSFPEDKRIPL
DVLINMWMELHDLDEEDAFAILVELSNKNLLTLCKDAQNRAGDIYSSYTE
LSVTQHDLLRDLALYVNNQEPSNTRRRLIMARRENELPKEWERNKDHQFE
AQIVSINTGEMKETDWFQMHFPKAEVLILSFCADVYFLPPFLSTMPKLRA
LILINYGTSCTSLQNCSVFTPLSNLRSLWLEKISVPPLPKSTVRLNNLRK
VSLVLCELNDSLRGSKVDLSSTLPRLSHLTIDHCIDVTELPSCICDINSL
ECLSISNCHDLSELPCEFGKLSSLEILRVYACPSLKNLPLSICRMKGLKY
LDISQSFNLRELPEELGYMTSLEKIDMRECSQLKTLPRSSSFLKSLGHVI
CDEDIALLWKEAERDIPDLRVQVAEESFNLDWLLE
>XP_042398504.1 probable disease resistance protein At4g33300 [Zingiber officinale]
METFFAGDIAKELIKELLNVVRQTYLCRPAAEQLKRSVDSLLPIIQEIRL
SGVELPQHRQKQLSELADNLRLALDLARKAAASPRWNVYRSMQLARKMER
IDHWITRWLERQVPAHLLADVHHIRVDYTARLDRIERTLDLTAASAVARG
PVAFGTAPFSVFPETIEGFVPIRAPIAMWSPPATSCFPMPEMMEGLMMPT
EAAAEAPVAMGKSPSSRFPVAEIMEGLMLAGEGVKPVGVGIRVGKEKVKE
MLMEGINRIAVVGISGIGGSGKTTLAREICRDPEIRSYFEDRIYFETLSQ
SQNLESLKLRLWEQISGNIVLGVYNQIPQWQMELVPKDKGPFLLVLDDVW
SVSELEELIFRVPGCKILVVSRFKFPAIVKSTYEMELLGEEDALSLFCHA
AFEQTYIPSTVDQKLIKQVVEECKGLPLALKVIGASLRDQPPKFWLRAKN
KLARGETISESHENKVLERMASSIDFLSGKARECFLDLGSFPEDKRIPLD
VLINLWMELHDLDEEDAFAILVELSNKNLLTLLKDAQNRAGDIYSSYTEL
CVTQHDLLRDLALHVNNQEPLNTRRRLIMPRREKELPKEWERFKDQQLEA
QIVSFNTGEMNESDWFQMHFPKTEVLILNFAADAYFLPPFLSVMPKLKTL
ILINYGASCTTLQNLSVFTSLSNLRSLWLEKIAVPPLPRTTVPLQNLRKV
SLVLCELTNSLRCSKVELSLTFPRLSHLAIDHCIDITKLPSAICDINSLE
CLSISNCHDLSELPCEFGKLSSLGILRVYACPALKRLPQSICLLKGLKYL
DISQSFNLQELPEELGHMTSLEKIDMRECSQLKTLPRSSSSLKSLGHVIC
DEDIASLWKEAEKDIPDLRIQVAEESFNLDWLVE
>XP_042398831.1 probable disease resistance protein At4g27220 [Zingiber officinale]
MASVLAACLKSLWDPMTHQLAYIFYLGRKLTELEKNKMALASAKADVLVE
VENAKIIGCTPTATVINWLREADNAVVEAEDICSNARSIMENSTCFRIKI
VMRYKLGKQILRASKFSSDVQGRKPGDLFVPPPPVVVLPFPTSLIKNNTS
SFRTLEKLRNFLQDDSIGKIGVWGMGGVGKTRLLRNLNNELQETKRFDVV
IFVTVSKNWNKDMQKLRNDIGKELYMELEKDNVRASRLLYKRLMQKKFLL
ILDDVWDKINLENLGIPSPTEHKGCKIAITTRQRGICNEMETDVEIMVEA
LPDEESWDLFHEKAGGNIPTTIENVARSVCRECCGLPLAIITVGSALRKE
VHLDQWKRALRLLQKSNFRFENMEDSVFVPLKFSYDMLRDDQLKKCFLFV
ALFPEDHEIADQDLIEYWVMEGYIEGAESLGDAYQDAHRLLILLIDSCLL
ERSRKKDMVKMHDVIRDMAIKITSDGTEEGTKFWVKAGMRLEELVETEDL
KDKDKISLMENNIQLIGVDLYCPNASTLLVKGNVMLYDIPERFFQYMKLL
SVLDLSATSIEFLPESISVLVNLSALILKECARLKRIDRVQCLKKLRFLD
MRESGIIELPEGIVHLTGLVYFKISCTYRLQKIPAGLIAQFSHLEDLEMN
QSFYLEGLKNPQEIIKQFKHLKSLNNLSLDLENDKLSSLLETHCNLNNLA
SFYLRVGSVMATSKTEYVAKKEGPRKPERRGRCLDITGDAACKRLAKFAN
KLCVYQNRKLRSISQLGLDNLECVEECWVWDCQEMWSIIISEEQKDNTYP
HLQLLHLERLPKLSIIFSYNVAAAPSFFNLRKINLCECNMIPFVFQEEMI
DQLGCLEELDVSSCRILKRIIEGYFKRDGMCLPKLRCISFSQLGKLEQLW
FSDLSLPSLVDIKIHRCPNLRPPRLTNELAPTLLVIEAEEQWWESLPEDE
IFKLHFASILKPVTVSFTHIFTSVHASSSH
>XP_042398833.1 probable disease resistance protein At4g27220 [Zingiber officinale]
MASVLAACLKSLWDPMTHQLAYIFYLGRKLTELEKNKMALASAKADVLVE
VENAKIIGCTPTATVINWLREADNAVVEAEDICSNARSIMENSTCFRIKI
VMRYKLGKQILRASKFSSDVQGRKPGDLFVPPPPVVVLPFPTSLIKNNTS
SFRTLEKLRNFLQDDSIGKIGVWGMGGVGKTRLLRNLNNELQETKRFDVV
IFVTVSKNWNKDMQKLRNDIGKELYMELEKDNVRASRLLYKRLMQKKFLL
ILDDVWDKINLENLGIPSPTEHKGCKIAITTRQRGICNEMETDVEIMVEA
LPDEESWDLFHEKAGGNIPTTIENVARSVCRECCGLPLAIITVGSALRKE
VHLDQWKRALRLLQKSNFRFENMEDSVFVPLKFSYDMLRDDQLKKCFLFV
ALFPEDHEIADQDLIEYWVMEGYIEGAESLGDAYQDAHRLLILLIDSCLL
ERSRKKDMVKMHDVIRDMAIKITSDGTEEGTKFWVKAGMRLEELVETEDL
KDKDKISLMENNIQLIGVDLYCPNASTLLVKGNVMLYDIPERFFQYMKLL
SVLDLSATSIEFLPESISVLVNLSALILKECARLKRIDRVQCLKKLRFLD
MRESGIIELPEGIVHLTGLVYFKISCTYRLQKIPAGLIAQFSHLEDLEMN
QSFYLEGLKNPQEIIKQFKHLKSLNNLSLDLENDKLSSLLETHCNLNNLA
SFYLRVGSVMATSKTEYVAKKEGPRKPERRGRCLDITGDAACKRLAKFAN
KLCVYQNRKLRSISQLGLDNLECVEECWVWDCQEMWSIIISEEQKDNTYP
HLQLLHLERLPKLSIIFSYNVAAAPSFFNLRKINLCECNMIPFVFQEEMI
DQLGCLEELDVSSCRILKRIIEGYFKRDGMCLPKLRCISFSQLGKLEQLW
FSDLSLPSLVDIKIHRCPNLRPPRLTNELAPTLLVIEAEEQWWESLPEDE
IFKLHFASILKPVTVSFTHIFTSVHASSSH
>XP_042398834.1 probable disease resistance protein At4g27220 [Zingiber officinale]
MASVLAACLKSLWDPMTHQLAYIFYLGRKLTELEKNKMALASAKADVLVE
VENAKIIGCTPTATVINWLREADNAVVEAEDICSNARSIMENSTCFRIKI
VMRYKLGKQILRASKFSSDVQGRKPGDLFVPPPPVVVLPFPTSLIKNNTS
SFRTLEKLRNFLQDDSIGKIGVWGMGGVGKTRLLRNLNNELQETKRFDVV
IFVTVSKNWNKDMQKLRNDIGKELYMELEKDNVRASRLLYKRLMQKKFLL
ILDDVWDKINLENLGIPSPTEHKGCKIAITTRQRGICNEMETDVEIMVEA
LPDEESWDLFHEKAGGNIPTTIENVARSVCRECCGLPLAIITVGSALRKE
VHLDQWKRALRLLQKSNFRFENMEDSVFVPLKFSYDMLRDDQLKKCFLFV
ALFPEDHEIADQDLIEYWVMEGYIEGAESLGDAYQDAHRLLILLIDSCLL
ERSRKKDMVKMHDVIRDMAIKITSDGTEEGTKFWVKAGMRLEELVETEDL
KDKDKISLMENNIQLIGVDLYCPNASTLLVKGNVMLYDIPERFFQYMKLL
SVLDLSATSIEFLPESISVLVNLSALILKECARLKRIDRVQCLKKLRFLD
MRESGIIELPEGIVHLTGLVYFKISCTYRLQKIPAGLIAQFSHLEDLEMN
QSFYLEGLKNPQEIIKQFKHLKSLNNLSLDLENDKLSSLLETHCNLNNLA
SFYLRVGSVMATSKTEYVAKKEGPRKPERRGRCLDITGDAACKRLAKFAN
KLCVYQNRKLRSISQLGLDNLECVEECWVWDCQEMWSIIISEEQKDNTYP
HLQLLHLERLPKLSIIFSYNVAAAPSFFNLRKINLCECNMIPFVFQEEMI
DQLGCLEELDVSSCRILKRIIEGYFKRDGMCLPKLRCISFSQLGKLEQLW
FSDLSLPSLVDIKIHRCPNLRPPRLTNELAPTLLVIEAEEQWWESLPEDE
IFKLHFASILKPVTVSFTHIFTSVHASSSH
>XP_042398835.1 probable disease resistance protein At4g27220 [Zingiber officinale]
MASVLAACLKSLWDPMTHQLAYIFYLGRKLTELEKNKMALASAKADVLVE
VENAKIIGCTPTATVINWLREADNAVVEAEDICSNARSIMENSTCFRIKI
VMRYKLGKQILRASKFSSDVQGRKPGDLFVPPPPVVVLPFPTSLIKNNTS
SFRTLEKLRNFLQDDSIGKIGVWGMGGVGKTRLLRNLNNELQETKRFDVV
IFVTVSKNWNKDMQKLRNDIGKELYMELEKDNVRASRLLYKRLMQKKFLL
ILDDVWDKINLENLGIPSPTEHKGCKIAITTRQRGICNEMETDVEIMVEA
LPDEESWDLFHEKAGGNIPTTIENVARSVCRECCGLPLAIITVGSALRKE
VHLDQWKRALRLLQKSNFRFENMEDSVFVPLKFSYDMLRDDQLKKCFLFV
ALFPEDHEIADQDLIEYWVMEGYIEGAESLGDAYQDAHRLLILLIDSCLL
ERSRKKDMVKMHDVIRDMAIKITSDGTEEGTKFWVKAGMRLEELVETEDL
KDKDKISLMENNIQLIGVDLYCPNASTLLVKGNVMLYDIPERFFQYMKLL
SVLDLSATSIEFLPESISVLVNLSALILKECARLKRIDRVQCLKKLRFLD
MRESGIIELPEGIVHLTGLVYFKISCTYRLQKIPAGLIAQFSHLEDLEMN
QSFYLEGLKNPQEIIKQFKHLKSLNNLSLDLENDKLSSLLETHCNLNNLA
SFYLRVGSVMATSKTEYVAKKEGPRKPERRGRCLDITGDAACKRLAKFAN
KLCVYQNRKLRSISQLGLDNLECVEECWVWDCQEMWSIIISEEQKDNTYP
HLQLLHLERLPKLSIIFSYNVAAAPSFFNLRKINLCECNMIPFVFQEEMI
DQLGCLEELDVSSCRILKRIIEGYFKRDGMCLPKLRCISFSQLGKLEQLW
FSDLSLPSLVDIKIHRCPNLRPPRLTNELAPTLLVIEAEEQWWESLPEDE
IFKLHFASILKPVTVSFTHIFTSVHASSSH
>XP_042398836.1 probable disease resistance protein At4g27220 [Zingiber officinale]
MASVLAACLKSLWDPMTHQLAYIFYLGRKLTELEKNKMALASAKADVLVE
VENAKIIGCTPTATVINWLREADNAVVEAEDICSNARSIMENSTCFRIKI
VMRYKLGKQILRASKFSSDVQGRKPGDLFVPPPPVVVLPFPTSLIKNNTS
SFRTLEKLRNFLQDDSIGKIGVWGMGGVGKTRLLRNLNNELQETKRFDVV
IFVTVSKNWNKDMQKLRNDIGKELYMELEKDNVRASRLLYKRLMQKKFLL
ILDDVWDKINLENLGIPSPTEHKGCKIAITTRQRGICNEMETDVEIMVEA
LPDEESWDLFHEKAGGNIPTTIENVARSVCRECCGLPLAIITVGSALRKE
VHLDQWKRALRLLQKSNFRFENMEDSVFVPLKFSYDMLRDDQLKKCFLFV
ALFPEDHEIADQDLIEYWVMEGYIEGAESLGDAYQDAHRLLILLIDSCLL
ERSRKKDMVKMHDVIRDMAIKITSDGTEEGTKFWVKAGMRLEELVETEDL
KDKDKISLMENNIQLIGVDLYCPNASTLLVKGNVMLYDIPERFFQYMKLL
SVLDLSATSIEFLPESISVLVNLSALILKECARLKRIDRVQCLKKLRFLD
MRESGIIELPEGIVHLTGLVYFKISCTYRLQKIPAGLIAQFSHLEDLEMN
QSFYLEGLKNPQEIIKQFKHLKSLNNLSLDLENDKLSSLLETHCNLNNLA
SFYLRVGSVMATSKTEYVAKKEGPRKPERRGRCLDITGDAACKRLAKFAN
KLCVYQNRKLRSISQLGLDNLECVEECWVWDCQEMWSIIISEEQKDNTYP
HLQLLHLERLPKLSIIFSYNVAAAPSFFNLRKINLCECNMIPFVFQEEMI
DQLGCLEELDVSSCRILKRIIEGYFKRDGMCLPKLRCISFSQLGKLEQLW
FSDLSLPSLVDIKIHRCPNLRPPRLTNELAPTLLVIEAEEQWWESLPEDE
IFKLHFASILKPVTVSFTHIFTSVHASSSH
>XP_042399255.1 putative disease resistance protein RGA4 [Zingiber officinale]
MIVQTAMESALVTAMTRIMGEKVAILIRRNKNVKEITDIEEKMEKLKELL
MIVNMVIQDVESRPFTYDVKILSRKLRYLVYDLEDVVDCYDTEVLRKQRS
RASFRSVHDFFSSNNQILFRSRLGSMIKAVTDSLDSILLQKSKLLNLSQG
NFYISPSDYKTTHSSISSDIMGRETEKQRIVDLLTDDDDVENNQDTMKVI
AIVGMGGLGKTRLAQLVFNDEKVKAHFASWRMWTVIGMEFDPTKIMKSIL
EQATNAPSTVTEINSVRQKLEHTLSGKRFLLVLDDVWNEDATRWGELRAA
LTCGARGSKILVTSRSLHVSSIMNSFITHQIQQLPPDDCLPLFQQFAFGD
EEKDQKLMDIGRKIVEKCGGVPLAIISLGSMLHNIQDETHWSSVLNSKIW
QLRDEEQKVLAALKWSYDTLPPQSKKCFAFASLFPKGYTIEKDELVRLWM
ANGFVQSEGNVDAKTMGNRVFDDLVLRSFFLLTPSKEHDFGDDSHVTKCM
MHDLMHDLARSVSGDVYWNVKEDLVTDIGNRTYHLLLYVKNLSNAYQALL
RKPLYLRTLILSDCYLYLNANLLEIIFSELKFLRVLDLSSNKIKKVPKSI
GNLIQLRYLNLSRNNIEVLPNSITLLHNLQYLNLSWNEELQELPKELRSM
CNINAFVIQM
>XP_042399479.1 disease resistance protein RPP8-like isoform X1 [Zingiber officinale]
MGMRSTFQTRHTGRETEMESTIVNLVLGKLGELASSEVAGLFNVGAEVES
LTKKLLLIQSYLRDADQKPRSEQSQSLQEWLRQIRNLAFEMEDLVDEYAT
RLGRASAAGGRESCLRRIAAFPSRILTRHRLASHLQDIRARFQDVCNQAS
QLGIHGSSSLALPSSSSSSSSSFSAADARLARRFELEEDIVGFEEDMKDI
KRQLFDVSSTDRVVLSIVGTGGLGKTTLANKIYKSAHVKNFFQCKAWVSV
SQKYAVKELLCSIAKQVFDFKDGQEKAMEELEMKEKLSEHLSNRRYLVVI
DDIWEVAAWNAIKAAFPKESRGSRVLLTTRKMKVANVADVPPHELKFWNV
EESWNLFCRKAFRTACCPPEFERFKEDIFKKTKGLPLAIVVLGGVLRGTS
QASNWRKKMEHISREFREGEDQILRILALSYHDLPNHLKPCFLYFAAFPE
DYSIWAERIIHLWIAEGFIQTNDKVDQTMEDLAEAYLKDLTDRSMLQIER
GRMYYSHQVRIHDLLLDLARHEARELNFFRTIDDIGDDPRSLRRLSVTEN
VSDHISLNCSTTKLRSLVTCRNEGFKRMLAVSIPGAKFLRVLDLQELPIE
HLPKEIGDLILLRYLNLERSKLKDLPSSIGNLIHLQTFNIFGTKIQHLPE
AFWKIRTLRHVFLTEENTSMPKAAYYCSEDIRTLENISIGPWVCDGVLEK
LRNLRALYLKSISSSDEDALANAVQNLFRLEKLGLVGESLPLSVLTSSSY
HHIQFLYLWGPLVRPARIHIEAENSRIFSNLISLFISETRLEKDEDIAML
ASLANLEILRLRFHAFVGRVLVFPKGGFPSLQEIELFDLSTMEQWEVGEG
AMPFLRELRLWNCIHMRMLPEGLVRLTELNQIGIRGMKMIERRVNKDTGE
DYHKIKHIPCIEIN
>XP_042399488.1 disease resistance protein RPP8-like isoform X2 [Zingiber officinale]
MGMRSTFQTRHTGRFELEEDIVGFEEDMKDIKRQLFDVSSTDRVVLSIVG
TGGLGKTTLANKIYKSAHVKNFFQCKAWVSVSQKYAVKELLCSIAKQVFD
FKDGQEKAMEELEMKEKLSEHLSNRRYLVVIDDIWEVAAWNAIKAAFPKE
SRGSRVLLTTRKMKVANVADVPPHELKFWNVEESWNLFCRKAFRTACCPP
EFERFKEDIFKKTKGLPLAIVVLGGVLRGTSQASNWRKKMEHISREFREG
EDQILRILALSYHDLPNHLKPCFLYFAAFPEDYSIWAERIIHLWIAEGFI
QTNDKVDQTMEDLAEAYLKDLTDRSMLQIERGRMYYSHQVRIHDLLLDLA
RHEARELNFFRTIDDIGDDPRSLRRLSVTENVSDHISLNCSTTKLRSLVT
CRNEGFKRMLAVSIPGAKFLRVLDLQELPIEHLPKEIGDLILLRYLNLER
SKLKDLPSSIGNLIHLQTFNIFGTKIQHLPEAFWKIRTLRHVFLTEENTS
MPKAAYYCSEDIRTLENISIGPWVCDGVLEKLRNLRALYLKSISSSDEDA
LANAVQNLFRLEKLGLVGESLPLSVLTSSSYHHIQFLYLWGPLVRPARIH
IEAENSRIFSNLISLFISETRLEKDEDIAMLASLANLEILRLRFHAFVGR
VLVFPKGGFPSLQEIELFDLSTMEQWEVGEGAMPFLRELRLWNCIHMRML
PEGLVRLTELNQIGIRGMKMIERRVNKDTGEDYHKIKHIPCIEIN
>XP_042399499.1 disease resistance protein RPP8-like [Zingiber officinale]
MASTVLNLVLGKLGEVVSSDVAGILNVDAEVKSLTETLALIQSSLRDADQ
KPRYEQSHSLQEWMRQIRNLAFEMEDLVDEYAMQLGRASAADGRMSSLQR
IGAFPSRILTRRLFASRLQDIRARFQDVCKQASQLGIHGSSSSSSSSSSA
FSAADARLARRFELEEDIVGFDEDMKGIKRQLFDIGSTDRVVLSVVGPGG
LGKTTLANKIYKSADVKKYFQCKAWVSVSQKYVVKELLLRIMKQVFDFKD
EQVKGMEELEMKEKLSEHLSDRRYLIVMDDIWEVAAWNAIKAAFPKESTG
SRVLLTTRKMNVANVADVPPHELKFWNVEESWNLFCRKAFRTSCCPPEFE
RFKEDIFKKTKGLPLAIVVLGGLLRGTSQASDWRKKLEHISYEFREGEDQ
ILRILALSYHDLPHHLKPCFLYFAAFPEDYSIRAERIRHLWIAEGFIQTN
DKVDQTMEDLAEAYLNDLTDRSMLQMERRGHIYKQKVGIHDLLLDLARHE
ARELNFFRSIDDIGDDPRALRRLSVNDHISLNCSTTKLRSLVIYPNEGFQ
RTLAVTIPGAKFLRVLDLQELPIEHLPKEIGDLILLRYLNLYQSKLKELP
SSIGNLIHLQTFNIQFTEIQHLPDAFWKIRTLRHVLLNEENTSMPKATYC
LEDIQTLVNISIGPWVSDGELEKLRNLRRLHLNNMSSSDEDALATAVQNL
SRLEMLALIGESLPMSVLTSSCYHHIQILLLWGPLVRPARIHIEAEKPRI
FSNLISLFICETRLEKDEDIVMLASLANLQNLELGIDAFVGRVLVFPKGG
FPRLQEIVLYKLSTLEQWEVGEGAMTLLRDLRLWDCRNLRMLPEGLVRLT
ELKQIEISGMEMIERRVDKDTGEDYHKIKHVPCIEID
>XP_042399524.1 disease resistance protein RGA2-like [Zingiber officinale]
MEGALVAAARFVADKVAILVQLDSKLKAMTGIEEKMEKLKEMSTIIDLVI
EDVESHPLNKDAVKDLLRKLKYLAYDLEDAVDYYDTKVFQKKQRSNTPFG
LVSDFISSDNQVLFNSRVGCMIEAVTDSLDSILLQKSILLNLPQSSSHLP
LYPYSETHSLNGFDVIGREPEKNNIVNILTNDDDEGSSHSTLRVIAIVGM
GGLGKTTLAQLVFNDEKVQGHFASLTMWKVVGAEFNPTKIMKSILELGTG
ASVNISEIDLVMQKLKKELSGKRFLLVLDDVWNEDPVKWRILKAALTFGA
RGSKILVTTRSQQVSSIMDSSYIHQIKQLSPADCLFLFQNFAFGDKEENR
TLMEIGAKIVEKCGGVPLAVISLGNTLRSTRDETYWSSVLNSEIMQLRDM
EEKVLAVLKWSYDTLPPWSKKCFAFASLYPKNSQMEKDELIKLWIANGFV
RSEKSFDAETLGNDVFDDLVRRSFFLLAPSRNFEYDSDETKCTMHDLMHD
LARSVSANVYWHSEQDSVEDIGNRTYHLQIYLRGESCMTQVLDKKPVNLR
TFMPFDFPYTQLYLSINLLQVISDSELKFLRALDLGDSGISEVPTSIGNL
IHLRYLNLRMNYIKILPMSIGNLIHLMYLNLLTNHIEVLPMSIGNLIHLR
YLNLYDNKIEVLPDSITLLSNLQYLNLGFNDKLRELPKELGNMQNLRVLD
LPNGHFQIDIHMPCGLSRLTNLRSLPVFFAGNRTGACSILELKNLKLHGE
MQIKFSKDFKSYSCGGKKILKNKDLNELLIEFNNVERYDKDILDDLCPHT
SLKELVIKDYGSSQFPTWLIELQLPNLVEVCLENCRGCEHIPPFGNLQFL
KKLVLVAMDVITHLGAEFHGYRSFPSLQELILNRMNNLEEWPDSHNGDDQ
LFPKLQSLHIFSCPKLNSMPRFPTIQELAISNCNGSLLSCVGRLTSLSVL
LLRWLDDMTSLPSGCIKNLTSLTKLEIMQCSQLQCLPGDELQHLEMLRSL
TIEQCPNLASFPLEVGRLSSFCSLDLLACPSIILQLEELVQILNSVKKFN
IQICGNKVNLRGQLQYLHTLKILSLCGAHLDRKRARFGDSKFLRICCCDE
LESLMTAEPASSVLEELSIDGIFNLTNLPDWLQHLKSLRSLSIRNCSRLE
RLPRNLKNLPMLTTLNIANCPLLKSRCERETGEDCPIISHLPYIYNRYGY
LML
>XP_042399564.1 disease resistance protein RGA2-like [Zingiber officinale]
MASTVVYLVLRKLGELASSEVAGLLNVGVEIASLTETLTLIQSRLRDADQ
KPRCEQSHSLQEWMRQIRNLAFEMEDLVDEYATRLGRASAAGGRKSCLRR
IAAFPSRILTRHRLASRLQDIHAKFQDLSKQTSQLGIQAPSSWPTSSSSS
YSSSSAADARLARRLELEEDIVGFDEDMKDIKRQLFDISSTDRVVLSVVG
PGGLGKTTLANKIYKSADVKNYFHCKAWVSVSQKYGVKELLCSIVKQVFD
FKDEQVKGMEELGMKEKLSDHLRDRRYLVVMDDIWQVAAWNAIKAAFPKE
STGSRVLLTTRKMNVANVADAPPHKLKFWNVEESWNLFCRKAFRTTSCPP
EFERFKKDIFRKSKGLPLAIVVLGGLLRGTSQASDWRKKLDYISYEFREG
EDQIQSILALSYHDLPHHLKPCFLYFAAFPEDYIINVERIIQLWIAEGFI
QTKDRVDQTMEDLAEAYLKDLTDRSMLQTSRMDHLYPHSVRIHDLLLDLA
RHEARELNFYRSINDRGDDPRALRRLCVTENVNDHISSNCSTTKLRSLVV
YPKEGFQRILAVTFSGAKFLRVLDLIELPIEQLPKEIGDLILLRYLNLAG
SKLKELPSSIGNLIHLQTFNIQFTAIQHLPDPFWKIRTLRHVFLNEENTS
MPNSTYCSEDIQTLANISSGPWVCDGALEKLRNLRRLFLRNVSSFDEDAL
ANAVQNLSRLEMLALVGESLPVSLLTSSCYHHIQIMDLAGPLVRPANIHI
EAENSRIFSNLIYLAIGRTRLEKDEDIALLASLANLENLLVHHDAFVGRV
LVFPKGGFPRLQGIVLYRVSTLEQWEVGEGAMPLLRGLRLWDCINLRMLP
EGLVRLTELKQIEISGMEMIERRVNKDTGEDYHKIKHVPCIEIN
>XP_042399567.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEAALVTAASRFMVQNVSDLLQLDEKLKAITASNKTKMKKLKELSAIIDA
VIQDVDSRPFIDAAVKILLTKLKYLAYDLEDVVDYYDTTVLQKKQRSNST
SLRLVRDFFSPNNQVVFKSRIGGMIKAITESLDSILLQKSVLLDLPQSTS
EPRLYRETHSRNSFVVIGREPERNKIVDLLTKDDDDESNHGTVKVIAIAG
MGGLGKTTLAQHVFDDERVKAQFENSRMWTVVGAEFDPAKVMKSVLEAAT
DAPVNISQIDSVRQNIEKALSGRKFLLVLDDVWNEDPLKWGILKAALTCG
VRGSKILVTTRNQQVSKIMGSSNTTHQLQQLSQDDCLSLFQQFAFGDEAV
DQKLVKIGEKIVEKCGGVPLAAISLGNMLRGTRDETYWSSVLKSEIWQLR
DEEDKVLAILKLSYDALPPRSKKCFAFASLFSKNYKMAKDELIKLWIAND
FVRSDKNFDAETIGNNVFDELVNKSFFLSASIRKRNYRDFSWEPSNELDC
EDACTMHDLMHDLARSVSANAYWNSDQDSVEDVGNRTYHVQIQGGEESSM
AQVLGKRPLYLRTFMAQNPSSGLSINLLEVFSELKFLRVLDLSYNHIKEV
PTSIGNLILLRYLNLSNNNIEVLPDSITLLSNLQYLNLSFNEEFQELPKK
LGNIQNLRDLDLTCGFFESDFRLTHMPSGLSRLTNLRSLSLFVAGDRIGA
CSIIELEDLKLQGGMTIKFSKNFTNYSCGGRKILKNQDLNALWIEFNNSD
RYDKDMLDDLCPNTSLKQLTISNYGSPQFPTWLMESQLPNLVEVNLQKCF
SCEHIPPFGNLQFLKKLDLKFISDITHMGAEFHGYGGFPSLQELCLSSMD
NLEEWSESHGVDELFPKLQLLQVFDCFKLKSMPRLPTIQHLDISYCSGSL
LSCIGRLTSLSVLSVDGMNDMTSLPSDCIRNLTSLKELEIINCRQLQSLP
GDEMQHLEMLRSLTIDNCDNLASFPSEVGRLSSLCSLQLSNCPIIILQPQ
ELIQILNSVDEFEIEICNKKVNLLGQLQYLHTLKDLSLCGAHDHRSDNFT
FRIPKLSICCCDELKSLMIAEAASHTVLEGICINGISNLTTLPDWLPHLK
SLRSLTIEKCPRLERVPRDLKDLPKLSELILINCPRLEERCERETGEDWP
IISHLLTIFI
>XP_042399568.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEAALVTAASRFMVQNVSDLLQLDEKLKAITASNKTKMKKLKELSAIIDA
VIQDVDSRPFIDAAVKILLTKLKYLAYDLEDVVDYYDTTVLQKKQRSNST
SLRLVRDFFSPNNQVVFKSRIGGMIKAITESLDSILLQKSVLLDLPQSTS
EPRLYRETHSRNSFVVIGREPERNKIVDLLTKDDDDESNHGTVKVIAIAG
MGGLGKTTLAQHVFDDERVKAQFENSRMWTVVGAEFDPAKVMKSVLEAAT
DAPVNISQIDSVRQNIEKALSGRKFLLVLDDVWNEDPLKWGILKAALTCG
VRGSKILVTTRNQQVSKIMGSSNTTHQLQQLSQDDCLSLFQQFAFGDEAV
DQKLVKIGEKIVEKCGGVPLAAISLGNMLRGTRDETYWSSVLKSEIWQLR
DEEDKVLAILKLSYDALPPRSKKCFAFASLFSKNYKMAKDELIKLWIAND
FVRSDKNFDAETIGNNVFDELVNKSFFLSASIRKRNYRDFSWEPSNELDC
EDACTMHDLMHDLARSVSANAYWNSDQDSVEDVGNRTYHVQIQGGEESSM
AQVLGKRPLYLRTFMAQNPSSGLSINLLEVFSELKFLRVLDLSYNHIKEV
PTSIGNLILLRYLNLSNNNIEVLPDSITLLSNLQYLNLSFNEEFQELPKK
LGNIQNLRDLDLTCGFFESDFRLTHMPSGLSRLTNLRSLSLFVAGDRIGA
CSIIELEDLKLQGGMTIKFSKNFTNYSCGGRKILKNQDLNALWIEFNNSD
RYDKDMLDDLCPNTSLKQLTISNYGSPQFPTWLMESQLPNLVEVNLQKCF
SCEHIPPFGNLQFLKKLDLKFISDITHMGAEFHGYGGFPSLQELCLSSMD
NLEEWSESHGVDELFPKLQLLQVFDCFKLKSMPRLPTIQHLDISYCSGSL
LSCIGRLTSLSVLSVDGMNDMTSLPSDCIRNLTSLKELEIINCRQLQSLP
GDEMQHLEMLRSLTIDNCDNLASFPSEVGRLSSLCSLQLSNCPIIILQPQ
ELIQILNSVDEFEIEICNKKVNLLGQLQYLHTLKDLSLCGAHDHRSDNFT
FRIPKLSICCCDELKSLMIAEAASHTVLEGICINGISNLTTLPDWLPHLK
SLRSLTIEKCPRLERVPRDLKDLPKLSELILINCPRLEERCERETGEDWP
IISHLLTIFI
>XP_042399569.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEAALVTAASRFMVQNVSDLLQLDEKLKAITASNKTKMKKLKELSAIIDA
VIQDVDSRPFIDAAVKILLTKLKYLAYDLEDVVDYYDTTVLQKKQRSNST
SLRLVRDFFSPNNQVVFKSRIGGMIKAITESLDSILLQKSVLLDLPQSTS
EPRLYRETHSRNSFVVIGREPERNKIVDLLTKDDDDESNHGTVKVIAIAG
MGGLGKTTLAQHVFDDERVKAQFENSRMWTVVGAEFDPAKVMKSVLEAAT
DAPVNISQIDSVRQNIEKALSGRKFLLVLDDVWNEDPLKWGILKAALTCG
VRGSKILVTTRNQQVSKIMGSSNTTHQLQQLSQDDCLSLFQQFAFGDEAV
DQKLVKIGEKIVEKCGGVPLAAISLGNMLRGTRDETYWSSVLKSEIWQLR
DEEDKVLAILKLSYDALPPRSKKCFAFASLFSKNYKMAKDELIKLWIAND
FVRSDKNFDAETIGNNVFDELVNKSFFLSASIRKRNYRDFSWEPSNELDC
EDACTMHDLMHDLARSVSANAYWNSDQDSVEDVGNRTYHVQIQGGEESSM
AQVLGKRPLYLRTFMAQNPSSGLSINLLEVFSELKFLRVLDLSYNHIKEV
PTSIGNLILLRYLNLSNNNIEVLPDSITLLSNLQYLNLSFNEEFQELPKK
LGNIQNLRDLDLTCGFFESDFRLTHMPSGLSRLTNLRSLSLFVAGDRIGA
CSIIELEDLKLQGGMTIKFSKNFTNYSCGGRKILKNQDLNALWIEFNNSD
RYDKDMLDDLCPNTSLKQLTISNYGSPQFPTWLMESQLPNLVEVNLQKCF
SCEHIPPFGNLQFLKKLDLKFISDITHMGAEFHGYGGFPSLQELCLSSMD
NLEEWSESHGVDELFPKLQLLQVFDCFKLKSMPRLPTIQHLDISYCSGSL
LSCIGRLTSLSVLSVDGMNDMTSLPSDCIRNLTSLKELEIINCRQLQSLP
GDEMQHLEMLRSLTIDNCDNLASFPSEVGRLSSLCSLQLSNCPIIILQPQ
ELIQILNSVDEFEIEICNKKVNLLGQLQYLHTLKDLSLCGAHDHRSDNFT
FRIPKLSICCCDELKSLMIAEAASHTVLEGICINGISNLTTLPDWLPHLK
SLRSLTIEKCPRLERVPRDLKDLPKLSELILINCPRLEERCERETGEDWP
IISHLLTIFI
>XP_042399571.1 putative disease resistance protein RGA3 [Zingiber officinale]
MEAALVSAASRFMVQNVSDLLQLEEKLKAITASNKTKMKKLKELSTIIDK
VIQDVDSRPLIDAAVKNLLTKLKYLAYDLEDVVDCYDTKVLQKQRSKTFL
RPVRYFFSSHDNQIVFKSRVGGMIKAITESLDSILLQKSILEILPQGSIR
MSELSLHRETHSRNSLVVIGREPEKNMIVDMLTKDDDVESRHSTLKVITI
VGMGGLGKTTLAQLVFNDEKVKAHFASSKMWTVVGAEFDPAKIMKSVLQL
ATGAPVNISEIELVRQNLETALSGKRFLLVLDDVWNEDQEKWEVLKATLI
CGAKGSKILVTTRSQKVSSIMGSSNTTTHQIQQLSKDDCLSLFQQFAFGD
NEADDHQNLMEIGGKIVEKCGGVPLAAKSLGSMLRGTRDETYWSSVLNSE
IWQLQDKEQKVLAVLKLSYDTLPPQSKKCFAFGSLFPKDYRMQKDELIKL
WIANYGFIHSEGNFDAETVANRVFDDLVSRSFFKDDRRVTKCTMHDLMHD
LARSMSENVYWNVEDSVEDIGNRTYHLHLYLADISKITQALDKKPLYLRT
LILNCCKLSLNGNLLKIDFSELKFLRVLDLSNNEIKEVPTSIGNLIYLRY
LNLSSNCIEVLPDSITLLPNLKYLNLSWNMELQELPKDLGNMQSLRDLNC
RRHDFQDFRLTHMPRGLSRLTDLRSLPLFVAGDGTDACPITELEKLKLHG
EMDIIFSENFTNYSCGGLKILKNKDLNKLCIKFNGSEKYDEAMLDDLCPN
TSLKKLCLKDYESRQFPAWLMESQLPNLVEVSLKCCCGCEHIPPFGDLQF
LKKLELCKMDGITQMGAEFHGDGGFPSLQELCLTRMDNLEAWSKSDGDDK
LFPSLQLLRLSDCLKLKIMPRLPTIQHLEISCCRGSLLSCIGSLTSLSDL
KLDKMHDMTFFPSGYIRNLTSLEELQITECRQLQSLPGDEMQHLKLLRLL
TIKGCPSIILQLEELVQILNSVQEFQIQICGNTVDLRGQLQSLHTLKELC
LRGAHGYKPKYGIAKLEICCCDDELDPLMTAEPTSSVLEKLYIDDFSNLR
TLPHWLQHLKSLSLLSIENCPRLQSVPDLKNLPMLKSLRVFDCPELERRC
EKKTGKD
>XP_042399572.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAADLVTGAARFLVKDLLHLDEELKAIMDTKRKMKKLKELSTIIDVVIQD
VDSRPFIDAAVKNLLTKLKYLAYDLEDVVDCYDTKVLQKQRSKARLRRVR
YFFSSRDNQIVFKSRVGGMIKAITESLDSILLQKSILENLPQGSSIRMSE
LSLHRETHSRNSLVVIGRDAEKNMIVDMLTKDDEGSHGTVKVIAIVGMGG
LGKSTLAQLVFNDEKVKAHFASSKMWTVVGAEFDPAKIMKSVLQLATGAP
VNISEIELVRQNLETALSGKRFLLVLDDVWNEDQEKWEVLKATLICGAKG
SKILVTTRSQKVSSIMGSSNTTTHQIQQLSKDDCLSLFQQFAFGDNEADD
HQNLMEIGGKIVEKCGGVPLAAKSLGSMLRGTRDETYWSSVLNSEIWQLQ
DKEQKVLAVLKLSYDTLPPQSKKCFAFGSLFPKDYRMQKDELIKLWIANY
GFIHSEGNFDAETVANRVFDDLVSRSFFKDDRRVTKCTMHDLMHDLARSM
SENVYWNVEDSVEDIGNRTYHLHLYLSDISKITQALDKKPLYLRTLILNC
CKLSLNANLLKIDFSELKFLRVLDLSNNEIKEVPTSIGNLIYLRYLNLSS
NCIEVLPDSITLLSNLQYLNLSWNMELQELPKDLGNMQSLRDLNCRRHDF
QDFRLTHMPRGLSRLTDLRSLPLFVAGDGTDACPITELENLKLHGEMDII
FSENFTNYSCGGLKILKNKDLNKLCIKFNGSERYDEAMLDDLCPNTSLKK
LCIKDYESRQFPAWLMKSQLPNLVEVSLKCCCGCEQIPLFGNLQFLKKLE
LCKMNGITQMGAEFHGHGGFPSLQELCLTRMDNLEEWSKSDGDDKLFPSL
QLLRVSDCLKLKSMPRLPTIQHLEISCCRVSLLSCIGSLTSLSVLKLDKM
RDMTFFPSGCIRNLTSLEELQITECRQLQSLPGDEMQHLKLLRLLTIKGC
PSIILQPEELVQILNSVQEFQIQICGNKVDLRGQLQSLHTLKELCLRGAH
GYKYGIAKLEICCCDDELESLMAAEPTSSVLEKLYIDEFFNLRTLPHWLQ
HLKSLSLLSMENCPRLQNVPDLKNLPMLKSLRVFNCPHLERRCEKKTGKD
>XP_042399573.1 putative disease resistance protein RGA3 [Zingiber officinale]
MEGALAAAASRFMVQKVADLLQLDQKLKAMTGIKRKMEKLKELSTIIDKV
IQDIDSRPSIDDAVKDLLEKLKYLAYDLEDVVDYYDIKVFQKQRSKTFLR
PVSDFFSSDNQVVFKSRVGGMIKTITESLDSILLQKSILQNLSQSSIRMS
EQRETHSRNSFVVIGREPEKNMIVNMLTKDDDDDDESNHGTVKVIAIVGM
GGLGKTTLAQIVYNDARVQDHFASLRMWKVVGAEFDPAKIMKSVLQLAAH
KSVEISEIDLVRQKLEKALSGKRFLLVLDDVWNEDPFEWGKLKAALTCGA
SGSKILVTTRSQQVSKIMGSSNTTHQLQQLSEDDCLSLFQQFAFGDQAVD
QKLMEISKQIIEKCGGVPLAAISLGSMLRGTRDKTYWSSVLKSEIWQLRD
EQKVLAVLKWSYDTLPLQSKKCFAFGSLFPKDYTMQKDELIKLWISNGFV
RSERNFDAETVGNRIFDDLVLRSFFLLAPFEDDPHVTHCTMHDLMHDLSR
SVSANVYWNVEDSVEDIGNRTYHLHLCSTHVSKITQALGKKPLYLRTLIL
SSCGLFLNANPLEIVFSELKFLRVLDLSDNDIREVPTSIGNLIHLRYLNL
STNKIEVLPDSMTLLPNLQYLNLSFNYKLRELPKDLGNMQSLRDLTCRRR
GFVGSFFRSGLGLTHMPCGLSRLINLHSLPVFVAGDRTGACSILELEDLK
LHGEIEVIFSKDFKNYSCGGRKIFKNKDLNEVYIEFNRSESNDKDMLDDL
GPNTSLNKLTIFHYGSRQFPTWLMELQLPNLVEVRLVNCRVCEHIPPFGN
LQFLKKLDLHSMYGITQMGAEFHGYGGFPSLQELRLTWMDNLDQWSEAHG
VGALFPVLQRVKIIHCPKLKSMPMLPTIQHLEISYCCGSILSCIGRLTSL
SFLKAAEINDMTSFPSGCIRNLISLTELKIIECRQLQSLPGDEMQHLEML
RSLTIEKCDNLASFPSEVGRLSSLCFLRLSESTSIIFQPEELVQILNSVP
KFQIQICSNKVNLRGQLQYLHTLKELSLRGQHYLFTKYRIGYEIAKLSIC
CCDELESLMTTEPTSSVLEKLYIDGISNLMTLPGWLQYLSSLCFLRLSGC
PSIVLQPEELVQILNSVPKFQIQICGNKVNLHGRLQHLHTLRGLFLMGAH
YGSSFYEYRERYENPKLSICCCDELESLMTAEATSSVLEELSIHGISNLT
TLPDWLRHLKSLRVLSLQNCSELGLLPRGLKNLPMLETFRVSNCPQLKRR
CEREIGEDWPIISHLPSVHIS
>XP_042399575.1 putative disease resistance protein RGA3 [Zingiber officinale]
MEGALAAAASRFMVQKVADLLQLDQKLKAMTGIKRKMEKLKELSTIIDKV
IQDIDSRPSIDDAVKDLLEKLKYLAYDLEDVVDYYDIKVFQKQRSKTFLR
PVSDFFSSDNQVVFKSRVGGMIKTITESLDSILLQKSILQNLSQSSIRMS
EQRETHSRNSFVVIGREPEKNMIVNMLTKDDDDDDESNHGTVKVIAIVGM
GGLGKTTLAQIVYNDARVQDHFASLRMWKVVGAEFDPAKIMKSVLQLAAH
KSVEISEIDLVRQKLEKALSGKRFLLVLDDVWNEDPFEWGKLKAALTCGA
SGSKILVTTRSQQVSKIMGSSNTTHQLQQLSEDDCLSLFQQFAFGDQAVD
QKLMEISKQIIEKCGGVPLAAISLGSMLRGTRDKTYWSSVLKSEIWQLRD
EQKVLAVLKWSYDTLPLQSKKCFAFGSLFPKDYTMQKDELIKLWISNGFV
RSERNFDAETVGNRIFDDLVLRSFFLLAPFEDDPHVTHCTMHDLMHDLSR
SVSANVYWNVEDSVEDIGNRTYHLHLCSTHVSKITQALGKKPLYLRTLIL
SSCGLFLNANPLEIVFSELKFLRVLDLSDNDIREVPTSIGNLIHLRYLNL
STNKIEVLPDSMTLLPNLQYLNLSFNYKLRELPKDLGNMQSLRDLTCRRR
GFVGSFFRSGLGLTHMPCGLSRLINLHSLPVFVAGDRTGACSILELEDLK
LHGEIEVIFSKDFKNYSCGGRKIFKNKDLNEVYIEFNRSESNDKDMLDDL
GPNTSLNKLTIFHYGSRQFPTWLMELQLPNLVEVRLVNCRVCEHIPPFGN
LQFLKKLDLHSMYGITQMGAEFHGYGGFPSLQELRLTWMDNLDQWSEAHG
VGALFPVLQRVKIIHCPKLKSMPMLPTIQHLEISYCCGSILSCIGRLTSL
SFLKAAEINDMTSFPSGCIRNLISLTELKIIECRQLQSLPGDEMQHLEML
RSLTIEKCDNLASFPSEVGRLSSLCFLRLSESTSIIFQPEELVQILNSVP
KFQIQICSNKVNLRGQLQYLHTLKELSLRGQHYLFTKYRIGYEIAKLSIC
CCDELESLMTTEPTSSVLEKLYIDGISNLMTLPGWLQYLSSLCFLRLSGC
PSIVLQPEELVQILNSVPKFQIQICGNKVNLHGRLQHLHTLRGLFLMGAH
YGSSFYEYRERYENPKLSICCCDELESLMTAEATSSVLEELSIHGISNLT
TLPDWLRHLKSLRVLSLQNCSELGLLPRGLKNLPMLETFRVSNCPQLKRR
CEREIGEDWPIISHLPSVHIS
>XP_042399586.1 putative disease resistance RPP13-like protein 3 isoform X1 [Zingiber officinale]
MYWFGRLICRETEMASTVVNLVLGKLGELASSEVAGLLNVGAEITSLTET
LALIQSRLRDADQKPRSEQSHSLQEWMRQIRNLAFEMEDLVDEYATRLGR
ASAAGGRKSCLRRIAAFPSRILTRHRLASRLQDIHARFQDLCKQTSQLGI
QASSSWPTSSSSSSSSSSATDARLARRFELEEDIVGFDEDMKDIKRQLFD
ISSTDRVVLSVVGPGGLGKTTLANKIYKSADVKNYFQCKAWVSVSQKYGV
KELLCSIVKQVFDFNDEQVKGMEELGMKEKLSDHLRDRRYLVVMDDIWEV
AAWNAIKAAFPKESTGSRVLLTTRKMNVANVADAPPHKLKFWNVEESWNL
FCRKAFRTTSCPPEFERFKKDIFRKSKGLPLAIVVLGGLLRGTSQASDWR
KKLDYISYEFREGEDQIQSILALSYHDLPHHLKPCFLYFAAFPEDYIIAA
ERITHLWIAEGFIQTKDKVDQTMEDLAEAYLKDLTDRSMLQTERMDHFYV
QSVRIHDLLLDLARHEARELNFYRSINDRGDDPRALRRLCVTENVNDHVS
LNCSTNKLRSLVIYPNEGFQRTLAVTVAGAKFLRVLDLVEIPIEHLPKEI
GDLILLRYLNLYQSKLKELPSSIGNLIHLQTFNIQFTEIQHLPDAFWKIR
TLRHVFLNEENTSMPNPTYCSEDIQTLSNISSGPWVCDGALEKLRNLRRL
YLRNLSSSDEDALANAVQNLSRLEMLALIGESLPVSLLTSSCYHHIQIMD
LAGPLVRPARIHIEAENSRIFSNLIYLAIVKTRLEKDEDIALLASLANLE
HLLVCLDAFVGRVLVFPKGGFPRLQGIILADLSTLEQWEVGEGAMPLLQH
LRLWGCINMRMLPEGLVRLTELKQIEIRGMEMIERRVNKDTGEDYHKIKH
VPCVVIN
>XP_042399593.1 putative disease resistance RPP13-like protein 3 isoform X2 [Zingiber officinale]
MYWFGRLICRETEMASTVVNLVLGKLGELASSEVAGLLNVGAEITSLTET
LALIQSRLRDADQKPRSEQSHSLQEWMRQIRNLAFEMEDLVDEYATRLGR
ASAAGGRKSCLRRIAAFPSRILTRHRLASRLQDIHARFQDLCKQTSQLGI
QASSSWPTSSSSSSSSSSATDARLARRFELEEDIVGFDEDMKDIKRQLFD
ISSTDRVVLSVVGPGGLGKTTLANKIYKSADVKNYFQCKAWVSVSQKYGV
KELLCSIVKQVFDFNDEQVKGMEELGMKEKLSDHLRDRRYLVVMDDIWEV
AAWNAIKAAFPKESTGSRVLLTTRKMNVANVADAPPHKLKFWNVEESWNL
FCRKAFRTTSCPPEFERFKKDIFRKSKGLPLAIVVLGGLLRGTSQASDWR
KKLDYISYEFREGEDQIQSILALSYHDLPHHLKPCFLYFAAFPEDYIIAA
ERITHLWIAEGFIQTKDKVDQTMEDLAEAYLKDLTDRSMLQTERMDHFYV
QSVRIHDLLLDLARHEARELNFYRSINDRGDDPRALRRLCVTENVNDHVS
LNCSTNKLRSLVIYPNEGFQRTLAVTVAGAKFLRVLDLVEIPIEHLPKEI
GDLILLRYLNLYQSKLKELPSSIGNLIHLQTFNIQFTEIQHLPDAFWKIR
TLRHVFLNEENTSMPNPTYCSEDIQTLSNISSGPWVCDGALEKLRNLRRL
YLRNLSSSDEDALANAVQNLSRLEMLALIGESLPVSLLTSSCYHHIQIMD
LAGPLVRPARIHIEAENSRIFSNLIYLAIVKTRKSFGVSKGRFSSSPRDH
TG
>XP_042399619.1 putative disease resistance protein RGA3 isoform X1 [Zingiber officinale]
MAGALVGATAGFLANKVAILVELDEKLKAMAGTKRKMEKFKELLTNIDLV
IQNVESRPFIDDAVKDLLKKLKYLAYDLEDVVDYYDTKVLHKKQRSHTAL
RPVRDFFSTNNQVLFKSRIGSMIKAITESLESILLQKSILLNLPPGMSQP
SPYRENHSRNRFVVIGREPEKEMIVNMLIDDDDESSHDTVKVIAIVGMGG
LGKTTLAQLVFHDETVKIHFASLRMWTVVEAEFDPLKIMNSVLELATGAP
ANYTQIDSARQNLEKVLTGKKFLLVLDDVWNEDPLKWGVLKAALICGVKG
SKILVTTRSLHISSIMGSSKTHQLQQLSKDHCLSLFQQFAFGDQTVDQSL
MEIGGKIVEKCGGVPLAAISLGSMLHSTRDESYWSSLLSSKIWKRDNENN
LLAVLKLSYNNLSLQSKKCFTFGSLYPKNCTMVKDELIKLWIANDFVRSD
DNFDAETIGNHVFTELVHKSFFLLASSKERDFRDFLWASSEGYDLGDVSH
VTNCTMHDVMHDLARSVSVNIYWNDKEDLAKDIGDRIYHLHMHKDFENLS
NTIQARGKKRLYLRTLILKDISLNTDQLEFVFSNLKFLRVLDLTGNKIKE
VPTSIRNLIHLRYLNLSRNIIEVLSDSITLLANLQYLNLSFNEGLQELPK
ELWNMQSLRDLDCRCCNSGFIRIPCGLSRLTNLQSLPVFVADSRSGACSI
TELEDLKLNGEMTIKFSENFTNYSCGGRKILQDKHLKELSLEFNRSETND
KGMLDDLCPNTSLKKLGIWHYGSSQFPTWFIQLQSQLPNLVEVSLNYCRG
CEHIPPFGNLHFLKKLDLISTYGITHLGAEFHGNGGFPSLQELNLHRMNN
LKEWSESHGADQLFPSLQRLRVYRCPELKCMPRLPNIQSLEIFYCDGSLL
SYVGSLTSLSILRVEKMDNMTSFPSGCIRNLTSLIELQIIGCDQLLSLPR
GEMKRLKKIRSLTIDRCDSLAFLPSEVGRLNSLRFLRLAGCPRIKLQPYE
VVQILNSVHEFEITICGKNVNLHEQLQRLYTLRELFITGEHDIYSDTQLC
ICCCEELESLMIADPASSVLQHLYINGISNLTKLPDWLQHLESLRFLSIH
NCSQLGMLPRFLGLQTLTISDCPQLKRRYERDSGEDWPIISHVPYVDI
>XP_042399620.1 putative disease resistance protein RGA3 isoform X2 [Zingiber officinale]
MAGALVGATAGFLANKVAILVELDEKLKAMAGTKRKMEKFKELLTNIDLV
IQNVESRPFIDDAVKDLLKKLKYLAYDLEDVVDYYDTKVLHKKQRSHTAL
RPVRDFFSTNNQVLFKSRIGSMIKAITESLESILLQKSILLNLPPGMSQP
SPYRENHSRNRFVVIGREPEKEMIVNMLIDDDDESSHDTVKVIAIVGMGG
LGKTTLAQLVFHDETVKIHFASLRMWTVVEAEFDPLKIMNSVLELATGAP
ANYTQIDSARQNLEKVLTGKKFLLVLDDVWNEDPLKWGVLKAALICGVKG
SKILVTTRSLHISSIMGSSKTHQLQQLSKDHCLSLFQQFAFGDQTVDQSL
MEIGGKIVEKCGGVPLAAISLGSMLHSTRDESYWSSLLSSKIWKRDNENN
LLAVLKLSYNNLSLQSKKCFTFGSLYPKNCTMVKDELIKLWIANDFVRSD
DNFDAETIGNHVFTELVHKSFFLLASSKERDFRDFLWASSEGYDLGDVSH
VTNCTMHDVMHDLARSVSVNIYWNDKEDLAKDIGDRIYHLHMHKDFENLS
NTIQARGKKRLYLRTLILKDISLNTDQLEFVFSNLKFLRVLDLTGNKIKE
VPTSIRNLIHLSFNEGLQELPKELWNMQSLRDLDCRCCNSGFIRIPCGLS
RLTNLQSLPVFVADSRSGACSITELEDLKLNGEMTIKFSENFTNYSCGGR
KILQDKHLKELSLEFNRSETNDKGMLDDLCPNTSLKKLGIWHYGSSQFPT
WFIQLQSQLPNLVEVSLNYCRGCEHIPPFGNLHFLKKLDLISTYGITHLG
AEFHGNGGFPSLQELNLHRMNNLKEWSESHGADQLFPSLQRLRVYRCPEL
KCMPRLPNIQSLEIFYCDGSLLSYVGSLTSLSILRVEKMDNMTSFPSGCI
RNLTSLIELQIIGCDQLLSLPRGEMKRLKKIRSLTIDRCDSLAFLPSEVG
RLNSLRFLRLAGCPRIKLQPYEVVQILNSVHEFEITICGKNVNLHEQLQR
LYTLRELFITGEHDIYSDTQLCICCCEELESLMIADPASSVLQHLYINGI
SNLTKLPDWLQHLESLRFLSIHNCSQLGMLPRFLGLQTLTISDCPQLKRR
YERDSGEDWPIISHVPYVDI
>XP_042399621.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAAALVSDASRFKGENVADLLQLKDKLKAITGIEGKMEKLKESSAIIDAV
IQDVDSRPFIDAAVKELVKKLKYLAYDLEDVVDYYDTKVLQKKPRSKTSF
GPVRDFFSSDNQVVYTSRISGMIQAVTESLESILLQKSILLNLPQGNILV
SKPSPYRETHSRNSFDVIGRESEKNMIVDMLTKDDDVDESSHGTLKVITI
VGMGGLGKTALAQLVFNDDSVKEYFYLRMWKVVGTEFDPAKIMKSVLELA
FAAPVKISEIDLVRQKLEAALSGKRFLLVLDDVWNENVLKWGVLKAALTC
RAPGSKILMTTRSQKVPLIMGSSKTTYHIQQLSRDDCLSLFYHFAFEDEP
VDQKLMEIGEKIVEKCDGVPLAVISLGSMLRGTRDITDWSTVLNCSEIYM
ADPR
>XP_042399622.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEAALVTATVRFMGEKVANLLELDKKLKVIIGVKGKMKKLKELSTIIDTV
IEDVESHPLIDVAVRNLLRKIEFLANDIEDVVDCYDTEALRKQRSSDFFR
PVRDFFSSNNQVVFNCRIDGMIKAITDSLDSILLQKSFLLNLPQSSIHIS
ELSFHRETHSRNSLVVLGRETEKQIIVNMLTDDESNHDTLKVIAIVGMGG
LGKTTLAQLVFNDEEVKAYFDSSRMWKVVGDEFNPTTIMKSVLELATGAP
VVISEIDLVRRNLEKALSGKKFLLVLDDVWNEDPFEWGKLKAVLTCGSRG
SKILVTTRNQQVSSIMDSSYSHQMMQLSPADCWFLFQKFAFGDKEVDQIL
MEIGGKIVEKCGGVPLAVISLGSMLRITRDETYWSSVLNSEIWQLGNEQV
KVLAVLKLSYDTLPPRSKKCFAFASLFSKNYRMSKDELIKLWISNGFVRS
EGNFDAETLGNHVFDDLVMRSFFLLVPSQDVTKCTMHDLMHDLARSVSAD
VYCNFYQDSMEDIGKRTYHLKIGKGKLPNMKQVLGKKPLYLRTFIFRNRF
SRFSYINLHEVFSELKFLRALDLTNMGIREVPTSIGNLIHLRYLNLSRNH
IEVLPDSIILLSNLQYLNLSFNEELQELPKELGNMQNLRSLPFFVAGDRI
GACSILELENLKLHGEMKIIFSKNFTNYSCGGRKILKNKDLNELCINFNG
SERYDKDMLDDLCPNTSLKKLGIWYYGSPQFPAWLIELQLPNLVEVHFCC
SCEHIPPFGNLQFLKKLELWFMNDITHLGVEFHGYGGFPSLQELRLSWMD
NLEEWSELHGVDELFPKLQSLTIFCCPKLKSMPRLIPRIQHLKISYCSDN
ILSCIGRLTSLSFLEVAEMNDMASIPSGCIRNLTSLTKLIITKCRQLQSF
PWDEMQHLKMIHSLTIENCDNLASFPSEVGCLIGSLYFLRLTRCPCIILQ
PEELIQILNSVHEFQIEICGNKVNLRGQLQYLHTLKELSLWGAHAYIITY
GIAKLSICCCDELELLMTAEQANSIVLDKLYIEGISNLTTLPDWLQHLKS
LRLLSIQNCPQLERMPRDLKNLCMLETLKVFNCPQLKRRCERETGEDWPV
ISHISYIDIL
>XP_042399667.1 putative disease resistance RPP13-like protein 3 [Zingiber officinale]
MASTVVNLVLGKLGELASSEVTGLLNVGAEITSLTETLALIQSRLRDADQ
NLAFEMEDLVDEYAMQLGRASAADGRMSSLRRIGAFPSRILTRHRLASRL
QDIHARFQDVCKQTSQLGIQASSSWPTSSSSSYSSSTAADARLARRFELE
EDIVGFDEDIKGIKRLLFDISSTDRVVLSVVGPGGLGKTTLANKIYKSAD
VKKYFQCKAWVSVSQKYGVKELLCSIVKQVFDFKDEQVKGMEELEMKEKL
SEHLRDRRYLVVMDDIWQVAAWNAIKAAFPKESAGSRVLLTTRRMNVANV
ADVPPHELKFWNVEESWNLFCRKAFRTACCPPEFERFKEDIFRKSKGLPL
AIVVLGGLLRGTSQASDWRKKLDYISYEFREGEDQIQSILALSYHDLPHH
LKPRFLYFAAFPEDYIIAAERITHLWIAEGFIQTKDKVDQTMEDLAEAYL
KDLTDRSMLQMERGPLMI
>XP_042399679.1 putative disease resistance RPP13-like protein 3 [Zingiber officinale]
MASTVVNLVLGKLGELASSEVAGLLNVGAQIASLTETLALIQSRLRDADQ
KPRSEQSHSLQEWMRQIRNLAFEMEDLVDEYATRLGRASAAGGRKSCLRR
IAAFPSRILTRHRLASRLQDIHAKFQDLCKQTSQLGIQAPSSWPTSSSSS
YSSSSAADARLARRCELEEDIVGFDEDMKDIKRQLFDISSTDRVVLSVVG
PGGLGKTTLANKVYKSADVKNYFQCKAWVSVSQNYGVKELLCSIVKQVFD
FNDEQVKGMEELEMKEKLSEHLRDRRYLVVMDDIWQVAAWNAIKAAFPKE
SAGSRVLLTTRKMNVANVADVPPHELKFWNVEESWNLFCRKAFRTTSCPP
EFERFKEDIFRKSKGLPLAIVVLGGLLRGTSQASDWRKKLDYISYEFREG
EDQIQSILALSYHDLPHHLKPCFLYFAAFPEDYIIAAERIIHLWIAEGFI
QTKDKVDQTMEDLAEAYLKDLTDRSMLQTERMNHFYVQSVRIHDLLLDLA
RHEARELNFYRSINDRGDDPRALRRLCVTENVNDHVSLNCSTNKLRSLVI
YPNEGFQRTLAVTVAGAKFLRVLDLVEIPIEHLPKEIGDLILLRYLNLYQ
SKLKELPSSIGNLIHLQTFNIQFTEIQHLPDAFWKIRTLRHVFLNEENTS
MPNPTYCSEDIQTLSNISSGPWVCDGALEKLRNLRRLYLRNLSSSDEDAL
ANAVQNLSRLEMLALIGESLPVSLLTSSCYHHIQIMDLAGPLVRPARIHV
EAENSRIFSNLISLAIVNTRLEKDEDIALLSSLANLENLLVCLDAFVGRV
LVFPKGGFPRLQGIVLYRVSTLEQWEVGEGAMPLLQHLRLCGCINMRKLP
EGLVRLTELKQIEIREMEMIERRVNKDTGEDYHKIKHVPCVVIN
>XP_042399690.1 putative disease resistance RPP13-like protein 3 [Zingiber officinale]
MYWFGRLICRETEMASTVVYLVLRKLGELASSEVAGLLNVGVEIASLTET
LALIQSRLRDADQKPRSEQSHSLQEWMRQIRNLAFEMEDLVDEYATRLGR
ASAAGGRKSCLRRIAAFPSRILTRHRLASRLQDIHAKFQDLCRQTSQLGI
QAPSSWPTFSSSSYSSSSAADARLARRCELEEDIVGFDEDMKDIKRQLFD
ISSTDRVVLAVVGPGGLGKTTLANKIYKSADVKNYFQCKAWVSVSQNYGV
KELLCSIVKQVFDFNDEQVKGMEELGMKEKLSDHLRDKRYLVVMDDIWQV
AAWNAIKAAFPKELTGSRVLLTTRKMNVANVADVPPHKLKFWNVEESWNL
FCRKAFRTTSCPPEFERFKEDIFRKSKGLPLAIVVLGGLLRGTSQASDWR
KKLDYISREFREGEDQIQSILALSYHDLPHHLKPCFLYFAAFPEDYIIAA
ERIIHLWIAEGFIQTNDKVDQTMEDLAEAYLKDLTDRSMLQTETTDLYVQ
TVRIHDLLLDLARHEARELNFYRSINDRGDDPRALRRLCVTENVNDHISS
NCSTTKLRSLVVCPNEGFQRTLAVTISGAKFLRVLDLIELPIEQLPKGPL
MQLPSPSSLQAFNTSGSRHESFLLSVFFELFPKSLQIANISFEPPIIGTL
LSLSICM
>XP_042399751.1 disease resistance protein RPP13-like isoform X1 [Zingiber officinale]
MYRFGPLICRETEMASTVVNLVLGKLGELASSEVAGLLNVGAEITSLTET
LALIQSRLRDADQKPRPEQSHSLQEWMRQIRNLAFEMEDLVDEYATRLGR
ASAARGRKSCLRRIAAFPSRILTRHRLASRLQDIHAKFQDLCKQTSQLGI
QASSSWPTSSSSSSSSSSAADARLARRFELEEDIVGFDEDMKDIKRQLFD
ISSTDRVVLSVVGPGGLGKTTLANKIYRSADVKNYFHCKAWVFVSQKYEV
KELLCSIVKQVFDFKDGQEKGMEELEMKEKLSEHLRDRRYLVVMDDIWQV
AAWNAIKAAFPKESAGSRVLLTTRKMNVANVADVPPHKLKFWNAEESWNL
FCRKAFRTACCPPEFERFKEDIFRKSKGLPLAIVVLGGLLRGTSQATDWR
KKLDYISYEFREGEDQIQSILALSYHDLPHHLKPCFLYFAAFPEDYIIAA
ERITHLWIAEGFIQTKDKVDQTMEDLAEAYLNDLTDRSMLQMERKGGISI
QFVRIHDLLLDLARHEARELNFYRSINDRGDDPRALRRLCVTENVNDHVS
LNCSTIKLRSLVVCRNEGFQRTLAVTISGAKFLRVLDLIKLPIEQLPKEI
GDLILLRYLDLSGSKLKELPSSIGNLIHLQTFNIQFTEIQHLPDAFWKIR
TLRHVLLNKGNMSMPNSTFCSEDIQTLGNISSGPWVCDGALEKLRNLRRL
HLRNMSSSDEDAFANAVQNLSRLEMLALIGESLPVSLLTSSCYHHIQIMD
LAGPLVRPARIHIEAENSRIFSNLISLAIVKTRLEKDEDIALLASLANLE
HLLVCLDAFVGRVLVFPKGGFPRLQEIILGDLNTLEQWEVGEGAMPLLRE
LKLWYCINLRMLPEGLVRLTELKQIEIRGMEMIEKRVNKDTGEDYHKIKH
VPCIEIN
>XP_042399759.1 disease resistance protein RPP13-like isoform X2 [Zingiber officinale]
MYRFGPLICRETEMASTVVNLVLGKLGELASSEVAGLLNVGAEITSLTET
LALIQSRLRDADQKPRPEQSHSLQEWMRQIRNLAFEMEDLVDEYATRLGR
ASAARGRKSCLRRIAAFPSRILTRHRLASRLQDIHAKFQDLCKQTSQLGI
QASSSWPTSSSSSSSSSSAADARLARRFELEEDIVGFDEDMKDIKRQLFD
ISSTDRVVLSVVGPGGLGKTTLANKIYRSADVKNYFHCKAWVFVSQKYEV
KELLCSIVKQVFDFKDGQEKGMEELEMKEKLSEHLRDRRYLVVMDDIWQV
AAWNAIKAAFPKESAGSRVLLTTRKMNVANVADVPPHKLKFWNAEESWNL
FCRKAFRTACCPPEFERFKEDIFRKSKGLPLAIVVLGGLLRGTSQATDWR
KKLDYISYEFREGEDQIQTFPEDYIIAAERITHLWIAEGFIQTKDKVDQT
MEDLAEAYLNDLTDRSMLQMERKGGISIQFVRIHDLLLDLARHEARELNF
YRSINDRGDDPRALRRLCVTENVNDHVSLNCSTIKLRSLVVCRNEGFQRT
LAVTISGAKFLRVLDLIKLPIEQLPKEIGDLILLRYLDLSGSKLKELPSS
IGNLIHLQTFNIQFTEIQHLPDAFWKIRTLRHVLLNKGNMSMPNSTFCSE
DIQTLGNISSGPWVCDGALEKLRNLRRLHLRNMSSSDEDAFANAVQNLSR
LEMLALIGESLPVSLLTSSCYHHIQIMDLAGPLVRPARIHIEAENSRIFS
NLISLAIVKTRLEKDEDIALLASLANLEHLLVCLDAFVGRVLVFPKGGFP
RLQEIILGDLNTLEQWEVGEGAMPLLRELKLWYCINLRMLPEGLVRLTEL
KQIEIRGMEMIEKRVNKDTGEDYHKIKHVPCIEIN
>XP_042399769.1 disease resistance protein RPP13-like isoform X3 [Zingiber officinale]
MYRFGPLICRETEMASTVVNLVLGKLGELASSEVAGLLNVGAEITSLTET
LALIQSRLRDADQKPRPEQSHSLQEWMRQIRNLAFEMEDLVDEYATRLGR
ASAARGRKSCLRRIAAFPSRILTRHRLASRLQDIHAKFQDLCKQTSQLGI
QASSSWPTSSSSSSSSSSAADARLARRFELEEDIVGFDEDMKDIKRQLFD
ISSTDRVVLSVVGPGGLGKTTLANKIYRSADVKNYFHCKAWVFVSQKYEV
KELLCSIVKQVFDFKDGQEKGMEELEMKEKLSEHLRDRRYLVVMDDIWQV
AAWNAIKAAFPKESAGSRVLLTTRKMNVANVADVPPHKLKFWNAEESWNL
FCRKAFRTACCPPEFERFKEDIFRKSKGLPLAIVVLGGLLRAFPEDYIIA
AERITHLWIAEGFIQTKDKVDQTMEDLAEAYLNDLTDRSMLQMERKGGIS
IQFVRIHDLLLDLARHEARELNFYRSINDRGDDPRALRRLCVTENVNDHV
SLNCSTIKLRSLVVCRNEGFQRTLAVTISGAKFLRVLDLIKLPIEQLPKE
IGDLILLRYLDLSGSKLKELPSSIGNLIHLQTFNIQFTEIQHLPDAFWKI
RTLRHVLLNKGNMSMPNSTFCSEDIQTLGNISSGPWVCDGALEKLRNLRR
LHLRNMSSSDEDAFANAVQNLSRLEMLALIGESLPVSLLTSSCYHHIQIM
DLAGPLVRPARIHIEAENSRIFSNLISLAIVKTRLEKDEDIALLASLANL
EHLLVCLDAFVGRVLVFPKGGFPRLQEIILGDLNTLEQWEVGEGAMPLLR
ELKLWYCINLRMLPEGLVRLTELKQIEIRGMEMIEKRVNKDTGEDYHKIK
HVPCIEIN
>XP_042399777.1 probable disease resistance protein At1g58390 isoform X4 [Zingiber officinale]
MKDIKRQLFDISSTDRVVLSVVGPGGLGKTTLANKIYRSADVKNYFHCKA
WVFVSQKYEVKELLCSIVKQVFDFKDGQEKGMEELEMKEKLSEHLRDRRY
LVVMDDIWQVAAWNAIKAAFPKESAGSRVLLTTRKMNVANVADVPPHKLK
FWNAEESWNLFCRKAFRTACCPPEFERFKEDIFRKSKGLPLAIVVLGGLL
RGTSQATDWRKKLDYISYEFREGEDQIQSILALSYHDLPHHLKPCFLYFA
AFPEDYIIAAERITHLWIAEGFIQTKDKVDQTMEDLAEAYLNDLTDRSML
QMERKGGISIQFVRIHDLLLDLARHEARELNFYRSINDRGDDPRALRRLC
VTENVNDHVSLNCSTIKLRSLVVCRNEGFQRTLAVTISGAKFLRVLDLIK
LPIEQLPKEIGDLILLRYLDLSGSKLKELPSSIGNLIHLQTFNIQFTEIQ
HLPDAFWKIRTLRHVLLNKGNMSMPNSTFCSEDIQTLGNISSGPWVCDGA
LEKLRNLRRLHLRNMSSSDEDAFANAVQNLSRLEMLALIGESLPVSLLTS
SCYHHIQIMDLAGPLVRPARIHIEAENSRIFSNLISLAIVKTRLEKDEDI
ALLASLANLEHLLVCLDAFVGRVLVFPKGGFPRLQEIILGDLNTLEQWEV
GEGAMPLLRELKLWYCINLRMLPEGLVRLTELKQIEIRGMEMIEKRVNKD
TGEDYHKIKHVPCIEIN
>XP_042399806.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MIPSIGIGQILNKIWDAASIFLARPRSRVEDLGRDAERLKAKLVDVNRAI
DEAERDGKTATAEARLWKREAEAFVYTEVAAIQQDYGAMRCLGGWSWNCV
AINWRVTKKLEEAKELISRVDVSRVAARLPPPPAVELPISNNIVGMQSDV
IQIVNQIKDENVRVIGIYGMGGIGKTTLLKLINNHEETSKLKFEHVVWIV
ASKGCKLQKLQMDLAKKVGLNLEDDESEDDRAYKLHNFLKGKNCLLFLDD
IWQSYEIVMLGMQPPKRGMEKKRKVIVFTTRYEQVCTGMSANVIKKVKGL
SSDEAWELFLKYAREDVINSERQINQLAKEITKECAGVPLALITVGRAMS
AKRSREAWHDALVQLKKSQMPEVTGMKERDPMFAAFKLSYDSLEDDNIRA
RLLCCSLWPEDFEIDKDELIQCWIGLDLIDEFDSINKAFDRGHSHIETLT
FACLLELVNKNGETRIKMHDVIRDMALWMASDCGSNQHRWIVKARARLNQ
LELENEQWQVVERASFMHNNLSSLPRQTPTFPKLSMLMLQQNPKLDLIPE
PFFKALPILAFLDLSGTNITDLPREINMLSELQYLNLNFTPIKALPVELS
SLAKLKYLLLVGTKHLAKVPKGTMSNIALLKLLDLYESKYSNLDELEGFK
GCRKYIGITLHSMIDLERLGSLPQLFTWKLQLQSMRDLAYPSQLFESIMS
SYNTRQGLERLEIVDVTTGGELTIAQSNNDHEEGLECLRYMTLITVNDLQ
EITWKVVEHQTVFPNLHELSIFDCKMLRNITWVLHLPNLNVLKVSNCGEM
EELINCVGSSANSSIGLRLLSLARLPSLNCISRQSLTFPYLEQLYVSSCP
ELRKLPFGAEICQNKLKGIFCQEDWWENIQWENANDKNSLLPYIKFGFQK
IVLKLGVKLPKDKSRIFKTVIELPGVTSMAGLEYVPFDRGG
>XP_042399807.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MIPSIGIGQILNKIWDAASIFLARPRSRVEDLGRDAERLKAKLVDVNRAI
DEAERDGKTATAEARLWKREAEAFVYTEVAAIQQDYGAMRCLGGWSWNCV
AINWRVTKKLEEAKELISRVDVSRVAARLPPPPAVELPISNNIVGMQSDV
IQIVNQIKDENVRVIGIYGMGGIGKTTLLKLINNHEETSKLKFEHVVWIV
ASKGCKLQKLQMDLAKKVGLNLEDDESEDDRAYKLHNFLKGKNCLLFLDD
IWQSYEIVMLGMQPPKRGMEKKRKVIVFTTRYEQVCTGMSANVIKKVKGL
SSDEAWELFLKYAREDVINSERQINQLAKEITKECAGVPLALITVGRAMS
AKRSREAWHDALVQLKKSQMPEVTGMKERDPMFAAFKLSYDSLEDDNIRA
RLLCCSLWPEDFEIDKDELIQCWIGLDLIDEFDSINKAFDRGHSHIETLT
FACLLELVNKNGETRIKMHDVIRDMALWMASDCGSNQHRWIVKARARLNQ
LELENEQWQVVERASFMHNNLSSLPRQTPTFPKLSMLMLQQNPKLDLIPE
PFFKALPILAFLDLSGTNITDLPREINMLSELQYLNLNFTPIKALPVELS
SLAKLKYLLLVGTKHLAKVPKGTMSNIALLKLLDLYESKYSNLDELEGFK
GCRKYIGITLHSMIDLERLGSLPQLFTWKLQLQSMRDLAYPSQLFESIMS
SYNTRQGLERLEIVDVTTGGELTIAQSNNDHEEGLECLRYMTLITVNDLQ
EITWKVVEHQTVFPNLHELSIFDCKMLRNITWVLHLPNLNVLKVSNCGEM
EELINCVGSSANSSIGLRLLSLARLPSLNCISRQSLTFPYLEQLYVSSCP
ELRKLPFGAEICQNKLKGIFCQEDWWENIQWENANDKNSLLPYIKFGFQK
IVLKLGVKLPKDKSRIFKTVIELPGVTSMAGLEYVPFDRGG
>XP_042399808.1 probable disease resistance protein At1g62630 isoform X1 [Zingiber officinale]
MLLKLINNHEEISKLKFEHVVWIVASKECKLQKLQMDVAKKYAGKDVINS
EQGINQLAREIAKVCSGVPLILITVRRVMSAKRSWRSDALMQLRQSRMLE
VTDMKERDPMFAAFLLSYDSLEDDNMRAPLLCGSLWPEGFKIHKVELIQR
WIGLGLINEFNSINKEFHRELSHIETLTFTCLLELVDSEHTVGIKMHDLI
RDMVLWMVSDYGSNQYKWIVKAHAGLNQLELENEE
>XP_042399828.1 disease resistance protein RPS2-like [Zingiber officinale]
MGQLSVDYWYETRSMPVPNSLLDCKSFSNHRLPNSFYTDCDPSICCFPSI
AMSISFDIGQFLNKICHVASIHLARPRSSVEDLHIDAELLGAKLSDVDRA
ISEAAGNGKIVMEEALVWKRLAEAFVSKEAAIQRDYKEMRCLGGWSWNCV
SINRRATEMKKMQELISRGNDIRVVAAPPPPPQLPVKLPISNNVVGMESN
VIQIVNQIMDANVRVIGIYGMGGIGKTTLLKLICNHDEISKLKFEYVIWI
VASKGCKLQKLQMDLAKKVGLKLEDDESEDDRASRLFDSLKEKNCLLFLD
DIWESYDLYKLGMEEVPAEHGKERKRKVIVFTTRYEHICTGMNANVIKKV
EGLSSDQAWELFLKYAREDVINSEPGINQLANEIAKECAGVPLALITVGR
AMSSKRSWEVWNDALTQLRQSQMPELTGMKESDPMFAAFKLSYDSLEDDN
MRARLLCCSLWPEDFEIDKVELIQCWIGLGLIAEFDSINKTFHRGHTHIE
TLTSACLLELADKKYATRIKMHDIIRDMTLWMASDCGFNQHKWIVKAQAR
FSQLELENEKWQVVERASFMHNDLSSLPRQTPIFPKLSMLMLQGNYKLSL
IPGSFLQALPVLTFLDLSNTKITELPREINMLSELQHLNLNMTPVEALPA
ELSSLAKLKYLLLVRTNRLAKVPKGTISNLPLLKLLDLYESKYADLDELE
EFKGCRRCIGITLQSVTTLDQLVSLQQLSTWKLQLKNMSDLAYPSQLFES
IMSSHNIRKSLERLEIVSVQTGDELIVARNNRDREEGLECLRYMVLKAVD
DLQEITWKAVKPQTVFPNLRELKISECKMLRNVTWVLQLPHLSVLTVSNC
DKIEELISCVGDSVNSSSSLRLLSLAQLPKLNCISQQSLTFPYLERICVN
SCPNLRKLPFGVEICQNKLKDIFGQTDWWNNIRWEDANDKISLTPYFKST
YMQKIVLKLNMEDAKSRAKALKTAVRIHGVVSVTLENDLLIMNGDQVDLV
ALSKTMRRNFGWVELISISEMVD
>XP_042399830.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MNPSINFGQFLNKIWDAASIYLARTRSRVEDLGRDAELLRAKLEDLNRAI
DEAERNGQTATEEAQLWKRRSETFLSTEVVAAIQRDYGAMRCLGGWSWNC
VSINRRATKKLEEVKELISRVDVSRVAAMLPPPSAVELPISNDIVGMQSD
VIQIVNQIRDENVSVIGIYGMGGIGKTTLLKLINNHHREISKLKFDHVIW
IVASQGCKLQKLQMDLAKNIGLNLKDDESEEGCACKLFNSLKEKNCLLFL
DDIWETYDLYMLGMEKTHVEQGKEQKRKVVVFTTRSEQVCTGMKANVKKK
VTGLASDKAWKLFLKNAGENVINSESRINRLAKEIAKECAGVPLALITVG
RAMSAKRSWEAWNDALTQLKQSQMPDVTGMKKRDPMFAAFKLSYDSLEDD
NMRVRLLCCSLWPEDFEIDKVELIQCWIGLGLIDEFDSINKIFDRGHSHI
ETLTFACLLELVHKEHAINIKMHDVIRDMALWMASDCGSNQHRWIVKAGA
RLYDLELENEQLQVVEQASFMHNYIRSLPSETPTFPKLSMLMLQQNLKLY
LIPGSFFQALPVLTFLDLSGTNITMLPREINLLFELQHLNLNFTPIEALP
ANLSNLSKLKYLFLKGTMRLTQVPKGTISNLPLLKLLDLYESKYDNLAEL
KGFKGYRRYIGITIRTMMALEQLGSLRQLYTWKLQLENMKDLAYPRQLFK
SITSNHNTRQSLERLEIVNILTGGELIVAQSNKDSEEGFECLRYMALIAV
DDLQKITWKAVEPQIIFPNLHELIIAKCKMLRNITWAVQLPNLSVLKVSY
CDEMEELISYVGSNVSSSIDLHLLSLAQLPKLNRISRRQLTFPYLERIYV
SECPKLKKLQFGAEICQNKLKGIFGRKKWWENIKWENAKDKNSLTSYFKS
SMQIIMLRLNIRGASFDMGDTNARAVAIKIALAIPGVMSAELDDECLIVR
GEQLDPVEIVARLQNLFQAELLNGDIEN
>XP_042399941.1 disease resistance protein SUMM2-like [Zingiber officinale]
MTLSTVLGQILNKICNAASFYLASPQSSVNYLGRAAERLTAKLEDVNQEI
AEAERNGQTTTNETRLLKRKAEAFVSEVAAIQRDYGAMRCLGGWSWNCVS
INQRVSERMEEVSELISGVDVSKVAAKLPPPAAVELPISNNVVGMRSNLI
QIVNQIRDENNSVIGIYGMGGIGKTTLLKHIHNHEDISKLKFEHVVWIVA
SQGCKLQKLQMDLAKKVRLKFEDDESEDDRVSKLYNFLKQKSCLLFLDDI
WESYDLVKLGMEQVPAEHGKEQKRKVVIFTTRSEQVCTEMSADVIKKVEG
LPYDQAWELFLKNAGEHVINIEPRITGLAKQIAEECAGVPLALITVGKVM
SAKRSIEAWNEVLRQLKKSHMPKVTGMKERDPMLAAFKLSYDNLEDDNMR
ARLLCCSLWPEDFEIHKVELIQCWIGLGLIDEFDSINEAFDRGHFHIETL
ASACLLELIDGEIHTTKIKMHDVIRDMALWTASN
>XP_042399942.1 disease resistance protein SUMM2-like [Zingiber officinale]
MTLSTVLGQILNKICNAASFYLASPQSSVNYLGRAAERLTAKLEDVNQEI
AEAERNGQTTTNETRLLKRKAEAFVSEVAAIQRDYGAMRCLGGWSWNCVS
INQRVSERMEEVSELISGVDVSKVAAKLPPPAAVELPISNNVVGMRSNLI
QIVNQIRDENNSVIGIYGMGGIGKTTLLKHIHNHEDISKLKFEHVVWIVA
SQGCKLQKLQMDLAKKVRLKFEDDESEDDRVSKLYNFLKQKSCLLFLDDI
WESYDLVKLGMEQVPAEHGKEQKRKVVIFTTRSEQVCTEMSADVIKKVEG
LPYDQAWELFLKNAGEHVINIEPRITGLAKQIAEECAGVPLALITVGKVM
SAKRSIEAWNEVLRQLKKSHMPKVTGMKERDPMLAAFKLSYDNLEDDNMR
ARLLCCSLWPEDFEIHKVELIQCWIGLGLIDEFDSINEAFDRGHFHIETL
ASACLLELIDGEIHTTKIKMHDVIRDMALWTASN
>XP_042399943.1 disease resistance protein SUMM2-like [Zingiber officinale]
MTLSTVLGQILNKICNAASFYLASPQSSVNYLGRAAERLTAKLEDVNQEI
AEAERNGQTTTNETRLLKRKAEAFVSEVAAIQRDYGAMRCLGGWSWNCVS
INQRVSERMEEVSELISGVDVSKVAAKLPPPAAVELPISNNVVGMRSNLI
QIVNQIRDENNSVIGIYGMGGIGKTTLLKHIHNHEDISKLKFEHVVWIVA
SQGCKLQKLQMDLAKKVRLKFEDDESEDDRVSKLYNFLKQKSCLLFLDDI
WESYDLVKLGMEQVPAEHGKEQKRKVVIFTTRSEQVCTEMSADVIKKVEG
LPYDQAWELFLKNAGEHVINIEPRITGLAKQIAEECAGVPLALITVGKVM
SAKRSIEAWNEVLRQLKKSHMPKVTGMKERDPMLAAFKLSYDNLEDDNMR
ARLLCCSLWPEDFEIHKVELIQCWIGLGLIDEFDSINEAFDRGHFHIETL
ASACLLELIDGEIHTTKIKMHDVIRDMALWTASN
>XP_042400834.1 putative disease resistance protein RGA1 [Zingiber officinale]
MVCDSLWAINSMIVIPKMGMLYNKCLEWDSVFDPELDVPAEFEDWERDVA
AAIIDVGELLSRIMDWEASLHRSIVGNTKQVHFRHVILVELKEMLCHLNS
LVLRGSAMGLRRDPMDSMNPLQEDYSIVLKNEVVGREEDLEKLIAILERQ
LVSSNNIGDDNNPFVIVIDGTPGVGKTTLAHMIYHHTWVRQQFHHRIWMD
LPLVSPFKMINIIGNEFLRSINKEEYCDQKLHLDLSLLAMWEYINEQLCG
SRYLLVLHCENLVSLMQSGEWNELKNILLRVGGPGSGVLIIYKFSTVSFV
RDTGFLNRMKDIITYPLKTLSADACVELFKRQAATTIPSSKQDKSERDAW
LLRNCIPTQAFGAKVFGSLSHNIPASFAHNLFYEVYMVRNLPLVIIRLHQ
YQHLLDVDNDYDVILHMLTAEYLIPTEGLERDWIQLYARPINKRTSLRLS
RMVHLHMKVPEYLTTIPRCCRYLCLKINHRAIPFRLPTMPVEVSNKLITL
ILREHEEATQEDVEEITLQAYKKRRMKATTAISKFLNKMSVRLVHLRILV
VETGMIQRLPNEVSKLVNLRYLHLSKLKMELLPKSLFDLPNLRILSLLRC
QKLQKIPERIHQLKKLQILKLAYCTKLQRLPKSITRLKNLEVIDVEGCCW
LSKLPDDLISFKSLRILNFTRCASLSQIPRGIEQSIDLRKLSGIFVGVDG
GFVLAQLQTLTNLQEIRLRNLERAEKTQTEVLMGQQSLRNLSLHWGGEEA
NESSESATPLQVLEALRPNVHLKMLEIISYKGVEFPTWMSKQELVDFDSL
VEVRLINLRRCATLPSLGRLPCLEKLEISGMDLIKHIDDTFYDDGNTYPK
LRELTFSEMLALEKWSMTEEKYFKFFPRLRKLTLVQCPKLKEIDLHYYSG
TMRIWLNNETTCSAKFCCWGNLRYIQTIEIVGCQELRCLPQGMKSMKYLN
KMTINSCNNLTTLVALDSLRALNIYACPVLAFNLESFTELVLLTIKGCPK
MQM
>XP_042401039.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MWKDELANKAAEIRKRFDQITEEWKLLTLPKNAGKRKRSPSSIDENRETC
SLVVESDVLGRVEEKDMLVEWLLSKDDTTRNGVSVMVVIGMGGLGKTTLA
QHPRVKSYFDLRGWVYVSENFHDGEDPTIIYKSESS
>XP_042401475.1 disease resistance protein RGA2-like [Zingiber officinale]
MEAALVATARFAADKVTILVQLDEKLKAMTGIEEKMKKLKEMSTIIDMVI
QDVESHPLNNDVVKDLLRKLKYLAYDLEDVVDCYDTETSRRQRSSIVSDF
FSSNNQVVFTSNISDMIQGVTNSLGSILLQKSILLNLPQSSSHMSLPYRG
THSRNTIEVVGRELEKNKIVNMLTKEDDDDDESDHGTVKVIAIVGMGGLG
KTTLAQLVFNDARVKDHFASPRMWKLVGAEFDPEKIMKSVLELATGAPVN
ISEIELVRQNLETALSGKRFLLVLDDVWNEDPFEWGTLKAALTCGAKGSK
ILVTTRSLHVCSIMGSSTATHQIQQLSRDDCLSLFQQFAFGDEAPDQKLM
KIGKKIVKKCDGVPLAAISLGNMLRGTRDETYWSSVLKSEIWQLRDEEQK
VLAVLKWSYDTLPLRSKKCFAFGSLFPKDYMMQKDKLIKLWIANGFVSSE
GNFEAETEGNRIFDDLVSRSFILLAPVQYDRRITKCTMHDLMHDLARSVS
GNIYWNSIQDLVEVIGERTYHLQINEGKLPNMTQVLAKKPTYLRTFFQDK
LSRLSINLHEVFSVLKFLRALNLTESGIRDIPTSIGNLIHLRHLNLYYNE
IEVLPDSITLLSNLQYLNLSFNYGLRELPKELGNMQNLRDLDLVMDYKLT
QIPCGLSRLTNLRSLPVFIASDKTGACSITELEDLKLYGKMGIKISHDFK
NYSRSGRKILKNSDLDELHIEFGVSEGYHKDMLDDLCPNTSLKMLRISNY
RSPQFPTWLIELQMPNLVVVDLGCCCGHILPFRNLQFLKKLSLGRMNGIT
QMVTEFHGFPDVLN
>XP_042401479.1 uncharacterized protein LOC121991551 [Zingiber officinale]
MAEALVSDAYRLMSERLADLLQLNDKLKATTGIEGKMEKLKFLSTIIDKV
IQEVDSRPFIDDAVKDLLKKLKYLACDLEDVVDHYDTKVLQMQISNASFE
SVRDFISSDNLFKSRVNCMIKAITQSLDFILLQKSILLNLPQSSSHMSLN
PYRETHSRNSFVVIGRETEKNMIVNMLTNDDDDDEEESNHATVKVIAIVG
MGGLGKTTLAQLVYNDTRVQEHFASLTMWKIVGPEFNPTKILKSILELAT
RKSVGISEIDLVRQELETTLSGKRFLLVLDDVWNEDALKWGVLKAALTCG
SRGSKILMTTRNQCVSSIMDSSYIHQMKQLSPADCSFLFQKFAFGDRKVD
RTLMEIGGKIAKKCGGVPLAAISLGSMLRITRDETYWSSVLNSEIWQLGN
EEDKVLAVLKLSYDTLPPRSKKCFTFGSLFPKNYRMAKDELIKLWIANDF
VCSEGNFDAETNGNLVFNDLLMGSFILWAPSNVYDDSHVNMCTMHDLMHD
LARSVSANAYWNSDQDSVEDVGNRTYHLQIQRGEESSMTQVLGKKPLYLR
TFMYNSSRLSINLLEVFSELKFLRALDLRYCGIREVPTSIGNLIHLRYIN
LSNNMIEVLPDSITLLSNLQYLNLGFNKELRELPKDLGNMQSLRDLDLSS
YLFDSGFKLTHMPCGLSRLTNLRSLSVFVAGDGTDACSIIELEDLKLHGE
MEIKFSDDFKNYSCGGRKILKNKDLNELCIKFNGSERYDKDMLDDLCPNT
SLKKLTISNYGSPQFPTWSIDLQLPNLVEVYITSRFCEHLPPFGNLQFLK
KLDLRCMHGIRQMGVEFHGCGGFPSLQELILDGMYILEEWSESHGVNQLF
PLLQRVKIINCPELKCMPRLPRIQELEVLWCRRRLLSCVGRLTSLSVLEV
VDVRDMVSLPSGCIRNLTFLTKLEIIACEQLQSLPGDEMKHLKMLRSLII
EGCYNLTSFPLEVGHLSSLCFLRLSGCPSIILHPEELVQILNSIPEFEIQ
ICGNKVNLSEQLQHLHTLGGLLLTGDHNASDLFENHAYEHPELCICCCDE
LELLMTAEAASNIVLEELHINGISNLTTLPDWLLHLKSLSLLSIENCPLL
ERLPKNLKNIHMLEGLTIDNCPQLESRCKRETGEDWPIISYLNFEISGIA
MEAPLLAVGRFMVDKVAILVELDEKLKAITGIKGKMEKLKELSTLIDMVI
QDVESHPLNKDAVKDLLRKIKYLAYDLEDVVDYYDTKVLQKKQRSNTALR
PVCDFFSSNNQVVFKSMIGGMIKAITDSLDSILLQNSIFLNLPQGSIRTS
ESNLHEERHSRTSLVVIGRDTEKNMIVDMLTKDDDEDESSTHDTLKVIAI
VGMGGLGKTTLAQLVFNDEKVKAHFESWRMWKVVGAEFDRKRLMKSVLEL
ATGKPVNISEIDLVRQELEKTLSGKKFLLVLDDVWNENASSWDVLKAALT
CGARGSKVLVTTRSLRVSSIMGSNTTHQIQQLSRDDCLSLFQQSAFGDEA
ADQKLMGIGGKIVEKCGGVPLAAISLGSMLHDTRDETYWSSVLKSEIWQL
QDEEQKVLAVLKWSYDSLPLQSKKCFAFGSLFPKNYMMNKDELIRLWIAN
GFVSSEGNFDAETLGNRIFDDLVSRSFFLLVPSQDVTECTMHDLMHDLAR
SVSADVYWNSNQDSVEDIGKRTYHYLQIFPGELPNDMFSQVLSKKPLYLR
TFMSQDTSSHLNINLLDVFSKLKFLRVLDLRSNNIKEVPASIGNLIHLRY
LNLSWNDIEVLPDSITLLLNLQYLHCNNLRLTYMPRGLSRLINLRCLPHF
DADNRSGACSITELEDLKLHGEMTIKFSKNFKNYSCGGRQILKNKHLSEL
SLHFNCSESNDKDMLDDLSPSTNLKKLSIRNYGSRQFPAWLIESHLPNLL
EVSLDNCYGCEHIPPFGNLQFLKKLRLCIMNDIFTQMGAEFHGHGGFPSL
RELSLSSIYNLEEWSESDGVDQLFPLLQKLRILRCPKLKSMPRFPKIQEL
EISYCSESLLSCIGRLSSLSVLKVEDMNDMTSLPSGCIRNLTCLKKLKIT
ECGRLQSLPGDEMQHLEMMRSLTIYSCNNLSSFPSEVERLRSLRLTRSQR
IAVEPELLVPFLNSLNKFRIEICGKKVNLRGQLQRLHTLKELLISGKHGT
FCFYRKATKLGICCCDELESLMTTTELAASSTVLLEDLYINEFSNLTTLP
EWLQHLKSLRILSIRNCQRLERVPRGLKDLSMLRVLKFINCPQLEGRCER
ETGDDWPIISHVTQVVVCQVPQIRLNIVQQAEG
>XP_042401480.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEGTLVATARFPANKVAILVQLDEKLKTETGTKRKMEKLKELSTIIGAVM
EDVESRSFIDDAVKDLLKMLKYLDYDLEDVVDYYDTKVLQKQQRSNTCLR
PVRDFFSSDNQVVFKCRIGGMIKVVIESLDSILLQKSILLNLPQGSIRMS
EPSLYKETYSHNSFDVRGREPEKNMIVDVLTKDDDDDENSRGTLKVIAIV
GMGGLGKTTLAQLVFNDERVKVHFVSSRMWTFVGTEFDPTKIMKSVLEQA
TFDPVNISETDLVRQNLEKTLSGKRFLLVLDDVWNEDQLKWDELKAALTC
GARGSKILMTTRSQQVSSIMGSFNTHQIQQLSRDDCLSLFQQSAFEDEAV
DQNLMKIGAKIVEKCGGVPLAAISLGSMLHGTRDEMYWSSVLMSEIWQSG
NDEYEVLATLKLTYDNISPQSKKCFAFASLFSKNYGMAKDELIKLWIANG
CVRSEGNFDAETVGNHVFDDLVLRSFFLLAPFEDVTKCTMHDLMHDLARS
VSADVYWNSNQDSVEDIGKRTYHLQIFPRELRNDMFSQVLGKKPLNLRTL
ILSKCKLDQNANLLEIVFSELKFLRVLDLSNNNIKEVPTSIRNLIHLRYL
NVSGNDIEILPNSIILLLNLQYLYCNNLRLTYMPRGLSQLSNLRILSFFA
AADRTGACSITELEDLKLHGEMTIKFSTNFTNYPRGGRQILKNKHLNQLL
FELNGSESNDKDMLDDLCPDTSLKRLSICNYGSRQFPAWLMESQLPNLIE
VSLEKCHGCEHIPPFGNLQFLKKLDLCMMNGITQLGAEFHGYRGFPSLQE
LFLHGMDNLEEWSESDDSNQLLPSLQGLRIFHCPKLKSMPWLARIQRLYI
FDCNEGLLSCVGRLTSLSILRVRWMKYMTSLPNGCIRNLTSLTKLKITEC
NLLQSIPGDEMQHLGTIQSLTIYWCNDLASFPSEVESLSSLRSLRLTKCL
HITVEPEILVRILNSLHKFRIEICCEKVNLRGQLQRLHSLGELLISGEHG
KFAFQRKATQLGICCCDDLESLMTTEQAASSVLEDLYIDGISELMTLPDW
LQHLRSLRILSIQNCPRLEKVPQGLKDLHMLSDLKLVNCPQLEGRCERET
GEDWPIISHVPQITIGLVP
>XP_042401481.1 putative disease resistance protein RGA4 [Zingiber officinale]
MEGALVAATRFVADKAVILFQLDEKLKAMTDIEEKMENIKELSTIIDMVI
EDVESHTLNKDAVKDWLRKLKYLAYDLEDVMDCYNTEALRRQRSSISSFE
PVRDFFSSNNQIVFTSRISDMIKAVTNSLDSILRQKSFLPNLPQSSGHMP
LNPYRETHSRNSFDVIGREIEKDMIVGMLTKDDDDDDDDDDDKSSHGTLK
VITIVGMGGLGKTTLAQLVFNDARVKDHFESSRMWTVVGAEFDPAKIMKS
VLELATGASVNISQIDLVRQKIEKALSGKKFLLVLDDVWNEDATKWNVLK
PALTCGARGSKILVTTRSQQVSSIMGSSNTTHQIQQLSRDDCLSLFQQFA
FGDEAVDQNLMEIGEKIVKKCGGVPLAAISLGSMLRITRDEPYWSSVLNS
EIWQLGNKEDKVLAVLKLSYDSLPPRSKKCFAFASLFSKNNRMTKDELIK
LWIANGFVSSEGNFDAETVGNRVFDDLVSRSFFLLVPSQDVTKCTMHDLM
HDLARSVSADVYCNSKQDSVKHIGNRTYHLHIYLANTSKVTRALSKKPLY
LRTLILNYVSLNADQLELVFSELKYLRVLELTGNKIKEVPTSIGNLIHLR
YLNLSKNRIRVLPDSITLLHNLQYLYCHHLRLTHMPCGLARLINLQSLSF
FAAADGAGACSIIELEHLKLHGEMKIQFSENFTNYSCGGRKILKNKHINE
LRLKFNCSESNDKDMLDDLCPNSSLKKLSICNYGSRQFPELLIESQLPNL
VEVCLKNCRCCEHIPPFGNLQFLKKLELHKMNAVTQMGAEFHGFGGFPSL
QELYLDRMDDLEEWSESDYADELFPLLKTLFIVKCPKLKSMPRLPRIQYL
DISYCSGSLLSCVGRLTSLSVLRVEAMDDMTSFPNGCIRNLTSLTAFEIK
GCKQLQCLPGDEMQHLEMIRTLTIDRCDNLASLPSEVGCLGSLCFLRLRE
EKIQNWQKGVRMHDIWRRDSLGARMHDSKSSDYNRQKAVNMIEENLQEDQ
QKLELHVFEMEVELTCLNEALLIEALSEKLGTADSEIKSLKEMVAMAERL
VESESVLKEMESSMKYPLEMEAEKSIWSSKEKAFLEASEKLKIQNNLMQK
LSENLL
>XP_042401482.1 putative disease resistance protein RGA4 [Zingiber officinale]
MEGALVAATRFVADKAVILFQLDEKLKAMTDIEEKMENIKELSTIIDMVI
EDVESHTLNKDAVKDWLRKLKYLAYDLEDVMDCYNTEALRRQRSSISSFE
PVRDFFSSNNQIVFTSRISDMIKAVTNSLDSILRQKSFLPNLPQSSGHMP
LNPYRETHSRNSFDVIGREIEKDMIVGMLTKDDDDDDDDDDDKSSHGTLK
VITIVGMGGLGKTTLAQLVFNDARVKDHFESSRMWTVVGAEFDPAKIMKS
VLELATGASVNISQIDLVRQKIEKALSGKKFLLVLDDVWNEDATKWNVLK
PALTCGARGSKILVTTRSQQVSSIMGSSNTTHQIQQLSRDDCLSLFQQFA
FGDEAVDQNLMEIGEKIVKKCGGVPLAAISLGSMLRITRDEPYWSSVLNS
EIWQLGNKEDKVLAVLKLSYDSLPPRSKKCFAFASLFSKNNRMTKDELIK
LWIANGFVSSEGNFDAETVGNRVFDDLVSRSFFLLVPSQDVTKCTMHDLM
HDLARSVSADVYCNSKQDSVKHIGNRTYHLHIYLANTSKVTRALSKKPLY
LRTLILNYVSLNADQLELVFSELKYLRVLELTGNKIKEVPTSIGNLIHLR
YLNLSKNRIRVLPDSITLLHNLQYLYCHHLRLTHMPCGLARLINLQSLSF
FAAADGAGACSIIELEHLKLHGEMKIQFSENFTNYSCGGRKILKNKHINE
LRLKFNCSESNDKDMLDDLCPNSSLKKLSICNYGSRQFPELLIESQLPNL
VEVCLKNCRCCEHIPPFGNLQFLKKLELHKMNAVTQMGAEFHGFGGFPSL
QELYLDRMDDLEEWSESDYADELFPLLKTLFIVKCPKLKSMPRLPRIQYL
DISYCSGSLLSCVGRLTSLSVLRVEAMDDMTSFPNGCIRNLTSLTAFEIK
GCKQLQCLPGDEMQHLEMIRTLTIDRCDNLASLPSEVGCLGSLCFLRLRG
CPSIIVQPEVLVQIMNLLHKFQIDICYKNVDVRGQLQHLHMLKKLSIDLM
IPIN
>XP_042401483.1 putative disease resistance protein RGA4 [Zingiber officinale]
MKSVLELATSASVNISQIDLVRQNLEKALSGKKFLLVLDDVWNKDPFEWG
KLKAALTCGTRGSKILVTTRSQQVSSIMGSSNTIHQIQQLSGDDYLYLFQ
QFAFGDQAVDQNLMEIGEKIAKKCGGVPLAAISLGSMLRITRDETYWSSV
LNSEIWQLGNEEDQVLAVLKLSYDTLPLRSKKCFAFASLFSKNDIMAKDE
LIKLWIANGFVRSEGNFNAETAGNRVFDDLVLRSFFLLVPSQDVIRCTIH
DLMHDLARSVSADVYWNSEQDSVENIGKRTYHLKISLSEESSMTHVLGKK
PLYLRTFMSRRVYSPLRTNMFEGFLELKFLRSIDLPCNGIIEVPTSIGNL
IHLRYLNLSRNGIKVLPDSITLLPNLQYLDLSFNEELQELPEELGNMQSL
RELDCRHLDFQELLPLFSHIQNIQDLDLLRALSHFNFGLTHMPCGLSRLT
NLQSLGAFYAGDRTGACSIIELEDLKLHGEMNIIFSKDFTNYSCGGRKIL
KNKDLNELRLEFNGSERYDKEMLDDLCPNKSLKKLSICNYGSRQFPAWLM
ESQLSNLVEVSLKNCRGCEHIPPFGNLQFLKKLDLRSINGITHMGVEFHG
HGGFPSLQELILNELYNLEEWLESHGVDELFPKLQSLKIFACPRLKSMPR
LPTIQYLDIFWCSGSLLSCVGRLTSLSLLRLVEMDDMTSLPNGCIRNLTS
LTTFEIQGCKQLQCLPGDEMQHLEIIRSLTIYRCNNLASFPSEVGCLGSL
RSLSLRGCPSIKVQPEVLVQILNSLHKFQIEICHKNVDIRRQLQHLHTLK
ELFITGVHGRYKNHSYIGRNNATQLGICCCDELESLITAEPTSNVLEELY
IDEIFKLTTLPDWLRHLESLRVLSIHNCSELGLLPRGLKNLPMLETFRVS
NCPQLKRRCEREIGEDWPIISHLPFIDIS
>XP_042401508.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MAMIPDFLVTRYLTKLTDFLEGEICKVLGVKEEIKKFQRRLERLSPYLQD
AEQKRHQDNRVNTWLRDLKGIVYDAEDIIEFCTLPGGSELMSLQPLSSSS
TLVSRPFTLLASCFACTKFRHEIAVSLKRLNDRLKEIKDDKDLIEGLIPS
MSHQWSQDHPTSQRLTTSLEVKADIVGAKVEDDAQTLILMILKHDHKHNG
VFGIVGMGGIGKTTMAHKIFHDERIKNSFPTRIWICVSKNYTRIDLLKAM
LKQAKGSDDGAQSIEELEFKLVGALVNRFFLVLDDVWSVNAWTDVLRNPI
LIAKSNGIILITGRHKTVMEDLRASYIHHVQRMNRDDGLELFHKVVFEEE
KNEDPDLDEMAAKIVSKCDGLPLAIKVIAGMLISKKRTRREWERVLESDL
WRMRDKEDELPAALYLSYEDLSSVLKQCFLCCASYIGISYRTDLVRLWIA
EGLIHVPNGGLMEEVAEDYYKELVMRNLLQLDPRSANETCYSMHDLLRAL
GTNLIGDEALVISDGRVADTNPNPLTQIRRLWMSSKGDTLRLPGAVLEQK
SLRVLQLYDCPETKTIEDEAAALPALKNLRVLDVCDTQIERLPDFIFTNL
LLLRYLDLDRTMIHEIPESIGRLANLQTLNISRCESLRSIPKAVTSLGML
RCLRVRGTPLTHLPRGMGSLTNLNHMEGFVVGHGDSPSNADVGCDMEELR
SLSNLRFLSACKLERATSMAGPSVLENKPLLRHLSLLWTNRKQGDDGEKE
AAEKTCSGLLPPSSLEELTLHNFPGRRFPNWMMSTSSGTSFPHLEFLILR
NFPCCTELPPLGQLPRLKFLKIEEASAVRKVGPEFLGVCFPQAVAFPRLE
VLKFTGLTNWEEWTLYAASEEVGDIQERSMNLFPRLERCTFTGCPKLRGL
PESIYCAARLKTVVVSTSDQLSEVEFRRRETMEMDDCPDLFLARDSTELP
HWLLDRIDRERDEKNSELPSRTVIKVKANVIIIQQNRQVDAV
>XP_042401510.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MLKQAKGSDDGTQSIEELEFKLVGALVNRFFLVLDDVWSVNAWTDVLRNP
ILNAKSNGIIIITGRHKTVMEDLIASYIHHVQRMNKDDGLELFHKVVFED
EKNEDPDLDEMAAKIVSKCDGLPLAIKVIAGMLISKKRTRREWERVLESD
LWRMRDKEDELPAALYLSYEDLSSVLKQCFLCCASYIGISYRTDLVRLWI
AEGLIHVLNGGLMEEVAEDYYKELVMRNLLHLDPRYSDEIRYSMHDLLRA
LGTNLIGDEALVISDGRVADTNPNPLTKIRRLWMSSKGDTLRLPGAVLEQ
KSLRVLQLYDCPETKTIEDEAAALPALKNLRVLDVCDTQIERLPDFIFTN
LLLLRYLDLDRTMIHEIPESIGRLANLQILNISGCTSLRNLPKAVTSLGM
LRWLRVRGTPLAHLPRGMGSLTNLNHMEGFVVGHGDSPSNADVGCDMEEL
RSLPNLRFLSACKLERATSMAGPSVLENKPLLRHLSLLWTNRKQGDDGEK
EAAEKTCSGLLPPSSLEELTLHNFPGRRFPNWMMSTSSGTSFHHLEFLIL
RNFPCCTELPPLGQLPRLKFLSIEGASAVRKVGPEFLGVCFPQAVAFPRL
EVLKFMGMPNWEEWTLYAASEEVGDIQERSMNLFPRLERCTFTGCPKLRG
LPESIYCAARLKTVVVSTSDQLSEVEFRRRETMEMDDCPDLFLARDSTEL
PHWLLDRIDREKDEKNSVLPSRTVITVKANVIIIQQNRRVDAV
>XP_042401511.1 disease resistance protein RPP8-like [Zingiber officinale]
MAMIPDFLVTRYLTKLTDLLEGEICKVLGVKEEIKKFQRRLERLSPYLQD
AEQKRHQDNRVNTWLRDLKGIVYDAEDIIEFCTIPGGSELMSLQPLSSSS
TLVSRPFTLLASCFACTKFRHEIAVSFERLNDRLKEIRDDSEIITGLVPL
MSHQWLQDHPTSQRLTTSLEVKADILGAKIEDDAQTLIRLILKHDHKDNG
VFGIVGMGGIGKTTMAHKIFHDERIKNNFPTRIWICVSKNYTRIELLKIG
PTNK
>XP_042401513.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MAMIPDLLVTRYLTKLTDFLEGEICKVIGVKEEIKKFKRRLERLSPYLQD
AEQKRHQDNRVNTWLRDLKGIVYDAEDIIELCTLHGGSELMSLQPSSSTL
VSRPFTLLASCFACTKFRHEIAVSFERLNDRLKEIKDDSEIIAGLVPLIS
HQWSQDHPTSQRLTTSLEVKADIVGAKIENDAQTLIRMILKHDHKHNGVF
GIVGMGGIGKTTMAHKIFHDERIKNSFPTRVWIHVSKNHKGIELLKQLLK
NAKGSDDEAQSIQELESKLVGALVNRFFLVLDDVWSVNAWRDVLRNPILN
AKSSGIILVTSRHENVMNDMRASHIHHVQRMNEDDGLELFHKVVFEDEEN
ENPELDEMATKILRKCDGLPLAIKLIAGVLISKKRTRRDWERVVESDSWR
MRNNEDELPRALYLSYEDLSSVLKQCFLCCASYVDVSFTADLVRLWIAEG
LINAPNGELMEEVAEDYYKELVMRNLLQFDPRSADKTHYSMHDLLRALGT
NLIGDEALVISDGRVADTNPNPSTQIRRLWMSSKGDTLRLPGAVLEQKSL
RVLQLYDCPETKTIEDEAAALPALKNLRVLDVCDTQIERLPDFIFTNLLL
LRYLDLDRTMIHEIPESIGRLANLQTLNITECESLRSIPKAVTSLGMLRC
LRVEGTPLTHLPRGMGSLTNLNHIEGFVVGHGDLPTNVDDGCDMEELRSL
SNLRYLTACKLERATLMAGPLVLENKPLLRHLSLSWTNREQRDDGEKEAA
EKTCSGLLPPSSLEELTLHNFPGRRFPHWMMSTSSGTSFPHLEYLILHNF
PCCTELPPLGQLPRLKFLKIEKASAVRKVGPEFLGVCFPQAVAFPRLEFL
KFTGMPNWEEWTLYAASEEVGAIQERSLKLFSRLERCTFTGCPKLRGLPE
SIYCAARLKTVVVSTRDQLSEVEFRRRETMEMDDCPDLILARDSTELPHW
LLDRIDREREEKNSVLPSRTVITVKAHEIIIQQNRRVEAV
>XP_042401514.1 probable disease resistance protein At1g63360 [Zingiber officinale]
MKNMISKLKFEHVVWIVASKECKLQKLQMDLAKNVGLNLKDDESEDDCSY
KLCNFLKEKHCLLFLDVIWQSYELFMLGMEQVTAEHGKEQKRKVIVFTML
SELASMH
>XP_042401516.1 disease resistance protein RPS2-like [Zingiber officinale]
MNANEKKKLANLASDPAWELFLKYAGKDVINSEPGINQLAREIVKECAGL
LALITVGRAMSAKRSWDSWNDALMQLRPSQMPEVTKLVDSEHTVGIKMHD
VIRDMDLWMVSDCGSNQYRLPFPQTFHAHAPTEPYATLNSWDIFQALLVL
AFLELSGTDIAELSREIKMLSELQHLNLNFTPIVTVPTELSSLAKLEYLL
LVGTERLIKVPMGTLSNLPLLKLLDSYESKYANLNELEEFQGRQKYIGIT
LDSKATLERLGSLPLLSIWKLQLQDMRDLACPSQLFERIMRSDNIRQGLE
RLEIVDAMIDDELIVTGNNKDIEKGFECLRYMALTTVNNLQEITWGAVKP
QTLFPILHELNISGCKMLRNITWALQLPNHSIFSSFMVLSVHYVYNANVI
CKIRYSNNN
>XP_042401592.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MSHQWSQDHPTSQRLTTSLEVKADIVGAKIENDAQTVINMILKHDHKHNG
LFGIVGMGGIGKTTMTHKIFHDERIKNSFPTRIWICVSKNYTRIELLKEM
LKQAKGSDDGAQSIEELELKLVGALVNRFFLVLDDVWSVNAWTDVLRKPI
LIAKSNGIILVTGRHKTVMEDLRASYIHHVQRMNKDDGLELFHKVVFEDE
KNEDPDLDEMAAKIVSKCDGLPLAIKVMAGMLISKKRTKREWERVLESDL
WRMRDKEDELPAALYLSYEDLSSVLKQCFLCCASYIGISYRTDLVRLWIA
EGLIHVPNGGLMEEVAEDYYKELVMRNLLHLNPRYSDEIRYSMHDLLRAL
ATNLIGDEALVISDGRVADTNNPNPLTQIRRLWMSSKGDTLRLPGAVLEQ
KSLRVLQLYDCTETKTIEDEAAALPALKNLRVLDVCETQIECLPDFIFMN
LLLLRYLDLDRTMIREIPESIGRLANLQTLNISECESLRSIPKAVTSLGM
LRCLRVRGTPLTHLPIGMGSLTNLNHIEGFVIGHGDPPSNADVGCDMEEL
RSLSNLRFLSACKLERATLMAGPSVLENKPLLRHLSLLWTKRKQRDDGEK
EAAEKTCSGLLPPSSLEELTLHNFPGRRFPNWMMSTSSGTSFPHLEFLIL
CNFPCCTELPPLGQLPRLKFLKIEEASAVRKVGPEFLGVCFPQAEAFPRL
EVLKFTGMPNWEEWTTLYAASEERSLKLFSRLERCTFTGCPKLRGLPESI
YCAARLKTVVVSTSDQLSEVEFRRRETMEMDDCPDLILARDSTELPHWLS
DRIDRERDEKNSELPSRTVITVKANVIIIKQNRQVDAV
>XP_042401709.1 putative disease resistance protein At5g47280 [Zingiber officinale]
MESFFAGEVATELIKELVKVIRGTYLCRPAAEQLKRSVDSLLPIVQEIRH
SGVELPQNRQSQLSDLADHLRLALDLARKAAASPRWNVYRSVQLARKMEC
IESWISRWIERHMPVHVLADVHHIRVDYVARLDRIERALSVAASSPVVAT
DSKVPMELGSAPFSGFPVPKTMEGFAQPSAEPVKAPFGIGNKLSSGFPMM
EQFFTSPDARKVPVAMGKSPSSGFRVANIMDGLMLAGEEVKPVGAGIRIG
KEKVKEMLMEGSDSDAVVGISGIGGSGKTTLAREICKDPEIRSYFNDRIY
SVTLSQSPNLESLKLKLWEQISGNMVLGAYNQIPKWQMELGAIDKGSFLI
ILDDVWSLSELEELIFRVPGCKILVVSRFKFPLVKKTYEIELLGEEDALS
LFCHAAFELKSVPFTIDKKLVKQVVKECKGLPLALKVIGASLRDQPPKFW
LRAKNKLSQGEAICESHENKLIERMSSSIEFLSVKVRECFLDLGCFPEDK
RIPIDVLINVWMELHDLDEEDAFAMLVELSNKNLLTLLKDAQSRAGDIYS
SYVELSVTQHDLLRDLALYVNNQESLNTRRRLIMSKRENELPKEWERNKD
QQFQAQIISINTGEMKESDWFQMHFPKAEVLILSFCADVYFLPPFLSTMP
KLRALILINYGTSCASLQNRTIFTSLNNLRSLWLEKITVPPLPKTTVPLR
NLRKVSLILCELNDSLRGSKVDLSSTLPRLSHLTIDHCVDVTKLPPYICN
INSLECLSISNCHDLSELPCEFGKLSSLKILRVCACPSLKSLPQSICRLK
GLKYLDISQSFNLRELPEELGYMMSLEKIDMRECSQLKTLPRSSSSLKSL
GHVICDEDIAFLWKEAEIEIPDLRVQVAEESFNLDWLVE
>XP_042402323.1 disease resistance protein RGA2-like [Zingiber officinale]
MESRSFLIIHQKEDFKESSPCKLLLLFSFSSKLLLTRATLTNFCILNSSG
AMEAALVATARFVADKVTILVQLDEKLKAMTDIKKKMEKLKKLSTIIDMV
IQGVESLRSTEDTVKVLLKELKYLAYDLEDVLDYYDTKVLQMQRSRSPFK
RVRHSFPSNNQVVFRSRMVGVMIKASVKRVRDSFSFNQVVFKSWMGGKIK
AVTDSLDSILSQKSILQNLPQDSIPMSELSLRMSEISLTHSRNSWDVKGR
DEEKKMIIDMLTEDDDDESNDGTLKVIAIIGMGGLGKTTLAQLVYNDQRV
QAYFASSTMWTVVGAEFNPVKIMKSVLEQATNASVSILEMDLVMRNLENL
LSRKRFLLVLDDVWNEDPDEWGKLKAALKFGARGSKILVTTRSQQVSKIM
DTSNTTHQIQQLSEDDCLSLFQQFAFGDEAPDQKLMKIGKKIVKKCRGVP
LAAISLGSMLRGRYETYWSSVSKSEIWKLKNKEEEKLFAILKLSYNVLPL
PSKKCFAFGSLFPKDFKMQKEKLIKLWIANGFASSEGNFEAETVGNCIFD
DLVSRSFILLAPVQYDPDVTECMMHDLMHDLARSVSSDAYWNSYQDLVEV
IGKRTYHLQVVEGKLPDMTQVLDKKPLYLRTFMALMPGYSSSLSINLLKV
FSKLKYLRVLDLTGCGIREIPTSIENLIHLRYLNLYYNKIEVLPDSITLL
PNLQYLNLGFNHELRRLPKKLGNMQNLRDLDLQNDFRLTKIPCGLSRLTN
LRSLPVFIAGDGTDACSILELEDLKLCGEMQIRISHDFKNYSRSGRKILK
NTDLNELHIEFHGSASYHKDMLDDLCPNTTLKKLEITNYDSPQFPTWMKE
LQLPNLVEVDLHGICGHIPQFRNLQFLTTLRFSMHGITHLGAEFHGSGGF
PSLQELYLDDMNDLEEWSEFHGANELFPLLKTLCIINCLKLKSMPKLPTI
QELEISCCNESLLSCIGRLTSLFILRVKEMDDMTCLPSGCIRNLTSLTEL
EIILCPQLQSLPGDEMQHLEMLQSLTIEGCDNLTSFPSEVGCLSSFCFLQ
LSCCPSVILQPEELVQILNSIDEFQIQICCNKVNLYGQLQHLHMLRRLSL
SGAHDVSSRFTNQYGNPNLRICCCDELESLMTTEPANKTVLEAVYIDGIS
NLTALPNWLQHLKSLRHLSITNCSQLETLPSGLKDLHRLEDLRIFNCPQL
KRRCEKELGEDWPIISHVSYVDIS
>XP_042402968.1 putative disease resistance protein RGA4 isoform X1 [Zingiber officinale]
MAGGRDVLFSTITMVLDKMHSLASSSTSSSSSSPHNAIEQEMSKLTETMR
RIQAKLDDSEEENHAKSHSEKLWLSELKDVAYDAEDVVEEYEYETLRSKQ
LHENSSGTHEDELANKATEIRKRFDEITKEWKLLKLPKNAGKRKRSPMLL
DMNREEGSSVVESDVFGREEEKDVLVKWLLSEDDTTGNGVSVIAVIGMGG
LGKTTLAKLVYNDERVKSYFDLTGWVCVSENFHVVSLTKKILQSFAKVKV
HEELDELQHALREKLQGKKFLLILDDVWNEEFTRWDELRKPLLSAHVGKV
IVTTRNQPAARIMGTRSPLNLNCLPFDVCWQLFKRDTLGGADKSPQPHLE
DLGRKIVDKCKGLPLAVKVLGGALRNNEDIDSWEDMLENEMWELEETNKG
VLPALKISYDCMPIQLKRCFQYLSLFPKDRILDSEEIVRFWMSQGLLPLD
GDKRAEDIGRNYIKRLAQRSIIHLEWDDTFLMRWKYFSMHDLVHDLAQCI
AQDECLCVMDKFDAKKLQKVRHLSVCIEYPHLLEHVEMIKDLQQLKLMRT
LFTTGPGCRSFMTRQYNSFKVLDDLFQKLKYIRALYLSEISITGLPDSLG
NLKLLRYLSIKDYDVVNIPESICSLYNLQTLDLEDTQISELPRQIGNLIN
LRHLLLPNDYADYDDYEGVFLPSGIGNMTNLQTLSCFNVSCEKEHCDIGE
LNSLMKLGGHISISDVASVNIFSNSTPPLKTKKYIDSLELDWYRDTLELS
EFKKDEKQAEWQLDYLEPHVNLKILEIKNYPGVKFVGWVGASSFTKLTTL
RVWNCKNCNKLPPLGQLPSLKMLEIRGMDSVQHVGREFCSMLMPSPSSSQ
NKIAFPSLKRLIFSNMENWEAWDGVEIGDFPSLDSIRIFRCPLLIKFPQW
SYMSSVKKMELGSSGVPDVSNFHSLTNLTIILISQEYSEWMPKCYFPMLQ
NLTLLSGFAKSVHLSQKVLPSLKTLEISYFSELQVVTGLKNLTSLNSLIL
KNCPNLEFKKLPTTLEQVKLDRCRLFEKGFKEQQHMRNVLGEEEEEEMEI
DM
>XP_042402969.1 putative disease resistance RPP13-like protein 1 isoform X2 [Zingiber officinale]
MLLDMNREEGSSVVESDVFGREEEKDVLVKWLLSEDDTTGNGVSVIAVIG
MGGLGKTTLAKLVYNDERVKSYFDLTGWVCVSENFHVVSLTKKILQSFAK
VKVHEELDELQHALREKLQGKKFLLILDDVWNEEFTRWDELRKPLLSAHV
GKVIVTTRNQPAARIMGTRSPLNLNCLPFDVCWQLFKRDTLGGADKSPQP
HLEDLGRKIVDKCKGLPLAVKVLGGALRNNEDIDSWEDMLENEMWELEET
NKGVLPALKISYDCMPIQLKRCFQYLSLFPKDRILDSEEIVRFWMSQGLL
PLDGDKRAEDIGRNYIKRLAQRSIIHLEWDDTFLMRWKYFSMHDLVHDLA
QCIAQDECLCVMDKFDAKKLQKVRHLSVCIEYPHLLEHVEMIKDLQQLKL
MRTLFTTGPGCRSFMTRQYNSFKVLDDLFQKLKYIRALYLSEISITGLPD
SLGNLKLLRYLSIKDYDVVNIPESICSLYNLQTLDLEDTQISELPRQIGN
LINLRHLLLPNDYADYDDYEGVFLPSGIGNMTNLQTLSCFNVSCEKEHCD
IGELNSLMKLGGHISISDVASVNIFSNSTPPLKTKKYIDSLELDWYRDTL
ELSEFKKDEKQAEWQLDYLEPHVNLKILEIKNYPGVKFVGWVGASSFTKL
TTLRVWNCKNCNKLPPLGQLPSLKMLEIRGMDSVQHVGREFCSMLMPSPS
SSQNKIAFPSLKRLIFSNMENWEAWDGVEIGDFPSLDSIRIFRCPLLIKF
PQWSYMSSVKKMELGSSGVPDVSNFHSLTNLTIILISQEYSEWMPKCYFP
MLQNLTLLSGFAKSVHLSQKVLPSLKTLEISYFSELQVVTGLKNLTSLNS
LILKNCPNLEFKKLPTTLEQVKLDRCRLFEKGFKEQQHMRNVLGEEEEEE
MEIDM
>XP_042402974.1 putative disease resistance protein RGA4 [Zingiber officinale]
MAGGRDVLFSTITMVLDKMHSLASSSTSSSSSSPHNAIEQEMSKLTETMR
RIQAKLDDSEEENHAKSHSEKLWLSELKDVAYDAEDVVEEYEYETLRSKQ
LHENSSGTHEDELANKAAEIRKRFDEITKEWKLLKLPTNAGKRKKSPMLL
DMNRETGSLVVESDVLGRAEEKDMLVKWLLSEDDTTGNGVSVIAVIGMGG
LGKTTLAQLVYNDQRVKSYFDLIGWVCVSETFHVVSLTEKILQSFAKVKV
HEELDELQHALREILQGKKFLLILDDVWNEEFTLWEDLSKPLLSAHVGKV
IVTTRNQSVARIMGTRSPLNLNCLPFDVCWPLFKRVTLGGADKSLQPHLE
HLGRKIVDKCKGLPLAVKVLGGALRNNEDIDSWEDFLQNEMWESEETNKE
VLPALKISYDCMPIQLKRCFQYLSLFPKDTSLDSEEIVRLWMSQGLLPLD
GDKRAEDIGRSYIKRLAERSIIHLEWDDTFLMGWKYFSMHDLVHDLAQYI
AQDEYLCVMDNKFDTKKLQKFRHLSFNVECHKLNIEALPELKLLRTLFMR
ELDCWKYRLPDDLFQKLKYIRTLVLNAYGIQELPYSLGNLKLLRYLSIKV
KVVESIPESICSLYNLQTLDLADTHISKVPRQIGNLINLRHLLLPNVGVF
FPSGIGNMTNLQTLRRFNVSCEKEHCDIGELNSLMKLGGHISISDIASVN
IFSNSKPPLKTKKYIDSLKLDWDVVTFDLLEDEKQAEWQLEYLEPHVNLE
NLEINNYPGIKFVGWVGASSFTKLTRLHVEYCKNCNKLPPLGQLPSLEEL
EMSRMGGIRHVGSEFCSMLMASPSSSQNKIAFPSLKDLIFRDMTNWEEWD
GVEIGDFPSLHSFKLFGCRRLIKFPRWPFLSSVEEMTLHSGGVPDVSNFH
SLTKLAIMFMSKKNSKWMSRCYFPTLQHLTLVYSIVQSVHLSQKVLPSLK
TLGILYSDQLRVVTGLKDLTSMNSLIIKACRNLEFKGLPATLEQVKLDGC
RLFEQGFKEQQHMRNVLMIEPHNSDDEEEEKEEMDVDDEEEEEEEE
>XP_042402976.1 putative disease resistance RPP13-like protein 1 isoform X1 [Zingiber officinale]
MAGGGFLSSMFTTMVDKLHSLAAPSATSSSSLSHNNIEREMSKLTETMRR
IQAKLDDSEEENHAKSHSEKLWLSELKDVAYDAEDVVEEYEYETLRSKQL
HENSSGTHEDELANKAAEIRKRFDEITKEWKLLKLPTNAGKRKRSPMLLD
MNRETGSLVVESDVLGRAEEKDMLVKWLLSEDDTTGNGVSVIAVIGMGGL
GKTTLAQLVYNDQRVKSYFDLIGWVCVSENFHVVSLTEKILQSFAKVKVH
EVLDELQHALREILQGKKFLLILDDVWNEEFTLWEDLSKPLLSAHVGKVI
VTTRNRSVARIMGTRSPLNLNCLPFDVCWPLFKRVTLGGADKSLQPHLEH
LGRKIVDKCKGLPLAVKVLGGALRNKEDIDSWKDILENEMWESEEINKGI
LPALKISYDCMPIQLKRCFQYLPLFPKDTSLDSEEIVRLWMSQGLLPLDG
DKRAEDIGRNYIKRLAERSLIHLERVDTLFMTEQSPLFMRKQSFSLHDLV
HDLAQYIAQDEYLCVMDNKFDTKKLQKFRHLSFNVEYHKSNIEALRELKL
LRTLFIRELDSWKYRKYKVLDDLFQELKYIRTLVLDNYGIEELPYSLGNL
KLLRYLSIKDDVVESIPESICSLYNLQTLDLTDTQISELPRQIGNLINLR
HLLLPCDYFGFKAIFFPSGIGNMINLQTLRRFNASCEKDHCDMGELNSLM
KLSGHISISELAFVNIFSNSKPPLKTKKYIDSLELCWRKYALYNNAFFDY
YRKDEKKAEWQLEYLEPHVNLENLEINSYPGIKFVGWVSASSFTKLTRLH
VEYCKNSNKLPPLGQLPSLEELKICRMDGVQCVGREFCSMLMASPSSSQN
KIAFPSLKDLIFRDMTNWEAWDGVEIGDFPSLHSIRITGCCRLIKFPRWP
FLSSVEKMMLESGGVPDVSNFHSLTNLTIMSMSKKNSKWMSKCYFPTLQH
LILLFSSAESVHLSHKVLPSLKTLEIRNSPTLRVVAGLKNLTSLNSLIIE
VCPNLEFKGLPATLEQVKLDGCRLFEQGFKEQQHMRNVLMIEPHNSDDEV
EEKEEMDVDDEEEEEEEEDMDVDDEEEEEEEMDGDDDDNNDDNMD
>XP_042402977.1 putative disease resistance RPP13-like protein 1 isoform X2 [Zingiber officinale]
MAGGGFLSSMFTTMVDKLHSLAAPSATSSSSLSHNNIEREMSKLTETMRR
IQAKLDDSEEENHAKSHSEKLWLSELKDVAYDAEDVVEEYEYETLRSKQL
HENSSGTHEDELANKAAEIRKRFDEITKEWKLLKLPTNAGKRKRSPMLLD
MNRETGSLVVESDVLGRAEEKDMLVKWLLSEDDTTGNGVSVIAVIGMGGL
GKTTLAQLVYNDQRVKSYFDLIGWVCVSENFHVVSLTEKILQSFAKVKVH
EVLDELQHALREILQGKKFLLILDDVWNEEFTLNLNCLPFDVCWPLFKRV
TLGGADKSLQPHLEHLGRKIVDKCKGLPLAVKVLGGALRNKEDIDSWKDI
LENEMWESEEINKGILPALKISYDCMPIQLKRCFQYLPLFPKDTSLDSEE
IVRLWMSQGLLPLDGDKRAEDIGRNYIKRLAERSLIHLERVDTLFMTEQS
PLFMRKQSFSLHDLVHDLAQYIAQDEYLCVMDNKFDTKKLQKFRHLSFNV
EYHKSNIEALRELKLLRTLFIRELDSWKYRKYKVLDDLFQELKYIRTLVL
DNYGIEELPYSLGNLKLLRYLSIKDDVVESIPESICSLYNLQTLDLTDTQ
ISELPRQIGNLINLRHLLLPCDYFGFKAIFFPSGIGNMINLQTLRRFNAS
CEKDHCDMGELNSLMKLSGHISISELAFVNIFSNSKPPLKTKKYIDSLEL
CWRKYALYNNAFFDYYRKDEKKAEWQLEYLEPHVNLENLEINSYPGIKFV
GWVSASSFTKLTRLHVEYCKNSNKLPPLGQLPSLEELKICRMDGVQCVGR
EFCSMLMASPSSSQNKIAFPSLKDLIFRDMTNWEAWDGVEIGDFPSLHSI
RITGCCRLIKFPRWPFLSSVEKMMLESGGVPDVSNFHSLTNLTIMSMSKK
NSKWMSKCYFPTLQHLILLFSSAESVHLSHKVLPSLKTLEIRNSPTLRVV
AGLKNLTSLNSLIIEVCPNLEFKGLPATLEQVKLDGCRLFEQGFKEQQHM
RNVLMIEPHNSDDEVEEKEEMDVDDEEEEEEEEDMDVDDEEEEEEEMDGD
DDDNNDDNMD
>XP_042403004.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAGGGGFLSSMFTTMVTKLHSLASPSTTSSSSSSPHNTIEQEMSKLTETM
RRIQAKLDDSESEEENHAKSHSEKLWLSELKDVAYDAEDVVEEYEYEVLR
SKQLHENNSGAHEDELANKAAAIRKRFDEITKEWKLLKLPKKAEKRKRSP
MLSDMNRETGSLVVESDVLGREEEKDMLVKWLLSKNDTTGNGVSVIAVIG
MGGLGKTTLAQLVYNDQRVKSYFDLTGWVCVSENFHVVSLTEKILESFTK
VEVHKELDGLQHALQEKLQGKRFLLILDDVWNEEFTLWDELRKPLVSAQV
SKVIVTTRNHRVAGIMGTRSPLDLNCLSFDICWQLFKRVTLEGAYKRLQP
HLEELGRKIVDKCKGLPLAVKVLGGALRNNEDIDSWEKILENEMWELEET
NNGVLPALKISYDCMPIQLKRCFQYLSIFPKDTSLDSEEIVRLWMSQGLL
PLDGDMRAEDIGRNYIKRLVERSMLNSVEINVDSSFVMHDLVHDLAQYIT
QDECLCVMDNKFDAKKLQKIRHLSVSVKYPNLLKPLETIKDLQQLKLMRT
LFITGPGWPYFMIRQYNFFKILDDLFQKLKYIRALHLSKIDITELPDSLG
NLKLLRYLSIRSAKIRMLPESICNLYYLQTLDLIATNVHEFPRKIGNLIS
LRHLLLPYNYKGVFFPSGIGNMTNLQTLRRFNVSCEKEHCDIGELNSLMK
LGGHISIYNVASVNIFSNSKPPLKTKKYIDSLELDWSGVPFDIFKDEKKA
KWQLEYLEPHVNLKILEINNYPAFKFVGWVGASSFTKLTKLVLKYCKYCS
KLPPLGQLPSLEELEIAGMHYVRHVGREFCSMLMASPSSSQNKIAFPSLK
DLIFRDMKNWEEWDGVEIGDFPSIHSIKLYGCPRLIKFPQWPFMSSVKKM
TLDSGGVPDVSCFPSLKHLEITVRTQEYSEVMSKCYFPTLQHLILSYSKV
ESIHLSQRRLPSLKTLKIHDSNELRVVTGLKNLTSLNSLIIKECPNLEFK
KLPATLAQVQLYRCRLFKKGFKEQHMRNVLGEEEEEIENLLDFLVWIAEE
DDNNDGGEDMRNEGEEEEMEIDLELRLWND
>XP_042403010.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAGGGFLSSIITMVLDKLHSLASLSTSSSSSSPHNNIEQEMSKLTETMRR
IQAKLDDTEEENRAKSHSEKLWLSELKDVAYDAEDVVAKYEYEVLRSKQL
HENSSWTQEDELANKAAEIRKKFDEITKEWKLLKLPQNVGKRKRSSWPLV
GNRETGSFVVESEVLGREKEKDMLVEWLLSEDDIIWNEVSVIVVIGMGGL
GKTTLAQLVYNDPRVKSYFDLTGWVCVSENFHVVSLTEKILQSFTTVKVH
EELDELQHALQENLQGKKFLLILDDVWNEEFTLWDELRKPLASAQVVKVL
VTTRNQSVARIMGTRSPLNLNCLPFDVCWQLFKRVTLGGADKSLQPHLEH
LGRKIVDKCKGLPLAVKLLGGALRNKEDVDSWEDILENEMWESEETNKGV
LPALKISYDCMPIQLKRCFQYLSLFPKDTSLDSEEIVRLWMSQGLLPLDG
DKRAEDIGRNYIKRLAERSLIHLKRADTLFMREQLRKQSFSLHDLVHDLA
QYIAQDECLCVIDDKFDIEKLQKIRHLSLGRSLVREDPHILKHLETIKDH
QQLKLMRTLFIKVRGLFGLTSIRRQDKIFGPLDDFFQKFENLRALHLSNI
IGFIGLLDSLGKLRLLKYLSIIDFDVVGIPESICSLYNLQTLDLTGTSIY
QLPRQIANLINLRHLLLPHYLNVFLPSGIGNLIDLQTLTHFDFCCEKEHC
DIEELNTLMKLGGHILISISTSVNTFSNSKPPLKTKKYLDSLELRWYGWY
DDAFDGSKKDEKNAEWQLEYLEPHVNLKTLRIFFYPGVSFVGWVGCSSFT
KLTSLSLYSCNNCNKLPPLGQLPSLEMLEICGMDGVQQVGREFCSLLMAS
PSSSQNKIAFPSLKYLHFSTMLHWEVWDGVEIGDFPRLQFIQISKCYVLI
KFPQWPFMSSMEEMTLDSGGVPDVSNFHSLTNLSIDVITQKNTKWLSNCY
FPTLQHLTLLYIGMESIHLSQRRLPSLKTLEIHDSKKLRVVTGLKNLTSL
NSLIIKACPNLEFQELPATLEQVKLNRCRLFKKGFKEQQHMRNVLGDGDK
SGVTTLK
>XP_042403014.1 disease resistance protein RGA2-like isoform X2 [Zingiber officinale]
MAGGGFLSSKFTTMVAKLHSLASSSTPSSSSSPHNNIEQEMRKLRKTMRR
IQAKLADSEEENQVKSHSEKLWLSELKDVACEAEDVVEEYEYEVMRSRQL
HESNSGAHEDELANKAAEIRKSFDEITKEWKLLTLPKNSGKRKRIVGNRE
TGSLVVESDVLGREEEKDMLVKWLLSEDDTSVNKVSVIAVIGMGGLGKTT
LAQLVYNDQRVKSHFDLTGWICVSENFHVVSLTEKILQSFAKVKVHEELD
ELQHTLQENFPGKGKVSEKLDVLQHALQDNLQGKKFLLILDDVWNEEFTL
WDELRKPLVSAQVGKVIVTTRNQPVAKIMETRSPLDLNCLPFDVCWQLFK
GVTLGGADKSLQPHLEYLGRKIVDKCKGLPRL
>XP_042403015.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAGGGFLSSIITMAVDKLHSLASPSTPSSSSSPHNNIEQEMSKLTETMRR
VQAKLADSEEDNHVKSHSEKLWLSELKEVAYDAEDLVEEYEYEVLRSKQL
HGNNSGTHEGELANKAAEIRKRFDEITKEWKLLTLPKNAGERKRSPLTLV
DNRETGSLVLESDVLGREEEKDMLVEWLLSEDDMTDNRVSVIAIIGMGGL
GKTTLAQLVYNDPKVKSYFNPRGWVCVSENFNVVNLTEKILQSFTEEKGK
GEVKIPETLDGLQRALEENLLGKKFLLILDDVWNEEFTLWNELRKPLVSA
QVGKVIVTTRNQPVARIMGIRSPLDLNCLPFDVCWQLFKRVTLGGADQPH
LEDLGRKIVDKCKGLPLAVKVLGGALRNKEDIDSWEDILENKKWELEETN
KGVLPALKISYDCMPIQLKRCFQYLSLFPKHTRLHSEIIVRLWMSQGLLP
LDEEIREQRTKAEIT
>XP_042403221.1 putative disease resistance protein RGA1 [Zingiber officinale]
MDTVGVAMMVGEWFAGYIIDKLVSFVASHVSDHWDLLTDVEEKLKEIQDR
LPRIQAVIHAAEGRPIRDPALVNWLRQIKEAAYEADDLLDEIEFVKNLFV
SDDELKRLKDLLGDVDKIYSEIDRKKVELDEDNAKHAASIRETSSFTQEV
VFGRDKEREKILEMLLSSGNDADFRNKGAGSSSHASLGVLPIVGIGGVGK
TTLAQIIYNDPRVADHFELRKWVYVSNDFNVKRIARDLEGEMASDSRPDH
ISLDTQLSNLSRATTAKRFLFVLDDVWDEAGRKWMELRSALTYGNRGSTV
LITTQSPLVAQVMGTMDQIELKLLEESDYWRLFEHCSFGSRVIDSYLRRK
LQLIG
>XP_042403231.1 disease resistance protein RPS2-like [Zingiber officinale]
MESILSILDSIFRPVVAFFTRTFGYAMSCEQYIESLQKEMGELRSKRDDV
KREVDREARQGMEATNEVMLWLQNVERLEEEAARITDDFETHYANPAADD
SRSKLVVSYHLSKRAEDACGEATVLKTKSHFNKVADRLMPIRFEERPSAL
TVGMDSMIEQLRKACDDDVGVIGIHGMGGVGKTALLNRFNNEVLVQVAHL
DVVISVKVTRNFDVEKIQREIGDRIGLSWDERKSDDERSMVLFKVLSRMR
FVLLLDDLWEPLDLSIVGIPTPTGASKIILTTRIEDVCDRMDARKMRMEC
LEWEDAWELFEKKAGRGLGTLLRGDPDIRRHAEDLAQRCGGLPLALITLG
RAMASKRTAKEWHHAVTTLANTPWHLLGMEESVLQPLKLSYDKLNDDRLK
TFLLYASLLMNKMPMHNATVINLCIGEGAINEFDDPEDAYSKGYHLLGVL
KAASLLESSGDDYVQMHPFVRAMVSWIICEHGKKDGKWLVQVGTGLAEVP
DYEKWEHAERVSLVSNEICSLPEDPYCPELLTLLLSRNYELSKIPNSFFL
SMPRLKVLDLSRTSIKELPPEIGKVLTLQHLDLYETNIASLPKELGNLVK
LKSLLLSSTPLLKEIPHGVIARFTELRVLSMNDSYGNWRVSSSGPGINFE
ELEGLKRLRYLDITLQNASTLQRLSRARRLSMSTRYLHIRGCLGLTTIHL
PSTSLGRYMKGLRGLRISQSSILEEIIVGGGSTIGEWSLLPNLHVLILQH
LLKAKFVFRDRNFQNLRFLYVWYCIGLEQLVKFEDELSEGQESEVITAFP
HLKELHLASLPELKSLGGERVLAFPCLRVLEVKECPKLKELSITGDGLTQ
ICCKQEWRDGLEWKDEKIKEALFPLFTPLQ
>XP_042403232.1 disease resistance protein RPS2-like [Zingiber officinale]
MESILSILDSIFRPVVAFFTRTFGYAMSCEQYIESLQKEMGELRSKRDDV
KREVDREARQGMEATNEVMLWLQNVERLEEEAARITDDFETHYANPAADD
SRSKLVVSYHLSKRAEDACGEATVLKTKSHFNKVADRLMPIRFEERPSAL
TVGMDSMIEQLRKACDDDVGVIGIHGMGGVGKTALLNRFNNEVLVQVAHL
DVVISVKVTRNFDVEKIQREIGDRIGLSWDERKSDDERSMVLFKVLSRMR
FVLLLDDLWEPLDLSIVGIPTPTGASKIILTTRIEDVCDRMDARKMRMEC
LEWEDAWELFEKKAGRGLGTLLRGDPDIRRHAEDLAQRCGGLPLALITLG
RAMASKRTAKEWHHAVTTLANTPWHLLGMEESVLQPLKLSYDKLNDDRLK
TFLLYASLLMNKMPMHNATVINLCIGEGAINEFDDPEDAYSKGYHLLGVL
KAASLLESSGDDYVQMHPFVRAMVSWIICEHGKKDGKWLVQVGTGLAEVP
DYEKWEHAERVSLVSNEICSLPEDPYCPELLTLLLSRNYELSKIPNSFFL
SMPRLKVLDLSRTSIKELPPEIGKVLTLQHLDLYETNIASLPKELGNLVK
LKSLLLSSTPLLKEIPHGVIARFTELRVLSMNDSYGNWRVSSSGPGINFE
ELEGLKRLRYLDITLQNASTLQRLSRARRLSMSTRYLHIRGCLGLTTIHL
PSTSLGRYMKGLRGLRISQSSILEEIIVGGGSTIGEWSLLPNLHVLILQH
LLKAKFVFRDRNFQNLRFLYVWYCIGLEQLVKFEDELSEGQESEVITAFP
HLKELHLASLPELKSLGGERVLAFPCLRVLEVKECPKLKELSITGDGLTQ
ICCKQEWRDGLEWKDEKIKEALFPLFTPLQ
>XP_042403233.1 putative disease resistance protein RGA3 [Zingiber officinale]
MDTAGVAMMVGGWFPGYIMDKLVNFVTSHTSDHWDLLTDVEEKLNEIQAR
LPRIRAVIHAAEGRPIRDPALVDWLRQLKEAAYEADDLLDQMEYRQLEDQ
VQDRSKVSALAASALRFFKNLFVSDDELKRLKNLLGDVDKIYSEIDRKNV
ELNEDNAKHTASIRETSSFTQEVVFGRDKERERILEMLLSSGNDADFLNK
GAGSGSHASLGVLPIVGIGGVGKTTLAQIIYHDPRVADHFELRKWVCVSN
DFNVKRIARELEAEEPSDYRWDHISLDSQLTKLIHATESKRFLFVLDDVW
DEAGRKWMELRSALTYGNRGSTILITTQSPIVAEVMGTIDRIELKLLEES
DYWSLFEHCSFGSRVIDPYLRRKLQLIGQQIAKKLHGLPLSGKVVGSLLH
ARLEEQYWKMIRESEWWENDFLLENILPSLGLSYQHLSSNVKQCFAFTAM
FPKGHIFDKEQLVEMWIAQGFVRPEAQHGRMTLEDIGNQIFDELTRRYFF
LHTVNKRYVIHDLIRELAVYISRDECFVIDDEPSKIPPTARHLTVMRTAE
LDTLAELSKLHKVRTLVFYRDYHPENFFSLGENGSRQFYESLERILKTLK
NLRILDLSYMLIEIKKLPDATCDLSHLRYLDISGTKIRHLPGSFSKSYHL
QVLKLNRCWIKKLPEGMNRLIKLRHLHADADTISLVDGIGRLTDLQELDE
FRITRKRGHQIGELKELRNIRRRLVIQNLEYVESQEEAMEAKLKDKEYLD
HLVLNFKEGKRSQGDIEKDIIEGLEPHCNLKRLVIQNYGCLNSPCWLEKN
YLTNLESIHLNCCARWEDLPPLGHLPFLMDIFIFNLPVRRIGAKFYGGAD
QVFPSLQELTFHTLNEWEELSESDSRPIFPCLMKMRIENCLKLRRIPVLP
LISIKHLDIRNSGDIGNALPDYLLTLTSLTYLELHNCAQRASVSLYNLQF
LEYLRLVQCPELSLIGGLQSLANLKDLIIHACPKLFEPAQMPEQPYVEQE
MRSLCTVWIDDDVLKHVWVILGRTPCIQVLRIHHCNDLSHFNPEHEEWFQ
QLTSLHFLEFHNCSKLRKLPSSLGTASIKILCIHHCPNIESLPDNGLPFL
LRKLEMHGCTKLRDRCRKDDGSDWPLISNIPNIDIDGELIQMK
>XP_042403243.1 putative disease resistance protein RGA3 [Zingiber officinale]
MDTTGVAIMVGENFASSIIDKLVDFVTSHVSGHWDLLSDVEEKVKQIQDR
LPRIQAVIHAAEGRPIRDPALVNWLRQLKEAAYEADDLLDEIEYRQLDDQ
VQDRGKVSALATLALRFVKNLFVSDDELKRLKNLLGDVDKVYSEIDRKKV
ELDEDNAKHTKSIGETSSFTQEVVFGRDKERERILEMLLSSGNDADFLNK
GAGSSSHASLGVLPIVGIGGVGKTTLAQIIYNDPRVADHFELRKWVYVSN
DFNVKRIARELEGKVASDSRPEHISLDAQLTNLSRAIASKRFLFVLDDVW
DEDGRKWMELRNAMSHGNRGSTVLITTQSPLVAEVMGTMDQIELKLLEES
DYWRLFEHCSFGSGVIDPYLGRKLQSIGRQIAKKLHGLPLSGKVVGSLLH
ARLEEQYWKMIRESEWWENDFLLENILPSLGLSYQHLSSNVKQCFADTAM
FPKGHIFDKEQLVQMWIAQGFVRPGTQRGRMTMEDIGNQIFDELTCRYFF
LHTINERYMIHDLIRELAVYISRDECFVIDDEPSKIPPTARHLTVVRTAK
LDTLAELSKLHKVRTLVFYRDYHPEDLFSLGENGSRKFYESLEGILKSLK
NLRILDLSYMRVELKKLPHATCDLSHLRYLDISGTKIRQLPGSFSKICHL
QVLNLKRCWIKKLPEGMNRLIRMRHLHADADTISLVDGIGRLTDLQELDE
FRITRKRGHQIGELKELRNIRRRLDIQNLEYVESQEEAMEAKLKDKEYLD
YLVLNFKEGKRSQGDIEKDIIEGLEPHCNLKRLMIQHYGGLNSPCWLEKN
YLTNLESIHLNWCARWEDLPPLGHLPFLMDISICKLPVRRIGAKFYGDAD
QVFPSLQELTFHTLNEWEELSESDSRPIFPCLMKMRIENCLKLRRIPVLP
LISMKQLDIWNSGDIGNALPDYLLTLTSLTYLELHNCAQRASVSLYNLQF
LEYLRLVQCPELNLIGGLQSLANLKDLIIHACPKLFEPVQMPEQPYVEQE
LRSLCTVWIDDDVLKHVWVILGRTPCIQVLRIHHCNDLSHFNPEHEEWFQ
QLTSLHFLEFHYCSKLRKLPSSLGTASIKILCIHHCPNIESLPDNGLPFL
LRKLEMHGCTKLRDRCRKDDGSDWPLISNIPNIDIDGELIQMK
>XP_042403311.1 disease resistance protein RGA2-like [Zingiber officinale]
MIGRFALASSEKVADSLLGALVGKAVEVAVQQFCEQRGVEDDRKQLQDSL
DHARLILGTIENVWIKDEIEQQGYEAGNLADAEDDRGSIQLLSLASPHMG
GDVDAIHLEGLDEESLWKFFKECAFGSSNSEVHHPHLEAMAKKMMCMLKG
SPLAAKILGGLLSMKLDEQHWKSILDSELWQLPQEENGIIFSESELIGLW
MAEGFIEPQESIRMEELASNYFHELVNRIEKDKSCEIPTTIHHLSMHEEG
>XP_042403382.1 disease resistance protein RGA2-like [Zingiber officinale]
MKDESLQQSLKEFLIRLKNAAYDADDLLDEFQYRILKQQIEQQGNEAGNR
ASSSSNSAPPPSKRTKTSFSSYNSGLFRKGDDNDDDVQRIRKIKGRLDDN
SVALEKIYSSLSAEDDRGKKQLVSWDSRQTSCFSTEPQLFGRDKDLQELK
DLLLKREIASKFGQSGFSVLSIAGIGGIGKTTLAQEVFNDSSVKEYFKLR
IWICVSENYSTDRLTREIIEYATKKKCDLPNFAALQEVLKEKITPERVLL
VLDDVWNEDRHKWESFCAPLRSGKPGSKILVTTRSRKIANMVGDVDPIYL
EGLDEESFWEFFKKCAFGSSNSGIHHPHLEALAKKMTYKLEGLPLAAKTL
GGLLSMKLDEQYWKSILDSEIWQLPQEENGTMPVLQLSYQYLPPHLKQCF
AFCSLFPKDYKFSESELISFWIAEGFIVPQGSTRMEELGSNYFHELVNRS
FFQKSKDEKFIMHGLIHDLAELISVGESYRIEKGKSHEILSTIRHLLVHE
EEEGTQTRRLTEFSHCNKLRTLMLSVPYKCKSFILDCCVLQKLKRIRVLV
LKNCALEEMPDSIVKLIHLRSLNLSCNFKIRRLSESLCDLYNLQSLILNH
CALEELPNNIGKLIHLYYLDLECNKEIRRLPESLCDLYNLQTLIISGCGK
LESLPHGMIKLINLKILDGADKFIPEITEVGKLTSLQNLSAFKVLKKNEH
KLAELNSLKQLRGALCITNLENVENKDEANIANLKSKEHLNHLELEWTFS
QESGSEVNLQISEQVLEGLRPHHNLQRLTIRGYNGARPPNWLNEQVYSRL
EALELVNCRRWNELSVIGQLSQLKSLSLVRIPVQIHNLHKLFDPKDCKFF
SQLEVLELKGITMLKDLPNLGQLPCLESLDIRSLPGVKMIGDRFFATTEE
GTCFPRLGFLHFDEMPAWEELYCSDDRNLFPYLKGLEISNCQRLQMLPPL
PPSITWLKLNKVGLVDCPRFWKADENSNITNSASVTNLSIQECPNLTSLE
EALLAHHLQQIHIQKCEQLLWVSVKRLTELTSLCSLSITECPKLMSMTQD
EYIDFQLPPSITQLCLSDCGNLSKSLPGCLRNLTSLHDLKISNCPNLVSL
PVEPLLNLARVTIKNCNELRSVEGLGVKSLQNLKIKGCPKLLLSQGEAQT
KKLLVLRLEIDDTSLIKNLISSVTELRISSSCEAAMFEGQGQESLQSLTS
LDLLSFSNCKNLQFLPTKLYTLTSLRYLWIHNCPQIQSLPEKGLPSALRD
LKFEGCHLALQQKLERHLSEIKKFGGVI
>XP_042403950.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MAMIPDFLVTRYLTKLTDFLEGEICKVLGVKEEIKKFKRRLERLSPYLQD
AEKKRHQDNRVNTWLRDLKGIVYDAEDIIELCTLPGGSELMSLQPLSSSS
TLVSRPFTLLASCFACTKFRHEIAVSFERLNDRLKEIKDDSEIIAGLVPL
MSHPWSQDHPTSQRLTTSLEVKADIVGAKIENDAQTVINMILKHDHKHNG
VFGIVGMGGIGKTTMAHKIFHDERVKNSFPTRIWICVSKNYTRIELLKEM
LKQAKGSDDGAQSIEELELKLVGALVNRFFLVLDDVWSVNAWTDVLRKPI
LIAKSNGIILVTGRHKTVMEDLRASYIHHVQRMNKDDGLELFHKVVFEDE
KNEDPDLDEMAAKIVSKCDGLPLAIKVMAGMLISKKRTRREWERVLESDL
WRMRDKEDELPAALYLSYEDLSSVLKQCFLCCASYIGISYRTDLVRLWIA
EGLIHVPNGGLMEEVAEDYYKELVMRNLLHLDPRYSDEIRYSMHDLLRAL
GTNLIGDEALVISDGRVADTNNPNPLTQIRRLWMSSKGDTLRLPGAVLEQ
KSLRVLQLHDCTETKTIEDEAAALPALKNLRVLDVCEIQIECLPDFIFMN
LLLLRYLDLDRTMIREIPESIGRLANLQTLNISGCESLRSIPKAVTSLGM
LRCLRVRGTPLTHLPIGMGSLTNLNHIEGFVVGHGDSRSNADVGCDMEEL
RSLSNLRFLSACKLERATLMAGPSVLENKPLLRHLSLLWTKRKQRDDGEK
EAAEKTCSGLLPPSSLEELTLHNFPGRRFPNWMMSTSSGTSFPHLEFLIL
CNFPCCTELPPLGQLPRLKFLKIEEASAVRKVGPEFLGVCFPQAEAFPRL
EVLKFTGMPNWEEWTTLYAASEERSLKLFSRLERCSFTGCPKLRGLPESI
YCAARLKTVVVSTSDQLSEVEFRRRETMEMDDCPDLILARDSTELPHWLL
DRIDRERDEKNSELPSRTVITVKANVIVIKQNRQVDAV
>XP_042404729.1 putative disease resistance protein RGA4 [Zingiber officinale]
MLDKAASYINVEEAQAARRKADKPPLVAYRPERRAPQTPDQPLPRARDAR
PTFQPRQDARPMPRVAAVQVPRPGPWGPRYCTYHRSHTHATNDCFQFAHD
SRRAAELGLPLPELAPQVQRMMEEQRNAAGQASRPRAEQEGPSMQPQGHT
GEPGEAREAENRGNADIRDIGMISGGPTDGDSGRARKSHEGRLEIHAIGC
SQEQAAGLVISFRPSVFEEMQIDASELQPVATSLYGFTDELANKAAEIRK
RFDEITKEWKLLKLPKKAGKRKRSPMLSDMNRETGSLVVESDVLGREEEK
DVLVKWLLSEDDTTGNGVSVIAVIGMGGLGKTTLAQLVYNDQRVKSYFDL
TGWVCVSENFHVVSLTEKILQSFTKVKVHEELDELQRALQENLQGKRFLL
VLDDVWNDNFCLWEQLKKPLLSAIAGKVIVTTRNHSVARIMQTTRDSLKL
NVLPFDVCWSLFKKVTLGGADRSLRPDLEDIGRRIVEKCKGLPLAAKLIG
GALRNEEDKESWTDIIESEIWKLDDRNIEVSPALQISYDCMLIQLKRCFQ
YLSLFPKDTSLSSKRIVQLWMPQGIFPLDGDKRAEDIGSDYIKRLVERSM
LNPEEGSYFSMHDLVHDLAQYVAQDECLCVIDNNFDRKKLQEIRHLSVNG
ENIKLCQDKTNFLESDNLFQKLKYIRALDLNYMNITKLPDSLGNLKLLRY
LSIEYTNVRSLPESICNLYNLQILHAESVYTLPRHIGNLINLRHLWFSHQ
VVFLPSGIGNLTNLQTLNHFSVSREEEHCNIGELNSLMKLGGSISIDNIG
EVNNFSNSKFPLKTKKYLDSLELYWYDWFDYADEKKAEWQLEYLEPHVNL
KTLEITKYPGIKFVGWVGASSFTKLIKLILRNCKNCSKLPPLGQLPSLEE
LEIIGMDGVQHVGREFCSMLIPSPSSQGELNIWKMDDVQHVGSGISSTLE
PFSSSYKIAFPSLKLLLFSSMKNWKAWDGIQSGDFPNLHFIEIYECSKLI
NFPKWPLLPSSGT
>XP_042404736.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MAGGGFLSSIITMVIDKLHSLASSSTSSSSSSPRNNIEQEMSKLTETMRR
IQAKLDDTEEENRAKSHSEKLWLSELKDVAYDAEDVVAKYEYEVLRSKQL
HENSSGTQEVPDSSVIRTAVNTAITFMILLLFSDELANKAAEIRKRFDEI
TKEWKLLKLPQNVGKRKRSSWPLVGNRETGSFVVESEVLGREKEKDMLVE
WLLSEDDIIWNEVSVIVVIGMGGLGKTTLAQLVYNDPRVKSYFDLTGWVC
VSENFHVVSLTEKILQSFAKVKVHEELDELQHALREKLQGKKFLLTLDDV
WNEEFTLWDELRKPLLSAHVGKVIVTTRNQSVARIMGTRSPLNLNCLPFD
VCWQLFKRVTLGGADKSLQPHLEDLGRKIVDKCKGLPLAVKVLGGALRNK
EDIDSWEDILENEMWESEETNKGVLPALKISYDCMPIQLKRCFQYLSLFP
KDTSLDSEEIVRLWMSQGLLPLDGDKRAEDIGRNYIKRLAERSLIHLKRA
DTLFMREQSRKQSFSLHDLVHDLAQYIAQDECLCVIDDKFDIEKLQKIRH
LSLGRSLVREDPHILKHLETIKDHQQLKLMRTLFIKVRGLFGLTSIRRQD
KIFGPLDDFFQKFENLRALHLSNIIGFIGLLDSLGKLRLLKYLSIIDFDV
VGIPESICSLYNLQTLDLTGTSIYQLPRQIANLINLRHLLLPHYLNVFLP
SGIGNLIDLQTLTHFDFCCEKEHCDIGELNSLMKLGGHILISISTSVNTL
SNSKPPLKTKKYLDSLELRWYGWYDDAFDGSKKDEKNAEWQLEYLEPHVN
LKTLQIFFYPGVSFVGWVGSSSFTKLTSLSLNSCNNCNKLPPLGQLPSLE
MLEICGMDGVQQVGREFCSLLMASPSSSQNKIAFPSLKYLHFSTMPNWEV
WDGVEIVALYTFGGRNDIGWWWCT
>XP_042405070.1 putative disease resistance protein RGA4 [Zingiber officinale]
MESALVTAMTRIMGEKVAILIRRNKNVKEITDIEEKMEKLKELLLIVNMV
IQDVESRPFTYDVKILSRKLRYLVYDLEDVVDCYDTEVLRKQRSRASFRS
VHDFFSSNNQILFKSRLGSMIKAVTESGFNFTAKVEAFEFVTSISSDIMG
RETEKQRIVDLLTDDDDDVENNQDTMKVITIVGMGGLGKTRLAQLVFNDE
KVKAHFASWRMWTVIGMEFDPTKIMKSILEQATNALSTVSETNSVRQKLE
HTLSGKRFLLVLDDVWNEDASRWGELRTALTCGARGSKILVTSRSLHVSS
IMNSFITHQIQQLPPDDCLPLFQQFAFGDEEKDQKLMDIGRKIVEKCGGV
PLAIISLGSMLHNIQDETHWSSVLNSKIWQLRDEEQKVLAALKWSYDTLP
PQSKKCFAFASLFPKGYTIEKDELVRLWMANGFVQSEGNVDAKTMGNRVF
DDLVLRSFFLLTPSKEHDFGDDSHVTKCMMHDLMHDLARSVSGDVYWNVK
EDLVTDIGNRTYHLLLYVKNLSNAYQALLRKPLTEILEGVRFKQ
>XP_042405112.1 putative disease resistance protein RGA3 [Zingiber officinale]
MEIQPFLIIHQKKEDFKESSPCIIVPLFSSKLSIVSQAQIHRKQLLHPSS
EAMAAALVSDASRFKGENVADLLQLKDKLKAITGIEGKMEKLKESSAIID
KVIQDVDSRPFDHAVKELVKKLKYLAYDLEDVVDYYDTKVLQKKPRSKTS
LGPVRDFFSSDNQVVYTSRISGMIQAVTESLESILLQKSILLNLPQGNIL
VSKPSPYRETHSRNSFDVIGRETEKKMIVDMLTKDDDDDESSHGTLKVIT
IVGMGGLGKTALAQLVFNDDSVKEYFYLRMWKVVGTEFDPAKIMRSVLEL
AIAAPVKISEIDLVRQNLEEALSGKRFLLVLDDVWNENVLKWGVLKAALT
CRAPGSKILMTTRSQKVPLIMGSSKTTYHIQQLPRDDCLSLFYHFAFEDE
PVDQKLMEIGEKIVEKCDGVPLAVISLGSMLRGTRDKTDWSTVLNCSEIW
QIPDKEQNVLDVHK
>XP_042405113.1 putative disease resistance protein RGA4 [Zingiber officinale]
MEGALVAATRFVADKAAILFQLDEKLKAMTDIEEKMENIKELSTIIDMVI
EDVESHTLNKDAVKDWLRKLKYLAYDLEDVMDCYDTEALRRQRSSISSFE
PVRDFFSSNNQIVFTSRISDMIQAVTNSLDSILRQKSFLPNLPQSSSHMS
LNPYRETHSRNSFDVIGREIEKNMIVGMLTNDDDESSTHGTLKVITIVGM
GGLGKTTLAQLVFNDEGVKAHFESSRMWTVVGAEFDPAKIMKSVLELATG
ASVNISQIDLVRQKIEKALSGKKFLLVLDDVWNEDATKWNVLKPALTCGA
RGSKILVTTRSQQVSSIMGSSNTTHQIQQLSRDDCLSLFQQFAFGDEAVD
QNLMEIGEKIVKKCGGVPLAAISLGSMLRITRDEPYWSSVLNSEIWQLGN
KEDKVLAVLKLSYDSLPPRSKKCFAFASLFSKNNRMAKDELIKLWIANGF
VSSEGNFDAETVGNRVFDDLVSRSFFLLIPSQDVTKCTMHDLMHDLARSV
SADVYCNSKQDSVKHIGNRTYHLHIYLANTSKVTRALSKKPLYLRTLILN
YVSLNGDQLEIVFSELKYLRVLELTGNKIKEVPTSIGNLIHLRYLNLSKN
RIKVLPDSITLLHNLQYLYCHHLRLTHMPCGLSRLINLRSLSFFAAADGA
GACSIIELEDLKLHGEMKIQFSENFTNYSCGGRKILKNKHLNELRLKFNC
SESNDKDMLEDLCPNSSLKKLSICNYGSRQFPELLIESQLPNLVEVCLKN
CRGCEHIPPFGNLQFLKKLELHKMNAVTQMGAEFHGFGGFPSLQELYLDR
MDDLEEWSESDYVDESFPLLKTLFIVKCPKLKSMPRLPRIQYLDISYCSG
SLLPCVGRLTSLSVLRVEAMDDMTSLPNGCIRNLTSLTAFEIKGCKQLQC
LPGDEMQHLEMIRTLTIDRCDNLASLPSEVGCLGSLCFLRLREEKIQNWQ
KGVRMRDIWRRDSLGARMHDSKSSDYNRQKAVNMIEENLQEDQQKLELHV
FEMEVELTCLNEALLIEALSEKLGTAGSEIKSLKEMVAMAERLVESESVL
KEMESSMKYPLEMEVEKSIWSSKEKAFLEASEKLKIQNNLMQKLSENLL
>XP_042405114.1 putative disease resistance protein RGA4 [Zingiber officinale]
MEGALVAATRFVADKAAILFQLDEKLKAMTDIEEKMENIKELSTIIDMVI
EDVESHTLNKDAVKDWLRKLKYLAYDLEDVMDCYDTEALRRQRSSISSFE
PVRDFFSSNNQIVFTSRMSDMIKAVTNSLDSILRQKSFLPNLPQSSSHMS
LKPYRETHSRNSFDVIGREIEKDMIVGMLTKDDDDDDDESSHGTLKVIAI
VGMGGLGKTTLAQLVFNDARVKDHFESSRLWTVVGAEFDLAKIMKSVLEL
ATSASVNISQIDLVRQNLEKALSGKRFLLVLDDVWNEDPFAWGKLKAALT
CGTRGSRILVTTRSQQVSSIMGSSNTIHQIQQLSGDDCLYLFQQFAFGDQ
AVDQNLMEIGEKIAKKCGGVPLAAISLGSMLRITRDETYWSSVLNSEIWQ
LGNEEDQVLAVLKLSYDTLPLRSKKCFAFASLFSKNDIMAKDELIKLWIA
NGFVRSEGNFNAETAGDRVFDDLVLRSFFLLVPSQDVTRCTMHDLMHDLA
RSVSADVYWNSEQDSVENIGKRTYHLKISQSEESSMTHVLGKKPLYLRTF
MSRRVYSPLRTNMFEGFLELKFLRSIDLPCNGIIEVPTSIGNLIHLRYLN
LSRNGIKVLPDSITLLPNLQYLDLSFNEELQELPEELGNMQSLRELDCRH
LDFQKLLPLFSHIQNIQDLDLLRALSHFNFGLTHMPCGLSRLTNLQSLGA
FYAGDRTGACSIIELEDLKLHGEMNIIFSKDFTNYSCGGRKILKNKDLSE
LRLEFNGSERYDKEMLDDLCPNKSLKKLSICNYGSRQYPAWLMESQLSNF
VEVSLKNCRGCEHIPPFGNLQFLKKLDLRSMNGITHMGVEFHGHGGFPSL
QELILNELYNLEEWLESHGVDELFPKLQSLKIFACPRLKSMPRLPTIQYL
DIFWCSGNLLSCVGRLTSLSLLRLVDMDDMTSLPNGCIRNLTSLTTFEIQ
GCKQLQCLPGDEMQHLEMIRSLTIYRFNNLASFPSEVGCLGSLRSLSLRG
CPSIKVQPEVLVQILNSLHKFQIEICHKNVDIRRQLQHLHTLKELFITGV
HGRYKNHSYIGRNNATQLGICCCDELESLITAEPTSNVLEELYIDEIFKL
TTLPDWLRHLESLRVLSIHNCSELGLLPRGLKNLPILETLRVSNCLQLKR
RCEREIGEDWPIISHLPFIDIS
>XP_042405133.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MAMIPDFLVTRYLTKLTDFLEGEICKVLGVKEEIKKFKRRLERLSPYLQD
AEQKRHQDNRVNTWLRDLKGIVYDAEDIIELCTLHGGSELMSLQPSSSTL
VSRPFTLLASCFACTKFRHEIAVSFERLNDRLKEIKDDSEIIAGLVPLMS
HQWSQDHPTSQRLTTSLEVKADIVGAKIENDAQTLIRMILKHDHKHNGVF
GIVGMGGIGKTTMAHKIVHDERIKNNFPTRIWICVSKNYTRIELLKEILK
QAKGSDNGTQSIEELEFKLVGALVNRFFLVLDDVWSVNAWTDVLRNPILI
AKSNGIILITGRHKTVMEDLRASYIHHVQRMNKDDGLELFHKVLFEDEKN
EDPDLDEMAAKIVSKCDGLPLAIKVIAGMLISKKRTRREWERVLESDLWR
MRDKEDELPAALYLSYEDLSSVLKQCFLCCASYIGISYRTDLVRLWIAEG
LIHVPNGGLMEEVAEDYYKELVMRNLLHLDPRYSDEIRYSMHDLLRALGT
NLIGDEALVIRDGRVAGTNPNPLTKIRRLWMSSKGDTLRLPGAVLEQKSL
RVLQLYDCPETKTIEDEAAALPALKNLRVLDVCETQIERLPDFIFTNLLL
LRYLDLDRTMIHEIPESIGRLANLQILNISGCTSLRNLPKAVTSLGMLRC
LRVRGTPLTHLPRGMGSLTNLNHIEGFVVGHGDFPTNADVGCDMEELRSL
SNLRFLSACKLERATSMAGPSVLENKPLLRHLSLLWTNRKQGDDGKKEAA
EKTCSGLLPPSSLEELTLHNFPGRRFPNWMMSGTSFPHLEFLILCNFPCC
TELPPLGQLPRLKFLKIEEASAVRKVGPEFLGICFPQAVAFPRLEVLKFT
GLPNWEEWTLYAASVEVGDIQERSMNLFPRLERCTFTGCPKLRGLPESIY
CAARLKTVVVSTSDQLSEVEFRRREIMEMDDCPDLFLARDSTELPHWLLD
RIDKEKDEKNSVLPSRTVITVKANVIIIQQNRRVDAV
>XP_042405134.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MAMIPDLLVTRYLTKLTDFLEGEICKVIGVKEEIKKFKRRLERLSPYLQD
AEQKRHQDNRVNIWLRDLKGIVYDAEDIIELCTLHGGSELMSLQPSSSTL
VSRPFTLLASCFACTKFRHEIAVSFERLNDRLKEIKDDSEIIAGLVPLIS
HQRSQDHPTSQRLTTSLEVKADIVGAKIENDAQTLIRMILGMGGIGKTTM
AHKIFHDERIKNSFPTRVRIHVSKNYKGIELLKQLLKNAKGSDDEAQSIQ
ELESKLVGALVNRFFLVLDDVWSVNAWRDVVFEDEENENPELDEMATKIL
RKCDGLPLAIKLIAGVLISKKRTRRDWERVVESDSWRMRNNEDELPRALY
LSYEDLSSVLKQCFLCCASYVDVSFTADLVRLWIAEGLINAPNGELMEEV
AEDYYKELVMRNLLQLDPRSADETHYSMHDLLRALGTNLIGDEALVISDG
RVADTNPNPSTQIRRLWMSSKGDTLRLPGAVLEQKSLRVLQLYDCPETKT
IEDEAAALPALKNLRVLDVCDTQIERLPDFIFTNLLLLRYLDLDRTMIYE
IPESIGRLANLQTLNIAECESLRSIPKAVTSLGMLRCLRVEGTPLTHLPR
GMGSLTNLNHIEGFVVGHGDLPTNVDDGCDMEELRSLSNLRYLTASKLER
ATLMAGPLVLENKPLLRHLSLSWTNREQRDDGEKEAAEKTCSGLLPPSSL
EELTLHNFPGRRFPNWMMSTSSGTSFPHLEFLILRNFPCCTELPPLGQLP
RLKFLKIEEASAVRKVGPEFLGVCFPQAVAFPRLEFLKFTGMPNWEEWTL
YAASEEVGAIQERSLKLFSRLARCTFTGCPKLRGLPESIYCAARLKTVVV
STRDQLSEVEFRRRETMEMDDCPDLILARDSTELPHWLLDRIDREREEKN
SVLPSRTVITVKAHEIIIQQNRPVEAV
>XP_042405156.1 disease resistance protein RPS2-like [Zingiber officinale]
MRADVIKKMEGLPYDQAWELFLKNAGENVINSEPGITRLAKQIAEECAGV
PLALITVGKVVSAKRSIEAWNDVLKQLKKSHLPKVTGMKERDPMLAAFKL
SYDNLEDDNMRARLLCCSLWPEDFEIHKDELIQCWIGLGLIDEFDSINEA
FDRGHSHIETLASASLLELIDEETTIMVKMHDVIRDMALWISSDCGSNQH
KWIVVAHAGLRQLEQKNEEWQVVERASFMHNELTCLPGQTATFPKLSVLM
LQQNIFLHLIPKSFFRSLPVLTFLDLSYTMIRELPREIIMLSELQHLNLN
FTPIEALRIELSNLAKLKYLLLEGTHSLVQVPMGTIFNLPLLKLLNLYKS
KYSNLDELERCQGCRKNIGITLHSMTDLERLGSLSQLSSWKLQLQNMRGL
AYSSQLFENIMSSHNTRQDLERLEIANVLTSGELIIARSNKDSTDGLESL
RYMALINVYWQKITWKAVKPQTVFPNLHELTIDNCKILRNITWVLQLPNL
SVLTVSNCGEMEELISCVESFANSSVGLRLLTLVGLPKLNCISRQPLNFP
YLEWMHVISCHKLRKLSFGAEICQNKLKSIVGEVDWWENTQWEDVNDKNS
LDVYFKSDWFMEALESTVTITYAEQAMESMQAMESTSTITDAELALKSTS
SITYAEQAMESTSTITDAEQDWFTHVLKSTSSITYAEQAMESMPMMESTS
TITDEDWFMQALKSSSNITYDSK
>XP_042405157.1 disease resistance protein SUMM2-like [Zingiber officinale]
MATFDFGKLLDRIWDAASIYLARPRSRVVDLHRDAELLKAKLVDFNGAID
EAVRNGKTVTKETQLWKRRAETFVSEEVDDAIQRDYRAMRCLGGWSWNCV
SINRIVTKKLKEVKELISQVDVSRVTVTQLLLPPASVELPISKNVVGMQS
NLIQIVNQIRDENASVIGIYGMGGIGKTTLLKLIHNHEEISKLKFQHVVW
IVASKGCKLQKLQTDLAKKVRLNLEDDESEDDRASKLCNFLKEKNCLLFL
DDIWESYELYKLGMEQVPAENGKEQKRKVVVSRRAASKYALK
>XP_042405172.1 disease resistance protein At4g27190-like [Zingiber officinale]
MGGVGKTALLEEIRRKVKEAEMFDLVIDVVVSQNPNIAQIQRDVADALGM
SESSNKMLVTRLKQEKKVLIMLDDVWAQLELVKEVGIPYQEHNGCKVILT
SRSAELCNLMETDVSVEVATLSEEDSWQLFRMRAGQVLESDDIEVVARKV
AQECCGLPLAIVVVGRALRSYKDSRYWEEALSQLKQSVPSNIGNVEEKLY
KSLELSYQNLKSSELKQLFLYCCLFHKDYDISEEEVTRYAVGENLLSNIS
TLEEARGRVHFLLETLKLSCLLLDSKKPRCVRLHGVVRDVAVYIGSKYDN
HFLVKAGLHLRYWRERENFAAWDRISLMNNDLQEIPENPNCSKLVLLLLN
MNPITSLPTNFFENMVTLNVLDLSDTYITCLPLSSACLKKLGTLRLDRCK
WLNDINVVGELKTLIILSLRECIQISALPENIVALVKLKLLDLSYCTSLP
IPRNLIPKLTRLEELYFRGCNVTEALFIENSDVISFCTGVVPPGSLHKLT
TLETLDTIHSRLLPSDTFKKLKQLKIMGCPCLKHVFLPSIANEFQSLEKL
EMKNNGSIETIITDKEVCDLKKGAFPMLQQLLLIKLPRLGCFFIGEPAKT
LDWPSLEYIHLSDCSNLARLPIGRESAQKLKKLHVASLNDVIWFKTLKWK
DNTTKSRFDIMNESDVLKAVQNVHAMIDKEVDNGVFYLTVLSVFPAIKLL
KAEYINHRV
>XP_042405322.1 putative disease resistance protein At5g47280 [Zingiber officinale]
MESFFAGEVATELIKELVKVIRGTYLCRPAAEQLKRSVDSLLPIVQEIRH
SGVELPQNRQSQLSDLADHLRLALDLARKAAASPRWNVYRSVQLARKMEC
IESWISRWIERHMPVHVLADVHHIRVDYAARLDRIERALSVAASSPVVAT
ASKVPMELGSASFSGFPLPKTMEGFAQPSAEPVKAPFAIGNKLSSGFPMM
EQFFTSPDARKVPVAMGKSPSSGFRVANIMDGLMLAGEEVKPVGAGIRIG
KEKVKEMLMEGSASDAVVGISGIGGSGKTTLAREICKDPEIRSYFNDRIY
SVTLSQSPNLESLKLKLWEQISGNMVLGAYNQIPKWQMELGAIDKGSFLI
ILDDVWSLSELEELIFRVPGCKILVVSRFKFPLVVKKTYEIELLGEEDAL
SLFCHAAFELKSVPFTIDKKLVKQVVKECKGLPLALKVIGASLRDQPPKF
WLRAKNKLSQGEAICESHENKLIERMSSSIEFLSVKVRECFLDLGCFPED
KRIPIDVLINVWMELHDLDEEDAFAMLVELSNKNLLTLLKDAQSRAGDIY
SSYVELSVTQHDLLRDLALYVNNQESLNTRRRLIMSKRENELPKEWERNK
DQQFEAQIISINTGEMKESDWFQMHFPKAEVLILSFCADVYFLPPFLSTM
PKLRALILINYGTSCASLQNRTIFTSLINLRSLWLEKITVPPLPKTTVPL
RNLRKVSLILCELNDSLRGSKVDLSSTLPRLSHLSIDHCVDVTKLPPYIC
NITSLECLSISNCHDLSELPCEFGKLSSLKILRVCACPSLKSLPQSICRL
KGLKYLDISQSFNLRELPEELGYMMSLEKIDMRECSQLKTLPRSSSSLKS
LGHVICDEDIALLWKEAEIEIPDLRVQVAEESFNLDWLVE
>XP_042406451.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAGGGFLSSMFTTMVAKLQSLASLSTISSSSSSPHNTIEQEMSKLTETMR
RIQAKLDDSEEENHAKSHSEKLWLSELKDVAYDAEDVVEEYEYEVLHSKQ
LHENNSGTHEDELANKAAEIRKRFDQITKEWKLLTLPKNVGKRKRSPSPL
DENRETGSLVVESDVLGREEEKDMLVKWLLSEDDTSVNKVSVIAVIGMGG
LGKTTLAQLVYNDQRVKSYFDLTRWVCVSENFHVVSLTEKILQSFAKVKV
HEELDELQHALREKQQGKKFLLILDDVWNEEFTLWDELRKPLASAQVVKV
IVTTRNQSVARIMGTRSPLNLNCLPFDVCWQLFKRVTLGGADKSLQPHLE
DLGRKIVDKCKGLPLAVKVLGGALRNNEDIDSWEDFLQNEMWESEETNKG
VLPALKISYDCMPIQLKRCFQYLSLFPKDTGFDSEEIVRLWMSQGLLPLD
GDKRAEDIGRSYIKRLAERSIIHLEWDDTFLMEWKYFLMHDLVHDLAQYI
AQDEYLCVMDNKFDTKKLQKFRHLSFNVECHKLNIEALPEPKLLRTLFMR
QLDSWKYRLPDDLFQKLKYIRTLVLNTYGIEELPYSLGNLKLLRYLSIKA
YHVVSIPESICSLYNLQTLDLADTQISELPRQIGNLINLRHLLLPYNFYD
WESIFLSSRIGNMTNLQTLRCFNVSCEREHCNIGELNSLMELGGHISIYN
VASVNIFSNSKPPLKTKKYIDSLELRWMKYGWHDNDAFDYYTKDEKKAEW
QLEYLEPHVNLKNLEIISYPGIKFVGWVGASSFTKLTRLCVEDCKNCNKL
PPLGQLPSLEYLFIGAMEGVQHVGREFCSMLMASPSSSQNKIAFPSLKDL
IFKDMTNWEAWDGVEIGDFPSLYSFKLSGCRRLIKFPRWPFLSSVEEMTL
DSGGVPDVLNFHSLTNLTVMSMTKKNSKWMSKCYFPTLQHLRLSFSTAKS
VHLSQKVLPSLKTLEISNCPTLRVVAGLKNLTSLNFLYIEVCPNLEFKGL
PATLEQVKLYCCSLFEKGYKEQQHMPNDLMIEAHNSDDEEEEKEEMDVND
EEEEEEEEEEEEEAEEEMDGDDDDNMD
>XP_042406453.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MAGGGGFLSSMFTTMVAKLHSLASPSITSSSSSLPHNNIEREMSKLTETM
RRIQAKLDDSEEENHAKSHSEKLWLSELKDVAYDAEDVVEEYEYKVLRSK
QLHEHNSGTYEDELANKAAEIRKRFDEITKEWKLLKLPKKAGKRKRNPML
SEMNRETGSLVVESDVLGREEEKDVLVKWLLSDDTTGNGVSVIAVIGMGG
LGKTTLAQLVYNDQRVKSYFDLTGWVCVSENFHVVSLTEKILQSFTKVKV
HEELDELQRALQEKLQGKRFLLVLDDVWNDNFCLWEQLKKPLLSAIAGKV
IVTTRNHSVARIMQTTRDSLKLNVLPFDVCWSLFKKVTLGGADISLRPDL
EDIGRRIVEKCKGLPLAAKLIGGALRNDEDKDSWTDIIESEVWKLDDRNI
EVLPALKISYDCMPIQLKRCFQYLSFFRKDTCLSSKGIVQLWMPQGIFPL
DGDKRAEDIGSDYIKRLVERSMLNPEEGSYFSMHDLVHYLAQYVAQDECL
CVIDDNFDRRKLQEIRHLSFDSENIKMIKDINLQQLKHLRTLLIRNGYWG
RVFPRQDKFFGVLDNLFQKLKYIRALGLNHTSVAELPDSLGNLKLLRYLS
IENTHVRSLPESICNLYNLQILHAGSVFKLPRHIGNLINLRHLWLSHQID
FLPSGIGNLTNLQTLSHFNISHEEEHCNIGELNSLMKLGGSISIDIIGYV
NNFSNSKFPLKTKKYLDSLKLCWYDWFDYADEKKAEWQLEYLEPHVNLKT
LKITEYPGVKFVGWVGALSFTKLTKLVLKDCKNCSKLPSLGQLPSLEELE
IAGMDGVQHVGREFCSMLIPSPSSQVELNIWQMDGVQHVGSGISSMLEPF
SSSYKIAFPSLKLLLFSRMKNWKAWDGIQSGDFPNLHVIEIFKCSKLINF
PKWSLLPSVKEMVLVSCGALDVRCWFSLTNLTIGISSQEHSEWMSKSYFP
ILQHLILLNSKVESVRLSQKRIPSLKTLEISDCPTLRVVAGLKNLTSLNS
LYIEACPNLEFKGLPATLKQVKLRRCSLFKKGLNEQQHMPNDLMIEAHNS
DDEDKEEEEEEEEEEMDVNDEEEEEEQEEMHVNDEEEGDGWRG
>XP_042406479.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MAGGGGVLSSMFTTMVAKLHGLASPSTISSSSSSPHNTIEQEMSKLTETM
RRIQAKLDDSEEENCVKSHSEELWLSELKGIAYDAEDVVEEYEYEVLRSK
QLHENNSGAHEDELANKAAEIRKRFDEITKEWKLLKLPKNAGKRKRSPVL
LDMNRETGSLVVESDVLGREEEKDMLVKWLLSEDDDTTGNGVSVIAVIGM
GGLGKTTLAQLVYNDQRVKSYFDLTGWVCVSENFHVVSLTEKILQSFTKV
KVHEELDELQSALQEKLQGKRFLLVLDDVWNDNFCLWEQLKKPLLSAIAG
KVIVTTRNHSVARIMQTTRDSLKLNVLPFDVCWSLFKKVTLGGAERSLRP
DLEDIGRRIVEKCKGLPLAAKLMGGALRNEEDKESWTDIIESEIWKLDDR
NIEVLPALQISYDCMPIQLKRCFQYFSLFPKLKSVSSKRIVQLWMSQGIF
PLDGDKTAEDIGSDYIKRLVERSMLNPKAGSYFWMHDLVHDLAQYVAQDE
CLCVIDDNFDRKKLQEIRHLSFDSENIKVIKDINLQRLKLLRTVLLLRNP
FEEMIFIPRPAINSGVLEDLFEKLKYIRALSLHSIGIAELPDSLGNLKLL
RYLSIENTHVRSLPESICNLYNLQILHAGTVYILPRHIGNLINLRHLWLS
RNVDFLPSGIGNLTNLQTLSHFNISHEEEHCPGGEYPLFCHHEEELCNI
>XP_042406480.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAGGGGVFLSSMFTTMVAKLHGLASPSASSSSSSPHNNIEQEMSKLTETM
RRIQAKLADSESEEENHAKSHSEKLWLSELKDVAYDAEDVVEEYEYEVLR
SKQLHENNSGAHEDELANKAAEIRKRFDEITKEWKLLKLPKNTGKRKRNP
MLLDMNRETGSLVVESDVLGREEEKYMLVKWLLSEDDTSVNKVSVIAVIG
MGGLGKTTLAQLVYNDQRVKSYFDLTGWVCVSENFHVVSLTEKILESFTK
VEVHKELDGLQHALQEKLQGKRFLLILDDVWNEEFTLWDELRKPLVSAQV
SKVIVTTRNHRVAGIMGTRSPLDLKCLSFDVCWQLFKRVTLEGAYKRLQP
HLEELGRKIVDKCKGLPLAVKVLGGALRNNEDIDSWEKILENEMWELEET
NNGVLPALKISYDCMPIQLKRCFQYLSIFPKDTSLDSEEIVRLWMSQGLL
PLDGDMRAEDISRNYIKRLVERSMLNSVEINVDSSFVMHDLVHDLAQYIT
QDECLCVMDNKFDAKKLQKIRHLSVSVKYPHLLKPLETIKDLQQLKLMRT
LFITGPGWPYFMIRQYNFFKVLDDLFQKLKYIRALHLSKIDITKLPDSLG
NLKLLRYLSIRSAKIRMLPESICNLYYLQTLDLIATNVHEFPRKIGNLIS
LRHLLLPYHYKGAFFPSGIGNMTNLQTLRRFNVSCEKEHCDIGELNSLMK
LGGHISIYNVASVNIFSNSKPPLKTKMYIDSLELRWFAFDCSKKDEKNAE
WQLQYLEPHVNLKTLQIFFYPGVSFVGWVGSSSFIKLTSLSLNSCNNCNK
LPPLGQLPSLEELEISRMDGIRHVGREFCSILMASPSSSQNKIAFPSLKD
LIFRDMTNWEEWDGVEIGDFPSIHSIKLYGCPRLIKFPQWPFMSSVKKMT
LDSGGVPDVSCFPSLKHLEIIVRTQEYSEVMSKCYFPTLQHLILSYSKVE
SIHLSQRRLPSLKTLKIHDSKELRVVTGLKNLTSLNSLIIEECPNLEFEE
LPATLAQVQLYRCRLFKKGFKEQKHMRNVLGEEEEEIENLLDFLLWIAEE
DDNNDGGEDMRNEGEEEDMEIDLELRLWND
>XP_042406481.1 putative disease resistance RPP13-like protein 1 isoform X1 [Zingiber officinale]
MAGGGFLSSIITMAVDKLHSLALPSTPSSSSSPHNNIEQEMSKLTETMRR
VQAKLADSEEDNHVKSHSEKLWLSELKEVAYDAEDLVEEYEYEVLRSKQL
HGNNSGTHEGELANKAAEIRKRFDEITKEWKLLTLPKNAGERKRSPLTLV
DNRETGSLVLESDVLGREEEKDMLVEWLLSEDDMTDNRVSVIAIIGMGGL
GKTTLAQLVYNDPKVKSYFNPRGWVCVSENFNVVNLTEKILQSFTEEKGK
GEVKIPETLDGLQRALEENLLGKKFLLILDDVWNEEFTLWYELRKPLVSA
QVGKVIVTTRNQPVARIMGIRSPLDLNCLPFDVCWQLFKRVTLGGADQPH
LEDLGRKIVDKCKGLPLAVKVLGGALRNKEDIDSWEDILENKKWELEETN
KGVLPALKISYDCMPIQLKRCFQYLSLFPKHTRLHSEIIVRLWMSQGLLP
LDEDDRDKRAEDKGRNYIERLAERSMIQLKWSDSFLMHNLVHDLAQYIAQ
DECFCMMDNKFDTKKLQKIRHLSVSIEDPHLLKHLETITDQQLKLMRTLF
IRVQDKSRGRPFITRQDKNFGVLDDLFQNLKYIRALHLSQIGIRELPDTL
GNLKLLNYLSIKDIAIKSIPESIHNLYNLQTLDLTQTNISELPRQIDNLI
NLRHLLLSHKVAFLPSGIGNLTNLQTLTHFNVGCGKKHCDIGELNSLMKL
GGHISIYNVALLHRSIATMPVNKFSNTKPTLKTKKYLDSLRLDWLREHDN
FDRFKQDEKKAEQQLAYLQPHVNLKFLEINNYPGVRFVEWVSDSSFTKLT
RLILEDCKNCTKLPPLGQLRYLEYLDIRGMDGVQHVGREFCSMLMASPSS
SQNNMAFPSLTHLEFSSMPNWKGWDGVEIGDFPSLHFIEISKCSKLIKFP
QWPFMSSVKEMTLGNCGALDVLNLHLWTNLSIGIKTQEHSKWMSKCYFPT
LQHLTLKSRVECVHLSQKRLPSLKTLEIQSSEELRVIGGLEGLTSLTSLI
IRNCFNLEFEKLPATLQQLRLSNCPLFHKGLEKQPHMLNVLREGEKRERE
ELIEFERRYPIIKDWSDAEQDNINRITWMSDHKDDKEYNGSKTARFLPSR
RDSYRMKRSRFAAG
>XP_042406482.1 putative disease resistance RPP13-like protein 1 isoform X1 [Zingiber officinale]
MAGGGFLSSIITMAVDKLHSLALPSTPSSSSSPHNNIEQEMSKLTETMRR
VQAKLADSEEDNHVKSHSEKLWLSELKEVAYDAEDLVEEYEYEVLRSKQL
HGNNSGTHEGELANKAAEIRKRFDEITKEWKLLTLPKNAGERKRSPLTLV
DNRETGSLVLESDVLGREEEKDMLVEWLLSEDDMTDNRVSVIAIIGMGGL
GKTTLAQLVYNDPKVKSYFNPRGWVCVSENFNVVNLTEKILQSFTEEKGK
GEVKIPETLDGLQRALEENLLGKKFLLILDDVWNEEFTLWYELRKPLVSA
QVGKVIVTTRNQPVARIMGIRSPLDLNCLPFDVCWQLFKRVTLGGADQPH
LEDLGRKIVDKCKGLPLAVKVLGGALRNKEDIDSWEDILENKKWELEETN
KGVLPALKISYDCMPIQLKRCFQYLSLFPKHTRLHSEIIVRLWMSQGLLP
LDEDDRDKRAEDKGRNYIERLAERSMIQLKWSDSFLMHNLVHDLAQYIAQ
DECFCMMDNKFDTKKLQKIRHLSVSIEDPHLLKHLETITDQQLKLMRTLF
IRVQDKSRGRPFITRQDKNFGVLDDLFQNLKYIRALHLSQIGIRELPDTL
GNLKLLNYLSIKDIAIKSIPESIHNLYNLQTLDLTQTNISELPRQIDNLI
NLRHLLLSHKVAFLPSGIGNLTNLQTLTHFNVGCGKKHCDIGELNSLMKL
GGHISIYNVALLHRSIATMPVNKFSNTKPTLKTKKYLDSLRLDWLREHDN
FDRFKQDEKKAEQQLAYLQPHVNLKFLEINNYPGVRFVEWVSDSSFTKLT
RLILEDCKNCTKLPPLGQLRYLEYLDIRGMDGVQHVGREFCSMLMASPSS
SQNNMAFPSLTHLEFSSMPNWKGWDGVEIGDFPSLHFIEISKCSKLIKFP
QWPFMSSVKEMTLGNCGALDVLNLHLWTNLSIGIKTQEHSKWMSKCYFPT
LQHLTLKSRVECVHLSQKRLPSLKTLEIQSSEELRVIGGLEGLTSLTSLI
IRNCFNLEFEKLPATLQQLRLSNCPLFHKGLEKQPHMLNVLREGEKRERE
ELIEFERRYPIIKDWSDAEQDNINRITWMSDHKDDKEYNGSKTARFLPSR
RDSYRMKRSRFAAG
>XP_042406483.1 putative disease resistance RPP13-like protein 1 isoform X1 [Zingiber officinale]
MAGGGFLSSIITMAVDKLHSLALPSTPSSSSSPHNNIEQEMSKLTETMRR
VQAKLADSEEDNHVKSHSEKLWLSELKEVAYDAEDLVEEYEYEVLRSKQL
HGNNSGTHEGELANKAAEIRKRFDEITKEWKLLTLPKNAGERKRSPLTLV
DNRETGSLVLESDVLGREEEKDMLVEWLLSEDDMTDNRVSVIAIIGMGGL
GKTTLAQLVYNDPKVKSYFNPRGWVCVSENFNVVNLTEKILQSFTEEKGK
GEVKIPETLDGLQRALEENLLGKKFLLILDDVWNEEFTLWYELRKPLVSA
QVGKVIVTTRNQPVARIMGIRSPLDLNCLPFDVCWQLFKRVTLGGADQPH
LEDLGRKIVDKCKGLPLAVKVLGGALRNKEDIDSWEDILENKKWELEETN
KGVLPALKISYDCMPIQLKRCFQYLSLFPKHTRLHSEIIVRLWMSQGLLP
LDEDDRDKRAEDKGRNYIERLAERSMIQLKWSDSFLMHNLVHDLAQYIAQ
DECFCMMDNKFDTKKLQKIRHLSVSIEDPHLLKHLETITDQQLKLMRTLF
IRVQDKSRGRPFITRQDKNFGVLDDLFQNLKYIRALHLSQIGIRELPDTL
GNLKLLNYLSIKDIAIKSIPESIHNLYNLQTLDLTQTNISELPRQIDNLI
NLRHLLLSHKVAFLPSGIGNLTNLQTLTHFNVGCGKKHCDIGELNSLMKL
GGHISIYNVALLHRSIATMPVNKFSNTKPTLKTKKYLDSLRLDWLREHDN
FDRFKQDEKKAEQQLAYLQPHVNLKFLEINNYPGVRFVEWVSDSSFTKLT
RLILEDCKNCTKLPPLGQLRYLEYLDIRGMDGVQHVGREFCSMLMASPSS
SQNNMAFPSLTHLEFSSMPNWKGWDGVEIGDFPSLHFIEISKCSKLIKFP
QWPFMSSVKEMTLGNCGALDVLNLHLWTNLSIGIKTQEHSKWMSKCYFPT
LQHLTLKSRVECVHLSQKRLPSLKTLEIQSSEELRVIGGLEGLTSLTSLI
IRNCFNLEFEKLPATLQQLRLSNCPLFHKGLEKQPHMLNVLREGEKRERE
ELIEFERRYPIIKDWSDAEQDNINRITWMSDHKDDKEYNGSKTARFLPSR
RDSYRMKRSRFAAG
>XP_042406484.1 putative disease resistance RPP13-like protein 1 isoform X1 [Zingiber officinale]
MAGGGFLSSIITMAVDKLHSLALPSTPSSSSSPHNNIEQEMSKLTETMRR
VQAKLADSEEDNHVKSHSEKLWLSELKEVAYDAEDLVEEYEYEVLRSKQL
HGNNSGTHEGELANKAAEIRKRFDEITKEWKLLTLPKNAGERKRSPLTLV
DNRETGSLVLESDVLGREEEKDMLVEWLLSEDDMTDNRVSVIAIIGMGGL
GKTTLAQLVYNDPKVKSYFNPRGWVCVSENFNVVNLTEKILQSFTEEKGK
GEVKIPETLDGLQRALEENLLGKKFLLILDDVWNEEFTLWYELRKPLVSA
QVGKVIVTTRNQPVARIMGIRSPLDLNCLPFDVCWQLFKRVTLGGADQPH
LEDLGRKIVDKCKGLPLAVKVLGGALRNKEDIDSWEDILENKKWELEETN
KGVLPALKISYDCMPIQLKRCFQYLSLFPKHTRLHSEIIVRLWMSQGLLP
LDEDDRDKRAEDKGRNYIERLAERSMIQLKWSDSFLMHNLVHDLAQYIAQ
DECFCMMDNKFDTKKLQKIRHLSVSIEDPHLLKHLETITDQQLKLMRTLF
IRVQDKSRGRPFITRQDKNFGVLDDLFQNLKYIRALHLSQIGIRELPDTL
GNLKLLNYLSIKDIAIKSIPESIHNLYNLQTLDLTQTNISELPRQIDNLI
NLRHLLLSHKVAFLPSGIGNLTNLQTLTHFNVGCGKKHCDIGELNSLMKL
GGHISIYNVALLHRSIATMPVNKFSNTKPTLKTKKYLDSLRLDWLREHDN
FDRFKQDEKKAEQQLAYLQPHVNLKFLEINNYPGVRFVEWVSDSSFTKLT
RLILEDCKNCTKLPPLGQLRYLEYLDIRGMDGVQHVGREFCSMLMASPSS
SQNNMAFPSLTHLEFSSMPNWKGWDGVEIGDFPSLHFIEISKCSKLIKFP
QWPFMSSVKEMTLGNCGALDVLNLHLWTNLSIGIKTQEHSKWMSKCYFPT
LQHLTLKSRVECVHLSQKRLPSLKTLEIQSSEELRVIGGLEGLTSLTSLI
IRNCFNLEFEKLPATLQQLRLSNCPLFHKGLEKQPHMLNVLREGEKRERE
ELIEFERRYPIIKDWSDAEQDNINRITWMSDHKDDKEYNGSKTARFLPSR
RDSYRMKRSRFAAG
>XP_042406485.1 putative disease resistance RPP13-like protein 1 isoform X1 [Zingiber officinale]
MAGGGFLSSIITMAVDKLHSLALPSTPSSSSSPHNNIEQEMSKLTETMRR
VQAKLADSEEDNHVKSHSEKLWLSELKEVAYDAEDLVEEYEYEVLRSKQL
HGNNSGTHEGELANKAAEIRKRFDEITKEWKLLTLPKNAGERKRSPLTLV
DNRETGSLVLESDVLGREEEKDMLVEWLLSEDDMTDNRVSVIAIIGMGGL
GKTTLAQLVYNDPKVKSYFNPRGWVCVSENFNVVNLTEKILQSFTEEKGK
GEVKIPETLDGLQRALEENLLGKKFLLILDDVWNEEFTLWYELRKPLVSA
QVGKVIVTTRNQPVARIMGIRSPLDLNCLPFDVCWQLFKRVTLGGADQPH
LEDLGRKIVDKCKGLPLAVKVLGGALRNKEDIDSWEDILENKKWELEETN
KGVLPALKISYDCMPIQLKRCFQYLSLFPKHTRLHSEIIVRLWMSQGLLP
LDEDDRDKRAEDKGRNYIERLAERSMIQLKWSDSFLMHNLVHDLAQYIAQ
DECFCMMDNKFDTKKLQKIRHLSVSIEDPHLLKHLETITDQQLKLMRTLF
IRVQDKSRGRPFITRQDKNFGVLDDLFQNLKYIRALHLSQIGIRELPDTL
GNLKLLNYLSIKDIAIKSIPESIHNLYNLQTLDLTQTNISELPRQIDNLI
NLRHLLLSHKVAFLPSGIGNLTNLQTLTHFNVGCGKKHCDIGELNSLMKL
GGHISIYNVALLHRSIATMPVNKFSNTKPTLKTKKYLDSLRLDWLREHDN
FDRFKQDEKKAEQQLAYLQPHVNLKFLEINNYPGVRFVEWVSDSSFTKLT
RLILEDCKNCTKLPPLGQLRYLEYLDIRGMDGVQHVGREFCSMLMASPSS
SQNNMAFPSLTHLEFSSMPNWKGWDGVEIGDFPSLHFIEISKCSKLIKFP
QWPFMSSVKEMTLGNCGALDVLNLHLWTNLSIGIKTQEHSKWMSKCYFPT
LQHLTLKSRVECVHLSQKRLPSLKTLEIQSSEELRVIGGLEGLTSLTSLI
IRNCFNLEFEKLPATLQQLRLSNCPLFHKGLEKQPHMLNVLREGEKRERE
ELIEFERRYPIIKDWSDAEQDNINRITWMSDHKDDKEYNGSKTARFLPSR
RDSYRMKRSRFAAG
>XP_042406486.1 putative disease resistance RPP13-like protein 1 isoform X1 [Zingiber officinale]
MAGGGFLSSIITMAVDKLHSLALPSTPSSSSSPHNNIEQEMSKLTETMRR
VQAKLADSEEDNHVKSHSEKLWLSELKEVAYDAEDLVEEYEYEVLRSKQL
HGNNSGTHEGELANKAAEIRKRFDEITKEWKLLTLPKNAGERKRSPLTLV
DNRETGSLVLESDVLGREEEKDMLVEWLLSEDDMTDNRVSVIAIIGMGGL
GKTTLAQLVYNDPKVKSYFNPRGWVCVSENFNVVNLTEKILQSFTEEKGK
GEVKIPETLDGLQRALEENLLGKKFLLILDDVWNEEFTLWYELRKPLVSA
QVGKVIVTTRNQPVARIMGIRSPLDLNCLPFDVCWQLFKRVTLGGADQPH
LEDLGRKIVDKCKGLPLAVKVLGGALRNKEDIDSWEDILENKKWELEETN
KGVLPALKISYDCMPIQLKRCFQYLSLFPKHTRLHSEIIVRLWMSQGLLP
LDEDDRDKRAEDKGRNYIERLAERSMIQLKWSDSFLMHNLVHDLAQYIAQ
DECFCMMDNKFDTKKLQKIRHLSVSIEDPHLLKHLETITDQQLKLMRTLF
IRVQDKSRGRPFITRQDKNFGVLDDLFQNLKYIRALHLSQIGIRELPDTL
GNLKLLNYLSIKDIAIKSIPESIHNLYNLQTLDLTQTNISELPRQIDNLI
NLRHLLLSHKVAFLPSGIGNLTNLQTLTHFNVGCGKKHCDIGELNSLMKL
GGHISIYNVALLHRSIATMPVNKFSNTKPTLKTKKYLDSLRLDWLREHDN
FDRFKQDEKKAEQQLAYLQPHVNLKFLEINNYPGVRFVEWVSDSSFTKLT
RLILEDCKNCTKLPPLGQLRYLEYLDIRGMDGVQHVGREFCSMLMASPSS
SQNNMAFPSLTHLEFSSMPNWKGWDGVEIGDFPSLHFIEISKCSKLIKFP
QWPFMSSVKEMTLGNCGALDVLNLHLWTNLSIGIKTQEHSKWMSKCYFPT
LQHLTLKSRVECVHLSQKRLPSLKTLEIQSSEELRVIGGLEGLTSLTSLI
IRNCFNLEFEKLPATLQQLRLSNCPLFHKGLEKQPHMLNVLREGEKRERE
ELIEFERRYPIIKDWSDAEQDNINRITWMSDHKDDKEYNGSKTARFLPSR
RDSYRMKRSRFAAG
>XP_042406487.1 putative disease resistance RPP13-like protein 1 isoform X2 [Zingiber officinale]
MAGGGFLSSIITMAVDKLHSLALPSTPSSSSSPHNNIEQEMSKLTETMRR
VQAKLADSEEDNHVKSHSEKLWLSELKEVAYDAEDLVEEYEYEVLRSKQL
HGNNSGTHEGELANKAAEIRKRFDEITKEWKLLTLPKNAGERKRSPLTLV
DNRETGSLVLESDVLGREEEKDMLVEWLLSEDDMTDNRVSVIAIIGMGGL
GKTTLAQLVYNDPKVKSYFNPRGWVCVSENFNVVNLTEKILQSFTEEKGK
GEVKIPETLDGLQRALEENLLGKKFLLILDDVWNEEFTLWYELRKPLVSA
QVGKVIVTTRNQPVARIMGIRSPLDLNCLPFDVCWQLFKRVTLGGADQPH
LEDLGRKIVDKCKGLPLAVKVLGGALRNKEDIDSWEDILENKKWELEETN
KGVLPALKISYDCMPIQLKRCFQYLSLFPKHTRLHSEIIVRLWMSQGLLP
LDEDDRDKRAEDKGRNYIERLAERSMIQLKWSDSFLMHNLVHDLAQYIAQ
DECFCMMDNKFDTKKLQKIRHLSVSIEDPHLLKHLETITDQQLKLMRTLF
IRVQDKSRGRPFITRQDKNFGVLDDLFQNLKYIRALHLSQIGIRELPDTL
GNLKLLNYLSIKDIAIKSIPESIHNLYNLQTLDLTQTNISELPRQIDNLI
NLRHLLLSHKVAFLPSGIGNLTNLQTLTHFNVGCGKKHCDIGELNSLMKL
GGHISIYNVALLHRSIATMPVNKFSNTKPTLKTKKYLDSLRLDWLREHDN
FDRFKQDEKKAEQQLAYLQPHVNLKFLEINNYPGVRFVEWVSDSSFTKLT
RLILEDCKNCTKLPPLGQLRYLEYLDIRGMDGVQHVGREFCSMLMASPSS
SQNNMAFPSLTHLEFSSMPNWKGWDGVEIGDFPSLHFIEISKCSKLIKFP
QWPFMSSVKEMTLGNCGALDVLNLHLWTNLSIGIKTQEHSKWMSKCYFPT
LQHLTLKSRVECVHLSQKRLPSLKTLEIQSSEELRVIGGLEGLTSLTSLI
IRNCFNLEFEKLPATLQQLRLSNCPLFHKGLEKQPHMLNVLRGREEGERR
AYRV
>XP_042406494.1 disease resistance protein RGA2-like [Zingiber officinale]
MAGGGGFLSSMFTTMVAKLHSLASPSITSSSLLHNNIEREMSRLTETMRR
IQAKLADSEEENHAKSHWEKLWLSELKDVAYDAEDVVEEYEYEVLRSKQL
HENNSGAHEDELANKAAEIRKRFDEITKEWKLLKLPKKAGKRKRSPMLSD
MNRETGSLVVESDVLGRVDEKDMLVEWLLSEDDSTEDRVSVIAIIGMGGL
GKTTLAQIVYNDPRVENYFYPRGWVCVSENFDVVGLTEKILQSLVDEKVH
KELDGLQHALGENLQGKGKVKVPEDLVVLQRALQENLQGKKFLLILDDVW
NENFTLWDELRKPLLSAQVGKVIVTTRNRPVARIMETIFPLDLIAYHLMY
AGNCSRESLWEEQIRAYNHILKTSAER
>XP_042406707.1 disease resistance protein RPS2-like [Zingiber officinale]
MESIISILDSIFRPVVAFFTRTFGYAMSCEQYIESLQKEMGELRSKRDDV
KREVDREARQGMEATNEVMLWLQNVERLEEEAARITDDFETHYANPAADD
SRSKLVVSYHLSKRAEDACGEATVLKTKSHFNKVADRLMPIRFEERPSAL
TVGMDSMIEQLRKACDDDVGVIGIHGMGGVGKTALLNRFNNEVLVQVAHL
DVVISVKVTRNFDVEKIQREIGDRIGLSWDERKSDDERSMVLFKVLSRMR
FVLLLDDLWEPLDLSIVGIPTPTGASKIILTTRIEDVCDRMDARKMRMEC
LEWEDAWELFEKKAGRGLGTLLRGDPDIRRHAEDLAQRCGGLPLALITLG
RAMASKRTAKEWHHAVTTLANTPWHLLGMEESVLQPLKLSYDKLNDDRLK
TFLLYASLLMNKMPMHNATVINLCIGEGAINEFDDPEDAYSKGYHLLGVL
KAASLLESSGDDYVQMHPFVHAMVSWIVCEHGKKDGKWLVQVGTGLAEVP
DYEKWEHAERVSLVSNEICSLPEDPYCPELLTLLLSRNYELSKIPNSFFL
SMPRLKVLDLSRTSIKELPPEIGKVLTLQHLDLYETNIASLPKELGNLVK
LKSLLLSSTPLLKEIPHGVIARFTELRVLSMNDSYGNWRVSSSGPGINFE
ELEGLKRLRYLDITLQNASTLQRLSRARRLSMSTRYLHIRGCLGLTTIHL
PSTSLGRYMKGLRGLRISQSSILEEIIVGGGSTIGEWSLLPNLHVLILQH
LLKAKFVFRDRNFQNLRFLYVWYCIGLEQLVKFEDELSEGQESEVITAFP
HLKELHLASLPELKSLGGERVLAFPCLRVLEVKECPKLKELSITGEGLTQ
ICCKQEWWDGLEWKDEKIKEALFPLFTPLQ
>XP_042408399.1 putative disease resistance protein At5g47280 [Zingiber officinale]
METFFVGDIAKELIKELLNVVRQTYLCRPAAEQLKCSVDSLLPIIQEIRL
SGVELPQHRQKQLSELTDNLRLALDLARKAAASPRWNVYRSMQLARKMER
IDHWITRWLERQVPAHLLADVHHIRVDYAARLDRIERTLDLTAASEVARG
PVAFGTAPFSVFPETIEGFVPIRAPIAMWSPPATSCFPMPEMMEGLMMPT
EAAAEAPVAMGKSPSSRFPVAEIMEGLMLAGEGVKPVGVGIRVGKEKVKE
MLMEGINRVAVVGISGIGGSGKTTLAREICRDPEIRSYFEDRIYFETLSQ
SQNLESLKLRLWEQISGNIVLGVYNQIPQWQMELVPKDKGPFLLVLDDVW
SVSELEELIFRVPGCKILVVSRFKFPAIVKSTYEMELLGEEDALSLFCHA
AFEQKYIPSTVDQKLIKQVVEECKGLPLALKVIGASLRDQPPKFWLRAKN
KLARGETISESHENKVLERMASSIDFLSGKARECFLDLGSFPEDKRIPLD
VLINLWMELHDLDEEDAFAILVELSNKNLLTLLKDAQNRAGDIYSSYTEL
CVTQHDLLRDLALHVNNQEPLNTRRRLIMPRREKELPKEWERFKDQQLEA
QIVSFNTGEMNESDWFQMHFPKTEVLILNFAADAYFLPPFLSVMPKLKTL
ILINYGASCTTLQNLSVFTSLSNLRSLWLEKIAVPPLPRTTVPLQNLRKV
TLVLCELTNSLRCSKVELSLTFPRLSHLAIDHCIDITKLPSAICDINSLE
CLSISNCHDLSELPCEFGKLSSLGILRVYACPALKRLPQSICLLKGLKYL
DISQSFNLQELPEELGHMTSLEKIDMRECSQLKTLPRSSSSLKSLGHVIC
DEDIAFLWKEAEKDIPDLRIQVAEESFNLDWLVE
>XP_042408683.1 probable disease resistance protein At4g27220 isoform X1 [Zingiber officinale]
MTSVLAASYVVPIECLKLLWDPMTRHLVYIFHFRRKLRELERNKRIHASV
MAHVSTEVGNAEIRGCICTDEVIDWLRDADTAVAEAEDICSNAGSMMQNS
SCFRFKIMMRYKLGKQILRASKFSFDVRLRKPENLFVPPPPVAVLPYPTS
LIKNNTSSSRALAKLWDFLQDDSIGKIGVWSMGGVGKTRLMRNLNNEFQG
TKRFDVVIFITVSKNWNKDMQKLRTDIGKELYMELEKENEARALRLLCER
LMKKKFLLILDDVWDKIDLENLGIPSPTEHKGCKIAITTRQRGICNEMET
DVEIMVEILPDKESWDLFYEKAGKNIPTTIENVARSVCRECSGLPLAIIT
VGSALRNEVHLDQWKRALRLLQKSNFRFENMKDRVFVPLKFSYDMLRDGQ
LKKCFLFVALFPEDHDIADQDLIEYWVMEGYIEGAESLGDAYQDAHRLLI
LLIDSCLLERSRKKDMVKMHDVIRDMAIKITSDSTEEGKRFWVKAGMRLE
ELVETEDLKDKDKISLMENNIQLIGVDLYCPNASTLLVKGNVMLYDIPER
FFQYMKLLSVLDLSATSIEFLPESISVLVNLSALILKECARLKRIDRVQC
LKKLRFLDMRESGIIELPEGMVHLTGLVYFKISYTYRLQKIPAGLIAQFS
HLEDLEMNQSFYLEGLQNPQEIIKQFKHLKCLNNLSLDLENDKLSSLLET
HCNLNNLASFYLRVGSVMATSKTEYVAKKEGPRKPERRGRCLDITGDAAC
KRLAKFANKLCVYQNRELRSISQLGLDNLECVEECWVWDCQEMWSIIISE
EQKDNTYPHLQLLHLERLPKLSIIFSYNVAAAPSFFNLQKIILCECNMIP
FVFQEEMIDQLGCLEELDVSSCRILKRIIEGYFKRDGMCLPKLRCISFSQ
LGKLEQLWFSDLSLPSLVDIKIRRCPNLRPPRLTNELAPTLLVIEAEEQW
WESLPEDEIFKVRFASIFKPATMPHTIMKPATMPHRIMKPVTGSFTDIFQ
SVHASSSH
>XP_042408684.1 probable disease resistance protein At4g27220 isoform X1 [Zingiber officinale]
MTSVLAASYVVPIECLKLLWDPMTRHLVYIFHFRRKLRELERNKRIHASV
MAHVSTEVGNAEIRGCICTDEVIDWLRDADTAVAEAEDICSNAGSMMQNS
SCFRFKIMMRYKLGKQILRASKFSFDVRLRKPENLFVPPPPVAVLPYPTS
LIKNNTSSSRALAKLWDFLQDDSIGKIGVWSMGGVGKTRLMRNLNNEFQG
TKRFDVVIFITVSKNWNKDMQKLRTDIGKELYMELEKENEARALRLLCER
LMKKKFLLILDDVWDKIDLENLGIPSPTEHKGCKIAITTRQRGICNEMET
DVEIMVEILPDKESWDLFYEKAGKNIPTTIENVARSVCRECSGLPLAIIT
VGSALRNEVHLDQWKRALRLLQKSNFRFENMKDRVFVPLKFSYDMLRDGQ
LKKCFLFVALFPEDHDIADQDLIEYWVMEGYIEGAESLGDAYQDAHRLLI
LLIDSCLLERSRKKDMVKMHDVIRDMAIKITSDSTEEGKRFWVKAGMRLE
ELVETEDLKDKDKISLMENNIQLIGVDLYCPNASTLLVKGNVMLYDIPER
FFQYMKLLSVLDLSATSIEFLPESISVLVNLSALILKECARLKRIDRVQC
LKKLRFLDMRESGIIELPEGMVHLTGLVYFKISYTYRLQKIPAGLIAQFS
HLEDLEMNQSFYLEGLQNPQEIIKQFKHLKCLNNLSLDLENDKLSSLLET
HCNLNNLASFYLRVGSVMATSKTEYVAKKEGPRKPERRGRCLDITGDAAC
KRLAKFANKLCVYQNRELRSISQLGLDNLECVEECWVWDCQEMWSIIISE
EQKDNTYPHLQLLHLERLPKLSIIFSYNVAAAPSFFNLQKIILCECNMIP
FVFQEEMIDQLGCLEELDVSSCRILKRIIEGYFKRDGMCLPKLRCISFSQ
LGKLEQLWFSDLSLPSLVDIKIRRCPNLRPPRLTNELAPTLLVIEAEEQW
WESLPEDEIFKVRFASIFKPATMPHTIMKPATMPHRIMKPVTGSFTDIFQ
SVHASSSH
>XP_042408685.1 probable disease resistance protein At4g27220 isoform X1 [Zingiber officinale]
MTSVLAASYVVPIECLKLLWDPMTRHLVYIFHFRRKLRELERNKRIHASV
MAHVSTEVGNAEIRGCICTDEVIDWLRDADTAVAEAEDICSNAGSMMQNS
SCFRFKIMMRYKLGKQILRASKFSFDVRLRKPENLFVPPPPVAVLPYPTS
LIKNNTSSSRALAKLWDFLQDDSIGKIGVWSMGGVGKTRLMRNLNNEFQG
TKRFDVVIFITVSKNWNKDMQKLRTDIGKELYMELEKENEARALRLLCER
LMKKKFLLILDDVWDKIDLENLGIPSPTEHKGCKIAITTRQRGICNEMET
DVEIMVEILPDKESWDLFYEKAGKNIPTTIENVARSVCRECSGLPLAIIT
VGSALRNEVHLDQWKRALRLLQKSNFRFENMKDRVFVPLKFSYDMLRDGQ
LKKCFLFVALFPEDHDIADQDLIEYWVMEGYIEGAESLGDAYQDAHRLLI
LLIDSCLLERSRKKDMVKMHDVIRDMAIKITSDSTEEGKRFWVKAGMRLE
ELVETEDLKDKDKISLMENNIQLIGVDLYCPNASTLLVKGNVMLYDIPER
FFQYMKLLSVLDLSATSIEFLPESISVLVNLSALILKECARLKRIDRVQC
LKKLRFLDMRESGIIELPEGMVHLTGLVYFKISYTYRLQKIPAGLIAQFS
HLEDLEMNQSFYLEGLQNPQEIIKQFKHLKCLNNLSLDLENDKLSSLLET
HCNLNNLASFYLRVGSVMATSKTEYVAKKEGPRKPERRGRCLDITGDAAC
KRLAKFANKLCVYQNRELRSISQLGLDNLECVEECWVWDCQEMWSIIISE
EQKDNTYPHLQLLHLERLPKLSIIFSYNVAAAPSFFNLQKIILCECNMIP
FVFQEEMIDQLGCLEELDVSSCRILKRIIEGYFKRDGMCLPKLRCISFSQ
LGKLEQLWFSDLSLPSLVDIKIRRCPNLRPPRLTNELAPTLLVIEAEEQW
WESLPEDEIFKVRFASIFKPATMPHTIMKPATMPHRIMKPVTGSFTDIFQ
SVHASSSH
>XP_042408686.1 probable disease resistance protein At4g27220 isoform X1 [Zingiber officinale]
MTSVLAASYVVPIECLKLLWDPMTRHLVYIFHFRRKLRELERNKRIHASV
MAHVSTEVGNAEIRGCICTDEVIDWLRDADTAVAEAEDICSNAGSMMQNS
SCFRFKIMMRYKLGKQILRASKFSFDVRLRKPENLFVPPPPVAVLPYPTS
LIKNNTSSSRALAKLWDFLQDDSIGKIGVWSMGGVGKTRLMRNLNNEFQG
TKRFDVVIFITVSKNWNKDMQKLRTDIGKELYMELEKENEARALRLLCER
LMKKKFLLILDDVWDKIDLENLGIPSPTEHKGCKIAITTRQRGICNEMET
DVEIMVEILPDKESWDLFYEKAGKNIPTTIENVARSVCRECSGLPLAIIT
VGSALRNEVHLDQWKRALRLLQKSNFRFENMKDRVFVPLKFSYDMLRDGQ
LKKCFLFVALFPEDHDIADQDLIEYWVMEGYIEGAESLGDAYQDAHRLLI
LLIDSCLLERSRKKDMVKMHDVIRDMAIKITSDSTEEGKRFWVKAGMRLE
ELVETEDLKDKDKISLMENNIQLIGVDLYCPNASTLLVKGNVMLYDIPER
FFQYMKLLSVLDLSATSIEFLPESISVLVNLSALILKECARLKRIDRVQC
LKKLRFLDMRESGIIELPEGMVHLTGLVYFKISYTYRLQKIPAGLIAQFS
HLEDLEMNQSFYLEGLQNPQEIIKQFKHLKCLNNLSLDLENDKLSSLLET
HCNLNNLASFYLRVGSVMATSKTEYVAKKEGPRKPERRGRCLDITGDAAC
KRLAKFANKLCVYQNRELRSISQLGLDNLECVEECWVWDCQEMWSIIISE
EQKDNTYPHLQLLHLERLPKLSIIFSYNVAAAPSFFNLQKIILCECNMIP
FVFQEEMIDQLGCLEELDVSSCRILKRIIEGYFKRDGMCLPKLRCISFSQ
LGKLEQLWFSDLSLPSLVDIKIRRCPNLRPPRLTNELAPTLLVIEAEEQW
WESLPEDEIFKVRFASIFKPATMPHTIMKPATMPHRIMKPVTGSFTDIFQ
SVHASSSH
>XP_042408687.1 probable disease resistance protein At4g27220 isoform X1 [Zingiber officinale]
MTSVLAASYVVPIECLKLLWDPMTRHLVYIFHFRRKLRELERNKRIHASV
MAHVSTEVGNAEIRGCICTDEVIDWLRDADTAVAEAEDICSNAGSMMQNS
SCFRFKIMMRYKLGKQILRASKFSFDVRLRKPENLFVPPPPVAVLPYPTS
LIKNNTSSSRALAKLWDFLQDDSIGKIGVWSMGGVGKTRLMRNLNNEFQG
TKRFDVVIFITVSKNWNKDMQKLRTDIGKELYMELEKENEARALRLLCER
LMKKKFLLILDDVWDKIDLENLGIPSPTEHKGCKIAITTRQRGICNEMET
DVEIMVEILPDKESWDLFYEKAGKNIPTTIENVARSVCRECSGLPLAIIT
VGSALRNEVHLDQWKRALRLLQKSNFRFENMKDRVFVPLKFSYDMLRDGQ
LKKCFLFVALFPEDHDIADQDLIEYWVMEGYIEGAESLGDAYQDAHRLLI
LLIDSCLLERSRKKDMVKMHDVIRDMAIKITSDSTEEGKRFWVKAGMRLE
ELVETEDLKDKDKISLMENNIQLIGVDLYCPNASTLLVKGNVMLYDIPER
FFQYMKLLSVLDLSATSIEFLPESISVLVNLSALILKECARLKRIDRVQC
LKKLRFLDMRESGIIELPEGMVHLTGLVYFKISYTYRLQKIPAGLIAQFS
HLEDLEMNQSFYLEGLQNPQEIIKQFKHLKCLNNLSLDLENDKLSSLLET
HCNLNNLASFYLRVGSVMATSKTEYVAKKEGPRKPERRGRCLDITGDAAC
KRLAKFANKLCVYQNRELRSISQLGLDNLECVEECWVWDCQEMWSIIISE
EQKDNTYPHLQLLHLERLPKLSIIFSYNVAAAPSFFNLQKIILCECNMIP
FVFQEEMIDQLGCLEELDVSSCRILKRIIEGYFKRDGMCLPKLRCISFSQ
LGKLEQLWFSDLSLPSLVDIKIRRCPNLRPPRLTNELAPTLLVIEAEEQW
WESLPEDEIFKVRFASIFKPATMPHTIMKPATMPHRIMKPVTGSFTDIFQ
SVHASSSH
>XP_042408688.1 probable disease resistance protein At4g27220 isoform X1 [Zingiber officinale]
MTSVLAASYVVPIECLKLLWDPMTRHLVYIFHFRRKLRELERNKRIHASV
MAHVSTEVGNAEIRGCICTDEVIDWLRDADTAVAEAEDICSNAGSMMQNS
SCFRFKIMMRYKLGKQILRASKFSFDVRLRKPENLFVPPPPVAVLPYPTS
LIKNNTSSSRALAKLWDFLQDDSIGKIGVWSMGGVGKTRLMRNLNNEFQG
TKRFDVVIFITVSKNWNKDMQKLRTDIGKELYMELEKENEARALRLLCER
LMKKKFLLILDDVWDKIDLENLGIPSPTEHKGCKIAITTRQRGICNEMET
DVEIMVEILPDKESWDLFYEKAGKNIPTTIENVARSVCRECSGLPLAIIT
VGSALRNEVHLDQWKRALRLLQKSNFRFENMKDRVFVPLKFSYDMLRDGQ
LKKCFLFVALFPEDHDIADQDLIEYWVMEGYIEGAESLGDAYQDAHRLLI
LLIDSCLLERSRKKDMVKMHDVIRDMAIKITSDSTEEGKRFWVKAGMRLE
ELVETEDLKDKDKISLMENNIQLIGVDLYCPNASTLLVKGNVMLYDIPER
FFQYMKLLSVLDLSATSIEFLPESISVLVNLSALILKECARLKRIDRVQC
LKKLRFLDMRESGIIELPEGMVHLTGLVYFKISYTYRLQKIPAGLIAQFS
HLEDLEMNQSFYLEGLQNPQEIIKQFKHLKCLNNLSLDLENDKLSSLLET
HCNLNNLASFYLRVGSVMATSKTEYVAKKEGPRKPERRGRCLDITGDAAC
KRLAKFANKLCVYQNRELRSISQLGLDNLECVEECWVWDCQEMWSIIISE
EQKDNTYPHLQLLHLERLPKLSIIFSYNVAAAPSFFNLQKIILCECNMIP
FVFQEEMIDQLGCLEELDVSSCRILKRIIEGYFKRDGMCLPKLRCISFSQ
LGKLEQLWFSDLSLPSLVDIKIRRCPNLRPPRLTNELAPTLLVIEAEEQW
WESLPEDEIFKVRFASIFKPATMPHTIMKPATMPHRIMKPVTGSFTDIFQ
SVHASSSH
>XP_042408689.1 probable disease resistance protein At4g27220 isoform X1 [Zingiber officinale]
MTSVLAASYVVPIECLKLLWDPMTRHLVYIFHFRRKLRELERNKRIHASV
MAHVSTEVGNAEIRGCICTDEVIDWLRDADTAVAEAEDICSNAGSMMQNS
SCFRFKIMMRYKLGKQILRASKFSFDVRLRKPENLFVPPPPVAVLPYPTS
LIKNNTSSSRALAKLWDFLQDDSIGKIGVWSMGGVGKTRLMRNLNNEFQG
TKRFDVVIFITVSKNWNKDMQKLRTDIGKELYMELEKENEARALRLLCER
LMKKKFLLILDDVWDKIDLENLGIPSPTEHKGCKIAITTRQRGICNEMET
DVEIMVEILPDKESWDLFYEKAGKNIPTTIENVARSVCRECSGLPLAIIT
VGSALRNEVHLDQWKRALRLLQKSNFRFENMKDRVFVPLKFSYDMLRDGQ
LKKCFLFVALFPEDHDIADQDLIEYWVMEGYIEGAESLGDAYQDAHRLLI
LLIDSCLLERSRKKDMVKMHDVIRDMAIKITSDSTEEGKRFWVKAGMRLE
ELVETEDLKDKDKISLMENNIQLIGVDLYCPNASTLLVKGNVMLYDIPER
FFQYMKLLSVLDLSATSIEFLPESISVLVNLSALILKECARLKRIDRVQC
LKKLRFLDMRESGIIELPEGMVHLTGLVYFKISYTYRLQKIPAGLIAQFS
HLEDLEMNQSFYLEGLQNPQEIIKQFKHLKCLNNLSLDLENDKLSSLLET
HCNLNNLASFYLRVGSVMATSKTEYVAKKEGPRKPERRGRCLDITGDAAC
KRLAKFANKLCVYQNRELRSISQLGLDNLECVEECWVWDCQEMWSIIISE
EQKDNTYPHLQLLHLERLPKLSIIFSYNVAAAPSFFNLQKIILCECNMIP
FVFQEEMIDQLGCLEELDVSSCRILKRIIEGYFKRDGMCLPKLRCISFSQ
LGKLEQLWFSDLSLPSLVDIKIRRCPNLRPPRLTNELAPTLLVIEAEEQW
WESLPEDEIFKVRFASIFKPATMPHTIMKPATMPHRIMKPVTGSFTDIFQ
SVHASSSH
>XP_042408691.1 probable disease resistance protein At4g27220 isoform X2 [Zingiber officinale]
MTSVLAASYVVPIECLKLLWDPMTRHLVYIFHFRRKLRELERNKRIHASV
MAHVSTEVGNAEIRGCICTDEVIDWLRDADTAVAEAEDICSNAGSMMQNS
SCFRFKIMMRYKLGKQILRASKFSFDVRLRKPENLFVPPPPVAVLPYPTS
LIKNNTSSSRALAKLWDFLQDDSIGKIGVWSMGGVGKTRLMRNLNNEFQG
TKRFDVVIFITVSKNWNKDMQKLRTDIGKELYMELEKENEARALRLLCER
LMKKKFLLILDDVWDKIDLENLGIPSPTEHKGCKIAITTRQRGICNEMET
DVEIMVEILPDKESWDLFYEKAGKNIPTTIENVARSVCRECSGLPLAIIT
VGSALRNEVHLDQWKRALRLLQKSNFRFENMKDRVFVPLKFSYDMLRDGQ
LKKCFLFVALFPEDHDIADQDLIEYWVMEGYIEGAESLGDAYQDAHRLLI
LLIDSCLLERSRKKDMVKMHDVIRDMAIKITSDSTEEGKRFWVKAGMRLE
ELVETEDLKDKDKISLMENNIQLIGVDLYCPNASTLLVKGNVMLYDIPER
FFQYMKLLSVLDLSATSIEFLPESISVLVNLSALILKECARLKRIDRVQC
LKKLRFLDMRESGIIELPEGMVHLTGLVYFKISYTYRLQKIPAGLIAQFS
HLEDLEMNQSFYLEGLQNPQEIIKQFKHLKCLNNLSLDLENDKLSSLLET
HCNLNNLASFYLRVGSVMATSKTEYVAKKEGPRKPERRGRCLDITGDAAC
KRLAKFANKLCVYQNRELRSISQLGLDNLECVEECWVWDCQEMWSIIISE
EQKDNTYPHLQLLHLERLPKLSIIFSYNVAAAPSFFNLQKIILCECNMIP
FVFQEEMIDQLGCLEELDVSSCRILKRIIEGYFKRDGMCLPKLRCISFSQ
LGKLEQLWFSDLSLPSLVDIKIRRCPNLRPPRLTNELAPTLLVIEAEEQW
WESLPEDEIFKNHEASNW
>XP_042408692.1 probable disease resistance protein At4g27220 isoform X2 [Zingiber officinale]
MTSVLAASYVVPIECLKLLWDPMTRHLVYIFHFRRKLRELERNKRIHASV
MAHVSTEVGNAEIRGCICTDEVIDWLRDADTAVAEAEDICSNAGSMMQNS
SCFRFKIMMRYKLGKQILRASKFSFDVRLRKPENLFVPPPPVAVLPYPTS
LIKNNTSSSRALAKLWDFLQDDSIGKIGVWSMGGVGKTRLMRNLNNEFQG
TKRFDVVIFITVSKNWNKDMQKLRTDIGKELYMELEKENEARALRLLCER
LMKKKFLLILDDVWDKIDLENLGIPSPTEHKGCKIAITTRQRGICNEMET
DVEIMVEILPDKESWDLFYEKAGKNIPTTIENVARSVCRECSGLPLAIIT
VGSALRNEVHLDQWKRALRLLQKSNFRFENMKDRVFVPLKFSYDMLRDGQ
LKKCFLFVALFPEDHDIADQDLIEYWVMEGYIEGAESLGDAYQDAHRLLI
LLIDSCLLERSRKKDMVKMHDVIRDMAIKITSDSTEEGKRFWVKAGMRLE
ELVETEDLKDKDKISLMENNIQLIGVDLYCPNASTLLVKGNVMLYDIPER
FFQYMKLLSVLDLSATSIEFLPESISVLVNLSALILKECARLKRIDRVQC
LKKLRFLDMRESGIIELPEGMVHLTGLVYFKISYTYRLQKIPAGLIAQFS
HLEDLEMNQSFYLEGLQNPQEIIKQFKHLKCLNNLSLDLENDKLSSLLET
HCNLNNLASFYLRVGSVMATSKTEYVAKKEGPRKPERRGRCLDITGDAAC
KRLAKFANKLCVYQNRELRSISQLGLDNLECVEECWVWDCQEMWSIIISE
EQKDNTYPHLQLLHLERLPKLSIIFSYNVAAAPSFFNLQKIILCECNMIP
FVFQEEMIDQLGCLEELDVSSCRILKRIIEGYFKRDGMCLPKLRCISFSQ
LGKLEQLWFSDLSLPSLVDIKIRRCPNLRPPRLTNELAPTLLVIEAEEQW
WESLPEDEIFKNHEASNW
>XP_042408694.1 probable disease resistance protein At4g27220 [Zingiber officinale]
MDSVPVACLKLLWDPMSHQLAYIFGFSQKLRQLEMNKGILTSAKADVLRE
IENAEIRGYIRTDGVICWLHDADMAVAEAEEICSKARRMKNSACFGIKIV
TRYKLGKQIVRASSFSSDVQGRTSMNFFVPPPPVVPPPVAELHYPTSQIK
NNTSSSRTLKKLRNFLQDDAIGKIGVWGMGGVGKTRLMINLNNEHQGTKC
FDVVIFETISKNWNKDVKKLRNNIGKWVYLELEKENERKASGVLYTRLKQ
KKFLLILDDVWDNIDLENLGISSPTEHNGSKIVIATRQKWICNEMETDVE
IMVKILPDEESWNLFYEKAGGNIHSRIGNVARSVCRECRGLPLAIITVGS
ALRKEVHLDQWERALRLLRESNFGVENMEDSVFVPLKFSYDMLRDDQLKK
CFLFAALFPEDHDIAVQELIQYWVMEGYIDGAKSLRDAYQDAHRLLILLI
DSCLIERSRKKDMVKMHDLIRDMAIKITTDSTEEGKRFWVKAGMGLEKLV
DTEDLKDKDKISLMENDIQLIEVDLNCPNASTLLVKGNASLYEIPEGFFQ
HMKLLSVLDLSATSIEFLPESISVLVNLSALILKECPHLRSIDRVQLLKK
LRFLDMRESGIIELPEGMVCLTQLVYFNISCTYRLKKIPAGLIAKFSRLE
DLEMNRSFYLRGLQNAKEIIEELEHLKRLNNLSLDLENQRLSFLLEKHCN
WNNLTSFYLRVGSVMAPIEYVEKKEEGPREPERRRGRCLDITSNAFACRR
LLKYANKLCVYQNTKLCSISELGLDNLECVEECWVWECEEMEFIIISEVG
KENTYPHLQLLHLEHLPRLVSIFSYHNVVAAPSFFNLRKINLCKCNMIQF
VFEEEMISQLGCLEELEVYGCPYLNMIIEDYSERDGMCLPKLRCISLSEL
KMLEELWLINLSLPSLVEIKIHQCPKLKPPRLTNELAPTLQVIEAEERWW
ESLPENEIFKLHFASIFKPSTKLYRESDQSGKGVQSTNTQASSSH
>XP_042409298.1 disease resistance protein RGA2-like [Zingiber officinale]
MEGALVAAARFVADKVAILVQLDAKLKAMTGIEEKMEKLKEMSTIIDLVI
EDVESHPLNKDAVKDLLRKLKYLAYDLEDAVDYYDTKVFQKKQRSNTSFG
LVSDFISSDNQVLFNSRVGCMIEAVTDSLDSILLQKSILLNLPQSSSHLS
LYPYSETHSLNGFDVIGREPEKNNIVNILTNDDDEGSSHSTLRVIAIVGM
GGLGKTTLAQLVFNDEMVQDHFASLTMWKVVGAEFNPTKIMKSILELATG
EPGNISEIDLVKQKLKKELSGKRFLLVLDDVWNEDPVKWRILKAALTFGA
RGSKILVTTRSQQVSSIMDSSYIHQIKQLSQTDCLILFQNFAFGDKEENR
TLMEIGAKIVEKCGGVPLAVISLGNTLRNTGDETYWSSVLNSEIMQLRYM
EEKVLAVLKWSYDTLPPRSKKCFAFASLYPKNSRMKKDELIKLWIANGFV
RSEKSFDAETLANDVFDDLVRRSFFLLAPSRNFKYFSYGTEYTMHDLMHD
LARSVSANVYWHSEQDSVEDIGNRTYHLQIYIRGESCMTQVLDKKPLNLR
TFMPFRFYRQSYLSINLLQVISDSELKFLRALDLSSSGISEVPTSIGNLI
HLRYLNLYNNGIEVLPDSITLLSNLQYLNLILNFNFRELPKELGNMQNLR
VLDLQRHHSQIDIHMPCGLSRLTNLRSLPVFFAGNRTGACSILELENLKL
HGEMQIKFSKDFKNYSCGGKKILKNKDLNDLLIEFNNLERYDKDMLDDLC
PDTSLKELIIKNYGSPQFPTWLMELQLPNLVEVCLENCGGCEHIPPFGNL
QFLEKLVLTAMDVITDLGAEFHGYRSFPSRQELILNRMNNLEEWPDSHDG
DNQLFPKLHSLHIFDCPKLNAEISYNPRAYYNQL
>XP_042409335.1 putative disease resistance protein RGA3 isoform X1 [Zingiber officinale]
MAGALVGATAGFFANKVAILVELDEKLKAMAGTKRKIEKFKELLTNTDSV
IQNVESRPSINPDVKELLKKLKYLAYDLEDVVDYYDTKVLQKKQRSNTAL
RPVRDFFSPNNQVVFKSRIGSMIKAITESLESILLQKSILLNLPPGMSQP
SPYRENHSRNRFVVKGREPEKQMIVNMLIDDDESSHDTVKVIAIVGMGGL
GKTTLAQLVYNDQRVQDHFASPTMWTVVGAEFDPANIMKSVLELTTEATV
NISEIDLVRQKLEKALSGKRFLLVLDDVWNEDQEKWDVLKATLICGAKGS
KILVTTRSQNVSSIMGSSNTTTHQIQQLSKDDCLSLFQQFAFGDNEADDH
QNLMEIGGKIVEKCGGVPLAAKSLGSMLRGTRDETYWSSVLKSEIWQLRD
EEQKVLAVLKLSYDVLSPQSKKCFTFGSLFPKDYPMRKDELIKLWIANDF
VRSEGNFDAETNGNHIFDDLVRRSFFLLDLFEDDPNVANITMHDLMHDLA
RSESAYAYWNSYQDSVEVIQKRAYHLQVVEGKLPDMTQVFGKKPLYLRTF
MSLMPRYSSSLSINLLEVFSKLKYLRALDLTGCGIRKISASIENLIHLRY
LNLYYNTIEVLPDSITYLSNLQYLNLGFNHELRELPKELGNMQNLRELDL
VMDNRLIHIPCGLSRLTNLRSLPVFIASDKTGACSIRELEDLKLQGEMII
KFSDDFKNYSCSGRKILKNKVLNKLLIEFNGSGSYHKDMLDDLSPNTTLK
KLHISNYTSPQFPTWMKELQLPNLVEVHLHCSCGHIPPPFRNLQSLKRLT
FSMHGITHLGAEFHGSGGFPSLQELKLSRMDDLQEWSESHVDDQLFPSLR
WLHIFRCPNLKSTPRLPTLRHLEILCCSQSILSCIGRLTSLSFLRVHSIY
GVTSLPSGCIRNLTSLTELQIISCRQLQSLPGDEMQYLQMLRSLTIEGCI
NLASFPSEVGSLTSLCRLQLSQCPSIILQPEEFVRILNSVDEFQIQICGD
NVNLCGRLQYLRMLEKLSLYGARYRAPLTWYTNQYKKSQLRICCCNELES
LMTAEPANNIVLEELYICGIYNLKTLPDWLQHLKFLRLLSVENCPLLETV
PRGLKNLHMLETLKIANCPLLESRCERETGVDWPIISHVRNVYVRSSAGH
GEEVEDEDWADMKTEQMKTRHEIIVASYEIL
>XP_042409337.1 putative disease resistance protein RGA3 isoform X2 [Zingiber officinale]
MSQPSPYRENHSRNRFVVKGREPEKQMIVNMLIDDDESSHDTVKVIAIVG
MGGLGKTTLAQLVYNDQRVQDHFASPTMWTVVGAEFDPANIMKSVLELTT
EATVNISEIDLVRQKLEKALSGKRFLLVLDDVWNEDQEKWDVLKATLICG
AKGSKILVTTRSQNVSSIMGSSNTTTHQIQQLSKDDCLSLFQQFAFGDNE
ADDHQNLMEIGGKIVEKCGGVPLAAKSLGSMLRGTRDETYWSSVLKSEIW
QLRDEEQKVLAVLKLSYDVLSPQSKKCFTFGSLFPKDYPMRKDELIKLWI
ANDFVRSEGNFDAETNGNHIFDDLVRRSFFLLDLFEDDPNVANITMHDLM
HDLARSESAYAYWNSYQDSVEVIQKRAYHLQVVEGKLPDMTQVFGKKPLY
LRTFMSLMPRYSSSLSINLLEVFSKLKYLRALDLTGCGIRKISASIENLI
HLRYLNLYYNTIEVLPDSITYLSNLQYLNLGFNHELRELPKELGNMQNLR
ELDLVMDNRLIHIPCGLSRLTNLRSLPVFIASDKTGACSIRELEDLKLQG
EMIIKFSDDFKNYSCSGRKILKNKVLNKLLIEFNGSGSYHKDMLDDLSPN
TTLKKLHISNYTSPQFPTWMKELQLPNLVEVHLHCSCGHIPPPFRNLQSL
KRLTFSMHGITHLGAEFHGSGGFPSLQELKLSRMDDLQEWSESHVDDQLF
PSLRWLHIFRCPNLKSTPRLPTLRHLEILCCSQSILSCIGRLTSLSFLRV
HSIYGVTSLPSGCIRNLTSLTELQIISCRQLQSLPGDEMQYLQMLRSLTI
EGCINLASFPSEVGSLTSLCRLQLSQCPSIILQPEEFVRILNSVDEFQIQ
ICGDNVNLCGRLQYLRMLEKLSLYGARYRAPLTWYTNQYKKSQLRICCCN
ELESLMTAEPANNIVLEELYICGIYNLKTLPDWLQHLKFLRLLSVENCPL
LETVPRGLKNLHMLETLKIANCPLLESRCERETGVDWPIISHVRNVYVRS
SAGHGEEVEDEDWADMKTEQMKTRHEIIVASYEIL
>XP_042409338.1 putative disease resistance protein RGA3 isoform X3 [Zingiber officinale]
MAGALVGATAGFFANKVAILVELDEKLKAMAGTKRKIEKFKELLTNTDSV
IQNVESRPSINPDVKELLKKLKYLAYDLEDVVDYYDTKVLQKKQRSNTAL
RPVRDFFSPNNQVVFKSRIGSMIKAITESLESILLQKSILLNLPPGMSQP
SPYRENHSRNRFVVKGREPEKQMIVNMLIDDDESSHDTVKVIAIVGMGGL
GKTTLAQLVYNDQRVQDHFASPTMWTVVGAEFDPANIMKSVLELTTEATV
NISEIDLVRQKLEKALSGKRFLLVLDDVWNEDQEKWDVLKATLICGAKGS
KILVTTRSQNVSSIMGSSNTTTHQIQQLSKDDCLSLFQQFAFGDNEADDH
QNLMEIGGKIVEKCGGVPLAAKSLGSMLRGTRDETYWSSVLKSEIWQLRD
EEQKVLAVLKLSYDVLSPQSKKCFTFGSLFPKDYPMRKDELIKLWIANDF
VRSEGNFDAETNGNHIFDDLVRRSFFLLDLFEDDPNVANITMHDLMHDLA
RSESAYAYWNSYQDSVEVIQKRAYHLQVVEGKLPDMTQVFGKKPLYLRTF
MSLMPRYSSSLSINLLEVFSKLKYLRALDLTGCGIRKISASIENLIHLRY
LNLYYNTIEVLPDSITYLSNLQYLNLGFNHELRELPKELGNMQNLRELDL
VMDNRLIHIPCGLSRLTNLRSLPVFIASDKTGACSIRELEDLKLQGEMII
KFSDDFKNYSCSGRKILKNKVLNKLLIEFNGSGSYHKDMLDDLSPNTTLK
KLHISNYTSPQFPTWMKELQLPNLVEVHLHCSCGHIPPPFRNLQSLKRLT
FSMHGITHLGAEFHGSGGFPSLQELKLSRMDDLQEWSESHVDDQLFPSLR
WLHIFRCPNLKSTPRLPTLRHLEILCCSQSILSCIDNSNLFLGMKCSTFK
CFVH
>XP_042409339.1 putative disease resistance protein RGA3 isoform X4 [Zingiber officinale]
MAGALVGATAGFFANKVAILVELDEKLKAMAGTKRKIEKFKELLTNTDSV
IQNVESRPSINPDVKELLKKLKYLAYDLEDVVDYYDTKVLQKKQRSNTAL
RPVRDFFSPNNQVVFKSRIGSMIKAITESLESILLQKSILLNLPPGMSQP
SPYRENHSRNRFVVKGREPEKQMIVNMLIDDDESSHDTVKVIAIVGMGGL
GKTTLAQLVYNDQRVQDHFASPTMWTVVGAEFDPANIMKSVLELTTEATV
NISEIDLVRQKLEKALSGKRFLLVLDDVWNEDQEKWDVLKATLICGAKGS
KILVTTRSQNVSSIMGSSNTTTHQIQQLSKDDCLSLFQQFAFGDNEADDH
QNLMEIGGKIVEKCGGVPLAAKSLGSMLRGTRDETYWSSVLKSEIWQLRD
EEQKVLAVLKLSYDVLSPQSKKCFTFGSLFPKDYPMRKDELIKLWIANDF
VRSEGNFDAETNGNHIFDDLVRRSFFLLDLFEDDPNVANITMHDLMHDLA
RSESAYAYWNSYQDSVEVIQKRAYHLQVVEGKLPDMTQVFGKKPLYLRTF
MSLMPRYSSSLSINLLEVFSKLKYLRALDLTGCGIRKISASIENLIHLSI
SISVSITNFESYQKS
>XP_042409344.1 putative disease resistance protein RGA3 [Zingiber officinale]
MEAALVTAASRFMVQNVSDLLQLDEKLKAITASNKTKMKKLKELSAIIDA
VIQDVDSRPFIDAAVKNLLTKLKYLAYDLEDVVDYYDTTVSQKKQRSNTS
LRPVRDFFSPNNQVVFKSRIGGMIKAITESLDSILLQKSVLLDLPQSKSE
PRLYRETHSRNSFVVIGREPERNKIVDLLTKDDDDESNHGTVKVIAIAGM
GGLGKTTLAQHVFDDERVKAQFENSRMWTVVGAEFDPAKVMKSVLEAATD
APVNISQIDSVRQNIEKALSGRKFLLVLDDVWNEDPLKWGILKAALTCGV
RGSKILLTTRNQQVSKIMGSSNTTHQLQQLSQDDCLSLFQQFAFGDEAVD
QKLVKIGEKIVEKCGGVPLAAISLGNMLRGTRDETYWSSVLKSEIWQLRD
EEDKVLAILKLSYDTLLPRSKKCFAFASLFSKNYKMAKDELIKLWIANDF
VRSDKNFMLRQLATTSLMNL
>XP_042409346.1 putative disease resistance protein RGA3 [Zingiber officinale]
MEATLVTAASRFMVQNVSDLLQLEEKLKAITASNKTKMKKLKELSKIIDA
VIQDVDSRPFIDAAVKILLTKLKYLAYDLEDVVDYYDTTVSQKKQRSNTS
LRSVRDFFSPNNQIVLKSRVGGMIKAITESLDDILLQKSILLNLPQGSIR
MSELSLHRDTHSRNSLVVIGREPEKNMIVDMLTKDDDDDESDHGTVKVIA
IVGMGGLGKTTLAQLVFNDARVKDHFASPRMWKLVGAEFDHAKIMKSVLE
LATGAPVNISEIELVRQNLETALSGKRFLLVLDDVWNEDQEKWEVLKATL
ICGAKGSKILVTTRSQKVSSIMGSSNTTTHQVQQLSKDDCLSLFQQFAFG
DQAVDQSLMEIGGKIVEKCGGVPLAAISLGSMLYGTRDETYWDSVLKSEI
WQLQDKEQKVLAVLKLSYDTLPPQSKKCFAFGSLFPKDYRMQKDELIKLW
IANYGFIHSEGNFDAETEANRVFDGLVLRSFFLSDPLEVHPHVTKCTMHD
LMHYLARSMSENVYWNVEDSVEDIGNRTYHLHLYLADISKITQALDKKPL
YLRTLILNCCKLSLNGNLLKIDFSELKFLRVLDLSNNEIKEVPTSIGNLI
YLRYLNLSSNCIEVLPDSITLLSNLQYLNLSWNMELQELPKDLGNMQSLR
DLNCRRHEFRDFRLTHMPRGLSRLTNLRSLPVFVAGDGPDACPITELENL
KLHGEMDIIFSENFTNYSCGGLKILKNKDLNKLCIKFNGSERYDEAMLDD
LCPNTSLKKLCIKDYVSRQFPAWLMKSQLPNLVEVSLKSCCGCEHIPQFR
NLQFLKKLELCKMDGITQMGAEFHGDGGFPSLQELCLTRMDNLEEWSKSD
GDGKLFPSLQLLRLSDCLKLKSMPRLPTIQHLEISCCRGSLLSCIGSLTS
LSDLKLDKMRDMTVFPSGYIRNLTSLEELQITECRQLQSLPGDEMQHLKL
LRLLTIKGCPSIILQPEELVQILNSVQEFQIQICGNTVDLRGQLQSLHTL
KELCLRGAHGYKPKYGIAKLEICCCDDELDPLMTAEPTSSVLEKLYIDDF
SNLRTLPHWLQHLKSLSLLSIENCPRLQSVPDLKNLPMLKSLRVFDCPEL
ERRCEKKTGKD
>XP_042409347.1 putative disease resistance protein RGA3 [Zingiber officinale]
MEATLVTAASRFMVQNVSDLLQLEEKLKAITASNKTKMKKLKELSKIIDA
VIQDVDSRPFIDAAVKILLTKLKYLAYDLEDVVDYYDTTVSQKKQRSNTS
LRSVRDFFSPNNQIVFKSRVGGMIKAITESLDDILLQKSILLNLPQGSIR
MSELSLHRDTHSRNSLVVIGREPEKNMIVDMLTKDDDDDESDHGTVKVIA
IVGMGGLGKTTLAQLVFNDARVKDHFASPRMWKLVGAEFDHAKIMKSVLE
LATGAPVNISEIELVRQNLETALSGKRFLLVLDDVWNEDQEKWEVLKATL
ICGAKGSKILVTTRSQKVSSIMGSSNTTTHQIQQLSKDDCLSLFQQFAFG
DQAVDQSLMEIGGKIVEKCGGVPLAAISLGSMLYGTRDETYWDSVLKSEI
WQLQDKEQKVLAVLKLSYDTLPPQSKKCFAFGSLFPKDYRMQKDELIKLW
IANYGFIHSEGNFDAETEANRVFDGLVLRSFFLSDPLEVHPHVTKCTMHD
LMHYLARSMSENVYWNVEDSVEDIGNRTYHLHLYLADISKITQALDKKPL
YLRTLILNCCKLSLNGNLLKIDFSELKFLRVLDLSNNEIKEVPTSIGNLI
YLRYLNLSSNCIEVLPDSITLLSNLQYLNLSWNMELQELPKDLGNMQSLR
DLNCRRHEFRDFRLTHMPRGLSRLTNLRSLPVFVAGDGPDACPITELENL
KLHGEMDIIFSENFTNYSCGGLKILKNKDLNKLCIKFNGSERYDEAMLDD
LCPNTSLKKLCIKDYVSRQFPAWLMKSQLPNLVEVSLKSCCGCEHIPQFR
NLQFLKKLELCKMDGITQMGAEFHGDGGFPSLQELCLTRMDNLEEWSKSD
GDGKLFPSLQLLRLSDCLKLKSMPRLPTIQHLEISCCRGSLLSCIGSLTS
LSDLKLDKMRDMTVFPSGYIRNLTSLEELQITECRQLQSLPGDEMQHLKL
LRLLTIKGCPSIILQPEELVQILNSVQEFQIQICGNTVDLRGQLQSLHTL
KELCLRGAHGYKPKYGIAKLEICCCDDELDPLMTAEPTSSVLEKLYIDDF
SNLRTLPHWLQHLKSLSLLSIENCPRLQSVPDLKNLPMLKSLRVFDCPEL
ERRCEKKTGKD
>XP_042409348.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAGALVGATAGFLANKVAILVELDEKLKAMAGTERKMEKFKELSTIIDMV
IQDVESHPSINDAVKELLKNLKYLAYDLEDAADYYDTKVLQKNQRPKTFL
RPVRNFFSSDNKVVFKGRVGGTIKAITESLESILLQKSILLNLPQGGVRM
SEQREIHSCNSFVVIGREPEKNKIVDMLTNDDDDESSHSTLKVIAIVGMG
GLGKTTLAQHVFNDEKVKAHFASSRMWTVVGAEFDPTKIMKSVLELATSK
SVNFLEIDLVRQKIEKALSRKRFLIVLDDVWNEDPYEWGKLKAALTCGAR
GSKILVTTRSLHVCSIMSSSNTTTHQIQQLSKDDCLSLFQQFAFGDNEAD
DHQNLMEIGGKIVEKCGGVPLAAISLGSMLRSTRDETYWSSVLKSEIWQL
RDEEQKVLAVLKWSYATLPLRSKKCFAFGSLFPKDYMMRKDQLIKLWISN
GFVRSENFFDAETVGNRVFDDLVLRSFFLLAPFEDDPHVTHCTMHDLMHD
LARSVSADVYWNSIQDSVEVIGNRTYHLYLDSTDVSKITEAFGKHLRTLI
LSSCRLFLNVNLLEIVSSELKFKFVRVLDLSCNDIEEMPSSIGNLIHLRY
LNLSNNHIEVLPDSITHLPNLQYLNLDFNYKLRELPKDLGNMQSLRELTC
RRRDFVGSVFQSGNGLTHMPHGLSRLTNLRSLPVFVAGDRTGACSILELE
DLKLHGKMEIIFSKDFKNYSCGGRKILKNKDLNELYIVFNRLESNDKDVL
DDLCPNTSLKKLIIFDYGSPQFPSWLIELPLPNLVEVCLVNCRVCEHIPP
FGNLQFLKKLDLKFISDITHMGAEFHGYRGFPSLRELCLTRMNNLEEWSE
YHGVHEFFPKLHLLQVSDCCKLKSMPRLPRIQELVISCCNGSLLSCIGRM
TSLSVLKVSHMYNMTSLPSGCIRNLTSLTELKITNCIELQSLPGDEMQHL
EMLRLLTIERCYNLASFPSEVGRLSSLCSLRLLDCHLIIFQPEELVQILN
LVHQFQIQICGNEVNLRGQLQYLHTIRELSLRGAHYGFTKFKIRKGIAKL
SICCCDELESLMTAEPTSRVLEKLCIDGISNLTTLPDWLQHLSSLCFLQL
SGCPSIILQPEELVQILNSIHNFQIQICGNRVNLLGQLQHLHTLRGLSLS
GAHYRSSIYEYRERYEDSELSICCCDELASLMTADAASSIVLEELYIDGI
SNLTTLPDWLQHLKSLRHLSIKNCSQLGTLPRGLKNLHMLETLSIFNCPQ
LKRRYENEIGEDWPTISHVSYVDIS
>XP_042409349.1 putative disease resistance protein RGA3 [Zingiber officinale]
MEGALAAAASRFMVQKVADLLQLDQKLKAMTGIKRKMEKLKELSTIIDKV
IQDIDSRPSIDDAVKDLLEKLKYLAYDLEDVVDYYDIKVFQKQRSKTFLR
PVSDFFSSDNQVVFKSRVGGMIKAITESLDSILLQKSILQNLSQSSIRMS
EQRETHSRNSFVVIGREPEKNMIVNMLTKDDDDDESNHGTVKVIAIVGMG
GLGKTTLAQIVYNDARVQDHFASLRMWKVVGAEFDPAKIMKSVLQLTAHK
SVEISEIDLVMQDLETALSGKRFLLVLDDVWNEDPFEWGKLKAALTCGAR
GSKILVTTRSQQVSKIMGSSNTTHQLQQLSQDDCLSLFQQFAFGDQAVDQ
KLMEISKQIVEKCGGVPLAAISLGSMLRGTRDKTYWSSVLKSEIWQLRDE
QKVLAVLKWSYDTLPLQSKKCFAFGSLFPKDYTMQKDELIKLWISNGFVH
SERNFDAETVGNRIFDNLVLRSFFLLALLKMILM
>XP_042409387.1 putative disease resistance protein RGA1 [Zingiber officinale]
MVRLLVFSSSLTRLNPKSPPLRRARPVRCRHAGAPPTSLSDSSRGIISHI
LRKQLLHNPSSGAMAEALVSDAYRLMSERLADLLQLNDKLKATTGIEGKM
EKLKFLSTIIDKVIQEVDSRPFIDDAVKDLLKKLKYLACDLEDVVDHYDT
KVLQMQISNASFESVRDFISSDNLFKSRVNCMIKAITQSLDFILLQKSIL
LNLPQSSSHMSLNPYRETHSRNSFVVIGRETEKNMIVNMLTNDDDDDEEE
SNHATVKVIAIVGMGGLGKTTLAQLVYNDARVQEHFASLTMWKIVGPEFN
PTKILKSILELATRKSVGISEIDLVRQELETTLSGKRFLLVLDDVWNEDA
LKWGVLKAALTCGSRGSKILMTTRNQCISSIMDSSYIHQMKQLSPADCSF
LFQKFAFGDRKVDRTLMEIGGKIAKKCGGVPLAAISLGSMLRITRDETYW
SSVLNSEIWQLGNEEDKVLAVLKLSYDTLPPRSKKCFTFGSLFPKNYRMA
KDELIKLWIANDFVRSEGNFDAETNGNHVFNDLLMGSFILWAPSNVYDDS
HVNMCTMHDLMHDLARSVSANAYWNSDQDSVEDVGNRTYHLQIQRGEESS
MTQVLGKKPLYLRTFMYNSSRLSINLLEVFSELKFLRALDLRYGGIREVP
TSIGNLIHLRYINLSNNMIEVLPDSITLLSNLQYLNLSFNKELRELPKDL
GNMQSLRDLDLSSYLFDSGFKLTHMPCGLSRLTNLRSLSVFVAGDGTDAC
SIIELEDLKLHGEMEIKFSDDFKNYSCGGRKILKNKDLNELCIKFNGSER
YDKDMLDDLCPNTSLKKLTISNYGSPQFPTWSIDLQLPNLVEVCITSRFC
QHLPPFGNLQFLKKLDLQCMHGIRQMGVEFHGWGGFPSLQELILDGMHIL
EEWSESHGVNQLFPLLQRVKIINCPELKCMPRLPRIQELEVLWCRRRLLS
CVGRLTSLSVLEVVDVRDMVSLPSGCIRNLTSLTKLEIICCLQLQSLPGN
EMKHLKMLRSLTIEGCYNLTSFPLEVGHLSSLCFLRLSGCPSIILHPEEL
VQILNSIPEFEIQICGNQVNLREQLQHLHTLGGLLLIGDHNAPDLFENHA
YEHPELCICCCDELELLMTAEAASSIVLEELHIIGISNLTTLPDWLLHLK
SLSLLSIENCPLLERLPKNLKNIHMLEGLTIANCPQLESRCKRETGEDWP
IISYL
>XP_042409388.1 putative disease resistance protein RGA4 isoform X1 [Zingiber officinale]
MAGALVGATAGFLANKVAILVELDEKLKAMAGTKRKMEKFKELLTNIDSV
IQNVESRPFIDDAVKDLLKKLKYLAYDLEDVVDYYDTKVLHKKQRSHSTV
LRPVRDFFSTNNQVLFKSRIGSMIKAITESLESILLQKSILLNLPPGMSQ
PSPYRENHSRNRFVVIGREPEKEMIVNMLIDDDDESSHETVKVIAIVGMG
GLGKTTLAQLVFHDETVKIHFASLRMWTVVEAEFDPLKIMNSVLELATGA
PANYTQIDSARQNLEKVLTGKKFLLVLDDVWNEDPLKWGVLKAALICGVK
GSKILVTTRSLHISSIMGSSKTHQLQQLSKDHCLSLFQQFAFGDQTVDQS
LMEIGGKIVEKCGGVPLAAISLGSMLHSTRDESYWSSLLSSKIWKRDNEN
NLLAVLKLSYNNLSLQSKKCFTFGSLYPKNCTMVKDELIKLWIANDFVRS
DANFDAETIGNHVFTELVHKSFFLLASSKERDFRDFLWASSEGYDLGDVS
HVTNCTMHDVMHDLARSVSVNIYWNDKEDLAKDIGDRIYHLHMHKDFENL
SNTIQARGKKRLYLRTLILKDISLNTDQLEFVFSNLKFLRVLDLTGNKIK
EVPTSIRNLIHLRYLNLSRNIIEVLSDSITLLANLQYLNLSFNEGLQELP
KELWNMQSLRDLDCRCCNSGFIRIPCGLSRLTNLQSLPVFVADSRSGACS
ITELEDLKLNGEMTIKFSENFTNYSCGGRKILQDKHLKELSLEFNRSETN
DKGMLDDLCPNTSLKKLGIWHYGSSQFPTWFIQLQSQLPNLVEVSLNYCR
GCEHIPPFGNLHFLKKLDLISTYGITHLGAEFHGNGGFPSLQELNLHRMN
NLKEWSESHGADQLFPSLQRLRVYRCPELKCMPRLPNIQSLEIFYCDGSL
LSYVGSLTSLSILRVEKMDNMTSFPSGCIRNLTSLIELRIIGCDQLLSLP
RGEMKRLKKIRSLTIDRCDSLAFLPSEVGRLNSLRFLRLAGCPRIKLQPY
EVVQILNSVHEFEITICGKNVNLHEQLQRLYTLRELFITGEHDIYSDTQL
CICCCEELESLMIPDPASSVLQHLYIDGISNLTKLPDWLQHLESLRFLSI
HNCSRLETLPRLLWLQTLTIIDCPQLKRRYERDSGEDWPIIAHVPYVDI
>XP_042409389.1 putative disease resistance protein RGA1 isoform X2 [Zingiber officinale]
MAGALVGATAGFLANKVAILVELDEKLKAMAGTKRKMEKFKELLTNIDSV
IQNVESRPFIDDAVKDLLKKLKYLAYDLEDVVDYYDTKVLHKKQRSHSTV
LRPVRDFFSTNNQVLFKSRIGSMIKAITESLESILLQKSILLNLPPGMSQ
PSPYRENHSRNRFVVIGREPEKEMIVNMLIDDDDESSHETVKVIAIVGMG
GLGKTTLAQLVFHDETVKIHFASLRMWTVVEAEFDPLKIMNSVLELATGA
PANYTQIDSARQNLEKVLTGKKFLLVLDDVWNEDPLKWGVLKAALICGVK
GSKILVTTRSLHISSIMGSSKTHQLQQLSKDHCLSLFQQFAFGDQTVDQS
LMEIGGKIVEKCGGVPLAAISLGSMLHSTRDESYWSSLLSSKIWKRDNEN
NLLAVLKLSYNNLSLQSKKCFTFGSLYPKNCTMVKDELIKLWIANDFVRS
DANFDAETIGNHVFTELVHKSFFLLASSKERDFRDFLWASSEGYDLGDVS
HVTNCTMHDVMHDLARSVSVNIYWNDKEDLAKDIGDRIYHLHMHKDFENL
SNTIQARGKKRLYLRTLILKDISLNTDQLEFVFSNLKFLRVLDLTGNKIK
EVPTSIRNLIHLSFNEGLQELPKELWNMQSLRDLDCRCCNSGFIRIPCGL
SRLTNLQSLPVFVADSRSGACSITELEDLKLNGEMTIKFSENFTNYSCGG
RKILQDKHLKELSLEFNRSETNDKGMLDDLCPNTSLKKLGIWHYGSSQFP
TWFIQLQSQLPNLVEVSLNYCRGCEHIPPFGNLHFLKKLDLISTYGITHL
GAEFHGNGGFPSLQELNLHRMNNLKEWSESHGADQLFPSLQRLRVYRCPE
LKCMPRLPNIQSLEIFYCDGSLLSYVGSLTSLSILRVEKMDNMTSFPSGC
IRNLTSLIELRIIGCDQLLSLPRGEMKRLKKIRSLTIDRCDSLAFLPSEV
GRLNSLRFLRLAGCPRIKLQPYEVVQILNSVHEFEITICGKNVNLHEQLQ
RLYTLRELFITGEHDIYSDTQLCICCCEELESLMIPDPASSVLQHLYIDG
ISNLTKLPDWLQHLESLRFLSIHNCSRLETLPRLLWLQTLTIIDCPQLKR
RYERDSGEDWPIIAHVPYVDI
>XP_042409573.1 disease resistance protein RPS2-like [Zingiber officinale]
MDLAKKVGLNLEDDESEDDRAYKLHNFLKEKNCLLFLDDIWQSYEVVMLG
MQPPKRGMEKKRKVIVFTTRYEQVCTGMSANVIKKVKGLSSDEAWELFLK
YAREDVINSERQINQLAKEITKECAGVPLALITVGRAMSAKRSREAWNDA
LVQLKKSQMPEVTGMKERDPMFGAFKLSYDSLEDDNIRARLLCCSLWPED
FEIDKDELIQCWIGLGLIDEFDSINKAFDRGHSHIETLTFACLLELVNKN
GATRIKMHDVIRDMALWMASDCGSNQHRWIVKARARLNQLELENEQWQVV
ERASFMHNNLSSLPRQTLTFPKLSMLMLQQNPKLDLIPEPFFKALPVLAF
LDLSGTNITDLPREINMLSELQYLNLNFTPIKALPVELSSLAKLKYLLLV
GTKRLAKVPKGTMSNIALLKLLDLYESKYANLDELEGFKGCRKYIGITLH
SMIDLERLGSLPQLSRWKLQLQSMRDLAYPSQLFESIMSSHNTRQGLERL
EIVDVTTGGELTVAQSNKDHEEGLECLRYMTLITIDDLQEITWKVVEHQT
IFPNLHELNIFDCKMLRNINWVLHLPNLNVLKVSNCGEMEELINCVGSSA
NSSIGLRLLSLTRLPSLNCIARQPLTFPYLEQLYVSSCPELRKLPFGAEI
CQNKLKGIFCQKDWWENIQWEDVNDKNSLFPYIKFGFDVIVLKLGVKLPK
AKSRIFKTVIEVPGVIQVRLDSSTCHLTVVGDGVDGATLMNRLQRNIGQV
ELISVGTTGG
>XP_042409574.1 probable disease resistance protein At1g62630 isoform X1 [Zingiber officinale]
MLLKLINNHEEISKLKFEHVVWIVASKECKLQKLQMDVAKKYAGKDVINS
EQGINQLAREIAKVCSGVPLILITVRRVMSAKRSWRSDALMQLRQSRMLE
VTDMKERDPMFAAFLLSYDSLEDDNMRAPLLCGSLWPEGFKIHKVELIQC
WIGLGLINEFNSINKEFHRELSHIETLTFACLLELVDSEHTVGIKMHDLI
RDMVLWMVSDYGSNQYKWIVKAHAGLNQLELENEE
>XP_042409576.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MPVPNSLLDCKSFSNHPLPNSFSTDCYPSIRCFPSIAMSISFDIGQFLNK
ICHVASIHLARPRSGVEDLHIDAELLGAKLSDVDRAINEAAGNGQIVMEE
ALVWKRLAEAFVSKEAAIQRDYNEMRCLGGWSWNCVFINRRVTEMKKMQE
LISRGNDIRVVAAPPPSSSPSPPPLQLPVKLPISNNVVGMESNVIQIVNQ
IMDANARVIGIYGMGGIGKTTLLKLICNHDEISKLKFEYVIWIVASKGCK
LQKLQMDLAKKVGLKLEDDESEDDRASRLFDSLKEKNCLLFLDDIWESYD
LYKLGMEEVPAEHDKERKRKVIIFTTRYEHICTGMNANVIKKVEGLSSDQ
AWELFLKYAREDVINSEPGINQLAIEIAKECAGVPLALITVGRAMSAKRS
WEVWNDALTQLRQSQMPELTGMKESDPMFAAFKLSYDSLEDDNMRARLLC
CSLWPEDFEIDKVELIQCWIGLGLIAELDSINKTFQRGHTHIETLTSACL
LELADKKYATRIKMHDIIRDMTLWISSDCGFNQHKWIVKAQARFSQLELE
NEKWQVVERASFMHNDLSSLPRHTPTFPKLSMLMLQGNYKLSLIPGPFLQ
ALPVLTFLDLSNTKITELPREINMLSELQHLNLNMTPVEALPAELSSLAK
LKYLLLVRTNRLAKVPKGTISNLPLLKLLDLYESKYADLDELEEFKGCRR
CIGITLQSVTTLDQLVSLQQLSTWKLQLKNISDLAYPSQLFESIMSSHNI
RKSLERLEIVNVQTGDELIVARNNRDREEGLECLRYMVLKAVDDLQEITW
KAVKPQTVFPNLRELKISECKMLRNVTWVLQLPHLSVLTVSNCDKIEELI
SCVGDSVNSSSSLRLLSLAQLPKLNCISQQPLTFPYLEQICVNSCPNLRK
LPFGVEICQNKLKDIFGQTDWWNNIRWEDANDKISLTPYFKSTYMQKIVL
KLNMEDAKSRAKALKTAVRIHGVVSVTLENDLLIMNGDQVDLVALSKTMR
RNFGWVELISISEMVD
>XP_042409577.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MNPSINFGQFLNKIWDAASIYLARPRSRVEDLGRDAELLRAKLEDLNRAI
DEAERNGQTATEEAQLWKRRSETFLSTEVVAAIQRDYGAMRCLGGWSWNC
VSINRRATKKLEEVKELISRVDVSRVAAMLPPPSAVELPISNDIVGMQSD
VIQIVNQIRDENVSVIGIYGMGGIGKTTLLKLINNHHREISKLKFDHVIW
IVASQGCKLQKLQMDLAKNIGLNLKDDESEEGCACKLFNSLKEKNCLLFL
DDIWETYDLYMLGMEKTHVEQGKEQKRKVVVFTTRSEQVCTGMKANVKKK
VTGLASDKAWKLFLKNAGENVINSESRINRLAKEIAKECAGVPLALITVG
RAMSAKRSWEAWNDALTQLKQSQMPDVTGMKKRDPMFAAFKLSYDSLEDD
NMRVRLLCCSLWPEDFEIDKVELIQCWIGLGLIDEFDSINKIFDRGHSHI
ETLTFACLLELVHKEHAINIKMHDVIRDMALWMASYCGSNQHRWIVKAGA
RLYDLELENEQLQVVEQASFMHNHIRSLPSETPTFPKLSMLMLQQNLKLY
LIPGSFFQALPVLTFLDLSGTNITMLPGEINLLFELQHLNLNFTPIEALP
TNLSNLSKLKYLFLKGTMRLTQVPKGTISNLPLLKLLDLYESKYDNLAEL
KGFKGYRRYIGITIRTMMALEQLGSLRQLYTWKLQLENMKDLAYPRQLFK
SITSNHNTRQSLERLDIVNILTGGELIVAQSNKDSEEGFECLRYMVLIAV
DDLQKITWKAVEPQIIFPNLHELIIAKCKMLRNITWALQLPNLSVLKVSY
CDEMEELISYVGSNVNSSIDLHLLSLAQLPKLNRISRRQLTFPYLERIYV
SECPKLKKLPFGAEICQNKLKGIFGRKKWWENIKWENAKDKNSLTSYFKS
SMQIIMLRLDIRSASFDMGDTNARAVAIKIALAIPGVMSAELDDECLIVR
GEQLDPVEIVARLQNLFQAELLNGDIEN
>XP_042409694.1 disease resistance protein RPS2-like [Zingiber officinale]
MRLRATGKPSWKKLLVWKRQAEAFVSKEAAIQRDYKAMRCLGGWSWNCVS
INRRVTKKVKKMQELISRGNDISIVVPPPQQQQQPPPQQQPPPQQPPQQP
QQQQSPPPPPPPPAMELPISNNVVGMQLNVIQIVNRIKDENAKVIGIYGM
GGIGKTTLLKLIHNHEEISKLKFEHVVWIVASQGCKLQKLQMDLAKKVRL
KFEDDESEDDRLSKLYNFLKQKNCLLFLDDIWESYDLIKLGMEQVPGKEQ
KRKVIVFTTRSEQVCTEISADVIKKVEGLPYDQAWELFLKNAGEHVINLE
PRITRLAKQIAEECAGVPLALITVGKAMSSKKSWEAWNDALTQLRQSQMP
KVTRMKERDPMFAAFKLSFDSLEDDNMRARLLCCSLWPEDFEIEKVELIQ
CWIGLGLIDEFDSINKAFHRGHSHIETLTSACLLELIDGEVHTTTIKMHD
VIRDMALWMASDCGSNQYRWIVIARTGLRQLELKNEECQVVERASFMHNK
LDYLPEQTATFPKLSVLMLQHNESLDLIPKSFFSSLPVLTFLDLSGTNIT
KLPKEINILSELQHLNLSFTNVEALPVELSSLVKLKYLLLERTESLAQVP
KGTISNLPLLKLLDLYESSYADLDELEGFQGCWKNIGITLDSMTNLKRLS
SLSQLSTWKLKLQNMIDLAYPSQLFKNIMSSYNTRQGLERLEIINVRTDD
GLIVVRSNKDHEEGLECLRYMALKHVDYLQEITWKAVEPQTIFPNLHELT
IDKCNKLINITWVLHLPNLSVLKVSDCDEMEELISCVESSVNSSIGLRLL
SLNRLPKLNCISRQPLTFPYLVRIDVISCYKIRKLPFGAEICQHKLKRII
CDEIWWELIEWENFKDKNSLTPYFKLINSFNCLGDYEYAEPRRKKRRDDL
DSFDPAWDSFDPEDSSDPEDPLDLAWIR
>XP_042409695.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MTSIAIGISEILKGIWGAASTYLARPRSRVENLHRDAELLNAKLVDFNGA
IERNGQTVTEETRLWKLRAETFLSTEVDAIQRDYRAMRCLGGWSWNCVSI
NRRVTKKLEEVKELISQVDVSKVATTPPPPAMKLSISNNVVGMQSNLIQI
VKQIRDENASVIGIYGMGGIGKTTLLKLINNHEEISKLMFEHVVWIVASK
GCKLQKLQMDLAKKVGLNLKDEESEDDRASKLCDFLKEKNCLLFLDDIWE
LYDLNMLGMEQVQVEHGKEQKRKVVVFTTRSEQVCTEMRVNMKKKVKGLT
FDQAWELFLKYAGEDVINSELAINRLAKEVAKECTGVPLALITVGRAMSA
KRSWEVWNDALTQLKLSQMPKVTGMRERDPMFAAFKLSYDSLEDDNMRAR
LLCCSLWPEDFEIDKVELIQCWIGLGLIDEFDSINRAFHRGHSHIETLTN
ACLLELVEEVRNKLIEEVHPTKIKMHDVIRDMALWIASDCESNQRKWIVI
SQAGLRQLELKNEEWQVVERASFMHNKLTYLPRQTATFPKLSVLMLQQNK
FLDFIPKSFFLSLPVLTFLDLSYTMIRELPREINMLSELQHLNLSFTKVE
ALPIELSSLAKLKYLLLERTWSLAQVPKGTISNLPLLKLLDLYKSKYTDL
GELEGFQGCRKNIGITLHSMIDLERLGSLSQLSIWKLQLRDMRDLAYPSQ
LFENIMRSHNTRLGLERLDIVNVTTGGKLAVAQSNKDHQEGLECLRYMTL
ITIDDLLEITWKEVQPQMVFPNLHELTINNCKMLRNITGVFQLPNLSILR
VSNCGEMEELISCVGSSVNSGIGLRSLFLYGLPKLNCISRQLLTFPYLER
INVFFCPELRKLPFGAEICQNKLKGIVGEVDWWENIQWKDINDKNSLAPY
FKFVY
>XP_042409944.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MALLFTLSDLGRLVVSLIDSLVEKLRRDEVHRLQMLPEVGVVLRDLETRV
IQIRHIISPAENSFAIATDQQIKLELKGLLMQLKNTVYDGEDLVEEIEHD
VLHHEVDQHQYEASSQSSSSFNSSIAKRTSAPSPVKLPALIKAADSSVYK
LRKINLRLGRIATAIAKIIQVTNSVGADDGQKIHNADSVSSNTTSFSVDG
KMYGRDGEFNTLRQLLLKPSVGSGSSNGSLSVVAIFGVGGVGKTTLAQQL
YRDTSITEYFQLKIWVYLSENFTVKRLIKKILQSANIDFPDHINLDMLQV
VVKKKIASKRFLLVIDDLWNAEWDMHKWGMLFAMLRPGVPSSKVLLTTRF
PRLPTVASNECAFHLDRMDEEEFWEFFKLCAFGSQSSQEKPPLIDIAKKM
VSRLNGLPLAARMVGEWVSIRDTYRVHVQVPYLQDLHKTLRPLSVFAEFV
KPERLMDIFVNERLRTLIFSSMKEPWCETKISANHLFNRLKCIRVLILHD
CGMIELPWTINRLIHLRYLDISDNFGIQQLPDSLSYLHNLQYFDLNNCQV
QTFPAGITNLINLRQLISVDEIISKINNIGKLINLQTLPTFKVLKGDGHK
LTELSSLTQLHGRLRILNLGNVEDKMEASAAKLHDKVHLDELVLAWTSDQ
NSSFDDNALHASEEILEELQPHSKLKSLTIRGYKGARAPSWVHTETLASL
ETLRLENCGRWEDVSFIRQLLHLRSLYLKGIPAMKQTTQELFGPIENKFF
QGLKELVLEGMDLLDELSSDEVMFCGVLDPILIRSREAPHPVGVLVLAST
AFEIKGNHFPCLEELKFSNMSEWEEWTWTGDSELFPCLLVLKIEDCPKLK
MLPPLPPSLMTLELWQNGLVELPGLWNKINGSSSNMIASLSKLYVSECPN
LRMLDQGLLFHDLPNIESIEIHECQELLWLPVKRFKEFTSLKNLSVKNCP
MLMSSTEYKSDELLLPPSIQKLTLLDCGNLSEPLPRCLLNLPSISQLEIG
HPPSQG
>XP_042409945.1 putative disease resistance protein RGA3 [Zingiber officinale]
MTMLFTLSDLGRLGVTLIGSFVEKLRRVEVHRLQMLPEVGVVLRDLETCV
IQIRHIISAAENSFTIATDELMKLELEGLLMHLKDTVYDGEDLVEKIEHD
VLHHGVDQHQYEARSQSSSSFNSSATKSKNASSPVKVHTVVEIEDSRVYK
LRKIYQSLDKIATALVKIIKVVNSVDADDRQNIHTADSISSNATSFLVNG
KVYGRDKEFNTLRQLLLKPSLGSGFSNGSLSFIRILGDEGVGKTTLAQRL
YSDTSITEYFQLKIWVYPSENFNGKRLTKEILQSANIDTPDCMNLDMLPV
MVKKKIASKRFLIVLDDLWNTDMHGWDMLCASLSSGVPGSKVLLTTRFPR
LPTVASNECAFHLNRMDEEELWEFFKFCAFGSQSSQEKPPLTDIAKKMVS
RLNGLPLAARMVRGLLNTNMDVSHWNNILNNEIWQIPEYGLLPVSQISYH
CLPVPLKRCIAFCSLFPRGYWFAEEKLIRIWNAEGFIVAQANRRMEDVGK
SYFQELVNRSFFQRLPHKSLQEEQTIFYVNHDLIHDLVE
>XP_042411847.1 putative disease resistance protein RGA3 [Zingiber officinale]
MTPFMLKALAWFADNFLGSLVGKAADYAVQQFGVQHGLRDDIDKLQSSSE
KSRLIIHQVEKLRIQDEGVKARLKGLLMQLKDAAYDADDLLDEFQYQVLM
KQVEQEENESTNFSLPSSSTALPATKKPRISVSTIADLISSSRDKDRVQK
IKERIENITGDISQLIPLFPLSDLENQQQLISSTSRTTSSVLVETEVFGR
DKYLKELKDLLLNASDGAGSSNISIPVLAIVGIGGIGKTTLAQQVYNDEA
IQEHFQLKIWVCVSGNFSVERLTKEIIESATRKKCMVGAVDPIHLYGLEA
ESFWAFFKKCVFGSQNNGDHPPDLETIAKTIAERLNGLPLAAKTVGGLLK
VNMEKSHWETIMKSEIWQLPQNESDVLPVLQLSYQCLPAHLKRCFAFCSL
FLKDYVFSKKELVRIWIAEGFVIPQGKERMEDVGSSYFEDLVSRSFFQKS
RIFSSKYVMHDLIHDLAQLVSDGECYQLENGNTQEVSSLVRHLSVWPPAS
KPAYQLERQVLVLSRNNKWRSLIWNDNFNFTIWRSLIWNDNYYNINNPTL
KDLWRSLKYIRVFILQRSGIVELPEDVAELRQLRYLDLSSNYQMKRLPDS
LCRLHNLQALKLDRCPIQSFPQGMSKLINLRHCDSKLISKIYRIGRLTSL
QQLDRFNVQKHPGHKLEELSGLTQLHGKLRISNLENVGSKEEANAGKLHN
KVFIDSLTLEWMPNQDGSSEGNQLLILEELLKDLKWHPTLKELEISGYSW
AAWDENYSWAKDIKLFPSVLHVLHVFCCPKLKRLPPLPPSLVDLQLSESG
LVKLPNIWEEIDGSGHCKVATLKHLYLHCPYLMSLEDGLLSQNLPCLQTI
ILEDCQELMWLPMEKLKVFASLKEMQILNCPKLLTMTHDLNDFLILPQSL
KKLSLSNCGDLDKLLPRCLHNLTSLAHLEIAECPHLHSLPKEPLLHLKQL
EYVKICGCDELRSMEGLGVLKSLKDLIILKCPNLLINGRDEHGEEEEQGL
LSLREICIDNTALLKIPPLRNALPSIHRLQIQSSVEEVMFEGEEQELLRR
LTVLRILMFSYCEELQSLPKELYTLPSLELLSIAYCPEIESLPETGLPTS
LTDLRCQCENPMLKQQIQEKMKELTSSGRYRPVHDRIIF
>XP_042411931.1 probable disease resistance protein At5g04720 [Zingiber officinale]
MSTSFAGEIATELIKELLNVVRMTYLCRPTAEQLKRSVDSLLPIVQEISL
SGVELPQHRQNQLSELADNLRLALELARKAAASPRWNVYRSMQLARKMER
IDNWITRWIERQIPAHVLADVHHIRADYAARFDRIERTLDITAASVMARG
PVALGTAPFSMFPEMMKGFVPLAAPAKAPIAMGSPPPSSGFPMPEMMEGL
MPSEEAAKVPVAMEKSQSSGFPVSEMMEGLILAGEGMKPVGVGIRFGKEK
VKEMLMDGFDRVAVVGISGIGGSGKTTLAREICKDPEIRSYFKDRIYFET
LSQSQNLESLKLKLWEQISGNMVLGAYNQIPQWQVELGTRDKGPFLLVLD
DVWSASELEELVFRVPGCKILVVSRFKFPSIVKNTYEIESLGEEDALSLF
CHAAFEQKYIPSTFDKKLVKQVVDECKGLPLALKVIGASLRDQPPKLWLR
AKNKLARGESICESHENKLLERMASSIEFLSGKVRECFLDLGSFPEDKRI
PLDVLINMWMELHDLDEEDAFAILVELSNKNLLTLLKDAQNRAGDIYSSY
TELSVTQHDLLRDLALHVNSQETLTSRRRLIMPRKENELPKEWDRVKDQQ
LEAQIVSINTGEMKESDWFQMHFPKAEVLILNFSADAYFLPPFLSIMPNL
KTLILINYGASCTTLQNLSVFTSLSNLRSLWLEKIAVPPLPKTTVPLQNL
RKVSLVLCELTNSLRGSKVDLSLTLPRLSHLTIDHCIDVTKLPSAICDIN
SLECLSISNCHDLSELPCEFGKLNSLKILRVYACPALKRLPHSICLLKGL
KYLDISQSFNLRELPEELGYMTSLEKFDMRECSQLKTLPRSSSSLKSLGH
VICDEDIALLWKEAERDIPDLHIQVAEESFNLDWLVE
>XP_042412499.1 probable disease resistance protein At1g58602 [Zingiber officinale]
MDASAVVRVVDKLSKLMYQEANYLGGFRDAVEWLNIELHRIQCFLKDAEP
KGSKGDERVKNWVREIRDVAYEIEDLIDIIGAASKRKNHRRRKRTFVGLA
SRYATAPFDYYSRHHLLCGIDRIKEKIVDISRSREIFGVSNFGGSRDPDR
VDVNLPTPLLASPDFEDEVHLVGFEEDKELLVRHLIDQQNQWRSFVSVVG
MGGLGKTTLAKKVYRDPRVRRQFDVLCWVSVSKNYRGAEFLNCIIEKVMG
LTGEELLRMRREELERKLDQRFQERRCLIVLDDVWLSSTCEDLKRLFPDH
KNGSRVLLTTRSLDVARSADPSFAPHMPRFLDDDESWELLQKKAFPSRRG
HERRCPGDLEEVGRKLAKNCHGLPLALVVLGSLLFKKGPFPATWNRVFES
LDWEFMEDGNKCFDILALSYDDLPDDSFRSCFLYISSFPEGSEIFVSRLI
ELWNAEGFIRPRPKEAVEKTAKDYIDELSQRCMVQVVKRIAGHGPAKSIR
IHDLLREWCISKARMEGFLHVVGGKEKNAAALDATTACRRTALPDGLNGG
GGPYVPSPKLRALLAFNCKNLGNSKQLSFTSLRTLRVLYLEGSSGIMKLP
EDIKSMVHLRYLGLKTRLVELPPSIGDLPYLEVLDARLSRIIQLPSRLWR
IATLKKVYVGSVEQPVKISKLGNSQSLRVVEWVDIAGGWIERTENEISSF
RKLGITGIQQAHRKALTRFLRKLRHLASLNLCFSDHDGEILTHVLRSLSD
HHELRSLKLHGRYFLAIARRAWGAFPPNLTKLVLNRFEFLQDPMEELEKL
RHLVDLQILAPEVGHRLVAPDYKVMTCSAGGFPRLQHLQMYGLKVEEWRI
EASAMRSLTSLTVISMVKVRKVPEGLQHIATLQELAFNDMSRDFYGRIKA
SEGEDWQFISHVPCVSIREGFMKIWLSDSFPSQQLKAFIFSRKAAKEFIM
GGRSSNVPEKLQLELLASEDSPGVLDETDTVIEGR
>XP_042413068.1 putative disease resistance protein RGA3 [Zingiber officinale]
MEMQSPQASAASIALFYSKSMVRGRLKFLHLKDVHASTSSFRSLPPFSLK
AGTLSACNTRAFVNATDSSSGLGILFGARFGESLEDQIMAMILTAFIPQV
IQVLDGITKREEILLLGVADEVKGLVRRLEELRNILQDAERRSYNEKEIQ
WWLTKLRDIIYDIDDMIDQCKIEGESHKRLLEQQAQSFRLRISTKCSVSL
FSFFNRSFHHEITERIKRLSSRLDQVIKEAAKFQLISSIHGYEVSLTNKC
IVRAMDPESVEFKFKKDAESMFKLLTMEERMNLLVITGVGGIGKTRLAQK
IYYDERTKAHFQVRIWICVTQQTTFIDMLKQIITGAGQTYGEAQTSEQLE
IELKRVLEHKKFLLVLDDVWSIQICNDLLQRSSQNIVSGSRVLITTRNET
LARELPGAHLHRMKPLSTKEGWSMLRKELYQEDHVQEMQELNNIGIKIVR
KCKGFPLAIRVIAGVLRTRGWSSEEWEKVFLDPAWSSFDLPNDVTRALYL
AYKDLPANLRQCLVYCSLFPEDHLFDQQSITKYWIAERLVEEKERSTIED
TAEGYYKELIWRNLLERDFGQQDAHKMHGLLRFLAHFLAGEENLFGNLDL
MDATSTKPRRLSIVAKGLMAIPTELKEQNSLRTLLLFRNPLSGKILDDFL
QGLNHLRVLDIHGTDVDSLPDCIGDLIHLRHLNVSSTRLKQLPDSIERLI
NLQFLSVRGCESMTALPQHLVKLQSIRSLDLVGTQVNWLPVGVGKLENLN
SLLGFLVDSGSEGILMSTLDDLGPLTMLKYLLLQKLERVSNGAESARANL
RRKKYLKNLSMHWSLNIADAQLLEVDKFKEVLEALCPSSSLEELEIMGYP
GLDLPSWISTVKKLTKLVLHRCSSIQQLPQLGHLPHLSFLYISGATAVTK
IGTEFFGLDAWPPFPKLNTLVMEDMINWEDWQWQLEDGEALPCLRELQLV
NCYKLPSLPDGLRHATALTVLAMDGANRLMKIENLSTIRKLSVSSSFNLV
EISNLSSLENLKVSNCSSLKKFEHLVHLQQLNVIDESMNNLPEGLGEYAT
KDLRWLELECNEDMFKSCHHGGSEWHKFQHIQDVHIHSKDRYMYFSYGKS
LQYCEEATGSESNLAIVPVVSNTPLTNTSPVAIPNTDMVTNQGHFCFSPQ
KLLLILYIYLTIYILFESFFLSPTHLSYLGSSLISFLIDVIFFLISLPLC
IMRDTFGSLSSVVSAAYKLFDMLVNVANYMDASIGAVVEPGVDFLFSSFS
FSSIVVLSWLIASYGGWFHQ
>XP_042413281.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAAADLKRILSQVLPSPSLKAQAGLLRVQNHLEMIEGSLWKINSMYMHGL
MTAITKPDVEQWTNDVKEAVLDVDQLLGRILRCQLPKEAAAKSPSVCGDI
LLWLTETAEKSPSVRGDILLGLTETASKLNHLAFGGASSLGLRAEMMDSI
DADHEDFSTVLNNEVQGLEDTTNKIVKELQSQQQYEEIPTIFYIVGHEGM
GKTTLARKVFHHNWVRNYFQHHVWVDSPDSFSFDPMTVARSFVEAVTKKP
CGHRGYLQQLWLDVSKKLNVGRYFLVLDDVPVLMKDRDKWEQLRHVFLRL
GSPGSRVVAVTSVHHSDFPEGNPTFKQLPPVLGLSRDSWTTLLRRRASAL
IRDDDEGKQIRKSSSAILDRFAGRLHEKSRGSPSLAKVWGSALQCTEVGR
WEDQIEKYLLPKPLQDEQHFGSWSSQYLIPKDAHLYLFSSLFQQDHEHDY
EDLFHVMAAQGFIQDSSNKALIISNLKRSLRHFATKDSRQQKSLTNDLIR
SLPILEATQPSSESEKKVLSYWKTKGFPKSTHQPQCQHLSVLIHPSTDLT
LPMTLPSKLRTLKLTMLVAENEEQKKKMEGQKIETVLKDEFSNLRHLRVL
DLRATKMAEMPDTVDGLVNLRYLNLSWSDIATLPDSFCNLGSLQILKLAH
CHKLSELPHRIGKLQNLQVMKLPFCENLTKLPKSVTNLIDLQELDLECCR
QLVEFPDEFGNLKSLRSLSLVGCLSLTKMPSGMRQLTELRQLSGFVVLQE
CGSCTVTELGPLKYLEDLQLRGLEGVRSTNDAEAMKLKNKRFTRNLVLHW
NGDDGASSDSLLEILECLQPSTALRTLEINSYSGKDFPMWMKDGQPYHYT
LTEIKLVNLRDCASLPPLGQLARLEVVEISGMVKVRKVDDEFYGLNGTFA
SLRKLTFSEMPELQKWVKVTRKSQLFPKLTELMIIQCPKLEQLEVEVTAV
KKLRLWLSNGTLLTSKSWDWSKFSGLTELEIVGCPGVKHLPKSMKILKQM
VDHLTLIGLGTLESLPNWLKKDCCLDISRCGKVKEQECQNASEAFSSATS
IESREWDKK
>XP_042413872.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MAFIKLNLNVDVNSCLSGLWASLQLAIGRPKTAIKKLEKEMARLRGKRND
IKNQIGEAEREGKIPTNEVNQWLQEVEELEGQVADINQDFQSMISCFSCN
CFSLTQEAGDQVPIREPSNCCSIIRRVVKKLGEANELMSRASIVLDPIAT
VGPPEPTVMLPIVHRPPVGIESYVEDIVGYIDGGEGNITGIYGMGGVGKT
TVLKSIQRHYYNHRIIFDHVIWVVASKDCQLKRLQMEIARTLGLNTLQES
DDEATCGDKLFSYLKNKNCLLLLDDSCEYLNLQLLGMAHSATEQGQQQHE
LRRKVVVFTTRSEIVCARLEAEKKIKVKCLDQDQAWQLFKENVDGDVLSS
DRGINSCAQEIAKECAGLPLALITVARAMLGKKSWELWKDALHQIRDKHE
WTSTIDLSEEDSVVMYKAFKLSYDSLENDSIRECLLCCALWPEDYEIHKF
KELIPCWIGCGIIREFNVINEAFTKGCSHLEALMAASLLEHSSRRPNYYE
AEHVKMHDVIRDMALLMFSELKGNRRKSIVKAGFGLHNLPRQEEWQEAER
ALFIENQIISLPEYEASSFPKLSMLILFFNYPPLNIPRSLFTSMPRLTYL
DLSKCFIIELPMEIGSLTELQYLNLSYNTITNLPLELGCLDKLEYLLLRD
NCLKTVPNGIISNLLMLKWLDISQQIPVCKQWWDELVHFRGCHQLSLEIS
IYATDLKRLNMLPNVSVRNLAMSGLSSKFQMLQWSLRVTDNLECLTISNV
WKGDQLMVNAGVDCESSFKCLKTLNLKFLYQLKINWMDGVGFNNLRDLYI
SNCYKLKDVSWVLQLPCLNLLSILNCQEMEEIISNVGSSNSSFGIKMLAL
SKMDNLQRIAHQPLHFPYLEYISVSYCPRLKKLPFGAETVKNRLKEIQGG
PNWWDDLDWDDYSIKDSLAPYFRDGSNLLRQEKWQPTLIVEDHIIWLPAG
LDDPEDDGSDDEEDGENEPEANGEGGSEQEDDEDDDNDDDEEEEDDEYEE
EENVEKDDELQHHQQRRGSEVYCCILLGYLVLVEFFIFFLFIFTSA
>XP_042415102.1 putative disease resistance protein RGA3 [Zingiber officinale]
MTMLFTLSDLGQLGVTLIDSFVEKLRRVEVHRLQMLPEVGVVLRDLETCV
IQIRHIISAAENSFTIATDELMKLELEGLLMHLKDTVYDGEDLVEKIEHD
VLHHGVDQHQYEALHTVVEIEDSHVYKLRKIYLSIYKIATALVKIIQVVN
SVDADDRQNIHTADSISSNATSFLVNGKVYGRDKEFNTLRQLLLKPSLGS
GFSNGSLSFIRILGDEGVGKTTLAQRLYSDTSITEYFQLKIWVYPSENFN
GKRITKEILQSANIDTPDCMNLDMLQVMVKKKIASKRFLIVLDDLWNKDR
HGWDMLCASLSSGVPGSKVLLTTRFPRLPTVASNECAFHLNRMDEEEFWK
IFKLCAFGFQSSQEKPPLTDIAKKMVSRLNGLPLAARMVGGLLNTNMDVN
H
>XP_042415103.1 putative disease resistance protein RGA3 [Zingiber officinale]
MIYLPRDDLGSDTAGTLGANDFTFCHIKVVNSVDADDRQNIHTADSISSN
ATSFLVNGKVYGRDIEFNTLRQLLLKPSLGSGFSNGSLSFIKILGDEGVG
KTTLAQRLYSDTSITEYFQLKIWVYPSENFNGKRITKEILQSANIDTPDC
MNLDMLQVMVKKKIASKRFLIVLDDLWNKDRHGWDMLCASLSSGVPGSKV
LLTTRFPRLPTVASNECAFHLNRMDEEEFQ
>XP_042415354.1 putative disease resistance protein RGA3 [Zingiber officinale]
MEMQSPQESAASIALFYSKSMVRGRLKFLHLKDVHASTSSFRSLPPFSLK
AGTLSACNTRAFVNATDSSSGLRILFGARTLGAKFGESLEDQIMAMILTA
FIPQVIQVLDGITKQEEILLLGVADEVKGLVRRLEELRNILQDAERRSYN
EKEIQWWLTKLRDIIYDIDDMIDQCKIEGESHKRLLEQQAQSFRLRISTK
CSVSLFSFFNRSFHHELAERIKKLSSRLDQVTKEASKFQLISSIHGYEVS
LTNKCIVRAMDPESVEFKFKKNAESMFKLLTMEERMNLLVITGVGGIGKT
RLAQKIYYDERTKAHFQVRIWICVTQQTTFIDMLKQIITGAGQTYGEAQT
SEQLEIELKRVLEHKKFLLVLDDVWSIQICNDLLQRSSQNIVSGSRVLIT
TRNETLARELPGAHLHRMKPLSTKEGWSMLRKELYQEDHVQELNIIGIKI
VRKCKGFPLAIRVIAGVLRTRGWSSEEWEKVFLDPAWSSFDLPNDVTRAL
YLAYKDLPANLRQCLVYCSLFPEDHLFDQQSITKYWIAERLVEEKERSTI
EDTAEGYYKELIWRNLLERDFGQQDAHKMHGLLRFLAHFLAGEENLFGNL
DLMDATSTKPRRLSIVAKGLMAIPTELKEQNSLRTLLLFRNPLSGKILDD
FLQGLNHLRVLDIHGTDVDSLPDCIGDLIHLRHLNVSSTRLKQLPDSIER
LINLQFLSVRGCESMTALPQYLVKLQSLRSLDLVGTQVNWLPVGVGKLEN
LSSLLGFLVDSGSEGILMSTLDDLGPLTMLKYLLLQKLERVCNGAESARA
NLRRKKYLKNLSMHWSLNIADAQLLEVDKFEEVLEALCPSSSLEELEIMG
YPGLNLPSWISTVKKLTKLVLHRCSSIQQLPQLGHLPHLSSLYISAATAV
TKIGTEFFGLDAWPPFPKLNTLVMEDMINWEDWQWQFEDGEALPCLRELQ
LVNCYKLPSLPDGLQHATALTVLAMDGANRLMKIENLSTIRKLSVSSSFN
LVEISNLSSLENLKVSNCPSLKKFEHLVLLQQLNVIDESMNNLPEGLGEY
ATKDLRWLELECNEGMFKSCHHGGSEWHKLQHIPDVHIHSKDRYMYFSYG
KSLQYCEEATGSESNLAIVPVVSNTPLTNTSPVTIPNTDMVTNQEHFCFS
PQNLLLILLPLCIMRDTFGSLSSVVSAAYKLFDMLVNVANYMDASIGAVV
EPGVDFLFSSFSFSSIVVLSWLIASYGDDKIQRQSRDREKKASKDDAMPL
ASIEVKAMAVAPCHCHTCRHRLTARSLKAFGADCQVSLLHAAGP
>XP_042416559.1 putative disease resistance protein RGA3 [Zingiber officinale]
MTPFMLKALVWFADNFLGSLVGKVADYAVQQFGVQHGLQDDIDKLQSSSE
KSRLIIHQVEKLRIQDEGVKARLKELLMQLKDAAYDADDLLDEFQYQVLM
KQVEQEENESTSFSLPSSSTALPATKKPRISVPTIADLISSSRDKDRVQK
IKERIENITGDINQLIPLFPLSDLENQQQLISSTSRTTSSVLVETEVFGR
DKYLNELKDLLLNASDGAGSSNISIPVLAIAGIGGIGKTTLAQQVYNDEA
IQEHFQLKIWVCVSGNFSVERLTKEIIESATRKKCELTNLDALHVILNEN
ITSKKFLLVLDDVWNEDSSKWEKFYAPLKNGAKGSKILVTTRSTTIAGMV
GAVDPIHLYGLEAESFWAFFKKCVFGSQNNGDHPPDLETIAKTIAERLNG
LPLAAKTVGGLLKVNMEKSHWETIMKSEIWQLPQNESDVLPVLQLSYQCL
PAHLKRCFAFCSLFHKDYVFDKEELVRIWIAEGFVIPQGKERMEDVGSSY
FEDLVSRSFFQKSTTRSYVMHDLIHDLAQLVSDGECYLLENGNTQEVSSL
VRHLSVWPPASKPAYQLERKLLVLSGNNKWRSLIWKGNYYYNNWRSLIWN
DNYYNNNNPTLKDLWRSLKYIRVLILQRSGIVELPEDVGELRHLRYLDLS
FNYEMIRLPDSLCRLHNLQVLQLYECPIQSFPQGMSKLINLRYIDFRDMT
LISKIYRIGRLTSLQQLNTFKVQNHPGHKLEELSGLTQLHGSLRISNLEN
VGSKEEANAGKLHNKVFIDSLTLEWMPNQDDSSEGNQLLILEELLKDLKW
HPTLKELEISGYSWAAWDENYSWAKDIKLFPSVLQELHVFYCPKLKRLPP
LPPSLVDLQLLQSGLTKLPNIWEEIDGSGHCKVATLKHLYIRCPYLTSLE
DGLLSQNLPCLEYLILEDCKELMWLPMEKLKVFASLKEMRIWNCPKLLTM
THDLNDFLILPQSLKKLTLSNCGDLDKLLPRCLHNLTSLAHLEIGECPHL
RSLPKEPLLHLKQLEYVKIHGCDELRSMEGLGVLKSLKNLIILECPNLLI
NGRDEHGKEEEEEEQGLLSLREICVDNTALLKIPPLRNALPSIHRLQIES
SVEEVMFEGEEQELLRRLTVLRILMFSYCKELQYLPKELCTLPSLELLSI
SSCPEIESLPETGLPTSLTDLRCQCVNPMLKQQIQEKIKELTSSGRYRSV
NERL
>XP_042416561.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAFKVKVLGWFADHFLGRLVGKAADFADQQFGEQHGVQDDINKLQSSSEK
SRLIIHQVEKLRIQDEGVKTRLKGLLMQLKDAAYDADDLLDEFQYQVLKK
QVEQQENESINFSLPSSSTAVPATKKPRISVSTIVDQISSSRDKDRVRKI
KERIESITGDISQLIPLFPLSDLDNCRNQQQLISSTSRTTSSVLVVTEVF
GRDKDLKELKDLLLNASDGAGSSNSSIPVLAIVGIGGIGKTTLAQQVYND
EAVQEHFQLKIWVCVSENFSVERLTKEIIESTTRNKCELTNLDALHVILK
EEVTSKKFFIVLDDVWNEDSGKWEKFYAPLKNGVQGSKILVTTRSTTIAG
MVGALDPIHLDGLEDESFWTFFKKCVFGSQNNCDHPPDLKAIAKTIAKRL
NGLPLAAKTVGGLLKVNMEKSHWETIMNSEIWQLPQNESDVLPVLQLSYQ
CLPAHLKRCFAFCSLFRKDYRFLKKELVRIWIAEGFVIPRGKERMEDVGS
NYFEDLVSRSFFQKSGRFLIEYVMHDLIHDLSQLVSDGECYRLENGNTQE
VSSLVRHLSVWPPASMTAGELCRNNKWRSLIWYDNYYNANTPTTKDLWRC
LKYIRVLILQRSGIVELPEDVGELRHLRYLDISFNYEMKRLPDSLCRLHN
LQVLKLYECPIQSFPQGMSKLINLRHIDFEDTILISKIYRIGRLASLQQL
DKFEVQNHPGHKLEELSGLTQLHGKLRISNLENVGSKEEANAGKLHNKVF
IEKLTLEQDGSSETNQLLILEELLKDLQPHPTLKKMNICGYSWTAAWDET
YSWAKDIKLFPSVLQELWVSDCPKLKRLPPLPPSLVNLELHRSGLIKLPN
IWEEIDGSGNCKVATLSRLYINCPNLTSLEEGLLSQNLPYLKTIILEDCE
ELMWLPMEKFKLFASLKELKIMNCPKLLTMTRDINYWPILPQSVEKLSLS
NYGDLDKLLPSCLHNLTSLAHLEIAECPHVRSFPKEPLLHLKQLDFVKIS
GCDELRLMEGLGVLQSLKDLIICKCPNLVINGRNEHGEEDGVLLSLRELC
IDNTALLKIFPLRNALQSIHRLQIQSSVEEVMFEGEEQELLRRLTVLRIL
MFGCCKKLQSLPKELYTLPSLELLSIWDCPEIQSLPETGLPTSLTDLKCD
RVNPMLSRQIWEKWEELRSSGRYRLVIERPKVL
>XP_042416647.1 probable disease resistance protein At4g33300 [Zingiber officinale]
MSTSLAGEIATELIKELLNVVRMTYLCRPTAEQLKRSVDSLLPIVQETSL
SGVELPQHRQNQLSELADNLRLALELARKAAASPRWNVYRSMQLARKMER
IDNWITRWIERQIPAHVLADVHHIRADYAARFDRIERTLDITAASVMARG
PVALGTAPFSMFPEMMKGFVPVAAPAKAPIAMGSPPPSSGFPMPEMMEGL
MPSEEAAKVPVAMGKSQSSGFPVAEMMEGLILAGEGMKPVGVGIRFGKEK
VKEMLMDGFDRVTVVGISGIGGSGKTTLAREICKDPEIRSYFKDRIYFET
LSQSQNLESLKLKLWEQISGNMVLGAYNQIPQWQVELGTRDKGPFLLVLD
DVWSASELEELVFRVPGCKILVVSRFKFPSIVKNTYEIESLGEEDALSLF
CHAAFEQKYIPSTFDKKLVKQVVEECKGLPLALKVIGASLRDQPPKLWLR
AKNKLARGESICESHENKLLERMASSIEFLSGKVRECFLDLGSFPEDKRI
PLDVLINMWMELHDLDEEDAFAILVELSNKNLLNLLKDAQNRAGDIYSSY
TELSVTQHDLLRDLALHVNSQETLTSRRRLIMPRKENELPKEWDRVKDQQ
LEAQIVSINTGEMKESDWFQMHFPKAEVLILNFAADAYFLPPFLSIMPNL
KTLILINYGASCTTLQNLSVFTSLSNLRSLWLEKIAVPPLPKTTVPLQNL
RKVSLVLCELTNSLRGSKVDLSLTLPRLSHLTIDHCIDVTKLPSAICDIN
SLECLSISNCHDLSELPCEFGKLNSLKILRVYACPALKRLPHSICLLKGL
KYLDISQSFNLRELPEELGYMTSLEKFDMRECSQLKTLPRSSSSLKSLGH
VICDEDIALLWKEAERDIPDLHIQVAEESFNLDWLVE
>XP_042417193.1 probable disease resistance protein At1g58602 [Zingiber officinale]
MDASAVVRVVDKLSKLIYQEANYLGSFRDAVEWLNIELHRIQCFLKDAEP
KGSKGDERVKNWVREIRDVAYEIEDLIDIIGAASKRKNHRRRKRTFVGLA
SRYATAPFDYYSRHHLLCGIDRIKEKIVDISRSREIFGVSNFGGSRDPDR
VDVNLPTPLLASPDFEDDVHLVGFEEDKELLVRHLIDQQNQWRSFVSVVG
MGGLGKTTLAKKVYRDPRVRKQFDVLCWVSVSKNYRGAEFLNCIIEKVMG
LTGEELLRMRREELERKLDQQFQERRCLIVLDDVWLSSTCEDLKRLFPDH
KNGSRVLLTTRSLDVARSADPSFAPHMPRFLDDDESWELLQKKAFPSRRG
HERRCPGDLEEVGRKLAKNCHGLPLALVVLGSLLFKKGPFPATWNRVFES
LDWEFMEDGNKCFDILALSYDDLPDDSFRSCFLYISSFPEGSEIFVSRLI
ELWNAEGFIRPRPKEAVEKTAKDYIDELSQRCMVQVVKRIAGHGPAKSIR
IHDLLREWCISKARMEGFLHVVGGKEKNAAAIDATTACRRTALPDGLNGG
GGPYVPSPKLRALLAFNCKNLGNSKQLSFTSLRTLRVLYLEGSSGIMKLP
EDIKSMVHLRYLGLKTRLVELPPSIADLPYLEVLDARLSRIIQLPSRLWR
IATLKKVYVGSVEQPVKISKLGNSQSLRVVEWVDIAGGWIERTENEISSF
RKLGITGIQQAHRKALTRFLRKLRHLASLNLCFSDHDGEILTHVLRSLSD
HHELRSLKLHGRYFLAISRRAWGAFPPNLTKLVLNRFEFLQDPMEELEKL
RHLVDLQILAPEVGHHLVAPDYKVMTCSAGGFPRLQHLQMYGLKVEEWRI
EASAMRSLTSLTVISMVKLRRVPEGLQHIATLQELAFNDMSRDFYRRIKA
SEGEDWQFISHVPCVSIREGFMKIWLSDSFPSQQLKAFIFSRKAAKEFIM
GGRSSNVPEKLQLELLTSEDSPGVLDETDTVIEGR
>XP_042417194.1 probable disease resistance protein At1g58602 [Zingiber officinale]
MDASAVVRVVDKLSKLIYQEANYLGSFRDAVEWLNIELHRIQCFLKDAEP
KGSKGDERVKNWVREIRDVAYEIEDLIDIIGAASKRKNHRRRKRTFVGLA
SRYATAPFDYYSRHHLLCGIDRIKEKIVDISRSREIFGVSNFGGSRDPDR
VDVNLPTPLLASPDFEDDVHLVGFEEDKELLVRHLIDQQNQWRSFVSVVG
MGGLGKTTLAKKVYRDPRVRKQFDVLCWVSVSKNYRGAEFLNCIIEKVMG
LTGEELLRMRREELERKLDQQFQERRCLIVLDDVWLSSTCEDLKRLFPDH
KNGSRVLLTTRSLDVARSADPSFAPHMPRFLDDDESWELLQKKAFPSRRG
HERRCPGDLEEVGRKLAKNCHGLPLALVVLGSLLFKKGPFPATWNRVFES
LDWEFMEDGNKCFDILALSYDDLPDDSFRSCFLYISSFPEGSEIFVSRLI
ELWNAEGFIRPRPKEAVEKTAKDYIDELSQRCMVQVVKRIAGHGPAKSIR
IHDLLREWCISKARMEGFLHVVGGKEKNAAAIDATTACRRTALPDGLNGG
GGPYVPSPKLRALLAFNCKNLGNSKQLSFTSLRTLRVLYLEGSSGIMKLP
EDIKSMVHLRYLGLKTRLVELPPSIADLPYLEVLDARLSRIIQLPSRLWR
IATLKKVYVGSVEQPVKISKLGNSQSLRVVEWVDIAGGWIERTENEISSF
RKLGITGIQQAHRKALTRFLRKLRHLASLNLCFSDHDGEILTHVLRSLSD
HHELRSLKLHGRYFLAISRRAWGAFPPNLTKLVLNRFEFLQDPMEELEKL
RHLVDLQILAPEVGHHLVAPDYKVMTCSAGGFPRLQHLQMYGLKVEEWRI
EASAMRSLTSLTVISMVKLRRVPEGLQHIATLQELAFNDMSRDFYRRIKA
SEGEDWQFISHVPCVSIREGFMKIWLSDSFPSQQLKAFIFSRKAAKEFIM
GGRSSNVPEKLQLELLTSEDSPGVLDETDTVIEGR
>XP_042417195.1 putative disease resistance RPP13-like protein 3 [Zingiber officinale]
MDASAVVRVVDKLSKLIYQEANYLGGFRDAVEWLNTELHRIQCFLKDAEP
KGSKGDERVKNWVREIRGVAYEIEDLIDIIGAASKRKNHRRRKRTFVGLA
SRYATAPFDYYSRHHLLCGIDRIKEKIVDISRSREIFGVSNFGGSRDPDR
VDVNLPTPLLASPDFEDDVHLVGLEEDKELLVRHLIDQQNQWRSFVSVVG
MGGLGKTTLAKKVYRDPRVRRQFDVLCWVSVSKNYRGAEFLNCIIEKVMG
LTGEELLRMRREELERKLDQQFKCWV
>XP_042418551.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MAFIKLNLNVDVNSCLSGLWASLQLAIGRPKTAIKKLEKEMARLRGKRND
IKNQISEAEREGKIPTNEVNQWLQEVEELEGQVADINQDFQSMISCFSCN
CFSFSLTQEAGDQVPIREPSNGCSIIRRVVKKLGEANELMSRASIVLDPI
ATVGPPEPTVMLPIVHRPPVGIESYVEDIVGYIDGGEGSIIGIYGMGGVG
KTTVLKSVQRHYYNHRIIFDHVIWVVASKDCQLKRLQMEIARTLGLNTLQ
ESDDEATCGDKLFSYLKNKNCLLLLDDSCEYLNLQLLGMAHSATEQGQQQ
HELRRKVVVFTTRSEIVCARMEAEKKIKVKCLDQDQAWQLFKENVDGDVL
SSDRGINSCAQEIAKECAGLPLALITVARAMLGKKSWELWKDALHQIRDK
HEWTSTIDLSEEDSVVMYKAFKLSYDSLENDSIRECLLCCALWPEDYEIH
KFKELIPCWIGCGIIREFNVINEAFTKGCSHLEALMAASLLEHSSRRPNY
YEAEHVKMHDVIRDMALLMFSELKGNRRKSIVKAGFGLHNLPRQEEWQEA
ERALFIENQIVSLPEYEASSFPKLSMLILFFNYPPLNIPRSLFTSMPRLT
YLDLSKCFIIELPMEIGSLTELQYLNLSYNTITSLPLELGCLGKLEYLLL
RDNCLKTVPNGIISNLLMLKWLDISQQIPVCEQWWDELVHFRGCHQLSLE
ISIYATDLKRLNMLPNVSVRNLAMSGLSSNFQMLQWSLRVTDNLECLTIS
NVWKGDQLMVNAGVDCESNFKCLKTLNFKFLYQLKINWVDGVGFNNLRDL
YISNCYKLKDVSWVLQLSCLNLLSILNCQEMEEIISNVGSSNSSFGIKML
GLSKMDNLQRIAYQPLHFPYLEYITVSYCPRLKKLPFGAETVKNRLKEIQ
GGPNWWDDLDWDDHRIKDSLTPYFRDGSNLLRQEKWQPTLIVEDHIIWLP
AGLDDPEDNGSDDEEDGENEPEANGEGGSEQEDDEDDDDEEEEDDEYEEE
ENVEKDDGLQHHQQRRGSEVYCCILLGYLVLVEFFIFFLVIFTSA
>XP_042419425.1 probable disease resistance protein At1g61310 [Zingiber officinale]
MTYEGTFSSLANEVGQLKGKSVDVKREVEAAERDGLTPRREVLGWLNSVQ
NMEDEAKSIEGIYDQKIKCLCSFPFNVCSAYRLRNRAEAALATIRELKQS
AEFTKLADNLNLTRSIKMPNTKTIGMDKVFEELQRHGKDDSLSVIGIHGM
GGVGKTALLRRFNNDFPSETEADVVIFHELSIDYKLEEVQKSLFDRLSLT
WQDEVTHRDRATKLFRVLSTLNFVLLLDNLWEPLNYQVIGIPLPAAPSKC
KIIFTTRTEDTCSHMGTDKMIKVECLEEEAAWNLFRNSARMDAIDADKNI
LFEARDLVKECGVLPAALIVLAQAMAHKKTWEEWIHALRIMKDVHQLPGM
TNNVFSILRN
>XP_042419437.1 disease resistance protein RPS2-like [Zingiber officinale]
MEDEAKSIEGIYDQKIKCLCSFPFNVCSAYRLRNRAEAALATIRELKQSV
EFTKLADNLNLTRSIKMPTTKTIGMDKVFEELLRHAKDDSLSVIGIHGMG
GVGKTALLRRFNNDFPSETEADVEPLNYQVVGIPLPAPPSKCKIIFTTRT
EDTCSHMGTEKMIKMECLEQEEAWNLFRNSARMDVIDADKNIRIKARDLV
KECGGLPAALIVLAQAMAPKKTWEEWMHALTIMKDAPHQLPGMTNNVFSI
LKLSYDRLSSDNLRVCASYGALFKKGSWMGKYNIRNLWIGEGIIDNAENI
WDCTRKTQFLLGILHATSLTERVHDDYFTIHPMTRAMILWVQRECGKKEN
KWLVRDRERIEEAPTAEKWQDAERIALDWNQISDLPEAPQCPNLIFLNLH
VNKFLRKIPNGFFLHMPHLKILDLQNTSIRELPVSIGNLVQLHFLDLSET
RITSLPKEMAALVNLKYLSLESMKYLRTIPDRLISGLRELQWLDMADSYS
GWREGQTWEGGVSFEELESLKRLKVIGITVSTLAALQNLCDSLRLAAFTH
WLHIEGCQDLTMFNIPSTDFHAETMLRLIRIQLHAMSELEEVVIGNRQPI
LLPLHELRLSSLPKAKLVWRPTFPNTLRQLKIEGCGAIDRLIKLEGEANG
SGETVITIFPDLHTMVLRRLPELKSLSDGERILNFPSLKTIKVEDCPKLT
KLMLVADGLKEIECERSWWEQLNWGDERTKSFQHLYKPMYID
>XP_042419482.1 disease resistance protein RPS2-like [Zingiber officinale]
MGSVSPSSLMDIFNLLKACCSPSCNYIMTYEGTFSSLASEVGQLKDKSSD
VKRDIEAATRDGQTPRSEVLGWLSSVQDMEGEAESIERKYNQKIKCLCSF
PLNVCSAYRLRNRAEAALATIRELKQSVEFTKLADNLNLTRSIKMPTTKT
IGMDKVFEELQRHAKDDSLSVIGIHGMGGVGKTALLRRFNNDFPSETEAD
VVIFLELSIDYKLEEVQKSLFDRLSLTWQDEVTHRDRATKLFRVLSTLKF
ILLLDNLWEPLNYQVVGIPLPAPPSKCKIIFTTRTEDTCSHMGTEKMIKM
ECLEEEAAWNLFRNSARMDVIDADKNVRIEARDLVKECSGLPAALIVLAQ
AMAPKKTWEEWMHALTIMKDTPHQLPGMTNNVFSILKLSYDRLSSDNMRV
CASYGVLFIKGSWIGKYNIRNSWIGEGIIDNVQNVMDADHKTQLLHDASH
DPGHDIVERECGKKENKWLVRDRERVEEAPAAEKWRDAERIALVWNQISD
LPEAPQCPNLVFLNLQVNKFLRKIPNGFFLHMPLLRILDLQNTSIEELPV
SIGNLVQLHFLELSRTRITSLPKEMAALVNLKYLSLAFMKYLRIIPDQLI
SSLRELQWLIMMDSYSGWKEGQSCEGGVSFEELESLKRLKVIGMTVSTLA
ALQNLCDSPRLAPLTHWLHIEGCPDLTMFNIPSMDFHAETMSSLGQIQLH
AMSELEEVVIGNRQPILLPLQDLQLSSLPKAKLVWRAMFPNTLRELKIEG
CGAIDRLIKLEGEANGSGETVITIFPDLHTMVLRRLPELKSLSDGERILI
FPSLKTIKVEDCPKLTKLMLVADGLKEIECERSWWEQLNWGDERTKSFQH
LYKPMYID
>XP_042419507.1 disease resistance protein RPS2-like [Zingiber officinale]
MECLEEEAAWNLFRNSARMDVIDADKNIRIQARDLVKECGGLPAALIVLA
QAMAPKKTLEEWIHALTIMKDTPHQLPVTTCEFAPLMVHYSKKDLGLANI
ILGIWIGEGIIDNADNIWDSTRKTQFLLGILHAASLTERVNDDYCLSRAP
ISNNYFTIHPMTRAMILWVQRECGKKENKWLVRDRERVEEASAVEKWRDA
ERIALVWNQIRDLPEAPQCPNLIFLNLDVNKYLRKFPNGFFLHMPHLKIL
DLQQTSIEELPVSIGNLMQLHFLQLSGTRITSLPKEMAALVNLKYLSLES
MKYLRTIPDRLISGLRELQWLDMVDSYSGWREGQTWEGGVSFEELESLKR
LKVIGITVSTLAALQNLCDSPRLAAFTHWLHIEGCQDLMMFNIPSMDFHA
ETMLRLIRIQLHAMSELEEVVIGNRQPILLPLQELRLSSLPKAKLVWRAW
FPNTLVALKIEDCRAIDRLIKLEGEANGSGETIITIFPYLQIMVLRQLPE
LKSLSDGQRILNFPSLKTIKVEDCPKLTKLTLVADGLKEIECERLWWEQL
NWGDERTKSFEHLYNPMI
>XP_042419532.1 disease resistance protein RPS2-like [Zingiber officinale]
MGSVSPSSVMDIFNLLKACCSQSCNYIMTYGGTFSSLASEVGQLKDKSSD
VKRDVEAATRDGQTPRSEVLGWLSSVQDMEGEAESIERKYNQKIKCLCSF
PLNVCSAYRLRNRAEAALATIRELKQSAEFTKLADNLNLTRSIKMPTTKT
IGMEKVFEELLCHAKDDSLSVIGIHGMGGVGKTALLRRFNNDFPSETEAD
VVIFLELSIDYKLEEVQKSLFERLSLTWQDEVTHRDRATKLFRVLSTLKF
ILLFDNLWEPLNYQVVGIPLPAPPSKCKIIFTTRTEDTCSHMGTEKMIKM
ECLEEEAAWNLFRNSARMDVIDADKNVRIEARDLVKECGGLPAALIVLAQ
AMAPKKTWDEWIHALTIMKDTPHQLPGMTNNVFSILKLSYDRLSSDDLRV
CASYGALFKKGSRIGKYNIRNLLIGEGIIDNVQNPIDADNKTQFLLGILH
AASLTVRVHDDYFTMHPMTRAMILWVQRECGKKENKWLVRDRDRVEEAPA
AEKWRDAERIALVWNQIRDLPEAPQCPNMIFLNLHVNKFLRKIPNGFFLH
MPHLKILDLQETSIEELPVSIGNLMQLHFLELSRTRITSLPKEMAALVNL
KYLSLESMKYLRTIPDRLISGLRELQWLDMVDSYSGWREGQTWEGGVSFE
ELESLKRLKVIGITVSTLAALQNLCDSPRLAAVTHWLHIEGCQDLTVFNI
PSTDFHAETMLRLIRIQLHAMSELEEVVIGNRQSILLPLVELRLSSLPKA
KLVWRPTFPNTLVALKIERCGAIDRLIKLEGEANGSGETVITIFPYLRTM
VLRRLPELKSLSDGERILNFPWLKTIKVEDCPKLTKLTLVADGLKEIECE
RSWWEQLNWGDEQTKSFQHLYNSM
>XP_042420179.1 probable disease resistance protein At4g27220 [Zingiber officinale]
MPSHRYCSGFIILLSPLVASGSILLAIIDIAEIMVPPCFNTCCGGIGSGT
GNEIVKYSWKKLKTHACYFIYCKKKFEKLKEQFDLLKAIRDDTQQKVEAA
KRNNKVISDEVNLWLNKVLELEGKFNNIEKNFNRIVEDEKFCIPSLVSRY
KVGREATRKKDKALKLLDRSNFQAFSHPLDPSTVNHPSNADFVSFGATKE
AMQKVIDALNDDKVNLIGIYGMGGVGKTTLMEEIGRMVKGAKTFDVVIDV
VVSQNPNIAQIQRDIADALDMRESSNKMLATRLKQEKKVLIMLDDVWARL
ELVKAVGIPYREHKGCKVILTSRKAETCNVMETDVSVEVATLSEEDSWHL
FRMRAGQVAASDGIEPIARKVAQECCGLPLAIVVVGRALRSYKDSSAWED
ALSQLKQAVPLNMEEVEEKLYKPLELSYQNLKTAELKQLFLYCCLFREDY
DISEDEVTRYAVGENLLSNLSTLEDVRGRVHFLLQKLKLSCLLLDSKKAG
CVKLHDVVRDVAVYIGSKDNNHFLVKAGHGLTDWPECGNLSDCKRISLSN
NFLQEIPEKPNCSKLILLLLNMNPITWVPINFFENMATLTVLDFSNTGIT
SLPSSLTCLNGLGTLRLDRCKQLKDINVVGELKTLIILTLQECRGISALP
ETIDGLLKLKLLDLSNCTSLQILRNFIPKLTQLEELYLRGYNVTEELLVE
VASLKRLVRVELYVKCARDFSEQVFPNNAYKVLRHFIIYNEPDWFSLASK
YQRNFFIKQASQSMISWGKPFLRSAEELRLDSCQWNFTDLMSCFATLKSL
LIVNCHQIQCLLWSTDDTPSNAFGELMKLTLSDMEKLEQVCHGQLPAHSL
GKLRTLELRWCRNIVDILPQDLLQRVHPSLVELLLEGCPGPHVLLNFEGL
GHDSIIFPKLQMIRVSQMSDVISFCNGVVPPGSLHNLTTFEVVNCKKLLN
LFSQTLDTTHSRLLPSETFKKLKQLQIMGCPCLKHVFLPSIANELQSLER
LEIKNNSSIETIIANEEGCNLKKGAFPILKRLLFIKLPRLICFFEGEPAK
TLDWPSLEYIHFGDCSNLARLPIGHESAQKLKKVHVARLDDVNWFESLKW
EVDTIKSRFDIIQSINEVK
>XP_042420180.1 probable disease resistance protein At4g27220 [Zingiber officinale]
MVDPCLSNFCGGLESAIVKYFWKKLKTHTSYFIYCKKKFEKFKQQFDHLK
AIRDGTQQKVEAAKRNNEVISDEVNLWLNDVLELEEKFNNIENNFNRIVR
DEKCCIPNLAPRYKVGRDATKKKAEASELLDRKNFQVFSHTIDPSNLGHS
SNKDFVSFGATNEAMQKVIDALNDDKVNLIGIYGMGGVGKTTLMEEVGRK
MKEAEIFHVVIDVVVSHNPNIAQIQRDIADQLGMRESSNKMLTTRLKQEK
KVLIMLDDVWARLELVKEVGIPYREHKGCKVMLTSRKAETCNVMEADVSV
EVANLSEEDSWQLFRMRAGQVAESDGIELVARKVARECCGLPLAIAVVGR
ALRSYKDASAWEDALSQLKQSVPLHMEELEEKLFKPLELSYQNLKTAELK
QLFLYCCLFREDYDISEDEVTQYVVGENLLSNLSTLEDVRGRVHFLLQKL
KLSCLVLDSKKAGCVKLHDVVRDVAIYIGSKDNNHFLVKAGLGLRGWPEC
KNLADCKRISLSNNFLQKFPEKPNCSKLILLLLNMNPITSVPDNFFENMA
TLNVLDFSNTDITSLPSSLTCLKCLGTLRLDRCKWLIDINVVGELKTLII
LTLQECRGISALPESLYCLVKLKLLDLSNCTMLQIPRNSIHKLTQLEELY
LRGYNVTEALLVEVASLKSLVRVELYVKYAKDFSEQIIPADSYKVLRHFI
IYNESDRFSLASKYQRNIFIKQANHSMISWGKPFLRRAEELRLDSCQWNF
TDLIPLENLSCFATLKSLLIVNCRQIQCLLRSTDDTPSNAFGELMKLTLL
DMEKLEQVCHGQLPAHSLGKLRTLELRRCRNIIDILPQDLLVRVHQSLVE
LLLEGCPGPHVLLNFEGLGHDSVIFPKLQMIRLSQMSNLISFCNGVVPLG
SLHNLTTFEVVNCKKLLNLFSQTLDATHSRLLPSETFKKLKQLQIMGCPC
LKHVFLPSIANELHSLERLEINNNGSIETIIADEDGCDLKKGAFPMLKKV
VFIKLPRLRYFFEGEPTKILDWPSLEYIHVVECWNLARLPIERGSFQKLE
NVHFVRFDNVNWFKTLKWEDHTTKSRFDIIQSINEVK
>XP_042420181.1 probable disease resistance protein At4g27220 [Zingiber officinale]
MRAGQVAESDGIEPIARKVAQECCGLPLAIVVVGRALRSYEDASAWEDAL
SQLKQSVPLNMEEVEEKLFKPLELSYQNLKTAELKQLFLYCCLFREDYNI
SEDEVTRYAVGENLLSNLSTLEDVRGRVHFLLQKLKLSCLVLDSKKAGCV
KLHDVVRDVAVYIGFKDNNHFLVKAGLGLIDWPKYENLADCKRISLSNNF
LQEIPEKPNCSKLVLLLLNMNPITSVPINFFENMVTLNVLDFSSTEITSL
PSSLTCLKRLGTLRLDRCKRLNDINVVGELKTLIILSLQQCKGISALPET
VDGLVKLKLLDLSNCTLLQIPRNLIPKLTQLEELYLRGYNVTEALFVEIA
SLKRLVRVELYVKDAQDFSLKVIPSNAFKNLCHFIIYNELDWFTMASAYQ
RKLFIKQASQSVIIWGMPFLRGTEDLMLDSCQCNLTDLTPLENMSCFANL
KSLTLTNNHQIQCLLRSTNGTPSNAFGELVKVNILNMEKLDQICHGHLPD
LSLRKLRTLVLKRCRNLVDIFPRDLLQRVHSSLVELLLEGCPGSGILLNF
EGLGHDSVFFPKLQTIRLSQISDVISFCTGVVPPGSLHNLTTFEVVNCEK
LSYLFSPTLDATHSRLLPSDTFKKLKHLKIMGCPCLKHVFLPSTANELQS
LERLEIKNNDSMETIIAEEEGCDLEKGAFPMLNRLLFIKLPVLCCFFKGE
PAKTLDWPSLEYIHLGDCSKLAGLPIGRESAQKLKKVHVVRPDDVDWFTT
LKWEDDTIKSRFDIIQSIDEVE
>XP_042420182.1 probable disease resistance protein At4g27220 isoform X1 [Zingiber officinale]
MPSHRSFSEFIILFIAVFFFFPDFILLTIIGIAEIMVVPCFSNFCGGMES
EIGNVIVKYFWNKLKTHACYFIYSKEKFEELKEHFDILKAIRDDTQQKME
AAERNNEVISDEVNLWLNNVLELEGKFNNIENNFNRIVRDEKCCIPSLVP
RYKVGREATKKRAKALELLDRKNFQAFSHTLDPSTLTHPSNKDFVSFGAT
KEAMRKVIDALNDDKVNLIGIYGMGGVGKTVLMEEIGRKMKEAETFDVVI
DVVVSQNPNIAQIQRHIADALGMRESSNKMLATRLEKEKKVLIMLDDVWA
RLELVTEVGIPYQEHKGCKVMLTSRKAETCNVMETDVSVEVATLSEEDSW
QLFRMRAGQVAESDGIEPVARKVAQECCGLPLAIAVVGRALRSYKDARAW
EDALSQLKQSVPGNMEEVEEKLFKPLELSYQNLKTAELKQLFLYCCLFRE
DYDISEDEITRYAVGENLLSNLSTLENVRGRVHFLLQKLKLSCLVLDSKK
AGCVKLHDVVRDVAVYIGFKDNNHFLVKAGLGLIDWPKYENLADCKRISL
SNNFLQEIPEKPNCPKLILLLLNINPITSVPDNFFENMVSLNVLDLSNTD
ITSLPSSLICLKGLGTLRLDRCKQLNDINVVGELKTLVILTLQECRGITA
LPETVYGLVKLKLLDLSNCTLLQIPRNLVPKLTQLEELYLRGYNVTEALL
VEVASLKKLVRVELYVKYARDFSEQIIPDNAYKALRHFIIYNEPDWFSLA
SKNQRDFFVKQASQSMISWGKPFLKRAEALRLDSCQWNFTDLIPLESMSC
FANLQSLLIVNCHQIQCLLRSTDDTPSNAFGELMKLTLLDMENLEQICPG
QLPAYSLKKLRTLELRRCRNIVDILPQDLLQRVHPSLVELLLEGCPGPHV
LLNFEGLGHDSVIFPKLQMIRLSQMSNLISFCNGVVPPGSLHNLTTFEVV
NCKKLLNLFTQTLEATHSRLLPSETFKKLKQLQIMRCPCLKHVFLPSIAN
ELQSLERLEIKNNDFLETIITDEEGCDLKKGAFPMLKQLLLIKLPSLRYF
FEGEPAKTLDWPSLEYIHLSDCLNLARLPIGHESAQKLKKVHVVRLDDVN
WFKTLIWEDNITKSRFDIIQSINEVK
>XP_042420183.1 probable disease resistance protein At4g27220 isoform X2 [Zingiber officinale]
MVVPCFSNFCGGMESEIGNVIVKYFWNKLKTHACYFIYSKEKFEELKEHF
DILKAIRDDTQQKMEAAERNNEVISDEVNLWLNNVLELEGKFNNIENNFN
RIVRDEKCCIPSLVPRYKVGREATKKRAKALELLDRKNFQAFSHTLDPST
LTHPSNKDFVSFGATKEAMRKVIDALNDDKVNLIGIYGMGGVGKTVLMEE
IGRKMKEAETFDVVIDVVVSQNPNIAQIQRHIADALGMRESSNKMLATRL
EKEKKVLIMLDDVWARLELVTEVGIPYQEHKGCKVMLTSRKAETCNVMET
DVSVEVATLSEEDSWQLFRMRAGQVAESDGIEPVARKVAQECCGLPLAIA
VVGRALRSYKDARAWEDALSQLKQSVPGNMEEVEEKLFKPLELSYQNLKT
AELKQLFLYCCLFREDYDISEDEITRYAVGENLLSNLSTLENVRGRVHFL
LQKLKLSCLVLDSKKAGCVKLHDVVRDVAVYIGFKDNNHFLVKAGLGLID
WPKYENLADCKRISLSNNFLQEIPEKPNCPKLILLLLNINPITSVPDNFF
ENMVSLNVLDLSNTDITSLPSSLICLKGLGTLRLDRCKQLNDINVVGELK
TLVILTLQECRGITALPETVYGLVKLKLLDLSNCTLLQIPRNLVPKLTQL
EELYLRGYNVTEALLVEVASLKKLVRVELYVKYARDFSEQIIPDNAYKAL
RHFIIYNEPDWFSLASKNQRDFFVKQASQSMISWGKPFLKRAEALRLDSC
QWNFTDLIPLESMSCFANLQSLLIVNCHQIQCLLRSTDDTPSNAFGELMK
LTLLDMENLEQICPGQLPAYSLKKLRTLELRRCRNIVDILPQDLLQRVHP
SLVELLLEGCPGPHVLLNFEGLGHDSVIFPKLQMIRLSQMSNLISFCNGV
VPPGSLHNLTTFEVVNCKKLLNLFTQTLEATHSRLLPSETFKKLKQLQIM
RCPCLKHVFLPSIANELQSLERLEIKNNDFLETIITDEEGCDLKKGAFPM
LKQLLLIKLPSLRYFFEGEPAKTLDWPSLEYIHLSDCLNLARLPIGHESA
QKLKKVHVVRLDDVNWFKTLIWEDNITKSRFDIIQSINEVK
>XP_042420184.1 putative disease resistance protein RGA4 [Zingiber officinale]
MAASRPAVSLHHSLFPPPALLSTIHRLASYLSSCRTPPPSSDLHRNLSAL
HASLLRTATLVDYVTRLPPSLTGKLVDAIFAADDLVDQLEYESLQKQVEE
MEKAEAEKDGVGGKIVDLSVFRGFQTGEDDDTANLKLAAPSSSISGSLRR
PALNPSVETEAKGAELTLESNTDRGLDVESRVPDPSICGCFCSSKTKKQR
ETRSSRFLSCCFGFNKDSRSAVNGNHAAKKEDSITVAARTEIGGEIGSGT
QKNDLSSSQVSNSEGQKNSLEEINVDRIMKIVESLDIVSAYLRESTGISF
STCDLESPHEILHKEKAASSLSLGDLFFYNDEKEQLVKELLKFNEDNVCI
FPILGPRGVGKTTLAHFVYQDERIEEYFHSRVWICASDDLNSMRITGVTA
DPPSISTPLAARELEKLKFMVRNLQDQLKEKRFLLVLDDVESIEWVMQFA
SLKDCGKGSKIIITAREEGVIDERGKGNKILLKGVIDEGNHFLSFFNWCA
FNCEDPQNYSELQVISKRISTLLNGNPLAAKAVGGVLQTEFTDAHWTRIL
NELLELKDDLTDIMPVLMLCYNHLPPHLKWCFAYCSVFSKGYPFDAQNLI
NMWISLGFVEPTDSNKTVEDVGREYLDGLLSRSFLELPIYNRSYWRSRYY
AMHNLMYDLSKSVGVKECLVYENETIYQLYLDRWKYFRSFICNSKHVINF
GVLSRIRVLDLSYSGMKQLSNSIGNCIHLRYLNLDGNNLYKLPESLCKLY
HLKFLAVPENCHRLPERFNNLINLRHLNASEEAIAWIANKGRLARLQELK
KFHVRLKKGYDIGQLKDLIELKGELCIQDLNDVGRKEEVIEADLNGKTRI
EKLQLKWRTWRKEGLRVDAQEVLESLKPPPCLKHLEIHSFGGSQSPGWLE
DQSLIFLQSIHLKNCNKWNQLPPFGHLPHLKVLKIEGMNVIVDGGTWMID
PYPSLRELYLDNTSIMFEDISWQEQRCKCFLKLKKLVAVKCKRVGGLPPL
ALLSSLEELEIKKSPDLESQLSGCLKHLKSLTTLKMSAPNLTHFPCQVLQ
HLKYLEIDGCQSLVSWLIDNEEDVHHSSLVSLSIVNSPLPAGPVLVKFLT
SIRELRIDQCIKISSFSKEQKEWFASLISLEKLSISNCAQLRELPPNLHQ
LLSLKQMIIQGCPNLDSLPSNLPESLKVFEILKCNSVLVSQLLGEEAPDW
IKRIPFRYIA
>XP_042420331.1 disease resistance protein RPP8-like [Zingiber officinale]
MAYTAVNLVLGKLGELAASEVSGLLNVDAEVKSLTETLALIQSFLRDADH
KPRYEQSHSSQEWMRQIRNLAFEMEDLVDDYATRLGRASADGGRNNRLRR
IAAFPSRIRTRHRLASHLQDIHARFQDVCKQASQLGIQGSSSLPTSSSSS
SSAANATLARRFELEEDIVGFDEDMKDIKRRLFDISLTARVVLSVVGPGG
LGKTTLANKIYKSADVKNYFHCKAWVFVSQKYEVKELLCSIVKQVFDFKD
GQEKGMEELEMKEKLSEQLRDRRYLVVMDDIWEVAAWNAIKAAFPKESAG
SRVLLTTRKMNVANVADVPPHELKFWNAEESWNLFCRKAFRTTSCPPEFE
RFKKDIFRKSKGLPLAIVVLGGLLRGTSQASDWRKKLEYISYEFREGEDQ
IQRILALSYHDLPHHLKPCFLYFAAFPEDYIISSDRITRLWIAEGFIQTK
DKVDQTMEDLAEAYLNDLTDRSMLQMERKDQNYTQDVWIHDLLLDLARHE
ARELNFFRSIDDIGDDPRALRRLSVNDHISLNCSTTKLRSLVIYPNEGFQ
RTLAVTIPGAKFLRVLDLQELPIEHFPKEIGDLILLRYLNLRKSKLKELP
SSIGNLIHLQTFDIQFTKIQHLPDAFWKIRTLRHVFLNKENTSMPKATYC
SEDIQTLANISSGPWVCDGVLEQLRNLRILQLKNMSSSDVDALANAVRNL
SRLEMLVLFGELLPNSVLTSSCYHHIQILYLIGPLVRPERIHIEAENSRI
FSNLIYLSIWKTRLEKDEDIAMLSSLANLQNLQLHVDAFVGRVLVFPKGG
FPRLQEIGLSDLRTLEQWEVGAGAMPLLRYLRLQYCRNLRMLPEGLVRLT
ELKQIEISGMEMIERRVDKDTGEDYHKIKHVPWIEIYFE
>XP_042421678.1 disease resistance protein RPS2-like [Zingiber officinale]
MADIISGIISFFTCLKDCCFQSSNYIVSYERIISSLATELAQLKSKREDI
KRQIEAAERDGLNPKREVLGWLQSVEALTSEAENINGTYHQMFKCLCNFP
VNVCSGYPLRSKAEAALMTAADLKEKAGEFTDVADDLDVDRFLEMPNPKT
VGMDTALAALQGNARDDDVSIIGIHGMGGVGKTALLRRFNNHFAEMEVDN
MDVVIYLELSTGYKVEEIQKSLFDRLKLTWKDEESQRNKAGRLFRVLSKM
TFSLLLDNVWEPLNCQIVGIPLPQPPSKSKIVFATRMEEVCSRMGAEKTI
KLECLSEEASWDLFRFNAKLELVNTNTLILNLARALVQQCAGLPAALITV
AQAMASKRTIAEWRHVLAIMKEAPFQLPGMEEHVYHPLKLSYDRLSDTLR
TCASYFALVQEGCWLSKFYVRELWIGEGFINDFERLSDTADKASYLLGML
LAASLIQRIDSEYFKMHPMVRSMILWMECDCGKKESKWLIGDRHSLAEAP
GAEKWRAAERISLGWNNIALLPDEPQCPDLIYLHLRNNHPLKNIPNEFFS
HMPCLRILDLQQTSIEELPPGIGNLSQLQLLDLSSTRIASLPREIQSLVN
LRYLAMSSATHLRSIPSAVIPCLHHLQWLNMYNSYSGWRVMGALQLDGEG
VLLNEVESLKKLKVLGVTMNSVTTLRRFCESQRLTAAVHWLQIEGCGGLT
SLDIPSTYCLGENMQNMVQIRLHAMTDLEEVFIGGDLHACNALSCLEYLR
LLALPKAKIIWKNRCLENLLELEIEDCNAIDRLMKVVTNATNSTETITIF
PRLRKIVLRKLPELESLSDGDQVIAFPSLKTMEVRNCPKLKKLALAAENL
TEIKCDREWQDELDWSDERTLSFQKLFERPDRR
>XP_042421684.1 disease resistance protein RPS2-like [Zingiber officinale]
MADIISGISSIFTCLKGCCFQSCNYIVSFEGAISSLIAELDQLKSKSMDI
KRQVEAAQRDELNVKQEVLGWVKSLEDLSSEAENINAAYRRKFKCLCNFP
INVCSSYPLRTRAEAALTAAADLKKKAGEFADVADDLDVDRVLEVPNPKV
IGMDTALEELQGHVRDDDVIIIGIHGMGGVGKTALLRRFNNDFAGKELDN
LDVVIYLDLPTEYQVEELQKPLFSQLKLTWKDEATQRDRAGRLFRVLSKM
RFLLLLDNVWEPLNCQVVGIPLPQPPSKSKIVFATRMEDVCSRMGAEKTI
KLECLSSEEAWDLFRFNAKLNLASTDASILDLARALARQCAGLPAALISV
AHAMASKRTFAEWRHVLAIMKEAPFQLPGMEEHVYHPLKLSYDRLSDTLR
TCASNFALVQEGRLLSKQYVTDLWIGQGFINDFEKSSDTSDKASYLLGML
LAASLIQRFDDKYFKMHPMVRSMILWMECDCGKKESKWLKRDGHGLAEAP
GAEKWRVAERISLGWNNIALLPDEPQCPDLIYLNLRKNPPLRNIPNKFFS
HMPCLRILDLQQTSIEELPSGIGNLSQLQLLDLSFTKIASLPREIQALVN
LRYLAMPSATHLRSISSAVIPCLHRLQWLDIYNSYSGWRVAGALQSDGEG
ILLDELESLKKLKVLGITISSETALRRLSELQRLAAAVHWLQIEGCGTLA
RLDIPSTYCFGENMKNLKQIRLQAMPDLEEVIIGGDLHARNALSCLNFLY
LSALPKAKIIWKNRCLANLCGLDIQDCNVIDRLLKLEDNAANSTETITIF
PRLTKIVLRKLPELESLSDGDRVIAFPSLKTMEVRNCPKLKKLTLVAENL
REIQCDKEWWDKLDWSDERTLSFQKLFKQAD
>XP_042421685.1 disease resistance protein RPS2-like [Zingiber officinale]
MADIISGISSIFTCLKGCCFQSCNYIVSFEGAISSLIAELDQLKSKSMDI
KRQVEAAQRDELNVKQEVLGWVKSLEDLSSEAENINAAYRRKFKCLCNFP
INVCSSYPLRTRAEAALTAAADLKKKAGEFADVADDLDVDRVLEVPNPKV
IGMDTALEELQGHVRDDDVIIIGIHGMGGVGKTALLRRFNNDFAGKELDN
LDVVIYLDLPTEYQVEELQKPLFSQLKLTWKDEATQRDRAGRLFRVLSKM
RFLLLLDNVWEPLNCQVVGIPLPQPPSKSKIVFATRMEDVCSRMGAEKTI
KLECLSSEEAWDLFRFNAKLNLASTDASILDLARALARQCAGLPAALISV
AHAMASKRTFAEWRHVLAIMKEAPFQLPGMEEHVYHPLKLSYDRLSDTLR
TCASNFALVQEGRLLSKQYVTDLWIGQGFINDFEKSSDTSDKASYLLGML
LAASLIQRFDDKYFKMHPMVRSMILWMECDCGKKESKWLKRDGHGLAEAP
GAEKWRVAERISLGWNNIALLPDEPQCPDLIYLNLRKNPPLRNIPNKFFS
HMPCLRILDLQQTSIEELPSGIGNLSQLQLLDLSFTKIASLPREIQALVN
LRYLAMPSATHLRSISSAVIPCLHRLQWLDIYNSYSGWRVAGALQSDGEG
ILLDELESLKKLKVLGITISSETALRRLSELQRLAAAVHWLQIEGCGTLA
RLDIPSTYCFGENMKNLKQIRLQAMPDLEEVIIGGDLHARNALSCLNFLY
LSALPKAKIIWKNRCLANLCGLDIQDCNVIDRLLKLEDNAANSTETITIF
PRLTKIVLRKLPELESLSDGDRVIAFPSLKTMEVRNCPKLKKLTLVAENL
REIQCDKEWWDKLDWSDERTLSFQKLFKQAD
>XP_042422892.1 disease resistance protein RGA2-like isoform X1 [Zingiber officinale]
MLVFLELKHLLLEVLPSPTMVAQGRLLCIQNHLAMVCDSLWAINSMIEIP
EMGVLFNYIWHHRFNSPLHVPVEFADWVTDVATAVIDMGELLSRIMDWEA
SLHFRHVILVELKEMLCDLNSLALRGSAMGLPRDPMGSMNPLREDYSIVL
KNEVVGRHEDLEKLIEIFQQQQLVPSNNNGDDYNPFVIVIDGEERVGKTT
LAYMIYHHTWVRQQFHHRIWVDLSPSVSTLEMIKIIGKEFAESINNEEYC
DQKLHLELPLQAMWEYINEQLDGSRYLLVLHCLDLNSLISQPEWSELKNI
LLRVGGPGSAVLVILKSSTQSVSDMSFQNRVKDITTYYLKPLSDDAWLEL
FKRHAAMTIPPSKRDIVFKGSTFAMPLFQLVGQTFGAKFWGSLGHSIQVE
DLFPCEIKDIHMVRNFPFAIVRLLQYHYLLDKDYNVILHMLTAESLIPVE
GLSPGWTEIYERFRYGRESTFCFPRKVYLHRKVPGDSTTIPRCCRYLRLE
INARAIPFRLPTMPVEVNKKMIALILREDEATTQEDDKRMTFQVYKKRLM
KPATTISLQVYKKRRTKAATTISKFLDKMSVRLVHLHILVVETSMIQSLP
NEISKLVSLRYLHLSKLEIELLPKSLFDLLNLQILSLLHCKNLQKMPGRI
HKLKKLQILKLAYCTKLQQLPRSITRLKNLEELNVEGCCFLRKLPEDLVS
FKSLKILNVAGCASLSQIPHGIEQSIGLRKLSGIFVGVNEGFVLTQLQVL
TNLQEIRLQNLERAEEIQTEVLMGQQSLWDLSLHWGGEEKKESSESTTSL
QVLEALRPSLQLKRLEIISYKGVEFPTWMSKQQLAGFNSLVEVRLINLKR
CATLPSLGQLANLGKLEISGMDLITHLDDTFYGDGDIFPMLTELTFSEML
ALEKWYMTKRKYIRYFSKLRQLSLIQCPKLKEINLFVYGTIRIWLNNETI
WSVKFCSWDNLQNIEIIEIVGCQELRCLPQSMQRLKHLYKMTINSCNNLT
TLVALDSLKELNIYACPVLAFDLEAFTKLRGLTSKGCPKMQIYHDAWKKK
DEERWWKNRRR
>XP_042422893.1 putative disease resistance protein RGA3 isoform X2 [Zingiber officinale]
MLVFLELKHLLLEVLPSPTMVAQGRLLCIQNHLAMVCDSLWAINSMIEIP
EMGVLFNYIWHHRFNSPLHVPVEFADWVTDVATAVIDMGELLSRIMDWEA
SLHFRHVILVELKEMLCDLNSLALRGSAMGLPRDPMGSMNPLREDYSIVL
KNEVVGRHEDLEKLIEIFQQQQLVPSNNNGDDYNPFVIVIDGEERVGKTT
LAYMIYHHTWVRQQFHHRIWVDLSPSVSTLEMIKIIGKEFAESINNEEYC
DQKLHLELPLQAMWEYINEQLDGSRYLLVLHCLDLNSLISQPEWSELKNI
LLRVGGPGSAVLVILKSSTQSVSDMSFQNRVKDITTYYLKPLSDDAWLEL
FKRHAAMTIPPSKRDIVFKGSTFAMPLFQLVGQTFGAKFWGSLGHSIQVE
DLFPCEIKDIHMVRNFPFAIVRLLQYHYLLDKDYNVILHMLTAESLIPVE
GLSPGWTEIYERFRYGRESTFCFPRKVYLHRKVPGDSTTIPRCCRYLRLE
INARAIPFRLPTMPVEVNKKMIALILREDEATTQEDDKRMTFQVYKKRLM
KPATTISLQVYKKRRTKAATTISKFLDKMSVRLVHLHILVVETSMIQSLP
NEISKLVSLRYLHLSKLEIELLPKSLFDLLNLQILSLLHCKNLQKMPGRI
HKLKKLQILKLAYCTKLQQLPRSITRLKNLEELNVEGCCFLRKLPEDLVS
FKSLKILNVAGCASLSQIPHGIEQSIGLRKLSGIFVGVNEGFVLTQLQVL
TNLQEIRLQNLERAEEIQTEVLMGQQSLWDLSLHWGGEEKKESSESTTSL
QVLEALRPSLQLKRLEIISYKGVEFPTWMSKQQLAGFNSLVEVRLINLKS
WDNLQNIEIIEIVGCQELRCLPQSMQRLKHLYKMTINSCNNLTTLVALDS
LKELNIYACPVLAFDLEAFTKLRGLTSKGCPKMQIYHDAWKKKDEERWWK
NRRR
>XP_042422965.1 disease resistance protein RGA2-like [Zingiber officinale]
MVEWLASSFIGRLADKICSYAGNQYEHQSYDTEEKIKQLGSKAKMIKDLI
HAAEASQTSNLIFADYILRLKNEFYVLDDIFDKFDYRKIEEKVRNRNKSQ
AAHGFFQWRLLNHAAKHAQVVINRLCFSDQDLNDLLEATRMLDNVHSEMS
NLTKLVQSDLAPKSDDSLEWRITTSISGTKLFGRDNEKVSLVKLLLQPFD
ATSSSSRNFSVISIVGVGGVGKTSLAQAAFNDPAVMARFTTKVWACAHRF
DLKSLSIEILAEASSRRQENFHNLRSLEKIQLSLMKHLRGKRFLIVLDDV
WNEASGKWEMLSRSFQSAKEGSIVLITTRNQRISDMMEAKESMKLEGLGN
KDFLPFFMNCAFGCHNPGHYPKLLQLGQQIARKMGGSPLAAKTVGGALKS
NLEEDHWRRILASKLWQLHQNEYDIVPALRLSYEQLPKHLKQCFAYCSIF
PKNHCFEKDSLVQMWMALGFVQPDGQRRLEDIAGEYIDDLYSRFFFQNAA
GRSNRFAIHDLLHDVGESVSTKDHFRLENETSEIPRSVNHLSSNATHLKK
VYEFAHEMKNLRSLVVFGEKPLARPAFVELFEEVLKQLKGLRIVVLHDLP
VTKLPEAIGNLVHLRYLEIQSSHAVEFPNSLYKLYHLQGLKIKIKMLSSV
NSYGWSPKPHPAAIGDLINLRYLRISPESLYAIPGIGSLTLLQDLEQFHA
RKSSGFQIKELGNLRQLHGEICIKNLDNVRSKKHAQEARLCNKEHLRKLS
LYWNYHRQGCPSTWEYEEVLEGLQPHQNLIELKIRRYMGIRSPSWMQTSN
LEYIELSHCNRWKLLPSLGQLPFLRFLHMRSMAELEELGTQFYGDNGTAF
ESLEELKIEDMPELKEWSYSSIEPSCNLFPRLTKLHIRNCPKLRGPIPTP
TLPKEIALFLSDKITPIANDKNKLCKRQDSRLVLTTDRIWRVAQCIPEAS
LGFIHWLEMSSSFLVTFTAEQEEWLQQLSYLRHLSFSECNNMTCLPAVLK
SITSLETLHIKKCPEVKSLPQNGLPGALKEIHINGCHRELKQRCSWSGAD
GHKISHVSTILIDGEERRRIKKMRA
>XP_042423127.1 putative disease resistance protein RGA3 [Zingiber officinale]
MDVPSYITIGGWFIQVIFDKYLSSRLLAWATNSGIGDDLEKLRIAMLRIQ
SLLSCTEKTSSNGFVRWMKELRNVVYDAEDLLDELEYRRLRQQLEGETSS
PVSAFLASNLEAARDAANRAGGFLSSNLFNSSEGDNAMKTKHGNSRPLNT
PELTWDRATKASIQTITERLNQASSGVSETLTLFKLEHCNGLTQRTEKGT
TSSVSSTKVFGRQNNAKNLVELLLRLDDVQVSILPIVGMGGIGKTTLAQL
VYSNPKIVEHFELRMWVHVSSSFSDMEFTREILECASDDKHEFDGVKNFD
RLQSAIKEKLMRKRYLLVLDDVWNQENSSKLSVMERWAKLLAPLKAGKNG
SKILMTTRSRVVSEMLTARNSINLKGLSDQDCWSLIKEITFSGANPVEEL
KLEEIGQKIAQRAKGSPLAAKAAAIILKNKQNAEEWKMMLEGKNLYSDII
PIMKPSYDNLPAHLQRCFAYCSIFPKCWKFSDDLIHLWMAQGYIQPKSKD
ARMQEIGQDYMDELVCRSFFEVEKKEFVTHYVIPDLLHEMACAICKDECI
RVEDNEPTNIPPSIRHLFIKSEQFAAVTDVYQFHNLRTLICCSEIQSNVR
NVLEDVLKNLKSIRVLDLSNCKMDDLPEAICHCIHLRYLNLSATSIRQLP
ESLCRLYHLQVLNLLGCSLLSLPSCMNRLVNLRHLAAAHQLVSDIAEIGR
LICLQRLEVFRVRYEIGYKIEELKDLNELQKSLHIRNLENVQGKNEASEA
MLHMKGHLSGLQLHWLPSQRNHMVDAEVLEGLRPHQNLKRLEIIGCRGNM
YPTWLETEWLTNLEIIYLSGNENWGCLPPLAQLPSLKVLWIQGLHSVKRI
GTELFGTDEKALKWLEELVLDDMPQLECLEGRQMFPHLKSVVIKDCNKLK
TLPPLPSSLTELTVLNQGFWLPYYDDMRMGKSPSVVSSLCIYNCSLLIAE
FSVLLLQETLSSLRTLCIGDLSLLTGLIIRKNLARLQNLDIQNCLEITLL
TIEQEKAFENLTALKSLCFSGCANLQYLPELRGLHSLEKLIILNCPLIQS
LPKKGLPSLLKVLEIDSCHPLLKEGFRNNCADYWLSIKHVPRVEIDGEMI
QENASGN
>XP_042423128.1 disease resistance protein RPS5-like [Zingiber officinale]
MGSGTGNAIVKYSWKKLKKHACYFIYYKKKFEKLKEQFDLLKAITDDTQQ
KVEISKRNNEIISDEVNLWLKKVIELEEKFNNIKNNFDRIVENEKYCIPS
LIFRYKVGREATRKKDKTLKLLDQSKFQSFSHTLDPSAVNHPSNIDFVSF
GATKEAMQKVIDALNDDKVNLIGIYGMGGVGKTTLMEEISRKMKETETFD
MVIDVVVSQNPNIAQIQRDIADVLGMRESSNKMLATRLKQVKKVLIMLDD
VWARLELVKEVGIPYQEHKGCKVILTSRKAETCNVMEADVSVEVATLSKE
DSWQLF
>XP_042423201.1 putative disease resistance protein RGA3 [Zingiber officinale]
MATASKLRHVLMKILPAPEMVAQGKTFHISNHLDMIRNSLWTINSFLLDA
TLSVVEQPDVAEWMKDVGVAVEDVDSLLKRILDYWEPNEEDEVEKKRMMI
SNFLSMSSRQAILVELKDMACMLNYLVNRGAALGLWVETMDSMDPTHDDY
SAILNEEVIGREEDIDQIIELLQQQQCDEDGNAPFIITLEGTMNGKTTLA
RTIYHHPWVHRHFQHRIWLDAPLSIRSIRDFKSNVIAKEIAKYTGKSCTN
TDYWPLINEHFGGDRYLLILDGVQVSHLFAYKWKEFMLKLLHCGAPGSKV
ILTGDCFYVFGMEFYIKNYKLNMLSEDTGARILLRYSTFVHPIEANSNHK
EKASPAAVTDMQIPLKYPLLVKGLGLIYRRINTRLDKEILRRYDLDTLLK
YYSWPIERERYFQYQELFGRYSNQCSDEDLFEILVAEGTLRYNWMKNTEY
DVPFNFKTDPCFFRMKAWEGSRIPLQCRHLYLPIHSKNISKIKKVIEKAG
VANRLRTLILHMKEKKEQIYQYQTVSKILESMFVNLKHLCTLHMGGIMIQ
DLPSSVGTLHCLRYLNLAENKIETLPESLCYLGNLCVLNLSSCNKLKELP
RQIHKLRKLQILKLSGFLRIQKLPESITWLVNLKELDVGDCCYLSKLPDD
LCSMKNLMQLKMHGCASLTRMPIGIGQLTNLEVLQGYDAIDGLGNVMLSE
LQTLTNLESLHIRHLERLELAEEKNISPPTNLLENQCLNELMLHWEWWND
MVAEGTLEPTMQLTQSFQHNLRDLIVLKMVSYMSDKFPSWLMIADRDSLL
NNLTTVHLINLRRCERLPPLGHLRNLKEVAISGFDSVKVVDETFYGKDHN
CVFLHLRRLTFSEMPRLEKWVGLKHTQSRLLFRSLKELTLIQCPKLKEFH
MRFPESLSLKLFLSNEMLMPISKFVGWQNLRQVNMLQIFGCQELRNLPDG
LRMIPNLETLEIINCNKLEALPIWLKKSRLKSLCLSGCPALSFIPEELKF
MERLTNLYVEACPKLQSQLSEVCWCSGDF
>XP_042423367.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MATIIAGITALFNTLKDCCFQSSNYIVSFEGIISSLAVELVQLKNKSEDI
NRQIEAAKRDELNPKQEVLGWLKSVEDFTSEAENINTAYRRMFKCLCNFP
VNLCSSYPLRNRAEAALTVAADLKRKAGEFADVADDLEVDRLFKMPNPQT
VGMDTAVEALLGHARDDDVSIIGIHGMGAVGKTTLLIRFNNDFAEKELNN
LDVVIYVDLPTEYNAEELQKSLFDRLKLTWKDEEPQRNRAGRLFRVLSKM
RFLLLLDNVWEPLNCQILGIPLPQPPCKSKIVFATRMEEVCSRMGAEKTI
KLECLPEEAAWDLFRFNAKLDLAGTDRRILDLARILVRQCAGLPAALITM
AQTMATKRKIEEWRHVLITMEEAPFQLPRMEENVYHPLKLSYDHLNDTLL
TCASYFALVPEGYRLSKYQVNWLWIGEGFINDSETWLESVDKASYLLGML
LAASLIQRIDDEFFKMHPMVRSMILGMQCDCGKKESKWLIRAGHGLEEAP
GAEKWRISERISLGWNNIALLPDEPQCPDLIYLLLQNNHPLKNIPDEFFS
HMPRLKVLDLQNSSIKELPPGIGNLSQLRLLDLSSTRIASLPREIQALVN
LRVLRMTSTTHLRSIPGDAIPCLHQLQWLDMFNSYSGWRVVGDQQLDGEG
ILLDEVESLKKLKKLKVLNITMSSVAALRRLCESQRLAAAVYCLQIEGCG
GLASLDIPSTFCLGENIHNVALIRLHDLEEVIIGGDLQVLNALSCLEYLR
LLALPKAKIIWKNRCLENLLELEIEDCNAIDRLMKVVNNATNSTETITIF
PRLRKIVLRKLPELENLSDGDQVIAFPSLKTMEVRNCPKLKKLTLAAENL
TEIKCDREWQDELDWSDERTLSFQELFKQAD
>XP_042423635.1 putative disease resistance protein RGA4 [Zingiber officinale]
MLASYELKYLLLKMRPSPTMMAIQPLGIQHHLEMIRDNLWAVNSMTARTR
FKLLYEVGWLKNEEMEWLRDVDVATADMKNLLNQILDSKKTIVESSGRHL
HCSCLSDIRPTHHRHLILVELKEMLLNLNYLMHRGSRLGLQRESMDSMDP
LEEEYMTILKSEVVGRDEDVDKIIAILQQPSFNNHNDDDDDNDDDDNNIN
HDDNDGGGGGAAVIDDENDDPLVIVINGSKMVGKTTFARMINHHTWVCQY
FHHRIWVDVDLNSSLNLTNMIVREFQRSIIKMGETSESVCKLKLGLPLQV
MWEFVNEQLGGSRYFLVLDCKDFPNRLQEEWDGLKRTLLRVGGQGSAILI
THRTRTEFDTDMLHGVRFVETYNLDGLSEDAWLKLFLRHHDASANPSEQP
KLSLGHAKQLFKDCNGLPIWAKYTASFRYDVDWINFEFENDNDPTETFSL
IRIRTFQYLSLFLSKPNPEVILHILIADGTILDFIGVIDEISYDFWQRKW
LFKGDEFDLIEIIDEISEEFWVRKLKLEEGKFDPNEMEAIVGIQYLQIRV
GKDSRVKIPRQCRHLCLVFDSKAGAFRLPTLPVEVSSKLRTLIVQDDETA
TPISKVQTRRRAEEAAAAMRTIKMLAKLVDLHTFYLETTLIRQLPREVSK
WVNLRYLHISKNDMEFLPESLCSLSNLLILSLLRCHKLQMLPERIHELQK
LQILELVHCTKLGKLPKLVTRLKNLEELNVEGCCWLMELPEDLSSMQTLR
VLNIVGCASMSLLPHGIQKMINLRKLSGIFITAGLSDGSFGLRELQALTN
LEELRLRNLERVSKTEDETHIEPLWMIQKLQYASLHWDNDMSACEPATLL
QLLEAFKFNTHLKSIEVISYMGMEFPSWMGKEISNANSLVEVKLINLKKC
STLRPLGELENLRKLEISGMDSIKEVDDACIGVSLKELTFSEMPALQQLS
IVSYYRFRALHELKLIQCTKLNSINMESWVLYDNKVNLWLNMEPWWSREF
SGWKNMKFVRSIEIVGCQELRYLPGGMQNLRNLQELKIMSCNNLVALPNW
LNKLKSLCSLHIYACPKLSYIPEIIKTHLRVLKIEECPKLQM
>XP_042423636.1 disease resistance protein RGA2-like [Zingiber officinale]
MPVFRELQHLLLQVLPSSSLMAQGRLLCIQNHLAMVCDSLWTINSMIVIS
EMGMMHNNYFKNWPGFNLLDVPVEFADWERDVAVAVIDAGELLSRIMDWE
ASLHRSIVGNTQQVNFRHVILVELKEMLCSLNSLVLRGSSMGLRRDPMGS
MNPLREDYSIVLKNEVVGRDEDLEKIIAILERQLVSSNNNGDDNNPFVIV
IVGKGGVGKTTLAHMIYHHTWVCQQFHHRIWVDLPLFSTFKMINIIGDEF
VRSINKEEYCDQKLHLDLPLPAMWEYINEQFCGSRYLLVLHCENLVSLMQ
PAEWNELKNILLRVGGPGSGVLIIDKSSTQSALRDMSFLNGMKDIITYRL
NPLSVDALVELFKRQAATTIPSSKQHKSKKDARIFRNYFPSQTFGVKVFR
SLSQNIPTTFVTEFLNDIYMVRNFPLVIVRLHQYHQLLNVDNDYDVILHM
LTAEYLIPTEGLERGWIQLYARSLSDINRIVLALRLSRMVYLHMKVPEDS
TTISRYCRYLCLKINHRAIPFRLPTMPIEVSNKLIILILREHEEATQEDV
EEITLQVYKKRSMKATTAISKFLNKMSVRLVHLHMLVVETGMIQRLPDEV
SKLVNLRYLHLSKLKMELLPKSLFDLPNLRILSLLRCQKLQKIPEQIHQL
KKLQILKLAYCTKLQRLPKSITRLKNLEVIDVEGCCWLNKLLDDLVSFKS
LRIRNVTRCASLSQIPHGIEQSIDLRKLSGIFVGVDGGFVLAQLQTLTNL
QEIRLRNLERAEKTQAEVLMGQQSLRDLSLHWGGEEANESSESATPLQVL
KALRPSVHLKSLEIMSYKGVEFPGWMSEQQLARFDSLVEVRLINLRRCAT
LPSLGQLPCLEKLEISGMDLIAHIEDTFYGDGGTFSMLRELTFSEMLALE
KLSVPERKDADFFPNFSQLTLVQCPKLQEIDLHNCSTMRIWLNNETIWSA
KYYNWDNLQDLRIIEIVGCQELWCLPQGIRSLKYLYGMTINSCNNLTTLV
ALDSLIELNIYACPLLAFNLEAFTRLGRLTIKGCPKMQIYHDVWKKKEEK
R
>XP_042423639.1 disease resistance protein RGA2-like [Zingiber officinale]
MSVFHELKHLLLQVLPSSSLMAQGRLLCIQNHLAMVCDNLWAINSMIAFP
EMRMLSKNFSERWANFGKVLDVPPEFEDWERDVAAAVIDVGELLSRIMDW
EASFHRSIVGNTQQVNFRHVILVELKEMLCSLNSLVLRGSSMGLRRDPMG
SMNPLREDYSIVLKNEVVGREEDLEKFIAILEQQLVSSNNNGDDDDPFVI
VIDGEQGVGKTTLAHMIYHHTWVCQQFHHRIWVDLPLVSTFKTINIIGNE
FVRSMNKEEYCDQKLHLDLPLPAMWEYINEQLCNSRYLLVLHCENLVSLM
QPTEWNELKNILLRVGGPGSGVLIIDKSSTQSALRDMNFLNGMKDIITYC
LNPLSMDAWVELFKRQAATTIPSLKQDKSKKDAWRIRNYFPSHTSGVKAF
GLLSQNATAATHLLNDIYMVRNFPLVIIRLHQYHHLLDAYNDYDVILHML
TAEYLIPTEGLERGWIQLYARSLRYINKRELALRLSRMVYLHMKVPENST
IISRCCRYLCLKISHRAIPFRLPTMPVEVSNKLITLILREQEEATQEDVE
EITLQLYKKRRMKATTAISKFLNKMSVRLVHLRILVVESGMIQRLPNEVS
KLVNLRYLHLSKLKMELLPKSLFDLPNLRILSLLRCQKLQKIPERIHQLK
KLQILKLAYCTKLQQLPKSITRLKNLEALDVEGCCWLSKLPEDLVNFKSL
RILNITRCASLSQIPHGIGQSIDLRKLSGIFISVDGGFVLTQLQALTNLQ
EIRLRNLERAEKTQTELLMGQQSLHDLSLHWGGEEVDESSELALSQQVLE
ALRPNVHLKSLEIMSYKGVEFPTWMSKRQLVRFDSLVEVRLINLRRCATL
PSLGQLPCLEKLEISGMDLIKHIDNTFYGDGDTFCVLRELTFSEMLALEK
WSMPERNVFVELEQLTLIQCPKLKEIDLHSRPSLFYDVTIRVWLNNETIW
SVEFYSWDKLHYIEFYSWDKLHYIEFYSWG
>XP_042423640.1 putative disease resistance protein RGA1 [Zingiber officinale]
MSVLLELKHLLLQVLPSPGMIAQGHLLCIQNHLAMVCDSLWAINSMIVIP
NMGMLYNNCLEWDSIFDPELDVPGEFEDWERDVAAAVIDVGELLSRIMDW
EASLHRSIVGNTKQVHFRHVILVELKEMLCHLNSLVLRGSAMGLRRDPMD
SMNPLQEDDSIVLKNEVVGREEDLEKLVAIFEQQLVSSNNNGDDNNPFVI
VIDGTPGVGKTTLAHMIYHHTWVRQQFHHRIWVDLPFISTFKMINLIENE
FVRSINKKEYCDQKLHLHLPLPSMWECINEQLCGSRYLLVLHCENLVSLM
QPGEWNELKNTLLCVGGPGSGVLIIYKLSTKAAVRDTGFLNGMKDIITYR
LKPLSIDALMELFKRQAATTIPLSKQDKSEKDAWQFRNYVPSQTFGAKVF
GSLSHNISASFACNLFYDVYMVRNLPLVIIRLHQYHHLLDVDNDYDVILH
MLTAEYLIPTEGLERGWIQLYARYINKRVLALVFSRMVYLHMKVPEDSTI
IPRYCRYLCLKINHRAIPFRLPTMPVEVSNKLITLILREHEEVAQEDVEE
ITLQVYKKRRMKATTAISKFLDKMSVRLIHLRILVVETSMIQRLPNEVSK
LVNLRYLHLSKLKMELLPKSLFDLPNLRILSLCRCQKLQKIPERIHQLKK
LQILKLAYCTKLQRLPKSITRLKNLEVIDVEGCCWLSKLPDDLVSFKSLR
ILNVTRCASLSQIPRGIEQSIDLRKLSGIFVGVDGGFVLAQLQTLTNLQE
IRLRNLERAEKTQTEVLMGQQSLRDLSLHWGGEEANESSESATPLQVLET
LRPNVCLKSLEIMSYQGAEFPSWMSKRQLARLDSLVEVKLINLTRCATLP
SLGQLPCLEKLEISGMDLIKHIDDTFYGDGDTIPKLRELTFSEMLALEKW
SVPKGKYFIFFPRLTQLTLVQCPKLKEIDLHYYCGTMRVWLNNETIWSAE
FCCWDNLRYTQEIEIVGCPQGLDQLVSGWEVVP
>XP_042423652.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MSGSHELKRLLLQVLPSSTMMAQGRLLCIQNHLAMVCDSLWAINSMIVIP
EMRVVYNEYFPSLEMLDVPVEFEDWETDVAAAVIDVGELLSRIMDWEASL
HRSIVGNTQQVNFRHVILVELKEMLCNLNSLVLRGSSMGLPRDPMGSMNP
LREDYSIVLKNEVVGREEDLEKIIAILEQQLVSSNNNGDDNNPFVIVIVG
KGVGKTTLAHMIYHHTWVRQQFHHRIWVDLPLFSTFKMINIIGDEFVRSI
NKEKCCDQKLHLDLPLPAIWEFINEQLCGSRYLLVLHCENLTTLMQPEWN
ELKNILLLVGSPGSGVLIIYKTSTQLESDMGFLNGTKDIITYCLNPLSLD
ARVELFKRHAKQDKSEKDAWIFRNYFPSQTFGAKIFGSLIHNIPTSFVTD
VLNDIYMIMNFPFVIIRLHQYHHLLDVENDNDVILHMLTAEYLIPTEGLE
RDWTQLYARYLRYINKTVLALVFSRMVYLHMKVPEDSTIIPWYCRYLCLK
INHRVIPFRLPTMPVEVSNKLITLILREHEEATQEDVEEITLEVYKKRRM
KATTAISKFLNKMSVRLVHLRILVVETGMIQRLPNEVSKLINLRYLHLSK
LKMELLPKSLFDLPNLRILSLLHCQKLQKIPERIHQLKKLQILKLAYCTK
LQQLPKSITRLKNLEVIDVEGCCWLSKLPDDLLSFKSLRILNVTRCASLS
QIPRGIEQSIDLRKLSGIFVDVDGGFVLAQLQTLTNLQEIRLRNLERAEK
TQTEVLMGQQSLRDLSLHWGGEEANESSESATPLQLRSDSSISGGVLHYH
HSLNFLVSRSLR
>XP_042423656.1 putative disease resistance protein RGA4 [Zingiber officinale]
MSVFRELQHLLLQVLPSSSLIAQGRLLCIQNHLAMVCDSLWTIDSMIVIP
EMGMMYNNYCKNWPGFNLLDMPVEFADWERDVAAVVIDAGELLSRIMDWE
ASLHRSIAGNTQQVHFRHVILVELKEMLCNLNSLVLRGSAMGLRRDPMGS
MNPLREDYSIVLKNEVVGREEDLEKLVAIFEQQLVSSNNNGDDNNPFVIV
IDGKVGVGKTTLAHMIYHHTWVRQQFHHRIWVDLPLVSTFKMINIIGNEF
VRSINKEEYCDQKLHLDLPLPAMWEYINEQLCGEWNELKNILLCVGGRGS
GVLIIYKSSTKSAVRDMGFLNGMKDIITYRLNPLSVDAWVELFKRQAVMR
IPSSKQDKSEKDAWLFQNYFPSKTFGAKVFGSLSHNILAPFANKLFNDIY
MVRNFPLVIIRLHQYHHLLDVDNDYDVILHMLTAEYLIPTEGLEQGWIQL
YARSLRYINMRVQALLFSRMVYLHMKVPEDSTIIPRYCRYLCLKINHRAI
PFRLLTIPVEVSNKLITLILREHEEATQEDVEEITLQVYKKRRMKATTAI
SKFLDKMSVRLIHLRILVVETGMIQRLPNEISKLVNLRYLHLSKLKIELL
PKSLFDLPNLRILSLLRCQNLQKIPEQIHRLKKLQILKLAYCTKLQRLPK
SITRLKNLEVIDVEGCCWLSKLLDYLVSFKSLRILNITRCASLSQIPHGI
EQSIDLRKLSGIFVGVDGGFVLAQLQTLTNLQEIRLRNLERAEKTQTEVL
MGQQSLCDLSLHWGGEEADESSESATSLQVLEALRPNVHLKRLEIISYKG
VEFPTWMSKQELVRFDSLVEVRLINLRRCATLPSLGQLPCLEKLEISGMD
LIKHIDNIFYGDGDTFSVLRELTFSEMLALEKWSVPKGKCILFFPRLTQL
TLVQCPKLKEIDLHYYCGTMRVWLNNETIWSAKFYCWDNFRYIRIIEIVG
CQELRCLPQGMRRFERLSKMTINSCNNLTTLVALDSLIELNIYACPLLAF
NLEAFTELRRLTIKGCPKMQM
>XP_042423666.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MVVFLELKHLLLEVLPSPTMVAQGRLLCIQNHLAMVCDGLWAINSMIEIP
EMGTLNNQLFKMFYRFDAVTSFVPAEFADWETDVATAVIDVGELLSRIMD
WEASSHRSIVGNTQQVHFRHVILIELKEILCDLNSLVLRGSAMGLRRDPM
GSMNPLREDYSIVLKNEVVGREEDMEKLIAIFEQQLVSSNNNGFDNNPFA
IVIVGKQGVGKRTLAHMIYHHTWIGQQFHHRIWVDLPLVSTFKMIDIIGN
EFVRSIDKEEYCDQKLHLDLPLPDMWEYINEQLCGNRYLLVLHCENLVSL
MQPEWNELKNIMLRVGGPGNGVLIIYKSSTESAVRDMRFLNRLKDITTFC
LNPLSDYAWVEFVSRHAATTIPSKQDKSKKDELIQLAKLYCTNFPGQTFG
AKVFGSLFHYIPTTFAILQSRLLDDICKVRNFPLVIIRLLQYHYLLNADT
DNYYDNDYDVISHMLTAECLIPTEGLEPGWIECYERHFTQIHRKRDLKEL
LFGRMVYWHMKIPKDSTTISRCCRCLCLEINPRVKPFRLPIMPIKVSSKL
ITLILQEDKKTTREDVEEITLRVYKKRCMKAATAISKFLNKMSVRFIHLH
MLVVETSMIQSLPNEISKLVSLRYLHLSKLKMELLPKSLFDLLNLRILSL
LHCKKLQKIPERIHKLKKLQILKLAYCTKLQWLPKSITRLTNLEELNMEG
CCFLSKLPEDLVSFKSLRILNVAGCASLSQLPRGIEQLIGLRKLSGIIVG
VQGGFVLTQLQALTNLQEIRLQNLERAEEIQTEVLMGQQSLRHLSLHWGG
EEANRGSETAPSQHVLEALRPNLHLKCLDIISYKGVEFPTWMSKQQLARF
DSLVEVRFINLRRCAILPSLGQLPFLEKLEISGMDLIKHIDYTFYGDGNT
FAMLRELTFSEMLGLKKWSVPSERKNKIFFPELRQLTLIQCPKLMEICPR
LFLMLQ
>XP_042425344.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAMVLDFFVSKFIKDTSDMVEKEIFKVLGVDKEIKTLQVWLGTINGYLRQ
AKQKRQGTDEIDIWVRKLKDIMYDADDIIDLCMIEGGKLLTAQVSSSSST
VSIPFNYLISCFKCLKYRHDIANQIISLNSRLEGLKNDAVIKNNLDQTIK
EPVENANKVVFARETSHLQVEGDIVGMQIENATEKLISLILENNPKKTRV
FGVVGTGGIGKSTLASKIFKDERIKENFPKRKWLYVSKNYIETDLLKKLI
RFEEGSETKGEIFEGKSKAELENKLVTVLTRNTFIVLDDVWNSIVWTDFL
RKPIVKCASSCTILITSRKEKVVTNMRPKYIHPVEKMNEESGWNLLKHLA
FEGEEEDEISSLKEIGSKLVKKCDGLPLAIKAIGGVLYQQNKAKWEEVLE
SDVWKMDQIEEELRPLYLSYEDLTSRLKQCFLYCSLYSQKGMYYKEIVQF
WIAEGLIMDDVPTEKQKTMEDIGEEIYRELIWRNVLEADAIVDVSKDYFS
MHDHFRSLGAHLMREEGILYRHGREFKTDDNIKIRRLSVSNMGSKLVLPS
QILKQGCLRTLILMDSRKTKTIEDSVLQELSCLRVLDLTSTSIEKIPDCI
GDLLHLRYLDLDGTNIHEIPKTIGNLVNLQTLNISECQYLERLTESITML
HNLRCLEMRDTPLLTYVPKGIGKLGNFYNLQGFMVGQDDSTSEEGCDLEE
LKNLSKLRGISIYRLERAERGASALADKPFLKQLTLGWMQPDEDDTDEED
ESEGSEEEEANEGGADDTVASESEADANDDEDAGNEKGDGNDDSSKQENE
NEEAEEAGNETEDETEEDEAEEEEKGWSDEQISKAERICNEMSQPSSSIE
DLLFVEYPGRQLPSWMICSSLAESFPNLAYLKLLGLPCCTELPPLGTLPQ
LKYLSIERASAITTIGSRFLGSRSSAFPKLEVLQFEDMPRWEEWTFDGVE
ELTGHGTPLSVKLFPSLRDCVLIDCPKLRALPADLYRATDLNELCLRQTY
QLGEIINLPMAYKFEVTNGSGLKKISNISSVRYLEVDNCPNLECVENLGK
LQHLVLICSEETEQLPQWLSSLIEQHNNTSSTHRSFRKFEMQCSLQLLKT
CLEGSENWDIIKQIPIVKVTTYSEKEYIRYTKDPYMYDPHVPAN
>XP_042425346.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAMVLDFFVSKFIKDTSDMVEKEIFKMLGVDKEIKTLQVKLGTINGYLQQ
AERKRHGNDEIDIWVRKLKDVMYDADDVIDLCMIEGGKLLMAHASSSSST
VSIPFSYLFSCFKCLKYRHDIANQIISLNSRLEGLKNDAVIKNNLDQAMK
EPIENANKVVFGRETSHLQVEGDIIGTQIENATEKLISLILENNPKKTRV
FGVVGTGGIGKSTLASKIFEDERIKENFSNRKWLYVSKNYIETDLLKKLI
RFEEGSETKGENFEGKSKADLENKLVSVLTRNTFIVLDDVWNSTVWIDLL
RKPIVKSASTCTILVTSRKEKVVMQMKPAYIHSVEKMNEESGWILLKHLV
FEGGEEEDEISSLEEIGIKLVKKCDGLPLAIKAIGGVLYQQNKAKWEEVL
ESDAWKMDQIEEELRPLYLSYEDLPSTLKQCFLYCSLYPQKNMYYKEVVQ
FWVAEGLIVDDQDKSRKDLPTGKQKTLEDLGEEIYRELILRNLLEADAIV
DVSKNYFSMHDHFRSLGAHLMREEGILYRHGREFKTDENIKIRRLSISNM
APKLVLPSQILNQACLRTLILMESPKTKAIEDSVLQSLPCLRVLDLTSTS
IEKIPDCIGDLLHLRYLDLDGTNIREIPTTIGNLVYLQNLNISECQYLER
LPKSITMLHNLRCLDMRDTPLLTYVPKGIGKLENFYNLQGFLVGQNDSTS
EEGCDLEELKNLSKLRGISIFRLERAERGASALADKPFLKQLTLGWMQPD
EDDADEEEESEGANEVGSDEEADNDGNDDKDAGNEKGDDNDDCSKQENEN
EEAEEAGNETEDETEEDEAEEDKKGWNEKQIRKAERICNEMSQPSSNIED
LFFYEYPGRQLPSWMISSSLAESFPNLAYLKLLGLPCCTELPPFGTLPQL
KYLSIERASAITTIGSRFLGSRSSAFPKLEVLQFDDMPKWEEWTFDGVEE
LTGHGTPLAVKLFPSLRDCVIFDCPKLRALPAGLYRATNFNELCLRQTYV
LGEIINLPMAYKLEVTNGSGLKKISNISSVRYLEVDNCPNLECVENLTKL
QHLVLICSEETEQLPQWLSGLIEQHNNTSSTHRSFRKFEMQCSLQLLQTC
LEGNENWDIIKQIPNVKVKTPSGKAYIRYTKDPYMYDPHVPAN
>XP_042425349.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAMILDFYVSRVIKVTADMVEAEIFKVLGVDKEIKTLQGRLRTINGYLHQ
AERKRQGNDEIDIWVRKLKDIMYDADDIIDLCMIEGGKVLRAQASSGSST
VSIPSSYLFSCFRCLRYRHEVANQIIALNGRLEALKNDSFIKNNLDQTVK
EPVENTHRVFGRETSHLQVEGDIIGSQIENATDKLINLILENNPKKTRVF
GVVGTGGIGKSTLASKIFEDERIKENFPNRKWLYVSKNYIETDLLKKLIR
FEEGSETKGETFEGKSKAELEDKLVTVLTKNTFIVLDDVWNATVWIDILR
KPIVKGASSCTILVTSRKEKVVTLMKPTHIHPVEKMNEESGWNLLKHLVF
EGGEEEDEISNLEEIGIKLVKKCDGLPLAIKAIGGVLYQQNKAKWEEVLE
SDAWKMDQIEEELRPLYLSYEDLPSTLKQCFLYCSLYHQKDMYYKEIVQF
WVAEGLIMDEQEKSRNDLPTEKQKTMEDIGEEIYRELIWRNLLEADALVD
ASKDYFSMHDHFRSLGAHLMREEGILYRHGREFKTDDNIKIRRLSISNMG
PKLVLPSQILKQGCLRTLILMDSSKTKTIEDSLLQALSCLRVLDLTSTSI
EKIPDCIGDLLHLRYLDLDGTNIREIPATIGNLVNLQTLNISECQYLERL
PKSITMLHNLRCLEMRNTPLLTYVPKGIGKLGNFYNLQGFLVGQNDSISE
EGCDLEELKNLSKLRGISIFRLERAERGASALADKPFLKQLTLGWMQPDE
DDADEEEESEGANEVGADEEADNDGNDDKDAGNEKGDDNDDGSKQENENE
EAEEAGNETEDETEEDEAEEEEKGWSDEQISKAERICNEMSQPSSSIEDL
FFYEYPGRQLPSWMISSSLAESFPNLAYLQLLGLPCCTELPPFGTLPQLK
YLRIEQASAITAIGSQFLGSRSSVFPKLELLRFVGMPKWEEWTLDGVEEL
TGHGTPLAVKLFPSLRDCILIDCPKLRALPADLYRATNFSELCLRQTYEL
GEIINLPMANKLEVTNASGLKKISNISSVRYLEVDNCPNLECVENIGKLQ
HLVLICSEEMEQLPQWLSVLIEQHNNTSSTHRSLRKFEMQCSLQLLKTCL
EGNENWDIIKQIPIVKVTTYSEKEYIRYTKDPYMYDPHVPAN
>XP_042425823.1 putative disease resistance protein RGA3 [Zingiber officinale]
MGGIGKTTLAQLVYSNPKIVEHFELRMWVHVSSSFSDMEFTREILECASD
DKHEFDGVKNFDRLQSAIKEKLMRKRYLLVLDDVWNQENSSKLSVMERWA
KLLAPLKAGKNGSKILMTTRSRVVSEMLTARNSINLKGLSDQDCWSLIKE
ITFSGANPVEELKLEEIGQKIAQRAKGSPLAAKAAAIILKNKQNAEEWKM
MLEGKNLYSDIIPIMKPSYDNLPAHLQRCFAYCSIFPKCWKFSDDLIHLW
MAQGYIQPKSKDARMQEIGQDYMDELVCRSFFEVEKKEFVTHYVIPDLLH
EMACAICKDECIRVEDNEPTNIPPSIRHLFIKSEQFAAVTDVYQFHNLRT
LICCSEIQSNVHNVLEDVLKNLKSIRVLDLSNCKMDDLPEAICHCIHLRY
LNLSATSIRQLPESLCRLYHLQVLNLLGCSLLSLPSCMNRLVNLRHLAAA
HQLVSDIAEIGRLICLQRLEVFRVRYEIGYKIEELKDLNELQKSLHIRNL
ENVQSKNEASEAMLHMKGHLSGLQLHWLPSQRNHMVDAEVLEGLRPHQNL
KRLEIIGCRGNMYPTWLETEWLTNLEIIYLSGNENWGCLPPLAQLPSLKV
LWIQGLHSVKRIGTELVGTDEKALKWLEELVLDDMPQLECLEGRQMFPHL
KSVVIKDCNKLKTLPPLPSSLTELTVLNQGFWLPYYDDMRMGKSPSVVSS
LCIYNCSLLIAEFSVLLLQETLSSLRTLCIGDLSLLTGLIIRKNLARLQN
LDIQNCLEITLLTIEQEKAFENLTALKSLCFSGCANLQYLPELRGLHSLE
KLIILNCPLIQSLPKKGLPSLLKVLEIDSCHPLLKEGFRNNCADYWLSIK
HVPRVEIDGEMIQENASGN
>XP_042425825.1 putative disease resistance protein RGA4 [Zingiber officinale]
MAASRPAASLHHSLFPPPALLSTIHRLASYLSSCRTPPPSSDLHRNLSAL
HASLLRTATLVDYVTRLPSSLTGKLVDAIFAADDLVDQLEYESLQKQVEE
MEKAEAEKDGVGGKIVDLSVFRGFQTGEDDDTANLKLAAPSSSISGSLRR
PALNTSVETEAKGAELTLESNTDRGQDVESRVPDPSICGCFCSSKTKKQR
ETRSSRFLSCCFGFNKDSRSAVNGNHAAKKEDSSTVAARTEIGGEIGSGT
QKNDLSSSQVSNSEGQKNSLEEINVDRIMKIVESLDIVSAYLRESTGIAF
STCHLESPHEILHKEKAASSLSLGDLFFYNDEKEQLVKELLKFNEDDVCI
FPILGPRGVGKTTLAHFVYQDERIEEYFHSRVWICASDDLNSMRITGVTA
DPPSISTPLAFRELEKLKFMVRNLQDQLKEKRFLLVLDDVESIEWVMQFA
SLKDCGKGSKIIITAREEGVIDERGKGNKILLKGVIDEGNHFLSFFNWCA
FNCEDPQGYSELQVISKRISTLLNGNPLAAKAVGGVLQTKFSDAHWTRIL
NELLELKDDLTLKDDLTDIMPVLMLCYNHLPPHLKWCFAYCSVFSKGYPF
DAQNLINMWISLGFVEPTDSNKTVEDVGREYLDGLLSRSFLELPIYNRSY
WRSRYYAMHNLMYDLSKSVGVKECLVYENETIYQLYLDRWKYFRSFICNS
KHVINFGVLSRIRVLDLSYSGMKQLSNSISNCIHLRYLNLDGNNLYKLPE
SLCKLYHLRFLAVPENCRRLPERFNNLINLRHLNASEEAIAWIANKGRLA
RLQELKKFHVRLKKGYDIGQLKDLIELKGELCIQDLDDVGRKEEVIEADL
NGKTRIEKLQLKWRTWRKKSLRVDAQEVLESLKPPPCLKHLEIHSFGGSQ
SPGWLEDQSLIFLQSIHLKNCNKWNQLPPFGHLPHLKVLKIEGMNVIVDG
GTWMIDPYPSLRELYLDNTSIMFEDISWQEQCCKCFLKLKKLVAVKCKRV
GGLPPLALLSSLEELEIKKSPDLESQLSGCLKHLKSLTTLKMSAPNLTHF
PCQVLQHLKYLEIDGCQSLVSWLIDNEEDVHHSSLVSLSIVNSPLPAGPV
LVKFLTSIRELRIDQCIKISSFSKEQKEWFASLISLEKLSISNCAQLREL
PPNLHQLLSLKQMIIQGCPNLDSLPSNLPESLKVFEILKCNSVLVSQLLG
EEAPDWIKRIPFRYIA
>XP_042426036.1 probable disease resistance protein At4g14610 [Zingiber officinale]
MRLDVAVKQLAGLVSFFEKYRENDFALAMVDAKKIAFDMEIESVFPTKRK
ISRKRHFDEIANTERENQSLEESFRTNYFILVVDIALGQLKISTKLPLEF
PDGTTPVTCQLGEELWFTVGGQHIPFGASPQQKWPISFPASLHSSLVSRI
AAFNLATTSCRTREPSPPLLRSWPNSKSKREDIKRQIDAAERDGLNPKRE
VIDWLQSVEALASEAENINAAYRQMFKCFCNFPVNVCSSYSLRNRAEAAL
MELVELKGHARDDDISIIGIHGMGCVGKTAILRRFNNDFEEKELDNLDVV
IYLELSTGYKVEELQRSLFDRLKLKWQDEEPQRNRAYRLFRVLSKMRFLL
LLDSVWEPLNSQVVGIPLPQPPSKSKIVFATRMEEVCSRMGAEKIIKLEC
LSEEEAWDLFRFNAKLDLAGTNQLIQNLARTLARQCAGLPEALITVARAM
ANKRTIAEWRHVLAIMKEAPFYDTLRTCVSYFAQAPGAEKESKWMIGDRR
GLTEAPGAEKWRVVERISLGCNNITVLPDEPQCPDLIYLSLRYNHPLKNI
PNEFFSHIPCLRSLDLRNTSIEELPDGIATHLRSIPCAVIPCLHQLQWLN
MNNIYSGWRVMGALQLDGEGILLDEVESLKKLKVLGITMSSETALRRFCQ
SQRLAAAGHWLQIEGCRGLASLNIPFTCCLGKNMQNMIMILLHAMHDLEE
VMIGGDLHVLNALSCLEYLRLLALPKAKIIWKNRCLVNLCVLEIKDCSVI
DRLLKLEDHETNSTETIATFPRLTKIVLRKLPELESLSDRDRVRAFPSLK
TMEARNCPKLKKLTLVAENLTEIKYDKEWRDELDWSDERTLSFQKLLK
>XP_042426042.1 disease resistance protein RPS2-like [Zingiber officinale]
MGTIIAGIAALFNTLKDCCFQSSNYIVSFEGAISSLALEVAQLKNKSEDI
NRQIEAAKRDELNPKQEVLGWLKSVEDLALEAENINASYRRMFKCLCNFP
INLCSSYPLRSRAEAALTAAADLKKAGEFVNVADNLDVDRVREMPNPKTV
GMDTTLEALLGHARDDDVSIIGIHGMGGIGKTALLRRFNNNLAEKELDNL
DVVIYVDLPIEYKVEELQRSLFDPLKLTWKDEEPQRNRAGRLFRVLSKMR
FLLLLDNVWEPLNCQVVGIPLPQPPSKSKIVFATRIEEVCSRMGAEKIIK
LECLSEEEAWDLFRFNAKLDLAGTNPWILDLARALVQQCDGLPAALITMA
QAMASKRTIEEWRHVLAIMEEAPFRLPGMEENVYHPLKLSYDRLSGTLRT
CASYFALVQEGRWLSKYYVRHLWIGEGCIGDFERLVDATDKSSYLFGMLL
GASLIQRIDGEYLKMHPMVRSMILWMECDCGKKESKWLTGEGHCLAEAPG
TEKWRIAERISLGWNNIALLPDEPRCPDLIYLNLRNNHPLKNIPDAFFSH
MPCLRVLDLQQTFIEELPSGIGNLSQLRLLDLTGTRIASLPREIQALVNL
RFLGMPSTTHLRNIPGDVIHCLHQLQLLDMYDSYSGWRVVGALQLDGEGI
LLDEVESLKKLKFLGITMSSLTTLRRFCESQRLAEAVYRLQIEGCGGLAS
LHIPSTYCLGESMKQTIRIRLHAMPDLEEVIIGGDLHVLNALSCLGNLEL
SALPKAKIIWKNRCLENLVELEIEDCNAIDRLMKLENNATHSTETIIVFP
ILTKIVLRKLPELESLSDGDQVIAFPSLQTMEVMNCPKLKKLTLVAENLT
EIRCDREWWDELDWSDERTLSFQELFKQAD
>XP_042426299.1 disease resistance protein RGA2-like [Zingiber officinale]
MLASYELKYLLLKMRPSPTMMAIQPLGIQHHLEMIRDNLWAVNSMTAKIR
FELLFAVGWLKNEEMDWLRDVDVAIADMKNLLNQILDSKKTIVESSGRHL
HCSCLSGIRPTHHRHLILVELKEMLLNLNYLMHRGSRLGLQRESMYSMDP
LEEEYMTILKSEVVGRDEDVDKIIAILQQPSFNNHNDDDDNDDDDDNDVN
HDDDDGGAAAAVIDDENDDPLVIVINGPKMVGKTTFARMIYHHTWVCQYF
HHRIWVDVDLNSSLNLTNMIVREFQRSIIKMGEASEHVCKLKLGLPLQVM
WEFVNEQLGGSRYFLVLDCKYFPNRLQEEWDGLKRTLLRVGGQGSAILIT
HRTRTEFDTDMLPGMRFVETYNLDGLSEDAWLKLFLRHHDASANPSEQPK
LSLGHAKQLFKDCNGLPIWAKYTGSFRYDVDWINFEFENDNDPTETFSLI
RIRTFQYLSLFLSKPNPEVILHVLIADGTILDFIGVIDEISYDFWQRKWL
FKGDDFDLIEIIDEISEEFWLGKLKLEEGKFDPNEMEAIVGIQYLQIRVG
KDSRVKIPRQCRHLCLVFDSKASAFRLPTLPVEVSSKLRTLIVQDDETAT
PISKVQTRRRPEEAAAAMRTIKMLAKLVDLHTFYLETTLIRQLPREVSKW
VNLRYLHISKNDMESLPESLCSLTNLLILSLVRCHKLQMLPERIHELQKL
QILELVHCTKLGKLPKLVTRLKNLEELNVEGCCWLMELPEDLSSMQTLRV
LNIVGCASMSLLPNGIQKMINLRKLSGIFITAGLSDGSFGLRELQALTNL
EELRLRNLERVSKTEDETHIEPLWMIQKLQYASLHWDNDMSVCEPATLLQ
LLEAFKFNTHLKSIEVISYMGMEFPSWMGKEISNANSLVEVKLINLKKCS
TLRPLGQLENLKKLEISGMDSIKEVDDACIGVSLEELTFSEMPALQQLSI
VSYYCDRALRELKLIQCTKLNSFNMDSWVLYDKKVDLWLNMEPWWSREFS
GWKNMKFVRSIEIVGCQELRYLPGDMQNLRKLQELKIMSCNNLVALPNWL
NKLKSLCSLHIYACPKLSYIPEIIKTHLRVLKIEECPMLQM
>XP_042426308.1 disease resistance protein RGA2-like [Zingiber officinale]
MSVLLELKHLLLQVLPSPGMIAQGHLLCIQNHLAMVCDSLWAINSMIVIP
KMGMLYNNCLKFYSIFDPELDVPAEFEDWERDVAAAVIDVGELLSRIMDW
EASLHRSIVGNTQQVNFRHVILVELKEMLCHLNSLVLRGSSMGLRRDPMG
SMNPLREDYSIVLKNEVVGREEDLEKLVAIFEQQLVSSNNTGDDNNPFVI
VIDGTPGVGKTTLAHMIFHHTWVRQQFHHRIWMDLPLVSPFKMINIIGNE
FARSINKEEYCDQKLLLDLPLLAMWEYINKQLCGSRYLLVLHCENLVSLM
QSGEWNELKNILLRVGGPGSGVLIIYKFSTVSFVRDTGFLNRMKDIITYP
LKTLSADACVELFKRQAATTIPSSKQDKSERDAWLLRNCIPEQAFGAKVF
GSLSHNIPAYFANSLFYEVYIVRNLPLVIIRLHQYQRLLDVYNDYDVILH
MLTAEYLIPTEGLERDWIRLYARPINERTSLRLSRMVHLHMKVPEYLTSI
PRCCRYLCLKINHRAIPFRLPTMPVEVSNKLITLILREHEEATQEDVEEI
TLQVYKKRCMKATTAISKFLNKMSVRLVHLRILVVETGMIQRLPNEVSKL
VNLRYLHLSKLKMELLPKSLFDLPNLRILSLLRCQKLQKIPERIHQLKKL
QILKLAYCTKLQRLPKSITRLQNLEVIDVEGCCWLSKLPDDLVSFKSLRI
LNFTRCASLSQIPRGIEQSIDLRKLSGIFVGVDGGFMLAQLQTLTNLQEI
RLRNLERAEKTQTEVLMGQQSLRDLSLHWGGEEANESSESATPLQVLEAL
RPNVHLKSLEIMSYQGVEFPTWMSKRQLARLDSLVEVKLINLRRCATLPS
LCQLPCLEKLEINGMDLIKHIDDTFYGDGDTIPKLRELTFSEMLALEKWS
MTEEKYFKFFPRLRKLTLVQCPKLKEIDLHYYSGTMRVWLNNETICSAKF
CCWGNLRYIQTIEIVGCQELRCLPQGMKSMKYLNKMTINSCNNLTTLVAL
DSLRALNIYACPLLAFNLESFTELVLLTIKGCPKMQIFHDVWKKKEGEEI
KRRRAEEEKRRQAQVEAYDNAIATRSVIDWLELW
>XP_042426309.1 disease resistance protein RGA2-like [Zingiber officinale]
MSAPLYRSHPSPKLKHLLLQVLPSSSMMAQGRLLCIQNHLAMVCDSLWAI
NSMIVIPEMRMLYNNMSERWTYFGKVLDVPPEFADWERDVAAAVIDAGEL
LSRVMDWEASLHRSIVGNTQQVNFRHVILVELKEMLCNLNSLVLRGSSMG
LPRDLMGSMNPLREDYSIVLKNEVVAREEDLEKLIAILERQLVSSNNNGD
DNNPFVIVIDGEQEVGKTTLAHMIYHHTWVRQQFHHRVWMYLPIVSTFKM
INIIGNEFVRSINKEEYCDQKLHLDLPLLAMWEYVNEQLCGSRYLLVLHC
ENLASLMQPEWNELKNILLRVGGPGSGVLIIYKTSTESAVRDMSFLNGMK
DIITYCLNPLSVDTWVALFKRHTATTIPSKQDKLEKDTWLIPFARQHSLD
LPSQTFGAKVFGSLIHINLAAFDRSFVAQEIFMVRNFPLVIV
>XP_042426310.1 putative disease resistance protein RGA4 [Zingiber officinale]
MSVFHELKHLLLQVLPSSSLMAQGRLLCIQNHLAMVCDNLWAINSMIAFP
EMRMLSKNFSERWANFGKVLDVPPEFEDWERDVAVAVIDVGELLSRIMDW
EVSLHRSIVGNTQQVNFRHVILVELKEMLCSLNSLVLRGSSMGLRRDPMG
SMNPLREDYSIVLKNEVVDREEDLEKFIAILEQQLVSSNNNDDDDDPFVI
VIDGEQGVGKTTLAHMIYHHTWVCQQFHHRIWVDLPLVSTFKTINIIGNE
FVRSINKEEYCDQKLHLDLPLPAMWEYINEQLCGSRYLLVLHCENLVSLM
QPAEWNELKNILLRVGGPRSGVLIIDKSSTQSAFRDMVFLNGMKDIITYC
LNPLSKDAWVELFKRQAATTIPSLKQDKSKKDAWRFRNYFPSHTSGVKVF
GLLSQNATAATHLLNDIYMVRNFPLVIIRLHQYHHLLDVYNDYDVILHML
TAEYLIPTEGLERGWIQLYARSLRYINRRELALRLSRMVYLHMKVPEDST
IISRCCRYLCLKISHRAIPFRLPTMPVEVSNKLITLILREQEEATQEDVE
EITLQLYKKRRMKATTAISKFLNKMSVRLVHLRILVVETGMIQRLPNEVS
KLVNLRYLHLSKLKMELLPKSLFDLPNLRILSLLRCQKLQKIPERIHQLK
KLQILKLAYCTKLQQLPKSITRLKNLEALDVEGCCWLSKLPEDLVNFKSL
RILNITRCASLSQIPHGIGQSISLRKLSGIFIGVNGGFVLTQLQTLTNLL
EIRLRNLERVEKTQTELLMGQQSLRDLSLHWDGEEADESSELAPSQQVLE
ALQPNVHLKMLEIISYKGVEFPTWMSKQQLALFDSLVEVRLINLKRCATL
PSLGQLPCLEKLEISGMDLIKHIDNTFYGDGDTFSVLRELTFLEMLALEK
WSMPERKNVHVFNKLERLTLIQCPKLKEIDLHSRPCLFFGVTIRVWLNNE
TIWSVEFYSWENLQYIEIIEIVGCQELRCLPQGMQSLKHLSEMTINSCSN
LTTLVALHSLEELNIYACPLLPFNLEAFRELRRLTIKGCPKMQM
>XP_042426311.1 putative disease resistance protein RGA4 [Zingiber officinale]
MVCDSLWAINSMIEIPEMGVRYNEYPPSWGKLDVPVEFVDWEIDVAAAVI
DVGELLSRIMDWEASLHRFIVGNTQQVNFRHVILVELKEMLCHLNSLVLR
GSSMGLRRDPMGSMNPLREDYSIVLKNEVVGREEDLEKLVAIFEQQLVSS
NNNGDDNNPFVIVIDGKPGVGKTTLAHMIYHHTWVRQQFHHRIWVDLPLV
STFKMITIIGNEFVRSINKEEYCDQKLHLDLPLPAMWEYINEQLCGSRYL
LVLHCENLVSLMQPGEWNELKNILLRVGGCGSGVLIIYKSSTKSVVRDTG
FLNGMKDIITYCLNPLSVDAWVELFKRQATTTIPSSKQDKSAKDAWLFRT
YFPSQTFGPKVFGSLSQNIQAPFKTDFLYNIYKVRNFPLVIIRLHQYHHL
LDVDNDYDVISHMLTAEYLIPTEGLERGWIQLYAGSLRYISRQLPALVFS
RIIYLHMKVPEDSTIIPRYCRYLCLKINHRAIPFRLPTMPVEVSNKLITL
ILREHEEATQEDVEEITLEVYKKRRMKTTTAISKFLDKMSVRLIHLRILV
VETGMIQRLPNEVSKLVNLRYLHLSKLKMELLPKSLFDLHNLRILSLLRC
QKLQKIPERIHQLKKLQILKLAYCTKVQQLPKSVTRLKYLQVLDVEGCCW
LSKLPEDLVSFKSLRILNVTRCASLSQIPHGIGQSIDLRKLSGIFIDVNG
GFVLTQLQALTNLQEIRLRNLERAEKTQTEVLMGQQSLCDLSLHWGGEEA
DESSESATPLQVLEALRPNMHLKMLEIISFKGVEFPTWMSKQQLVRFDSL
VEVRLINLRRCATLPSLGQLPCLKKLEISGMDLIKHIDNTFYGDGGTFSV
LRELTFSEMLALEKWSEPERKNAYVFDKLQQLTLIQCPKLKEIDLHSRPY
LFFGGTMRVWLNNEIIWSAEFCNWNNLRYIEIIEIVGCQELKCLPQGMRS
FECLSKMTINSCNNLTTLVALDSLIELNIYACPLLAFNPEAFTSLRRLTI
KGCPKMQM
>XP_042426317.1 disease resistance protein RGA2-like [Zingiber officinale]
MELKHLLLEVLPSSTMVAQGRLLCIQNHLAMVCDSLWAINSMIEIPEMGL
LYNNAWHHRFNSPLDVPVEFADWVTDVATAVIDVGELLSRIMDWEASLYF
RHVILVELKEMLCDLNSLVLRGSAMGLPRDPMGSMNPLREDYSIVLKNEV
VGRHEDLEKLIEIFQQQQLVPSNNNGDDYNPFVIVIDGQKGVGKTTLAYM
IYHHTWVRQLFHHRIWVDLPPGVSTPKMINFIGKEFAKSIKNEEYCDKKL
HLELPLQAMWEFINEQLDGSRYLLVLHCPDLASLILQPEWNELKKILLRV
GGPGSAVLVILKSSTQSVSDMSFQNRVKDITTYCLKPLSDDAWLELFKRH
AAMTIPPSNRDIVFKCSPYAMPHFQFVGETFGAKFWGSLGHNIQLGNLYP
CEIKDIHMVRNFPFAIVRLLQYHYLLDKDYNFILHMLTAEGLIPVEGLSP
SWTEIYDRFRYNRILTFCLPRKVYLHRKVPGVSTTIPRCCRYLHLEINPR
AIPFRLPTMPVEVSKKMIALVLREDEATTQEDDEVMTLQVYKKRRTKAAT
AISKFLDKTSVRLVHLHILVVETRMIQRLPNEVSKLVSLRYLHLSKLEIE
LLPKSLFDLPNLRILSLLHCKNLQKIRERIHKLKKLQILKLAYCTKLQQL
PRSITRLKNLEELNVEGCCFLRKLPEDLVSFKSLRILNVAGCASLSQIPH
GIEQSIGLRKLSGIFVGVNEGFGLTQLQALTNLHELKLRNIERTEETQTE
VLMGQQSLWDLSLHWGGEEKKESSESTTSLQLLEALRPSLQLRRLEIISY
KGVEFPTWMSKQQLAGFNSLVEVRLINLKRCATLPSLGQLANLEKLEISG
MDLITHLDDTFYGDGDIFPKLTELTFSEMLALEKWYMPKRKYIPLGQLSL
IQCPKLKEINLFVYNTIRIWLNNETIWSVRFCSWDNLQSIQIIEIVGCQE
LRCLPQSMQRLKHLYKMIINSCNNLTTLVALDSLEALNIYACPVLAFDLA
AFTNLWTLTIKGCPKMQIYHDAWKKKDEERW
>XP_042426321.1 putative disease resistance protein RGA3 [Zingiber officinale]
MVAQGRLLCIQNHLAMVCDGLWAINSMIEIPEMGVLYNYIWHHRFNSPLD
VPVEFADWVTDVATAVIDVGELLSRIMDWEASLHFRHVILVELKEMLRDL
NSLVLRGSAMGLPRDPMGSMNPLREDYSIVLKNEVVGRHEDLEKLIEIFQ
QQQLVPSNNNGDDYNPFVIVIDGEERVGKTTLAYMIYHHTWVRQQFHHRI
WVDLPLSVSTLKMINIIGKEFAKSINNEEYCDQKLHLELLLQAMWEYINE
QLDGSRYLLVLHCLDLNRLISQPKWSELKNILLRVGGPGSAVLVILKSST
QSVSDMSFQNEVKDITTYCLKPLSDDAWLELFKRHAAMIIPPSKRDIVFK
GGTFAMPLFQLVGQTFGAKFWGSLGHSIQVEDLFPCEIKDIHMVRNFPFA
IVRLLQYHYLLDKDYNVILHMLTAEGLIPVEGLSPGWTEIYERFHYGRVS
TFCFPRKVYLHRKVPGDSTSIPRCCRYLHLEINPRAIPFRLPTMPVEVSK
KMIALILREDEATTQEDIAEMTFQVYKKRRTKAATAISKFLDKMSVRLVH
LHILVVETSMIQCLPNEISKLVSLRYLHLSKLEIELLPKSLFDLPNLQIL
SLLHCKNLQKMPGRIHKLKKLKILKLAYCTKLQQLPRSITRIKNLEELNV
EGCCFLRKLPEDLVSFKSLRILNVAGCASLSQIPHGIEQSIGLRKLSRIF
VGVNEGFVLTQLQVLTNLQEIRLQNLERAEEIQIEVLMGQQSLWDLSLHW
GGEKKEESSESTTSLQVLEALRPSLQLKRLEIISYKGVEFPTWMSKQQLA
GFNSLVEVRLINLKRCATLP
>XP_042426322.1 disease resistance protein RPS4-like [Zingiber officinale]
MVVFLELKRLLLEVLPSPTMMAQGRLQCIQNHLALVCDSLWAINSMIEIP
EMGMLNNHFSKKFYGFDVVTSFVPAEFADWETDVATAVHFRHVILVELKE
ILCHLNSLVLRGSAMGLRRDLMASMNPLREDYSIVLKNEVVGREEELEKL
IAIFEQQLVSSNNNGFDNNPFAIVIVGKQGVGKRTLAHMIYHHTWIGQQF
HHRIWVDLPLVSTFKMINIIGNEFVRSIDKKEYCDQKLHLDLPLPDMWEY
INEQLCGSRYLLVLHCENLVSLMQPEWNELKNIMLRVGRSGSGVLIIYKS
STESAVRYMSFLNRLKDITTFCLNPLSADAWVELVSRHAATTIPLKRDKS
EKDELIPFAEQHSSNFLGQTFGAKVFGSLFHDIPTTFATLESCSLDDIYM
VRNFPLVIVRLLQYRHLLDADTDKYYDNDYDVISHMLTAECLIPTEGLEP
GWIERYERFFTEIDIKWELFELLFRRMVYLHMKIPKDSTTIYRCCRCLCL
EINPRVIPFRLPIMPIKVSSKLITLILHEDKKTTREDVEEITLRVYKKRR
MKAATAISKFLNKMSVRFVHLHMLVVETSMIQSLPNEISKLVSLRYLHLS
KLKMELLPKSLFDLLNLRILSLLHCKKLQKIPERIHKLKKLQILKLAYCT
KLQWLPKSITRLTNLEELNTQGCCFLSKLPEDLVSFKSLRILNVAGCASL
SQLPRGIEQSIGLRKLSGIFIGVQGGFVLTQLQALTNLQTIRLKNLERVE
EIQTVKC
>XP_042426395.1 probable disease resistance protein At4g27220 [Zingiber officinale]
MVVPCFSNSCGGMESEIGNVIVKYFWNKLKTHVCYFIYSKEKFEKLKEHF
DILKAIRDDTQQKMEAAERNNEVISDEVNLWLNNVLELEGKFNNIENNFN
RMVRDEKCYMPSLVPRYKVGREATKKRAEALELLDRKNFQAFSHTLDPST
LNYPSNKDFVSFGATKEAMRKVIDALNDDKVNLIGIYGMGGVGKTVLMEE
IGRKMKEAETFDVVIDVVVSQNPNIAQIQRCIADALGMRESSNKMLATRL
EKEKKVLIMLDDVWARLELVTEVGIPYQEHKGCKVMLTSRKAETCNVMET
DVSVEVATLSEEDSWQLFRMRAGQVAESDGIEPVARKVAQECCGLPLAIA
VVGRALRSYKDASAWEDALSQLKQSVPGNMEEVEEKLFKPLELSYQNLKT
AELKQLFLYCCLFREDYDISEDEITRYAVGENLLSNLSTLENVRGRVHFL
LQKLKLSCLVLDSKKAGCVKLHDVVRDVAVYIGFKDNNHFLVKAGLGLID
WPKYENLADCKRISLSNNFLQEIPEKPNCPKLILLLLNINPITSVPDNFF
ENMVSLNVLDLSNTDITSLPSSLICLKGLGTLRLDRCKQLNDINVVGELK
TLVILTLQECRGISALPETVYGLVKLKLLDLSNCTLLQIPRNLVPKLTQL
EELYLRGYNVTEALLVEVASLKKLVRVELYVKYARDFSEQIIPDNAYKAL
RHFIIYNEPDWFSLASKNQRDFFVKQASQSMISWGKPFLKRAEALRLDSC
QWNFTDLIPLESMSCFANLQSLLIVNCHQIQCLLRSTDDTPSNAFGELMK
LTLLDMENLEQICPGQLPAHSLKKLRTLELRRCRNIVDILPQDLLQRVHP
SLVELLLEGCPGPDVLLNFEGLGHDSVIFPKLQMIRLSQISDVISFCTGV
VPPGSLHNLTTFEVVNCKKLLNLFSQILEATHSRLLPSETFKKLKQLQIM
GCPCLKHVFLPSIANELQSLERLEIKNNDFLETIITDEEGCDLKKGAFPM
LKQLLFIKLPSLRYFFEGEPAKTLDWPSLEYIHLSDCLNLARLPIGHESA
QKLKKVHVVRLDDVNWFKTLIWEDNITKSRFDIIQSINEVK
>XP_042426591.1 disease resistance protein RGA2-like isoform X1 [Zingiber officinale]
MVVFMELKHLLLEVLPSPTMVAQGRLLCIQNHLAMVCDSLWAINSMIEIP
EMGVLFNYIWHRRFNSPLHVPVEFADWVTDVATAVIDVGELLSRIMDWEA
SLHFRHVILVELKEMLCDLNSLVLRGSAMGLPRDPMGSMNPLREDYSIVL
KNEVVGRHEDLEKLIEIFQQQLVPSNNNGDDYNPFVIVIDGEERVGKTTL
AHMIYHHTWVRQQFHHRIWVDLPPSVSTLEMIKIIGKEFAESINNEEYCD
QKLHLELPLQAMWEYINEQLDGSRYLLVLHCLDLNSLISLPEWSELKNIL
LRVGGPGSAVLVILKSSTQSMSDMSFQNRVKDITTYCLKPLSDDAWLELF
KRHAAMTIPPSKRDIVFKRISYAMPRFQLAGQTFGAKFWGSLGHNFQVEN
LFPYKIEDIPMVRDFPFAIIQLLQYHYLLDKDYNVILHMLTAEGLIPVEG
LSPGWTEIYERFPYGRVSIFCFPRKVYLHRKVPGDSTSIPRCCRYLCLEI
NPRAIPFRRPIMLVEVSKKMIALILREDEATTQEDNAEMTFQVYKKRLMK
PATTISLQVYKKRQTKAATAISKFLDKMSVRLVHLHILVVETSMIQSLSN
EISKLVSLRYLHLSKLEIELLPKSLFDLPNLRILSLLHCKKLQKIRERIH
KLKKLQILKLAYCTKLQQLPRSITRLKNLEELNMEGCCFLRKLPEDLVSF
KSLRILNVAGCASLSQIPHGIEQSIGLRKLSGIFVGVNEGFVLTQFQVLT
NLQEIRLQNLERAEEIQIEVLMGQQSLWDLSLHWGGEKKKESSESTTSVL
KALRPSLQLKRLEIISYKGVEFPTWMSKQQLAGFNSLVEVRLINLKRCAT
LPSLGQLANLGKLEISGMDLITHLDDTFYGDGDIFPMLTELTFSEMLALE
KWYMPKRKYIRYFSKLRQLSLIQCPKLKEINLFVYGTIRIWLNNETIWSV
KFCSWDNLQNIEIIEIVGCQELRCLPQGMQSLNFLSKMTINSCNNLTTLV
ALDSLEELNIYACPVLAFNLAAFTKLRTLTIKGCPKMQIHNVIISVITMP
GRKKMRNDGEKTEEDRR
>XP_042426592.1 disease resistance protein RGA2-like isoform X2 [Zingiber officinale]
MVVFMELKHLLLEVLPSPTMVAQGRLLCIQNHLAMVCDSLWAINSMIEIP
EMGVLFNYIWHRRFNSPLHVPVEFADWVTDVATAVIDVGELLSRIMDWEA
SLHFRHVILVELKEMLCDLNSLVLRGSAMGLPRDPMGSMNPLREDYSIVL
KNEVVGRHEDLEKLIEIFQQQLVPSNNNGDDYNPFVIVIDGEERVGKTTL
AHMIYHHTWVRQQFHHRIWVDLPPSVSTLEMIKIIGKEFAESINNEEYCD
QKLHLELPLQAMWEYINEQLDGSRYLLVLHCLDLNSLISLPEWSELKNIL
LRVGGPGSAVLVILKSSTQSMSDMSFQNRVKDITTYCLKPLSDDAWLELF
KRHAAMTIPPSKRDIVFKRISYAMPRFQLAGQTFGAKFWGSLGHNFQVEN
LFPYKIEDIPMVRDFPFAIIQLLQYHYLLDKDYNVILHMLTAEGLIPVEG
LSPGWTEIYERFPYGRVSIFCFPRKVYLHRKVPGDSTSIPRCCRYLCLEI
NPRAIPFRRPIMLVEVSKKMIALILREDEATTQEDNAEMTFQVYKKRLMK
PATTISLQVYKKRQTKAATAISKFLDKMSVRLVHLHILVVETSMIQSLSN
EISKLVSLRYLHLSKLEIELLPKSLFDLPNLRILSLLHCKKLQKIRERIH
KLKKLQILKLAYCTKLQQLPRSITRLKNLEELNMEGCCFLRKLPEDLVSF
KSLRILNVAGCASLSQIPHGIEQSIGLRKLSGIFVGVNEGFVLTQFQVLT
NLQEIRLQNLERAEEIQIEVLMGQQSLWDLSLHWGGEKKKESSESTTSVL
KALRPSLQLKRLEIISYKGVEFPTWMSKQQLAGFNSLVEVRLINLKRCAT
LPSLGQLANLGKLEISGMDLITHLDDTFYGDGDIFPMLTELTFSEMLALE
KWYMPKRKYIRYFSKLRQLSLIQCPKLKEINLFVYGTIRIWLNNETIWSV
KFCSWDNLQNIEIIEIVGCQELRCLPQGMQSLNFLSKMTINSCNNLTTLV
ALDSLEELNIYACPVLAFNLAAFTKLRTLTIKGCPKMQIYHDAWKKKDEE
RW
>XP_042426593.1 putative disease resistance protein RGA4 isoform X3 [Zingiber officinale]
MVVFMELKHLLLEVLPSPTMVAQGRLLCIQNHLAMVCDSLWAINSMIEIP
EMGVLFNYIWHRRFNSPLHVPVEFADWVTDVATAVIDVGELLSRIMDWEA
SLHFRHVILVELKEMLCDLNSLVLRGSAMGLPRDPMGSMNPLREDYSIVL
KNEVVGRHEDLEKLIEIFQQQLVPSNNNGDDYNPFVIVIDGEERVGKTTL
AHMIYHHTWVRQQFHHRIWVDLPPSVSTLEMIKIIGKEFAESINNEEYCD
QKLHLELPLQAMWEYINEQLDGSRYLLVLHCLDLNSLISLPEWSELKNIL
LRVGGPGSAVLVILKSSTQSMSDMSFQNRVKDITTYCLKPLSDDAWLELF
KRHAAMTIPPSKRDIVFKRISYAMPRFQLAGQTFGAKFWGSLGHNFQVEN
LFPYKIEDIPMVRDFPFAIIQLLQYHYLLDKDYNVILHMLTAEGLIPVEG
LSPGWTEIYERFPYGRVSIFCFPRKVYLHRKVPGDSTSIPRCCRYLCLEI
NPRAIPFRRPIMLVEVSKKMIALILREDEATTQEDNAEMTFQVYKKRLMK
PATTISLQVYKKRQTKAATAISKFLDKMSVRLVHLHILVVETSMIQSLSN
EISKLVSLRYLHLSKLEIELLPKSLFDLPNLRILSLLHCKKLQKIRERIH
KLKKLQILKLAYCTKLQQLPRSITRLKNLEELNMEGCCFLRKLPEDLVSF
KSLRILNVAGCASLSQIPHGIEQSIGLRKLSGIFVGVNEGFVLTQFQVLT
NLQEIRLQNLERAEEIQIEVLMGQQSLWDLSLHWGGEKKKESSESTTSVL
KALRPSLQLKRLEIISYKGVEFPTWMSKQQLAGFNSLVEVRLINLKRCAT
LPSLGQLANLGKLEISGMDLITHLDDTFYGDGDIFPMLTELTFSEMLALE
KWYMPKRKYIRYFSKLRQLSLIQCPKLKEINLFVYGTIRIWLNNETIWSV
KFCSWDNLQNIEIIEIVGCQELRCLPQALDSLEELNIYACPVLAFNLAAF
TKLRTLTIKGCPKMQIHNVIISVITMPGRKKMRNDGEKTEEDRR
>XP_042426594.1 putative disease resistance protein RGA4 isoform X4 [Zingiber officinale]
MVVFMELKHLLLEVLPSPTMVAQGRLLCIQNHLAMVCDSLWAINSMIEIP
EMGVLFNYIWHRRFNSPLHVPVEFADWVTDVATAVIDVGELLSRIMDWEA
SLHFRHVILVELKEMLCDLNSLVLRGSAMGLPRDPMGSMNPLREDYSIVL
KNEVVGRHEDLEKLIEIFQQQLVPSNNNGDDYNPFVIVIDGEERVGKTTL
AHMIYHHTWVRQQFHHRIWVDLPPSVSTLEMIKIIGKEFAESINNEEYCD
QKLHLELPLQAMWEYINEQLDGSRYLLVLHCLDLNSLISLPEWSELKNIL
LRVGGPGSAVLVILKSSTQSMSDMSFQNRVKDITTYCLKPLSDDAWLELF
KRHAAMTIPPSKRDIVFKRISYAMPRFQLAGQTFGAKFWGSLGHNFQVEN
LFPYKIEDIPMVRDFPFAIIQLLQYHYLLDKDYNVILHMLTAEGLIPVEG
LSPGWTEIYERFPYGRVSIFCFPRKVYLHRKVPGDSTSIPRCCRYLCLEI
NPRAIPFRRPIMLVEVSKKMIALILREDEATTQEDNAEMTFQVYKKRLMK
PATTISLQVYKKRQTKAATAISKFLDKMSVRLVHLHILVVETSMIQSLSN
EISKLVSLRYLHLSKLEIELLPKSLFDLPNLRILSLLHCKKLQKIRERIH
KLKKLQILKLAYCTKLQQLPRSITRLKNLEELNMEGCCFLRKLPEDLVSF
KSLRILNVAGCASLSQIPHGIEQSIGLRKLSGIFVGVNEGFVLTQFQVLT
NLQEIRLQNLERAEEIQIEVLMGQQSLWDLSLHWGGEKKKESSESTTSVL
KALRPSLQLKRLEIISYKGVEFPTWMSKQQLAGFNSLVEVRLINLKRCAT
LPSLGQLANLGKLEISGMDLITHLDDTFYGDGDIFPMLTELTFSEMLALE
KWYMPKRKYIRYFSKLRQLSLIQCPKLKEINLFVYGTIRIWLNNETIWSV
KFCSWDNLQNIEIIEIVGCQELRCLPQALDSLEELNIYACPVLAFNLAAF
TKLRTLTIKGCPKMQIYHDAWKKKDEERW
>XP_042426595.1 putative disease resistance protein RGA3 isoform X5 [Zingiber officinale]
MVVFMELKHLLLEVLPSPTMVAQGRLLCIQNHLAMVCDSLWAINSMIEIP
EMGVLFNYIWHRRFNSPLHVPVEFADWVTDVATAVIDVGELLSRIMDWEA
SLHFRHVILVELKEMLCDLNSLVLRGSAMGLPRDPMGSMNPLREDYSIVL
KNEVVGRHEDLEKLIEIFQQQLVPSNNNGDDYNPFVIVIDGEERVGKTTL
AHMIYHHTWVRQQFHHRIWVDLPPSVSTLEMIKIIGKEFAESINNEEYCD
QKLHLELPLQAMWEYINEQLDGSRYLLVLHCLDLNSLISLPEWSELKNIL
LRVGGPGSAVLVILKSSTQSMSDMSFQNRVKDITTYCLKPLSDDAWLELF
KRHAAMTIPPSKRDIVFKRISYAMPRFQLAGQTFGAKFWGSLGHNFQVEN
LFPYKIEDIPMVRDFPFAIIQLLQYHYLLDKDYNVILHMLTAEGLIPVEG
LSPGWTEIYERFPYGRVSIFCFPRKVYLHRKVPGDSTSIPRCCRYLCLEI
NPRAIPFRRPIMLVEVSKKMIALILREDEATTQEDNAEMTFQVYKKRLMK
PATTISLQVYKKRQTKAATAISKFLDKMSVRLVHLHILVVETSMIQSLSN
EISKLVSLRYLHLSKLEIELLPKSLFDLPNLRILSLLHCKKLQKIRERIH
KLKKLQILKLAYCTKLQQLPRSITRLKNLEELNMEGCCFLRKLPEDLVSF
KSLRILNVAGCASLSQIPHGIEQSIGLRKLSGIFVGVNEGFVLTQFQVLT
NLQEIRLQNLERAEEIQIEVLMGQQSLWDLSLHWGGEKKKESSESTTSVL
KALRPSLQLKRLEIISYKGVEFPTWMSKQQLAGFNSLVEVRLINLKSWDN
LQNIEIIEIVGCQELRCLPQGMQSLNFLSKMTINSCNNLTTLVALDSLEE
LNIYACPVLAFNLAAFTKLRTLTIKGCPKMQIHNVIISVITMPGRKKMRN
DGEKTEEDRR
>XP_042426596.1 putative disease resistance protein RGA3 isoform X6 [Zingiber officinale]
MVVFMELKHLLLEVLPSPTMVAQGRLLCIQNHLAMVCDSLWAINSMIEIP
EMGVLFNYIWHRRFNSPLHVPVEFADWVTDVATAVIDVGELLSRIMDWEA
SLHFRHVILVELKEMLCDLNSLVLRGSAMGLPRDPMGSMNPLREDYSIVL
KNEVVGRHEDLEKLIEIFQQQLVPSNNNGDDYNPFVIVIDGEERVGKTTL
AHMIYHHTWVRQQFHHRIWVDLPPSVSTLEMIKIIGKEFAESINNEEYCD
QKLHLELPLQAMWEYINEQLDGSRYLLVLHCLDLNSLISLPEWSELKNIL
LRVGGPGSAVLVILKSSTQSMSDMSFQNRVKDITTYCLKPLSDDAWLELF
KRHAAMTIPPSKRDIVFKRISYAMPRFQLAGQTFGAKFWGSLGHNFQVEN
LFPYKIEDIPMVRDFPFAIIQLLQYHYLLDKDYNVILHMLTAEGLIPVEG
LSPGWTEIYERFPYGRVSIFCFPRKVYLHRKVPGDSTSIPRCCRYLCLEI
NPRAIPFRRPIMLVEVSKKMIALILREDEATTQEDNAEMTFQVYKKRLMK
PATTISLQVYKKRQTKAATAISKFLDKMSVRLVHLHILVVETSMIQSLSN
EISKLVSLRYLHLSKLEIELLPKSLFDLPNLRILSLLHCKKLQKIRERIH
KLKKLQILKLAYCTKLQQLPRSITRLKNLEELNMEGCCFLRKLPEDLVSF
KSLRILNVAGCASLSQIPHGIEQSIGLRKLSGIFVGVNEGFVLTQFQVLT
NLQEIRLQNLERAEEIQIEVLMGQQSLWDLSLHWGGEKKKESSESTTSVL
KALRPSLQLKRLEIISYKGVEFPTWMSKQQLAGFNSLVEVRLINLKSWDN
LQNIEIIEIVGCQELRCLPQALDSLEELNIYACPVLAFNLAAFTKLRTLT
IKGCPKMQIHNVIISVITMPGRKKMRNDGEKTEEDRR
>XP_042426616.1 disease resistance protein RGA2-like [Zingiber officinale]
MLLSSGNDADYRNKGAGSSSHASLGVLPIVGIGGVGKTTLAQIIYNDPRV
ADHFELRKWVYVSNDFNVKRIARVLEGEVASDSRSEDISLDAQLTNLSRA
TSCKRFLFVLDDVWDEAGRNWMELGSALTYGNRGSTVLITAQSPLVAQVM
GTMEQIELKLLEESDYWRLFEHCSFGSRVIDSYLRRKLQLIGQQIAKKLH
GLPLAGKVVGSLLHARLEEQYWKMIQESEWWENDFVLENILPSLGLSYQH
LSSNVKQCFAFTAMFPKGHIFDKEQLVQMWIAQGFVRPGTQHGRMTPEYI
GNQMFDELTCRYFFLHTINKGYVIHDLIRELAVYISRDECFVIDDEFSKI
PPTVRHLTVIRTAKLDTLAELSKLHKVRTLVFYRDYHPEDFFSLGENSSR
KFYESLEGILKSLKKLRILDLSYMRIDIKTLPSATCDLSHLRYLDISSTK
IRRLPESFSKIYHLQMLKLKRCWIKKLPAGMNRLIKMRHLHADADTISLV
DGIGRLTDLQELVEFRITRKRGHQIGELKELRNIRRRLDIHNVECVESQK
EALEAKLKDKEHLDHLKLYFKEATRSQGDIEKDILEGLEPHCNLKRLLIQ
NYGGLNSPCWLEKNYLTNLESIHLNCCARWEDLPPLGHLPFLMDIFILNL
PVRRIGAKFYGDADQIFPSLQELQFHTLNELEELSESDSRPIFPCLRKMR
IENCLKLRRIHVLPLTMKQLDIKNSGYIGNALFEYLLTLTSLTFLELNKC
SQRASVSLYNLRVLENLRLIECQELTLIGGLQSLTNLKNILIEKCPKLIE
PAQMPMQPYVEQELGFLCTVWIDEYVLKHVWAILGRTPCIQVLRIHHCYV
LSHFYPDQEEWFQQLTALNLLEFHMCPKLRKLPSSLGNAASIKIFKIVDC
PNIESLPHNGLPFLVQNLEMHRCIKLKDRCRKDDGADWPLISNIPNINID
GELIQRSELV
>XP_042426626.1 putative disease resistance protein RGA4 [Zingiber officinale]
MDTAGVAMMVGGWFPGYIMDKLVNFVTSHTSDHWDLLTDVEEKLNEIQAR
LPRIRAVIHAAEGRPIRDPALVDWLRQLKEAAYEADDLLDQMEYRQLEDQ
VQDRSKVSALAASALRFFKNLFVSDDELKRLKNLLGDVDKIYSEIDRKNV
ELNEDNAKHTASIRETSSFTQEVVFGRDKERERILEMLLSSGNDADFLNK
GAGSGSHASLGVLPIVGIGGVGKTTLAQIIYHDPRVADHFELRKWVCVSN
DFNVKRIARELEAEESSDYRWDHISLDSQLTKLIHATESKRFLFVLDDVW
DEAGRKWMELRSALTYGNRGSTILITTQSPIVAEVMGTMDQIELKLLEES
DYWSLFEHCSFGSRVIDPYLRRKLQSIGRQIAKKLHGLPLSGKVVGSLLH
ARLEEQYWKMIRESEWWENDFLLENILPSLGLSYQHLSSNVKQCFAFTAM
FPKGHVFDKEQLVEMWIAQGFVRPEAQHGRMTLEDIGNQIFDELTCRYFF
LHSINKRYVIHDLIRELAVYISRDECFVIDDEPSKIPPTARHLTVMRTAE
LDTLAELSKLHKVRTLVFYRDYHPENFFSLGENGSRQFYESLERILKTLK
NLRILDLSYMLIEIKKLPDATCDLSHLRYLDISGTKIRHLPGSFSKSYHL
QVLKLNRCWIKKLPEGMNRLIKLRHLHADADTISLVDGIGRLTDLQELDE
FRITRKRGHQIGELKELRNIRRRLVIQNLECVESQEEAMEAKLKDKEYLD
HLVLNFKEGKRSQGDIQKDILEGLEPHCNLKRLVIQNYGCLNSPCWLEKN
YLTNLESIHLNCCARWEDLPPLGHLPFLMDIFIFNLPVRRISAKFYGDAD
QVFPSLQELAFHTLNEWEELSESDSRPIFPCLMKMRIENCLKLRRIPVLP
LISIKHLDIRNSGDIGNALPDYLLTLTSLTYLELHNCAQRASVSLYNLQF
LEYLRLVQCPELSLIGGLQSLANLKDLIIHACPKLFEPAQMPEQPYVEQE
MRSLCTVWIDDDVLKHVWVILGRTPCIQVLRIHHCNDLSHFNPEHEEWFQ
QLTSLHFLEFHNCSRLRKLPSSLGTASIKILCIHHCPNIESLPDNGLPFL
LRKLEMHGCTKLRDRCRKDDGSDWPLISNIPNIDIDGELIQMK
>XP_042426638.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MALATFARVLRLIDSSEASIPPSRTRPAFLSDLSKHMAALKQNLTRIQVA
IRGAEERQAIDPSAKLWLYEITSLAYDAEDVLLDFDDLLLRPQIRSALNH
SDSGLLPNSFSSLASISQRIKELGERLVELHGKSEALQLGEEGGVEGSAD
VRRLRPTGSLMDGESPIFGREKDKEKILELLRPSGDEGPIPNKLLVLPIV
GMGGLGKTTLAQQVYADDQIKYFFDLKIWIHVSQDFNLINLTKAMVESVT
GNPCFLSELHSLQSELGKILEGKRFFLVLDDVWDESSSHWESLQMPLLSA
NLDSKVLLTTRSHGVARSIGTMPSFNLDPLKDDDAWLLFSENAFHGREPG
ERLVTIGKKIVKECNGLPLTLIALGLHLCNEEREDKWSAILESNIWHLSG
SQETILPILMLSYLQLPAPVKQCFAYCSLFGKGHLFLRHKIVRHWIAQGF
VETDGERKAEDVGSEYFYILLSRSFFQQCARNQYFITHDLIHDLAEDVSG
AERFKIDLLQDEDGSRMKVERAYNFPEGVRHTSLTFHSTSTETDLQPLLE
ANSLRTLMVNCTSWPPMPHPHANVLNDLFVKLRYLRVLLLDYTFAPAPRL
PDSISNLKYLHYLRIGRLSFQGQGFPESVCSLRNLQTLEWYSDESIELPR
GISNLINLRHLHSETYYASFPEGIGRLTKLQELPDFHTSKEHRCARIAEL
KDLVNLQGELKLLNLENVIDVEDARAADLKGKPGLTALELQWGKHNRSPQ
NAPLVLQYLQPHTNIQELRIGNYKHGQLSEWICHPSYSKLVTIKIQYCFL
STVPAFGQLLSLEHLSLVSIKGLEYIGPVFFHGGFPSLKKLRLSAIYKMV
EWSGADHGHFPHLNELTVTSCPSLRCLPIDNFTSLKGLHISHCSNLQTLY
SENSPLVGIQQHCSLKNLEVVQCPKLKFLPEYQVPESLQLLDITKSTLLI
NWYRRIAGKLTHVKNLLGVDLKEVKLDDIFSVEEARNACLTKQRIYMLHL
EWETSSLRSVDDTNCEVDEVLEYLQPNVSLNKLVIRGYRGLKLAEWLCSP
LYSNLISIKLDLCPNCKFLPALGQLPYLMELHLERLNGITSIDLSFYGNG
SQKGFQSLRRLQLMSMAGLEEWKGASDGGFPILRQLIVQDCMKLGGLPCL
SPSVQEIKVEDCPALTLELPSSLAALLSLHVSNVAEMNELHNLSYLSVLA
VENCSGCRLIELPSLRSLMINGWSERMLLDSLPGLTALTTLKISCLENLE
ALPLHNFRILEELLVSDCPKLVSIECFSTSTYEPYYVEGLQSLSALKCMV
LSGCPELHFSASEQLPASLQSLTISRCPTLRIWYERYSSKFRTSVVQFAD
>XP_042426666.1 disease resistance protein RPS2-like [Zingiber officinale]
MADIISGISGRASPGDLPGLIPGCEQWPPTPTPSSQTNSSFRVFHLFSPV
NSRFGIVGLRATARINHNLIPPLSGIISFFTCLKDCCFQSCNYIVSYERI
ISSLATELAQLKSKREDIKRQIEAAERDGLNPKKEVLGWLQSVEALTSET
ENINAAYHQMFKCLCNFPVNVRSGYPLRSKAKAALITAADLKEKAREFTD
VADNLDVEKAREFTDVADNLDVDRFLEMPNPKTVGMKTALAALQGNARDD
DVSIIGIHGMGGVGKTALLRRFNNHFAEKEVDNLDVVIYLELSTGYKVEE
IQKSLFDRLKLTWKDEESQRNRAGRLFRVLSKMTFSLLLDNVWEPLNCQI
VGIPLLQKPSKSKIVFATRMEEVCSSMGAEKTIKLECLSEEASWDLFRFN
AKLELVNTSTLILNLARALVQQCAGLPAALITVAQAMASKRTIAEWRHVL
AIMKEAPFQLPGMEEHVYHPLKLSYDRLSDTLRTCASYFALVQEGCWLSK
FYVRELWIGEGFINDFERLSDTADKASYLLGMLLAASLIQRIDSEYFKMH
PMVRSMILWMECDCGKKESKWLIGDRHSLAEAPGAEKWRVAERISLGWNN
ITLLPDEPQCPDLIYLHLRNNHPLKNIPNEFFSHMPCLRILDLQQTSIDE
LPPGIGNLSQLQLLDLSSTRIASLPREIQALVNLRYLAMSSATHLRSIPS
AVIPCLHHLQWLNMYNSYSGWRVMGALQLDGEGVLLNEVESLKKLKVLGI
TMSSVTTLRRFCESQRLTAAVHWLQIEGCGGLTSLDIPSTYCLGENMQNM
VQIRLHAMTDLEEVFIGGDLHACNALSGLEYLRLLALPKAKIIWKNRCLE
NLLELEIEDCNAIDRLMKVVTNATNSTETITIFPRLRKIVLRKLPELESL
SDGDQVIAFPSLETMEVRNCPKLKKLTLAAENLTEIKCDREWQDELDWSD
ERTLSFQKLFERPDRR
>XP_042426758.1 putative disease resistance protein RGA1 isoform X1 [Zingiber officinale]
MLVFLELKHLLLEVLPSPTMVAQGRLLCIQNHLAMVCDSLWAINSMIEIP
EMGVLFNYIWHHRFNSPLDVPVEFADWVTDVATAVIDVGELLSRIMDWEA
SLHFRHVILVELKEMLCDLNSLVLRGSAMGLPRDPMGSMNPLREDYSIVL
QNEVVGRHEDLEKLIEIFQQQQQQLVPSNNNGDDYNPFVIVIDGEERVGK
TTLAHMIYHHTWVRQQFHHRIWVDLPPSVSTLEMIKIIGKEFAESINNEE
HCDQKLHLELPLQAMWKYISEQLDGSRYLLVLHCLDLNSLILQPEWSELK
NILLRVGGPGSAILVILKSSTQSVSDMSFQNRVKDITTYCLKPLSDDAWL
ELFKRHAAMTIPLSKRDIVFKGSTFAMPLFQLVGQTFGAKFWGSLGHSIQ
VEDLFPCEIKDIHMVRNFPFAIVRFLQYHYLLDKDYNVILHMLTAEGLIP
VEGLSPGWTEIYERFRYGRESTFCFPRKLYLHRKVPGDSTTIPRCCRYLR
LEINPRVIPFRLPTMPVEVSKKMIALILREDEATTRAFQVYKKRLMKPAT
TISLQVYKKRRTKAATAISKFLDKMSVRLVHLHILVVETSMIQSLPNEIS
KLVSLRYLHLSKLEIELLPKSLFDLPNLRILSLLHCKNLQKIPERIHKLK
KLQILKLAYCTKLQQLPRSITRLKNLEELNVEGCCFLRKLPEDLVSFKLL
RILNVAGCASLSHIPHGIEQSIGLRKLSGIFVGVNEGFELTQLQALTNLH
ELRLRNIERTEETQTEVLMGQQSLWDLSLHWGGEEKKESSESTTSLQVLE
ALRPSLQLKRLEIISYKGVEFPTWMSKQQLAGFNSLVEVRLINLKRCATL
PSLGQLANLEKLEISGMDLITHLDDTFYGDDGIFPMLTELTFSEMLALEK
WYVPKKKIFYIFHALCNCH
>XP_042426759.1 uncharacterized protein LOC122014564 isoform X2 [Zingiber officinale]
MLVFLELKHLLLEVLPSPTMVAQGRLLCIQNHLAMVCDSLWAINSMIEIP
EMGVLFNYIWHHRFNSPLDVPVEFADWVTDVATAVIDVGELLSRIMDWEA
SLHFRHVILVELKEMLCDLNSLVLRGSAMGLPRDPMGSMNPLREDYSIVL
QNEVVGRHEDLEKLIEIFQQQQQQLVPSNNNGDDYNPFVIVIDGEERVGK
TTLAHMIYHHTWVRQQFHHRIWVDLPPSVSTLEMIKIIGKEFAESINNEE
HCDQKLHLELPLQAMWKYISEQLDGSRYLLVLHCLDLNSLILQPEWSELK
NILLRVGGPGSAILVILKSSTQSVSDMSFQNRVKDITTYCLKPLSDDAWL
ELFKRHAAMTIPLSKRDIVFKGSTFAMPLFQLVGQTFGAKFWGSLGHSIQ
VEDLFPCEIKDIHMVRNFPFAIVRFLQYHYLLDKDYNVILHMLTAEGLIP
VEGLSPGWTEIYERFRYGRESTFCFPRKLYLHRKVPGDSTTIPRCCRYLR
LEINPRVIPFRLPTMPVEVSKKMIALILREDEATTRAFQVYKKRLMKPAT
TISLQVYKKRRTKAATAISKFLDKMSLSRCLEEKR
>XP_042426774.1 putative disease resistance protein RGA4 [Zingiber officinale]
MLVFLELKHLLLEVLPSPTMVAQGRLLCIQNHLAMVCDSLWAINSMIEIP
EMGVLFNYIWHHRFNSPLDVPVEFADWVTDVATAVIDVGELLSRIMDWEA
SLHFRHVILVELKEMLCDLNSLVLRGSAMGLPRDPMGSMNPLREDYSIVL
KNEVVGRHEDLEKLIEIFQQQQLVPSNNNGDDYNPFVIVIDGEERVGKTT
LAHMIYHHTWVRQQFHHRIWVDLPPSVSTLEMIKIIGKEFAESINNEEYC
DQKLHLELPLQAMWEYISEQLDGSRYLLVLHCLDLNSLILQPKWNELKNI
LLRVGGTGSAVLVILKSSTQSVSDMSFQNGVKDITTYCLKPLSDDAWLEL
FKRHAAMTIPPSKRDIVFKGSTFAMPLFQLVGQTFGAKFWGSLGHSIQVE
DLFPCEIKDIHMVRNFPFAIVRLLQYHYLLDKDYNVILHMLTAEGLIPVE
GLSPSWTEIYDRFRYGRESTFCFPRKVYLHRKVPGDSTTIPRCCRYLRLE
INPRAIPFRLPTMPIEVSKKMIALILREDEATTQEDDKRMTFQVYKKRLM
KPATTISLQVYKKRRTKAATAISKFLDKMSVRLVHLHILVVETSMIQSLP
NEISKLVSLRYLHLSKLEIELLPKSLFDLPNLQILSLLHCKNLQKMPGRI
HKLKKLQILKLAYCTKLQQLPRSITRLKNLEELNVEGCCFLRKLPEDLVS
FKSLRILNVAGCASLSQIPHGIEQSIGLRKLSGIFVGVNEGFGLTQLQAL
TNLHELKLRNIERTEETQTEVLMGQQSLWDLSLHWGGEEKKESSESTTSL
QVLEALRPSLQLKRLEIISYKGVEFPTWMSKQQLAGFNSLVEVRLINLKR
CATLPSLGQLANLGKLEISGMDLITHLDDTFYGDGDIFPKLTELTFSEML
ALEKWYVPKKKYILYFSRLMQLSLIQCPKLKEINLFAYGTIRIWLNNETI
WSVRFCSWDNLRNIYIIEIVGCQELRCLPQGMQRLKRLYKMIFNSCNNMT
TLVALDSLEELNIYACPVLAFNLAAFTKLRTLTIKGCPKMQIYLDAWKKK
YEERWW
>XP_042426804.1 putative disease resistance protein RGA4 [Zingiber officinale]
MIRNSLWTINSFLLDATLSVVEQPDVAEWMKDVGVAVEDVDSLLKRILDY
WEPSEEDKVENRRLMISNFLSMSSRQAILVELKDMACMLNYLVNRGAALG
LWVEMMDSMDPTHDDYSAILSKEVIGREEDIDQIIELLQQQQCDEDGNAP
FIITLEGTMNGKTTLARTIYHHPWVHRHFQHRIWLDAPLSIRSIRDFKSN
VIAKEIAKYTGKSCTNTDYWPLINEHFGGDRYLLILDGVQVSHLFAYKWK
EFMLKLLHCGAPGSKVILTGDCFYVFGMEFYIKNYKLNMLSEDTGARILL
RYSTFVHPIEANSNHKEKASPAVTDMQIPLKYPLLVKGLGLIYRRINTRL
DKEILSRYDLDTLLKYYSWPIERERYFQYQELFGRYSNQCSDEDLFEILV
AEGTLRYNWMKNTEYDVPFNFKTDPCFFRMKAWEGSRIPLQCRHLYLPIH
SKNISKIKKVIEKAGVADRLRTLILHMKEKKEQIYQYQTVSKILESMFVN
LKHLCTLHMGGIMIQYLPSSVGTLHCLRYLNLAENKIETLPESLCNLGNL
CVLNLSSCKKLKELPRQIHKLRKLQILKLSSCLRIQKLPESITWLVNLKE
LDVGDCCYLSKLPDDLCSMKNLMQLEMHGCASLTRMPIGIRQLTNLEVLR
GYDAIDGLGNVMLSELQTLTNLESLHIRHLERLELAEEKNITPPTNLLEN
QCLNELTLHWEWWNDMVAEGTLEPTMQLTQGFQHNLRDLIVLKMVSYMSD
KFPSWLMIADRDSLLNNLTTVHLINLRRCERLPPLGHLRNLKEVAISGFD
SVKVVDETFYGEDHNSVFLHLRRLTFSEMPRLEKWVGLKHTHSRLLFRSL
KELTLIQCPKLKEFHMRFPESLSLKLLLSNEMLMPISKFVGWQNLRQVNM
LQIFGCQELRNLPDGLRMIPNLETLEIINCNKLEALPIWLKKSRLKSLFL
SGCPALSFIPEELKFMERLTNLYVEACPKLQRQSQLSELCRCSGDF
>XP_042426873.1 uncharacterized protein LOC122014612 [Zingiber officinale]
MLVFLELKHLLLEVLPSPTMVAQGRLLCIQNHLAMVCDSLWAINSMIEIP
EMGLLFNYIWHHRFNSPLDVPVEFADWVTDVATAVIDVGELLSRIMYWEA
SLHFRHVILVELKEMLCDLNSLVLRGSAMGLPRDPMGSMNPLREDYSIVL
QNEVVGRHEDLEKLIEIFQQQQLVPSNNNGDDYNPFVIVIDGEERVGKTT
LAHMIYHHTWVRQQFHHRIWVDLPPSVSTLEMIKIIGKEFAESINNEEYC
DQKLHLELPLQAMWEYINEQLDGSRYLLVLYCLDLNSLISQPEWSELKNI
LLRVGGPGSAVLVILKSSTQSVSDMSFQNRVKDITTYCLKPLSDDAWLEL
FKRHAAMTIPPSKRDIVFKGSTFAMPLFQLVGQTYGAKFWGSLGHSIQVE
DLFPCEIKDIHMVRNFPFAIVRLLQYHYLLDKDYNVILHILTVEGLIPVE
GLSPGWTEIYERFRYGEESTFCFPRKVYLHRKVPGDSTTIPRCCRYLRLE
INPRAIPFRLPTMPVEVSKKMIALILREDEATTQEDDKRMTFQVYKKKAN
ETSNYNITSSIQKKANQSSNCNIEVPRQDVGKTRTFAYISCRN
>XP_042427091.1 putative disease resistance protein RGA4 [Zingiber officinale]
MIGWFALTSLGWLAESFMAALVGKAVDRIVQQFGEQHGVEDDLEKLQDSL
DHARLTISTIESLRIKDKGLQKKLKEFLTSLKDAAYDADDLLDEFQYRIL
KQQIEQQGNEAGNRASFSSYSTPPPSKKLKTSFSSYTSGLFGKGDDNNDD
VRRIRKIKRRLDDNSVALEKIYSSLGVQDDRGKKQLVSSASRQMSSFWTK
PRLFGRDKELQELKDLLLEPEAVSGQSGFSVLSIVGIGGIGKTTLAQEVF
NDSSVKEYFELRIWVRVSENFSTEKLTREIIEYATKKNCNLPNFAALQDF
LKEKITPERFLLVLDDVWNEDRHQWESLCAPLRSGKPGSKILVTTRSRKI
AGMVGDLDAIHLEGLDEKCFWEFFKKCAFSSSNSGVHHYHLEAMAKKMIY
KLKGLPLAAKTLGGLLSMKLDEQHWKSILDSEIWQLPQEEENGIIPALQL
SYQYLPPHLKQCFAFCSLFPKNYSFSESKLISIWIAEGFIVPQGSIRMEE
LGNNYFHELVNRSFFQKIKSKGFIKQFGMHDLIHDLTELISVGESSRIEK
SNFHEIPNTIRHLSVHQEEEGMQTRCLTEFSHYNKLRTLMLPRRYSNNSL
LVDSSVLEKLKKIRVLILSKCALKELPDNIGKLIHIRYLDLSDNYDIRSL
PESLCDLYNLQTLILYRCYKLESLPHDMVKLINLRKLDGVAPMFFLKITE
VGKLTSLQNLPVFKVLKDNGYKLAELKGLKQLRGELRITNLENVENKGEA
NIANLKSKEHLDKLVLEWTSDSDVNLHISEQVLEGLQPHNNLQSLTIREY
NGARPPNWLDEQVYSRLEKLELQNCKRWNDLSVIGQLSQLKRLYLGRTSV
HTQNLHKLFDPIHCKFFFQLESLSLEGITMLEDLPNLGQLPCLEFLDIRS
LPGVKMIGDRFFSTSEEGSCFPSLHTLHFNEMPAWEEFYCSEDRDLFPCL
IELQISDCQNLRMLPPLSPSIELLQLSNVGLVDCPRFWKVIDESSNVTNS
ASITELFIQECPNLTILEQGLLAHHLQQIDIQKCEQLLWAPVKRLKELTS
LESLSIKECPKLMSMTQDEYINFELPPSITQLCLSDCGNLSKSLPGCLHN
LTSLRDLEISNCPNLVSLPVEQLLNLESVTIKNCNELRSVERLQIKSLHN
LKIAGCPKLLLSQGEAQTEKSALQMLEIDDTAFMKQSVIKNLLSSVNYLR
ISSSCEAVMFEGDDQESLQSLTSLDSLSFSDCKNLQSLPTKLYTLTSLQI
LGIHYCPQIQSLPEKGLPPSLTNLYFHGCHLALEQQLERHLAGIKKFG
>XP_042427126.1 putative disease resistance protein RGA1 [Zingiber officinale]
MIGFALTALGWLAESFMVALAGKAVDRAVQQFGEQHGVEEDLKKLKDSLA
NAMLQISTIENLWLKDESLQKRLKELLIGLKDAAYDADDLLDEFQYRILK
QQIEQQADEAGNRASSSSYSTPPPGKKIKTSLSSYASGLFGKGDDDDNNN
DVQRMREIKRRLDDNSAALEKIYSSLGAEDDRGKKQLVSSESRQTSSFSI
EPQLFGRDKELQELKDLLLKSEVASKFDQGGVSVLSITGIGGIGKTTLAQ
EVFNDNTVEEYFKLRIWVCVSENFSTERLTREIIEYTTKKKCNVPNFAAL
QVVLKEKITQERFLLVLDDVWNEERHKWESLCAPLRFGKPGSKILVTTRS
RSIAGMVGDVDPIHLDGMDEKSFWNFFKKCAFGSSNSGIHHPHLEAMAKK
MTYKLKGLPLAAKTLGGLMSMKLDEQHWKSILDSEIWQLPQEENGIMPAL
QLSYQYLPPHLKQCFAFCSLFPKDYEFSESKLIGIWIAEGFIVHQGSIRM
EELGSNYFHELVNRSFFEKSTTRMVERGSNYFHELVYRRSFFQKLGTTTD
RRGRVFIQSSTDEKFVMHDLIHDLAELISMGESYRVEKGKFHAIPSTIRH
LSMYKEEEGMLTRGLIDYLITINYER
>XP_042427161.1 putative disease resistance protein RGA1 [Zingiber officinale]
MIEFALAALGWLAQSIIGALVGKAADRAVQQFGEQHGVEEDLEKLKDSLA
SAMLKINDIENLWLKDDESRQQRVKELLIRLKDAAYDADDLLDEFQYRIL
KQQIEQRGDEAGNRASSSSYSTPPPSKKIKTSLSSYTSGLFGKGDDDDNN
NDVQRMREIKGRLDDNSVALEKIYSSPGAEDDRGKKQLVSSSSRQTSSLS
TERQLFGRRNDLQELKAKLLESEVASEFGQSGCSVLSIVGIGGIGKTALA
QEVFNDSEVKEYFKLRIWVCVSENFCTDRLTREILEYVTMVKCDLTNFAV
LQEVLKEKITPERFLLVLDDVWNEDRHKWESFCAPLRSGKPGSKILVTTR
SRKIANMVGDVDPICLEGLDEESFWEFFKKCAFGSSNSGAHHPHLEALAK
KMTCKLKGLPLAAKTLGGLLSMKLDEQYWKSILDSEMWQLPQQENDIMPV
LQLSYQYLPPHLKQCFVFCSLFPKDYRFSESELIVIWIAEGIIVPKGSIR
MEELGSYYFHELVNRSFFQKSQDIEFIMHDLIHDLAKLISKDEFYRTEKD
ILSEIPSTIRHLSMHGMEEGMQIRRLTEFSHYNKLRTLRLSGPYICKSFI
LDCGVLQKIKKIRVLVLNNCALEELPDSIGKLIYLRSLNLSYNYMIRKLP
ESLCDLYNLQSLILNHCGLEELPNNIGNLIQLRYLDLSCNSNIRRLPKSL
YDLYNLQTLIFSRTA
>XP_042427758.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAMVLDFFVSKFIKDTSDMVEKEIFKMLGVDKEIKTLQVKLGTINGYLQQ
AERKRHGNDEIDIWVRKLKDIMYDADDVIDLCMIEGGKLLMAHASSSSST
VSIPFSYLFSCFKCLKYRHDIANQIISLNSRLEGLKNDAVIKNNLDQAMK
EPIENANKVVFGRETSHLQVEGDIIGTQIENATEKLISLILENNPKKTRV
FGVVGTGGIGKSTLASKIFEDERIKENFSNRKWLYVSKNYIETDLLKKLI
RFEEGSETKGENFEGKSKADLENKLVSVLTRNTFIVLDDVWNSTVWIDLL
RKPIVKSASTCTILVTSRKEKVVMQMKPAYIHSVEKMNEESGWNLLKHLV
FEGGEEEDEISSLEEIGIKLVKKCDGLPLAIKAIGGVLYQQNKAKWEEVL
ESDAWKMDQIEEELRPLYLSYEDLPSTLKQCFLYCSLYPQKNMYYKEVVQ
FWVAEGLIVDDQDKSRKDLPTGKQKTLEDLGEEIYRELILRNLLEADAIV
DVSKNYFSMHDHFRSLGAHLMSEEGILYRHGREFKTDENIKIRRLSISNM
APKLVLPSQILNQACLRTLILMESPKTKAIEDSVLQSLPCLRVLDLTSTS
IEKIPDCIGDLLHLRYLDLDGTNIREIPTTIGNLVYLQNLNISECQYLER
LPKSITMLHNLRCLDMRDSPLLTYVPKGIGKLENFYNLQGFLVGQNDSTS
DEGCDLEELKNLSKLRDISIYRLERAERGASALADKPFLKQLTLGWMQPD
EDDADEEEESEGANEVGSDEEADNDGNDDKDAGNEKGDDNDDGSKQENEN
EEAEEAGNETEDETEEDEAEEDKKGWSEKQIRKAERICNEMSQPSSNIED
LFFYEYPGRQLPSWMISSSLAESFPNLAYLKLLGLPCCTELPPFGTLPQL
KYLSIERASAITTIGSRFLGSRSSAFPKLEVLQFDDMPKWEEWTFDGVEE
LTGHGTPLAVKLFPSLRDCVIFDCPKLRALPAGLYRATNFNELCLRQTYV
LGEIINLPMAYKLEVTNGSGLKKISNISSVRYLEVDNCPNLECVENLTKL
QHLVLICSEETEQLPQWLSGLIEQHNNTSSTHRSFRKFEMQCSLQLLQTC
LEGNENWDIIKQIPNVKVKTPSGKAYIRYTKDPYMYDPHVPAN
>XP_042427808.1 probable disease resistance protein At4g27220 isoform X1 [Zingiber officinale]
MPSHRYCSGFIILLSPLVASGSILLAIIDIAEIMVPPCFNTCCGGIGSGT
GNEIVKYSWNKLKTHACYFIYCKKKFEKLKEQFDLLKAIRDDTQQKVEAA
KRNNKVISDEVNLWLNKVLELEGKFNNIEKNFNRIVEDEKYYIPSLVSRY
KVGREATRKKDKALKLLDRSNFQAFSHPLDPSTVNHPSNADFVSFGATKE
AMQKVIDALNDDKVNLIGIYGMGGVGKTTLMEEIGRMVKEAKTFDVVIDV
VVSQNPNIAQIQRDIADALDMRDSSNKMLVTRLKQEKKVLIMLDDVWARL
ELVKAVGIPYREHKGCKVILTSRKAETCNVMETDVSVEVATLSEEDSWYL
FRMRAGQVAASDGIEPVARKVAQECCGLPLAIVVVGRALRSYKDSSAWED
ALSQLKQAVPLNMEEVEEKLYKPLELSYQNLKTAELKQLFLYCCLFREDY
DISEDEVTRYAVGENLLSNLSTLEDVRGRVHFLLQKLKLSGLLLDSKKAG
CVKLHDVVRDVAVYIGSKDNNHFLVKAGHGLADWPECGNLADCKRISLSN
NFLQEIPEKPNCCKLILLLLNMNPITRVPINFFENMATLNVLDFSNTGIT
SLPSSLTCLNGLGTLRLDRCKELKDINVVGELKTLIILTLQECRGITALP
ETIDGLVKLKLLDLSNCTSLQILRNLIPKLTQLEELYLRGYNVTEELLVE
VASLKRLVRVELYVKCARDFSEQVFPNNAYKVLRHFIIYNEPDWFSLASK
YQRNFFIKQASQSMISWGKPFLRSAEELRLDSCQWNFTDLMSCFATLKSL
LIVNCHQIQCLLWSTDDTPSNAFGELMKLTLSDMEKLEQVCHGQLPAHSL
GKLRTLELRWCRNIVDILPQDLLQRVHPSLVELLLEGCPRPHVLLNFEGL
GHDSVIFPKLQMIRVSQMSDVISFCNGVVPPGSLHNLTTFEVVNCKKLLN
LFSQTLDTTHSRLLPSETFKKLKQLQIMGCPCLKHVFLPSIANELQSLER
LEIKNNSSIETIIANEEGCDLKKGAFPILKRLLFIKLPRLICFFEGEPAK
TLDWPSLEYIHFGDCSNLARLPIGHESAQKLKKVHVARLDDVNWFESLKW
EVDTIKSRFDIIQSINEVK
>XP_042427809.1 probable disease resistance protein At4g27220 isoform X2 [Zingiber officinale]
MPSHRYCSGFIILLSPLVASGSILLAIIDIAEAIRDDTQQKVEAAKRNNK
VISDEVNLWLNKVLELEGKFNNIEKNFNRIVEDEKYYIPSLVSRYKVGRE
ATRKKDKALKLLDRSNFQAFSHPLDPSTVNHPSNADFVSFGATKEAMQKV
IDALNDDKVNLIGIYGMGGVGKTTLMEEIGRMVKEAKTFDVVIDVVVSQN
PNIAQIQRDIADALDMRDSSNKMLVTRLKQEKKVLIMLDDVWARLELVKA
VGIPYREHKGCKVILTSRKAETCNVMETDVSVEVATLSEEDSWYLFRMRA
GQVAASDGIEPVARKVAQECCGLPLAIVVVGRALRSYKDSSAWEDALSQL
KQAVPLNMEEVEEKLYKPLELSYQNLKTAELKQLFLYCCLFREDYDISED
EVTRYAVGENLLSNLSTLEDVRGRVHFLLQKLKLSGLLLDSKKAGCVKLH
DVVRDVAVYIGSKDNNHFLVKAGHGLADWPECGNLADCKRISLSNNFLQE
IPEKPNCCKLILLLLNMNPITRVPINFFENMATLNVLDFSNTGITSLPSS
LTCLNGLGTLRLDRCKELKDINVVGELKTLIILTLQECRGITALPETIDG
LVKLKLLDLSNCTSLQILRNLIPKLTQLEELYLRGYNVTEELLVEVASLK
RLVRVELYVKCARDFSEQVFPNNAYKVLRHFIIYNEPDWFSLASKYQRNF
FIKQASQSMISWGKPFLRSAEELRLDSCQWNFTDLMSCFATLKSLLIVNC
HQIQCLLWSTDDTPSNAFGELMKLTLSDMEKLEQVCHGQLPAHSLGKLRT
LELRWCRNIVDILPQDLLQRVHPSLVELLLEGCPRPHVLLNFEGLGHDSV
IFPKLQMIRVSQMSDVISFCNGVVPPGSLHNLTTFEVVNCKKLLNLFSQT
LDTTHSRLLPSETFKKLKQLQIMGCPCLKHVFLPSIANELQSLERLEIKN
NSSIETIIANEEGCDLKKGAFPILKRLLFIKLPRLICFFEGEPAKTLDWP
SLEYIHFGDCSNLARLPIGHESAQKLKKVHVARLDDVNWFESLKWEVDTI
KSRFDIIQSINEVK
>XP_042428062.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAMILDFYVSRVIKVTADMVEAEIFKVLGVDKEIKTLQGRLRTINGYLHQ
AERKRQGNDEIDIWVRKLKDIMYDADDIIDLCMIEGGKVLRAQASSGSST
VSIPSSYLFSCFRCLRYRHEVANQIIALNGRLEALKNDSFIKNNLDQTVK
EPVENTHRVFGRETSHLQVEGDIIGSQIENATDKLINLILENNPKKTRVF
GVVGTGGIGKSTLASKIFEDERIKENFPNRKWLYVSKNYIETDLLKKLIR
FEEGSETKGETFEGKSKAELEDKLVTVLTKNTFIVLDDVWNATVWIDILR
KPIVKGASSCTILVTSRKEKIVTLMKPTHIHPVEKMNEESGWNLLKHLVF
EGGEEEDEISNLEEIGIKLVKKCDGLPLAIKAIGGVLYQQNKAKWEEVLE
SDAWKMDQIEEELRPLYLSYEDLPSTLKQCFLYCSLYHQKDMYYKEIVQF
WVAEGLIMDEQEKSRNDLPTEKQKTMEDIGEEIYRELIWRNLLEADALVD
ASKDYFSMHDHFRSLGAHLMREEGILYRHGREFKTDDNIKIRRLSISNMG
PKLVLPSQILKQGCLRTLILMDSSKTKTIEDSLLQALSCLRVLDLTSTSI
EKIPDCIGDLLHLRYLDLDGTNIREIPATIGNLVNLQTLNISECQYLERL
PKSITMLHNLRCLEMRNTPLLTYVPKGIGKLGNFYNLQGFLVGQNDSISE
EGCDLEELKNLSKLRGISIFRLERAERGASALADKPFLKQLTLGWMQPDE
DDADEEEESEGANEVGADEEADNDGNDDKDAGNEKGDDNDDGSKQENENE
EAEEAGNETEDETEEDEAEEEEKGWSDEQISKAERICNEMSQPSSSIEDL
FFYEYPGRQLPSWMISSSLAESFPNLAYLQLLGLPCCTELPPFGTLPQLK
YLRIEQASAITAIGSQFLGSRSSVFPKLELLRFVGMPKWEEWTLDGVEEL
TGHGTPLAVKLFPSLRDCILIDCPKLRALPADLYRATNFSELCLRQTYEL
GEIINLPMANKLEVTNASGLKKISNISSVRYLEVDNCPNLECVENIGKLQ
HLVLICSEEMEQLPQWLSVLIEQHNNTSSTHRSLRKFEMQCSLQLLKTCL
EGNENWDIIKQIPIVKVTTYSEKEYIRYTKDPYMYDPHVPAN
>XP_042428556.1 putative disease resistance protein RGA1 isoform X1 [Zingiber officinale]
MAVSLTVVGGWVAQAFIQTLIDKASDTAIQLFAERRGFAADMKKLRTSLL
ETRIILDKVQSSGSNSTKWKTLMRDLKDAAYDAEDLIDEFQYHLLRQKIK
GEEEDKASGSSGLSNIFSAAKKRLFASSYSLGEDDIRARVREIQERLEGI
AISVKDIMKVLPPNDQPEVKFQARESCSSPVTDILFGRDKELNQVVDWLL
GSASQVKPASGFVNDTFSVLPIVGIGGVGKTTLAQYVHKDNRVQDHFHLK
IWVCVSDNFSVQRLTKSIIESVTLKKEYDNIELEPLQKIFHQHIAKKKFL
LFLDDVWSDDKSIWEKFCALLKVGEHGSKIIVTTRDMKVSKMVSPAEPIL
LHDLDEDAFWKLFKKCSFGTLNPEDYPELEDIGRKIARKLKGSPLAAKTL
GSVLQLDLRKQHWATIMKSDIWKVKQDEDSIMPALHLSYQYLNENLKQCF
AFCSVFTKDTSYHKAHLVPMWMAEGFIEDNNTKRMEDVGNDYFLEFVNRS
FFQEFKHGFYPYMMHDLIHDLAEMIAEEETCKIQSNEQTKKLPSTVRHLL
VEKRKLPLELSGYDKLCTLLLKNSPPDSLFEKLRSIRVLDLSFCGLLELS
GHIGKLIHLRFLDLSYNPEIKFLPDSLCDLYNLQTLRARNCFSMESIPQE
LHKLVNLRHIDADKKIWLMIKDVWRLTNLQELLTFSVREGDALKLGRLQD
MTQFHGTLHIQNLENVVDSKEAQHAELKNKVHLKELVLEWNDEKDAKLEE
EVIEGLQPHDSLEILKIEGYNGGRSPSWLMPKVLSNLKKLELVNCKGWDD
DLPFIGQRLHLIELRMDNMPALKRLSHEFEGKCFPKLEMLMLFNLPAFEE
WFWTDGKDLFPCMRELVVINCPKLKRLPPFPPSLETLIIRGCPELILNNE
TADDEECDRLLLPSLKVLELSDSGEYAKLLPDCLHNLCLVTRLTISHCPH
ITSIPLVQLVELRSLAISYCDELTRMECLRLLKSLDLLEIIGCPKLVQLD
VEDEQAGSLSSLRKLCVDNTAVLKMFPLRNSLSFIKELEIASCSEEVIFE
EAMQSLTAVTSLIFYNCKKLQSLPTELLHSLPYLEELTVANCPQIHSLPD
KGLLPSLWMLTIDNCPQIHSLPEKGLPTLLECLHIFDCPQIHVMPDQEGL
PKSLYVFDCIGDVHPTLKEQSQKFYTDRNRRVSTPDAHHRLPNVIAFFSD
L
>XP_042428565.1 putative disease resistance protein RGA1 isoform X2 [Zingiber officinale]
MAVSLTVVGGWVAQAFIQTLIDKASDTAIQLFAERRGFAADMKKLRTSLL
ETRIILDKVQSSGSNSTKWKTLMRDLKDAAYDAEDLIDEFQYHLLRQKIK
GEEEDKASGSSGLSNIFSAAKKRLFASSYSLGEDDIRARVREIQERLEGI
AISVKDIMKVLPPNDQPEVKFQARESCSSPVTDILFGRDKELNQVVDWLL
GSASQVKPASGFVNDTFSVLPIVGIGGVGKTTLAQYVHKDNRVQDHFHLK
IWVCVSDNFSVQRLTKSIIESVTLKKEYDNIELEPLQKIFHQHIAKKKFL
LFLDDVWSDDKSIWEKFCALLKVGEHGSKIIVTTRDMKVSKMVSPAEPIL
LHDLDEDAFWKLFKKCSFGTLNPEDYPELEDIGRKIARKLKGSPLAAKTL
GSVLQLDLRKQHWATIMKSDIWKVKQDEDSIMPALHLSYQYLNENLKQCF
AFCSVFTKDTSYHKAHLVPMWMAEGFIEDNNTKRMEDVGNDYFLEFVNRS
FFQEFKHGFYPYMMHDLIHDLAEMIAEEETCKIQSNEQTKKLPSTVRHLL
VEKRKLPLELSGYDKLCTLLLKNSPPDSLFEKLRSIRVLDLSFCGLLELS
GHIGKLIHLRFLDLSYNPEIKFLPDSLCDLYNLQTLRARNCFSMESIPQE
LHKLVNLRHIDADKKIWLMIKDVWRLTNLQELLTFSVREGDALKLGRLQD
MTQFHGTLHIQNLENVVDSKEAQHAELKNKVHLKELVLEWNDEKDAKLEE
EVIEGLQPHDSLEILKIEGYNGGRSPSWLMPKVLSNLKKLELVNCKGWDD
DLPFIGQRLHLIELRMDNMPALKRLSHEFEGKCFPKLEMLMLFNLPAFEE
WFWTDGKDLFPCMRELVVINCPKLKRLPPFPPSLETLIIRGCPELILNNE
TADDEECDRLLLPSLKVLELSDSGEYAKLLPDCLHNLCLVTRLTISHCPH
ITSIPLVQLVELRSLAISYCDELTRMECLRLLKSLDLLEIIGCPKLVQLD
VEDEQAGSLSSLRKLCVDNTAVLKMFPLRNSLSFIKELEIASCSEEVIFE
EAMQSLTAVTSLIFYNCKKLQSLPTELLHSLPYLEELTVANCPQIHSLPD
KGLLPSLWMLTIDNCPQIHSLPEKGLPTLLECLHIFDCPQIHVMPDQEGL
PKSLYVFDCIGDVHPTLKEQSQKFYTDRNRRERALK
>XP_042428581.1 putative disease resistance protein RGA1 isoform X1 [Zingiber officinale]
MAFLLTAGGWFAPFFIQNLVDKASNKAIQLFAEGQGFEEDMDKLCTSLLK
TQIILDEVQSSGSNNTKWKTLMQELKDAAYDAEDLIDEFQYHVFKKKIKD
EEKYEASGSIGLPNILSRAKKKLFGSSYYMRERVRRIQGKLERIANSMES
IKNVLPRNDKGMQPEVKFQARESCSSPVTDILFGRDKELNQVVDWLLGSA
SQVELESGFANDTFSVLPIVGIGGAGKTTLAQYVHRDDRVQDHFHLKIWI
CVSDNFTVQGLTKSIIESVTLQKQYDSMRLEPLQKILQQHIAKKKFLLFL
DDVWSDDKSIWENFCALLKVGAHGSKIIVTTRDMKVSKMVSLVEPILLHG
LDEDAFWQLFNKCSFGTLNPKDYPELENIGRKIAHRLKGSPLAAKTLGRV
LQSNLCQQHWATVMESDIWKVKQDEDSIMPALHLSYQYLNENLKQCFAFC
SLFPKDYEFNKDKLIQMWMAEGFIEDKNTNRMEDVGSDYFLEFVNRSFFE
EFGNYGLYHFVMHDLIHDLAEMIAAEETCRIKSNERRKMLATVRHLRVEE
RILPLEFSGFDKLRTLVLRNSPPNSLFGKLRSIRVLDVSRCHFRELSKHI
DKLIHLRYLDLSYNSEIKFLPNSLGDLYNLQTLKVKGCSKLESIPQELGK
LVNLRHIDANCKFWVIMKDVRRLTNLQELPTFRIQEDDAHKLGQLKDMTQ
LHGTLSIQNLENVVDSKEAHHAELKNKVHLKELELEWNDEKDAKLEEEVI
EGLQPHESLKKLRIRGYNGAKSPSWLMPKVLSNLEKLDLEDCKGWDDVLP
FIGQRLHLIKLYMINMPALKQLSHEFEGKCFPKLEVLYLFDLPALEEWSW
TEGRDLFPCMRKLCVQICPKLKRLPPFPPSLEKLTIVRCPKLILNSKTED
DEEGGRHFPPSLKVLELINCGEYAKLLPDCLHNLCLVTRLEIGHCPHITS
IPLVQLVELQYLNISNCDELRRMECLGLLISLKKLKIVGCPKLVQLDVED
ERAQSLSSLLKLCVDNTALLKMFPLRNSLSFITKLQIESCSEEVIFIEPI
LVRSLTAVTSLRFIDCDKLQSLPTELLHCLPFLEKLVMYHCPQLQSLPEK
GILPSLRRLKIDDCPRIQSLSEKGLPPLLEELNIFDCPQIRAMPEDGLPM
SLIFFHCFGDVHPTLKEQSEKFYADRKRRVSTLDASYFHV
>XP_042428588.1 putative disease resistance protein RGA1 isoform X2 [Zingiber officinale]
MAFLLTAGGWFAPFFIQNLVDKASNKAIQLFAEGQGFEEDMDKLCTSLLK
TQIILDEVQSSGSNNTKWKTLMQELKDAAYDAEDLIDEFQYHVFKKKIKD
EEKYEASGSIGLPNILSRAKKKLFGSSYYMRERVRRIQGKLERIANSMES
IKNVLPRNDKGMQPEVKFQARESCSSPVTDILFGRDKELNQVVDWLLGSA
SQVELESGFANDTFSVLPIVGIGGAGKTTLAQYVHRDDRVQDHFHLKIWI
CVSDNFTVQGLTKSIIESVTLQKQYDSMRLEPLQKILQQHIAKKKFLLFL
DDVWSDDKSIWENFCALLKVGAHGSKIIVTTRDMKVSKMVSLVEPILLHG
LDEDAFWQLFNKCSFGTLNPKDYPELENIGRKIAHRLKGSPLAAKTLGRV
LQSNLCQQHWATVMESDIWKVKQDEDSIMPALHLSYQYLNENLKQCFAFC
SLFPKDYEFNKDKLIQMWMAEGFIEDKNTNRMEDVGSDYFLEFVNRSFFE
EFGNYGLYHFVMHDLIHDLAEMIAAEETCRIKSNERRKMLATVRHLRVEE
RILPLEFSGFDKLRTLVLRNSPPNSLFGKLRSIRVLDVSRCHFRELSKHI
DKLIHLRYLDLSYNSEIKFLPNSLGDLYNLQTLKVKGCSKLESIPQELGK
LVNLRHIDANCKFWVIMKDVRRLTNLQELPTFRIQEDDAHKLGQLKDMTQ
LHGTLSIQNLENVVDSKEAHHAELKNKVHLKELELEWNDEKDAKLEEEVI
EGLQPHESLKKLRIRGYNGAKSPSWLMPKVLSNLEKLDLEDCKGWDDVLP
FIGQRLHLIKLYMINMPALKQLSHEFEGKCFPKLEVLYLFDLPALEEWSW
TEGRDLFPCMRKLCVQICPKLKRLPPFPPSLEKLTIVRCPKLILNSKTED
DEEGGRHFPPSLKVLELINCGEYAKLLPDCLHNLCLVTRLEIGHCPHITS
IPLVQLVELQYLNISNCDELRRMECLGLLISLKKLKIVGCPKLVQLDVED
ERAQSLSSLLKLCVDNTALLKMFPLRNSLSFITKLQIESCSEEVIFIEPI
LVRSLTAVTSLRFIDCDKLQSLPTELLHCLPFLEKLVMYHCPQLQSLPEK
GILPSLRRLKIDDCPRIQSLSEKGLPPLLEELNIFDCPQIRAMPEDGLPM
SLIFFHCFGDVHPTLKEQSEKFYADRKRRLTTARLELE
>XP_042428600.1 putative disease resistance protein RGA4 isoform X1 [Zingiber officinale]
MAVELIVGGWFAQPFIKYLVDKAIDKAIQPFAESWGFTEDMENLRISLLK
TQTILDEVQISRSNKTKWEPLMKELKDAAYDAEDLIDEFQYHVLRQKIKG
EEEDKASGSTTGLPNIFAAAKKKLFGSSYDMGSRVKEIQGRLEKFANTAK
DIMQVLPPNDRGKQLEVKFQVRESCSSPVTDILFGRDRELNQVVDWLLGS
ANQVEPASGTFSVLAIEGIGGVGKTTLTQYVYKDDKVQDHFDLKIWVCVS
DNFTVQRLTKSTIESITLKKKYDNMELEALQKILHQHITKKKFLLVLDDV
WSDNKSIWETFCSLLKVGAHGSKIIVTTRDMKVSKMVSRVEPILLDGLEG
YFFWELFKKCSFGTLNPEEYPELQDIGRKIASKLEGSPLAAKTLGSVLQS
DLSQQHWTTVMKSDIWKVKQDECGIMPALELSYQYLNENLKQCFAFCSLF
PKDYEFNKTELVQMWMAEGFIEDKNTKRMEDVGSDYFLEFVNRSFFQKSR
YNEFRYNEVEDESEIGFLMHDLIHDLAEMISAEETCRIENNRQIKTLSTV
RHLRVVEVKLPLEFFGYNKLRTLVVLKNSPPDSLFEKLRSIRVLDVRLGG
FQKLSEHIGKLIHLRYLDLSYNYEIEILPDSLCDLYNLQTLKVEVCSKLK
TIPRELDKLANLRHIVADDRFWVTIKNVRRLTNLQEWPRPFRIQKDDGLK
LGQLKDLTQLHGTLRIENLENVVDSKEAQLAELKNKVHLKELELVWYFNW
NIDENDAKLEEEVIEGLQPHDSLKILKIEGYNGGRSPSWLMPKVLSNLKK
LELVNCKGWDDVLPFIGQRLHLIELRMVNMPALKQLSHEFEGKCFPKLKV
LKLYNLPALEEWSWTEGEDLFPCMRELRVSYCPKLKRLPPFPPSLKILRI
INCPSLILNSKTEDDEEGSRHLPPSLKELELTTCGEYAKLLADCLHNLHS
VTRLEISDCPCITSIPQAQLVKLKYLYISSCDELIRMECLGLFKSLKELK
IVGCPKLVQLDVEDEKAGSLSSLRKLCVDNTALLKMFPLRNSLSYIRELT
IESSSEEVIFEEAILVRRLTAVTSLRFSYCEKLQSLPTELLHCLPLLKYL
MMYDCPQLRSLPSFSSSLRKLKIINCPQIQSLPEKGLPPLLQLLDISDCP
QIQAMPEAGLPMSLDIFYCTGKVHPTLKEQSEKFYADRETRREASGSAAS
LFPEFLEPLDGSYVPCDSIPTGWTIYGPPTFPRQF
>XP_042428613.1 putative disease resistance protein RGA4 isoform X1 [Zingiber officinale]
MAVELIVGGWFAQPFIKYLVDKAIDKAIQPFAESWGFTEDMENLRISLLK
TQTILDEVQISRSNKTKWEPLMKELKDAAYDAEDLIDEFQYHVLRQKIKG
EEEDKASGSTTGLPNIFAAAKKKLFGSSYDMGSRVKEIQGRLEKFANTAK
DIMQVLPPNDRGKQLEVKFQVRESCSSPVTDILFGRDRELNQVVDWLLGS
ANQVEPASGTFSVLAIEGIGGVGKTTLTQYVYKDDKVQDHFDLKIWVCVS
DNFTVQRLTKSTIESITLKKKYDNMELEALQKILHQHITKKKFLLVLDDV
WSDNKSIWETFCSLLKVGAHGSKIIVTTRDMKVSKMVSRVEPILLDGLEG
YFFWELFKKCSFGTLNPEEYPELQDIGRKIASKLEGSPLAAKTLGSVLQS
DLSQQHWTTVMKSDIWKVKQDECGIMPALELSYQYLNENLKQCFAFCSLF
PKDYEFNKTELVQMWMAEGFIEDKNTKRMEDVGSDYFLEFVNRSFFQKSR
YNEFRYNEVEDESEIGFLMHDLIHDLAEMISAEETCRIENNRQIKTLSTV
RHLRVVEVKLPLEFFGYNKLRTLVVLKNSPPDSLFEKLRSIRVLDVRLGG
FQKLSEHIGKLIHLRYLDLSYNYEIEILPDSLCDLYNLQTLKVEVCSKLK
TIPRELDKLANLRHIVADDRFWVTIKNVRRLTNLQEWPRPFRIQKDDGLK
LGQLKDLTQLHGTLRIENLENVVDSKEAQLAELKNKVHLKELELVWYFNW
NIDENDAKLEEEVIEGLQPHDSLKILKIEGYNGGRSPSWLMPKVLSNLKK
LELVNCKGWDDVLPFIGQRLHLIELRMVNMPALKQLSHEFEGKCFPKLKV
LKLYNLPALEEWSWTEGEDLFPCMRELRVSYCPKLKRLPPFPPSLKILRI
INCPSLILNSKTEDDEEGSRHLPPSLKELELTTCGEYAKLLADCLHNLHS
VTRLEISDCPCITSIPQAQLVKLKYLYISSCDELIRMECLGLFKSLKELK
IVGCPKLVQLDVEDEKAGSLSSLRKLCVDNTALLKMFPLRNSLSYIRELT
IESSSEEVIFEEAILVRRLTAVTSLRFSYCEKLQSLPTELLHCLPLLKYL
MMYDCPQLRSLPSFSSSLRKLKIINCPQIQSLPEKGLPPLLQLLDISDCP
QIQAMPEAGLPMSLDIFYCTGKVHPTLKEQSEKFYADRETRREASGSAAS
LFPEFLEPLDGSYVPCDSIPTGWTIYGPPTFPRQF
>XP_042428623.1 putative disease resistance protein RGA1 isoform X2 [Zingiber officinale]
MAVELIVGGWFAQPFIKYLVDKAIDKAIQPFAESWGFTEDMENLRISLLK
TQTILDEVQISRSNKTKWEPLMKELKDAAYDAEDLIDEFQYHVLRQKIKG
EEEDKASGSTTGLPNIFAAAKKKLFGSSYDMGSRVKEIQGRLEKFANTAK
DIMQVLPPNDRGKQLEVKFQVRESCSSPVTDILFGRDRELNQVVDWLLGS
ANQVEPASGTFSVLAIEGIGGVGKTTLTQYVYKDDKVQDHFDLKIWVCVS
DNFTVQRLTKSTIESITLKKKYDNMELEALQKILHQHITKKKFLLVLDDV
WSDNKSIWETFCSLLKVGAHGSKIIVTTRDMKVSKMVSRVEPILLDGLEG
YFFWELFKKCSFGTLNPEEYPELQDIGRKIASKLEGSPLAAKTLGSVLQS
DLSQQHWTTVMKSDIWKVKQDECGIMPALELSYQYLNENLKQCFAFCSLF
PKDYEFNKTELVQMWMAEGFIEDKNTKRMEDVGSDYFLEFVNRSFFQKSR
YNEFRYNEVEDESEIGFLMHDLIHDLAEMISAEETCRIENNRQIKTLSTV
RHLRVVEVKLPLEFFGYNKLRTLVVLKNSPPDSLFEKLRSIRVLDVRLGG
FQKLSEHIGKLIHLRYLDLSYNYEIEILPDSLCDLYNLQTLKVEVCSKLK
TIPRELDKLANLRHIVADDRFWVTIKNVRRLTNLQEWPRPFRIQKDDGLK
LGQLKDLTQLHGTLRIENLENVVDSKEAQLAELKNKVHLKELELVWYFNW
NIDENDAKLEEEVIEGLQPHDSLKILKIEGYNGGRSPSWLMPKVLSNLKK
LELVNCKGWDDVLPFIGQRLHLIELRMVNMPALKQLSHEFEGKCFPKLKV
LKLYNLPALEEWSWTEGEDLFPCMRELRVSYCPKLKRLPPFPPSLKILRI
INCPSLILNSKTEDDEEGSRHLPPSLKELELTTCGEYAKLLADCLHNLHS
VTRLEISDCPCITSIPQAQLVKLKYLYISSCDELIRMECLGLFKSLKELK
IVGCPKLVQLDVEDEKAGSLSSLRKLCVDNTALLKMFPLRNSLSYIRELT
IESSSEEVIFEEAILVRRLTAVTSLRFSYCEKLQSLPTELLHCLPLLKYL
MISNHCQRKDFLLFSNY
>XP_042428874.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAVSLTMVGGWFAQAFIQTLIDKASDKAIQLFAERRGFAADMETLCTSLL
ETQIILDKVQSSQSNDTKWKTLMQKLKDAAYDAEDLIDEFQYHVLMQKIK
GEEEDKAASCSGGLPNIFSAAKEKLFGSSHSLEEDAMRASVVEIQGRLER
IANSMKSIMNVLPPNDRGKQPDQMKFQSRESCSSPVTDILFGRDKELNQV
VEWLLGSANQVEPTSGFLNDALSVLPIVGIGGAGKTTLAQYAHKDIRVQD
HFHLKIWVCVSNNFTVQGLVKSIIESITLQKQYDNMGLESLQKILHQHIA
QKKFLLVLDDVWSDNKRIWEKFCALLKVGAYGSKIIVTTRDMKISKMVSL
VEPILLHGLDEDTFWQLFKKSSFGTLNPEEYPELEDIGRKIVRKLKGSPL
AAKTLGSVLQSNLCQQHWATVMESDIWKVKQDEDDIMPALHLSYRYLNEN
LKQCFAFCSVFPKDNVFKEAELVRMWIAEGFIQNKNTKRMEDVGSDYFLE
FVNRSFFQEVKYSRFVMHDLIHDLAEMISTEETCRIENSSQRKMFSTIRH
LRVEGKLPLEVSGYDKLRTLMLRKNSPPDSLFEKLRSIHVLDLSDCGLQE
LSEHVGKLIHLRYLDISWNSEIKILPDSLCHLHNLQTLEILGCHKLESIP
QELGKKMVNLRHINAVNKFWVMIKDVRRLTNLQELPTFSVQVDDGLKLVQ
LKDLTQLHGTLHIQNLENVVDSKEAQHAELKNKVHLKELVLEWNYWQRDR
RNDVKLEEEVIEGLQPHESLKKLKIKWYNGGRSPSWLMPKVLSNLEKLEL
SNCKGWDDVLPFIGQRLHLIELCMNRMPALKQLSHEFEGKCFPKLKVLNL
WNLPALEESGRGLRAKIYFPACVNFASAVAPN
>XP_042428887.1 disease resistance protein RGA2-like [Zingiber officinale]
MAVSLTVVGGWFAQAFIQTLIDKASDKSIQLFAERRGFAADMDKLRISLL
ETQIILDEVQISRSNNTKWKRLMQELKNAAYDAEDLIDEFQYHFLRQKVK
GEEDDKESGSSGLPDIFSAAKEKLFGSSHSLEEDAMRASVVEIQGRLDRI
ANSMKSIMNVLPLNDRGKQPDQMKFQTRESCSSPVTDILFGRDKELNQVV
DWLLGSAKQVEPASGFLNDALSVLPIVGIGGAGKTTLAQYAHKDNRVQDH
FHLKIWVYVSNNFTVQGLAKSIIESVTLQKQYDNMGLESLQKILHQHIAQ
KKFLLVLDDVWSDNKRIWEKFCALLKVGAYGSKIIVTTRDMKISKMVSLV
EPILLDGLDKDVFWQLFKKCSFGTLNPEDYPELEDIGRKISRKLKGSPLA
AKTLGSVLQSDLCQQHWAIIMESDIWKVKQDEDDIMPALHLSYQYLNENL
KQCFAFCSLFPKDYRFYKAELIQMWMAEGFIEDKNTKRMEDVGSDYFLEF
VNRSFFQEFRYDYEFEDEFVMHDLIHDLAEMISTEEICRIENNRQTKPPS
TTRHLQVEEEKLPLEFLGYNKLRTLVLRKNLPPDSLFEKLRSIRVLDVSS
CDLQELPEHIGKLIHLRYIDISYNFKIKILPGSLCDLYNLQTLKVICCPE
LQFIPQELGKLVNLRHIVADDEFWVMIKDVRKLTNLQELQRFSVEEDDRL
KLGQLKDLTQLHGTLCIQNLENVVDSKEAQDAELKNKVHLKQLELDWNDE
KDAKLEEEVIEGLQPHESLKILKIEGYNGGRSPSWLMPKVLSNLEKLELV
NCNGWDDVLPFIGQRLHLIELIMYSMPALKQLSHEFEGKCFPKLKVLNLW
NLPALEEWSWTEGKDLFPCMRKLLVSNCPKLKRLPPFPPSLEILEIKKCP
NLILNSKTEDEEEEEVGRHALSSLKVLELANSGEYAKLLTDFLHNLRLVT
RLNIRDCPYITSIPQAQLLELQYLSISNCVELGRMECLGLLKSLKELRIV
GCPKLVQLDVGDEQAGRLSSLRKLYVDNTALLKMFPLRNSLSFITELKIE
SCSEEVIFEESILARSLTAVTSLSFSYCKKLQTLPTKLLHSFPLLENLMV
YCCPQLQSLPEIGLSPLLKKLEICHCPQIQAMPEDGLPMSLDVFKCSGYV
HPTLMEQSEKFNAKREMRRDIEVV
>XP_042428912.1 disease resistance protein RGA2-like isoform X1 [Zingiber officinale]
MAVALTVGGWFAQAFIQTLIDKASDKSIQLFAERRGFAEDMENLHPSLLE
IQIILDEVQSSGCNDTKWKTLIQELKDAAYDAEDLIDEFQYHVLRQKIKG
EEEDKLATGSSGLSNMFYAAKKKLLGSSHSLEEDDTRARVRKMQGRLEKI
ANRMKSIMNVLPPNDRRKRPEVKFQARESCSSPVTDILFGRDKELNQVVD
WLLGSANQVEPASAFVNDAFSVLPIVGIGGAGKTTLAQYAHKHNRVQVHF
HLKIWVCVSDNFTVQGLAKSIIQSVTPQKQYDNMGLEPLQKLLHEHIANK
KFLLVLDDMWSDNKSIWHKLCALLKVGAHGSKIIVTTRDMKVSKMVSLVE
PILLHGLDEDAFWQLFKKCSFGTLDPEDYPELKDIGRNIAGKLKGSPLAA
KTLGSVLQSDLCQQHWDTIMKSDIWKIKQDEDDIMPALHLSYQYLNENLK
QCFTFCSLFPKDYLFDKDKLVQMWMAEGFIEDNNTKRMEDVGSDYFLEFI
NRSFFQELQFGEFVMHDLIHDLAEMISTEETCRIENNRQTKMLSTIRHLR
VGGKLPLDFSGYDKLHTLMLRKKSSPDSLFEKLRSIRVLDVSWCSLQELS
EHIGKLIHLRYLDISWNSEIKILPDLLSYLYNLQTLKVKGCSKLEYIPQE
LSKLVNLRCIDANDMFLVMMKDVRRLTNLQELPTFSVQEDDGLKLEQLKD
MTQLHGTLHIQNLENVVDGTEAQHAELKNKVHLKELVLQWNDEKDAKLEE
EVIEGLQPHESLKILTIRGYNGGRSPSWLMPKVLSNLETLDLVNCKGWDD
VLPFIGQRLHLIELRMVSMPALKQLSHEFEGKCFPKLEMLELYDLPALEE
WSWTEGKDLFPCMRELCARDCPKLNRLPPFPPSLEILAITNCPSLILNNK
TEDDEEGSCHLPPSIKVLELDNCGEYSKLLPDCLPNLRLVTRLTIRHCPR
IASIPLVQLVELQYLYISNCDELRRMECLGLLKSLEKLKIVRCPMLVQLD
VEDEQAGGLSSLRKLCVDNTALLKMFPLRNSLSFIKELEIESCSEEVIFE
DAILMQSLTAVTSLSFRYCKKLQSLPTELLHNFPLLEKLEMCDCPQLQSL
PEIRLSPFLKALEICNCPQIQAMPEDGLPMSLDVFICIGKVHPTLEEQSE
RFYMERVMRRVSSLDARLFPCTESFYYCTPSFVLLVNPQISFHVIIYIRF
IINFFLPHNFFSFVQAPKCLCYFLDI
>XP_042428919.1 disease resistance protein RGA2-like isoform X2 [Zingiber officinale]
MAVALTVGGWFAQAFIQTLIDKASDKSIQLFAERRGFAEDMENLHPSLLE
IQIILDEVQSSGCNDTKWKTLIQELKDAAYDAEDLIDEFQYHVLRQKIKG
EEEDKLATGSSGLSNMFYAAKKKLLGSSHSLEEDDTRARVRKMQGRLEKI
ANRMKSIMNVLPPNDRRKRPEVKFQARESCSSPVTDILFGRDKELNQVVD
WLLGSANQVEPASAFVNDAFSVLPIVGIGGAGKTTLAQYAHKHNRVQVHF
HLKIWVCVSDNFTVQGLAKSIIQSVTPQKQYDNMGLEPLQKLLHEHIANK
KFLLVLDDMWSDNKSIWHKLCALLKVGAHGSKIIVTTRDMKVSKMVSLVE
PILLHGLDEDAFWQLFKKCSFGTLDPEDYPELKDIGRNIAGKLKGSPLAA
KTLGSVLQSDLCQQHWDTIMKSDIWKIKQDEDDIMPALHLSYQYLNENLK
QCFTFCSLFPKDYLFDKDKLVQMWMAEGFIEDNNTKRMEDVGSDYFLEFI
NRSFFQELQFGEFVMHDLIHDLAEMISTEETCRIENNRQTKMLSTIRHLR
VGGKLPLDFSGYDKLHTLMLRKKSSPDSLFEKLRSIRVLDVSWCSLQELS
EHIGKLIHLRYLDISWNSEIKILPDLLSYLYNLQTLKVKGCSKLEYIPQE
LSKLVNLRCIDANDMFLVMMKDVRRLTNLQELPTFSVQEDDGLKLEQLKD
MTQLHGTLHIQNLENVVDGTEAQHAELKNKVHLKELVLQWNDEKDAKLEE
EVIEGLQPHESLKILTIRGYNGGRSPSWLMPKVLSNLETLDLVNCKGWDD
VLPFIGQRLHLIELRMVSMPALKQLSHEFEGKCFPKLEMLELYDLPALEE
WSWTEGKDLFPCMRELCARDCPKLNRLPPFPPSLEILAITNCPSLILNNK
TEDDEEGSCHLPPSIKVLELDNCGEYSKLLPDCLPNLRLVTRLTIRHCPR
IASIPLVQLVELQYLYISNCDELRRMECLGLLKSLEKLKIVRCPMLVQLD
VEDEQAGGLSSLRKLCVDNTALLKMFPLRNSLSFIKELEIESCSEEVIFE
DAILMQSLTAVTSLSFRYCKKLQSLPTELLHNFPLLEKLEMCDCPQLQSL
PEIRLSPFLKALEICNCPQIQAMPEDGLPMSLDVFICIGKVHPTLEEQSE
RFYMERVMRRLMKARLELK
>XP_042428936.1 disease resistance protein RGA2-like [Zingiber officinale]
MAVSLTVVGGWFAQAFIQTLIDKASDKAIQLFAERRGFAADMETLCTSLL
ETQIILDKVQSSQSNDTKWKTLMQKLKDAAYDAEDLIDEFQYHVLRLKIK
GEEEDKAVSGSGGLPNIFSAAKEKLFGSSHSLEEDAMRASVVEIQGRLER
IANSMKSIMNVLPPNDRGKQPDQMKFQTRESCSSPVTDILFGRDKELNQV
VEWLLGSANQVEPASGFLNDTFSVLSIVGIGGAGKTTLAQYAHKDNRVQD
YFHLKIWICVSNNFTVQELAKSIIESVTLQKQYDNMGLESLQKILHQHIA
QKKFLLVLDDVWSDNKRIWEKFCALLKVGAYGSKIIVTTRDMKISKMVSL
VEPILLHGLDEDTFWQLFKKCSFGTLNPEEYPELEDIGRKIVRKLKGSPL
AAKTLGGVLQSNLCQQHWATVMESDIWKVKQDEDDIMPALHLSYQYLNEN
LKQCFAFCSVFPKDYRFGKAELVRMWMAEGFIKDKNTRGWKMLEATIFLS
LLTSLSFKNTNLVHL
>XP_042428946.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAVSLTVVGGWFAQAFIQTLIDKASDKSIQLFAERRGFAADMDKLRISLL
ETQIILDEVQISRSNNTKWKRLMQELKDAAYDAEDLIDEFQYHFLRQKVK
GEEDDKESGSSGLPDIFSAAKEKLFGSSHSLEEDAMRASVVEIQGRLDRI
ANSIKSIMNVLPPNDRGKQPDQMKFQTRESCSSPVTDILFGRDKELNQVV
DWLLGSAKQVEPASGFLNDALSVLPIVGIGGAGKTTLAQYAHKDNRVQDH
FHLKIWVCVSNNFTVQGLAKSIIESVTLQKQYDNMGLESLQKILHQHIAQ
KTFLLVLDDVWSDNKRIWEKFCALLKVGAYGSKIIVTTRDMKISKMVSLV
EPILLHGLDKDTFWQLFKKSSFGTLNPEEYPELEDIGRKIVRKLKGSPLA
AKTLGSVLQSNLCQQHWATVMESDIWKVKQDEDDIMPALHLSYQYLNENL
KQCFVFCSLFPKDYKFYKAELIQMWMAEGFIEDKNTKRMEDVGSDYFLEF
VNRSFFQEFRYDYEFEDEFVMHDLIHDLAEMISTEEICRIENNRQTKPPS
TTRHLRVEEEKLPLEFSGYNKLRTLVLRKNLPPDSLFEKLRSIRVLDVSW
CDLQELSEHIGKLTHLRYIDISYNFKIKILPGSLCDLYNLQTLKVICCPE
LQFIPQELGKLVNLRHIVADDEFWVMIKDVRKLTNLQELQRFSVEEDDRL
KLGQLKDLTQLHGTLCIQNLENVVDSKEAQHAELKNKVHLKQLELDWNDE
KDAKLEEEVIEGLQPHESLKILKIEGYNGGRSPSWLMPKVLSNLEKLELV
NCNGWDDVLPFIGQRLHLIELIMYSMPALKQLSHEFEGKCFPKLKVLNLW
NLPALEEWSWTEGKDLFPCMRKLLVSNCPKLKRLPPFPPSLEILEIKKCP
NLILNSKTEDEEEVGRHALPSLKVLELANSGEYAKLLTDFLHNLRLVIRL
NIRDCPYITSIPQAQLLELQYLSISNCVELRTMECLGFLKSLKELRIVGC
PKLVQLDVGDEQAGRLSSLRKLYVDNTALLKMFPLRNSLSFITELKIESC
SEEVIFEESILARSLTAVTSLSFSYCKKLQSLPTKLLHSFPLLENLMVYC
CPQLQSLPEIGLSPLLKKLEICHCPQIQAMPEDGLPMSLDVFKCSGYVHP
TLMEQSEKFNAKREMRRDIEVV
>XP_042428969.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAVSLTVVGGWFAQAFIQTLIDKASDKAIQLFAERRGFAADMETLCTSLL
ETQIILDKVQSSQSNDTKWKTLMQKLKDAAYDAEDLIDEFQYHVLRQKIK
GEEEDKAASGSGGLPNIFSAAKEKLFGSSHSLEEEAMRASVVEIQGRLER
IANSMKSIMNVLPPNDRGKQPDQMKFQTRESCSSPVTDILFGRDKELNQV
VDWLLGSANQVEPASGFLNDSSSVLPIVGIGGAGKTTLAQYAHKDNRVQD
HFHLKIWVCVANNFTVQGLAKSIIESVTLQKQDDNMGLEPLQKILHQHIT
KKKFLLVLDDVWSNNKSIWEKFCALLKFGAHGSKIIVTTRDLKVSKMVSL
AEPISLHGLDEDVFWQLFKKCSFGTLNPEDYPELEDIGRKIALKLKGSPL
AAKTLGSVLQTDLCQQHWATVMESDIWKVKQDEDGIMPALHLSYQYLNEN
MKQCFAVCSVFPKDYVFEEAELVQMWMAKGFTQNKNAKRMEDIGSNYFLE
FINRTFFQEFKFGGFVMHDLIHDLAEMISTEETCRIENNRQTKMFSTIRH
LRVEGKLPLEVSGYDKLRTLMLKKNSPPDSLFEKLRSIRVLNVSQCGLQE
LSEHIGKLIHLRYLDLSFNYEVKVLPDSLCDLYNLQTLKTRKCNAIESVP
QELCKLVNLRHIDADDEFWVMIKDVRRLTNLQELPTFSVQEDDGLKLAQL
KDLAQLHGTLHIQNLENVVDSKEAQHAELKNKVHLKELVLEWNDEKDAKL
EEEVIEGLQPHESLKILKIEGYNGGRSPSWLMPKVLPNLEKLELAICKGW
DDVLPFIGQRLHLIELRMHRMSALKQLSHEFEGKCFPKLKVLNLWNLPAL
EEWSWTEGKHLFPCMRELRVCSCPKLKRLPPFPPSLEILTIEDCPELKLN
SKTENDEEGGCHLLPSLKELDLSYCGEYAKLLPDCLHSLCLITRLEINHC
PHITSISLVQLVELQSLYISNCDELRRMECLGVLKSLEKLTIIGCPKLVQ
LDVEDEQAASLLSSLRKLCVDNIALLKMFPLRNSLSFITKLKIESCSEEM
IFEETIWMQNLTAVTSLCFRFCEKLQSLPIELLHSFPFLEELMMYGCPQL
QSLPEIGLSPFLKTLVISNCPRIQPMPEEGLPKSLDVFHCSGNVHPTLMK
QSKKFFADRYR
>XP_042428980.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAVALTVGGWFAQAFIQTLIDKASDKSIQLFAQRRGFAEDMENLHPSLLE
IQIILDEVQISRSNNTKWKTLMQELKDAAYDAEDLIDEFQYHVLRQKVKG
KEEDKAASGSSGLSNMFYAAKIKLLGSSHSLEEDDMRARVRKMQGRLEKI
ANRMKSIMNVLPPHDRRKQPEVKFQARESCSSPATDIMFGRDKELNQVVD
WLLESANQVEPASAFVNDTFSVLPIVGIGGAGKTTLAQYAHKHNRVQVHF
HLKIWVCVSDNFTVQGLVKSIIQSVAPQKRYDNMGLEPLQKLLHEHIADK
KFLLVLDDVWSDNKSIWHKLCALLKVGAHGSKIIVTTRDVKVSKMVSLVE
PILLHGLDEDAFWQLFKKCSFGTLNPGDYPELEDIGRKIARKLKGSPLAA
KTLGSVLQSDLRQQHWNTIMKSDIWKVKQDEEDIMPVLHLSYEYLNENMK
QCFAFCSVFPKDYKFDKAVLVQMWIAEGFIEDKNTKRMEDVGSDYFLEFV
NRSFFQEFVYGLFVMHDLIHDLAEMIYAEETCRIENNRQTKMLSTIRHLR
VEEGKLPLEFSGYDKLHTLMLRKNSPPNSLFEKLRSIRVLDVSRCGLQEL
SEHIGKLIHLRYLDISWNSEIKILPDSLFDLYNLQTLKVEGCSKLEYIPQ
ELSKLVNLRCIDADDMFLVMVKDVRRLTNLQELPTFSVQEDDGLKLEQLK
DMTQLHGTLHIQNLENVVDSTEAQQAELKNKVRLNKLVLEWNDEKDAKLE
EEVIEGLQPHKSLKILKIEGYNGSRSPSWLMPKVLSNLEKLYLVNCKGWD
DVLPFIGQRLHLIELHMDGMPALKQLSHEFEGKCFPKLEVLYLYELPALE
EWSWTEGKDLFPCMRELRVSYCHKLKRLPPFPPSLEMLTIECCPRLKLNS
RTEDDEEGGCHLPPSLKGLKISQWPHITSISLVQSVELQYLYISKCDELR
WMECLGVLKSLKQLNIVGCPKLVQLDVEDEQSASLLPSLRYLCVDNTALL
KMFPLRNSLPFITELVFVSCSEEVIFEEPILVRSLTAVTSLSFIGCEKLQ
SLPAKLLHCLPFLKTLMVYNCPQLQSLPEIGLSPFLKTLDICDCPQIQAM
PEDGLPMSLDDFQCSGDVHPKLKEQSDKFFVDTYNKRKARLELE
>XP_042428988.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAVALTVGGWFAQAFIQTLIDKASDKSIQLFAQRRGFAEDMENLHPSLLE
IQIILDEVQISRSNNTKWKTLMQELKDAAYDAEDLIDEFQYHVLRQKVKG
KEEDKAASGSSGLSNMFYAAKIKLLGSSHSLEEDDMRARVRKMQGRLEKI
ANRMKSIMNVLPPHDRRKQPEVKFQARESCSSPATDIMFGRDKELNQVVD
WLLESANQVEPASAFVNDTFSVLPIVGIGGAGKTTLAQYAHKHNRVQVHF
HLKIWVCVSDNFTVQGLVKSIIQSVAPQKRYDNMGLEPLQKLLHEHIADK
KFLLVLDDVWSDNKSIWHKLCALLKVGAHGSKIIVTTRDVKVSKMVSLVE
PILLHGLDEDAFWQLFKKCSFGTLNPGDYPELEDIGRKIARKLKGSPLAA
KTLGSVLQSDLRQQHWNTIMKSDIWKVKQDEEDIMPVLHLSYEYLNENMK
QCFAFCSVFPKDYKFDKAVLVQMWIAEGFIEDKNTKRMEDVGSDYFLEFV
NRSFFQEFVYGLFVMHDLIHDLAEMIYAEETCRIENNRQTKMLSTIRHLR
VEEGKLPLEFSGYDKLHTLMLRKNSPPNSLFEKLRSIRVLDVSRCGLQEL
SEHIGKLIHLRYLDISWNSEIKILPDSLFDLYNLQTLKVEGCSKLEYIPQ
ELSKLVNLRCIDADDMFLVMVKDVRRLTNLQELPTFSVQEDDGLKLEQLK
DMTQLHGTLHIQNLENVVDSTEAQQAELKNKVRLNKLVLEWNDEKDAKLE
EEVIEGLQPHKSLKILKIEGYNGSRSPSWLMPKVLSNLEKLYLVNCKGWD
DVLPFIGQRLHLIELHMDGMPALKQLSHEFEGKCFPKLEVLYLYELPALE
EWSWTEGKDLFPCMRELRVSYCHKLKRLPPFPPSLEMLTIECCPRLKLNS
RTEDDEEGGCHLPPSLKGLKISQWPHITSISLVQSVELQYLYISKCDELR
WMECLGVLKSLKQLNIVGCPKLVQLDVEDEQSASLLPSLRYLCVDNTALL
KMFPLRNSLPFITELVFVSCSEEVIFEEPILVRSLTAVTSLSFIGCEKLQ
SLPAKLLHCLPFLKTLMVYNCPQLQSLPEIGLSPFLKTLDICDCPQIQAM
PEDGLPMSLDDFQCSGDVHPKLKEQSDKFFVDTYNKRKARLELE
>XP_042428995.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAVALTVGGWFAQAFIQTLIDKASDKSIQLFAQRRGFAEDMENLHPSLLE
IQIILDEVQISRSNNTKWKTLMQELKDAAYDAEDLIDEFQYHVLRQKVKG
KEEDKAASGSSGLSNMFYAAKIKLLGSSHSLEEDDMRARVRKMQGRLEKI
ANRMKSIMNVLPPHDRRKQPEVKFQARESCSSPATDIMFGRDKELNQVVD
WLLESANQVEPASAFVNDTFSVLPIVGIGGAGKTTLAQYAHKHNRVQVHF
HLKIWVCVSDNFTVQGLVKSIIQSVAPQKRYDNMGLEPLQKLLHEHIADK
KFLLVLDDVWSDNKSIWHKLCALLKVGAHGSKIIVTTRDVKVSKMVSLVE
PILLHGLDEDAFWQLFKKCSFGTLNPGDYPELEDIGRKIARKLKGSPLAA
KTLGSVLQSDLRQQHWNTIMKSDIWKVKQDEEDIMPVLHLSYEYLNENMK
QCFAFCSVFPKDYKFDKAVLVQMWIAEGFIEDKNTKRMEDVGSDYFLEFV
NRSFFQEFVYGLFVMHDLIHDLAEMIYAEETCRIENNRQTKMLSTIRHLR
VEEGKLPLEFSGYDKLHTLMLRKNSPPNSLFEKLRSIRVLDVSRCGLQEL
SEHIGKLIHLRYLDISWNSEIKILPDSLFDLYNLQTLKVEGCSKLEYIPQ
ELSKLVNLRCIDADDMFLVMVKDVRRLTNLQELPTFSVQEDDGLKLEQLK
DMTQLHGTLHIQNLENVVDSTEAQQAELKNKVRLNKLVLEWNDEKDAKLE
EEVIEGLQPHKSLKILKIEGYNGSRSPSWLMPKVLSNLEKLYLVNCKGWD
DVLPFIGQRLHLIELHMDGMPALKQLSHEFEGKCFPKLEVLYLYELPALE
EWSWTEGKDLFPCMRELRVSYCHKLKRLPPFPPSLEMLTIECCPRLKLNS
RTEDDEEGGCHLPPSLKGLKISQWPHITSISLVQSVELQYLYISKCDELR
WMECLGVLKSLKQLNIVGCPKLVQLDVEDEQSASLLPSLRYLCVDNTALL
KMFPLRNSLPFITELVFVSCSEEVIFEEPILVRSLTAVTSLSFIGCEKLQ
SLPAKLLHCLPFLKTLMVYNCPQLQSLPEIGLSPFLKTLDICDCPQIQAM
PEDGLPMSLDDFQCSGDVHPKLKEQSDKFFVDTYNKRKARLELE
>XP_042429001.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAVALTVGGWFAQAFIQTLIDKASDKSIQLFAQRRGFAEDMENLHPSLLE
IQIILDEVQISRSNNTKWKTLMQELKDAAYDAEDLIDEFQYHVLRQKVKG
KEEDKAASGSSGLSNMFYAAKIKLLGSSHSLEEDDMRARVRKMQGRLEKI
ANRMKSIMNVLPPHDRRKQPEVKFQARESCSSPATDIMFGRDKELNQVVD
WLLESANQVEPASAFVNDTFSVLPIVGIGGAGKTTLAQYAHKHNRVQVHF
HLKIWVCVSDNFTVQGLVKSIIQSVAPQKRYDNMGLEPLQKLLHEHIADK
KFLLVLDDVWSDNKSIWHKLCALLKVGAHGSKIIVTTRDVKVSKMVSLVE
PILLHGLDEDAFWQLFKKCSFGTLNPGDYPELEDIGRKIARKLKGSPLAA
KTLGSVLQSDLRQQHWNTIMKSDIWKVKQDEEDIMPVLHLSYEYLNENMK
QCFAFCSVFPKDYKFDKAVLVQMWIAEGFIEDKNTKRMEDVGSDYFLEFV
NRSFFQEFVYGLFVMHDLIHDLAEMIYAEETCRIENNRQTKMLSTIRHLR
VEEGKLPLEFSGYDKLHTLMLRKNSPPNSLFEKLRSIRVLDVSRCGLQEL
SEHIGKLIHLRYLDISWNSEIKILPDSLFDLYNLQTLKVEGCSKLEYIPQ
ELSKLVNLRCIDADDMFLVMVKDVRRLTNLQELPTFSVQEDDGLKLEQLK
DMTQLHGTLHIQNLENVVDSTEAQQAELKNKVRLNKLVLEWNDEKDAKLE
EEVIEGLQPHKSLKILKIEGYNGSRSPSWLMPKVLSNLEKLYLVNCKGWD
DVLPFIGQRLHLIELHMDGMPALKQLSHEFEGKCFPKLEVLYLYELPALE
EWSWTEGKDLFPCMRELRVSYCHKLKRLPPFPPSLEMLTIECCPRLKLNS
RTEDDEEGGCHLPPSLKGLKISQWPHITSISLVQSVELQYLYISKCDELR
WMECLGVLKSLKQLNIVGCPKLVQLDVEDEQSASLLPSLRYLCVDNTALL
KMFPLRNSLPFITELVFVSCSEEVIFEEPILVRSLTAVTSLSFIGCEKLQ
SLPAKLLHCLPFLKTLMVYNCPQLQSLPEIGLSPFLKTLDICDCPQIQAM
PEDGLPMSLDDFQCSGDVHPKLKEQSDKFFVDTYNKRKARLELE
>XP_042429011.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAVALTVGGWFAQAFIQTLIDKASDKSIQLFAERRGFAADMDKLRISLLE
TQIILNEVQISRSNDTKWKTLMQELKDAAYDAEDLIDEFQYHVLRKKIKG
EEDDKASGSGVLSNIFSATKNKLLGSSHSLEEDAMRASVVEIQGRLERIA
NSMKSIMNVLPPNDRGKQPDQMKSQTRESCSSPVTDILLGRDEELNQVVD
WLLGSANQAEPASGFLNNTLSVLPIVGIGGAGKTTLAQYALKDKRVQDHF
DLNIWVCVSDNFTVQGLTKSIIESVTLKKQDDNMGLEPLRKLLHEHIANK
KFLLVLDDVWSDNKSIWHKFCALLIIGAHGSKIIITTRDKKVSKMVSLAE
PILIDGLKEGFFWQLFKKCSFGTLNPEDYPELEDIGRKIALKLKGSPLAA
KTLGSVLQSDLCQQHWDTILKSDIWKVKQDEDDIMPALHLSYQYLNENLK
QCFAFCSLFPKDYEFNKAELVRMWMAEGFIEDTNTKRMEDVGSDYFLEFV
YRSFFQELQFGGFVMHDLIHDLAEMISAEDTCIIEKKRQTKTPSTVRHLR
VEGKLPLEFFGYDKLRTWMLRKNSPPDSLFEKLRSIRVLNISQCGLQELS
EHIGKLIHLRYLDLSFNYEIKILPDSLCDLYNLQTLKAQQCIAIESVPQE
LCKLVNLRCIDADDMFLVMMKDVRRLTNLQELPTFSVQEDEGLKLVQLKD
LTQLHGSLHIQNLENVVDSKEAQDAELKNKVHLKELVLEWNDEKDAKMEE
EVIEGLQPHESLKILKIEGYNGGRSPSWLMPKVLPNLEKLELVNCMGWDD
VLPFIGQRLHLIELSMEDMPALKQLSHQFEGKCFPKLEVLYLFDLPALEE
WSWTEGKDLFPCMRVLRVIDCPKLKRLPPFPPSLEILTIQHCPSLMLNSK
TEDDEEGDGHLPPSLKELELRDCGKYEKLLLDCLHNLRLVTRLEINDFPH
ITSISLVHLVELQYLCITNCEELRWMECLGLLKSLKKLKIVGCPKLVQLD
VEDEQSASLLSSLHTLCVDNIALFKMFPLRNSLSFITELLFVSCSEEVIF
EEAILVRSLTAVTSLSFLRCDKLRSLPAELLHCLPFLKTLMVSNCPQLQS
LPEMRLSPFLERLEIYNCPQIQAMPEDGLPMSLDVFICSGDVHPKLREQS
EKFFVDRYNRRVKLELE
>XP_042429017.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAVALTVGGWFAQAFIQTLIDKASDKSIQLFAERRGFAADMDKLRISLLE
TQIILNEVQISRSNDTKWKTLMQELKDAAYDAEDLIDEFQYHVLRKKIKG
EEDDKASGSGVLSNIFSATKNKLLGSSHSLEEDAMRASVVEIQGRLERIA
NSMKSIMNVLPPNDRGKQPDQMKSQTRESCSSPVTDILLGRDEELNQVVD
WLLGSANQAEPASGFLNNTLSVLPIVGIGGAGKTTLAQYALKDKRVQDHF
DLNIWVCVSDNFTVQGLTKSIIESVTLKKQDDNMGLEPLRKLLHEHIANK
KFLLVLDDVWSDNKSIWHKFCALLIIGAHGSKIIITTRDKKVSKMVSLAE
PILIDGLKEGFFWQLFKKCSFGTLNPEDYPELEDIGRKIALKLKGSPLAA
KTLGSVLQSDLCQQHWDTILKSDIWKVKQDEDDIMPALHLSYQYLNENLK
QCFAFCSLFPKDYEFNKAELVRMWMAEGFIEDTNTKRMEDVGSDYFLEFV
YRSFFQELQFGGFVMHDLIHDLAEMISAEDTCIIEKKRQTKTPSTVRHLR
VEGKLPLEFFGYDKLRTWMLRKNSPPDSLFEKLRSIRVLNISQCGLQELS
EHIGKLIHLRYLDLSFNYEIKILPDSLCDLYNLQTLKAQQCIAIESVPQE
LCKLVNLRCIDADDMFLVMMKDVRRLTNLQELPTFSVQEDEGLKLVQLKD
LTQLHGSLHIQNLENVVDSKEAQDAELKNKVHLKELVLEWNDEKDAKMEE
EVIEGLQPHESLKILKIEGYNGGRSPSWLMPKVLPNLEKLELVNCMGWDD
VLPFIGQRLHLIELSMEDMPALKQLSHQFEGKCFPKLEVLYLFDLPALEE
WSWTEGKDLFPCMRVLRVIDCPKLKRLPPFPPSLEILTIQHCPSLMLNSK
TEDDEEGDGHLPPSLKELELRDCGKYEKLLLDCLHNLRLVTRLEINDFPH
ITSISLVHLVELQYLCITNCEELRWMECLGLLKSLKKLKIVGCPKLVQLD
VEDEQSASLLSSLHTLCVDNIALFKMFPLRNSLSFITELLFVSCSEEVIF
EEAILVRSLTAVTSLSFLRCDKLRSLPAELLHCLPFLKTLMVSNCPQLQS
LPEMRLSPFLERLEIYNCPQIQAMPEDGLPMSLDVFICSGDVHPKLREQS
EKFFVDRYNRRVKLELE
>XP_042429023.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAVALTVGGWFAQAFIQTLIDKASDKSIQLFAERRGFAADMDKLRISLLE
TQIILNEVQISRSNDTKWKTLMQELKDAAYDAEDLIDEFQYHVLRKKIKG
EEDDKASGSGVLSNIFSATKNKLLGSSHSLEEDAMRASVVEIQGRLERIA
NSMKSIMNVLPPNDRGKQPDQMKSQTRESCSSPVTDILLGRDEELNQVVD
WLLGSANQAEPASGFLNNTLSVLPIVGIGGAGKTTLAQYALKDKRVQDHF
DLNIWVCVSDNFTVQGLTKSIIESVTLKKQDDNMGLEPLRKLLHEHIANK
KFLLVLDDVWSDNKSIWHKFCALLIIGAHGSKIIITTRDKKVSKMVSLAE
PILIDGLKEGFFWQLFKKCSFGTLNPEDYPELEDIGRKIALKLKGSPLAA
KTLGSVLQSDLCQQHWDTILKSDIWKVKQDEDDIMPALHLSYQYLNENLK
QCFAFCSLFPKDYEFNKAELVRMWMAEGFIEDTNTKRMEDVGSDYFLEFV
YRSFFQELQFGGFVMHDLIHDLAEMISAEDTCIIEKKRQTKTPSTVRHLR
VEGKLPLEFFGYDKLRTWMLRKNSPPDSLFEKLRSIRVLNISQCGLQELS
EHIGKLIHLRYLDLSFNYEIKILPDSLCDLYNLQTLKAQQCIAIESVPQE
LCKLVNLRCIDADDMFLVMMKDVRRLTNLQELPTFSVQEDEGLKLVQLKD
LTQLHGSLHIQNLENVVDSKEAQDAELKNKVHLKELVLEWNDEKDAKMEE
EVIEGLQPHESLKILKIEGYNGGRSPSWLMPKVLPNLEKLELVNCMGWDD
VLPFIGQRLHLIELSMEDMPALKQLSHQFEGKCFPKLEVLYLFDLPALEE
WSWTEGKDLFPCMRVLRVIDCPKLKRLPPFPPSLEILTIQHCPSLMLNSK
TEDDEEGDGHLPPSLKELELRDCGKYEKLLLDCLHNLRLVTRLEINDFPH
ITSISLVHLVELQYLCITNCEELRWMECLGLLKSLKKLKIVGCPKLVQLD
VEDEQSASLLSSLHTLCVDNIALFKMFPLRNSLSFITELLFVSCSEEVIF
EEAILVRSLTAVTSLSFLRCDKLRSLPAELLHCLPFLKTLMVSNCPQLQS
LPEMRLSPFLERLEIYNCPQIQAMPEDGLPMSLDVFICSGDVHPKLREQS
EKFFVDRYNRRVKLELE
>XP_042429036.1 disease resistance protein RGA2-like [Zingiber officinale]
MAVALTVGGWFAQAFIQTLLDKASDKSIQLFAERRGFAEDMENLRASLLE
IQIILDEVQSRGCNDTKWKTLIQELKDAAYDAEDLIDEFQYHVLRQKIKG
EEEGKAATGSSGLSNMFYAAKKRLLGSSHSLEEDDTRARVRKMQGRLEKI
ANRMKSIMNVLPPNDRRKQPEVKFQARESCSSPATDKMFGRDKELNQVVD
WLLGSANQVELASGFVNNTFSVLPIVGIGGVGKTTLAQYAHKDNRVQDHF
HLKIWVCVSDNFTVQGLAKSIIESVTLQKQDDNMGLEPLQKILHQHIAKK
KFLLVLEDAWSDNKNIWEKFYALLKVGAHGSKIIVTTRDMKVSKMVSLVE
PILLDGLDEDAFWQLFKKCSFVTLNPEDYPELEDIGRKIARKLKGLPLAA
KTLGSVLQSDLSQQHWATIMKSDNWKVKQDEDDIMPALHLSYQYLNENMK
QCFAFCSVFPKDYVFEEAKLVRMWMAEGFIQNKNTKRMEDVGSDHFLEFV
NRSFFQKFKFGGFVMHDLIHDLAEMISAEDTCSIEKKRQTKMLSTIRHLR
VKEGKLPLEFSGYDKLRTLMLRKNSPPNSLFEKLRSIRVLDVSRCDLQEL
SEHIGKLIHLRYLDLSSNYEIKILPDSFCHLHNLQTLEILGCHKLESIPQ
ELGKKMVNLRHINADNKFWVMIKDVRRLTNLQELPTFSVQEDDGLKLVQL
KDLTQLHGTLHIQNLENVVDSKEAQDAELKNKVHLKGLGLEWNDEKDAKL
EEEVIEALLPHESLKRLKIEGYNGGRSPSWLMPKVLSNLEKLYLANCKGW
DDVLPFIGQRLHLIELCMERMPSLKQLSHEFEGKCFPKLKVLNLWSLPAL
EEWSWTEGKDLFPCLRILCVSGCPKLKRLPPFPPSLEKLIIRDCPRLILN
TKTEDDEEGGCYLPPSLKVLELDNCGEYSKLLPDCLHNLRLVTRLVINDC
PHITSIPLVQLVELQYLYICNCDELRWMECLGVLKSLEELKIVGCPKLVQ
LDVENEQAASLLSSLRYLCVDNTALLKMFPLRNSLSFITEFEIESCSEEL
IFEETIFRRSLTAVTSLSFIYCDKLQSLPTELLHCLPFLKTLMVSNCPQL
QSLPEMGLSPFLERLEICNCPQIQAMPEDGLPMSLDVFDCSGSIHPTLKE
QSEKFNADRVMRRVRLELE
>XP_042430259.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MLVFLELKHLLLEVLPSPTMVAQGRLLCIQNHLAMVCDGLWAVNSMIEIP
EMGMLNNHFSKKFYGVDAVTSFVPAETADWVTDVATAVIDVGELLSRIMD
WEASSHRSIVGNTQQVHFRHVILVELKEILCNLNSLVLRGSAMGLWRDPM
GSMNPLREDYSIVLKNEVVGREEDLEELIAIFEQQLVSSNNNGFDNNPFA
IVIVGKQGVGKRTLAHMIYHHTWIRQQFLHRIWVDLPLVSTFKMIDIIGN
EFVRSIDKEEYCDQKLHLDLPLPDMWEYINEQLCGSRYLLVLHCENLVSL
MQPEWNELKNIMLRVGGPGSGVLIIYKSSTESAVRNMRFLNRLKDITTFY
LNPLSDYAWVELVSRHAATTIPLKQDKSNKDELIQLAKLYCTNFPGQTFG
AKVFGSLFHYIPTTFAILQSRLLDDICKVRNFPLVIVRLLQYHYLLDADT
DNYYDNDYDVILHMLTAECLIPTEGLEPGWIECYERHFTQIHRKRDLPEL
LFGRMVYWHMKIPKDSTTISRCCRCLCLEINPRVKPFRLPIMPIKVSSKL
ITLILQEDKKTTREDVEEITLRVYKKRCMKAATAISKFLNKMSVRFIHLH
MLVVETSMIQSLPNEISKLVSLRYLHLSKLKMELLPKSLFDLLNLRILSL
LHCKKLQKIPERIHKLKKLQILKLAYCTKLQWLPKSITRLTNLEELNMEG
CCFLSKLPEDLVSFKSLRILNVAGCASLSQLPRGIEQLIGLRKLSGIIVG
VQGGFVLTQLQALTNLQEIRLQNLEREEEIQTEVLMGQQSLRHLSLHWGG
EEATKSSETAPSQHVLEALRPNLHLKCLDIISYKGVEFPTWMSKQQLARF
DSLVEVRFINLRRCAILPSLGQLPFLEKLEISGMDLIKHIDYTFYGDGNT
FAMLRELTFSEMLGLKKWSVPSERKNKIFFPELRQLTLIQCPKLKEISPW
LFLHDYDTMRIWLNNETIWSTVFCSWDNLRYLEIIEIVGCQELRCLPQRM
QSLQISKMTINSCNNLTTLVALDSLIELNIYACPLLAFNLEAFAELRILT
IKGCPKMQIYHDAWKKKDEERREKEERRRYNYESSSSSSSSPN
>XP_042430601.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAMVLDFYVSRVMKVTADMVEAEIFKVLGVDKEIKTLQGRLRTINGYLHQ
AERKIQGNNEIDIWVRKLKDIMYDADDIIDLCMIEGGKVLRAQASSGSST
VSIPSSYLFSCFRCLRYRHEVANQIIALNGRLEALKNDSFIKNNLDQAVK
EPVENAHREFGRETSHLQIEGDIIGSQIENATDKLINLILENNPKKTRVF
GVVGTGGIGKSTLASKIFEDERIKENFPNRKWLYVSKNYIETDLLKKLIR
FEEGNETKGETFEGKSKAELEDKLVTILTKNTFIVLDDVWNATVWIDILR
KPIVKSASSCTILVTSRKEKVVAQMKPSYIHPVEKMDEESGWNLLKHLVF
EGGEEEDEISSLAEIGIKLVKKCDGLPLAIKAIGGVLYQQNKAKWEEVLE
SDAWKMDQIEEELRPLYLSYEDLPSTLKQCFLYCSLYHQKDMYYKEIVQF
WVAEGLIMDEQEKSRNDLPTEKQKTMEDIGEEIYRELIWRNLLEADANFD
VSKDYFSMHDHFRSLGAHLMREEGILYRHGREFKTDDNIKIRRLSISNMG
PKLVLPSQILKQGCLRTLILMDSPKTKTIEDSVLQELSCLRVLDLTSTSI
EKIPDCIGDLLHLRYLDLDGTNIREIPKTIGKLVNLQTLNISKCQYLERL
PESITMLHNLRCLDMSDTPLLTYVPKGIGKLGNFYNLKGFLVGQNDSTSE
EGCDLEELKNLSKLRGISILRLERAERGASALADKPFLKQLTLGWMQPDE
DDADEEEESEGANEVGADEEADNDGNDDKDAGNEKGDDNDDGSKQENENE
EAEEAGNETEDETEEDEAEEEEKGWSDEQISKAERICNEMSQPSSSIEDL
FFYEYPGRQLPSWMISSSLAESFPNLAYLQLLGLPCCTELPPFGTLPQLK
YLRIEQASAITAIGSQFLGSRSSVFPKLELLRFVGMPKWEEWTLDGVEEL
TGHGTPLAVKLFPSLRDCILIDCPKLRALPADLYRATNFSELCLRQTYEL
GEIINLPMANKLEVTNASGLKKISNISSVRYLEVDNCPNLECVENIGKLQ
HLVLICSEEMEQLPQWLSVLIEQHNNTSSTHRSLRKFEMQCSLQLLKTCL
EGNENWDIIKQIPIVKVTTYSGKEYVRYTKDPYMYDPHVPSN
>XP_042430704.1 disease resistance protein RPS2-like [Zingiber officinale]
MADIISGISSIFTCLKDCCFQSCNYIVSFEGAISSLIAELDQLKSKSMDI
KRQVEAAQRDELNVKQEVLGWLKSVEDLSSEAENINAAYRRKFKCLCNFP
INVCSSYPLRTRAEAALTAAADLKKKAGEFADVADDLDIDRVLEVPNPKV
IGMDTALEELQGHARDDDVIIIGIHGMGGVGKTALLRRFNNDFAEKALDN
LDVVIYLDLPTEYQVEELQKPLFCQLKLTWQDEATQRDRAGRLFRVLSKM
RFLLLLDNVWEPLNCQVVGIPLPQPPSKSKIVFATRMEDVCSRMGAEKTI
KLECLSSEEAWDLFRFNAKLNLATTDASILDLARALARQCAGLPAALISV
AHAMASKRTFAEWRHVLAIMKEAPFQLPGMEEHVYHPLKLSYDRLSDTLR
TCASNFALVQEGRLLSKQYVTDLWIGQGFINDFEKSSDTSDKASYLLGML
LAASLIQRFDDKYFKMHPMVRSMILWMECDCGKKESKWLKRDGHGLAEAP
GAEKWRVAERISLGWNNIALLPDKPLCLDLIYLNLRKNPPLRNIPNKFFS
HMPCLRILDLQQTSIEELPSGIGNLSQLQLLDLSFTRIASLPREIQDLVN
LRYLAMLSATQLRSIPGAVIPCLQQLQWLDIYSSYSGWRVAGALQSDGEG
ILLDELESLKKLKVLGITISSETALRRLSELQRLAATVHWLQIEGCGTLA
RLDIPSTYCFGENMKNLKQIRLQAMPDLEEVIIGGDLHARNALSCLNFLY
LSALPKAKIIWKNRCLANLCGLDIQDCNVIDRLLKLEDNAANSAETITIF
PRLTKIVLRKLPELESLSDGDRVIAFPSLKTMEVRNCPKLKKLTLVAENL
REIQCDKEWWDKLDWSDERTLSFQELFKQAD
>XP_042430705.1 disease resistance protein RPS2-like [Zingiber officinale]
MADIISGISSIFTCLKDCCFQSCNYIVSFEGAISSLIAELDQLKSKSMDI
KRQVEAAQRDELNVKQEVLGWLKSVEDLSSEAENINAAYRRKFKCLCNFP
INVCSSYPLRTRAEAALTAAADLKKKAGEFADVADDLDIDRVLEVPNPKV
IGMDTALEELQGHARDDDVIIIGIHGMGGVGKTALLRRFNNDFAEKALDN
LDVVIYLDLPTEYQVEELQKPLFCQLKLTWQDEATQRDRAGRLFRVLSKM
RFLLLLDNVWEPLNCQVVGIPLPQPPSKSKIVFATRMEDVCSRMGAEKTI
KLECLSSEEAWDLFRFNAKLNLATTDASILDLARALARQCAGLPAALISV
AHAMASKRTFAEWRHVLAIMKEAPFQLPGMEEHVYHPLKLSYDRLSDTLR
TCASNFALVQEGRLLSKQYVTDLWIGQGFINDFEKSSDTSDKASYLLGML
LAASLIQRFDDKYFKMHPMVRSMILWMECDCGKKESKWLKRDGHGLAEAP
GAEKWRVAERISLGWNNIALLPDKPLCLDLIYLNLRKNPPLRNIPNKFFS
HMPCLRILDLQQTSIEELPSGIGNLSQLQLLDLSFTRIASLPREIQDLVN
LRYLAMLSATQLRSIPGAVIPCLQQLQWLDIYSSYSGWRVAGALQSDGEG
ILLDELESLKKLKVLGITISSETALRRLSELQRLAATVHWLQIEGCGTLA
RLDIPSTYCFGENMKNLKQIRLQAMPDLEEVIIGGDLHARNALSCLNFLY
LSALPKAKIIWKNRCLANLCGLDIQDCNVIDRLLKLEDNAANSAETITIF
PRLTKIVLRKLPELESLSDGDRVIAFPSLKTMEVRNCPKLKKLTLVAENL
REIQCDKEWWDKLDWSDERTLSFQELFKQAD
>XP_042430735.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAMTLNFYVSRVMKVTADLVEAEIFKVLGVDKEIKTLQGRLRAINGYLHQ
AERKRQGNDEIDIWVRKLKNIMYDADDIIDLCMIEGGKVLRAQASSGSST
VSIPSSYLFSCFRCLRYRHEVANQIIALNGRLEALKNDSFIKNNLDQTVK
EPVENAHRVFGRETSHLQVEGDIIGSQIENATDKLINLILENNPKKTRVF
GVVGTGGIGKSTLASKIFEDERIKENFPNRKWLYVSKNYIETDLLKKLIR
FEEGSETKGEIFEGKSKAELEDKLVTVLTKNTFIVLDDVWNATVWIDILR
KPIVKSASSCTILVTSRKEKVVAQMKPSYIHQVEKMDEESGWNLLKHLVF
EGGEEEDEISSLEEIGIKLVKKCDGLPLAIKAIGGVLYQQNKAKWEEVLE
SDAWKMDQIEEELRPLYLSYEDLPSTLKQCFLYCSLYRQKDMYYKEIVQF
WVAEGLIMDEHEKSRNDLPTEKQKTMEDIGEEIYRELIWRNLLEADANFD
VSKDYFSMHDHFRSLGAHLMREEGILYRHGKEFKTDDNVKIRRLSISNMG
PKLVLPSQILKQGCLRTLILMDSPKTKTIEDSVLQALSCLRVLDLTSTSI
EKIPDCIGDLLHLRYLDLDGTNIREIPKTIGNLVNLQSLNISECQYLERL
PKSITMLQNLRCLDIRDSPLLTYVPKGIGRLENFYNLQGFLVGQNDSTSD
EGCDLEELKNLSKLRGISIYRLERAERGASALADKPFLKQLTLGWMQPDE
DDTDEEDESEGSEEEEANEGGADDTVASESEADGNDDEDARNDDSSKQEN
ENEEAEEAGNETEDETEEDEAEEEEKGWSDEQISKAERICNEMSQPSSSI
EDLLFDEYPGRQLPSWMICSSLAESFPNLAYLKLLGLPCCTELPPLGTLP
QLKYLSIERASAITTIGSQFLGSRSSVFPKLEVLRFVDMPKWEEWTLEEL
TRHGTPLAVKLFPSLTECKLIHCPKLRALPADLYRATNFNELYLVKTYDL
GEIINLPVAYKLEVRNGRGLKKISNISSVRYLEVNNCPNLECVENLSKLQ
HLVLICSKEMEQLPLWLSALIEQHNNTSSTHRSFRKFEMQCSLQLLQTCL
EGNENWDIIKQIPIVKVTTYSEKEYIRYTKDPYMYDPHVPSN
>XP_042430877.1 probable disease resistance protein At4g27220 [Zingiber officinale]
MVSPCLNTFCGGMGSGTGNAIVKYLWKKSKKHACYFIYYKKKFEKFKEQF
DLLKAITDDTQRKVEISKRNNEVISDEVNLWLNKVIELEEKFNNIENNFD
RIVENEKYCIPSLIFRYKVGREATRKKDKTLKLLDQSKFQSFSHILDPSA
VNHPSNIDFVSFGATKEAMQKVIDALNDDKVNLIGIYGMGGVGKTTLIEE
ISRKMKEAETFDMVMDVVVSQNPNIAQIQRDIADALGMRESSNKMLATRL
KQVKKVLIMLDDVWARLELVKEVGIPYREHKGCKVILTSRKAETCNVMEA
DVSVEVATLSKEDSWQLFRMRAGQVAESDGIEPIARKVAQECCGLPLAIV
VVGRALRSYEDASAWEDALSQLKQSVPLNMEEVEEKLFKPLELSYQNLKT
AELKQLFLYCCLFREDYNISEDEVTRYAVGENLLSNLSTLEDVRGRVHFL
LQKLKLSCLVLDSKKAGCVKLHDVVRDVAVYIGFKDNNHFLVKAGLGLID
WPKYENLAECKRISLSNNFLQEIPEKPNCSKLVLLLLNMNPITSVPINFF
ENMVTLNVLDFSSTEITSLPSSLTCLKCLGTLRLDRCKRLNDINVVGELK
TLIILSLQQCKGISALPETVDGLVKLKLLDLSNCTLLQIPRNLIPKLTQL
EELYLRGYNVTEALFVEIASLKRLVRVELYVKDAQDFSLKVIPSNAFKNL
CHFIIYNELDWFTMASAYQRKLFIKQASQSVIIWGMPFLRGTEDLMLDSC
QCNLTDLTPLENMSCFANLKSLTLTNNHQIQCLLRSTNGTPSNAFGELVK
VNILNMEKLEQICHGHLPDLSLRKLRTLVLKRCRNLVDILPRDLLQRVHS
SLVELLLEGCPGPGILLNFEELGHDSVFFPKLQTIRLSQISDVISFCTGV
VPPGSLHNLTTFEVVNCEKLSYLFSPTLDATHSRLLPSDTFKKLKHLKIM
GCPCLKHVFLPSIANELQSLERLEIKNNDSMETIIAEEEGCDLEKGAFPM
LNRLLFIKLPVLCCFFKGEPAKTLDWPSLEYIHLGDCSKLAGLPIGRESA
QKLKKVHVVRLNDVDWFTTLKWEDDTIKSRFDIIQSIDEVE
>XP_042430878.1 probable disease resistance protein At4g27220 [Zingiber officinale]
MVNPCLSNFCGGLESAIVKYFWKKLKTHTSYFIYYKKKFEKFKQQFDHLK
AIRDGTQQKVEAAKRNNEVISDEVNLWLNDVLELEEKFNNIENNFNRIVR
DEKCCIPNLAPRYKVGRDATKKKAEASELLDRKNFQVFSHTIDPSNLGHS
SNKDFVSFGATNEAMQKVIDALNDDKVNLIGIYGMGGVGKTTLMEEVGRK
MKEAEIFHVVIDVVVSHNPNIAQIRRDIADQLGMRESSNKMLTTRLKQEK
KVLIMLDDVWARLELVKEVGIPYREHKGCKVMLTSRKAETCNVMEADVSV
EVANLSEEDSWQLFRMRAGQVAESDGIELVARKVARECCGLPLAIAVVGR
ALRSYKDASAWEDALSQLKQSVPLHMEELEEKLFKPLELSYQNLKTAELK
QLFLYCCLFREDYDISEDEVTQYVVGENLLSNLSTLEDVRGRVHFLLQKL
KLSCLVLDSKKDGCVKLHDVVRDVAIYIGSKDNNHFLVKAGLGLRGWPEC
KNLADCKRISLSNNLLQKFPEKPNCSKLILLLLNMNPITSVPDNFFENMA
TLNVLDFSNTDITSLPSSLTCLKCLGTLRLDRCKWLIDINVVGELKTLII
LTLQECRGISALPESLYCLVKLKLLDLSNCTMLQIPRNSIHKLTQLEELY
LRGYNVTEALLVEVASLKSLVRVELYVKYAKDFSEQIIPADSYQVLHHFI
IYNESDRFSLASKYQRNIFIKQANQSMISWGKPFLRIAEELRLDSCQWNF
TDLIPLENLSCFATLKSLLIVNCRQIQCLLRSTDDTPSNAFGELMKLTLL
DMEKLEQVCHGQLPAHSLGKLRTLELRRCRNIIDILPQDLLVRVHQNLVE
LLLEGCPGPHVLLNFEGLGHDSVIFPKLQMIRLSQMSNLISFCNGVVPPG
SLHNLTTFEVVNCKKLLNLFSQTLDATRSRLLPSETFKKLKQLQIMGCPC
LKHVFLPSIANELHSLERLEINNNGSIETIIADEDGCDLKKGAFPMLKKV
VFIKLPRLRYFFEGEPTKILDWPSLEYIHVVECWNLARLPIERGSLQKQE
NVHFVRLDDVNWFKTLKWEDHTTKSRFDIIQSINEVK
>XP_042431506.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAMVLDFFVSKFIKDTSDMVEKEIFKVLGVDKEIKTLQVWLRTINGYLRQ
AEQKRQGNDEIDIWVRKLKDIMYDVDDVIDLCMIEGGKLLTAQVSSSSST
VSIPYNYLISCFKCLKYRHDIANQIISLNSRLEGLKNDAVIKNNLDQAIK
EPVENANKVVFAHETSHLQVEGDIVGMQIENATEKLISLILENNPKKTRV
FGVVGTGGIGKSTLASKIFEDERIKENFPKRKWLYVSKNYIETDLLKKLI
RFEEGSETKGETFEGKSKAELENKLVTVLTRNTFIVLDDVWNSIVWTDFL
RKPIVKCASSCTILITSRKEKVVTNMRPKYIHPVEKMNEESGWNLLKHLA
FEGEEEDEISSLEEIGSKLVKKCDGLPLAIKAIGGVLYQQNKAKWEEVLE
SDVWKMDQIEEELRPLYLSYEDLTSRLKQCFLYCSLYSQKGMYYKEIVQF
WIAEGLIMDDVPTEKKKTMEDIGEEIYRELIWRNVLEADAIVDVSKDYFS
MHDHFRSLGAHLMREEGILYRHGREFKTDDNIKIRRLSVSNMGSKLVLPS
QILKQGCLRTLILMDSRKTKTIEDSVLQELSCLRVLDLTSTSIEKIPDCI
GDLLHLRYLDLDGTNIHEIPKTIGNLVNLQTLNISECQYLERLTESITML
HNLRCLEMRDTPLLTYVPKGIGKLGNFYNLQGFLVGQNDSTTDKGCDLEE
LKNLSKLRGISIYRLERAERGASALADKPFLKQLTLGWMQPDKDDTDEED
ESEGSEEEEANEGGADDTVASESEADANDDEDAGNEKGDGNDDSSKQENE
NEEAEEVGNETEDETEEDEAEEEEKGWSDEQISKAERICNEMSQPSSSIE
DLLFVEYPGRQLPSWMICSSLAEFFPNLAYLKLLGLPCCTELPPLGTLPQ
LKYLSIERASAITTIGSRFLGSRSSAFPKLEVLQLEDMPRWEEWTFDGVE
ELTGHGTPLSVKLFPSLRDCVLIDCPKLRALPADLYRATDLNELCLRQTY
QLGEIINLPMAYKLEVTNGSGLKKISNISSVRYLEVDNCPNLECVENIGK
LQHLVLICSEEMEQLPQWLSVLIEQHNNTSSTHRSLRKFEMQCSLKLLKT
CLEGNENWDIIKQIPIVKVTTYSEKEYIRYTKDPYMYDPHVPAN
>XP_042432455.1 disease resistance protein RPS2-like [Zingiber officinale]
MVKCSPAVSVWMHYRYSRFVGYSRLSRLQIEKVLCRSEVLAVNPTRVQIF
VRVIWVIFRCLDEGAHPVEDSCHGGSKSQGGQRSDIIDQLGDKWSFGRSD
ETGVAKFQLNGRDTGEAKFGPSSQPAQAATYSLYYPSTSFWELVPLTPGM
DNQKIIRENFGKHADLGEHARALQELYIKGDPSIGGVSSETMMNTFTQEL
IEGEFFRLLIRKLPRDFDHLLRKANEYINMEEAQTARKKETSAEPASTLE
RRPSNNLLALSCLKDCTSDSCNYVVSYEDNLSSLAGEVSQLKSKSEDVKR
EVEATMRQGLRPRNEVLGWLSAVEEVAGEADQIRAKYERMVKCFCRFPAN
ICTSVKLRRRAEAALASARELKQRDLPEVVHRHNLVRFIRMQNQQTAGAE
KAFEELQRHARDDGVTCFGIHGMGGVGKSALLREFNNYLENELEYLDIII
FLESSTEHKVEELHKFLFARLNLTWQNGVSQMDRAANIFRVLSQLKFVLI
VDNLWEPLDYRAVGIPFPEPESRCKIIVASRIEDVCSHMRMERMIRMERI
EEEAAWELFRFNARLEPNEADERIIRIAKVMARKCGGLPAALVVVAQTMA
NKKTVQEWMHAVNLMRDAPFQLPGMEERVLYPLKLSYDRLLTDRDRLCAS
YFSLVPEGCLVDNYFIRKLWIGEGIIDDFNNVWESANEAHYLLGMLSSSS
LIQRIDGKSYASEKPIESDRFKMHPMTRAMILWVGRECGKKGSKWLAHYG
DGLAEAPTAEKWRVAERVALGQNKIKALPEAPQAPDLIYLDLGYNDLLVK
IPNGFFSRMPKLKILDLQDNPIEDFPVGICNLALLQFLTLSGTKITSLPR
ELGGLVNLRYLACSSTTRLKRIPDQLMSRLQELRWLKMCDGYNQWRAAPS
EEEEAYLEELEVLTKLKVLGIAISTVTSLRRLFESQRLTTSVHWLQVEDC
RGLTRLDIPSTEFPQESMPNIMELRVHAMNELEEFAIQGTALANLMELHL
SHLPKASLVCRAVGCLGSLRTLRIENCKEIARLIQLDAGTNDGEEIAIFP
ALKRMVLKRLPKFESFSDESRTVTFSSLESIEIEECPKLTRLNLCCGKLK
SVRSERAWWDELEWEDDLTKLSFENLFKPL
>XP_042432494.1 disease resistance protein RGA2-like [Zingiber officinale]
MTMMDQPMATISQLRHIVMKILSEPEMVAQGKAFRISNHLEMIRDSLWAI
NSFLMDGALCVLEEPDVAEWMKDVGVAVEDVNSLLKRILDYWDPNEEDET
EKKRKMNNFFHPLVDNSIQSMSSRRSILLELKETACLLNYLVNRGAALGL
WVEMMDSMDPTHDDYSTILSDEVMGRDEDEDHIIELLQQQQCDKYGNIPF
FIAIKGDKYYGKTTLARKIYHHTWVRQHFQHRIWLDASSFSDFNSNMIAK
EIARLLTGKPCANINCWPLINEHLHGDRYLLILDDVDVSGVLKYKWEQLK
MNLIHYGTPGSKVILAGYTFHGIERDFNVTEYKINQLPNDAWVRILLRYA
TFVYPIESNNNIHKEKVAPVAIDFLIPLVEKYSQNCLGAKCMGLMFSWRD
MTQGQELANQLYNFDDFPYKFNLLSIEEIRSSLCMLLSEGFSCESYHEED
VLHMLVAEGTLTNTRLKSNLRHISTKFNLDLCFFKMKVSEDSSIPPQCRH
LHLLMDSKNILKSKKAIEKAGIANKLRSLALHREEKKEPISQIETKRLEG
MFLNLRHLGTLHMRAIMIEDLPSSICTLHCLRYLNFAENKIETLPESLCN
LSNLCVLILSLCKKLKELPRRIHKLRKLQILKLTCCLRIHKLPESITQLL
NLKELDVGGCCWLSKMPDDLSNMKNLAQLKMHGCASLTRMPSGIRQLTNL
EVLWGYDAIDGLGNVMLSELQALTNLESLHIQHLERLVSAEVEEKDITPP
TILQENQHVNELMLHWQWWNDMVAEGTFKLTLQLTQGFYRNLEELKVLRI
VSYMSKKLPSWLIKDGDSALNRLTTVHLVNLRRCERLPPLGQLHQLEEVA
ISGFDSVRVIDDDFYGRMPKAQGIPCPRYNHVSLKLWLSNELLMPTSKFN
DWESLWGIRTLQIFGSQELRSLSDSLRKIPNLEKLAIINCNKLEALPIWL
VWKLSLKSLCVYGCPMLAIIPEGLRVKGRLTNLIVEACPKLQSQKYLPDK
WDYFR
>XP_042432499.1 putative disease resistance protein RGA3 [Zingiber officinale]
MATISQLRHIVMKILPAPEMVAQGKAFRISNHLEMIQDCLWAINSFLMDA
ALRVLTEHNVEEWMEDVGVVDWMKDVGVAVEDVDSLLKRILDYWEPNEQD
EAKKKKKMSNFFHPLVNINNNIQSTSSRQAILVELKEMACLLNYLVKRGT
VLGLWAEMMDSMDPCHDDYAAILSKEMMGRQEDEDQIIELLQQQQCDEDG
NVPFIIDIRGDEFSGRTTLARKIYHHPWVRQHFQHRIWLDASSFREFNSK
MIAKEIARLLTGKPCANINCWPLISEHLRGDRYLLILDDADVPNVFRYKW
EEFKLNLLHCGAPGSRVILARHTFAGNPYGEYGIEFNVKKYKLKELPEDA
WVRILLRYATFAHSTEGNNNIHKEKASPIATTNMLIPLAKKCRLDHWHRD
RNLLIAKGVGLMFRWRDMNEWKELPNQLYRFEILHCYFLLVHQQYGSFEN
IRPSLYNLLLGGSEAESFGEGESYGEDVLYMLIAEGILTNTRLTRNIQYI
GSEFNLDPCFFRMKVSEDSSIPPQCRHLYLPIHSKNVSKSKKAIERAGVA
NKLRTLVLHREEKKGHIYHIETKKFEGMFLNLTCLCTLHMRAIMIHDLPI
TICTLHCLRYLNLAENKIETLPESLYNLSNLCVLILSLCKKLKELPRQIY
KLRKLQILKLSYCQRIQKLPESITRLMNLKELDVGGCCWLSKLPDDLSDM
KNLVQLNMLGCASLTRMPGGIRQLTNLEVLCGYDAIDGLGNVMLSELRDL
TNLESLHLQHLERLVSAKAKEPNDITAPPTILQENQHVNELMLHWEWWND
MVAEETFEPTLQLTQGFHRNIEELKILRIVSYMSIKLPSWLIREESISVM
NKLTTVHLVNLRRCERLPPLGKLPNLKELAISGFDSIRLIDDDFYGEGGS
ALFPLLKRLTFSQMPRLEKWDPPSYFKENPYKFRDRTFYCLKELTLIQCP
KLREFHMPICVSHTSRFSLKVWLSNEMLMPTSKFNDWGNLSGIQSLQIFG
CQELRSLPDGLKTLLYLDTLVIINCNKLESLPIWLERSRLESLCVYGCPA
LSIIPEGLKATGRLRNLIVEACACPKLHSQV
>XP_042432500.1 disease resistance protein RGA2-like [Zingiber officinale]
MSMLTAVQLRHIVMKILPAPEMVAQGKAFRISNHLEMIRDSLWAINSFLM
DSTCWVGEFEPPDVTEWMKDVGVAVEDVDNLLKRILDYWDPNEENEAKKK
MKMNNFLHPLVNNNIRSTSNRRSILLEFKQTVCLLNYLVKGGIALGLRME
MMDSMDPNHDDYAAILNEEVIGRDEDEDQIIDLLQQQQCDKDGNVPFIVA
IRGSESSGKTTLARKIYHHTWVRQHFQHRIWLDASSFEDFNSSMIAKEIA
RLLTRKPCMNVDCWPLINEHLYGERYLLVLDDVYVSDDLEYKWEELKMNL
LHCGAPGSKVIVTEYPYLVYERGFNVKEYELNQLPEDAWVRLLLRYATFV
HPIEDNNSIHKEKYPPIECRQHSFLRNCLGAKYIGLMFRWRDTNQWQELA
DQFDASPYNSIVWMHSKYWSIEVTQTFLYELLFEGSSDESYREEDVLHML
VAEGTLTNTRRKRNLEYMTPYTRPPADLEYKSDFNLDLCFFRMKVGEVSS
IPPQCRHLSLLMDSKNILRSKTAIEKAGVANKLRSLALHREEKKEPICQI
ETKILEGMFLNLTCLGMLHMRAIMIEDLPSSVATLHCLRYLNIAENKIET
LPESLCNLSNLCVLILSLCKRLKELPRRIHKLRKLQILKLSCCLRIQKLP
ESITRLVNLKILDVGGCCWLSKLFDDLSNMKNLVQLKINGCASLTRMPGG
IKQLTNLEVLWGYDAVDGLGNVMLPELQALTNLESLHIQHLERLISVETE
AEEKDITPPTSLLKNQLLNELILHWEWWNDMTTEGTSKSTEQLIEGLKRN
LRELKVFRIISYMSNKLPSWLMREGSVLVLNKLTTVHLVNLRRCKRLPPL
GLLPHLLMVAISGFDSVIVIDDDFYGEGSPSPFDNLLRLTFSEMPRLEKW
DPPSYFQNNPKKSCESYFNKLEELTLIQCPKLRELHVPIFVSDYSQLLLK
LWLSNEMLMPTSKFNDWGSLQGIRKLQIFGCQELRSLPDDIREIHYLRAL
AIINCNKLEALPIWLEQKLSLESLWISGCPALSSIPEGLKVEGRLRNLIV
EACPKLSQVLF
>XP_042432979.1 putative disease resistance protein At3g14460 [Zingiber officinale]
MDFLKASGEALLESFVNPYIIRHPKGHTVPRLDEKSMETMLEFLEKIEAD
LPRDETNTQLNPPPSFPSPIRRPSPIACVSRLAFATSSSLRLFSAKHSSV
QKLHLHPLSSHLLQMAIGEATQFGIIVVLACNREQFRTRDEGAGKNHEEM
SESVAKIMETPRDSLKLNVSPFDVCWSLFKGIAFEGRDPSMHDTFVEIGL
KIVEKCRGLPLAVKVLGYALRNKDDEYMWMDVLESEMWEFDEGKDEILPA
RQISYDYMNITGLRRCFPYLSLFPKDIVLRPGRIVLLWMSQGFLQPASRI
GLLHPRDDDCPIYAETDETYTMHDVFQSLAQFVVRDECLGIEDNVGQGPL
CRASICGSLADLLRNSGTDVKSLPDSICNLYNLETLNLNKTYVSELPRQI
VNLTSLRHLLLYVSCVYLPQGIGELTNLQTLSNFRIVTLLSRPIAEEDHD
DCEDEEYYGNSKEGKGDEHAIKEKRLLEYLRPHANLKMLQIYDYPGVSFA
KWVGTSSFSKPVQLWLCRCRKCNFLPPLGQLHSLKILCIQEMDGMHIVGR
EFCSSPMVKAFPSLESLAFVRMPNWEVWDEVEVGDFPHLQHIKLYECPKL
TKFPHHLMSSVKELSIKGCDGVSGLLKFH
>XP_042432980.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MRAEAQHEKIAEEWIALKLIKKSSKRKRTPPISNQQMGVAESGVLEREQE
KKILVDWILSEDDASMNRVSVIALTGMGGLGNTTVAHLMYKDLRVKSYFD
LRGWISVSEHFDVAALS
>XP_042432981.1 disease resistance protein RGA2-like [Zingiber officinale]
MAAKAARRRRRSCGRSALRRRREVEKGRGPSATVAAGVSPSRRRRAPVRR
RQPPLLLLVLDDVWNEELKLWNPLKRPLMSAKVGKVIVTTRLDSVARIMQ
TTDPLILESLPFDMCWLLFKQIAFTR
>XP_042433025.1 putative disease resistance protein RGA3 [Zingiber officinale]
MSMAIASQLRHIAMKILSTPEMVEQGKAFRISNHLEMIRDNLWAINSFLM
DGALRIQKEPDVAKWMQDVGVTLEDVDSLLKRILDCWEPNDENEGKKKRK
MSNFLHVSINNNIQSTNNCRSILLELKETACLLNYLVKRGTTLGLWVEMM
DSMDPSHDDYATILSEEVIGREDEDQIIDLLQQQQCDEDGNAPFIIAIDG
SKYSGKTTLARKIYHHPWVRQHFQHRIWLDASSFRDFNSSMIAKEIARLL
SQKPCTNVDCWPFINEHLGGDRYLLIFDDVYVSDVLKYKWEELMLNLLHC
GAPGSKVILAGYTFYEYIREFNIKEYKLKQLPKDAWVRILLRYAISVRPI
KGNNNIHKEKASPAVTDILIPLAKKFIQDYDSGYCLGAKCMGLMFRWRDK
SQWGELANQWFNIEHLRKYFLWVHRQYWSIEDTRSSLYKLLFEGSEDDSY
DEDVLYMLIAEGTLTNTRLKRNLQIMSFEFDLDQCFFRMKVGEDSSIPPQ
CRHLHLLINSKNILKSKKAIEVAGVANKLRTLILHRKEKKGHIYQIETKK
LEGLFLNLTCLCTLHMRAIMIQDLPSTVSTLHCLRYLNLAENKIETLPES
LCNLSNLCALILSLCKELKELPRQIHKLRKLQILKLSCCLRIQKLPESIT
RLVNLKELDVGGCCWLSKLPDDLSNLKNLMQLNMHGCASLTRMPSGIRQL
TNLEVLLGYDAMDGLGNVMLSELQALTNLESLHIQHLERLISATEEEKDI
TELTILQENQHLNELMLHWEWWNDMVAEETFEPTLQLTQGFHRNLEELKV
LRIISYMSIKLPSWLIRDRDSVLNKLTIVHLVNLRRCERLPALGLLPKLE
EIVISGFDLVRVIDDDFYGKDREVPFYGLKRLTFSEMPMLEKWDLPIYFK
RRLRWIKANAKIEALAKADDKGLLNAMVRVKAEAWAEAWAEAKARAWAEA
KARAWVEARIETEAKAWDRAWDRAWDWAQTHAWQQAWGRARAWDRAQALA
RARASARARAKDRGETWAQIRDWAEAKAPSKAWNQAYVPPHLRAEFRARA
ESKAEAWARAEAEAKVRAEVKAQVRAKEWAWTRVLAYSASTRAKAKVGDD
YFVRPAKVETNYFTSLIEAEAKANYFARWIEADYFVKLVELTLIQCPKLR
EFHLSFPTSSKLKLKLWLSNEMLMPTFKFNDWSEFWRICRLQLFGCQELR
SLPDGLKKITDLEELAIINCNKLEALPIWLEQSSLNSLCVSGCSALSFIP
EGLKVKGRLRNLIVEACSKLQNLKHLTDEWNPF
>XP_042433065.1 disease resistance protein RPS2-like [Zingiber officinale]
MDDVSRASNDTIFHRARQLKAERSKRGGRKAKKWFCKIVPSIEGCAKPPD
ADPPMSFLDGPSRQQQQQQQQKKRSSRGGCSCCCLSSCLCGGKADERTPR
TSKKQIPAAEIRLREAGAVFDELPTRNTRDAVNVVVNEVVTARRSEPADH
VFDALSPKKPVEENTNLAERLPPPSKGHVSAASMVLPERLPPGPARDLPV
PNPIVGQEVYLKTALSYLTDDAIGIMGIYGTGGVGKTTLLRSINNKFCGN
AARTEFDHVILVAVGKDPDVKKLQRDIAYEVGLLLMDDESEVTRAAAIFD
FLKTKNFLLLLDDLWGPLQLAKVGIPHPLSDGYKQKVIISSRLMDVSGKM
QAHKFLILECLKWEEAWNLFSSKVGEENLADQRIRSIAVALAKECGGLPL
ALVAMGSAMSAKKTLEEWQKAVSLLKTAPPLHEISGYQMLKENLISTWMG
LGSITDFDDINEAYNIGNSIIESLKAVSLMENSEKSYRRMEMHDVIREMA
LWTASGKESSKNKWLVGAKPSETRSDEWSKAERISLMFNEIEALPDSCYC
PNLQSLILRGNKRLMKIPNGLFPCMVLLRFLDLSHTGIVELPNEVGTLIN
LQFLNLSYTKIACLPKEMKELTTLKYLELEGTRELRKIPDGVISSLEMLQ
ELNLYMSGFANWSWLSVCSRDNIMFEELVSLQRLRSVGFTVRNIQCLLRL
FSILRVLTHSLTIRELRGLISLHLLPGLLSKNKMGRLKNLTIEFSQGLKE
LVMGEEAKPLNWRLYQLEVFNLVCLPELERVIWRGVAAHVCLPNLRFLSL
FYCNSLRNIAWVAHLPLLQELYIQNCNEMEQVIADEPPTASSEKEEKPAT
SFPNLKYIFLRDLKSLVKIDDQVLEFPCLERILVHNCIELKQLPLGATSA
QKLRIIFGERNWWESLEWGDHCIKSIFTTCFREIPAGYEPSMKILEGL
>XP_042433067.1 probable disease resistance protein At5g63020 isoform X1 [Zingiber officinale]
MGFLCKFWCSWTPMILFSAAPWDCAILRHQDIVGLPLCFIYGWSLQFLWL
LPHPSGFLDSLAVEIHELKSKRDDIERDVSRARRVGKEPRSQVLWWLDRV
ELLETKFAKTRREFERRFMLPGGFAVNILSSYRLSVRANEMIAEACYLKS
KGSFNQVANRAAPNHFEEVPSAPTVGMDAVLAQLKQAVEDDAVGLIGIYG
MGGVGKTALLSRFHNEFLADATDLDMVIFIDSCRDLDVESIQNKIRHRLG
LSWKKSKSQKEKASMLYKVLFKMKFVLILDDLWEPLSLQMVGIPIPKQGS
SCKIMLATRIEELCDQMDVKNKIKVDLLPWDTAWRLFADKVGEETINSDP
GIRHQAEILVKKCGGLPVALITVARALASKRSVDEWKHAVTIMGNSPVQL
PGMVEQVFCSLKLSYDHLPSDTLRSCAMHFALYWEGCRLHKNLIQEYWIG
EGILDDFKDVEQANNKACYFLGILSSASLIERVDADGYTRMHPMVRAMAL
WIACEFGKKENQWFVREREGLMEAPEAETWRGAARMALGYNSITVLPEAP
ESLNLVSLKLKSNFGLERIPDGFFRFMPCLVALDLHSTPIKEIPSGISNL
QRLQFLELGGTKLKSLPKELASLKNLKYLGLNWTAELASIPERLIQSLSE
LRVLRMIVSYSSWKAIPAGGGNGVSLRELEALKRLRVLDITVGNAPAFNM
LTQSQRLAPATAALLLKGCPGLTAVELPSGLGRSLKSLKWLRVSHSTELE
EVLIAGDGRESDDAVLPELENLVLECLLKAKIVWRSSCIQHLRGLYIYGC
SGMEQLIWYKDDDDSDAENRGRRGVSPFPNLKQIAFRGLPKLKRVSDERQ
LVFPLLESIEVAECPQLKKLNLVAEKLREIRCHRSWWDQLEWEDDAARFS
PQMILKPLN
>XP_042433069.1 probable disease resistance protein At5g63020 isoform X2 [Zingiber officinale]
MDINGFLVQVLVFLDTNDTVFCCSVGLCNPSPPGFLDSLAVEIHELKSKR
DDIERDVSRARRVGKEPRSQVLWWLDRVELLETKFAKTRREFERRFMLPG
GFAVNILSSYRLSVRANEMIAEACYLKSKGSFNQVANRAAPNHFEEVPSA
PTVGMDAVLAQLKQAVEDDAVGLIGIYGMGGVGKTALLSRFHNEFLADAT
DLDMVIFIDSCRDLDVESIQNKIRHRLGLSWKKSKSQKEKASMLYKVLFK
MKFVLILDDLWEPLSLQMVGIPIPKQGSSCKIMLATRIEELCDQMDVKNK
IKVDLLPWDTAWRLFADKVGEETINSDPGIRHQAEILVKKCGGLPVALIT
VARALASKRSVDEWKHAVTIMGNSPVQLPGMVEQVFCSLKLSYDHLPSDT
LRSCAMHFALYWEGCRLHKNLIQEYWIGEGILDDFKDVEQANNKACYFLG
ILSSASLIERVDADGYTRMHPMVRAMALWIACEFGKKENQWFVREREGLM
EAPEAETWRGAARMALGYNSITVLPEAPESLNLVSLKLKSNFGLERIPDG
FFRFMPCLVALDLHSTPIKEIPSGISNLQRLQFLELGGTKLKSLPKELAS
LKNLKYLGLNWTAELASIPERLIQSLSELRVLRMIVSYSSWKAIPAGGGN
GVSLRELEALKRLRVLDITVGNAPAFNMLTQSQRLAPATAALLLKGCPGL
TAVELPSGLGRSLKSLKWLRVSHSTELEEVLIAGDGRESDDAVLPELENL
VLECLLKAKIVWRSSCIQHLRGLYIYGCSGMEQLIWYKDDDDSDAENRGR
RGVSPFPNLKQIAFRGLPKLKRVSDERQLVFPLLESIEVAECPQLKKLNL
VAEKLREIRCHRSWWDQLEWEDDAARFSPQMILKPLN
>XP_042433072.1 putative disease resistance protein RGA1 [Zingiber officinale]
MIGRFALTAFGWLAESIVSALVGKAVNHAVQQFGEQHGVEDDLKKLKDSL
ANARLKISTIENLWLKDEFLQQRVKDLLIDLKNAAYDADDLLDEFQYRIL
KQQIEQQGDEAGKRASSSSYSAPPPSKRTKTSIASYTSDLFRKGDDDDDD
NVQKIRKIKGSLDDYSAALEEIYSSLGAEDDRGNKQLVSPASRQTSSFST
EPQLFGRDKELQELKDLLFKPAVASEFGQSGVSVLSIYGMGGIGKTTLAQ
EVFNHSSVKKYFKLRIWVCVSENFCTDRLTREIIECATTEKCDLTNLDTL
QKIVNEKITPERFLLVLDDVWNEDRHKWESLCAPLRSGKPGSKILVTTRS
RKIAKMVGDVDVIHLQGLDEESFWEFFKKCAFGCSNSGFHHPHMEAMAKK
MTCKLKGLPLAAKTLGGLLSMKLDEQYWESILDSEIWQLPQEENGIMPVL
QLSYQHLPPHLKQCFAFCSLFPKDYRFYESDLIGIWIAEGFIVTQGSTRM
EELGSNYFHELVNRSFIQESKSGGFIMHDLIHDLAELISVGESYRIEKGK
FHDIPSTIRHLSIYTNEEGIETRLLTEFSHCDKLRTMMLIVEKFSWKNFN
FDCGVLEKLKNIHVLVLKNCSLKELPDSIDKLIHLRYLDLSQNDFRRLPE
SLCDLYNLQTLKLDCCSNLEGLPHGMTKLINLRNIYAVVNFIHKIAEIGK
LTSLQNLYAFKVTKDNGHKLVELKGLNQLRGFLCITNLENVENKDEANIA
SLKSKEHLDELVLEWTSLQESDSDVNLHMSEHVLEGLQPHHNLQSLIIRG
YNGARPPNWLHEQVYSRLKALKLENCKRWNDLSAIGQLSQLKHLFLVRIS
VQTKNIHKLFDPKVCQFFSQLEKLVLEGITMLEDLPNLGQLPCLTSICIE
NLPGVKMIGEKFFATTEEGSCFPRLCTLRFIEMPAWEVFYGSDDRNLFPC
LEDLYISNCQKLKMLPPLPPSIQCVKLNNVGLVDCPRYWKAIDECSSTTN
SVSLKDLAIWNCPNLTSLERGLLPHHLLQIHIKKCEQLLWVPVKRLKELA
SLRSLSIKKCPKLMSMTPDKYIDFQLPPSITYLRLSDCGNLSKSLPDLLH
NLLTPLLISKCPNPVSLPLEPWLRVIDLEIEKTTNNLQFLRIKGCPNLLL
ELTDNLAGLELEINDTALMKQPLIKKLLSSVGKLIISSSCEAVMFEGEDQ
ESLQSLTSLQTLCFSDCENLQSLPTKLYTLTSLENLWISNCPQIQSLPEW
LPPSLEDLEFEDCDLALEQRHLAEIKKFRLIPLSLREEEEDDDEDKEEEE
EEEEEVEDEEEEAGVDAI
>XP_042433073.1 putative disease resistance protein RGA1 [Zingiber officinale]
MIGRFALTAFGWLAESIVSALVGKAVNHAVQQFGEQHGVEDDLKKLKDSL
ANARLKISTIENLWLKDEFLQQRVKDLLIDLKNAAYDADDLLDEFQYRIL
KQQIEQQGDEAGKRASSSSYSAPPPSKRTKTSIASYTSDLFRKGDDDDDD
NVQKIRKIKGSLDDYSAALEEIYSSLGAEDDRGNKQLVSPASRQTSSFST
EPQLFGRDKELQELKDLLFKPAVASEFGQSGVSVLSIYGMGGIGKTTLAQ
EVFNHSSVKKYFKLRIWVCVSENFCTDRLTREIIECATTEKCDLTNLDTL
QKIVNEKITPERFLLVLDDVWNEDRHKWESLCAPLRSGKPGSKILVTTRS
RKIAKMVGDVDVIHLQGLDEESFWEFFKKCAFGCSNSGFHHPHMEAMAKK
MTCKLKGLPLAAKTLGGLLSMKLDEQYWESILDSEIWQLPQEENGIMPVL
QLSYQHLPPHLKQCFAFCSLFPKDYRFYESDLIGIWIAEGFIVTQGSTRM
EELGSNYFHELVNRSFIQESKSGGFIMHDLIHDLAELISVGESYRIEKGK
FHDIPSTIRHLSIYTNEEGIETRLLTEFSHCDKLRTMMLIVEKFSWKNFN
FDCGVLEKLKNIHVLVLKNCSLKELPDSIDKLIHLRYLDLSQNDFRRLPE
SLCDLYNLQTLKLDCCSNLEGLPHGMTKLINLRNIYAVVNFIHKIAEIGK
LTSLQNLYAFKVTKDNGHKLVELKGLNQLRGFLCITNLENVENKDEANIA
SLKSKEHLDELVLEWTSLQESDSDVNLHMSEHVLEGLQPHHNLQSLIIRG
YNGARPPNWLHEQVYSRLKALKLENCKRWNDLSAIGQLSQLKHLFLVRIS
VQTKNIHKLFDPKVCQFFSQLEKLVLEGITMLEDLPNLGQLPCLTSICIE
NLPGVKMIGEKFFATTEEGSCFPRLCTLRFIEMPAWEVFYGSDDRNLFPC
LEDLYISNCQKLKMLPPLPPSIQCVKLNNVGLVDCPRYWKAIDECSSTTN
SVSLKDLAIWNCPNLTSLERGLLPHHLLQIHIKKCEQLLWVPVKRLKELA
SLRSLSIKKCPKLMSMTPDKYIDFQLPPSITYLRLSDCGNLSKSLPDLLH
NLLTPLLISKCPNPVSLPLEPWLRVIDLEIEKTTNNLQFLRIKGCPNLLL
ELTDNLAGLELEINDTALMKQPLIKKLLSSVGKLIISSSCEAVMFEGEDQ
ESLQSLTSLQTLCFSDCENLQSLPTKLYTLTSLENLWISNCPQIQSLPEW
LPPSLEDLEFEDCDLALEQRHLAEIKKFRLIPLSLREEEEDDDEDKEEEE
EEEEEVEDEEEEAGVDAI
>XP_042434296.1 putative disease resistance protein RGA1 isoform X1 [Zingiber officinale]
MIGRFALTAFGWLAESIVGALVGKAVNHAVQQFGEQHGVEDDLKKLKDSL
ANARLKISTIENLWLKDEFLQQRVKDLLIDLKNAAYDADDLLDEFQYRIL
KQQIEQQGDEAGKRASSSSYSAPPPSKRTKTSIASCTSGLFRKGDDDDDN
NNVQKIRKIKGSLDDYSAALEEIYSSLAAEDDRGNKQLVSPASRQTSSFS
TEPQLFGRDKELQELKDLLFKPAVASEFGQSGVSVLSIYGMGGIGKTTLA
QEVFNDSSVKEYFKLRIWVCVSENFCTDRLTREIIECATTEKCDLTNLDT
LQKIVNEKITPERFLLVLDDVWNEDRHKWESLCAPLRSGKPGSKILVTTR
SRKIADMVSDADAIHLQGLDVESFWDFFKKCAFGCSHSGAHHPHMEAMAK
KMTCKLKGLPLAAKTLGGLLSVKLDEQYWESILDSEIWQLPQEENGIMPV
LQLSYQHLPPHLKQCFAFCSLFPKDYKFSESELIGIWMAEGFIVPQGSTR
MEELGSNYFHELVNRSFIQGSKRIGFIMHDLIHDLAEFISVGESYRIEKG
KFHDIPSTIRHLSIYKDEEGIGTRLLTEFSHCNKLRTLLLRGFTSMSFNF
DCSVLERFKNIHVLVLQNCSLKELPDSIGKLIHLRYLDLSKNNFQRLPES
LCDLYNLQTLKLYYCSNLEGLPHGMTKLINLRKLDGAGRFIPKITEVGKL
TSLQNLYDFKVTKYNGHKLPELNGLKQLRGKLRITNLENVENKDEANIAS
LKSKEHLDELVLEWTSMQESDSDINLHISEQVLEGLQPHHNLQRLTIRGY
NGARPPNWLHKQVYSRLESLHLENCKRWNDLSAIGQLSQLKSLSLVRTPV
QTKNTHKLFDPKVCKFFSQLENLVLEGITMLEDLPNLGQLPCLTYICIQS
LLGVKKIGDKFFAMTEEGRCFPRLRTLRFTEMPAWEEFYGSDDRNLFPCL
EDFDISNCQKLQMLPPLPPSLQQLKLNNVGLVYCPRFWKAFDECSSTTTS
VSLTYLSIQNCPNLTSLDQVLLPHHLFPCLKDLYISNCQKLQMLPPLPPS
IQVLQLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLDQV
LLPHHLFPCLVDLDISNCQKLQMLPPLPPSIQVLQLNNVGLVDCPRFWKA
FDEGSSTTNSASLTYLSIQNCPNLTSLEPGLLSHHLKAIDLKKCERLSWV
SVKRLKELASLCSLSIKECPKLMGMTPDEYIDFQLPPSIEKLCLSDCGNL
SKSLPGCLHNLTSLTFLSISKCPTLVALPVEPSLRLTCLEIQNCNELRSV
EELPIKNVDVLQMRGCPKLLLPQTKKLPLWKLEIDDTAFMKQPIIKNSLS
SVSELTISSSREAAMFEGEDQKSLQSLTSLHFFCFSDCKNLQSLPAKLYT
LKSLRFLGIYNCPQIQSLPEKGLPPSLTDLEFKGCDPALEQQLVRHLTEI
KKSWLIPHH
>XP_042434297.1 putative disease resistance protein RGA1 isoform X1 [Zingiber officinale]
MIGRFALTAFGWLAESIVGALVGKAVNHAVQQFGEQHGVEDDLKKLKDSL
ANARLKISTIENLWLKDEFLQQRVKDLLIDLKNAAYDADDLLDEFQYRIL
KQQIEQQGDEAGKRASSSSYSAPPPSKRTKTSIASCTSGLFRKGDDDDDN
NNVQKIRKIKGSLDDYSAALEEIYSSLAAEDDRGNKQLVSPASRQTSSFS
TEPQLFGRDKELQELKDLLFKPAVASEFGQSGVSVLSIYGMGGIGKTTLA
QEVFNDSSVKEYFKLRIWVCVSENFCTDRLTREIIECATTEKCDLTNLDT
LQKIVNEKITPERFLLVLDDVWNEDRHKWESLCAPLRSGKPGSKILVTTR
SRKIADMVSDADAIHLQGLDVESFWDFFKKCAFGCSHSGAHHPHMEAMAK
KMTCKLKGLPLAAKTLGGLLSVKLDEQYWESILDSEIWQLPQEENGIMPV
LQLSYQHLPPHLKQCFAFCSLFPKDYKFSESELIGIWMAEGFIVPQGSTR
MEELGSNYFHELVNRSFIQGSKRIGFIMHDLIHDLAEFISVGESYRIEKG
KFHDIPSTIRHLSIYKDEEGIGTRLLTEFSHCNKLRTLLLRGFTSMSFNF
DCSVLERFKNIHVLVLQNCSLKELPDSIGKLIHLRYLDLSKNNFQRLPES
LCDLYNLQTLKLYYCSNLEGLPHGMTKLINLRKLDGAGRFIPKITEVGKL
TSLQNLYDFKVTKYNGHKLPELNGLKQLRGKLRITNLENVENKDEANIAS
LKSKEHLDELVLEWTSMQESDSDINLHISEQVLEGLQPHHNLQRLTIRGY
NGARPPNWLHKQVYSRLESLHLENCKRWNDLSAIGQLSQLKSLSLVRTPV
QTKNTHKLFDPKVCKFFSQLENLVLEGITMLEDLPNLGQLPCLTYICIQS
LLGVKKIGDKFFAMTEEGRCFPRLRTLRFTEMPAWEEFYGSDDRNLFPCL
EDFDISNCQKLQMLPPLPPSLQQLKLNNVGLVYCPRFWKAFDECSSTTTS
VSLTYLSIQNCPNLTSLDQVLLPHHLFPCLKDLYISNCQKLQMLPPLPPS
IQVLQLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLDQV
LLPHHLFPCLVDLDISNCQKLQMLPPLPPSIQVLQLNNVGLVDCPRFWKA
FDEGSSTTNSASLTYLSIQNCPNLTSLEPGLLSHHLKAIDLKKCERLSWV
SVKRLKELASLCSLSIKECPKLMGMTPDEYIDFQLPPSIEKLCLSDCGNL
SKSLPGCLHNLTSLTFLSISKCPTLVALPVEPSLRLTCLEIQNCNELRSV
EELPIKNVDVLQMRGCPKLLLPQTKKLPLWKLEIDDTAFMKQPIIKNSLS
SVSELTISSSREAAMFEGEDQKSLQSLTSLHFFCFSDCKNLQSLPAKLYT
LKSLRFLGIYNCPQIQSLPEKGLPPSLTDLEFKGCDPALEQQLVRHLTEI
KKSWLIPHH
>XP_042434298.1 putative disease resistance protein RGA1 isoform X1 [Zingiber officinale]
MIGRFALTAFGWLAESIVGALVGKAVNHAVQQFGEQHGVEDDLKKLKDSL
ANARLKISTIENLWLKDEFLQQRVKDLLIDLKNAAYDADDLLDEFQYRIL
KQQIEQQGDEAGKRASSSSYSAPPPSKRTKTSIASCTSGLFRKGDDDDDN
NNVQKIRKIKGSLDDYSAALEEIYSSLAAEDDRGNKQLVSPASRQTSSFS
TEPQLFGRDKELQELKDLLFKPAVASEFGQSGVSVLSIYGMGGIGKTTLA
QEVFNDSSVKEYFKLRIWVCVSENFCTDRLTREIIECATTEKCDLTNLDT
LQKIVNEKITPERFLLVLDDVWNEDRHKWESLCAPLRSGKPGSKILVTTR
SRKIADMVSDADAIHLQGLDVESFWDFFKKCAFGCSHSGAHHPHMEAMAK
KMTCKLKGLPLAAKTLGGLLSVKLDEQYWESILDSEIWQLPQEENGIMPV
LQLSYQHLPPHLKQCFAFCSLFPKDYKFSESELIGIWMAEGFIVPQGSTR
MEELGSNYFHELVNRSFIQGSKRIGFIMHDLIHDLAEFISVGESYRIEKG
KFHDIPSTIRHLSIYKDEEGIGTRLLTEFSHCNKLRTLLLRGFTSMSFNF
DCSVLERFKNIHVLVLQNCSLKELPDSIGKLIHLRYLDLSKNNFQRLPES
LCDLYNLQTLKLYYCSNLEGLPHGMTKLINLRKLDGAGRFIPKITEVGKL
TSLQNLYDFKVTKYNGHKLPELNGLKQLRGKLRITNLENVENKDEANIAS
LKSKEHLDELVLEWTSMQESDSDINLHISEQVLEGLQPHHNLQRLTIRGY
NGARPPNWLHKQVYSRLESLHLENCKRWNDLSAIGQLSQLKSLSLVRTPV
QTKNTHKLFDPKVCKFFSQLENLVLEGITMLEDLPNLGQLPCLTYICIQS
LLGVKKIGDKFFAMTEEGRCFPRLRTLRFTEMPAWEEFYGSDDRNLFPCL
EDFDISNCQKLQMLPPLPPSLQQLKLNNVGLVYCPRFWKAFDECSSTTTS
VSLTYLSIQNCPNLTSLDQVLLPHHLFPCLKDLYISNCQKLQMLPPLPPS
IQVLQLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLDQV
LLPHHLFPCLVDLDISNCQKLQMLPPLPPSIQVLQLNNVGLVDCPRFWKA
FDEGSSTTNSASLTYLSIQNCPNLTSLEPGLLSHHLKAIDLKKCERLSWV
SVKRLKELASLCSLSIKECPKLMGMTPDEYIDFQLPPSIEKLCLSDCGNL
SKSLPGCLHNLTSLTFLSISKCPTLVALPVEPSLRLTCLEIQNCNELRSV
EELPIKNVDVLQMRGCPKLLLPQTKKLPLWKLEIDDTAFMKQPIIKNSLS
SVSELTISSSREAAMFEGEDQKSLQSLTSLHFFCFSDCKNLQSLPAKLYT
LKSLRFLGIYNCPQIQSLPEKGLPPSLTDLEFKGCDPALEQQLVRHLTEI
KKSWLIPHH
>XP_042434299.1 putative disease resistance protein RGA1 isoform X1 [Zingiber officinale]
MIGRFALTAFGWLAESIVGALVGKAVNHAVQQFGEQHGVEDDLKKLKDSL
ANARLKISTIENLWLKDEFLQQRVKDLLIDLKNAAYDADDLLDEFQYRIL
KQQIEQQGDEAGKRASSSSYSAPPPSKRTKTSIASCTSGLFRKGDDDDDN
NNVQKIRKIKGSLDDYSAALEEIYSSLAAEDDRGNKQLVSPASRQTSSFS
TEPQLFGRDKELQELKDLLFKPAVASEFGQSGVSVLSIYGMGGIGKTTLA
QEVFNDSSVKEYFKLRIWVCVSENFCTDRLTREIIECATTEKCDLTNLDT
LQKIVNEKITPERFLLVLDDVWNEDRHKWESLCAPLRSGKPGSKILVTTR
SRKIADMVSDADAIHLQGLDVESFWDFFKKCAFGCSHSGAHHPHMEAMAK
KMTCKLKGLPLAAKTLGGLLSVKLDEQYWESILDSEIWQLPQEENGIMPV
LQLSYQHLPPHLKQCFAFCSLFPKDYKFSESELIGIWMAEGFIVPQGSTR
MEELGSNYFHELVNRSFIQGSKRIGFIMHDLIHDLAEFISVGESYRIEKG
KFHDIPSTIRHLSIYKDEEGIGTRLLTEFSHCNKLRTLLLRGFTSMSFNF
DCSVLERFKNIHVLVLQNCSLKELPDSIGKLIHLRYLDLSKNNFQRLPES
LCDLYNLQTLKLYYCSNLEGLPHGMTKLINLRKLDGAGRFIPKITEVGKL
TSLQNLYDFKVTKYNGHKLPELNGLKQLRGKLRITNLENVENKDEANIAS
LKSKEHLDELVLEWTSMQESDSDINLHISEQVLEGLQPHHNLQRLTIRGY
NGARPPNWLHKQVYSRLESLHLENCKRWNDLSAIGQLSQLKSLSLVRTPV
QTKNTHKLFDPKVCKFFSQLENLVLEGITMLEDLPNLGQLPCLTYICIQS
LLGVKKIGDKFFAMTEEGRCFPRLRTLRFTEMPAWEEFYGSDDRNLFPCL
EDFDISNCQKLQMLPPLPPSLQQLKLNNVGLVYCPRFWKAFDECSSTTTS
VSLTYLSIQNCPNLTSLDQVLLPHHLFPCLKDLYISNCQKLQMLPPLPPS
IQVLQLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLDQV
LLPHHLFPCLVDLDISNCQKLQMLPPLPPSIQVLQLNNVGLVDCPRFWKA
FDEGSSTTNSASLTYLSIQNCPNLTSLEPGLLSHHLKAIDLKKCERLSWV
SVKRLKELASLCSLSIKECPKLMGMTPDEYIDFQLPPSIEKLCLSDCGNL
SKSLPGCLHNLTSLTFLSISKCPTLVALPVEPSLRLTCLEIQNCNELRSV
EELPIKNVDVLQMRGCPKLLLPQTKKLPLWKLEIDDTAFMKQPIIKNSLS
SVSELTISSSREAAMFEGEDQKSLQSLTSLHFFCFSDCKNLQSLPAKLYT
LKSLRFLGIYNCPQIQSLPEKGLPPSLTDLEFKGCDPALEQQLVRHLTEI
KKSWLIPHH
>XP_042434300.1 putative disease resistance protein RGA3 isoform X2 [Zingiber officinale]
MIGRFALTAFGWLAESIVGALVGKAVNHAVQQFGEQHGVEDDLKKLKDSL
ANARLKISTIENLWLKDEFLQQRVKDLLIDLKNAAYDADDLLDEFQYRIL
KQQIEQQGDEAGKRASSSSYSAPPPSKRTKTSIASCTSGLFRKGDDDDDN
NNVQKIRKIKGSLDDYSAALEEIYSSLAAEDDRGNKQLVSPASRQTSSFS
TEPQLFGRDKELQELKDLLFKPAVASEFGQSGVSVLSIYGMGGIGKTTLA
QEVFNDSSVKEYFKLRIWVCVSENFCTDRLTREIIECATTEKCDLTNLDT
LQKIVNEKITPERFLLVLDDVWNEDRHKWESLCAPLRSGKPGSKILVTTR
SRKIADMVSDADAIHLQGLDVESFWDFFKKCAFGCSHSGAHHPHMEAMAK
KMTCKLKGLPLAAKTLGGLLSVKLDEQYWESILDSEIWQLPQEENGIMPV
LQLSYQHLPPHLKQCFAFCSLFPKDYKFSESELIGIWMAEGFIVPQGSTR
MEELGSNYFHELVNRSFIQGSKRIGFIMHDLIHDLAEFISVGESYRIEKG
KFHDIPSTIRHLSIYKDEEELFFERTT
>XP_042434515.1 disease resistance protein RPS2-like [Zingiber officinale]
MDPIAPAATLITKLWDPIALKLAFIVEAGDNVRSLLLSMNRLKDKSIDVA
NRVSAAKAQLLTPIQEVLGWLRRVEELEAEVSAIEQDFLNQPTCFCSCHY
DLSSSYRIGREAKRKASEAAEMQARSFDVVATDDSAPAVALDLPTPPDVG
VESPLENAFQYLFDDQRCVIGVHGMGGVGKTTLLRRINNSFVGRSDFDLV
IMVEASLDFKIEQLQQAIADRVGLPLSQNGTSKSWAIEIKRSLNRKKFLL
LLDNIWDPINLTDAGIPTGPSKCKIVISSRFESTCAQMGAEKKIKMECLT
PDKAWELFRQNLSGDLLNDPEIEDLAKQVAEDCNGLPLALVVVAATMSTR
TTREEWQYAVRQMRKMHLESLVPLEANLIPTLKLSYDNLPNDQLKLCFLS
CSFYPRGHSILKEELIESWMGLGFLEEHNDINEIYQKGHFLIGKLREASL
VVPGDDERRVKVHDIICALALHISSVGLTPRTEKASSSSSRSDPEKIWAV
DAGTGLTDIRADYLEGSSIERLSLMHNNIDTLPEKTDFPELLSLMLQCND
SLPRVFPRGFFKGMGRLQYLDLSNTTVEDIHGIGQLLCLEHLNLSGTPIS
KLPQEIRFLTRLKYLYLINTYSLEIIFAKSFSGLHNLRVFNAYGSSFRFW
ATDGAADVDRASLSELNELINLKALGISVGTQSTFQKLFDMSIPIRYLYI
SDPDTAPIDISFNQLRLPSNTLRSRSKIDTSLLEMTIKNCQDLEVVTIGE
DRKGAPENVDGGFCRLCTFKGLEKLHLLHLGKLSNITWNGVKPCEYFPRL
RLLRIVGCDKLRSITWTKQLPDLVNLYISGCAEVQQIIAEEDEDVEQEGR
EVFPRLKEFVLRDLPKLTSIYQRTLPFPNLVSLQVFRCPKLASLPFGEGS
ACRLQEIHGGKEWWGNLKWANRASFDRHFKQAAS
>XP_042434516.1 putative disease resistance protein RGA1 isoform X1 [Zingiber officinale]
MIGRFALTAFGWLAESIMGALVGKAVDRAVQQFGEQHGFEDDLEKLQDSL
DHARLTISTIERLRIKDEGQQKTLRKLLIRLKNSAYDADDLLDEFQYRIL
KQQIEQQGDEAGNRASSSSYSTPPPSKRTKTSFSSISTSGIFRKGDDDDD
VQRIRKIKGRLDDNSAALEKIYNSLGAEDDRGEKQLVSSASRQTSSFSTE
PRLVGRDKELQELKDLLLKPEVASEFGQSGVSVLSICGLGGIGKTTLAQE
VFNDSSVKEYFKLRIWVCVSENFCTDRLIREIIECATTEKCDLTNLDTLQ
RIVNEKITPERFLLVLDDVWNEDRHKWEILCAPLRSGKPGSKILVTTRSR
KIADMVSDVDAIHLQGLDEESFWDFFKKCAFGCSHSGAHHPHMEAMAKKM
TCKLKGLPLAAKTLGGLLSMKLDEQYWESILDSEIWQLPQEENGIMPVLQ
LSYQHLPPHLKQCFAFCSLFPKDYKFSESELIGIWMAEGFIVPQGSTRME
ELGSNYFHELVNRSFIQESKSGRFIMHDLIHDLAELISAGESYRIEKGKS
HDIPSTIRHLSIYTDKEGMQTILTEFSHWNKLRTMMLTVERFPREDFNFV
CGVLEKLKNIHVLVLKNCSLRELPDGIDKLIHLRYLDLSNNKGIQRLPEL
LCDLYNLQTLILRFCDNLKSLPHGMMKLINLRKLYGVDRLISGITEIGKL
TSLQNLYSFKVTKDNGHKLPELNGLKQLRGKLRITNLENVENKDEANIAS
LKSKEHLNELVLEWTSIQESDSDINLHISEQVLEGLQPHHNLQRLTIRGY
NGARPPNWLHKQVYSRLESLHLENCKRWNDLSAIGQLSQLKSLSLVRTPV
QTKNIHKLFDPKVCKFFSQLENLVLEGITMLEDLPNLGQLPCLTYIRIQS
LLGVKKIDDKFFAMTEEGSCFPRLCTLQFTEMPAWEELYGSDDRNLFPCL
EGLYISNCQKLQMLPPLPPSIQQLKLNNVGLVDCPRFWKAFDECSSTTTS
VSLTYLSIQNCPNLTSLDQGLLPHHLFPCLVDLDISNCQKLQMLPPLPPS
IQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLDQG
LLPHHLFPCLEHLDISNCQKLQMLPPLPPSIQSLDLNDVGLVDCPRFWKA
IDECSSTTNYASLRYLFIQNCPNLTSLEPGLLPHHLQHIYIAKCEQLSWV
SVKRLKELASLCSLSIKECPKLMSMTRDEYIDFQLPPSIKELCLSDCENL
FKSLPGCLHNLTSLTSLSISKCPNLVSLPVEPSLRLIHPEIQDCNELRSV
EGLPIKNLKVLKIKGCPKLLLPQTEKLPLWKLEIDDTAFLKQPLIKNSLS
SVCELTISSSREAVMFEGEDQESLQSLTSLHLFCFSDCKNLQSLPAKLYT
LKSLRFLWIYNCPQIQSLPEKGLPPSLTDLEFKGCDPALEQQLVRHLAEI
NKSWLIPSSLRHLWWSDN
>XP_042434517.1 putative disease resistance protein RGA1 isoform X1 [Zingiber officinale]
MIGRFALTAFGWLAESIMGALVGKAVDRAVQQFGEQHGFEDDLEKLQDSL
DHARLTISTIERLRIKDEGQQKTLRKLLIRLKNSAYDADDLLDEFQYRIL
KQQIEQQGDEAGNRASSSSYSTPPPSKRTKTSFSSISTSGIFRKGDDDDD
VQRIRKIKGRLDDNSAALEKIYNSLGAEDDRGEKQLVSSASRQTSSFSTE
PRLVGRDKELQELKDLLLKPEVASEFGQSGVSVLSICGLGGIGKTTLAQE
VFNDSSVKEYFKLRIWVCVSENFCTDRLIREIIECATTEKCDLTNLDTLQ
RIVNEKITPERFLLVLDDVWNEDRHKWEILCAPLRSGKPGSKILVTTRSR
KIADMVSDVDAIHLQGLDEESFWDFFKKCAFGCSHSGAHHPHMEAMAKKM
TCKLKGLPLAAKTLGGLLSMKLDEQYWESILDSEIWQLPQEENGIMPVLQ
LSYQHLPPHLKQCFAFCSLFPKDYKFSESELIGIWMAEGFIVPQGSTRME
ELGSNYFHELVNRSFIQESKSGRFIMHDLIHDLAELISAGESYRIEKGKS
HDIPSTIRHLSIYTDKEGMQTILTEFSHWNKLRTMMLTVERFPREDFNFV
CGVLEKLKNIHVLVLKNCSLRELPDGIDKLIHLRYLDLSNNKGIQRLPEL
LCDLYNLQTLILRFCDNLKSLPHGMMKLINLRKLYGVDRLISGITEIGKL
TSLQNLYSFKVTKDNGHKLPELNGLKQLRGKLRITNLENVENKDEANIAS
LKSKEHLNELVLEWTSIQESDSDINLHISEQVLEGLQPHHNLQRLTIRGY
NGARPPNWLHKQVYSRLESLHLENCKRWNDLSAIGQLSQLKSLSLVRTPV
QTKNIHKLFDPKVCKFFSQLENLVLEGITMLEDLPNLGQLPCLTYIRIQS
LLGVKKIDDKFFAMTEEGSCFPRLCTLQFTEMPAWEELYGSDDRNLFPCL
EGLYISNCQKLQMLPPLPPSIQQLKLNNVGLVDCPRFWKAFDECSSTTTS
VSLTYLSIQNCPNLTSLDQGLLPHHLFPCLVDLDISNCQKLQMLPPLPPS
IQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLDQG
LLPHHLFPCLEHLDISNCQKLQMLPPLPPSIQSLDLNDVGLVDCPRFWKA
IDECSSTTNYASLRYLFIQNCPNLTSLEPGLLPHHLQHIYIAKCEQLSWV
SVKRLKELASLCSLSIKECPKLMSMTRDEYIDFQLPPSIKELCLSDCENL
FKSLPGCLHNLTSLTSLSISKCPNLVSLPVEPSLRLIHPEIQDCNELRSV
EGLPIKNLKVLKIKGCPKLLLPQTEKLPLWKLEIDDTAFLKQPLIKNSLS
SVCELTISSSREAVMFEGEDQESLQSLTSLHLFCFSDCKNLQSLPAKLYT
LKSLRFLWIYNCPQIQSLPEKGLPPSLTDLEFKGCDPALEQQLVRHLAEI
NKSWLIPSSLRHLWWSDN
>XP_042434518.1 putative disease resistance protein RGA1 isoform X1 [Zingiber officinale]
MIGRFALTAFGWLAESIMGALVGKAVDRAVQQFGEQHGFEDDLEKLQDSL
DHARLTISTIERLRIKDEGQQKTLRKLLIRLKNSAYDADDLLDEFQYRIL
KQQIEQQGDEAGNRASSSSYSTPPPSKRTKTSFSSISTSGIFRKGDDDDD
VQRIRKIKGRLDDNSAALEKIYNSLGAEDDRGEKQLVSSASRQTSSFSTE
PRLVGRDKELQELKDLLLKPEVASEFGQSGVSVLSICGLGGIGKTTLAQE
VFNDSSVKEYFKLRIWVCVSENFCTDRLIREIIECATTEKCDLTNLDTLQ
RIVNEKITPERFLLVLDDVWNEDRHKWEILCAPLRSGKPGSKILVTTRSR
KIADMVSDVDAIHLQGLDEESFWDFFKKCAFGCSHSGAHHPHMEAMAKKM
TCKLKGLPLAAKTLGGLLSMKLDEQYWESILDSEIWQLPQEENGIMPVLQ
LSYQHLPPHLKQCFAFCSLFPKDYKFSESELIGIWMAEGFIVPQGSTRME
ELGSNYFHELVNRSFIQESKSGRFIMHDLIHDLAELISAGESYRIEKGKS
HDIPSTIRHLSIYTDKEGMQTILTEFSHWNKLRTMMLTVERFPREDFNFV
CGVLEKLKNIHVLVLKNCSLRELPDGIDKLIHLRYLDLSNNKGIQRLPEL
LCDLYNLQTLILRFCDNLKSLPHGMMKLINLRKLYGVDRLISGITEIGKL
TSLQNLYSFKVTKDNGHKLPELNGLKQLRGKLRITNLENVENKDEANIAS
LKSKEHLNELVLEWTSIQESDSDINLHISEQVLEGLQPHHNLQRLTIRGY
NGARPPNWLHKQVYSRLESLHLENCKRWNDLSAIGQLSQLKSLSLVRTPV
QTKNIHKLFDPKVCKFFSQLENLVLEGITMLEDLPNLGQLPCLTYIRIQS
LLGVKKIDDKFFAMTEEGSCFPRLCTLQFTEMPAWEELYGSDDRNLFPCL
EGLYISNCQKLQMLPPLPPSIQQLKLNNVGLVDCPRFWKAFDECSSTTTS
VSLTYLSIQNCPNLTSLDQGLLPHHLFPCLVDLDISNCQKLQMLPPLPPS
IQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLDQG
LLPHHLFPCLEHLDISNCQKLQMLPPLPPSIQSLDLNDVGLVDCPRFWKA
IDECSSTTNYASLRYLFIQNCPNLTSLEPGLLPHHLQHIYIAKCEQLSWV
SVKRLKELASLCSLSIKECPKLMSMTRDEYIDFQLPPSIKELCLSDCENL
FKSLPGCLHNLTSLTSLSISKCPNLVSLPVEPSLRLIHPEIQDCNELRSV
EGLPIKNLKVLKIKGCPKLLLPQTEKLPLWKLEIDDTAFLKQPLIKNSLS
SVCELTISSSREAVMFEGEDQESLQSLTSLHLFCFSDCKNLQSLPAKLYT
LKSLRFLWIYNCPQIQSLPEKGLPPSLTDLEFKGCDPALEQQLVRHLAEI
NKSWLIPSSLRHLWWSDN
>XP_042434519.1 putative disease resistance protein RGA1 isoform X1 [Zingiber officinale]
MIGRFALTAFGWLAESIMGALVGKAVDRAVQQFGEQHGFEDDLEKLQDSL
DHARLTISTIERLRIKDEGQQKTLRKLLIRLKNSAYDADDLLDEFQYRIL
KQQIEQQGDEAGNRASSSSYSTPPPSKRTKTSFSSISTSGIFRKGDDDDD
VQRIRKIKGRLDDNSAALEKIYNSLGAEDDRGEKQLVSSASRQTSSFSTE
PRLVGRDKELQELKDLLLKPEVASEFGQSGVSVLSICGLGGIGKTTLAQE
VFNDSSVKEYFKLRIWVCVSENFCTDRLIREIIECATTEKCDLTNLDTLQ
RIVNEKITPERFLLVLDDVWNEDRHKWEILCAPLRSGKPGSKILVTTRSR
KIADMVSDVDAIHLQGLDEESFWDFFKKCAFGCSHSGAHHPHMEAMAKKM
TCKLKGLPLAAKTLGGLLSMKLDEQYWESILDSEIWQLPQEENGIMPVLQ
LSYQHLPPHLKQCFAFCSLFPKDYKFSESELIGIWMAEGFIVPQGSTRME
ELGSNYFHELVNRSFIQESKSGRFIMHDLIHDLAELISAGESYRIEKGKS
HDIPSTIRHLSIYTDKEGMQTILTEFSHWNKLRTMMLTVERFPREDFNFV
CGVLEKLKNIHVLVLKNCSLRELPDGIDKLIHLRYLDLSNNKGIQRLPEL
LCDLYNLQTLILRFCDNLKSLPHGMMKLINLRKLYGVDRLISGITEIGKL
TSLQNLYSFKVTKDNGHKLPELNGLKQLRGKLRITNLENVENKDEANIAS
LKSKEHLNELVLEWTSIQESDSDINLHISEQVLEGLQPHHNLQRLTIRGY
NGARPPNWLHKQVYSRLESLHLENCKRWNDLSAIGQLSQLKSLSLVRTPV
QTKNIHKLFDPKVCKFFSQLENLVLEGITMLEDLPNLGQLPCLTYIRIQS
LLGVKKIDDKFFAMTEEGSCFPRLCTLQFTEMPAWEELYGSDDRNLFPCL
EGLYISNCQKLQMLPPLPPSIQQLKLNNVGLVDCPRFWKAFDECSSTTTS
VSLTYLSIQNCPNLTSLDQGLLPHHLFPCLVDLDISNCQKLQMLPPLPPS
IQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLDQG
LLPHHLFPCLEHLDISNCQKLQMLPPLPPSIQSLDLNDVGLVDCPRFWKA
IDECSSTTNYASLRYLFIQNCPNLTSLEPGLLPHHLQHIYIAKCEQLSWV
SVKRLKELASLCSLSIKECPKLMSMTRDEYIDFQLPPSIKELCLSDCENL
FKSLPGCLHNLTSLTSLSISKCPNLVSLPVEPSLRLIHPEIQDCNELRSV
EGLPIKNLKVLKIKGCPKLLLPQTEKLPLWKLEIDDTAFLKQPLIKNSLS
SVCELTISSSREAVMFEGEDQESLQSLTSLHLFCFSDCKNLQSLPAKLYT
LKSLRFLWIYNCPQIQSLPEKGLPPSLTDLEFKGCDPALEQQLVRHLAEI
NKSWLIPSSLRHLWWSDN
>XP_042434520.1 putative disease resistance protein RGA1 isoform X1 [Zingiber officinale]
MIGRFALTAFGWLAESIMGALVGKAVDRAVQQFGEQHGFEDDLEKLQDSL
DHARLTISTIERLRIKDEGQQKTLRKLLIRLKNSAYDADDLLDEFQYRIL
KQQIEQQGDEAGNRASSSSYSTPPPSKRTKTSFSSISTSGIFRKGDDDDD
VQRIRKIKGRLDDNSAALEKIYNSLGAEDDRGEKQLVSSASRQTSSFSTE
PRLVGRDKELQELKDLLLKPEVASEFGQSGVSVLSICGLGGIGKTTLAQE
VFNDSSVKEYFKLRIWVCVSENFCTDRLIREIIECATTEKCDLTNLDTLQ
RIVNEKITPERFLLVLDDVWNEDRHKWEILCAPLRSGKPGSKILVTTRSR
KIADMVSDVDAIHLQGLDEESFWDFFKKCAFGCSHSGAHHPHMEAMAKKM
TCKLKGLPLAAKTLGGLLSMKLDEQYWESILDSEIWQLPQEENGIMPVLQ
LSYQHLPPHLKQCFAFCSLFPKDYKFSESELIGIWMAEGFIVPQGSTRME
ELGSNYFHELVNRSFIQESKSGRFIMHDLIHDLAELISAGESYRIEKGKS
HDIPSTIRHLSIYTDKEGMQTILTEFSHWNKLRTMMLTVERFPREDFNFV
CGVLEKLKNIHVLVLKNCSLRELPDGIDKLIHLRYLDLSNNKGIQRLPEL
LCDLYNLQTLILRFCDNLKSLPHGMMKLINLRKLYGVDRLISGITEIGKL
TSLQNLYSFKVTKDNGHKLPELNGLKQLRGKLRITNLENVENKDEANIAS
LKSKEHLNELVLEWTSIQESDSDINLHISEQVLEGLQPHHNLQRLTIRGY
NGARPPNWLHKQVYSRLESLHLENCKRWNDLSAIGQLSQLKSLSLVRTPV
QTKNIHKLFDPKVCKFFSQLENLVLEGITMLEDLPNLGQLPCLTYIRIQS
LLGVKKIDDKFFAMTEEGSCFPRLCTLQFTEMPAWEELYGSDDRNLFPCL
EGLYISNCQKLQMLPPLPPSIQQLKLNNVGLVDCPRFWKAFDECSSTTTS
VSLTYLSIQNCPNLTSLDQGLLPHHLFPCLVDLDISNCQKLQMLPPLPPS
IQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLDQG
LLPHHLFPCLEHLDISNCQKLQMLPPLPPSIQSLDLNDVGLVDCPRFWKA
IDECSSTTNYASLRYLFIQNCPNLTSLEPGLLPHHLQHIYIAKCEQLSWV
SVKRLKELASLCSLSIKECPKLMSMTRDEYIDFQLPPSIKELCLSDCENL
FKSLPGCLHNLTSLTSLSISKCPNLVSLPVEPSLRLIHPEIQDCNELRSV
EGLPIKNLKVLKIKGCPKLLLPQTEKLPLWKLEIDDTAFLKQPLIKNSLS
SVCELTISSSREAVMFEGEDQESLQSLTSLHLFCFSDCKNLQSLPAKLYT
LKSLRFLWIYNCPQIQSLPEKGLPPSLTDLEFKGCDPALEQQLVRHLAEI
NKSWLIPSSLRHLWWSDN
>XP_042434521.1 putative disease resistance protein RGA1 isoform X1 [Zingiber officinale]
MIGRFALTAFGWLAESIMGALVGKAVDRAVQQFGEQHGFEDDLEKLQDSL
DHARLTISTIERLRIKDEGQQKTLRKLLIRLKNSAYDADDLLDEFQYRIL
KQQIEQQGDEAGNRASSSSYSTPPPSKRTKTSFSSISTSGIFRKGDDDDD
VQRIRKIKGRLDDNSAALEKIYNSLGAEDDRGEKQLVSSASRQTSSFSTE
PRLVGRDKELQELKDLLLKPEVASEFGQSGVSVLSICGLGGIGKTTLAQE
VFNDSSVKEYFKLRIWVCVSENFCTDRLIREIIECATTEKCDLTNLDTLQ
RIVNEKITPERFLLVLDDVWNEDRHKWEILCAPLRSGKPGSKILVTTRSR
KIADMVSDVDAIHLQGLDEESFWDFFKKCAFGCSHSGAHHPHMEAMAKKM
TCKLKGLPLAAKTLGGLLSMKLDEQYWESILDSEIWQLPQEENGIMPVLQ
LSYQHLPPHLKQCFAFCSLFPKDYKFSESELIGIWMAEGFIVPQGSTRME
ELGSNYFHELVNRSFIQESKSGRFIMHDLIHDLAELISAGESYRIEKGKS
HDIPSTIRHLSIYTDKEGMQTILTEFSHWNKLRTMMLTVERFPREDFNFV
CGVLEKLKNIHVLVLKNCSLRELPDGIDKLIHLRYLDLSNNKGIQRLPEL
LCDLYNLQTLILRFCDNLKSLPHGMMKLINLRKLYGVDRLISGITEIGKL
TSLQNLYSFKVTKDNGHKLPELNGLKQLRGKLRITNLENVENKDEANIAS
LKSKEHLNELVLEWTSIQESDSDINLHISEQVLEGLQPHHNLQRLTIRGY
NGARPPNWLHKQVYSRLESLHLENCKRWNDLSAIGQLSQLKSLSLVRTPV
QTKNIHKLFDPKVCKFFSQLENLVLEGITMLEDLPNLGQLPCLTYIRIQS
LLGVKKIDDKFFAMTEEGSCFPRLCTLQFTEMPAWEELYGSDDRNLFPCL
EGLYISNCQKLQMLPPLPPSIQQLKLNNVGLVDCPRFWKAFDECSSTTTS
VSLTYLSIQNCPNLTSLDQGLLPHHLFPCLVDLDISNCQKLQMLPPLPPS
IQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLDQG
LLPHHLFPCLEHLDISNCQKLQMLPPLPPSIQSLDLNDVGLVDCPRFWKA
IDECSSTTNYASLRYLFIQNCPNLTSLEPGLLPHHLQHIYIAKCEQLSWV
SVKRLKELASLCSLSIKECPKLMSMTRDEYIDFQLPPSIKELCLSDCENL
FKSLPGCLHNLTSLTSLSISKCPNLVSLPVEPSLRLIHPEIQDCNELRSV
EGLPIKNLKVLKIKGCPKLLLPQTEKLPLWKLEIDDTAFLKQPLIKNSLS
SVCELTISSSREAVMFEGEDQESLQSLTSLHLFCFSDCKNLQSLPAKLYT
LKSLRFLWIYNCPQIQSLPEKGLPPSLTDLEFKGCDPALEQQLVRHLAEI
NKSWLIPSSLRHLWWSDN
>XP_042434522.1 putative disease resistance protein RGA3 isoform X2 [Zingiber officinale]
MIGRFALTAFGWLAESIMGALVGKAVDRAVQQFGEQHGFEDDLEKLQDSL
DHARLTISTIERLRIKDEGQQKTLRKLLIRLKNSAYDADDLLDEFQYRIL
KQQIEQQGDEAGNRASSSSYSTPPPSKRTKTSFSSISTSGIFRKGDDDDD
VQRIRKIKGRLDDNSAALEKIYNSLGAEDDRGEKQLVSSASRQTSSFSTE
PRLVGRDKELQELKDLLLKPEVASEFGQSGVSVLSICGLGGIGKTTLAQE
VFNDSSVKEYFKLRIWVCVSENFCTDRLIREIIECATTEKCDLTNLDTLQ
RIVNEKITPERFLLVLDDVWNEDRHKWEILCAPLRSGKPGSKILVTTRSR
KIADMVSDVDAIHLQGLDEESFWDFFKKCAFGCSHSGAHHPHMEAMAKKM
TCKLKGLPLAAKTLGGLLSMKLDEQYWESILDSEIWQLPQEENGIMPVLQ
LSYQHLPPHLKQCFAFCSLFPKDYKFSESELIGIWMAEGFIVPQGSTRME
ELGSNYFHELVNRSFIQESKSGRFIMHDLIHDLAELISAGESYRIEKGKS
HDIPSTIRHLSIYTDKEGMQTILTEFSHWNKLRTMMLTVERFPREDFNFV
CGVLEKLKNIHVLVLKNCSLRELPDGIDKLIHLRYLDLSNNKGIQRLPEL
LCDLYNLQTLILRFCDNLKSLPHGMMKLINLRKLYGVDRLISGITEIGKL
TSLQNLYSFKVTKDNGHKLPELNGLKQLRGKLRITNLENVENKDEANIAS
LKSKEHLNELVLEWTSIQESDSDINLHISEQVLEGLQPHHNLQRLTIRGY
NGARPPNWLHKQVYSRLESLHLENCKRWNDLSAIGQLSQLKSLSLVRTPV
QTKNIHKLFDPKVCKFFSQLENLVLEGITMLEDLPNLGQLPCLTYIRIQS
LLGVKKIDDKFFAMTEEGSCFPRLCTLQFTEMPAWEELYGSDDRNLFPCL
EGLYISNCQKLQMLPPLPPSIQQLKLNNVGLVDCPRFWKAIDECSSTTNY
ASLRYLFIQNCPNLTSLEPGLLPHHLQHIYIAKCEQLSWVSVKRLKELAS
LCSLSIKECPKLMSMTRDEYIDFQLPPSIKELCLSDCENLFKSLPGCLHN
LTSLTSLSISKCPNLVSLPVEPSLRLIHPEIQDCNELRSVEGLPIKNLKV
LKIKGCPKLLLPQTEKLPLWKLEIDDTAFLKQPLIKNSLSSVCELTISSS
REAVMFEGEDQESLQSLTSLHLFCFSDCKNLQSLPAKLYTLKSLRFLWIY
NCPQIQSLPEKGLPPSLTDLEFKGCDPALEQQLVRHLAEINKSWLIPSSL
RHLWWSDN
>XP_042436751.1 putative disease resistance protein RGA1, partial [Zingiber officinale]
PISNSIFRKGDDDDDDVQRIRKIKGRLDDYSAALEEIYSSLGAEDDRGKK
QLVSSTSRQTSSFSTEPQLFGRDKELQELKDLLFKPAVASEFGQSGVAVL
SIYGMGGIGKTTLAQEVFNDSSVKKYFKLRIWVCVSENFCTDRLTREIIE
YATKKKCDLTNFAALQVALKEKITPKRFLLVLDDVWNEDRHKWESLCAPL
RSGKPGSKILVTTRSRKIAKMVGDVDAIHLQGLDEESFWEFFKKCAFGCS
NSGFHHPHMEAMAKKMTCKLKGLPLAAKTLGGLLSMKLDEQYWESILDSE
IWQLPQEENGIMPVLQLSYQNLPPHLKQCFAFCSLFPKDYKFSESELIGI
WIAEGFIVPRGSTRMEELGSNYFHELVNRSFIQKSKDREFIMHDLIHDLA
ELVSLGESYRIEKGKSHNIPSTIRQLSIYIEEEGIETRLLTEFSHCDKLR
TLLLERFASMSFNFDCSVLERFKNIHVLVLKWCSLKELPDSIGKLIHLRY
LDLSNNEGIRWLPESLCDLYNLQTLILRYCFNLKCLPHGMMKLINLRNLY
GVDMFIPEITEIGKLTSLQNLHAFKVTKDNGHKLVELKGLNQLRGFLCIT
NLENVENKDEAHIASLKSKEHLDELVLEWTSLQESDSDVNLHISEQVLEG
LQPHHNLQRLTIRGYNGARPPNWLHEQVYSRLESLRLENYKRWNDLSAIG
QLSQLKSLSLVRIPVQTKNIHKLFDPKICKFFSQLENLVLEGITMLEDLP
NLGQLPCLTYICIQSLLGVKKIGDKFFAMTEEGSCFPRLRTLRFTEMPAW
EEFYGSDDRNLFPCLEYLHISKCQKLKMLPPLPPSIRSLDLNDVGLVDCP
RFWKAIDECSSTTNSASLTSLSIQNCQI
>XP_042436844.1 disease resistance protein RPS2-like [Zingiber officinale]
MYFSGISQALGCLKDCTSDSCNYVVSYEDNLSSLAGEVSQLKSKSEDVKR
EVEATMRQGLTTRNEVLGWLRAVEGVAGEADQIRAKYERMIKCFCRFPAN
ICTSVKLRRRAEAALASARELKQRDLPEVVHRHNLVRFIRMQNQQTAGVE
KAFEELRRHARDDGVTCIGIHGMGGVGKSALLREFNNYLENELEYLDIII
FLESSTEHKVEELHKFLFARLNLTWQNGVSQMDRAANIFRVLSHLKFVLI
VDNLWEPLDYRAVGIPFPEPESRCKIIVASRIEDVCSHMRMERMIRMERI
EEEAAWELFRFNARLEPNDADERIIRIAKVMARKCGGLPAALVVVAQTMA
NKKTVQEWMHAVNLMRDAPFQLPGMEERVLYPLKLSYDRLLTDRDRLCAS
YFSLVPEGCLVDNYFIRKLWIGEGIIDDFNNVWESANETHYLLGMLSSSS
LIQRIDGKSYASEKPIESDRFKMHPMTRAMILWVGRACGKKGSKWLAHYG
DGLAEAPTAEKWRVAERVALGQNKIRALPEAPQAPDLIYLDLGYNDLLVK
IPNGFFSRMPKLKILDLQDNPIEDFPVGICNLALLQFLTLSGTKITSLPR
ELGALVNLRYLACSSTTRLKRIPDQLMSRLQELRWLKMCDGYNQWRAAPS
EEEEAYLEELEVLTKLKVLGIAISTETSLRRLFESQRLTTSVHWLQVEDC
RGLTRLDIPSTEFPQESMPNIMELRVHAMNELEEFAIQGTALANLMELHL
SHLPKASLVCRAVGCLGSLRTLRIENCKEIARLIQLDAGTNDGEEIAIFP
ALKRIVLKRLPKFESFSDESRTLTFSSLESIEIEECPKLTRINLCCGKLK
SVRSERAWWDELEWEDDLTKLSFENLFKPL
>XP_042436888.1 putative disease resistance protein RGA3 [Zingiber officinale]
MATISQLRHILMKILPAPEMVAQGKAFRISNHLEMIQDCLWAINSFLMDA
ALRVLTEHNVEEWMEDVGVVDWMKDVGVAVEDVDSLLKRILDYWEPNEQD
EAKKKKKMSNFFHPLVNINNNIQSTSSRQAILVELKETACLLNYLVKRGT
ALGLWAEMMDSMDPCHDDYAAILSKETMGRQEDEDQIIELLRQQHCDEDG
NVPFIIDIRGEEFSGRTTLARKIYHHPWVRQHFQHRIWLDASSFREFNSK
MIAKEIARLLTGKACANINCWPLIIEHLRGDRYLLILDDADVPNVFRYKW
EEFKLNLLHCGAPGSRVILARHTFAGNPYGGYGIEFNVKKYKLKELPEDA
WVRILLRYATFAHSTEGNNNIHKEKASPSATTNMLIPLAKKCRLDHWHRD
RNLLIAKGVGLMFRWKDRNEWQELPDQLYRFEILHCYFLLVHQQYGSFEN
IRPSLYNLLLGESEAESFGEAESYGEDVLYMLIAEGILTNTRLTRNIQYI
GSEFNLDPCFFRMKVSEDSSIPPQCRHLYLPIHSKNVSKSKKAIEKAGVA
NKLRTLVLHREEEKGHTYHIETKKFEGMFLNLTCLCTLHMRAIMIQDLPI
TICTLHCLRYLNLAENKIETLPESLCNLSNLCVLILSLCKKLKELPRQIY
KLRKLQILKLSYCQRIQKLPESITRLMNLKELDVGGCCWLSKLPDDLSDM
KNLVQLNMLGCASLTRMPGGIRQLTNLEVLCGYDAIDGLGNAMLSELRDL
TNLESLHIQHLERLVSAEAKEPNDITAPPTILQENQHVNELMLHWEWWND
MVAEETFEPTLQLTQGFHRNIEELKILRIVSYMSIKLPGWLIREESTSVL
NKLTTVHLVNLRRCERLPSLGNLPNLKELAISGFDSIRLIDDDFYGEGSS
ALFPGLRRLTFSQMPRLEKWDPPSYFKEKSYQFRDRTFHFLEELTLIQCP
KFREFHMPICVSHTSRSSLKVWLSNEMLMPTSKFNDWGNLCGIQSLQIFG
CQELRSLPDGLKTLLYLDTLVIINCNKLEALPIWLEQSRLESLCVYGCPA
LSIIPEGLKVTGRLRNLIVEACACPKLHSQVGSAQQTLLLSILYLLTLLF
QFRGHKVKMREHHQSSTPTFEELYDFLSYYSVASK
>XP_042436889.1 putative disease resistance protein RGA1 [Zingiber officinale]
MSMLTAVQLRHILMKILPAPEMVAQGKAFRISNHLEMVRDSLWAINSFLM
DSTCWVGEFEPPDVTDWMKDVGVAVEDVDNLLKRILDYWEPNEENEAEKK
MKTNNFLHPLVNNNIRSTSNRRSILLELKQTACLLNYLVKGGIALGLRME
MMDSMDPNHDDYAAILNEEVIGRDEDEDQIIDLLQQQQCDKDGNVPFIVA
IRGSDRCGKTTLARKIYHHTWVRQHFQHRIWLDASSFEDFNSSMIAKEIA
RLLTRKPCMNVDCWPLINEHLYGERYLLVLDDVYVSDDLEYKWEELKMNL
LHCGAPGSKVIVTEYPYLVYERGFNVKEYELNQLPEDAWIRLLLRYATFV
HPIEDNNSIHKEKYPPIEWRQHSFLRNCLGAKYIGLMFRWRDTNQWQELA
DQFDASPYNSIVWMHSKYWSIEVTQTFLYELLFEGSSDESYREEDVLHML
VAEGTLTNTRRKRSLEYMTPYTRPPADLEYKSDFNLDLCFFRMKVGEVSS
IPPQCRHLSLLMDSKNILRSKTAIEKAGVANKLRSLALHREENKEPICQI
ETKILEEVAGVNHSPREFENFRCWRLLLAFEIV
>XP_042437454.1 probable disease resistance protein At5g63020 isoform X1 [Zingiber officinale]
MGFLCKFWCSWTPMILFSAAPWDCAILRHQDIVGLPLCFIYGWSLQFLWP
LPHPSGFLDSLAVEIHELKSKRDDIERDVSRARRVGKEPRSQVLWWLDRV
ELLETKFAKTRREFERRFMLPGGFAVNILSSYRLSVRANEMIAEACYLKS
KGSFNQVANRAAPNHFEEVPSAPTVGMDAVLAQLKQAVEDDAVGLIGIYG
MGGVGKTALLSRFHNEFLADATDLDMVIFIDSCRDLDVESIQNKIRHRLG
LSWKKSKSQKEKASMLYKVLFKMKFVLILDDLWEPLSLQMVGIPIPKQGS
SCKIMLATRIEELCDQMDVKNKIKVDLLPWDTAWRLFADKVGEETINSDP
GIRHQAEILVKKCGGLPVALITVARALASKRSVDEWKHAVTIMGNSPVQL
PGMAEQVFCSLKLSYDHLPSDTLRSCAMHFALYWEGCRLHKNLIQEYWIG
EGILDDFKDVEQANNKACYFLGILSSASLIERVDADGYTRMHPMVRAMAL
WIACEFGKKENQWFVREREGLMEAPEAETWRSAARMALGYNSITVLPEAP
ESLNLVSLKLKSNFGLERIPDGFFRFMPCLVALDLHSTSIKEIPSGISNL
QRLQFLELGGTKLKSLPKELASLKNLKYLGLNWTAELASIPERLIQSLSE
LRVLRMIVSYSSWKAIPAGGGNGVSLRELEALKRLRVLDITVGNASAFNM
LTQSQRLAPATAALLLKGCPGLTAVELPSGLGRSMKSLKWLRLSHSTELE
GVLIAGDGRENDGAALPELENLVLECLLKAKIVWRSSCIQHLRGLYIYGC
SGMEQLIWYKDDDESDAENRGRRGVSPFPNLKQIAFRGLPKLKRVSDERQ
LVFPLLESIEVAECPQLKKLNLVAEKLREIRCHRSWWDQLEWEDDAARFS
PQMILKPLN
>XP_042437455.1 probable disease resistance protein At5g63020 isoform X2 [Zingiber officinale]
MDINGFLVQVLVFLDTNDTVFCCSMGLCNPSPPGFLDSLAVEIHELKSKR
DDIERDVSRARRVGKEPRSQVLWWLDRVELLETKFAKTRREFERRFMLPG
GFAVNILSSYRLSVRANEMIAEACYLKSKGSFNQVANRAAPNHFEEVPSA
PTVGMDAVLAQLKQAVEDDAVGLIGIYGMGGVGKTALLSRFHNEFLADAT
DLDMVIFIDSCRDLDVESIQNKIRHRLGLSWKKSKSQKEKASMLYKVLFK
MKFVLILDDLWEPLSLQMVGIPIPKQGSSCKIMLATRIEELCDQMDVKNK
IKVDLLPWDTAWRLFADKVGEETINSDPGIRHQAEILVKKCGGLPVALIT
VARALASKRSVDEWKHAVTIMGNSPVQLPGMAEQVFCSLKLSYDHLPSDT
LRSCAMHFALYWEGCRLHKNLIQEYWIGEGILDDFKDVEQANNKACYFLG
ILSSASLIERVDADGYTRMHPMVRAMALWIACEFGKKENQWFVREREGLM
EAPEAETWRSAARMALGYNSITVLPEAPESLNLVSLKLKSNFGLERIPDG
FFRFMPCLVALDLHSTSIKEIPSGISNLQRLQFLELGGTKLKSLPKELAS
LKNLKYLGLNWTAELASIPERLIQSLSELRVLRMIVSYSSWKAIPAGGGN
GVSLRELEALKRLRVLDITVGNASAFNMLTQSQRLAPATAALLLKGCPGL
TAVELPSGLGRSMKSLKWLRLSHSTELEGVLIAGDGRENDGAALPELENL
VLECLLKAKIVWRSSCIQHLRGLYIYGCSGMEQLIWYKDDDESDAENRGR
RGVSPFPNLKQIAFRGLPKLKRVSDERQLVFPLLESIEVAECPQLKKLNL
VAEKLREIRCHRSWWDQLEWEDDAARFSPQMILKPLN
>XP_042437544.1 disease resistance protein RPS2-like [Zingiber officinale]
MDDVSRASNDTIFHRARQLKAERSKRGGRKAKKWFCKIVPSIEGCAKPPD
ADPPMSFLDGPSRQQQQQQQKKKRSSRGGCSCCCLSSCLCGGKADERTPR
TSKKQIPAAEIRLREAGAVFDELPTRNTRDAVNVVVNEVVTARRSKPADH
VFDALSPKKPVEENTNLAERLPPPSKGHVSAASMVLPERLPPGPARDLPV
PNPIMGQEVCLKTALSYLTDDAIGIMGIYGTGGVGKTTLLRSINNKFCGN
AARTEFDHVILVAVGKDPDVKKLQRDIAYEVGLLLMDDESEVTRAAAIFD
FLKTKNFLLLLDDLWGPLQLAKVGIPHPLSDGYKQKVIISSRLMDVSGKM
QAHKFLILECLKWEEAWNLFSSKVGEENLADQRIRSIAVALAKECGGLPL
ALVAMGSAMSTKKTPEEWQKAVSLLKTAPPLHEISGYQMLKENLIRSWMG
LGSITDFDDINEAYNIGYSIIESLKAVSLMENSEKSYRRMEMHDVIREMA
LWTASGKESNKNKWLVGAKPSETRSDEWSKAERISLMFNEIEALPDSCYC
PNLQSLILRGNKRLMKIPNGLFPCMVLLRFLDLSHTGIVELPNEVGTLIN
LQFLNLSYTKIACLPKEMKELTTLKYLELEGTRELRKIPDGVISSLEMLK
ELNLYMSGFANWSWLSVCSRDSIRFEELVSLQRLRSVGFTVRSIQCLLRL
FSILRVLTHSLTIRELRGLISLRLLPGLLSKNKMGRLKNLTIEFSQGLKE
LVMGEEAKTLNWRLYQLEVFNLVCLPELERVIWRGVAAHVCLPNLRFLSL
FYCNSLRNIAWVAHLPLLQELYIQNCNEMEQVIADEPPTASSEKEEKPAT
SFPNLKYIFLRDLKSLVKIDDQVLEFPCLERILVHNCIELKQLPLGATSA
QKLRIIFGERNWWESLEWGDHSIKPIFTTCFREIPAGYEPSMKILEGL
>XP_042438090.1 putative disease resistance protein RGA1 [Zingiber officinale]
MIGRFALTAFGWLAESIVGVLVGKAVDRAVQQFGEQHGVEDDLKKLKDSL
ANAKLKISTIENLWLKDEFLQQRVKDLLIDLKNAAYDADDLLDEFQYRIL
KQQIEQQGDEAGKRASSSSYSAPPPSKRTKTSIASCTSGLFRKGDDDDDN
NNVQKIRKIKGSLDDYSAALEEIYSSLGAEDDRGKQQLVSSASRQTSSFS
TEPQLFGRDKELQELKDLLFKPAVASEFGQSGVSVLSIYGMGGIGKTTLA
QEVFNDSSVKEYFKLRIWVCVSENFCTDRLTREIIECATTEKCDLTNLDT
LQKIVNEKITPERFLLVLDDVWNEDRHKWESLCAPLRSGKPGSKILVTTR
SRKIADMVSDADAIHLQGLDVESFWDFFKKCAFGCSHSGAHHPHMEAMAK
KMTCKLKGLPLAAKTLGGLLSVKLDEQYWESILDSEIWQLPQEENGIMPV
LQLSYQHLPPHLKQCFAFCSLFPKGYKFSESDLIGIWIAEGFIVPRGSTR
MEELGSNYFHELVNRSFIQESKYGEWIMHDLIHDLAELISAGESYRIEKG
KSHDIPSTIRHLSIYTDKEGMQTILTEFSHWNKLRTMMLTVERFPREDFN
FDCGVLEKLKNIHVLVLNNCSLRELPDGIDKLIHLRYLDLSYNEGIQRLP
ELLCDLYNLQTLILGFCDNLKSLPHGMMKLINLRKLYGVDRLISGITEIG
KLTSLQNLYSFKVTKDNGHKLVELNGLKQLRGFLCITNLENVKNKDEANI
ASLKSKEYLDVLELEWTSLQESDSDVNLHISEQVLEGLQPHHNLQRLIIK
GYNGARPPNWLHKQVYSRLGSLHLENCKRWNDLSAIGQLSQLKFLYLVRT
PIQTKNIHKLFNPKVCKFFSQLEELVLEGITMLEDLPNLGQLPCLTFIRI
QSLPGVKKIGDKFFAMTEEGSCFPRLRTLRFIEMPAWEELYGSDDRNLFP
CLEDLYISNCQKLQMLPPLPPSIQQLKLNNVGLVDCPRFWKAFDEGSSTT
NSASLTYLSIQNCPNLTSLDQGLLPHHLFPCLVNLDISNCQKLQMLPPLP
PSIQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLD
QGLLPHHLFPCLVNLDISNCQKLQMLPPLPPSIQQLKLNNVGLVDCPRFW
KAFDEGSSTTNSASLTYLSIQNCPNLTSLEPVLLPHHHHLQKIHLKKCEQ
LSWVPVKRLKELTSLWSLSLKDCPKLMGMSTPDEYIDFQLPPSITELCLS
DCENLFKSLPGCLHNLTSLTSLSVSKCPNLVSLPVEPSLRLTRLEIQNCN
ELRSVEGLPIKNLEVLKIKGCPKLLLPQTEKLPLLKLEIDDTAFMKQPLI
KNSLSSVRGLTISSSREAVMFEGEDQESLQSLTSLYSFCFSDCKNLQTLP
AKLYTLKSLRFLQIHNCPQIQSLPEKGLPPSLAHINFEGCDQALEQQLVR
HLAEINKS
>XP_042438091.1 putative disease resistance protein RGA1 [Zingiber officinale]
MIGRFALTAFGWLAESIVGVLVGKAVDRAVQQFGEQHGVEDDLKKLKDSL
ANAKLKISTIENLWLKDEFLQQRVKDLLIDLKNAAYDADDLLDEFQYRIL
KQQIEQQGDEAGKRASSSSYSAPPPSKRTKTSIASCTSGLFRKGDDDDDN
NNVQKIRKIKGSLDDYSAALEEIYSSLGAEDDRGKQQLVSSASRQTSSFS
TEPQLFGRDKELQELKDLLFKPAVASEFGQSGVSVLSIYGMGGIGKTTLA
QEVFNDSSVKEYFKLRIWVCVSENFCTDRLTREIIECATTEKCDLTNLDT
LQKIVNEKITPERFLLVLDDVWNEDRHKWESLCAPLRSGKPGSKILVTTR
SRKIADMVSDADAIHLQGLDVESFWDFFKKCAFGCSHSGAHHPHMEAMAK
KMTCKLKGLPLAAKTLGGLLSVKLDEQYWESILDSEIWQLPQEENGIMPV
LQLSYQHLPPHLKQCFAFCSLFPKGYKFSESDLIGIWIAEGFIVPRGSTR
MEELGSNYFHELVNRSFIQESKYGEWIMHDLIHDLAELISAGESYRIEKG
KSHDIPSTIRHLSIYTDKEGMQTILTEFSHWNKLRTMMLTVERFPREDFN
FDCGVLEKLKNIHVLVLNNCSLRELPDGIDKLIHLRYLDLSYNEGIQRLP
ELLCDLYNLQTLILGFCDNLKSLPHGMMKLINLRKLYGVDRLISGITEIG
KLTSLQNLYSFKVTKDNGHKLVELNGLKQLRGFLCITNLENVKNKDEANI
ASLKSKEYLDVLELEWTSLQESDSDVNLHISEQVLEGLQPHHNLQRLIIK
GYNGARPPNWLHKQVYSRLGSLHLENCKRWNDLSAIGQLSQLKFLYLVRT
PIQTKNIHKLFNPKVCKFFSQLEELVLEGITMLEDLPNLGQLPCLTFIRI
QSLPGVKKIGDKFFAMTEEGSCFPRLRTLRFIEMPAWEELYGSDDRNLFP
CLEDLYISNCQKLQMLPPLPPSIQQLKLNNVGLVDCPRFWKAFDEGSSTT
NSASLTYLSIQNCPNLTSLDQGLLPHHLFPCLVNLDISNCQKLQMLPPLP
PSIQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLD
QGLLPHHLFPCLVNLDISNCQKLQMLPPLPPSIQQLKLNNVGLVDCPRFW
KAFDEGSSTTNSASLTYLSIQNCPNLTSLEPVLLPHHHHLQKIHLKKCEQ
LSWVPVKRLKELTSLWSLSLKDCPKLMGMSTPDEYIDFQLPPSITELCLS
DCENLFKSLPGCLHNLTSLTSLSVSKCPNLVSLPVEPSLRLTRLEIQNCN
ELRSVEGLPIKNLEVLKIKGCPKLLLPQTEKLPLLKLEIDDTAFMKQPLI
KNSLSSVRGLTISSSREAVMFEGEDQESLQSLTSLYSFCFSDCKNLQTLP
AKLYTLKSLRFLQIHNCPQIQSLPEKGLPPSLAHINFEGCDQALEQQLVR
HLAEINKS
>XP_042438092.1 putative disease resistance protein RGA1 [Zingiber officinale]
MIGRFALTAFGWLAESIVGVLVGKAVDRAVQQFGEQHGVEDDLKKLKDSL
ANAKLKISTIENLWLKDEFLQQRVKDLLIDLKNAAYDADDLLDEFQYRIL
KQQIEQQGDEAGKRASSSSYSAPPPSKRTKTSIASCTSGLFRKGDDDDDN
NNVQKIRKIKGSLDDYSAALEEIYSSLGAEDDRGKQQLVSSASRQTSSFS
TEPQLFGRDKELQELKDLLFKPAVASEFGQSGVSVLSIYGMGGIGKTTLA
QEVFNDSSVKEYFKLRIWVCVSENFCTDRLTREIIECATTEKCDLTNLDT
LQKIVNEKITPERFLLVLDDVWNEDRHKWESLCAPLRSGKPGSKILVTTR
SRKIADMVSDADAIHLQGLDVESFWDFFKKCAFGCSHSGAHHPHMEAMAK
KMTCKLKGLPLAAKTLGGLLSVKLDEQYWESILDSEIWQLPQEENGIMPV
LQLSYQHLPPHLKQCFAFCSLFPKGYKFSESDLIGIWIAEGFIVPRGSTR
MEELGSNYFHELVNRSFIQESKYGEWIMHDLIHDLAELISAGESYRIEKG
KSHDIPSTIRHLSIYTDKEGMQTILTEFSHWNKLRTMMLTVERFPREDFN
FDCGVLEKLKNIHVLVLNNCSLRELPDGIDKLIHLRYLDLSYNEGIQRLP
ELLCDLYNLQTLILGFCDNLKSLPHGMMKLINLRKLYGVDRLISGITEIG
KLTSLQNLYSFKVTKDNGHKLVELNGLKQLRGFLCITNLENVKNKDEANI
ASLKSKEYLDVLELEWTSLQESDSDVNLHISEQVLEGLQPHHNLQRLIIK
GYNGARPPNWLHKQVYSRLGSLHLENCKRWNDLSAIGQLSQLKFLYLVRT
PIQTKNIHKLFNPKVCKFFSQLEELVLEGITMLEDLPNLGQLPCLTFIRI
QSLPGVKKIGDKFFAMTEEGSCFPRLRTLRFIEMPAWEELYGSDDRNLFP
CLEDLYISNCQKLQMLPPLPPSIQQLKLNNVGLVDCPRFWKAFDEGSSTT
NSASLTYLSIQNCPNLTSLDQGLLPHHLFPCLVNLDISNCQKLQMLPPLP
PSIQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLD
QGLLPHHLFPCLVNLDISNCQKLQMLPPLPPSIQQLKLNNVGLVDCPRFW
KAFDEGSSTTNSASLTYLSIQNCPNLTSLEPVLLPHHHHLQKIHLKKCEQ
LSWVPVKRLKELTSLWSLSLKDCPKLMGMSTPDEYIDFQLPPSITELCLS
DCENLFKSLPGCLHNLTSLTSLSVSKCPNLVSLPVEPSLRLTRLEIQNCN
ELRSVEGLPIKNLEVLKIKGCPKLLLPQTEKLPLLKLEIDDTAFMKQPLI
KNSLSSVRGLTISSSREAVMFEGEDQESLQSLTSLYSFCFSDCKNLQTLP
AKLYTLKSLRFLQIHNCPQIQSLPEKGLPPSLAHINFEGCDQALEQQLVR
HLAEINKS
>XP_042438093.1 putative disease resistance protein RGA1 [Zingiber officinale]
MIGRFALTAFGWLAESIVGVLVGKAVDRAVQQFGEQHGVEDDLKKLKDSL
ANAKLKISTIENLWLKDEFLQQRVKDLLIDLKNAAYDADDLLDEFQYRIL
KQQIEQQGDEAGKRASSSSYSAPPPSKRTKTSIASCTSGLFRKGDDDDDN
NNVQKIRKIKGSLDDYSAALEEIYSSLGAEDDRGKQQLVSSASRQTSSFS
TEPQLFGRDKELQELKDLLFKPAVASEFGQSGVSVLSIYGMGGIGKTTLA
QEVFNDSSVKEYFKLRIWVCVSENFCTDRLTREIIECATTEKCDLTNLDT
LQKIVNEKITPERFLLVLDDVWNEDRHKWESLCAPLRSGKPGSKILVTTR
SRKIADMVSDADAIHLQGLDVESFWDFFKKCAFGCSHSGAHHPHMEAMAK
KMTCKLKGLPLAAKTLGGLLSVKLDEQYWESILDSEIWQLPQEENGIMPV
LQLSYQHLPPHLKQCFAFCSLFPKGYKFSESDLIGIWIAEGFIVPRGSTR
MEELGSNYFHELVNRSFIQESKYGEWIMHDLIHDLAELISAGESYRIEKG
KSHDIPSTIRHLSIYTDKEGMQTILTEFSHWNKLRTMMLTVERFPREDFN
FDCGVLEKLKNIHVLVLNNCSLRELPDGIDKLIHLRYLDLSYNEGIQRLP
ELLCDLYNLQTLILGFCDNLKSLPHGMMKLINLRKLYGVDRLISGITEIG
KLTSLQNLYSFKVTKDNGHKLVELNGLKQLRGFLCITNLENVKNKDEANI
ASLKSKEYLDVLELEWTSLQESDSDVNLHISEQVLEGLQPHHNLQRLIIK
GYNGARPPNWLHKQVYSRLGSLHLENCKRWNDLSAIGQLSQLKFLYLVRT
PIQTKNIHKLFNPKVCKFFSQLEELVLEGITMLEDLPNLGQLPCLTFIRI
QSLPGVKKIGDKFFAMTEEGSCFPRLRTLRFIEMPAWEELYGSDDRNLFP
CLEDLYISNCQKLQMLPPLPPSIQQLKLNNVGLVDCPRFWKAFDEGSSTT
NSASLTYLSIQNCPNLTSLDQGLLPHHLFPCLVNLDISNCQKLQMLPPLP
PSIQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLD
QGLLPHHLFPCLVNLDISNCQKLQMLPPLPPSIQQLKLNNVGLVDCPRFW
KAFDEGSSTTNSASLTYLSIQNCPNLTSLEPVLLPHHHHLQKIHLKKCEQ
LSWVPVKRLKELTSLWSLSLKDCPKLMGMSTPDEYIDFQLPPSITELCLS
DCENLFKSLPGCLHNLTSLTSLSVSKCPNLVSLPVEPSLRLTRLEIQNCN
ELRSVEGLPIKNLEVLKIKGCPKLLLPQTEKLPLLKLEIDDTAFMKQPLI
KNSLSSVRGLTISSSREAVMFEGEDQESLQSLTSLYSFCFSDCKNLQTLP
AKLYTLKSLRFLQIHNCPQIQSLPEKGLPPSLAHINFEGCDQALEQQLVR
HLAEINKS
>XP_042438094.1 putative disease resistance protein RGA1 [Zingiber officinale]
MIGRFALTAFGWLAESIVGVLVGKAVDRAVQQFGEQHGVEDDLKKLKDSL
ANAKLKISTIENLWLKDEFLQQRVKDLLIDLKNAAYDADDLLDEFQYRIL
KQQIEQQGDEAGKRASSSSYSAPPPSKRTKTSIASCTSGLFRKGDDDDDN
NNVQKIRKIKGSLDDYSAALEEIYSSLGAEDDRGKQQLVSSASRQTSSFS
TEPQLFGRDKELQELKDLLFKPAVASEFGQSGVSVLSIYGMGGIGKTTLA
QEVFNDSSVKEYFKLRIWVCVSENFCTDRLTREIIECATTEKCDLTNLDT
LQKIVNEKITPERFLLVLDDVWNEDRHKWESLCAPLRSGKPGSKILVTTR
SRKIADMVSDADAIHLQGLDVESFWDFFKKCAFGCSHSGAHHPHMEAMAK
KMTCKLKGLPLAAKTLGGLLSVKLDEQYWESILDSEIWQLPQEENGIMPV
LQLSYQHLPPHLKQCFAFCSLFPKGYKFSESDLIGIWIAEGFIVPRGSTR
MEELGSNYFHELVNRSFIQESKYGEWIMHDLIHDLAELISAGESYRIEKG
KSHDIPSTIRHLSIYTDKEGMQTILTEFSHWNKLRTMMLTVERFPREDFN
FDCGVLEKLKNIHVLVLNNCSLRELPDGIDKLIHLRYLDLSYNEGIQRLP
ELLCDLYNLQTLILGFCDNLKSLPHGMMKLINLRKLYGVDRLISGITEIG
KLTSLQNLYSFKVTKDNGHKLVELNGLKQLRGFLCITNLENVKNKDEANI
ASLKSKEYLDVLELEWTSLQESDSDVNLHISEQVLEGLQPHHNLQRLIIK
GYNGARPPNWLHKQVYSRLGSLHLENCKRWNDLSAIGQLSQLKFLYLVRT
PIQTKNIHKLFNPKVCKFFSQLEELVLEGITMLEDLPNLGQLPCLTFIRI
QSLPGVKKIGDKFFAMTEEGSCFPRLRTLRFIEMPAWEELYGSDDRNLFP
CLEDLYISNCQKLQMLPPLPPSIQQLKLNNVGLVDCPRFWKAFDEGSSTT
NSASLTYLSIQNCPNLTSLDQGLLPHHLFPCLVNLDISNCQKLQMLPPLP
PSIQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLD
QGLLPHHLFPCLVNLDISNCQKLQMLPPLPPSIQQLKLNNVGLVDCPRFW
KAFDEGSSTTNSASLTYLSIQNCPNLTSLEPVLLPHHHHLQKIHLKKCEQ
LSWVPVKRLKELTSLWSLSLKDCPKLMGMSTPDEYIDFQLPPSITELCLS
DCENLFKSLPGCLHNLTSLTSLSVSKCPNLVSLPVEPSLRLTRLEIQNCN
ELRSVEGLPIKNLEVLKIKGCPKLLLPQTEKLPLLKLEIDDTAFMKQPLI
KNSLSSVRGLTISSSREAVMFEGEDQESLQSLTSLYSFCFSDCKNLQTLP
AKLYTLKSLRFLQIHNCPQIQSLPEKGLPPSLAHINFEGCDQALEQQLVR
HLAEINKS
>XP_042438096.1 putative disease resistance protein RGA1 [Zingiber officinale]
MIGRFALTAFGWLAESIVGVLVGKAVDRAVQQFGEQHGVEDDLKKLKDSL
ANAKLKISTIENLWLKDEFLQQRVKDLLIDLKNAAYDADDLLDEFQYRIL
KQQIEQQGDEAGKRASSSSYSAPPPSKRTKTSIASCTSGLFRKGDDDDDN
NNVQKIRKIKGSLDDYSAALEEIYSSLGAEDDRGKQQLVSSASRQTSSFS
TEPQLFGRDKELQELKDLLFKPAVASEFGQSGVSVLSIYGMGGIGKTTLA
QEVFNDSSVKEYFKLRIWVCVSENFCTDRLTREIIECATTEKCDLTNLDT
LQKIVNEKITPERFLLVLDDVWNEDRHKWESLCAPLRSGKPGSKILVTTR
SRKIADMVSDADAIHLQGLDVESFWDFFKKCAFGCSHSGAHHPHMEAMAK
KMTCKLKGLPLAAKTLGGLLSVKLDEQYWESILDSEIWQLPQEENGIMPV
LQLSYQHLPPHLKQCFAFCSLFPKGYKFSESDLIGIWIAEGFIVPRGSTR
MEELGSNYFHELVNRSFIQESKYGEWIMHDLIHDLAELISAGESYRIEKG
KSHDIPSTIRHLSIYTDKEGMQTILTEFSHWNKLRTMMLTVERFPREDFN
FDCGVLEKLKNIHVLVLNNCSLRELPDGIDKLIHLRYLDLSYNEGIQRLP
ELLCDLYNLQTLILGFCDNLKSLPHGMMKLINLRKLYGVDRLISGITEIG
KLTSLQNLYSFKVTKDNGHKLVELNGLKQLRGFLCITNLENVKNKDEANI
ASLKSKEYLDVLELEWTSLQESDSDVNLHISEQVLEGLQPHHNLQRLIIK
GYNGARPPNWLHKQVYSRLGSLHLENCKRWNDLSAIGQLSQLKFLYLVRT
PIQTKNIHKLFNPKVCKFFSQLEELVLEGITMLEDLPNLGQLPCLTFIRI
QSLPGVKKIGDKFFAMTEEGSCFPRLRTLRFIEMPAWEELYGSDDRNLFP
CLEDLYISNCQKLQMLPPLPPSIQQLKLNNVGLVDCPRFWKAFDEGSSTT
NSASLTYLSIQNCPNLTSLDQGLLPHHLFPCLVNLDISNCQKLQMLPPLP
PSIQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLD
QGLLPHHLFPCLVNLDISNCQKLQMLPPLPPSIQQLKLNNVGLVDCPRFW
KAFDEGSSTTNSASLTYLSIQNCPNLTSLEPVLLPHHHHLQKIHLKKCEQ
LSWVPVKRLKELTSLWSLSLKDCPKLMGMSTPDEYIDFQLPPSITELCLS
DCENLFKSLPGCLHNLTSLTSLSVSKCPNLVSLPVEPSLRLTRLEIQNCN
ELRSVEGLPIKNLEVLKIKGCPKLLLPQTEKLPLLKLEIDDTAFMKQPLI
KNSLSSVRGLTISSSREAVMFEGEDQESLQSLTSLYSFCFSDCKNLQTLP
AKLYTLKSLRFLQIHNCPQIQSLPEKGLPPSLAHINFEGCDQALEQQLVR
HLAEINKS
>XP_042438097.1 putative disease resistance protein RGA1 [Zingiber officinale]
MIGRFALTAFGWLAESIVGVLVGKAVDRAVQQFGEQHGVEDDLKKLKDSL
ANAKLKISTIENLWLKDEFLQQRVKDLLIDLKNAAYDADDLLDEFQYRIL
KQQIEQQGDEAGKRASSSSYSAPPPSKRTKTSIASCTSGLFRKGDDDDDN
NNVQKIRKIKGSLDDYSAALEEIYSSLGAEDDRGKQQLVSSASRQTSSFS
TEPQLFGRDKELQELKDLLFKPAVASEFGQSGVSVLSIYGMGGIGKTTLA
QEVFNDSSVKEYFKLRIWVCVSENFCTDRLTREIIECATTEKCDLTNLDT
LQKIVNEKITPERFLLVLDDVWNEDRHKWESLCAPLRSGKPGSKILVTTR
SRKIADMVSDADAIHLQGLDVESFWDFFKKCAFGCSHSGAHHPHMEAMAK
KMTCKLKGLPLAAKTLGGLLSVKLDEQYWESILDSEIWQLPQEENGIMPV
LQLSYQHLPPHLKQCFAFCSLFPKGYKFSESDLIGIWIAEGFIVPRGSTR
MEELGSNYFHELVNRSFIQESKYGEWIMHDLIHDLAELISAGESYRIEKG
KSHDIPSTIRHLSIYTDKEGMQTILTEFSHWNKLRTMMLTVERFPREDFN
FDCGVLEKLKNIHVLVLNNCSLRELPDGIDKLIHLRYLDLSYNEGIQRLP
ELLCDLYNLQTLILGFCDNLKSLPHGMMKLINLRKLYGVDRLISGITEIG
KLTSLQNLYSFKVTKDNGHKLVELNGLKQLRGFLCITNLENVKNKDEANI
ASLKSKEYLDVLELEWTSLQESDSDVNLHISEQVLEGLQPHHNLQRLIIK
GYNGARPPNWLHKQVYSRLGSLHLENCKRWNDLSAIGQLSQLKFLYLVRT
PIQTKNIHKLFNPKVCKFFSQLEELVLEGITMLEDLPNLGQLPCLTFIRI
QSLPGVKKIGDKFFAMTEEGSCFPRLRTLRFIEMPAWEELYGSDDRNLFP
CLEDLYISNCQKLQMLPPLPPSIQQLKLNNVGLVDCPRFWKAFDEGSSTT
NSASLTYLSIQNCPNLTSLDQGLLPHHLFPCLVNLDISNCQKLQMLPPLP
PSIQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLD
QGLLPHHLFPCLVNLDISNCQKLQMLPPLPPSIQQLKLNNVGLVDCPRFW
KAFDEGSSTTNSASLTYLSIQNCPNLTSLEPVLLPHHHHLQKIHLKKCEQ
LSWVPVKRLKELTSLWSLSLKDCPKLMGMSTPDEYIDFQLPPSITELCLS
DCENLFKSLPGCLHNLTSLTSLSVSKCPNLVSLPVEPSLRLTRLEIQNCN
ELRSVEGLPIKNLEVLKIKGCPKLLLPQTEKLPLLKLEIDDTAFMKQPLI
KNSLSSVRGLTISSSREAVMFEGEDQESLQSLTSLYSFCFSDCKNLQTLP
AKLYTLKSLRFLQIHNCPQIQSLPEKGLPPSLAHINFEGCDQALEQQLVR
HLAEINKS
>XP_042438098.1 putative disease resistance protein RGA1 [Zingiber officinale]
MIGRFALTAFGWLAESIVGVLVGKAVDRAVQQFGEQHGVEDDLKKLKDSL
ANAKLKISTIENLWLKDEFLQQRVKDLLIDLKNAAYDADDLLDEFQYRIL
KQQIEQQGDEAGKRASSSSYSAPPPSKRTKTSIASCTSGLFRKGDDDDDN
NNVQKIRKIKGSLDDYSAALEEIYSSLGAEDDRGKQQLVSSASRQTSSFS
TEPQLFGRDKELQELKDLLFKPAVASEFGQSGVSVLSIYGMGGIGKTTLA
QEVFNDSSVKEYFKLRIWVCVSENFCTDRLTREIIECATTEKCDLTNLDT
LQKIVNEKITPERFLLVLDDVWNEDRHKWESLCAPLRSGKPGSKILVTTR
SRKIADMVSDADAIHLQGLDVESFWDFFKKCAFGCSHSGAHHPHMEAMAK
KMTCKLKGLPLAAKTLGGLLSVKLDEQYWESILDSEIWQLPQEENGIMPV
LQLSYQHLPPHLKQCFAFCSLFPKGYKFSESDLIGIWIAEGFIVPRGSTR
MEELGSNYFHELVNRSFIQESKYGEWIMHDLIHDLAELISAGESYRIEKG
KSHDIPSTIRHLSIYTDKEGMQTILTEFSHWNKLRTMMLTVERFPREDFN
FDCGVLEKLKNIHVLVLNNCSLRELPDGIDKLIHLRYLDLSYNEGIQRLP
ELLCDLYNLQTLILGFCDNLKSLPHGMMKLINLRKLYGVDRLISGITEIG
KLTSLQNLYSFKVTKDNGHKLVELNGLKQLRGFLCITNLENVKNKDEANI
ASLKSKEYLDVLELEWTSLQESDSDVNLHISEQVLEGLQPHHNLQRLIIK
GYNGARPPNWLHKQVYSRLGSLHLENCKRWNDLSAIGQLSQLKFLYLVRT
PIQTKNIHKLFNPKVCKFFSQLEELVLEGITMLEDLPNLGQLPCLTFIRI
QSLPGVKKIGDKFFAMTEEGSCFPRLRTLRFIEMPAWEELYGSDDRNLFP
CLEDLYISNCQKLQMLPPLPPSIQQLKLNNVGLVDCPRFWKAFDEGSSTT
NSASLTYLSIQNCPNLTSLDQGLLPHHLFPCLVNLDISNCQKLQMLPPLP
PSIQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLD
QGLLPHHLFPCLVNLDISNCQKLQMLPPLPPSIQQLKLNNVGLVDCPRFW
KAFDEGSSTTNSASLTYLSIQNCPNLTSLEPVLLPHHHHLQKIHLKKCEQ
LSWVPVKRLKELTSLWSLSLKDCPKLMGMSTPDEYIDFQLPPSITELCLS
DCENLFKSLPGCLHNLTSLTSLSVSKCPNLVSLPVEPSLRLTRLEIQNCN
ELRSVEGLPIKNLEVLKIKGCPKLLLPQTEKLPLLKLEIDDTAFMKQPLI
KNSLSSVRGLTISSSREAVMFEGEDQESLQSLTSLYSFCFSDCKNLQTLP
AKLYTLKSLRFLQIHNCPQIQSLPEKGLPPSLAHINFEGCDQALEQQLVR
HLAEINKS
>XP_042438099.1 putative disease resistance protein RGA1 [Zingiber officinale]
MIGRFALTAFGWLAESIVGVLVGKAVDRAVQQFGEQHGVEDDLKKLKDSL
ANAKLKISTIENLWLKDEFLQQRVKDLLIDLKNAAYDADDLLDEFQYRIL
KQQIEQQGDEAGKRASSSSYSAPPPSKRTKTSIASCTSGLFRKGDDDDDN
NNVQKIRKIKGSLDDYSAALEEIYSSLGAEDDRGKQQLVSSASRQTSSFS
TEPQLFGRDKELQELKDLLFKPAVASEFGQSGVSVLSIYGMGGIGKTTLA
QEVFNDSSVKEYFKLRIWVCVSENFCTDRLTREIIECATTEKCDLTNLDT
LQKIVNEKITPERFLLVLDDVWNEDRHKWESLCAPLRSGKPGSKILVTTR
SRKIADMVSDADAIHLQGLDVESFWDFFKKCAFGCSHSGAHHPHMEAMAK
KMTCKLKGLPLAAKTLGGLLSVKLDEQYWESILDSEIWQLPQEENGIMPV
LQLSYQHLPPHLKQCFAFCSLFPKGYKFSESDLIGIWIAEGFIVPRGSTR
MEELGSNYFHELVNRSFIQESKYGEWIMHDLIHDLAELISAGESYRIEKG
KSHDIPSTIRHLSIYTDKEGMQTILTEFSHWNKLRTMMLTVERFPREDFN
FDCGVLEKLKNIHVLVLNNCSLRELPDGIDKLIHLRYLDLSYNEGIQRLP
ELLCDLYNLQTLILGFCDNLKSLPHGMMKLINLRKLYGVDRLISGITEIG
KLTSLQNLYSFKVTKDNGHKLVELNGLKQLRGFLCITNLENVKNKDEANI
ASLKSKEYLDVLELEWTSLQESDSDVNLHISEQVLEGLQPHHNLQRLIIK
GYNGARPPNWLHKQVYSRLGSLHLENCKRWNDLSAIGQLSQLKFLYLVRT
PIQTKNIHKLFNPKVCKFFSQLEELVLEGITMLEDLPNLGQLPCLTFIRI
QSLPGVKKIGDKFFAMTEEGSCFPRLRTLRFIEMPAWEELYGSDDRNLFP
CLEDLYISNCQKLQMLPPLPPSIQQLKLNNVGLVDCPRFWKAFDEGSSTT
NSASLTYLSIQNCPNLTSLDQGLLPHHLFPCLVNLDISNCQKLQMLPPLP
PSIQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLD
QGLLPHHLFPCLVNLDISNCQKLQMLPPLPPSIQQLKLNNVGLVDCPRFW
KAFDEGSSTTNSASLTYLSIQNCPNLTSLEPVLLPHHHHLQKIHLKKCEQ
LSWVPVKRLKELTSLWSLSLKDCPKLMGMSTPDEYIDFQLPPSITELCLS
DCENLFKSLPGCLHNLTSLTSLSVSKCPNLVSLPVEPSLRLTRLEIQNCN
ELRSVEGLPIKNLEVLKIKGCPKLLLPQTEKLPLLKLEIDDTAFMKQPLI
KNSLSSVRGLTISSSREAVMFEGEDQESLQSLTSLYSFCFSDCKNLQTLP
AKLYTLKSLRFLQIHNCPQIQSLPEKGLPPSLAHINFEGCDQALEQQLVR
HLAEINKS
>XP_042438100.1 putative disease resistance protein RGA1 [Zingiber officinale]
MIGRFALTAFGWLAESIVGVLVGKAVDRAVQQFGEQHGVEDDLKKLKDSL
ANAKLKISTIENLWLKDEFLQQRVKDLLIDLKNAAYDADDLLDEFQYRIL
KQQIEQQGDEAGKRASSSSYSAPPPSKRTKTSIASCTSGLFRKGDDDDDN
NNVQKIRKIKGSLDDYSAALEEIYSSLGAEDDRGKQQLVSSASRQTSSFS
TEPQLFGRDKELQELKDLLFKPAVASEFGQSGVSVLSIYGMGGIGKTTLA
QEVFNDSSVKEYFKLRIWVCVSENFCTDRLTREIIECATTEKCDLTNLDT
LQKIVNEKITPERFLLVLDDVWNEDRHKWESLCAPLRSGKPGSKILVTTR
SRKIADMVSDADAIHLQGLDVESFWDFFKKCAFGCSHSGAHHPHMEAMAK
KMTCKLKGLPLAAKTLGGLLSVKLDEQYWESILDSEIWQLPQEENGIMPV
LQLSYQHLPPHLKQCFAFCSLFPKGYKFSESDLIGIWIAEGFIVPRGSTR
MEELGSNYFHELVNRSFIQESKYGEWIMHDLIHDLAELISAGESYRIEKG
KSHDIPSTIRHLSIYTDKEGMQTILTEFSHWNKLRTMMLTVERFPREDFN
FDCGVLEKLKNIHVLVLNNCSLRELPDGIDKLIHLRYLDLSYNEGIQRLP
ELLCDLYNLQTLILGFCDNLKSLPHGMMKLINLRKLYGVDRLISGITEIG
KLTSLQNLYSFKVTKDNGHKLVELNGLKQLRGFLCITNLENVKNKDEANI
ASLKSKEYLDVLELEWTSLQESDSDVNLHISEQVLEGLQPHHNLQRLIIK
GYNGARPPNWLHKQVYSRLGSLHLENCKRWNDLSAIGQLSQLKFLYLVRT
PIQTKNIHKLFNPKVCKFFSQLEELVLEGITMLEDLPNLGQLPCLTFIRI
QSLPGVKKIGDKFFAMTEEGSCFPRLRTLRFIEMPAWEELYGSDDRNLFP
CLEDLYISNCQKLQMLPPLPPSIQQLKLNNVGLVDCPRFWKAFDEGSSTT
NSASLTYLSIQNCPNLTSLDQGLLPHHLFPCLVNLDISNCQKLQMLPPLP
PSIQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLD
QGLLPHHLFPCLVNLDISNCQKLQMLPPLPPSIQQLKLNNVGLVDCPRFW
KAFDEGSSTTNSASLTYLSIQNCPNLTSLEPVLLPHHHHLQKIHLKKCEQ
LSWVPVKRLKELTSLWSLSLKDCPKLMGMSTPDEYIDFQLPPSITELCLS
DCENLFKSLPGCLHNLTSLTSLSVSKCPNLVSLPVEPSLRLTRLEIQNCN
ELRSVEGLPIKNLEVLKIKGCPKLLLPQTEKLPLLKLEIDDTAFMKQPLI
KNSLSSVRGLTISSSREAVMFEGEDQESLQSLTSLYSFCFSDCKNLQTLP
AKLYTLKSLRFLQIHNCPQIQSLPEKGLPPSLAHINFEGCDQALEQQLVR
HLAEINKS
>XP_042438379.1 putative disease resistance protein RGA1 [Zingiber officinale]
MTSGRWFALTALGWLAESFVGALVGKAVDRAVQQFGEQHGVEDDLEKLKD
SLDHARLTISTVECLRINDEVLQQRLKELLIRLKNAAYDADDLLDEFQYR
ILEQQIEQQGDEAGNRPSSSSYSTPPPTKRTKISFSSYTSGLFRKGDDDD
VQKIRKIKGRLDDNSVALEKIYSSLSAEDDRGKKQLVSSASRQTSSLSTE
PHLFGRDKELQELKDLLLKPEVVSEFGQSGVSVLSIYGMGGIGKTTLAQE
VFNDSSVEEYFKLRIWVCVSENFYTDRLTREIIEYATKKKCDLTSFAALQ
VDLKEKITPERFLLVLDDVWNEDRHKWESLCAPLRYGKPGSKILVTTRSR
KIADMIGDVDPIHLEGLDEESFWEFFKKCAFGCSNSGFLHPHMEAMAKKM
TCKLKGLPLAAKTLGGLLSMKLDEQYWESILDSEIWQLPQEENGIMPVLQ
LSYQHLPPHLKQCFAFCSLFPKDYKFSEFELIGIWIAEGFIVPQGSTRME
ELGSNYFHELVNRSFIQKSKDGVFIMHDLIHDLAELISMGEFHRIEKDKS
HDISNNIRHLSMHEEEEGMQTRVLTEFSHYDKLRTMMLSVRLSSKSFNFD
CGILEKLKNIHVLALNNCSLEELPDSIGKLIHLRYLDLSGNYDIRRLPES
LCDLYNLQTLKLNYCYNLESLPHGMMKLINLRKLDVENKFISEITEVGKL
TSLQNLAAFKVTKDNGHKLPELNGLKQLRGKLRITNLENVENKDEANIAS
LKSKEHLNELELEWTSMQESDSDVNLHISEQVLEGLQPHHNIQSLTIRGY
NGARPPNWLHGQVYSRLEAFHLENCKRWNDLSVIGQLSQLKSLSLVKIPV
HTQNLHNLFDPIVCKFFSQLESLVLEGITMLEDLPNLGQLPCLTVISIKS
LPGVKMLGNKFFARTKEGSCFPRLRTLRFTEMPAWEEFYGSDDRNLFPCL
EDLDISNCQKLQMLPPLPPSIQHVKLNNVGLVDCPRFWKAIDECSRITNS
ASLTYLSIQNCPNLTSLEQGLLPHHLQRIRIENCEQLSWVPVKRLKELNS
LWSLSIKECPKLMGMSTPDEYIDFQLPPSIKELCLSDCGNLSQSLLGFLH
NLTSLAVLLISKCPNLVSLPVEPSLRLIRIEIQNCNELRSVEGLPIKNLE
VLKIKGCPKLLLPQTEKLPVWELEIDDTAFMNQPLIKNSLSSVSELTISS
SREAVMFEGEDQESLQSLTSLHSFCFSDCKNLQSLPTKLYTLKSLQVLRI
HNCPQIQSLPEKGLPPSLTDLEFEGCDRALEQQLVRHLAEIKKSWLIPSS
LRHLVVEGTC
>XP_042438776.1 disease resistance protein RPS2-like [Zingiber officinale]
MDLINPGATLITKLWDLIALKLAFIVNAGDNVRRLRLPMNRLKDKSIDVA
NRVSAAKAQLLTPTQEVLGWLRRVEELEAEVSAIEQDFLNQPTCFCSCHY
DLCSSYRIGRKVKRKASEATAMEAKSFDVVATDDSAPAVALDLPTRPDVG
VESPLENAFQYLFDDQRCVIGVHGMGGVGKTTLLRRINNSFVGRSDFDLV
IMVEASLDFKIEHLQQAIADRVGLPLSQNGTSKSWAIEIKRSLNRKKFLL
LLDNIWDPINLTDAGIPTGPSKCKIVISSRFESTCAQMGAEKKIKMECLT
PDKAWELFRQNLSGDLLNDPEIEDLAKQVAEDCNGLPLALVVVAATMSTR
TTREEWQYAVRQMRKMHLESLVPLEANLIPTLKLSYDNLPNDQLKLCFLS
CSFYPRGHSILKEELIESWMGLGFLEEHNDINEIYQKGHFLIGKLREASL
VVPGDDERRVKVHDIICALALHISSVGLTPRTEKASSSSSRSDPEKIWAV
DAGTGLTDIRADYLEGSSIERLSLMHNNIDTLPEKTDFPELLSLMLQCND
SLPRVFPRGFFKGMGCLQYLDLSNTTVEDIHGIGQLLCLEHLNLSGTPIS
KLPQEIRFLTRLKYLYLINTYSLEIIFAKSFSGLHNLRVFNAYGSSFRFW
ATDGAADVDRASLSELNELINLKALGISVGTHSTFQKLFDMSIPIRYLYI
SDPDTAPIDISFNQLRLPSNTLRSRSKIDASLLEMTIKNCQDLEVVTIGE
DRKGEPENADGGFCRLCTFKGLEKLHLLHLGKLSNITWNGVKPCEYFPRL
RLLRIVGCDKLRSITWTKQLPGLVKLYISGCSEVQQIIAEEDEDVEQEGR
EVFPRLKEFILRDLPKLTSIYQRTLPFPNLVSLQVFRCPKLASLPFGEGS
ACRLQEIHGGKEWWGNLKWANRASFDRHFKQAAS
>XP_042438777.1 disease resistance protein RPS2-like [Zingiber officinale]
MDLINPGATLITKLWDLIALKLAFIVNAGDNVRRLRLPMNRLKDKSIDVA
NRVSAAKAQLLTPTQEVLGWLRRVEELEAEVSAIEQDFLNQPTCFCSCHY
DLCSSYRIGRKVKRKASEATAMEAKSFDVVATDDSAPAVALDLPTRPDVG
VESPLENAFQYLFDDQRCVIGVHGMGGVGKTTLLRRINNSFVGRSDFDLV
IMVEASLDFKIEHLQQAIADRVGLPLSQNGTSKSWAIEIKRSLNRKKFLL
LLDNIWDPINLTDAGIPTGPSKCKIVISSRFESTCAQMGAEKKIKMECLT
PDKAWELFRQNLSGDLLNDPEIEDLAKQVAEDCNGLPLALVVVAATMSTR
TTREEWQYAVRQMRKMHLESLVPLEANLIPTLKLSYDNLPNDQLKLCFLS
CSFYPRGHSILKEELIESWMGLGFLEEHNDINEIYQKGHFLIGKLREASL
VVPGDDERRVKVHDIICALALHISSVGLTPRTEKASSSSSRSDPEKIWAV
DAGTGLTDIRADYLEGSSIERLSLMHNNIDTLPEKTDFPELLSLMLQCND
SLPRVFPRGFFKGMGCLQYLDLSNTTVEDIHGIGQLLCLEHLNLSGTPIS
KLPQEIRFLTRLKYLYLINTYSLEIIFAKSFSGLHNLRVFNAYGSSFRFW
ATDGAADVDRASLSELNELINLKALGISVGTHSTFQKLFDMSIPIRYLYI
SDPDTAPIDISFNQLRLPSNTLRSRSKIDASLLEMTIKNCQDLEVVTIGE
DRKGEPENADGGFCRLCTFKGLEKLHLLHLGKLSNITWNGVKPCEYFPRL
RLLRIVGCDKLRSITWTKQLPGLVKLYISGCSEVQQIIAEEDEDVEQEGR
EVFPRLKEFILRDLPKLTSIYQRTLPFPNLVSLQVFRCPKLASLPFGEGS
ACRLQEIHGGKEWWGNLKWANRASFDRHFKQAAS
>XP_042439612.1 putative disease resistance protein RGA3 isoform X1 [Zingiber officinale]
MIGWFALTALGWLAESIMVALVGKAVDRAVQQFGEQRGVEDDLEKLKDSL
VHARLTISTVECLRINDEVLQQRLKELLIRLKNAAYDADDLLDEFQYRIL
KQQIEQQGDEAGKQASSSFYSAPPPSKRTKTSIASYTSGLFRKGDDDDDD
DNVQKIRKILDDNSAALEKIYSSLGAGDDRGKKQLVSSASRQTSSFSTEP
QLFGRDKELQELKDLFLKPAVASEFGQSGVSVLSIYGMGGIGKTTLAQEV
FNDSSVKEYFKLRIWVCVSEYFCIDRLTREIVECATTEKCDLTNLATLQK
IVNEKITPERFLLVLDDVWNEDRHKWEILCAPLRSGKPGSKILVTTRSRK
IADMVSDVDAIHLQALDEESFWEFFKKCAFGCSNSGAHHPHMEAMAKQMT
HKLKGLPLAAKALGGLLSMKLDEQYWENILDSEIWQLPQEENGIMPVLQL
SYQHLPPHLKQCFAFCSLFPKDYKFSESELIGIWMAEGFIVPRESTRMEE
LGSNYFHELVNRSFFQKSKHGEFIMHDLMHDLAELISADESYRVEEGKSH
DIPCTIRHLSIYIEKEDMLTRLLTEFSHWNELRTMMLSIGLANMSLNFDF
GFLEKLKNIRVLVMKNRFLKELPNSIDKLIHLRYLDLYGSYNIERLPESL
CNLYNLQTLKLYGYHKLERLPHDMMKLINLRNLTGVVKLIADITEVGKLA
SLQNLPAFKVTKDNGHKLAELNGLKQLRGILRITNLENVENKNEANIASL
KSKEHLNRLELEWTSLQDVDLHISEQVLEGLQPHHNLQRLTIRGYNGARP
PNWLYEQVYSRLEGLKLENCKSWNDLSVIGQLPQLKSLSLVRIPVHTQNL
HKLFDPKVCKFFSQLKSLVLEGITMLEDLPNLGQLPCLTSICIENLPGVK
MIGDKFFAMTEEGSCFPRLCTLRFTEMPTWEEFYGSDNRNLFPCLVDLDI
SNCQKLQTLPALPPSIQHVKLKNVGLVDCPRFWKAIDECSSTTTSVSLTY
LSIQNCPNLTSLDPGLLPHHLFPCLVDLDISNCQKLQMLPPLPPSIQQLK
LNNVGLVDCPRFWKAFDEGSSTTNSATLTYLSIQNCPHLTSLEPVLLPHH
LQHIHLKKCEQLSWVPVKKLKELTSLRSLSIEECPKLMSMSTPDEYIDFQ
LPPSIEKLCLTDCGNLSKSLPGLLSLTPLLISKFPNLVSFPLEPWPRVIH
LEIQKTTNNLELLRIKGCPNLLLHIIHNLPVLELEIDDTAFMKQSPIKNL
LSSVSKLTISSLGEAVMFEGEDQESLQSLTSLQKLCFSDCWNLQSLPTKL
YTLKSLRVLMIHNCPQIQSLPDKGLPPSLIEIGFKDCDPALEQQLTRHLV
ENPKIRFLQYQEDMWSYRSTRWRWMPSRRK
>XP_042439613.1 putative disease resistance protein RGA3 isoform X2 [Zingiber officinale]
MIGWFALTALGWLAESIMVALVGKAVDRAVQQFGEQRGVEDDLEKLKDSL
VHARLTISTVECLRINDEVLQQRLKELLIRLKNAAYDADDLLDEFQYRIL
KQQIEQQGDEAGKQASSSFYSAPPPSKRTKTSIASYTSGLFRKGDDDDDD
DNVQKIRKILDDNSAALEKIYSSLGAGDDRGKKQLVSSASRQTSSFSTEP
QLFGRDKELQELKDLFLKPAVASEFGQSGVSVLSIYGMGGIGKTTLAQEV
FNDSSVKEYFKLRIWVCVSEYFCIDRLTREIVECATTEKCDLTNLATLQK
IVNEKITPERFLLVLDDVWNEDRHKWEILCAPLRSGKPGSKILVTTRSRK
IADMVSDVDAIHLQALDEESFWEFFKKCAFGCSNSGAHHPHMEAMAKQMT
HKLKGLPLAAKALGGLLSMKLDEQYWENILDSEIWQLPQEENGIMPVLQL
SYQHLPPHLKQCFAFCSLFPKDYKFSESELIGIWMAEGFIVPRESTRMEE
LGSNYFHELVNRSFFQKSKHGEFIMHDLMHDLAELISADESYRVEEGKSH
DIPCTIRHLSIYIEKEDMLTRLLTEFSHWNELRTMMLSIGLANMSLNFDF
GFLEKLKNIRVLVMKNRFLKELPNSIDKLIHLRYLDLYGSYNIERLPESL
CNLYNLQTLKLYGYHKLERLPHDMMKLINLRNLTGVVKLIADITEVGKLA
SLQNLPAFKVTKDNGHKLAELNGLKQLRGILRITNLENVENKNEANIASL
KSKEHLNRLELEWTSLQDVDLHISEQVLEGLQPHHNLQRLTIRGYNGARP
PNWLYEQVYSRLEGLKLENCKSWNDLSVIGQLPQLKSLSLVRIPVHTQNL
HKLFDPKVCKFFSQLKSLVLEGITMLEDLPNLGQLPCLTSICIENLPGVK
MIGDKFFAMTEEGSCFPRLCTLRFTEMPTWEEFYGSDNRNLFPCLVDLDI
SNCQKLQTLPALPPSIQHVKLKNVGLVDCPRFWKAIDECSSTTTSVSLTY
LSIQNCPNLTSLDPGLLPHHLFPCLVDLDISNCQKLQMLPPLPPSIQQLK
LNNVGLVDCPRFWKAFDEGSSTTNSATLTYLSIQNCPHLTSLEPVLLPHH
LQHIHLKKCEQLSWVPVKKLKELTSLRSLSIEECPKLMSMSTPDEYIDFQ
LPPSIEKLCLTDCGNLSKSLPGLLSLTPLLISKFPNLVSFPLEPWPRVIH
LEIQKTTNNLELLRIKGCPNLLLHIIHNLPVLELEIDDTAFMKQSPIKNL
LSSVSKLTISSLGEAVMFEGEDQESLQSLTSLQKLCFSDCWNLQSLPTKL
YTLKSLRVLMIHNCPQIQSLPDKGLPPSLIEIGFKDCDPALEQQLTRHLV
ENPKIRFLQYQEDMWRSTRWRWMPSRRK
>XP_042441191.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MDWITLLQHLGLPELVKKVVEFLLTKACSEVSLLQGVEDEIAKLRRTHER
IQSLLVDAEERRHIEDESVKSWLRELKTVGFDADDLLDGFRAHVDVFKHA
KEAPSRKRKRSWYDVPIPSLGVDTRLVRRYNIATEIVKIQSRLDEIYKRR
KNLQLKPSDGRQRNEGSNMAVFFPAVASLDVSKVVGRSKQCDSIVAALKV
DSDLPLRVIAIYGIAGIGKTTLAQLVFNHFSGRDREEVSPNPSGSLSGVD
RHFEMKIWVSLPKVCDTARATKEIIEGITGEICKLPSLNHLQDCLKKCVK
DKKFLLVLDNFWAEDFKFWEILRLPLLKGAKGSSVLITTQNEAVSRLVAT
MPLHLEGLEMDDSLKLFTALAFPQAEEDVDQLKDIGERIVERCQGSPLAT
ISLGKLLRSESNVDNWEIVLNEMLALEGSANSSTRPILPSLMISYHHLNY
QLKQCFTYCSIFPDNFEFDKDQLVRMWIAEGLIQQNGRRPPEAIGSRLFD
YLLWMSFFERSTKPCSNGTICKYTMPNLIHDLARLLSNNELLVMEDNELN
PSSGQFRYASLLHRKCVPIMFEKIYNQEHLRALKLCNESKIDVAGIPKDL
FGKLKYLRLLDLSNSGIEKLPDSVGKLVHLRYLGLSETNVEELPESVEDL
YNLQTLELNFCSNLSSLPEGTSKLVNLRHLGLHLDWEQINDLRRMPTGID
RLTSLMTLSRFTVTNYVDGCNLRELKNLDLRGELCICKLENVTNASDASE
ANLGEKRIDKLMLRWSNETSNVQQGANISNVQQGVNICKEVAERLQPYKY
LKCLWILNYPGSKFPDWLENSGFSSLEMVRLSCSGECESLPSLGQLPKLK
HLHIEGMKRLINLKNMIKGFLSLETLTIKDMPDLNMLCKFKDNFPKLSKV
VVSQCPKLCRPKDLPRRIELIIIPQSTDNVNGNDVSS
>XP_042441192.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MDWITVLQHLGLPELVKKVVEFLLTKACSEVSRIQGVEDEIAKLRRTHER
IQSLLVDAEERRHIEDESVKSWLRELKTVGFDADDLLDGFRTHVDVFKHA
KEAPSRKRKRSWYDVPIPSLGVDTRLVRRYNIATEIVKIQSRLDEIYKRR
KNLQLKPSDGRQRNEGSNMAVFFPAVASLDVSKVVGRSKQCDSIVAALKV
DSDLPPRVIAIYGIAGIGKTTLAQLVFNHFSGRDREEVSPNPSGSLSGVD
RHFEMKIWVSLPKVCDIARATKEIIEGITGEICKLPSLNHLQDCLKKCVK
DKKFLLVLDNFWAEDFKFWEILRLPLLKGAKGSSVLITTQNKEVSRLVAT
MPLHLEGLEMNDCLKLFTALAFPQAEEDVDQLKDIGERIVERCQGSPLAT
ISLGKLLRSESNVDNWEIVLNEMLALEGSANSSTRPILPSLMISYHHLNY
QLKQCFTYCSIFPDNFEFDKDQLVRMWIAEGLIQQNGRRPPEAIGSRLFD
YLLWMSFFERSTKPCSNGTICKYTMPNLIHDLARLLSNNELLVMEDNELN
PSSGQFRYASLLHRKCVPIMFEKIYNQEHLRALKLCNESKIDVAGIPKDL
FGKLKYLRLLDLSNSGIEKLPDSVGKLVHLRYLGLSETNVEELPESVEDL
YNLQTLELNFCSNLSSLPEGTSKLVNLRHLGLHLDWEQINDLRRMPTGID
RLTSLMTLSRFTVTNYVDGCNLRELKNLDLRGELCICKLENVTNASDASE
ANLGEKRIDKLMLRWSGETSNVQQGANTSNVQQGVNICKEVAERLQPYKY
LKCLWILNYPGSKFPDWLENIGFSSLEMVRLSCSGECESLPSLGQLPKLK
HLYIEGMKRLVNLKNMIKGFLSLETLTIKDMPILNMLCKFKGNFPKLSKV
VVCQCPKLRRPKDLPRRIELIIIPQSTDNVDGNDVSSDLSHSA
>XP_042441193.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MDWITVLNGLGLPELVKKVVEILLTMAYSDVSRLQGLEDEIDKLRWTHKQ
IRYFVIDAEERRDIEDESVLRELKTVGFDADDLLDSFQTLIDVFKHTKEA
PSRKRKRSWYCIPIPSLSINTGLVWPYIISTETAKIQSRLDKINENQRNL
RLMPSYGRQQNEGSKRAVFFPAVASLPVSRIIGRDKEFDFILAAMKADSD
LPLRVIAIYGFAGIGKTALAQWVFDHFSENDREEVSPNPSRSLSSAKRHF
EMTIWVSLLKGRDTAMATKHVIEGIIGKICKLPNLNHLQDRLKKFVKGKK
FLLVLDDVRVEDFKFWDNLQRPLLEGAKGSSVLITTQNGEVSRHMANMPL
LHLKGLERDDCQKLFNALAFREAKENVDQLKDIGEQIVRRCQGSPLAAIS
LGKILGSETTVDNWEIALNEMLALEVSPNSGIGPLLSSFMASYHQMNYQL
KQCFTYCSIFPDNFEFDKDQLIRMWIAEGLIEQNGRQPPETIGSELFKYL
MWMSFFERSIKCSDGTICKYTMPNLIHDLARLLSKHELMVMKDNGLNFSS
GQFRYALLHQKHAPIVFEKIYHQVHLRALKLCNESKIDVVGIPKDLFDKL
KYLRVLDLTNSGIEKLPDSVGKLVHLRYLSLSETNIKKLPESVEDLYNLQ
TLELNFCSNLSSLPEGTSKLVNLRHLGLHLDWEQINDLRRMPTGIDRLTS
LMTLSRFTVTNVDGVGCNLKELKNLDLRGELCICKLENVTNASDASEANL
GEKWIDKLMLRWSGATYNVQPGANISNVQQDVNICKEVAERLQPYKYLKC
VWILNYPGSKFPNWLENSDFPSLETVTLSCSGECESLSSLGQLPKLKHLH
IEGMKRLRNLKNMMKGFLSLETLTIKDMPDLNMLCKFKGNFPKLLNIVVS
QCPNLPCRRPKDLPRRIKYLIIIPQSTDNVNGNDVSS
>XP_042441287.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MGSEITIAGWLAALLKASTAKLAADQHLQDKAVEQNLKKLQFNLDKIITA
SQLDRKQIGSHSIKDWFSSFKDAIYAADDVIEEFVQQLEKHKKQSSTSST
LRKSANFVSKMIQGGLFNGDDMKQLDEVTKTFDDVVSDIFGLLKVVQQLE
GSGGTKQQEIIPSWRLTTSPYKGRTTTIGRTSEGKKMLEALLEEGGGSTS
NFCNFSVVCVVGTGGIGKTDLARFAYNNEKVRRHFDLKAWVAVCNNFDEK
RLTIEIIESASVERPSDLHSITSLEPIQNTLAKGMKDKRFLIVLDDVWED
SNASWEHLTTPFTHGKEGSRIIVTTQLESVAKSTKAKETIHLDGLEEQEY
LALFKKCAFGDKDKVHQPTLESICTEIAKKYDGSPLAAVSIGLELRSDPT
EEHWRRVARNKLGVIERREGDIVSVLGFSYEQLPARLKQCYLACALFPKK
HLFYKNQLIRIWTALRFVSADGNGGNPVDELASKSFFVNSISKREDGQFM
LHAVLHELADLLCDGEFFRVEDEAGGQEIKIPQKARHVYVSKADNFVRVS
EALAEKEQLRSLVIDGSVPSDATLRANFMVSLETVLKKCKFLRLLMLPEK
FPLESLVAIGRLSRLRCLDFHGIQRKALPQYLESLNLLQWPDLKQRPVAS
NLTKGGSRIWKQHSAGSEKDATSSASGPVRSTSNSSPNLPSP
>XP_042441290.1 disease resistance protein RGA2-like [Zingiber officinale]
MDPQVIVLTVIGWIVPHLVTLASLAIKKTLNNPPKDDQDKNLEEKAFKMI
KVFDQIYPEITSSKIVKNSLCDFKTFLIEEMEAIKENQKHDERRRNWKPD
GTTMSDMLEEALDMRIMEVAEARQEDEEYKFRCTTGARKHSVKLRGRDEE
TRGLLSWLLENSQRSSCSDSKKLSILSIVGLGGIGKTELARQAYNNDRAD
FGIKAWVSVCKNCDVKKLTIEIMESADFKLLPSLHSMYSSEKIQSIFTEI
IKDQRVLVVFDDVWEEFSTPWEELYASLSHGRQGSRVIVTTQLERVAKLI
GSDETINLDPLEHQEYWKLFEECAFGNQNPNNYPELQQLGQAIASKFEGS
PLAAVEIGRTLASNLTKRHWEKIAGSQFGVLQRSRGDILSALEFCYEQLP
TRLKQCYLSCALFPKNYCFDKDQLLRMWVALGFSPSLADEEIRSLAEDLA
SRSFFVNAERRNNKFMIHPVYHELADMICDGEFFRLEEETEETKIPEKAR
HVYVKADILVKVCKGLGEKENLYSLVIDGSLSSGIPNSKSDFHNSLNKVL
NDLKGLRVLILSELPGNRLLKSVRKLGHLGYLEIPSNKNRTVPESFLASY
HRVQVNLNQVPRDLFIKCEGMDELAKLCGVAADTQKKAISTTSLSRRKKR
SRRRAARRDQLLREQ
>XP_042441291.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MGSEITIAGWLAALLKASTAKLAANQHLQEKAVEQNLKKLQFNLDKIITA
AQLDRKQIGSHSIKDWFSSFKDAIYSADDVIEEFVQQLEKDKKQSSTLST
LRKSANFVSKIIQGGQFNGDDMKQLDEVTKTFDNLVSDIFELLKVVQQLE
GSGGTKQQEIIPSWRLTTSPYKGRTTTSGRGSEGKKMLEALLEEGGGSTS
DCCNFSVVCVVGTGGIGKTDLARFAYNNEKVRRHFDLKAWVAVCNNFDEK
RLTIEIIESASVERPSDLHSITSLEPIQNTLAKGMKDKRFLIVLDDVWED
SNASWEHLTTPFTHGKEGSRIIVTTQLESVAKSTKAKETIHLDGLEEQEY
LALFKKCAFGDKDKVHQPTLESICTEIAKKYDGSPLAAVSIGLELRSDPT
EEHWRRVARNKLGVIERREGDIVSVLGFSYEQLPARLKQCYLACALFPKK
HLFYKNQLIRIWTALRFVSADGNGGNPVDELASKSFFVNSISKREDGQFM
LHAVLHELADLLCDGEFFRVEDEAGGQEIKIPQKARHVYVSKADNFVRVS
EALAEKEQLRSLVIDGSVPSDATLRANFMVSLETVLKKCKFLRLLMLPEK
FPLESLVAIGRLSRLRCLDFHGIQRKALPQYLESLNLLQWPDLKQRPVAS
NLTKGGSRIWKQHSAGSEKDATSSASGPVRSTSNSSPNLPSP
>XP_042441885.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MATDLGTWIRSLLNRSLTSPLPCDPPSSVEADLEKLKTILHRIHAVLYDA
ERRDIQYKSDQLRQKELKELAYDAEDVLDYYHYHILQSRAKAKASHKRKR
DEEVLVDLTISSPQLSTCFTCINGKIGELDEIYEAGNVEKLDEISRQIKK
IYDRFTEIVESSIQFSFTQLDGEHIIEGSRHPPVASSMVNESCIFGRERE
KKELINLLLSENREENVSVICISGMAGKGKTTLAQIAYNNDRVRKHFDRK
GWVGVPLDFDITKLTKSVLEAVTENACGLTELSTLQHALKNELWKKKVLL
VLDNVWNVSSSNWESFLMPFVDAENVRIVITTRYEVVTEITQSQPYPLGE
LADVECWSLFTYYAFGGRNSRQAELCEIGEKIVQKCGRLPLAIKALACLL
RNDTEVKCWDEVLKSEIWELEKENEILPALMLSYKYLPIHLKPLFLFCSM
FPKGYLFEKDELVRFWMAHNYIQPRRCKRVEDVGQECFNELKERSFFDVV
AETTKYKMHDMIRSLGQSIANKEFQAALSKDHADISDDVRHLFVKGKGEV
VESLCFKKPNVLRTLLYERLDVGVPRIPRALPKLRCLQHVFTDSTHESNS
SYFPDLIHLRYLRVYNKEFGRFPESICQLYNLQSLILDYCGDLEELPDGV
GNLVNLRYIGLSSLNIARLPDSICQLSNLQKLKLNDCRKIKELPNGINNL
FHLRELTLCEMEISELPDSVCLLTNLQVLNLSGCGNFSGLPKDIGNLSNL
YTLEVTKTEIQELPESFCRLAKLQKLSLSGNWKLKDLPSNFGKLASLNYL
ELNDVGITLLPKCIVDLSLRYLRFSAVY
>XP_042442506.1 disease resistance protein RPM1-like [Zingiber officinale]
MAEAVIACLIEKIITAVASVSHSFLDRPVQNIHMKMNNIRRVLELTKAFL
KHTRTYTGENELVDAWAKLIQDVAYDIKDIVDEYIFLMTSGRWAGLITRI
NNDVKAKSLHELGKKLEEREASLWKLVRMKDSYGIRVPERFSSSPEENDL
ICHLAESALSVEEDDLVGIEEIKYKLIRLLIDEEPQRTIISVLGMGGVGK
TTLVARVYMNQMVISHFSCCAWISVSKSNTVDDLLKKILKELHRERKEVI
TLDFDSMDYKTLVENLRLHLAHRRYLIILDDVWQADVWTDISYALFANNC
RSRVVITTRVQDVSSLAGEERIVRVNPLPDAMAWDLFCKKAFPTEVGNTC
PQNLIQWARKMVDECDGLPLAIAAIANLLSHKEREELTWKKIHDSLALST
NQDNQELQKVPRILSLSITNLPHHLKNCLMHCSLFPEDYPIARNRLIRLW
VAEGFVKERGGMSMEDVAEDYLNQLVGRSLLQVTDRNELGRVRFCRVHDL
VRELIIEKSREEHFVDVLEGEFKDVSDRVRRLSIIKDYQGATVNQSMEIS
SLRSFHTFTPVPISVLLKCRLLRVLDLHAAPVEALPNAIGHLANLQYLSI
RKTNVKRLPNSLGDLQKLETLDAIYTNIEELPSGIKKLGNLRHLLVKKFH
RQTSKYTILGGGVEVPGGVGNLKGLQTLKAVVANGKMVLQLAKLTQIRSL
DVRGVTTQHSFVLSSSLSKMDRLARLVVMAKHKDDTLLLSDMKPPPQLRK
LSLYGNLDKRMLPSWFSTLENLTHLVLKMSRLKEDPLPQLTALPNLVTLF
LMQAYNGSKLQFHAQCFCRLRSLGLCDMSHLNCIEIEENALECLHEMTLV
RCSQLKTIPVGLEHLTRLQKLEVEGMPIELVTKLQNGGETEEDSNRLKHI
PIIKNWLGRDGIWVEDRLK
>XP_042442508.1 disease resistance protein RPM1-like [Zingiber officinale]
MAEAVIACLIEKIITAVASVSHSFLDRPVQNIHMKMNNIRRVLELTKAFL
KHTRTYTGENELVDAWAKLIQDVAYDIKDIVDEYIFLMTSGRWAGLITRI
NNDVKAKSLHELGKKLEEREASLWKLVRMKDSYGIRVPERFSSSPEENDL
ICHLAESALSVEEDDLVGIEEIKYKLIRLLIDEEPQRTIISVLGMGGVGK
TTLVARVYMNQMVISHFSCCAWISVSKSNTVDDLLKKILKELHRERKEVI
TLDFDSMDYKTLVENLRLHLAHRRYLIILDDVWQADVWTDISYALFANNC
RSRVVITTRVQDVSSLAGEERIVRVNPLPDAMAWDLFCKKAFPTEVGNTC
PQNLIQWARKMVDECDGLPLAIAAIANLLSHKEREELTWKKIHDSLALST
NQDNQELQKVPRILSLSITNLPHHLKNCLMHCSLFPEDYPIARNRLIRLW
VAEGFVKERGGMSMEDVAEDYLNQLVGRSLLQVTDRNELGRVRFCRVHDL
VRELIIEKSREEHFVDVLEGEFKDVSDRVRRLSIIKDYQGATVNQSMEIS
SLRSFHTFTPVPISVLLKCRLLRVLDLHAAPVEALPNAIGHLANLQYLSI
RKTNVKRLPNSLGDLQKLETLDAIYTNIEELPSGIKKLGNLRHLLVKKFH
RQTSKYTILGGGVEVPGGVGNLKGLQTLKAVVANGKMVLQLAKLTQIRSL
DVRGVTTQHSFVLSSSLSKMDRLARLVVMAKHKDDTLLLSDMKPPPQLRK
LSLYGNLDKRMLPSWFSTLENLTHLVLKMSRLKEDPLPQLTALPNLVTLF
LMQAYNGSKLQFHAQCFCRLRSLGLCDMSHLNCIEIEENALECLHEMTLV
RCSQLKTIPVGLEHLTRLQKLEVEGMPIELVTKLQNGGETEEDSNRLKHI
PIIKNWLGRDGIWVEDRLK
>XP_042442624.1 disease resistance protein RPM1-like [Zingiber officinale]
MAETIAPIVQLVASTIAGPIANEGQNLLTVEEKVGWLRRELRRMHSFLAD
AERSATDDPQSSRWISEIRDLVYDSEDIIDAFDAIGMYPVACFFCHLRSR
HQIGSRILELKSRLDEFFRSKSDYGIPTDGGPNSDDRWIHGLLASSPLIH
QGDFVGFESHFNEVIDWAMSDRQELSVLSLVAMGGSGKTTLVKRVFNHNV
VKRRFDRLAWIYVSKSFRMRNLFKEVAKGLMTMPSEEVNALNEKQLQELL
LETLKEKRFLLVLDDVWDASVWEAIRLVLPRNENGSRVIITTRNSAVASS
ITEVKSCCHELQPLSFEQSWELFCRKVFPESEPCPDELKEDAEGIVKNCH
GLPLAIVTIGGMMSRKGRSQLEWNNVLAKMYSNLIGNEVEVQGPLFLSYK
HLPYPLKSCFLLFSIFPHDSNIRSKKLIRLLMAEGLVKEGEGEGERMEDV
AEKYLMELINRSMIQISILGSTGRVKTFRIHHLIHQLSISIAKMQSFSIV
HEDRRAKHPNNAYRISLQKSSYDALNNTGEKKLRSLFVFGIDEPLHINHR
IVDKLRFLRVLDLEDVCLFKLPNEVGNLIHLRYLSLKGTRLKMLPLSLNN
LLNLQTLDIRRTRLRKLLFEINNLKNLRNLEMKQGEKSIIIPSQFSQLEN
LQVITGVQADQAVVRGVGKLTHLRKLAIEDIQIENVSELCSSINNLPGLL
SLSMYSIDVSTTLELEKLNPLSLQKLHIAGRLERLPSWFSGIRNLTKLRL
GLTNLSADPFEALQQLPNLVFLQLYQAYQGKVMRCSHHGFRKLKILILTD
LEKLEEWKVEDGTLQCIQEIWIMSCLELRRVPPGLKYLVTLLQLRLVSMP
QNFISRLNPLGGADFPAIKHIPSIQVT
>XP_042442820.1 putative disease resistance protein RGA1 [Zingiber officinale]
MSTALAIGGWFAQGFIQTLLDKASDSAVQRLAGLRGLDGDLRRLRASLFK
IHALLDMAERRRCYSSNLVELMKQLKDASFDAENLLDEFEYQTLKHKIEG
QASDFFTLAFNAAKNLFSADGDDFGSRLRAIQEKLCEIAADMIDIMQLLS
MDDEGRQSTGKLVRRETSSFLTEEIVFGRDNEREKVIALLLGSAEGSESS
NHVFSVLPLVSIGGVGKTTLAQLVYNDDRVGNYFQLKIWICVSDDFDVKR
LTKELIESTTKEEQSGLTNLDTLQSRLKEKIELKRFLLVLDDVWSENKDE
WDKLCAPLSFGAHGSKIIVTTRHTKVASIVGTVSTIFLHGLEDDALWELF
KKHAFASQIVVEEHPELVIIGRDIAGKLKGSPLAAKTLGSLLRSDLNEQH
WRTIMESEVWQLPQQENEILPVLQLSYHYLSGHLKQCFAFCSVFRKDYIF
CEHTLVSIWMAEGFIAPQENMRMEDVGSSCFHELVSRSFFQETQRRGRFV
MHDLIHDLAQFVSVGECHRVDGDKSEEIPKTICHLSATLTAQRKLMEFSG
YHKLRTLMINYQNNQNQFVLRIETPLVPDDLFRRLKDIRVLSLQKCGMKE
LTETIGEIIHLRYLDISYNSGIVKLPESLCVLYNLQVLRLCGCQLQGFPQ
GMSNLINLRQLHAADEIVSKVKEVGKLISLQELPIFKVLKYDDGHKLAQL
CDLKQLHGELTISNLENVNSEEEASLAKLKNKKYLDALKLEWKSGQESNL
EKEHVSEEVLEGLQPHHSLRSLTIRKFNGGVLPSWLQASPVLKLETLKLE
NCKRCRDLSCTGELPLLKVLHIKGMPQVKQISPSLCCHTKSKFFQQLHEL
VLEDMLALEELPDLGQLPYLKSLQMKGMNALRCIGNGFHGANGSNWFLRL
EKLRLQNMQAMEELPFLGHLPCLKVIDVRQMPALKHIYHAHYDSIERNWF
STLEVMVLENMLSLEELPCLGRLPHVKYLRLDVKKIAHGFFRVPSENNWL
PKLEKLELKGIPGYQELPSLEQLPHLTVLHLDGMTSVKAIRQGCTFTAEQ
IKCFSRLEELVFRDMPAWEEWSWAEGGEHFSCLRRLKIAQCPKLKQLPSL
PACLLELELIHVGLTELPGLWKGTNGNSSSKISSVTRLHISECPSLRNLE
EGLLSNHLPHINSILILDCVELMFLPVKKFAELTSLEMFSVRHCPKLMMT
QSQDIDLQLPTSIKILGLCNCASFGKSLPGCLYSLSLLTRLSISNCPHME
TLPGEAMLHLKQLWDVSIKSCVELRSIGGITFLSTLTRFELADCPKLLLN
GMVEEGKCSSLLELRVDNTALLKVSPILHSLPSIHFLYIFSSYQAVMFDG
EDQGLLQSLTAIKCLEFGLCKNLKSLPTELHSLPSLKSLALFECPEIQSL
PEKRLPPFLTDLRFQGCHSLLTKKLEEHLQEIKNSGRFDSVFA
>XP_042443029.1 disease resistance protein RGA2-like [Zingiber officinale]
MDPHIIVLTVIGWIVPAVVTMAINKTLNNPPKDDKAKKLEEEIEKKSRII
AQLDEEITSNQIVKHGLWGVKNVVGGAKEAIENYRKHDGRCRKVLFWKPD
ARTNWLEEAHGMLDQTDVDFGAVAVARQHDEEYKFRRTTGERKHFTKLRG
RDAETRALLNWLENSQRSFSSSRKKLSILSVVGPGGIGKTELAREAYNAR
ASFGIKAWVSVCKNCDVKKMTIEIMDSADIKLPPGLHSINSPEQIRSIFT
KRIKGQRVLVVFDDVWEGFSTAWEELYASLSHGKQGSRVIVTTQLERVAK
LIGSDETINLDPLEHQEYWKLFEECAFGNQNPNNYPELQQLGQAIAAKFE
GSPLAAVEIGRRLASNLTKRHWEKIAGSQFGELQRSRGDILSALEFCYEQ
LPTRLKQCYLSCALFPKNYCFDKDQLLRLWVALGFAPSLADEEVRSLAED
LASRSFFVNAERRNNKFMIHPVYHELADMICDGEFFRLEEETEETKIPEK
ARHVYVKADILVKVCKGLGEKENLYSLVIDGSLSSGIPNSMSDFHNSLNK
VLDDLKGLRVLILPELPGNGSLRSIQKLSHLEYLEIPSNENRTLSKSFLA
RYRRGQVKLNQVSMDLFIKREGMDELAKLYGVTADRQPEAISTASLGRRR
RKRSLPRAARKDQLLKEQ
>XP_042443121.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAYLDVRCILFDMLPSPAIVEQGRALGVARQLESIRLHLWAINAVTMDAE
LRGQEDWMATVGTTMVDLEVLLTRIADRHETASDRWTSGPFLGLCASFRL
ACKLTKMVRRLRALVAEASALNLHEDTMRLMDPLREDYSDILKEEVLGRD
GDRDEIVKSIQQQQPKEEDKFGDAPPCVIVIYGPSGMGKTTLARMVYHHD
WVRRCFRHRIWVNVSDLFSFDMVGVSTEIARSLAGGGPCMKLRSHLQSIS
EFVLGALAGDRYLLVLDGIDVKGEAADFETSQSKLIQKWDQMTHQIFSVG
APGSTIIVAVADEYQAKIFKSATTHNLTALSENDWLDLFKKHAIKNRPDK
DEETAAAACTEDALLPFFKGCYEDFSGSPLEAKLLGSAFRHTEVKRWRRE
IVDLGLLKRSMRENQRYSTASFHHLPTRSARLHLYCSLFPELKRATPLED
FIHMMLVEGLVPDSGDRDEAIRYLKDNVVAGFHQQLTRSQHYFTWEVGRE
HSSRIPKQCRHLCLLLDSNAPISATALQGATKLRTLILRTTKNMQQKHQK
YQFADLPDAIFLQLFDYLRILHLADSKIQTLPRAIEKLSDLRYLNLSNSE
IVELPGSLCSLQNLQVLKLNHCKMLLGLPGEIHKLEKLRILKLAHCEKLQ
KLPDSVTSLVNLQELNVKGCCFLVELPEDFSGMQNLTELNMQECASLIRV
PCGIEQLSELRTLLGYSLVHPIGTWINFTSLTQLGLEKLEHDMAMQNIVR
TKLLEQITNLENLALHWQWSERNDAANNDIQLDSLILLDHLEPRECLKKL
EIFSYFGVAYPKWMESINNLIEIRLVNLKACKSLPPLGHLPRLQIAVISG
MEMVVMVADSFYAGGKFLRLRELTFSEMPNLRTWNTPGSENCGTEENEEY
FPLLKELTLFQCPKLKELNVFLGAWRLKMSLSNGLLLTSQIQKSWDNLKH
LEELEIVGCQELERLPAAMANLKYLRKLTIIWCNNLVALPNWLLGLRYLS
RLQVSDCPNLSWMPQGLRQQQPGIAISVHDCPNLQLC
>XP_042443692.1 disease resistance protein RPM1-like [Zingiber officinale]
MAEAVIACLIEKIITAVASVSHSFLDRPVQNIHMKMNNIRRVLELTKAFL
KHTRTYTGENELVDAWAKLIQDVAYDIKGIVDEYIFLMTSGTWAGFITRI
NNDVKAKSLHELGKKLEEREASLWKLVRMKDSYGIRVPERFSSSPEENDL
ICHLAESALSVEEDDLVGIEEIKYKLIRLLIDEEPQRTIISVLGMGGVGK
TTLVARVYMNQMVISHFSCCAWISVSKSNTVDDLLKKILKELHRERKEVI
TLDFDSMDYKTLVENLRLHLAHRRYLIILDDVWQADVWTDISYALFANNC
RSRVVITTRVQDVSSLAGDERIVRVNPLPDAMAWDLFCKKAFPTEVGNTC
PQNLIQWARKMVDECDGLPLAIAAIANLLSHKEREELTWKRIHDSLAWST
NEDNQELQKVPRILSLSITNLPHHLKNCLMHCSLFPEDYPIARNRLIRLW
VAEGFVKERGGMSMEDVAEDYLNQLVGRSLLQVTDRNELGRVRFCRVHDL
VRELIIEKSREEHFVDVLEGEFKDVSDRVRRLSIIKDYQGATVNQSMEIS
SLRSFHTFTPVPISVLLKCRLLSVLDLHAAPVEALPNAIGHLANLQYLSI
RKTNVKRLPNSLGDLQKLETLDAIYTNIEELPSGIKKLGNLRHLMVKKFH
RQTSKYTILGGGVEVPGGVGNLKGLQTLKAVVANGKMVLQLAKLTQIRSL
DVRGVTTQHSFVLSSSLSKMDRLARLLVMARHKDDTLLLSDMKPPPQLRK
LSLYGNLDKRMLPPWFSTLENLTHLVLKMSRLKEDPLPQLTALPNLVSLF
LMQAYNGSKLQFHAQCFCRLRSLGLCDMSHLNCIEIEENALECLHEMTLV
RCSQLKTIPVGLEHLTRLQKLEVEGMPIELVTKLQNGGETEEDSNRLKHI
PIIKNWLGRDGIWVEDRLK
>XP_042443742.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MASEIFSLIASATSKLHALVSSSIISSEDVIQNLKDIKELVYEAKEQQRK
MGDQSINQWLKQLKAVAVDAEDLVEERLYDMTRIQVEDHQRNPRSIHHTK
GKNEAKKDGERVISESSAFSRIIRFDIPINLLERIENIRYLFGEISKGWK
PQQVGQAGKKSLDLTNLNVCLHKFLTRGEQLLPRTSSRSRAFTVTETENF
RELVILFTGIDSDSSVEPTNRDLRSARSQVISPASSDPISSVTDDLIMKN
MECVPEDCIQGDKQFDTPSSSSMAHGTAVSQDTEALCLLDDDDKNCFFGY
SKDSSLTNKIFGRDQDKENIIQWLLFDASSYSFAFTDGRRRSKFSVISIV
GTAAVGKTTLAKLVYDDPVVCEHFSARGWIHVGNDSSVARLSKAILSSIT
GKSCDEKEPNDLQTIVQRELAGKRLLLVLDDIEDLNPSLWNTLQATLCGV
RIVKFIITSPNEGDGNMWKLTKIYHLDVLPLDLSWDLFHECAFLSARAFY
RGYTPPKTEIVDIGKKIVQKCKGLPLALKTLGSILSYQTNKQTWVGALES
TLWDSTKNVILPALELSYYLLPKYLKPCFLFCSMFPRGYKFEKYELVRLW
MALQYIASEGSKRVEDIACRYFYELQRMSFFEKFWDGTFIMHDLIYNLSE
LMSEGECISIQGDLDTISDHVCHLHVLSCKRTHKSSFLEVKKNLRTFFCQ
SLDGTLPKFLSIPSDMTMQYLRALVLKVHGDSGDFTTNQEATLKQSKASS
IMYSRFIHLRHLQICDKSIIILPTSVCQLYNLQTLILNKCFMLRELPKEL
GNLLNLQCLAISESSIKRLPESVSQLFNLESLILDYCRNFTDLPFRIQNL
TNLHYVGLSGTSVGGLHESISDLQKLSILKLNDCKMFMELPNSIRYLTNL
QSIQITHAKLQRLPESVCHLPKLRLLDLSHSMVVELPSGIGELVELGYLG
VSHTNICDLPESLCQLSSLHTLKLNGCRNLSNLPSGIGALKNLHNLILSG
TDIEELPVSLCQLWNLQTLELDGCTRFFRIPSHIGDLTNLCRIKLSDTAV
TELPSSLCQLPNLQMLDLNGCHKLSQLPSGIGNLSNLYQLEITETSIREL
PKSLCQLSQLRKLNLNGNSNLQELPSNIENLVNLRQLELSEVGIEVLPKS
IAHLSKLYKLSFEYQQTPIASYL
>XP_042443855.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MDWIALLQHLGLPELVKKVVEFLLTKACSEVSLLQGVEDEIAKLRRTHER
IQSLLVDAEERRHIEDESVKSWLRELKTVGFDADDLLDGFRAHVDVFKHA
KEAPSRKRKRSWYDVPIPSLGVDTRLVRRYNIATEIVKIQSRLDEIYKRR
KNLQLKPSDGRQRNEGSNMAVFFPAVASLDVSKVVGRSKQCDSIVAALKV
DSDLPLRVIAIYGIAGIGKTTLAQLVFNHFWRDREEVSPNPSGSLSGVDR
HFEMKIWVSLPKVCDTARATKEIIEGITGEICKLPSLNHLQDCLKKCVKD
KKFLLVLDNFWAEDFKFWEILRLPLLKGAKGSSVLITTQNEGVSRLVATM
PLHLEGLEMDDSLKLFTALAFPQAEEDVDQLKDIGERIVERCQGSPLATI
SLGKLLRSESNVDNWEIVLNEMLALEGSANSSTRPILPSLMISYHHLNYQ
LKQCFTYCSIFPDNFEFDKDQLVRMWIAEGLIQQNGRRPPEAIGSRLFDY
LLWMSFFERSTKPCSNGTICKYTMPNLIHDLARLLSNNELLIMEDNELNP
SSGQFRYSSLLHRKRVPIMFEKIYHQEHLRALKLCNESKIDVAGIPKDLF
GKLKYLRLLDLSNSGIEKLPDSVGKLVHLRYLGLSETNVEELPESVEDLY
NLQTLELNFCSNLSSLPEGTSKLVNLRHLGLHLDWEQINDLRRMPTGIDR
LTSLMTLSRFTVTNVDGVGCNLKELKNLDLRGELCICKLENVTNASDASE
ANLGEKRIDKLMLRWSGATSSVQPGVNFSNVQHGANICKEVAERLQPYKY
LKCLWILNYPGSKFPNWLENSGFPSLEMVRLSCSGECESLPSLGQLPKLK
HLHIEGMKRLRNLKNMMKGFLSLETFTIKDMPDLNMLCKFKDNFPKLSKV
VVSQCPNLPRRRPKDLPRRIELIIIPQSTDNVNGNDVSS
>XP_042443935.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MANDFRTRIWSLCERFLTSPQSSEPPPSFQEDLEKLKTILDRIHAVLYDG
ERRDIEYRSDQVRLKELKNLAHDAEDVLDDYYYYILRSRAEAKASHKRKR
DEEVLVDLSNSSPQLSICFGNRINGNIGELDEISLQISEICHDGNVKKLD
NISFQIRKIDDKFTEIVESSVQFSFTQHDGKHISEGSRDQPVTSSMVNES
GIFGRVKEKKEVINFLLSENREENVSVICISGMAGQGKTTLAQIAYNNER
VCRHFDRKGWVYVPRDFDITKLTKSVLEAVTVNAFDLTELNTLQHVLKNE
LWQKKVLLVLDNVWDVSSSNWESFLMPFVDAEKVRIVITTRNKVTEIMQR
QLYPLGELPDAECWSLFKHYAFGGLNSRQAELCEIGEKIVQKCGRLPLAI
KALACLLRNGTEVKCWDEVLKSEIWELEKENEILPALMLSYKYLPTHLKP
LFLFCSMFPKGYLFEKDELVRFWMAHNYIQPRRCKRVEDVGQECFNELKE
RSFFDVVAETTKYKMHDMIRSLGQSIANKEFQAALSKDHADISDDVRHLF
VKGKGEIVESLCFKKPNVLRTFLYERLDVGVPRIPRALPKLRCLQHVFTD
STHESNSSYFADLIHLRYLRVYNKEFGRFPESICQLYNLQSLILDYCGDL
EELPDGIGNLVNLRYIGLSSLNIARLPDSICQLSNLQKLRLNDCRKIKEL
PNGINNLFHLRELTLCEMEISELPDSVCLLTNLQVLNLSGCGNFSGLPKD
IGNLSNLYTLEVTKTEIQELPESFCRLAKLQKLSLSGNWKLKDLPSNFGK
LASLNYLELNDVGIPMLPKCIFDLSLRSLRFSAVY
>XP_042443959.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAYLDVRCILFDMLPSPAIVEQGRALGVARQLESIRLHLWAINAVTMDAE
LRGQEDWMATVGTTMVDLEVLLTRIADRHETASDRWASGPFLGLCASFRL
ACKLTKMVRRLRVLVAEASALNLHEDTMRLMDPLREDYSDILKEEVLGRD
GDRDEIVKSIQQQQPKEEDKFGDAPPCVIVIYGPSGMGKTTLARMVYHHD
WVRRCFRHRIWVNVSDLFSFDMVGVSTEIARSLAGGGPCMKLRSHLQSIS
EFVLGALAGDRYLLVLDGIDVKGEAADFETSQSKLIQKWDQMTHQIFSVG
APGSTIIVTVADKYQAEIFKSATTHNLTALSENDWLDLFKKHAIKNRPDK
DEETAAAAFTEDALLPFLKGCYEDFSGSPLEAKLLGSAFRHTEVKRWRRE
IVDLGLLKRSMRENQRYSTASFHHLPTRFARLQLYCSLFPELKRATPLED
FIHMMLVEGLVPDSGDRDEAIRYLKDNVVAGFHQQLTRSQHYFTWEVGRE
HSSRIPKQCRHLCLLLDSNAPISATALQGATKLRTLILRTTKNMQQKHQK
YQFADLPEAIFLQLFDYLRILHLADSKIQTLPRAIEKLSDLRYLNLSNSE
IVELPGSLCSLRNLQVLKLNHCKMLLGLPGEIHKLEKLRILKLAHCEKLQ
KLPDSVTSLVNLQELNVKGCCFLVELPEDFSGMQNLTELNMQECASLIHV
PRGIEQLSELRRLLGYSLVHPIGTWINFTSLKQLGLEKLEHDMAMQNIVR
TKLLEQITNLENLALHWQWSERNDAANNDIQLDSLILLDHLEPRECLKKL
EIFSYFGVAYPKWMESINNLVEIRLVNLKACKSLPPLGHLPRLQIAVISG
MEMVVMVADSFYAGGKFLRLRELTFSEMPNLRTWNTPGSENCGTEENEEY
FPLLKELTLFQCPKLKELNVFLGAWRLKMSLSNGLLLTSQIQKSWDNLKH
LEELEIVGCQEVLERLPAAMANLKYLRKLTIIWCNNLVALPNWLLGLRHL
SRLQVCDCPNLSWMPQGLKQQQPGIAISVHGCPNLQRC
>XP_042443968.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MGSEITIAGWLAALLKASTAKLAANQHLQEKAVEQNLKKLQFNLDKIITA
AQLDRKQIGSHSIKDWFSSFKDAIYSADDVIEEFVQQLAKDKKQSSTLST
LRKSANFVSKMIQGGQFNGDDMKQLDEVTKTFDDLVSDIFELLKVVQQLE
GSGGTKQQEIIPSWRLTTSPYKGRTTTSGRGSEGKKMLEALLEEGGGSTS
DCCNFSVVCVVGTGGIGKTDLARFAYNNEKVRRHFDLKAWVAVCNNFDEK
RLTIEIIESASVERPSDLHSITSLEPIQNTLAKGMKDKRFLIVLDDVWED
SNASWEHLTTPFTHGKEGSRIIVTTQLESVAKSTKAKETIHLDGLEEQDY
LALFKKCAFGDKDKDHQPTLESICTEIAKKYDGSPLAAVSIGLELRSDPT
EEHWKRVARNKLGVIERREGDIVSVLGFSYEQLPARLKQCYLACALFPKK
HLFYKNQLIRIWTALRFVSADGNGGNPVDELASKSFFVNSISKREDGQFM
LHAVLHELADLLCDGEFFRVEDEAGGQEIKIPQKARHVYVSKADNFVRVS
EALAEKEQLRSLVIDGSVPSDATLRADFMVSLETVLKKCKFLRLLMLPEK
FPLESVVAIGRLSRLRCLDFHGIQRKALPQYLESLNLLQWPDLKQRPEAW
NLTKGGSRIRKQPSAGSEKDISSASGPIRSTSNSSANLPSP
>XP_042445238.1 disease resistance protein RGA2-like [Zingiber officinale]
MDPHIIVLTVIGWIVPAVVTMAINKTLNNPPKDDKAKKLEEEIEKKSRII
AQLDEEITSNQIVKHGLWGVKNVVGGAKEAIENYRKHDGRCRKVFFWKPD
ARTNWLEEAHGMLDQTDVDFRAVAVARQNDEEYKFRRTTGERKHFTKLRG
RDAETRALLNWLENSQRSFSSGSKKFSILSVVGPGGIGKTELAREAYNAR
ASFGIKAWVSVCKNCDVKKMTIEIMDSADIKLPPGLHSINSPEQIRSIFT
KRIKGQRVLVVFDDVWEGFSTSWEELYASLSHGKQGSRVIVTTQLERVAK
LIGSDETINLDPLEHQEYWKLFEECAFGNQNPNNYPELQQLGQAIAAKFE
GSPLAAVEIGRRLASNLTKRHWEKIAGSQFGELQRSRGDILSALEFCYEQ
LPTRLKQCYLSCALFPKNYCFDKDQLLRMWVALGFAPSLADEEIRSLAED
LASRSFFVNAERRNNKFMIHPVYHELADMICDGEFFRLEEETEETKIPEK
ARHVYVKADILVKVCKGLGEKENLYSLVIDGSLSSGIPNSKSDFHNSLNK
VLDDLKGLRVLILPELPGNGSLRSIQKLSHLEYLEIPSNENRTLSKSFLA
RYRRGQVKLNQVSRDLFIKREGMDELAKLYGVTADWQPEAISTASLGRRR
RKRSLPRAARKDQLLWEQ
>XP_042445827.1 disease resistance protein RPM1-like [Zingiber officinale]
MEAAFISLLINKLAQVAFSQAESRCSQLLLQHTTPPLDQIHARVRRITDE
FIVMKAFLEGSNWSTIAATNKPLEAWIEQVRKVAFEIEDIIDEYLYLVGR
QREMTWKNYLMAPSDLCFNLAKAWRGIDSRLEKMERDLSELSSRRDRFGI
TISGNEDGVKNSERDTHHYRAYSPMFTDEDDLVGIEDNKSKLLSWLTNAD
TCRKMTAIAVWGMGGHGKTTLVANVYRNKTVKNHFDCQVWVTVSKTYSAL
EELLRIMIQEIFKGQKELVPNGVTTMQRLELFDIIKESLQQKRYIIVLDD
VWQVDLCNDISCAFVDSNNGSRLIITTRMHEVARIANEEHIMKLQQLNEK
DAWILFCKKAFRRENNKDCPKELEDYTGRILNKCQGSPLAIVAIGSLLSF
KEKSETEWKKAYDNLQWEFENNPALDKVKNILNLSFNDLPYYLKNCFVYC
SIFPEDYLIKRKKLIRLWVAEGFVEAKSSNRSMEEEAEDYLAELVDRSML
QVVNRNAFGRLQTFKMHDVVREVTQAISRKAKFSMILDGSQSGLDYQTRR
LSIQTTDESLDLDKSLSLSQLRSLVMLSTCNSSSDSLSAILISFKMLRVL
ELEFQPISNLPNEISALFNLHYLGLRGTKVENLPNNIQKLQSLETLDLRC
SNIVKLPRGVTQLKQLRHLFMFAREIEFGGSTVVGCVPTLKGARQWKNLQ
TLRQVKANKSLVQQLEDMKELRTLAVTEVEYAHCPQLCTSLTKLTKLHSL
CLSARSEEQLNFEILNSPPPPLQKLTLSGRLFEGKMPKFICSCEELTYVQ
LMSSHLIEDPLPSLGQLHKLVELTLWEDSYDGQKLHFRTGWFLNLKVLYL
ETLRNLNNIVIEEGAMPNLLKLIMSSLGELRMIPPGIEFLTNLQSLELCA
LPEELVEKLRNDDDNEILQRIRGTRNVVVDSISN
>XP_042446008.1 putative disease resistance protein RGA3 [Zingiber officinale]
MDVVSPILDRARAKVIDKLIDKVSTYVQDQYYWKANLQEELQNLKRLLPQ
IQAVVGYAEDKLTMYESHNPALIKWLWQFRDDIDEAEEVLDELEYRELEK
KYDGDKSRLSTIIDPYFRAAKRFLKSDDDVLERLRTCLENLKTSASDVEK
FRALVTPTSGIGTGQMQQEQESLTLSNQSRITSCLPELSFKGREEEKGKI
IQYLLGEESEIQTSQNVHCLPLVAMGGMGKTALAQQVFDHFENEKKEHFD
IKIWVCDSLPDLNASNLMKKILECLTDQSESGPLERIPVKLKEKLHSKRF
LLVLDDAWDDKNQREWEKLRAPLLHGQKGSWIILTTRLESVAKMVSKVIK
GGTMKPMTLQGLPKDECRSLLYEHAFVDQDPNEFPLLKKIGEEIVEKLHG
VPLLAKSIGGALNNKLEADHWTSISGSELWKMPQDLNNYEFIPALTLSFK
MLSPRLKRCFSYCSIFPQDYKFEKQKLVYMWVAAGLIYLDGSEEGSDEDI
ANYCFDILCNKSFFDVHTDNWSAFQEGITPYGLEAIYYTMHDMLNGLSRH
VSRYECCRIVHDTPSYICDYNAIRHISISITSIDAQLGDLANMVCKFKHL
RTLRIEKYYDNSQKLDDFIRDACKSPRRIRVLIIESNQCLESISDFVKLR
FLEISSQLPSLSICKFYFLQVLIGYNAILAKDTSKLTNLRHLYRVPYNVL
FSVAKVGKLTSLQELYFNVGTEPGYRIDELMNMNNLCELSISNLSNVHNL
EEANNVNLVSKSYLTSLKLNWKKAYWYESDQDEASSNIGHDQQEVLAALQ
PPSTIRKLIITKYKGGRPAPWMNPRSLSRLESLELYGCTNLEELPPLWKL
PCLKLIKLIDMKAIRSLGCHSSDPMERQFPVLEELEFRDLPLLEEWNGAD
DYQWFPPLKRFKIENCPKLKKIPDLPLSIKNLCMKKLWLESLPRSYKCSN
GSITFGGFQQLMSLKSLEMHGYSENVDIGSIGEEDGNFLPSSLEILKLEI
LQKHKDLASYLRGLTSLIELSLSCLQGMTSLPLTNELEHLTTLRSLDIWN
CEDLTSPGGLYIIKSLKHLGIKDCPKFLTTDVES
>XP_042446009.1 putative disease resistance protein RGA3 [Zingiber officinale]
MDVVSPILDRARAKVIDKLIDKVSTYVQDQYYWKANLQEELQNLKRLLPQ
IQAVVGYAEDKLTMYESHNPALIKWLWQFRDDIDEAEEVLDELEYRELEK
KYDGDKSRLSTIIDPYFRAAKRFLKSDDDVLERLRTCLENLKTSASDVEK
FRALVTPTSGIGTGQMQQEQESLTLSNQSRITSCLPELSFKGREEEKGKI
IQYLLGEESEIQTSQNVHCLPLVAMGGMGKTALAQQVFDHFENEKKEHFD
IKIWVCDSLPDLNASNLMKKILECLTDQSESGPLERIPVKLKEKLHSKRF
LLVLDDAWDDKNQREWEKLRAPLLHGQKGSWIILTTRLESVAKMVSKVIK
GGTMKPMTLQGLPKDECRSLLYEHAFVDQDPNEFPLLKKIGEEIVEKLHG
VPLLAKSIGGALNNKLEADHWTSISGSELWKMPQDLNNYEFIPALTLSFK
MLSPRLKRCFSYCSIFPQDYKFEKQKLVYMWVAAGLIYLDGSEEGSDEDI
ANYCFDILCNKSFFDVHTDNWSAFQEGITPYGLEAIYYTMHDMLNGLSRH
VSRYECCRIVHDTPSYICDYNAIRHISISITSIDAQLGDLANMVCKFKHL
RTLRIEKYYDNSQKLDDFIRDACKSPRRIRVLIIESNQCLESISDFVKLR
FLEISSQLPSLSICKFYFLQVLIGYNAILAKDTSKLTNLRHLYRVPYNVL
FSVAKVGKLTSLQELYFNVGTEPGYRIDELMNMNNLCELSISNLSNVHNL
EEANNVNLVSKSYLTSLKLNWKKAYWYESDQDEASSNIGHDQQEVLAALQ
PPSTIRKLIITKYKGGRPAPWMNPRSLSRLESLELYGCTNLEELPPLWKL
PCLKLIKLIDMKAIRSLGCHSSDPMERQFPVLEELEFRDLPLLEEWNGAD
DYQWFPPLKRFKIENCPKLKKIPDLPLSIKNLCMKKLWLESLPRSYKCSN
GSITFGGFQQLMSLKSLEMHGYSENVDIGSIGEEDGNFLPSSLEILKLEI
LQKHKDLASYLRGLTSLIELSLSCLQGMTSLPLTNELEHLTTLRSLDIWN
CEDLTSPGGLYIIKSLKHLGIKDCPKFLTTDVES
>XP_042446010.1 putative disease resistance protein RGA3 [Zingiber officinale]
MDVVSPILDRARAKVIDKLIDKVSTYVQDQYYWKANLQEELQNLKRLLPQ
IQAVVGYAEDKLTMYESHNPALIKWLWQFRDDIDEAEEVLDELEYRELEK
KYDGDKSRLSTIIDPYFRAAKRFLKSDDDVLERLRTCLENLKTSASDVEK
FRALVTPTSGIGTGQMQQEQESLTLSNQSRITSCLPELSFKGREEEKGKI
IQYLLGEESEIQTSQNVHCLPLVAMGGMGKTALAQQVFDHFENEKKEHFD
IKIWVCDSLPDLNASNLMKKILECLTDQSESGPLERIPVKLKEKLHSKRF
LLVLDDAWDDKNQREWEKLRAPLLHGQKGSWIILTTRLESVAKMVSKVIK
GGTMKPMTLQGLPKDECRSLLYEHAFVDQDPNEFPLLKKIGEEIVEKLHG
VPLLAKSIGGALNNKLEADHWTSISGSELWKMPQDLNNYEFIPALTLSFK
MLSPRLKRCFSYCSIFPQDYKFEKQKLVYMWVAAGLIYLDGSEEGSDEDI
ANYCFDILCNKSFFDVHTDNWSAFQEGITPYGLEAIYYTMHDMLNGLSRH
VSRYECCRIVHDTPSYICDYNAIRHISISITSIDAQLGDLANMVCKFKHL
RTLRIEKYYDNSQKLDDFIRDACKSPRRIRVLIIESNQCLESISDFVKLR
FLEISSQLPSLSICKFYFLQVLIGYNAILAKDTSKLTNLRHLYRVPYNVL
FSVAKVGKLTSLQELYFNVGTEPGYRIDELMNMNNLCELSISNLSNVHNL
EEANNVNLVSKSYLTSLKLNWKKAYWYESDQDEASSNIGHDQQEVLAALQ
PPSTIRKLIITKYKGGRPAPWMNPRSLSRLESLELYGCTNLEELPPLWKL
PCLKLIKLIDMKAIRSLGCHSSDPMERQFPVLEELEFRDLPLLEEWNGAD
DYQWFPPLKRFKIENCPKLKKIPDLPLSIKNLCMKKLWLESLPRSYKCSN
GSITFGGFQQLMSLKSLEMHGYSENVDIGSIGEEDGNFLPSSLEILKLEI
LQKHKDLASYLRGLTSLIELSLSCLQGMTSLPLTNELEHLTTLRSLDIWN
CEDLTSPGGLYIIKSLKHLGIKDCPKFLTTDVES
>XP_042446148.1 disease resistance protein RGA2-like [Zingiber officinale]
MYVCMLHIVTGTGEMLPDFCLAGTPLGRDSIYAGMKEMCQLLQADASDGQ
YQSDLASATRETSSFLISKVLGREEEQKRIIELLLRSTDESASASDKGSS
FSVIPLVGIGGVGKTTLAQLVYKDKEIQNHFGLKIWICVSENFNVQRLTK
EIIESVTKTEHSSQMKLDVLQNILKEKIASKMILLVLDDVWNEDEEEWRK
LCAPFQDAAAGSKVIVTTRSKSIADKIGTVEAIVLGDLDKISFWELFKKC
AFGPSKPEEYPELEEIGRIIASKLKGLPLAAKTVGNLLGSNMNPHYWRSI
MKSEVWELQQNKNDIIPVLQLSYQYLSAPLKRCFAFCSLFQKDYKFSEIE
LTRMWMAEGFVVAQGNQRMEDVASKYFHELVNMSLFQQETSWLGHYYVMH
DLIHDLTQAVSVDEISRTNDGKSNKISTTLRHLALETGFVQTKYLRSRFK
KLHSLFFRCLHLKSPPIGFIKKLRSIRVLVLSRCRLRMLPISVGELVHLR
YLDISYNGIKKLPGSLCELYNLQTLKANCNSLISLPEDISQIINLRHIDV
ENEVVVKIKMIGRLTSLQELSEFHVRKEVGFKITELSGLKQLHGKLKITN
LENVESKEEAEKAQMKNKEYLDALELGWGFDPKLDDNKLVVMEEVLEGLQ
PHESLKRLKIRRYCGATSPSWMKKEELSNLEILELSYCESWKDISCTALL
PHLKVFHIKSMCFSKSCFEVCGSRESKLFPMLEELQLTNMNVLEEFPNLG
RFPCLRVVRMTEIKSLKHIDFATFGATENALFPMLEELELMHMHALEELS
FLGHFPRLKFLRMKEMRLLKHIGFASVHATENDPFPVLEVLELMDLPVLE
ELPDLGSLPCLKSLCLCGMSMLKHIDFSFYGATEKVLLPRVETLVLRDLE
ALEELPNNLGRLPCLKVLNILKISAVKQIGHGFFSTEAISKCFLSLERLW
IGSMSACEGWCWIDGSELFPSLQRLFITECPKLERLPPLPPSLTHLTLEK
VGSTELPSLRELETNGSGYNQTTSSLSYLRISECNNLASLEKGLMSQNLS
DIEAIHVEGCNELMRMPLKRFENFTSLKELQIKACPKLSLTQEEEAALLP
PSFKVFILNDCGDLNKLWLGHPYRSTF
>XP_042446149.1 disease resistance protein RGA2-like [Zingiber officinale]
MYVCMLHIVTGTGEMLPDFCLAGTPLGRDSIYAGMKEMCQLLQADASDGQ
YQSDLASATRETSSFLISKVLGREEEQKRIIELLLRSTDESASASDKGSS
FSVIPLVGIGGVGKTTLAQLVYKDKEIQNHFGLKIWICVSENFNVQRLTK
EIIESVTKTEHSSQMKLDVLQNILKEKIASKMILLVLDDVWNEDEEEWRK
LCAPFQDAAAGSKVIVTTRSKSIADKIGTVEAIVLGDLDKISFWELFKKC
AFGPSKPEEYPELEEIGRIIASKLKGLPLAAKTVGNLLGSNMNPHYWRSI
MKSEVWELQQNKNDIIPVLQLSYQYLSAPLKRCFAFCSLFQKDYKFSEIE
LTRMWMAEGFVVAQGNQRMEDVASKYFHELVNMSLFQQETSWLGHYYVMH
DLIHDLTQAVSVDEISRTNDGKSNKISTTLRHLALETGFVQTKYLRSRFK
KLHSLFFRCLHLKSPPIGFIKKLRSIRVLVLSRCRLRMLPISVGELVHLR
YLDISYNGIKKLPGSLCELYNLQTLKANCNSLISLPEDISQIINLRHIDV
ENEVVVKIKMIGRLTSLQELSEFHVRKEVGFKITELSGLKQLHGKLKITN
LENVESKEEAEKAQMKNKEYLDALELGWGFDPKLDDNKLVVMEEVLEGLQ
PHESLKRLKIRRYCGATSPSWMKKEELSNLEILELSYCESWKDISCTALL
PHLKVFHIKSMCFSKSCFEVCGSRESKLFPMLEELQLTNMNVLEEFPNLG
RFPCLRVVRMTEIKSLKHIDFATFGATENALFPMLEELELMHMHALEELS
FLGHFPRLKFLRMKEMRLLKHIGFASVHATENDPFPVLEVLELMDLPVLE
ELPDLGSLPCLKSLCLCGMSMLKHIDFSFYGATEKVLLPRVETLVLRDLE
ALEELPNNLGRLPCLKVLNILKISAVKQIGHGFFSTEAISKCFLSLERLW
IGSMSACEGWCWIDGSELFPSLQRLFITECPKLERLPPLPPSLTHLTLEK
VGSTELPSLRELETNGSGYNQTTSSLSYLRISECNNLASLEKGLMSQNLS
DIEAIHVEGCNELMRMPLKRFENFTSLKELQIKACPKLSLTQEEEAALLP
PSFKVFILNDCGDLNKLWLGHPYRSTF
>XP_042446150.1 disease resistance protein RGA2-like [Zingiber officinale]
MYVCMLHIVTGTGEMLPDFCLAGTPLGRDSIYAGMKEMCQLLQADASDGQ
YQSDLASATRETSSFLISKVLGREEEQKRIIELLLRSTDESASASDKGSS
FSVIPLVGIGGVGKTTLAQLVYKDKEIQNHFGLKIWICVSENFNVQRLTK
EIIESVTKTEHSSQMKLDVLQNILKEKIASKMILLVLDDVWNEDEEEWRK
LCAPFQDAAAGSKVIVTTRSKSIADKIGTVEAIVLGDLDKISFWELFKKC
AFGPSKPEEYPELEEIGRIIASKLKGLPLAAKTVGNLLGSNMNPHYWRSI
MKSEVWELQQNKNDIIPVLQLSYQYLSAPLKRCFAFCSLFQKDYKFSEIE
LTRMWMAEGFVVAQGNQRMEDVASKYFHELVNMSLFQQETSWLGHYYVMH
DLIHDLTQAVSVDEISRTNDGKSNKISTTLRHLALETGFVQTKYLRSRFK
KLHSLFFRCLHLKSPPIGFIKKLRSIRVLVLSRCRLRMLPISVGELVHLR
YLDISYNGIKKLPGSLCELYNLQTLKANCNSLISLPEDISQIINLRHIDV
ENEVVVKIKMIGRLTSLQELSEFHVRKEVGFKITELSGLKQLHGKLKITN
LENVESKEEAEKAQMKNKEYLDALELGWGFDPKLDDNKLVVMEEVLEGLQ
PHESLKRLKIRRYCGATSPSWMKKEELSNLEILELSYCESWKDISCTALL
PHLKVFHIKSMCFSKSCFEVCGSRESKLFPMLEELQLTNMNVLEEFPNLG
RFPCLRVVRMTEIKSLKHIDFATFGATENALFPMLEELELMHMHALEELS
FLGHFPRLKFLRMKEMRLLKHIGFASVHATENDPFPVLEVLELMDLPVLE
ELPDLGSLPCLKSLCLCGMSMLKHIDFSFYGATEKVLLPRVETLVLRDLE
ALEELPNNLGRLPCLKVLNILKISAVKQIGHGFFSTEAISKCFLSLERLW
IGSMSACEGWCWIDGSELFPSLQRLFITECPKLERLPPLPPSLTHLTLEK
VGSTELPSLRELETNGSGYNQTTSSLSYLRISECNNLASLEKGLMSQNLS
DIEAIHVEGCNELMRMPLKRFENFTSLKELQIKACPKLSLTQEEEAALLP
PSFKVFILNDCGDLNKLWLGHPYRSTF
>XP_042446332.1 putative disease resistance protein RGA3 [Zingiber officinale]
MADGWMDKKGRTLINLLVNGTKGNVFVESVNTSGYSYTMDKMFELLYKFV
YCIGENNMVHIITDNASRNVNAGKDCSRVLCTVHQQSGAVREWKALLCSI
PTANPEFQHKARLQIEKCSSHLLLISQGKQNSEKLQRIAEFLIAESSSLK
SIKDLSYFESKQYNAFDVTKQIYGRNSDREHIISWLLLGTNSRFSLFEDE
RSRNKFSAIAIVGEAGVGKTALAKEVYNDPLICKYFNSRVWLHFTEESDA
VSLSKAFFVSITGKSCDGKEPVHLQSVMKETLKGKKLLLVLDDPHDLNPR
LWEYLQAPLAGVRMAKFIITSLTELDASKLRGIESYPLGCLHIDLSWDLF
QYYAFREDSSHPPELVEIGKYIVQKCRGLPIAVKTLGSLLGYQMDRRIWI
DVLESELWKLQETENDISPALQLSYYLLPTYLKPCFLYCSLFPRGCKFDK
YELVRLWMAQGYIQHEDEDEDDQSLETVGCNYFHELQMLTIFDRSWDGTF
TIHDLLYDVSKYMSNGECSSLSDGKMYTDSGKIRQLYVTSSKKTNELHSS
NENLTLQLLYKSLGGVLPNDILTMALIKSMQGIRALELTHHGDSSIAETI
QERALDKLNASSVSNLRFIHLRYLRICDRFIELLPAAVCQLYNLQTLTLD
KCLKLRELPSDICMLVNLRYLELSEANIEMFPESICLLRNLQSLIVDYCR
NLKELPRNIGNLFNLCHLGLCGTSIKRLPESVDRLSKLPTLKLDHCKILM
ELPSSIGNLVNLQHVTVCKTKITKLPESLCLLSNLLTLDLAYSNLSELPN
DIGNLSNLNYLALSYTNISILPEALCQLTSLRTLKLNGCTNLSQLPSGIG
ALKRLSHLVVSGIDIEHMPASVCQLFSLEALEMDGCRRFFSLPDDIGYLT
ELRQLKLSDTEIQELPESICQLSKLQNLELNGCQRLSKLPESIGDLSELS
NLEVTETKIKALPVSFCRLSNLQVLNLNGNLDLQELPSGIENLANLSQLE
LSEVGIEVLPRCIGRLTNLEKLSFEHKQKPFENYQL
>XP_042446333.1 putative disease resistance protein RGA3 [Zingiber officinale]
MANNPFSSFGSKIDDLLPLLAEATIGLSDVAAGSSPEVPLKELKDIKAIL
KNIKGLLYDSGRQIREDAIKLLLKELQDLVIEVEDLVDDYEYKMFQREAE
FLNKIEQPSGYVSSDRLRGLDGGAMHSPGLDGGAKSCVTGSSPGLGGGAR
SPINPSPELSVGASPSSGLDVGASHHSCITDFSSGLGGGARSTIDPSPEF
SEGAGHSSGLDGGASSCITTDPSSGLGGGASHSPGSRGGVSQCTTHLTLA
LRRVQWIWMELREQLRKSQKFASHLLLVSQENQTFKKLQRVRKFLLAESE
DTIRGRKHYNAFDVTKQIYGRNTDREHIISWLLLGTNSRFSLFEDERSRN
KFSAISIVGEAGVGKTALAKEVYNDPLVCKYFNSRVWLHFTEESDAVSLS
KAFFVSITGKSCDGKEPVHLQSVMKEELKGKKLLLVLDDLQDLNPRLWKY
LQAPLAGVRMAKFIITSQTELGTSKSRGIESYPLGRLSLDLSWNVFQHYA
FCEDSSCPPELIEIGKHIVQKCWGLPLAVKTLGSLLGYQMDKRIWIDVLD
SELWELQESETHICPALQLSYYLLPTYLKPCFLYCSLFPRGYKFDKYELV
RLWMAQGYIQHKYGQSLETVGCNYFHELQMLTIFDRSWDGTFTIHDLLYD
VSKYMSNGECSSLPNVKMYKDSGKIRQLYVTSSKGTNELQSSNAILTLQL
LYRSLGGFLPNDILTMALIESVQGIRALELTCHADSSIAETIQEKALDKL
NASSVSSLRFIHLRYLRICDRFIELLPAAVCELYNLQTLTLDKCLKLREL
PSDIGKLVNLRYLGLSEANIEKLPKSVYQLRNLQSLKVDYCRNLKDLPYN
IGSLVNLCHLGLSGTSIKRLPRSVHRLSKLSTLKLDQCKILMELPSSIGN
LVNLRHVTACKTKITKLPESICSLFNLLTLDLAYSNLSELPNDIGNLSNL
NYLALSYTNISILPESFMLLFLASILNSLSASVCQLLNLEVLEMDGCRRF
FSLPDGIGYLTKLHQLKLSDTEIRELPESIGQLSNLQNLDLNGCQRLSKL
PESIGYLSELSNLEVTETKIKTLPASFCQLSNLKVLNLNGNLDLQELHSG
IENLANLSQLELSEVGIEVLPRCIGRLANLEKLSFEHKQKPFENYQL
>XP_042446624.1 putative disease resistance protein RGA3 [Zingiber officinale]
MEGAAALTVGGWLAQPVIKMLVDSVWTSSLRGKLHGLEDDDLQKLQRSLL
NIHTIVDKAGMRWSRDARLVEMMKQLQDAAYDAEDFLDELTFHGMKQKIK
EEASHKVLNQFSRAIRNAKTKLFSDSVKRLNKIQKKLDCVYADMKEMCQS
LQVDASDGRYQSDLAPATRETSSFLISKVLGREEEKKRIIELLLRSTEES
ASASDEGSSFSVIPLVGIGGVGKTTLAQLVYKDEKIQNHFTFKSWICVSD
NFNVQRLTKEMIESVTKTEHSSQMTLDVLQGILKEKIASKMILLVLDDVW
NEDEEEWRKLCAPFMYAAAGSKVIVTTRSLSIAKNIGSVEAIVLGSLDEI
SYWELFKQCAFGSSKPEDHPELADIGRSIALKLKGLPLAAKTVGNLLGSN
MNPHHWRSIMKSEIWELQQNKNDIIPVLLLSYQYLSAPLKLCFAFCSLFQ
KDHRFSEIELTRIWIAEGFIVAQGNQRMEDVASKYFHELVNMSLFQQEAT
FGRHYYVMHDLIHDLTQSLSMDETSRITDGKSNKISTTLRHLAVETEFVE
TKQLRSIFKKLHSLFCQYLESPPLDIIEKLRSIRVLVLSDCCLLMLPTSI
GELVHLRYLDISHNFIRKLPESLCELYNLQTLKAHSKSLISLPEDISQLI
NLRHIDVENEVVVKIKMIRRLTSLQELSEFQVRKEVGFKIMELSGLKQLH
GKLKITNLENVETKEEAENAQMKNKEYLDALELEWESDPKLENKLVATEE
VLEGLQPHESLKRLKISRYYGFRSPSWLKKEELSNLERLELSHCESWKDI
SCTALLPHLKVFHIESMCFSKSCFAVCGSRESKLFPMLEELQLTNMNVSE
EFPNLGRFPCLRVVRMTKIESLKHIDFAASCAMENSLFPMLEELELKHMP
ALEEFSILGHFPRLRILLIIGIWSLKRIIFAASGVIENSLFPMLEELELR
NLHALEEFSGLGHFPLLKVLRMIEMRSLKHIDFAASGAIENSLFPMLEEL
ELSNLHALEEFSGLGHFPRLRVLRMIGMRLLKHIDFAAAGAIENSLFPML
EELELRNLHALKEFSDLGYFPRLRVLRMIGMRLLKHIVFAASGGIENSLF
PILEELELMHMHALEEFSFLGHFPRLRFLRMKEMRLLKHIEFASSVHGTE
NDPFPVLEVLELMNLPVLEALPDLGSLPCLKSLCMCGMSMLKHIDFSFYG
ATEKVLLPRVETLVLRDLEALEELPNNLGRLPCLKVLNILKISAVKQIDH
GFFSTEAISKCFLSLERLWIGGMSACERWCWIDGSELFPSLQRLFITECT
KLERLPPLPPSLTHLTLEKVGLTELPSLRELETNESGYNQTTSSLSYLRI
SECNNLASLEEGLLSQNLSDIEAIHVEGCNELMRMPLKRFENFTSLKELQ
IKACPKLSLTQEEEAALLPPSFKVFILNDCGDLNKLWLGHPYRWTF
>XP_042446626.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEGAAALAVGGWLAQPVIKMLVDSVWTSSLRGKLYGLQDNDLQKLQRSLL
NIHTIVDKAAMRWSRDARLVEMMKQLQDAAYDAEDFLDELRFHGMKQKIK
EEASHKVLTQFSRAIRNAKTKLFSDSVKRLNKIQKTLDDIYADMKEMCQS
LQVDASDGQYQSDLASATRETSSFLISKVFGREEEQKRIIEQLLRSTDES
ASASDNGSSFSVIPLVGIGGVGKTTLAQLVYKDEEIQNHFALKIWICVSE
NFNVQRLTKEMIESVTETEHASQMKLDVLQNILKREIASKMILLVLDDVW
NEDKEEWRKLCAPFMYAAAGSKVIVTTRSKSIADKIGTVEAIVLGSLDEI
SYWELFKQCAFGSSKPEEHPELADIGRSIALKLKGLPLAAKTVGNLLGSN
MNPRHWRSIMKSEIWELQQNKNDIIPVLQLSYQYLNPPLKRCFAFCSLFQ
KNYMFSEIELTRMWMAEGFVVAQGNQRMEDVASKYFHELVNMSLFQQEAT
FGRHYYVMHDLIHDLTQLVSVDETSRMDNGKSNKISTTLRHLAVETKLVE
TKDLRSRFKKLHSLFCQHLKSPSVNFIEKLRSIRVLVLCDCGLQMLPTSV
GELVHLRYLDISYNKIKKLPESLCELYNLQTLEASCNSLISLPEDISQLI
NLRHLDVENEIVVKIKMIGRLTSLQELSELQVRKEVGFMITELSGLQQLH
GKLKITNLENVGSKEEAEKAQMKYKEYLDALELEWGFDPELENKLVAVEE
VLEGLQPHESLKRLDIRRYCGARSPSWMKKEELSDLERLELSYCESWKDI
SCTALLPHLKVFNIEGMWFLKSCFEVCGSRESKLFPMLEELQMWNMNASE
ELPNLGRFPCLRVVRMIEIKSLKHIDFTASGAIENSLFPMLEELELRDMH
ALEDISTLGHFPHLRILLMIGMPLLRDIDFAASGAIENSLFPMLEELELM
HMDVLEEFSYLGHFPRLRILRMIGMQLLRHIGFASVHATENDLFPVLEVL
ELMDLPVLEELPYFGSLACLKSLCMCGMSMLKHIDFSFYGATENVLLPRV
ETLVLRDLEALEELPSNLGRLPCLKLLDIVNISAVKQIDHGFFSTEAISK
CFLSLESFSISNMPACEGWCWIDGSELFPSLQRLVIYGCPKLERLPPLPP
SLTHLTLEEVGLTELSNGSGGNQTTSSLSDLRISECNNLTSLEEGLLSQN
LSNIEVIHIETCNELMRMPLKRFENFTSLKELWIRACPKLSLTLEEEAAL
LPPSIKILKLDDCGDLDKLLLGNLYNLTSLTEFEIANCRHVQSLPRGLFL
CLSRLERLTITDCHELRLVEGLEGSRSLWRLVIRRCPNLSSNPVEQGGEG
FLHQLRSYEID
>XP_042446810.1 disease resistance protein RGA2-like isoform X1 [Zingiber officinale]
MEGAAALAVGGWLAKPVIRMLVDRVSTSSLRGKLHGLQDDDLQKLQRSLL
NIHTIVDKAGMRWSRDARLVEMTKQLQDAAYDAEDFLDDLTFHDMKQKIE
EEASHMASNRISRAIRNAKAKLFSDSVKRLNKIQKKLDDIYADMEKMCQS
LQVDASDVQYQSDLASATRETSSFLISNVLGREEEQKRIIELLLRSTDES
ASASDKGSSFSVIPLVGIGGVGKTTLAQLVYKDKEIQNHFALKIWICVSE
NFNVQRLTKEMIESVTKTELSSQMKLDVLQNILKEKIASKMVLLVLDDVW
NEEEEEWRKLCAPFMYAAAGSKVIMTTRSKSIADKIGTVEAIVLGDLDEI
SFWELFKQCAFGSSKPEEHPALVEIGRSIASKLKGLPLAAKTVGNLLGSN
MNPDHWRSIMKSEVWELQQNNKNDIIPVLQLSYQYLSAPLKRCFAFCSLF
QKDYKFSEIELTRMWMAEGFVVAQGNQRIEDVASKYLHELVNMSLFQQET
SSSSEHYFVMHDLIHDLTQSVYVDETSRMDNGKSNKISTTLRHLAVETEF
VETKELRSRFKKLHSLFCQHLKSLPLDFIEKLRSIRVLVLYDCGLQMLPT
SVGELVHLRYLDIAYNEMEELPESLCELYNLQTLTASYNSLISLPEDISQ
LVFLRHLDVENQIVVKIKMIGRLTSLQELSEFQVRKEVGFMITELSGLQQ
LHGKLKITNLENVESKEEAEKAQMKNKEYLNALELEWGFDHKLDDNKLVA
MENVLEGLQPHESLKQLKIRRYCGARSPSWMKKEELSNLERLELSYCESW
KDISCTALLPHLKVFHIDQSMWFSKSCFEVCGSRESKLFPMLEELQLRNM
NASEELPNLGRFPCLRVIRMTEIKSLKHIDFAASGAIENSLFPMLEELEL
RGMPALEEISNLGHFPRLKVLHMMRMRLLKHIDFAASCAIENSLFPMLEV
LELRDMHALEKLSTLGHFPRLRVLHMIRTWSLKHIVFAASGAIENSLFPM
LEELDLRYMPALEEFSSRGHFPRLRVLGMVAMPLLKHIGFASVHATENDL
FPALEVLELMDLPVLEELPDLGSLPCLKSFHMRRMSMLKHIDFAFYGATK
KVILPKVETLVLDDLEALEELPSNLGRLPCLKVLKIVKISAVKQIAHGFF
STEVISKCFLSLESLWISDLPACERWCWIGGSELFPSLQKLTIYECPKLE
RLPPLPPSLRYLSLREVGLTELPSLQELETNGSGDNQTTSSLSDLRIIEC
NNLTSFEEGLLSQNLSNIKDIYVAGCNELMWMPLKRFENFTSLKELQIKA
CPKLSLTQEEEAALLPPSFKVFILNDCGDLNKLWLGHPYRSTF
>XP_042446811.1 disease resistance protein RGA2-like isoform X1 [Zingiber officinale]
MEGAAALAVGGWLAKPVIRMLVDRVSTSSLRGKLHGLQDDDLQKLQRSLL
NIHTIVDKAGMRWSRDARLVEMTKQLQDAAYDAEDFLDDLTFHDMKQKIE
EEASHMASNRISRAIRNAKAKLFSDSVKRLNKIQKKLDDIYADMEKMCQS
LQVDASDVQYQSDLASATRETSSFLISNVLGREEEQKRIIELLLRSTDES
ASASDKGSSFSVIPLVGIGGVGKTTLAQLVYKDKEIQNHFALKIWICVSE
NFNVQRLTKEMIESVTKTELSSQMKLDVLQNILKEKIASKMVLLVLDDVW
NEEEEEWRKLCAPFMYAAAGSKVIMTTRSKSIADKIGTVEAIVLGDLDEI
SFWELFKQCAFGSSKPEEHPALVEIGRSIASKLKGLPLAAKTVGNLLGSN
MNPDHWRSIMKSEVWELQQNNKNDIIPVLQLSYQYLSAPLKRCFAFCSLF
QKDYKFSEIELTRMWMAEGFVVAQGNQRIEDVASKYLHELVNMSLFQQET
SSSSEHYFVMHDLIHDLTQSVYVDETSRMDNGKSNKISTTLRHLAVETEF
VETKELRSRFKKLHSLFCQHLKSLPLDFIEKLRSIRVLVLYDCGLQMLPT
SVGELVHLRYLDIAYNEMEELPESLCELYNLQTLTASYNSLISLPEDISQ
LVFLRHLDVENQIVVKIKMIGRLTSLQELSEFQVRKEVGFMITELSGLQQ
LHGKLKITNLENVESKEEAEKAQMKNKEYLNALELEWGFDHKLDDNKLVA
MENVLEGLQPHESLKQLKIRRYCGARSPSWMKKEELSNLERLELSYCESW
KDISCTALLPHLKVFHIDQSMWFSKSCFEVCGSRESKLFPMLEELQLRNM
NASEELPNLGRFPCLRVIRMTEIKSLKHIDFAASGAIENSLFPMLEELEL
RGMPALEEISNLGHFPRLKVLHMMRMRLLKHIDFAASCAIENSLFPMLEV
LELRDMHALEKLSTLGHFPRLRVLHMIRTWSLKHIVFAASGAIENSLFPM
LEELDLRYMPALEEFSSRGHFPRLRVLGMVAMPLLKHIGFASVHATENDL
FPALEVLELMDLPVLEELPDLGSLPCLKSFHMRRMSMLKHIDFAFYGATK
KVILPKVETLVLDDLEALEELPSNLGRLPCLKVLKIVKISAVKQIAHGFF
STEVISKCFLSLESLWISDLPACERWCWIGGSELFPSLQKLTIYECPKLE
RLPPLPPSLRYLSLREVGLTELPSLQELETNGSGDNQTTSSLSDLRIIEC
NNLTSFEEGLLSQNLSNIKDIYVAGCNELMWMPLKRFENFTSLKELQIKA
CPKLSLTQEEEAALLPPSFKVFILNDCGDLNKLWLGHPYRSTF
>XP_042446812.1 disease resistance protein RGA2-like isoform X2 [Zingiber officinale]
MEGAAALAVGGWLAKPVIRMLVDRVSTSSLRGKLHGLQDDDLQKLQRSLL
NIHTIVDKAGMRWSRDARLVEMTKQLQDAAYDAEDFLDDLTFHDMKQKIE
EEASHMASNRISRAIRNAKAKLFSDSVKRLNKIQKKLDDIYADMEKMCQS
LQVDASDVQYQSDLASATRETSSFLISNVLGREEEQKRIIELLLRSTDES
ASASDKGSSFSVIPLVGIGGVGKTTLAQLVYKDKEIQNHFALKIWICVSE
NFNVQRLTKEMIESVTKTELSSQMKLDVLQNILKEKIASKMVLLVLDDVW
NEEEEEWRKLCAPFMYAAAGSKVIMTTRSKSIADKIGTVEAIVLGDLDEI
SFWELFKQCAFGSSKPEEHPALVEIGRSIASKLKGLPLAAKTVGNLLGSN
MNPDHWRSIMKSEVWELQQNNKNDIIPVLQLSYQYLSAPLKRCFAFCSLF
QKDYKFSEIELTRMWMAEGFVVAQGNQRIEDVANETSRMDNGKSNKISTT
LRHLAVETEFVETKELRSRFKKLHSLFCQHLKSLPLDFIEKLRSIRVLVL
YDCGLQMLPTSVGELVHLRYLDIAYNEMEELPESLCELYNLQTLTASYNS
LISLPEDISQLVFLRHLDVENQIVVKIKMIGRLTSLQELSEFQVRKEVGF
MITELSGLQQLHGKLKITNLENVESKEEAEKAQMKNKEYLNALELEWGFD
HKLDDNKLVAMENVLEGLQPHESLKQLKIRRYCGARSPSWMKKEELSNLE
RLELSYCESWKDISCTALLPHLKVFHIDQSMWFSKSCFEVCGSRESKLFP
MLEELQLRNMNASEELPNLGRFPCLRVIRMTEIKSLKHIDFAASGAIENS
LFPMLEELELRGMPALEEISNLGHFPRLKVLHMMRMRLLKHIDFAASCAI
ENSLFPMLEVLELRDMHALEKLSTLGHFPRLRVLHMIRTWSLKHIVFAAS
GAIENSLFPMLEELDLRYMPALEEFSSRGHFPRLRVLGMVAMPLLKHIGF
ASVHATENDLFPALEVLELMDLPVLEELPDLGSLPCLKSFHMRRMSMLKH
IDFAFYGATKKVILPKVETLVLDDLEALEELPSNLGRLPCLKVLKIVKIS
AVKQIAHGFFSTEVISKCFLSLESLWISDLPACERWCWIGGSELFPSLQK
LTIYECPKLERLPPLPPSLRYLSLREVGLTELPSLQELETNGSGDNQTTS
SLSDLRIIECNNLTSFEEGLLSQNLSNIKDIYVAGCNELMWMPLKRFENF
TSLKELQIKACPKLSLTQEEEAALLPPSFKVFILNDCGDLNKLWLGHPYR
STF
>XP_042446865.1 putative disease resistance protein RGA3 isoform X1 [Zingiber officinale]
MKKILEYSTGQSESGPSELIPVKLKDKLHSKRFLLVLDDAWDDKNHTEWE
KLCIPLLHGQKGSWILLTTRLESVAKMVSKIIKGGTMKPMTLQGLPKDEC
RSLLYEHAFVDQDPNEFPLLKKIGEEIVEKLHGVPLLAKSIGGALNNKLE
ADHWTSISRSELWKMSQDLNNYEFIPALTLSYKMLPPRLKQCFSYCSIFP
QDYTFKKQKLVCIWVAAGLIYSDGSEEGSDEDIANYCFDMLCNKSFFDVH
TNKWSAFQQDIAPYALEVIFYTMHDMLNGLSRHVSRYECCRIVHDTPSYI
CDYNAIRHISISITSIDAQLGDLANMVCKFKNLRTLRIEQYYGDSQKLDD
FIRDACKSPRRIRVLTIRPYKYFESISDFVKLRFLEITTLPPSVSISKFY
FLQVLTGYRGILAKDTSKLRNLRHLYRVPENALFSVAEVGKLTCLQELCF
TVGIEPGYRIDELMNMDNLRQLSIAKLSNVHSLEEANNVDLVSKSHLTSL
ELNWYKPDLDEASSNLGHDQQEVLAALQPPPTIRKLIIREYKGGRPAPWM
NTQSLSRLESLELYNCTNLEELPPLWKLPCLKFIKLSDMKVIRSLGCHSS
DMMDRQFSVLEKLEFRDLPLLEEWNGADDYQWFPCLKRFEIEKCPKLKKI
PDLPLSIENLCMKKLGLEALPRFYKCSNGSTTFEGFQQLMSLEFLEMDDY
SEIVDIGSIGEEDGNFLPSELKKLKLKILNKHEDLASYLRGLTSLTELSL
SRLQGMTSLPLTNELEHLTTLRSLYICDCEDLTSPGDVYIIKSLKHLYMY
NCPKFLTAEVESQQLLKDKTRKHAASSSSVFDHSTSNKAASTLPSSLESL
TFSTSKISQESLGCCLQGLTSLKSLDISKCNHLVSLPNIEYLHNLTVLWI
SDCEELCKLESLTALISLRQLFISNCPKLIATTMSTVQNPAATTEQSATK
IKKGTLPSIETIQIDNIFCLSILPIPEKLKTLSILNEITCFPSEIEEYRE
SLNIGTDPSSAIFTHNFGEFFIAQGS
>XP_042446866.1 putative disease resistance protein RGA3 isoform X1 [Zingiber officinale]
MKKILEYSTGQSESGPSELIPVKLKDKLHSKRFLLVLDDAWDDKNHTEWE
KLCIPLLHGQKGSWILLTTRLESVAKMVSKIIKGGTMKPMTLQGLPKDEC
RSLLYEHAFVDQDPNEFPLLKKIGEEIVEKLHGVPLLAKSIGGALNNKLE
ADHWTSISRSELWKMSQDLNNYEFIPALTLSYKMLPPRLKQCFSYCSIFP
QDYTFKKQKLVCIWVAAGLIYSDGSEEGSDEDIANYCFDMLCNKSFFDVH
TNKWSAFQQDIAPYALEVIFYTMHDMLNGLSRHVSRYECCRIVHDTPSYI
CDYNAIRHISISITSIDAQLGDLANMVCKFKNLRTLRIEQYYGDSQKLDD
FIRDACKSPRRIRVLTIRPYKYFESISDFVKLRFLEITTLPPSVSISKFY
FLQVLTGYRGILAKDTSKLRNLRHLYRVPENALFSVAEVGKLTCLQELCF
TVGIEPGYRIDELMNMDNLRQLSIAKLSNVHSLEEANNVDLVSKSHLTSL
ELNWYKPDLDEASSNLGHDQQEVLAALQPPPTIRKLIIREYKGGRPAPWM
NTQSLSRLESLELYNCTNLEELPPLWKLPCLKFIKLSDMKVIRSLGCHSS
DMMDRQFSVLEKLEFRDLPLLEEWNGADDYQWFPCLKRFEIEKCPKLKKI
PDLPLSIENLCMKKLGLEALPRFYKCSNGSTTFEGFQQLMSLEFLEMDDY
SEIVDIGSIGEEDGNFLPSELKKLKLKILNKHEDLASYLRGLTSLTELSL
SRLQGMTSLPLTNELEHLTTLRSLYICDCEDLTSPGDVYIIKSLKHLYMY
NCPKFLTAEVESQQLLKDKTRKHAASSSSVFDHSTSNKAASTLPSSLESL
TFSTSKISQESLGCCLQGLTSLKSLDISKCNHLVSLPNIEYLHNLTVLWI
SDCEELCKLESLTALISLRQLFISNCPKLIATTMSTVQNPAATTEQSATK
IKKGTLPSIETIQIDNIFCLSILPIPEKLKTLSILNEITCFPSEIEEYRE
SLNIGTDPSSAIFTHNFGEFFIAQGS
>XP_042446867.1 putative disease resistance protein RGA3 isoform X1 [Zingiber officinale]
MKKILEYSTGQSESGPSELIPVKLKDKLHSKRFLLVLDDAWDDKNHTEWE
KLCIPLLHGQKGSWILLTTRLESVAKMVSKIIKGGTMKPMTLQGLPKDEC
RSLLYEHAFVDQDPNEFPLLKKIGEEIVEKLHGVPLLAKSIGGALNNKLE
ADHWTSISRSELWKMSQDLNNYEFIPALTLSYKMLPPRLKQCFSYCSIFP
QDYTFKKQKLVCIWVAAGLIYSDGSEEGSDEDIANYCFDMLCNKSFFDVH
TNKWSAFQQDIAPYALEVIFYTMHDMLNGLSRHVSRYECCRIVHDTPSYI
CDYNAIRHISISITSIDAQLGDLANMVCKFKNLRTLRIEQYYGDSQKLDD
FIRDACKSPRRIRVLTIRPYKYFESISDFVKLRFLEITTLPPSVSISKFY
FLQVLTGYRGILAKDTSKLRNLRHLYRVPENALFSVAEVGKLTCLQELCF
TVGIEPGYRIDELMNMDNLRQLSIAKLSNVHSLEEANNVDLVSKSHLTSL
ELNWYKPDLDEASSNLGHDQQEVLAALQPPPTIRKLIIREYKGGRPAPWM
NTQSLSRLESLELYNCTNLEELPPLWKLPCLKFIKLSDMKVIRSLGCHSS
DMMDRQFSVLEKLEFRDLPLLEEWNGADDYQWFPCLKRFEIEKCPKLKKI
PDLPLSIENLCMKKLGLEALPRFYKCSNGSTTFEGFQQLMSLEFLEMDDY
SEIVDIGSIGEEDGNFLPSELKKLKLKILNKHEDLASYLRGLTSLTELSL
SRLQGMTSLPLTNELEHLTTLRSLYICDCEDLTSPGDVYIIKSLKHLYMY
NCPKFLTAEVESQQLLKDKTRKHAASSSSVFDHSTSNKAASTLPSSLESL
TFSTSKISQESLGCCLQGLTSLKSLDISKCNHLVSLPNIEYLHNLTVLWI
SDCEELCKLESLTALISLRQLFISNCPKLIATTMSTVQNPAATTEQSATK
IKKGTLPSIETIQIDNIFCLSILPIPEKLKTLSILNEITCFPSEIEEYRE
SLNIGTDPSSAIFTHNFGEFFIAQGS
>XP_042446934.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MEGAAALAVGGWLAKPVIRMLVDRVSTSSLRGKLHGLQDDDLQKLQRSLL
NIHTIVDKAGMRWSRDARLVEMMKQLQDAAYDAEDFLDYLTFHGMKQKIK
EEASHMAGNRISRAIRNAKAKLFSDSVKRLNKIQKKLDCIYADMKEMCQL
LQADASDGQYQSDLASATRETSSFLISKVLGREEEQKRIIELLLRSTDES
ASASDKGSSFSVIPLVGIGGVGKTTLAQLVYKDKEIQNHFALKIWICVSE
NFNVQRLTKEIIESVTKTEHSSQMKLDVLQNILKEKIASKMILLVLDDVW
NEDEEEWRKLCAPFEDAPAGSKVIVTTRSKSIADKIGTVEAIVLGDLDKI
SFWELFKKCAFGPSKPEEYPELEEIGRIIASKLKGLPLAAKTVGNLLGSN
MNPHYWRSIMKSEVWELQQNKNDIIPVLQLSYQYLSAPLKRCFAFCSLFQ
KDYKFSEIELTRMWMAEGFVVAQGNQRIEDVASKYLHELVNMSLFQQETS
SSSEHYFVMHDLIHDLTLSVSVDETSRMNDGKSNKISTTLRHVALETEFV
EIKYLRSRFKKLHSLFFRCLLLKSPPIDFIKKLRSIRVLVLSRCGLRMLP
TSIGELVHLRYLDISYNGIKKLPESLCELYNLQTLIAKDNSLISLPEDIS
ELYNLETLIDNSLISLPEDISSGLYNLQTPIAKGKPLISLPEDISQLINL
RHIDVENEVAVKIKMIGRLTSLQELSEFQVRKEVGFKITELSGLKQLHGK
LKITNLENVETKEEAENAQMKNKEYLDALELEWESDPKLENKLVATEEVL
EGLQPHESLKRLKISRYYGVRSPSWLKKEELSNLERLELSHCESWKDISC
TALLPHLKVFHIESMCFSKSCFEVCGSRESKLFPMLEELQLTNTNVSEEF
LNLGRSPCLRVVRMTKIESLKHIDFAASCAMENSLFPMLEELELKHMAAL
EELSTLGHFPLLRVLRMIEMRSLKYIDFAASGAIENSLFPMLEELELRNL
HALEEFSSPGHFPLLRVFRMIEMRSLKHIDFAASGAIENSLFPMLEELEL
RYIPTLEEFSGLGHFPLLRVLRMIEMRSLKHIDFAASDAIENSLFPMLEE
LHLKGMHTLEEFSNLGHFSRLRVLRMIEMRLLKHIDFTASGAIKNSLFPM
LEELDLRNLHALEEFSGLGHFPRLKVLRVIQMQLLKRIGFASVHATENEL
FPVLEVLELMELPVLDELSDLGSLPCLRSLCMTRMPMVKHIDFAFRGATE
KVLLPRMETLVLHDLEALEELPSNLGRLPCLEVLKIVNIPAVKQIGHGFF
STEAISKCFLSLKNLFINHMPACEGWCWIDGSELFPSLRRLAIYRCPKLE
RLPPLPPSLTNLVLYAVGLTELPSLRELETNGTGGNQTTSSLSKLQISKC
NNLTSLEEGLLLQNLSNIEVIYVVGCNELMRMPLKRFENFTSLKELQIRA
CPNLSLTQEEEAALLPPSVKRLILLD
>XP_042446935.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MEGAAALAVGGWLAKPVIRMLVDRVSTSSLRGKLHGLQDDDLQKLQRSLL
NIHTIVDKAGMRWSRDARLVEMMKQLQDAAYDAEDFLDYLTFHGMKQKIK
EEASHMAGNRISRAIRNAKAKLFSDSVKRLNKIQKKLDCIYADMKEMCQL
LQADASDGQYQSDLASATRETSSFLISKVLGREEEQKRIIELLLRSTDES
ASASDKGSSFSVIPLVGIGGVGKTTLAQLVYKDKEIQNHFALKIWICVSE
NFNVQRLTKEIIESVTKTEHSSQMKLDVLQNILKEKIASKMILLVLDDVW
NEDEEEWRKLCAPFEDAPAGSKVIVTTRSKSIADKIGTVEAIVLGDLDKI
SFWELFKKCAFGPSKPEEYPELEEIGRIIASKLKGLPLAAKTVGNLLGSN
MNPHYWRSIMKSEVWELQQNKNDIIPVLQLSYQYLSAPLKRCFAFCSLFQ
KDYKFSEIELTRMWMAEGFVVAQGNQRIEDVASKYLHELVNMSLFQQETS
SSSEHYFVMHDLIHDLTLSVSVDETSRMNDGKSNKISTTLRHVALETEFV
EIKYLRSRFKKLHSLFFRCLLLKSPPIDFIKKLRSIRVLVLSRCGLRMLP
TSIGELVHLRYLDISYNGIKKLPESLCELYNLQTLIAKDNSLISLPEDIS
ELYNLETLIDNSLISLPEDISSGLYNLQTPIAKGKPLISLPEDISQLINL
RHIDVENEVAVKIKMIGRLTSLQELSEFQVRKEVGFKITELSGLKQLHGK
LKITNLENVETKEEAENAQMKNKEYLDALELEWESDPKLENKLVATEEVL
EGLQPHESLKRLKISRYYGVRSPSWLKKEELSNLERLELSHCESWKDISC
TALLPHLKVFHIESMCFSKSCFEVCGSRESKLFPMLEELQLTNTNVSEEF
LNLGRSPCLRVVRMTKIESLKHIDFAASCAMENSLFPMLEELELKHMAAL
EELSTLGHFPLLRVLRMIEMRSLKYIDFAASGAIENSLFPMLEELELRNL
HALEEFSSPGHFPLLRVFRMIEMRSLKHIDFAASGAIENSLFPMLEELEL
RYIPTLEEFSGLGHFPLLRVLRMIEMRSLKHIDFAASDAIENSLFPMLEE
LHLKGMHTLEEFSNLGHFSRLRVLRMIEMRLLKHIDFTASGAIKNSLFPM
LEELDLRNLHALEEFSGLGHFPRLKVLRVIQMQLLKRIGFASVHATENEL
FPVLEVLELMELPVLDELSDLGSLPCLRSLCMTRMPMVKHIDFAFRGATE
KVLLPRMETLVLHDLEALEELPSNLGRLPCLEVLKIVNIPAVKQIGHGFF
STEAISKCFLSLKNLFINHMPACEGWCWIDGSELFPSLRRLAIYRCPKLE
RLPPLPPSLTNLVLYAVGLTELPSLRELETNGTGGNQTTSSLSKLQISKC
NNLTSLEEGLLLQNLSNIEVIYVVGCNELMRMPLKRFENFTSLKELQIRA
CPNLSLTQEEEAALLPPSVKRLILLD
>XP_042447048.1 putative disease resistance protein RGA1 [Zingiber officinale]
MKNDSFSRFASKIDDLFRLLAAETIELSDVAARSSPEVPQKELKDIKAIL
KNIKGLLYDSGRQIREDAIKLRLKEFQDLVIEVEDFVDDYQYKKFQREAE
FRSLHGATSDSVDDLPRSRALSGRRLLERNRRNRASSHRKKPVATEGSLG
GVTMRRTTHSPPLYIDGERPCTIDPDPVRQSQIDESFVNQAESFGSAFLP
WIYGSSDSSFVPSLRTDGNFVNQVLVHWTAHLNKPVEIEVPLNIVVRIEV
MKRTIDDLLAQRQKAQKCSSHLLLISQEKQDPKKLQRVAEFLLAESLKSD
QDLSYLPEDSIRGSKQYQAHDVTKEIYGRNSDREHIISWLLLGTNSRFSL
FEDERSRNKFSAISIVGEAGVGKTALAKEVYNDPLVCKYFNSRVWLHFTE
ESDAVSFSKAFFVSITGKSCDGKEPVHLQSVMKEELKGKKLLLVLDDLQD
LNLRLWEYLQAPLAGVRMAKFIITSRTELEASKLRGIESYPLGCLPLDLS
WDLFQHCAFREDSSHPPELIEIGKHIVQKCWGLPLAVKTLGSLLGYQMDR
QIWRGVLESELWELQETETDISPALQLSYYLLPTYLKPCFLYCSLFPRGY
KFDKYELVRLWMAQGYIQHEDEDYQSLETVGCNYFHELQMLTIFDRSWDG
TFTIHDLLYDVSKYMSNGECSSLPNVKMYKDSGKIHQLYVTSSKGTNELQ
SSNANLTLQSLYKSLGAFPPNDILTMALIESVQGIRALELTCHGDSSIAE
TTQEEALNEVNASSVSNLRFIHLRYLRICDRFIEVLPAAVCELYNLQTLN
LDKCLKLRELPSDIGKLVNLRYLGLSEANIEKLPKSVYQLQKLQSLKVDY
CRNLKELPYNIGNLVNLCHLGLSGTSIKRLPRSVHRLSKLSTLKLDQCKI
LMELPSSIGNLVNLRHVTACRTKITKLPESICSLFNLLTLDLAYSNLSEL
PNDIGNLSNLNYLALSYTNISILPESLCYLSRLCTLKLNGCTNLSQLPSG
IGALKTLSHLVVSGINIEQLPESVCQLLNLEVLVMDGCRRFFSLPDGIGY
LTKLHQLKLSDTEIQELPESIGQLSNLQNLDLNGCQRLSKLPESIGYLSE
LSNLEVTETKIKTLPASFCQLSNLKVLNLNGNLDLQELPSGIENLANLCQ
LELSEVGIEVLPRCIVRLTNLEKLTFEHKKKPFENYQL
>XP_042447050.1 putative disease resistance protein RGA1 [Zingiber officinale]
MKNDSFSRFASKIDDLFRLLAAETIELSDVAARSSPEVPQKELKDIKAIL
KNIKGLLYDSGRQIREDAIKLRLKEFQDLVIEVEDFVDDYQYKKFQREAE
FRSLHGATSDSVDDLPRSRALSGRRLLERNRRNRASSHRKKPVATEGSLG
GVTMRRTTHSPPLYIDGERPCTIDPDPVRQSQIDESFVNQAESFGSAFLP
WIYGSSDSSFVPSLRTDGNFVNQVLVHWTAHLNKPVEIEVPLNIVVRIEV
MKRTIDDLLAQRQKAQKCSSHLLLISQEKQDPKKLQRVAEFLLAESLKSD
QDLSYLPEDSIRGSKQYQAHDVTKEIYGRNSDREHIISWLLLGTNSRFSL
FEDERSRNKFSAISIVGEAGVGKTALAKEVYNDPLVCKYFNSRVWLHFTE
ESDAVSFSKAFFVSITGKSCDGKEPVHLQSVMKEELKGKKLLLVLDDLQD
LNLRLWEYLQAPLAGVRMAKFIITSRTELEASKLRGIESYPLGCLPLDLS
WDLFQHCAFREDSSHPPELIEIGKHIVQKCWGLPLAVKTLGSLLGYQMDR
QIWRGVLESELWELQETETDISPALQLSYYLLPTYLKPCFLYCSLFPRGY
KFDKYELVRLWMAQGYIQHEDEDYQSLETVGCNYFHELQMLTIFDRSWDG
TFTIHDLLYDVSKYMSNGECSSLPNVKMYKDSGKIHQLYVTSSKGTNELQ
SSNANLTLQSLYKSLGAFPPNDILTMALIESVQGIRALELTCHGDSSIAE
TTQEEALNEVNASSVSNLRFIHLRYLRICDRFIEVLPAAVCELYNLQTLN
LDKCLKLRELPSDIGKLVNLRYLGLSEANIEKLPKSVYQLQKLQSLKVDY
CRNLKELPYNIGNLVNLCHLGLSGTSIKRLPRSVHRLSKLSTLKLDQCKI
LMELPSSIGNLVNLRHVTACRTKITKLPESICSLFNLLTLDLAYSNLSEL
PNDIGNLSNLNYLALSYTNISILPESLCYLSRLCTLKLNGCTNLSQLPSG
IGALKTLSHLVVSGINIEQLPESVCQLLNLEVLVMDGCRRFFSLPDGIGY
LTKLHQLKLSDTEIQELPESIGQLSNLQNLDLNGCQRLSKLPESIGYLSE
LSNLEVTETKIKTLPASFCQLSNLKVLNLNGNLDLQELPSGIENLANLCQ
LELSEVGIEVLPRCIVRLTNLEKLTFEHKKKPFENYQL
>XP_042447051.1 putative disease resistance protein RGA1 [Zingiber officinale]
MKNDSFSRFASKIDDLFRLLAAETIELSDVAARSSPEVPQKELKDIKAIL
KNIKGLLYDSGRQIREDAIKLRLKEFQDLVIEVEDFVDDYQYKKFQREAE
FRSLHGATSDSVDDLPRSRALSGRRLLERNRRNRASSHRKKPVATEGSLG
GVTMRRTTHSPPLYIDGERPCTIDPDPVRQSQIDESFVNQAESFGSAFLP
WIYGSSDSSFVPSLRTDGNFVNQVLVHWTAHLNKPVEIEVPLNIVVRIEV
MKRTIDDLLAQRQKAQKCSSHLLLISQEKQDPKKLQRVAEFLLAESLKSD
QDLSYLPEDSIRGSKQYQAHDVTKEIYGRNSDREHIISWLLLGTNSRFSL
FEDERSRNKFSAISIVGEAGVGKTALAKEVYNDPLVCKYFNSRVWLHFTE
ESDAVSFSKAFFVSITGKSCDGKEPVHLQSVMKEELKGKKLLLVLDDLQD
LNLRLWEYLQAPLAGVRMAKFIITSRTELEASKLRGIESYPLGCLPLDLS
WDLFQHCAFREDSSHPPELIEIGKHIVQKCWGLPLAVKTLGSLLGYQMDR
QIWRGVLESELWELQETETDISPALQLSYYLLPTYLKPCFLYCSLFPRGY
KFDKYELVRLWMAQGYIQHEDEDYQSLETVGCNYFHELQMLTIFDRSWDG
TFTIHDLLYDVSKYMSNGECSSLPNVKMYKDSGKIHQLYVTSSKGTNELQ
SSNANLTLQSLYKSLGAFPPNDILTMALIESVQGIRALELTCHGDSSIAE
TTQEEALNEVNASSVSNLRFIHLRYLRICDRFIEVLPAAVCELYNLQTLN
LDKCLKLRELPSDIGKLVNLRYLGLSEANIEKLPKSVYQLQKLQSLKVDY
CRNLKELPYNIGNLVNLCHLGLSGTSIKRLPRSVHRLSKLSTLKLDQCKI
LMELPSSIGNLVNLRHVTACRTKITKLPESICSLFNLLTLDLAYSNLSEL
PNDIGNLSNLNYLALSYTNISILPESLCYLSRLCTLKLNGCTNLSQLPSG
IGALKTLSHLVVSGINIEQLPESVCQLLNLEVLVMDGCRRFFSLPDGIGY
LTKLHQLKLSDTEIQELPESIGQLSNLQNLDLNGCQRLSKLPESIGYLSE
LSNLEVTETKIKTLPASFCQLSNLKVLNLNGNLDLQELPSGIENLANLCQ
LELSEVGIEVLPRCIVRLTNLEKLTFEHKKKPFENYQL
>XP_042447355.1 putative disease resistance protein RGA3 [Zingiber officinale]
MDVVSPILDRACAKVIDKLIDKVSTYVQDQYYWKANLQEELQNLKRLLPQ
IQAVVGYAEDKLTMYESHNPALIKWLWQFRDDIDEAEEVLDELEYHELEK
KSDGDKSRLSTIIDPYFRAAKRFLKSDDDVLERLRTCVENLKTSASDVET
FRALVMPTSGVGTGQMQQEQESLTLSNQSRITSCLPELSFKGREEEKGKI
IQYLLGEESEIQTSQNVHCLPLVAMGGMGKTALAQQVFDHFENEKKGHFD
VKIWVCDSLPDLNASSLMKKILECLTDQSESGPLERIPVKLKEKLHSKRF
LLVLDDAWDDKNQREWEKLRAPLLHGQKGSWIILTTRLESVAKMVSKVIK
GGTMKPMTLQGLPKDECRSLLYEHAFVDQDPNEFPLLKKIGEEIVEKLHG
VPLLAKSIGGALNNKLEADHWTSISGSELWKMPQDLDNYEFIPALTLSFK
MLPPRLKRCFSYCSIFPQDYKFKKQKLVCMWVAAGLIYSDGSEEGSDEDI
ANYCFDILCNKSFFDVHIDNWSAFQEGITPYGLEAIYYTMHDMLNGLSRH
VSRYECCRIVHDTPSYICDYNAIRHISISITSIDAQLGDLANMVCKFKHL
RTLRIEKYYDNSQKLDDFIRDACKSPRRIRVLIIESNQCLESISDFVKLR
FLEISSQLPSLSICKFYFLQVLIGYNAILAKDTSKLTNLRHLYRVPYNVL
FSVAKVGKLTSLQELYFNVGTEPGYRIDELMNMDNLCELSISNLSNVHNL
EEANNVNLVSKSYLTSLKLNWKKAYWYESDRDEASSNIGHDQQEVLAALQ
PPSTIRKLIITKYKGGRPAPWMNPRSLSRLESLELYGCTNLEELPPLWKL
PCLKLIKLIDMKAIRSLGCHSSDPMERQFPVLEELEFRDLPLLEEWNGAD
DYQWFPPLKMFKIENCPKLKKIPDLPLSIKNLCMKKLWLESLPRSYKCSN
GSITFGGFQQLMSLKSLEMHGYSENVDIGSIGEEDGNFLPSSLEILKLEI
LQKHKDLASYLRGLTSLIELSLSCLQGMTSLPLTNELEHLTTLRSLDIWN
CEDLTSPGGLYIIKSLKHLGIKDCPKFLTTDVES
>XP_042447356.1 putative disease resistance protein RGA3 [Zingiber officinale]
MDVVSPILDRACAKVIDKLIDKVSTYVQDQYYWKANLQEELQNLKRLLPQ
IQAVVGYAEDKLTMYESHNPALIKWLWQFRDDIDEAEEVLDELEYHELEK
KSDGDKSRLSTIIDPYFRAAKRFLKSDDDVLERLRTCVENLKTSASDVET
FRALVMPTSGVGTGQMQQEQESLTLSNQSRITSCLPELSFKGREEEKGKI
IQYLLGEESEIQTSQNVHCLPLVAMGGMGKTALAQQVFDHFENEKKGHFD
VKIWVCDSLPDLNASSLMKKILECLTDQSESGPLERIPVKLKEKLHSKRF
LLVLDDAWDDKNQREWEKLRAPLLHGQKGSWIILTTRLESVAKMVSKVIK
GGTMKPMTLQGLPKDECRSLLYEHAFVDQDPNEFPLLKKIGEEIVEKLHG
VPLLAKSIGGALNNKLEADHWTSISGSELWKMPQDLDNYEFIPALTLSFK
MLPPRLKRCFSYCSIFPQDYKFKKQKLVCMWVAAGLIYSDGSEEGSDEDI
ANYCFDILCNKSFFDVHIDNWSAFQEGITPYGLEAIYYTMHDMLNGLSRH
VSRYECCRIVHDTPSYICDYNAIRHISISITSIDAQLGDLANMVCKFKHL
RTLRIEKYYDNSQKLDDFIRDACKSPRRIRVLIIESNQCLESISDFVKLR
FLEISSQLPSLSICKFYFLQVLIGYNAILAKDTSKLTNLRHLYRVPYNVL
FSVAKVGKLTSLQELYFNVGTEPGYRIDELMNMDNLCELSISNLSNVHNL
EEANNVNLVSKSYLTSLKLNWKKAYWYESDRDEASSNIGHDQQEVLAALQ
PPSTIRKLIITKYKGGRPAPWMNPRSLSRLESLELYGCTNLEELPPLWKL
PCLKLIKLIDMKAIRSLGCHSSDPMERQFPVLEELEFRDLPLLEEWNGAD
DYQWFPPLKMFKIENCPKLKKIPDLPLSIKNLCMKKLWLESLPRSYKCSN
GSITFGGFQQLMSLKSLEMHGYSENVDIGSIGEEDGNFLPSSLEILKLEI
LQKHKDLASYLRGLTSLIELSLSCLQGMTSLPLTNELEHLTTLRSLDIWN
CEDLTSPGGLYIIKSLKHLGIKDCPKFLTTDVES
>XP_042447357.1 putative disease resistance protein RGA3 [Zingiber officinale]
MDVVSPILDRACAKVIDKLIDKVSTYVQDQYYWKANLQEELQNLKRLLPQ
IQAVVGYAEDKLTMYESHNPALIKWLWQFRDDIDEAEEVLDELEYHELEK
KSDGDKSRLSTIIDPYFRAAKRFLKSDDDVLERLRTCVENLKTSASDVET
FRALVMPTSGVGTGQMQQEQESLTLSNQSRITSCLPELSFKGREEEKGKI
IQYLLGEESEIQTSQNVHCLPLVAMGGMGKTALAQQVFDHFENEKKGHFD
VKIWVCDSLPDLNASSLMKKILECLTDQSESGPLERIPVKLKEKLHSKRF
LLVLDDAWDDKNQREWEKLRAPLLHGQKGSWIILTTRLESVAKMVSKVIK
GGTMKPMTLQGLPKDECRSLLYEHAFVDQDPNEFPLLKKIGEEIVEKLHG
VPLLAKSIGGALNNKLEADHWTSISGSELWKMPQDLDNYEFIPALTLSFK
MLPPRLKRCFSYCSIFPQDYKFKKQKLVCMWVAAGLIYSDGSEEGSDEDI
ANYCFDILCNKSFFDVHIDNWSAFQEGITPYGLEAIYYTMHDMLNGLSRH
VSRYECCRIVHDTPSYICDYNAIRHISISITSIDAQLGDLANMVCKFKHL
RTLRIEKYYDNSQKLDDFIRDACKSPRRIRVLIIESNQCLESISDFVKLR
FLEISSQLPSLSICKFYFLQVLIGYNAILAKDTSKLTNLRHLYRVPYNVL
FSVAKVGKLTSLQELYFNVGTEPGYRIDELMNMDNLCELSISNLSNVHNL
EEANNVNLVSKSYLTSLKLNWKKAYWYESDRDEASSNIGHDQQEVLAALQ
PPSTIRKLIITKYKGGRPAPWMNPRSLSRLESLELYGCTNLEELPPLWKL
PCLKLIKLIDMKAIRSLGCHSSDPMERQFPVLEELEFRDLPLLEEWNGAD
DYQWFPPLKMFKIENCPKLKKIPDLPLSIKNLCMKKLWLESLPRSYKCSN
GSITFGGFQQLMSLKSLEMHGYSENVDIGSIGEEDGNFLPSSLEILKLEI
LQKHKDLASYLRGLTSLIELSLSCLQGMTSLPLTNELEHLTTLRSLDIWN
CEDLTSPGGLYIIKSLKHLGIKDCPKFLTTDVES
>XP_042447378.1 disease resistance protein RPM1-like isoform X2 [Zingiber officinale]
MEAAFISLLINKLGEIAVGQAQSRCSLLLLQHTTPPLDQIHARVERITGE
FKVMQAFLEGSNWSTAAATNKPLEAWIEQVREVAFKIEDIIDEYLYLVGR
QRERTWKNCLMAPSDLCFNLAKAWRGIDSRLEKLETDLSELTSRRDRYGL
TISSNDDRAKNSETNNTYHYRAYSPMLTDEDDLVGIEVNKSKLLSWLTNA
DTCRKMTTIAVWGMGGHGKTTLVANVYRNDAVKSHFDCQVWITVSQTYGV
EELLKSMIQEIFKGKKEPVPNGVTTMQQLELFDIIKESLQRKKYIIVLDD
VWHVDLWTDISHLFVDTNNGSRLIVTTRMLEVARMANDEHIMKLQQLDEK
DAWILFC
>XP_042447463.1 disease resistance protein RGA2-like [Zingiber officinale]
MEGAAALAVGGWLTQPVIKMLVDSVWTSSLRGKLYGLRDNDLQKLHRSLL
NIDTIVDKAGMRWSREARLVEMMKQLQDAAYDAEDFLDDLTFHGMKQKIK
EDASHKVLNQFSRAFSKTKTKLFSNSVKRLNKIQKKLDDIYADMEKMCQS
LQVDASDGQYQSDLASATRETSSFLISKVFGREEEQKRIIGLLRRSTDLS
ASASDNGNSFSVIPLVGIGGVGKTTLAQLVYKDEEIQNHFAVKIWICVSE
NFNVQRLTKEMIESVTETEHDSQMKLDVLQNILKREIASKMILLVLDDVW
NEDKEEWRKLCAPFMYAAAGSKVIVTTRSKSIADKIGTVEAIVLGDLDGI
SFWELFKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAAKTVGNLLGSN
MNPHYWRSIMKSEVWELQQNKNDIIPVLQLSYHYLSAPLKRCFAFCSLFQ
KNHEFSEIELTRMWMAEGFVVAQGNQRMEDVASKYFHELVNMSLFQPETT
FWRHYYVMHDLIHDLTHSVSVDETSRMDNGKSNKISTTLRHLAVETEFVE
TKELRYRFKKLHTVFCQHLKSPPLDFIEKLRSIRVLVLSHCSLRMLPTRV
GELVHLRYLDISYNGIENLPESLCELYNLQTLIAKGNFPNSLPEEITQLI
NLRHLDVENTEVENIKMIGRLTSLQELSEFLVRKEVGFKITELSGLKQLH
GKLQITNLENVGSKEEAEKAQMKNKEYLDALELEWGFDPKLENKLVAMEE
VLEGLQPHESLKQLKIRRYCGARSPSWIKKEELSNLERLELSNCESWRDI
FCTALLPHLKVFHIESSMWFSKSCFEVCGSRESKLFPMLEELQLRNMIAS
EELPNLGRFPCLKVVRMTEIESLKHIDFAASSAIENSLFSMLECLELIYM
PALEEFSTLGYFPRLRVLRMIGMRLLKHIVFAASGAIENSLFPMLEELEL
RDMPALEEFSCVGHFPRLRVLHMIGMRLLKHIDFVASGAIENSLFPMLKE
FHLKDMHALEGFSNLGHFPRLRVLRMIEMRLLKHIDFAASGAIENSLFPM
LEELELRGMYALEEISNLGHFPRLKVLRMMRMRLLKHIGLASVATENDQF
PMLEELELRHLPVLEELPDLGSLPCLKSLDIIRMRMLKHTDFAFYDVTEK
VLLPRVEKLVLHDLEALKELPSNLGRLPCLKVLSIENISAVKQIGHGFFS
TEAISQCFLSLRSLSILNMPSCEGWCWIDGSELFPSLQVLTIHGCPKLER
LPPLPPSLTDLTLTEVGLTELPSLRETGTNGSGCNQTTSSLSNLKISECN
NLTSLEEGLLSQNLSNIEVIYVEGCYELMRMPLKRFENSTSLKELQIKAC
PNLSLTQEEEAVLLSRGGSRNYMEERFFRITVGGPVLGGYRRFDRLWLDN
CYRWT
>XP_042447464.1 disease resistance protein RGA2-like [Zingiber officinale]
MEGAAALAVGGWLTQPVIKMLVDSVWTSSLRGKLYGLRDNDLQKLHRSLL
NIDTIVDKAGMRWSREARLVEMMKQLQDAAYDAEDFLDDLTFHGMKQKIK
EDASHKVLNQFSRAFSKTKTKLFSNSVKRLNKIQKKLDDIYADMEKMCQS
LQVDASDGQYQSDLASATRETSSFLISKVFGREEEQKRIIGLLRRSTDLS
ASASDNGNSFSVIPLVGIGGVGKTTLAQLVYKDEEIQNHFAVKIWICVSE
NFNVQRLTKEMIESVTETEHDSQMKLDVLQNILKREIASKMILLVLDDVW
NEDKEEWRKLCAPFMYAAAGSKVIVTTRSKSIADKIGTVEAIVLGDLDGI
SFWELFKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAAKTVGNLLGSN
MNPHYWRSIMKSEVWELQQNKNDIIPVLQLSYHYLSAPLKRCFAFCSLFQ
KNHEFSEIELTRMWMAEGFVVAQGNQRMEDVASKYFHELVNMSLFQPETT
FWRHYYVMHDLIHDLTHSVSVDETSRMDNGKSNKISTTLRHLAVETEFVE
TKELRYRFKKLHTVFCQHLKSPPLDFIEKLRSIRVLVLSHCSLRMLPTRV
GELVHLRYLDISYNGIENLPESLCELYNLQTLIAKGNFPNSLPEEITQLI
NLRHLDVENTEVENIKMIGRLTSLQELSEFLVRKEVGFKITELSGLKQLH
GKLQITNLENVGSKEEAEKAQMKNKEYLDALELEWGFDPKLENKLVAMEE
VLEGLQPHESLKQLKIRRYCGARSPSWIKKEELSNLERLELSNCESWRDI
FCTALLPHLKVFHIESSMWFSKSCFEVCGSRESKLFPMLEELQLRNMIAS
EELPNLGRFPCLKVVRMTEIESLKHIDFAASSAIENSLFSMLECLELIYM
PALEEFSTLGYFPRLRVLRMIGMRLLKHIVFAASGAIENSLFPMLEELEL
RDMPALEEFSCVGHFPRLRVLHMIGMRLLKHIDFVASGAIENSLFPMLKE
FHLKDMHALEGFSNLGHFPRLRVLRMIEMRLLKHIDFAASGAIENSLFPM
LEELELRGMYALEEISNLGHFPRLKVLRMMRMRLLKHIGLASVATENDQF
PMLEELELRHLPVLEELPDLGSLPCLKSLDIIRMRMLKHTDFAFYDVTEK
VLLPRVEKLVLHDLEALKELPSNLGRLPCLKVLSIENISAVKQIGHGFFS
TEAISQCFLSLRSLSILNMPSCEGWCWIDGSELFPSLQVLTIHGCPKLER
LPPLPPSLTDLTLTEVGLTELPSLRETGTNGSGCNQTTSSLSNLKISECN
NLTSLEEGLLSQNLSNIEVIYVEGCYELMRMPLKRFENSTSLKELQIKAC
PNLSLTQEEEAVLLSRGGSRNYMEERFFRITVGGPVLGGYRRFDRLWLDN
CYRWT
>XP_042448088.1 disease resistance protein RPM1-like [Zingiber officinale]
MEAALIFFLFNKLGGITVDQVQAQSRCSELLLQYTTPPLDQIHARIERNA
AKFRVIHCFLERSNRSTDVAAASEAWIKEVRVVAFKMEDIIDEYLYLVEE
QRGRTWKYYLSTPSILICGSLGKAWHDIDSKLENMEKHLSELESMNNLYG
LTISGNEDRVNSESDDAHHYRVCDPMLIDEDDVVGIEEHKSKLLSWLTNA
DTCRKMTAIAVWGMGGLGKTTLVANVYRHSTVKSHFDCQVWVTVSQTYRV
DELLRTMVQEIFKGKKEFAPDGITTMPRSQLLESIRESLQQKRYIVVLDD
VWRVDLWEKISHAFVDCNNGSRLLVTTRYHEVARIANEVHMIKLQQLNEK
DAWILFCKKAFRRENNNDCPQELEDYSNRILNKCQGSPLAITVIGRLLST
KEKSESGWKEVYDCLHWEFEKNPSLDALKSILNLSFNDLPFYLKNCFVYC
SIFPEDYLIKRKKLIRLWVAEGFMKKNNNNRVMEEEAEYYLAQLVDRSML
QVVERNNFGRLKAFRMHDVVREVTLEISRNAKFCMILDGSQSVLDNQTRR
LSIQTNDESLDLDRRSFSQLRSLLMFSTCNFSSDSLRAVLISFQMLRVLE
LEDAPISNLPNEVSALFNLHYLGLRETGVQQLPNNIQKLQSLQTLDLRDS
NIVKLPRGVTQLKQLRHLFVTEIEIEFGGSTVVGCVPTLERAWQWKNLQT
LRSVKANEKLVQRLADMKELRSLAVEEVEHAHCPQLCTSLAMMSNLRSLW
LSARRNEQLNFEMLNSPTPPLQKLYLEGRLFEGKMPRFICSCADLTRVRL
FGSLLIEDPLPSLSQLPKLVELSLGYAFDEQKLHFRKGWFLNLKSLSLKG
LNKLNNIVIEKGTLTNLRELLISGLRELRMIPLGIEFLTNLQSLSLFGMP
KELVGKLREDDGNEDRQKIRHIPNVFFY
>XP_042448098.1 disease resistance protein RPM1-like [Zingiber officinale]
MEAAFISLLINKLAQVAFNQAQSRCSQILLQHTTPPLDQIHARVRRITDE
FIVMKAFLEGSNWFTIAATNKPLEAWIEQVRKVAFEIEDIIDEYLYLVGR
QRERTWKNCLMAPSDLCFNLAKAWRGIDSRLEKMEKDLSELSSRRDRFGI
TISGNEDGVKNSERDTHHYRAYSPMLNDEDDLVGIEVNKSKLLSWLTNAD
TCRKMTAIAVWGMGGHGKTTLVANVYRNNTVKSHFDCQVWVTVSQTYSVL
EELLRIMIKEIFKGKEDLVPNGITTMQRLELFDIIKESLQLKRYIIVLDD
VWHVDLCNHISRAFIDSNNGSRLIITTRMHEVARIASDEHIMKLQQLNEK
DAWTLFCKKAFRRENNKDCPKELEDYIGRILNKCQGSPLAIVAIGSLLSF
KEKSQTEWKKVYDNLQWEFENNPALDKVKSILNLSFNDLPYYLKNCFVYC
SIFPEDYLINRKKLIRLWVAEGFVEAKSKNRSMEEEAEGYLAELVDRSML
QVVNRNAFGRLQTFKLHDVVREVTLAIVSIIQTCYLATYFFFLYISSDKL
SYIPVKENGGVSFPYPMLSPHNYTVWAIKTEAILDAQGVWEAVEPAEGAQ
VDAKKDKKARAYILQCVPEDILLQIATKKTAKDVWDSLKTRYLGSDRVKK
ARVQTLKSEFDALRMKETETIDEFAGKLSALSSKFSTLGATLEDSSLVKK
LLDSVPDKFFPIVAGIEQFYDLESIPFEEAIGRLKAYEERTLRLCSNTNG
TEGELLLTHAEWQMRQKGSNVDTSSGGKGRGSSSPSRGKWRSRGRGTPSQ
DSAGGTSGNNSGTRGKRHIKCFNCEKMGHYASECYSKRRGDEAHLTCATD
EEPALMMTMFHEESQRQDTILLSKEMLLPEVYRGVKKGEDKDVWYLDNGA
SNHMTGHQAENEVHMKGDTMKVIDRNGKLLMLIKRTQNRLYKITLKIFKQ
ACLLARQEDPTWLGHMQGREPVVRGALSMCKSARGRLGIHPSRACAQGML
SRAAVQGCPSPSLTGGRLGKPTSMAWAQAIPSRGLAMRWARSKPKFAGGR
LGSKAGVAGMQHMPSSKGGQMDLSVVRADGLARVAEGADRRDLFVATNVR
ADGLARVTKRTNRRDLFVVPKRSSHGPSTWCASRLWRRAKETEPWITQTD
GLVRGTDKWTARGAKDGHIVVEFVNTGEQRADVITKALSEVKPPCDNYSA
FYFVLFFLFCSWVLCAIVSYSRPTAISRKAKFSMILDGSQSGLDFQTRRL
SIQTNDESLDLDRSLSLSQLRSLVMLSTCYSSSDPLRAVLTSLKMLRVLE
LEGTPISNLPNEISALFNLHYLGLRGTKVEKLPNNIQKLQSLETLDLRGS
NIVKLPRGVTQLKQLRHLFMFAREIEFGGSTVVGCVPTLKGARQWKNLQT
LRQVKSNKSLVQQLEDMKELRTLAVVSVEYAHCPQLCTSLTKLTKLHSLC
LSARSEEQLNFEILISPPPPLQKLTLSGRLFEGKMPKFICSCEELTYVQL
MSSHLIEDPLPSLGQLHKLVELTLWEDSYDGQKLHFRTGWFLNLKVLYLE
TLRNLNNIVIEEGAMPNLLKLIMSSLGELRMIPPGIEFLTNLQSLELCDL
PEELVEKLRNDDDNEILQRIRGTRNVVVDSISN
>XP_042448200.1 disease resistance protein RPM1-like isoform X1 [Zingiber officinale]
MHEVARIANEEHIMKLQQLNEKDAWILFCKKAFRRENNKDCPKELEDYTG
RILNKCQGSPLAIVAIGSLLSFKEKSETEWKKAYDNLQWEFENNPALDKV
KNILNLSFNDLPYYLKNCFVYCSIFPEDYLIKRKKLIRLWVAEGFVEAKS
SNRSMEEEAEDYLAELVDRSMLQVVNRNAFGRLQTFKMHDVVREVTQEIS
RKAKFSMILDGSQSGLDYQTRRLSIQTTDESLDLDKSLSLSQLRSLVMLS
TCNSSSDSLSAILISFKMLRVLELEFQPISNLPNEISALFNLHYLGLRGT
KVENLPNNIQKLQSLETLDLRCSNIVKLPRGVTQLKQLRHLFMFAREIEF
GGSTVVGCVPTLKGARQWKNLQTLRQVKANKSLVQQLEDMKELRTLAVTE
VEYAHCPQLCTSLTKLTKLHSLCLSARSEEQLNFEILNSPPPPLQKLTLS
GRLFEGKMPKFICSCEELTYVQLMSSHLIEDPLPSLGQLHKLVELTLWED
SYDGQKLHFRTGWFLNLKVLYLETLRNLNNIVIEEGAMPNLLKLIMSSLG
ELRMIPPGIEFLTNLQSLELCALPEELVEKLRNDDDNEVLQRIGGTRNVV
VDSISN
>XP_042448201.1 disease resistance protein RPM1-like isoform X2 [Zingiber officinale]
MEAAFISLLINKLAQVAFDQAQSRCSQLLLQHTTPPLDQIHAKVRRITDE
FIVMKAFLEGSNWSTIAATNKPLEAWIEQVRKVAFEIEDIIDEYLYLVGR
QREMTWKNYLMAPSDLCFNLAKAWRGIDSRLEKMERDLSELSSRRDRFGI
TISGNEDGVKNSERDTHHYRAYSPMFTDEDDLVGIEDNKSKLLSWLTNAD
TCRKMTAIAVWGMGGHGKTTLVANVYRNKTVKNHFDCQVWVTVSKTYSAL
EELLRIMIQEIFKGQKELVPNGVTTMQRLELFDIIKESLQQKRYIIVFR
>XP_042448305.1 disease resistance protein RGA2-like [Zingiber officinale]
MEGAAALAVGGWLAKPVIRMLVDRVSTSSLRGKLHGLQDDDLQKLQRSLL
NIHTIVDKAGMRWSRDARLVEMMKQLQDAAYDAEDFLDYLTFHGMKQKIK
EEASHMAGNRISRAIRNAKTKLFSDSVKRLNKIQKKLDCIYADMKEMCQL
LQADASDGQYQSDLASATRETSSFLISKVLGREEEQKRIIELLLRSTDES
ASASDKGSSFSVIPLVGIGGVGKTTLAQLVYKDEEIQNHFALKIWICVSE
NFNVQRLTKEIIESVTKTEHSLQMKLDVLQNILKEKIASKMILLVLDDVW
NEDEEEWRKLCAPFEDAAAGSKVIVTTRSKSIADKIGTVEAIVLGDLDKI
SFWELFKKCAFGPSKPEEYPELEDIGRIIASKLKGLPLAAKTVGNLLGSN
MNPHYWRSIMKSEVWELQQNENDIIPVLQLSYQYLSAPLKRCFAFCSLFR
KDYEFSEIELTRMWMAEGFVVAQGNQRMEDVASKYFHELVNMSLFQQEAT
FGRQYYVMHDLIHDLTQSVSVDETSRMNDGKSNKISATLRHLAIETKFVE
TKELRSRFKKLHSLFFRCLLLKSPSIDFIKKLRSVRVLVLSRCGLRMLPT
SVGELVHLRYLDISYNGIKKLPESLCELYNLQTLIAKDKSLISLPEDISE
LDNLETLIDNSLISLLGDISSRHYSWQTPIAKGKSLISLPEDISQLINLR
HIDVENEVAVKIKMIGRLTSLQELSEFQVRKEVGFKITELSGLKQLHGKL
KITNLENVETKEEAENAQMKNKEYLDALELEWESDPKLKNKLAATEVLEG
LQPHESLKRLKISRYYGVRSPSWLKKELSNLERLELSHCESWKDISCTAL
LPHLKVFYIESMCFSKSCFEVCGSRESKLFPMLEELQLTNINVSEEFLNL
GRSPCLRVVRMTKIESLKHIDFAASCAMENSLFPMLEELELKHMPALEEL
STLGYFPLLRVLRMIEMRSLKYIDFAPSGAIENSLFPMLEELELRYIPAL
EEFSGLGHFPLLRILRMIEMRSLKHIDFAASGAIENSLFPMLEELHLKGM
HTLEEFSNLGHFSRLRVLRMIEMRLLKHIDFTSSGAIKNSLFPMLEELDL
RNLHALEEFSGLGHFPRLKVLRVIQMQLLKRIGFASVHATENELFPVLEV
LELMELPVLDELPDLGSLPCLKSLCMTRMPMVKHIDFAFRGATEKVLLPR
VETLVLHDLEALEELPSNLGRLPCLKVLKIVNIPAVKQIGHGFFSTEAIS
KCFLSLENLFINHMPACEGWCWIDGSELFPSLRRLAIYRCPKLERLPPLP
PSLTNLVLYAVGLTELPSLRELETNGTGGNQTTSSLSKLQISKCNNLTSL
EEGLLLQNLSNIEVIYVVGCNELMRMPLKRFENFISLKELQIRACPKLSL
TQEEEAALLPPSIKRLILLD
>XP_042448306.1 disease resistance protein RGA2-like isoform X1 [Zingiber officinale]
MEGAAALAVGGWLAKPVIRMLVDRVSTSSLRGKLHGLQDDDLQKLQRSLL
NIHTIVDKAGMRWSRDARLVEMTKQLQDAAYDAEDFLDDLTFHDMKQKIE
EEASHMASNRISRAIRNAKAKLFSDSVKRLNKIQKKLDDIYADMEKMCQS
LQVDASDVQYQSDLASATRETSSFLISNVLGREEEQKRIIELLLRSADES
ASASDKGSSFSVIPLVGIGGVGKTTLAQLVYKDKEIQNHFALKIWICVSE
NFNVQRLTKEMIESVTKTELSSQMKLDVLQNILKEKIASKMVLLVLDDVW
NEEEEEWRKLCAPFMYAASGSKVIMTTRSKSIADKIGTVEAIVLGDLDEI
SFWELFKQCAFRSSKPEEHPALVEIGRSIASKLKGLPLAAKTVGNLLGSN
MNPDHWRSIMKSEVWELQQNNKNDIIPVLQLSYQYLSAPLKRCFAFCSLF
QKNHEFSEIELTRMWMAEGFIVAQGNQRMEDVASKYFHELVNMSLFQPET
TFWRHYYLMHDLIHDLTQSVSVDETNRMDNGKSNKISTTLRHLAVKKEFV
ETTDLRSRFKKLHSLFCQHLVSPPLDFIEKLRSIRVLVLCDCGLQMLPTS
VGELVHLRYLDISYNGIKKLPEPLCKLYNLQTLKAICNSQISLPEDISQL
VNLRHLDVENQIVVKTKMIGRLTSLQELSEFHVRKKVGFKITELSGLKQL
HGKLKITNLENVESKEEAESAQMKNKEYLDVLELEWKFDPKLENKLVAMQ
EVLEGLQPHESLKRLKIRRYCGARSPSWMKKELSNLERLELSFCESWKDI
SCTALLPRLKVFCIDKSMWFSKSCFNVCGSRESKLFPMLEELQLRNMNAS
EELPNLGRFPCLRVVRLTEIKSLKHIDFAASGTIENSLFPMLEELELIDM
DALEEFSNLGHFQRLRVLRMVRMPLFKHIGLASVHATEKDLFPMLEKLQL
MHLPVLEELPDLGSLPCLKFLQMKRMPVLKHIDFAFDGATDKILLPRVET
LELYDLEALEELPSNLGRLPCLTDLIIGNISAVKQISNGFFSIEAISKCF
LSLESLSISGMPACEGWCWLDGSELFPSLQRLTIYGCPKLERLPPLPPSL
TDLTIRKVGLTELPNIQELETNRSRVNQTTPSLSDLRISECNNLTSLEEG
LLSQNLSNIKVIHVEGCNELMRMPLKKFENFTSLKKLQIKACPKLSLTQE
EEAALLPPSIETLKLDVCCDLDKLLLGNLYNFTD
>XP_042448307.1 disease resistance protein RGA2-like isoform X2 [Zingiber officinale]
MEGAAALAVGGWLAKPVIRMLVDRVSTSSLRGKLHGLQDDDLQKLQRSLL
NIHTIVDKAGMRWSRDARLVEMTKQLQDAAYDAEDFLDDLTFHDMKQKIE
EEASHMASNRISRAIRNAKAKLFSDSVKRLNKIQKKLDDIYADMEKMCQS
LQVDASDVQYQSDLASATRETSSFLISNVLGREEEQKRIIELLLRSADES
ASASDKGSSFSVIPLVGIGGVGKTTLAQLVYKDKEIQNHFALKIWICVSE
NFNVQRLTKEMIESVTKTELSSQMKLDVLQNILKEKIASKMVLLVLDDVW
NEEEEEWRKLCAPFMYAASGSKVIMTTRSKSIADKIGTVEAIVLGDLDEI
SFWELFKQCAFRSSKPEEHPALVEIGRSIASKLKGLPLAAKTVGNLLGSN
MNPDHWRSIMKSEVWELQQNNKNDIIPVLQLSYQYLSAPLKRCFAFCSLF
QKNHEFSEIELTRMWMAEGFIVAQGNQRMEDVASKYFHELVNMSLFQPET
TFWRHYYLMHDLIHDLTQSVSVDETNRMDNGKSNKISTTLRHLAVKKEFV
ETTDLRSRFKKLHSLFCQHLVSPPLDFIEKLRSIRVLVLCDCGLQMLPTS
VGELVHLRYLDISYNGIKKLPEPLCKLYNLQTLKAICNSQISLPEDISQL
VNLRHLDVENQIVVKTKMIGRLTSLQELSEFHVRKKVGFKITELSGLKQL
HGKLKITNLENVESKEEAESAQMKNKEYLDVLELEWKFDPKLENKLVAMQ
EVLEGLQPHESLKRLKIRRYCGARSPSWMKKELSNLERLELSFCESWKDI
SCTALLPRLKVFCIDKSMWFSKSCFNVCGSRESKLFPMLEELQLRNMNAS
EELPNLGRFPCLRVVRLTEIKSLKHIDFAASGTIENSLFPMLEELELIDM
DALEEFSNLGHFQRLRVLRMVRMPLFKHIGLASVHATEKDLFPMLEKLQL
MHLPVLEELPDLGSLPCLKFLQMKRMPVLKHIDFAFDGATDKILLPRVET
LELYDLEALEELPSNLGRLPCLTDLIIGNISAVKQISNGFFSIEAISKCF
LSLESLSISGMPACEGWCWLDGSELFPSLQRLTIYGCPKLERN
>XP_042448308.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MEAATLAVGGWLVQPVIKMLVDRLCTLRGELHGLQDDDLQKLHRSLLNIH
TIVDKAGMRWSRDARLVEMMKQLQDAAYDAEDFLDDLTFHGMKQKIKKEA
SHKASNLFSKAFRKTKTKLFSDSVKRLNKIQKKLDCIYADMEKMCQFLQM
DALSGGQYQSDSGSVTRETSPFLICKVLGREKEQKRITELLLRSTDESAS
ASDNDSSFSVIPLVGIGGVGKTTLAQLVYEDDEIQNHFALKLWICVSNNF
NVQRLTKEMIESVTETQHSSQMKLAVLQNILKKEIESKMILLVLDDVWNE
VEEEWRKLCAPFMYAAAGSKVIVTTRIKSIADKIGTVEAIVLGDLDEISF
WELFKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAARTVGNLLGSNMN
PHHWRSIMKSEVWELQQNKNDIIPVLQLSYQYLSAPLKRCFAVCCLFHKD
YKFSEIELTRIWMAEGFIVAQGNQRMEDVASKYLHELVNMSLFQQETTFG
SHYYVMHDLIHDLTQSVSVDETSRMDNGKSNKISTTLRHLAVKKEFVETK
DMLRSRIKKLHSLFCQQLKSPPLDVIEKLRSIRVLVLYDCGLQMLPTSVG
ELIHLRYLDISYNKIKELPESLCELYNLQTLKANNSPLICLPEDISQLIN
LRHLDIENRLVVQIKKIGRLTSLQELSEFQVRKEVGFKITELSGLKQLHG
KLKITNLENVESKEEAENAQMKNKEYLDVLELEWKFDPKLENKLVAMEEV
LEGLQPHESLKQLQIKRYCGARSPSWMKKELSNLERLELSFCESWKDISC
TALLPHLKVFHIYQSMWFSKSCFEVCGSRESKLFPILEELQLSYMNASEE
LPNLGRFPCLRVVRMTGIKSLKHIDFTASGAIENSLFPMLEELDLRYMPA
LEEFCSRGHFPRLRVLCMVAMPLLKHIGFASVHATENDLFPALEVLELMD
LPALEELPDLCSLPCLKSFHMRRMSMLKHIDFALYGSTEKVILPRVETLV
LDDLEALEELPSNLGRLPCLKVLKIVKISAVKQIGHGFFSTEVITKCFLS
LENLWISDMPACERWCWIGGSELFPSLQKLTIYECPKLERLPPLPPSLIY
LSLRAVGLTELPSLQELETNGSGGNQTTSSLSALRIRKCNNLTSLEEGLL
SQNISNIEDIYVEGCNKLMRMPLKRFENFTSLKELQIKACPKLSLTQEEE
AALLPPSFKVFILNDCGDLNKLRLGHPYRSTF
>XP_042448309.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MEAATLAVGGWLVQPVIKMLVDRLCTLRGELHGLQDDDLQKLHRSLLNIH
TIVDKAGMRWSRDARLVEMMKQLQDAAYDAEDFLDDLTFHGMKQKIKKEA
SHKASNLFSKAFRKTKTKLFSDSVKRLNKIQKKLDCIYADMEKMCQFLQM
DALSGGQYQSDSGSVTRETSPFLICKVLGREKEQKRITELLLRSTDESAS
ASDNDSSFSVIPLVGIGGVGKTTLAQLVYEDDEIQNHFALKLWICVSNNF
NVQRLTKEMIESVTETQHSSQMKLAVLQNILKKEIESKMILLVLDDVWNE
VEEEWRKLCAPFMYAAAGSKVIVTTRIKSIADKIGTVEAIVLGDLDEISF
WELFKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAARTVGNLLGSNMN
PHHWRSIMKSEVWELQQNKNDIIPVLQLSYQYLSAPLKRCFAVCCLFHKD
YKFSEIELTRIWMAEGFIVAQGNQRMEDVASKYLHELVNMSLFQQETTFG
SHYYVMHDLIHDLTQSVSVDETSRMDNGKSNKISTTLRHLAVKKEFVETK
DMLRSRIKKLHSLFCQQLKSPPLDVIEKLRSIRVLVLYDCGLQMLPTSVG
ELIHLRYLDISYNKIKELPESLCELYNLQTLKANNSPLICLPEDISQLIN
LRHLDIENRLVVQIKKIGRLTSLQELSEFQVRKEVGFKITELSGLKQLHG
KLKITNLENVESKEEAENAQMKNKEYLDVLELEWKFDPKLENKLVAMEEV
LEGLQPHESLKQLQIKRYCGARSPSWMKKELSNLERLELSFCESWKDISC
TALLPHLKVFHIYQSMWFSKSCFEVCGSRESKLFPILEELQLSYMNASEE
LPNLGRFPCLRVVRMTGIKSLKHIDFTASGAIENSLFPMLEELDLRYMPA
LEEFCSRGHFPRLRVLCMVAMPLLKHIGFASVHATENDLFPALEVLELMD
LPALEELPDLCSLPCLKSFHMRRMSMLKHIDFALYGSTEKVILPRVETLV
LDDLEALEELPSNLGRLPCLKVLKIVKISAVKQIGHGFFSTEVITKCFLS
LENLWISDMPACERWCWIGGSELFPSLQKLTIYECPKLERLPPLPPSLIY
LSLRAVGLTELPSLQELETNGSGGNQTTSSLSALRIRKCNNLTSLEEGLL
SQNISNIEDIYVEGCNKLMRMPLKRFENFTSLKELQIKACPKLSLTQEEE
AALLPPSFKVFILNDCGDLNKLRLGHPYRSTF
>XP_042448310.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MEAATLAVGGWLVQPVIKMLVDRLCTLRGELHGLQDDDLQKLHRSLLNIH
TIVDKAGMRWSRDARLVEMMKQLQDAAYDAEDFLDDLTFHGMKQKIKKEA
SHKASNLFSKAFRKTKTKLFSDSVKRLNKIQKKLDCIYADMEKMCQFLQM
DALSGGQYQSDSGSVTRETSPFLICKVLGREKEQKRITELLLRSTDESAS
ASDNDSSFSVIPLVGIGGVGKTTLAQLVYEDDEIQNHFALKLWICVSNNF
NVQRLTKEMIESVTETQHSSQMKLAVLQNILKKEIESKMILLVLDDVWNE
VEEEWRKLCAPFMYAAAGSKVIVTTRIKSIADKIGTVEAIVLGDLDEISF
WELFKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAARTVGNLLGSNMN
PHHWRSIMKSEVWELQQNKNDIIPVLQLSYQYLSAPLKRCFAVCCLFHKD
YKFSEIELTRIWMAEGFIVAQGNQRMEDVASKYLHELVNMSLFQQETTFG
SHYYVMHDLIHDLTQSVSVDETSRMDNGKSNKISTTLRHLAVKKEFVETK
DMLRSRIKKLHSLFCQQLKSPPLDVIEKLRSIRVLVLYDCGLQMLPTSVG
ELIHLRYLDISYNKIKELPESLCELYNLQTLKANNSPLICLPEDISQLIN
LRHLDIENRLVVQIKKIGRLTSLQELSEFQVRKEVGFKITELSGLKQLHG
KLKITNLENVESKEEAENAQMKNKEYLDVLELEWKFDPKLENKLVAMEEV
LEGLQPHESLKQLQIKRYCGARSPSWMKKELSNLERLELSFCESWKDISC
TALLPHLKVFHIYQSMWFSKSCFEVCGSRESKLFPILEELQLSYMNASEE
LPNLGRFPCLRVVRMTGIKSLKHIDFTASGAIENSLFPMLEELDLRYMPA
LEEFCSRGHFPRLRVLCMVAMPLLKHIGFASVHATENDLFPALEVLELMD
LPALEELPDLCSLPCLKSFHMRRMSMLKHIDFALYGSTEKVILPRVETLV
LDDLEALEELPSNLGRLPCLKVLKIVKISAVKQIGHGFFSTEVITKCFLS
LENLWISDMPACERWCWIGGSELFPSLQKLTIYECPKLERLPPLPPSLIY
LSLRAVGLTELPSLQELETNGSGGNQTTSSLSALRIRKCNNLTSLEEGLL
SQNISNIEDIYVEGCNKLMRMPLKRFENFTSLKELQIKACPKLSLTQEEE
AALLPPSFKVFILNDCGDLNKLRLGHPYRSTF
>XP_042448311.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MEAATLAVGGWLVQPVIKMLVDRLCTLRGELHGLQDDDLQKLHRSLLNIH
TIVDKAGMRWSRDARLVEMMKQLQDAAYDAEDFLDDLTFHGMKQKIKKEA
SHKASNLFSKAFRKTKTKLFSDSVKRLNKIQKKLDCIYADMEKMCQFLQM
DALSGGQYQSDSGSVTRETSPFLICKVLGREKEQKRITELLLRSTDESAS
ASDNDSSFSVIPLVGIGGVGKTTLAQLVYEDDEIQNHFALKLWICVSNNF
NVQRLTKEMIESVTETQHSSQMKLAVLQNILKKEIESKMILLVLDDVWNE
VEEEWRKLCAPFMYAAAGSKVIVTTRIKSIADKIGTVEAIVLGDLDEISF
WELFKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAARTVGNLLGSNMN
PHHWRSIMKSEVWELQQNKNDIIPVLQLSYQYLSAPLKRCFAVCCLFHKD
YKFSEIELTRIWMAEGFIVAQGNQRMEDVASKYLHELVNMSLFQQETTFG
SHYYVMHDLIHDLTQSVSVDETSRMDNGKSNKISTTLRHLAVKKEFVETK
DMLRSRIKKLHSLFCQQLKSPPLDVIEKLRSIRVLVLYDCGLQMLPTSVG
ELIHLRYLDISYNKIKELPESLCELYNLQTLKANNSPLICLPEDISQLIN
LRHLDIENRLVVQIKKIGRLTSLQELSEFQVRKEVGFKITELSGLKQLHG
KLKITNLENVESKEEAENAQMKNKEYLDVLELEWKFDPKLENKLVAMEEV
LEGLQPHESLKQLQIKRYCGARSPSWMKKELSNLERLELSFCESWKDISC
TALLPHLKVFHIYQSMWFSKSCFEVCGSRESKLFPILEELQLSYMNASEE
LPNLGRFPCLRVVRMTGIKSLKHIDFTASGAIENSLFPMLEELDLRYMPA
LEEFCSRGHFPRLRVLCMVAMPLLKHIGFASVHATENDLFPALEVLELMD
LPALEELPDLCSLPCLKSFHMRRMSMLKHIDFALYGSTEKVILPRVETLV
LDDLEALEELPSNLGRLPCLKVLKIVKISAVKQIGHGFFSTEVITKCFLS
LENLWISDMPACERWCWIGGSELFPSLQKLTIYECPKLERLPPLPPSLIY
LSLRAVGLTELPSLQELETNGSGGNQTTSSLSALRIRKCNNLTSLEEGLL
SQNISNIEDIYVEGCNKLMRMPLKRFENFTSLKELQIKACPKLSLTQEEE
AALLPPSFKVFILNDCGDLNKLRLGHPYRSTF
>XP_042448312.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MEAATLAVGGWLVQPVIKMLVDRLCTLRGELHGLQDDDLQKLHRSLLNIH
TIVDKAGMRWSRDARLVEMMKQLQDAAYDAEDFLDDLTFHGMKQKIKKEA
SHKASNLFSKAFRKTKTKLFSDSVKRLNKIQKKLDCIYADMEKMCQFLQM
DALSGGQYQSDSGSVTRETSPFLICKVLGREKEQKRITELLLRSTDESAS
ASDNDSSFSVIPLVGIGGVGKTTLAQLVYEDDEIQNHFALKLWICVSNNF
NVQRLTKEMIESVTETQHSSQMKLAVLQNILKKEIESKMILLVLDDVWNE
VEEEWRKLCAPFMYAAAGSKVIVTTRIKSIADKIGTVEAIVLGDLDEISF
WELFKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAARTVGNLLGSNMN
PHHWRSIMKSEVWELQQNKNDIIPVLQLSYQYLSAPLKRCFAVCCLFHKD
YKFSEIELTRIWMAEGFIVAQGNQRMEDVASKYLHELVNMSLFQQETTFG
SHYYVMHDLIHDLTQSVSVDETSRMDNGKSNKISTTLRHLAVKKEFVETK
DMLRSRIKKLHSLFCQQLKSPPLDVIEKLRSIRVLVLYDCGLQMLPTSVG
ELIHLRYLDISYNKIKELPESLCELYNLQTLKANNSPLICLPEDISQLIN
LRHLDIENRLVVQIKKIGRLTSLQELSEFQVRKEVGFKITELSGLKQLHG
KLKITNLENVESKEEAENAQMKNKEYLDVLELEWKFDPKLENKLVAMEEV
LEGLQPHESLKQLQIKRYCGARSPSWMKKELSNLERLELSFCESWKDISC
TALLPHLKVFHIYQSMWFSKSCFEVCGSRESKLFPILEELQLSYMNASEE
LPNLGRFPCLRVVRMTGIKSLKHIDFTASGAIENSLFPMLEELDLRYMPA
LEEFCSRGHFPRLRVLCMVAMPLLKHIGFASVHATENDLFPALEVLELMD
LPALEELPDLCSLPCLKSFHMRRMSMLKHIDFALYGSTEKVILPRVETLV
LDDLEALEELPSNLGRLPCLKVLKIVKISAVKQIGHGFFSTEVITKCFLS
LENLWISDMPACERWCWIGGSELFPSLQKLTIYECPKLERLPPLPPSLIY
LSLRAVGLTELPSLQELETNGSGGNQTTSSLSALRIRKCNNLTSLEEGLL
SQNISNIEDIYVEGCNKLMRMPLKRFENFTSLKELQIKACPKLSLTQEEE
AALLPPSFKVFILNDCGDLNKLRLGHPYRSTF
>XP_042448313.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MEAATLAVGGWLVQPVIKMLVDRLCTLRGELHGLQDDDLQKLHRSLLNIH
TIVDKAGMRWSRDARLVEMMKQLQDAAYDAEDFLDDLTFHGMKQKIKKEA
SHKASNLFSKAFRKTKTKLFSDSVKRLNKIQKKLDCIYADMEKMCQFLQM
DALSGGQYQSDSGSVTRETSPFLICKVLGREKEQKRITELLLRSTDESAS
ASDNDSSFSVIPLVGIGGVGKTTLAQLVYEDDEIQNHFALKLWICVSNNF
NVQRLTKEMIESVTETQHSSQMKLAVLQNILKKEIESKMILLVLDDVWNE
VEEEWRKLCAPFMYAAAGSKVIVTTRIKSIADKIGTVEAIVLGDLDEISF
WELFKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAARTVGNLLGSNMN
PHHWRSIMKSEVWELQQNKNDIIPVLQLSYQYLSAPLKRCFAVCCLFHKD
YKFSEIELTRIWMAEGFIVAQGNQRMEDVASKYLHELVNMSLFQQETTFG
SHYYVMHDLIHDLTQSVSVDETSRMDNGKSNKISTTLRHLAVKKEFVETK
DMLRSRIKKLHSLFCQQLKSPPLDVIEKLRSIRVLVLYDCGLQMLPTSVG
ELIHLRYLDISYNKIKELPESLCELYNLQTLKANNSPLICLPEDISQLIN
LRHLDIENRLVVQIKKIGRLTSLQELSEFQVRKEVGFKITELSGLKQLHG
KLKITNLENVESKEEAENAQMKNKEYLDVLELEWKFDPKLENKLVAMEEV
LEGLQPHESLKQLQIKRYCGARSPSWMKKELSNLERLELSFCESWKDISC
TALLPHLKVFHIYQSMWFSKSCFEVCGSRESKLFPILEELQLSYMNASEE
LPNLGRFPCLRVVRMTGIKSLKHIDFTASGAIENSLFPMLEELDLRYMPA
LEEFCSRGHFPRLRVLCMVAMPLLKHIGFASVHATENDLFPALEVLELMD
LPALEELPDLCSLPCLKSFHMRRMSMLKHIDFALYGSTEKVILPRVETLV
LDDLEALEELPSNLGRLPCLKVLKIVKISAVKQIGHGFFSTEVITKCFLS
LENLWISDMPACERWCWIGGSELFPSLQKLTIYECPKLERLPPLPPSLIY
LSLRAVGLTELPSLQELETNGSGGNQTTSSLSALRIRKCNNLTSLEEGLL
SQNISNIEDIYVEGCNKLMRMPLKRFENFTSLKELQIKACPKLSLTQEEE
AALLPPSFKVFILNDCGDLNKLRLGHPYRSTF
>XP_042448315.1 disease resistance protein RGA2-like [Zingiber officinale]
MEGAAALAVGGWLAKPVIRMLVDRVSTSSLRGKLHGLQDDDLQKLQRSLL
NIHTIVDKAGMRWNRDARLVEMMKQLQDAAYDAEDFLDDLTFHGMKQKIE
EEASHMAGNRISRAIRNAKAKLFSDSVKRLNKIQKKLDCIYADMKEMCQL
LQADASDGQYQSDLASATRETSSFLISKVLGREEEQKRIIELLLRSTDES
ASASDKGSSFSVIPLVGIGGVGKTTLAQLVYKDKEIQNHFGLKIWICVSE
NFNVQRLTKEIIESVTKTEHSSQMKLDVLQNILKENVASKMIMLVLDDVW
NEDEEEWRKLCAPFEDAAAGSKVIVTTRSKSIADKIGTVEAIVLGDLDKI
SFWELFKKCAFGPSKPEEYPELEEIGRIIASKLKGLPLAAKTVGNLLGSN
MNPHYWRSIMKSEVWELQQNKNDIIPVLQLSYQYLSAPLKRCFAFCSLFQ
KDYKFSEIELTRMWMAEGFVVAQGNQRMEDVASKYFHELVNMSLFQQETS
WLGHYYVMHDLIHDLTQSVSVDEISRTNDGKSNKISTTLRHLALETGFVQ
TKYLRSRFKKLHSLFFRCLHLKSPPIGFIKN
>XP_042448470.1 disease resistance protein RGA2-like [Zingiber officinale]
MEGAAALAVGGWLAQPVIRMLVDRVSTSSLRGKLHGLQDDDLQKLQRSLL
NIHTIVDKAGMRWSRDARLVEMMKQLQDAAYDAEDFLDYLTFHGMKQKIK
EEASHMAGNRISRAIRNAKAKLFSDSVKRLNKIQKKLDCIYADMKEMCQL
LQADASDGQYQSDLASATRETSSFLISKVLGREEEQKRIIELLLRSTDES
ASASDKGSSFSVIPLVGIGGVGKTTLAQLVYKDKEIQNHFALKIWICVSE
NFNVQRLTKEIIESVTKTEDSSQMKLDVLQNILKEKIASKMIMLVLDDVW
NEDEEEWRKLCAPFEDAAAGSKVIVTTRSKSIADKIGTVEAIVLGDLDKI
SFWELFKKCAFGPSKPEEHPELEEIGRIIASKLKGLPLAAKTVGNLLGSN
MNPHYWRSIMKSEVWELQQNQNDIIPVLQLSYQYLSAPLKRCFAFCSLFQ
KDYEFSEIELTRMWMAEGFVVSQGNQRMEDVASKYFHELVNMSLFQQETT
FGRQYYVMHDLIHDLTQSVSMDETSRMNDGKSNKISTTLRHLVVETEFVE
IKYVRSRLKKLHSLFFRESPPIDFVKKLRSIRVLVLSGCGLRMLPTSVGK
LVHLRYLDISYNGIKKLPESLCELYNLQTLIAKDNSLISLPEDISELDNL
QTLIDNELISLLGDISSRHYSWQTPIAKGKSLISLPEDISQLINLRHIDV
ENEVAVKIKMIGRLTSLQELSEFQVRKEVGFKITELSGLKQLHGKLKITN
LENIETKEEAENAQMKNKEYLDALELEWESDPKLKNKLAATEVLEGLQPH
ESLKRLKISRYYGVRSPSWLKKELSNLERLELSHCESWKDISCTALLPHL
KVFYIESMCFSKSCFEVCGSRESKLFPMLEELQLTNINVSEEFLNLGRSP
CLRVVRMTKIESLKHIDFAASCAMENSLFPMLEELELKHMPALEELSTLG
HFPLLRVLRMIEMRSLKHIDFAASGAIENSLFPMLEELELRNLHALEEFS
SPGHFPLLRVFRMIEMRSLKHIDFAASGAIENSLFPMLEELELRNLHALE
EFSSPGHFPLLRVFRMIEMRSLKHIDFAASSAIENSFFPMLEELELRNLH
ALEEFSSPGHFPLLRVFRMIEMRSLKHIDFAASRAIENSLFLMLEELELR
NLHALEEFSSPRHFSLLRVFRMIEMRSLKHIDFAASGAIENSLFPMLEEL
ELKHIPELEEFSTLGHFPLLKVFRIIEMRSLKHIDFAASGAIENSLFPML
QELELRNLHALEEFSSPRRFPLLRVFRMIEMRSLKHIDFAASGAIENSLF
PMLEELELRYMPALVEFSGLGHFPLLRILHMIEMRSLKHIDSVASGAIEN
SLFLMLEELELRNLHALEEFSGLGHFPRLRVLRMIQMQLLKHIGFASVHA
TKNELFPVLEVLELMELPVLDELSDLGSLPCLKSLCITRMPMVKHIDFAF
YGATEKVLLPRMETLVLHDLEALEELPSNLGRLPCLKVLKIVNIPAVKQI
GHGFFSTEAISKCFLSLENLFINHMPACEGWCWIDGSELFPSLRRLAIYR
CPKLERLPPLPPSLTNLVLYEVGLTELPSLRELETNGSGGNQMTSFLSKL
QISKCNNLTSLEEGLLLQNLSNIEVIHVIGCHELMRMPLKRFENFTSLKQ
LQIRACPKLSLTQEEEAALLPPSIKRLILLD
>XP_042448507.1 putative disease resistance protein RGA3 [Zingiber officinale]
MESALAVGGWLAQPVISMLVDSGWTSSLRGKLYGLQDDDLPKLRRSLLKI
HSIVDKAGMRWSRDARLVEMMKQLQDAAYDAEDFLDDLTFHGMKQKIKEE
ASHKARKRPFSDIRNATTKLFNDSVKRLNKIQKKLDELYDDMKEICQLLQ
MDASDGQYQSDLASATRETSSFLISKVLGREEEQQRIIELLLRSTDESAS
ASDNGSSFSVIPLVGLGGVGKTTLAQLVYKDEKIQNHFALKIWICVSENF
NVQRLAKEMIESVTQTEHSSQMRLDVLQNILKEKIASKMILLVLDDVWNE
DEEEWRKLCAPFMFAAAGSKVIVTTRSMSIANKIGTVEAIVLGGLNEISF
WELFKQCAFGSSKPEEHPELVEIGRSIASKLTGLPLAAKTVGNLLGSNMN
PHHWRRIMKSEVWELQQNKNDIIPVLQLSYQYLSAPLKRCFAFCSLFQKD
QRFSEIELTRIWMAEGFIVAQGNQRMEDVASKYFHELVNMSLFQTSWGNY
YVMHDLIHDLTQSVSMDEISRMTDSKSNTISATLRHLSVETEFIETKELR
SRIKKLYSLFCQHLKSPPLDFIEKLRSIRVLVLSHCSLLLLPTSVGELVH
LRYLDISYNLLTELPESLCELYNLQTLKANRTSLISLPKDISQLVNLRHL
DVENEIVVKIKMIGRLTSLQEVSEFQVRKEVGFKITELSGLKQLHGKLKI
TNLENVESKEEAEKAQMKNKEYLDALELEWGFDPQLENKLVAMEEVLEGL
QPHESLKGLKIRRYCGARSPSWMKKELFNLERLELSYCENWKDISCTALL
PHLKVFHITSSMWFSKSCFEVCGSRERKLFPMLEELVLRETNALEELPNF
GRFPCLRVVEMTGIESLKHIDFEASSATKNSLFPMLEELNLRFMYALEEF
SNLGHFPRLRVLCMLQIPLLKHIGLASVNATENDPFPVLEKLQLISLPVL
EELPDLGSLPCLKSLVMSMMSMLKHIDFAFSSATRKSTTSKGRDASIA
>XP_042448881.1 putative disease resistance protein RGA1 [Zingiber officinale]
MKNDSFSRFASKIDDLFRQLAAEMIELSRRPWREVSQEELKDIKATLKNI
KGLLYDSGRQIKEDAIKLRLKELQDLVVEVEDFVDDYQYKMFLPQAEFHN
KIKQLLSYLYSDPSPGLDGGTMHFPGLDGAAKSCITDSSPGLGGGARSPI
NPSPELSVEASHSSGHDNLVVRIAGAKHNLLAQLQKSQKFASHLLLVSQE
NQDSEKLQRVTEFLLAESSSQKSTKDLNYFPEDTIRGRKHYNAFDVTKQI
YGRNSDREHIISWLLLGTNSRFSLFEDERSRNKFSAISIVGEAGVGKTVL
AKEVYNDPLVCKYFNSRVWLHFTEESDAVSLSKAFFVSITGKSCDGKEPL
HLQSVMKETLKGKKLLLVLDDLQDLNPRLWEYLQAPLAGVRMAKFIITSR
TELEASKLSGIESYPLGCLPLDLSWDLFQHCAFREDHSSHPPRLVRIGKY
IVQKCRGLPIAVKTLGSLLGYQMNRRIWIDVLESELWKLQETENDISPAL
QLSYYLLPTYLKPCFLYCSLFPRGYKFDKYELVRLWMAQGYIQHEDEDYQ
SLETVGCNYFHELQMLTIFDRSWDGTFTIHDLLYDVSKYMSNGECSSLPN
VKMYKDSGKICQLYVTSSKGTNELQSSNAILTLQLLYRSLGGFLPNDILT
MALIESVQGIRALELTCHGDSSIAVTIQEKSLDKLNASSLRELPSDIGKL
VNLRYLELSEANIEMLPESICLLRNLQSLIVDYCRNLKKLPHNIGNLFSL
CHLGLCGTSIKMLPESVDRLSKLPTLKLDHCKILMELPSSIGKLVNLQHV
TVCMTKITKLPESICSLSNLLTLDLAYSNLSELPNDIGNLSNLNYLALSY
TNISILPEPLCQLTSLRTLKLNGCTNLSQLPSGIGALKRLSHLVVSGIDI
EQLPASVCQLFSLEALEMDGCRRFFSLPDDIGYLTELRQLKLSDTEIQEL
PESICQLSKLQNLELNGCQRLSKLPESIGDLSELSNLEVTETKIKALPVS
FCRLSNLKVLNLNGNLDLQELPGGIENLANLSQLELSEVGIEVLPRCIGR
LTNLEKLSFEHKQKPFENYQL
>XP_042449102.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MHRIKEILEESGSNILTELGSKTILYIATVVYNQASLIRGLEDAVDKLRR
SHKRIQCFLNDAESLDIVQEVVRGWVCEMKTSAFAAENLIDEFQTLAYVI
EHAKEAPSRKRKLPVPSFGSVKNLFKRRKIAMDIVEIDNKRDEIHESWRN
LRLRPSDGQRRSDGSNEMDSVPTVATFDKSRIVGRNKEYQSVVDHLKADS
VSNLRVVVIYGLAGIGKTTLAQLIFKHFSEAISYTNFEMMIWVSLTKVYD
VLEATKEIIKEITGENCSSQNFSHLQNSLKELVKDKKFLLVLDNFCMKES
MFSWERLSIPLMEGATGSRVLITAQNSGVPRGMINCHLVQLQGLQKDDSW
KLFSDIAFPQANRDIYQKLKDIGESIVDICQGSPLAIISLGEVLKLEANV
DNWQAICNEILRLENNSICPILRSFMTSYHQLNYESKQCFAFCSIFQNSY
EFDKDELVRMWTAQDWVQRMSEAKGSMLFNNLQSLSFFECSTESSSSKYT
CKYTMPKLIRRLACSLFKNELLVMEDNELNPPSGQFRYASIFHKKDEILF
EKLYNQVSLRVLKLINESGAGVGRIPNDLFNKLKNLWLLDLSNSGIEELP
DSVGKLIHLRYLGLARTNVRKLPESIENLYNLQTLELKFCYNLSSLPQGT
SNLVNLKHLILHLDWERIRDLSFMPPGINYMTSLKTLSRFTVTKEDGCNL
RELKDLDLHGELCICKLENITNASDAKKANLRAKGHIDKLMLRWSDDTSS
VQQGTNTWKKVVKQMLRWSDDTSSAQQGTSTWKEVADELRPHEYLRCLWI
MNYPGSEFPNWLADTSFSSIEMVRLSCSKECESLPPLGLLPKLKHLHIEG
MKKLRNLENMKGFPSLKTLTIKDMPVLETFCEFVDDEFPNLIEIVIHRCP
NLPDTSRLNIPGWIDVSRIDAPSTDNGNGNDRS
>XP_042449189.1 putative disease resistance protein RGA3 [Zingiber officinale]
MNETKYKFYPLFGLELIFNKTSPFLICKVLGREKEQKRIIELLLRSTDES
ASASDSGSGFSVLPLVGIGGVGKTTLAQLVYKHEEIQNHFALKIWICVSD
NFNVQRLTKEIIEFVTETQHSSQMKLAVLQNILKKEIASKRILLVLDDVW
NEDEEWRKLCAPFQDAAAGSKVIVTTRSKNIADKIGTVEAIVLGDLDKIS
FWELFKKCAFGPSKPEEHPELEEIGRIIASKLRGLPVAAKTVGNLLGSNM
NPHYWRRIMKSEVWELQQNKNDIIPVLQLSYQYLSAPLKWYFVFDLFSLS
KESRVF
>XP_042449190.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEGAAALAVGGWLAQPVIKMLVDSVWTSSLRGKLHGLQDADLQKLQRSLL
NIHTIVDKAAMRWSRDARLVEMMKQLQDAAYDAEDFLDELRFHGMKQKIK
EEASHKVLKQFSRAIRNAKTKLFSDSVKRLNKIQKTLDDIYADMKEMCQS
LQVDASDGQYQSDLASDTRETSSFLISKVFGREEEQKRIIEQLLRSTDES
ASASDNGSSFSVIPLVGIGGVGKTTLAQLVYKDEEIQNHFALKIWICVSE
NFNVQRLTKEMIESVTETEHASQMKLDVLQNILKREIASKMILLVLDDVW
NEDKEEWRKLCAPFMYAAAGSKVIVTTRSKSIADKIGTVEAIVLGSLDEI
SYWELFKQCAFGSSKPEEHPELADIGRSIALKLKGLPLAAKTVGNLLGSN
MNPRHWRSIMKSEIWELQQNKNDIIPVLQLSYQYLNPPLKRCFAFCSLFQ
KNYMFSEIELTRMWMAEGFVVAQGNQRMEDVASKYFHELVNMSLFQQEAT
FGRHYYVMHDLIHDLTQLVSVDETSRMDNGKSNKISTTLRHLAVETKLVE
TKDLRSRFKKLHSLFCQHLKSPSVNFIEKLRSIRVLVLYDCGLQMLPTSV
GELVHLRYLDISYNKIKKLPESLCELYNLQTLEASCNSLISLPEDISQLI
NLRHLDVENEIVVKIKMIGRLTSLQELSELQVRKEVGFMITELSGLQQLH
GKLKITNLENVESKEEAEKAQMKYKEYLDALELEWGFDPELENKLVAVEE
VLEGLQPHESLKRLDIRRYCGARSPSWMKKEELSDLERLELSYCESWKDI
SCTALLPHLKVFNIEGMWFLKSCFEVCGSRESKLFPMLEELQMWNMNASE
ELPNLGRFPCLRVVRMIEIKSLKHIDFTASGAIENSLFPMLEELELRDMH
ALEDISTLGHFPHLRVLLMIGMPLLRDIDFAASGAIENSLFPMLEELELM
HMDVLEEFSYLGHFPRLRILRMIGMQLLRHIGFASVHATENDLFPVLEVL
ELMDLPVLEELPYFGSLPCLKSLCMCGMSMLKHIDFSFYGATENVLLPRV
ETLVLRDLEALEELPSNLGRLPCLKLLDIVNISAVKQIDHGFFSTEAIYK
CFLSLESFSISNMPACEGWCWIDGSELFPSLQRLVIYGCPKLERLPPLPP
SLTHLTLEEVGLTELSNGSGGNQTTSSLSDLRISECNNLTSLEEGLLSQN
ISNIEDIYVEGCNKLMRMPLKRFENFTSLKELQIKACPKLSLTLEEEAAL
LPPSIKILKLDDCGDLDKLLLGNLYNLTSLTEFEIANCRHVQSLPRGLFL
CLSRLERLTITDCHELRLVEGLEGSRSLWRLVIRRCPNLSSNPVEQGGEG
FLHQLRSYEID
>XP_042449191.1 putative disease resistance protein RGA3 [Zingiber officinale]
MKLDVLQNILKEKIASKIILLVLDDVWNEDKEEWRKLCAPFMYAAPGSNV
IWKPIVLGDLDEISFWELFKQCAFGPSKPEEHPELVEIGRSIASKLKGLP
LAAKTVGNLLGSNMNPHYWRSIMKSEVWILQQNNKNDIIPVLQLSYQYLS
APLKRCFAFCSLFQKNYMFSEIELTRMWIAEGFVVAQGNQRMEDVASKYL
HELVNMSLFQTSRGDYYVMHDLIHDLTQSVSVDETSRMDNGKSNKISTTL
RHLAVETEFVETKELRCIRVLVLSHCGLQMLATSVGGLVHLRYLDISYNE
LEELPESLCELYNLQTLIVKGNFLISLPEDIIQLVNLRHLDVENEIVVKI
KMIGRLISLEELFEFRVRKEVGFMITELSGLQQLHGKLKITNSEIVESKE
EAEMAQMKNKEYLDALELGWGFYTKLENKLVATEEVLEGLQPHESLKGLK
IRRYCGARSPSWMKKEELSNLERLELSFCESWKDISCTALLPHLMVFHIE
STWFSKSCFEVCGSSESKLFPMLEEL
>XP_042449236.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEGVALAVGGWLAQPVINMLVDRVWTLRGKLHGLQDDDLQKLHRSLLNIH
TIVDKAGMRWSRDARLVEMMKQLQDAAYDAEDFLDELTFHGMKQKIKEEA
SHKVLNQFSRAIRDAKTKLFSDSVKRLNKIQKKLDDIYADMERMCQSLQV
DASDGQYQSDLASTTRETSSLLISKVLGREEEQQRIIELLLRSTDESASD
NGSSFSVIPLVGIGGVGKTTLAQLVYKDEEIQNHFAHKIWICVSENFNVQ
RLTKEMIESVTETEHSSHMKLDVLQNILKREIASKMILLVLDNVWNEDEE
EWRKLCSPFMYAAAGSKVIVTTRSLSIANKIGSVEAIVLGDLGEISFWEL
FKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAAKTVGNLLRSNMNPHH
WRSIMKSEVWELQQNNKNDIIPVLQLSYQYLSAPLKRCFAFCSLFQKDYK
FSKLELTRMWMAEGFVVAQGNQRMEDVASQYFHELVNMSLFQQETSSSLE
HYFVMHDLIHDLTQSVSVDETIRMDNGKSNKISTTLRHLAVETGFIETKE
LRSRFKKLHSLFCQHLKSPPLDFIEKIRSIRVLVLSHCRLHMLPTSVGEL
VHLRYLDISNNEIEKLPESLCKLYNLQTLKANYNWLGISFPDIIQLVNLR
HLDVDNEVLGMIKMIGRLTSLQELYNFHAQKEVGFKITELSGLKQLHGKL
RITNLENVESKEEAEKAQMKNKEYLDALELRWGFDSKLDDNKLVVMEEVL
EGLQPHESLKRLKIRRYCGATSPSWMKKEELSNLEILKLSYCKSWKDISC
TALLPHLKVFHIESSMWFSKSCFEVCGSRESKLFPMLEELQLRKMNASEE
LPNLGRFPCLKVVRMTEIESLKHIDFAASGATKNALFPMLEELELRDMPA
LEEISNLGHFPRLRFFRMIGMPLLKHIGLASIDATENDLFPMLEELQLMD
LPVLEELPDLGSLPCLKSLRIIRMSMLKHIIDFAFSSATEKVLLPRVETL
VLDGLKALEELPSNLGRLPCLKFLQILNISVVKQIGHGFFSTEAISKCFL
SLESLFIIGMPACEGWCWIDGSELFPRLQRLFITGCPKLERLPPLPPSLT
HLTLGNVGLTELPSLQELETNGSGGNQTTSFLSKLQISKCNNLTSLEEGL
LSQNLSNIEHIYVTGCNELMRIPLKRFENFTSLKKLQIEACPKLSLTQEE
EAALLPPSFKVFILNDCGDLNKLRLGHPYRSTFDFLPTTDPHRPSSMSHK
FSWFRSHNILGTFFLA
>XP_042449237.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEGVALAVGGWLAQPVINMLVDRVWTLRGKLHGLQDDDLQKLHRSLLNIH
TIVDKAGMRWSRDARLVEMMKQLQDAAYDAEDFLDELTFHGMKQKIKEEA
SHKVLNQFSRAIRDAKTKLFSDSVKRLNKIQKKLDDIYADMERMCQSLQV
DASDGQYQSDLASTTRETSSLLISKVLGREEEQQRIIELLLRSTDESASD
NGSSFSVIPLVGIGGVGKTTLAQLVYKDEEIQNHFAHKIWICVSENFNVQ
RLTKEMIESVTETEHSSHMKLDVLQNILKREIASKMILLVLDNVWNEDEE
EWRKLCSPFMYAAAGSKVIVTTRSLSIANKIGSVEAIVLGDLGEISFWEL
FKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAAKTVGNLLRSNMNPHH
WRSIMKSEVWELQQNNKNDIIPVLQLSYQYLSAPLKRCFAFCSLFQKDYK
FSKLELTRMWMAEGFVVAQGNQRMEDVASQYFHELVNMSLFQQETSSSLE
HYFVMHDLIHDLTQSVSVDETIRMDNGKSNKISTTLRHLAVETGFIETKE
LRSRFKKLHSLFCQHLKSPPLDFIEKIRSIRVLVLSHCRLHMLPTSVGEL
VHLRYLDISNNEIEKLPESLCKLYNLQTLKANYNWLGISFPDIIQLVNLR
HLDVDNEVLGMIKMIGRLTSLQELYNFHAQKEVGFKITELSGLKQLHGKL
RITNLENVESKEEAEKAQMKNKEYLDALELRWGFDSKLDDNKLVVMEEVL
EGLQPHESLKRLKIRRYCGATSPSWMKKEELSNLEILKLSYCKSWKDISC
TALLPHLKVFHIESSMWFSKSCFEVCGSRESKLFPMLEELQLRKMNASEE
LPNLGRFPCLKVVRMTEIESLKHIDFAASGATKNALFPMLEELELRDMPA
LEEISNLGHFPRLRFFRMIGMPLLKHIGLASIDATENDLFPMLEELQLMD
LPVLEELPDLGSLPCLKSLRIIRMSMLKHIIDFAFSSATEKVLLPRVETL
VLDGLKALEELPSNLGRLPCLKFLQILNISVVKQIGHGFFSTEAISKCFL
SLESLFIIGMPACEGWCWIDGSELFPRLQRLFITGCPKLERLPPLPPSLT
HLTLGNVGLTELPSLQELETNGSGGNQTTSFLSKLQISKCNNLTSLEEGL
LSQNLSNIEHIYVTGCNELMRIPLKRFENFTSLKKLQIEACPKLSLTQEE
EAALLPPSFKVFILNDCGDLNKLRLGHPYRSTFDFLPTTDPHRPSSMSHK
FSWFRSHNILGTFFLA
>XP_042449238.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEGVALAVGGWLAQPVINMLVDRVWTLRGKLHGLQDDDLQKLHRSLLNIH
TIVDKAGMRWSRDARLVEMMKQLQDAAYDAEDFLDELTFHGMKQKIKEEA
SHKVLNQFSRAIRDAKTKLFSDSVKRLNKIQKKLDDIYADMERMCQSLQV
DASDGQYQSDLASTTRETSSLLISKVLGREEEQQRIIELLLRSTDESASD
NGSSFSVIPLVGIGGVGKTTLAQLVYKDEEIQNHFAHKIWICVSENFNVQ
RLTKEMIESVTETEHSSHMKLDVLQNILKREIASKMILLVLDNVWNEDEE
EWRKLCSPFMYAAAGSKVIVTTRSLSIANKIGSVEAIVLGDLGEISFWEL
FKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAAKTVGNLLRSNMNPHH
WRSIMKSEVWELQQNNKNDIIPVLQLSYQYLSAPLKRCFAFCSLFQKDYK
FSKLELTRMWMAEGFVVAQGNQRMEDVASQYFHELVNMSLFQQETSSSLE
HYFVMHDLIHDLTQSVSVDETIRMDNGKSNKISTTLRHLAVETGFIETKE
LRSRFKKLHSLFCQHLKSPPLDFIEKIRSIRVLVLSHCRLHMLPTSVGEL
VHLRYLDISNNEIEKLPESLCKLYNLQTLKANYNWLGISFPDIIQLVNLR
HLDVDNEVLGMIKMIGRLTSLQELYNFHAQKEVGFKITELSGLKQLHGKL
RITNLENVESKEEAEKAQMKNKEYLDALELRWGFDSKLDDNKLVVMEEVL
EGLQPHESLKRLKIRRYCGATSPSWMKKEELSNLEILKLSYCKSWKDISC
TALLPHLKVFHIESSMWFSKSCFEVCGSRESKLFPMLEELQLRKMNASEE
LPNLGRFPCLKVVRMTEIESLKHIDFAASGATKNALFPMLEELELRDMPA
LEEISNLGHFPRLRFFRMIGMPLLKHIGLASIDATENDLFPMLEELQLMD
LPVLEELPDLGSLPCLKSLRIIRMSMLKHIIDFAFSSATEKVLLPRVETL
VLDGLKALEELPSNLGRLPCLKFLQILNISVVKQIGHGFFSTEAISKCFL
SLESLFIIGMPACEGWCWIDGSELFPRLQRLFITGCPKLERLPPLPPSLT
HLTLGNVGLTELPSLQELETNGSGGNQTTSFLSKLQISKCNNLTSLEEGL
LSQNLSNIEHIYVTGCNELMRIPLKRFENFTSLKKLQIEACPKLSLTQEE
EAALLPPSFKVFILNDCGDLNKLRLGHPYRSTFDFLPTTDPHRPSSMSHK
FSWFRSHNILGTFFLA
>XP_042449239.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEGVALAVGGWLAQPVINMLVDRVWTLRGKLHGLQDDDLQKLHRSLLNIH
TIVDKAGMRWSRDARLVEMMKQLQDAAYDAEDFLDELTFHGMKQKIKEEA
SHKVLNQFSRAIRDAKTKLFSDSVKRLNKIQKKLDDIYADMERMCQSLQV
DASDGQYQSDLASTTRETSSLLISKVLGREEEQQRIIELLLRSTDESASD
NGSSFSVIPLVGIGGVGKTTLAQLVYKDEEIQNHFAHKIWICVSENFNVQ
RLTKEMIESVTETEHSSHMKLDVLQNILKREIASKMILLVLDNVWNEDEE
EWRKLCSPFMYAAAGSKVIVTTRSLSIANKIGSVEAIVLGDLGEISFWEL
FKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAAKTVGNLLRSNMNPHH
WRSIMKSEVWELQQNNKNDIIPVLQLSYQYLSAPLKRCFAFCSLFQKDYK
FSKLELTRMWMAEGFVVAQGNQRMEDVASQYFHELVNMSLFQQETSSSLE
HYFVMHDLIHDLTQSVSVDETIRMDNGKSNKISTTLRHLAVETGFIETKE
LRSRFKKLHSLFCQHLKSPPLDFIEKIRSIRVLVLSHCRLHMLPTSVGEL
VHLRYLDISNNEIEKLPESLCKLYNLQTLKANYNWLGISFPDIIQLVNLR
HLDVDNEVLGMIKMIGRLTSLQELYNFHAQKEVGFKITELSGLKQLHGKL
RITNLENVESKEEAEKAQMKNKEYLDALELRWGFDSKLDDNKLVVMEEVL
EGLQPHESLKRLKIRRYCGATSPSWMKKEELSNLEILKLSYCKSWKDISC
TALLPHLKVFHIESSMWFSKSCFEVCGSRESKLFPMLEELQLRKMNASEE
LPNLGRFPCLKVVRMTEIESLKHIDFAASGATKNALFPMLEELELRDMPA
LEEISNLGHFPRLRFFRMIGMPLLKHIGLASIDATENDLFPMLEELQLMD
LPVLEELPDLGSLPCLKSLRIIRMSMLKHIIDFAFSSATEKVLLPRVETL
VLDGLKALEELPSNLGRLPCLKFLQILNISVVKQIGHGFFSTEAISKCFL
SLESLFIIGMPACEGWCWIDGSELFPRLQRLFITGCPKLERLPPLPPSLT
HLTLGNVGLTELPSLQELETNGSGGNQTTSFLSKLQISKCNNLTSLEEGL
LSQNLSNIEHIYVTGCNELMRIPLKRFENFTSLKKLQIEACPKLSLTQEE
EAALLPPSFKVFILNDCGDLNKLRLGHPYRSTFDFLPTTDPHRPSSMSHK
FSWFRSHNILGTFFLA
>XP_042449240.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEGVALAVGGWLAQPVINMLVDRVWTLRGKLHGLQDDDLQKLHRSLLNIH
TIVDKAGMRWSRDARLVEMMKQLQDAAYDAEDFLDELTFHGMKQKIKEEA
SHKVLNQFSRAIRDAKTKLFSDSVKRLNKIQKKLDDIYADMERMCQSLQV
DASDGQYQSDLASTTRETSSLLISKVLGREEEQQRIIELLLRSTDESASD
NGSSFSVIPLVGIGGVGKTTLAQLVYKDEEIQNHFAHKIWICVSENFNVQ
RLTKEMIESVTETEHSSHMKLDVLQNILKREIASKMILLVLDNVWNEDEE
EWRKLCSPFMYAAAGSKVIVTTRSLSIANKIGSVEAIVLGDLGEISFWEL
FKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAAKTVGNLLRSNMNPHH
WRSIMKSEVWELQQNNKNDIIPVLQLSYQYLSAPLKRCFAFCSLFQKDYK
FSKLELTRMWMAEGFVVAQGNQRMEDVASQYFHELVNMSLFQQETSSSLE
HYFVMHDLIHDLTQSVSVDETIRMDNGKSNKISTTLRHLAVETGFIETKE
LRSRFKKLHSLFCQHLKSPPLDFIEKIRSIRVLVLSHCRLHMLPTSVGEL
VHLRYLDISNNEIEKLPESLCKLYNLQTLKANYNWLGISFPDIIQLVNLR
HLDVDNEVLGMIKMIGRLTSLQELYNFHAQKEVGFKITELSGLKQLHGKL
RITNLENVESKEEAEKAQMKNKEYLDALELRWGFDSKLDDNKLVVMEEVL
EGLQPHESLKRLKIRRYCGATSPSWMKKEELSNLEILKLSYCKSWKDISC
TALLPHLKVFHIESSMWFSKSCFEVCGSRESKLFPMLEELQLRKMNASEE
LPNLGRFPCLKVVRMTEIESLKHIDFAASGATKNALFPMLEELELRDMPA
LEEISNLGHFPRLRFFRMIGMPLLKHIGLASIDATENDLFPMLEELQLMD
LPVLEELPDLGSLPCLKSLRIIRMSMLKHIIDFAFSSATEKVLLPRVETL
VLDGLKALEELPSNLGRLPCLKFLQILNISVVKQIGHGFFSTEAISKCFL
SLESLFIIGMPACEGWCWIDGSELFPRLQRLFITGCPKLERLPPLPPSLT
HLTLGNVGLTELPSLQELETNGSGGNQTTSFLSKLQISKCNNLTSLEEGL
LSQNLSNIEHIYVTGCNELMRIPLKRFENFTSLKKLQIEACPKLSLTQEE
EAALLPPSFKVFILNDCGDLNKLRLGHPYRSTFDFLPTTDPHRPSSMSHK
FSWFRSHNILGTFFLA
>XP_042449241.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEGVALAVGGWLAQPVINMLVDRVWTLRGKLHGLQDDDLQKLHRSLLNIH
TIVDKAGMRWSRDARLVEMMKQLQDAAYDAEDFLDELTFHGMKQKIKEEA
SHKVLNQFSRAIRDAKTKLFSDSVKRLNKIQKKLDDIYADMERMCQSLQV
DASDGQYQSDLASTTRETSSLLISKVLGREEEQQRIIELLLRSTDESASD
NGSSFSVIPLVGIGGVGKTTLAQLVYKDEEIQNHFAHKIWICVSENFNVQ
RLTKEMIESVTETEHSSHMKLDVLQNILKREIASKMILLVLDNVWNEDEE
EWRKLCSPFMYAAAGSKVIVTTRSLSIANKIGSVEAIVLGDLGEISFWEL
FKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAAKTVGNLLRSNMNPHH
WRSIMKSEVWELQQNNKNDIIPVLQLSYQYLSAPLKRCFAFCSLFQKDYK
FSKLELTRMWMAEGFVVAQGNQRMEDVASQYFHELVNMSLFQQETSSSLE
HYFVMHDLIHDLTQSVSVDETIRMDNGKSNKISTTLRHLAVETGFIETKE
LRSRFKKLHSLFCQHLKSPPLDFIEKIRSIRVLVLSHCRLHMLPTSVGEL
VHLRYLDISNNEIEKLPESLCKLYNLQTLKANYNWLGISFPDIIQLVNLR
HLDVDNEVLGMIKMIGRLTSLQELYNFHAQKEVGFKITELSGLKQLHGKL
RITNLENVESKEEAEKAQMKNKEYLDALELRWGFDSKLDDNKLVVMEEVL
EGLQPHESLKRLKIRRYCGATSPSWMKKEELSNLEILKLSYCKSWKDISC
TALLPHLKVFHIESSMWFSKSCFEVCGSRESKLFPMLEELQLRKMNASEE
LPNLGRFPCLKVVRMTEIESLKHIDFAASGATKNALFPMLEELELRDMPA
LEEISNLGHFPRLRFFRMIGMPLLKHIGLASIDATENDLFPMLEELQLMD
LPVLEELPDLGSLPCLKSLRIIRMSMLKHIIDFAFSSATEKVLLPRVETL
VLDGLKALEELPSNLGRLPCLKFLQILNISVVKQIGHGFFSTEAISKCFL
SLESLFIIGMPACEGWCWIDGSELFPRLQRLFITGCPKLERLPPLPPSLT
HLTLGNVGLTELPSLQELETNGSGGNQTTSFLSKLQISKCNNLTSLEEGL
LSQNLSNIEHIYVTGCNELMRIPLKRFENFTSLKKLQIEACPKLSLTQEE
EAALLPPSFKVFILNDCGDLNKLRLGHPYRSTFDFLPTTDPHRPSSMSHK
FSWFRSHNILGTFFLA
>XP_042449242.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEGVALAVGGWLAQPVINMLVDRVWTLRGKLHGLQDDDLQKLHRSLLNIH
TIVDKAGMRWSRDARLVEMMKQLQDAAYDAEDFLDELTFHGMKQKIKEEA
SHKVLNQFSRAIRDAKTKLFSDSVKRLNKIQKKLDDIYADMERMCQSLQV
DASDGQYQSDLASTTRETSSLLISKVLGREEEQQRIIELLLRSTDESASD
NGSSFSVIPLVGIGGVGKTTLAQLVYKDEEIQNHFAHKIWICVSENFNVQ
RLTKEMIESVTETEHSSHMKLDVLQNILKREIASKMILLVLDNVWNEDEE
EWRKLCSPFMYAAAGSKVIVTTRSLSIANKIGSVEAIVLGDLGEISFWEL
FKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAAKTVGNLLRSNMNPHH
WRSIMKSEVWELQQNNKNDIIPVLQLSYQYLSAPLKRCFAFCSLFQKDYK
FSKLELTRMWMAEGFVVAQGNQRMEDVASQYFHELVNMSLFQQETSSSLE
HYFVMHDLIHDLTQSVSVDETIRMDNGKSNKISTTLRHLAVETGFIETKE
LRSRFKKLHSLFCQHLKSPPLDFIEKIRSIRVLVLSHCRLHMLPTSVGEL
VHLRYLDISNNEIEKLPESLCKLYNLQTLKANYNWLGISFPDIIQLVNLR
HLDVDNEVLGMIKMIGRLTSLQELYNFHAQKEVGFKITELSGLKQLHGKL
RITNLENVESKEEAEKAQMKNKEYLDALELRWGFDSKLDDNKLVVMEEVL
EGLQPHESLKRLKIRRYCGATSPSWMKKEELSNLEILKLSYCKSWKDISC
TALLPHLKVFHIESSMWFSKSCFEVCGSRESKLFPMLEELQLRKMNASEE
LPNLGRFPCLKVVRMTEIESLKHIDFAASGATKNALFPMLEELELRDMPA
LEEISNLGHFPRLRFFRMIGMPLLKHIGLASIDATENDLFPMLEELQLMD
LPVLEELPDLGSLPCLKSLRIIRMSMLKHIIDFAFSSATEKVLLPRVETL
VLDGLKALEELPSNLGRLPCLKFLQILNISVVKQIGHGFFSTEAISKCFL
SLESLFIIGMPACEGWCWIDGSELFPRLQRLFITGCPKLERLPPLPPSLT
HLTLGNVGLTELPSLQELETNGSGGNQTTSFLSKLQISKCNNLTSLEEGL
LSQNLSNIEHIYVTGCNELMRIPLKRFENFTSLKKLQIEACPKLSLTQEE
EAALLPPSFKVFILNDCGDLNKLRLGHPYRSTFDFLPTTDPHRPSSMSHK
FSWFRSHNILGTFFLA
>XP_042449243.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEGVALAVGGWLAQPVINMLVDRVWTLRGKLHGLQDDDLQKLHRSLLNIH
TIVDKAGMRWSRDARLVEMMKQLQDAAYDAEDFLDELTFHGMKQKIKEEA
SHKVLNQFSRAIRDAKTKLFSDSVKRLNKIQKKLDDIYADMERMCQSLQV
DASDGQYQSDLASTTRETSSLLISKVLGREEEQQRIIELLLRSTDESASD
NGSSFSVIPLVGIGGVGKTTLAQLVYKDEEIQNHFAHKIWICVSENFNVQ
RLTKEMIESVTETEHSSHMKLDVLQNILKREIASKMILLVLDNVWNEDEE
EWRKLCSPFMYAAAGSKVIVTTRSLSIANKIGSVEAIVLGDLGEISFWEL
FKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAAKTVGNLLRSNMNPHH
WRSIMKSEVWELQQNNKNDIIPVLQLSYQYLSAPLKRCFAFCSLFQKDYK
FSKLELTRMWMAEGFVVAQGNQRMEDVASQYFHELVNMSLFQQETSSSLE
HYFVMHDLIHDLTQSVSVDETIRMDNGKSNKISTTLRHLAVETGFIETKE
LRSRFKKLHSLFCQHLKSPPLDFIEKIRSIRVLVLSHCRLHMLPTSVGEL
VHLRYLDISNNEIEKLPESLCKLYNLQTLKANYNWLGISFPDIIQLVNLR
HLDVDNEVLGMIKMIGRLTSLQELYNFHAQKEVGFKITELSGLKQLHGKL
RITNLENVESKEEAEKAQMKNKEYLDALELRWGFDSKLDDNKLVVMEEVL
EGLQPHESLKRLKIRRYCGATSPSWMKKEELSNLEILKLSYCKSWKDISC
TALLPHLKVFHIESSMWFSKSCFEVCGSRESKLFPMLEELQLRKMNASEE
LPNLGRFPCLKVVRMTEIESLKHIDFAASGATKNALFPMLEELELRDMPA
LEEISNLGHFPRLRFFRMIGMPLLKHIGLASIDATENDLFPMLEELQLMD
LPVLEELPDLGSLPCLKSLRIIRMSMLKHIIDFAFSSATEKVLLPRVETL
VLDGLKALEELPSNLGRLPCLKFLQILNISVVKQIGHGFFSTEAISKCFL
SLESLFIIGMPACEGWCWIDGSELFPRLQRLFITGCPKLERLPPLPPSLT
HLTLGNVGLTELPSLQELETNGSGGNQTTSFLSKLQISKCNNLTSLEEGL
LSQNLSNIEHIYVTGCNELMRIPLKRFENFTSLKKLQIEACPKLSLTQEE
EAALLPPSFKVFILNDCGDLNKLRLGHPYRSTFDFLPTTDPHRPSSMSHK
FSWFRSHNILGTFFLA
>XP_042449244.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEGVALAVGGWLAQPVINMLVDRVWTLRGKLHGLQDDDLQKLHRSLLNIH
TIVDKAGMRWSRDARLVEMMKQLQDAAYDAEDFLDELTFHGMKQKIKEEA
SHKVLNQFSRAIRDAKTKLFSDSVKRLNKIQKKLDDIYADMERMCQSLQV
DASDGQYQSDLASTTRETSSLLISKVLGREEEQQRIIELLLRSTDESASD
NGSSFSVIPLVGIGGVGKTTLAQLVYKDEEIQNHFAHKIWICVSENFNVQ
RLTKEMIESVTETEHSSHMKLDVLQNILKREIASKMILLVLDNVWNEDEE
EWRKLCSPFMYAAAGSKVIVTTRSLSIANKIGSVEAIVLGDLGEISFWEL
FKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAAKTVGNLLRSNMNPHH
WRSIMKSEVWELQQNNKNDIIPVLQLSYQYLSAPLKRCFAFCSLFQKDYK
FSKLELTRMWMAEGFVVAQGNQRMEDVASQYFHELVNMSLFQQETSSSLE
HYFVMHDLIHDLTQSVSVDETIRMDNGKSNKISTTLRHLAVETGFIETKE
LRSRFKKLHSLFCQHLKSPPLDFIEKIRSIRVLVLSHCRLHMLPTSVGEL
VHLRYLDISNNEIEKLPESLCKLYNLQTLKANYNWLGISFPDIIQLVNLR
HLDVDNEVLGMIKMIGRLTSLQELYNFHAQKEVGFKITELSGLKQLHGKL
RITNLENVESKEEAEKAQMKNKEYLDALELRWGFDSKLDDNKLVVMEEVL
EGLQPHESLKRLKIRRYCGATSPSWMKKEELSNLEILKLSYCKSWKDISC
TALLPHLKVFHIESSMWFSKSCFEVCGSRESKLFPMLEELQLRKMNASEE
LPNLGRFPCLKVVRMTEIESLKHIDFAASGATKNALFPMLEELELRDMPA
LEEISNLGHFPRLRFFRMIGMPLLKHIGLASIDATENDLFPMLEELQLMD
LPVLEELPDLGSLPCLKSLRIIRMSMLKHIIDFAFSSATEKVLLPRVETL
VLDGLKALEELPSNLGRLPCLKFLQILNISVVKQIGHGFFSTEAISKCFL
SLESLFIIGMPACEGWCWIDGSELFPRLQRLFITGCPKLERLPPLPPSLT
HLTLGNVGLTELPSLQELETNGSGGNQTTSFLSKLQISKCNNLTSLEEGL
LSQNLSNIEHIYVTGCNELMRIPLKRFENFTSLKKLQIEACPKLSLTQEE
EAALLPPSFKVFILNDCGDLNKLRLGHPYRSTFDFLPTTDPHRPSSMSHK
FSWFRSHNILGTFFLA
>XP_042449245.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEGVALAVGGWLAQPVINMLVDRVWTLRGKLHGLQDDDLQKLHRSLLNIH
TIVDKAGMRWSRDARLVEMMKQLQDAAYDAEDFLDELTFHGMKQKIKEEA
SHKVLNQFSRAIRDAKTKLFSDSVKRLNKIQKKLDDIYADMERMCQSLQV
DASDGQYQSDLASTTRETSSLLISKVLGREEEQQRIIELLLRSTDESASD
NGSSFSVIPLVGIGGVGKTTLAQLVYKDEEIQNHFAHKIWICVSENFNVQ
RLTKEMIESVTETEHSSHMKLDVLQNILKREIASKMILLVLDNVWNEDEE
EWRKLCSPFMYAAAGSKVIVTTRSLSIANKIGSVEAIVLGDLGEISFWEL
FKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAAKTVGNLLRSNMNPHH
WRSIMKSEVWELQQNNKNDIIPVLQLSYQYLSAPLKRCFAFCSLFQKDYK
FSKLELTRMWMAEGFVVAQGNQRMEDVASQYFHELVNMSLFQQETSSSLE
HYFVMHDLIHDLTQSVSVDETIRMDNGKSNKISTTLRHLAVETGFIETKE
LRSRFKKLHSLFCQHLKSPPLDFIEKIRSIRVLVLSHCRLHMLPTSVGEL
VHLRYLDISNNEIEKLPESLCKLYNLQTLKANYNWLGISFPDIIQLVNLR
HLDVDNEVLGMIKMIGRLTSLQELYNFHAQKEVGFKITELSGLKQLHGKL
RITNLENVESKEEAEKAQMKNKEYLDALELRWGFDSKLDDNKLVVMEEVL
EGLQPHESLKRLKIRRYCGATSPSWMKKEELSNLEILKLSYCKSWKDISC
TALLPHLKVFHIESSMWFSKSCFEVCGSRESKLFPMLEELQLRKMNASEE
LPNLGRFPCLKVVRMTEIESLKHIDFAASGATKNALFPMLEELELRDMPA
LEEISNLGHFPRLRFFRMIGMPLLKHIGLASIDATENDLFPMLEELQLMD
LPVLEELPDLGSLPCLKSLRIIRMSMLKHIIDFAFSSATEKVLLPRVETL
VLDGLKALEELPSNLGRLPCLKFLQILNISVVKQIGHGFFSTEAISKCFL
SLESLFIIGMPACEGWCWIDGSELFPRLQRLFITGCPKLERLPPLPPSLT
HLTLGNVGLTELPSLQELETNGSGGNQTTSFLSKLQISKCNNLTSLEEGL
LSQNLSNIEHIYVTGCNELMRIPLKRFENFTSLKKLQIEACPKLSLTQEE
EAALLPPSFKVFILNDCGDLNKLRLGHPYRSTFDFLPTTDPHRPSSMSHK
FSWFRSHNILGTFFLA
>XP_042449374.1 putative disease resistance protein RGA3 [Zingiber officinale]
MANDSVSRFATKIGNLFRPLAAEMIRVSLSDLAARSMPEVQRYKLEGIKV
ILKNIKGLLYDSGRQIREDDIKLWLKELQDLVIEVEDLVDDYQYKMFQRE
AEFLNKIEQPSGYVSSDPLRGLDGGAMHSPGLDGAAKSCIIDSCPGLGGG
ARSSIHPSPELSVGASHSSGLDVGTSHHSGITDFSSGFGGGARSTIDPSP
EFSSGLGGGARSTIDPSPEFFTIDPSPDFSPELDGRRRIGFFGPHSSLLD
QLLDQHKKIDKIISSWKKEEEVISCITTDPSSGLDGGARHSPGFREVVGP
STIRNEVDASPIKGPFNIVVRIAWVKHNLLAQLQKSQKFASHLLLVSQEN
QDSEKLQRVREFLLAESSSQKSTKDLNYFPADTIRGRKHYNAFDVTKQIY
GRNRDKEFIISWLFSTNSRFSLFEDERSRNKFSAISIVGEAGVGKTTLAK
EVYNDPLICKYFNSRVWLHFTEESDAVSFSKAFFVSITGKSCDGKLPVHL
QSVMKEELKGKKLLLVLDDLQDLNPRLWEYLQAPLAGVRMAKFIITSRTE
LEASKLRGIESYPLGCLPLDLSWDLFQHCAFREDSSHPPKLIEIGKRIVQ
ECRGLPIAVKTLGSVLGYQMDKQIWLDVLDSELWELQETETDISPALQLS
YYLLPTYLKPCFLYCSLFPRGYKFDKYELVRLWMAQGYIQHEYGQSLETV
GCNYFHELQMLTIFDRSWDGTFTIHNLLYDVSRYMSNGECSSLPYGKMYK
DSGKIRQLYVTSSKGTNELQSSNANLTLQLLYKSLGGFLPNDILTMTLIE
SVQGIRALELTCHGDSSIAETIQEKALDKLNASSVSSLRFIHLRYLRICD
RFIELLPAAVCELYNLQTLTLDKCLKLIELPSDIGKLVNLRYLGLSEANI
EKLPKSVYQLRNLQSLKVDYCRNLKDLPYNIGSLVNLCHLRLSGTSIKRL
PRSVHCLSKLSTLKLDQCKILMALPSSIGNLVNLRHVTACKTKITKLPES
ICLLFNLLTLDLAYSNLSELPNDIGNLSNLNYLALSYTNISILPESLCYL
YRLRILKLNGCTNLSQLPSGIGALKRLSHLVVSGINIEQLPASVCQLLNL
EVLEMDGCRKFFSLPDGIGYLTKLHQLKLSDTEIQELPESIGQLSNLQNL
ELNGCQRLCKLPESIGDLSELSNLEVTETKIKALPASFCQLSNLKVLNLN
GNLDLQELPSGIENLANLCQLELSEVGIEVLPRCIVRLTNLEKLTFEHKQ
KPFENYQL
>XP_042449396.1 putative disease resistance protein RGA4 isoform X1 [Zingiber officinale]
MDVVSPILDRARAKVIDKLIDKVSTYVQDQYYWKANLQEELQNLKRLLPQ
IQAVVGYAEDKLTMYESHNPALIKWLWQFRDDIDEAEEVLDELEYRELEK
KSDGDKSRLSTIIDPYFRAAKRFLKSDDDVLERLRTCVENLKTSASYVET
FRALVTPTSGIGTGQMQQEQESLTLSNQSRITSSLPGLSFKGREEEKGKI
IQYLLGEESEIQTSQNVHCLPLVAMGGMGKTALAQQVFDHFEKEKKGHFN
VKIWVCDSLPNLNASNLMKKILEYSTGQSESGPSELMPVKLKDKLHSKRF
LLVLDDAWDDKNHTEWEKLCIPLLHGQKGSWILLTTRLESVAKMVSKIIK
GGTMKPMTLQGLPKDECRSLLYEHAFVDQDPNGFPLLKKIGEEIVEKLHG
VPLLAKSIGGALNNKLEADHWTSISRSELWKMPQDLNNYEFIPALTLSYK
MLPPRLKQCFSYCSIFPQDYTFKKQKLVCIWVAAGLIYSDGSEEGSDEDI
ANYCFDMLCNKSFFDVHTNNWSAFHQDIAPYALEVIFYTMHDMLNGLSRH
VSRYECCRIVHDTPSYICDYNAIRHISISITSIDAQLGDLANMVCKFKNL
RTLRIEQYYGDSQKLDDFIRDACKSPRRIRVLTIRPYKYFESISDFVKLR
FLEITALPPSVSISKFYFLQVLTGYRGILAKDTSKLRNLRHLYGVPENAL
FSVAEVGKLTCLQELCFTVGIEPGYRIDELMNMDNLRQLSIAKLSNVHRL
EEANNVDLVSKSHLTSLELNWYKPDLDEASSNLGHDQQEVLAALQPPPTI
RKLIIREYKGGRPAPWMNTQSLSRLESLELYNCTNLEELPPLWKLPCLKF
IKLSDMKVIRSLGCHSSDMMDKQFSVLEKLEFRDLPLLEEWNGADDYQWF
PRLKRFEIEKCPKLKKIPDLPLSIENLCMKKLGLEALPRFYKCSNGSRTF
EGFQQLMSLEFLEMDDYSEIVDIGSIGEEDGNFLPSELKKLKLKILNKHE
DLASYLRGLTLLTELSLSRLQGMTSLPLTNELEHLTTLRSLYICDCEDLT
SPGGVYIIKSLKHLYMYNCPKFLTAEVESQQLLKDKTRKHAASSSSIFDH
STSNKAASTLPSSLESLTFSTSKISQESLGCCLQGLTSLKSLDISKCNHL
VSLPNRDYLHNLTALQTLWIANCKELCKLESLTALISLRELYIYNCPKLH
TTTLSTVQNPAATTEQSATKIKKGTLLSLEKIQIDNIFYLPILPIPEKLK
TLYIKKEITCFPSEIEEWLLQCQESLENLCLEKMPHLQSLPVILESFSSL
KFLSISSAPELKSLPRMPASLEQLTIHGCSAKLEKRCQKNIGPDWPNIEH
IPHIKITAVKEDKAKFLQDVLFS
>XP_042449397.1 putative disease resistance protein RGA4 isoform X1 [Zingiber officinale]
MDVVSPILDRARAKVIDKLIDKVSTYVQDQYYWKANLQEELQNLKRLLPQ
IQAVVGYAEDKLTMYESHNPALIKWLWQFRDDIDEAEEVLDELEYRELEK
KSDGDKSRLSTIIDPYFRAAKRFLKSDDDVLERLRTCVENLKTSASYVET
FRALVTPTSGIGTGQMQQEQESLTLSNQSRITSSLPGLSFKGREEEKGKI
IQYLLGEESEIQTSQNVHCLPLVAMGGMGKTALAQQVFDHFEKEKKGHFN
VKIWVCDSLPNLNASNLMKKILEYSTGQSESGPSELMPVKLKDKLHSKRF
LLVLDDAWDDKNHTEWEKLCIPLLHGQKGSWILLTTRLESVAKMVSKIIK
GGTMKPMTLQGLPKDECRSLLYEHAFVDQDPNGFPLLKKIGEEIVEKLHG
VPLLAKSIGGALNNKLEADHWTSISRSELWKMPQDLNNYEFIPALTLSYK
MLPPRLKQCFSYCSIFPQDYTFKKQKLVCIWVAAGLIYSDGSEEGSDEDI
ANYCFDMLCNKSFFDVHTNNWSAFHQDIAPYALEVIFYTMHDMLNGLSRH
VSRYECCRIVHDTPSYICDYNAIRHISISITSIDAQLGDLANMVCKFKNL
RTLRIEQYYGDSQKLDDFIRDACKSPRRIRVLTIRPYKYFESISDFVKLR
FLEITALPPSVSISKFYFLQVLTGYRGILAKDTSKLRNLRHLYGVPENAL
FSVAEVGKLTCLQELCFTVGIEPGYRIDELMNMDNLRQLSIAKLSNVHRL
EEANNVDLVSKSHLTSLELNWYKPDLDEASSNLGHDQQEVLAALQPPPTI
RKLIIREYKGGRPAPWMNTQSLSRLESLELYNCTNLEELPPLWKLPCLKF
IKLSDMKVIRSLGCHSSDMMDKQFSVLEKLEFRDLPLLEEWNGADDYQWF
PRLKRFEIEKCPKLKKIPDLPLSIENLCMKKLGLEALPRFYKCSNGSRTF
EGFQQLMSLEFLEMDDYSEIVDIGSIGEEDGNFLPSELKKLKLKILNKHE
DLASYLRGLTLLTELSLSRLQGMTSLPLTNELEHLTTLRSLYICDCEDLT
SPGGVYIIKSLKHLYMYNCPKFLTAEVESQQLLKDKTRKHAASSSSIFDH
STSNKAASTLPSSLESLTFSTSKISQESLGCCLQGLTSLKSLDISKCNHL
VSLPNRDYLHNLTALQTLWIANCKELCKLESLTALISLRELYIYNCPKLH
TTTLSTVQNPAATTEQSATKIKKGTLLSLEKIQIDNIFYLPILPIPEKLK
TLYIKKEITCFPSEIEEWLLQCQESLENLCLEKMPHLQSLPVILESFSSL
KFLSISSAPELKSLPRMPASLEQLTIHGCSAKLEKRCQKNIGPDWPNIEH
IPHIKITAVKEDKAKFLQDVLFS
>XP_042449398.1 putative disease resistance protein RGA4 isoform X1 [Zingiber officinale]
MDVVSPILDRARAKVIDKLIDKVSTYVQDQYYWKANLQEELQNLKRLLPQ
IQAVVGYAEDKLTMYESHNPALIKWLWQFRDDIDEAEEVLDELEYRELEK
KSDGDKSRLSTIIDPYFRAAKRFLKSDDDVLERLRTCVENLKTSASYVET
FRALVTPTSGIGTGQMQQEQESLTLSNQSRITSSLPGLSFKGREEEKGKI
IQYLLGEESEIQTSQNVHCLPLVAMGGMGKTALAQQVFDHFEKEKKGHFN
VKIWVCDSLPNLNASNLMKKILEYSTGQSESGPSELMPVKLKDKLHSKRF
LLVLDDAWDDKNHTEWEKLCIPLLHGQKGSWILLTTRLESVAKMVSKIIK
GGTMKPMTLQGLPKDECRSLLYEHAFVDQDPNGFPLLKKIGEEIVEKLHG
VPLLAKSIGGALNNKLEADHWTSISRSELWKMPQDLNNYEFIPALTLSYK
MLPPRLKQCFSYCSIFPQDYTFKKQKLVCIWVAAGLIYSDGSEEGSDEDI
ANYCFDMLCNKSFFDVHTNNWSAFHQDIAPYALEVIFYTMHDMLNGLSRH
VSRYECCRIVHDTPSYICDYNAIRHISISITSIDAQLGDLANMVCKFKNL
RTLRIEQYYGDSQKLDDFIRDACKSPRRIRVLTIRPYKYFESISDFVKLR
FLEITALPPSVSISKFYFLQVLTGYRGILAKDTSKLRNLRHLYGVPENAL
FSVAEVGKLTCLQELCFTVGIEPGYRIDELMNMDNLRQLSIAKLSNVHRL
EEANNVDLVSKSHLTSLELNWYKPDLDEASSNLGHDQQEVLAALQPPPTI
RKLIIREYKGGRPAPWMNTQSLSRLESLELYNCTNLEELPPLWKLPCLKF
IKLSDMKVIRSLGCHSSDMMDKQFSVLEKLEFRDLPLLEEWNGADDYQWF
PRLKRFEIEKCPKLKKIPDLPLSIENLCMKKLGLEALPRFYKCSNGSRTF
EGFQQLMSLEFLEMDDYSEIVDIGSIGEEDGNFLPSELKKLKLKILNKHE
DLASYLRGLTLLTELSLSRLQGMTSLPLTNELEHLTTLRSLYICDCEDLT
SPGGVYIIKSLKHLYMYNCPKFLTAEVESQQLLKDKTRKHAASSSSIFDH
STSNKAASTLPSSLESLTFSTSKISQESLGCCLQGLTSLKSLDISKCNHL
VSLPNRDYLHNLTALQTLWIANCKELCKLESLTALISLRELYIYNCPKLH
TTTLSTVQNPAATTEQSATKIKKGTLLSLEKIQIDNIFYLPILPIPEKLK
TLYIKKEITCFPSEIEEWLLQCQESLENLCLEKMPHLQSLPVILESFSSL
KFLSISSAPELKSLPRMPASLEQLTIHGCSAKLEKRCQKNIGPDWPNIEH
IPHIKITAVKEDKAKFLQDVLFS
>XP_042449399.1 putative disease resistance protein RGA4 isoform X1 [Zingiber officinale]
MDVVSPILDRARAKVIDKLIDKVSTYVQDQYYWKANLQEELQNLKRLLPQ
IQAVVGYAEDKLTMYESHNPALIKWLWQFRDDIDEAEEVLDELEYRELEK
KSDGDKSRLSTIIDPYFRAAKRFLKSDDDVLERLRTCVENLKTSASYVET
FRALVTPTSGIGTGQMQQEQESLTLSNQSRITSSLPGLSFKGREEEKGKI
IQYLLGEESEIQTSQNVHCLPLVAMGGMGKTALAQQVFDHFEKEKKGHFN
VKIWVCDSLPNLNASNLMKKILEYSTGQSESGPSELMPVKLKDKLHSKRF
LLVLDDAWDDKNHTEWEKLCIPLLHGQKGSWILLTTRLESVAKMVSKIIK
GGTMKPMTLQGLPKDECRSLLYEHAFVDQDPNGFPLLKKIGEEIVEKLHG
VPLLAKSIGGALNNKLEADHWTSISRSELWKMPQDLNNYEFIPALTLSYK
MLPPRLKQCFSYCSIFPQDYTFKKQKLVCIWVAAGLIYSDGSEEGSDEDI
ANYCFDMLCNKSFFDVHTNNWSAFHQDIAPYALEVIFYTMHDMLNGLSRH
VSRYECCRIVHDTPSYICDYNAIRHISISITSIDAQLGDLANMVCKFKNL
RTLRIEQYYGDSQKLDDFIRDACKSPRRIRVLTIRPYKYFESISDFVKLR
FLEITALPPSVSISKFYFLQVLTGYRGILAKDTSKLRNLRHLYGVPENAL
FSVAEVGKLTCLQELCFTVGIEPGYRIDELMNMDNLRQLSIAKLSNVHRL
EEANNVDLVSKSHLTSLELNWYKPDLDEASSNLGHDQQEVLAALQPPPTI
RKLIIREYKGGRPAPWMNTQSLSRLESLELYNCTNLEELPPLWKLPCLKF
IKLSDMKVIRSLGCHSSDMMDKQFSVLEKLEFRDLPLLEEWNGADDYQWF
PRLKRFEIEKCPKLKKIPDLPLSIENLCMKKLGLEALPRFYKCSNGSRTF
EGFQQLMSLEFLEMDDYSEIVDIGSIGEEDGNFLPSELKKLKLKILNKHE
DLASYLRGLTLLTELSLSRLQGMTSLPLTNELEHLTTLRSLYICDCEDLT
SPGGVYIIKSLKHLYMYNCPKFLTAEVESQQLLKDKTRKHAASSSSIFDH
STSNKAASTLPSSLESLTFSTSKISQESLGCCLQGLTSLKSLDISKCNHL
VSLPNRDYLHNLTALQTLWIANCKELCKLESLTALISLRELYIYNCPKLH
TTTLSTVQNPAATTEQSATKIKKGTLLSLEKIQIDNIFYLPILPIPEKLK
TLYIKKEITCFPSEIEEWLLQCQESLENLCLEKMPHLQSLPVILESFSSL
KFLSISSAPELKSLPRMPASLEQLTIHGCSAKLEKRCQKNIGPDWPNIEH
IPHIKITAVKEDKAKFLQDVLFS
>XP_042449400.1 putative disease resistance protein RGA4 isoform X1 [Zingiber officinale]
MDVVSPILDRARAKVIDKLIDKVSTYVQDQYYWKANLQEELQNLKRLLPQ
IQAVVGYAEDKLTMYESHNPALIKWLWQFRDDIDEAEEVLDELEYRELEK
KSDGDKSRLSTIIDPYFRAAKRFLKSDDDVLERLRTCVENLKTSASYVET
FRALVTPTSGIGTGQMQQEQESLTLSNQSRITSSLPGLSFKGREEEKGKI
IQYLLGEESEIQTSQNVHCLPLVAMGGMGKTALAQQVFDHFEKEKKGHFN
VKIWVCDSLPNLNASNLMKKILEYSTGQSESGPSELMPVKLKDKLHSKRF
LLVLDDAWDDKNHTEWEKLCIPLLHGQKGSWILLTTRLESVAKMVSKIIK
GGTMKPMTLQGLPKDECRSLLYEHAFVDQDPNGFPLLKKIGEEIVEKLHG
VPLLAKSIGGALNNKLEADHWTSISRSELWKMPQDLNNYEFIPALTLSYK
MLPPRLKQCFSYCSIFPQDYTFKKQKLVCIWVAAGLIYSDGSEEGSDEDI
ANYCFDMLCNKSFFDVHTNNWSAFHQDIAPYALEVIFYTMHDMLNGLSRH
VSRYECCRIVHDTPSYICDYNAIRHISISITSIDAQLGDLANMVCKFKNL
RTLRIEQYYGDSQKLDDFIRDACKSPRRIRVLTIRPYKYFESISDFVKLR
FLEITALPPSVSISKFYFLQVLTGYRGILAKDTSKLRNLRHLYGVPENAL
FSVAEVGKLTCLQELCFTVGIEPGYRIDELMNMDNLRQLSIAKLSNVHRL
EEANNVDLVSKSHLTSLELNWYKPDLDEASSNLGHDQQEVLAALQPPPTI
RKLIIREYKGGRPAPWMNTQSLSRLESLELYNCTNLEELPPLWKLPCLKF
IKLSDMKVIRSLGCHSSDMMDKQFSVLEKLEFRDLPLLEEWNGADDYQWF
PRLKRFEIEKCPKLKKIPDLPLSIENLCMKKLGLEALPRFYKCSNGSRTF
EGFQQLMSLEFLEMDDYSEIVDIGSIGEEDGNFLPSELKKLKLKILNKHE
DLASYLRGLTLLTELSLSRLQGMTSLPLTNELEHLTTLRSLYICDCEDLT
SPGGVYIIKSLKHLYMYNCPKFLTAEVESQQLLKDKTRKHAASSSSIFDH
STSNKAASTLPSSLESLTFSTSKISQESLGCCLQGLTSLKSLDISKCNHL
VSLPNRDYLHNLTALQTLWIANCKELCKLESLTALISLRELYIYNCPKLH
TTTLSTVQNPAATTEQSATKIKKGTLLSLEKIQIDNIFYLPILPIPEKLK
TLYIKKEITCFPSEIEEWLLQCQESLENLCLEKMPHLQSLPVILESFSSL
KFLSISSAPELKSLPRMPASLEQLTIHGCSAKLEKRCQKNIGPDWPNIEH
IPHIKITAVKEDKAKFLQDVLFS
>XP_042449401.1 putative disease resistance protein RGA4 isoform X2 [Zingiber officinale]
MDVVSPILDRARAKVIDKLIDKVSTYVQDQYYWKANLQEELQNLKRLLPQ
IQAVVGYAEDKLTMYESHNPALIKWLWQFRDDIDEAEEVLDELEYRELEK
KSDGDKSRLSTIIDPYFRAAKRFLKSDDDVLERLRTCVENLKTSASYVET
FRALVTPTSGIGTGQMQQEQESLTLSNQSRITSSLPGLSFKGREEEKGKI
IQYLLGEESEIQTSQNVHCLPLVAMGGMGKTALAQQVFDHFEKEKKGHFN
VKIWVCDSLPNLNASNLMKKILEYSTGQSESGPSELMPVKLKDKLHSKRF
LLVLDDAWDDKNHTEWEKLCIPLLHGQKGSWILLTTRLESVAKMVSKIIK
GGTMKPMTLQGLPKDECRSLLYEHAFVDQDPNGFPLLKKIGEEIVEKLHG
VPLLAKSIGGALNNKLEADHWTSISRSELWKMPQDLNNYEFIPALTLSYK
MLPPRLKQCFSYCSIFPQDYTFKKQKLVCIWVAAGLIYSDGSEEGSDEDI
ANYCFDMLCNKSFFDVHTNNWSAFHQDIAPYALEVIFYTMHDMLNGLSRH
VSRYECCRIVHDTPSYICDYNAIRHISISITSIDAQLGDLANMVCKFKNL
RTLRIEQYYGDSQKLDDFIRDACKSPRRIRVLTIRPYKYFESISDFVKLR
FLEITALPPSVSISKFYFLQVLTGYRGILAKDTSKLRNLRHLYGVPENAL
FSVAEVGKLTCLQELCFTVGIEPGYRIDELMNMDNLRQLSIAKLSNVHRL
EEANNVDLVSKSHLTSLELNWYKPDLDEASSNLGHDQQEVLAALQPPPTI
RKLIIREYKGGRPAPWMNTQSLSRLESLELYNCTNLEELPPLWKLPCLKF
IKLSDMKVIRSLGCHSSDMMDKQFSVLEKLEFRDLPLLEEWNGADDYQWF
PRLKRFEIEKCPKLKKIPDLPLSIENLCMKKLGLEALPRFYKCSNGSRTF
EGFQQLMSLEFLEMDDYSEIVDIGSIGEEDGNFLPSELKKLKLKILNKHE
DLASYLRGLTLLTELSLSRLQGMTSLPLTNELEHLTTLRSLYICDCEDLT
SPGGVYIIKSLKHLYMYNCPKFLTAEVESQQLLKDKTRKHAASSSSIFDH
STSNKAASTLPSSLESLTFSTSKISQESLGCCLQGLTSLKSLDISKCNHL
VSLPNRDYLHNLTALQTLWIANCKELCKLESLTALISLRELYIYNCPKLH
TTTLSTVQNPAATTEQSATKIKKGTLLSLEKIQIDNIFYLPILPIPEKLK
TLYIKKEITCFPSEIEEWLLQCQESLENLCLEKMPHLQSLPVILESFSSL
KFLSISSAPELKSLPRMPASLEQLTIHGCSAKLEKRCQKNIGPDWPNIEH
IPHIKITAVKEDKAKDVLFS
>XP_042449620.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MESVALAVGGWLAQPVINMLVDRVWTLRGKLHGLQDDDLKKLHRSLLNIH
TIVDKAGMRWSRDARLVEMMKQLQDAAYDAEDFLDDLTFHGMKQKIKKEA
SHKASNLFSKAFRKTKTKLFSDSVKRLNKIQKKLDCIYADMEKMCQFLQM
DALSGGQYQSDSASVTRETSPFLICKVLGREKEQKRIIELLLRSTDESAS
ASDNGSSFSVIPLVGIGGVGKTTLAQLVYEDDEIQNHFALKLWICVSDNF
NVQRLTKEMIESVTETQHSSQMKLAVLQNILKKEIESKMILLVLDDVWNE
VEEEWRKLCAPFMYAAAGSKVIVTTRIKSIADKIGTVEAIVLGDLDEISF
WELFKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAARTVGNLLGSNMN
PHHWRSIMKSEVWELQQNKNDIIPVLQLSYQYLSAPLKRCFAVCCLFHKD
YKFSEIELTRIWMAEGFIVAQGNQRMEDVASKYLHELVNMSLFQQETTFG
SHYYVMHDLIHDLTQSVSVDETSRKDNGKSNKISTTLRHLAVKKEFVETK
DMLRSRIKKLHSLFCQQLKSPPLDVIEKLRSIRVLVLYDCGLQMLPTSVG
ELIHLRYLDISYNKIKELPESLCELYNLQTLKANNSPLICLPEDISQLIN
LRHLDIENRLVVQIKKIGRLTSLQELSEFQVRKEVGFKITELSGLKQLHG
KLKITNLENVESKEEAENAQMKNKEYLDVLELEWKFDPKLENKLVAMEEV
LEGLQPHESLKQLQIKRYCGARSPSWMKKELSNLERLELSFCESWKDISC
TALLPHLKVFHIYQSMWFSKSCFEVCGSRESKLFPILEELQLSYMNASEE
LPNLGRFPCLRVVRMTGIKSLKHIDFTASGAIENSLFPMLEELDLRYMPA
LEEFCSRGHFPRLRVLCMVAMPLLKHIGFASVHATENDLFPALEVLELMD
LPALEELPDLCSLPCLKSFHMRRMSMLKHIDFTLYGSTEKVILPRVETLV
LDDLEALEELPSNLGRLPCLKVLKIVKISAVKQIGHGFFSTEVITKCFLS
LENLWISDMPACERWCWIGGSELFPSLQKLTIYECPKLEKLPPLPPSLIY
LSLREVGLTELPSLQELETNESGGNQTTSSLSALRIRKCNNLTSLEEGLL
LQNISNIEDIYVEGCNKLMRMPLKRFENFTSLKELRIKACPKLSLTQEEE
AALLPPSFKVFILNDCGDLNRLRLGHPYRSTF
>XP_042449621.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MESVALAVGGWLAQPVINMLVDRVWTLRGKLHGLQDDDLKKLHRSLLNIH
TIVDKAGMRWSRDARLVEMMKQLQDAAYDAEDFLDDLTFHGMKQKIKKEA
SHKASNLFSKAFRKTKTKLFSDSVKRLNKIQKKLDCIYADMEKMCQFLQM
DALSGGQYQSDSASVTRETSPFLICKVLGREKEQKRIIELLLRSTDESAS
ASDNGSSFSVIPLVGIGGVGKTTLAQLVYEDDEIQNHFALKLWICVSDNF
NVQRLTKEMIESVTETQHSSQMKLAVLQNILKKEIESKMILLVLDDVWNE
VEEEWRKLCAPFMYAAAGSKVIVTTRIKSIADKIGTVEAIVLGDLDEISF
WELFKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAARTVGNLLGSNMN
PHHWRSIMKSEVWELQQNKNDIIPVLQLSYQYLSAPLKRCFAVCCLFHKD
YKFSEIELTRIWMAEGFIVAQGNQRMEDVASKYLHELVNMSLFQQETTFG
SHYYVMHDLIHDLTQSVSVDETSRKDNGKSNKISTTLRHLAVKKEFVETK
DMLRSRIKKLHSLFCQQLKSPPLDVIEKLRSIRVLVLYDCGLQMLPTSVG
ELIHLRYLDISYNKIKELPESLCELYNLQTLKANNSPLICLPEDISQLIN
LRHLDIENRLVVQIKKIGRLTSLQELSEFQVRKEVGFKITELSGLKQLHG
KLKITNLENVESKEEAENAQMKNKEYLDVLELEWKFDPKLENKLVAMEEV
LEGLQPHESLKQLQIKRYCGARSPSWMKKELSNLERLELSFCESWKDISC
TALLPHLKVFHIYQSMWFSKSCFEVCGSRESKLFPILEELQLSYMNASEE
LPNLGRFPCLRVVRMTGIKSLKHIDFTASGAIENSLFPMLEELDLRYMPA
LEEFCSRGHFPRLRVLCMVAMPLLKHIGFASVHATENDLFPALEVLELMD
LPALEELPDLCSLPCLKSFHMRRMSMLKHIDFTLYGSTEKVILPRVETLV
LDDLEALEELPSNLGRLPCLKVLKIVKISAVKQIGHGFFSTEVITKCFLS
LENLWISDMPACERWCWIGGSELFPSLQKLTIYECPKLEKLPPLPPSLIY
LSLREVGLTELPSLQELETNESGGNQTTSSLSALRIRKCNNLTSLEEGLL
LQNISNIEDIYVEGCNKLMRMPLKRFENFTSLKELRIKACPKLSLTQEEE
AALLPPSFKVFILNDCGDLNRLRLGHPYRSTF
>XP_042449622.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MESVALAVGGWLAQPVINMLVDRVWTLRGKLHGLQDDDLKKLHRSLLNIH
TIVDKAGMRWSRDARLVEMMKQLQDAAYDAEDFLDDLTFHGMKQKIKKEA
SHKASNLFSKAFRKTKTKLFSDSVKRLNKIQKKLDCIYADMEKMCQFLQM
DALSGGQYQSDSASVTRETSPFLICKVLGREKEQKRIIELLLRSTDESAS
ASDNGSSFSVIPLVGIGGVGKTTLAQLVYEDDEIQNHFALKLWICVSDNF
NVQRLTKEMIESVTETQHSSQMKLAVLQNILKKEIESKMILLVLDDVWNE
VEEEWRKLCAPFMYAAAGSKVIVTTRIKSIADKIGTVEAIVLGDLDEISF
WELFKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAARTVGNLLGSNMN
PHHWRSIMKSEVWELQQNKNDIIPVLQLSYQYLSAPLKRCFAVCCLFHKD
YKFSEIELTRIWMAEGFIVAQGNQRMEDVASKYLHELVNMSLFQQETTFG
SHYYVMHDLIHDLTQSVSVDETSRKDNGKSNKISTTLRHLAVKKEFVETK
DMLRSRIKKLHSLFCQQLKSPPLDVIEKLRSIRVLVLYDCGLQMLPTSVG
ELIHLRYLDISYNKIKELPESLCELYNLQTLKANNSPLICLPEDISQLIN
LRHLDIENRLVVQIKKIGRLTSLQELSEFQVRKEVGFKITELSGLKQLHG
KLKITNLENVESKEEAENAQMKNKEYLDVLELEWKFDPKLENKLVAMEEV
LEGLQPHESLKQLQIKRYCGARSPSWMKKELSNLERLELSFCESWKDISC
TALLPHLKVFHIYQSMWFSKSCFEVCGSRESKLFPILEELQLSYMNASEE
LPNLGRFPCLRVVRMTGIKSLKHIDFTASGAIENSLFPMLEELDLRYMPA
LEEFCSRGHFPRLRVLCMVAMPLLKHIGFASVHATENDLFPALEVLELMD
LPALEELPDLCSLPCLKSFHMRRMSMLKHIDFTLYGSTEKVILPRVETLV
LDDLEALEELPSNLGRLPCLKVLKIVKISAVKQIGHGFFSTEVITKCFLS
LENLWISDMPACERWCWIGGSELFPSLQKLTIYECPKLEKLPPLPPSLIY
LSLREVGLTELPSLQELETNESGGNQTTSSLSALRIRKCNNLTSLEEGLL
LQNISNIEDIYVEGCNKLMRMPLKRFENFTSLKELRIKACPKLSLTQEEE
AALLPPSFKVFILNDCGDLNRLRLGHPYRSTF
>XP_042449623.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MESVALAVGGWLAQPVINMLVDRVWTLRGKLHGLQDDDLKKLHRSLLNIH
TIVDKAGMRWSRDARLVEMMKQLQDAAYDAEDFLDDLTFHGMKQKIKKEA
SHKASNLFSKAFRKTKTKLFSDSVKRLNKIQKKLDCIYADMEKMCQFLQM
DALSGGQYQSDSASVTRETSPFLICKVLGREKEQKRIIELLLRSTDESAS
ASDNGSSFSVIPLVGIGGVGKTTLAQLVYEDDEIQNHFALKLWICVSDNF
NVQRLTKEMIESVTETQHSSQMKLAVLQNILKKEIESKMILLVLDDVWNE
VEEEWRKLCAPFMYAAAGSKVIVTTRIKSIADKIGTVEAIVLGDLDEISF
WELFKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAARTVGNLLGSNMN
PHHWRSIMKSEVWELQQNKNDIIPVLQLSYQYLSAPLKRCFAVCCLFHKD
YKFSEIELTRIWMAEGFIVAQGNQRMEDVASKYLHELVNMSLFQQETTFG
SHYYVMHDLIHDLTQSVSVDETSRKDNGKSNKISTTLRHLAVKKEFVETK
DMLRSRIKKLHSLFCQQLKSPPLDVIEKLRSIRVLVLYDCGLQMLPTSVG
ELIHLRYLDISYNKIKELPESLCELYNLQTLKANNSPLICLPEDISQLIN
LRHLDIENRLVVQIKKIGRLTSLQELSEFQVRKEVGFKITELSGLKQLHG
KLKITNLENVESKEEAENAQMKNKEYLDVLELEWKFDPKLENKLVAMEEV
LEGLQPHESLKQLQIKRYCGARSPSWMKKELSNLERLELSFCESWKDISC
TALLPHLKVFHIYQSMWFSKSCFEVCGSRESKLFPILEELQLSYMNASEE
LPNLGRFPCLRVVRMTGIKSLKHIDFTASGAIENSLFPMLEELDLRYMPA
LEEFCSRGHFPRLRVLCMVAMPLLKHIGFASVHATENDLFPALEVLELMD
LPALEELPDLCSLPCLKSFHMRRMSMLKHIDFTLYGSTEKVILPRVETLV
LDDLEALEELPSNLGRLPCLKVLKIVKISAVKQIGHGFFSTEVITKCFLS
LENLWISDMPACERWCWIGGSELFPSLQKLTIYECPKLEKLPPLPPSLIY
LSLREVGLTELPSLQELETNESGGNQTTSSLSALRIRKCNNLTSLEEGLL
LQNISNIEDIYVEGCNKLMRMPLKRFENFTSLKELRIKACPKLSLTQEEE
AALLPPSFKVFILNDCGDLNRLRLGHPYRSTF
>XP_042449714.1 putative disease resistance protein RGA3 [Zingiber officinale]
MQQEQESLTLSNQSRITSSLPGLSFKGREEEKGKIIQYLLGEESEIQTSQ
NVHCLPLVVMGGMGKTALAQQVFDHFENEKKEHFDIKIWVCDSLPDLNAS
NLMKKILEYLTGLSESEPLELIPVKLKEKLHSKRFLLVLDDAWDDKNHIE
WEKLCIPLLHGQKGSWILLTTRLESVAKMVSKVIKGGTMKPMTLQGLPKD
ECRSLLYEHAFVDQDPNEFPLLKKIGEEIVEKLHGVPLLAKSIGGALNNK
LEADHWTSISRSELWKMPQDLNNCEFIPALTLSYKMLSPRLKQCFSYCSI
FPQDYKFNKQKLMCMRIAAGLMYSDGLKEGSNEDIANYCFDMLCNKSFFD
VHTNNWSAFRKGIAPYDLEVIYYTMHDMLNGLSRHVSRYECCRIVHDTPS
YICDYNAIRHISISITSIDAQLGDLANMVCKFKNLRTLRIEQYYGDSQKL
DDFIRDACKSPRRIRVLIIQPYKCLKSISDFVKLRFLEITALPLSVSISK
FYFLQVLTGYRGILAKDTSKLRNLRHLYEVPENALFSMAEVGKLTCLQEL
CFTVGTKPGYRIDELMNMDNLRQLSIAKLSNVHSLEETNNVNLVSKSYLT
SLELNWYKPDLDEASSNLGHDQQKVLAALHPPPTIRKLIIREYKGGRPAS
WMNTKSLSRLESLELYNCTNLEELPPLWKLSCLKFIKLSDMKAIRSLGCR
SSDPMDRQFSVLEELEFWDLPLLEEWNGADDYQWFPRLKRFEIGNCTKLK
KIPDLPLSIENLCMKKLGLEVLPRFYKCSNGSTTFGGFQQLMSLESLEMD
DYSEIVDIGSIGEEDGNFLPPALKKLKLKILNKHEDLASYLRGLTSLTKL
SLSCLQGMTSLPLTNELEHLTTLRSLYICDCEDLTSPGGLYIIKSLEQLH
MYNCPKFLTAEVESQQLLKEKTRSASDKAASILPSSLEFLRFSTSKISQE
SLGCCLQGLTSLKRLDISNCNHLVSLPNIEYLHNLTALQTLWISDCEELC
KLESLTALISLIQLSIFNCPKLIATTLSTVQNPAATTEQSATKIKKGTLL
SLEEIQIDNIFYLPILPIPEKLKTLYIKKEITCFPSEIEEWLSQCRESLK
ILILQQMTHLQSLPTILESFSSLKVLGINSAPELKSLPRMHASLELLVIN
GCSAKLEKRCQKNIGLDWPNIKHIPDIYITAVKEDKAKKVL
>XP_042449715.1 putative disease resistance protein RGA3 [Zingiber officinale]
MQQEQESLTLSNQSRITSSLPGLSFKGREEEKGKIIQYLLGEESEIQTSQ
NVHCLPLVVMGGMGKTALAQQVFDHFENEKKEHFDIKIWVCDSLPDLNAS
NLMKKILEYLTGLSESEPLELIPVKLKEKLHSKRFLLVLDDAWDDKNHIE
WEKLCIPLLHGQKGSWILLTTRLESVAKMVSKVIKGGTMKPMTLQGLPKD
ECRSLLYEHAFVDQDPNEFPLLKKIGEEIVEKLHGVPLLAKSIGGALNNK
LEADHWTSISRSELWKMPQDLNNCEFIPALTLSYKMLSPRLKQCFSYCSI
FPQDYKFNKQKLMCMRIAAGLMYSDGLKEGSNEDIANYCFDMLCNKSFFD
VHTNNWSAFRKGIAPYDLEVIYYTMHDMLNGLSRHVSRYECCRIVHDTPS
YICDYNAIRHISISITSIDAQLGDLANMVCKFKNLRTLRIEQYYGDSQKL
DDFIRDACKSPRRIRVLIIQPYKCLKSISDFVKLRFLEITALPLSVSISK
FYFLQVLTGYRGILAKDTSKLRNLRHLYEVPENALFSMAEVGKLTCLQEL
CFTVGTKPGYRIDELMNMDNLRQLSIAKLSNVHSLEETNNVNLVSKSYLT
SLELNWYKPDLDEASSNLGHDQQKVLAALHPPPTIRKLIIREYKGGRPAS
WMNTKSLSRLESLELYNCTNLEELPPLWKLSCLKFIKLSDMKAIRSLGCR
SSDPMDRQFSVLEELEFWDLPLLEEWNGADDYQWFPRLKRFEIGNCTKLK
KIPDLPLSIENLCMKKLGLEVLPRFYKCSNGSTTFGGFQQLMSLESLEMD
DYSEIVDIGSIGEEDGNFLPPALKKLKLKILNKHEDLASYLRGLTSLTKL
SLSCLQGMTSLPLTNELEHLTTLRSLYICDCEDLTSPGGLYIIKSLEQLH
MYNCPKFLTAEVESQQLLKEKTRSASDKAASILPSSLEFLRFSTSKISQE
SLGCCLQGLTSLKRLDISNCNHLVSLPNIEYLHNLTALQTLWISDCEELC
KLESLTALISLIQLSIFNCPKLIATTLSTVQNPAATTEQSATKIKKGTLL
SLEEIQIDNIFYLPILPIPEKLKTLYIKKEITCFPSEIEEWLSQCRESLK
ILILQQMTHLQSLPTILESFSSLKVLGINSAPELKSLPRMHASLELLVIN
GCSAKLEKRCQKNIGLDWPNIKHIPDIYITAVKEDKAKKVL
>XP_042449716.1 putative disease resistance protein RGA3 [Zingiber officinale]
MQQEQESLTLSNQSRITSSLPGLSFKGREEEKGKIIQYLLGEESEIQTSQ
NVHCLPLVVMGGMGKTALAQQVFDHFENEKKEHFDIKIWVCDSLPDLNAS
NLMKKILEYLTGLSESEPLELIPVKLKEKLHSKRFLLVLDDAWDDKNHIE
WEKLCIPLLHGQKGSWILLTTRLESVAKMVSKVIKGGTMKPMTLQGLPKD
ECRSLLYEHAFVDQDPNEFPLLKKIGEEIVEKLHGVPLLAKSIGGALNNK
LEADHWTSISRSELWKMPQDLNNCEFIPALTLSYKMLSPRLKQCFSYCSI
FPQDYKFNKQKLMCMRIAAGLMYSDGLKEGSNEDIANYCFDMLCNKSFFD
VHTNNWSAFRKGIAPYDLEVIYYTMHDMLNGLSRHVSRYECCRIVHDTPS
YICDYNAIRHISISITSIDAQLGDLANMVCKFKNLRTLRIEQYYGDSQKL
DDFIRDACKSPRRIRVLIIQPYKCLKSISDFVKLRFLEITALPLSVSISK
FYFLQVLTGYRGILAKDTSKLRNLRHLYEVPENALFSMAEVGKLTCLQEL
CFTVGTKPGYRIDELMNMDNLRQLSIAKLSNVHSLEETNNVNLVSKSYLT
SLELNWYKPDLDEASSNLGHDQQKVLAALHPPPTIRKLIIREYKGGRPAS
WMNTKSLSRLESLELYNCTNLEELPPLWKLSCLKFIKLSDMKAIRSLGCR
SSDPMDRQFSVLEELEFWDLPLLEEWNGADDYQWFPRLKRFEIGNCTKLK
KIPDLPLSIENLCMKKLGLEVLPRFYKCSNGSTTFGGFQQLMSLESLEMD
DYSEIVDIGSIGEEDGNFLPPALKKLKLKILNKHEDLASYLRGLTSLTKL
SLSCLQGMTSLPLTNELEHLTTLRSLYICDCEDLTSPGGLYIIKSLEQLH
MYNCPKFLTAEVESQQLLKEKTRSASDKAASILPSSLEFLRFSTSKISQE
SLGCCLQGLTSLKRLDISNCNHLVSLPNIEYLHNLTALQTLWISDCEELC
KLESLTALISLIQLSIFNCPKLIATTLSTVQNPAATTEQSATKIKKGTLL
SLEEIQIDNIFYLPILPIPEKLKTLYIKKEITCFPSEIEEWLSQCRESLK
ILILQQMTHLQSLPTILESFSSLKVLGINSAPELKSLPRMHASLELLVIN
GCSAKLEKRCQKNIGLDWPNIKHIPDIYITAVKEDKAKKVL
>XP_042449717.1 putative disease resistance protein RGA3 [Zingiber officinale]
MQQEQESLTLSNQSRITSSLPGLSFKGREEEKGKIIQYLLGEESEIQTSQ
NVHCLPLVVMGGMGKTALAQQVFDHFENEKKEHFDIKIWVCDSLPDLNAS
NLMKKILEYLTGLSESEPLELIPVKLKEKLHSKRFLLVLDDAWDDKNHIE
WEKLCIPLLHGQKGSWILLTTRLESVAKMVSKVIKGGTMKPMTLQGLPKD
ECRSLLYEHAFVDQDPNEFPLLKKIGEEIVEKLHGVPLLAKSIGGALNNK
LEADHWTSISRSELWKMPQDLNNCEFIPALTLSYKMLSPRLKQCFSYCSI
FPQDYKFNKQKLMCMRIAAGLMYSDGLKEGSNEDIANYCFDMLCNKSFFD
VHTNNWSAFRKGIAPYDLEVIYYTMHDMLNGLSRHVSRYECCRIVHDTPS
YICDYNAIRHISISITSIDAQLGDLANMVCKFKNLRTLRIEQYYGDSQKL
DDFIRDACKSPRRIRVLIIQPYKCLKSISDFVKLRFLEITALPLSVSISK
FYFLQVLTGYRGILAKDTSKLRNLRHLYEVPENALFSMAEVGKLTCLQEL
CFTVGTKPGYRIDELMNMDNLRQLSIAKLSNVHSLEETNNVNLVSKSYLT
SLELNWYKPDLDEASSNLGHDQQKVLAALHPPPTIRKLIIREYKGGRPAS
WMNTKSLSRLESLELYNCTNLEELPPLWKLSCLKFIKLSDMKAIRSLGCR
SSDPMDRQFSVLEELEFWDLPLLEEWNGADDYQWFPRLKRFEIGNCTKLK
KIPDLPLSIENLCMKKLGLEVLPRFYKCSNGSTTFGGFQQLMSLESLEMD
DYSEIVDIGSIGEEDGNFLPPALKKLKLKILNKHEDLASYLRGLTSLTKL
SLSCLQGMTSLPLTNELEHLTTLRSLYICDCEDLTSPGGLYIIKSLEQLH
MYNCPKFLTAEVESQQLLKEKTRSASDKAASILPSSLEFLRFSTSKISQE
SLGCCLQGLTSLKRLDISNCNHLVSLPNIEYLHNLTALQTLWISDCEELC
KLESLTALISLIQLSIFNCPKLIATTLSTVQNPAATTEQSATKIKKGTLL
SLEEIQIDNIFYLPILPIPEKLKTLYIKKEITCFPSEIEEWLSQCRESLK
ILILQQMTHLQSLPTILESFSSLKVLGINSAPELKSLPRMHASLELLVIN
GCSAKLEKRCQKNIGLDWPNIKHIPDIYITAVKEDKAKKVL
>XP_042449718.1 putative disease resistance protein RGA3 [Zingiber officinale]
MQQEQESLTLSNQSRITSSLPGLSFKGREEEKGKIIQYLLGEESEIQTSQ
NVHCLPLVVMGGMGKTALAQQVFDHFENEKKEHFDIKIWVCDSLPDLNAS
NLMKKILEYLTGLSESEPLELIPVKLKEKLHSKRFLLVLDDAWDDKNHIE
WEKLCIPLLHGQKGSWILLTTRLESVAKMVSKVIKGGTMKPMTLQGLPKD
ECRSLLYEHAFVDQDPNEFPLLKKIGEEIVEKLHGVPLLAKSIGGALNNK
LEADHWTSISRSELWKMPQDLNNCEFIPALTLSYKMLSPRLKQCFSYCSI
FPQDYKFNKQKLMCMRIAAGLMYSDGLKEGSNEDIANYCFDMLCNKSFFD
VHTNNWSAFRKGIAPYDLEVIYYTMHDMLNGLSRHVSRYECCRIVHDTPS
YICDYNAIRHISISITSIDAQLGDLANMVCKFKNLRTLRIEQYYGDSQKL
DDFIRDACKSPRRIRVLIIQPYKCLKSISDFVKLRFLEITALPLSVSISK
FYFLQVLTGYRGILAKDTSKLRNLRHLYEVPENALFSMAEVGKLTCLQEL
CFTVGTKPGYRIDELMNMDNLRQLSIAKLSNVHSLEETNNVNLVSKSYLT
SLELNWYKPDLDEASSNLGHDQQKVLAALHPPPTIRKLIIREYKGGRPAS
WMNTKSLSRLESLELYNCTNLEELPPLWKLSCLKFIKLSDMKAIRSLGCR
SSDPMDRQFSVLEELEFWDLPLLEEWNGADDYQWFPRLKRFEIGNCTKLK
KIPDLPLSIENLCMKKLGLEVLPRFYKCSNGSTTFGGFQQLMSLESLEMD
DYSEIVDIGSIGEEDGNFLPPALKKLKLKILNKHEDLASYLRGLTSLTKL
SLSCLQGMTSLPLTNELEHLTTLRSLYICDCEDLTSPGGLYIIKSLEQLH
MYNCPKFLTAEVESQQLLKEKTRSASDKAASILPSSLEFLRFSTSKISQE
SLGCCLQGLTSLKRLDISNCNHLVSLPNIEYLHNLTALQTLWISDCEELC
KLESLTALISLIQLSIFNCPKLIATTLSTVQNPAATTEQSATKIKKGTLL
SLEEIQIDNIFYLPILPIPEKLKTLYIKKEITCFPSEIEEWLSQCRESLK
ILILQQMTHLQSLPTILESFSSLKVLGINSAPELKSLPRMHASLELLVIN
GCSAKLEKRCQKNIGLDWPNIKHIPDIYITAVKEDKAKKVL
>XP_042449720.1 putative disease resistance protein RGA3 [Zingiber officinale]
MQQEQESLTLSNQSRITSSLPGLSFKGREEEKGKIIQYLLGEESEIQTSQ
NVHCLPLVVMGGMGKTALAQQVFDHFENEKKEHFDIKIWVCDSLPDLNAS
NLMKKILEYLTGLSESEPLELIPVKLKEKLHSKRFLLVLDDAWDDKNHIE
WEKLCIPLLHGQKGSWILLTTRLESVAKMVSKVIKGGTMKPMTLQGLPKD
ECRSLLYEHAFVDQDPNEFPLLKKIGEEIVEKLHGVPLLAKSIGGALNNK
LEADHWTSISRSELWKMPQDLNNCEFIPALTLSYKMLSPRLKQCFSYCSI
FPQDYKFNKQKLMCMRIAAGLMYSDGLKEGSNEDIANYCFDMLCNKSFFD
VHTNNWSAFRKGIAPYDLEVIYYTMHDMLNGLSRHVSRYECCRIVHDTPS
YICDYNAIRHISISITSIDAQLGDLANMVCKFKNLRTLRIEQYYGDSQKL
DDFIRDACKSPRRIRVLIIQPYKCLKSISDFVKLRFLEITALPLSVSISK
FYFLQVLTGYRGILAKDTSKLRNLRHLYEVPENALFSMAEVGKLTCLQEL
CFTVGTKPGYRIDELMNMDNLRQLSIAKLSNVHSLEETNNVNLVSKSYLT
SLELNWYKPDLDEASSNLGHDQQKVLAALHPPPTIRKLIIREYKGGRPAS
WMNTKSLSRLESLELYNCTNLEELPPLWKLSCLKFIKLSDMKAIRSLGCR
SSDPMDRQFSVLEELEFWDLPLLEEWNGADDYQWFPRLKRFEIGNCTKLK
KIPDLPLSIENLCMKKLGLEVLPRFYKCSNGSTTFGGFQQLMSLESLEMD
DYSEIVDIGSIGEEDGNFLPPALKKLKLKILNKHEDLASYLRGLTSLTKL
SLSCLQGMTSLPLTNELEHLTTLRSLYICDCEDLTSPGGLYIIKSLEQLH
MYNCPKFLTAEVESQQLLKEKTRSASDKAASILPSSLEFLRFSTSKISQE
SLGCCLQGLTSLKRLDISNCNHLVSLPNIEYLHNLTALQTLWISDCEELC
KLESLTALISLIQLSIFNCPKLIATTLSTVQNPAATTEQSATKIKKGTLL
SLEEIQIDNIFYLPILPIPEKLKTLYIKKEITCFPSEIEEWLSQCRESLK
ILILQQMTHLQSLPTILESFSSLKVLGINSAPELKSLPRMHASLELLVIN
GCSAKLEKRCQKNIGLDWPNIKHIPDIYITAVKEDKAKKVL
>XP_042449824.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEGVALAVGGWLAQPVINMLVDRVWTLRGKLHGLQDDDLQKLHRSLLNIH
TIVEKAGMRWSRDARLVEMMKQLQDAAYDAEDFLDELTFHGMKQKIEEEA
SHKAPNRFYRAIRNAKTKLISDSVKRLNKIQKKLDCIYADMKEMCQLLQV
DAVDASDVQYQSDLASATRETSSFLISNVLGREEEQKRIIGLLLRSTDES
ASASDKGSSFSVIPLVGIGGVGKTTLAQLVYKDKEIQNHFGLKIWICVSE
NFNVQRLTKEIIESVTKTEHSSQMKLDVLQNILKEKIASKMVMLVLDDVW
NEDEEEWRKLCAPFEDAAAGSKVIVTTRSMSIANKIGSVEAIVLGGLDEI
SFWELFKQCAFGPSKPEEHAELVGIGRSIAWKLKGLPLAAKTVGNLLGSN
MNTHHWRSIMKSEVWELQQNKNDIIPVLQLSYQYLSAPLKRCFALCSLFQ
KDYKFSKTELTRIWMAEGFVVAQGNQRMEDVASKYFHELVNMSLFQQETS
FWGHYYVMHDLIHDLTQSVSVDETSRMEYGKSNKISTTLRHLAVETEFIE
TKELRSRFKKLHSLFCQHLESQPLDFIEKLRSIRVLVLSHCGLQMLPTSV
GELVHLRYLDISHNEMEELPESLCELYNLQTLNVNNSPLISLPEDISRLI
NLRHLDDENGIVLKIKMIGRLTSLQELSEFQVRKEVGFKITELSGLKQLH
GNLKITNLENVESKEEAEKAQMKNKEYLDALVLEWGFDPELENKLVAMEE
VLDGLQPYESLKQLEIRRYCGARSPSWMKKEELSNLESLELSYCESWKEL
SILGQFPCLRVVRLTGIESLKRIGFAASGAKENSWFPMLEEFELNNMHAL
EEFYTLGHFPRLRVLRMEGMRLLKHIDFAAFGSVENSLFPMLEELELIDM
DVLEEFSNLGHFQRLRILRMVRMPLLKHIGLASVDATENDLFPMLERLQL
MYLPILEELPDLGSLPCLKFLQMKRMPVLKHIDFAFDGATDKILLPRVET
LELYDLEALEELPSNLGRLPCLTDLNIANISAVKQISNGFFSIEAISKCF
LNLESLSITNMPACEGWCWLDGS
>XP_042450165.1 disease resistance protein RPM1-like isoform X1 [Zingiber officinale]
MEAAFISLLINKLGEITVGQAHSRCSQLLLQHTTPPLDQIHARVERITNE
FKVMQAFLEGSNWSTAAATNKPLEAWIEQVREVAFKIEDIIDEYLYLVGR
QRERTWKSCLTAPSDFCFNLAKAWRGIDSRLEKLETDLSELTSRRDRYGL
TINGNDDDRAKNSETNNTHHYRAYSPMLTDEDDLVGIEVNKSKLLSWLTN
ADTCRKMTAIAVWGMGGHGKTTLVSNVYRNNTVKSHFDCQVWVTVSQTYS
ALEELLGIMIQEIFKGKKEPVPNGITTMQRLELFDIIKESLQQKRYIIVL
DDVWHVDLCNDISRAFVDSNNGSRLIITTRMHEVARMANDEHIIKLQQLD
EKDAWILFCKKAFQRGNSRDCPKELEDYTGRILNKCQGSPLAIVAVGSLL
SFKEKSETEWKKVHDRLHWELENNPALDKVKNILNLSFNDLPYYLKNCFV
YCSIFPEDYLIKRKKLIRLWVAEGFMTTRSSGKSMEEEADDYLAELVDRS
MLQVVKRNGFGRLKAFRMHDVVREVTLAISRKAKFCMILDGSQSVLDNQT
RRVSIKTNDESLDLSTSLSRLCSLIAFSTSVFRNRAVLISFKMLRVLELQ
NLRIHSLPNEVSALFNLHYLGLKETGIKQLPNHIQKLQSLQTLDLRYSRI
RKLPRGVTQLKKLRHLFGTRIEIEFGGSTIAGCVPTLEGSWQCKNLQTLK
EVFGNKKLVQRLGDMKEIRTLGVTGVNLTNCPQFCTSLTKMRNLRCLRLT
LFGNEDEQFTFEMLNSPPPLLQKLDLNFNLGRLFEGKMPTFICSCAELTH
VSLSGTQLIENPLPSLGQLHKLVALTLRDNAYEGHKLHFKTGWFLNLKRL
YLGGLKNLSKILIEEGAMASLYKLYMEDLPELRMVPSGIEFLTHLQKLTL
CVMSGELVGKLRKDYVNEEERRRIRHIPIVTII
>XP_042450166.1 disease resistance protein RPM1-like isoform X2 [Zingiber officinale]
MEAAFISLLINKLGEITVGQAHSRCSQLLLQHTTPPLDQIHARVERITNE
FKVMQAFLEGSNWSTAAATNKPLEAWIEQVREVAFKIEDIIDEYLYLVGR
QRERTWKSCLTAPSDFCFNLAKAWRGIDSRLEKLETDLSELTSRRDRYGL
TINGNDDDRAKNSETNNTHHYRAYSPMLTDEDDLVGIEVNKSKLLSWLTN
ADTCRKMTAIAVWGMGGHGKTTLVSNVYRNNTVKSHFDCQVWVTVSQTYS
ALEELLGIMIQEIFKGKKEPVPNGITTMQRLELFDIIKESLQQKRYIIVL
DDVWHVDLCNDISRAFVDSNNGSRLIITTRMHEVARMANDEHIIKLQQLD
EKDAWILFCKKAFQRGNSRDCPKELEDYTGRILNKCQGSPLAIVAVGSLL
SFKEKSETEWKKVHDRLHWELENNPALDKVKNILNLSFNDLPYYLKNCFV
YCSIFPEDYLIKRKKLIRLWVAEGFMTTRSSGKSMEEEADDYLAELVDRS
MLQVVKRNGFGRLKAFRMHDVVREETGIKQLPNHIQKLQSLQTLDLRYSR
IRKLPRGVTQLKKLRHLFGTRIEIEFGGSTIAGCVPTLEGSWQCKNLQTL
KEVFGNKKLVQRLGDMKEIRTLGVTGVNLTNCPQFCTSLTKMRNLRCLRL
TLFGNEDEQFTFEMLNSPPPLLQKLDLNFNLGRLFEGKMPTFICSCAELT
HVSLSGTQLIENPLPSLGQLHKLVALTLRDNAYEGHKLHFKTGWFLNLKR
LYLGGLKNLSKILIEEGAMASLYKLYMEDLPELRMVPSGIEFLTHLQKLT
LCVMSGELVGKLRKDYVNEEERRRIRHIPIVTII
>XP_042450498.1 disease resistance protein RPM1-like isoform X1 [Zingiber officinale]
MEAAFISLLINKLAQVAFNQAHSRCSQILLQHTTPPLDQIHARVRRITDE
FIVMKAFLEGSNWFTIATNKPLEAWIEQVRKVAFEIEDIIDEYLYLVGRQ
RERTWKNCLTAPSDLCFNLAKAWRGIDSRLEKMERDLSELSSRRDRFGIT
ISGNEDGVKNSERDTHHYRAYSPMLNDEDDLVGIEVNKSKLLSWLTNADT
CRKMTAIAVWGMGGHGKTTLVADVYRNNTVKSHFDCQVWVTVSQTYSVLE
ELLRIMIKEIFKGKKELVPNGITTMQRLELFDIIKESLQQKRYIIVLDDV
WHVDLCNDISRAFIDSNNGSRLIITTRMHEVARIANEEHIMKLQQLNEND
AWILFCKKAFRRENNKDCPQELEDYTGRILNKCQGSPLAIVAIGSLLSFK
EKSETEWKKVYDNLQWEFENNPVLDKVKNILNLSFNDLPYYLKNCFVFCS
IFPEDYLINRKKLIRLWVAEGFVEAKSSNRSMEEEAEDYLAELVDRSMLQ
VVNRNAFGRLHTFKMHDVVREVTLAISRKAKFSMILDGSQSGLDFQTRRL
SIQTNDESLDLDRSLSLSQLRSLVMFSTCNSSSDSLRAVLTSFKMLRVLE
LEGTPISNLPNEISALFNLHYLCLRDTEVEKLPNNIQKLQSLETLDLSGS
NIVKLPRGVTQLKQLRHLFMFPCEIEFGGSTVVGCVPTLKGAWQWKNLQT
LRHVKANKNLFQQLEDMKELRTLAVTEVEYAHCPQLCTSLTKLTKLHSLS
LSARSEEQLNFEILNSPPPPLQKLVLCGRLFEGKMPRFICSCEELTDVLL
FSSHLIEDPLPSLGQLHKLVELTLWGDSYDGQKLHFRTGWFLNLKVLFLD
TLTNLNNIVIEEGAMPNLLKLIMRSLGELRMIPPGIEFLANLQSLDLCNM
PEELVEKLRNDDDNEDRQRIRGIPNVVIGLISSLIMSEICEDEHWL
>XP_042450499.1 disease resistance protein RPM1-like isoform X2 [Zingiber officinale]
MEAAFISLLINKLAQVAFNQAHSRCSQILLQHTTPPLDQIHARVRRITDE
FIVMKAFLEGSNWFTIATNKPLEAWIEQVRKVAFEIEDIIDEYLYLVGRQ
RERTWKNCLTAPSDLCFNLAKAWRGIDSRLEKMERDLSELSSRRDRFGIT
ISGNEDGVKNSERDTHHYRAYSPMLNDEDDLVGIEVNKSKLLSWLTNADT
CRKMTAIAVWGMGGHGKTTLVADVYRNNTVKSHFDCQAFRRENNKDCPQE
LEDYTGRILNKCQGSPLAIVAIGSLLSFKEKSETEWKKVYDNLQWEFENN
PVLDKVKNILNLSFNDLPYYLKNCFVFCSIFPEDYLINRKKLIRLWVAEG
FVEAKSSNRSMEEEAEDYLAELVDRSMLQVVNRNAFGRLHTFKMHDVVRE
VTLAISRKAKFSMILDGSQSGLDFQTRRLSIQTNDESLDLDRSLSLSQLR
SLVMFSTCNSSSDSLRAVLTSFKMLRVLELEGTPISNLPNEISALFNLHY
LCLRDTEVEKLPNNIQKLQSLETLDLSGSNIVKLPRGVTQLKQLRHLFMF
PCEIEFGGSTVVGCVPTLKGAWQWKNLQTLRHVKANKNLFQQLEDMKELR
TLAVTEVEYAHCPQLCTSLTKLTKLHSLSLSARSEEQLNFEILNSPPPPL
QKLVLCGRLFEGKMPRFICSCEELTDVLLFSSHLIEDPLPSLGQLHKLVE
LTLWGDSYDGQKLHFRTGWFLNLKVLFLDTLTNLNNIVIEEGAMPNLLKL
IMRSLGELRMIPPGIEFLANLQSLDLCNMPEELVEKLRNDDDNEDRQRIR
GIPNVVIGLISSLIMSEICEDEHWL
>XP_042450500.1 disease resistance protein RPM1-like isoform X3 [Zingiber officinale]
MTAIAVWGMGGHGKTTLVADVYRNNTVKSHFDCQVWVTVSQTYSVLEELL
RIMIKEIFKGKKELVPNGITTMQRLELFDIIKESLQQKRYIIVLDDVWHV
DLCNDISRAFIDSNNGSRLIITTRMHEVARIANEEHIMKLQQLNENDAWI
LFCKKAFRRENNKDCPQELEDYTGRILNKCQGSPLAIVAIGSLLSFKEKS
ETEWKKVYDNLQWEFENNPVLDKVKNILNLSFNDLPYYLKNCFVFCSIFP
EDYLINRKKLIRLWVAEGFVEAKSSNRSMEEEAEDYLAELVDRSMLQVVN
RNAFGRLHTFKMHDVVREVTLAISRKAKFSMILDGSQSGLDFQTRRLSIQ
TNDESLDLDRSLSLSQLRSLVMFSTCNSSSDSLRAVLTSFKMLRVLELEG
TPISNLPNEISALFNLHYLCLRDTEVEKLPNNIQKLQSLETLDLSGSNIV
KLPRGVTQLKQLRHLFMFPCEIEFGGSTVVGCVPTLKGAWQWKNLQTLRH
VKANKNLFQQLEDMKELRTLAVTEVEYAHCPQLCTSLTKLTKLHSLSLSA
RSEEQLNFEILNSPPPPLQKLVLCGRLFEGKMPRFICSCEELTDVLLFSS
HLIEDPLPSLGQLHKLVELTLWGDSYDGQKLHFRTGWFLNLKVLFLDTLT
NLNNIVIEEGAMPNLLKLIMRSLGELRMIPPGIEFLANLQSLDLCNMPEE
LVEKLRNDDDNEDRQRIRGIPNVVIGLISSLIMSEICEDEHWL
>XP_042450523.1 disease resistance protein RPM1-like [Zingiber officinale]
MEAAFISLLINKLAQVAFDQAQSRCSQLLLQHTTPPLDQIHAKVRRITDE
FIVMKAFLEGSNWSTIAATNKPLEAWIEQVRKVAFEIEDIIDEYLYLVGR
QREMTWKNYLMAPSDLCFNLAKAWRGIDSRLEKTEKDLSELSSRRDRFGI
TISGNEDGVKNSERDTHHYRAYSPMLTDEDDLVGIEDNKSKLLSWLTNAD
TCRKMTAIAVWGMGGHGKTTLVANVYRNKTVKNHFDCQVWVTVSKTYSAL
EELLRIMIQEIFKGQKELVPNGITTMQRLELFDIIKESLQQKRYIIVLDD
VWQADLCNDISCAFVDSNNGSRLIITTRMHEVARIANEEHIMKLQQLNEK
DAWILFCKKAFRRENNKDCPKELEDYTGRILNKCQGSPLAIVAIGSLLSF
KEKSETEWKKAYDNLQWEFENNPALDKVKNILNLSFNDLPYYLKNCFVYC
SIFPEDYLIKRKKLIRLWVAEGFVEAKSSNRSMEEEAEDYLAELVDRSML
QVVNRNAFGRLQAFKMHDVVREVTLAISRKAKFSMILDGSQSGSDFQTRR
LSIQTNDESLDLDKSLSLSQLRSLVMFSTCNSSSDSLSAILISFKMLRVL
ELEFQPISNLPNEISALFNLHYLGLRGTKVEKLPNNIQKLQSLETLDLRC
STIVKLPRGVTQLKQLCHLFMFAREIEFGGSTVVGCVPTHKGARQWKNLQ
TLRQVKANKNLVQQLEDMKELRTLAVVSVEYAHCPQLCTSLTKLTKLHSL
CLSARSEEQLNFEILNSPPPPLQKLTLSGRLFEGKMPKFICSCEELTYVQ
LMSSHLIEDPLPSLGQLHKLVELTLWEDSYDGQKLHFRTGWFLNLKVLYL
ETLRNLNNIVIEEGAMPNLLKLIMSSLGELRMIPPGIEFLTNLQSLELCA
LPEELVEKLRNDDDNEFLQRIRGTRNVVVDSISN
>XP_042450644.1 disease resistance protein RPM1-like [Zingiber officinale]
MEAAFISLLIKKLAQVAFDQAQSRCSQLLLQHTTPPLDQIHARVRRITDE
FIVMKAFLEGSNWSTIAATNKPLEAWIEQVRKVAFEIEDIIDEYLYLVGR
QRERTWKNCLMAPSDLCFNLAKAWRGIDSRLEKMEKDLSELSSRRDRFGI
TISGNEEGVKNSERDTHHYRAYSPMLNDEDDLVGIEVNKSKLLSWLTNAD
TCRKMTAIAVWGMGGHGKTTLVANVYRNNTVKSHFDCQVWVTVSQTYSVL
EELLRIMIKEIFKGKEDLVPNGITTMQRLELFDIIKESLQRKRYIIVLDD
VWHVDLCNDISRAFIDSNNGSRLIITTRMHEVARIANDEHIMKLQQLNEK
DAWILFCKKAFRRENNKDCPQELEDYTGRILNKCQGSPLAIVAIGSLLSF
KEKSQTEWKKVYDNLQWEFENNPALDKVKSILNLSFNDLP
>XP_042450658.1 disease resistance protein RPM1-like [Zingiber officinale]
MEAAFISLLINKLGEIAVGQAQSRCSLLLLQHTTPPLDQIHARVERITGE
FKVMQAFLEGSNWSTAAATNKPLEAWIEQVREVAFKIEDIIDEYLYLVGR
QRERTWKNCLMAPSDLCFNLAKAWRGIDSRLEKLETDLSELTSRRDRYGL
TISSNDDKAKNSETNNTHHYRTYSPMLTDEDDLVGIEDNKSKLLSWLTNA
DTCRKMTTIAVWGMGGHGKTTLVANVYRNDAVKSHFDCQVWITVSQTYGV
EELLKSMIQEIFKGKKEPVPNGATTMQQLELFDIIKESLQRKKYIIVLDD
VWHVDLWTDISHLFVDTNNGSRLIVTTRMHEVARMANDEHIIKLQQLDEK
DAWILFCKKAFQRGNSKDCPKELEDYTGRILNKCRGSPLAIVAVGSLLSF
KEKSETEWKKVHDRLHWELENNPALDKVKNILNLSFNDLPYYLKNCFVYC
SIFPEDYLIKRKKLIRLWIAEGFMMTRSSGKSIEEEADDYLAELVDRSML
QVVKRNGFGRLKAFRMHDVVREVTLAISRKAKFCMILDGSQSVLDNQTRR
VSVQTNDESLDLSTSLSRLCSLIAFSNSVFRNRAVLISFKMLRVLELQSL
RIHSLPNEVSALFNLHYLGLKETGIKQLPNHIQKLQSLQTLDLCYSRIRK
LPRGVTQLKQLRHLSGTWIEVEFGGSTIEGSWQCKNLQTLKEVFVTEKLV
QRLGDMKELRTLGVTGVDGTNCPQLCTSLTKMRNLRCLRLTLFGNEEEQL
NFEMLNSPPPLLQKLDLNFNSGRLFGEKMPAFICSCAELTHVSLSGSRLI
EDPLPSLRQLHKLVALALRDDAYEGQKLQFRTGWFLDLKRLYLEGLKNLN
NIVIEEGAMASLYKLYMEDLPELKMIPRGIEFLTHLQKLTLCGMSEELEG
KLREDDANEEGRRIRHIPIVTII
>XP_042451419.1 putative disease resistance protein RGA3 [Zingiber officinale]
MATETQVFGRCSEINQLIDMLLDTSTSDTDDNISVVSIAGRRGVGKTTVA
QSVYCNRKVEKHFDLKAWICFKSKPFQLRISMIDMTRSAPMEISDYDNDL
LDLLDLDRIEEILCEVLKGNKYLIVLDSVWDERNWKEMRSYWLVLYAIFD
QLGKEGSKILVTTCSHDVANYLNARGAIVLKCLKDQVFWKLFRSCAFGDD
ANLSENLECIGQEISNKLVGLPLAAKVVGGLLHSRMEEHYWRDVLDNMSW
QQDQETDGILTSLRLSYEFLPQHLKPCFLYCSLFPEEHRFEKDALVHYWM
ALDYIGSCAEGGEGEKRTPEDVGRDYFTELQHRSFFQKRKMLETSKTEFY
VTHSLLHDVAKFVAGDVIYRYEYGNFIRPRIPNEVCHLYLGSTDWVNVLR
RQISEVKKLQSLVVHPPPYTDSTVVDLKAIFTALSNVRILIFLDQDVATH
VLTECVDSMLQLRYLEVAGGAECYKPWGGNHLCHLQVLKVTKIKYRLDDI
SFGSCLTQVFAKLNNLRHLYMDFYSAVSGIGLLTSLQELSRVFKVGEHEG
KISQLKHLNQLRGSLLIKGLENVRDEREAKEAMLENKEYLEKLDLCWSPA
DKVNAASIERNENVLRGLQPHSNLKELKIISYWGPMAPSWISETKLSNIE
RIELFGCRIMQVFPPLGELPLLRVLRLVNLDFLEYIGNEVYGKADDQAFP
MLEELVLLRLLQLKEWSEPKGGGKITMMPRLRILEIQQCRELKLPIPFAL
DSPLGEFKVGLYSPKLKGISLLTTYIPVNCKLSGLKILSIGPTSKVERFS
GDENEWFERLTSLEELRFTDCEDLKSLPATLRSLPSLKRLHIDKCRQIHF
LLEELPAALEELNMIDNCLQQATSAGAKPAE
>XP_042451645.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAMVLDFYVSRVMKVTADMVEAEIFKVLGVDKEIKTLQGRLRTINGYLHQ
AERKIQGNNEIDIWVRKLKDIMYDADDIIDLCMIEGGKVLRAQASSGSST
VSIPSSYLFSCFRCLRYRHEVANQIIALNGRLEALKNDSFIKNNLDQAVK
EPVENAHREFGRETSHLQIEGDIIGSQIENATDKLINLILENNPKKTRVF
GVVGTGGIGKSTLASKIFEDERIKENFPNRKWLYVSKNYIETDLLKKLIR
FEEGNETKGETFEGKSKAELEDKLVTILTKNTFIVLDDVWNATVWIDILR
KPIVKSASSCTILVTSRKEKVVAQMKPSYIHPVEKMDEESGWNLLKHLVF
EGGEEEDEISSLAEIGIKLVKKCDGLPLAIKAIGGVLYQQNKAKWEEVLE
SDAWKMDQIEEELRPLYLSYEDLPSTLKQCFLYCSLYHQKDMYYKEIVQF
WVAEGLIMDEQEKSRNDLPTEKQKTMEDIGEEIYRELIWRNLLEADANFD
VSKDYFSMHDHFRSLGAHLMREEGILYRHGREFKTDDNIKIRRLSISNMG
PKLVLPSQILKQGCLRTLILMDSPKTKTIEDSVLQELSCLRVLDLTSTSI
EKIPDCIGDLLHLRYLDLDGTNIREIPKTIGKLVNLQTLNISKCQYLERL
PESITMLHNLRCLDMSDTPLLTYVPKGIGKLGNFYNLKGFLVGQNDSTSE
EGCDLEELKNLSKLRGISILRLERAERGASALADKPFLKQLMLGWMQPEE
DDTDEEDESEANVGGGDETVDSESASGGNDDEDARNEKGDGSDDGFKQEN
ENEDAQEAGNETEDRTEEDEEEEEEKGWSEEQISNAERICNEMSQPSSSI
VDLQFDEYPGRQFPSWIVSSSLAESFPNLAYLNLRGLPCCTELPPLGTLP
QLKYLSIEQASALITIGSQFLGSRSSAFPKLELIQFEDMPKWEEWTFDGV
EELTGHGTPVSVKLFPSLRDCVLIDCPKLRALPAVLYRATNFNELYLRQT
YELREIIDLPIAYKLEVTNGSGLKKISNISSVRYLEVNNCPNLECVENLS
KLQHLVLICSKEMEQLPLWLSALIEQHNNTSSTHRSFRKFEMQCSLQLLK
TCLEGNENWDIIKQIPIVKVTTYSGKEYVRYTKDPYMYDPHVPSN
>XP_042452850.1 putative disease resistance protein RGA3 [Zingiber officinale]
MGKTALAQEVFDHFKNVKKEHFDIKIWVCDSLPDLNSSNLTKKILEYSTG
RSESGPLELIPEKLKEKLHSKRFLLVLDDAWDDKNQREWEKLCAPLLYGQ
KGSWVLLTTRSKSVANMVAREIKGTMMPMMLQGLSEDECLSLLYEHAFAG
QDPNGFPLLKEIGREIVKKLKGVPLLAKSIGGALNSKLEADHWTNILRSE
LWKRSQDSTYNFIPVLTLSYVMLPPRLKRCFAYCSIFPQDYKFNK
>XP_042452853.1 putative disease resistance protein RGA3 [Zingiber officinale]
MGKTALAQEVFDHFKNVKKEHFDIKIWVCDSLPDLNSSNLTKKILEYSTG
RSESGPLELIPEKLKEKLHSKRFLLVLDDAWDDKNQREWEKLCAPLLYGQ
KGSWVLLTTRSKSVANMVAREIKGTMMPMMLQGLSEDECLSLLYEHAFAG
QDPNGFPLLKEIGREIVKKLKGVPLLAKSIGGALNSKLEADHWTNILRSE
LWKRSQDSTYNFIPVLTLSYVMLPPRLKRCFAYCSIFPQDYKFNK
>XP_042453113.1 disease resistance protein RPM1-like [Zingiber officinale]
MQRLELFDIIKESLQQKRYIIVLDDVWQVDLCNDISCAFVDSNNGSRLII
TTRMHEVARIANEEHIMKLQQLNEKDAWILFCKKAFRRENNKDCPKELED
YTGRILNKCQGSPLAIVAIGSLLSFKEKSETEWKKAYDNLQWEFENNPAL
DKVKNILNLSFNDLPYYLKNCFVYCSIFPEDYLIKRKKLIRLWVAEGFVE
AKSSNRSMEEEAEDYLAELVDRSMLQVVNRNAFGRLQTFKMHDVVREVTQ
EISRKAKFSMILDGSQSGLDYQTRRLSIQTTDESLDLDKSLSLSQLRSLV
MLSTCNSSSDSLSAILISFKMLRVLELEFQPISNLPNEISALFNLHYLGL
RGTKVENLPNNIQKLQSLETLDLRCSNIVKLPRGVTQLKQLRHLFMFARE
IEFGGSTVVGCVPTLKGARQWKNLQTLRQVKANKSLVQQLEDMKELRTLA
VTEVEYAHCPQLCTSLTKLTKLHSLCLSARSEEQLNFEILNSPPPPLQKL
TLSGRLFEGKMPKFICSCEELTYVQLMSSHLIEDPLPSLGQLHKLVELTL
WEDSYDGQKLHFRTGWFLNLKVLYLETLRNLNNIVIEEGAMPNLLKLIMS
SLGELRMIPPGIEFLTNLQSLELCALPEELVEKLRNDDDNEVLQRIGGTR
NVVVDSISN
>XP_042453116.1 disease resistance protein RPM1-like [Zingiber officinale]
MEAAFISLLINKLAQVAFNQAQSRCSQILLQHTTPPLDQIHARVRRITDE
FIVMKAFLEGSNWFTIAATNKPLEAWIEQVRKVAFEIEDIIDEYLYLVGR
QREMTWKNYLMAPSDLCFNLAKAWRGIDSRLEKMEKDLSELSSRRDRFGI
TISGNEDGVKNSERDTHHYRAYSPMLNDEDDLVGIEVNKSKLLSWLTNAD
TCRKMTAIAVWGMGGHGKTTLVANVYRNNTVKSHFDCQVWVTVSQTYSVL
EELLRIMIKEIFKGKEDLVPNGITTMQRLELFDIIKESLQLKRYIIVLDD
VWHVDLCNHISRAFIDSNNGSRLIITTRMHEVARIASDEHIMKLQQLNEK
DAWTLFCKKAFRRENNKDCPKELEDYIGRILNKCQGSPLAIVAIGSLLSF
KEKSQTEWKKVYDNLQWEFENNPALDKVKSILNLSFNDLPYYLKNCFVYC
SIFPEDYLINRKKLIRLWVAEGFVEAKSKNRSMEEEAEGYLAELVDRSML
QVVNRNAFGRLQTFKLHDVVREVTLAISRKAKFSMILDGSQSGLDFQTRR
LSIQTNDESLDLDRSLSLSQLRSLVMLSTCYSSSDSLRAVLTSLKMLRVL
ELEGTPISNLPNEISALFNLHYLGLRGTKVEKLPNNIQKFQSLETLDLRG
SNIVKLPRGVTQLKQLRHLLMFEGEIEFGGSTVVGCVPTLKGAGQWKNLQ
TLRQVKANKNLVQQLEDMKELRTLEVTEVEYAHCPQLCTSLTKLAKLHSL
CLSARSEEQLNFEILNSPPPPLQKLTLSGRLFEGKMPKFICSCEELTYVQ
LMSSHLIEDPLPSLGQLHKLVELTLWEDSYDGQKLHFRTGWFLNLKVLYL
ETLRNLNNIVIEEGAMPNLVKLIMSSLGELRMIPPGIEFLTNLQSLELCA
LPEELVEKLRNDDDNEVLQRIGGTRNVVVDSISN
>XP_042454058.1 putative disease resistance protein RGA3 [Zingiber officinale]
MSNFLHVSINNNIQSTHKCRSILLELKETACLLNYLVKRGAAFGLWVETL
DSMDPSHDDYATILSEEVIGREDEDQIIDLLQQQCDEDGNEPFIIAINGS
KYSGKTTLARKIYHHPWVRQHFQHRIWLDASSFRDFNSSMIAIEIARLLT
RKPCMNVNCWPLINEHLGGDRYLLIFDDVCISDVLKYKWEELKLNLLHCG
APGSKVILVGYIFNRDGREFNVKKYILNHLREDAWVRILLRYATFVRPIK
GNNNIHREKASPTVTDILIPLAKKFRQDYDSGDYLGAKCMGLMFRWRDKS
QWGELANQLFNIKHLHKYFLSVHQQYRSIEDTRSSLYKLLFEGSKDESYD
EDVLYMLIAEDTLTNTRLKRNLQIMSFKFNLDQCFFRMKVGEDLSIPPQC
RHLHLFINSKNILKSKKAIEVAGVANKLRTLILHRKEKKGHIYQIETKKL
EGLFLNLTCLCTLHMRAIMIQDLPSTVSTLHCLRYLNLAENKIETLPESL
CNLSNLCALILSLCKKLKELPRQIHKLRKLQILKLSCCLRIQKLPDSITR
LVNLKELGCWRLLLAFEVA
>XP_042454428.1 disease resistance protein RPS2-like [Zingiber officinale]
MGSVSPSSLMDIFNLLKACCSPSCNYIMTYEGTFSSLASEVGQLKDKSSD
VKRDIEAATRDGQTPRSEVLGWLSSVQDMEGEAESIERKYNQKIKCLCSF
PLNVCSAYRLRNRAEAALATIRELKQSVEFTKLADNLNLTRSIKMPTTKT
IGMDKVFEELLRHAKDDSLSVIGIHGMGGVGKTALLRRFNNDFPSETEAD
VVIFLELSIDYKLEEVQKSLFDRLSLTWQDEVTHRDRATKLFRVLSTLKF
ILLLDNLWEPLNYQVVGIPLPAPPSKCKIIFTTRTEDTCSHMGTEKMIKM
ECLEEEVAWNLFRNSARMDVIDADKNVRIEARDLVKECGGLPAALIVLAQ
AMAPKKTWEEWMHALTIMKDTPHQLPGMTNNVFSILKLSYDRLSSDNLRV
CASYGALFIKGSWIGKYNIRNLWIGEGIIDNVQNPMDADNKTQFLLGILH
AASLTVRVHDDYFTMHPMIRAMILWVQRECGKKENKWLVRDRERVGEAPA
AEKWRDAERIALDWNQISDLPEAPQCPNLIFLNLQVNKFLRKIPNGFFLH
MPHLKILDLRDTSIKELPWLIMVDSYSGWREGHTLEGGVSFEELESLKRL
KVIGITVSTLAALQNLCDSPRLAPLTHWLHIEGCPDLTMFNIPSMDFHAE
TMSRLGQIQLHAMSELEEVVIGNRQPILLPLQELRLSSLPKAKLVWRPTF
PNTLLALKIEVD
>XP_042454429.1 disease resistance protein RPS2-like [Zingiber officinale]
MGYVSPSSLMDIFNLLKACCSPSCNYIMTYDGTFSSLASEVGQLKDKSSD
VKRDVEAATRDGMTPRSEVLGWLSSVQDMEGEAESIERKYNQKIKCLCSF
PLNICSAYRLRNRAEAALATIRELKQSAEFTKLSDNLNLTRSIKMPTTKT
IGMDKVFEELQRHAKDDSLSVIGIHGMGGVGKTALLRRFNNDFPSETEAD
VVIFLELSIDYKLEEVQKSLFDRLSLTWQDEVTHRDRATKLFRVLSTLKF
ILLLDNLWEPLNYQVVGIPLPAPPSKCKIIFTTRTEDTCSHMGTEKMIKM
ECLEEEAAWNLFRNSARMDVIDADKNVRIEARDLVKECGGLPAALIVLAQ
AMAPKKTWEEWIHALTIMKDTPHQLPGMTNNVLSILKLSYDRLSSDNLRV
CASYGALFEKGSWIYKYNIRHYWIGEGIIDNADTILDATRKTQFLLGILH
AASLTVRVDDVYFTMHPMTRAMILWVQRECGKKENKWLVLNREQVKEENW
RDAERISLGVNQIRELPETPQCPDLIFLNLEFNELLSKIPNGFFLHMPHL
KILNLRNTSIQELPASIGNLVQLHYLDLSRTRITSLPKEMAALVNLKLLS
LAFMTSLRIIPDQLFSSLRELQWLDMCDSYTGWREGQIWEGGVSFEELES
LKRLRVIGITVSTLAALQNLCISPRLAAFTCWLYIEGCRDLTLFDIPSKD
FHLENMLEVFCIRLHAMCELEEVVIGNLKPILQSLQQLRLSSLPKAKLVW
RATFPSTLFKLEIDGCGAIDRLIKLEGEANGSGETVITIFPDLHTMVLRR
LPELKSLSDGERILNFPSLKTIKVEDCPKLTKLTLVADGLKEIKCQRSWW
EQLNWGDERTKSFEHLYNPMNID
>XP_042454430.1 disease resistance protein RPS2-like [Zingiber officinale]
MGYVSPSSLMDIFNLLKACCSPSCNYIMTYDGTFSSLASEVGQLKDKSSD
VKRDVEAATRDGMTPRSEVLGWLSSVQDMEGEAESIERKYNQKIKCLCSF
PLNICSAYRLRNRAEAALATIRELKQSAEFTKLSDNLNLTRSIKMPTTKT
IGMDKVFEELQRHAKDDSLSVIGIHGMGGVGKTALLRRFNNDFPSETEAD
VVIFLELSIDYKLEEVQKSLFDRLSLTWQDEVTHRDRATKLFRVLSTLKF
ILLLDNLWEPLNYQVVGIPLPAPPSKCKIIFTTRTEDTCSHMGTEKMIKM
ECLEEEAAWNLFRNSARMDVIDADKNVRIEARDLVKECGGLPAALIVLAQ
AMAPKKTWEEWIHALTIMKDTPHQLPGMTNNVLSILKLSYDRLSSDNLRV
CASYGALFEKGSWIYKYNIRDYWIGEGIIDNADTILDATRKTQFLLGILH
AASLTVRVDDVYFTMHPMTRAMILWVQRECGKKENKWLVLNREQVKEENW
RDAERISLGVNQIRELPETPQCPDLIFLNLEFNELLSKIPNGFFLHMPHL
KILNLRNTSIQELPASIGNLVQLHYLDLSRTRITSLPKEMAALVNLKLLS
LAFTTSLRIIPDQLFSSLRELQWLDMCDSYTGWREGQIWEGGVSFEELES
LKRLRVIGITVSTLAALQNLCISPRLAAFTCWLYIEGCRDLTLFDIPSKD
FHLENMLEVFCIRLHAMCELEEVVIGNLKPILQSLQQLRLSSLPKAKLVW
RATFPSTLFKLEIDGCGAIDRLIKLEGEANGSGETVITIFPDLHTMVLRR
LPELKSLSDGERILNFPSLKTIKVEDCPKLTKLTLVADGLKEIKCQRSWW
EQLNWGDERTKSFEHLYNPMNID
>XP_042454436.1 disease resistance protein RPS2-like isoform X1 [Zingiber officinale]
MEGQATAGRRILLQDRISNASLGHTARLLLFVTSRSSSTMGSVSPSSLMD
IFNLLKACCSPSCNYIMAYEGTFSSLASEVGQLKDKSSDVKRDVEAATRD
GQTPRSEVLGWLSSVQDMEGEAESIERKYNQKIKCLCSFPLNVCSAYRLR
NRAEAALATIRELKQSAEFTKLADNLNLTRSIKMPTTKTIGMEKVFEELL
CHAKDDSLSVIGIHGMGGVGKTALLRRFNNDFPSETEADVVIFLELSIDY
KLEEVQKSLFERLSLTWQDEVTHRDRATKLFRVLSTLKFILLFDNLWEPL
NYQVVGIPLPAPPSKCKIIFTTRTEDTCSHMGTEKMIKMECLEEEAAWNL
FRNSARMDVIDADKNILIKARDLVKECGGLPAALIVLAQAMAPKKTWEEW
IHALTIMKDTPHQLPGEGIIDNADNIGDSTRKTQFLLGILHAASLIERVH
DNYFRIHPMTRAMILWVQRECGKKENKWLVPDRDRVEEAPAAEKWRDAER
IALVWNQIRDLPEAPQCPNMIFLNLHVNKFLRKIPNGFFLHMPHLKILDL
QETSIEELPVSIGNLMQLHFLELSRTRITSLPKEMAALVNLKYLSLESMK
YLRTIPDRLISGLRELQWLNMVDSYSGWREGGVSFEELESLKRLKVIGIT
VSTLAALQNLCDSPRLAAVTHWLHIEGCQDLTMFNIPSTDFHAETMLRLI
RIQLHAMSELEEVVIGNRQPILLPLQEFRLSSLPKAKLVWRATFPNALRE
LKIEDCGAIDRLIKLEGEANGGGETVITIFPDLHTMVLRRLPELKSLSDG
ERILNFPSLKTIKVEDCPKLMKLTLVADGLKEIECERSWWEQLNWGDERS
KSFEHLYNPMYID
>XP_042454437.1 disease resistance protein RPS2-like isoform X2 [Zingiber officinale]
MEGQATAGRRILLQDRISNASLGHTARLLLFVTSRSSTMGSVSPSSLMDI
FNLLKACCSPSCNYIMAYEGTFSSLASEVGQLKDKSSDVKRDVEAATRDG
QTPRSEVLGWLSSVQDMEGEAESIERKYNQKIKCLCSFPLNVCSAYRLRN
RAEAALATIRELKQSAEFTKLADNLNLTRSIKMPTTKTIGMEKVFEELLC
HAKDDSLSVIGIHGMGGVGKTALLRRFNNDFPSETEADVVIFLELSIDYK
LEEVQKSLFERLSLTWQDEVTHRDRATKLFRVLSTLKFILLFDNLWEPLN
YQVVGIPLPAPPSKCKIIFTTRTEDTCSHMGTEKMIKMECLEEEAAWNLF
RNSARMDVIDADKNILIKARDLVKECGGLPAALIVLAQAMAPKKTWEEWI
HALTIMKDTPHQLPGEGIIDNADNIGDSTRKTQFLLGILHAASLIERVHD
NYFRIHPMTRAMILWVQRECGKKENKWLVPDRDRVEEAPAAEKWRDAERI
ALVWNQIRDLPEAPQCPNMIFLNLHVNKFLRKIPNGFFLHMPHLKILDLQ
ETSIEELPVSIGNLMQLHFLELSRTRITSLPKEMAALVNLKYLSLESMKY
LRTIPDRLISGLRELQWLNMVDSYSGWREGGVSFEELESLKRLKVIGITV
STLAALQNLCDSPRLAAVTHWLHIEGCQDLTMFNIPSTDFHAETMLRLIR
IQLHAMSELEEVVIGNRQPILLPLQEFRLSSLPKAKLVWRATFPNALREL
KIEDCGAIDRLIKLEGEANGGGETVITIFPDLHTMVLRRLPELKSLSDGE
RILNFPSLKTIKVEDCPKLMKLTLVADGLKEIECERSWWEQLNWGDERSK
SFEHLYNPMYID
>XP_042454438.1 disease resistance protein RPS2-like isoform X3 [Zingiber officinale]
MGSVSPSSLMDIFNLLKACCSPSCNYIMAYEGTFSSLASEVGQLKDKSSD
VKRDVEAATRDGQTPRSEVLGWLSSVQDMEGEAESIERKYNQKIKCLCSF
PLNVCSAYRLRNRAEAALATIRELKQSAEFTKLADNLNLTRSIKMPTTKT
IGMEKVFEELLCHAKDDSLSVIGIHGMGGVGKTALLRRFNNDFPSETEAD
VVIFLELSIDYKLEEVQKSLFERLSLTWQDEVTHRDRATKLFRVLSTLKF
ILLFDNLWEPLNYQVVGIPLPAPPSKCKIIFTTRTEDTCSHMGTEKMIKM
ECLEEEAAWNLFRNSARMDVIDADKNILIKARDLVKECGGLPAALIVLAQ
AMAPKKTWEEWIHALTIMKDTPHQLPGEGIIDNADNIGDSTRKTQFLLGI
LHAASLIERVHDNYFRIHPMTRAMILWVQRECGKKENKWLVPDRDRVEEA
PAAEKWRDAERIALVWNQIRDLPEAPQCPNMIFLNLHVNKFLRKIPNGFF
LHMPHLKILDLQETSIEELPVSIGNLMQLHFLELSRTRITSLPKEMAALV
NLKYLSLESMKYLRTIPDRLISGLRELQWLNMVDSYSGWREGGVSFEELE
SLKRLKVIGITVSTLAALQNLCDSPRLAAVTHWLHIEGCQDLTMFNIPST
DFHAETMLRLIRIQLHAMSELEEVVIGNRQPILLPLQEFRLSSLPKAKLV
WRATFPNALRELKIEDCGAIDRLIKLEGEANGGGETVITIFPDLHTMVLR
RLPELKSLSDGERILNFPSLKTIKVEDCPKLMKLTLVADGLKEIECERSW
WEQLNWGDERSKSFEHLYNPMYID
>XP_042454439.1 disease resistance protein RPS2-like isoform X4 [Zingiber officinale]
MEGQATAGRRILLQDRISNASLGHTARLLLFVTSRSSSTMGSVSPSSLMD
IFNLLKACCSPSCNYIMAYEGTFSSLASEVGQLKDKSSDVKRDVEAATRD
GQTPRSEVLGWLSSVQDMEGEAESIERKYNQKIKCLCSFPLNVCSAYRLR
NRAEAALATIRELKQSAEFTKLADNLNLTRSIKMPTTKTIGMEKVFEELL
CHAKDDSLSVIGIHGMGGVGKTALLRRFNNDFPSETEADVVIFLELSIDY
KLEEVQKSLFERLSLTWQDEVTHRDRATKLFRVLSTLKFILLFDNLWEPL
NYQVVGIPLPAPPSKCKIIFTTRTEDTCSHMGTEKMIKMECLEEEAAWNL
FRNSARMDVIDADKNILIKARDLVKECGGLPAALIVLAQAMAPKKTWEEW
IHALTIMKDTPHQLPGEGIIDNADNIGDSTRKTQFLLGILHAASLIERVH
DNYFRIHPMTRAMILWVQRECGKKENKWLVPDRDRVEEAPAAEKWRDAER
IALVWNQIRDLPEAPQCPNMIFLNLHVNKFLRKIPNGFFLHMPHLKILDL
QETSIEELPWLNMVDSYSGWREGGVSFEELESLKRLKVIGITVSTLAALQ
NLCDSPRLAAVTHWLHIEGCQDLTMFNIPSTDFHAETMLRLIRIQLHAMS
ELEEVVIGNRQPILLPLQEFRLSSLPKAKLVWRATFPNALRELKIEDCGA
IDRLIKLEGEANGGGETVITIFPDLHTMVLRRLPELKSLSDGERILNFPS
LKTIKVEDCPKLMKLTLVADGLKEIECERSWWEQLNWGDERSKSFEHLYN
PMYID
>XP_042454571.1 probable disease resistance protein At4g33300 [Zingiber officinale]
MDSSFAGEVATELIKELMKVIRGTYLCRPAAEQLKRSVDSLLPIVQEIRH
SGVELPQHRQSQLSELADRLRFALDLARKAAASPRWNVYRSVQLARKMEG
IENWISRWIERHMPVHVLADVHHIRVDCAARLDRIERALDMAASSPVAAT
ASKVPVAFGSAPFSGFPMSDMMDPMAPVKTPFAMGNTLSSGFPTMEGFFP
SPAPTKVPVAMGKPPSSGYPVANIMDGLMMAGEGVKPVGVGIRIGKEKVK
EMLMEGSDRSPVVGIFGIGGSGKTTLAREICKDPEIRSYFKDRIYFTTLS
QSPNLESLKLKLWEQISGNMVLGAYNQIPKWQMELGQIEKGFSLIVLDDV
WSLSELEELIFSLRGCKILVVSRFNFPSIVKNTYEIELLGEEDALSLFCH
AAFEQKSVPFSVDKKLVKQVVDKCKGLPLALKVIGASLRDQPPKFWLRAK
NKLTRGEAICESHENKLIERMASSIEFLSAKVRECFLDLGSFPEDKRIPL
DVLINMWMELHDLDEEDAFAILVELSNKNLLTLCKDAQNRAGDIYSSYTE
LSVTQHDLLRDLALYVNNQEPSNTRRRLIMARRENELPKEWERNKDHQFE
AQIVSINTGEMKETDWFQMHFPKAEVLILSFCADVYFLPPFLSTMPKLRA
LILINYGTSCTSLQNCSVFKPLSNLRSLWLEKISVPPLPKSTVRLNNLRK
VSLVLCELNDSLRGSKVDLSSTLPRLSHLTIDHCIDVTELPSCICDINSL
ECLSISNCHDLSELPCEFGKLSSLKILRVYACPSLKSLPLSICRMKGLKY
LDISQSFNLRELPEELGYMTSLEKIDMRECSQLKTLPRSSSFLKSLGHVI
CDEDIALLWKEAERDIPDLRVQVAEESFNLDWLLE
>XP_042454711.1 disease resistance protein RPP8-like [Zingiber officinale]
MASTVVNLVLGKLGEVVSSDVAGILNVDAEVKSLTETLALIQSSLRDADQ
KPRYEQSHSLQEWMRQIRNLAFEMEDLVDEYAMQLGRASAADGRMSSLQR
IGAFPSRILTRRLFASRLQDIRARFQDVCKQASQLGIHGSSSSSSSSSSA
FSAADARLARRFELEEDIVGFDEDMKGIKRQLFDIGSTDRVVLSIVGPGG
LGKTTLANKIYKSADVKKYFQCKAWVPVSQKYVVKELLLRIMKQVFDFKD
EQVKGMEELEMKEKLSEHLSDRRYLIVMDDIWEVAAWNAIKAAFPKESTG
SRVLLTTRKMNVANVADVPPHELKFWNVEESWNLFCRKAFRTSCCPPEFE
RFKEDIFKKTKGLPLAIVVLGGLLRGTSQASDWRKKLEHISYEFREGEDQ
ILRILALSYHDLPHHLKPCFLYFAAFPEDYSIRAERIRHLWIAEGFIQTN
DKVDQTMEDLAEAYLNDLTDRSMLQMERRGHIYKQKVSIHDLLLDLARHE
ARELNFFRSIDDIGDDPRALRRLSVNDHISLNCSTTKLRSLVIYPNEGFQ
RTLAVTIPGAKFLRVLDLQELPIEHLPKEIGDLILLKYLNLYQSKLKELP
SSIGNLIHLQTFNIQFTEIQHLPDAFWKIRTLRHVLLNEENTSMPKATYC
LEDIQTLVNISIGPWVSDGVLEKLRNLRRLHLNNMSISDEDALATAVQNL
SRLEMLALIGESLPMSVLTSSCYHHIQILLLWGPLVRPARIHIEAEKPRI
FSNLISLFICETRLEKDEDIVMLASLANLQNLELGIDAFLGRVLVFPKGG
FPRLQEIVLYKLSTLEQWEVGEGAMTLLRDLRLWNCRNLRMLPEGLVRLT
ELKQIEISGMEMIERRVDKDTGEDYHKIKHVPCIEID
>XP_042454713.1 disease resistance protein RPP13-like [Zingiber officinale]
MESTIVNLVLGKLGELASSEVAGLFNVGAEVESLTKKLLLIQSYLRDADQ
KPRSEQSQSLQEWLRQIRNLAFEMEDLVDEYATRLGRASAAGGRESCLRR
IAAFPSRILTRHRLASHLQDIRARFQDVCNQASQLGIHGSASLALPSSSS
SSSSSSSFSAANARLARRFELEEDIVGFDEDMKDIKRQLIDMSSTDRVVL
SVVGTGGLGKTTLANKIYRSADVKNYFQCKAWVSVSQKYAVKELLCSIAK
QVFDFKDGQEKAMEELEMKEKLSEHLSNRRYLVVIDDIWEVAAWNAIKAA
LPKESRGSRVLLTTRKMKVANVADVPPHELKFWNVEESWNLFCRKAFRTA
CCPPEFERFKEDIFKKTKGLPLAIVVLGGVLRGTSQASDWRKKMEHISRE
FREGEDQILRILALSYHDLPHHLKPCFLYFAAFPEDYSIWAERIIHLWIA
EGFIQTNDKVDQTMEDLAEAYLKDLTDRSMLQIERGRMYYSHQVRIHDLL
LDLARHEARELNFFRSIDDIGDDPRSLRRLSVTENVNDHISLNCSTTKLR
SLVTCRNEGFKRMLAVAIPGAKFLRVLDLQELPIEHLPKEIGDLILLRYL
NLERSKLKELPSSIGNLIHLQTFNIFGTKIQHLPDAFWKIRTLRHVFLTE
ENKSMPKAAYYCSEDIRTLENISIGPWVCDGALEKLRNLRALYLKSISSS
DEDALANAVQNLFRLEKLGLVGESLPMSVLTSSSYHHIQFLYLWGPLVRP
ARIHIEAENSRIFSNLISLFISETRLEKDEDIAMLASLANLEILRLRFRA
FVGRVLVFPKGGFPSLQEMELFDLSTMEQWEVGEGAMPFLRELRLWNCIH
MRMLPEGLVRLTELNQIDIRGMKMIERRSTRILEKIITRSSIFLALK
>XP_042454717.1 putative disease resistance RPP13-like protein 3 [Zingiber officinale]
MASTVVNLVLGKLGELASSEVAGLFNVGAEITSLTETLALIQSRLRDADQ
KPRPEQSHSLQEWMRQIRNLAFEMEDLVDEYATRLGRTSAAGGRKSCLRR
IAAFPSRILTRHRLASRLQDINARFQDLCKQTSQLGIQASSSWPTSSSSS
SSSSSAADARLARRCELEEDIVGFDEDMKDIKRQLFDISSTDRVVLAVVG
PGGLGKTTLANKIYKSADVKNYFQCKAWVSVSQKYGIKELLCSIVKQVFD
FNYEHVKGMEELEMKEKLSDHLRDRRYLVVMDDIWQVAAWNAIKAAFPKE
STGSRVLLTTRKMNVANVADVPPHKLKFWNVEESWNLFCRKAFRTTSCPP
EFERFKKDIFRKSKGLPLAIVVLGGLLRGTSQASDWRKKLDYISYEFREG
EDQIQSILALSYHDLPHHLKPCFLYFAAFPEDYRIAAERIIQLWIAEGFI
QTKDKVDQTMEDLAEAYLKDLTDRSMLQMETIGFYLRIVCIHDLLLDLVR
HEARELNFYRSINDRGDDPRALRRLCVSENVNDHISSNCSTTKLRSLVVC
RNEGFQRNLAVTISGAKFLRVLDLIKLPIEQLPKEIGDLILLRYLNLSGS
KLKELPSSIGNLIHLQTFNIYGTEIHQLPDAFWKIRTLRHVFLDKENMSM
PNSTFCSEDIQTLGNISSGPWVCDGALEKLRNLRRLHLRNMSSSDEDAFA
NAVQNLSLLEMLALIGESLPMSLLTSSCYHHIQIMDLAGPLVRPARILIE
AENSRIFSNLISLAIVKTRLEKDEDIALLASLANLEYLLVCLDAFVGRVL
VFQKGGFPRLQEIILGDLNTLEQWEVGEGAMPLLRELRLWDCINLRMLPE
GLVRLTELKQIEIRGMEMIERRVNKDTGEDYHKIKHVPCIEIN
>XP_042454720.1 putative disease resistance RPP13-like protein 3 [Zingiber officinale]
MASTVVNLVLGKLGELASSEVAGLLNVGAEITSLTETLALIQSRLRDADQ
KPRPEQSHSLQEWMRQIRNLAFEMEDLVDEYATRLGRTSAAGGRKSCLRR
IAAFPSRILTRHRLASRLQDINARFQDLCKQTSQLGIQASSSWPTSSSSS
SSSSSAADARLARRCELEEDIVGFDEDMKDIKRQLFDISSTDRVVLAVVG
PGGLGKTTLANKIYKSADVKNYFQCKAWVSVSQKYGIKELLCSIVKQVFD
FNYEHVKGMEELEMKEKLSDHLRDRRYLVVMDDIWQVAAWNAIKAAFPKE
STGSRVLLTTRKMNVANVADVPPHKLKFWNVEESWNLFCRKAFRTTSCPP
EFERFKKDIFRKSKGLPLAIVVLGGLLRGTSQASDWRKKLDYISYEFREG
EDQIQSILALSYHDLPHHLKPCFLYFAAFPEDYRIAAERIIQLWIAEGFI
QTKDKVDQTMEDLAEAYLKDLTDRSMLQMETIGFYLRIVCIHDLLLDLVR
HEARELNFYRSINDRGDDPRALRRLCVSENVNDHISSNCSTTKLRSLVVC
RNEGFQRNLAVTISGAKFLRVLDLIKLPIEQLPKEIGDLILLRYLNLSGS
KLKELPSSIGNLIHLQTFNIYGTEIHQLPDAFWKIRTLRHVFLDKENMSM
PNSTFCSEDIQTLGNISSGPWVCDGALEKLRNLRRLHLRNMSSSDEDAFA
NAVQNLSLLEMLALIGESLPMSLLTSSCYHHIQIMDLAGPLVRPARILIE
AENSRIFSNLISLAIVKTRLEKDEDIALLASLANLEYLLVCLDAFVGRVL
VFPKGGFPRLQEIILGDLNTLEQWEVGEGAMPLLRELRLWDCINLRMLPE
GLVRLTELKQIEIRGMEMIERRVNKDTGEDYHKIKHVPCIEIN
>XP_042454725.1 putative disease resistance RPP13-like protein 3 [Zingiber officinale]
MASTVVNLVLGKLGELASSEVAGLLNVGAEITSLTETLALIQSRLRDADQ
KPRPEQSHSLQEWMRQIRNLAFEMEDLVDEYATRLGRTSAAGGRKSCLRR
IAAFPSRILTRHRLASRLQDINARFQDLCKQTSQLGIQASSSWPTSSSSS
SSSSSAADARLARRCELEEDIVGFDEDMKDIKRQLFDISSTDRVVLAVVG
PGGLGKTTLANKIYKSADVKNYFQCKAWVSVSQKYGIKELLCSIVKQVFD
FNYEHVKGMEELEMKEKLSDHLRDRRYLVVMDDIWQVAAWNAIKAAFPKE
STGSRVLLTTRKMNVANVADVPPHKLKFWNVEESWNLFCRKAFRTTSCPP
EFERFKKDIFRKSKGLPLAIVVLGGLLRGTSQASDWRKKLDYISYEFREG
EDQIQSILALSYHDLPHHLKPCFLYFAAFPEDYRIAAERIIQLWIAEGFI
QTKDKVDQTMEDLAEAYLKDLTDRSMLQMETIGFYLRIVCIHDLLLDLVR
HEARELNFYRSINDRGDDPRALRRLCVSENVNDHISSNCSTTKLRSLVVC
RNEGFQRNLAVTISGAKFLRVLDLIKLPIEQLPKEIGDLILLRYLNLSGS
KLKELPSSIGNLIHLQTFNIYGTEIHQLPDAFWKIRTLRHVFLDKENMSM
PNSTFCSEDIQTLGNISSGPWVCDGALEKLRNLRRLHLRNMSSSDEDAFA
NAVQNLSLLEMLALIGESLPMSLLTSSCYHHIQIMDLAGPLVRPARILIE
AENSRIFSNLISLAIVKTRLEKDEDIALLASLANLEYLLVCLDAFVGRVL
VFQKGGFPRLQEIILGDLNTLEQWEVGEGAMPLLRELRLWDCINLRMLPE
GLVRLTELKQIEIRGMEMIERRVNKDTGEDYHKIKHVPCIEIN
>XP_042454782.1 disease resistance protein RPP8-like [Zingiber officinale]
MASTVVNLVLEKLGELASSEVSSLLNVGAEIKSLTETLALIQSFLRDADQ
KPRYEQSNSLQEWMRQIRNSVFEMEDLVDEYAMLLGRASTAGCWKSRLRR
IAAFPSRILTRHLLARRLRDIHARFQDVCKQASQLGIQCSSSLPTSSSSS
SAADATLARRFELEEDIVGFDEDMKGIKRQLFDIGSTTRVVLSVVGPGGL
GKTTLANKIYKSADVKNYFQCKAWVSVSQKYELKELLCSIVKQVFDFKDE
EVKGMEELEMKEKLSEHLRDRRYLVVMDDIWEVAAWNAIKAAFPKESTGS
RVLLTTRKMNVANVADVPPHELKFWNVEESWNLFCRKAFRTTCCPPEFER
FKEDIFKKTKGLPLAIVVLGGVLRGTSQASNWRKKLEHISREFREGEDQI
QRILALSYHDLPHHLKPCFLYFAAFPEDYSIWAERLIHLWIAEGFIQTND
KVDQTMEDLAEAYLNDLTDRSMLQIQRGRMYYSHEVRIHDLLLDLARHEA
RELNFFRSIDDIGDDPRSLRRLSVTENVNDHISLNCSTTKLRSLVTCRNE
GFKRMLAVAIPGAKFLRVLDLQELPIEHLPKEIGDLILLRYLNLERSKLK
ELPSSIGNLIHLQTFNIYGTKIQHLPDAFWKIRTLRHVFLTEENTSMPKA
AYYCLEDIRTLENISIGPWVCDGALEKLRNLRALYLKSISSSDEDALANA
VQNLFRLEKLGLVGESLPMSVLSSSCYHHIQFLYLYGPLVRPARIHIEAE
NSMIFSNLISLFISETRLEKDEDIAMLASLANLQILRLRFGAFVGRVLVF
PKGGFPSLQEIELYRLRTLEQWEVGDGAMPFLRELRMWNCKNMRMLPEGL
VRLTELNQIYIRGMKMIERRVNKDTGEDYHKIKHIPCIEIN
>XP_042455014.1 putative disease resistance protein RGA1 [Zingiber officinale]
MGLEPLQKILHQHIVKKKFLLVLDDVWSDDKSIWEKFCALLKVGAHGSKI
IVTTRGMKVSKMVSLAEPILLHGLDEDAFWQLFNECSFGTLNPEDYPGLE
DIGRKIVRKLNGSPLAAKTIGRVLRSNICQQHWATVMESDIWKAKQDEDD
IMPALQLSYQYLDENLKHCFAFCSLFPIDHKFDKTELVRMWMAEGFINED
KNTKSMEDVGSDYFLEFVNSSFFQESRYHYEFWDGFGIRIVMHDLIHDLA
EMISTEETCRIENSRHTKPASTTRHLRVEKEKLPLEFSGYNKLRTLVLKL
SLPDSSLFEILRSIRVLVVSWCGLLELSERIGKLIHLRYLDISYSKIKIL
PDLLCDLYNLQTLKAEYCYELESIPQELGKLVNLRHFDISNNFKIKILPD
SLCDLYNLQTLKVNGCSELESIPQELGKLVNLRHIDADKKIWLMIKDVWR
LTNLQELPTFSVREDDELKLGQLKDLTQLHGTLCIQNLENVVDGKEAQRA
KLKSKVHLKELVLEWNLRLDGAKDAKLDEEVIEVLQPHESLKILTIRWYN
GGRSPSWLMPKVLPNLEKLELENCMEWDDVLPFIGQRLHLIELRMTGMPA
LKRLSHEFEGKCFPKLQVLKLCKFKALREWSCTEGKDLFPCLRELCVIDC
PKLKRLPPFPPSLEMLTIECCPRLILNSKTEDDEEGGRHLPPSLKELKNM
QNFCPTACTTLLDWK
>XP_042455015.1 putative disease resistance protein RGA1 [Zingiber officinale]
MGLEPLQKILHQHIVKKKFLLVLDDVWSDDKSIWEKFCALLKVGAHGSKI
IVTTRGMKVSKMVSLAEPILLHGLDEDAFWQLFNECSFGTLNPEDYPGLE
DIGRKIVRKLNGSPLAAKTIGRVLRSNICQQHWATVMESDIWKAKQDEDD
IMPALQLSYQYLDENLKHCFAFCSLFPIDHKFDKTELVRMWMAEGFINED
KNTKSMEDVGSDYFLEFVNSSFFQESRYHYEFWDGFGIRIVMHDLIHDLA
EMISTEETCRIENSRHTKPASTTRHLRVEKEKLPLEFSGYNKLRTLVLKL
SLPDSSLFEILRSIRVLVVSWCGLLELSERIGKLIHLRYLDISYSKIKIL
PDLLCDLYNLQTLKAEYCYELESIPQELGKLVNLRHFDISNNFKIKILPD
SLCDLYNLQTLKVNGCSELESIPQELGKLVNLRHIDADKKIWLMIKDVWR
LTNLQELPTFSVREDDELKLGQLKDLTQLHGTLCIQNLENVVDGKEAQRA
KLKSKVHLKELVLEWNLRLDGAKDAKLDEEVIEVLQPHESLKILTIRWYN
GGRSPSWLMPKVLPNLEKLELENCMEWDDVLPFIGQRLHLIELRMTGMPA
LKRLSHEFEGKCFPKLQVLKLCKFKALREWSCTEGKDLFPCLRELCVIDC
PKLKRLPPFPPSLEMLTIECCPRLILNSKTEDDEEGGRHLPPSLKELKNM
QNFCPTACTTLLDWK
>XP_042455018.1 disease resistance protein RGA2-like [Zingiber officinale]
MEPASGFLNDTLSVLPIVGIGGAGKTTLAQYAHKDSRVQDHFHLKIWICV
SDNFTMQGLAKSIIESVTLQKQDDNMRLEPLQKILHQHIAKKKFLLVLDD
VWSNNKSIWEKFCALLKVGAHGSKIIVTTRDLKVSKMVSLAEPISLHGLD
EDVFWQLFKKCSFGALNLEGYPELEDIGRKKALKLKGSPLAAKTLGSVLQ
SNLCKQHWATIMESDIWKVKQDENDIMPALHLSYQYLNENLKQCFTFCSL
FPKDYRFYEDKLIRMWMAEGFINEDKSTKRMEDVGSDYVLEFLTRSFFQE
FEYDGFVMHDLIHDLSERISELSEHIGKLIHLRYLDLSYNSEIKILPESL
CDLYNLQTLKAVGCSELESTPQQLSKLVNLRHIFADEKFWVMIKDIRRLT
NLQELPTFRVQEEDGLKLVQLKNLTQLRGTLHIQNLENGVDSKEAQTAQY
AELKKKVHVQELVLTWNDEKDAKLEEEVIEGLQPHDLLKILKIEGYNGGR
SPSWLMPKVLSNLEKLELVNCKGWDDVLPFIGQRLYLIELIMYSMPALKQ
LSHEFKGKCFPKLEMLDLYELPALEEWSWTEGKDLFPRMRQLRVWKCPKL
NRLPPFPHSLEILTIYDCSKLILNSKTEDGEECGCYLPPSLKVLELDNCG
EYSKLLPGCLHSLRLVTRLAIRYCPHITSIPPVQLVELQYLYISNCDELR
RMDCLALLKSLKELKIVGCPKLVQLDVEDEQAGSLSSLCKLCVDNTALLK
IFPLRNSLSFITELRIESCSEEVIFEEAILMQSLTAVTSLTFCNCDKLQS
LPTELVRSLTAVTSLNFIDCKKLQSLPTELLQSLPLLKQLNIYWCPQFQS
LPEEELPPLLNHQNAVVFLPSLLYSNAIVAAPRNILLL
>XP_042455019.1 putative disease resistance protein RGA1 [Zingiber officinale]
MSWDKHLIFRHINCSWNNKSSGNLQRYINCRGINYSVVCRLLFCFDLQLP
FSNFCFLRVYCSLLKHRRLNGNNDHLQIHFISRSTLFGDLKEEQRFALFC
NQMAVSLTVGGWLAQAFIQTLIDKASDKAIQLFAERRGFAEDMKKLRTSL
LQTQITLDEVQSSRSNNIKWKTLMQELQDASYDAEDLIDEFQYNILRQKI
KGEEEDKASGSSGLLSILPAAKKLFGSSYDMRARVREIQERLETSMKSIV
NLPATHDRRKQPEVKFQARESCSSPMADKLIGREKELNQVVDWLLGSANQ
VEPASGFVNNTFSVLPIVGIGGAGKTTLAQYAHKDNRIQDHFHLKIWVCV
SDNFTVQGLTKSIIESVTLQKQDENMLEPLQKILHQHIAKKKFLLVLDDV
WSDDKSIWEKFCALLKVGAHGSKIIVTTRDMKVSKMVSLTEPILLHGLDE
DAFWQLFMKCSFGTLNPEDYPGLEDIGRKIARKLKGSPLAAKTIGRVLRS
NICQQHWATIMESDIWKVKQDEDDIMPALQLSYQYLDENLKQCFAFCSLF
PKDHKFDKAELVRMWMAEGFINEDKNTKSMEDVGSDYFLEFVNSSFFQEF
RYHYEFGDGFGIRIVMHDLIHDLAEMISAEETCRIENSRHTKPPSTTRHL
RVEKEKLPLEFSGYNKLRTLVSKLSLPDSSLFEILRSIRVLDVSWCGLLE
LSEHIGKLIHLRYLDISGNSKVKILPDSLCDLYNLQTLKTECCSELESIP
QELGKLVNLRHFDISSNFKIKILPDSLCDLYNLQTLKVNGCSELESIPQE
LGKLVNLRQIDADGEFWVMLKDVRRLTNLQELPIFSVQEDDAFKLGQLKD
LTQLHGTLCIQNLENVVDGKEAQRAKLKSKVHLKELVLDWNLRWYGGKDA
KLDEEVIEGLQPHESLKILTIRRYNGGRSPSWLMPKVLSNLEKLELSNCM
EWDDVLPFIGQRLHLIELRMTDMPALKRLSHEFEGKCFPKLQVLKLCKFQ
ALREWSWTEGKDLFPCLRELCVIDCPKLKRLPPFPPSLEMLTIECCPRLI
LNSKTEDDEEGGRHLPPSLKELKLTDCGEYAKLLSDCLHNLTRLEINDCL
YIPSISLVQLVELQCLCISDCDELRRIECLGLLKSLKELKIVECPKLVQL
DVGDEQAGSLSSLRKLCVDNTALLKMFPLRNSLPFITELEIESCSEEVIF
VEPIWVPSLAAVTSLTLRNCKKLQYLPTELLHGLPLLENLIMKNCPQIKS
LPDKGLPPRLQRLQIYGCPHIQLQEIPENLRPIIPCMSLLSFNIF
>XP_042455021.1 putative disease resistance protein RGA3 [Zingiber officinale]
METLCTSLLKTQTMLAKVKSSQSNDTKWMPIMPLMQKLKDAAYDAEDLID
EFQYHVLRQKIKGEEEDKAASGSGGLPNILPAAKEKLFGPSHSLEEDAMR
TSVVEIQGRLERIANSMEGIMNVLPLNDRGTQLEVKFQSRESCSSPATDI
LFGREKELNQVVEWLLGSANQVEPAPGVVNDTFSVLPITGIGGVGKTTLA
QYVYKDTRIQHHFDLKIWVCVSHNFSVQGLTKSIIQSVTQQKQHDNMCLE
SLRKILDEHIANKKFLLFLDDMWSDKESIWENFCALLKDGGAHGSKIIVT
TRVMKVSKMVNPAESILLHGLDEDVFWQLFNKCSFGILNPEDYPGLEDIG
RKIARKLKGSPLAAKTIGKVMKSNLCWQHWTTIMESDIWEVKQDEDGIMP
ALQLSYQYLDENMKQCFAFCSMVPKDYTFDKVELVLMWMAERR
>XP_042455807.1 disease resistance protein Pik-2-like [Zingiber officinale]
MMAMKVVDFSFLSIAGKLEKMLEEEAALLAGVEDDVCDIVAELRSVTSFL
TAMSTRRNLDDQLQNWVQEVREVAYDAEDSIDEFVCRLRLRSTPYDENGV
KAFFKHFLRDIKSLKARHDMASRLKKLKVQVEKVRKRHDRYSHPNEATSS
GTATSLEMAGRYSDPRIIGHFVEEAQLVGINQRRDKIIGWVMDENRLELT
VISIVGLGGLGKTTLAKTVYDNSIIIAGSHFQPRAWIVVSQNYSIRELLK
KIILQISVDEQQIRDVLGCPDASLNTEQLLNMMEESQLVQTVRGHLHGKR
YMLIFDDVWRTDTWESLSIALPPGREGSRVIVTTRIEEVANTSCSRNHQF
IFKISPLSCQLSWELFCRRVFEAPDYNCPPELENVGREILQKCDGLPLAI
VTIGGVLASRSDKKLEEWKDLRDHLRLEIQTNDILSKIHRILLLSYNDLP
YHLKPCCLFLGIFPEDFEIHRKRLIRRWIAEGIVSGIDGFPAEKVAERCF
NQLVGRSLVQPSQFDDSGTVKSCRVHDMMLDVILSISKKENFAVLLNEHP
TIPPQHQKIRRLSWRRGSSGVLVPANDLSHLRSFTAFGEDVPPPKDYRKQ
RQLRAIDLEGCEALFDLHPKSFSKLFLLKYLSLRNTGLSELPDSIGDLQN
LEFLDMRGTRIKELPNTMVKLQKLVYLLAGPQGFKFLKGIGKLKRLVAFG
MAYADKMQSLQEIGELVDLQKLAITFGEHDLSLRMLEEIRALLSKLNGTL
RSLTIFPPVNVSLKNALDEVASPPLLLCKLQIGCRLGQLPPWFASLKHVV
KISLVGTLLQLEDLQVLRNLPALVNLKLGFKSFVNNDEDLVFDRGGFAQL
KFLQIKCQHVSFRVGAVRSLEILEIFFPPESVNGIEHLHGLREIYILTFN
EHISEMVKDIAANHSNRPKCFVNQL
>XP_042456145.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAAADLKRILSQVLPSPSLKAQAGLLRVQNHLEMIEGSLWKINSMYMHGL
MTAITKPDVEQWTNDVKEALLDVDQLLGRILRCRLPKEAAAKSPSVCGDI
LLWLKETAAKSPSVRGDILLGLAETAAKSPSVRGDILLGLTETASKLNHL
AFGGASSLGLRAEMMDSIDADHEDFSTVLNNEVQGLEDTTNKIVKELQSQ
QLYEEIPTIFYIVGHEGMGKTTLARKVFHHDWVRNYFQHHVWVDSPDSFS
FDPMTVARSFVEAVTKKPCGHRGYLQQLWLDVSKKLNVGRYFLVLDDVPV
LMKDRDKWEQLRHVFLRLGSPGSRVVAVTSVHHSDFPEGNPTFKKLPPVL
GLSRDSWTSLLRRRASALIRDDDEGKQIRKSSSAILDRFAGKLHEKSRGS
PSLAKVWGSALQCTEVGRWEDQIEKDLLPKPLQDEQHFGSWSSQYLIPKD
AHLYLFSSLFQQDHDEHDYEDLFHMMAAQGFIQDSSNKALIISNLKRSLR
HFATKDSRQQESLTNDLIRSLPILEATQPSSESEKKVLSYWKTKGFPKST
HQLQCLHLSVLIHPSTDLTLPVTLPSKLRTLKLTMLVAENEEQKKKMEGQ
KIETVLKDEFSNLRHLRVLDLRATKMAEMPDTVDGLVNLRYLNLSWSDIA
TLPDSFCNLGSLQILKLAHCHKLSELPHRIGKLQNLQVMKLPFCENLTKL
PKSVTNLIDLQELDLECCRQLVEFPDEFGNLKSLRSLSLVGCLSLTKMPS
GMRQLTELRQLSGFVALQECGSCTVTELGPLKYLEDLHLRGLEGVRSTND
AEAMKLKNKRFIRNLVLHWNGDDGASSDSLLEILECLQPSTALRTLEINS
YSGKDFPKWMKDGQPYHYTLTEIKLVNLRDCASLPPLGQLARLEVVEISG
MVKVRKVDDEFYGLNGAFASLRKLTFSEMPELQKWVKVTRKFQLFPKLTE
LMIIQCPRLEQLEVELTAVKKLSLWLSNGTLLTSKSWDWSKFSGLTELEI
VGCPGVKHLPKSMKILEQMVDHLTLVGLGTLESLPNWLKKDCCLDITRCG
KVKEQECQNASEAFSSATSIESREWDKK
>XP_042456968.1 disease resistance protein Pik-2-like [Zingiber officinale]
MGSMEMTIAMKVVGFSFQFIAGKLESMLVEEAALLAGVEDDVRYIVAELS
SMTSFLKAMSTRHNLDDQLQNWVQEVKEAAYDAEDSIDEFLCHLGSIPYD
QRRVKGFFKHFLRSIKLMKARHDIASDLKKLKVNVEEVRKRHDRYSHPNE
ATSSGIATSLEMAGTYSDPRIIGHFVEEAQLVGIKESKGTLIEWVLDKNR
LELTTIPLVGFGGLGKTTLAKTVYDDPIIVGGHFQSRAWITVSQNYSIQE
LLKKIIRQISVNEQRIRDVLGCQDAGLNTEQLLNMMDKTQLEKTIRDHLQ
GKRYLLVFDDVWRTQAWNDLSIALPPGEEGSRVIVTTRIEEVANISCSRN
HQFIFKVSPLSPELSWELFCRRVFEAPDYSCPPELENVGREILQKGNGLP
LAIVTIGGLLASRPDKKLEEWKDLRDHLRLEIETNDMLLKIHQILVLSYN
DLPFHLKPCFLFLGIFPEDFEIRRKRLMRRWIAEGIVSGEDDSPAEKVAE
RCFNQLVSRSLVQPSQFDDSGTVKSCRVHDMMLDVILSISRKENFAVLLK
EHPTIPQRHQKIRRLSWHGGSSGLVPDTDLSHLRSFTAFGEDVPLKDYRK
QRRLRAIDLEGCWNLFDLHPKSFSKLYLLKYLSLRDSRISVLPDLMGDLQ
NLEFLDIRGTNIYKLPNTIVKLQKLIYLLASNYLKVPKRIEKLKRLVTFG
IAYVENVQSLQEIGELVDLQKLGIGFRQHDDLSLRMQEISALFSKLIGSL
RSLKIFSWPNSGLKTALDEVASPPLMLCKLGIHFKLGELPPWFASLNHVV
KISLVCTQLQLEDLQVLGNLPALVNLKLGYRSFVHYDLVFDRGGFAKLKF
LEIERHNVSFKVGAFPSLEILKIHFDYQSINGIEYLHGLREVHIKTSHED
TIEMVKNISANHSNRLKCFATQL
>XP_042457027.1 disease resistance protein Pik-2-like [Zingiber officinale]
MADRYSDPRIIGHFVEEAQLVGINPSRDKIIGWVMDENCPELTAISLLGF
GGLGKTTLAKTVYDDPIIVEGHFQPRAWIAVSQNYNIKELLKKIIRQISV
NEKQIRDVSGFRDARLNTEQCLNMMDESQLVQTVRGHLHGKRYFIVFDDV
WSVEAWESLSIALPQGKEGSRVIVTTRINDVANASCSRNRRFIFKISPLS
PELSWELFCRKVFDAPDYNCPPELENIGREILQKCDGLPLAIVTIGGLLA
SKPDNNFEEWKDLRDHLRLEIQTNDMLSKINQILGLSYNDLPYYLKPCFL
FLGTFPEDYEIRRKRLMRRWIAEGIVHGVDGLPDEKMAERCFNQLVNRSL
VQPSEFDYNGTVRSCRVHDMMLDVIISISRKENFAVVLNKHSTQTNIQPR
HQRIRRLSRQGGSSGLVPNTDLSHLRSFTAFGEDVPVSDYRKQRLLRAID
LEGCRNLDDFHPKSFSKLCLLKYLSMRNTGLSELPDSIGDLQNLEFLEIR
GTYIQKLPNAIVKLQKLVYLLGGPFIGFKFPKGIRKLKRLTTFGTARAHN
VHSLQEISELINLQKLDIFLGRSDLSLRMLEEISALLSKLNGSLRSLKIL
HLGNSSLKKALDEVALPPLLLCKIEIGCRLGELPPWFASLKHVVKISLFR
TQLQLEDLQVLRNLPALVNLILDDESFVYNGENLVFDREGFAQLKLLTVA
RHNMSFEVGAVPSLEILKILGPNKSVNGIEHLHGLKEVHIYTDNENIIEM
VKNIAANHSNRPKCFAKLLKSA
>XP_042457056.1 disease resistance protein Pik-2-like [Zingiber officinale]
MEIGIATTMAMQLVEFSFQSMTGKLEKMLEEKASLLAGVEDDAQDMVDEL
RSITSYLTAMSTRRNLDVQQQNWVNEVREVAYNAEDSIDEFDYHLRSTPY
DERGVKGFFKHFLPRIKSLKARDCIASDIKKLKVKVEDIKKRHDRYSLPN
EATRSGTATGLDMAERYSDPRIIGHFVEEAHLVGINQSRDKIIGWVMDEN
CLELIVISLVGFGGLGKTTLAKTIYDDPIRGHFQSRAWIAVSQNYSIKEL
LKKIIQQISVKKKEIQDVLGCRDAKLNTEKLLSQMDESQLVQTVRGHLHG
KRYLIVFDDVWSTEAWESLSIALPQGKEGSRVIVTSRSEEVANYSCSRNR
QFIFKVSPLSPELSWELFRRKVFEAPDYSCPPELENVGREILQKCNGLPL
AIVTIGGLLASKPDKKLEEWKDLRDHLRLEIQTNDMLSKINQILGLSYND
LPYYLKPCFLFLGTFPEDYEIRRKRLMRRWIAKGIVNGVGGLPDEKMAER
CFNQLVNRSLVQPSEFDDNGTVRSCRVHDMMLDVIISISRKENFAVVLNK
HSTQTTIQPRHQRIRRLSWQGGSSGLVPNTDLSHLRSFAAFGEDVPVNDY
RKQRLSRAIDLEGCRNLDDFHPKSFSKLCLLKYLSLTNTGLSELPDSIGD
LQNLEFLDIRETYINKLPNAIVKLQKLVHLLAGGYIKWPCMEDSFFLNVY
LPKGIRKLKKLRTFGLVRAHDVHSLQEIGELVDLQKLGMSFGFRDLKRKA
LEEISALLSKLNGSLRSLTLANSNLKKALDEVVSPPLLLHKLQIHAARGG
FPAWFASLKQVVKITLSNTRLQLQDLQVLRNLNTLVKLVLGFHSFDDNYE
DFVFDQVGFANLKFLEIEMHSVSFEEGALQSLEILKMDKIFIGYSVDGIE
HLHGLKEVHIQTENDDTIEMVKNIAANHSNRPKCFAKLLKSA
>XP_042457080.1 disease resistance protein Pik-2-like [Zingiber officinale]
METAIATKLVLFSFQSIAGKLGKMLEEEAALLAGVEDDVRYIVAEHKSIT
SFLTAISSRRKLDVELNNWAQELSEVAYDAEDSIDEFDCRLRSTQGFFKY
FLRSIKLLKDRHSIASEIKKLKVQVEDIKRRHDRYFHPNEATISGTATGL
DMTDRYSDPRIISHFVEKAQLVGINHSRDKITGWVMDGNCPQLTVISLVG
FGGLGKTTLAKTAYDDLIIVEGHFQSRAWITVSQNYNIKELLKKIIRQIS
VNEKQIRDVSGCQDARLNTEQLLNMMDELQLVQTIRDHLHGKRYLLVLDD
VWSIEAWESLSIALPQGIEGSRVIVTTRIEDVAYTSCSRNRQFIFKISPL
SPEKSWELFCRKVFDAPDYNCPPELQNIGREIVQKCDGLPLAIVTIGGLL
ASKPDNKFEEWKELRDQFSLEIQTNKKLSKIDQILGLSYNDLPYDLKPCF
LFLGIFPEDYEIDRKRLMRRWIAEGIVSDVGSFPAEKVAERCFNELVSRS
LVQPSKFNYNGTVKSGRVHDMMLEVIISISRKVNFAVLLNEHPTNLPQYQ
KIRRLSSHEGSSGLVPNTDLSHLRSFTSFGEDVPPLKDYRKHRLLRAIDL
EGCTAVYHFHRKSFSKLLLLKYLSLRNTELSELPDSIGDLQNLEFLDIRG
NAIKELPNTIVKLQKLVYLLAGRFCRNPTFINLKVPKEIRKLKGLRAFGT
ASVDDDVQLLQEIGELVNLEMLSICFGDYDVSHGMLKEINPLLSKLNGSL
RSLTIIQSFVNLKKALDEVASPPLLLCKLHIQTILGGLPGWFASLKQVVK
ITLCNTQLQLQDLQVLRNLHTLVKLVLETRSFVRYEQDLVFDQRWFTNLK
FLKIRRQCVSFEEGTLQSLEILKMSFFFPGWSINGIEHLHGLKEIHVDTS
DMHIKEMVKNIAANHSNRPKCFAITNRFA
>XP_042457081.1 disease resistance protein Pik-2-like [Zingiber officinale]
MATMMAMKVVDFASQSIMEKLERMLVEEAALLAGVEDDVRDIVAELRSIT
SFLTVMSTRRSLDDQVQNWVQEVREVAYDAEDSIDEFECRLRSTPYDERG
VKGFFMRFCRCLKSLKARHDIASALKKLKVEVEEIRKRHDRYSHPNEAAS
SGTATSLDMADSYSDPRIIGHFVEEAQLVGINQSRDTLIEWVMDENCLEF
TSISLVGFGGLGKTTLAKAIYDDPIIVGGHFQSRAWIAVSQNYNIRELLK
KIIRQISVKEQQVRDVLGCQDASLNTEQLLNMMDESQLVQTVRGCLHGKR
YLAAFDDVWSTEAWESLSIALPQGKEGSRVIVTSRSEAVANACCSRNRQF
IFKISPLSPELSWELFCRKVFDAPDYGCPPELENVGREIVQKCDGLPLAI
VTVGGLLASKPDKILEEWKDLRDHLGFEIEKSKIHRILVLSYNDLPYHLK
PCFLFLGIFPEDYEIHRKRLTRRWIAEGIVSGVGGFPAEKVAERCFNQLV
SRSLMQPSKFDDNGTVKSCRVHDMMLEVIISISRKENFVVLLNERPPRHQ
KIRRLSSHGGSSGLVPDTDLSHLRSFTAFGKDVPLKDYRKQRLLRAIDLE
GISNLFDLHPRSFSKLFLLKYLSLRDSPISALPDSVGDLQNLEFLDMRGT
YIEELPHTIAKLQKLVYLLGGLNQQHPPDMFKILHFVTLFRLKFPKGIRE
LKRLRKLGMTFADDEQLLQEIGELAELEKLAICFGDDDLVSGVLEGISAL
LSKLSGSLRSLTIFHAAYGDLKRALDEVASPPLLLCKIQIDVVLGGLPAW
FASLKQVVKITLFNTRLQLQDLQVLRNLHALVKLVLGCESFDNDDEDLIF
DRGGFTQLKLLEIQSHCVSFEEGALQNLEILKLAGYFPNEYGVYGIEHLH
GLREVHVHTGNEDLGEMVKNIAVYHAARPKCFVKIEESPSDI
>XP_042457083.1 disease resistance protein PIK6-NP-like [Zingiber officinale]
METAIATKVVDFAFNSMAGKLEKMLEEEAVLLAGVEEDVRYIVDELRSIT
SFLTVMSTRQNLDAQLQNWVQEVREVAYDAEDSIDEFDCRLRSTPYNDLG
VKGIFKRFLHNIKSLKARHGIASEFKKLKVQIEEIRKRHDRYSHLYEADT
GMAECSDPRIIGQFIEEAQLVGIKQSRDKIIGWVMDQNCPELTAISLVGF
GGLGKTTLAKTVYDDLIIVGGHFQYRAWIVVSQNYSIIELLKKIIRQISV
EEKRIRDVYGCQDRTVDTEQLLNKMDKSQLVETVRGHLHEKRYLIAFDDV
WRTEAWENLSIALPPGKEGSRVIVTTRNDEVANYSCSRNRQFIFKVYPLS
SELSWELFRRKVFDAPDYSCPPELDNVGREIVQKCSGIPLAIVTVGGLLA
SKSDKKFEEWKDFGNYFRSEIQTNNRLLKINQILLLSYNDLPYHLKPCFL
FLGIFPEDYEIGRKRLMRRWIAEGIVSGLGGFPAEKVAERCFNELVSRSL
VQPSEFNDNGKVKSCRVHDMMLEVIISISNKVNFAVLLNEHTTNLPQHQK
IRRLSWHGGSSGLSTNTDLSHLRSFTAFGSDGRDVPVPLKDYRKQRLLRA
IELEGSFNLSDHLHPKSFSKLFLLKYLSLRDSGISTLPDSIGDLQNLQFL
DIRGTYIEELPNSIVKLQKLVYLLGGLIVHKFTREYPNMYEEVPKYAYAG
NSNPYETYREPYLFNFINYQSMSEYDKFTIDVSTSSVKLKFPKGIRELNG
LRKLGMTYADDEQLLQEIGELVKLEKLAICFGEDDQVSGVLEGIRVLLSK
LSGSLRSLTISHAKYGDLKRALDGVDSPPLLLCKLQIHANLGGLPAWFAS
LKQVVKITLYFTRLQLQDLQVLRNLHKLVHLVLGFRSFDNAAENLVFDRG
GFTHLKFLEIQSNGVIFEEGALQSLEILKMSYFAHGYSVDGIDHLRGLKE
VHIYNSTQGIVQMVENILSCHSNHPKCYSDACSIM
>XP_042457443.1 disease resistance protein RPP8-like [Zingiber officinale]
MASTAVNLVLEKLGELVSSDVAGILNLDAEVKPLTETLALIQSFIRDADQ
KPRYEQSHSLHEWMRQIRNLAYEMEDLVDEYAMQVGRASAADGRISRLQR
IAAFPSRIRTRRLLASRLQDIRARFQDVCKQAWQLGIQGSSSLPTSSSSS
SSSSSAADATLARRFELEEDIVGFDEDMKDIKRQLFDVSLTARVVLSVVG
PGGLGKTTLANKIYRSADVKNYFQCKAWVSVSQKYVVKELLCSIVKQAFD
FKDEQVKGMEELEMKEKLSEHLSDRRYLVVMDDIWEVAAWNAIKAAFPKE
STGSRVLLTTRKMNVANVADVPPHELKFWNVEESWNLFCRKAFRTACCPP
EFERFKEDIFKKTKGLPLAIVVLGGLLRGTSQASDWRKKLEYISYEFREG
EDQILRILALSYHDLPHHLKPCFLYFAAFPEDYCVSAERIKRLWIAEGFI
QTKDKVDQTMEDVAEAYLKDLTSRSMLQIERWGQLYIREVHIHDLLLDLA
RHEARELNFFRSIDDIGDDPRALRRLSVTENVDDHISSNCLTTKLRSLVI
YPNEGFQRTLAIAIPGAKFLRVLDLQKVPIEHLPKEIGDLILLRYLSLSR
SKLKELPPSIGNLIHLQTFNIGNTKIQHLPDAFWKIRTLRHVFLNEENTS
MPKATYCSEDIQTLVNISSGPWVRDGVLEKLRNLRKLHLNNISSSDEDAL
ANAVQNLSRLDMLVLNGESLPMSFLTSSCYHHIQFLILRGPWVRPARIHM
EAENSRIFSNLIYLAIWLTRLEKDEDIAMLASLANLQCLLLCDDAFVGRV
LVFPKGGFPRLQHIELYELSALEEWEVGEGAMPVLQELILWHCRNMRMLP
EGLVRLTELKQIEIRGMEMIERRVDKDTGEDYHKIKHVPCIEIN
>XP_042457964.1 uncharacterized protein LOC122042090 [Zingiber officinale]
MDESASHSSEPCTSTLTIRIAGPSSEIGEKSVPISPSISLSPHLNSPSPP
SSAFVSALQSPYISPRALEPPNGTNSYSTTATMPSTTTSNSALHSDDIPS
TSYTPPSESSDFVADQIEQKHKFSDAMLPRISFSFPVPRTSLTRGSVSPP
SNLKLHGCDVYIGYNGNNHVLVRFCKWLKTELELQGIASFVADRAKYSDS
QSHEIADRIICSAAFGVIVVTPSSFLNRLSVEEIRFFAQKKNLISVLFDT
ELSEIVSLSNERLEGKESREALEGFTKCNEFKIETNGSNWRSCISKVVAV
LKSRLGRRSIAEVETETFEELLFPRNGHFVGREKEVAEIEAAFFGCVEAH
EMECPKPSLTRGSSSDGFADEEIDTVRTSKKYISLEMRKSKEPTLEAWIE
PVIELASKGRSLQKQRSKHKKSRCGANKGHGNASVFCVNGSSGIGKTELA
LEFAYRYAQRYRMVLWIGGETRYLRQNILNLSLKLGLDLSAEAEKERGRI
RSFDEQEFDAFLRVKRELFRDIPYLLVIDNLETEKEWWEGKDLHDLIPRN
TGATHVIITTRLSKVMSFEPMQLPLLSLADSLLLLKGRRKKDYSSEESQV
LKKFVERMERLSFGMSVVGSLLSELPISPSELLETIDRISVNDGNEDGLW
RSSIFLMKTLAFCFAVVDQAAGRSLASRMAQTGAWFASVPVSSTLLAAAS
DNLPTKGSFCQWGKDLTDVFLCGTRCCLAASQARKTEVDSAMLLVNLGLA
KRSMRQPGCWIQLHPITQVFAKRKGGLPPAKAAVHGAMRAGNAAMNLDHL
WASAFLVFGFKQEPPLVQLSALDMAFFIRKTALPLAIRSFMTFSRCNSTL
ELLKVCTNALEEAEKSFVSQIQDWHRGRLCWTKKLQFNQKVDEYVWQDVT
LLKATLLETRAKLLLRGGHFDEGEELCRTCVSIRTVMLGHNHAQTLAAQE
TLAKLVRFRRKM
>XP_042459206.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MAFIKLNFNVDVHKCLSGLKATLGLGRPKSSIDKLEREMERLRAKRDDIR
NQIVDAERDGKLPTNEVNRWLDEVEELEGKVTSINQDFRSMSCFSCNCFN
QTGGTTNQTRQVGDQVPIRESSNCYSINRRAAEKLNEANELMSRTNALDP
IAITTIPSRIGSDIQETMARLRAKRDDIKNQINQAEREGKIPTNEVGQWL
LEVEKLDGQVATINQIPIRESPWKYSIIQRVAKKHNEVNELMIRADVLDP
IVTVGPPKPIVTLPILYRSHVGIGSYVEEIVGYIDGGKDNIIGIHGMGGV
GKTTVLKSIQHHYLLKHTIFDPVIWVVASKDCQLKRLQMDIAKSLGLKTL
QESDDEQTCSDKLFSYLKNKKCLLFLDDIWEHLDLQLLGMAHSATDQGQQ
QQQRKVVVFTTRNQIVCAQMEAEKKIKIECLNPAQAWQLFVKNFKSDAPF
SDAGIHFVAQELVKECAGLPLALITVARAMLGKKSRDVWNHALHQIRNKH
QWTTIGLSEDSNVMYKAFKLSYDSLEDDSTRECLLCCALWPEDHDIHIFE
ELIPCWIGCGIIHYDNVFKRYSISDAFQEGCWHLEALINASLLEHSSRRP
DYYEAQHVKMHDVIRDMTLLTLKENKRKWIVKAGIGLRHLPRQEEWQEAE
RASFMDNEITSLQDYGASTFPKLSMLNLHSNHLSEIHPMLFTNMPLLTYL
NLSLNLGIEELPKEIGCLTELQYLNLSETSITNLPAEFGRLGKLKYLLLR
DTKLETVPNGTISNLSTLRWLDIREIYPSHEWWWDELEHFRGRSKYLSLG
ITINPDKLKRLETLPNNVSVWSLTVRGLGSSKLPEYNLGTLQWNNKVRYL
VESLEISDVPGHELTMPGDWNRILEFYCLKTLCFRTLEQLENIRFNPVEY
EFNNLRDLYICGCNKLKDVSCVLDLRYLNLLDIKNCEEIEELISNVGNSN
SISRIRMLSLNGMRNLHRFAHQPFQFPALEYIRVLYCPRLKKLPFEAKML
KKIEGEEEWWNNWNWDEESNDFSTPCFRLKEIEGEKDWWNNLDWDDESIK
DSLTPYFREVFY
>XP_042459940.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MACINININIDVNRCLSELRTSLKLLVRPKSGIQKLEKEMARLRGKRDDI
KYQIDLMEREGEIPIDEWIQWLREMEELEGQVAAIKQDFQSMSCFSCHCF
NRAGGTSSQTQQAESSNFYSIILRMAKKLIEANELMSLTGAPVPIARFRP
RRFTTRLPIPHLPPVGIDSYLNDIVGYIDGGEGNTIGIYGMGGVGKTTIL
MSIQQHYLLEDTIFDRVIWVVASQNCQLKRLQMDIAMGLGLKTLKESDDE
QTCGDKLFSYLKNKACLLLLDDIWEHLDLQLLGMTHSATEQSQQQQQQKQ
PRKVVVFTTRDKAKCEQMNAEKKIKVECLNPDQAWQLFEQNSDGDVLSSD
AGIKFLAEELAKECAGLPLALVTVARAMSGKRSWEAWKEALHQIRDKHVS
TPIGLPEESLPMYKSFKSSYDSLENDLIRECLLCCVLWPKDYDIHKFDEL
IPCWIGCGIINDFNVINEAFHKGCYYLETLIAASLLEDSRRQSYYKAEHV
KMPNSIRDMVLLMVSELKGNGRKWIVKAGIELSHLPSQEEWQEAERASFM
RNNITSLQDYEASTFSKLCILILHGNHLSEIPPTLLTNMPLLTCLNLSLN
FGIEELPKEIGSLTKLQYLNLSSTDIKSLPLEFGCLKKLEYLLLRNTRIK
TIPNEIMSNLSMLKWLDIGGYFPVCDSWLNELKCLREEHHKISLGITINP
ANFEILNMLPNVSVWNLTVSGSESSKFSVHNLGTLKWSHRISDNLECLTI
LDVPGDELAINAGVDCESSFGCLKTLYFRRLGKLKNIRWNGVGFNNLHDL
YISDCYMLKDVSWVLQLPCLDFLRISNCWEMEELISNVGNFNSSFGIKML
ILFQMNNLHRISHQPLHFPNLKNINVCHCPRLKKLPFGTGILRSGLKEII
GDQTWWDSLDWDDNSNRDSLTTLFRNQLD
>XP_042459945.1 putative disease resistance protein At3g15700 [Zingiber officinale]
MAFIKLNLNVDVNSCLSGLKATLRLGRPKSGIEKLKKEIKNLRDKRDDIK
NRIDQAELEGKIPTNQVSQWLLDVETLESQVAAIEQDFQSTSCFSCHCFN
QTQTQTGGTSQTQQAGDQVPMRESSNCCSIILRVAKKLGEVKELMDRADR
LDPVATVRPSEPTVMIPISHRSPVGIESYEEDIVGYVDGGKGDIIGIYGM
GGVGKTTMLTRIQQHYLLKHTIFDRVIWVVASKDCQLKRLQMDIAKSLGL
KTLQESDDERTCGDKLFTFLKSRNCLLLLDDIWEHLDLQLLGMAHSATTE
RGQQQQPRKTVVFTTRSEAVCVQMKAEKKIKVKCLDPVQAWRLFEENSEK
DVLNSDAGIKFVAEKLAKECAGLPLALITIARAMSGKKSWEAWDAALRQI
RDEHQWKTVCLPEDSVVMYKAFKMSYDSLENASYAALCGLKIMISINSMI
>XP_042459946.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MAFIKLNLNVDVNSCLSGLKATLRLGRPKSGIEKLKKEMNNLRDKRDDIK
NRIDLAELEGRIPTNRVSRWLRDVETLEGQVAAIEQDFQSTSCFSCCCFN
QTQTGGTSQTQQAGDQVPMREPSNCCSIILRVAKKLGEVKELMDRADKLD
PVKLDPVTTVGPSVPAVMLSISHRPPVGIESDVEGIVSYIDGGEGNIIGI
YGMGGVGKTTMLQRIQQHYHRNHAVFDRVIWVVASKDCQLKRLQMNIAKS
LGLNTLQENDDEKTCGDKLFSYLMNKNCLLLLDDIWEHLDLQLLGMAHSA
TDRGQQQQPRKTVVFTTRSEAVCVQMKAEKKIKIKCLDPVQAWQLFEENS
EGDVLNSDAGIKFVAEKLVEECAGLPLALITIARAMSGKKTWGDWDAALR
QIRDEHQWKTVCLPEDSVVMYKAFKMSYDSLENDSIRECLLCCALWPEDY
DIYKFYDLIPCWIGCGIIREFNVINEAFTKGCSHLEALMAASLLEQSSVI
EFPYRDTGVKMHDVIRDMALLMVSGLDLEGNKRKWIVKAGIGLSHLPRQE
EWPEAERASFMRNNITSLQEYGAFTFPKLYMLILRENRNLKTIPSSLFAS
MPRLTYLDLNGCGIRELPREICSLTELQYLDLSYNLITSLPAEFGCLSKL
EYLLLSDTDLKIVPKGTISNLLMLKWLDISKVPLVPEWWWDELKCFKGRY
QLSVGISINATTDNIERLNMLPNVSIWKLTLDGDNISKHQQVMDLGTKQW
GCRVSDHLEFLRINYLRIDKLMLAAGVGHESSFGYLKSLYFEDLELLKEI
SLNRVRLFNLRKIHIFGCHMLKDASWVLQLPCLNFLEIISCEGMKELISE
VGNSNSISNPSIQRLFLIDMPNLNRIANQPLHFPNLEYIRVHSCPELKKL
PFGAEILNRLKWIDGEEYWWNNLNWDDKSIKDSLTPYVWFN
>XP_042459947.1 disease resistance protein RPS2-like isoform X1 [Zingiber officinale]
MKAEKKIKVKCLDPVQAWQLFEQNSERDVLNSDAGIKFVAEQLAKECAGL
PLALITIARAMSGKKTWEAWVATLRQIRDEHQWKTVCLPEDSLVMYKAFK
LSYDSLENDSIRECLLCCALWPEDYEINTFDQLIPCWIGCGIIHEFNVIN
EAFAKGCSHLEALMAASLLEECIPKGRPLHWYGPCVKMHDVIRDMALLMV
SGLEGNKRKWIVKAGIGLSDLHRQEEWQEAERASFMMNKITSLPEYEANF
TFPKLSMLILCQNKGLKTIPSSLFASIPRLTYLDLNGCSIRELPMEICSL
NELQYLDLSSNLITSLPAEFGCSVN
>XP_042459948.1 probable disease resistance protein At5g43740 isoform X2 [Zingiber officinale]
MAFIKLNLNVDVNSCLSGLKTTLRLGGPKSGIEKLKKEMKKLRGKRDDIK
NRIDQAELEGRIPTNQVSQWLLDVETLEGQVAAIEQDFQSTSCFSCHCFN
QTQTQTGGTSQTQQAGDQAPMRESSNCCSIILRVSKKLGEVKELMDRADR
LDPVATVGPSEPAVMLPISHRSPVGIESYEEDIVGYVDGGKADIIGIYGM
GGVGKTTMLKRILQHYHLNHAIFDRVIWVVASKDCQFKKAPD
>XP_042459949.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MACINLNLDVDVNSCLSGLWASLPVLGRPKSGIQKLEKEMARLRGKRDDI
KNQIDQADRQGKIPTNEVSQWLREVEILEGKVGVIEQDFQSVSCFSCNCF
NQTDGTSSQTQRAGDQVLIRQSSNYCSIIRRVAKELGEANELMSRAGALD
PVATVGPLKPTVMLPISHRPPVGIESYVEDIVSYIDGGEDNIIGIYGMGG
VGKTTTLNRIQQHYLLKHTIFDRVIWVVASKDCQLKRLQMDIAKSLGLNT
LQENDDEKTCGDKLCSYLMNKNCLMFLDDIWEHLNLQLLGMAHSTTEQSQ
QQHQQPRKVTVFTTRSETVCAQMKAEKKIIVRCLDSEQAWQLFEQNSDGD
VLSSDAGIKFLAEELAKECAGLPLALVTVARAMLGKRSWEAWKEALHQIR
DKHEWTTIGLSEDSLVMYKAFKLSYDSLENDSIRECLLCCALWPEDYEIN
QFSELIPCWIGCGIIREFNVINEAFAQGYSHLEALVAASLLEQCGDFNFR
YSKKRVKMHDVIRDMALLMASRLEGNKRQWIVKARIGMSELPRQEEWQEA
ERASFMFNNITSLQDYEASTFPKLSMLILNYNHLKQIPPSLFASMPHLKY
LDLSGCDITELPKEICSLAELQYLNLSDSSIIRLPFEFGCLGKLEYLLLR
ATCLEIVPNGTISNLSMLKWLDIREICLVSEWWWDELKCFKGRHQLSVGI
TINVTTDNIQRLNMLPLNVSIWELTLDGENISKHEQVMDLGTLQWGCRVS
DHLEILCIQNLRLDRFELAVGVGRESSFGWLNSLHFTGLKLLEEISLNRV
RLYNLRQLYIFGCPMLKDVSWILQLPCLNFLDITMCGKMKQVISEVGNSN
SISSSSIRCLILWHMSNLNLIANRSLHFPYLEYVQVYNCPKLKKLPFGVE
ILKNRLKVIKGEDNWWNNMDWNDESIKDSLTPYFRSWHR
>XP_042459950.1 probable disease resistance protein At1g61300 isoform X1 [Zingiber officinale]
MACINLNLDVDVNSCVSGLWASLPVLGRPKSGIQKLEKEMARLRGKRDDI
KKQIDQADRQGKIPTNEVSQWLREVEELEGQVAAIIQDFQSMSFFSCNCF
NQTGSTSSQTQQAGDQVSIGESSNFCSIIRRVAKKLGEATELTNRAGALD
PIATVGPPEPTVMLPIAHQPPVGIESYVEDIVGYINGGEGNIIGIFGMGG
VGKTTILESIQQYYLHDHTIFDHVIWVVASKGCQLKKLQIDIAKSLKLDT
LEKNDDERTCGDKLFSYLKDKNCLLLLDDIWERLDLQLLGMAHSATERGQ
QQQKHPRKVVVLTTRSETVCAQMKAEKKIKVRCLDSEQAWQLFEQNSDGD
VLSSDAGIKFIAEELAKECAGLPLALVTVARAMSGKRSWEVWNDAFNQIR
DKHEWTTVCLPEDSLVMYKAFKLSYDSLENDSIRECLLCCALWPEDYEIN
QFSELIPCLIGCGIIREFNVINEAFAQGCSHLEALMATSLLEKCNNINTP
YEDTLVKMHDVIRDMALLMVSSLERNKRKWIVKAGIGLLNLPRQEEWQQA
ERVSFMNNRITSLQEYGASTFPKLSMLILRENMDLEAIPSSLLKSMPHLT
YLDLSFCSIIELPMEIGSLTELQYLDLSYNSIAKLPAELGCLCKLEYLLL
SYMPLEIVPNGTISNLLMLKWLDISDNYIVPEWWWDELECFKGHHQLSVA
ININATTDSIQRLNMLPNVSIWRLTLDGENVSKLPNYDLGTPQWGCRVSD
KLDILNIIDLRVSRLVLAAGMGRESSFGCLKRLHFECLELLVEISLNRVR
LYNLRQIYIYSCDMLKDVSWVLQLPCLNFLRIECCRKMKELISEVGNSNS
ISSSSSIQSLILGYLPNLNCIANRPLHFPYLEYIDVKGCPELKRLPFGIE
MLKNRLKWIRGEEYWWNNLDWDDESIKDSLTPYFRPQISK
>XP_042459951.1 disease resistance protein RFL1-like isoform X2 [Zingiber officinale]
MACINLNLDVDVNSCVSGLWASLPVLGRPKSGIQKLEKEMARLRGKRDDI
KKQIDQADRQGKIPTNEVSQWLREVEELEGQVAAIIQDFQSMSFFSCNCF
NQTGSTSSQTQQAGDQVSIGESSNFCSIIRRVAKKLGEATELTNRAGALD
PIATVGPPEPTVMLPIAHQPPVGIESYVEDIVGYINGGEGNIIGIFGMGG
VGKTTILESIQQYYLHDHTIFDHVIWVVASKGCQLKKLQIDIAKSLKLDT
LEKNDDERTCGDKLFSYLKDKNCLLLLDDIWERLDLQLLGMAHSATERGQ
QQQKHPRKVVVLTTRSETVCAQMKAEKKIKVRCLDSEQAWQLFEQNSDGD
VLSSDAGIKFIAEELAKECAGLPLALVTVARAMSGKRSWEVWNDAFNQIR
DKHEWTTVCLPEDSLVMYKAFKLSYDSLENDSIRECLLCCALWPEDYEIN
QFSELIPCLIGCGIIREFNVINEAFAQGCSHLEALMATSLLEKCNNINTP
YEDTLVKMHDVIRDMALLMVSSLERNKRKWIVKAGIGLLNLPRQEEWQQA
ERVSFMNNRITSLQEYGASTFPKLSMLILRENMDLEAIPSSLLKSMPHLT
YLDLSFCSIIELPMEIGSLTELQYLDLSYNSIAKLPAELGCLCKLEYLLL
SYMPLEIVPNGTISNLLMLKWLDISDNYIVPEWWWDELECFKGHHQLSVA
ININATTDSIQRLNMLPNVSIWRLTLDGENVSKLPNYDLGTPQWGCRAWV
GNQVLDV
>XP_042459952.1 probable disease resistance protein At1g61300 isoform X1 [Zingiber officinale]
MACIKLNLNVDVNKGLSGLKATLRLGRPKSGTEKLEKEMTRLRCKRDDIK
NQINEAEREGKIPTNEVSQWLREVEILEGKVADIDQDFQSMIHCCVSLGC
FSCNCFNRTGGSSSNPTEAFAANIQEVEENAATDQTQQAGDDVPIRESSN
CCSIIRRAAKKLDEANELMSRAGALDPIATVGPPEPTLMLPISHRSPVGI
ESYVEDIVGYVDGGEGNIIGIYGMGGIGKTTMLKRIQQHYLLKHTIFDRV
IWVVASKDCQLKRLQMNIAKSLGLQTLQENDDEQTCGDKLFSFLKNRNCL
LLLDDIWEHVDLQLLGMAHSAIEQGQQQQPRKVVVFTTRSEIVCAQMKAE
KKTKVKCLDSDQAWKLFEQNSDGDVLSSDAGIKFVAEELTKECAGLPLAL
VTVARAMSGKRSWEAWNDALHQIRDKHEWTTIALPEDSLVMYKAFKLSYD
SLENDSVRECLLCCALWPEDYEIFKFSKLIPCWIGCGIIHEFNVINEAFA
KGYSHLEALGAASLLEKCDSDYVVKMHDVIRDMALLMVSGLKGNKRKWIV
KAGIGLSDLPRQEEWQEAERASFMINEITCLQEYGASTFPKLSMLILHGN
QNLKTIPPSLFASLPRLTYLDLSDCCITELPKEICSLTELQYLNLSDNHI
IRLPIEFGCLSKLEYLFLRYTGLETVPNGTIANLLMLQWLDIRGIPLASD
WWWDELKCYKGRHQLSVGIHINATTDNIERLNMLPLNVSIWELILDGEHI
SKLPSYDLGTPQWGCRVSDKLEFLYVTRVRLDRLVLAAGVGRESSLGCLK
RLDFHFLTLLEVISLNRVRLNNLRELIIFGCLMLKDVSWVLQLPCLNFLQ
IRYCREMKELISESGNSNSITISSIQTLVLDNMSNLNRIANRPLHFPYLE
YIDVKDCPELKKLSFGVEMLKNRIKRIRGEDDWWNNLDWDDATNFGMKHG
PFGQGGYKAFTI
>XP_042459953.1 probable disease resistance protein At1g61300 isoform X2 [Zingiber officinale]
MACIKLNLNVDVNKGLSGLKATLRLGRPKSGTEKLEKEMTRLRCKRDDIK
NQINEAEREGKIPTNEVSQWLREVEILEGKVADIDQDFQSMIHCCVSLGC
FSCNCFNRTGGSSSNPTEAFAANIQEVEENAATDQTQQAGDDVPIRESSN
CCSIIRRAAKKLDEANELMSRAGALDPIATVGPPEPTLMLPISHRSPVGI
ESYVEDIVGYVDGGEGNIIGIYGMGGIGKTTMLKRIQQHYLLKHTIFDRV
IWVVASKDCQLKRLQMNIAKSLGLQTLQENDDEQTCGDKLFSFLKNRNCL
LLLDDIWEHVDLQLLGMAHSAIEQGQQQQPRKVVVFTTRSEIVCAQMKAE
KKTKVKCLDSDQAWKLFEQNSDGDVLSSDAGIKFVAEELTKECAGLPLAL
VTVARAMSGKRSWEAWNDALHQIRDKHEWTTIALPEDSLVMYKAFKLSYD
SLENDSVRECLLCCALWPEDYEIFKFSKLIPCWIGCGIIHEFNVINEAFA
KGYSHLEALGAASLLEKCDSDYVVKMHDVIRDMALLMVSGLKGNKRKWIV
KAGIGLSDLPRQEEWQEAERASFMINEITCLQEYGASTFPKLSMLILHGN
QNLKTIPPSLFASLPRLTYLDLSDCCITELPKEICSLTELQYLNLSDNHI
IRLPIEFGCLSKLEYLFLRYTGLETVPNGTIANLLMLQWLDIRGIPLASD
WWWDELKCYKGRHQLSVGIHINATTDNIERLNMLPLNVSIWELILDGEHI
SKLPSYDLGTPQWGCRVSDKLEFLYVTRVRLDRLVLAAGVGRESSLGCLK
RLDFHFLTLLEVISLNRVRLNNLRELIIFGCLMLKDVSWVLQLPCLNFLQ
IRYCREMKELISESGNSNSITISSIQTLVLDNMSNLNRIANRPLHFPYLE
YIDVKDCPELKKLSFGVEMLKNRIKRIRGEDDWWNNLDWDDVSIKDSLTP
CFRPPISE
>XP_042459954.1 probable disease resistance protein At1g61300 isoform X3 [Zingiber officinale]
MACIKLNLNVDVNKGLSGLKATLRLGRPKSGTEKLEKEMTRLRCKRDDIK
NQINEAEREGKIPTNEVSQWLREVEILEGKVADIDQDFQSMSCFSCNCFN
RTGGSSSNPTEAFAANIQEVEENAATDQTQQAGDDVPIRESSNCCSIIRR
AAKKLDEANELMSRAGALDPIATVGPPEPTLMLPISHRSPVGIESYVEDI
VGYVDGGEGNIIGIYGMGGIGKTTMLKRIQQHYLLKHTIFDRVIWVVASK
DCQLKRLQMNIAKSLGLQTLQENDDEQTCGDKLFSFLKNRNCLLLLDDIW
EHVDLQLLGMAHSAIEQGQQQQPRKVVVFTTRSEIVCAQMKAEKKTKVKC
LDSDQAWKLFEQNSDGDVLSSDAGIKFVAEELTKECAGLPLALVTVARAM
SGKRSWEAWNDALHQIRDKHEWTTIALPEDSLVMYKAFKLSYDSLENDSV
RECLLCCALWPEDYEIFKFSKLIPCWIGCGIIHEFNVINEAFAKGYSHLE
ALGAASLLEKCDSDYVVKMHDVIRDMALLMVSGLKGNKRKWIVKAGIGLS
DLPRQEEWQEAERASFMINEITCLQEYGASTFPKLSMLILHGNQNLKTIP
PSLFASLPRLTYLDLSDCCITELPKEICSLTELQYLNLSDNHIIRLPIEF
GCLSKLEYLFLRYTGLETVPNGTIANLLMLQWLDIRGIPLASDWWWDELK
CYKGRHQLSVGIHINATTDNIERLNMLPLNVSIWELILDGEHISKLPSYD
LGTPQWGCRVSDKLEFLYVTRVRLDRLVLAAGVGRESSLGCLKRLDFHFL
TLLEVISLNRVRLNNLRELIIFGCLMLKDVSWVLQLPCLNFLQIRYCREM
KELISESGNSNSITISSIQTLVLDNMSNLNRIANRPLHFPYLEYIDVKDC
PELKKLSFGVEMLKNRIKRIRGEDDWWNNLDWDDATNFGMKHGPFGQGGY
KAFTI
>XP_042459956.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MACINLNLDVDVNSCLSGLWASLPVLGRPKSGIQKLDKEMARLRVKRDDI
KNQIDQADRQGKIPTNEVSQWLREVEELERQLAAIKQDFQSMSCFSCNCF
NQTSGTSSQTQEVGDQVLIRESSNYCSIIRRVAKKLGEATELTSRAGALD
PIATVGPPEPTMMLPISHRPPVGIESYVEDIVSYIDGGEGNIIGIYGMGG
VGKTTMLKRIQQHYHLNHAIFDRVIWVVASKDCQLKRLQMDIAKSLGLET
LQESESEQTCGDKLFSYLKNKNCLMFLDDIWEHLNLQLLGMAHSATEQSQ
QQHQQQHQQPRKVMVFTTRSETVCAQMKAEKKIKVRCLDSEQAWQLFEQN
SDGDVLSSDAGIKFLAEELAKECAGLPLALVTVARAMSGKRSWEAWKEAL
HQIRDKHEWTTIGLSEDSLVMYKAFKLSYDSLENDSIRECLLYCALWPED
YEIDKFYELIPCWIGCGIIHEFNVINEAFAKGYSHLEALGAASLLEKCDS
DKVVKMHDVIRDMALLMVSGLKGNKRKWMVKAGIALSDLPRQEEWQEAER
ASFMCNKITSLREYRASTFSKLSMLILLGNRDLETIPPSLFASMPNLTYL
DLSYCHITELPREMCSLTELRYLNLSNCHITRLPIEFGCLVKLEYLLLVN
TGLEIVPNGTISNLSMLKWLDISHIYPATEWWWDELKCFKGRHQLSVEID
INATTDDIERLNMLSPNVSIWKLTLDGENISKLPNYDLGTPQWGCRVSDN
LEFLCIHNLRLDRLELAVGVDRESSLGCLKSLRFIGLKLLEEILLNRVRL
YNLREIFIFDCPMLKDVSWVLQLPCLKSLEINMCRTMKEVISEVGNSNSI
SSSSIQRLILWYMSDLNLIANRSLYFPYLEYVQVYDCPKLKKLPFGSEIL
KNRLKVIKGEEDDESIKDSLTPYFRPRPY
>XP_042459957.1 disease resistance protein RFL1-like [Zingiber officinale]
MACIKLNLNVDVNDCLRGLKATLRLGRPKSGIEKLEKEMTRLRSKRDDIK
NQINEAERQGKIPTNEVSQWLREVEILEGEVADIEQDFQSMSCFSCNCFN
RTGGTSSNPTEAFAANQEDEENAATQTQQAGDGVPIRESSNCCSIIQRAA
KKLDEANELMSRAGALDPIATVGPPEPTVMLPISHRSPVGIESDVEDIVG
YVDGGKVDIIGIYGMGGVGKTTTLKSIQQHYSLLKHSTFDCVIWVVASKD
CQLKRLQMDIAKSLGLKTLQESDDERTCGDKLFSFLKKRNCLLLLDDIWE
HVDLQLLGMAHSVIEQGQQQQPRKVVVFTTRNETVCAEMKAEKKIKVRCL
DSEQAWQLFEQNSDGDVLSSDAGIKFVAEELAKECAGLPLALVTVARAMS
GKRSWEAWKEALSQIRDKHEWTTVCLPEDSVMYKTFKLSYDSLENDFIRK
CLLCCALWLEDHMIRKLELIPCWIGCGIISEFNVINEALVKGCSYLEALI
ATSLLEKCTDIDSSYGDTLVKMHDVIRDMALLMVSDLESNKRKWIVKAGI
GLSDLPRQEEWQEAERASFMRNRITSLQGYGAFAFPKLSMLILLGNLDLE
AIPSSLFASMPHLTYLDLGCCGITELPMEIGSLTELQYLDFSFNPIAKLP
AELGCLCKLEYLFLNSTCLKIVPNGTISNLLMLKWLDISNNPLVPEWWWD
ELKSFKGRHQLSVGININATTDNIQRLNM
>XP_042459958.1 probable disease resistance protein At1g61300 isoform X1 [Zingiber officinale]
MACINLNLDVDVNSCLSGLWASLPVLGRPKSGIQKLEKEMARLRGKRDDI
KNQIDQADRQGKIPTNEVSQWLREVEILEGKVGVIEQDFQSVSCFSCNCF
NQTDGTSSQTQRAGDQVLVRQSSNYCSIIRRVAKELGEANELMSRAGALD
PVATVGPLKSTVMLPISHRPPVGIESYVEDIVGYIDGGEDNIIGIYGMGG
FGKTTTLNRIQQHYLLKHTIFDRVIWVVASKGCQLKRLQMDIAKSLGLNT
LQENDGENTCGDKLCSYLMNKNCLMFLDDIWEHLNLQLLGMAHSATEQGQ
QQHQQPRKVVVFTTRSETVCAQMKAEKKIKVRCLDSEQAWQLFEQNIDGD
VLSSDAGIKFLAEELAKECAGLPLALVTVARAMSGKRSWEAWKEALHQTR
DKHEWTTIGLSEDSLVMYKAFKLSYDSLENDSIRECLLYCALWPEDYEIN
KFEELIPCWIGCGIFDEFNMINEAFAKGYSHLEALGAASLLEKCDSDKVV
KMHDVIRDMALLMVSGLQGNKRKWIVKAEIGLSDLPRQEEWQEAERASFM
RNEITSLQEYEASTFPKLSMLILHGNINLKTIPPSLFTSMPRLTYLDLSD
CCITELPKEICSLAELQYLNLSDNHIIRLQFEFGCLSKLENLFLRGTGLE
IVPNGTISNLSMLQWLDIRNIPLVTDWWWDELKCFKGRHQLSVGITINAT
TDNIQRLNMLPPTVSIWHLTLDGENISKLPNYDLGTLQWGCRVSDNLEFL
CIQNLRLDRLELAVGVGRESSLGCLKRLDFRFLNLLEEISLNRVRLNNLR
ELSICGCPMLNDVSWILQLPCLNFLEIIYCEGMKEVISEVGNSNPISSSS
IQCLILWHMSDLNLIANRPFHFPYLEYVQVYDCPKLKKLPFGAEILKNRL
KVIKGEDNWWNNLDWDDESIKDSLTPYFRSWPR
>XP_042459959.1 probable disease resistance protein At1g61300 isoform X2 [Zingiber officinale]
MSRAGALDPVATVGPLKSTVMLPISHRPPVGIESYVEDIVGYIDGGEDNI
IGIYGMGGFGKTTTLNRIQQHYLLKHTIFDRVIWVVASKGCQLKRLQMDI
AKSLGLNTLQENDGENTCGDKLCSYLMNKNCLMFLDDIWEHLNLQLLGMA
HSATEQGQQQHQQPRKVVVFTTRSETVCAQMKAEKKIKVRCLDSEQAWQL
FEQNIDGDVLSSDAGIKFLAEELAKECAGLPLALVTVARAMSGKRSWEAW
KEALHQTRDKHEWTTIGLSEDSLVMYKAFKLSYDSLENDSIRECLLYCAL
WPEDYEINKFEELIPCWIGCGIFDEFNMINEAFAKGYSHLEALGAASLLE
KCDSDKVVKMHDVIRDMALLMVSGLQGNKRKWIVKAEIGLSDLPRQEEWQ
EAERASFMRNEITSLQEYEASTFPKLSMLILHGNINLKTIPPSLFTSMPR
LTYLDLSDCCITELPKEICSLAELQYLNLSDNHIIRLQFEFGCLSKLENL
FLRGTGLEIVPNGTISNLSMLQWLDIRNIPLVTDWWWDELKCFKGRHQLS
VGITINATTDNIQRLNMLPPTVSIWHLTLDGENISKLPNYDLGTLQWGCR
VSDNLEFLCIQNLRLDRLELAVGVGRESSLGCLKRLDFRFLNLLEEISLN
RVRLNNLRELSICGCPMLNDVSWILQLPCLNFLEIIYCEGMKEVISEVGN
SNPISSSSIQCLILWHMSDLNLIANRPFHFPYLEYVQVYDCPKLKKLPFG
AEILKNRLKVIKGEDNWWNNLDWDDESIKDSLTPYFRSWPR
>XP_042459960.1 disease resistance protein SUMM2-like isoform X1 [Zingiber officinale]
MDIAKSLGLKTLQESDDERTCGDKLFSFLKKRNCLLLLDDIWEHVDLQLL
GMAHSVIEQGQQQQPRKVVVFTTRSETVCAQMKAEKKIKVRCLDSEQAWQ
LFEQNSDGDVLSSDAGIKFIAEELAKECAGLPLALLTVARAMSGKRSWEA
WNDALNQIRDRHEWTTVCLPEDSVMYKAFKLSYDSLENDFIRKCLLCCAL
WPEDHMISKLELIPCWIGCGIISEFNVINEALAKGCSYLEALIATSLLEK
CTDIDSSYGDTLVKMHDVIRDMALLMVSGLESNKRKWIVKAGIGLSDLPR
QEEWQEAERASFMRNKITSLQGYEASAFPKLSMLILLGNLDLEAIPSSLF
ASMPHLTYLDLGCCGITELPMEIGSLTELQYLDFSFNPIAKLPAELGCLC
KLEYLFLNSTRLKIVPNGTISNLLMLKWLDISNNPLVPEWWWDELKSFKG
RHQLSVGININATTDNIQRLNMLPNVSIWGLTLDGENISKHEQVMDLGTP
QWGCRVSDKLDILNIVCLGLRRFVLAAGISRESSFGCLKRLHFQFLKLLV
EISLKRVRFYNLREIYISNCPMLKDVSWVLQLPCLKFLEIHSCGKMKELI
SEVGNSNSITISSIQTLTLDKMSNLNRIANRPLHFPYLEFIDVQDCPELK
KLSFRAEMLKNKLKEICGEYYWWNNLDWDDESIKDSLTPYFRPPIWT
>XP_042459961.1 probable disease resistance protein At1g12290 isoform X2 [Zingiber officinale]
MDIAKSLGLKTLQESDDERTCGDKLFSFLKKRNCLLLLDDIWEHVDLQLL
GMAHSVIEQGQQQQPRKVVVFTTRSETVCAQMKAEKKIKVRCLDSEQAWQ
LFEQNSDGDVLSSDAGIKFIAEELAKECAGLPLALLTVARAMSGKRSWEA
WNDALNQIRDRHEWTTVCLPEDSVMYKAFKLSYDSLENDFIRKCLLCCAL
WPEDHMISKLELIPCWIGCGIISEFNVINEALAKGCSYLEALIATSLLEK
CTDIDSSYGDTLVKMHDVIRDMALLMVSGLESNKRKWIVKAGIGLSDLPR
QEEWQEAERASFMRNKITSLQGYEASAFPKLSMLILLGNLDLEAIPSSLF
ASMPHLTYLDLGCCGITELPMEIGSLTELQYLDFSFNPIAKLPAELGCLC
KLEYLFLNSTRLKIVPNGTISNLLMLKWLDISNNPLVPEWWWDELKSFKG
RHQLSVGININATTDNIQRLNMLPNVSIWGLTLDGENISKHEQVMDLGTP
QWGCRA
>XP_042459962.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MACINLNLDVDVNSCLSGLWASLPLLGRPKSGIQKLEKEMARLRGKRDDI
KNQIDQADRQGKIPTNEVSQWLREVEILEGKVGVIEQDFQSVSCFSCNCF
NQTDGTSSQTQRAGDQVLIRQSSNYCSIIRRVAKELGEANELMSRAGALD
PVATVGPLKSTVMLPISHRPPVGIESYVEDIVGYIDGGEDNIIGIYGMGG
VGKTTTLNRIQQHYLLKHTIFDRVIWVVASKGCQLKRLQMDIAKSLGLNT
LQENDGENTCGDKLCSYLMNKNCLMFLDDIWEHLNLQLLGMAHSATEQGQ
QQHQQPRKVVVFTTRSETVCAQMKAEKKIKVRCLDSEQAWQLFEQNIDGD
VLSSDAGIKFLAEELAKECAGLPLVLVTIARAMSGKRSWEAWKEALHQTR
DKHEWTTIGLSEDSLVMYKAFKLSYDSLENDSIRECLLYCALWPEDYEIN
KFEELIPCWIGCGIFDEFNMINEAFAKGYSHLEALGAASLLEKCDSDKVV
KMHDVIRDMALLMVSGLQGNKRKWIVKAEIGLSDLPRQEEWQEAERASSM
RNEITSLQEYEASTFPKLSMLILHGNINLKTIPPSLFTSMPRLTYLDLSD
CCITELPKEICSLAELQYLNLSDNHIIRLQFEFGCLSKLENLFLRGTGLE
IVPNGTISNLSMLQWLDIRNIPLVTDWWWDELKCFKGRHQLSVGITINAT
TDNIQRLNMLPPTVSIWHLTLDGENISKLPNYDLGTLQWGCRVSDNLEFL
CIQNLRLDRLELAVGVGRESSLGCLKRLDFRFLNLLEEISLNRVRLNNLR
ELSICGCPMLNDVSWILQLPCLNFLEIIYCEGMKEVISEVGNSNPISSSS
IQCLILWHMSDLNLIANRPFHFPYLEYVQVYDCPKLKKLPFGAEILKNRL
KVIKGEDNWWNNLDWDDESIKDSLTPYFRSWPR
>XP_042459963.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MACTCINLNLNLDCNSCLSVLWASLRLCRPKSGIQKLEKEITILRAKRDD
IKNQIDQAEREGRIPTNQVSQWLLEVEMLEGQVADIEQDFQSISYFSCNC
FNPTRGASTTSQTQQAGDQVPIRESSNCCSIIRRVAKKLGEANELMSRAG
ALDPIATVGPPEPTVMLPISHQPPVGIESYVEDIVGYINGGEGNIIGIYG
MGGVGKTTMLKSIQQHYLPKHTIFDRVIWVVASKDWQLKRLQIDIAKSLE
LMTLKESDNERTCGDKLFSYLKNKNCLLLLDDIWELVDLQLLGMAHSATE
QGQHQQQPRKVVVFTTRSETVCTQMKAEKKIKAKCLDPDQAWQLFEQNSD
KKFLSSDGGINFVAQELAKECAGLPLALVTVTRAMSGKKSWEAWKDALHQ
IRDKHEWTTIDLSEDSVVMYKAFQLSYDSLENDSIRECLLCCALWPEDYK
IHKFKELIPCWIGCGIIHEFNVINEAFTNGCPHLEALMAASLLEQCNDQK
DIRYLDTFVKMHDVIRDMALLMVSGLKGNGRKWIVKAGIGLSHLPIQEAW
QEEWQEAERASFMDNEIASLPDYGASTFSKLSMLFLHGNDSLTTIPPSLF
PSMPLLTYLDLSKCHITELPMEICRLTELQYLNLSKNPITRLPTEFGCLC
KLEYLLLRKTEIKSVTRGTISKLSMLRWLDIRRAFPIRGCLKNGRKIIGM
RPISEWWWDELKCFRGRHKLSVAIDINVTTANIKRVNMLPNVSIWNLTME
GGNFLQLQTLHLGTLQWSCSVSDNLESLSFKNVAVDKLMLTAGVGRESSF
GCLKTLHFYNLRKLEKISLNGVGLYNLRELCIHSCSMLKDVSWVLQLPCL
NLLLISRCFEMKEVISNVGNTNSSSSIQRLSLSLLPNLNCIAHQPLYFPY
LEYVHVYKCPIFKKLSFGAEILKSRLKEIRGIQTWWDNMEWDDESNKNLL
TPLFIPFTESFD
>XP_042459967.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MAFATINLNVDVNSCLGGLWASLRLGRPKSGIQKLEKEMTRLRGKRDDIK
NQIEEAEREGKIPTNEASQWLLDVEELEGQLAVIKQDFQSMSCFSCNCFN
QTGGTSSQTQEAGDQLSIRESSNCCSIIRRVAKMLSEANELMSRAGALDP
IVTVRPPRPTVMLSISHRPPVGIESDVEGIVSYIDGGEGNIIGIYGMGGV
GKTTMLKRIQRHYHLNHAIFDCVIWVVASKDCQLKRLQMDIAKSLGLNTL
QENDDEKTCGDKLFSYLMNKSCLMFLDDIWEHLNLQLLGMAHSATEQGQQ
QHQQPRKVMVFTTRSETVCAQMKAEKKIKVRCLDSEQAWQLFEQNSDGDV
LSSDAGIKFVAEELAKECAGLPLALVTVARAMSGKRSWEAWKEALHQIRD
KHEWTTISLSEDSLVMYKAFKLSYDSLENDSIRECLLCCALWPEDYEINK
FEELIPCWIGCGIFDEFNVINEAFAKGYSHLEALGAASLLEKCDSDYVVK
MHDVIRDMALLMVSGLKGNKRKWIVKAGIGLSDLPRQEEWQEAERASFMR
NKITSLQEYGASIFPKLYMLILHGNRGLKRIPLSLFASMPHLTYLDLSNC
GITNLPKEICSLTELQYLNLSSNPITRLSAKFGCLIKLEYLLLRYTNLEI
VPNGTISNLSMLKWLDIPHAYPANEWWWDELKYFKGRHQLSVGITINATT
NDIERLNMLPLNVSIWELTLDGENISKLPNYDLGSSQWGCRVSDKLEFLY
IQNLRLDRLELAVGVGRESSFGCLKRLWFIDLELLEEISLNRIRLYNLRE
IYISECPMLKDVSWVLQLPCLNSLCIVNCEKMEELISEVGNSNSISSSSI
QNLALDNMPNLNRIANRPLHFPYLEYIDVNDCPELKKLPFGAEILKNRLK
VIKGEEYWWNNLDWDDESLKDSLAPYFRSRHFNFWPISKWSIDLLVKEAI
EFDRRKRKGSK
>XP_042460049.1 probable disease resistance protein At5g43740 [Zingiber officinale]
MACCIKLNLNVDVNSCLSGMWATLQSGRPKSGIKKLEKGMTRLRGKRDDI
KNKITEAEREGKIPTSQVSQWLREVEILEAKVGDIDQDFQSISCFSCNCF
NRTDGTSSNPTEAFAAHLEDAENAVTQTQQAGDDVPIRESSNCCSIIPRV
AKRLDEANELMSRAGGLDPIATVGPPEPTLMLPISHRSPVGIESDVEDIV
GYVDGREGNIIGIYGMGGIGKTTMLKSIQRHYYNQRIFDCVIWVVASKDC
QLGRLQMDIAKSLGLSTLQESDDERTCGDKLFRFLEDRNCLLLLDDIWEH
VDLQLLGMAHSATERGQQQKPRKIVVFTTRSETVCAQMKAEKKIKVKCLD
SDQAWQLFEQNSDGDVLCSDAGIKFVAEKLTKECGGLPLALVTVARAMSG
KRSWEAWKEALHQIRDKHEWTTIGLSEDSLVMYKAFKLSYDSLENDSIRK
CLLCCVLWPEDYEINKLSDLIPCWIGCGIIHEFNVINESFDKGYSCLEAL
MAASLLEQCSSMDYYRDTAVKMHDVIRDMALLMVSGSEGNRRKWMVKAGI
GLRDLPRQEEWQEAERASFMRNKITSLQDYIASPFPKLSMLILNENRFLK
MIPPSLFANMPCLTYLDLSGCGITELPKEICSLTELRYLNLWANPITRLP
AEFGCLGKLEYLLLRGTHLKIVPTGTISNLSMLKWLDMANIFPTTDWWYD
ELKCFKGHHQLCVGIKINATTDNIE
>XP_042460056.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAGVGMSVVEWFATYVMDKLVDFASSRLADPHRDVFSVVDEKLKEMEGRL
PRIHAAIHAAEGRPIRDPALASWMRQLKDAAFEADDLLDELDYRQLEARV
QDRSKVSAFASSSLRFLKNLFVSDDELRRLKNILGDLDKISLEINQRKAE
LEEYNHARQQNRETSSFSTQEVVFGRDKERDLILEILLSAGDGPDYDDTK
RAGSSRHLANLDVLPILGIGGVGKTTLAQLVYSDQRVAQHFELRKWVYVS
DNFDVKRIAMELETNVTSDSHPFRDASLDAQLCKLRDATANKRFLFVLDD
VWDEIESSWTKLRSALTFGSKGSTILITTQSPLVAEIMGTVKPIKLELLE
EDDYWRLFEHCSLGDKEIDLDLRRKLELLGQQIAKKMHGLPLAAKTVGSM
LRCRLEEQYWKAIQESEWWEHDFVVDNILPSLGLSYQHLSSNYKQCFAYT
SIFPKGHMFNKERLVQMWIAQGFIQEKTLRGRMTLEDIGSQIFDELTSRY
FFMRTVNDRYVMHDLIRELAVCVSIDECLVLHDEHVKIPATVCHLTLRVV
KMNALPELRKLQKLRTLIFYPEYDSEFLLLPRDGSKEFFKFLEGLLEDMK
SLRVIDLSQDRSGINKLPDAICDLPHLRYLDVSWTKIKQLPKGFPKLYHL
QVLNLKRRGTFSILPQGMNRLIKLRHLYADANTVSLIHGIGKLTELQELE
EFHVSNKRGRQIEELKDLRYLRRRLTIQDIQNVESKEEAVGANLDDKENL
HELILNRKPDIRSQGDKEKEILDGLQPHHNLKSLEIHHYGGMKSPSWLEN
NQITNLEFVYLNKCARWDTLPPLGKLPFLKNLVFKMMPSIQRIGREFFGD
GDTVFPSLEKLIFDQLNEWEEWSGTDKKSVFPRLFEINIINCVKLRQIPL
LPLRSMSVLKIWNCGDIGTTLPQYLLHLTSLVDLSLENYPHRVSVCLSNL
TALKNLELQNCPELILLGGFQSLGNLKLLKVTKCPKLNESSQPLEEPYVE
EGLRSLSYIITDESIINHVWVIVGRAQAVKSLILANCEHLKHFKPELEEW
FQQLTSLQELQFVSCPDLQRLPANLETVFSIRRLIITHCPSIDSLPENGL
PISLKELKIYGCRKLKDRCQKDDGPDWPKIAMIPHIVIEGEVISGAEEAA
>XP_042460057.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAGVGMSVVEWFATYVMDKLVDFASSRLADPHRDVFSVVDEKLKEMEGRL
PRIHAAIHAAEGRPIRDPALASWMRQLKDAAFEADDLLDELDYRQLEARV
QDRSKVSAFASSSLRFLKNLFVSDDELRRLKNILGDLDKISLEINQRKAE
LEEYNHARQQNRETSSFSTQEVVFGRDKERDLILEILLSAGDGPDYDDTK
RAGSSRHLANLDVLPILGIGGVGKTTLAQLVYSDQRVAQHFELRKWVYVS
DNFDVKRIAMELETNVTSDSHPFRDASLDAQLCKLRDATANKRFLFVLDD
VWDEIESSWTKLRSALTFGSKGSTILITTQSPLVAEIMGTVKPIKLELLE
EDDYWRLFEHCSLGDKEIDLDLRRKLELLGQQIAKKMHGLPLAAKTVGSM
LRCRLEEQYWKAIQESEWWEHDFVVDNILPSLGLSYQHLSSNYKQCFAYT
SIFPKGHMFNKERLVQMWIAQGFIQEKTLRGRMTLEDIGSQIFDELTSRY
FFMRTVNDRYVMHDLIRELAVCVSIDECLVLHDEHVKIPATVCHLTLRVV
KMNALPELRKLQKLRTLIFYPEYDSEFLLLPRDGSKEFFKFLEGLLEDMK
SLRVIDLSQDRSGINKLPDAICDLPHLRYLDVSWTKIKQLPKGFPKLYHL
QVLNLKRRGTFSILPQGMNRLIKLRHLYADANTVSLIHGIGKLTELQELE
EFHVSNKRGRQIEELKDLRYLRRRLTIQDIQNVESKEEAVGANLDDKENL
HELILNRKPDIRSQGDKEKEILDGLQPHHNLKSLEIHHYGGMKSPSWLEN
NQITNLEFVYLNKCARWDTLPPLGKLPFLKNLVFKMMPSIQRIGREFFGD
GDTVFPSLEKLIFDQLNEWEEWSGTDKKSVFPRLFEINIINCVKLRQIPL
LPLRSMSVLKIWNCGDIGTTLPQYLLHLTSLVDLSLENYPHRVSVCLSNL
TALKNLELQNCPELILLGGFQSLGNLKLLKVTKCPKLNESSQPLEEPYVE
EGLRSLSYIITDESIINHVWVIVGRAQAVKSLILANCEHLKHFKPELEEW
FQQLTSLQELQFVSCPDLQRLPANLETVFSIRRLIITHCPSIDSLPENGL
PISLKELKIYGCRKLKDRCQKDDGPDWPKIAMIPHIVIEGEVISGAEEAA
>XP_042460059.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAGVGMSVVEWFATYVMDKLVDFASSRLADPHRDVFSVVDEKLKEMEGRL
PRIHAAIHAAEGRPIRDPALASWMRQLKDAAFEADDLLDELDYRQLEARV
QDRSKVSAFASSSLRFLKNLFVSDDELRRLKNILGDLDKISLEINQRKAE
LEEYNHARQQNRETSSFSTQEVVFGRDKERDLILEILLSAGDGPDYDDTK
RAGSSRHLANLDVLPILGIGGVGKTTLAQLVYSDQRVAQHFELRKWVYVS
DNFDVKRIAMELETNVTSDSHPFRDASLDAQLCKLRDATANKRFLFVLDD
VWDEIESSWTKLRSALTFGSKGSTILITTQSPLVAEIMGTVKPIKLELLE
EDDYWRLFEHCSLGDKEIDLDLRRKLELLGQQIAKKMHGLPLAAKTVGSM
LRCRLEEQYWKAIQESEWWEHDFVVDNILPSLGLSYQHLSSNYKQCFAYT
SIFPKGHMFNKERLVQMWIAQGFIQEKTLRGRMTLEDIGSQIFDELTSRY
FFMRTVNDRYVMHDLIRELAVCVSIDECLVLHDEHVKIPATVCHLTLRVV
KMNALPELRKLQKLRTLIFYPEYDSEFLLLPRDGSKEFFKFLEGLLEDMK
SLRVIDLSQDRSGINKLPDAICDLPHLRYLDVSWTKIKQLPKGFPKLYHL
QVLNLKRRGTFSILPQGMNRLIKLRHLYADANTVSLIHGIGKLTELQELE
EFHVSNKRGRQIEELKDLRYLRRRLTIQDIQNVESKEEAVGANLDDKENL
HELILNRKPDIRSQGDKEKEILDGLQPHHNLKSLEIHHYGGMKSPSWLEN
NQITNLEFVYLNKCARWDTLPPLGKLPFLKNLVFKMMPSIQRIGREFFGD
GDTVFPSLEKLIFDQLNEWEEWSGTDKKSVFPRLFEINIINCVKLRQIPL
LPLRSMSVLKIWNCGDIGTTLPQYLLHLTSLVDLSLENYPHRVSVCLSNL
TALKNLELQNCPELILLGGFQSLGNLKLLKVTKCPKLNESSQPLEEPYVE
EGLRSLSYIITDESIINHVWVIVGRAQAVKSLILANCEHLKHFKPELEEW
FQQLTSLQELQFVSCPDLQRLPANLETVFSIRRLIITHCPSIDSLPENGL
PISLKELKIYGCRKLKDRCQKDDGPDWPKIAMIPHIVIEGEVISGAEEAA
>XP_042460060.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAGVGMSVVEWFATYVMDKLVDFASSRLADPHRDVFSVVDEKLKEMEGRL
PRIHAAIHAAEGRPIRDPALASWMRQLKDAAFEADDLLDELDYRQLEARV
QDRSKVSAFASSSLRFLKNLFVSDDELRRLKNILGDLDKISLEINQRKAE
LEEYNHARQQNRETSSFSTQEVVFGRDKERDLILEILLSAGDGPDYDDTK
RAGSSRHLANLDVLPILGIGGVGKTTLAQLVYSDQRVAQHFELRKWVYVS
DNFDVKRIAMELETNVTSDSHPFRDASLDAQLCKLRDATANKRFLFVLDD
VWDEIESSWTKLRSALTFGSKGSTILITTQSPLVAEIMGTVKPIKLELLE
EDDYWRLFEHCSLGDKEIDLDLRRKLELLGQQIAKKMHGLPLAAKTVGSM
LRCRLEEQYWKAIQESEWWEHDFVVDNILPSLGLSYQHLSSNYKQCFAYT
SIFPKGHMFNKERLVQMWIAQGFIQEKTLRGRMTLEDIGSQIFDELTSRY
FFMRTVNDRYVMHDLIRELAVCVSIDECLVLHDEHVKIPATVCHLTLRVV
KMNALPELRKLQKLRTLIFYPEYDSEFLLLPRDGSKEFFKFLEGLLEDMK
SLRVIDLSQDRSGINKLPDAICDLPHLRYLDVSWTKIKQLPKGFPKLYHL
QVLNLKRRGTFSILPQGMNRLIKLRHLYADANTVSLIHGIGKLTELQELE
EFHVSNKRGRQIEELKDLRYLRRRLTIQDIQNVESKEEAVGANLDDKENL
HELILNRKPDIRSQGDKEKEILDGLQPHHNLKSLEIHHYGGMKSPSWLEN
NQITNLEFVYLNKCARWDTLPPLGKLPFLKNLVFKMMPSIQRIGREFFGD
GDTVFPSLEKLIFDQLNEWEEWSGTDKKSVFPRLFEINIINCVKLRQIPL
LPLRSMSVLKIWNCGDIGTTLPQYLLHLTSLVDLSLENYPHRVSVCLSNL
TALKNLELQNCPELILLGGFQSLGNLKLLKVTKCPKLNESSQPLEEPYVE
EGLRSLSYIITDESIINHVWVIVGRAQAVKSLILANCEHLKHFKPELEEW
FQQLTSLQELQFVSCPDLQRLPANLETVFSIRRLIITHCPSIDSLPENGL
PISLKELKIYGCRKLKDRCQKDDGPDWPKIAMIPHIVIEGEVISGAEEAA
>XP_042460061.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAGVGMSVVEWFATYVMDKLVDFASSRLADPHRDVFSVVDEKLKEMEGRL
PRIHAAIHAAEGRPIRDPALASWMRQLKDAAFEADDLLDELDYRQLEARV
QDRSKVSAFASSSLRFLKNLFVSDDELRRLKNILGDLDKISLEINQRKAE
LEEYNHARQQNRETSSFSTQEVVFGRDKERDLILEILLSAGDGPDYDDTK
RAGSSRHLANLDVLPILGIGGVGKTTLAQLVYSDQRVAQHFELRKWVYVS
DNFDVKRIAMELETNVTSDSHPFRDASLDAQLCKLRDATANKRFLFVLDD
VWDEIESSWTKLRSALTFGSKGSTILITTQSPLVAEIMGTVKPIKLELLE
EDDYWRLFEHCSLGDKEIDLDLRRKLELLGQQIAKKMHGLPLAAKTVGSM
LRCRLEEQYWKAIQESEWWEHDFVVDNILPSLGLSYQHLSSNYKQCFAYT
SIFPKGHMFNKERLVQMWIAQGFIQEKTLRGRMTLEDIGSQIFDELTSRY
FFMRTVNDRYVMHDLIRELAVCVSIDECLVLHDEHVKIPATVCHLTLRVV
KMNALPELRKLQKLRTLIFYPEYDSEFLLLPRDGSKEFFKFLEGLLEDMK
SLRVIDLSQDRSGINKLPDAICDLPHLRYLDVSWTKIKQLPKGFPKLYHL
QVLNLKRRGTFSILPQGMNRLIKLRHLYADANTVSLIHGIGKLTELQELE
EFHVSNKRGRQIEELKDLRYLRRRLTIQDIQNVESKEEAVGANLDDKENL
HELILNRKPDIRSQGDKEKEILDGLQPHHNLKSLEIHHYGGMKSPSWLEN
NQITNLEFVYLNKCARWDTLPPLGKLPFLKNLVFKMMPSIQRIGREFFGD
GDTVFPSLEKLIFDQLNEWEEWSGTDKKSVFPRLFEINIINCVKLRQIPL
LPLRSMSVLKIWNCGDIGTTLPQYLLHLTSLVDLSLENYPHRVSVCLSNL
TALKNLELQNCPELILLGGFQSLGNLKLLKVTKCPKLNESSQPLEEPYVE
EGLRSLSYIITDESIINHVWVIVGRAQAVKSLILANCEHLKHFKPELEEW
FQQLTSLQELQFVSCPDLQRLPANLETVFSIRRLIITHCPSIDSLPENGL
PISLKELKIYGCRKLKDRCQKDDGPDWPKIAMIPHIVIEGEVISGAEEAA
>XP_042460062.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAGVGMSVVEWFATYVMDKLVDFASSRLADPHRDVFSVVDEKLKEMEGRL
PRIHAAIHAAEGRPIRDPALASWMRQLKDAAFEADDLLDELDYRQLEARV
QDRSKVSAFASSSLRFLKNLFVSDDELRRLKNILGDLDKISLEINQRKAE
LEEYNHARQQNRETSSFSTQEVVFGRDKERDLILEILLSAGDGPDYDDTK
RAGSSRHLANLDVLPILGIGGVGKTTLAQLVYSDQRVAQHFELRKWVYVS
DNFDVKRIAMELETNVTSDSHPFRDASLDAQLCKLRDATANKRFLFVLDD
VWDEIESSWTKLRSALTFGSKGSTILITTQSPLVAEIMGTVKPIKLELLE
EDDYWRLFEHCSLGDKEIDLDLRRKLELLGQQIAKKMHGLPLAAKTVGSM
LRCRLEEQYWKAIQESEWWEHDFVVDNILPSLGLSYQHLSSNYKQCFAYT
SIFPKGHMFNKERLVQMWIAQGFIQEKTLRGRMTLEDIGSQIFDELTSRY
FFMRTVNDRYVMHDLIRELAVCVSIDECLVLHDEHVKIPATVCHLTLRVV
KMNALPELRKLQKLRTLIFYPEYDSEFLLLPRDGSKEFFKFLEGLLEDMK
SLRVIDLSQDRSGINKLPDAICDLPHLRYLDVSWTKIKQLPKGFPKLYHL
QVLNLKRRGTFSILPQGMNRLIKLRHLYADANTVSLIHGIGKLTELQELE
EFHVSNKRGRQIEELKDLRYLRRRLTIQDIQNVESKEEAVGANLDDKENL
HELILNRKPDIRSQGDKEKEILDGLQPHHNLKSLEIHHYGGMKSPSWLEN
NQITNLEFVYLNKCARWDTLPPLGKLPFLKNLVFKMMPSIQRIGREFFGD
GDTVFPSLEKLIFDQLNEWEEWSGTDKKSVFPRLFEINIINCVKLRQIPL
LPLRSMSVLKIWNCGDIGTTLPQYLLHLTSLVDLSLENYPHRVSVCLSNL
TALKNLELQNCPELILLGGFQSLGNLKLLKVTKCPKLNESSQPLEEPYVE
EGLRSLSYIITDESIINHVWVIVGRAQAVKSLILANCEHLKHFKPELEEW
FQQLTSLQELQFVSCPDLQRLPANLETVFSIRRLIITHCPSIDSLPENGL
PISLKELKIYGCRKLKDRCQKDDGPDWPKIAMIPHIVIEGEVISGAEEAA
>XP_042460288.1 disease resistance protein Pik-2-like [Zingiber officinale]
MPSFFGCQDARLNTEPLLNMMDELQPVQTIRDHLHGKMYLLVLDDVWSIE
AWESLSIALPRGKEGSRVIVTTRIERIKVFDAPDYNCPPELENIGREILQ
KCDGLPLAIVTIGGLLASKPDNNFEEWKDLRDHLRLEIQTNDMLSKINQI
LGLSYNDLPYYLKPCFLFLGTFPEDYEIRRERLMRRWIAEGIVHGVDGLP
DEKMAERCFNQLVNRSLVQPSEFDDNGTVRSCRVHDMMLDVIISISRKEN
FAVVLNKHSTQTNIQPRHQRIRRLSWQRGSSTGLVPNIADLCHLRSFTAT
A
>XP_042460292.1 disease resistance protein Pik-2-like [Zingiber officinale]
METTIAMKLVDFSFQSIVGKLGKMLEEEAALLAGVEDDVRYIVAEHKSIT
SFLMDISTRRNLDAELKNWAQELSEVAYDAEDSIDEFDCHLRSTQGFFKH
FLRSIKLLKDRRNIATEIKKLKVQVEDIKKRHDRYFHPNEATSSGTVTGL
DMTDRYSDPRIIGHFVEEAQLVGINQSRDKILGWVMDENCPELTAISLVG
FGGLGKTTLAKTVYDDPSIVGGRFQSRAWIAVSQNYDIKELLKKIIRQIS
VNEEQIRDVSGCRDARLNTEQLLNMMDEAQLVQTIRDHLHGKRYLIALDD
VWSTVAWESLSLALPQGEEGSRVIVTSRSEEVANYSCSRNRQFIFKVSPL
SPELSWELFRRKVFEAPDYTCPPELENVGREILQKCNGLPLAIVTIGGLL
ASKPDKKLEEWKDLHDHLRLEIQTNDMLSKINQILGLSYNDLPYYLKPCF
LFLGTFPEDYEIRRKRLMRRWIAEGIVHGVDGLPDEKMAERCFNQLVNRS
LVQPSEFDYNGTVRSCRVHDMMLDVIISISRKENFAVLLNRHSTLTTIQP
RHQRIRRLSWHGGSGGLVPNTDLSHLRSFASFGVDVSPPKDYRKQRLLRA
VDLEGCRAIDYFHPKSFSKLFLLKYLSLRNTWLQRLPDSIGDLQNLEFLD
IRETLITKLPNTIIKLQKLVYLLGGPSIGFKFPKGIRKLKRLTTFGTARA
HNVHSLQEIGELVHLHKLGIAFNGSDLSLRMVEEISALLSKLIGSLRSLK
ILHLVNSSLKKALDEVALPPLPLCKIEIGCRLGELPPWFASLKHVVKISL
FRTQLQLKDLQVLRNLPALVNLNLRYNSFVNSVEDMVFDRGGFAQLKFLE
IVKKNVSFEEGAVRSLEILKILRPPESVNGIEHLHGLKEVHIYTENENII
EMVKNIAANHSNRPKCFATLLQS
>XP_042460363.1 putative disease resistance protein RGA3 [Zingiber officinale]
MEAAAQLRHILMKILPAPEMVAQRKAFRISNHLEMIRDSLWVINSFVMDG
SLRALEQPDVAEWMKEVGAAVEDVHNLLERILDYWKPSNEDAAERKRKMI
NNFFQSTSSRRSILLELQEIVCTLNYLANRGATFGLWAEMMDSMDPSHDD
YAAIMSEEVMGSHEETVIKLLQEQHHWSQRDMIAIRGDEYFGKTTLARKV
YHHPWVRQHFQRRIWLDASSFNDFNSNMISKEIARLLTRRPYMDLNCWKI
VDEHLYRVRYLFIMDNLYSYGASGHKLDELVRKLFHWAAPGSKFIFTVYP
PYEYETHFFCDTYDDLSPLPDGAWVRLLLKYATFVHPIEGNNNQKVKVSP
AATNMLIQFAKKYSSQNYVQNFLIPKGMGLMFRQRDVSQWQELANELLIR
HYPSTSRHFSLMHLHYWSFGRIRRFLYELLFGGSSVPGYDEDVFHILVAE
GTLTYYWHKRNIDFTPLEYGVDLCFFRMEVSGASRIPRQCRHLYLPINSK
NISKFKKAIEVARVARKLRTLVLHREEINEHICQIETKILESMFSSLTSL
CTLDMRAIMIQGLPRAVVTLRCLRYLNLAENKIETLPESICNLYNLCVLN
LSNCEKLKELPRRIHELRKLQILKLCYCLRIQKLPESIICLVNLNELDIR
GCCRLSELPDDLSGMKNLMQLNMAGCAALTRMPSGIRRWINLQSLRGIDA
VDGHGNVTLSELHDLRNLESLHIQHLERLELDELKSATLPTYLLKDQDLY
ELVLHWERWNDMATKGTSNPMVQLLEGFLRSLRELKVLRIISYMSKRLPT
WLMLEPRLIVLKKLKRVELVNLRRCATLPPLGVLPQLEEVTISGFDSVRV
IDDEFYGEDRKPFVFPELRKLTFSEMPRLEMWLGMKSMNRLEKDLGLKSM
PRLEKWLGMKSIRRHGLFAKLEELTLIQCPKLMVFLAQFPTSSQLKLKLW
LSNEMLMPTSKFNSWSNLGGINMVQIFGCQELRSLPNDTREIHNLKTLTI
MNCNKLEALPIWLEQSCLESLCMYGCRALSFIPEELKVKGRLKNLIVEAC
PKLQSQKYLSHKWNPFS
>XP_042460563.1 disease resistance protein RPS2-like [Zingiber officinale]
MESVSTSCLMDIFNLLKACCSRPCNYIMTYEGTFSSLANEVGQLKDKSVD
VKREVEAAERDGLTPRREVLGWLNSVQNMEDEAKSIEGIYDQKIKCLCSL
PFNICSTYRLRNRAEAALETIRELKQSAEFTKLADNLNLTRSIKIPTTKT
IGMDKVFEELQRHAKDDSLSVIGIHGMGGVGKTALLRRFNNDFPSEKEAD
VVIFLELSIDYKLEEVQKSLFDRLSLTWQDEVTHRDRATKLFRVLSMLKF
ILLLDNLWEPLNYQVVGIPFPAPPSKCKIIFTTRTEDTWPHGNVVFTFNC
DHINNSVEHFLTNEMMLKFNMFCPRVEDRIRQAAWNLFRNSARMDVIDAD
KNIRIEARNLVKECGGLPAALIVLAQAMAPKKTWEEWIHALTIMKDTPHQ
LPTSLTVRVDDVYFTMHPMTRAMILWVQRECGKKENKWLVRDRERVEEAP
VAKKWRDAERIALVWNQIIDLPETPQCPDLIFLNLQVNKFLRKIPNGFFL
HMPLLKILDLQETSIEELPVSIGNLVQLHYLNLCGTRITSLPKEMTALVN
LKYLSLASMKYLRLIPDQLISSLRELQWLIMMDSYTGWKEVQSCEGGVSF
KELESSKRLKAIGITVSTLAALQNLCDSPRLTAFTHWLHIKGCPNLTSIP
SLDFHAETMPRVISIQLHAMSELEEVVIGNRQPILLPLQELRLSSLPKAK
LVWRARFPNTLLALKIEDCRAIDRLIKLEGEANGSGETNYPSLKTIEVKD
CPNLKKLTLVANGLKEIKCQKSWWEQLNWGDERTKSFEHLYNPMNID
>XP_042460580.1 disease resistance protein RPS2-like [Zingiber officinale]
MESVSTSSVMDILNLLKACCSQSCNYIMTYGGTFSSLASEVGQLKDKSSD
VKRDVEAATRDGQTPRSEVLGWLSSVQDMEGEAESIERKYNQKIKCLCSF
PLNVCSAYRLRNRAEAALATIRELKQSAEFTKLADNLNLTRSIKMPTTKT
IGMDKVFEELQRHAKDDSLSVIGIHGMGGVGKTALLRRFNNDFPSETEAD
VVIFLELSIDYKLEEVQKSLFDRLSLTWQDEVTHRDRATKLFRVLSTLKF
ILLLDNLWEPLNYQVVGIPLPAPPSKCKIIFTTRTEDTCSHMGTEKMIKM
ECLEEEAAWNLFRNSARMDVIDADKNVRIEARDLVKECGGLPAALIVLAQ
AMAPKKTWEEWMHALTIMKDTPHQLPGMTNNVFSILKLSYDRLSSDNMRV
CASYGALFIKGSWIGKFNIRNSWIGEGIIDNVQNVMDADHKTQFLLGILH
AASLTVRVHDDYFTMHPMTRAMILWVQRECGKKENKWLVRDRERVEEAPA
AEKWRDAERIALVWNQISDLPEAPQCPNLIFLNLQFNKFLRKIPNGFFLH
MPPLRILDLQQTSIEELPVSIGNLVQLHFLELSRTRITSLPKEMAALVNL
KYLSLAFMKYLRIIPDQLISSLRELQWLIMMDSYSGWKEGQSC
>XP_042460738.1 disease resistance protein RFL1-like [Zingiber officinale]
MACCIKLNLNVDVNRCLSGLWATLQLGRPKFAVKKLEKEMPRLQGKRDDI
KNQINEAELEGKIPTNEVKQWLREVEILERKAAAIEQDFQSMSCFSCNCF
NRTGGTSSKPKEAFAANIQEEETQRAGDDVPITESSNCCSISWRAVKTLD
EANELMSRAGQLDPIATVGPPEPAVMLPISHRPLVGIESYVEDIVRYVNG
GESNIIGIYGMGGVGKTTMLKRIQQHYLLKHTIFDRVIWVAASKDCQLKR
LQMDIAESLGLKTLQESDDERTRGDKLFSYLKNRNCLLLLDDIWKQVDLQ
LLGMAHSAAEPGQQKQPRKVVVFTTRSKTVCAQMKPEKTIKVKCSDTGRK
YEDLFFRRNLK
>XP_042460763.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAGVGMSVGDWFATYVMEKLVDFASSRLADAHRDVFSVVDEKLKEMEGRL
PRIHAAIHAAEGRPIRDPALASWMRQLKDAAFEADDLLDELDYRQLEARV
QDRSKVSAFASSSLRFLKNLFVSDDELRRLKNILGDLDKISLEINQRKAE
LEEYNHARHQSRETSSFSTQEHKESGSSRHLANLDVLPILGIGGVGKTTL
AQLVYSDQRVAQHFELRKWVYVSDNFDVKRIAMELETNVTSDSHPFRDAS
LDAQLSKLRDATANKRFLFVLDDVWDETESSWTKLRSALTFGSKGSTILI
TTQSPLVAEIMGTVKHIKLELLEEDDYWRLFEHCSLGDKEIDLDLRRKLE
LLGQQIAKKMHGLPLAAKTVGSMLRCRLEEQYWKAIQESEWWEHDFVVDN
ILPSLGLSYQHLSSNYKQCFAYTSIFPKGHMFNKERLVQMWIAQGFIQEK
TLRGRMTLEDIGSQIFDELTSRYFFMRTVNDRYVMHDLIRELAVCVSIDE
CLVLHDEHVKIPATVCHLTLRVVKMNALPELRKLQKMRTLIFYPEYDSEF
LLLPRDGSKEFFKFLEGLLEDMKILRVIDLSQDRSGINKLPDAICDLPHL
RYLDVSWTKIKQLPKGFPKLYHLQVLNLKRRGTFSILPQGMNRLIKLRHL
YADANTISLIHGIGKLTELQELEEFHVSNKRGRQIEELKDLRYLRRRLTI
QDIQNVESKEEAVGANLDDKENLHELMLNRKPDIRSQGDKEKEILDGLQP
HHNLKSLEIHHYGGMKSPSWLENNQITNLEFVYLNKCARWDILPPLGKLP
FLKNLVFNMMPSIRRIGSEFYGDTDTVFPSLEKLTFNQLNEWEEWSGTDK
KSVFPRLSEIKIQDCVKLRQIPLLPLGSMGNLRIQNCGDISSTLPRYLLH
LTSLVDLLLENYPHRVSVCLSNLTTLKNLELCNCLELMLLGGFQSLVNLK
YLRVSKCPKLNESSQPLEEPYVEEGLRSLSHLDTDESIINHVWVTVGRTQ
TVKSLIFTNCEHLKNFEPEQEEWFQQLTSLQELHFVSCPNLQRLPANLET
VFSIRKLTITHCPSIDSLPENGLPILLKELKIYGCRKLKDRCQKDDGPDW
PKIALIPYIVIDSEVIQML
>XP_042460876.1 putative disease resistance RPP13-like protein 3 [Zingiber officinale]
MAYTAVNLVLGKLGELAASEVSGLLNVDTEVKSLTETLALIQSFLRDADQ
KPRYEQSHSSQEWMRQIRNLAFEMEDLVDDYATRLGRASDDGGRKNRLRR
IAAFPSRIRTRHRLASHLQDIHARFQDVCKQASQLGIQGSSSLPTSSSSS
SSAANATLARRFELEEDIVGFDEDMKDIKRRLFDISLTARVVLSVVGPGG
LGKTTLANKIYKSADVKNYFHCKAWVFVSQKYEVKELLCSIVKQVFDFKD
GQEKGMEELEMKEKLSEQLRDRRYLVVMDDIWEVAAWNAIKAAFPKESAG
SRVLLTTRKMNVANVADVPPHELKFWNAEESWNLFCRKAFRTTSCPPEFE
RFKKDIFRKSKGLPLAIVVLGGLLRGTSQASDWRKKLEYISYEFREGEDQ
IQRILALSYHDLPHHLKPCFLYFAAFPEDYIISSDRITRLWIAEGFIQTK
DKVDQTMEDLAEAYLNDLTDRSMLQMERKDQNYTQDVWIHDLLLDLARHE
ARELNFFRSIDDIGDDPRALRRLSVNDHISLNCSTTKLRSLVIYPNEGFQ
RTLAVTIPGAKFLRVLDLQELPIEHFPKEIGDLILLRYLNLRKSKLKELP
SSIGNLIHLQTFDIQFTKIQHLPDAFWKIRTLRHVFLNKENTSMPKATYC
SEDIQTLANISSGPWVCDGVLEQLRNLRRLLLKNMSSSDVDALANAVRNL
S
>XP_042460878.1 disease resistance protein RGA2-like [Zingiber officinale]
MVGRQFKFVKETLGVSFVETADHGHIPKAGGRTGGLRSASHHRDNKGRAE
ERRLRGLEKKTETTVNQCKDHQKRRNQKNAEIGRGLLGAKCEGEGRVFIG
APRQADAGRMVAKEVAKNAKAKLLIGNALYRQLVVVPELEWSMKPDQVAT
TKGGARWLDVSRVSGGWVGHRLWGLTGSRCINRLLLGGDVQGGKVLTGDA
LSRQLVVVLELEWSMKPDQVATTKGGARCISKLRRSGEGYRCQTKIRGRN
IADLASHRGAGLDGFIVDFLPSWPFVVRYVLVWSIDLQRNRNGVYGGELG
AGEAWRTCFQRGRRPPQRGCRDRVADGNTGTDSIPSQSADQKPRSEQSHS
LQEWMRQIRNLAFEMEDLVDEYATRLGRASASGGRKSCLRRIAAFPSRIL
TRHRLASRLQDIHTRFQDLCKQTSQLGIQAPSSWPTSSSSSYSSSSAADA
RLARRFELEEDIVGFDEDMRDIKRQLFDSSSTDRVVLSVVGPGGLGKTTL
ANKIYKSADVKNYFQCKAWVSVSQKYGVKELLCSIVKQVFDFKDEQVKGM
EELEMKEKLSEHLRDRRYLVVMDDIWQVAAWNAIKGAFLKESAGSRVLLT
TRKMNVANIADVPPHELKFWNVEESWNLFCRKAFRTACCPPEFERFKEDI
FRKSKGLPLAIVVLGGILRGTSQASDWRKKLDYISYEFREGEDQIQSILA
LSYHDLPHHLKPCFLYFAAFPEDYSIWADRITHLWIAEGFIQTKDKVDQT
MEDLAEAYLKDLTDRSMLQMETIGFYARLVRIHDLLLDLARHEARELNFF
RSIDDIGDDPRSLRRLCVTENVNDHVSLNCSTNKLRSLVIYPNEGFQTTL
AVTVAGAKFLRVLDLIELPIEQFPKEIGDLILLRYLNLSRSKLKELPSSI
GNLIHLQTFNIQFTEIQRLPDAFWKIRTLRHVFLNEKNTSMPNSTYCSED
IQTLANISSGPWVCDGVLEKLRNLRRLFLRNMSSSDEDALANAVQNLSRL
EMLALIGESLPVSLLTSSCYHHIQIMDLAGPLVRPARIHVEAENSRIFSN
LISLAIVNTRLEKDEDIALLSSLANLENLLVCLDAFVGRVLVFPKGGFPR
LQGIVLYRVSTLEQWEVGEGAMPLLQHLRLCGCINMRMLPEGLVRLTELK
QIEIKGMKMIERRVNKDTGEDYHKIKHVPCIVIN
>XP_042460879.1 putative disease resistance RPP13-like protein 3 [Zingiber officinale]
MEACRYEWISTSSSSSSSSESVTTPTREDPKALRRLSVAENINRLIVDLF
LPSWPFVVRYVLVWSIDLQKTEMASTVVNLVLGKLGELASSEVAGLLNVG
AQIASLTETLALIQSRLRDADQKPRSEQSHSLQEWMRQIRNLAFEMEDLV
DEYATRLGRASAAGGRKSCLRRIAAFPSRILTRHRLASRLQDIHAKFQDL
CKQTSQLGIQAPSSWPTSSSSSYSSSSAADARLARRCELEEDIVGFDEDM
KDIKRQLFDISSTDRVVLSVVGPGGLGKTTLANKVYKSADVKNYFQCKAW
VSVSQNYGVKELLCSIVKQVFDFNDEQVKGMEELGMKEKLSEHLRDKRYL
VVMDDIWQVAAWNAIKAAFPKESAGSRVLLTTRKMNVANVADVPPHELKF
WNVEESWNLFCRKAFRTTSCPPEFERFKEDIFRKSKGLPLAIVVLGGLLR
GTSQASDWRKKLDYISYEFREGEDQIQSILALSYHDLPHHLKPCFLYFAA
FPEDYIIAAERIIHLWIAEGFIQTKDKVDQTMEDLAEAYLKDLTDRSMLQ
TERMNHFYVQSVRIHDLLLDLARHEARELNFYRSINDRGDDPRALRRLCV
TENVNDHVSLNCSTNKLRSLVIYPNEGFQRTLAVTVAGAKFLRVLDLVEI
PIEHLPKEIGDLILLRYLNLYQSKLKELPSSIGNLIHLQTFNIQFTEIQH
LPDAFWKIRTLRHVFLNEENTSMPNPTYCSEDIQTLSNISSGPWVCDGAL
EKLRNLRRLYLRNLSSSDEDALANAVQNLSRLEMLALIGESLPVSLLTSS
CYHHIQIMDLAGPLVRPARIHVEAENSRIFSNLISLAIVNTRLEKDEDIA
LLSSLANLENLLVCLDAFVGRVLVFPKGGFPRLQGIVLYRVSTLEQWEVG
EGAMPLLQHLRLCGCINMRMLPEGLVRLTELKQIEIREMEMIERRVNKDT
GEDYHKIKHVPCVVIN
>XP_042460881.1 putative disease resistance RPP13-like protein 3, partial [Zingiber officinale]
MSKNYFQCKAWVSVSQKYAVKELLCSIVKQVFDFNDEQVKGMEELEMKEK
LSEHLSNRRYLVVMDDIWEVAAWNAIKAAFPKESTGSRVLLTTRKMNVAN
VADVPPHELKFWNVEESWNLFCRKAFRTACCPPEFERFKEDIFKKTKGLP
LAIVVLGGVLRGTSQASNWRKKMEHISREFREGEDQILRILALSYHDLPN
HLKPCFLYFAAFPEDYSIWAERIIHLWIAEGFIQTNDKVDQTMEDLAEAY
LKDLTDRSMLQIERGRMYYSHQVRIHDLLLDLARHEARELNFFRTIDDIG
DDPRSLRRLSVTENVNDHILLNCSTTKLRSLVTCRNEGFKRMLAVAIPGA
KFLRVLDLQELPIEHLPKEIGDLILLRYLNLERSKLKELPSSIGNLIHLQ
TFNIFGTKIQHLPDAFWKIRTLRHVFLTEENTSMPKAAYYCSEDIRTLEN
ISIGPWVCDGVLEKLRNLRALYLKSISSSDEDALANAVQNLFRLEKLGLV
GESLPMSVLTSSSYHHIQFLYLWGPLVRPARIHIEAENSMIFSNLISLFI
SETRLEKDEDIAMLASLANLEILRLRFGAFVGRVLVFPKGGFPSLQEIEL
FDLSTLEQWEVGEGAMSFLRELRLLN
>XP_042460909.1 disease resistance protein RPP8-like [Zingiber officinale]
MASTVVNLVLEKLGELASSEVSGLLNVGAEIKSLTETLALIQSFLRDADQ
KPRYEQSNCLQEWMRQIRNSVFEMEDLVDEYAMLLGRASAAGCWKSRLRR
IAAFPSRILDHSPSAREAPAGHPSSSWLTLFELEEDIVGFDEDMKGIKRQ
LFDIGSTTRVVLSVVGPGGLGKTTLANKIYKSADVKNYFQCKAWVSVSQK
YELKELLCTIVKKVFDFKDEQVKGMEELEMKEKLSEHLRDRRYLVVMDDI
WEVAAWNAIKAAFPKESAGSRVLLTTRKMNVANVADVPPHELKFWNVEES
WNLFCRKAFRTTCCPPEFERFKEDIFKKTKGLPLAIVVLGGVLRGTSQAS
NWRKKMEHISREFREGEDQIQRILALSYHDLPHHLKPCFLYFAAFPEDYS
IWAERLIHLWIAEGFIQTNDKVDQTMEDLAEAYLNDLTERSMLQIERGRM
YYSHEIRIHDLLLDLARHEARELNFFRSIDDIGDDPRSLRRLSVTENVND
HISLNCSTTKLRSLVTCRNEGFKRMLAVAIPGAKFLRVLDLQELPIEHLP
KEIGDLILLRYLNLERSNLKELPSSIGNLIHLQTFNIYGTKIQHLPDAFW
KIRTLRHVFLTEENMSMPKAASYCLEDIRTLENISIGPWVCDGALEKLRN
IRALYLKSISISDEDALANAVQNLFRLEKLGLVGESLPMSVLTSSCYHHI
QFLYLCGPLVRPARIHIEAENSMIFSNLISLFISETRLEKDEDIAMLASL
ANLQILRLRFGAFVGRVLVFPKGGSLSLQEIELYRLRTLEQWEVGDGAMP
FLRELRLWNCKNMRMLPEGLARLTELNQIYLRGMKMIERRVNKDTGEDYH
KIKHIPCIEIN
>XP_042462049.1 disease resistance protein Pik-2-like [Zingiber officinale]
METAITTKLVDFSFQSIAGKLGKMLEEEAALLAGVEDDVRYIVAEHKSIT
SFLTAIATRRNLDAELKNWAQELSEVAYDAEDSIDEFNYHLRSTQGFFKH
FLRSIKLLKDRRNIATEIKKLKVQVEDIKKRHDRYFHPNEATSSGTVTGL
DMTDRYSDPRIIGHFVEETQLVGINQSRDKIIGWVMDENCPELTAISLLG
FGGLGKTTLAKTVYDDPIIVEGHFQPRAWIAVSQNYNIKELLKKIIRQIS
VNEKQIRDVSGCRDARLNTEQCLNMMDESQLVQTVRGHLHGKRYFIVFDD
VWSVEAWESLSIALPQGKEGSRVIVTTRIKDVANTSCSRNRRFIFKISPL
SPELSWELFCRKVFDAPDYNCPPELENIGREILQKCDGLPLAIVTIGGLL
ASKPDNNFEEWKDLRDHLRLEIQTNDMLSKINQILGLSYNDLPYYLKPCF
LFLGIFPEDYEIGRKRLMRRWIAEGIVHGVDGLPDEKMAERCFSQLVNRS
LVQPSEFDDNGTVRSCRVHDMMLDVIISISRKENFALVLNEQSTLTTIQP
RHQRIRRLSWQGGSSGLGPNTELSHLRSFTSLGEDVPPLKDYRKHRLLRE
IDLEGCRAIHHFHRKSFSKLFLLKYLSLRNTWLDTLPDSIGDLQNLEFLD
IRGTDIRKLPNSIVKLQKLVYLLAGPFIGFKFPKGIRKLKRLTTFGMARA
HNVHSLQEIGELVHLHKLGIAFEDSDLSLRMVEEISALLSKLNGSLRSLK
ILHLENSSLKKALDEVALPPLLLCEIEINCRLGELPPWFASLKHVVKISL
FRTQLQLEDLQVLRNLPALVNLQLGGESFVYNGENLVFDREGFAQLKLLT
IARHNVSFEVGAVPSLEILKILGPNKSVNGVEHLHGLKEVHIHTGNENII
EMVKNIAANHSNRPKCFVKLHKSA
>XP_042462167.1 disease resistance protein Pik-2-like [Zingiber officinale]
MMFNSCSKVKRLTSEFSALPKHRRTEMGSMETMIAMKVVGFSFQFIAGKL
ERMLAEEAAMLAGVEDDVRYMVDELKSMTSFLKAMSTRHNLDDQLQNWVQ
EVKEAAYDAEDLIDEFSCHLGSIPYDQRRVKGFFKHFLRSIKSMKARHDI
ASDLKKLKVHVEEEVRKRHDRYSLLNEATSSGIATSLEMAGTYSDPRIIG
HFVEEAQLVGINESRHTLIEWVLDKNRLVLTVISLVGFGGLGKTTLAKTV
YDDPIIVGGHFQPRAWISVSQNYNIKELRKKIIRQISVNEQQIRDVIGCQ
DARLNTEQLLNMMDETQLMETIRDHLQGKRYLLVFDDVWRTEAWEGLSTA
LPPGKEGSRVIVTTRIEEVANTSCSELENVGREILQKGNGLPLAIVTIAG
LLASRPDKKLEEWKDLRDHLRLEIETNDKLLKIHQILVLSYNDLPYHLKP
CFLFLGTFPEDFEIHRKRLMRRWIAEGIVSGEGGLPAEKVAERYFNQLVN
RSLVQPSQFDDSGTVKSCRVHDMMLDVILSISSKENFAVILNEHTTIPPQ
HQKIRRLSWHGGNSGVVPDPYLSRLRSFTAFGVDVQPPIDYRKQRQLRAI
DLEGCRALHYLHPKCFSKSFLLKYLSLRNTGLSELPDSIGDLQNLEFLDI
RGTQIYYKLPKTIVKLQKLVYLLASNYLKVPKRIEKLKRLVTFGIAYVEN
VQSLQEIGELVDLQKLGIGFRQHDDLSLRMQEISALFSKLIGSLRSLKIF
SWPNSGLKTALDQVASPPLMLCKLGIHFKLGELPPWFASLNHVVKISLSN
TLLQLEDLQVLRNLPALVNLILGYRSFVHYDLVFDRGGFTQLKFLEISWY
NVSFKEGAVRSLEILKIFFVTGVRSVNGIEHLHRLREVHIKTRDEEIIEM
VKNISASHSNRLKCFATQH
>XP_042462216.1 disease resistance protein Pik-2-like [Zingiber officinale]
MATMMAMKVVDFSFQSIAGKLQKMLEEEAELLAGVEDDARYIVAELRSIT
SFLTAMTTKRNLDDQLQNWLQEVKELAYDAEDSIDEFVCRLRSTPYDERG
VKYFFKHFLGCIKSLKARHGIASDLKKLKVQVEEIRKRHDRYSHPNEVFT
SSGTPTSFDMADRYSDPRIIGHFVEEAQLVGINQSRDKIIGWVMDENCLE
LTVISLVGFGGLGKTTLAKTVYDETVISGGYIQYRAWIAVSQNYSIKELL
KKIIRQISIKEQQNRDVQGRQDASLITELNMMDELQLVQTARDVLHGKRY
LLVFDDVWRTEAWESLCIALPPGKEGSRVIVTTRVEEVANTSCSRNRQFI
FKVSPLSPDLSWELFCRKVFDAPDYSCPPELENVGREILQKCKGLPLAIV
TIGGLLASRPDKKLEEWKDLHDHLRLEIETNDMLSKIHQILVLSYNDLPY
HLKPCLLFLGIFPEDYEICRKRLMRRWIAEGIVSGVDDFPAEKVAERCFN
QLVSRSLVQPSQFDDSGTVKSCRVHDMMLDVILSISRKENFAVLLKEHPT
IPQQRQKIRRLSWHGGSSGLVPDTDLSHLRSFTAFGEDAPPLKDYRKQRL
LRAIDLEGCWNLFDLHPKSFSKLYLLKYLSLRDSGISVLPDSIGDLQNLE
FLDIRGTDIDELPNTIVKLQKLVHLLAGPERFKFPKGIGKLNRLVVFGMV
RADSVQLLQEIGELVNLQKLDICFGGHDLSLRMLEEISALLSKLNGTLRS
LTISHSINDSLKKALDEVASPPWLLCKLRISCKLGELPPWFTSLKHVVKI
SLSFTRLRLQDLRVLRDLPALVDLKLGIASFLNHYENLVFDRGGFAQLKF
LEIEGHNVSFEEGALRSLEILNIRRFNTGFSVEGIENLHGLREVHILTNN
EDIIEMVKNIAANHSNRPKCFETILPSPAQGI
>XP_042462219.1 disease resistance protein Pik-2-like [Zingiber officinale]
MFPIKHLTSEFSALPKHRRTEIGSMETMIAMKVVGFSFQFIAGKLERMLV
EEAALLAGVEDDVRYIVVELRSMTSFLTAMSTRHNLDDQLQNWVQEVKEA
AYDAEDSIDEFLCHLGSIPYDQRRVKGFFKHFLRSIKSMKARHDIASDLK
KFKVHVEEVRKRQDRYSHPNEVSSSGTATSLEMASTYSDPRIIGHFVEEA
QLVGINESRHTLIEWVLDKNRLELTVISLFGFGGLGKTTLAMTVYDDPTI
VRGHFQSRAWIAVSQNYSIKGLLKKIIRQISVNEQQIRDVLGCQDDRLNT
EQLLNMMDETQLVKTVRDHLQGKRYLLVFDDVWRTQAWEGLSIALPPGKE
GSRVIVTTRIEEVANISCSRNHRFIFKVSPLSPELSWELFCRRVFEAPDY
NCPPELENVGREILQKCNGLPLAIVTIGGLLASKPDKKLEEWKDLRDNLR
LEIETNDMLLKIHQILVLSYNDLPCHLKPCFLFLGIFPEDFEIHRKRLMR
RWIAEGIVSGVGDLPAEKVAERNFNQLVNRSLVQPSQFDDSGTVKSCRVH
DMMLDVILSISRKENFAVLLKEHPTIPQQHQEIRRLSWHGGSSGLVADTD
LSHLRSFTAFAFAEDVPPLKDYRKQRQLRAIDLEGCRALLYLHPKSFSKL
FLLKYLSLRDCNISVLPDSIGDLQNLEFLDIRGTHIDELPKTIVKLQKLV
YLLASKYLKVPERIGKLNRLVVFGIVRADSVQLLQEIGELVNLQKLGIGF
SHRDDLSLRMLEEISALLSKLNGSLRSLKIFSWPNSSLKTALDEVASPPF
LLCKLQICYELGKLPPWFAYLNHVVKIYLEYTQLQLEDLQVLRNLPALVN
LILEYRSFVHHDLVFDQGGFTQLKFLEISGYNVSFKVGAVRSLEILKIYF
GTGGSSVNGIKHLHGLREVHIKTRDEDVIEMVKNIAANHSNRPKCFATLH
>XP_042462284.1 disease resistance protein Pik-2-like [Zingiber officinale]
METTIATKLVEFSFQSIAGKLGKMLEEEAALLAGVEDDVRYIVAEHKSIT
SFLTAISTRRNLDVELKNWAQELSEVAYDAEDSIDEFDCHLRSTQGFFKH
FLRSIKLLKDRRNIATEIKKLKVQVEDIKKRHDRYFHPNEATSSGTVTGL
DMTDRYSDPRIIGHFVEETQLVGIKQSRDKIIGWVMDENCPELTAISLLG
FGGLGKTTLAKTVYDDPIIVEGHFQPRAWIAVSQNYNIKELLKKIIRQIS
VNEKQIRDVSGCRDARLNTEQLLNMMDESQLVQTVRGHLHGKRYFIVFDD
VWSVEAWESLSIALPQGKEGSRVIVTTRIKDVANTSCSRNRRFIFKISPL
SPELSWELFCRKVFDAPDYNCPPELENIGREILQKCDGLPLAIVTIGGLL
ASKPDNNFEEWKDLRDHLRLEIQTNDTLSKINQILGLSYNDLPYYLKPCF
LFLGTFPEDYEIRRKRLMTRWVAEGIVSGVGGFPAEKVAERCFNELVSRS
LVQPSEFNDNGKVKSCRVHDMMLEVIISISKKVNFAVLLNEHTTNLPQHQ
KIRRLSWQGGSSTELVPNTDLSHLRSFTSLGEDVPPLKDYRKHRLLRAID
LEGCRAIDYFHPKSFSKLFLLKYLSLRDCNNISALPDSIGDLQNLEFLDI
RRTFISKLPNTIVKLQKLVYLLGSPFNVFKFPKGIRKLKRLSTFGMARAH
NVHSLQETGQLVHLHKLGIYLSRSDLSLRMLEEISALLSKLNGSLRSLKI
WHWGNNRLKKALDEVASPPLLLCKFYIYGQLGELPPWFASLKHVIKITLS
NTRLQLEDLQVLRNLPALVNLDLSWKAFVNSDEDLVFDREGFAQLKFLEI
VEQGVSFEEGAVRSLEILKIFRPPKSVNGIEHLHGLKEVHIQTENDDIIE
MLKNIAANHSNRPKCFAKLLKSA
>XP_042462286.1 disease resistance protein Pik-2-like [Zingiber officinale]
METTIAMKLVDLSFHSIAGKLGKMLEEEAALLAGVEDDVRYIVAEHKSIT
SFLTAMSTRSNLNVELKNWVQELSEVAYDAEDSIDEFDCRLRSTQGFFKH
FLLSIKSLKDRHNIASEIKKLKVQVEDVKKRHDRYFHPNESTSSGTATGL
DMTDRYSDPRIIGHFVEEAQLVGINESRYKIIGWVINKNCPELTAISLVG
FGGLGKTTLAKTVYDDPIIVGGHFQSRAWIAVSQNYNIKELLKKIIRQIS
VNEEQLRDVSGCQDARLNTEQLLNVMDESQLVQTIRDHLHGKRYLLVLDD
VWSVEAWESLSIALPQGKEGSRIIVTTRIEDVANTSCSRNRQFIFKISPL
SPELSWELFCRKVFDAPDYNCPPELENIGREILQKCDGLPLAILTIGGLL
ASKPDNNFEEWKDLRNQFRLEMQTNKKLSKIDQILGLSYNDLPYDLKPCF
LFLGIFPEDYEIGRKRLMRRWIAEGIVSDVGGFPAEKVAERCFNELVSRS
LVQPSKFNYNGTVKSCRVHDMMLEVIISISRKVNFAVLLNEHPTNLPQYQ
KIRRLSWHEGSSGLGPNTDLCHLRSFSSFGADVPPLKDYRKHRLLRAIDL
EGCSDLDHLHPKSFSKLFLLKYLSLRNCDISALPDSIEDLQNLEFLDIRG
THIEELPNTIVKLQKLVYLLGGFLTFPKGIRKLKRLTTFGTARAHNVHSL
QEIGQLVDLQKLAISFGGSDLSLRMSALLSKLNGSLRSLTIWHWGDCSLK
KALNEVASPPLLLGKLMIQCRLYELPPWFASLKHVVKISLFRTLLQLEDL
QVLRNLPALVNLRLGIESFVNHNENLVFDRGGFAQLKFLKIERLNVSFKE
GAVRSLEILKIIYPHELTNGIEHLHGLREVHIYTPNQYVIEMVKNIAANH
SNRPKCFATLPQSAREEFNSE
>XP_042462287.1 disease resistance protein Pik-2-like [Zingiber officinale]
METAITTKLVEFSFQSIAGKLGKMLEKEAALLAGVEDDVRYIVAEHKSIT
SFLTAISTRHNLDAEVKNWAQELSEVAYDAEDSIDEFDCRLRSTLGFFKH
SLRSIKSLKGRHDIASEIKKLKVQVEDIKKRHDRYFHPNEATSSGTATGL
NMADRYSDPRIIGHFVEEAQLVGINQSRDKILGWVMDENCPELTAISLLG
FGGLGKTTLAKTVYDDLIIVEGHFQPRAWIAVSQNYNIKELLKKIIRQIS
VNEKQIRDVSGFRDARLNTEQCLNMMDESQLVQTVRGHLHGKRYFIVFDD
VWSVEAWESLSIALPQGKEGSRVIVTTRIKDVANASCSRNRRFIFKISPL
SPELSWELFCRKVFDAPDYNCPPELENIGREILQKCDGLPLAIVTIGGLL
ASKPDNNFEEWKDLRDHLRLEIQTNDMLSKINQILGLSYNDLPYYLKPCF
LFLGTFPEDYEIRRKRLMRRWIAEGIVHGVDGLPDEKMAERCFNQLVNRS
LVQPSEFDDNGTVRSCRVHDMMLDVIISISRKENFAVVLNKHSTQTNIQP
RHQRIRRLSWQGGSSGLVPNTDLSHLRSFTAFGEDVPVSDYRKQRLLRAI
DLEGCRNLDDFHPKSFSKLCLLKYLSMRNIGLSELPDSIGDLQNLEFLEI
RGTYIQKLPNAIVKLQKLVYLLGGPFIGFKFPKGIRKLKRLTTFGTARAH
NVHSLQEIGELINLQKLDIFLGRSDLSLRMLEEISALLSKLNGSLRSLKI
LHWADSSLKKALDEV
>XP_042462288.1 disease resistance protein Pik-2-like [Zingiber officinale]
MFDQCSKVKQDLSSQQLYLSFIVLISLPYRCRTEIGSMETTIAMKLVDFS
FQSIVGKLRKMLEEEAALLAGVEDDVRYIVAEHKSIISFLTAISTRHNLD
AELKNWAQELSEVAYDAEDSIDEFDCHLRSTQSFFKHFLRSIKLLKDRRN
IASEIKKLKVQVEDIKKRHDRYFHLNEATSSGTVTGLDMTDRYSDPRIIG
HFVEEAQLVGINQSRDKILGWVMDENCPELTAISLVGFGGLGKTTLAKTV
YDDPVIVGGYFQSRAWIAVSQNYDIKELLKKIIRQISVNEEQIRDVSGCR
DARLNTEQLLNMMDESQLVQTIRDHLHGKRYLIAFDDVWSTVAWESLSIA
LPQGEEGSRVIVTSRSEEVANYSCSRNRQFIFKVSPLSPELSWELFRRKV
FEAPDYSCPPELENVGREILQKCNGLPLAIVTIGGLLASKPDKKLEEWKD
LRDHLRLEIQTNDMLSKINQILGLSYNELPYYLKPCFLFLGTFPEDYEIR
RKRLMRRWIAEGIVHGVDGLPDEKMAERCFNQLVNRSLVQPAEFDDNGIV
RSCRVHDMMLDVIISISRKENFAVVLNKHSMLTTIQPRHQRIRRLSWQGG
SSTGLVPNTADLCHLRSFTATAFGEDVPPLKDYRKHRLLRAIDLEGCWAI
DHFHRKSFSKLFLLKYLSLRNTELFELPDSIGDLQNLEFLDIRGTYIQKL
PNTIVKLQKLVYLLGSSDREFNFPKGIRKLKRLTTFGMARADNVHSLHEI
GQLVHLHKLGIYFGGSDLSLRMVEEISALLSKLNGSLRSLNIFRTPNINL
KKALDEVASPPLLLCKFQIDGRLYELPPWVASLKHIVKISLYLTRLQLEG
LQVLRNLPALVYLKLGYESFVINDEDLVFYRGGFAQLKFLEIERHNVSFE
EGAVRSLEVLKIRPFGTRFSVKGIENLHGLSEVHIRTNNEDIIEMVKNIA
ANHSNRPKCFAKLHEYEYHL
>XP_042462317.1 disease resistance protein Pik-2-like [Zingiber officinale]
MEIGIATTMAMQLVEFSFQSMTGKLEKMLEEKASLLAGVEDDAQDMVDEL
RSITSYLTAMSTRRNLDVQQQNWVNEVREVAYNAEDSIDEFDYHLRSTPY
DERGVKGFFKHFLPRIKSLKARDCIASDIKKLKVKVEDIKKRHDRYSLPN
EATRSGTTTGLDMADRYSDPRIIGHFVEEAHLVGINQSRDKIIGWVMDES
CLELIVISLVGFGGLGKTTLAKTVYDDPIRGHFQSRAWIAVSQNYSIKEL
LKKIIQQISVRKKEIQDVLGCRDAKLNTEKLLNQMDESQLVQTVRGHLHG
KRYFIVFDDVWSTEAWESLSIALPQGKEGSRVIVTSRSEEVANYSCSRNR
QFIFKVSPLSSELSWELFCRKVFEAPDYSCPTELENVGREILQKCNGLPL
AIVTIGGLLASKPDKKLEEWKDLRDHLRLEIQTNDMLSKINQILGLSYND
LPYYLKPCFLFLGTFPEDYEIRRKRLMRRWIAEGIVNGVGGLPDEKMAER
CFNQLVNRSLVQPSEFDDNGTVRSCRVHDMMLDVIISISRKENFAVVLNK
HSTQTTIQPRHQRIRRLSWQGGSSGLVPNTDLSHLRSFTAFGEDVPVNDY
RKQRLSRAIDLEGCRNLDDLHPKSFSKLCLLKYLSLRNTGLSELPDSIGD
LQNLEFLDIRETYINKLPNAIVKLQKLVHLLAGGYIKWPCMEDSFFLNVY
LPKGIRKLKKLRTFGLVRAHDVHSLQEIGELVDLEKLGMSFGFRDLKRKA
LEEISALLSKLNGSLRSLTLANSNLKKALDEVVSPPLLLHKLQIHAARGG
FPAWFASLKQVVKITLSNTRLQLQDLQVLRNLHTLVKLVLGFHSFDDNYE
DFVFDQVGFANLKFLEIEMHSVSFEEGALQSLEILKMDKIFIGYSVDGIE
HLHGLKEVHIQTESDDIIEMVKNIAANHSNRPKCFAKLLKSA
>XP_042462341.1 disease resistance protein Pik-2-like [Zingiber officinale]
METAIATKLVLFSFQSIAGKLGKMLEEEAALLAGVEDDVRYIVAEHKSIT
SFLTAISSRRKLDVELNNWSQELSEVAYDAEDSIDEFDCRLRSTQGFFKY
FLRSIKLLKDRHNIASEIKKLKVQVEDIKRRHDRYFHPNEATISGTATGL
DMTDRYSDPRIISHFVEKAQLVGINHSRDKITGWVMDGNCPQLTVISLVG
FGGLGKTTLAKTAYDDLIIVEGHFQSRAWITVSQNYNIKELLKKIIRQIS
VNEKQIRDVSGCQDARLNTEQLLNMMDELQLVQTIRDHLHGKRYLLVLDD
VWSIEAWESLSIALPQGIEGSRVIVTTRIEDVAYTSCSHNRQFIFKISPL
SPEKSWELFCRKVFDAPDYNCPPELENIGREIVQKCDGLPLAIVTIGGLL
ASKPDNKFEEWKELRDQFSLEIQTNKKLSKIDQILGLSYNDLPYDLKPCF
LFLGIFPEDYEIGRKRLMRRWIAEGIVSDVGCFPAEKVAERCFNELVSRS
LVQPSKFNYNGTVKSGRVHDMMLEVIISISRKVNFAVLLNEHPTNLPQYQ
KIRRLSSHEGSSGLVPNTDLSHLRSFTSFGEDVPPLKDYRKHRLLRAIDL
EGCTAVYHFHRKSFSKLFLLKYLSLRNTELSELPDSIGDLQNLEFLDIRG
NAIKELPNTIVKLQKLVYLLAGRFCRNPNFINLKVPKEIRKLKGLRAFGT
ASVDDNVQLLQEIGELVNLEMLSICFGDYDVSHGMLKEINPLLSKLNGSL
RSLTIIQSFVNLKKALDEVASPPLLLCKLHIQTILGGLPGWFASLKQVVK
ITLCNTQLQLQDLQVLRNLHTLVKLVLETRSFVRYEQDLVFDQRWFTNLK
FLKIRRQCVSFGEGTLQSLEILKMSFFFPGWSIKGIEHLHGLKEIHVDTS
DMHIKEMVKNIAANHSNRPKCFAITNRFA
>XP_042462342.1 disease resistance protein Pik-2-like [Zingiber officinale]
MATMMAMKVVDFASQSIMEKLERMLVEEAALLAGVEDDVRDIVAELRSIT
SFLTVMSTRRSLDDQVQNWVQEVREVAYDAEDSIDEFDCRLRSTPYDERG
VKGFFMRFCRCFKSLKARHDIASALKKLKVEVEEIRKRHDRYSHPNEAAS
SGTATSLDMADSYSDPRIIGHFVEEAQLVGINQSRDTLIEWVMDENCLEF
TAISLVGFGGLGKTTLAKTIYDDPIIVGGHFQFRAWIAVSQNYNIRELLK
KIIRQISVKEQQVRDVLGCQDASLNTEQLLNMMDESQLVQTVRGCLHGKR
YLVAFDDVWSTEAWESLSIALPQGKEGSRVIVTSRSEAVANACCSRNRQF
IFKISPLSPELSWELFCRKVFDAPDYNCPPELENIGREIVQKCDGLPLAI
VTVGGLLASKPDKILEEWKDLRDHLGFEIEKSKIHQILVLSYNDLPYHLK
PCFLFLGIFPEDYEIHRKRLTRRWIAEGIVSGVGGFPAEKVAERCFNQLV
SRSLMQPSKFDDNGTVKSCRVHDMMLEVIISISRKENFVVLPSEHPPRHQ
KIRRLSSHGGSSGLVPDTDLSHLRSFTAFGKDVPLKDYRKQRLLRAIDLE
VSSNLFDLHPRSFSKLFLLKYLSLRDSPISALPDSVGDLQNLEFLDIRGT
YIEELPNTIVKLQKLVYLLGGLNQQHPPGMFTILRFVTLFKLKFPKGIRE
LKRLRKLGMTYADDEQLLQEIGELAELEKLAICFGDDDLVIGVLEGISAL
LSMLSGSLRSLTIFHASYGDLKRALDEVASPPLLLCKLQIDVVLGGLPAW
FASLKQVVKITLFNTRLQLQDLQVLRNLHALVKLVLGCESFDNDDEDMIF
DRGGFTQLKLLEIQSHCVSFEEGALQNLKILKLAGYFPNEYGVYGIEHLH
GLREVHVHTGNEDLGEMVKNIAVYHAARPKCFVKIEESPSDI
>XP_042462343.1 disease resistance protein Pik-2-like [Zingiber officinale]
MATMMAMKDVDFSFQSIAGKLEKMLEEEAALLAGVEDDVRYIVAELKSIT
SFLTAMSTRRNMDVELQNWVQEVREVAYDAEDSIDEFNCRLRSTPYSKCG
VKGFFNHFLRRIKSLKSRHVIASEIKKLKIQVEEIKKRHDRYSHTNEAIS
FGTATNLDMTERYPDPRIIGHFVEETQLVGINQSRDTLIKWVMDENYPEL
TTISLVGFGGLGKTTLAKLVYDDPIIVGGHFQSRVWIAVSQNYSIKELLK
KIIRQISIKEQQIRDVFGCQDASLNTVQLLNIMDESQLVKTIRDHLHGKR
YMIVFDDVWSTEAWESLRIVLPPGKERSRVIVTTRIEEVSNTSCSRNRQF
IFKMSPLSPEKSWELFCRKVFEAPEYSCPRELENVGREILQKCDGLPLAI
VTIGGLLASKSDKKHEEWKDFGDHLRLEIQTNDMLSKIHQILLLSYNDLS
FHLKPCFLFLGIFPEDYEICRKRLMRRWIAEGIVSGVGGFPAEKVAERCF
NELVSRSLVQPSEIYYNGTVKSCRVHDMMLDVIISISRKENFVVLLNEHP
TIPPQHQKIRRLSWQGGSSGLVPNTDLSHLRSFTATAFGEDVPLTDYRKQ
RLLKAIDLEGCRDLDHLHPKSFSKLFLLKYLSLRNNIRLRRLPDSLGDLQ
NLEFLDIRGTRIEELPNTIVKLQNLVYLLFDLRIIQLPKGMRRLKKLRTL
GMARVDNVQLLQEIGELVDLQKLAICFGDNTLTVRMLDAMSALLSKLNGN
LRSLNILHIPNDNLKKALDEAASPPLLLCKLNICAHLGGLPTWFASLDNV
VKITLRNTQLRLQDLQVLRNLHTLVTLVLGTESFLSNEVLIFDQGGFTHL
KYLDIETNSVSFEEGALQSLEILKMPDFFFGYSVISVDGIEHLHGLKEVH
IQTKNQDTIELLKNIPANHSNLPKCFATTDRIFRYKI
>XP_042462344.1 disease resistance protein Pik-2-like [Zingiber officinale]
MATMMAMKVVDFASQSIMEKLERMLVEEAALLAGVEDDVRDIVAELRSIT
SFLTVMSTRRSLDDQLQNWVQEVREVAYDAEDSIDEFECRLRSTSYDERG
VKGFFMRFCRCLKSLKARHDIASALKKLKVEVEEIRKRHDRYSHPNEAAS
SGTATSLDMADSYSDPRIIGHFVEEAQLVGINQSRDTLIEWVMDENCLEF
TAISLVGFGGLGKTTLAKTIYDDPIIVGGHFQSRAWIAVSQNYNIRELLK
KIIRQISVKEQQVRDVLGCQDASLNTEQLLNMMDESQLVQTVRGCLHGKR
YLVAFDDVWSTEAWESLSIALPQGKEGSRVIVTSRSEAVANACCSRNRQF
IFKISPLSPELSWELFCRKVFDAPDYGCPPELENVGREIVQKCDGLPLAI
VTVGGLLASKPDKILEEWKDLRDHLGFEIEKSKIHRILVLSYNDLPYHLK
PCFLFLGIFPEDYEIHRKRLMRRWIAEGIVSGVGGFAAEKVAERCFNQLV
SRSLMQPSKFDDNGTVKSCRVHDMMLEVIISISRKENFVVLLNERPPRHQ
KIRRLSSHGGSSGLVPDTDLSHLRSFTAFGKDVPLKDYRKQRLLRAIDLE
VSSNLFDLHPRSFSKLFLLKYLSLRDSPISALPDSVGDLQNLEFLDIRGT
YIEELPNTIVKLQKLVYLLGGLNQQHPPGMFTILRFVTLFKLKFPKGIRE
LKRLRKLGMTYADDEQLLQEIGELAELEKLAICFGDDDLVSGVLEGISAL
LSKLSGSLRSLTIFHAAYGDLKRALDEVASPPLLLCKLQIDVVLGGLPAW
FASLKQVVKITLFNTRLQLQDLQVLRNLHALVKLVLGCESFDNDDEDLIF
DRGGFTQLKLLEIQSHCVSFEEGALQNLEILKLAGYFPNEYGVYGIEHLH
GLREVHVHTGNEDLGEMVKNIAVYHAARPKCFVKIEESPSDI
>XP_042462345.1 disease resistance protein Pik-2-like isoform X1 [Zingiber officinale]
MATMMAMKAVDFSFQSIAGKLEKMLEEEAALLAGVEDDVRYIVAELKSIT
SFLTAMSTRRNMDVELQNWVQEVREVAYDAEDSIDEFNCRLRSTPYSKCG
VKGFFNHFLRRIKSLKSRHVIASEIKKLKIQVEEIKKRHDRYSHTNEATS
FGTATNLDMTDRYSDPRIIGHFVEETQLVGINQSRDTLIKWVMDENYPEL
TTISLIGFGGLGKTTLAKIVYDDPIIVGGHFQSRVWIAVSQNYSIKELLK
KIIRQISINEQQIRDVFGCQDASLNTEQLLNIMDEAQLVKTIRDHLHGKR
YMIVFDDVWSTEAWESLSIALPQGKEGSRVIVTSRSEEVANYSCSRNRQF
IFKISPLSPEKSWELFCRKVFEAPEYSCPRELENVGKEILQKCDGLPLAI
VTIGGLLASKPDKKHEEWKDFGDHLRLEIQTNDMLSKIHQILLLSYNDLS
FHLKPCFLFLGIFPEDYEIRRKRLMRRWIAEGIVSGVGGVPAEKVAERCF
NELVSRSLVQPSEFYYNGTVKFCRVHDMMLDVIISISRKENFVVLLNEHP
TIPPQHQKIRRLSWQGGSSGLVPNTDLSHLRSFTATAFGEDVPLKDYRNQ
RLLRAIDLEGCSALFDLHPMSFSKLCLLKYLSLRKTGLRKLPDSIGDLQN
LEFLDIRRTDIEELPNTIVKLQKLVYLLCEPPIFQFPKGIRKLKKLRVLR
IACADNVQLLQEIGELVELENLIICVIVDDLESRMLEEISTLLSKLNGSL
RSLKIMQISDSGLKRALHELASPPLLLSKIHILAKTDGLPTWFASLEKVV
EITLGGTRLQLQDLQVLRNLHTLVKLVLRNGSFDKNGEDLVFDQGWFTHL
KYLEIETDGVSFKKVGVKI
>XP_042462346.1 disease resistance protein Pik-2-like isoform X2 [Zingiber officinale]
MATMMAMKAVDFSFQSIAGKLEKMLEEEAALLAGVEDDVRYIVAELKSIT
SFLTAMSTRRNMDVELQNWVQEVREVAYDAEDSIDEFNCRLRSTPYSKCG
VKGFFNHFLRRIKSLKSRHVIASEIKKLKIQVEEIKKRHDRYSHTNEATS
FGTATNLDMTDRYSDPRIIGHFVEETQLVGINQSRDTLIKWVMDENYPEL
TTISLIGFGGLGKTTLAKIVYDDPIIVGGHFQSRVWIAVSQNYSIKELLK
KIIRQISINEQQIRDVFGCQDASLNTEQLLNIMDEAQLVKTIRDHLHGKR
YMIVFDDVWSTEAWESLSIALPQGKEGSRVIVTSRSEEVANYSCSRNRQF
IFKISPLSPEKSWELFCRKVFEAPEYSCPRELENVGKEILQKCDGLPLAI
VTIGGLLASKPDKKHEEWKDFGDHLRLEIQTNDMLSKIHQILLLSYNDLS
FHLKPCFLFLGIFPEDYEIRRKRLMRRWIAEGIVSGVGGVPAEKVAERCF
NELVSRSLVQPSEFYYNGTVKFCRVHDMMLDVIISISRKENFVVLLNEHP
TIPPQHQKIRRLSWQGGSSGLVPNTDLSHLRSFTATAFGEDVPLKDYRNQ
RLLRAIDLEGCSALFDLHPMSFSKLCLLKYLSLRKTGLRKLPDSIGDLQN
LEFLDIRRTDIEELPNTIVKLQKLVYLLCEPPIFQFPKGIRKLKKLRVLR
IACADNVQLLQEIGELVELENLIICVIVDDLESRMLEEISTLLSKLNGSL
RSLKIMQISDSGLKRALHELASPPLLLSKIHILAKTDGLPTWFASLEKVV
EITLGGTRLQLQDLQVLRNLHTLVKLVLRNGSFDKNGEDLVFDQGWFTHL
KYLEIETDGVSFKKGVKI
>XP_042462347.1 disease resistance protein PIK6-NP-like [Zingiber officinale]
METVIATKVVEFAFNSIAGKLEKMLEEEVALLAGVEDEVRDIVAELKTIN
SFLTDMSTRRNLDDRQQNWVQEVREVAYDAEDLIDEFECRLRSIPYEERG
VKGLFMRFCRCLKSLKIRHGVASELQKLKVEVEEIRKRHDRYSHPNESLT
SLATVTCLDMADRYSDPRIIGHFVEEAELVGIVESREKIIEWTFKWTEDT
YDECRKLTVISLVGFGGLGKTTLAKTVYDDPRIRGFFRYRIWIVVSQQYN
IKELLKQIIRNVSKDSGWTTDLDNMDESQLVQTARDHLHGYPYFLVFDDV
WRNDTWKSLSIALPDDYNGSRVIVTTRSEEVANISCSRDRRFIFKVSPLS
PEQSWELFCRKVFEAPDYNCPPDLENVGREIVQKCNGLPLAIVTVGGLLA
SKSNKNHEEWKNSRDHLRLEIEHILGLSYNDLSYDLKPCFLFLGTYPKNY
EIPRKHLMRRWIAEGIVSGVGGLLAEEEAERLFYELVSRNLVQPSQFDDS
GTVKSCRVHEEMLNVIISISRKENFAVQLKEHPTNPPQHQKIRRLSWHDG
NSGLVPNTDLSHLRSFTAFGDDIPLKDYRKQRLLRAIVLEGCRNSLHLHP
KSFSKLFLLKYLSLRDSRISALPDSIGALQNLEFLDIRGTDIEELPNSII
KLQKLTHLLSGSLKVYNLLTSEGFKRLKVPKGIRKLKKLRTLGMACADNV
RLLREIGELVELKKLAICFGIDDLSSRMMEEINALLFKLNRSLQSLTILH
FAEGSIKEALDEVASPPLLLCKLQINALLAGLPAWFASLEKVVEITLSNT
QLQLQDLQVLRNLHTLVKLFLGSGSFDDNGEDLVFDHVGFTHLKFLTIQS
QSVNFEKGSVQRLEILKMISFTGYSVNGIEYLHGLKEVHIHTENGDIMKM
VKNIAANHSNHPKCFAITTDPLAKGI
>XP_042462349.1 disease resistance protein Pik-2-like [Zingiber officinale]
METTMAVKLVEFSLQSMVGKLEKMLEEEAVLLAGVEDDARCIVEELRSIT
SFLMAMSKRRNLDDQLQNWVREVRELAYDAEDSIDEFDCRLRSTPYNERG
FKDFFNNLFNSIKLLKPRHDIALELKKLKVQVEEIRKRHVRYSHPNEATT
SLDMADRYSDLRIIGHFVEKSQLVGINQSRDLIIRWVTDEKCPELTTISL
VGFGGLGKTTLAKTVYDDPIIVGGHFQPRAWIAVSQNYNIKELLKNIIRK
ISIDEKQIRDVSGCQDTRLNTEQLLNMMDELQLVQTIRDHLHEKKYLLVF
DDVWSTEAWESLSIALPSGKEGSRVIVTTRIEDVANTSCSGNRQFIFKVS
PLSPELSWDLFCRKVFDAPDYSCPPKLKNVGREILQKCDGLPLAILTIGG
LLASKRHNKLEEWKNFRNHFRSEIQTNKKLSKIDQILGLSYNDLPYDLKP
CFLFLGIFPEDYEIGRKRLMRRWVAEGIVSGVGGFPAEKVAERCFNELVS
RSLVQPSEFNDNGKVKSCRVHDMMLQVIISISNKVNFAVLLNEHTTNLPQ
HQKIRRLSWQGGSSGLSTNTDLSHLRSFTAFGSDGRDVPVPLKDYRKQRL
LRAIDLEGSFNLSDRLHPNSFSKLFLLKYLSLRNNIRLRRLPDSIGDLQN
LQCLDIRGTYIEELPNSIVKLQKLVYLLGGLIVHTFTRKEPNMYEEVPRY
AYPDNSNHMYDKFTIDVYTSSVKLKFPKGIRELNGLRKLGMTYADDEQLL
QEIGELVKLEKLAICFGEDDQVSGVLEGIRVLLSKLSGSLRSLTISHAKY
GDLKRALDEVASPPLLLCKLQIHANLGGLPAWFASLKQVVKITLYFTRLQ
LQDLQVLRNLHTLVHLVLGYRSFDNAAENLVFDRGGFTHLKFLEIQSHGV
IFEEAALQSLKILKMSYFAHGYSVDGIEHLRGLKEVHIYKSTLGIVKMVE
DISRCHSNHPKCYSDADVSKGSWTRSD
>XP_042462483.1 disease resistance protein RGA2-like [Zingiber officinale]
MYTTGVAMMVGDWFAGYTINKLANFVASHVSDHWDVLTDVEEKLKEIQDR
LPRIQAVIHEAEGRPIRDPALVNWLRQIKEAAYEADDLLDEIEYRQLEDQ
VQDKGKVSALAASALRFVKNLFVSDDELKRLKNLLGDVDKIYSEIDRKNV
ELKEDNAKHTASIRETSSFTQEVVFGRDKERERILEMLLSSGNDANFLNK
GAGSSSHASLGVLPIVGIGGVGKTTLAQIIYNDPRVADHFELRKWVYVSN
DFNVKRIARDLEGEMASDSRPGHISLDTQLSNLSHATAGKRFLFVLDDVW
DEAGKNWKELRSALTYGNRGSTILITTQSPLVAEFMGTMDQIELQLLKES
DYWRLFEHCAFGSRVVDSYLRRKLQLIGQQIAKKLHGLPLAGKVLGSLLH
TRLEEQYWKMIQESEWWANDFVLENILPSLGLSYQHLSSNVKQCFAFTAM
FPKSHIFDKEQLVQMWIAQGFITPETQHGRMTLEDIGNQIFDELTCRYFF
LHTINERYVIHDLIRELALYISRDECFVIDDEPSKIPSTARHVTVIKTAK
LDTLAELTKLHKVRTLVFYRDYHPEDLFSLGENGSIKFYESLEGILRNLK
NLRILDLSYMRIEIKKLPDAICDLSHLRYLDISGTKIRQLPESFSKIYHL
QVLKLKLCWIKKLPAGMNRLIKMRHLHADADTISLVDGIGRLTDLQELDE
FRITRKRGHQIGELKELRDIRRRLVIQNLECVETQEEALEAKLKDKEHLD
HLVLNFKEGTRSQGDIQKDIMEGLEPHYNIKRLTIQHYRGLNSPCWLEKN
HLTNLVSISLERCARWEDLPPLGHLPFLMAIYIFKLPVRKIGAKFYGDAR
QVFPSLQELTFNTLNEWEELSESDSRTIFPCLRIMRIETCPNLRRIPVLP
LISMTHFQIWNSGDIGNALPDYLLTLTSLICLELRNCAQRASVSLYNLRF
LEYLRLLECPELTLIGGLQSLANLKDIIIEKCPKLIEPAQMPAQAYGEQE
LRSLSTVWIDDSVLKHVWEILGRIPCIQMLRIQHCNDLSHFNTEQEEWFQ
QLTALNLLEFQHCQKLQKLPSSLGTASSIKILSILDCPNIESLPDNGLPF
LLQKLEMYGCTKLKDRCRKDDGLDWPLISNIPNINIDGELIQMQEQQHQR
DWSWFRMDSNREQNSYHEGRPQ
>XP_042462506.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MALATFARVLRLIDSSEASIPPSRTRPAFLSDLSKHMAALKQNLTRIQVA
IRGAEERQASDPSAKLWLTEITSLAYDAEDVLLDFDDLLPRPQIRSALNH
SDSGLLLNSFSSLASISQRIKELGERLVELHGKSEALQLGEQGGAEGSAD
ARRLRPTGSLMDGESPIFGREKDKENILELLRPSGDEGSIPNKLLVLPIV
GMGGLGKTTLAQQVYADDQIKYFFDLRIWIHVSQDFNLFNLTKAMVESVT
GNPCFLSELHSLQSELGKILEGKRFFLVLDDVWDESSSHWESLQVPLLSA
NLDSKVLLTTRSHGVARSIGTMPSFNLDPLKDDDAWLLFSENAFHGREPG
ERLVTIGKKIVKECNGVPLTLKALGLHLCNEEREDKWSAILESNIWHLSG
SQETILPILMLSYLQLPAPVKQCFAYCSLFGKGHLFLRHKIVRHWIAQGF
VETDGERKAEDVGSEYFYILLARSFFQQCARNKYFIMHDLIHDLAEYVSG
AECFKIDVLQDEDGSRMNVERAYNFPEGVRHTSLTFHSTSTETDLQPLLE
ANSLRTLMVNCTSWPPMPHPHANVLNDLFVKLRYLRVLLLDYTFAPAPRL
PDSISNLKYLHYLRIGRLSFQGQGFPESVCSLRNLQTLEWYSDESIELPR
GISNLINLRHLHSETYYASFPEGIGRLTKLQELPDFHTSKEHGRARIAEL
KDLVNLQGELKLLNLENVIDVEDSRTADLKGKPGLTALELDWGKHNRSPQ
NAPLVLQYLQPHTNIQELRIANYKHGQLSEWICHPSYSKLVTIKIQYCFL
STVPAFGQLLSLEHLSLVSIKGLEYIGPVFFHGGFPSLKKLRLSAIYKMV
EWSGAEHGHFPHLNELTVTSCPSLRCLPIDNFTSLKRLHISHCSNLQTLY
SENSPLVGIQQHCSLKNLEVIQCPKLKFLPEYQVPESLQLLDITKSTLLI
NWYRRIAGKLTHVKNLLGVDLKEVKLDDIFSVEEARNACLTKQRIYMLHL
EWETSSLRSVDDTNCEADEVLEYLQPNVSLNKLVIRGYRGLKLAEWLCSP
LYSNLISIKLDLCPNCKFLPALGQLPYLMELHLERLNGITSIDLSFYGNG
SQKGFQSLRRLQLMSMAGLEEWKGASDGGFPILRQLIVQDCMKLRGLPCL
SPSVQEIKVEDCPALTLELPSSLAALLSLHVSNVAAMDELCNLSYLSVLA
VENCSGCRLIELPSLRSLMINGWSERMLLDSLPGLTALTTLKISCLENLE
ALPLHNFRILEELVVSDCPKLVSIECSSTSTYEPYYVEGLQSLSALKCMV
LSGCPELHFSASEQLPASLQSLTISRCPTLRIWYERYSSKFRTSVVQFAD
>XP_042462792.1 disease resistance protein RPP8-like [Zingiber officinale]
MASTAVNLVLEKLGELVSSDVAGILNLDAEVKPLTETLALIQSFLRDADQ
KPRYEQSHSLHEWMRQIRNLAYEMEDLVDEYAMQLGRASAVDGRMSRLQR
IAAFPSRIRTRRLLASRLQDIRTRFQDVCKQAWQLGIQGSSSLPTSSSSS
SSSAADTTLARRFELEDDIVGFDEDMKDIKRQLFDVSLTARVVLSVVGPG
GLGKTTLANKIYRSADVKNYFQCKAWVSVSQKYVVKELLCSIVKQVFDLK
DEQVKGMEELEMKEKLSEHLSDRRYLIVMDDIWEVAAWNAIKAAFPKESA
GSRVLLTTRKMNVANVADVPPHELKFWNVEESWNLFCRKAFRTACCPPEF
DRFKEDIFKKTKGLPLAIVVLGGLLRGTSQASDWRKKLEYISYEFREGED
QILRILALSYHDLPHHLKPCFLYFAAFPEDYCVSAERIKRLWIAEGFIQT
KDKVDQTMEDVAEAYLKDLTSRSMLQIERWGQLYIREVHIHDLLLDLARH
EARELNFFRSIDDIGDDPRALRRLSVTENVDDHISSNCLTTKLRSLVIYP
NEGFQRTLAIAIPGAKFLRVLDLQKVPIEHLPKEIGDLILLRYLSLSRSK
LKELPPSIGNLIHLQTFNIGNTKIQHLPDAFWKIRTLRHVFLNEENTSMP
KATYCLQDIQTLVNISSGPWVRDGVLEKLRNLRKLHLNNISSSDEDVLAN
AVQNLSRLDMLVLNGESVTMSFLTSSCYHHIQFLILRGAWVRPARIHMEA
ENSRIFSNLIYLAIWLTRLEKEEDIAMLASLANLQCLLLCDDAFVGRVLV
FPKGGFPRLQHIELYELSALEEWEVGEGAMPLLQELILWHCRNMRMLPEG
LVRLTELKQIEIRGMEMIERRVDKDTGEDYHKIKHVPCIEIN
>XP_042462806.1 disease resistance protein RGA2-like [Zingiber officinale]
MIGFALTALGWLVENFISALVGKAADRAVQQFGEQHGVEHDLQKLHDSVT
HARFTISTIESLRIKDEGLQQRLKELLIHLKDAAYDADDLLDEFQYRILK
QQIEQQADEAGNRASSSSYSTPPSSKKIKTSFSSYTSGLFGKGDDDDDDV
LRVRKIKGRVDDISVAFEKIYSLLDAEDDRGKKQLMSPASRHTSSFSTEP
QLFGRDEELQELKDLLLESEVAFGQSGFSVLTIDGIGGIGKTTLAQEVFN
DCSIEEYFKLRIWICVSENFCTDRLTREIIEYTTKEKCNVPNFPALQVVL
KEKITPERFLLVLDDVWNEDKHKWESLCAPLRSGKPGSKILVTTRSRKIA
DMVGDVDAIHLEGLDEESFWEFFKKCAFGSSNSGVHQPHLEAMAKKMICK
LKGLPLAAKTLGGLLSMKLDEQYWKSILDSEIWQLPQEENGIMPVLQLSY
QYLPSHLKQCFAFCSLFPKDYRFSESELIRIWIAEGFIMPQGSIRMEELG
RNYFHELVNRSFIQKSKDREFIMHDLIHDLAELIYVGESYRIEEGKSHEI
PSTIRHLSMHVEKEGMQARCLSEFSHYNKLRTLMLSVSYICKSFILDCGV
LEKLKKIRVLILRNCALEELPDNIGKLIHLRYLKLSYNYNIRRLPEALCN
LYNLQSLILQNCALEELPNSIGKLIHLRYLDLTYNRNIQRLPESLCDLYN
LQTLILWNCALKELPNSIGKLIHLRFLKLYYNYNIRRLPESLCDLYNLQS
LILQNCALEELPNSIGKLIHLRYLDLSGNNNIRRLPQSLCDLYNLQTLVL
YSCDNLESLPHDMMKLTNLRKLAGADKFIPGITKVGNLTSLQNLSLFKVL
KDNGHKLAELNGLKQLQGGLCITNLENVENKDEANIANLKSIEHLDSLVL
EWTSLQEFDLDINLHISEQVLEGLQPHHNLQWLTIRGYNGARPPNWLQKQ
VYSRLETLELQNCKNWNDLSVIGQLSQLKYLYLGRIPVHTQNLHRLFDPK
DCKFFSQLEDLVLEGITMLEDLPNLGQLPCLKSLGIRSLPAVKIIGDRFF
AGAEEDSCFPRLHTLRFDDMPAWEEFFCSNDRNLFLYLDFLDISNCQKLR
MLPPLPPSITRLKLNNVGLVDFPRFWKAIDECSSITNSAFVTELPIQECP
NLTSLEQGLLPHHLQQIHIQKCEQLLWVPVKRLKELTSLWSLSIKECPKL
MSMTQDQDIDFQLPPSITQLCLSDCGNLSKSLPGCLHNLTSLRDLEISNC
PNLVSLPVEQLLNLDSVTIKNCTELRLERLQIKSLQKLKIAGCPKLLLSQ
GEAQTEKLSLQRLDIDDTAFMKQSLIKNSLSSVTHLRISSSCEVTMFDRE
DQESLQSLTSLYSLYFSDCKNLQSLPTKLYTLTSLQFLRIHNCSQIQSLP
EKGLPPALTDLKFEGCHLALEQQLESHLAEIKKSGPYCKIFCQ
>XP_042462812.1 disease resistance protein RGA2-like [Zingiber officinale]
MIGFALTALGWLVENFISALVGKAADRAVQQFGEQHGVEHDLQKLHDSVT
HARFTISTIESLRIKDEGLQQRLKELLIHLKDAAYDADDLLDEFQYRILK
QQIEQQADEAGNRASSSSYSTPPSSKKIKTSFSSYTSGLFGKGDDDDDDV
LRVRKIKGRVDDISVAFEKIYSLLDAEDDRGKKQLMSPASRHTSSFSTEP
QLFGRDEELQELKDLLLESEVAFGQSGFSVLTIDGIGGIGKTTLAQEVFN
DCSIEEYFKLRIWICVSENFCTDRLTREIIEYTTKEKCNVPNFPALQVVL
KEKITPERFLLVLDDVWNEDKHKWESLCAPLRSGKPGSKILVTTRSRKIA
DMVGDVDAIHLEGLDEESFWEFFKKCAFGSSNSGVHQPHLEAMAKKMICK
LKGLPLAAKTLGGLLSMKLDEQYWKSILDSEIWQLPQEENGIMPVLQLSY
QYLPSHLKQCFAFCSLFPKDYRFSESELIRIWIAEGFIMPQGSIRMEELG
RNYFHELVNRSFIQKSKDREFIMHDLIHDLAELIYVGESYRIEEGKSHEI
PSTIRHLSMHVEKEGMQARCLSEFSHYNKLRTLMLSVSYICKSFILDCGV
LEKLKKIRVLILRNCALEELPDNIGKLIHLRYLKLSYNYNIRRLPEALCN
LYNLQSLILQNCALEELPNSIGKLIHLRYLDLTYNRNIQRLPESLCDLYN
LQTLILWNCALKELPNSIGKLIHLRFLKLYYNYNIRRLPESLCDLYNLQS
LILQNCALEELPNSIGKLIHLRYLDLSGNNNIRRLPQSLCDLYNLQTLVL
YSCDNLESLPHDMMKLTNLRKLAGADKFIPGITKVGNLTSLQNLSLFKVL
KDNGHKLAELNGLKQLQGGLCITNLENVENKDEANIANLKSIEHLDSLVL
EWTSLQEFDLDINLHISEQVLEGLQPHHNLQWLTIRGYNGARPPNWLQKQ
VYSRLETLELQNCKNWNDLSVIGQLSQLKYLYLGRIPVHTQNLHRLFDPK
DCKFFSQLEDLVLEGITMLEDLPNLGQLPCLKSLGIRSLPAVKIIGDRFF
AGAEEDSCFPRLHTLRFDDMPAWEEFFCSNDRNLFLYLDFLDISNCQKLR
MLPPLPPSITRLKLNNVGLVDFPRFWKAIDECSSITNSAFVTELPIQECP
NLTSLEQGLLPHHLQQIHIQKCEQLLWVPVKRLKELTSLWSLSIKECPKL
MSMTQDQDIDFQLPPSITQLCLSDCGNLSKSLPGCLHNLTSLRDLEISNC
PNLVSLPVEQLLNLDSVTIKNCTELRLERLQIKSLQKLKIAGCPKLLLSQ
GEAQTEKLSLQRLDIDDTAFMKQSLIKNSLSSVTHLRISSSCEVTMFDRE
DQESLQSLTSLYSLYFSDCKNLQSLPTKLYTLTSLQFLRIHNCSQIQSLP
EKGLPPALTDLKFEGCHLALEQQLESHLAEIKKSGPYCKIFCQ
>XP_042462829.1 disease resistance protein RGA2-like [Zingiber officinale]
MIGFALTALGWLAESFMVALAGKAVDRAVQQFGEQHGVEDDLKKLKDSLA
NAMLQISTIENLWLKDEVLQQRLKELLIDLKDAAYDADDLFDEFQYRILK
QQIEQQGDEAGNRASSSSYSTPPPGKKIKTSLSSYASGLFGKGDDDDNNN
NDVQRMREIKGRLDDNSVALEKIYSSLGTEDDRGKKQLVSSESRQTSSFS
IEPQLFGRDKELQQLKDLLLKSEVASKFGQSGVSVLSIDGIGGIGKTTLA
QEVFNDSSVEEYFKLRIWVCVSENFSTERLTREITEYTTKEKCNVPNFAA
LQVVLKEKITQERFLLVLDDVWNEERHKWESLCAPLRFGKPGSKILVTTR
SRSIAGMVGDVDPIHLDRMDEKSFWEFFKKCAFGFSNSGVHDPHLEAMAK
KMTCKLKGLPLAAKTLGGLLSKKLDEQHWKSILDSEIWQLPQEENGIMPA
LQLSYQYLPPHLKQCFAFCSLFPKDYKFSESELIGIWIAEGFIVHQGSIR
MEELGSNYFHELVNRSFFQKSTTRLRKQGSRSNYFHELVYRRSFFQKLGT
KTDRRGRFFIESSTDGKFVMHDLIHDLAELISMSESYRVEKGKSHAIPST
IRHLSLHKEEKGTQTRCLTEFSHYNKLRTLNLSFGYTRESFIFDCGVLEK
FKKIRVLDLSHCALRELPDNIGMLIHLRYLDLSWNQKIRRLPESLCNLYN
LQTLILRECINLESLPHGMMKLINLRKLDAMEHVVDKFIHNITEIGKLTS
LQNLSTFKVLKDNGHKLAELNGLKRLRGKLCITNLENVENKDEASIASLN
SKEHLNRLELQWTSLQESDSDDKLHISEQVLEGLQPHHNLQWLTIRGYNG
ARPPNWLHEQVYSRLEALQLQNCKNWNDLLVIGQLSQLKHLSLVRIPVQI
QNLHNLFNPKHCKFFSQLEELVLEGITMLEDLPNLGQLPSLKSLDIRSLT
GVKMIGDKFFAAIEGGSCFPKLHTLRFNNMSAWEEFYCSDDRNLFPCLDL
LNISNCQKLLMLPRLPPSITCLQLNDVGLEDCPRFWKAIDEGSSITNSAS
VTELSIQECPNLKILEEGLLAHHLQQIYIHKCEQLSSVPVKRLKELTSLW
SLSITECPKLTSMTQDECIDFQLPPLITELCLSDCGNISISLPGCLHNLS
SLTVLIIGKCSDLVSLPIQPLFNLNRLIIENCNELRSVGGLLIKSLMDLE
ITGCPMLQLSQREAQTEKLLLRKLVIDDTAFMQQSPIKNSLSSVEILSIS
SSCEAVMFEGEDQESLQSLTSLYQLSFSDCKNLQFLPTKLYTLTSLQVLR
ILNCPQIQSLPEKGLPPALINLVFRDCHLALEQQLLVHLEEIKKSGRCRG
ITYG
>XP_042462901.1 disease resistance protein RGA2-like [Zingiber officinale]
MIGFALTALGWLAESFMIALVGKAVDRAVQQFGEQHGVEEDLKKLKDSLA
NAMLQISTIENLWLKDDVLQQRLKELLIGLKDAAYDADDLLDEFQYRILK
QQSEQQGDEAGNRASSSSYSTPPPGKKIKTSLSSYASGLFGKGDDDDNNN
DVQRMREIKGRLDDNSVALEKIYSSLGTEDDRGKKQLVSSESRQTSSFSI
EPQLFGRDKELQQLKDLLLKSEVASKFGQSGVSVLSITGIGGIGKTTLAQ
EVFNDNTVEEYFKLRIWVCVSENFSTERLTREIIEYTTKEKCNVPNFAAL
QVVLKEKITQERFLLVLDDVWNEERHKWESLCAPLRFGKPGSKILVTTRS
RSIAGMVGDVDPIHLDRMDEKSFWEFFKKCAFGSSNSGIHHPHLEAMAKK
MTYKLKGLPLAAKTLGGLMSMKLDEQHWKSILDSKIWQLPQEENGVMPAL
QLSYQYLPSHLKQCFAFCSLFPKDYEFSESKLISIWIAEGFIVPQGSIKM
EELGSNYFHELVNRSFFQKSTTRMVERGSNYFHELVYKWSRFQKLRTTTN
SRGRVCFPSSTDEKFVMHDLIHDLAELISMGESYRVEKGKFHAIPSTIRH
LSMYKEEEGMLTRGLTELSHYNKLRTLMLSSRYTHESFIFDCGVLEKFKK
IRVLGLRDCAIRELPNSIGTLIHLRYLDLSYNHKIRRLPESLCDLYNLQT
LILWKCFNLESLPHGMMKLINLRKLDASKYVVDKFIHNITEVGKLTSLQN
LSTFKVLKDNGHKLAELNRLKQLRGKLCITNLENVENKDEANIASLNSKE
HLNRLELEWTFSRESGSEVTLQISEQVLEGLQPHHNLQWLTIRGYNGARP
PNWLHEQVYSRLDTLQLQNCKNWNDLLVIGQLSQLKHLCLVRIQVQTQNL
HNLFNPKHCKFFSQLEELVLEGITMLEDLPNLGQLPSLKSLDIRSLTGVK
MIGDKFFAAMEEGSCFPKLHTLRFNSMSAWEEFYCSDDRNLFPCLDLLNI
SNCQKLLMLPSLPPSITCLQLKNVGLEDCPRFWKAIDGGSSITNSASVIE
LSIQECPNLKILEEGLLAHHLQQIYIHKCEQLSSVPVKRLKELTSLWSLS
ITECPKLTSMTRDECIDFQLPPLITELCLYDCGNLSISLPGCLHNLSSLT
VLIIGKCSDLVSLPIQPLFNLNRLIIENCNELRSVGVLKKSLKNLEITGC
PMLQLSQREAQTEKLLLRKLVIDDTAFMQQFPIKNSLSSVELLSISSSCE
AVMFDGEDQESLQSLTSLQQLSFSDCKNLQFLPTKLYTLTSLQVLQIHNC
PQIQSLPEKGLPPALINIDFRGCHLALGQQLVIHLEEIKKSGRYDGITYV
>XP_042462913.1 disease resistance protein RGA2-like isoform X1 [Zingiber officinale]
MIGFALTALGWLAESFMVALAGKAVDRAVQQFGEQHGVEDDLKKLRDSLA
NGRLKISTIENLWLKDEVLQQRLNELLIGLKDAAYDADDLFDEFQYRILK
QQIEQQGDEAGNRASSSSYSTPPPGKKIKTSLSSYASGLFGKGDDDDNNN
DVQRMREIKGRLDDNSVALEKIYSSLGTEDDRGKKQLVSSESRQTSSFSI
EPQLFGRDKELQQLKDLLLKSEVASKFGQSGVSVLSITGIGGIGKTTLAQ
EVFHDNTVEEYFKLRIWVCVSENFSTERLTREIIEYTTKEKCNVPNFAAL
QVVLKEKITQERFLLVLDDVWNEERHKWESLCAPLRFGKPGSKILVTTRS
RSIAGMVGDADPIHLDRMEEKSFWEFFKKCAFGSSNSDIHYPHLEAMAKK
MTYKLKGLPLAAKTLGGLMSTKLDEQHWKSILDSKIWQLPQEENGIMPAL
QLSYQYLPPHLKQCFASCSLFPKDYEFSESELISLWIAEGFIVPQGSIRM
EELGSNYFHELVNRSFFQKSTTRLWKQGSQSNYFHELVYRRSFFQKLGTT
TDSRGRVFIQSSTDEKFVMHDLIHDLAELISMSESYRVEKGKSHAIPSTI
RHLSMYKKEEGMQTRGLTEFSHYNKLRTLILSSRYTRESFIFDCGVWEKF
KKIRVLGLRDCALRELPDSIGTLIHLRYLDLSCNRKIRRLPESLCDLYNL
QTLILQGCFNLESLPRGMMKLINLRKLDGVNHFILNIIEVGKLTSLQNLP
TFKVLKDNGYKLVELNGLKQLRGELCITNLENVKNKDEASIASLNRKEHL
NQLKLEWTFSQESGSEVNLQISEQVLEGLQPHHNLQWLTIRGYNGARPPN
WLHEQVYSRLDTLQLQNCKNWNDLLVIGQLSQLKHLCLVRIPVHTQNLHN
LFNPKHCKFFSQLEELVLEGITMLEDLPNLGQLPSLKSLDIRSLTGVKMI
DDKFFAATKEGSCFPKLHTLRFNNMSAWEEFYCSDDRNLFPCLDLLNISN
CQKLLMLPRLPPSITCLQLNNVGLEDCPRFWKAIDEDSSITNSASVTELF
IQECPKLEILEQGLLAHHLQQIYIHKCEQLLWMPVKRLKELTSLWSLSIT
ECPKLMSMTQDECIDFQLPPLITELCLYDCGNLSISLPGCLHNLTSLSVL
IIGKCPALISLPIKPLLNLNYLRIENCNELRSVEVLLIKSLRDLDVTGCP
MLQLSQREAQTEKLLLRKLVIDDTAFMQQSPIKNSLSVEILSISSSCEAV
MFEGEDQESLQSLTSLYQLSFSNCKNLQFLPTKLYTLTSLQVLQIHNCPQ
IQSLPEKGLPPALINLVFHGCHLALEQQLVIHLEEIKKSGRYDGITYG
>XP_042462923.1 disease resistance protein RGA2-like isoform X1 [Zingiber officinale]
MIGFALTALGWLAESFMVALAGKAVDRAVQQFGEQHGVEDDLKKLRDSLA
NGRLKISTIENLWLKDEVLQQRLNELLIGLKDAAYDADDLFDEFQYRILK
QQIEQQGDEAGNRASSSSYSTPPPGKKIKTSLSSYASGLFGKGDDDDNNN
DVQRMREIKGRLDDNSVALEKIYSSLGTEDDRGKKQLVSSESRQTSSFSI
EPQLFGRDKELQQLKDLLLKSEVASKFGQSGVSVLSITGIGGIGKTTLAQ
EVFHDNTVEEYFKLRIWVCVSENFSTERLTREIIEYTTKEKCNVPNFAAL
QVVLKEKITQERFLLVLDDVWNEERHKWESLCAPLRFGKPGSKILVTTRS
RSIAGMVGDADPIHLDRMEEKSFWEFFKKCAFGSSNSDIHYPHLEAMAKK
MTYKLKGLPLAAKTLGGLMSTKLDEQHWKSILDSKIWQLPQEENGIMPAL
QLSYQYLPPHLKQCFASCSLFPKDYEFSESELISLWIAEGFIVPQGSIRM
EELGSNYFHELVNRSFFQKSTTRLWKQGSQSNYFHELVYRRSFFQKLGTT
TDSRGRVFIQSSTDEKFVMHDLIHDLAELISMSESYRVEKGKSHAIPSTI
RHLSMYKKEEGMQTRGLTEFSHYNKLRTLILSSRYTRESFIFDCGVWEKF
KKIRVLGLRDCALRELPDSIGTLIHLRYLDLSCNRKIRRLPESLCDLYNL
QTLILQGCFNLESLPRGMMKLINLRKLDGVNHFILNIIEVGKLTSLQNLP
TFKVLKDNGYKLVELNGLKQLRGELCITNLENVKNKDEASIASLNRKEHL
NQLKLEWTFSQESGSEVNLQISEQVLEGLQPHHNLQWLTIRGYNGARPPN
WLHEQVYSRLDTLQLQNCKNWNDLLVIGQLSQLKHLCLVRIPVHTQNLHN
LFNPKHCKFFSQLEELVLEGITMLEDLPNLGQLPSLKSLDIRSLTGVKMI
DDKFFAATKEGSCFPKLHTLRFNNMSAWEEFYCSDDRNLFPCLDLLNISN
CQKLLMLPRLPPSITCLQLNNVGLEDCPRFWKAIDEDSSITNSASVTELF
IQECPKLEILEQGLLAHHLQQIYIHKCEQLLWMPVKRLKELTSLWSLSIT
ECPKLMSMTQDECIDFQLPPLITELCLYDCGNLSISLPGCLHNLTSLSVL
IIGKCPALISLPIKPLLNLNYLRIENCNELRSVEVLLIKSLRDLDVTGCP
MLQLSQREAQTEKLLLRKLVIDDTAFMQQSPIKNSLSVEILSISSSCEAV
MFEGEDQESLQSLTSLYQLSFSNCKNLQFLPTKLYTLTSLQVLQIHNCPQ
IQSLPEKGLPPALINLVFHGCHLALEQQLVIHLEEIKKSGRYDGITYG
>XP_042462931.1 disease resistance protein RGA2-like isoform X1 [Zingiber officinale]
MIGFALTALGWLAESFMVALAGKAVDRAVQQFGEQHGVEDDLKKLRDSLA
NGRLKISTIENLWLKDEVLQQRLNELLIGLKDAAYDADDLFDEFQYRILK
QQIEQQGDEAGNRASSSSYSTPPPGKKIKTSLSSYASGLFGKGDDDDNNN
DVQRMREIKGRLDDNSVALEKIYSSLGTEDDRGKKQLVSSESRQTSSFSI
EPQLFGRDKELQQLKDLLLKSEVASKFGQSGVSVLSITGIGGIGKTTLAQ
EVFHDNTVEEYFKLRIWVCVSENFSTERLTREIIEYTTKEKCNVPNFAAL
QVVLKEKITQERFLLVLDDVWNEERHKWESLCAPLRFGKPGSKILVTTRS
RSIAGMVGDADPIHLDRMEEKSFWEFFKKCAFGSSNSDIHYPHLEAMAKK
MTYKLKGLPLAAKTLGGLMSTKLDEQHWKSILDSKIWQLPQEENGIMPAL
QLSYQYLPPHLKQCFASCSLFPKDYEFSESELISLWIAEGFIVPQGSIRM
EELGSNYFHELVNRSFFQKSTTRLWKQGSQSNYFHELVYRRSFFQKLGTT
TDSRGRVFIQSSTDEKFVMHDLIHDLAELISMSESYRVEKGKSHAIPSTI
RHLSMYKKEEGMQTRGLTEFSHYNKLRTLILSSRYTRESFIFDCGVWEKF
KKIRVLGLRDCALRELPDSIGTLIHLRYLDLSCNRKIRRLPESLCDLYNL
QTLILQGCFNLESLPRGMMKLINLRKLDGVNHFILNIIEVGKLTSLQNLP
TFKVLKDNGYKLVELNGLKQLRGELCITNLENVKNKDEASIASLNRKEHL
NQLKLEWTFSQESGSEVNLQISEQVLEGLQPHHNLQWLTIRGYNGARPPN
WLHEQVYSRLDTLQLQNCKNWNDLLVIGQLSQLKHLCLVRIPVHTQNLHN
LFNPKHCKFFSQLEELVLEGITMLEDLPNLGQLPSLKSLDIRSLTGVKMI
DDKFFAATKEGSCFPKLHTLRFNNMSAWEEFYCSDDRNLFPCLDLLNISN
CQKLLMLPRLPPSITCLQLNNVGLEDCPRFWKAIDEDSSITNSASVTELF
IQECPKLEILEQGLLAHHLQQIYIHKCEQLLWMPVKRLKELTSLWSLSIT
ECPKLMSMTQDECIDFQLPPLITELCLYDCGNLSISLPGCLHNLTSLSVL
IIGKCPALISLPIKPLLNLNYLRIENCNELRSVEVLLIKSLRDLDVTGCP
MLQLSQREAQTEKLLLRKLVIDDTAFMQQSPIKNSLSVEILSISSSCEAV
MFEGEDQESLQSLTSLYQLSFSNCKNLQFLPTKLYTLTSLQVLQIHNCPQ
IQSLPEKGLPPALINLVFHGCHLALEQQLVIHLEEIKKSGRYDGITYG
>XP_042462938.1 disease resistance protein RGA2-like isoform X2 [Zingiber officinale]
MIGFALTALGWLAESFMVALAGKAVDRAVQQFGEQHGVEDDLKKLRDSLA
NGRLKISTIENLWLKDEVLQQRLNELLIGLKDAAYDADDLFDEFQYRILK
QQIEQQGDEAGNRASSSSYSTPPPGKKIKTSLSSYASGLFGKGDDDDNNN
DVQRMREIKGRLDDNSVALEKIYSSLGTEDDRGKKQLVSSESRQTSSFSI
EPQLFGRDKELQQLKDLLLKSEVASKFGQSGVSVLSITGIGGIGKTTLAQ
EVFHDNTVEEYFKLRIWVCVSENFSTERLTREIIEYTTKEKCNVPNFAAL
QVVLKEKITQERFLLVLDDVWNEERHKWESLCAPLRFGKPGSKILVTTRS
RSIAGMVGDADPIHLDRMEEKSFWEFFKKCAFGSSNSDIHYPHLEAMAKK
MTYKLKGLPLAAKTLGGLMSTKLDEQHWKSILDSKIWQLPQEENGIMPAL
QLSYQYLPPHLKQCFASCSLFPKDYEFSESELISLWIAEGFIVPQGSIRM
EELGSNYFHELVNRSFFQKSTTRLWKQGSQSNYFHELVYRRSFFQKLGTT
TDSRGRVFIQSSTDEKFVMHDLIHDLAELISMSESYRVEKGKSHAIPSTI
RHLSMYKKEEGMQTRGLTEFSHYNKLRTLILSSRYTRESFIFDCGVWEKF
KKIRVLGLRDCALRELPDSIGMF
>XP_042463327.1 uncharacterized protein LOC122046615 [Zingiber officinale]
MDKSASHSSEPCTSTLTIRIAGPSSEIGEKSVPISPSISLSPHLNSPSPP
SSAFVSALQSPYISPRALEPPNGNNSYSTTATMPSTTTSNSALHSDDIPS
TSYTPPSESSDFVADQIEQKHKFSDAMLPRISFSFPVPRTSLTRGSVSPP
SNLKLHGCDVYIGYNGNNHVLVRFCKWLKTELELQGIASFVADRAKYSDS
QSHEIADRIICSASFGVIVVTPSSFLNRLSVEEIRFFAQKKNLISVLFDT
ELSEIVSLSNERLEGKESREALEGFTKCNEFKIETNGSNWRSCISKVVAI
LKSRLGRRSIAEVETETFEELPFPRNGHFVGREKEVAEIEAAFFGCVEAH
EMECPKPSLTRGSSSDGFADEEIDTVRTSKKYISLEMRKSKEPTLEAWIE
PVIELPSKGRSLQKQRSKHKKSRCGANKGHGNASVFCVNGSWGIGKTELA
LEFAYRYAQRYRMVLWIGGETKYLRQNILNLSLKLGLDLSAEAEKERGRI
RSFDEQEFDAFLRVKRELFRDIPYLLVIDNLETEKEWWEGKDLHDLIPRN
TGATHVIITTRLSKVMSFEPMQLPLLSLADSLLLLKGRRKKDYTSEDSQV
LKKIVERMERLSFGMSVVGSLLSELPISPSELLETIDRISVNDGNEDGLW
RSSSFLMKTLAFCFAVVDQAAGRSLASRMAQTGAWFASVPVSSTLLAAAS
NNLPTKGSFCQWGKDLTDVFLCGTRCCLATSQARKTEVDSAMLLVNLGLA
KRSLRQPGCWIQLHPITQVFAKRKGGLPPAKAAVHGAMRAGNAAMNLDHL
WASAFLVFGFKQEPPLVQLSALDMAFFIRKTALPLAIRSFMTFSRCNSTL
ELLKVCTNALEEAEKSFVSQIQDWHRGRLCWTKKLQFNQKVDEYVWQDVT
LLKATLLETRAKLLLRGGHFDEGEELCRTCVSIRTVMLGHNHAQTLAAQE
TLAKLVRFRRKM
>XP_042464445.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAVSLTVVGGWVAQAFIQTLIDKASDTAIQLFAERRGFAADMKKLRTSLL
ETRIILDKVQSSGSNSTKWKTLMRDLKDAAYDAEDLIDEFQYHLLRQKIK
GEEEDKASGSSGLSNIFSAAKKRLFASSYSLGEDDIRARVREIQERLEGI
AISVKDIMKVLPPNDQPEVKFQARESCSSPVTDILFGRDKELNQVVDWLL
GSASQVKPASGFVNDTFSVLPIVGIGGVGKTTLAQYVHKDNRVQDHFHLK
IWVCVSDNFSVQRLTKSIIESVTLKKEYDNIELEPLQKILHQHIAKKKFL
LFLDDVWSDDKSIWEKFCALLKVGEHGSKIIVTTRDMKVSKMVSPAEPIL
LHDLDEDAFWKLFKKCSFGTLNPEDYPELEDIGRKIARKLKGSPLAAKTL
GSVLQLDLRKQHWATIMKSDIWKVKQDEDSIMPALHLSYQYLNENLKQCF
AFCSVFTKDTSYHKAHLVPMWMAEGFIEDNNTKRMEDVGNDYFLEFVNRS
FFQEFKHGFYPYMMHDLIHDLAEMIAEEETCKIQSNEQTKKLPSTVRHLL
VEKRKVPLELSGYDKLRTLLLKNSPPDSLFEKLRSIRVLDLSFCGLLELS
GHIGKLIHLRFLDLSYNTEIKFLPDSLCDLYHLQTLRARNCFSMESIPQE
LHKLVNLRHIDADEKIWLMIKDVWRLTNLQELLTFSVREGDALKLGQLKD
MTQFHGTLHIQNLENVVDSKEAQHAELKNKVHLQELVLKWNDEKDAKLEE
EVIEGLQPHESLEILKINGYNGGRSPSWLMPKVLSILKKLELVNCKRWDD
DLPFIGQRLHLIELLMDNMPALKRLSHEFEGKCFPKLEMLKLFNLPAFEE
WFWTDGKDLFPCMRELVVINCPKLKRLPPFPPSLETLIIRGCPELILNNE
TADDEECDRLLPPSLKVLELSDSGEYAKLLPDCLHNLCLVTRLTISHCPH
ITSIPLVQLVELRWLFINYCDELTRMESLGLLKSLELLQIIGCPKLVQLN
VEDEQAGSLSSLRKLCVDNTAVLKMFPLRNSLSFIIELEIAACSGEVIFE
EAMQSLTAVTSLIFYNCKKLQSLPTELLHSLPYLEELTVANCPQIHSLPD
IGLLPSLRMLTIDNCPQIHSLPEKGLPTLLECLNICDCPQIHEMPDQEGF
PKSLYVFRCIGDVHPTLKEQSQKFYTDRNMRERALKLE
>XP_042464484.1 disease resistance protein RGA2-like isoform X1 [Zingiber officinale]
MAFLLTAGGWFAPFFIQNLVDKASNKAIQLFAEGQGFEEDMDKLCTSLLK
TQIILDEVQSSGSNSTKWKTLMQELKDAAYDAEDLIDEFQYHVFKKKIKD
EEKYEASGSIGLPNILSRAKKKLFGSSYYMRERVRRIQGKLERIANSMES
IKNVLPRNDKGMQPEVKFQARESCSSPVTDILFGRDKELNQVVDWLLGSA
SQVELESGFANDTFSVLPIVGIGGAGKTTLAQYVHRDDRVQDHFHLKIWI
CVPDNFTVQGLTKSIIESVTLQKQYDSMRLEPLQKILQQHIAKKKFLLFL
DDMWSDEKSIWENFCALLKVGAHGSKIIVTTRDMKVSKMVSLVEPILLHG
LDEDAFWQLFNKCSFGTLNPKDYPELENIGRKIAHRLKGSPLAAKTLGRV
LQSNLCQQHWATVMESDIWKVKQDEDSIMPALHLSYQYLNENLKQCFAFC
SLFPKDYEFNKDKLIQMWMAEGFIEDKNTNRMEDVGSDYFLEFVNRSFFE
EFGNYGLYHFVMHDLIHDLAEMIAAEETCRIKSNERRKMLATVRHLRVEE
RILPLEFSGFDKLRTLVLRNSPPNSLFGKLRSIRVLDVSRCHFRELSKHI
DKLIHLRYLDLSYNSEIKILPNSLGDLYNLQTLKVKGCSKLESIPQELGK
LVNLRHIDANCKFWVLMKDVRRLTNLQELPTFRVQEDDAHKLGQLKDMTQ
LHGTLNIQNLENVVDSKEAHHAELKNKVHLKELELEWNDEKDAKLEEEVI
EGLQPHESLKKLRIRGYNGAKSPSWLMPKVLSNLEKLDLVDCKGWDDVLP
FIGQRLHLIKLYMINMPALKQLSHEFEGKCFPKLEVLYLFDLPALEEWSW
TEGRDLFPCMRKLCVQICPKLKRLPPFPPSLEKLTIVRCPKLILNSKTEV
DEEGGRHFPPSLKVLELINCGEYAKLLPDCLHNLCLVTRLEIGHCPHITS
IPLVQLVELQYLNISNCDELRRMECLGLLISLKKLKIVGCPKLVQLDVED
ERAQSLSSLLKLCVDNTDLLKMFPLRNSLSFITKLQIESCSEEVIFIEPI
LVRSLTAVTSLRFIDCDKLQSLPTELLHCLPFLEKLVMYHCPQLQSLPEK
GILPSLRILKIDDCPRIQSLSEKGLPPLLEELNIFDCPQIRAMPEDGLPM
SLIFFHCFGDVHPTLKEQSEKFYADRKRRVSTLDASYFHV
>XP_042464494.1 disease resistance protein RGA2-like isoform X2 [Zingiber officinale]
MAFLLTAGGWFAPFFIQNLVDKASNKAIQLFAEGQGFEEDMDKLCTSLLK
TQIILDEVQSSGSNSTKWKTLMQELKDAAYDAEDLIDEFQYHVFKKKIKD
EEKYEASGSIGLPNILSRAKKKLFGSSYYMRERVRRIQGKLERIANSMES
IKNVLPRNDKGMQPEVKFQARESCSSPVTDILFGRDKELNQVVDWLLGSA
SQVELESGFANDTFSVLPIVGIGGAGKTTLAQYVHRDDRVQDHFHLKIWI
CVPDNFTVQGLTKSIIESVTLQKQYDSMRLEPLQKILQQHIAKKKFLLFL
DDMWSDEKSIWENFCALLKVGAHGSKIIVTTRDMKVSKMVSLVEPILLHG
LDEDAFWQLFNKCSFGTLNPKDYPELENIGRKIAHRLKGSPLAAKTLGRV
LQSNLCQQHWATVMESDIWKVKQDEDSIMPALHLSYQYLNENLKQCFAFC
SLFPKDYEFNKDKLIQMWMAEGFIEDKNTNRMEDVGSDYFLEFVNRSFFE
EFGNYGLYHFVMHDLIHDLAEMIAAEETCRIKSNERRKMLATVRHLRVEE
RILPLEFSGFDKLRTLVLRNSPPNSLFGKLRSIRVLDVSRCHFRELSKHI
DKLIHLRYLDLSYNSEIKILPNSLGDLYNLQTLKVKGCSKLESIPQELGK
LVNLRHIDANCKFWVLMKDVRRLTNLQELPTFRVQEDDAHKLGQLKDMTQ
LHGTLNIQNLENVVDSKEAHHAELKNKVHLKELELEWNDEKDAKLEEEVI
EGLQPHESLKKLRIRGYNGAKSPSWLMPKVLSNLEKLDLVDCKGWDDVLP
FIGQRLHLIKLYMINMPALKQLSHEFEGKCFPKLEVLYLFDLPALEEWSW
TEGRDLFPCMRKLCVQICPKLKRLPPFPPSLEKLTIVRCPKLILNSKTEV
DEEGGRHFPPSLKVLELINCGEYAKLLPDCLHNLCLVTRLEIGHCPHITS
IPLVQLVELQYLNISNCDELRRMECLGLLISLKKLKIVGCPKLVQLDVED
ERAQSLSSLLKLCVDNTDLLKMFPLRNSLSFITKLQIESCSEEVIFIEPI
LVRSLTAVTSLRFIDCDKLQSLPTELLHCLPFLEKLVMYHCPQLQSLPEK
GILPSLRILKIDDCPRIQSLSEKGLPPLLEELNIFDCPQIRAMPEDGLPM
SLIFFHCFGDVHPTLKEQSEKFYADRKRRLTTARLELE
>XP_042464508.1 putative disease resistance protein RGA1 [Zingiber officinale]
MALSLTVGGWLAQAFIQTLIDKASDKAIQLFAERRGFAEDMKKLRTSLLQ
TQITLDEVQSSRSNNIKWKTLMQELKDASYDAEDLIDEFQYNILRQKIKG
EEEDKASGSSGLLSILPAAKKLFGSSYDMRARVREIQERLETSMKSIVNL
PATHDRRKQPEVKFQARESCSSPMADKLIGREKELNQVVDWLLGSANQVE
PASGFVNDTFSVLPIVGIGGAGKTTLAQYAHKDNRIQDHFHLKIWVCVSD
NFTVQGLTKSIIESVTLQKQDENMGLEPLQKILHQHIAKKKFLLVLDDVW
SDDKSIWEKFCALLKVGSHGSKIIVTTRDMKVSKMVSLTEPILLHGLDAD
AFWQLFMKCSFGTLNPEDYPGLEDIGRKIARKLKGSPLAAKTIGRVLRSN
VCQQHWATIMESDIWKVKQDEDDIMPALQLSYQYLDENLKQCFAFCSLFP
KDHKFDKVELIRMWMAEGFINEDKNTKSMEDVGSDYFLEFVNSSFFQEFR
YHYEFGDGFGIRIVMHDLIHDLAEMISAEETCRIENSRHTKPPSTTRHLR
VEKEKLPLEFSGYNKLRTLVSKLSLPDSSLFEILRSIRVLDVSWCGLLEL
SEHIGKLIHLRYLDISGNSKVKILPDSLCDLYNLQTLKAECCSELESIPQ
ELGKLVNLRHFDISSNFKIKILPDSLCDLYNLQTLKVNSCSELESIPQEL
GKLVNLRQIDADGEFWVMLKDVRRLTNLQELPIFSVQEDDAFKLGQLKDL
TQLHGTLCIQNLENVVDGKEAQRAKLKSKVHLKELVLDWNLRWYGGKDAK
LDEEVIEGLQPHESLKILTIRRYNGGRSPSWLMPKVLSNLEKLELENCME
WDDVLPFIGQRLHLIELRMTDMPALKRLSHEFEGKCFPKLQVLKLCKFKA
LREWSCTEGKDLFPCLRELCVIDCPKLKRLPPFPPSLEMLTIECCPRLIL
NSKTEDDEEGGRHLPPSLKELKLTDCGEYAKLLSDCLHNLTRLEINDCLY
IPSISLVQLVELQCLCISDCDELRRIECLGLLKSLKELKIVECPKLVQLD
VGDEQAGSLSSLRKLCVDNTALLKMFPLRNSLPFITELEIESCSEEVIFV
EPIWVPSLAAVTSLTLRNCKKLQYLPTELLHGLPLLENLIMKNCPQIKSL
PDKGLPPRLQRLQIYGCPHIQLQAIPENLLPIIPFM
>XP_042464516.1 putative disease resistance protein RGA1 [Zingiber officinale]
MALSLTVGGWLAQAFIQTLIDKASDKAIQLFAERRGFAEDMKKLRTSLLQ
TQITLDEVQSSRSNNIKWKTLMQELKDASYDAEDLIDEFQYNILRQKIKG
EEEDKASGSSGLLSILPAAKKLFGSSYDMRARVREIQERLETSMKSIVNL
PATHDRRKQPEVKFQARESCSSPMADKLIGREKELNQVVDWLLGSANQVE
PASGFVNDTFSVLPIVGIGGAGKTTLAQYAHKDNRIQDHFHLKIWVCVSD
NFTVQGLTKSIIESVTLQKQDENMGLEPLQKILHQHIAKKKFLLVLDDVW
SDDKSIWEKFCALLKVGSHGSKIIVTTRDMKVSKMVSLTEPILLHGLDAD
AFWQLFMKCSFGTLNPEDYPGLEDIGRKIARKLKGSPLAAKTIGRVLRSN
VCQQHWATIMESDIWKVKQDEDDIMPALQLSYQYLDENLKQCFAFCSLFP
KDHKFDKVELIRMWMAEGFINEDKNTKSMEDVGSDYFLEFVNSSFFQEFR
YHYEFGDGFGIRIVMHDLIHDLAEMISAEETCRIENSRHTKPPSTTRHLR
VEKEKLPLEFSGYNKLRTLVSKLSLPDSSLFEILRSIRVLDVSWCGLLEL
SEHIGKLIHLRYLDISGNSKVKILPDSLCDLYNLQTLKAECCSELESIPQ
ELGKLVNLRHFDISSNFKIKILPDSLCDLYNLQTLKVNSCSELESIPQEL
GKLVNLRQIDADGEFWVMLKDVRRLTNLQELPIFSVQEDDAFKLGQLKDL
TQLHGTLCIQNLENVVDGKEAQRAKLKSKVHLKELVLDWNLRWYGGKDAK
LDEEVIEGLQPHESLKILTIRRYNGGRSPSWLMPKVLSNLEKLELENCME
WDDVLPFIGQRLHLIELRMTDMPALKRLSHEFEGKCFPKLQVLKLCKFKA
LREWSCTEGKDLFPCLRELCVIDCPKLKRLPPFPPSLEMLTIECCPRLIL
NSKTEDDEEGGRHLPPSLKELKLTDCGEYAKLLSDCLHNLTRLEINDCLY
IPSISLVQLVELQCLCISDCDELRRIECLGLLKSLKELKIVECPKLVQLD
VGDEQAGSLSSLRKLCVDNTALLKMFPLRNSLPFITELEIESCSEEVIFV
EPIWVPSLAAVTSLTLRNCKKLQYLPTELLHGLPLLENLIMKNCPQIKSL
PDKGLPPRLQRLQIYGCPHIQLQAIPENLLPIIPFM
>XP_042464619.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MAFIKLNFNVDVHKCLSGLKATLGLGRPKSSIDKLEKEMERLRAKRDDIR
NQIVEAVLEGKVPTNEVNRWLDEVEELEGKVTAINQDFQSMSCFSCNCFN
QTGGATNQTRQVGDQVPIRESSNCYSINRRAAEKLNEANELMSRTNALDP
IAITTIPSRIGSDIQETMARLRAKRDDIENQIKQAEREGKIPTNEVSQWL
LEVEKLDGQVATINQVPIRESSSHHSIRAKKCNEINELMIRADVLDPIAT
VGPPKPIVTLPIVYRSHVGIGSYVEEIVGYIDGGKDNIIGIHGMGGVGKT
TVLKSIQHHYLLKHTIFDPVIWVVASKDCQLKRLQMDIAKSLGLKTLQES
DDEQTCSDKLFSYLKNKKCLLFLDDIWEHVDLQLLGMAHSATDQGQQQQR
KVVVFTTRNLIVCAQMEAEKKIKIECLNPAQAWQLFVKNFKSDAPFSDAG
IYSVAQELVKECAGLPLALITVARAMLGNKSRDVWNHALHQIRNKHQWTT
IGLSEDSTVMYKAFKLSYDSLKNDSIRECLLCCALWPEDHDIHKFEELIP
CWIGCGIIHNDIVFPPYSINDAFQQGCLHLEALINASLLEHSSRRPDYYE
AQHVKMHDVIRDMTLLTLKGNKRKWIVKAGIGLRHLPRQEEWQEIERASF
MDNEITSLQDYGASTFPKLSMLNLHSNHLSEIHPMLFTNMPRLTYLNLSL
NLGIEELPKEIGCLTELQYLNLSETSITNLPAEFGRLGKLKYLFLRDTKL
ETVPNGTISNLSMLKFLDIREIYPSHEWWWDELEHFRRRPKYLSLGITID
PDKLKRLDTLPYNVFVRSLTVRGLGSSKLPEYNLGTLQWNHKASGWVESL
EISDVPGDELTMTEDWNRMLEFNCLKTLCFRTLEQLENVRFNQVEVGYKF
KNLRDLYICGCNKLKDVSWVLHLPYLNLLDIKNCEEIEELISNLGNSNSI
SPIRMLSLNGMRNLHRFAHQPFQFPALEYIRVLYCPRLKKLPFEAKMLEK
MEGEKEWWNNCNWDEESNDFPTCFRLKEIEGEKDWWNNLDWDDESIKDSL
TPYFREVFY
>XP_042464694.1 disease resistance protein RGA2-like [Zingiber officinale]
MSKVSNLDKTKTNTLPTVTNCSYPIYLLTDACRVDRVGLAISKQAKRLVP
LGDRYRHDPGTRPTTDLKEEQRFALFCNQVAVSLTVGGWLAQAFIQTLID
KASDKAIQLFAERRGFAEDMKKLHTSLLQTQITLDEVQSSRSNNIKWKTL
MQELKDASYDAEDLIDEFQYNILRQKIKGEEEDKASGSSGLLSILPAAKK
LFGSSYDERARVREIQGRLETSMKSIVNLPATHDRGKQPEVKFQARESCS
SPVADKLIGREKELNQVVEWLLGSANQVEPAYGFVNDTFSILPIVGIGGA
GKTTLVQYAHKDNRVQDHFHLKIWVCVSDNFTVQGLTKSIIESVTLQKQD
ENMGLEPLQKILHQHIVKKKFLLVLDDVWSDDKSIWEKFCALLKVGAHGS
KIIVTTRGMKVSKMVSLAEPILLHGLDEDAFWQLFNECSFGTLNPEDYPG
LEDIGRKIARKLKGSPLAAKTIGRVLRSNICQQQWATVMESDIWKVKQDE
DDIMPALQLSYQYLDENLKHCFAFCSLFPKDHKFDKTELVRMWMAEGFIN
EDKNTKSMEDVGSDYFLEFVNNSFFQESDIIMNFGMDLGLEL
>XP_042464828.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAVSLTVVGGWFAQAFIQTLIDKASDKAIQLFAERRGFAADMETLCTSLL
ETQIILDKVQSSQSNDTKWKTLMQKLKDAAYDAEDLIDEFQYHVLRQKIN
GEEEDKAVSGSGGLPNIFSAAKEKLFGSSHSLEEEAMRASVVEIQGRLER
IANSMKSIMNVLPPNDRGKQPDQMKFQSRESCSSPVTDILFGRDKELNQV
VDWLLGSANQVEPASGFLNDALSVLPIVGIGGAGKTTLAQYAHKDNRVQE
HFQLKIWVCVSDNFTVQRLTKSMIESVTLKKEYDNMELESLQKILHQHIA
QKKFLLVLDDLWSDNKRIWEKFCALLKVGAYGSKIIVTTRDMKISKMVSM
VEPILLHGLDEDTFWQLFKKCSFGTLNPEEYPELEDIGRKIVRKLKGSPL
AAKTLGGVLQSNLCQQHWATVMESDIWKVKQDEDDIMPALHLSYQYLNEN
MKQCFAFCSVFPKDYRFGKAELVRMWMAEGFIKDKNTKRMEDVGSDYFLE
FVNKSFFQEYEFGAFVMHDLEYEFGAFVMHDLIHDLAEMISAEETCRIKN
NRQTKMLSTIRHLRVEEEEKLPLEFSGYDKLHTLLLRTNSPPDNLFEKLR
SIRILDVSWCDLEELSEHIGKLIHLRYLDISWNSKIKILPDSLCDLYNLQ
TLKVNGCSKLESIPQELGKLVNLRHIDAGYEFWNMIKLDVHRLTNLQELP
TFSVREDDELKLGRLKDLTQLHGTLRIQNLENVVDSKEAQRAGLKSKVHL
KKLVLEWNYWKLHGGKDAILDEEVIEGLQPHESLKMLKIRGYNGGRSPSW
LMPKVLSNLEKLELVNCKGWDDVLPFIGQRLHLIELRMEDMPALKQLSHE
FSGKCFPKLKVLNLLNLPALEEWSWTEGKDLFPCMRELRVRDCPKLNRLP
SFPPSLEKLKISWCPSLIFNSKMKDDEEGGCYLPPAVKVLELDNCGEYSK
LLLECLSNLHLVTRLTIRHCPHITSIPPVQLVELQYLYISKCDELRRMEC
LGLLKSLERLKIVGCPKLVQLDVEDEQAARLLSSLRYLCVDNTALLKMFP
LRNSLSFITELEIESCPEEMIFEEPILVRSLTAVTSLSFNCCDKLQSLPT
ELLHCLPFLKKLMVSNCPQLQSLPEIGLSPFLKTLEICNCPQIQPMPEDG
LPMSLDVFHCSGNAHPTLMKHYKKFHADRCR
>XP_042464837.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAVSLTVVGGWFAQAFIQTLIDKASDKGMQLFAERRGFTADMDKLRISLL
ETQIILDEVQISRSNNTKWKRLMQELKDAAYDAEDLIDEFQYHFLRKKVK
GEEDDKESGSSGLPDIFSAAKEKLFGSSHSLEEDAMRASVVEIQGRLERI
ANSMKSIMNVLPPNDRGKQPDQVKFQTRESCSSPVTDILFGRDKELNQVV
DWLLESANQVEPASGFLNDALSVLPIVGIGGAGKTTLAQYAHKDNRVQNH
FHLKIWVCVSNNFTVQGLAKSIIESVTLQKQYDNMGLESLQKILHQHIAQ
KKFLLVLDDVWSDNKRIWEIFCALLKVGAYGSKIIVTTRDMKVSKMVSLA
EPILLDGLDKDAFWQLFKKCSFGTLNPEDYPELEDIGRKISHKLKGSPLA
AKTLGSVLQSDLCQQHWAIIMESDIWKVKQDEDDIMPALHLSYQYLNENL
KQCFAFCSLFPKDYRFYKAELIQMWMAEGFIEDKNTKKMEDVGSDYFLEF
VNRSFFQEFRYDYEFEDEFVMHDLIHDLAEMISTEEIYRIENNRQTKPPS
TTRHLRVEEEKLPLEFSGYNKLRTLMLRKNLPTDSLFEKLRSIRVLDVSW
CDLQELSEHIGKLIHLRYVDISYNFKIKILPGSLCDLYNLQTLKVICCPE
LQFIPQELGKLVNLRHIVADDEFWVMIKDVRKLTNLQELQRFSVEEDDRL
KLGQLKDLTQLHGTLCIQNLENVVDSKEAQHAELKNKVHLKQLELDWNDE
KDAKLEEEVIEALQPHESVKILKVEGYNGGRSPSWLMPKVLPNLEKLELV
NCNGWDDVLPFIGQRLHLIELIMYSMPALKQLSHEFEGKCFPKLKVLNLW
NLPALEEWSWTEGKDLFPCMRKLLVSNCPKLKRLPPFPPSLEILEIKKCP
NLILNSKTEDEEEVDRHALPSLKVLELANSGEYAKLLTDFLHNLRLVTRL
NIRDCPYITSIPQAQLLELQYLSISNCVELRRMECLGLLKSLKELRIVGC
PKLVQLDVGDEQAGRLSSLRKLYVDNTALLKMFPLRNSLSFITELKIESC
SEEVIFEELILARSLTAVTSLSFSYCKKLQSLPTKLLHSFPLLENLMVYC
CPQLQSLPEIGLSPLLKKLEICHCPQIQAMPEDGLPMSLDVFKCSGYVHP
TLMEQSEKFNAKREMRRASTLDARYFHDIEVV
>XP_042464849.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAVSLTVVGGWFAQAFIQTLIDKASDKSIQLFAERRGFAADMDKLRISLL
ETQIILDEVQISRSNNTKWKRLMQELKDAAYDAEDLIDEFQYHVLRQKVK
GEEENKASGSSGLPNIFSVAKEKLFGSSHSLEEDAMRASVVEIQGRLERI
ANSMKSIMNVLPSNDRGKQPDQVKFQARESCSSPVTDILFGRDKELNQVV
DWLLGSANQVEPASEFVTDTFSVLPIVGIGGAGKTTLAQYAHKHNRVQVH
FHLKIWVCVSDNFTVQGLAKSVIQSVTPQKQYDSMGLEPLQKLLHEHIAN
KKFLLVLDDVWSDNKSIWHKFCALLKVGAHGSKIIVTTRDMKVSKMVSLV
EPILLHGLDEDAFWQLFKKCSFGTLDPTDYPELEDIGRKIARKLKGSPLA
AKTLGSVLKSDLCQQHWDTIMKSDIWKVKQDEDDIMPALHLSYQYLNENL
KQCFSFCSVFPKDYVFEEAELVRMWMAEGFIEDKNTKRMEDVGSDYFLEF
VNRSFFQEFKFGGFVMHDLIHDLAEMISAEDTCSIEIKRQTNTLSIVRHL
RVEGKLPLEFFGYDKLHTLLLRTKSPPDSIFEKLRSIRVLDVSWCDLQEL
SEHISKLIHLRYLDISWNSEIKILPNSLCDLYNLQTLKIQGCDELKSVPQ
ELSKLANLRHIYADPKFWKMIKDVRKLTNLQELSIFRVQEDDGLKLGQLK
DMTQLHGTLGICNLENVVDSTEAQQAELKNKVRLNKLVLEWNDKKDAKLE
EEVIEGLQPHESLKILKIEGYNGGRSPSWLMPKVLSNLEELELANCKGWD
DVLPFIGQRLHLIELRMTNMPALKRLSHEFEGKCFPKLKVLELSYFPALR
EWSWTEGKDLFPCMRELRVCLCPKLKRLPPFPPSLEILRIEDCPKLILNS
RTEDDGEGGCYLPPSLKVLELDNCGEYSKLLPECLPNLRLVTRLTIRHCP
HKTSIPLVQLDVEDEQAASFLSSLRYLCVDNTALLKMFPLRNSLPFITEL
EINSCSEEVIFEEEILVRSLPAVTSLSFCFCDALQSLPTELLHSFPFLEE
LKIHNCPQLQSLPDIGLSPFLKTLRICYCPQIPAIPEAGLPQSLEIFDCF
GNVHPTLKEQSQKFYADRYDIGEQGWN
>XP_042464861.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAVALTVGGWFAQAFIQTLIDKASDKSIQLFAQRRGFAEDMENLHPSLLE
IQIILDEVQISRSNNTKWKTLMQELKDAAYDAEDLIDEFQYHVLRQKIKG
EEEDKVAGGSSGLSNMFYAAKKKLLGSSHSLEEDDTRARVRKMQGRLEKI
ANRMKSIMNVLPPHDRRKQPEVKFQARESCSSPATDIMFGRDKELNQVVD
WLLESANQVEPASAFVNDTFSVLPIVGIGGAGKTTLAQYAHKHNRVQVHF
HLKIWVCVSDNFTVQGLAKSIIQSVAPQKQYDNMGLEPLQKLLHEHIADK
KFLLVLDDVWSDNKSIWHKLCALLKVGAHGSKIIVTTRDVKVSKMVSLVE
PILLHGLDEDAFWQLFKKCSFGTLNPGDYPELEDIGRKIARKLKGSPLAA
KTLGSVLQSDLRQQHWDTIMKSDIWKVKQDEEDIMHVLHLSYEYLNENMK
QCFAFCSVFPKDYKFDKAVLVQMWIAEGFIEDKNTKRMEDVGSDYFLEFV
NRSFFQEFGYGLFVMHDLIHDLAEMISAEETCRIENNRQTKMLSTIRHLR
VEEEGKLPLEFSGYDKLHTLMLRKNSPPNSLFEKLRSIRVLDVSWCGLQE
LSEHIGKLIHLRYLDISWNSEIKILPDSLFDLYNLQTLKVEGCSKLEYIP
QELSKLVNLRCIDADDMFLVMVKDVRRLTNLQELPTFSVQEDDGLKLEQL
KDMTQLHGTLHIQNLENVVDSTEAQQAELKNKVRLNKLVLEWNDEKDAKL
EEEVIEGLQPHKSLKILKIKGYNGGRSPSWLMPKVLSNLEKLYLVNCKGW
DDVLPFIGQRLHLIELHMDGMPALKQLSHEFEGKCFPKLEVLYLYELPAL
EEWSWTEGKDLFPCMRELRVSYCHKLKRLPPFPPSLEMLTIECCPRLKLN
SRTEDDEEGGCHLPPSLKGLKISQWPHITSISLVQSVELQYLYISKCDEL
RWMECLGVLKSLKQLNIVGCPKLVQLDVEDEQSASLLPSLRYLCVDNTAL
LKMFPLRNSLPFITELVFVSCSEEVIFEEPILVRSLTAVTSLSFIGCEKL
QSLPAKLLHCLPFLKTLMVYNCPQLQSLPEIGLSPFLKTLDICDCPQIQA
MPEDGLPMSLDDFQCSGDVHPNLKEQSDKFFVDTYNKRKARLELE
>XP_042464870.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAVALTVGGWFAQAFIQTLIDKASDKSIQLFAQRRGFAEDMENLHPSLLE
IQIILDEVQISRSNNTKWKTLMQELKDAAYDAEDLIDEFQYHVLRQKIKG
EEEDKVAGGSSGLSNMFYAAKKKLLGSSHSLEEDDTRARVRKMQGRLEKI
ANRMKSIMNVLPPHDRRKQPEVKFQARESCSSPATDIMFGRDKELNQVVD
WLLESANQVEPASAFVNDTFSVLPIVGIGGAGKTTLAQYAHKHNRVQVHF
HLKIWVCVSDNFTVQGLAKSIIQSVAPQKQYDNMGLEPLQKLLHEHIADK
KFLLVLDDVWSDNKSIWHKLCALLKVGAHGSKIIVTTRDVKVSKMVSLVE
PILLHGLDEDAFWQLFKKCSFGTLNPGDYPELEDIGRKIARKLKGSPLAA
KTLGSVLQSDLRQQHWDTIMKSDIWKVKQDEEDIMHVLHLSYEYLNENMK
QCFAFCSVFPKDYKFDKAVLVQMWIAEGFIEDKNTKRMEDVGSDYFLEFV
NRSFFQEFGYGLFVMHDLIHDLAEMISAEETCRIENNRQTKMLSTIRHLR
VEEEGKLPLEFSGYDKLHTLMLRKNSPPNSLFEKLRSIRVLDVSWCGLQE
LSEHIGKLIHLRYLDISWNSEIKILPDSLFDLYNLQTLKVEGCSKLEYIP
QELSKLVNLRCIDADDMFLVMVKDVRRLTNLQELPTFSVQEDDGLKLEQL
KDMTQLHGTLHIQNLENVVDSTEAQQAELKNKVRLNKLVLEWNDEKDAKL
EEEVIEGLQPHKSLKILKIKGYNGGRSPSWLMPKVLSNLEKLYLVNCKGW
DDVLPFIGQRLHLIELHMDGMPALKQLSHEFEGKCFPKLEVLYLYELPAL
EEWSWTEGKDLFPCMRELRVSYCHKLKRLPPFPPSLEMLTIECCPRLKLN
SRTEDDEEGGCHLPPSLKGLKISQWPHITSISLVQSVELQYLYISKCDEL
RWMECLGVLKSLKQLNIVGCPKLVQLDVEDEQSASLLPSLRYLCVDNTAL
LKMFPLRNSLPFITELVFVSCSEEVIFEEPILVRSLTAVTSLSFIGCEKL
QSLPAKLLHCLPFLKTLMVYNCPQLQSLPEIGLSPFLKTLDICDCPQIQA
MPEDGLPMSLDDFQCSGDVHPNLKEQSDKFFVDTYNKRKARLELE
>XP_042464878.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAVALTVGGWFAQAFIQTLIDKASDKSIQLFAQRRGFAEDMENLHPSLLE
IQIILDEVQISRSNNTKWKTLMQELKDAAYDAEDLIDEFQYHVLRQKIKG
EEEDKVAGGSSGLSNMFYAAKKKLLGSSHSLEEDDTRARVRKMQGRLEKI
ANRMKSIMNVLPPHDRRKQPEVKFQARESCSSPATDIMFGRDKELNQVVD
WLLESANQVEPASAFVNDTFSVLPIVGIGGAGKTTLAQYAHKHNRVQVHF
HLKIWVCVSDNFTVQGLAKSIIQSVAPQKQYDNMGLEPLQKLLHEHIADK
KFLLVLDDVWSDNKSIWHKLCALLKVGAHGSKIIVTTRDVKVSKMVSLVE
PILLHGLDEDAFWQLFKKCSFGTLNPGDYPELEDIGRKIARKLKGSPLAA
KTLGSVLQSDLRQQHWDTIMKSDIWKVKQDEEDIMHVLHLSYEYLNENMK
QCFAFCSVFPKDYKFDKAVLVQMWIAEGFIEDKNTKRMEDVGSDYFLEFV
NRSFFQEFGYGLFVMHDLIHDLAEMISAEETCRIENNRQTKMLSTIRHLR
VEEEGKLPLEFSGYDKLHTLMLRKNSPPNSLFEKLRSIRVLDVSWCGLQE
LSEHIGKLIHLRYLDISWNSEIKILPDSLFDLYNLQTLKVEGCSKLEYIP
QELSKLVNLRCIDADDMFLVMVKDVRRLTNLQELPTFSVQEDDGLKLEQL
KDMTQLHGTLHIQNLENVVDSTEAQQAELKNKVRLNKLVLEWNDEKDAKL
EEEVIEGLQPHKSLKILKIKGYNGGRSPSWLMPKVLSNLEKLYLVNCKGW
DDVLPFIGQRLHLIELHMDGMPALKQLSHEFEGKCFPKLEVLYLYELPAL
EEWSWTEGKDLFPCMRELRVSYCHKLKRLPPFPPSLEMLTIECCPRLKLN
SRTEDDEEGGCHLPPSLKGLKISQWPHITSISLVQSVELQYLYISKCDEL
RWMECLGVLKSLKQLNIVGCPKLVQLDVEDEQSASLLPSLRYLCVDNTAL
LKMFPLRNSLPFITELVFVSCSEEVIFEEPILVRSLTAVTSLSFIGCEKL
QSLPAKLLHCLPFLKTLMVYNCPQLQSLPEIGLSPFLKTLDICDCPQIQA
MPEDGLPMSLDDFQCSGDVHPNLKEQSDKFFVDTYNKRKARLELE
>XP_042464916.1 putative disease resistance protein At3g14460 [Zingiber officinale]
MAVALTVGGWFAQAFIQTLIDKASDKSIQLFAQRRGFAEDMENLHPSLLE
IQIILDEVQSSGCNDTKWKTLIQELKDAAYDAEDLIDEFQYHVLRQKIKG
EEEDKVATGSSGLSNMFYAAKKRLLGSSHSLEEDDTRARVRKMQGRLEKI
ANRMKSIMNVLPPNDRRKQPEVKFQARESCSSPATDKMFGRDKELNQVVD
WLLGSANQVELASGFVNNTFSVLPIVGIGGAGKTTLAQYAHKDNRVQEHF
HLKIWVCVSNNFTVQRLTKSMIESVTLKKEYDNMELECLQKILHQHIAQK
KFLLFLDDVWSDNKNIWHKFCALLKVGAHGSKIIVTTRDMKVSKMVSLVE
PILLHGLDEVAFRQLFNKCSFGTLDPEDYPELQDSGRNIADKLKGSPLAA
KTLGSVLQSDLCQQHWDTIMKSDIWKVKQDEDDIMPALHLSYQYLNENLK
QCFSFCSVFPKDYVFEEAELVRMWMAEGFIEDKNTKRMEDVGSDYFLEFV
NRSFFQKFKFGGFVMHDLIHDLAEMISAEDTCSIEKKRQTKTLSTVRHLR
VEGKLPLEFFGYDKLRTWMLRKTSPPNSLFEKLRSIRVLNVSQCGMQELS
EHIGKLIHLRYLDISFNYEIKILPDSLCDLYNLQTLKAQQCIAMESVPQE
LCKLVNLRCIDADDMFLVMIKDVRRLTNLQELPTFSVQEDEGLKLVQLKD
LTQLHGSLHIQNLENVVDSKEAQDAELKNKVHLKELVLEWNDEKDAKLEE
EVIEGLQPHESVKILKIEGYNGGRSPSWLMPKVLPNLEKLELVNCMGWDD
VLPFIGQRLHLIELSMEDMPALKQLSHQFEGKCFPKLEVLYLFDLPALEE
WSWTEGKDLFPCMRVLRVIDCPKLKRLPPFPPSLEILAIEHCPSLILNSK
TEDDEEADGHLPPSLKELELRDCGKYEKLLLDCLHNLRLVTRLEINDFPH
ITSISLVHLVELQYLCITNCEELRWMECLGLLKSLKKLKIVGCPKLVQLD
VEDEQSASLLSSLHTLCVDNIALLKMFPLRNSLSFITELLFVSCSEEVIF
EEAILVRSLTAVTSLSFLRCDKLRSLPAELLHCLPFLKTLMVSNCPQLQS
LPEMGLSPFLERLEIYNCPQIQAMPEDGLPMSLDVFICSGDVYPKLTEKS
EKFFVDRYNRRVKLELVWNKNLDGSINYNKKDLVL
>XP_042464929.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAVPLTVVGGWFAQAFIQTLIDKASDKAIQLFAESRGFAEDMENLHPSLL
EIQIILDEVQSRGCNDTKWKTLIQELKDAAYDAEDLIDEFQYHALRQKIK
GEEEDKAASGSSGLSNMFYAAKIKLLGSSHSLEEDDMRARVRKMQGRLER
IANRMKSIINVLPRNDRRKQPNQMKFQTRESCSSPVTDVLFGRDKELNQV
VDWLLGLANQVELASGFFSNTFSVLPIVGIGGVGKTTLAQYAYKDIRVQD
HFHLKIWVCVSDDFTVQGLTKSIIQSVTPQKQYDNMGLEPLQKLLHEHIE
NKKFLLVLDDVWSDNKSIWETFCALLKVGAHGSKIIVTTRDMQVSKMVSL
AEPILLHGLDEDAFWQLFKKCSFGTLSPEDYPGLEDIGRKIARKLKGSPL
AAKTIGRVLQSNICQQHWATIMESDIWKVKQNEDDIMPALQLSYQYLDEN
LKQCFAFCSFFPKDYKFDKAELIQMWMAEGFIEDTKRMEEVESDYFLEFV
NRSFFQESEYDQFVMHDLIHDLAEMISAEEICRIKSNEQTKMLSTIRHLR
VEEGKLPLEFSGYNKLRTLSLVNSPPDSLFEKLRSIRVLDVSWCDLLELS
EHIGKLIHLRYLDLSYNFKVKNLPDSLCDLYNLQTLKVNGCSKLESLPQE
LGKLVNLRHIVAEYWVMTKDAWKLANLQDLPTFSVQEGDGFNLVQLKDLT
QLHGSLHIRNLENVVDSKEAQHAELKNKVHLKELVLEWNHRKDAKLEEEV
IEDLQPHESLKILKIEGYHGGRSPSWLMPKVLSKLEKLELVNCKGWDDVL
PFIGPRLHLIELRIYHMFALKQLSHEFEGKCFPKLKVLDLWNLRALEEWS
WTEGKDLFPCMRELRVRDCPKLKRLPPFPPSLEILTIQHCPELKLNSKTE
NDEEGGCHLPPSLKGLELSYCGEYSKLLPDCLHNLCLITSLEISHCPHIT
SISLVQLVELQYLDISDCVELRLMECLGHLKSLKELKIVGCPELRWMECL
GLLNSLEELRIVGCPKLVQLDVEDEQAGGLSSLRKLCVDNTALLKMFPLR
NSLSFITELEIESSSEEVIFEEAILMRSLTAVTSLKFFNCEKLQSLPTEL
LHNFPFLERLEMCDCPQLQSLPEIGLSPFLKELHIYDCPQIQAMPELGLP
KSLDDFYCFGNVHPTLKEQSQKFNI
>XP_042464937.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAVPLTVVGGWFAQAFIQTLIDKASDKAIQLFAESRGFAEDMENLHPSLL
EIQIILDEVQSRGCNDTKWKTLIQELKDAAYDAEDLIDEFQYHALRQKIK
GEEEDKAASGSSGLSNMFYAAKIKLLGSSHSLEEDDMRARVRKMQGRLER
IANRMKSIINVLPRNDRRKQPNQMKFQTRESCSSPVTDVLFGRDKELNQV
VDWLLGLANQVELASGFFSNTFSVLPIVGIGGVGKTTLAQYAYKDIRVQD
HFHLKIWVCVSDDFTVQGLTKSIIQSVTPQKQYDNMGLEPLQKLLHEHIE
NKKFLLVLDDVWSDNKSIWETFCALLKVGAHGSKIIVTTRDMQVSKMVSL
AEPILLHGLDEDAFWQLFKKCSFGTLSPEDYPGLEDIGRKIARKLKGSPL
AAKTIGRVLQSNICQQHWATIMESDIWKVKQNEDDIMPALQLSYQYLDEN
LKQCFAFCSFFPKDYKFDKAELIQMWMAEGFIEDTKRMEEVESDYFLEFV
NRSFFQESEYDQFVMHDLIHDLAEMISAEEICRIKSNEQTKMLSTIRHLR
VEEGKLPLEFSGYNKLRTLSLVNSPPDSLFEKLRSIRVLDVSWCDLLELS
EHIGKLIHLRYLDLSYNFKVKNLPDSLCDLYNLQTLKVNGCSKLESLPQE
LGKLVNLRHIVAEYWVMTKDAWKLANLQDLPTFSVQEGDGFNLVQLKDLT
QLHGSLHIRNLENVVDSKEAQHAELKNKVHLKELVLEWNHRKDAKLEEEV
IEDLQPHESLKILKIEGYHGGRSPSWLMPKVLSKLEKLELVNCKGWDDVL
PFIGPRLHLIELRIYHMFALKQLSHEFEGKCFPKLKVLDLWNLRALEEWS
WTEGKDLFPCMRELRVRDCPKLKRLPPFPPSLEILTIQHCPELKLNSKTE
NDEEGGCHLPPSLKGLELSYCGEYSKLLPDCLHNLCLITSLEISHCPHIT
SISLVQLVELQYLDISDCVELRLMECLGHLKSLKELKIVGCPELRWMECL
GLLNSLEELRIVGCPKLVQLDVEDEQAGGLSSLRKLCVDNTALLKMFPLR
NSLSFITELEIESSSEEVIFEEAILMRSLTAVTSLKFFNCEKLQSLPTEL
LHNFPFLERLEMCDCPQLQSLPEIGLSPFLKELHIYDCPQIQAMPELGLP
KSLDDFYCFGNVHPTLKEQSQKFNI
>XP_042464948.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAVALTVGGWFAQAFIQTLIDKASDKSIQLFAQRRGFAEDMENLHPSLLE
IQIILDEVQSSGCNDTKWKTLIQELKDAAYDAEDLIDEFQYHVLRQKIKG
EEEDKVATGSSGLSNMFYAAKKRLLGSSHSLEEDDTRARVRKMQGRLEKI
ANRMKSIMNVLPPNDRRKQPEVKFQARESCSSPATDKMFGRDKELNQVVD
WLLGSANQVELASGFVNNTFSVLPIVGIGGAGKTTLAQYAHKDNRVQEHF
HLKIWVCVSNNFTVQRLSKSMIESVTLKKEYDNMELECLQKILHQHIAQK
KFLLFLDDVWSDNKNIWHKFCALIKVGAHGSKIIVTTRDMKVSKMVSLVE
PILLHGLDEVAFRQLFNKCSFGTLDPEDYPELQDSGRNIADKLKGSPLAA
KTLGSVLQSDLCQQHWDTIMKSDIWKVKQDEDDIMPALHLSYQYLNENLK
QCFSFCSVFPKDYVFEEAELVRMWMAEGFIEDKNTKRMEDVGSDYFLEFV
NRSFFQKFKFGGFVMHDLIHDLAEMISAEDTCSIEKKRQTKMLSTIRHLR
VKEGKLPLEFSGYDKLRTLMLRKNSPPNSLFEKLRSIRVLDVSRCDLQEL
SEHIGKLIHLRYLDLSSNYEIKILPDSFCHLHNLQTLEILGCHKLESIPQ
ELGKKMVNLRHINADNKFWVMIKDVRRLTNLQELPTFSVQEDDGLKLVQL
KDLTQLHGTLHIQNLENVVDSKEAQDAELKNKVHLKGLGLEWNDEKDAKL
EEEVIEALLPHESLKRLKIEGYNGGRSPSWLMPKVLSNLEKLYLANCKGW
DDVLPFIGQRLHLIELCMERMPSLKQLSHEFEGKCFPKLKVLYLWSLPAL
EEWSWTEGKNLFPCLRELRVNDCPKLKR
>XP_042465415.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MACINININIDVNRCLSELRTLLKLLLRPKSGIQKLEKEMAILRGKRDDI
MNQIDLAEREGQIPTHEWILWLHKMEELEGQVAAIEQDFQSMSCFSCHCF
NRAGGTSSQTQQAKSSNFYSIIRRMANTLDEANELMSLTGALVPIAGFWP
WRFTTRLPIPHLPPVGIESYLDDIVGYINGGEGSTIGIYGMGGVGKTTIL
MSIQQHYYLLEDTIFDRVIWVVASHCQLKRLQMDIAMSLGLKTLKESDDE
QTCGDKLFSYLKNKSCLLLLDDIWEHLDLQLSGMTHLATEQSQQQQQQQK
QPRKVVVFTTRSETMCAQMNAEKKIKVECLNPDQAWQLFEQNSDGDVLSS
DAQIKLAAKELVKECGGLPLALITTAKAMSGKKSWEVWYDTLYMIRDKHE
SIPIGLPKESLPMYKSFKLRYDSLENDLIRECLLCCVLWPKDYDIHKFDE
LIPCWIGCGIINKFNVINEAFHEGCCHLETLIAASLLEDSRRQNYYKAEH
VKMPNTIRDMALLMVSELKGNGRKWIVKAGIELSHLPRQEERQEAERASF
MRNNITSLQDYEASTLSKLCILILHGNHLSKIPPTLLTNMPLLTYLSLSR
NFGIEELPKEIGSLTKLQYLNLSSTDIKSLPLEFGRLKKLEYLLLRNTRI
KTIPNEIMSNLSMLKWLDIGGYFPVCDSWLNELKCLREEHHKISLGITIN
PAIFEILNMLPNVSVWNLTVSGSESSKFSVHNLGTLKWSHRISDNLECLT
ILDVPGDELAINAGVDYESSFGCLKTLYFRRLGKLKNIRWNGVGFNNLHD
LYISDCYMLKDVSWVLQLPCLDFLRISNCWEMEELISNVGNFNSSFGIKM
LILFQMNNLHRISHQPLHFPNLKNINVCHCPRLKKLPFGTGILRSGLKEI
IGDQTWWDSLVWDDNSNRDSLTTLFRNQLD
>XP_042465420.1 probable disease resistance protein At1g61300 isoform X1 [Zingiber officinale]
MACIKLNLNVDVNSCLSGLKATLRLGRPKSGIEKLKKEMKNLRDKRDDIK
NRIDQAELEGKIPTYQVSQWLLDVETLEGQVAAIEQDFQSTSCFSCHCFN
QTQTQTQTGGTSQTQQAGDQVPIRESSNCCSIILRVAKKLGEVKELMDRA
DRLDPVATVRPSEPTVMIPISHRSPVGIESYEEDIVGYVDGGKGDIIGIY
GMGGVGKTTILKRIQQHYHLNHAIFDRVIWVVASKDCQLKRLQMDIAKSL
GLKTLQESDDERTCGDKLFTFLKSRNCLLLLDDIWEHLDLQLLGMAHSAT
TERGQQQQPRKTVVFTTRSEAVCVQMKAEKKIKVKCLDPVQAWRLFEENS
EKDVLNSDAGIKFVAEKLAKECAGLPLALVTVARAMSGKKSWEAWNGALR
QIRDEHQWKTVCLPEDSVVMYKAFKLSYDSLENDSIRECLLCCALWPEDW
QINQFYNLIPCWIGCGLICEFNVINEAFDKGYSYLEALMAASLLEECIPM
RRSVHWDPCVKMHDVIRDMALLMVSGLEGNKRKWIVKAGIGLSDLPRQEE
WQEAERASFMRNNITSFQEYGTSTFPKLSMLILCHNKGPKTIPSSLLSSM
PRLTYLGLNGCGIRELPMEICSLTELQYLDLSYNPITSLPAKFGCLSKLE
YLLLSDTDLKIVPKGTISNLLILRWLDITEIPLVPECWWDELKYFKGRHQ
LSLGINIDATTDNIKQLNMLPNVSIWKLTLDGSNISKHEQVTDLGTQQWG
CRVSDHLEFLCFYFLKLDKLVLATGVGRESNFGCLKSLYFEDLEQLEEIS
LNGVRLYNLRKIYIDTCRMLKDVSWVLELPCLNFLEIIYCEEMKELISEV
GNSNSISSSSIQRLILSRMPNLNRIANQPLHFPYFEYIQVHRCPKLKKLP
FMAEILKSRLKCIEGEEDWWNNLVWDDENIKDSLTPYFRFN
>XP_042465421.1 probable disease resistance protein At4g14610 isoform X2 [Zingiber officinale]
MACIKLNLNVDVNSCLSGLKATLRLGRPKSGIEKLKKEMKNLRDKRDDIK
NRIDQAELEGKIPTYQVSQWLLDVETLEGQVAAIEQDFQSTSCFSCHCFN
QTQTQTQTGGTSQTQQAGDQVPIRESSNCCSIILRVAKKLGEVKELMDRA
DRLDPVATVRPSEPTVMIPISHRSPVGIESYEEDIVGYVDGGKGDIIGIY
GMGGVGKTTILKRIQQHYHLNHAIFDRVIWVVASKDCQLKRLQMDIAKSL
GLKTLQESDDERTCGDKLFTFLKSRNCLLLLDDIWEHLDLQLLGMAHSAT
TERGQQQQPRKTVVFTTRSEAVCVQMKAEKKIKVKCLDPVQAWRLFEENS
EKDVLNSDAGIKFVAEKLAKECAGLPLALVTVARAMSGKKSWEAWNGALR
QIRDEHQWKTVCLPEDSVVMYKAFKLSYDSLENDSIRECLLCCALWPEDW
QINQFYNLIPCWIGCGLICEFNVINEAFDKGYSYLEALMAASLLEECIPM
RRSVHWDPCVKMHDVIRDMALLMVSGLEGNKRKWIVKAGIGLSDLPRQEE
WQEAERASFMRNNITSFQEYGTSTFPKLSMLILCHNKGPKTIPSSLLSSM
PRLTYLGLNGCGIRELPMEICSLTELQYLDLSYNPITSLPAKFGCLSKLE
YLLLSDTDLKIVPKGTISNLLILRWLDITEIPLVPECWWDELKYFKGRHQ
LSLGINIDATTDNIKQLNMLPNVSIWKLTLDGSNISKHEQVTDLGTQQWG
CRAWVANQILDV
>XP_042465422.1 probable disease resistance protein At1g61300 isoform X1 [Zingiber officinale]
MACINLNLDVDVNNCLSGLRASLPVLGRPKSGIQKLEKEMARLRGERDDI
KNQIDQADRQGKIPTNKVSQWLREVEELEAQVAAINQDFQSMSCFSCNCF
NQTGGTSGQTQQAGDQVPIRESSNCCSINRRAKEKLGKANELMSQTDALD
PITTVGPPEPTMMLSISHRSPVGIESYVEGIVSYIDGGEGNIISIYGMGG
VGKTTMLKRIQRHYHHNHAIFDRVIWVVASKDCQLKKLQIDIARSLNLYT
LEENDDEQICGVKLCSFLKNKNCLLLLDDIWERLDLQLLGMAHSGTEQGQ
QQHQQPRKVVVFTTRSETVCAQMKAEKKFKVRCLDSEQAWQLFVQNSDGD
VLGSDPGIMFVAKELVQECAGLPLALVTVARAMSGRRSWEAWNDALHQIR
DKHEWTTIALPEDSVMYKAFKLSYDNLENDSVRECLLCCTLWPEDYEIDK
LSELIPCWIGCGIIHEYNVINEAFAKGYSHLEALGAASLLEKCDSDKVVK
MHDVIRDMALLLISGLEGNKRKWIVKAGIRLSDLPRQEEWQEAERASFIW
NQITSLQEYEASTFPKLSMLILHGNKNLKTIPSSLFASMPRLTYLDLSDC
YITELPMMIGTLTELQYLNLSKNPITRLPLEFGCLGKLEYLLLRATCLKI
VPNGTISNLSMLKWLDIRQTPLVPEWWWDELKCFKGRHQLSVGININATT
GSIDRLNMLSPNVSIWELTLDGNYISELSNDDMGTPQWGCRVSDNLEYLN
IMHLVLDRLILAAGVGRESSFGCLKRLQFCFLKLLKEISLNRVRLYNLRE
VVFRECHELKDVSWVLQLPCLKFLEINYCEKMKELISEVGNSNSISSSSS
SSSIQRLILCGMLNLNRIANIPLHFPYLEYIAVYECPRFQKLPFGAEILN
NKLKMIKGEKNWWNNLKWDDESIKDSLTPCFRSYDDDF
>XP_042465423.1 probable disease resistance protein At4g14610 isoform X2 [Zingiber officinale]
MACINLNLDVDVNNCLSGLRASLPVLGRPKSGIQKLEKEMARLRGERDDI
KNQIDQADRQGKIPTNKVSQWLREVEELEAQVAAINQDFQSMSCFSCNCF
NQTGGTSGQTQQAGDQVPIRESSNCCSINRRAKEKLGKANELMSQTDALD
PITTVGPPEPTMMLSISHRSPVGIESYVEGIVSYIDGGEGNIISIYGMGG
VGKTTMLKRIQRHYHHNHAIFDRVIWVVASKDCQLKKLQIDIARSLNLYT
LEENDDEQICGVKLCSFLKNKNCLLLLDDIWERLDLQLLGMAHSGTEQGQ
QQHQQPRKVVVFTTRSETVCAQMKAEKKFKVRCLDSEQAWQLFVQNSDGD
VLGSDPGIMFVAKELVQECAGLPLALVTVARAMSGRRSWEAWNDALHQIR
DKHEWTTIALPEDSVMYKAFKLSYDNLENDSVRECLLCCTLWPEDYEIDK
LSELIPCWIGCGIIHEYNVINEAFAKGYSHLEALGAASLLEKCDSDKVVK
MHDVIRDMALLLISGLEGNKRKWIVKAGIRLSDLPRQEEWQEAERASFIW
NQITSLQEYEASTFPKLSMLILHGNKNLKTIPSSLFASMPRLTYLDLSDC
YITELPMMIGTLTELQYLNLSKNPITRLPLEFGCLGKLEYLLLRATCLKI
VPNGTISNLSMLKWLDIRQTPLVPEWWWDELKCFKGRHQLSVGININATT
GSIDRLNMLSPNVSIWELTLDGNYISELSNDDMGTPQWGCRVL
>XP_042465424.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MACIKLNLNVDVNSCLSGLWASLPVLGRPKSGIQKLEKEMARLRGKRDDI
KNQIEEADRQGKIPTNQVSQWLREVEELEAQVAAIKQDFQSMSCFSCNCF
NQTGGTSSQTQQAGDQVSIGESSNFCSIIRRVAKKLCEATELMSRAGALD
PIATVGPPEPTVMLPIAHQPPVGIESYVEDIVGYINGGEGNIIGIFGMGG
VGKTTMLKRIQQHYHLNHSIFDRVIWVVASKDCQLKRLQIDIAKSLNLHT
LEENDDEQTCGVKLCSFLKNKNCLLLLDDIWERLYLQLLGMAHSGTEQGQ
QQHQQPRKVVVFTTRSETMCAQMKAEKKMKVNCLDSDQAWQLFVQNSDGD
VLGSDAGIKFVAEKLAKECAGLPLALVTVARSMSGKRSWEAWNDALHQIR
DKHEWTTIALPEDSLVMYKAFKLSYDSLENDSVRECLLCCALWPEDYEIF
KSSELIPCWIGSGIIREFNVINEAFAKGYSHLEALGAASLLEKCDSDKVV
KMHDVIRDMALLMVSGLKGNKRKWMVKAGIGLSDLPRQEEWQEAERASFM
MNNITSLQEYEASTFPKLSMLILHHNHSPITIPPSLFASMPHLTYLDLDG
CGITELPREICSLTKLQYLNLSFNPITRLPAEFGCLVKLECLLLMDAGLE
IVPNGTISNLSMLKWLNIASTYPVTEWWCDELKCFKGRHQLSVGITINAT
TDNIERLNMLPPNVSIWQLILDGENISKLPNYDLGIPQWSCRVSDKLEIL
CISNLRLDRLVLAAGVGGESSLGCLKRLGFHFLILLEEISLNRVRLNNLR
ELSICGCPMLNDVSWVLQLPCINFLYISMCRKMKEVISEVGNSNSISSST
IRRLILWSMPNLNHIANRSLHFPYLEYIRVDECPELKKLPFGAEILKNRL
KVIKGEEDWWNNLDWDDENIKDSLTPYFRPLI
>XP_042465425.1 probable disease resistance protein At1g61300 isoform X1 [Zingiber officinale]
MACINLNLDVDVNSCLSGLWASLPVLGRPKSGIQKLEKEMARLRGKRDDI
KNQIDQADRQGKIPTNEVSQWLREVEELEGQVAAIKQDFQSMSQYAPLYT
FCFSFSCQFNCPALCFNAYTTTTYVLYCFVFSLGCFSCNCFNQTGGTSSQ
TQQAGDQVSIGESSNFCSIIRRVAKKLGEATELTSRAGALDPIATVGPPE
PTVMLPIAHQPTVGIESYVEDIVGYINGGEGNIIGIFGMGGVGKTTILES
IQQYYLHDHTIFDHVIWVVASKGCQLKKLQNDIAKSLKLDTLEKNDDERT
CGDKLFSYLKDKNCLLLLDDIWERLDLQLLGMAHSATERGQQQQKHPRKV
VVLTTRSETVCAQMKAEKKIKVRCLDSEQAWQLFEQNSDGDVLSSDAGIK
FIAEELAKECAGLPLALVTVARAMSGKRSWEVWNDAFNQIRDKHEWTTVC
LPEDSLVMYKAFKLSYDSLENDSIRECLLCCALWPEDYEINQFSELIPCL
IGCGIIREFNVINEAFAQGCSHLEALMATSLLEKCNNINPPYEDTLVKMH
DVIRDMALLMVSSLERNKRKWIVKAGIGLHDLPRQEEWQQAERVSFMSNQ
ITSLQEYGASTFLKLSMLILHDNMGLETIPSSLLKSMPHLTYLDLSFCGI
TELPMEIGSLTELQYLDLSYSSIAKLPAELGCLCKLEYLLLSSMYLKIVP
NGTISNLLMLKWLDISDNYLVPEWWWDELECFKGRHQLSVAISINATTDN
IQRLNMLPNVSIWRLTLDGENVSKLPNYDLGTPQWGYRVSDKLDILNIMY
LKVSRLVLAAGMGRESSFGCLKRLHFECLQLLVEISLNRVRLYNLRQIFI
HDCPMLKDVSWVLELPCLNFLQIEYCRKMKELISEVGNSNSISSSSSVQS
LILGYMPNLNCIANRPLHFPYLEYIDVKDCPELKRLPFGTEMLKNRLKRI
RGEEYWWNNLDWDDESIKDSLTPYFRPQISK
>XP_042465426.1 probable disease resistance protein At1g61300 isoform X2 [Zingiber officinale]
MACINLNLDVDVNSCLSGLWASLPVLGRPKSGIQKLEKEMARLRGKRDDI
KNQIDQADRQGKIPTNEVSQWLREVEELEGQVAAIKQDFQSMSCFSCNCF
NQTGGTSSQTQQAGDQVSIGESSNFCSIIRRVAKKLGEATELTSRAGALD
PIATVGPPEPTVMLPIAHQPTVGIESYVEDIVGYINGGEGNIIGIFGMGG
VGKTTILESIQQYYLHDHTIFDHVIWVVASKGCQLKKLQNDIAKSLKLDT
LEKNDDERTCGDKLFSYLKDKNCLLLLDDIWERLDLQLLGMAHSATERGQ
QQQKHPRKVVVLTTRSETVCAQMKAEKKIKVRCLDSEQAWQLFEQNSDGD
VLSSDAGIKFIAEELAKECAGLPLALVTVARAMSGKRSWEVWNDAFNQIR
DKHEWTTVCLPEDSLVMYKAFKLSYDSLENDSIRECLLCCALWPEDYEIN
QFSELIPCLIGCGIIREFNVINEAFAQGCSHLEALMATSLLEKCNNINPP
YEDTLVKMHDVIRDMALLMVSSLERNKRKWIVKAGIGLHDLPRQEEWQQA
ERVSFMSNQITSLQEYGASTFLKLSMLILHDNMGLETIPSSLLKSMPHLT
YLDLSFCGITELPMEIGSLTELQYLDLSYSSIAKLPAELGCLCKLEYLLL
SSMYLKIVPNGTISNLLMLKWLDISDNYLVPEWWWDELECFKGRHQLSVA
ISINATTDNIQRLNMLPNVSIWRLTLDGENVSKLPNYDLGTPQWGYRVSD
KLDILNIMYLKVSRLVLAAGMGRESSFGCLKRLHFECLQLLVEISLNRVR
LYNLRQIFIHDCPMLKDVSWVLELPCLNFLQIEYCRKMKELISEVGNSNS
ISSSSSVQSLILGYMPNLNCIANRPLHFPYLEYIDVKDCPELKRLPFGTE
MLKNRLKRIRGEEYWWNNLDWDDESIKDSLTPYFRPQISK
>XP_042465427.1 probable disease resistance protein At1g61300 isoform X3 [Zingiber officinale]
MACINLNLDVDVNSCLSGLWASLPVLGRPKSGIQKLEKEMARLRGKRDDI
KNQIDQADRQGKIPTNEVSQWLREVEELEGQVAAIKQDFQSMSQYAPLYT
FCFSFSCQFNCPALCFNAYTTTTYVLYCFVFSLGCFSCNCFNQTGGTSSQ
TQQAGDQVSIGESSNFCSIIRRVAKKLGEATELTSRAGALDPIATVGPPE
PTVMLPIAHQPTVGIESYVEDIVGYINGGEGNIIGIFGMGGVGKTTILES
IQQYYLHDHTIFDHVIWVVASKGCQLKKLQNDIAKSLKLDTLEKNDDERT
CGDKLFSYLKDKNCLLLLDDIWERLDLQLLGMAHSATERGQQQQKHPRKV
VVLTTRSETVCAQMKAEKKIKVRCLDSEQAWQLFEQNSDGDVLSSDAGIK
FIAEELAKECAGLPLALVTVARAMSGKRSWEVWNDAFNQIRDKHEWTTVC
LPEDSLVMYKAFKLSYDSLENDSIRECLLCCALWPEDYEINQFSELIPCL
IGCGIIREFNVINEAFAQGCSHLEALMATSLLEKCNNINPPYEDTLVKMH
DVIRDMALLMVSSLERNKRKWIVKAGIGLHDLPRQEEWQQAERVSFMSNQ
ITSLQEYGASTFLKLSMLILHDNMGLETIPSSLLKSMPHLTYLDLSFCGI
TELPMEIGSLTELQYLDLSYSSIAKLPAELGCLCKLEYLLLSSMYLKIVP
NGTISNLLMLKWLDISDNYLVPEWWWDELECFKGRHQLSVAISINATTDN
IQRLNMLPNVSIWRLTLDGENVSKLPNYDLGTPQWGYRATNFEMKHRPFG
QGGYRTFNVLIVVNGQIVGFFGWSDMYLNLIDDS
>XP_042465428.1 probable disease resistance protein At1g61300 isoform X4 [Zingiber officinale]
MACINLNLDVDVNSCLSGLWASLPVLGRPKSGIQKLEKEMARLRGKRDDI
KNQIDQADRQGKIPTNEVSQWLREVEELEGQVAAIKQDFQSMSQYAPLYT
FCFSFSCQFNCPALCFNAYTTTTYVLYCFVFSLGCFSCNCFNQTGGTSSQ
TQQAGDQVSIGESSNFCSIIRRVAKKLGEATELTSRAGALDPIATVGPPE
PTVMLPIAHQPTVGIESYVEDIVGYINGGEGNIIGIFGMGGVGKTTILES
IQQYYLHDHTIFDHVIWVVASKGCQLKKLQNDIAKSLKLDTLEKNDDERT
CGDKLFSYLKDKNCLLLLDDIWERLDLQLLGMAHSATERGQQQQKHPRKV
VVLTTRSETVCAQMKAEKKIKVRCLDSEQAWQLFEQNSDGDVLSSDAGIK
FIAEELAKECAGLPLALVTVARAMSGKRSWEVWNDAFNQIRDKHEWTTVC
LPEDSLVMYKAFKLSYDSLENDSIRECLLCCALWPEDYEINQFSELIPCL
IGCGIIREFNVINEAFAQGCSHLEALMATSLLEKCNNINPPYEDTLVKMH
DVIRDMALLMVSSLERNKRKWIVKAGIGLHDLPRQEEWQQAERVSFMSNQ
ITSLQEYGASTFLKLSMLILHDNMGLETIPSSLLKSMPHLTYLDLSFCGI
TELPMEIGSLTELQYLDLSYSSIAKLPAELGCLCKLEYLLLSSMYLKIVP
NGTISNLLMLKWLDISDNYLVPEWWWDELECFKGRHQLSVAISINATTDN
IQRLNMLPNVSIWRLTLDGENVSKLPNYDLGTPQWGYRAWVGNQVLDV
>XP_042465429.1 probable disease resistance protein At1g61300 isoform X5 [Zingiber officinale]
MLPIAHQPTVGIESYVEDIVGYINGGEGNIIGIFGMGGVGKTTILESIQQ
YYLHDHTIFDHVIWVVASKGCQLKKLQNDIAKSLKLDTLEKNDDERTCGD
KLFSYLKDKNCLLLLDDIWERLDLQLLGMAHSATERGQQQQKHPRKVVVL
TTRSETVCAQMKAEKKIKVRCLDSEQAWQLFEQNSDGDVLSSDAGIKFIA
EELAKECAGLPLALVTVARAMSGKRSWEVWNDAFNQIRDKHEWTTVCLPE
DSLVMYKAFKLSYDSLENDSIRECLLCCALWPEDYEINQFSELIPCLIGC
GIIREFNVINEAFAQGCSHLEALMATSLLEKCNNINPPYEDTLVKMHDVI
RDMALLMVSSLERNKRKWIVKAGIGLHDLPRQEEWQQAERVSFMSNQITS
LQEYGASTFLKLSMLILHDNMGLETIPSSLLKSMPHLTYLDLSFCGITEL
PMEIGSLTELQYLDLSYSSIAKLPAELGCLCKLEYLLLSSMYLKIVPNGT
ISNLLMLKWLDISDNYLVPEWWWDELECFKGRHQLSVAISINATTDNIQR
LNMLPNVSIWRLTLDGENVSKLPNYDLGTPQWGYRVSDKLDILNIMYLKV
SRLVLAAGMGRESSFGCLKRLHFECLQLLVEISLNRVRLYNLRQIFIHDC
PMLKDVSWVLELPCLNFLQIEYCRKMKELISEVGNSNSISSSSSVQSLIL
GYMPNLNCIANRPLHFPYLEYIDVKDCPELKRLPFGTEMLKNRLKRIRGE
EYWWNNLDWDDESIKDSLTPYFRPQISK
>XP_042465430.1 putative disease resistance protein At5g05400 [Zingiber officinale]
MIHCCVSLGCFSCNCFNRTGGTSSNPTQQAGDDVPIIESSNCCSIIRRAA
KKLDEANELMSRAGALDPIATVGPPEPTLMLPISHQSPVGIESYVEDIVG
YVDGGEGNIIGIYGMGGIGKTTVLKRIQQHYLLKHTIFDRVIWVVASKDC
QLKRLQMNIAKSLGLQTLQENDDEQTCGDKLFSFLKNRNCLLLLDDIWEH
VDLQLLYWGWHTQLLSEASSSSRVKLWCSRPAVR
>XP_042465431.1 disease resistance protein SUMM2-like [Zingiber officinale]
MACINLNLDADINKCLSGLWASLPVLGRPKSGIQKLEKEMARLRVKRDDI
KNQIDQADRQGKIPTNEVSQWLREVEELEAQVAAIKQDFQSMSCFSCNCF
NQTGGTSTQTQQAGDQVSIGESSNCCSIIRRVAKKLGEATELTNRAGALD
PIATVGPPEPTMMLPISHRPPVGIESYVEGIVSYIDGGEGNIIGIYGMGG
VGKTTMLKRIQQHYHLNHAIFDRVIWVVASKDCQLKRLQIDIARSLNLHT
LEENDDEQTCGVKLCSFLKNKNCLLLLDDIWERLDLQLLGMAHSGTEQGQ
QQHQQPRKVVVFTTRSEIMCAQMNAEKKVKVNCLDSDQAWQLFVQNSDGD
VLGSDAGIKFVAEKLAKECAGLPLALVTVARAMSGKRSWEAWNDALHQIR
DKHEWATIALPEDSLVMYKAFKLSYDSLENDSVRECLLCYALWPEDYQFD
KFFELIQCWIGCGIIHEFNVINEAFAQGYSHLETLVAASLLEQCGDLNFP
YGNKSVKMHDVIRDMALLMVSRLEGNKRQWIVKAGIGMSELPRQEEWQEA
ERASFMRNEITSLQEYEASTFPKLSMLILHYNHHLKQIPPSLFASMPRLK
YLDLSGCRITELPKEICSLAELQYLNLSDNRIIRLPFEFGCLSKLQYLFL
SSTRLKIVPNGAISNLLMLKWLDISNNPLVPEWWWDELKCFKGRHQLSVT
IDINATTDNIERLNMLPPNVSLWVLTLDGENISKLPNYDLDTLQWGCRVS
DNLVFLCIQNLRLDRLELAVGVGRESSFGCLKSLRFIDLTLLEEISLNRV
RFYNLREIYIHDCPMLKDASWVLQLPCLNCLDISMCGKMKEVISEVGNSN
SICSSSIQYLILWNMSDLNLIANRPLHFPYLEYIRVRECPKLIKLPFGTE
ILKNRLKVIKGEEDWWNNLDWDDESIKDSLTPYFRSWHR
>XP_042465433.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MACTCINLNLNLDGNSCLSVLWASLRLCRPKSGIQKLEKEITILRAKRDD
IKNQIDQAEREGRIPTNQVSQWLLEVEMLEGQVADIEQDFQSISYFSCNC
FNPTGGASTTSQTQQAGDQVPIRESSNCCSIIRRVAKKLGEANELMSRAG
ALDPIATVGPPEPTVMLPISHQPPVGIESYVEDIVGYINGGEGNIIGIYG
MGGVGKTTMLKSIQQHYLPKHTIFDRVIWVVASKDWQLKKLQMDIAKSLE
LMTLKESDNERTCGDKLFSYLKNKNCLLLLDDIWELMDLQLLGMAHSATE
QGQHQQQPRKVVVFTTRSETVCTQMKADKKIKAKCLDPDQAWRLFEQNSD
KKFLSSDGGINFVAQELAKECAGLPLALVTVARAMSGKKSWEAWKDALHQ
IRDKHEWTTIDLSEDSVVMYKAFQLSYDSLENDSIRECLLCCALWPEDYK
IHKFKELIPCWIGCGIIHEFNVINEAFTKGCPHLEALVAASLLEQCNDQK
DIRYLDTFVKMHDVIRDMALLMVSGLKGNGRKWIVKAGIGLSHLPIQEAW
QEEWQEAERASFMDNEIASLPDYGASTFSKLSMLFLHGNDSLTTIPPSLF
PSMPLLTYLDLSKCHITKLPMEICRLTELQYLNLSKNPITRLPAKFGCLC
KLEYLLLRKTEIKSVPSGTISKLSMLRWLDIRRAFPIRGCLKNGRKIIGM
RPISEWWWDELKCFRGRHKLSVAIVINVTTANIKRLNMLPNVSIWNLTME
GGNFLQLQTLHLGTLQWSCNVSDNLESLSFKNVAVDKLMLTAGVGRESSF
GCLKTLHFYNLRKLENISLNGVGLCNLRELCIHSCSMLKDVSWVLQLPCL
NLLKISRCFEMKEVISNVGNTNSSSSIQRLSLSLVPNLNCIAHQPLYFPY
LEYVHVYKCPIFKKLPFEVEILKSRLKEIRGVQTWWDNLEWDDESNKNLL
TPLFIPFIESFD
>XP_042465434.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MGGIGKTTMLKRIQQHYLLKHTIFDRVIWVVASKGCQLKRLQIDIAKSLK
LHTLEENDDEQTCGDKLFSFLKSRNCLLLLDDIWEHVDVQLLGMAHSATE
RGQQQQPRKVVVFTTRSEIVCAQMKAEKKTKVKCLDSDQAWKLFEQNSDG
DVLSSDAGIKFVAEKLAKECAGLPLALVTIARALSGKKSWEVWNDALNQI
RDKHEWTTVCLPEDSFVMYKAFKLSYDSLENDSIRECLLCCALWPEDHKI
NKFELIPCWIGCGIISEFNVINEALAKGCSYLEALMATSLLEKCSDMDSS
YGDTLVKMHDVIRDMALLMVFGLESNKRKWIVKAGVGLSDLPRQEE
>XP_042465435.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MGGIGKTTMLKRIQQHYLLKHTIFDRVIWVVASKGCQLKRLQIDIAKSLK
LHTLEENDDEQTCGDKLFSFLKSRNCLLLLDDIWEHVDVQLLGMAHSATE
RGQQQQPRKVVVFTTRSEIVCAQMKAEKKTKVKCLDSDQAWKLFEQNSDG
DVLSSDAGIKFVAEKLAKECAGLPLALVTIARALSGKKSWEVWNDALNQI
RDKHEWTTVCLPEDSFVMYKAFKLSYDSLENDSIRECLLCCALWPEDHKI
NKFELIPCWIGCGIISEFNVINEALAKGCSYLEALMATSLLEKCSDMDSS
YGDTLVKMHDVIRDMALLMVFGLESNKRKWIVKAGVGLSDLPRQEE
>XP_042465436.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MACINLNLDVDVNSCLSGLWASLPVLGRPKSGIQKLEKEMARLRVKRDDI
KNQIDQADRQGKNPTNEVSQWLREVEELEGQLAAINQDFQSMSCFSCNCF
NQTSGTSSQTQEVGDQVLIRESSNYCSIIRRVAKKLGEATELTSRAGALD
PIATVGPPEPTMMLPISHRPPVGIESYVEDIVSYIDGGEGNIIGIYGMGG
VGKTTMLKRIQQHYHLNHAIFDRVIWVVASKDCQLKRLQMDMAKSLGLET
LQESESEQTCGDKLFSYLKNKNCLMFLDDIWEHLNLQLLGMAHSATEQGQ
QQHQQPRKVMVFTTRSETVCAQMKAEKKIKVRCLDSEQAWQLFEQNSDGD
VLSSDAGIKFIAEELAKECAGLPLALVTVARAMSGKRSWEAWKEALHQIR
DKHEWTAISLSEDSLVMYKAFKLSYDSLENDSIRECLLCCALWPEDYEIN
KFEELIPCWIGCGIFDEFNVINEAFAKGYSHLEALGAASLLEKCDSDYVV
KMHDVIRDMTLLMVSGLKGNKRKWIVKAGIGLSDLPRQEEWQEAERASFM
VNNITSLQEYGASTFSKLSMLILRRNRGLETIPPSLFASMPNLTYLDLSY
CHITELPREMCSLTELRYLNLTNCYITRLPIEFGCLVKLEYLLLVNTGLE
IVPNGMISNLSMLKWLNISHIYPATEWWWDELKCFKGHHQLSVEIGINAT
TDDIERLNMLSPNVSIWKLTLDGENISKLPNYDLGTPQWGCRVSDNLEIL
YIQDLRLDRLELAIGVGRESSFGCLNILRFINLKLLEEISLNRVRLYNLR
EVLIFDCPMLKDVSWVLQLPCLKSLDIRLCRTMKQVISEVGNSNSISSSS
IQHLKLWHMSDLNLFANRPFHFPYLEYVQVYGCPKLKKLPFGVEILKNRL
KVIKGEEYWWNNLDWDDESIKDSLTPYFRSRPY
>XP_042465437.1 probable disease resistance protein At1g61190 [Zingiber officinale]
MACINLNLDVDVNRCLSGLWASLPVLGRPKSGIKKLEKQMARLRSKRDDI
KNQITEAEREGKIPTNEVSQWLREVEELEGQLAAIKQDFQSISCFSCNCF
NRGTSSNPTEAFAANPEDEENAATQTQQARDDVPIRESSNCCSIILRMAE
KLRETDELMSRAGALDLIATVCPPESNVMLSISHRPPVGIESYVEDIVGY
VDGGKDNIIGIYGMGGVGKTTMLKRIQRHYYNHRIFDSVIWVVASNDCQL
KRLQMDIAKSLELKTLKESDDEQTCGDKLFSFLKNRNCLLLLDDIWGHVD
LQLLGMAHSATKRGQQQPRKVVVFTTRSETVCAQMKAEKKVKVKCLDSDQ
AWQLFEQNSDGDVFSSDAGIKFVAEELAKECAGLPLALITVARVMSGKKS
WEVWNDALNQIRDKHEWTTVCLPEDSVMYKAFKLSYDSLENDSIRECLLC
CALWPEDHKINKFSELIPCWIGCGIIHEFNVINEAFTKGCSHLEALVDAS
LLEQCSDLDFPDRSTVVKMHDVIRDMALLMVSGLEGNKRKWIVKARIGLS
DLLRQEEWQEAERASFMMNEITSLQEYGTSIFPKLSMLILCHNRGLKTIP
PSLFTSMPRLTYLDLCKCRITELPEDIGSLTELQYLDLSFNPITTLPVKF
GCLGKLEYLLLCYTGLKIVPNGSISNLSMLKWLDISQIPLIPEWWWDELK
CFKGRQLSVGININATTYNIERLNMLPPNVSIWHLVLDEHNISKLPNYDL
STPQWGCRVSDKLEFLWIRRLRLDRLVLAADMGRESSFGCLKSLHFQGLR
LLRDFIE
>XP_042465438.1 disease resistance protein RFL1-like [Zingiber officinale]
MACIKLNLNVDVNDCLRGLKATLRLGRPKSAIEKLGKEMTRLRGKRDDIK
NQINEAEREGKIPTNEVSQWLREVEILEGKVADIDQDFQSMSCFSCNCFN
RTGGTSSNPTEAFAANTQEDEENAATQTQQAGDGVPIRESSNCCSITQRA
AKKLDEANELISRAGALDPIATVGPPEPTVMLPISHRSPVGIESDVEDIV
GYVDGGKGDIIGIYGMGGVGKTTTLKSIQQHYSLLKHSTFDCVIWVVASK
DCQLKRLQMDIAKSLGVKTLQESDDEPTCGDKLFSFLKKRNCLLLLDDIW
EHVDLQLLGMAHSVNEQGQQQQPRKVVVFTTRSETVCAQMKAEKRIKVRC
LDSERAWQLFEQNSDGDVLSSDAGIKFVAEELAKECAGLPLALVTVARAM
SGKRSWEAWKEARSQIRDKHEWTTVCLPEDSVMYKAFKLSYDSLENDFIR
KCLLCCALWPEDHMVSKLELIPCWIGCGIISEFNVINEALDKGCSYLEAL
IATSLLEKCTDIDSSYRDTLVKMHDVIRDMAMLMVSGLESNKRKWIVKAG
IGLSDLPREEEWQEAERASFMRNKITSLQGYGASAFPKLSMLILLGNLDL
EAIPSSLFASMPHLAYLDLGCCGITELPMEFGSLTELQYLDLSFNPIAKL
PTELGCLCKLEYLFLNSTRLKIVPDFQFINAQVAGYK
>XP_042465439.1 disease resistance protein RFL1-like [Zingiber officinale]
MACIKLNLNVDVNDCLRGLKATLRLGRPKSAIEKLGKEMTRLRGKRDDIK
NQINEAEREGKIPTNEVSQWLREVEILEGKVADIDQDFQSMSCFSCNCFN
RTGGTSSNPTEAFAANTQEDEENAATQTQQAGDGVPIRESSNCCSITQRA
AKKLDEANELISRAGALDPIATVGPPEPTVMLPISHRSPVGIESDVEDIV
GYVDGGKGDIIGIYGMGGVGKTTTLKSIQQHYSLLKHSTFDCVIWVVASK
DCQLKRLQMDIAKSLGVKTLQESDDEPTCGDKLFSFLKKRNCLLLLDDIW
EHVDLQLLGMAHSVNEQGQQQQPRKVVVFTTRSETVCAQMKAEKRIKVRC
LDSERAWQLFEQNSDGDVLSSDAGIKFVAEELAKECAGLPLALVTVARAM
SGKRSWEAWKEARSQIRDKHEWTTVCLPEDSVMYKAFKLSYDSLENDFIR
KCLLCCALWPEDHMVSKLELIPCWIGCGIISEFNVINEALDKGCSYLEAL
IATSLLEKCTDIDSSYRDTLVKMHDVIRDMAMLMVSGLESNKRKWIVKAG
IGLSDLPREEEWQEAERASFMRNKITSLQGYGASAFPKLSMLILLGNLDL
EAIPSSLFASMPHLAYLDLGCCGITELPMEFGSLTELQYLDLSFNPIAKL
PTELGCLCKLEYLFLNSTRLKIVPDFQFINAQVAGYK
>XP_042465440.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MAFATINLNVDVNSCLGGLWASLRLGRPKSGIQKLEKEMTRLRGKRDDIK
NQIEEAEREGKIPTNEASQWLRDVEELEGQLAVIKQDFQNISCFSCNCFN
QTGGTSSQTQEAGDQLSIRESSNCCSIIRRVAKMLSEANELMSRAGALDP
IVTVRPPRPTVMLSISHRPPVGIESDVEGIVSYIDGGEGNIIGIYGMGGV
GKTTMLKRIQRHYHLNHAIFDCVIWVVASKDCQLKRLQMDIAKSLGLNTL
QENDDEKTCGDKLFSYLMNKSCLMFLDDIWEHLNLQLLGMAHSATEQGQQ
QHQQPRKVTVFTTRSETVCAQMKAEKKIKVRCLDSEQAWQLFEQNSDGDV
LSSDAGIKFIAEELAKECAGLPLALVTVARAMSGKRSWEAWKEALHQIRD
KHEWTTISLSEDSLVMYKAFKLSYDSLENDSIRECLLCCALWPEDYEINK
FEELIPCWIGCGIFDEFNVINEAFAKGYSHLEALGAASLLEKCDSDYVVK
MHDVIRDMALLMVSGLKGNKRKWIVKAGIGLSDLPRQEEWQQAERASFMH
NKMTSLQEYGASTFPKLYMLILHGNRGLKRIPLSLFASMPHLTYLDLSNC
GITNLPKEICSLTELQYLNLSSNPITRLSAKFGCLIKLEYLLLRYTNLEI
VPNGTISNLSMLKWLDIPHAYPANEWWWDELKCFKGRHQLSVGITINAIT
DDIERLNMLPLNVSIWELTLDGENISKLPNYDLGTPQWGCRVSDKLEFLY
IQNLRLDRLELAVGVDRESSFGCLKRLWFIDLELLEEISLNRIRLYNLRE
IYISECPMLKDVSWVLQLPCLNSLCIVNCEKMEELISEVGNSNSISSSSI
QNLALDNMPNLNRIANRPLHFPYLEYIDVNDCPELKKLPFGAEILKNRLK
MIKGEEYWWNDLDWDDESLKDSLTPYFRSRHFNFWPISKWSIDLLVKEAI
EFDRRKRKGSK
>XP_042465442.1 putative disease resistance protein At3g15700 [Zingiber officinale]
MAFATINLNVDVNSCLGGLWASLRLGRPKSGIQKLEKEMTRLRGKRDDIK
NQIEEAEREGKIPTNEASQWLRDVEELEGQLAVIKQDFQSMSCFSCNCFN
QTGGTSSQTQEEAGDQLSIRESSNCCSIIRRVAKKLSEANELMSRAGALD
PIITVRPPGPTAMLSISHRPPVGIESYVGDIVGYIDGGEGNIIGIYGMGG
VGKTTILNRIQQHYLPKHTIFDRVIWAVASKDCQLKRLQMNIAKSLGLQT
LQENDDEQTCGDKLFSYLKNRSCLLLLDDIWEHMKSVQLLGMAHSATEPG
QQQPRKVMVFTTRSETVCAQMKAGKKIKVRCLDSEQAWQLFEQNSDEDVL
SSDAGIKFVAEELAKECAGLPLALVTVARAMSGKRSWEAWSDALHQIRDE
HQWKTVCLPEDSLVMYKAFKLSYDSLENDSIRECLLCCALWPEDYEINTF
DQLIPCWIGCGIIHEFNLINEAFAKGYSHLETLVAASLLEQHSPMFFSSM
DIDVKMHDVIRDMALLMVSGSEGNKRKWIVRAGIGFSDLPRQEEWQEAER
ASFMCNKITS
>XP_042465569.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAGVGMSVVEWFATYVMEKLVDFASSRLADPHRDVFSVVDEKLKEMEGRL
PRIHAAIHAAEGRPIRDPALASWMRQLKDAAFEADDLLDELDYRQLEARV
QDRSKVSAFASSSLRFLKNLFVSDDELRRLKNILGDLDKISLEINQRKAE
LEEYNHARQQNRETSSFSTQEVVFGRDKERDLILEILLSAGDGPDYDDTK
RAGSSRHLANLDVLPILGIGGVGKTTLAQLVYSDQRVAQHFELRKWVYVS
DNFDVKRIAMELETNVTSDAHPFRDSSLDAQLSKLRDATANKRYLFVLDD
VWDEIESSWAKLRSALTFGSKGSTILITTQSPLVAEIMGTVKPIKLELLE
EDDYWRLFEHCSLGDKEIDLDLRRKLELLGQQIAKKMHGLPLAAKTVGSM
LRCRLEEQYWKAIQESEWWEHDFVVDNILPSLGLSYQHLSSNYKQCFAYT
SIFPKGHMFNKERLVQMWIAQGFIQEKTLRGRMTLEDIGSQIFDELTSRY
FFMRTVNDRYVMHDLIRELAVCVSIDECLVLHDEHVKIPATVCHLTLRVV
KMNALPELRKLQKLRTLIFYPEYDSEFLLLPRDGSKEFFKFLEGLLEDMK
SLRVIDLSQDRSGINKLPDAICDLPHLRFLDVSWTKIKQLPKGFPKLYHL
QVLNLKRRGTFSILPQGMNRLIKLRHLYADANTISLIHGIGKLTELQELE
EFHVSNKRGRQIEELKDLRYLRRRLTIQDIQNVESKEEAVGANLDDKENL
HELMLNRKPDIRSQGDKEKEILDGLQPHHNLKSLEIHHYGGMKSPSWLEN
NQITNLEFVYLNKCARWDTLPPLGKLPFLKNLVFKMMPSIRRIGREFFGD
GDTVFPSLEKLIFDQLNEWEEWSGTDKKSVFPRLFEINIINCVKLRQIPL
LPLRSMSVLKIWNCGDIGTTLPQYLLHLTSLVDLSLENYPHRVSVCLSNL
TALKNLELQNCPELILLGGFQSLGNLKLLKVTKCPKLNESSQPLEEPYVE
EGLRSLSYIITDESIINHVWVIVGRAQAVKSLILANCEHLKHFKPELEEW
FQQLTSLQELQFVSCPDLQRLPANLETVFSIRRLIITHCPSIDSLPENGL
PISLKELKIYGCRKLKDRCQKDDGPDWPKIAMIPHIVIEGEVISGAEEAA
>XP_042465619.1 disease resistance protein PIK6-NP-like [Zingiber officinale]
MATMMAMKVVDFSFLSIAGKLEKMLEEEAALLAGVEDDVCDIVAELRSVT
SFLTAMSTRRNLDDQLQNWVQEVREVAYDATSLEMAGRYSDPRIIGHFVE
EAQLVGINQRRDKIIGWVMDENRLELTVISIVGLGGLGKTTLAKTVYDNS
IIAGSHFQPRAWIVVSQNYSIRELLKKIILQISVDEQQIRDVLGCPDASL
NTEQLLNMMEESQLVQTVRGHLHGKRYMLIFYDVWRTDTWESLRNTGLSE
LPDSIGDLQNLEFLDMRGTRIKELPNTMVKLQKLVYLLAGPQGFKFLKGI
GKLKRLVAFGMAYADKMQSLQEIGELVDLQKLAISFGEHDLSLRMLEEIR
ALLSKLNGTLRSLTIFPPVNISLKNALDEVASPPLLLCKLQIGCRLGQLP
PWFASLKHVVKISLVGTLLQLEDLQVLRNLPALVNLKLGFKSFVNNDEDL
VFDRGGFAQLKFLQIKCQHVSFRVGAVRSLEILEIFFPPESVNGIEHLHG
LREIYILTFNEHISEMVKNIAANHSNRPKCFVNQL
>XP_042466334.1 probable disease resistance protein At5g43730 [Zingiber officinale]
MACIKLNLNVDVNSCLSGLKATLRLGRPKSGIKKLKKEMKILKVKRDDIK
NRIDQAELEGRIPTNQVSHWLWTWRRWKAKKIERKKKSLFRSSGCFSCHC
FNQTQTQTGGTSQTQQAGDQVPIRESSNCCSIILRVAKKLGEVKELMDRA
DRLDPVATVGPSEPAVMLPISHRSPVGIESYEEDIVGYVDGGKGDIIGIY
GMGGVGKTTMLTRIQQHYLLKHTIFDRVIWVVASKDCQLKRLQMDIAKSL
GLKTLQESDDERTCGDKLFTFLKSRNCLLLLDDIWEHLDLQLLGMAHSAT
TERGQQQQPRKTVVFTTRSEGVCVQMEAEKKIKVKCLDPVQAWQLFEENS
EGDVLNSDAGIKFVAEKLAKECAGLPLALVTVARAMSGKKSWEVWDAALR
QIRDEHQWKTVCLPEDSVVMYKAFKLSYDSLENDSIRECLLCCALWPEDF
KIDQFSRLIPCWIGCGIICEFNVINEAFAKGCSHLEALKTASVEIGKYFG
RALEEKNVWTIFARTILGTPSLLERKTDENFAYQPLICNIFTMRFHYIDQ
IKDSASLLEHSADFIKMHDVIRDMALLMVSGSDGNKRKWIVKAGIGMSDL
PRQEEWQEAERASFMNNRITSLPDYGASTFPKLSMLIIHHNKGLKTIPPS
LFASMPRLVYLDLSDCRITKLPKEICSLTELQYLNLSDNHITGLPAEFGC
LGKLEYLFLMNTDLQIVPNGAISNLSMLKWLDIKENPLALEWWWDELKCF
KGRHQLSVAISINATIDNIERLNMLPPNVSIWHLTLAGENISKLPNNYDL
GTTQWGCRVSDKLESLYIVNLGLDRLVLAAGEGRESSFGCLKLLYFTELK
LLEDISLNRVRLHNLRKIYIFDCPMLKDVSWVLQLPCLNSLSIVNCGKME
ELISDVGNSNSISSSSIQHLFLGNIPNLNRIANRSLHFPYLEFIDVIDCP
KLKKLPFGIEILKNKLKRIDGEDDWWNNLDWDDETIKDSLTPYFR
>XP_042466335.1 disease resistance protein RFL1-like [Zingiber officinale]
MACCIKLNLNVDVNSCLSGLWATLQLGRPKYAVKKLEKEMPRLRGKRDDI
KNQINEAELEGKIPTNEVKQWLREVEILERKAAAIERDFQSMSCFSCNCF
NRTGGTSSKPKEAFAANIQEEETQRAGDDVPIRESSNCCSIIWRAVKTLD
EANELTSRAGQLDPIAKVGPPEPVVMLPISHRPLVGIESYVEDIVRYVNG
GESEIIGIYGMGGVGKTTMLKRIQQHYLLKHAIFDRVIWVAASKDCQLKR
LQMDIAESLGLKTLQESDDKRTRGDKLFSYLKNRNCLLLLDDIGKQVDLQ
LLGMAHSATEPGQQKQPRKVVMFTTRSETVCAQMKPEKTIKVKCSDTGRK
YEDIFFRRNLK
>XP_042466338.1 disease resistance protein RFL1-like [Zingiber officinale]
MKAEKKTKVKCLDSDQAWKLFEQNSDGDVLSSDAGIKFVAEELAKECAGL
PLALVTVARAMSGKRSWEAWNDALHQIRDKHEWTTIALQEDSLVMYKAFK
LSYDSLENDSVRECLLCCALWPEDYEIFKFSKLIPCWIGCGIIHEFNVIN
EAFAKGYSHLEALGAASLLEKCDSDKVVKMHDVIRDMTLLMVSGLKGNKR
KWIVKAGIGLSDLPRQEEWQEAERASFMINEITYLQEYGAPTFPKLSMLI
LHGNENLKTIPPSLFASLPRLTYLDLSDCCITELPKEICSLTELQYLNLS
DNRIIRLLIEFGCLSKLEYLFLRYTGLETVSNGTIANLLMLQWLDIRGIP
LASDWWWDELKCYKGRHQLSVGIHINATTDNIERLNMLPLNVSVWELILD
GEHISKLPSYDLGTPQWGCRATNFEMKHGPFGQGGYRAFTILIVDNGHIV
GFFGWLDMYLNLLDDS
>XP_042466343.1 probable disease resistance protein At4g14610 [Zingiber officinale]
MNLLNHSPEYGKHGESIACNSLECNCFDQTDGTSSQRVAKKLSEANELGP
PEPTVMLPISHQPPVGIELYVEDIVGYINGGEGNIIGIYGMGGVRKITML
KSIQQHYLPKHTIFDRVIWVMASKDWQLKRLQMDIAKSLELMALKESDKE
RTCGDKLFSYLKNKNCLLLLDDIWEHVDLQLLGMAHSATERGQQQPRKVM
VFMTRSETVCAQMKAEKKIKVRCLDSEQAWQLFEQNSDGDVLSSDARIKF
LAEELAKECAGLPLALVTVARAMSGKRSWEAWNDALHQIRDKHEWTTIAL
LEDSLVMYKAFKLNYDSCGIIHKFNVINEAFAKGCFYLEALVTAFLLEKC
SDPDFPFGDTNVKMHDVIRDMILLMVSGLEGNKRKWIVKQGIGLSDLPTQ
QQWQEAERASFMMNDDTMEVKVKMVNTQMSKSRAEDKDNGR
>XP_042466551.1 disease resistance protein Pik-2-like [Zingiber officinale]
MAGILETMIAANVVGFSFQFIVGKLEKMLEEEAALLAGVEDDVRYIVAEL
RSITSFLTALSTRRNLQDDQLQNWMQEVREVAYDAEDSIDEFVCRLGWTP
CDERGVKGFIKHFLHRIKSLKARHCIASDLKKLKVHVEEVRKRHDRYSHP
NEATGTATSLEMAGTYSDPRIIGHFVEEAQLVGIKESKGTLIEWVLDKNR
LELTVISLFGFGGLGKTTLVRTVYDDPTIVGGHFESRAWITVSQNYSIKG
LLKKIIRQISVNEQQIRDVLGCQDDRLNTEQLLNMMDETQLVKTVRDHLQ
GKRYLLVFDDVWRTQAWEGLSIALPPGKEGSRVIVTTRIEDVANISCSRN
HRFIFKVDPLSPELSWELLCKRVFEAPYYSCPPELENVGREILQKCNGLP
LAIVTIGGLLASKPDKKLEEWKDLSNHLRLEIATNDMLLKIHQILVLSYN
DLPYHLKPCFLFLGIFPEDFEIHRKRLMRRWIAEGIVSGIGGLPAEKVGE
RYFNQLVNRSLVQPSQFDDSGTVKSCRVHDMMLDVILWISSKENFAVILD
EQTTTPPQRQKIRRLSWHGGNSGLVPDPDLSRLRSFTAFGVDVPPPKDYR
KLRQLRAIDLEGCRALHYLLPTSFSKLYILKYLSLRNTGLSELSDSIGDL
HNLEFLDIRGNHISKLPNTIVKLQKLVYLLASNYLKVPKRIEKLKRLVAF
GMAYVENVQSLQEIGELVDLQKLGIGFHDDLSLRMQEISALFSKLIGSLR
SLKISSWPNSGLKTALDEVASPPLLLCKLQIWCKLGELPPWFASLNHVVK
ISLIWTLLQLENLQVLKNLRALVNLKLGFRSFVHHDLVFDQGGFTQLKFL
EISGYNVSFKVGAVRSLEILKIFFVTGGRRVNGIEHLHGLREVHIKTRDE
EIIEMVKNISANHSNRLKCFATQL
>XP_042466619.1 putative disease resistance protein RGA3 [Zingiber officinale]
MEAAAQLRHILMKILPAPEMVAQRKAFRISNHLEMIRDSLWVINSFVMDG
SLRALEQPDVAEWMKEVGAAVEDVHNLLERILDYWKPSNEDEAERKWKMI
NNFFQSTSSRRSILLELREIVCTLNYLANRGAAFGLWVEMMDSMDPSHDD
YAAIMSEEVMGSHEETVIKLLQEQHHWSQRDMIAIRGDEYFGKTTLARKV
YHHPWVRQHFQRRIWLDASSFNDFNSNMIAKEIARLLTGRPCTDLNCWKI
VDEHLYRVRYLFILDNLYSYGASGHKLDELVRKLFHWAAPGSKFIFTVYP
PYEYETHFFCDTYDDLSPLPDGAWVRLLLKYATFVHPIEGNNNHKVKVSP
AATNMLIQFAKKYSSQNYVQNFLIPKGMGLMFRQRDVSQWQELANELLIR
HYPSTSRHFSLMHLHYWPFGRIRRFLYELLFGGSSVPGYDEDVFHILVAE
GTLTYYWYKRNIEFTPLEYGVDLCFFRMEVSGPSRIPPQCRHLYLPINSK
NISKFKKAIEVARVARKLRTLVLHREEINEHICQIETKILESMFSSLTSL
CTLDMRAIMIQGLPRAVVTLRCLRYLNLAENKIETLPESICNLYNLCVLN
LSNCEKLKELPRRIHELRKLQILKLSYCLRIQKLPESIICLVNLNELDIG
GCCRLSELPDDLSGMKNLMQLNMAGCAALTRMPSGIRRWINLQSLRGIDA
VDGHGNVTLSELQDLRNLESLHIQHLERLELDELKSATLPTYLLKDQDLY
ELVLHWERWNDMATKGTSNPMVQLLEGFLRSLRELKVLRIISYMSKRLPT
WLMLEPRLIVLKKLKRVELVNLRRCATLPPLGVLPQLEEVTISGFDSVRV
IDDEFYGEDRKPFVFPQLRKLTFSEMPRLEMWLGMKSKNRLEKWLGMKSI
RRHGLFAKLEELTLIQCPKLMVFLVQFPTSSQLKLKLWLSNEMLMPTSKF
NSWSNLGGINMLQIFGCQELRSLPNDTREIHNLKTLTIMNCNKLEALPIW
LEQSCLESLCIYGCRALSFIPE
>XP_042467161.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAVVLSFFVKRYIDKLSEFIEGEISKVLGVKEEIKRLHRKLSRISIYIQD
AEKKRQKDPVIDNWVKELKDIMYDAEDILDLCLIEGGRLLEAHPSSSGVC
SPVSLLSSCFQCSKFRRNICHQIKRVDERLDEIKEDNRVIPRLLEHRYEG
LQETPVKKSISPTSPIHVAADIVGTQIVDAAEGLISEIEHSKKRCSVLGI
SGMGGIGKTILAQKIFNDEMVKKQFPNRVWLHVSKDYSHIELLKQVLRGV
RGNDDGVQSRAEVEGRIVSLLSESLLLVLDDIWSASVWRDLLRNPILNGS
CRTAILFTTRHEDVATDMRADFVHHVEKMDQDNGWELIRKIVFGDGEDQI
ISELKEVGMEIVRKCDGLPLAIKVIAGVLFRKERTKREWKNVIESDLWFM
KENENEVSKALYLSYENLPCHLKQCFLSCAFYCAISIRSDIIRLWVAEGF
VIERSNSLMEDIAEDYYKELIASNLLQMDNIFLTGTRFVMHDILRSFGEN
LMEEEGIIINNALYTNINSLTKIRRLSISSQGDLLLLPNAIIEQKCLRAL
HLVNCPQIKRIENHAFENLKRLRVLDLCDTSIDSLPDSLTKLLHLKYLGL
DRTKIRRLPESIKCLANLQTLNLSGCESLHELPKGITRLINLRCLRIEDK
LERATSTGSRNFVLANKAFLRRLNLGWTMNINEYSEEQITEAERIFNQLS
PPPTLQGLRITVNFPGRQFPEWMVSTSGLDSLADLTFFNLVNFPSCTVLP
PLGQLPNLKILHIEGGEAIKSIGPEFLGCRTPAFPKLMYVAFKNMTNWET
WVLSETQDVVEPNEDVHARNLNSFPNLKECKIIHCPKLKNSILPSNRYLQ
INNCPNLEYVEKIGMFQYFRVVFPSEIQQLPQWASCLVNVTLHKFSMECN
SLLLDSCSKGKQNWHIIQRIPKVTIDSIDRERRLLLNKDSYKYEIKDEFG
SVEETCQTLRSYWIKLNPIKYLFGAKGGHFLGYIVTERGIEVNPGKVKAL
QDMSPPRNLKEVQRLTGKITALSRFISKSSDRSLPFFKILRRATKFQWDD
GCDQAFKELKQYLSSLPILAKPIVGEPFWIYLSSIEYAIGSALVRQEGGI
Q
>XP_042467164.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MSAGGCEELAIAKQEKVKRFKGQKTYWLNYRRNTDAEKCGRWGRTNAGRE
SKWRWERKLTRKRSPKEQEGGTPPEHRRRVAEEFEDEMCSMWLRTALTWR
RLQVLRGVGGNDVGVETKAEVEGRLDPLLSGSLLLVLDDIWSANVWRELL
RNPILKGSCRSVILFTTRHEVVAREMRADYVHPAEKIDEGSGWELIRKIV
FGDGEDAIISELEEVGMEIVRKCDGLPLAIKVMAGVLFHKERTKTEWKKV
VESDLWFRKEIKLSNALYLSYEDLPNHLKQCFLSCAFYHGISHRSDIIRL
WVAEGFVIEELDSLMEVTAKDYYKELIARNLLQIDQRFEDGRLFVMHGVL
RSFGEKLMEEEGIIISGDPYRNSLPDSLVKLSHLKYLNLDGTKIRKLPES
IKDLANLQTLCLSGCKSLHELPDGITRLSNLRCLRILSTPLTHFPKGFGK
LKNLNNLAGFFVGHRDSMSMMEGGCDLDELQYLCNLNDLVISKLERARTT
NFVLENKTFLRILTLGWTMNNNENNDEQSSEAERICKQLSPPATLEGLSI
DNFPGRQFPDWMVSTSLADLTFLALDKFPSCRENK
>XP_042467165.1 putative disease resistance protein RGA3 [Zingiber officinale]
MVGVGAVPKRGREEEGHRGVGLAVCSGEERWWWLTLAKKQLIHQPQEMAV
VLSFFVKRYIDKLSEFIEGEISKVLGVKEEIKRLHRKLSRISIYIQDAEK
KRQKDPVIDNWVKELKDIMYDAEDILDLCLIEGGRLLEAHPSSSGVCSPV
SLLSSCFQCSKFRRNICHQIKRVDERLDEIKEDNRVIPRLLEHRYEGLQE
NPVKKSISPTSPIHVAADIVGTQIVDAAEGLISEIEHSKKRCSVLGISGM
GGIGKTILAQKIFNDEMVKKQFPNRVWLHVSKDYSHIELLKQVLRGVRGN
DDGVQSRAEVEGRIVSLLSESLLLVLDDIWSASVWRDLLRNPILNGSCRT
AILFTTRHEDVATDMRADFVHHVEKMDQDNGWELIRKIVFGDGEDQIISE
LKEVGMEIVRKCDGLPLAIKVIAGVLFRKERTKREWKKVIESDLWFMKEN
ENEVSKALYLSYENLPCHLKQCFLSCAFYCAISIRSDIIRLWVAEGFVIE
RSNSLMEDIAEDYYKELIASNLLQMDNIFLTGTRFVMHDILRSFGENLME
EEGIIINNALYTNINSLTKIRRLSISSQGDLLLLPNAIIEQKCLRALHLV
NCPQIKRIENHAFENLKRLRVLDLCDTSIDSLPDSLTKLLHLKYLGLDRT
KIRRLPESIKCLANLQTLNLSGCESLHELPKGITRLINLRCLRIEGTPLT
HVPKGVGKLKNLNHLSGFLVGHCDSTSEMDGGCDMDELQHLCNLRFLRID
KLERATSTGSRNFVLANKAFLRRLNLGWTMNINEYNEEQITEAERIFNQL
SPPPTLQGLRITVNFPGRQFPEWMVSTSGLDSLADLTFFNLVNFPSCTVL
PPLGQLPNLKILHIEGGEAIRSIGPEFLGSRTPAFPKLMYVAFKNMTNWE
TWVLSETQDVVEPNEDLHARNLNSFPNLKECKIIHCPKLKNSILPSNRYL
QINNCPNLEYVEKIGMFQYFRVVFPSEIQLLPQWASCLVNVTLHTFSMEC
NSLLLDSCSKGKQNWHIIQRIPKVTIDSIDRERRLLLNKDSYKYEIKDEF
GSFITLDQSILSVSEEIGQDQASFHG
>XP_042467167.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MRADYVHPAEKIDEGSGWELIRKIVFGDGEDAIISELEEVGMEIVRKCDG
LPLAIKVMAGVLFHKERTKTEWKKVVESDLWFRKEIKLSNALYLSYEDLP
NHLKQCFLSCAFYHGISHRSDIIRLWVAEGFVIEELDSLMEVTAKDYYKE
LIARNLLQIDQRFEDGRLFVMHDVLRSFGEKLMEEEGIIISGENHCMNFQ
MASQGHRDSMSMMEGGCDLDDLQYLCNLNDLVISKLERARTTNFVLESKT
FLRILTLGWTMHNNENNDEQSGEAERICKQLSPPATLEVLSINNFPGRQF
PDWMVSTSLADLTFLALDKFPSCTALPPLGQLPNLKILHIEGGEAIKSIG
PEFLGRRTPAFPKLEYLAFDSMRNWEEWVLRVAPIEDVHASNLNFFPNLE
KCYFYDCPKLKNSIHPPTRLLQINGCPNLESMEKVGMLQLRKFEVVLPSE
IKQLPKWISSLINMTLQSLQLFNMQCNSLVLDSCRKGKQNWHIIQHIPKV
IIHSIGLETRLLRSKDGYQYQIKDELGSSFITPGKSFDHQSSGPLGWI
>XP_042467168.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MGGIGKTTLAQKIFNDEMVKKQFSNRVWLHVSKDYSHIELLKQVLRGVRG
NDDGVQSRAEVEGRIVSLLSESLLLVLDDIWSASAWRDLLRNPILNGSCR
TAILFTTRHEDVATDMRADFVHHVEKMDEDNGWELIRKIVFEDGEDQIIS
ELKEVGMEIVRKCDGLPLAIKVIAGVLFRKERTKREWKKVIESDLWFMKE
NENEVSKALYLSYENLPCHLKQCFLSCAFYCAISIRSDIIRLWVAEGFVI
ERSNSLMEDIAEDYYKELIASNFLQMDHIFLTGTRFVMHDILRSFGENLM
VDEGIIINDGQCTNTNSLTKIRHLSISNQGDLLLLPNVIIEQKCLRALHL
VNCPQIKKIEDHAFKSLKRLRVLDLRDTCIDNLSDSLMKLLHLKYLGLDR
TKIRKLPESIECLANLHTLNLSGCESLHELPKNITRLSNLRCLRIEDTPL
THVPKGVGKLKNLNYLSGFLVGHCDSMNKMDGGCDLDELQYLCNLRYLRM
DKLERATSTVNRNFVLANKTFLRRLTLGWTMNDNENNEEQITEAERIFNQ
LCPPPTLQGLRIIDSFPGRHFPEWMVSTSVLDSLADLTFLCFVNFPSCTV
LPPLGQLPNLKILEIEVGEAIKNIGPEFFGYRTPAFPKLEYLEFKNMPNW
EAWVLREAQDGVDPNEDVHASNLNLFPSLKQCFFRYCPKLKNSILPSNRL
LQINLCPKLEYVEKVGMLQQLEVIFPSEINQLPQWVSRLINGILHSLQTF
YMECNSVLLDSCSKGKQNWHIIQQIPKVTIDSIDRERRLLLNKDSYKYEI
KDEFGSFITLVSPLFS
>XP_042467180.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MLARNVYNDSRIHDFFPRKTWLYVSKRFSGDELLKEQIRSFGGDHGKARS
KAELELKLSHLLPKKFFIVLDDLWNANVWEDLLKPPFKYSSGGILITARD
ERVARQMGASIHCVEKMDKVTSWMLLSTLVSRDGEDEELCKLKATGGEIV
KKYDGLPLAIKTVAGVLRSKERCEKEWNKVLERLLLGIWVAEGFVKPQGY
RLLEDLAEGYYEELLGRNLLQLHPFYLDNSRCSMHGLLRSLAVYLVEEES
VSISNGERLERPNSLTKIRHLSVSDMGEEVAVPEEVVTQNCLRTLLVWNS
LKTKRIRADLHEKLGQLRVLCFSNTEIDRIPDSLGNLIQLRFLLYLPDAI
TKLQNLRCLRVGGTPLNHLPKGIGNLTKINHLNGFLIGHERDTQGQVEDC
ALDDLQSLNDLRFLYVAALKRARRGSLADLTLCGNQIAEDFAESLSELFP
PSSLECFTEEENQRNVRLFSELSLPSSLEGLSICHFLGQELPKCMDRCMP
MSFPNLQILGLHCFLLCAQLPVLGQLPQLKVLSIARADAIVTVGPELLYG
QSPLTTLVAFPKLEYLEFMIMPNWEQWSFGETETAKAQELQLLPSLKRLC
VVDCPKLKALPDGLHHATNLEELRIYGAHELGEVKNLPSLTTELFLRDNK
KLEKVSNLPMLKSLIVGSCPLLKQVDSLSALEKLELQQNSSRRLPESLGT
QEDPLPVWLPELLEQHMKGYAASGVLLVYCSFSLLCSCCKDGPYWHTIQQ
SPGVTMKSLEGRAYMTYTKNPFKYESNASFHCYHFSSL
>XP_042467181.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAEILSDFAGRCLSKLLSFVEGEATKILGVKDDLKKLQRRLLRVRGVLED
AEKKRHGSAEINAWVREMKDIMYDVEDLLDLCKTKAENLWVNHSPLPSAS
DFSCLPLSRQIANKVREVNDRLDEISEDRHVMSRLHEIDPSIHDSGINTR
NTSPLLIQSDIVGTQIKEVSESLVKSLITERDEGWKIFGIVGMGGIGKTT
LARNVYNDSRIPGYFPRKTWLCVSKEFSGNELLKELIRSVGGDHGEARSK
SELELILSHLLPKKFFIVLDDLWNANVWEDLLRAPFKCSSGGILITTRDE
RVARQIGASSIHCVEKMDKLTSWMLLSTMVSRDGEDEDLCQLEAIGGEIV
KKCDGLPLAIKTVAGVLRSKERCEKEWNKVLESEIWSMNQLQEELPRALY
LSYEDLPSHLKQCFLFCSLYPENISMHYKDLTRSWVAEGFVKPQGYRLLE
DLAEGYYEELLGRNLLQLHPLYLDNSVCTMHGLLRSLAVYLVEEESVSIS
NGERLESTNTLTKIRHLSVSNMGEEVAVPVELVSQNCLRTLLVWNSFKTK
RIGADLFEKLGQLRVLCIAATEIERIPDSLGNLIQLRYLDLDRTNVHSLP
ESIGCLKNLEILNLQSCRSLHYLPDDITKLQNLRCLRVRGTPLNHLPKGI
GNLTKINHLEGFLIGHERDTQGEVEDCALDDLQSLNDLRFLHVAALKRAR
RGSLVLANKTFLKHLDLRWLPPCVKADLTRCGNQAAEDIAKSYSDLFPPS
SLECLTEAESQRNVRLFSELSLPSSLEFLSIYHFLGQELPKCMERCTPMS
FPNLQFLDLNCFISCTHLPVLGQLPQLKILSIARADAIVTVGPELLYGQS
PLTTLVAFPKLEYLEFMIMPNWEQWSFGEIETAKAQELKLLPSLKRLCVV
DCPKLKALPDGLHHATNLQELRIYGAHELGEVKNLPSLTNELFLRDNKKL
EKVSNLPMLKSLIVGSCPLLKQVDSLSALEMLELRHNSSQRLPSDASLQH
LSLDTQEDPLPVWLPELLEQNMKGYAGSGVLLVECSLSLLRRCCKDGPYW
HTIQQFAGVLMQSEEGSAYMTYTKNPFNLLSTAARHWSLTFVADRCRLPP
APPPPVARRRRPSPPVAGHRPPPSPLPAGRRPPAVAHRRRLAMTVACCGD
RRWRRQLVADGCRKLRQRCGDHR
>XP_042467201.1 disease resistance protein RGA2-like [Zingiber officinale]
MESSAIAAAGFLGQRVFALLQLEEKLKELVGIEARMENLKELSAIIDTVI
QDVEACSVTDAALKNLLRKLKHLAYDLEDVVDYYDTEASRKERSRAYSRP
VRDFFSSNNNQLVFKSRISGMMKAVTKNLDSILKQKSILENLRQGTNRIS
LSAYRGIHPHNNLDVKGRETEKEMIVNMLTADEGSSNDTMKVIAIVGMGG
LGKTTLARHVFNDERVKSYFGNFRMWKVVGAEFDPTKIMKSVLELAATAI
GAPVNTSEPGIIMKSNLQLATQALVNTSELERMKSILQLAKGAPVNTSEL
DLMRFILQSAKGAPANISEPELVRGELEKALSDKRFLLVLDDVWNEDALP
WRELKEALSCGARGSKVLVTTRNQNVASIMGSFKTHHIQQLSRDDCFSLF
QQFSFGDEEPNENLKKIGGKIVEKCAGVPLAAVSLGSALHSIRDETYWSS
VLNSEVWQLRDEDQKFLAVLKLSYDALPLRSKKCFAFGSLFPKNYVMDKD
ELIQMWTTNGFVCSDRNFDAETLGKHIFDDLVLRSFFLLAPSEKCDDGFH
VTKCTMHDLMHDLARSVSEDEYCNIKDNQTKNIQKRTYHLRIEYTKEKFS
LFKKEKPFYLRTLLLRKCNLSGKVHLLQFIFSELKFLRALDLSENGIKGV
PTSVGNSIHLRYLTLSKNKIKFLPDTITLLQNLLFLNLTENPLQELPKRL
RYMQSLWYLYCDCDSLTHMPPGLSGLTSLRSLSSFVVENRTGSCSITQLE
DLKLHGAMEIKFSKNFSSYSCGGRKIFMNKDFNELSLSFNCSTTNDMSML
DDLCPNKSLKKLKICNYGSRHFPTWLMESQLPNLVVVILQNCNFCEHIPH
FRNLQFLRKLVIDGMSGVKHMVAECHGHGPIRGCPSLQEFKLISMTNLEG
WSESDGVDELFPILKKLEIWNCPKLKNIPKLQTIELLKLHDCSGSLLSSV
GRMTSLSHLKLEDVKGMTSLPSGCLRNLTSLMKLEIISCHELQFLPMDEM
QQLTMVHSLFIQKCFNLRLQNCDSNTAQPEILVQILNSLHEFDIQICCKN
GNLRGQLQHLHRLGQLSISGSHRICDPFMSSSIKANLSICCYDELESLMT
EAPSTSVLEDLYICNIPKLMTLPEWLQHLGSLRGLCIYNCYQLESLPRSL
QELRLLENLMIFKCHRQLKRRCKRVTGEDWPNISHVRCIRIYARENLCRD
AALCCAAALCCVPLILCYLVFEYLISSSESIPQDRERHNFN
>XP_042467204.1 putative disease resistance protein RGA4 [Zingiber officinale]
MEKLKELSTIIDMVIQDVEACPVMDAAVKNLLRKLKHLAYEVEDVVDYYD
TKALRKQRSRAYSRPVRDFFSSNNNQLVFKSKISGMIKAVTENLDSILLE
KSILKNLSQGSNPSAYGEIHAHNSLAVIGRETEKAMIVNMLTDDEGSSSG
TLKVIAIVGMGGLGKTTLARHVFNDKRVKDHFNTYWKVVGKNFKPTEIMK
SILELAVDAKVDISEPELVRGRLETVLSLSGKRFLLVLDDVWNEDALLWR
ELKAALSCGARGSTVLVTTRSQKVSSIMGKFNTHQIQQLSRDDCLSLFRK
FAFGDAEPNENLMKIGEKIVEKCAGVPLAAVSLGSALHSIRDETYWSSVL
NSEVGQLRDEDQKFLAVLKLSYDALPPWSKKCFAFVSLFPKNYAMKKDDL
IQMWAANGFVSSEGNFDAETVGNSIFDDLVLRSCFLPSKKCDDGRHVTES
TMHDLMHDLARSISKDQYYNKGYSEPTIYA
>XP_042467405.1 putative disease resistance protein RGA3 [Zingiber officinale]
MYLLDALVNNLVDHVSQELQKVHGVADELVTLQNIVSSIQAVLKDAQESE
ETRNSVKQQLNELREVAYRANDILDDVATEQQRQQLIKYAAVRNSLGAVN
PKRFFFKQDVYDRIQSIKTELDEIVKKCPLSALTSHNGSQRTHISETTSV
SPPCVLGRERDKQKIKELLVPLNGQSDSTASVISIFGMPGVGKTTLAQQL
FDDETVKKHFELRLWVYVSNDFDLMRIMRCMIESIDRFKCDLASLNNLQQ
EIRKKVSGRRYLLVLDDVGQESQEWERLKNCLYSADEGSKILVTTKNEQV
AAFMAANSPPVLYRLEGLSMEDCWSLICQPALSRNPSASFTLDFYRSHAV
NRCGGLPMAAKALGQRLAREADRNKWGAILTSQSWEFSGAGSTSITEPLG
LSYKYLPNYLKPCFAYLSIIPKRCELERDFIIQLWMRKASSGREGRNRWK
TSAATTSTPSGAARSCSIHISITRAVGKEECSVIEPGTELHLSASVRHLS
VNYEEFVRRVTPDEVYKCKGLQSLLLIGNSTSRPIMVLPGDLAQKLSSLR
TLMLTNSRLTQLPESIGDLRHLRCLQLQNTSIKRLPDSVSRLYNLQTLGL
RNCYDLEELPKDMSRLRNLRHLDLHLDDNSQGTLRCMPPEIGLLTHLRTL
NRFVVSKRHECGLSQLENLNDLRSELLIERLDLVSSREDATNANLSSKGH
IHRLELTWNYSSVTDASARSAGYNSRENILEYLKPHPRLKEIGVVGYGGT
LLPKWMGDSSLFNLETVRISKTYSWLNLLPPLGQLPNLKYLFLEEMHGLK
HLDCSFCGRNEIRFPKLEKLHLENMSGLQEWLGDHRCALPSLSELTIKNC
PALQQLTHELPSLTKLVIEASPYFAGLPDFPKLQSLEVKTNDDWIWRSCR
AAISSLPSLTLSGLTRADLPFYIGSRHASIRRLEIGYCSQLKFIPDGWLP
ECLSRFVIRHCPMLQNVPAGLTRLTMLEDLEIENCEQLEHLPVGLRNMNS
LAHLEISDCPALAWLPSDGLPRKLQFLSISNCPELIQKLQHQDLFTRRQD
LQLWINGERVVT
>XP_042467407.1 putative disease resistance protein RGA3 [Zingiber officinale]
MEFVSMFLLDALVNTLADTLQDHVFQELQKVHRVGDELVKLEKSVSSIQA
ILSDAQEIEETRNIVKQLLNELREVAYRANDILDDVATEQQRQQLIKFAA
VRNSLGAVNPMRFFFKQDVYHKIQSIDEELDKIVKRCPLIALSPRNRSQR
THSSESTPAIPPCVLGRERDKQKIKELLMPFSGRTDSAASVISIFGMPGV
GKTTLAQELFDDETVKKHFELRLWVYVSHDFDLMRIMRFMIESIDGFKCD
LTSLNNLQQEVRKKVSRRRYLLVLDNVWQESQEWEKLKSFLYSADEGSKI
LVTTKSEQVARFMAANSPPYHLEGLSMDDCWSLICQQVLSGNPSATLTHD
FSQSHALRRCMGLPMAAKALGQRLAREADRSKWEAILTGQSWEFSGADRS
ITETLSLSYQHLPHYLKPCFEYLSVIPKGFKLERDFIIQLWMAQSFIRPK
GTEHMEDVGSDYLDSLRSSSFLQYSHFDHKSRRQRYVMHDVFHEFARHVA
AEGCSVMEPSTELHLSLSAGVRHLSVNYEELVRRVPRGGDMYEQVYKCKG
LQSLLLIGNSTSRPTMVVPDDLAQRLRSLRTLMLTNSCLTQLPESIGDLS
HLRCLQLQNTGIKRLPDSVSRLYNLQTLGLRNCYDLEELPKDMSKLRNLR
HLDLHLNGNSQGSNAGGKLRLMPPEIGLLTHLRTLSRFVVSKRHECGLSQ
LENLNDLRSELLIERLDLVSSGEDAKNANLSSKEHIHRLELTWNYSDVTE
ASASSAGYNSRENILKYLRPHNKLKEIGVVGYGGTLLPTWMGDSSLENLE
TVWISKTYSCQNLPPLGQLPKLKYLFLEEMHGLKHIECSFCGRNEIRFPK
LEKLHLENMSGLQEWLGDHRCALPSLRELTIKNCPALQQLTHELPSLTKL
VIEASPYFAGLPDFPKLQSLEVKTNDDWIWRSCATISSLPSLTLSGLRRA
NLPSEIGSCHSFIRRLEISYCSQLIFIPDGWLPAFLSHFVIRHCPKLQNL
PAELTRLTRLEDLEIEKCEKLEQLPFGLRNMNLLAHLEISDCPGLSWLHG
LPRKLQFLSISNCPELSQKLQDQGWFTRRKDLQVWINGKHVLT
>XP_042467552.1 disease resistance protein RGA2-like [Zingiber officinale]
MSDLTKVLQTEIAIHLTELLWKRTHHVIKSLRMHRKSKVLIANSGLEELL
AFLRYNWFSMTDYLYNKISNKFLQDWLWRFDDFFYMTEDVLDDFEFMLFP
SDKPQGRDDFSAFDEAMQKLPEVIDTAADLFLEITDFRVARKEFPRLSYE
EVMEMRTILKRPAAFEQVQSRVEKPLATSSGLPTLPYEVRELKGRVVEKN
KILEALFHRAEGESKKLPISISISGPVGIGKTDLARAVYNSAQVEAEFDV
RAWIYMGNHHLDKWLTLQRSESDSVDQPSKLHRSSILDILNILETEMTAK
KVLIVLDNLEGMGDEVDVNNIIYQCRRKGARIIVTTQSEDVGRLSAVWLN
VELNGLEEEDYLELFKECALGDRNRNKYPELENIVGEIAKRFGGNPLAAV
MIGRHLKWHQSEDRWRIISRSNLGMIDPTESNILSVLRHSYEKLPGDQKQ
CYLACALFPKNYPFKQNQLFKIWKAIGCCSHISNQSSWTWKNIEPFFVSS
ARKDGEFILHAIFHELADYICDGEFFRLEDEIKEEDDVVQIPDKARHVYV
TADYSVKVYRVLQEKTHLRSLVIGGVLSSEEHKSSFMGWLEEVLRNLKGL
RLLLIYVLPSGKLPDAIGGLRHLQYLELPIDTITKESIQELPAWLSDNRF
VGLRRLLNLKALREAILKKGSIQEHPTW
>XP_042468718.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MAVVLNFFVIRYLGKLSDVIEGEIVKVLGVKEEIKRLHRKLLRISPYIQD
AEKRIHRDPAINNWVKELKDIMYDAEDILDLCLIEGGRLLEAHPSSPLEV
CSPVSLLSSCFQCCKFRRNIWNKIKRVNDRLDEIKDDSNVIPRLVAHRNE
GLQDNTVKMSSPTSSTHVATDIVGTQIVDAAQMLISEIERNKNKCSVLGI
SGMGGIGKTTLAQKIFNDEMVKKQFPKRVWLHVSKDYSQIELLKQILRGV
GGHDDGVQSRAEVEGRIVPLLSESLLLVLDDIWSASAWGDLIRNPILNGS
CRATVLFTTRHEDVVAEMRADFVHHVEKMHEDSGWELIRKIVFGEGENEI
ISELKEVGMEIVRKCDGLPLAIKVMAGVLFHKERTKREWIKVVESDLWFM
TENRNEVSNALYLSYEDLPSHLKQCFLSCAFYRGISFRSDLIRLSMAEGF
VIEQSDRLMEDTAEKYYEELIARNLLQNYTKNLNSVGVVMHDVLRSFGEK
LMEEEGIIINNGQCTSTNSLSKIRRLSISNQGDDVLSLPNVITEQKCLRV
LRLINCPRINRIENHAFESLKRLRVLDLCDTSIDSLPDCLTKLLHLKYLD
LDRTKIRRLPESIGCLANLQTLNLSECESLHELPMGITKLSNLRCLRIEK
TPLTHVPKGVGKLKNLSTLFGFFVGHCDSMSKMDGGCDLDELQYLCNLRH
LRIDKLERATRTRNGNFMLANKKFLRRLILEWTKNNNENNEEQITEAEMI
CNQFSPPPTLQSLAIKNFPGRQFPEWMVSTSALDSLANLTLLSLANFPSY
TVLPPLGQLPNLKVLDIEGGEAIRSIGPEFLGRRTPAFPKLEYIAFDNMR
NWEAWILREALDVQATNLNLFPNLKSCNIINCPKLKNSILPSNRYLQINL
CPNLECVEKVGMLQQLVVIFPAEIKQLPQWLSSLINATLHSLQLFYMHCD
SLLLDSCSKGKQNCHIIQQIPKVTIYSIDRKTRLLFNKDSYKYEIKDEFG
SFISLDQPSFHG
>XP_042468719.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MAVVLNFFVIRYLGKLSDVIEGEIVKVLGVKEEIKRLHRKLLRISPYIQD
AEKRIHRDPAINNWVKELKDIMYDAEDILDLCLIEGGRLLEAHPSSPLEV
CSPVSLLSSCFQCCKFRRNIWNKIKRVNDRLDEIKDDSNVIPRLVAHRNE
GLQDNTVKMSSPTSSTHVATDIVGTQIVDAAQMLISEIERNKNKCSVLGI
SGMGGIGKTTLAQKIFNDEMVKKQFPKRVWLHVSKDYSQIELLKQILRGV
GGHDDGVQSRAEVEGRIVPLLSESLLLVLDDIWSASAWGDLIRNPILNGS
CRATVLFTTRHEDVVAEMRADFVHHVEKMHEDSGWELIRKIVFGEGENEI
ISELKEVGMEIVRKCDGLPLAIKVMAGVLFHKERTKREWIKVVESDLWFM
TENRNEVSNALYLSYEDLPSHLKQCFLSCAFYRGISFRSDLIRLSMAEGF
VIEQSDRLMEDTAEKYYEELIARNLLQNYTKNLNSVGVVMHDVLRSFGEK
LMEEEGIIINNGQCTSTNSLSKIRRLSISNQGDDVLSLPNVITEQKCLRV
LRLINCPRINRIENHAFESLKRLRVLDLCDTSIDSLPDCLTKLLHLKYLD
LDRTKIRRLPESIGCLANLQTLNLSECESLHELPMGITKLSNLRCLRIEK
TPLTHVPKGVGKLKNLSTLFGFFVGHCDSMSKMDGGCDLDELQYLCNLRH
LRIDKLERATRTRNGNFMLANKKFLRRLILEWTKNNNENNEEQITEAEMI
CNQFSPPPTLQSLAIKNFPGRQFPEWMVSTSALDSLANLTLLSLANFPSY
TVLPPLGQLPNLKVLDIEGGEAIRSIGPEFLGRRTPAFPKLEYIAFDNMR
NWEAWILREALDVQATNLNLFPNLKSCNIINCPKLKNSILPSNRYLQINL
CPNLECVEKVGMLQQLVVIFPAEIKQLPQWLSSLINATLHSLQLFYMHCD
SLLLDSCSKGKQNCHIIQQIPKVTIYSIDRKTRLLFNKDSYKYEIKDEFG
SFISLDQPSFHG
>XP_042468785.1 putative disease resistance RPP13-like protein 1 isoform X1 [Zingiber officinale]
MAVVLDFFVKRYLGRLSDFLDGEIGKVLEVKEEIKKLHRKLSRISPYIQD
AEKRRHRDPVINNWVKELKDIMYDAEDILDLCMVEGGRFLEAQPFAPSGV
CSSVSLLSSCFQCYKFRTNIWNQIKRVNDRLDEIKRVIPRLVEHRNEGLQ
DNIVKMSSSTSPTHVAEDIVSKQIIDAAQNLISEIEHNKKKCSVFGISGM
GGIGKTTLAQKIFNDEMMKKQFPNRVWLHVSKDYSQIELLKQILRGVGGH
DDGVQSRAEVEGRIIPLLSESLLLVLDDIWSASAWGDLIRNPILNGSCRT
AIIFTTRHEDVAREMRADFVHHVKKMHDDSGWEFIRKIVFGDGEDIMISE
LKEIGMEIVKKCDGLPLAIKVMAGVLFHKERTKREWKKIVESDSWFMKET
EDKLLKALYLSYEDLPSHLKQCFLSCAFYRSISYRWDIIRLWVAEGFVIE
QSNSLMEDIAENYYEELIARNLLQIDSRFLDGRVFVMHDVLRSFGEKLME
EEGIIINDTQCTSTTSLTKVRRLSISNQGDVLLLPNVIIEQKCLRALHLL
NCSQIKRIEDHVFESLKRLRVLDLHDTSIVSLPDSLLKLLHLKYLNLCGT
KIRKLPESIECLANLQTLNLSECESLHELPKGITRMSNLRCLQIVSTPLT
HVPKGVGKLKNLNTFDGFFVGHCDSMSKMDGSCDLDELQYLCNLRYLSIY
KLERARTIGSRHTVLANKPFLRGLKLVWTMNIENNEEQITEGERICNQLS
PPETLKDLWIDNFPGQQFPAWMVSTHDSFADLTTLWLCNFPSCMVLPPLG
QLPNLKHLHIEGGEAIRSIGPEFLGCTTPAFPKLEHLKFTSMPNWESWVL
REAQDDEKPNEDVHARNLNLFPNLKQCYFLHCPKLKSSLLPPTRFLKIKI
CPNLEYVEKVGILQLRKLEVIFPSEIQQLPPWVSGLINATLHSLQTLYMR
CNLVLLDSCRTGKQNWHTIEEIPKVIIHSIDPEARLLLSKDGYKYQIKDE
FGSFVDLDQ
>XP_042468786.1 putative disease resistance RPP13-like protein 1 isoform X2 [Zingiber officinale]
MYDAEDILDLCMVEGGRFLEAQPFAPSGVCSSVSLLSSCFQCYKFRTNIW
NQIKRVNDRLDEIKRVIPRLVEHRNEGLQDNIVKMSSSTSPTHVAEDIVS
KQIIDAAQNLISEIEHNKKKCSVFGISGMGGIGKTTLAQKIFNDEMMKKQ
FPNRVWLHVSKDYSQIELLKQILRGVGGHDDGVQSRAEVEGRIIPLLSES
LLLVLDDIWSASAWGDLIRNPILNGSCRTAIIFTTRHEDVAREMRADFVH
HVKKMHDDSGWEFIRKIVFGDGEDIMISELKEIGMEIVKKCDGLPLAIKV
MAGVLFHKERTKREWKKIVESDSWFMKETEDKLLKALYLSYEDLPSHLKQ
CFLSCAFYRSISYRWDIIRLWVAEGFVIEQSNSLMEDIAENYYEELIARN
LLQIDSRFLDGRVFVMHDVLRSFGEKLMEEEGIIINDTQCTSTTSLTKVR
RLSISNQGDVLLLPNVIIEQKCLRALHLLNCSQIKRIEDHVFESLKRLRV
LDLHDTSIVSLPDSLLKLLHLKYLNLCGTKIRKLPESIECLANLQTLNLS
ECESLHELPKGITRMSNLRCLQIVSTPLTHVPKGVGKLKNLNTFDGFFVG
HCDSMSKMDGSCDLDELQYLCNLRYLSIYKLERARTIGSRHTVLANKPFL
RGLKLVWTMNIENNEEQITEGERICNQLSPPETLKDLWIDNFPGQQFPAW
MVSTHDSFADLTTLWLCNFPSCMVLPPLGQLPNLKHLHIEGGEAIRSIGP
EFLGCTTPAFPKLEHLKFTSMPNWESWVLREAQDDEKPNEDVHARNLNLF
PNLKQCYFLHCPKLKSSLLPPTRFLKIKICPNLEYVEKVGILQLRKLEVI
FPSEIQQLPPWVSGLINATLHSLQTLYMRCNLVLLDSCRTGKQNWHTIEE
IPKVIIHSIDPEARLLLSKDGYKYQIKDEFGSFVDLDQ
>XP_042468787.1 putative disease resistance RPP13-like protein 1 isoform X1 [Zingiber officinale]
MLHTQSSISELIHLSQEMAMVLEFFVSRYLKKLSDFIEGEICKMLGVKEE
IERLHRKLSRIRIYIQDAERRRHRDSVINNWVKELKDIMYDVEDILDLCM
IEGGRLLEAQPSTSSWVCSRISLLSSYIHRSTFNTNIWNQIKRVNARLDE
IKEDSSVIPRLFEHITEAFQDNLVKKSSPSSFKHVATDIVGKQIADDAQN
LISKIDQSKKSCYVLGISGMGGIGKTTLAQKIFNDEMVKKQFPKRVWLHV
SKDCSHINLLKELLREVGGNDNGVQSRAEIEGRIIPLLSESMLLVLDDIW
SASVWMDLLGNFILNDSRRTTILFTTRHENVAKEMTYDFVHHVKKMDEGS
GWKLIRKIVFGDGNDQIISELKEVGMEIVKKCYGLPLAFKVIAGVLRNKE
KTKREWEKVASDLWSMKEKVDELSNALYLSYEDLPSHLKQCFLSCAFYRG
VSLRSDIIRLWVDEGFVIEQSDNLMENIAEDYYKELIARNLLQIDFRLLD
GVRFVMHDGLRSLGEKLMEDQAIFINDAQYTSTNSLTKVRCLSISNQADV
LWLPNAIIEQKCLRALHFANCPQIERIENHAFESLKYLRVLNLNDTSIGS
FPDSLMKLFHLKYLDLDRTKITKLPESIECLANLQTLSLSGCESLHELPK
GITRLSNLRCLRIVDTPLTHVPKGVAKLKNMNQLEGFLVGHCDSMSRMDG
GCDLDELQDLCNLIYLFIDKLERATTRGNRNFVLANKLFLRRLTLGWRVN
NENNEEQITEAERICNQLRPPPTLEVLCFSNFVGRQFPEWMVSTSILDSL
VDLTYLNLNIFPSCTMLPPLGQLPNLKLLNIEQGEAIKSIGPEFLGCRTP
AFPKLEYLAFDNMPNWEEWVLRMAQDVVDPIEDVHARNLNLFPNLNSCGI
IRCPKLKNSILPLTRLLKIKLCPNLEYVEKVGMLQQLFVIFPPEIQQLPQ
WVSNLINATLHSLQTFDMECNSLLLDSCSKGKQNWHIIQKIPKVTINSID
REARLLLHKGSYKYEIKNEFGSFITLDQSSNKRRSACLQHPRQPTRKLTR
RR
>XP_042468788.1 putative disease resistance RPP13-like protein 1 isoform X2 [Zingiber officinale]
MYDVEDILDLCMIEGGRLLEAQPSTSSWVCSRISLLSSYIHRSTFNTNIW
NQIKRVNARLDEIKEDSSVIPRLFEHITEAFQDNLVKKSSPSSFKHVATD
IVGKQIADDAQNLISKIDQSKKSCYVLGISGMGGIGKTTLAQKIFNDEMV
KKQFPKRVWLHVSKDCSHINLLKELLREVGGNDNGVQSRAEIEGRIIPLL
SESMLLVLDDIWSASVWMDLLGNFILNDSRRTTILFTTRHENVAKEMTYD
FVHHVKKMDEGSGWKLIRKIVFGDGNDQIISELKEVGMEIVKKCYGLPLA
FKVIAGVLRNKEKTKREWEKVASDLWSMKEKVDELSNALYLSYEDLPSHL
KQCFLSCAFYRGVSLRSDIIRLWVDEGFVIEQSDNLMENIAEDYYKELIA
RNLLQIDFRLLDGVRFVMHDGLRSLGEKLMEDQAIFINDAQYTSTNSLTK
VRCLSISNQADVLWLPNAIIEQKCLRALHFANCPQIERIENHAFESLKYL
RVLNLNDTSIGSFPDSLMKLFHLKYLDLDRTKITKLPESIECLANLQTLS
LSGCESLHELPKGITRLSNLRCLRIVDTPLTHVPKGVAKLKNMNQLEGFL
VGHCDSMSRMDGGCDLDELQDLCNLIYLFIDKLERATTRGNRNFVLANKL
FLRRLTLGWRVNNENNEEQITEAERICNQLRPPPTLEVLCFSNFVGRQFP
EWMVSTSILDSLVDLTYLNLNIFPSCTMLPPLGQLPNLKLLNIEQGEAIK
SIGPEFLGCRTPAFPKLEYLAFDNMPNWEEWVLRMAQDVVDPIEDVHARN
LNLFPNLNSCGIIRCPKLKNSILPLTRLLKIKLCPNLEYVEKVGMLQQLF
VIFPPEIQQLPQWVSNLINATLHSLQTFDMECNSLLLDSCSKGKQNWHII
QKIPKVTINSIDREARLLLHKGSYKYEIKNEFGSFITLDQSSNKRRSACL
QHPRQPTRKLTRRR
>XP_042468789.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAVVLEFFVKIFLSKLSVFIQGEIGKVLGVKKEIERLHRKLSRIRFYIQD
AERRRHRDSAINNWVKELKDVMYDAEDIFDRCLIESGRLLEAQPSASSGV
HSWFRTLNFRRNICDEIRRVNNRLNEINDDNNVVRRLVEDKHEGRLVQRS
SSTSPTHVSTDIVGTQIVDATQNLISKIEESKNKCTVLGISGTGGIGKTT
LAQKIFNDEMVKKQFPNRVWLHVFKDYSEIEILKQVLRGVGGNDVGVETK
AEVEGRLDPLLSGSLLLVLDDIWSANVWRELLRNPILKGSCRSVILFTTR
HEVVAREMRADYVHPAEKIDEGSGWELIRKIVFGDGEDAIISELEEVGME
IVRKCDGLPLAIKVMAGVLFHKERTKTEWKKVVESDLWFRKEIKLSNALY
LSYEDLPNHLKQCFLSCAFYHGISHRSDIIRLWVAEGFVIEELDSLMEVT
AKDYYKELIARNLLQIDQRFEDGRLFVMHDVLRSFGEKLMEEEGIIISGE
NHCMNFQMASQG
>XP_042468790.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MAMVLEFFVSRYLKKLSDFIEGEICKMLGVKEEIERLHRKLSTIRIYIQD
AERRRHRDSVINNWVKKLKDIIYDVEDILDLCMVEGGRLLEAQPSTSSWV
CSRISLLSSYIHRYTFNRNIWNQIKRVNARLDEIKEDSSVIPRLFEHITE
AFQDNLVKKSSPSSFKHVATDIVGKQIADDAQNLISKIDQSKKSCYVLGI
SGMGGIGKTTLAQKIFNDEMVKKQFPKRVWLHVSKDCSHINLLKELLREV
GGNDNGVQSRAEIEGRIIPLRPKSMLLVLDDIWSASVWMNLLRNFIWDDS
CRTTILFTTRHENVAREMRADFVHHVKKMKDDNGWELIRKIVFGDEEDII
ISELEEVGMEIVKKCDGLPLAVKVIAGVLFHKEKTKREWENVAKSDLWFM
KENEDQLSNVLYLSYEDLPSHLKQCFLSCAFYRGVSLRSDIIRLWVDEGF
VIEQSDNFMENIAEDYYKELIARNLLQIDFRFLDGIRFVMHDGLRSIGEK
LMEDEAIFINDAPCTSTNSLTKVRRLSISNQADVLLLPNTIIEQKCLRAL
HFTNCPQIERIENHAFESLKYLRVLNLNDASIGSFPDSLMKLFHLKYLDL
DRTKITKLPESIECLANLQTLSLSGCESLHELPKGITRLSNLRCLRIVDT
PLTHVPKGVAKLKNMNHLEGFLVGHCDSMSRMDGGCDLDELQDLCNLIYL
FIDKLERATTRGNRNFVLANKLFLRRLTLGWRVNNENNEEQITEAERICN
QLSPPPTLEVLRIGNFIGRQFPEWMVSTSILDSLVDLTYLSLVIFPSCTA
LPPLGQLPNLKLLNIEQGEAIKSIGPEFLGCRTPVFPKLEYLAFDNMRNW
EEWVLRVAQDVVDPIEDVHASNLNLFPNLEKCYFIDCPKLKNSILPSTRL
LQIKLCPNLEYVEKVGMLQQLFVIFPPEIQQLPQWVSNLINATLHSLQTF
DMECNSLLLDSCSNGKQNWHIIQQIPKVTINSIDRETRLLLHKGSYKYKI
KNEFGSFITLD
>XP_042468791.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MAMVLEFFVSRYLKKLSDFIEGEICKMLGVKEEIERLHRKLSTIRIYIQD
AERRRHRDSVINNWVKKLKDIIYDVEDILDLCMVEGGRLLEAQPSTSSWV
CSRISLLSSYIHRYTFNRNIWNQIKRVNARLDEIKEDSSVIPRLFEHITE
AFQDNLVKKSSPSSFKHVATDIVGKQIADDAQNLISKIDQSKKSCYVLGI
SGMGGIGKTTLAQKIFNDEMVKKQFPKRVWLHVSKDCSHINLLKELLREV
GGNDNGVQSRAEIEGRIIPLRPKSMLLVLDDIWSASVWMNLLRNFIWDDS
CRTTILFTTRHENVAREMRADFVHHVKKMKDDNGWELIRKIVFGDEEDII
ISELEEVGMEIVKKCDGLPLAVKVIAGVLFHKEKTKREWENVAKSDLWFM
KENEDQLSNVLYLSYEDLPSHLKQCFLSCAFYRGVSLRSDIIRLWVDEGF
VIEQSDNFMENIAEDYYKELIARNLLQIDFRFLDGIRFVMHDGLRSIGEK
LMEDEAIFINDAPCTSTNSLTKVRRLSISNQADVLLLPNTIIEQKCLRAL
HFTNCPQIERIENHAFESLKYLRVLNLNDASIGSFPDSLMKLFHLKYLDL
DRTKITKLPESIECLANLQTLSLSGCESLHELPKGITRLSNLRCLRIVDT
PLTHVPKGVAKLKNMNHLEGFLVGHCDSMSRMDGGCDLDELQDLCNLIYL
FIDKLERATTRGNRNFVLANKLFLRRLTLGWRVNNENNEEQITEAERICN
QLSPPPTLEVLRIGNFIGRQFPEWMVSTSILDSLVDLTYLSLVIFPSCTA
LPPLGQLPNLKLLNIEQGEAIKSIGPEFLGCRTPVFPKLEYLAFDNMRNW
EEWVLRVAQDVVDPIEDVHASNLNLFPNLEKCYFIDCPKLKNSILPSTRL
LQIKLCPNLEYVEKVGMLQQLFVIFPPEIQQLPQWVSNLINATLHSLQTF
DMECNSLLLDSCSNGKQNWHIIQQIPKVTINSIDRETRLLLHKGSYKYKI
KNEFGSFITLD
>XP_042468793.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MAMVLEFFVSRYLKKLSDFIEGEICKMLGVKEEIERLHRKLLRIRIYIQD
AERRRHRDSVINNWVKELKDIMYDVEDILDLCMVEGGRLLEAQPSTSSWV
RSRVSKLLSYLMSSPNENASKFSRNIWNQIKRVNDRLDEIKEDSSVVPRL
LEHITEDLQDNPGKKSSPTSPTHVATDVVGTQIVDAAQNLISKIEQSKKK
CSVLGISGMGGIGKTTLTQKIFNDEMVKKQFPKRVWLHVSKDCSYINILK
ELLREVGGNDNGLQSRAEIERRIVPLLSESLLLVLDDIWTATVWMDWLRN
LILNSSCRTAILFTTRNENVVKEMRPDFVHHVKKMKDDSGWELIRKIIFG
DEEDIIISELEEVGMEIVRKCYGLPLAIKVIAGVLFHKKRTKREWKKVVE
SDLWSMKEKVDELSNALYLSYEDLPSHLKQCFLSCAFYRGVSLRSDIIRL
WVDEGFVIEQSDNLMENIAEDYYTELIARNLLQIDFRFLYGVKFVMHDVL
RSLGEKLIEEEGILINDAQCTSKNSLTKVRRLSISNQADVLLLPKAIIEQ
KCLRALHVTNCPQIERIENHAFESLKYLRVFHLNDTSIDSFPDSLMKLFH
LKYLDLDRTKITKLPESIECLANLQTLSLSGCESLHELPKGITRLSNLRC
LRIEGTQITHVPKGVGKLKNLTHLAGFVVGHCDSMSRMDGGCDLDELQYL
CSLINLFIYKLERATTIGNRNFVLANKLFLRRLILAWTVNNENNEEQITE
AERICNQLSPPPTLEVLCFSNFIGRQFPEWMVSTSILDSLVDLTYLNLNI
FPSCTMLPPLGQLPNLQILNIEQGEAIKSIGPEFLGCRTPAFPKLEYLAF
NNMCNWEEWVLRMAQDVVDPIEDVHARNLNLFPNLNSCNIIHCPKLKNSI
LPLTRHLQIKLCPNLEYVEKVGMLQQLFVIFPPEIQQLPQWVSNLINATL
HSLQTFDMECNSLLLDSCSKGKQNWHIIQKIPKVTINSIDREARLLLHKG
SYKYEIKNEFGSFITLDQSSNKRRSACLQHPRQPTRKLTRRR
>XP_042468853.1 disease resistance protein RGA2-like [Zingiber officinale]
MFFHFQQIAIRPYSPKGLSFAIPIMAEILSDFAGRCLSKLLSFVEGEATK
ILGVKDDLKKLQRRLLRVRGVLEDAEKKRHGSAEINAWVREMKDIMYDVE
DLLDLFKTKAENLWVSHYSPLPSASDFSCLPLARQIANKVREVNDRLDDI
SEDRHVMSRLHEIDPSIQESGINTRDTSPLLIQSDIVGTQIKEVSESLVK
SLITERDEGWKIFGIVGMGGIGKTTLARNVYNDSRIHDFFPMKTWLCVSK
RFSGNELLKELIRSFGGDHGEARSKAELELKLSHLLPKKFFIVLDDLWNA
NVWEDLLRAPFKCSSGGILITTRDERVARQIGASSIHCVEKMDKLTSWML
LSTMVSRDGEDEDLCQLEAIGGEIVKKCDGLPLAIKTVAGVLRSKERCEK
EWNKVLESEIWSMNQLQEELPRALYLSYEDLPSHLKQCFLFCSLYPENHI
MHYQDLTRFWIAEGFVKPQGDRLLEDLAEGYYEELLGRNLLQMYAMYLGN
SGCTMHGLLRSLAVYLVEEESVSISNGERLERQNSLTKIRHLSVSNMGEE
VAVPEEVASQNCLRTLLVSNSFKTKRIGADLFEKLGQLRVLCIDDTEIDR
IPDSLGNLIQLRYLDLDRTNVQSLPESIGCLRNLETLNLQSCRFLHYLPD
AITKLQNLRCLRVAETPLNHLPKGIGNLTKINHLDGFLIGHERDTQSQVE
DCALDDLQSLNDLRFLHLAALKRACRGSLALANKTLLKHLFLNWLPPCVE
ADLTWCGNQVAEALAKGFSGLFPPSSLECFPEEECHRNVRLFNELSLPSS
LELLSIYHFLGQELPKCMDRCMPMAFPNLQFLFLHCFISCTQLPVLGQLP
QLKFLSIARAEAIVTIGPELLCGQSPSTTLAAFPKLEYLVFSIMPNWEQW
SFGETKTAITHELKLLPSLKRLLLIDCPKLKALPDGLHHATNLQELWING
AHELGAVKNLPSLTTELFLEDNKKLEKVSNLPMLKSLIVGSCPLLKRVDS
LSALEMLELRHNSSWRLPESWWNPSLRHLSLDSQEGPLPVWLPETA
>XP_042468946.1 putative disease resistance protein RGA4 [Zingiber officinale]
MIKAVRKNLDSILKQKSILENLRQGTNRISLSAYRGIHPQNSLDVKGRET
EKEMIVNMLTADEGSSNDTMKVIAIVGMGGLGKTTLARHVFNDERVKSYF
GNFRMWKVVGAEFDPTKIMKSVSELAATAIGAPVNTSEPGIIMKSNLQLA
TQALVNTSELERMKSILQLAKGAPVNTTELDLMKFILQSAKGAPVNTSEP
ELVRGELEKALSDKRFLLVLDDVWNEDALPWRELKEALSCGAIGSKVLVT
TRNQNVSSIMGSFKTHHIQQLSRDDCFSLFQQFSFGDEEPNENLKKIGGK
IVEKCGGVPLAAISIGSMLHSTRDETYWSSVLNSEVWQLKDEDQKLLPVL
KLSYDALPLRSKKCFAFGSLFPKNYVMDKDELIQMWTTNGFVCSDRNFDA
ETLGNRIFDDLVLRSFFLLAPSEKCDDGRHVTKCTMHDLMHDLARLVSED
EYCNIKDNQVKNIQKRTYYLRIEYTKEKISLFKKEKPLYLRTLLLRKCNL
SGKVHLLQFIFSELKFLRALDLSENGIKGVPTSVGNLIHLRYLTLSKNKI
KFLPDTITLLQNLLFLNLTENPLQELPKRLRYMQSLWYLYCDCDSLTHMP
PGLSGLTSLRSLSSFVVENRTGSCSITQLEDLKLHGAMEIKFSKNFSSYS
CGGRKIFMNKDFNELSLSFNCSTTNDMSMLDDLCPNKSLKKLKICNYGSR
HFPTWLMESQLPNLVVVILQNCNFCEHIPHFRNLQFLRKLVIDGMSGVKH
MVAECHGHGPIRGCPSLQEFKLISMTNLEGWSESDGVDELFPILKKLEIW
NCPKLKNIPKLQTIELLKLHDCSGSLLSSVGRMTSLSHLKLEDVKGMTSL
PSGCLRNLTSLMKLEIISCHELQFLPMDEMQQLTMVHSLFIQKCFNLRLQ
NCDSNTAQPEILVQILNSLHEFDIQICCKNGNLRGQLQHLHRLGQLSISG
SHHNFEQFMSSSIKANLRICCCDELESLMTEAPSTSVLEDLRICNIPNLM
TLPEWLQHLGSLRQLWIYNCSLLESLPRSLQELRLLEYLAIIRCHRRLNR
RCKRVTGEDWPNISHVRYILIYPGEPLCDVAALCCAAALCCAPLLLCCLV
LEYLKSPSESIPQDRERHNFN
>XP_042468953.1 disease resistance protein RGA2-like [Zingiber officinale]
MEPLAISAAGFLGQRLVSLLQLDKKLKDLVDIERKMEKLKELPTIIDTVI
QYVEACSVRDAAVKKLLRNLKHLAYDLEDVVDYYDTKALRKQRSRAYSRP
VRDFFSFNNNQLVFKSRISGMIKAVTENLDSILLDKAILENLPQGTNRIS
QSAYREFHSHNSLAVIGRETEKEMIINMLTDEEGSSNSTTMKVIAIVGMG
GLGKTTLARHVFNDERVKAHFGKLNTYWKVVGAEFDPTKIMKSILELATG
APVSISEPELVKRELEKALSEKRFLLVLDDVWNEDKSQWTALEAVLTCGA
RGSKVLVTTRSPKVSSIMGSFNTHQIQQLPRDDCLSLFQQFAFGDEEPNE
NLMEIGGKIVEKCGGVPLAAKSLGSLLHSTRDETYWSSVLNSEVWQLGDE
GEKFLAVLKLSYDALPLRSKKCFAFGSLFPKNYVMKKDELIQLWTANSFV
CSEGNFNAETDGNRIFDDLVLRSFFLLAPSEKCDDDGRHVTECTMHDLMH
DLARSISEDEFYNDVDDGKKDIQKRTYHIWLKYEEISNTSLFKMPLYLRT
LSLRSCLSFKKAHLLQFVFSKLKLLRVLDLSNNYIKEVPTSIGNLILLRY
LTLSGNRIKFLPDAITLLQNLRYLSLIENPLQQLPKKLRNMQSLEYLHCD
CRDLTHMPLGLSRLTSLRSLSCYVSDDNRNGSCSITELEDLKLHGNMRIK
FSKNSSNYSCGGRKILKNKIFNELSLSFNCSETNDMSMLDDLCPNMNLKK
LQILDYGSRQFPTWLMESQLLNLVEIILRDCNFCEHIPHFGNLQFLRKLV
LDDIDGVKHLGAEFHGHGPIRGFPSLQELQLEWMRNLEEWSESDDADKSF
PLLKTLKIRHCPKLKAVPRFPTIEFLNLDNCSESLVSCVRRMTSLSHLIL
VGMKGMTSLPSGCLRNLTSLMRLEILSCNELQFLPMDEMQLLTMVHSLSI
KKCNNLTSFPLEMGRLGALRYLCLKNPDNNTLAPNNGSLIVQILNSVHEF
DIQICGKNVNLLGQLQHLHTLQQLRISGSHDTSYGPAILGCIRASLSICC
CDELESLMTTAPSTSVLEILDIYDIPNLTILPEWLQYLGSLRMLWICNCP
QLGSLPRGLQDLRSLNFLRIDGCCLQLKRRCKRETGEDWPNISHVPRIGI
STRDEAQRCGPFDKFFKINPTRWREI
>XP_042468954.1 putative disease resistance protein RGA4 isoform X1 [Zingiber officinale]
MIASPFLSILCLCFCYCFSFPLLPSSSNVSCSHIHSKQTTRPSFQLAGIA
MEPLAISAAGFLGQRLVSLLQLDKKLKDLVDIERKMEKLKELPTIIDTVI
QYVEACSVRDAAVKKLLRNLKHLAYDLEDVVDYYDTKALRKQRSRAYSRP
VRDFFSFNNNQLVFKSRISGMIKAVTENLDSILLDKAILENLPQGTNRIS
QSAYREFHSHNSLAVIGRETEKEMIINMLTDEEGSSNSTTMKVIAIVGMG
GLGKTTLARHVFNDERVKAHFGKLNTYWKVVGAEFDPTKIMKSILELATG
APVSISEPELVKRELEKALSEKRFLLVLDDVWNEDKSQWTALEAVLTCGA
RGSKVLVTTRSPKVSSIMGSFNTHQIQQLPRDDCLSLFQQFAFGDEEPNE
NLMEIGGKIVEKCGGVPLAAKSLGSLLHSTRDETYWSSVLNSEVWQLGDE
GEKFLAVLKLSYDALPLRSKKCFAFGSLFPKNYVMKKDELIQLWTANSFV
CSEGNFNAETDGNRIFDDLVLRSFFLLAPSEKCDDDGRHVTECTMHDLMH
DLARSISEDEFYNDVDDGKKDIQKRTYHIWLKYEEISNTSLFKMPLYLRT
LSLRSCLSFKKAHLFQFVFSKLKLLRVLDLSNNDIKEVPTSIGNLIHLRY
LNLFMNEIKVLPDAITLLQNLRYLNLIENPLQQLPKKLRNMQSLGYLHCD
CFDLTHMPLGLSRLTSLRSLSCFVSDDNRTGSCSITELEDLKLHGNMRIQ
FSKNSSNYSCGGRKILKNKNFNELSLSFNFSETNDMSMLDDLCPNMNLKK
LEICNYGSRQFPTWLMELQFPNLVEVILNYSYNCEHVPPFGNLQSLRKLA
INSMGEVKRMGAEFHGHGPIRGFPSLQELQLEWMLNLEEWSESDDAEKLF
PLLKTLKILNCPKLKTMPRFPTIEFLNLDNCSESLVSCVRRMTSLSHLIL
EGMKGMTSLPSGCLRNLTSLMRLEILSCNELQFLPREEMQLLTMLHSLSI
EKCNNLTSFPLEMGRLGALRYLCFKNPDNNTLAPNNGSLIVQILNSVHEF
DIQICGKNVNLLGQLQHLHTLRELRISGSHDSTDEGVILEYIRASLRICC
CDELESLMTTAPSTSVLEVLYIYDTPNLTILPEWLQYLRSLVRYRSTTAS
N
>XP_042468955.1 putative disease resistance protein RGA4 isoform X2 [Zingiber officinale]
MEPLAISAAGFLGQRLVSLLQLDKKLKDLVDIERKMEKLKELPTIIDTVI
QYVEACSVRDAAVKKLLRNLKHLAYDLEDVVDYYDTKALRKQRSRAYSRP
VRDFFSFNNNQLVFKSRISGMIKAVTENLDSILLDKAILENLPQGTNRIS
QSAYREFHSHNSLAVIGRETEKEMIINMLTDEEGSSNSTTMKVIAIVGMG
GLGKTTLARHVFNDERVKAHFGKLNTYWKVVGAEFDPTKIMKSILELATG
APVSISEPELVKRELEKALSEKRFLLVLDDVWNEDKSQWTALEAVLTCGA
RGSKVLVTTRSPKVSSIMGSFNTHQIQQLPRDDCLSLFQQFAFGDEEPNE
NLMEIGGKIVEKCGGVPLAAKSLGSLLHSTRDETYWSSVLNSEVWQLGDE
GEKFLAVLKLSYDALPLRSKKCFAFGSLFPKNYVMKKDELIQLWTANSFV
CSEGNFNAETDGNRIFDDLVLRSFFLLAPSEKCDDDGRHVTECTMHDLMH
DLARSISEDEFYNDVDDGKKDIQKRTYHIWLKYEEISNTSLFKMPLYLRT
LSLRSCLSFKKAHLFQFVFSKLKLLRVLDLSNNDIKEVPTSIGNLIHLRY
LNLFMNEIKVLPDAITLLQNLRYLNLIENPLQQLPKKLRNMQSLGYLHCD
CFDLTHMPLGLSRLTSLRSLSCFVSDDNRTGSCSITELEDLKLHGNMRIQ
FSKNSSNYSCGGRKILKNKNFNELSLSFNFSETNDMSMLDDLCPNMNLKK
LEICNYGSRQFPTWLMELQFPNLVEVILNYSYNCEHVPPFGNLQSLRKLA
INSMGEVKRMGAEFHGHGPIRGFPSLQELQLEWMLNLEEWSESDDAEKLF
PLLKTLKILNCPKLKTMPRFPTIEFLNLDNCSESLVSCVRRMTSLSHLIL
EGMKGMTSLPSGCLRNLTSLMRLEILSCNELQFLPREEMQLLTMLHSLSI
EKCNNLTSFPLEMGRLGALRYLCFKNPDNNTLAPNNGSLIVQILNSVHEF
DIQICGKNVNLLGQLQHLHTLRELRISGSHDSTDEGVILEYIRASLRICC
CDELESLMTTAPSTSVLEVLYIYDTPNLTILPEWLQYLRSLVRYRSTTAS
N
>XP_042470163.1 disease resistance protein RGA2-like [Zingiber officinale]
MSTETPQTEIARYLAQSLHNRSLKAIQRSWEHQEPEVYKAKAGLGKLIRD
ILEFIQDLHIYDQHKQISNDCLDDWLWRFKEFFYATEDVLDDLDFIEFRS
GKWQGDGASAFEEMRFMKAIGKLPEVIKTAAGLFSENKHFKNELQKSKPV
FSSLDQQIITGSGLRTLPYKVRELKGRAMEKAKILEAIFHKAEGESKKSP
VMISITGPVGIGKTDLARAVYNSAQVAAEFDVRAWIYMGNHHLGEWWLTL
QRSVSASVYKQSKIHRTSGSSLGDSILETMKTEIKGRKVLIVLDNLTEGF
CDDLLKYGAKVGSRIIVTSQFRHVGNSDDLLFDVELDGLEEEEYLKLFKE
CALGDRNRNKNPELEDIVEEIAKRFGGNPLAAVRIGRLLKSQADKDHWRI
ISRSNLGVIDPTESNILSVLRRSYEQLPWLSKQCYLAYALFPKNYPFEKG
QLLRIWNATGFGSCDSFGVFSERSFFVSSAKENDKLVLQATLHELADCIC
DGEFFRLETEIKEKDVIEIPHKAQHVYVTADNFVKVCKVLQKQTHLRSLV
IGGTLSSEEHKTNFMELLEEVLRNWKGLRLLMISVLPSGKLPGAIGGLRH
LRYLELPTETITKDSVQELPAWLSDKQFVGLRQLQNLKELRQAIRKLQTG
ESSDEFETIEELSPREPRDSSVSPPLEFSKDDPRVLEEKKTTESWSKSKR
ESDDTEYVDVDEKRWVLGGFSGRFKDEELQKKILYYQEMIGSVILNFNVF
I
>XP_042470164.1 putative disease resistance protein At3g14460 [Zingiber officinale]
MDPILIIITIVGWMATPLMTKLINSAHLLRNQRMSDQLNRLKQRLYAIGK
MAENAQIGNWQADVPYFRDWLRRFKDVIYDAEDVIYSHKLDERQIDKILE
KFQRLTNEIEDFLQGLNKREEIPTWRKTTYLMSRSIRGRTTQINELENWL
LSDQSTNSSKNFSLQSIVGPGGIGKTVLSQLVFNNPEVQQKFEVTAWVLL
CNPTTPDIKIKPSPRSLYQKIISLFQTNDSTNTPEILDEFESKFESRMKG
KTFFMVLDDMRELPTNWDNFYWPLFNCGKQGSKIIVTTQFERTANMIDSD
LPINLDVLEQDQYWELFKECAFGHNSTPSHHSVLEDVGRNISNKFGCSPL
AAVEVGRELKCSLNKTRWNSISHNKFCIVDRRDGDIISILGLCYEQLPER
LKQCYLSCALFPRNYPFEEEELNLIWIGLGFLHFESKTTNYVDDFSKRSF
LVNATRTNGRYVFHHVLHELAEYISDGEFLRLEEEIRGCEDTEIPSHTRH
LYINANNFVEATKALGKNSKLRSLVIVGGLSIPDHKRTFLKYLEKVLEKL
EFLRFLVLPLPPTNLSETVGTLKYLRYLQFPKNQQELPKLSNSILGKYKL
KLWNGCNYLLVSNDINKLIQRHCSLENIEDLSDLVP
>XP_042470165.1 putative disease resistance protein At3g14460 [Zingiber officinale]
MDPILIIITIVGWMATPLMTKLINSAHLLRNQRMSDQLNRLKQRLYAIGK
MAENAQIGNWQADVPYFRDWLRRFKDVIYDAEDVIYSHKLDERQIDKILE
KFQRLTNEIEDFLQGLNKREEIPTWRKTTYLMSRSIRGRTTQINELENWL
LSDQSTNSSKNFSLQSIVGPGGIGKTVLSQLVFNNPEVQQKFEVTAWVLL
CNPTTPDIKIKPSPRSLYQKIISLFQTNDSTNTPEILDEFESKFESRMKG
KTFFMVLDDMRELPTNWDNFYWPLFNCGKQGSKIIVTTQFERTANMIDSD
LPINLDVLEQDQYWELFKECAFGHNSTPSHHSVLEDVGRNISNKFGCSPL
AAVEVGRELKCSLNKTRWNSISHNKFCIVDRRDGDIISILGLCYEQLPER
LKQCYLSCALFPRNYPFEEEELNLIWIGLGFLHFESKTTNYVDDFSKRSF
LVNATRTNGRYVFHHVLHELAEYISDGEFLRLEEEIRGCEDTEIPSHTRH
LYINANNFVEATKALGKNSKLRSLVIVGGLSIPDHKRTFLKYLEKVLEKL
EFLRFLVLPLPPTNLSETVGTLKYLRYLQFPKNQQELPKLSNSILGKYKL
KLWNGCNYLLVSNDINKLIQRHCSLENIEDLSDLVP
>XP_042470166.1 putative disease resistance protein At3g14460 [Zingiber officinale]
MDPILIIITIVGWMATPLMTKLINSAHLLRNQRMSDQLNRLKQRLYAIGK
MAENAQIGNWQADVPYFRDWLRRFKDVIYDAEDVIYSHKLDERQIDKILE
KFQRLTNEIEDFLQGLNKREEIPTWRKTTYLMSRSIRGRTTQINELENWL
LSDQSTNSSKNFSLQSIVGPGGIGKTVLSQLVFNNPEVQQKFEVTAWVLL
CNPTTPDIKIKPSPRSLYQKIISLFQTNDSTNTPEILDEFESKFESRMKG
KTFFMVLDDMRELPTNWDNFYWPLFNCGKQGSKIIVTTQFERTANMIDSD
LPINLDVLEQDQYWELFKECAFGHNSTPSHHSVLEDVGRNISNKFGCSPL
AAVEVGRELKCSLNKTRWNSISHNKFCIVDRRDGDIISILGLCYEQLPER
LKQCYLSCALFPRNYPFEEEELNLIWIGLGFLHFESKTTNYVDDFSKRSF
LVNATRTNGRYVFHHVLHELAEYISDGEFLRLEEEIRGCEDTEIPSHTRH
LYINANNFVEATKALGKNSKLRSLVIVGGLSIPDHKRTFLKYLEKVLEKL
EFLRFLVLPLPPTNLSETVGTLKYLRYLQFPKNQQELPKLSNSILGKYKL
KLWNGCNYLLVSNDINKLIQRHCSLENIEDLSDLVP
>XP_042471863.1 putative disease resistance protein At3g14460 [Zingiber officinale]
MEFIPIGLTAVGWVASPWATVWINSFRSRRKQSRTGKQKLNLLKQFVDLG
REDKVPHSQGDLLYSKNWLRRFKDAISDAEDAIYSHEFAKDDNQINNILE
IFEDLAGEKKAFSQKLMQQEISTWRRTNYLMCREIKGRTDETEKLKNWLL
SDQSSTNSNTNVSALSIIGTGGIRKTILSQLAFNNQEVQQNFEVRAWVFL
YEPTRPGPTVYIKANESNSASSDQTSTSFEDFHNKFVSNTKNKRFFMVLD
DLWNEFADEWDKYLSLFKCGKHGSKIIVTARLKGVANVINLDPDSQIDLD
VLRQDEYLKLFKECVFGNSELLSEEFAFGNKSSREDYSALENVLFRIAMR
FGGSPLAAVEVGRELKLSLDQERWNSILPNKFCIADPREKDIISILGLCY
RKLPGRLEQCYLSCALFPRDYQFEEHQLNLIWIGMGFVHSGSTAGNYIKD
FSIRSFFIDTARTDNKYVFHHVLHELAEYISDGEFFRLEKKIMESESIEI
PEEARHVYILADNFAKASEALRRNEKLRSLVIDGPLSNSNDEKSFMKSLG
KVLNNLKSLRFLVLSVLPQNLPTTVGKLKYLRYLEFPINQEKLPKLSNSF
QRNYTLKRWDSKYLLVAKDIDKLIEHRCSSAKIVNEDMIYYCC
>XP_042472123.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MGGIGKTTLAQKIFDDEMMKKQFSKKVWLHIFKDYSEIEILKQVLRGVGG
NDVGVKTKAEVEGRLDPLLSGSLLLVLDDIWSANVWRELLRNPILKGSCR
SVILFITRHEVVAREMRANYVHLAEEIDEGSGWELIRKIVFGDGEDAIIS
ELEEVGMEIVRNVMVFLRQSK
>XP_042472124.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MYDAEDIFDRCLIEGGRLLEAQPSASSGGHSWLRTLNFRRNICDEIRRVN
DRLNEINDDNNVVLRGVGGNDVGVETKAEVEGRLDPLLSGSLLLVLDDIW
SANVWRELLRNPILKGSCRSVILFTTRHEVVARKMRADYVHPAEKIDEGS
GWELIRKIVFGDGEDAIISELEEVGMEIVRKCDGLPLAIKVMAGVLFHKE
RTKTEWKKVVESDLWFRKEIKLSNALYLSYEDLPNHLKQCFLSCAFYHGI
SHRSDIIRLWVAEGFVIEELDSLMEVTAKDYYKELIARNLLQIDQRFEDG
RLFVMHDVLRTFGEKLMEEEGSIISGDPYRSTNSLTTINSSTKIRRLSIS
NQVNVLSLPNMIIEQKCLRTLHLVNCPQIKLIEDHVFKRLKRLRVVNLCD
TSIDSLPDSLVKLSHLKYLNLDGTKIRKLPESIKDLANLQTLCLSGCKSL
HELPDGITRLSNLRCLRILNTPLTHVPKGVGKLKNLNNLAGCFVGHRDSM
SMMEGGCDLDELQYLCNLNDLVISKLERARTTNFVLENKTFLRILTLGWT
MHNNENNDEQSSEAERICKQLSPPATLEGLSIDNFPGRQFPDWMVSTSLA
DLTFLALDKFPSCTALPPLGQLPNLKILHTEGGEAIKSIGPEFLGRRTPA
FPKLEYLAFDSMRNWEEWVLRVAQDVVAPIEDVHASNLNLFPNLEKCYFI
DCPKLKNSILPPTRLLQINGCPNLEYMEKVGMLQLRKFEVVLPSEIKQLS
QWISSLINMTLQSLQLFNMQCNSLVLDSCRKGKQNWHIIQHIPKVIIHSI
GLETRLLRSEDGYQYQIKDELGSSFITPCKSFDH
>XP_042472127.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MGGIGKTTLAQELFNDEMVKKQFSNRVWLHVSKDYSQIELLKQVLRGVRG
NDDGVQSRAEVEGRIVSLLSESLLLVLDDIWSASVWRDLLRNSILNGSCR
TAILFTTRHEDVATDMRADFVHHVEKMDEDNGWELIRKIVFGNGEDQIIS
ELKEVGMQIVRKCDGLPLAIKVIAGVLFRKEKTKREWKKVVESDLWFMKE
NENEVSKTLYLSYEDLPGHLKQCFLSCVFYRAITNQSDIIRLWVAEGFVI
ERSDILMEDIAEDYYKELIASNFLQMDHIFLTGTRFVMHDILRSFGENLM
VDEGIIINDGQCANANSLRKIRHLSISNQGDLLLLPKVIIEQKCLRALHL
VNCPQIKKIEDHAFKSLKRLRVLDLRDTCIDNLSDSLMKLLHLKYLGLDR
TKIRKLPESIERLANLQTLNLSGCESLHELPKNITRLSNLRCLRIEDTPL
THVPKGVGKLKNLNYLSGFLVGHCDSMNKMDGGCDLDELQYLCNLRYLRM
DKLERATSTVNRNFVLANKAFLRRLTLGWTMNDNETNEEQITEAERIFNQ
LCPPPTLQGLRIIDMLPPLGQLPNLKILEIEVGEAIKNIGPEFFGYRNPA
FPKLEYLEFKNMPNWEAWVLREAHDVVDPNEDVHASNLNLFPSLKQCFFR
YCPKLKNSILPSNRLLQINLCPKLEYVEKVGMLQQLEVIFPSEINQLPQW
VSRLINAILHSLQTFYMECNSLLLDSCSKGKQNWHIIQQIPKVTIDSIDR
ERRLLLNKDSYKYEIKDEFGSFITLVSPLFS
>XP_042472136.1 putative late blight resistance protein homolog R1A-3 [Zingiber officinale]
MDNSKQKVKQDVPAMDNSKSTLARNVYNDSRIHDFFPRKTWLCVSKRFLG
NELLKELIRSFGGDHGEARSKAELELKLSHLLPKKFFIVLDDLWNANVWE
DLLRAPFKCSSGGILITTRDERVARQMGASIHCVEKMDKVTSWMLLSTLV
SRDGEDEEVCKLKAIGGEIVNKCDGLPLAIKTVAGVLRSKERCEKEWNKV
LERLLLGIWVAEGFVKPQGYRLLEDLAEGYYEELLGRNLLQLHPFYLDNS
>XP_042472137.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAEILSDFAGRCMSKLLSFVEGEATKILGVKDDLKKLQRRLLRVRGVLED
AEKKRHGSAEINAWVREMKDIMYDVEDLLDLCKTKAENLWVSHSPLPSAS
DFSCLPLSRQIANKVREVNDRLDEISEDRHVMSRLHEIDPSIHDSGINTR
NTSPLLIQSDIVGTQIKEVSESLVKSLITKRDEGWKIFGIVGMGGIGKTT
LARNVYNDSRIPGYFPRKTWLCVSKEFSGNELLKELIRSVGGDHGEARSK
AELELILSHLLPKKFFIVLDDLWNANVWEDLLRAPFKCSSGGILITTRDE
RVARQMGASIHCVEKMDKVTSWMLLSTLVSRDGEDEEVCKLKAIGGEIVK
KCDGLPLAIKTVAGVLRSKERCEKEWNKVLESEIWSMNQLQEELPRALYL
SYEDLPSHLKQCFLFCSLYPENISMHYKDLTRSWVAEGFVKPQGYRLLED
LAEGYYEELLGRNLLQLHPLYLDNSVCTMHGLLRSLAVYLVEEESVSISN
GERLESTNTLTKIRHLSVSNMGEEVAVPVELVSQNCLRTLLVWNSFKTKR
IGADLFEKLGQLRVLCIAATEIERIPDSLGNLIQLRYLDLDRTHVQSLPE
SIGCLKNLEILNLQSCRSLQYLPDAITKLQNLRCLRVRGTPLNHLPKGIG
NLTKINHLEGFLIGHERDTQGEVEDCALDDLQSLNDLRFLHVAALKRARR
GSLVLANKTFLKHLDLRWLPPCVKADLTRCGNQAAEDIAKSYSDLFPPSS
LECLTEAESQRNVRLFSDLSLPSSLEFLSIYHFLGQELPKCMERCTPMSF
PNLQFLDLNCFISCTQFPVLGQLPQLKILSIARADAIVTVGPELLYGQSP
LTTLVAFPKLEYLEFMIMPNWEQWSFGETETAKAQELQLLPSLKRLCVVD
CPKLKALPDGLHHATNLQELRIYGAHELGEVKNLPSLTNELFLRDNKKLE
KVSNLPMLKSLIVGSCPLLKQVDSLSALEMLELRHNSSQRLPSDASLQHL
NLDTQEDPLPVWLPELLEQNMKGYAGSGVLLVECSLSLLRRCCKDGPYWH
TIQQFAGVLMQSEEGSAYMTYTKNPFKYESNAFSHQKFIEQRI
>XP_042472138.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MAEILSDFAGRCLSKLLSFVEGEATKILGVKHDLKKLQWRLLRVRGVLED
AEKKRHGSAEINAWVREMKDIMYDVEDLLDLCKTKAENLWVSHYSPLPSA
SDFSCLPLARQIANKVREVNDRLDDISEDRHVMSRLHEIEPSIQESGINT
RDTSPLLIQSDIVGTQIKEVSESLVKSLITERDEGWKIFGIVGMGGIGKT
TLARNVYNDSRIHDFFPMKTWLCVSKRFSGNELLKELIRSFGGDHGEARS
KAELELKLSHLLPKKFLIVLDDLWNANVWEDLLRAPFKCSSGGILMTTRD
ERVARQMGASIHCVEKMDKVTSWMLLSTLVSRDGEDEEVCKLKAIGGEIV
KKCDGLPLAIKTVAGVLRSKERCEKEWNKVVESEIWSMNQLQEELPRALY
LSYEDLPSHLKQCFLFCSLYPENHIMHYQDLTRFWIAEGFVKPQGDRLLE
DLAEGYYEELLGTTLLKHLFLNWLPPCVEADLTRCGNQVAEALAKGFSGL
FPPSSLECFPEEEYHRNVRLFNELSLPSSLELLSIYHFLGQELPKCMDRC
MPMSFPNLQFLFLHCFISCTQLPVLGQLPQLKFLSIARAEAIVAIGPELL
CGQSPSTTLAAFPKLEYLVFSIMPNWEQWSFGETKTAIAHELKLLPSLKR
LLLIDCPKLKALPDGLHHATNLQELWINGAHELGAVKNLPSLTTELFLED
NKKLEKVSNLPMLKSLIVGSCPLLKQVDSLSALEMLELRHNSSWRLPESW
WNPSLRHLSLDSQEGPLPVWLPELLEQRMKGYAASGVLLVKCSLSLLRRC
CKDGPYWHTIQQLPGVMMKSKESSAYMTYTKNPFKYESNASFRC
>XP_042472309.1 putative disease resistance protein RGA1 [Zingiber officinale]
MREIERFTIEVIEYTTKEKCNVPNFAALQVVLKEKITQERFLLVLDDVWN
EERHKWESLCAPLRFGKPGSKILVTTRSRSIAGMVGDVDPIHLDRMDEKS
FWEFFKKCAFGSSNSGIHHPHLEAMAKKMTYKLKGLPVAAKTLGGLISMP
LDEHHWKGVSDSEIWTNFPKKKWD
>XP_042472352.1 putative disease resistance protein RGA3 [Zingiber officinale]
MEFVSMDLLNALVHTLDHVSKELQKVYGVRDELVKLRNIVSSIQGVLKDA
QESEETRNSVKQQLNELREVAYLANDILDDVTTEQQRQQLIKFAAVRNFL
DDVNPKRFFFKQDVYDRIQWIKTELDEIVKKCPLSTLTSHNGSQRTHISE
TTSLSPPCVLGREREKQEIKELLVPLSGQSDSTASVISICGMPGVGKTTL
AQQLFDDETVKKHFELRLWVYVSNDFDLMRIMRCMIESIDRFKCDLASLN
NLQQEIRKKVSGRRYLLVLDDVGQESREWERLKNCLYSADEGSKILVTTK
NEQVAAFMAANSPPVLYRLEGLAMEDCWSLICQPALSRNPSASFTLDFYR
SHAVNRCGGLPMAAKALGQRLAREADRNKWGAILTSQSWEFSGADSTRCE
LERDFIIQLWMAQGFIRPRGTEQMEDVGSDYIDSLRRSSFLQYSHFDHKS
RRQRYVMQNVFHEFARYAAAEECSVIEPGMELHLSASVRHLSVNYEEFVR
RVTPDEVYKCKGLQSLLLIGNSTSRPIMALPGDLAQKLSSLRTLMLTNSR
LTQLPESIGDLRHLRCLQLQNTSIKRLPDSVSRLYNLQTLGLRNCYDLEE
LPKDMSKLRNLRHLDLHLDGNSQGTLRCMPPEIGLLTHLRTLNRFVVSKR
HECGLSQLENLNDLRSDLLIERLDLVSSREDATNANLSSKEHIHRLELTW
NYSCVTDASARSAGYNSRENILEYLKPHPRLKEIGVVGYGGTLLPKWMGD
SSLFNLETVRISKTYSCLNLLPPLGQLPNLKYLFLEEMHGLKHLDCSFCG
RNEIRFPKLEKLHLENMSGLQEWLGDHRCALPSLSELTIKNCPALQQLTH
ELPSLTKLVIEASPYFAGLPDFPKLQSLEVKTNDDWIWRSWAAISLLPSP
TLSGLTRADLPFHIGSRHASIRRLEISYCSQLKFIPDGWLPECLSHFVIR
HCPILQNVPVGLTRLTMLEDLEIENCEQLEHLPVGLRNMNSLAHLEISDC
PALSWLPSDGLPRKLQFLSISNCPELIQKLQRQDLFTRRQDLQVWINGEH
VVT
>XP_042472353.1 putative disease resistance protein RGA3 [Zingiber officinale]
MPGVGKTTLAQELFNDVTVMEHFELRLWVYVPHDFDLMKILRCMIESIDG
FKCDLASLDTLQQEVRKKVSGRRYLLVLDDVWEESEEWERLKSFLYSADG
GSKILVTTKREQVARFMAANSTPYHLEGLSMDDCWSLICQQVLSRNPSAS
FTHDFSQSDALRRCMGLPMAAKALGQRLAREADRSKWEAILTSQPWEFSG
SGPSSNTMKPLSLSYQYLPHHLKPCSAYLSIIPKGWELETDLIIQLWMAQ
SFIRPRGTEEMEDVGSDYIDSLRRSSFLQYSHFDHKSRRQRYVMHDVFHE
FVRHVAAEECSVMEPGTGLYLAHSERVRHLSVNYEELIRRVPSGGDMYEQ
VYKCKGLQSLLLIGNSTSRPTMVVRDDLAERLSSLRTLMLTNSCLTQLPE
SIGDLRHLRCLQLQNTDIKRLPDSVSRLYNLQTLGLRNCYHLKELPKDMS
YLRNLRHLDLHLDGNSQGTNAGGKLRRMPPEIGLLTHLRTLSRFVVSKRR
NCGLSQLKNLNDLCSELLIERLDLVSSREDAKNANLSSKEHIHRLELTWN
YTIVTDASARKNILEYLKPHHGLKEIGVIGYGGTLLPTWMGDSSFNNLEK
VWISKTYSCLNLPPLGQLPNLKYLLLKEMHGLTHLDCSFCGTNEIRFPKL
EKLHLENMPELQEWLGADNCALPSLRELTIKDCLALQRLRHELPSLTKLV
IEASPSFARLPYFPKLQSLEVKTNDDWIWRSWAALSSLTSLTLSGLTRAD
LPFEINSCHASIRRLEISYCSQLKFIPDGWLPPCLSSFVIRHCPMLQNLP
AAGLTKLTMLEDLEIEECEQLEHLPVGLRNINSLAHLEISDCPGLSWLPS
NGFPSKLQFLSISNCPELIQKLRDQGWLAADREYPQVWINGVHLVT
>XP_042472472.1 putative disease resistance protein At3g14460 [Zingiber officinale]
MSLFAETPQFEIATYLSKLLEERTYHVIESLRQHQDLEVYNAIAILERLR
EILPKILRKPWKLRTDNFHTTISNKFLEDWLCRFKGFFYMTEDVFDDLDI
IVLPSDKRQGDYLSAFGKRMLICKKAIAKLPEVIDAATGLLGENKNLMEG
MREFEQILYRRWKEQQVTSSELPTLPYKVRELKGRAGEEKKILEALLHKE
EGESKKSTRLIRIAGPVGIGKTELARAVYNSAQVEAEFDVRAWIYMGNHH
RDDNWLTLQRSEPASVDKSSKLQRLNGLAIFNIFDTLERELQSKKVLIVL
DNLADKAEHSSYLGTFRSFRATEDCRIIVTTQFEYVGRVNASLNVELDGL
EEEEYLELFKECAALGDKNHDKYPAELENTCKEIAKRFGGNPLAAVMIGR
HLKWHQSEDRWRVISRSNLGMIDPTESNIISVLKHSYEELTGNQKQCYLA
CALFPKNYPFKQNQLFEIWKAIGCCSHTSNQWSWAWTDIEPFFVSSARKD
GEFILHAIFHELADYICDGDFFRLEDEIKEEDGIEIPDKARHVYVTADNF
VKIYKVLQEKTHLRSLVICGVLSSKEHKSSFMGLLEEVLQNLEGLRLLMI
SVLPTGKLPDAIGSLRHLRYLELPIDKHTLTKESFLELPTWISDDGFAGL
RKLQNLEELRGAIQKLKTGESSHSFKSIGPELSYRESSDPSDQLFRP
>XP_042473836.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MADVLNFFVIRYLDKLSDVIKGEIGKVLGVKEETKRLHRKLSRIRPYIQD
AEKRRRRDPAINNWVKELKDIMYDVEDTLDLCLIEGGRLLEALPSSPLEV
CSPVSLLSFCFQCYKFRRNIWNQIKRVNDRLDEIKDDSNVIPRLVAHINE
GLQDNTVKMSSPTSSTHVATDIVGTQIVDAAQMLISEIERNKKKCSVLGI
SGMGGIGKTTLAQKIFNDEMVKKQFPKRVWLHVSKDYSQIELLKQILRGV
GGHDDGVQSRAEVEGRIVPLLSESLLLVLDDIWSASAWGDLIRNPILNGS
CRATVLYTTRHEDVVAEMRADFVHHVEKMHEDSGWELIRKIVFGEGENEI
ISELKEVGMEIVRKCDGLPLAIKVMAGVLFHKDRTKREWIKVVESDLWFM
TENRNEVSNALYLSYEDLPSHLKQCFLSCAFYRGISFRSDLIRLLMAEGF
VIEESNRLMEDTAENYYEELIARNLLQNHTKNLNSVGVVMHDVLRSFAEK
LMEEEGIIINNGQCTSTNSLTKIRRLSISNQGDDVLSLPNVITEQKCLRV
LRLINCPRINRIENHAFESLQRLRVLDLCDTSIESLPDCLTKLLHLKYLD
LDRTKIRRIPESIECLANLQTLNLSGCESLHELPMGITKLSNLRCLRIEK
TPLTHVPKGVGKLKNLNTFLGFFVGHCDSMSKMDGGCDLDELQYLCNLRH
LRIDKLERATRTRNGNFMLANKKFLRRLILEWTKNNNENNEEQITEAEMI
CNQFSPPSNLQSLAIKNFPGRQFPEWMVSTSALDSLANLTLLSLANFPSY
TVLPPLGQLPNLKVLDIEGGEAIRSIGPEFLGCRTPAFPKLEYIAFDNMR
NWEAWILREALDVQATNLNLFPNLKSCNIINCPKLKNSILPSNRYLQINL
CPSLEYVEKVGTLQQLVVIFPAEIKQLPQWLSSLINATLHSLQLFYMHCD
SLLLDSCSKGKQNCHIIQQIPKVTIYSVDRKTRLLLNKGSYKYEIKDEFG
SFISLDQPSFHG
>XP_042473837.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MADVLNFFVIRYLDKLSDVIKGEIGKVLGVKEETKRLHRKLSRIRPYIQD
AEKRRRRDPAINNWVKELKDIMYDVEDTLDLCLIEGGRLLEALPSSPLEV
CSPVSLLSFCFQCYKFRRNIWNQIKRVNDRLDEIKDDSNVIPRLVAHINE
GLQDNTVKMSSPTSSTHVATDIVGTQIVDAAQMLISEIERNKKKCSVLGI
SGMGGIGKTTLAQKIFNDEMVKKQFPKRVWLHVSKDYSQIELLKQILRGV
GGHDDGVQSRAEVEGRIVPLLSESLLLVLDDIWSASAWGDLIRNPILNGS
CRATVLYTTRHEDVVAEMRADFVHHVEKMHEDSGWELIRKIVFGEGENEI
ISELKEVGMEIVRKCDGLPLAIKVMAGVLFHKDRTKREWIKVVESDLWFM
TENRNEVSNALYLSYEDLPSHLKQCFLSCAFYRGISFRSDLIRLLMAEGF
VIEESNRLMEDTAENYYEELIARNLLQNHTKNLNSVGVVMHDVLRSFAEK
LMEEEGIIINNGQCTSTNSLTKIRRLSISNQGDDVLSLPNVITEQKCLRV
LRLINCPRINRIENHAFESLQRLRVLDLCDTSIESLPDCLTKLLHLKYLD
LDRTKIRRIPESIECLANLQTLNLSGCESLHELPMGITKLSNLRCLRIEK
TPLTHVPKGVGKLKNLNTFLGFFVGHCDSMSKMDGGCDLDELQYLCNLRH
LRIDKLERATRTRNGNFMLANKKFLRRLILEWTKNNNENNEEQITEAEMI
CNQFSPPSNLQSLAIKNFPGRQFPEWMVSTSALDSLANLTLLSLANFPSY
TVLPPLGQLPNLKVLDIEGGEAIRSIGPEFLGCRTPAFPKLEYIAFDNMR
NWEAWILREALDVQATNLNLFPNLKSCNIINCPKLKNSILPSNRYLQINL
CPSLEYVEKVGTLQQLVVIFPAEIKQLPQWLSSLINATLHSLQLFYMHCD
SLLLDSCSKGKQNCHIIQQIPKVTIYSVDRKTRLLLNKGSYKYEIKDEFG
SFISLDQPSFHG
>XP_042473838.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MADVLNFFVIRYLDKLSDVIKGEIGKVLGVKEETKRLHRKLSRIRPYIQD
AEKRRRRDPAINNWVKELKDIMYDVEDTLDLCLIEGGRLLEALPSSPLEV
CSPVSLLSFCFQCYKFRRNIWNQIKRVNDRLDEIKDDSNVIPRLVAHINE
GLQDNTVKMSSPTSSTHVATDIVGTQIVDAAQMLISEIERNKKKCSVLGI
SGMGGIGKTTLAQKIFNDEMVKKQFPKRVWLHVSKDYSQIELLKQILRGV
GGHDDGVQSRAEVEGRIVPLLSESLLLVLDDIWSASAWGDLIRNPILNGS
CRATVLYTTRHEDVVAEMRADFVHHVEKMHEDSGWELIRKIVFGEGENEI
ISELKEVGMEIVRKCDGLPLAIKVMAGVLFHKDRTKREWIKVVESDLWFM
TENRNEVSNALYLSYEDLPSHLKQCFLSCAFYRGISFRSDLIRLLMAEGF
VIEESNRLMEDTAENYYEELIARNLLQNHTKNLNSVGVVMHDVLRSFAEK
LMEEEGIIINNGQCTSTNSLTKIRRLSISNQGDDVLSLPNVITEQKCLRV
LRLINCPRINRIENHAFESLQRLRVLDLCDTSIESLPDCLTKLLHLKYLD
LDRTKIRRIPESIECLANLQTLNLSGCESLHELPMGITKLSNLRCLRIEK
TPLTHVPKGVGKLKNLNTFLGFFVGHCDSMSKMDGGCDLDELQYLCNLRH
LRIDKLERATRTRNGNFMLANKKFLRRLILEWTKNNNENNEEQITEAEMI
CNQFSPPSNLQSLAIKNFPGRQFPEWMVSTSALDSLANLTLLSLANFPSY
TVLPPLGQLPNLKVLDIEGGEAIRSIGPEFLGCRTPAFPKLEYIAFDNMR
NWEAWILREALDVQATNLNLFPNLKSCNIINCPKLKNSILPSNRYLQINL
CPSLEYVEKVGTLQQLVVIFPAEIKQLPQWLSSLINATLHSLQLFYMHCD
SLLLDSCSKGKQNCHIIQQIPKVTIYSVDRKTRLLLNKGSYKYEIKDEFG
SFISLDQPSFHG
>XP_042473932.1 putative disease resistance RPP13-like protein 1 isoform X1 [Zingiber officinale]
MAVVLDFFVKRYLGRLSDFLDGEIGKVLEVKEEIKKLHRKLSRISPYIQD
AEKRRHRDPVINNWVKELKDIMYDAEDILDLCMVEGGRFLEAQPFAPSGV
CSSVSLLSSCFQCYKFRTNIWNQIKRVNDRLDEIKRVIPRLVEHRNEGLQ
DNIVKMSSSTSPTHVAEDIVSKQIIDAAQNLISEIEHNKKKCSVFGISGM
GGIGKTTLAQKIFNDEMMKKQFPNRVWLHVSKDYSQIELLKQILRGVGGH
DDGVQSRAEVEGRIIPLLSESLLLVLDDIWSASAWGDLIRNPILNGSCRT
AIIFTTRHEDVAREMRADFVHHVKKMHDDSGWEFIRKIVFGDGEDIMISE
LKEIGMEIVKKCDGLPLAIKVMAGVLFHKERTKREWKKIVESDSWFMKET
EDKLLKALYLSYEDLPCHLKQCFLSCAFYRSISYRWDIIRLWVAEGFVIE
QSNSLMEDTAENYYEELIARNLLQIDSRFLDGRVFVMHDVLRSFGEKLME
EEGIIINDTQFTSTTSLTKVRRLSISNQGDVLLLPNVIIEQKCLRALHLL
NCSQIKRIEDHVFESLKRLRVLDLHDTSIDSLPDSLLKLLHLKYLNLCGT
KIRKLPESIECLANLQTLNLSECESLHELPKGITRMSNLRCLQIVSTPLT
HVPKGVGKLKNLNTLDGFFVGHCDSMSKMDGGCDLDELQYLCNLRYLSIY
KLERARTIGSRHTVLANKPFLRGLKLVWTINIENNEEQITEGERICNQLS
PPETLKDLWIDNFPGRQFPAWMVSTHDSFADLTTLWLCNFPSCMVLPPLG
QLPNLKHLHIEGGEAIRSIGPEFLGCTTPAFPKLEHLKFTSMPNWESWVL
REAQDVHARNLNLFPNLKQCYFLHCPKLKSSLLPPTRFLKIKICPNLEYV
EKVGMLQLRKLEVIFPSEIQQLPPWVSSLINATLHSLQTLYMRCNLVLLD
SCRTGKQNWHTIEEIPKVIIHSIDREARLLLSKDGYKYQIKDEFGSFVAL
DQRGFNG
>XP_042473933.1 putative disease resistance RPP13-like protein 1 isoform X2 [Zingiber officinale]
MYDAEDILDLCMVEGGRFLEAQPFAPSGVCSSVSLLSSCFQCYKFRTNIW
NQIKRVNDRLDEIKRVIPRLVEHRNEGLQDNIVKMSSSTSPTHVAEDIVS
KQIIDAAQNLISEIEHNKKKCSVFGISGMGGIGKTTLAQKIFNDEMMKKQ
FPNRVWLHVSKDYSQIELLKQILRGVGGHDDGVQSRAEVEGRIIPLLSES
LLLVLDDIWSASAWGDLIRNPILNGSCRTAIIFTTRHEDVAREMRADFVH
HVKKMHDDSGWEFIRKIVFGDGEDIMISELKEIGMEIVKKCDGLPLAIKV
MAGVLFHKERTKREWKKIVESDSWFMKETEDKLLKALYLSYEDLPCHLKQ
CFLSCAFYRSISYRWDIIRLWVAEGFVIEQSNSLMEDTAENYYEELIARN
LLQIDSRFLDGRVFVMHDVLRSFGEKLMEEEGIIINDTQFTSTTSLTKVR
RLSISNQGDVLLLPNVIIEQKCLRALHLLNCSQIKRIEDHVFESLKRLRV
LDLHDTSIDSLPDSLLKLLHLKYLNLCGTKIRKLPESIECLANLQTLNLS
ECESLHELPKGITRMSNLRCLQIVSTPLTHVPKGVGKLKNLNTLDGFFVG
HCDSMSKMDGGCDLDELQYLCNLRYLSIYKLERARTIGSRHTVLANKPFL
RGLKLVWTINIENNEEQITEGERICNQLSPPETLKDLWIDNFPGRQFPAW
MVSTHDSFADLTTLWLCNFPSCMVLPPLGQLPNLKHLHIEGGEAIRSIGP
EFLGCTTPAFPKLEHLKFTSMPNWESWVLREAQDVHARNLNLFPNLKQCY
FLHCPKLKSSLLPPTRFLKIKICPNLEYVEKVGMLQLRKLEVIFPSEIQQ
LPPWVSSLINATLHSLQTLYMRCNLVLLDSCRTGKQNWHTIEEIPKVIIH
SIDREARLLLSKDGYKYQIKDEFGSFVALDQRGFNG
>XP_042473934.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MAVVLDYFVSRYLGKLSDFIEGEICKVLGVREEIERLHRKLSRIKIYIQD
AEKRRHRDSAINNWVKELKDIMYDAEDILDLCMVEGGRFLEAQPSASSWV
RSRLSKLSSYLMSSPNENASKFSRNIWNQIKRVNDRLDEIKEDSSVVPRL
LEHITEDLQDNPGKKSSPTSPTHVATDVVGTQIVDAAQNLISKIEQSKKM
CSVLGISGMGGIGKTTLTQKIFNDEMVKKQFPKRVWLHVSKDCSHINILK
ELLREVGGNDNGLQSRAEIERRIVPLLSESLLLVLDDIWTATVWMDWLRN
LILNSSCRTAILFTTRNENVVKEMRPDFVHHVKKMKDDSGWELIRKIIFG
DEEDIIISELEEVGMEIVRKCYGLPLAIKVIAGVLFHKKRTKREWKKVVE
SDLWFMKEIDDELSNALYLSYEDLPSHLKQCFLSCAFYRGVSLRSDIIRL
WVDEGFVIEQSDNLMENIAEDYYKELIARNLLQIDFRFLFGVRFVMHDVL
RSLGEKLMEDEAIFINDAQCRSTNSLTKVRCLSISNQADVLLLPDAIIEQ
KCLRALHFTNCPQIERIDQNHAFESLKYLRVFHLNDTSIGSFPDSLMKLF
HLKYLDLDRTKITKLPESIECLANLQTLSLSGCESLHELPKGITRLSNLR
CLRIENTPLTHVPKGVGKLKNLNHLDGFLVGHCDSMIRMDGGCDLDELQD
LCNLMDLFIDKLERATTRGNRNFVLANKLFLRILTLVWRVNNEKNEEQIT
EAERICNQLSPPPTLEVLRIGNFVGRQFPEWMVSTSILDSLVDLTFLTLI
IFPSCTALPPLGQLPNLKILNIEVGEAIKSIGPEFLGCRTPAFPKLEYLA
FDSMPNWEEWVLRVAQDVVDPIEDVHARNVNSFPNLKECNIIHCPKLKNS
ILPLTRHLQIKLCPNLEYVENLGMLQQLFVIFPPELQQLPQWVSNLINAT
LHSLQTFDMECNSLLLDSCSKGKQNWHIIQKIPKVTINSIDREARLLFHK
GSYKYEKKNEFGSFITLD
>XP_042473935.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MAVVLDYFVSRYLGKLSDFIEGEICKVLGVREEIERLHRKLSRIKIYIQD
AEKRRHRDSAINNWVKELKDIMYDAEDILDLCMVEGGRFLEAQPSASSWV
RSRLSKLSSYLMSSPNENASKFSRNIWNQIKRVNDRLDEIKEDSSVVPRL
LEHITEDLQDNPGKKSSPTSPTHVATDVVGTQIVDAAQNLISKIEQSKKM
CSVLGISGMGGIGKTTLTQKIFNDEMVKKQFPKRVWLHVSKDCSHINILK
ELLREVGGNDNGLQSRAEIERRIVPLLSESLLLVLDDIWTATVWMDWLRN
LILNSSCRTAILFTTRNENVVKEMRPDFVHHVKKMKDDSGWELIRKIIFG
DEEDIIISELEEVGMEIVRKCYGLPLAIKVIAGVLFHKKRTKREWKKVVE
SDLWFMKEIDDELSNALYLSYEDLPSHLKQCFLSCAFYRGVSLRSDIIRL
WVDEGFVIEQSDNLMENIAEDYYKELIARNLLQIDFRFLFGVRFVMHDVL
RSLGEKLMEDEAIFINDAQCRSTNSLTKVRCLSISNQADVLLLPDAIIEQ
KCLRALHFTNCPQIERIDQNHAFESLKYLRVFHLNDTSIGSFPDSLMKLF
HLKYLDLDRTKITKLPESIECLANLQTLSLSGCESLHELPKGITRLSNLR
CLRIENTPLTHVPKGVGKLKNLNHLDGFLVGHCDSMIRMDGGCDLDELQD
LCNLMDLFIDKLERATTRGNRNFVLANKLFLRILTLVWRVNNEKNEEQIT
EAERICNQLSPPPTLEVLRIGNFVGRQFPEWMVSTSILDSLVDLTFLTLI
IFPSCTALPPLGQLPNLKILNIEVGEAIKSIGPEFLGCRTPAFPKLEYLA
FDSMPNWEEWVLRVAQDVVDPIEDVHARNVNSFPNLKECNIIHCPKLKNS
ILPLTRHLQIKLCPNLEYVENLGMLQQLFVIFPPELQQLPQWVSNLINAT
LHSLQTFDMECNSLLLDSCSKGKQNWHIIQKIPKVTINSIDREARLLFHK
GSYKYEKKNEFGSFITLD
>XP_042473936.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MLHTQSSISELIHLSQEMAMVLEFFVSRYLKKLSDFIEGEICKMLGVKEE
IERFHRKLSTIRIYIQDAERRRHRDSVINNWVKKLKDIIYDVEDILDLCM
VEGGRLLEAQPSTSSWVCSRISLLSSYIHRYTFNRNIWNQIKRVNARLDE
IKEDSSVIPRLFEHITEAFQDNLVKMSSPSSFKHVATDIVGKQIADDAQN
LISKIDQGKKSCYVLGISGMGGIGKTTLAQKIFNDEMVKKQFPKRVWLHV
SKDCSHINLLKELLREVGGNDNGVQSRAEIEGRIIPLRPKSMLLVLDDIW
SASVWMDLLRKFIWDDSCRTTILFTTRNENVVKEMRPDFVHHVKKMKDDS
GWELIRKIVFGDEEDIIISELEEVGMEIVKKCDGLPLAVKVIAGVLFHKE
KTKREWKKVAKSDLWFMKENEDELSNVLYLSYEDLPSHLKQCFLSCAFYR
GVSLRSDIIRLWVDEGFVIEQSDNLMENIAEDYYKELIARNLLQINFRFL
EGARFVMHDVLRSLGEKLMEDEAIFINDAQCTSTNSLTKVRRLSISNQAD
VLLLPNAIIKQKCLRALHFTNCPQIERIENHAFESLKYLRVFHLNDTSIG
SFPDSLMKLFHLKYLDLDRTKITKLPESIECLANLQTLSLSGCESLHELP
KGITRLSNLRCLRIENTPLTHVPKGVGKLKNLNHLDGFLVGHCDSMIRMD
GGCDLDELQDLCNLIDLFIDKLERATTRGNRNFVLEKKLFLRRLKLVWTV
NNENNEEQITEAERICNQLRPPPTLEVLRIGNFIGRQFPEWMVSTSILDS
LVDLTYLSLIIFPSCTVLPPLGQLPNLKLLNIEQGEAIKSIGPEFLGRRT
PAFPKLEYLAFDNMRNWEEWVPIEDVHASNLNLFPNLEKCYFIDCPKLKN
SILPSTRLLQIKLCPNLEYVEKVGMLQQLFVFFPPEIQQLPQWVSNLINA
NLNSLQTFDMVCNSHLLDSCSNGKQNWLIIQQIPKVTIHSIDPEKRLLLH
KGSYKYEEKKNKFGNFITLDQSSNKRRSACLQHPCQPIRKLTRRR
>XP_042474088.1 putative disease resistance protein RGA4 [Zingiber officinale]
MESSAIAAAGFLGKRVFALLQLEEKLKELVGIEARMENLKELSTIIDTVI
QDVEACSVTDAALKNLLRKLKYLAYDLEDVVDYYDTEASRKERSRAYSRP
VRDFFSSNNNQLVFKSRISGMIKAVRKNLDSILKQKSILENLRQGTNRIS
LSAYRGIHPQNSLDVKGRETEKEMIVNMLTADEGSSNDTMKVISIVGMGG
LGKTTLARHVFNDERVKSYFGNFRMWKVVGAEFDPTKIMKSVSELAATAI
GAPVNTLEPGISNLQLATQALVNTSELERMKSILKLAKGAPVNTSELDLM
KFILQSAKGAAVNTSEPELVRGELEKALSDKRFLLVLDDVWDEKILQWRE
LKEALSCGARGSKVLVTTRNQNVSSIMGSFKTHHIQQLSRDDCLSLFQQF
SFGDEEPNENLKEIGGKIVEKCGGVPLAAISLGSMLHSTRDETYWSSVLN
SEVWQLRDEDQTLLPVLKLSYDALPLRSKKCFAFGSLFPKNYVMDKDELI
QMWTTNGFVCSDRNFDAETLGNRIFDDLVLRSFFLLAPSEKCDDGRHVTK
CTMHDLMHDLARLVSEDEYCNIKDNQAKNIQKRTYHLRIEYTKEKISLFK
KEKPFYLRTLLLRKCNLSGKVHLLQFIFSELKFLRALDLSENGIKGVPTS
VGNSIHLRYLTLSKNKIKFLPDTITLLQNLLFLNLTENPLQELPKRLRYM
QSLWYLYCDCDSLTHMPPGLSGLTSLRSLSSFVVENRTGSCSITQLEDLK
LHGAMEIKFSKNFSSYSCGGRKIFTNKDFNELSLSFNCSTTNDMSMLDDL
CPNTSLKKLKICNYGSRHFPTWLMESQLPNLVVVILQNCNFCEHIPHFRN
LQFLRKLVLDGMSGVKHMVAECHGHGPIRGFPSLQEFKLISMTNLEGWSE
SDGVDELFPILKKLEIWNCPKLKNIPKLQTIELLKLHDCSGSLLSSVGRM
TSLSHLKLEDVKGMTSLPSGCLRNLTSLMKLEIISCNGLRFLPMDEMQQL
TMVHSLFIQKCNNLSLQNCDSNTLQPEILVQILNSLHEFDIQICFKNGNL
RGQLQHLHRLGRLWISGSHHVFDPFKSSSIKTNLSICCCDELESLMTEAP
STSVLEDLHICYIPNLTTLPEWLQHLGSLRQLWIYNCSRLESLPRSLQEL
RLLEYLTIFGCHRRLNRRCKRVTGEDWPNISHVRSIEIYPGETPCCVAAL
CCVAALCCAAALCCVPLILCYPLFEYLSSSESIPQDRERHNFN
>XP_042474099.1 putative disease resistance protein RGA4 [Zingiber officinale]
MAMDADLATYAVGFKELVGIQGRMEKLKELSTIIDMVIQDVEACSVTVTD
AAVKNLLRKLKHLAYEVEDVVDYYDTKALRKQRSRAYSRPVRDFFSSNNN
QLVFKSKISGMIKAVTENLDSILLEKSILKILSQGSNPSAYGEIHAHNSL
AVIGRETEKEMIVNMLTDDEGSSSGTLKVIAIVGMGGLGKTALARHVFND
KRVKDHFNTYWKVVGKIFKPTEIMKSILELAVDAKVDISEPELVRGRLET
VLSRKRFLLVLDDVWNEDALLWRELKAALSCGARGSTVLVTTRSQKVSSI
MGSFKTHQIQQLSRDDCLSLFREFAFGDAEPNENLMEIGEKIVEKCAGVP
LAAVSLGSALHSIRDETYWSSVLNSEVWQLRDEDQKFLAVLKLSYDALPP
WSKKCFAFAALFPKKYAMKKDDLIQMWAANGFVSSEGNFDAETVGNSIFD
DLVLRSCFLPSKKCDDGRHVTESTMHDLMHDLTRSISKDQYYNSKDCQPK
DIQKRTYHLCIEDAKFSNTCLLKKPLYLRTLLLRKCHLYDKVHLRQFVLS
KLKFLRVLDLSENFIEEVPTSVENLIHLRYLNLSRNKIKVQPDAITRLQN
LRYLNLTENPLQELPKKLRNMQSLCYLHCDCDYLTHMPPGLSRLTNLRSL
SCFVAGNRTGSCSIIELEDLKLHGQMEIKFSGNFTNYSCGGRKILKNKDF
NELSLLFNCSDTNDMSMLEDLCPNTSLKKLKVSNYGSQQFPTWLIESQLP
NLVEVVLEKCYKCQHIPHFGDLQFLRSLVIDTMHEVRHIGVELHGHCGFP
SLQELKLIRISNLEEWSEDEGGVNELFPLLKRLEICNCPKLKNMPRLPRI
ELLNLRNCNESLVSGFGRMTSLSHLILEDMEGMRSLPIGCLRNLTFLKEL
EIRRCNELESLPMDELQLLTMVHSLSIEECNNLASFPLEVERVSSLRYLC
FKNVDSNALQSEILVEILNSLNEFDIQICGKKVNLGGQLQHLHTLRQLWI
SDSHHFSYDMKISGSIQANLSICCCDELESLMTEAPSTSVLEDLHICDIP
NLKTLPEWLQHLGSLHQLSIRNCPQLESLPRSLQGLRLLNSLLIDECSLQ
LERRCKRETGEDWPSISHVPHIDISTRVIYETQCCGPFFRVDRTRSREV
>XP_042474101.1 putative disease resistance protein RGA4 [Zingiber officinale]
MAMEVALATSAVRFLGQRVADLLQLDKKLKELVGIEGRMEKLKELSTIID
AVIQDVEVCSVRDATAKDLLRKLKYLAYDLEDVVDYYDTETLRKQRSKAY
SRPVRDFFSSNNNQLVFKSRISGMIKAVRKNLDSILKQKSILENLPQGTN
RISPSAYREIHSHNSLVVVGRETEKKMIVNMLTDDEGSSSGTLKVIAIVG
MGGLGKTTLARHVFNDERVKAYFRKLRMWKVVGAEFDLTKIMKSILELAT
DAPVKISEAESVRRKLEKALSEKRFLLVLDDVWNEDALQWMALEAALSCG
ARGSKVLLTTRSREVSSIMGSFNTHQMQQLSRDDCLSLFQQFAFGDEEPN
KKLMEIAGKIVEKCGGVC
>XP_042474102.1 putative disease resistance protein RGA4 [Zingiber officinale]
MEPALLTAVSLFMGPWVADLNKKLKEVVGIEGRMAKLRELSTIIDAVIQD
VEACSVRDATAKDLLRKLKYLAYDLEDVVDYYDTETLRKQRSKAYSRPVR
DFFSSNNNQLVFKSKISGMIKAVTENLDSILLQRSILLNLPQGTVRMSPI
AYREIHSHNSLAVIGRDTEKEMIIKMLTDEEGSSNGTMKVIAIVGMGGLG
KTTLARHVFKDERVKTHFGELNMYWKVVGEEFDPTKIMKSIFELATGAPV
NISEPELVKRELEKALLEKRFLLVLDDVWNEDKSQWTALEAALTCGARGS
KVLVTTRSREVSSIMGSFNTHQIQQLSRDDCLSLFRRFAFGDEEPNKNLM
KIGEKIVEKCGGVPLAAVSLGSTLHSIRDETYWSSVLNSEIWQLGDEGEK
FLAVLKLSYDALPPRSKKCFAFASLFPKNRMMSKDELIQLWTANGFASSE
GNFDAETVGNRIFDDLVLRAFFLLAPSKECDECTMHDLMHELGRSVAEDE
YHNRNDYKKKENIKITDHLFKKPLYLRTLLLRNCFPFGKFQLLQLVFSKL
KFLRALDLSKNGFTEVPTSVGNLIHLRYLNLSDNCIKFLPDAITLLQNLQ
YLNFTKNPLEELPKKLRNMQSLRYLDFDLYKLTHMPLGLSRLTSLRSLSC
FVSDDNITGSCSITELEDLKLHGKMKIKFSGNFSNYSCGGRKILKNKDFN
ELSLSFNYSVTNDMSMLDDLCPNTSLKKLQISKYGSQQFPTWFMKSQLPN
LVEVILEDCKICEHIPHFGNLQFLRKLVLDDIGGVKHLGAEFHGHGGFPS
LQKLELLSMFDLEEWSESDSVDELFPLLNKLQIDDCPKLETVPRLPRIKQ
LALFNCSKSLMSGVGRMTSLSHLILEGMKDMTYLPSGCLRNLTSLMTLEI
RGCNELQFLPWDEMQLLPKLHSLSIKKCDNLCLKNHDSDTLQLDMLVQIL
NSVHEFDIQIRGKNVNSSFFSQNNVQSHQGIIKYLLL
>XP_042474103.1 putative disease resistance protein RGA4 [Zingiber officinale]
MEPALLTAVSLFMGPWVADLNKKLKEVVGIEGRMAKLRELSTIIDAVIQD
VEACSVRDATAKDLLRKLKYLAYDLEDVVDYYDTETLRKQRSKAYSRPVR
DFFSSNNNQLVFKSKISGMIKAVTENLDSILLQRSILLNLPQGTVRMSPI
AYREIHSHNSLAVIGRDTEKEMIIKMLTDEEGSSNGTMKVIAIVGMGGLG
KTTLARHVFKDERVKTHFGELNMYWKVVGEEFDPTKIMKSIFELATGAPV
NISEPELVKRELEKALLEKRFLLVLDDVWNEDKSQWTALEAALTCGARGS
KVLVTTRSREVSSIMGSFNTHQIQQLSRDDCLSLFRRFAFGDEEPNKNLM
KIGEKIVEKCGGVPLAAVSLGSTLHSIRDETYWSSVLNSEIWQLGDEGEK
FLAVLKLSYDALPPRSKKCFAFASLFPKNRMMSKDELIQLWTANGFASSE
GNFDAETVGNRIFDDLVLRAFFLLAPSKECDECTMHDLMHELGRSVAEDE
YHNRNDYKKKENIKITDHLFKKPLYLRTLLLRNCFPFGKFQLLQLVFSKL
KFLRALDLSKNGFTEVPTSVGNLIHLRYLNLSDNCIKFLPDAITLLQNLQ
YLNFTKNPLEELPKKLRNMQSLRYLDFDLYKLTHMPLGLSRLTSLRSLSC
FVSDDNITGSCSITELEDLKLHGKMKIKFSGNFSNYSCGGRKILKNKDFN
ELSLSFNYSVTNDMSMLDDLCPNTSLKKLQISKYGSQQFPTWFMKSQLPN
LVEVILEDCKICEHIPHFGNLQFLRKLVLDDIGGVKHLGAEFHGHGGFPS
LQKLELLSMFDLEEWSESDSVDELFPLLNKLQIDDCPKLETVPRLPRIKQ
LALFNCSKSLMSGVGRMTSLSHLILEGMKDMTYLPSGCLRNLTSLMTLEI
RGCNELQFLPWDEMQLLPKLHSLSIKKCDNLCLKNHDSDTLQLDMLVQIL
NSVHEFDIQIRGKNVNSSFFSQNNVQSHQGIIKYLLL
>XP_042474104.1 putative disease resistance protein RGA4 [Zingiber officinale]
MEPALLTAVSLFMGPWVADLNKKLKEVVGIEGRMAKLRELSTIIDAVIQD
VEACSVRDATAKDLLRKLKYLAYDLEDVVDYYDTETLRKQRSKAYSRPVR
DFFSSNNNQLVFKSKISGMIKAVTENLDSILLQRSILLNLPQGTVRMSPI
AYREIHSHNSLAVIGRDTEKEMIIKMLTDEEGSSNGTMKVIAIVGMGGLG
KTTLARHVFKDERVKTHFGELNMYWKVVGEEFDPTKIMKSIFELATGAPV
NISEPELVKRELEKALLEKRFLLVLDDVWNEDKSQWTALEAALTCGARGS
KVLVTTRSREVSSIMGSFNTHQIQQLSRDDCLSLFRRFAFGDEEPNKNLM
KIGEKIVEKCGGVPLAAVSLGSTLHSIRDETYWSSVLNSEIWQLGDEGEK
FLAVLKLSYDALPPRSKKCFAFASLFPKNRMMSKDELIQLWTANGFASSE
GNFDAETVGNRIFDDLVLRAFFLLAPSKECDECTMHDLMHELGRSVAEDE
YHNRNDYKKKENIKITDHLFKKPLYLRTLLLRNCFPFGKFQLLQLVFSKL
KFLRALDLSKNGFTEVPTSVGNLIHLRYLNLSDNCIKFLPDAITLLQNLQ
YLNFTKNPLEELPKKLRNMQSLRYLDFDLYKLTHMPLGLSRLTSLRSLSC
FVSDDNITGSCSITELEDLKLHGKMKIKFSGNFSNYSCGGRKILKNKDFN
ELSLSFNYSVTNDMSMLDDLCPNTSLKKLQISKYGSQQFPTWFMKSQLPN
LVEVILEDCKICEHIPHFGNLQFLRKLVLDDIGGVKHLGAEFHGHGGFPS
LQKLELLSMFDLEEWSESDSVDELFPLLNKLQIDDCPKLETVPRLPRIKQ
LALFNCSKSLMSGVGRMTSLSHLILEGMKDMTYLPSGCLRNLTSLMTLEI
RGCNELQFLPWDEMQLLPKLHSLSIKKCDNLCLKNHDSDTLQLDMLVQIL
NSVHEFDIQIRGKNVNSSFFSQNNVQSHQGIIKYLLL
>XP_042474105.1 putative disease resistance protein At3g14460 [Zingiber officinale]
MELESLQKILHQHIAQKKFLLFLDDVWSDNKNIWHKFCALLKVGAHGSKI
IVTTRDMKVSKMVSLVEPILLHGLDEVAFRQLFNKCSFGTLDPEDYPELQ
DIGRNIADKLKGSPLAAKTLGSVLQSDLCQQHWDTIMKSDIWKVKQDEDD
IMPALHLSYKYLNENLKQCFAFCPLFPKDYKFDKAELVRMWMAEGFIEDT
NTKRMEDVGSDYFLEFVNRAFFQKYKFGGFVMHDLIHDLAEMISAEETCS
IENNRQTKMFSTIRHLRVEGKLPLEVSGYDKLHTLMLRKNSPSDSLFEKL
RSIRILNVSQCGLQELSEHIGKLIHLRYLDISWNSEIKILPDSLCHLHNL
QTLEILGCHKLESIPQELSKKMVNVRHINANNKFWGMIKDVQRLTNLQEL
PTFSVQEDDGLRLVQLKDLAQLHGTLHIENLENVVDSKEVQHAELKNKVH
LTELVLEWNHQKDAKLEEEVIEGLQPHESLKILTISGYKGAKSPSWLMPK
VLSNLEKLELVNCMGWDDVLPFIGQRLHLIELHMDGMPALKQLSHEFEGK
CFPKLKVLNLWNLPALEEWSWTEGKDLFPCMRELRVWKCPKLKRLPPFPP
SLEILTIEDCPELKLNSKTEDDEEGGCYLPPSLKVLELDNCGEYSKLLPE
CLPNLRLVTRLTIRHCPHITSIPPVQLVELQFLYISNCDELRRMECLGLL
KSLERLQIAGCPMLVQLDVEDEQAASLLSSLRKLCVDNTALLKMSPLRHS
LPFITELVIESCSEEVIFEEAILVRSLTAVTSLRFLRCDKLRSLPAELLH
CLPFLKTLMVSNCPQLQSLPEMGLSPFLERLEIYNCPQIQAMPEDGLPMS
LDVFICSGDVHPKLREQSEKFFVDRYNRRVSTLDARYFHA
>XP_042474107.1 putative disease resistance protein RGA4 [Zingiber officinale]
MEPALLTAVSLFMGPWVADLNKKLKEVVGIEGRMAKLRELSTIIDAVIQD
VEACSVRDATAKDLLRKLKYLAYDLEDVVDYYDTETLRKQRSKAYSRPVR
DFFSSNNNQLVFKSKISGMIKAVTENLDSILLQRSILLNLPQGTVRMSPI
AYREIHSHNSLAVIGRDTEKEMIIKMLTDEEGSSNGTMKVIAIVGMGGLG
KTTLARHVFKDERVKTHFGELNMYWKVVGEEFDPTKIMKSIFELATGAPV
NISEPELVKRELEKALLEKRFLLVLDDVWNEDKSQWTALEAALTCGARGS
KVLVTTRSREVSSIMGSFNTHQIQQLSRDDCLSLFRRFAFGDEEPNKNLM
KIGEKIVEKCGGVPLAAVSLGSTLHSIRDETYWSSVLNSEIWQLGDEGEK
FLAVLKLSYDALPPRSKKCFAFASLFPKNRMMSKDELIQLWTANGFASSE
GNFDAETVGNRIFDDLVLRAFFLLAPSKECDECTMHDLMHELGRSVAEDE
YHNRNDYKKKENIKITDHLFKKPLYLRTLLLRNCFPFGKFQLLQLVFSKL
KFLRALDLSKNGFTEVPTSVGNLIHLRYLNLSDNCIKFLPDAITLLQNLQ
YLNFTKNPLEELPKKLRNMQSLRYLDFDLYKLTHMPLGLSRLTSLRSLSC
FVSDDNITGSCSITELEDLKLHGKMKIKFSGNFSNYSCGGRKILKNKDFN
ELSLSFNYSVTNDMSMLDDLCPNTSLKKLQISKYGSQQFPTWFMKSQLPN
LVEVILEDCKICEHIPHFGNLQFLRKLVLDDIGGVKHLGAEFHGHGGFPS
LQKLELLSMFDLEEWSESDSVDELFPLLNKLQIDDCPKLETVPRLPRIKQ
LALFNCSKSLMSGVGRMTSLSHLILEGMKDMTYLPSGCLRNLTSLMTLEI
RGCNELQFLPWDEMQLLPKLHSLSIKKCDNLCLKNHDSDTLQLDMLVQIL
NSVHEFDIQIRGKNVNSSFFSQNNVQSHQGIIKYLLL
>XP_042474108.1 putative disease resistance protein RGA4 [Zingiber officinale]
MEPALLTAVSLFMGPWVADLNKKLKEVVGIEGRMAKLRELSTIIDAVIQD
VEACSVRDATAKDLLRKLKYLAYDLEDVVDYYDTETLRKQRSKAYSRPVR
DFFSSNNNQLVFKSKISGMIKAVTENLDSILLQRSILLNLPQGTVRMSPI
AYREIHSHNSLAVIGRDTEKEMIIKMLTDEEGSSNGTMKVIAIVGMGGLG
KTTLARHVFKDERVKTHFGELNMYWKVVGEEFDPTKIMKSIFELATGAPV
NISEPELVKRELEKALLEKRFLLVLDDVWNEDKSQWTALEAALTCGARGS
KVLVTTRSREVSSIMGSFNTHQIQQLSRDDCLSLFRRFAFGDEEPNKNLM
KIGEKIVEKCGGVPLAAVSLGSTLHSIRDETYWSSVLNSEIWQLGDEGEK
FLAVLKLSYDALPPRSKKCFAFASLFPKNRMMSKDELIQLWTANGFASSE
GNFDAETVGNRIFDDLVLRAFFLLAPSKECDECTMHDLMHELGRSVAEDE
YHNRNDYKKKENIKITDHLFKKPLYLRTLLLRNCFPFGKFQLLQLVFSKL
KFLRALDLSKNGFTEVPTSVGNLIHLRYLNLSDNCIKFLPDAITLLQNLQ
YLNFTKNPLEELPKKLRNMQSLRYLDFDLYKLTHMPLGLSRLTSLRSLSC
FVSDDNITGSCSITELEDLKLHGKMKIKFSGNFSNYSCGGRKILKNKDFN
ELSLSFNYSVTNDMSMLDDLCPNTSLKKLQISKYGSQQFPTWFMKSQLPN
LVEVILEDCKICEHIPHFGNLQFLRKLVLDDIGGVKHLGAEFHGHGGFPS
LQKLELLSMFDLEEWSESDSVDELFPLLNKLQIDDCPKLETVPRLPRIKQ
LALFNCSKSLMSGVGRMTSLSHLILEGMKDMTYLPSGCLRNLTSLMTLEI
RGCNELQFLPWDEMQLLPKLHSLSIKKCDNLCLKNHDSDTLQLDMLVQIL
NSVHEFDIQIRGKNVNSSFFSQNNVQSHQGIIKYLLL
>XP_042474109.1 putative disease resistance protein RGA4 [Zingiber officinale]
MIASPFLSIFCFCFCFSFPLLSSSSNVSCSHIHSKQTTRPSFQLAGIAME
PLAISAAGFLGQRLVSLLQLDKKLKDLVDIERKMEKLKELPTIIDTVIQY
VEACSVRDAAVKKLLRNLKHLAYDLEDVVDYYDTKALRKQRSRSYSRPVR
DFFSFNNNQLVFKSRISGMIKAVTENLDSILLDKAILENLPQGTNRISQS
AYREFHSHNSLAVIGRETEKEMIINMLTDEEGSSNSTTTKVIAIVGMGGL
GKTTLARHVFNDERVKAHFGKLNTYWKVVGAEFDPTKIMKSILELATGAP
VNISEPELVKRELEKALSEKRFLLVLDDVWNEDKSQWTALEAVLTCGARG
SKVLVTTRSPKVSSIMGSFNTHQIQQLPRDDCLSLFQQFAFGDEEPNENL
MEIGGKIVEKCGGVPLAAKSLGSMLHSTRDETYWSSVLNSEVWQLGDEGE
KFLAVLKLSYDALPLRSKKCFAFGSLFPKNYVMKKDELIQLWTANGFVCS
EGNFNAETDGNRIFDDLVLRSFFLLAPPKKCDDDGRHVTECTMHDLMHDL
ARSISEDEYYNDVDDEEKDIQKRTYHIWLKYEEISHTSLFKMPLYLRTLS
LRSCLSFKKAHLLQFVFSKLKLLRVLDLSENGIEEVPTSIGNLIHLRYLT
LSGNRIKFLPDAITLLQNLRYLSLIDNPLQQLPKKLRNMQSLGYLHCDCY
YLTHMPLGLSRLTSLRSLSCYVSDDNRTGSCSITELEDLKLHGNMRIKFS
KNSSNYSCGGRKILKNKNFNELSLSFNCSETNDMSMLDDLCPNMNLKKLK
ISYYGSRQFPTWLMEPQLPNLVEVILNYSYTCEHVPPFGNLQSLRKLAMI
RMDNVKRMGAEFHGHGPIRGFPSLQELQLEWMRNLEEWSESDGADELFPL
LKTLKILNCPKLKTMPRFPTIEFLNLDNCSESLVSCVRRMTSLSHLILEG
MKGMTSLPSGCLRNLTSLMRLEILSCNELQFLPRDEMQLLTMVHSLSIEK
CNNLTSFPLEMGRLGALRYLCLKNPDNNTLAPNNGSPIVQILNSVHEFDI
QICGKNVNLLGQLQHLHTLRELTISGSHDTTYGPAIMGYIIRASLSICCC
DELESLMTTAPSTSVLEILGIFDIPNLTILPEWLRHLGSLDMLWIRNCPQ
LGSLPRGLQELRSLNILRIDGCCLQLKRRCKRETGEDWPNISHVSLIRIS
PRDEAQRCRPFDRFFKINPTRWREI
>XP_042474790.1 putative disease resistance protein RGA3 isoform X1 [Zingiber officinale]
MEFLTAVVPLLASNLAHMRQELQTVYGLHVELGRLQNSVSMIQAVLSEAQ
ENEQSRNAVKHLLPELSQAAYEANDALDDVATEWQRCQLIKYASVRNFLA
PVNPKREKFKREMGIRLREIENRLSYIASRCPLHNLHSGSPRLYGYQTTS
LSPPRLLGREFDKQKLKELLIPLNEVTGSGVSVIPIFGMPGVGKTTLAQL
VCNDESVKDHFELRLWVNVSRDFDLVRIMSTIIEFIDGFQCDLVTLSDLQ
NEITKKLSGKRCLLVLDDVWQESQEWERLKSFLYSADEGSKILVTTKSEQ
VAAFMATNSPPYHLEGLSRDDCWSLICQYAFARDPTATFALEGYRILAVS
KCKGFPLAAIALGQRLFREADRSKWGAILRSNSSPLPLSSGLSGADGSIM
DAFSLSYQNFPQYLKSCLAYFSMIPKGSEFEKDFIIQLWMAQSFIQTRGD
EQVEDIANDYFDSLVQSSFLQYSRFDHKSHQHRYMVQDVFHECARCIAAE
ECSNMEPGLDLHVAASLRHLSVNYEQFAASFPWFQGHSYLYEEVYKCKGL
QSLLLIGNSTNGPTMVVPDDLAKKLSSLRTLMLTNLCLNQLPESIGDLKH
LRCLQLQNTSIKRLPESVSYLYNLQTLGLRNCYRLKELPKDTRNLLNLRH
LDLHLDQNSRVSLAPEDTNTSGELRCMPPEIGSLTHLRTLPRFIVSTRPE
CGLSQLRYLNNLRGELAIERLDLVFGVGEAVEANLSSKEHIHRLELTWKY
NNLTEAVAQSVGNDSRETILKYLRPHSNLREIGIVGYGGAMFPTWMGDSS
FYNLETVQISQTYNCLNLPPLGQLPKLKYLFLKEMHGLKCMDCSLCGKNK
TRFPALETLHLENMSGLQEWWGDDDCTLLSLRELRIKNCMALDQLRHKLP
SLERLVIEASRNFVGLQDFPELKSLEVKTNDDWIWSSWPVMSLLPSLTLS
GLQRRTLPFYVEGRHALIRRLEISSCSQLLSLPDAWLPAGLSDFAVRHCS
ELQHLPKGLTELRELEHLEIENCKRLKYLPVGLRNMNSLTYLEVSDCPGL
LCLPTDGFPANLRFLGISNCPELRQQCQGMGDQGWFDLQHGLRVWIDGRL
VSFSGHRHPHAPEAPTTFRTVIV
>XP_042474791.1 putative disease resistance protein RGA3 isoform X2 [Zingiber officinale]
MEFLTAVVPLLASNLAHMRQELQTVYGLHVELGRLQNSVSMIQAVLSEAQ
ENEQSRNAVKHLLPELSQAAYEANDALDDVATEWQRCQLIKYASVRNFLA
PVNPKREKFKREMGIRLREIENRLSYIASRCPLHNLHSGSPRLYGYQTTS
LSPPRLLGREFDKQKLKELLIPLNEVTGSGVSVIPIFGMPGVGKTTLAQL
VCNDESVKDHFELRLWVNVSRDFDLVRIMSTIIEFIDGFQCDLVTLSDLQ
NEITKKLSGKRCLLVLDDVWQESQEWERLKSFLYSADEGSKILVTTKSEQ
VAAFMATNSPPYHLEGLSRDDCWSLICQYAFARDPTATFALEGYRILAVS
KCKGFPLAAIALGQRLFREADRSKWGAILRSNSSPLPLSSGLSGADGSIM
DAFSLSYQNFPQYLKSCLAYFSMIPKGSEFEKDFIIQLWMAQSFIQTRGD
EQVEDIANDYFDSLVQSSFLQYSRFDHKSHQHRYMVQDVFHECARCIAAE
ECSNMEPGLDLHVAASLRHLSVNYEQFAASFPWFQGHSYLYEEVYKCKGL
QSLLLIGNSTNGPTMVVPDDLAKKLSSLRTLMLTNLCLNQLPESIGDLKH
LRCLQLQNTSIKRLPESVSYLYNLQTLGLRNCYRLKELPKDTRNLLNLRH
LDLHLDQNSRVSLAPEDTNTSGELRCMPPEIGSLTHLRTLPRFIVSTRPE
CGLSQLRYLNNLRGELAIERLDLVFGVGEAVEANLSSKEHIHRLELTWKY
NNLTEAVAQSVGNDSRETILKYLRPHSNLREIGIVGYGGAMFPTWMGDSS
FYNLETVQISQTYNCLNLPPLGQLPKLKYLFLKEMHGLKCMDCSLCGKNK
TRFPALETLHLENMSGLQEWWGDDDCTLLSLRELRIKNCMALDQLRHKLP
SLERLVIEASRNFVGLQDFPELKSLEVKTNDDWIWSSWPVMSLLPSLTLS
GLQRRTLPFYVEGRHALIRRLEISSCSQLLSLPDAWLPAGLSDFAVRHCS
ELQHLPKGLTELRELEHLEIENCKRLKYLPVGLRNMNSLTYLEVSDCPGL
LCLPTDGFPANLRFLGISNCPELRQQCQGMGDQGWFDLQHGLRVWIDGRL
VSFSGHRHPHAPEAPTTFS
>XP_042474792.1 putative disease resistance protein RGA3 [Zingiber officinale]
MEFVSMFLLDALVNTLADTLQDHVFQELQKVHRVGDELVKLQKSVSSIQA
VLSDAQESEETRNIVKQLLNELRDVAYRANDILDDVATEQQRQQLINYAP
VRNFFGPVNLMRLLFQRDVYHKIQSIDEELDKIVKRCPLIALSPRNRSQR
THSSESTPAIPPCVLGRERDKQKIKELLVPFSGRTDSAASVISIFGMPGV
GKTTLAQQLFDDETVKKHFELRLWVYVSHDFDLMRIMRCMIESIDGFKCD
LTSLNNLQQEVRKKVSRRRYLLVLDNVWQESQEWEKLKSFLYSADEGSKI
LVTTKSEQVARFMAANSPPYHLEGLSMDDCWSLICQQVLSRNPSATFTHD
FSQSHALRRCMGLPMAAKALGERLAREADRSKWEAILTSQSWEFSGAGIS
ITETLSLSYQHLPHYLKPCFEYLSIIPKGFKLERDFIIQLWMAQSFIRPK
GTEHMEDVGSDYLDSLRSSSFLQYSHFDHKSRRQRYVMHDVFHEFARHVA
AEECSVMEPSTEPSTDLHLSLSARVRHLSVNYEELVRRVPRGGDMYEQVY
KCKGLQSLLLIGNSTSRPTMVVPDNLAQRLRSLRTLMLTNSCLTQLPESI
GDLSHLRCLQLQNTGIKRLPDSVSRLYNLQTLGLRNCYDLEELPKDMSKL
RNLRHLDLHLDGNSQGSNAGGKLRLMPPEIGLLTHLRTLSRFVVSKRHEC
GLSQLENLNDLRSDLLIERLDLVSSGEDAKNANLWSKEHIHRLELTWNYS
DVTEASASSAGYNSRENILKYLRPHNKLKEIGVVGYGGTLLPTWMGDSSL
ENLETVWISKTYSCQNLPPLGQLPKLKYLFLEEMHGLKHIDCSFCGRNEI
RFPKLEKLHLENMSGLQEWLGDHRCALPSLRELTINNCPALQQLTHELPS
LTKLVIEASPYFAGLPDFPKLQSLEVKTNDDWIWRSCATISSLPSLTLSG
LRRANLPSEISSCHSFIRRLEISYCSQLIFIPDGWLPAFLSHFVIRHCPK
LQNLPAELTRLTRLEDLEIEKCEKLEQLPFGLRNMNLLAHLEISDCPGLS
WLHGLPRNLQFLSISNCPELSQKLQDQGWFTRRKDLQVWINGHRLDFMKI
SH
